<SEC-DOCUMENT>0001628279-25-000230.txt : 20250717
<SEC-HEADER>0001628279-25-000230.hdr.sgml : 20250717
<ACCEPTANCE-DATETIME>20250418172846
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001628279-25-000230
CONFORMED SUBMISSION TYPE:	DRS/A
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20250418
<PUBLIC-REL-DATE>20250717
DATE AS OF CHANGE:		20250418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Heartflow, Inc.
		CENTRAL INDEX KEY:			0001464521
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				260506743
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-07711
		FILM NUMBER:		25851088

	BUSINESS ADDRESS:	
		STREET 1:		331 E EVELYN AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94041
		BUSINESS PHONE:		650-241-1221

	MAIL ADDRESS:	
		STREET 1:		331 E EVELYN AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardiovascular Simulation, Inc.
		DATE OF NAME CHANGE:	20090519
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html><head><title>HeartFlow, Inc. - DRS/A #2</title></head><body><div style="background-color: #E4E4E4; font-family: Arial, Sans Serif; word-wrap: break-word;"><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 783pt;"><div style="width: 594pt;"></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 594pt;"><div style="line-height: 7.28pt; position: absolute; top: 0pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 603pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 36pt;"></font></font><font style="left: 639pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 36pt;"></font></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_679" style="position: absolute; top: 9pt;"></div><div style="line-height: 5.46pt; position: absolute; top: 9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">Confidential Draft Submission No. 3 as confidentially submitted to the U.S. Securities and Exchange Commission on April 18, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 17.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 34.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 505.18pt; position: absolute; text-decoration: none; white-space: pre;">Registration No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="position: absolute; top: 46.4pt; width: 612pt;"><div style="font-size: 0pt; left: 9pt; position: absolute; top: 0pt; width: 594pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 594pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 57.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 266.32pt; position: absolute; text-decoration: none; white-space: pre;">UNIT<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 289.63pt; position: absolute; text-decoration: none; white-space: pre;">ED STAT<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 332.36pt; position: absolute; text-decoration: none; white-space: pre;">ES<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 72.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 199.98pt; position: absolute; text-decoration: none; white-space: pre;">SECURITIES AND EXCHANGE COMMISSION<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 249.38pt; position: absolute; text-decoration: none; white-space: pre;">Washington, D.C. 20549<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 99.4pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 11.64pt; position: absolute; top: 115.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 267.8pt; position: absolute; text-decoration: none; white-space: pre;">FORM S-1<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 16pt; line-height: 11.64pt; position: absolute; top: 134.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 194.49pt; position: absolute; text-decoration: none; white-space: pre;">R<font style="display: inline-block; height: 11.64pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 206.04000000000002pt; position: absolute; text-decoration: none; white-space: pre;">EGISTRATION STATEM<font style="display: inline-block; height: 11.64pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 385.52pt; position: absolute; text-decoration: none; white-space: pre;">ENT<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 153.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 288.23pt; position: absolute; text-decoration: none; white-space: pre;">UNDER<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 165.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 232.17pt; position: absolute; text-decoration: none; white-space: pre;">THE SECURITIES ACT OF 1933<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 180.8pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 16.01pt; position: absolute; top: 196.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 22pt; font-style: normal; font-weight: bold; left: 230.85pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow, Inc.<font style="display: inline-block; height: 16.01pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 219.93pt; position: absolute; text-decoration: none; white-space: pre;">(Exact name of registrant as specified in its charter)<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="position: absolute; top: 234.6pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="position: absolute; top: 250.6pt; width: 612pt;"><div style="font-size: 0pt; left: 9pt; position: absolute; top: 0pt; width: 594pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 83.64pt; position: absolute; text-decoration: none; white-space: pre;">Delaware<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 0pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 91.22pt; position: absolute; text-decoration: none; white-space: pre;">3841<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396pt; position: absolute; top: 0pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 80.33pt; position: absolute; text-decoration: none; white-space: pre;">26-0506743<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 18pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 11.25pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 51.03pt; position: absolute; text-decoration: none; white-space: pre;">(State or other jurisdiction of<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 11.03pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 49.09pt; position: absolute; text-decoration: none; white-space: pre;">incorporation or organization)<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 11.25pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 51.99pt; position: absolute; text-decoration: none; white-space: pre;">(Primary Standard Industrial<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 11.03pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 51.21pt; position: absolute; text-decoration: none; white-space: pre;">Classification Code Number)<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 396pt; position: absolute; top: 11.25pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 72.2pt; position: absolute; text-decoration: none; white-space: pre;">(I.R.S. Employer<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 11.03pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 61.9pt; position: absolute; text-decoration: none; white-space: pre;">Identification Number)<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="position: absolute; top: 284.85pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 5.09pt; position: absolute; top: 295.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 270.05pt; position: absolute; text-decoration: none; white-space: pre;">331 E. Evelyn Avenue<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.09pt; position: absolute; top: 304.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 252.77pt; position: absolute; text-decoration: none; white-space: pre;">Mountain View, California 94041<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.09pt; position: absolute; top: 312.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 282.08pt; position: absolute; text-decoration: none; white-space: pre;">(650) 241-1221<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 321.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 113.13pt; position: absolute; text-decoration: none; white-space: pre;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="position: absolute; top: 332.45pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.09pt; position: absolute; top: 347.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 273.18pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 355.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 243.64pt; position: absolute; text-decoration: none; white-space: pre;">President and Chief Executive Officer <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 364.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 282.11pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow, Inc.<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 372.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 270.05pt; position: absolute; text-decoration: none; white-space: pre;">331 E. Evelyn Avenue<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 381.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 252.77pt; position: absolute; text-decoration: none; white-space: pre;">Mountain View, California 94041<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="line-height: 5.09pt; position: absolute; top: 389.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 282.08pt; position: absolute; text-decoration: none; white-space: pre;">(650) 241-1221 <font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.09pt; position: absolute; top: 397.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 137.99pt; position: absolute; text-decoration: none; white-space: pre;">(Name, address, including zip code, and telephone number, including area code, of agent for servi<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 463.90000000000003pt; position: absolute; text-decoration: none; white-space: pre;">ce)<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="position: absolute; top: 409.25pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.09pt; position: absolute; top: 417.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: italic; font-weight: bold; left: 288.91pt; position: absolute; text-decoration: none; white-space: pre;">Copies to&#58;<font style="display: inline-block; height: 5.09pt;"></font></font></div><div style="position: absolute; top: 425.65pt; width: 612pt;"><div style="font-size: 0pt; left: 9pt; position: absolute; top: 0pt; width: 594pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 0pt; overflow: hidden; position: absolute; top: 0pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 75.1pt; position: absolute; text-decoration: none; white-space: pre;">Shelly Heyduk<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 198pt; overflow: hidden; position: absolute; top: 0pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 74.52pt; position: absolute; text-decoration: none; white-space: pre;">Angela Ahmad<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 0pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 75.1pt; position: absolute; text-decoration: none; white-space: pre;">Dave Peinsipp<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 0pt; overflow: hidden; position: absolute; top: 9pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 75.49pt; position: absolute; text-decoration: none; white-space: pre;">Ryan Coombs<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 198pt; overflow: hidden; position: absolute; top: 9pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 75.11pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow, Inc.<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 9pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 68.89pt; position: absolute; text-decoration: none; white-space: pre;">Kristin VanderPas<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 0pt; overflow: hidden; position: absolute; top: 18pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 59.36pt; position: absolute; text-decoration: none; white-space: pre;">O&#8217;Melveny &#38; Myers LLP<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 198pt; overflow: hidden; position: absolute; top: 18pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 63.05pt; position: absolute; text-decoration: none; white-space: pre;">331 E. Evelyn Avenue<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 18pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 79.77pt; position: absolute; text-decoration: none; white-space: pre;">Denny Won<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 0pt; overflow: hidden; position: absolute; top: 27pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 37.61pt; position: absolute; text-decoration: none; white-space: pre;">610 Newport Center Drive, 17th Floor<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 198pt; overflow: hidden; position: absolute; top: 27pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 45.77pt; position: absolute; text-decoration: none; white-space: pre;">Mountain View, California 94041<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 27pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 74.33pt; position: absolute; text-decoration: none; white-space: pre;">Charles S. Kim<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 0pt; overflow: hidden; position: absolute; top: 36pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 44.79pt; position: absolute; text-decoration: none; white-space: pre;">Newport Beach, California 92660<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 198pt; overflow: hidden; position: absolute; top: 36pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 75.08pt; position: absolute; text-decoration: none; white-space: pre;">(650) 241-1221 <font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 36pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 79.77pt; position: absolute; text-decoration: none; white-space: pre;">Cooley LLP<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 0pt; overflow: hidden; position: absolute; top: 45pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 75.08pt; position: absolute; text-decoration: none; white-space: pre;">(949) 823-6900<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 45pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 42.86pt; position: absolute; text-decoration: none; white-space: pre;">3 Embarcadero Center, 20th Floor<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 54pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 46.35pt; position: absolute; text-decoration: none; white-space: pre;">San Francisco, California 94111<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 9pt; left: 396pt; overflow: hidden; position: absolute; top: 63pt; width: 198pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 2.63pt; width: 198pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 75.08pt; position: absolute; text-decoration: none; white-space: pre;">(415) 693-2000<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="position: absolute; top: 505.65pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 521.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">Approximate date of commencement of proposed sale to the public&#58;<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 251.74pt; position: absolute; text-decoration: none; white-space: pre;"> As soon as practicable after the effective date of this Registration Statement.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 530.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.78pt; position: absolute; top: 539.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">box. <font style="display: inline-block; height: 5.78pt;"></font></font><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 25.25pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 548.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.78pt; position: absolute; top: 557.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">registration statement number of the earlier effective registration statement for the same offering. <font style="display: inline-block; height: 5.78pt;"></font></font><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 331.08pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 566.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.78pt; position: absolute; top: 575.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">of the earlier effective registration statement for the same offering. <font style="display: inline-block; height: 5.78pt;"></font></font><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 229.46pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 584.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.78pt; position: absolute; top: 593.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">of the earlier effective registration statement for the same offering. <font style="display: inline-block; height: 5.78pt;"></font></font><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 229.46pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 602.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 540.73pt; position: absolute; text-decoration: none; white-space: pre;">growth<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 563.22pt; position: absolute; text-decoration: none; white-space: pre;"> company. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 611.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="position: absolute; top: 620.65pt; width: 612pt;"><div style="font-size: 0pt; left: 9pt; position: absolute; top: 0pt; width: 593.25pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 269.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 27pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 269.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 27.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 269.25pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 269.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Large accelerated filer<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 269.25pt; position: absolute; top: 0pt; width: 27pt;"><div><div style="line-height: 5.78pt; position: absolute; top: 2.63pt; width: 27pt;"><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 296.25pt; position: absolute; top: 0pt; width: 269.25pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 269.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accelerated filer<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 565.5pt; position: absolute; top: 0pt; width: 27.75pt;"><div><div style="line-height: 5.78pt; position: absolute; top: 2.63pt; width: 27.75pt;"><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 11.25pt; width: 269.25pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 269.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Non-accelerated filer<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 269.25pt; position: absolute; top: 11.25pt; width: 27pt;"><div><div style="line-height: 5.78pt; position: absolute; top: 2.63pt; width: 27pt;"><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#9746;<font style="display: inline-block; height: 5.78pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 296.25pt; position: absolute; top: 11.25pt; width: 269.25pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 269.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Smaller reporting company<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 565.5pt; position: absolute; top: 11.25pt; width: 27.75pt;"><div><div style="line-height: 5.78pt; position: absolute; top: 2.63pt; width: 27.75pt;"><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 296.25pt; position: absolute; top: 22.5pt; width: 269.25pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 269.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Emerging growth company<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 565.5pt; position: absolute; top: 22.5pt; width: 27.75pt;"><div><div style="line-height: 5.78pt; position: absolute; top: 2.63pt; width: 27.75pt;"><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#9746;<font style="display: inline-block; height: 5.78pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 667.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.78pt; position: absolute; top: 676.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <font style="display: inline-block; height: 5.78pt;"></font></font><font style="font-family: &#39;Wingdings&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 284.75pt; position: absolute; text-decoration: none; white-space: pre;">&#9744;<font style="display: inline-block; height: 5.78pt;"></font></font></div><div style="position: absolute; top: 692.4pt; width: 612pt;"><div style="font-size: 0pt; left: 256.12pt; position: absolute; top: 0pt; width: 99.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 99.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 703.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 712.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 721.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">amended, or until the registration statement shall become effective on such date as the U.S. Securities and Exchange Commission, acting pursuant to said Section <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 730.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 9pt; position: absolute; text-decoration: none; white-space: pre;">8(a), may determine.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="position: absolute; top: 742.4pt; width: 612pt;"><div style="font-size: 0pt; left: 9pt; position: absolute; top: 0pt; width: 594pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 594pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 3pt double #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 756pt;"><div style="width: 540pt;"></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 540pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_685" style="position: absolute; top: 36pt;"></div><div style="line-height: 7.28pt; position: absolute; text-align: justify; text-align-last: var(--justify); top: 36pt; width: 612pt;"><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre; width: 539.9pt;">The information in this preliminary prospectus is not complete and may be changed. We may not sell these<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 575.9pt; position: absolute; text-decoration: none; white-space: pre; width: 2.77pt;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; text-align: justify; text-align-last: var(--justify); top: 48pt; width: 612pt;"><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre; width: 539.87pt;">securities until the registration statement filed with the U.S. Securities and Exchange Commission is effective.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 575.87pt; position: absolute; text-decoration: none; white-space: pre; width: 2.77pt;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; text-align: justify; text-align-last: var(--justify); top: 60pt; width: 612pt;"><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre; width: 539.96pt;">This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 575.96pt; position: absolute; text-decoration: none; white-space: pre; width: 2.77pt;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; text-align: justify; text-align-last: var(--justify); top: 72pt; width: 612pt;"><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre; width: 300.86pt;">securities in any jurisdiction where the offer or sale is not perm<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 336.86pt; position: absolute; text-decoration: none; white-space: pre; width: 23.86pt;">itted.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="color: #f1665f; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">Subject to Completion, dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">Preliminary prospectus<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 18pt; line-height: 13.1pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 13.1pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 161pt; position: absolute; text-decoration: none; white-space: pre;">shares<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="position: absolute; top: 169.6pt; width: 612pt;"><div style="left: 36pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 57.27pt; width: 331.2pt;" src="heartflowlogoa.jpg" alt="heartflowlogoa.jpg"></div></div></div><div style="font-size: 18pt; line-height: 13.1pt; position: absolute; top: 239.87pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">Common <font style="display: inline-block; height: 13.1pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 118.96pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 269.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">This <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.65pt; position: absolute; text-decoration: none; white-space: pre;">is<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.87pt; position: absolute; white-space: pre;"> an initial public offering of shares of common stock of Heartflow, Inc. We are offering&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">common stock to be sold in this offering. The initial public offering price is expected to be between $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 293.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">share. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 313.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">Prior to this offering, there has been no public market for our common stock. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.16pt; position: absolute; text-decoration: none; white-space: pre;">We have applied to list our common stock on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 325.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">the Nasdaq Global Select Market under the trading symbol &#8220;HTFL,&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 335.36pt; position: absolute; white-space: pre;">and this offering is contingent upon obtaining such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 337.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">approval.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 357.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">Upon completion of this offering, our executive officers, directors, owners of 5% or more of our capital stock and their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 369.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">respective affiliates will own, in the aggregate, approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our common stock (assuming no exercise of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 381.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">underwriters&#8217; option to purchase additional shares and no purchases of shares in this offering by anyone in this group). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 393.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">These stockholders will be able to exercise significant control over matters requiring stockholder approval, including the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 405.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">election of directors, amendment of our organizational documents, and approval of any merger, sale of assets, and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">major corporate transactions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 437.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">We are an &#8220;emerging growth company&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.91pt; position: absolute; text-decoration: none; white-space: pre;">as<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.47pt; position: absolute; white-space: pre;"> defined under the U.S. federal securities laws and, as such, have elected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">comply with certain reduced public company reporting requirements in this prospectus and may elect to do so in future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 461.47pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">filings. See the section titled &#8220;Prospectus summary&#8212;Implications of being an emerging growth company.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 481.47pt; width: 612pt;"><div style="font-size: 0pt; left: 36.75pt; position: absolute; top: 0pt; width: 538.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.13pt; position: absolute; text-decoration: none; white-space: pre;">Per share<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 473.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.89pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12pt; width: 402pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 402pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Initial public offering price<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 115.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 117.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 118.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 118.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405pt; position: absolute; top: 12pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 473.25pt; position: absolute; top: 12pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 26.25pt; width: 402pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 402pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Underwriting discounts and commissions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 183.74pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 191.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 193.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 194.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 194.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.12pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405pt; position: absolute; top: 26.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 473.25pt; position: absolute; top: 26.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 40.5pt; width: 402pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 402pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Proceeds to Heartflow, Inc., before expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 201.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 203.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 204.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.09pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405pt; position: absolute; top: 40.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 473.25pt; position: absolute; top: 40.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 544.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54pt; position: absolute; text-decoration: none; white-space: pre;">See the section titled &#8220;Underwriting&#8221; for a description of the compensation payable to the underwriters.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">We have granted the underwriters an option for a period of 30 days to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; white-space: pre;">common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">Investing in our common stock involves a high degree of risk. Please see &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 391.28pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">Risk factors</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 448.49pt; position: absolute; white-space: pre;">&#8221; beginning on page <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 547.79pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">20</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 558.91pt; position: absolute; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">Neither the Securities and Exchange Commission (&#8220;SEC&#8221;) nor any state securities commission has approved or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">disapproved of these securities&#160;or determined if this prospectus is truthful or complete. Any representation to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 36pt; position: absolute; white-space: pre;">the contrary is a criminal offense.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.22pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">The underwriters expect to deliver the shares of common stock to the purchasers on or about&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 679.22pt; width: 612pt;"><div style="font-size: 0pt; left: 37.12pt; position: absolute; top: 0pt; width: 537.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 165.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 20.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 165.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 20.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 165.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 165.75pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 165.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">J.P. Morgan<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 186pt; position: absolute; top: 0pt; width: 165.75pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 165.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 23.35pt; position: absolute; text-decoration: none; white-space: pre;">Morgan Stanley<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 372pt; position: absolute; top: 0pt; width: 165.75pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 165.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 60.04pt; position: absolute; text-decoration: none; white-space: pre;">Piper Sandler<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="position: absolute; top: 712.47pt; width: 612pt;"><div style="font-size: 0pt; left: 37.12pt; position: absolute; top: 0pt; width: 537.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 179.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 179.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 179.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 179.25pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 179.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stifel<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 358.5pt; position: absolute; top: 0pt; width: 179.25pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 179.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 39.15pt; position: absolute; text-decoration: none; white-space: pre;">Canaccord Genuity<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 742.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 88.63pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.89pt; position: absolute; text-decoration: none; white-space: pre;">i<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_688" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Table of contents<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="position: absolute; top: 107.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 432.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 35.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 0pt; width: 35.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.13pt; position: absolute; text-decoration: none; white-space: pre;">Page<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 18.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_691">Prospectus summary</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 96.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 98.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 99.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 99.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 18.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.06pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_691">1</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">Risk factors</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 54.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 54.980000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 55.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 55.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 39pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_697">20</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1039">Special note regarding forward-looking statements</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 225.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 227.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 228.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 229.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 229.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.68pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 59.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1039">69</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 79.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1064">Market and industry data</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 112.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 113.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 114.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 114.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 114.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 114.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.89999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 79.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1064">71</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1089">Use of proceeds</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 75.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 77.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 78.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 79.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 79.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 79.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 79.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 99.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1089">72</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 120pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1114">Dividend policy</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 69.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 70.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 70.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 70.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 120pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1114">74</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 140.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1139">Capitalization</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 62.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 63.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 64.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 64.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 64.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.9pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 140.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1139">75</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 160.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1164">Dilution</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 35.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 38.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.720000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 160.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1164">78</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 180.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_533">Management&#8217;s discussion and analysis of financial condition and results of operations</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 381.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 383.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 384.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 384.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 384.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 384.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.77pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 180.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_533">82</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 201pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1189">Business</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 43.190000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 44.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 44.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.940000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 201pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 21.5pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1189">98</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 221.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1233">Management</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 60.980000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 64.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 64.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 64.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 64.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 221.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1233">146</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 241.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1258">Executive and director compensation</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 166.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 168.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 169.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 169.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 241.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1258">155</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 261.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1286">Certain relationships and related-party transactions</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 228.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 229.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 229.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 229.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 261.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1286">162</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 282pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1309">Principal stockholders</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 99.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 100pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 100.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 282pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1309">168</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 302.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1337">Description of capital stock</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 121.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 123.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 124.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 124.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 124.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 124.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 302.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1337">172</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 322.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1360">Shares eligible for future sale</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 132.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 134.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 134.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 134.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 134.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.82999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 322.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1360">179</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 342.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1408">Material U.S. federal income tax consequences to non-U.S. holders</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 300.90999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 303.21999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 304.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 304.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 304.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.71999999999997pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 342.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1408">182</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 363pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1434">Underwriting</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 58.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 59.900000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 59.980000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 60pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 363pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1434">186</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 383.25pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1505">Legal matters</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 64.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 383.25pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1505">198</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 403.5pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1531">Experts</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 36.510000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.400000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 39.690000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 39.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 403.5pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1531">198</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 423.75pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1578">Where you can find additional information</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 186.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 188.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 189.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 189.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 189.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 423.75pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 15.94pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_1578">198</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 6pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 444pt; width: 432.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 432.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_77">Index to consolidated financial statements</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 188.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 189.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 189.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 189.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432.75pt; position: absolute; top: 444pt; width: 35.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 35.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 17.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_77">F-</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.06pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_77">1</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 578.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Through and including &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025 (the 25th day after the date of this prospectus), all dealers effecting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions in our common stock, whether or not participating in this offering, may be required to deliver <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a prospectus. This delivery requirement is in addition to a dealer&#8217;s obligation to deliver a prospectus when <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acting as an underwriter and with respect to an unsold allotment or subscription.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have not, and the underwriters have not, authorized anyone to provide you any information or to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">make any representations other than those contained in this prospectus or in any free writing prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prepared by or on behalf of us or to which we have referred you. Neither we nor the underwriters take <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibility for, or provide any assurance as to the reliability of, any other information others may give <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">you. We and the underwriters are offering to sell only the shares offered hereby, and only under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances and in jurisdictions where it is lawful to do so. We are not, and the underwriters are not, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. The <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.78pt; position: absolute; text-decoration: none; white-space: pre;">ii<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information contained in this prospectus is accurate only as of the date of this prospectus, regardless of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the time of delivery of this prospectus or any sale of the shares of our common stock. Our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, and results of operations may have changed since that date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For investors outside the United States&#58; We have not, and the underwriters have not, done anything that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would permit this offering or the possession or distribution of this prospectus or any free writing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus in connection with this offering in any jurisdiction where action for that purpose is required, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other than in the United States. Persons outside the United States who come into possession of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus must inform themselves about, and observe any restrictions relating to, the offering of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock and the distribution of this prospectus outside the United States. &#8220;Heartflow,&#8221; the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow logos, and other trade names, trademarks, or service marks of Heartflow appearing in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus are the property of Heartflow. Other trade names, trademarks, or service marks appearing in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus are the property of their respective holders. We do not intend our use or display of other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies&#8217; trade names, trademarks, or service marks to imply a relationship with, or endorsement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sponsorship of us, by these other companies. Solely for convenience, trade names, trademarks, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">service marks referred to in this prospectus appear without the &#174;, &#8482;, and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 398.72pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">SM<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.46pt; position: absolute; white-space: pre;"> symbols, but those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">references are not intended to indicate, in any way, that we will not assert, to the fullest extent under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable law, our rights or that the applicable owner will not assert its rights, to these trade names, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trademarks, and service marks.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">1<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_691" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Prospectus summary<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This summary highlights select information contained in greater detail elsewhere in this prospectus. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summary is not complete and does not contain all of the information you should consider in making your <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment decision. Before investing in our common stock, you should carefully read this entire <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus. You should carefully consider, among other things, the sections titled &#8220;Risk factors,&#8221; &#8220;Special <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">note regarding forward-looking statements,&#8221; &#8220;Business,&#8221; and &#8220;Management&#8217;s discussion and analysis of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition and results of operations&#8221; and our consolidated financial statements and the related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notes included elsewhere in this prospectus before making an investment decision. Unless the context <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise requires, the terms &#8220;Heartflow,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; in this prospectus refer to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow, Inc. and its wholly owned subsidiaries, or either or both of them as the context may require.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 245.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have pioneered the use of software and AI to delive<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.78pt; position: absolute; text-decoration: none; white-space: pre;">r a more ac<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.32pt; position: absolute; white-space: pre;">curate and clinically effective non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive solution for diagnosing and managing coronary artery disease (&#8220;CAD&#8221;), a leading cause of death <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 269.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">worldwide. As of December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.76pt; position: absolute; text-decoration: none; white-space: pre;">, our Heartflow Platform has been used to assess CAD in more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 281.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">400,000 patients, including 132,000 in 2024 alone. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.13pt; position: absolute; white-space: pre;">We believe that we are the most widely adopted AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 293.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered test for CAD. Our novel platform leverages <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.6pt; position: absolute; text-decoration: none; white-space: pre;">AI<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.03pt; position: absolute; white-space: pre;"> and advanced computational fluid dynamics to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized 3D model of a patient&#8217;s heart from a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;), a specialized type of scan that provides detailed images of the heart&#8217;s arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition thereby overcoming the limitations of traditional non-invasive imaging tests which rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures of coronary disease and lead to higher false negative and false positive rates, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated by our PRECISE trial. We believe the differentiated accuracy and clinical utility of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, along with its ability to enhance workflows, will continue to support our growth and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advance the &#8220;CCTA + Heartflow&#8221; pathway as the definitive standard for the non-invasive diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally. In the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alone, the Centers for Disease Control (&#8220;CDC&#8221;) estimates that approximately 805,000 people suffer a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">heart attack each year. Despite significant advancements in therapeutic and interventional treatments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD remains a leading cause of death globally because healthcare systems generally lack scalable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methods to efficiently detect, diagnose and quantify CAD at a personalized level. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our analyses using Clarivate&#8217;s ProcedureFinder data repository, we estimate that there were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137pt; position: absolute; text-decoration: none; white-space: pre;">9.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.89pt; position: absolute; white-space: pre;"> million non-invasive tests (&#8220;NITs&#8221;) in the United States in 2023 for patients experiencing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stable or acute chest pain, which we refer to as symptomatic CAD patients. These NITs primarily include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress tests, such as single-photon emission computed tomography (&#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.19pt; position: absolute; text-decoration: none; white-space: pre;">SPECT&#8221;), echocardiography and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 573.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">positron emission tomography (&#8220;PET&#8221;),<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.62pt; position: absolute; white-space: pre;"> which infer the presence of heart disease based on how well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood is supplied to the heart, and do not measure the actual disease itself. Accordingly, these tests have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been shown to be unreliable and inconsistent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA has emerged as a leading non-invasive imaging method for evaluating CAD, offering direct and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">detailed visualization of the coronary arteries. Unlike traditional stress-based NITs, CCTA enables <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physicians to identify the presence and extent of coronary blockage. As a result, CCTA has become the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred first-line test for patients with suspected CAD, as evidenced by the AHA and ACC guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elevating CCTA to Class 1, Level A. However, while CCTA provides superior anatomical imaging, it does <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not independently quantify the severity of CAD, assess blood flow limitations, or characterize plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition&#8212;critical factors for determining the most appropriate, personalized course of treatment for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 701.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">2<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform builds upon the well established strengths of CCTA by going beyond its limitations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and providing new quantified insights and compelling visualizations of data. By applying our advanced AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered technology to a single CCTA scan, we generate a precise, patient-specific analysis that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quantifies blood flow, measures plaque burden, and characterizes plaque composition&#8212;at every point in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the major coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have developed three software products under the Heartflow Platform that provide physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the critical insights needed to effectively diagnose and manage CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: absolute; text-decoration: none; white-space: pre;"> offers a highly intuitive anatomic visualization of the coronary arteries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">helping physicians quickly identify clinically relevant areas to focus their review.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 163.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.05pt; position: absolute; text-decoration: none; white-space: pre;"> calculates blood flow and pinpoints clinically significant CAD, which is CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with a fractional flow reserve (&#8220;FFR&#8221;) value of 0.80 or below, at every point in the major coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">arteries. FFR measures the severity of blood flow restriction in the coronary arteries on a scale of 1.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(no restriction) to 0.0 (complete blockage) by assessing pressure differences across a stenosis during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">induced stress, guiding decisions on whether a patient requires invasive revascularization.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.09pt; position: absolute; text-decoration: none; white-space: pre;"> provides a comprehensive assessment of coronary plaque, enabling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimized medical treatment strategies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe we are the first and most widely-adopted AI-powered test for CAD. With over a decade of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial presence, we have established a competitively differentiated data set of over 100 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">annotated images, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157pt; position: absolute; text-decoration: none; white-space: pre;">which is <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.32pt; position: absolute; white-space: pre;">primarily sourced from our commercial relationships with customers, driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">training and refinement of our algorithms for over 10 years and the ability to train new AI models for future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe our Heartflow Platform delivers the following key benefits&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.68pt; position: absolute; text-decoration: none; white-space: pre;">, clinically validated to provide superior assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">blood flow, plaque volume and plaque characterization compared to traditional non-invasive methods. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments, personalized care, and better risk stratification<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 452.03pt; position: absolute; text-decoration: none; white-space: pre;">, positively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">impacting physician decisions on which patients should receive an intervention, supporting more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficient intervention planning and driving more personalized medical management.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency and enhanced interventional treatment planning<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.25pt; position: absolute; text-decoration: none; white-space: pre;">, accurately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifying more patients who need interventional treatment while reducing unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures&#8212;significantly improving the efficiency of the catheterization lab and therefore hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">economics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Proprietary, secure bi-directional data communication with customers <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.31pt; position: absolute; text-decoration: none; white-space: pre;">that feeds a growing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">database of over 100 million annotated CCTA images that we leverage to improve the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Platform&#8217;s accuracy, automation and clinical utility and seamlessly deliver new features and workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficiencies to our customers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.03pt; position: absolute; text-decoration: none; white-space: pre;"> through our Heartflow RoadMap Analysis that, as demonstrated in our SMART-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CT study, reduces CCTA interpretation times by approximately 25% and reduces variability between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviewing physicians by approximately 40%, leading to more consistent diagnoses and standardized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patient care. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.66999999999996pt; position: absolute; text-decoration: none; white-space: pre;">, by leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.96pt; position: absolute; text-decoration: none; white-space: pre;"> approximately 20 mi<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.16999999999996pt; position: absolute; text-decoration: none; white-space: pre;">nutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. By providing a definitive diagnosis upfront, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform eliminates the need for layered testing, streamlining the patient journey and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reducing anxiety associated with uncertain or inconclusive results.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">3<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.65pt; position: absolute; text-decoration: none; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.65pt; position: absolute; white-space: pre;">9.5 million unique stable chest pain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients receive NITs in the United States annually. In addition, based on our FORECAST randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trial, we further estimate that 33% of patients have stenosis levels between 40% and 90%, which results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in approximately 2.8 million patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 363.02pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.68pt; position: absolute; white-space: pre;"> Analysis in the stable setting. Based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the Martin paper, where there were approximately 577,000 hospital discharges in the United States in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020 due to a principal diagnosis of acute chest pain, and the Bhatt paper, where No ST Elevation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;NSTE&#8221;) related acute chest pain accounted for approximately 70% of acute chest pain, we further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that the annual incidence of patients who have acute chest pain with NSTE is approximately 0.4 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million patients. Of these approximately 0.4 million patients, we estimate based on the Kofoed paper that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 70% have obstructive disease and are eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 439.17pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.83pt; position: absolute; white-space: pre;"> Analysis, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results in approximately 0.3 million acute chest pain patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 470.78pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.44pt; position: absolute; white-space: pre;"> Analysis. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Therefore, we believe there is a market opportunity of approximately 3.1 million patients eligible for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis, which, at a U.S. average sales price of $1,067, translates to an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market opportunity of approximately $3.3 billion in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we believe our Heartflow Plaque Analysis is applicable to approximately 60% of those 9.5 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million NIT patients annually and the majority of patients experiencing acute chest pain. Based on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PROMISE trial and the Hoffmann paper, we estimate that approximately 60% of CCTA patients have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque and are eligible for plaque analysis, which translates to approximately 5.1 million patients eligible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our Heartflow Plaque Analysis in a stable setting. Based on our internal analysis and the findings in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Wang paper, where less than 5% of patients were expected to be contraindicated for CCTA, we also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that all of the approximately 0.4 million patients with acute chest pain with NSTE referred to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above will be eligible for our Heartflow Plaque Analysis. Therefore, we believe there is a market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunity of approximately 5.5 million patients eligible for our Heartflow Plaque Analysis, which, at an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated U.S. sales price of $300, translates to an estimated market opportunity of approximately an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incremental $1.7 billion in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Beyond the commercialization of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 283.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.26pt; position: absolute; white-space: pre;"> Analysis and Heartflow Plaque Analysis in symptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, we see a significant market opportunity for our technologies in at-risk individuals who show no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptoms, a segment comprised of approximately 200 million people globally, based on data from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Census Bureau, CDC, Eurostat, United Kingdom Office of National Statistics, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.19pt; position: absolute; text-decoration: none; white-space: pre;">the Yang paper and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the MacDonald paper<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.01999999999998pt; position: absolute; white-space: pre;">. To unlock this potential, we are continuing to evaluate new product opportunities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and appropriate clinical evidence supporting eventual regulatory approval, payor coverage and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the Heartflow Platform is the most extensively studied AI-enabled test for CAD. Our belief is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">grounded in our analysis, including that the Heartflow Platform and its accuracy, clinical utility and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic benefits have been evaluated in over 100 clinical studies and more than 130,000 patients, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including our PRECISE and FORECAST trials, each a large randomized controlled trial, with results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">published in over 600 peer-reviewed clinical publications. Our studies, including the PRECISE, NXT and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PACIFIC trials, have consistently demonstrated that the Heartflo<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 354.48pt; position: absolute; text-decoration: none; white-space: pre;">w Platform is more accu<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.1pt; position: absolute; text-decoration: none; white-space: pre;">rate than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">traditional no<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 129.22pt; position: absolute; text-decoration: none; white-space: pre;">n-invasive tests and highly concordant to invasive testing, reduces unnecessary<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.44pt; position: absolute; white-space: pre;"> invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">testing, and enables physicians to optimize treatment and ultimately provide more efficient care.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 494.52pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have developed a highly scalable, capital efficient commercial model that combines Territory Sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Managers (&#8220;TSMs&#8221;) who drive new account adoption with Territory Account Managers (&#8220;TAMs&#8221;) who focus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on increasing utilization by educating referring physicians. Our commercial team does not cover cases or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise spend time in an operating room or lab setting, which enables them to focus solely on driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial adoption and educational activities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology is simple and intuitive and does not require the purchase of any capital equipment. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">onboarding process seamlessly integrates the Heartflow Platform into the customer&#8217;s daily wo<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.01pt; position: absolute; text-decoration: none; white-space: pre;">rkflow. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">4<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These unique attributes of our business model afford our commercial organization a differentiated level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency and scalability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current clinical guidelines strongly support the adoption of the Heartflow Platform. The CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis pathway is supported by the American Heart Association (&#8220;AHA&#8221;) and American College of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiology (&#8220;ACC&#8221;) guidelines, with CCTA identified as a Class 1, Level A test and Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 500.55pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis identified as a <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.42000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Class 2a, Level B<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.18pt; position: absolute; white-space: pre;"> test for the diagnosis of CAD in certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acute chest pain and no known CAD. The AHA and ACC guidelines utilize Classes and Levels to indicate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strength of a recommendation and the quality of supporting evidence, respectively. Class 1 represents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strongest recommendation, followed by Class 2a, which represents a moderate recommendation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, Level A signifies the highest quality of evidence, while Level B indicates moderate quality.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe current reimbursement policies support the adoption of the Heartflow Platform. Our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis is reimbursed under a dedicated Category 1 Current Procedural Terminology (&#8220;CPT&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">code, effective as of January 1, 2024, and has established coverage policies representing approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">99% of covered lives in the United States. A Category 1 CPT code was also recently established for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis, which will take effect in January 2026, and it is covered by all seven Medicare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative contractor (&#8220;MACs&#8221;). A Category 1 CPT code designates a procedure or service that has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received Food and Drug Administration (&#8220;FDA&#8221;) clearance, is frequently performed by physicians across <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States for its intended clinical use, aligns with current medical practice, and has documented <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficacy in literature. The established Category 1 CPT code for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 431.32pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.98pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis validates its widespread use and distinguishes it from emerging technologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that are assigned a Category 3 CPT code.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We primarily generate revenue on a &#8220;pay per click&#8221; basis each time a physician chooses to review either <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.2pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 153.62pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.28pt; position: absolute; white-space: pre;"> Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.26pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.24pt; position: absolute; white-space: pre;">Plaque Analysis, or both. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.99pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.97pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 429.39pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.05pt; position: absolute; white-space: pre;"> Analysis has served <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as our commercial foundation, representing 98% of our total revenue as of December 31, 2024. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">second half of 2023, we initiated limited market education efforts for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.4pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.38pt; position: absolute; white-space: pre;">Plaque Analysis, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">second commercial product. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.2pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.18pt; position: absolute; white-space: pre;">RoadMap Analysis is generally provided as a workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency tool to drive customer retention and loyalty and is not a stand-alone product. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have experienced significant revenue growth since we began commercializing the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in 2015. We recognized revenue of $125.8&#160;million for the year ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue of $87.2 million for the year ended December 31, 2023, representing&#160;44% year-over-year growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The software-based nature of our Heartflow Platform produces an attractive gross margin profile, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continues to expand as we leverage AI to automate an increasing portion of our &#8220;human-in-the loop&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality control process, where learnings are fed back into our algorithms to make them smarter and more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficient. For the twelve months ended December 31, 2024, we generated gross margins of&#160;75%, an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase of&#160;8 percentage points year-over-year from December 31, 2023. Our net losses were $95.7 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million and $96.4&#160;million for the years ended December 31, 2023 and 2024, respectively. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accumulated deficit was $874.5 million and $971.0 million as of December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Market overview and opportunity <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview of CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Key risk factors, including high cholesterol, hypertension, smoking, diabetes, obesity, physical inactivity, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and genetic predisposition, accelerate plaque formation and destabilization. In the United States alone, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the CDC estimates that approximately 805,000 people suffer a heart attack each year. CAD can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectively treated with well-established therapeutics designed to reduce plaque progression and change <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its composition, or interventional procedures used to open the arteries and restore blood flow. However, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieving an accurate diagnosis for the condition has historically been the primary roadblock for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective care and management of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">NITs are the first line approach for detecting CAD in symptomatic patients. Based on our analyses using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Clarivate&#8217;s ProcedureFinder data repository, with 9.5 million tests performed for the diagnosis of CAD in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States in 2023, NITs are by far the most widely used method to diagnose CAD. However, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">traditional NITs are not able to measure lesion-specific blood flow and are not an efficient or effective way <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to calculate plaque volume and composition. As a result, they lack the key metrics physicians need to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guide treatment decisions and have been clinically shown to be unreliable and inconsistent for diagnosing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Limitations of traditional non-invasive tests for CAD<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are two primary types of NITs&#58; (i) stress tests, which infer the presence of CAD based on blood <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perfusion, and (ii) CCTA which directly images the patient&#8217;s coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stress-based NITs include SPECT, PET and<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.3pt; position: absolute; white-space: pre;"> stress <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.5pt; position: absolute; text-decoration: none; white-space: pre;">echocardiography<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.24pt; position: absolute; white-space: pre;">. Stress-based NITs rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surrogate markers of CAD to deduce the disease in the coronary artery without actually assessing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disease itself. As a result, approximately 20&#8211;50% of patients who undergo stress-b<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.95pt; position: absolute; text-decoration: none; white-space: pre;">ased<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.63pt; position: absolute; white-space: pre;"> NITs go home <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with false negatives, or undetected CAD that should have required an intervention, based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Nakanishi paper and the Yokota paper. In addition, based on the 2014 Patel paper, up to 55% of patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receive false positives and are sent to the cardiac catheterization lab for an invasive diagnostic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography when an intervention was never needed exposing patients to unnecessary risks including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vascular injury and bleeding complications. This results in significant additional costs to the healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">system and poor patient experience.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA is a high-resolution 3D imaging method that uses X-rays to produce detailed pictures of the heart's <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arteries and other structures. The analyses performed by our Heartflow Platform rely on CCTA images <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from third-party CT manufacturers. Because CCTA images are used across multiple medical practices, by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different medical professionals and others, CT scanners have historically and currently output CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">images in standard file formats rather than proprietary formats. Unlike stress tests that rely on indirect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">measures to infer heart disease, CCTA provides direct visualization of the patient&#8217;s anatomy and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allow for a comprehensive visual assessment of coronary stenosis and plaque burden. CCTA has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinically demonstrated in the SCOT-HEART trial to have the highest diagnostic performance of all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">traditional non-invasive imaging tests for CAD. In recognition of its superior diagnostic accuracy, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">October 2021 the AHA and ACC elevated CCTA to a first line Class 1, Level A test in the guidelines for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain patients with stable or acute chest pain and no known CAD, above stress testing which is Class 1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level B. While CCTA accurately identifies stenosis in the coronary arteries, it does not calculate the blood <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">flow through the arteries to identify whether the stenosis is clinically significant and does not provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque quantification or composition without significant and time-consuming and variable manual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calculations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform, which requires a CCTA image from a CT scanner to perform its analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly improves the clinical utility of CCTA and addresses the limitations of traditional non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD testing by combining existing CCTA images with our AI algorithms to provide actionable data on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood flow, stenosis, plaque volume and plaque composition. This delivers superior clinical utility relative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to other NITs and compelling economic benefits, which are supported by extensive clinical evidence. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, we believe the CCTA + Heartflow pathway will become the standard of care for the non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnosis of CAD over time<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 101.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 98.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 126pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 142.5pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="4"><div style="left: 0pt; position: absolute; top: 0pt; width: 468pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 468pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;">Traditional NITs vs. Heartflow<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 15.75pt; width: 101.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 101.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 9.11pt; position: absolute; text-decoration: none; white-space: pre;">Stress Echocardiogram<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 101.25pt; position: absolute; top: 15.75pt; width: 98.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 98.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 19.22pt; position: absolute; text-decoration: none; white-space: pre;">SPECT and PET<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 199.5pt; position: absolute; top: 15.75pt; width: 126pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 126pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 52.42pt; position: absolute; text-decoration: none; white-space: pre;">CCTA<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 325.5pt; position: absolute; top: 15.75pt; width: 142.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 6.75pt; width: 142.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 26.28pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 5.82pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.2pt; font-style: normal; font-weight: normal; left: 77.75999999999999pt; position: absolute; text-decoration: none; top: 2.037pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 3.7830000000000004pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: normal; left: 84.68pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 182.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 0pt; position: absolute; top: 31.5pt; width: 325.5pt;"><div><div style="position: absolute; top: 1.6pt; width: 325.5pt;"><div style="left: 0.75pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 175.19pt; width: 324pt;" src="prospectussummary1ba.jpg" alt="prospectussummary1ba.jpg"></div></div></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 325.5pt; position: absolute; top: 31.5pt; width: 142.5pt;"><div><div style="position: absolute; top: 15.55pt; width: 142.5pt;"><div style="left: 2.85pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 147.27pt; width: 136.8pt;" src="picture5a.jpg" alt="picture5a.jpg"></div></div></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 302.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 1&#58; A comparison of the visual output of traditional non-invasive tests. Left&#58; Stress echocardiogram. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Center&#58; SPECT and PET. Right&#58; CCTA image.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 279.63pt; position: absolute; white-space: pre;">Far Right&#58; Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 390.66pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 399.32pt; position: absolute; white-space: pre;"> Analysis image which color <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">codes coronary blood flow to identify clinically significant blockages.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our symptomatic CAD market opportunity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that there were approximately 9.5 million NITs in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States for the diagnosis of CAD in 2023. In addition, based on our FORECAST randomized trial and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 414.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Wang paper, we believe there were approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.06pt; position: absolute; text-decoration: none; white-space: pre;">8.6<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.95pt; position: absolute; white-space: pre;"> million patients that were addressable with CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after accounting for layered testing and contraindications to CCTA. CCTA testing volumes have grown <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rapidly, and we believe they will continue to outpace the broader market growth driven by the recently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">established Class 1, Level A guidelines, superior clinical utility to stress tests and improved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 482.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.49pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis is reimbursed for use on any CCTA showing 40% to 90% stenosis, which, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 494.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">based on our FORECAST randomized trial, we estimate to be approximately 33% of all CCTAs annually. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 506.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We believe that CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 245.14pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.49pt; position: absolute; text-decoration: none; white-space: pre;">Analysis therefore is applicable to 33% of the NIT market and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 518.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">majority of patients experiencing acute chest pain, which represents 3.1 million patients and an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 530.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">market opportunity of approximately $3.3 billion in the United States. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.35pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.33pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 542.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reimbursed for plaque identified on CCTA with 1% to 69% stenosis, which, based on our PROMISE trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 554.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and the Hoffmann paper, we estimate to cover approximately 60% of all CCTAs annually and a majority of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 566.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">patients experiencing acute chest pain. We believe that CCTA + Heartflow Plaque Analysis is therefore <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 578.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">applicable to 60% of the NIT market, which represents 5.5 million patients and an estimated market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 590.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">opportunity of an incremental approximately $1.7 billion in the United State<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.39pt; position: absolute; text-decoration: none; white-space: pre;">s<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.39pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">While our current focus is on the United States and the Heartflow Platform has been cleared by the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(K213857), our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.42000000000002pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 205.84pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.5pt; position: absolute; white-space: pre;"> Analysis has commercial presence and regulatory approval in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Kingdom, European Union, Australia, Canada and Japan. The Heartflow Platform has also been cleared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the equivalent regulatory authorities in Israel, Saudi Arabia, United Arab Emirates, and licensed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bahrain. In the future we may expand our international presence beyond these markets and extend our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">platform to additional indications.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">7<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our technology<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow enhances CCTA, the most advanced non-invasive imaging modality for assessing CAD, with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AI-powered analysis to deliver more accurate and clinically actionable insights for diagnosing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managing CAD. The Heartflow Platform applies deep learning, an advanced form of AI, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computational fluid dynamics to CCTA images to create a personalized 3D model of a patient&#8217;s heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on a single CCTA image. This model provides actionable insights into blood flow, stenosis, plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume and plaque composition allowing precise diagnosis, risk stratification, and treatment planning &#8211; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 166.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without the need for an invasive <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.31pt; position: absolute; text-decoration: none; white-space: pre;">procedure.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.1pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The CCTA + Heartflow pathway addresses the limitations of traditional non-invasive tests that only assess <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures for coronary disease and therefore result in higher rates of false negative and false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positive CAD diagnoses, as demonstrated by our PRECISE trial. We believe the differentiated accuracy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and clinical utilit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.98000000000002pt; position: absolute; text-decoration: none; white-space: pre;">y of the CCTA + Heartflow pathway will continue to support our growth and advance the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">standard for the non-invasive diagnosis and management of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We designed our AI-powered software platform to be highly scalable, seamlessly integrate into existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">physician workflows for diagnosing CAD, and improve as we ingest more data over time. By leveraging AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to process massive volumes of cases and a &#8220;human-in-the loop&#8221; quality control process, where learnings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">are fed back into our algorithms to improve their performance and efficiency, we have rapidly scaled our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">platform to deliver accurate, timely results to benefit physicians and patients alike.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 322.4pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 121.27pt; width: 468pt;" src="figure2a.jpg" alt="figure2a.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 456.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;"> Figure 2&#58; The CCTA + Heartflow pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 476.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our product portfolio <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have created three software products in a unified platform and user experience that provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the critical data physicians need to effectively manage patients with suspected CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 528.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.47pt; position: absolute; text-decoration: none; white-space: pre;"> The Heartflow RoadMap Analysis provides <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 129.6pt; left: 418.32pt; position: absolute; top: 530.63pt; width: 114.06pt; z-index: 3;"><div><div><div style="position: absolute;"><img style="height: 129.6pt; width: 114.06pt;" src="roadmapanalysisa.jpg" alt="roadmapanalysisa.jpg"></div></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 540.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">a highly intuitive anatomic visualization of the patient&#8217;s coronary anatomy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 552.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">based on CCTA images. It rapidly orients the imaging physician to clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 564.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">relevant areas of the patient anatomy and provides a preview of what they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 576.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">will review in the native CCTA images to aid the physician in accurately, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 588.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">efficiently and consistently identifying stenosis in the coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 600.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis supports more efficient radiology workflow, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 612.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">improving CCTA read times by 25% and increasing consistency between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 624.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reviewing physicians by approximately 40%, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.33000000000004pt; position: absolute; text-decoration: none; white-space: pre;">as demonstrated in<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.33pt; position: absolute; text-decoration: none; white-space: pre;"> our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 636.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">SMART-CT study. Physicians use <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.61pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.59000000000003pt; position: absolute; text-decoration: none; white-space: pre;">Roadmap Analysis as a first-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 648.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">line assessment tool along with CCTA interpretation to determine whether to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 660.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">order our more detailed <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.66pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.64pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 243.06pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.41pt; position: absolute; text-decoration: none; white-space: pre;">Analysis or <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.06pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.04pt; position: absolute; text-decoration: none; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 672.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis reports. We generally provide <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 245.12pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.1pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis to accounts as an integrated feature <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 684.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to enhance the efficiency and consistency of their CCTA programs and it is not a stand-alone product. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 696.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">believe the efficiency that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.79000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.77pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis provides our customers has resulted in enhanced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 708.67pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">customer loyalty and re<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.32pt; position: absolute; text-decoration: none; white-space: pre;">tention<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 205.32pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">8<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 139.72pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 148.38pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 192.25pt; position: absolute; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.57999999999998pt; position: absolute; white-space: pre;"> Our flagship product, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.88pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.86pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 358.28pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 125.28pt; left: 418.5pt; position: absolute; top: 70.88pt; width: 115.2pt; z-index: 2;"><div><div><div style="position: absolute;"><img style="height: 125.28pt; width: 115.2pt;" src="ffrctanalysis.jpg" alt="ffrctanalysis.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis, consists of a patient-specific, interactive, 3D anatomical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reconstruction of the coronary anatomy that identifies <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.73pt; position: absolute; text-decoration: none; white-space: pre;">clinically <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.72pt; position: absolute; white-space: pre;">significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD at every point in the major coronary arteries to determine the need for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.64pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.62pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 213.04pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.7pt; position: absolute; white-space: pre;"> Analysis has the highest diagnostic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accuracy for a non-invasive CAD test and has demonstrated a high level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">concordance to invasive FFR, as seen in our PRECISE, NXT and PACIFIC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trials. Current AHA and ACC guidelines designated CCTA as a Class 1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level A test for CAD in certain patients with stable or acute chest pain and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">no known CAD, and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.65pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.63pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 228.05pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 236.71pt; position: absolute; white-space: pre;"> Analysis as a Class 2a, Level B test to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">help physicians guide patient treatment decisions. As of December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.78pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.76pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 164.18pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.84pt; position: absolute; white-space: pre;"> Analysis represented 98% of our total revenue.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">H<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 79.22pt; position: absolute; text-decoration: none; white-space: pre;">eartflow Plaque Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.02pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248pt; position: absolute; white-space: pre;">Plaque Analysis transforms <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 131.26pt; left: 418.5pt; position: absolute; top: 227.5pt; width: 115.2pt; z-index: 1;"><div><div><div style="position: absolute;"><img style="height: 131.26pt; width: 115.2pt;" src="plaqueanalysis.jpg" alt="plaqueanalysis.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary plaque assessment from a time-consuming and variable manual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">process, which is seldom clinically used, into a rapid, automated, and highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">precise AI-driven solution. The Heartflow Plaque Analysis automatically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provides a comprehensive 3D assessment of a patient&#8217;s coronary plaque, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including a characterization of plaque types and quantification of plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volumes at every point in the major coronary arteries. The <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.09pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.07pt; position: absolute; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis has been validated against the reference standard of invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">i<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.22pt; position: absolute; text-decoration: none; white-space: pre;">ntrava<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102pt; position: absolute; text-decoration: none; white-space: pre;">scular ultrasound<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.12pt; position: absolute; text-decoration: none; white-space: pre;"> (&#8220;IVUS&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.52pt; position: absolute; white-space: pre;"> and shown to have a 95% agreement with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IVUS in quantifying total coronary plaque volume in our REVEALPLAQUE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">study. Because coronary plaque volume is a strong predictor of a patient&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">risk of having a heart attack, this data offers incremental predictive power <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">over risk factors and stenosis alone and can aid the physician in optimizing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical management. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.54000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 237.52pt; position: absolute; white-space: pre;">Plaque Analysis was cleared by the FDA in October 2022. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">began our<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.02000000000001pt; position: absolute; text-decoration: none; white-space: pre;"> limited market education efforts<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.46000000000004pt; position: absolute; white-space: pre;"> in the second half of 2023, and we expect to broaden our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market education efforts as payor coverage for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.23pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.21000000000004pt; position: absolute; white-space: pre;">Plaque Analysis increases. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Key benefits of our Heartflow Platform<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the unique features of our technology allow us to offer superior clinical utility and economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value to our customers and the broader healthcare system. The key benefits offered by our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform include&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.78pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow products provide a more accurate non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">invasive assessment of blood flow, plaque characterization and plaque volume compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">traditional non-invasive tests. Our clinical trials have demonstrated that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 469.88pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.54pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis have a high level of concordance to the invasive reference standards of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR and IVUS, respectively, and that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 321.35pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.01pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis has superior diagnostic accuracy to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA alone as well as both SPECT and PET.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments and personalized care&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 422.6pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.26pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis have been clinically demonstrated to improve physician decisions on intervention <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and treatment planning. Multiple studies and registries have demonstrated that physicians changed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">their treatment approach after reviewing our AI-powered reports.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: absolute; text-decoration: none; white-space: pre;"> Our PRECISE prospective randomized controlled trial demonstrated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 191.05pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.70999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was 78% more likely to identify patients in need of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revascularization and showed a 69% reduction in unnecessary invasive tests as compared to a &#8220;usual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">care&#8221; pathway. The net effect of this pathway was 2x the yield of invasive coronary angiography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">leading to a revascularization procedure. As a result, our internal analysis based on the PRECISE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">data demonstrated a 20% increase in net revenue for the cardiac catheterization lab, on average. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.22pt; position: absolute; text-decoration: none; white-space: pre;">9<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.36pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow RoadMap Analysis offers significant workflow benefits, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improving workflow efficiency by reducing CCTA interpretation times by approximately 25%, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demonstrated in our SMART-CT study. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Enhanced interventional treatment planning&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.03pt; position: absolute; text-decoration: none; white-space: pre;"> The additional detail on individual patient anatomy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and disease state provided by our Heartflow Platform allows for pre-operative selection of appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tools. We believe this saves valuable cardiac catheterization lab time and facilitates a more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedure.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276pt; position: absolute; text-decoration: none; white-space: pre;"> By leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in approximately 20 minutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. By providing a definitive diagnosis upfront, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform eliminates the need for layered testing, streamlining the patient journey and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reducing anxiety associated with uncertain or inconclusive results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the benefits of our Heartflow Platform add significant value across all the subspecialties that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact cardiovascular care including referring cardiologists, imaging physicians and interventionalists. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have structured our sales force to efficiently call on these key physician stakeholders, with a primary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">focus on the imaging physicians who are instrumental in new account adoption and the referring <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physicians who are critical to driving volume growth at our existing accounts. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our success factors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the continued growth of our company will primarily be driven by the following success factors&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Differentiated approach to the non-invasive diagnosis and management of CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Market leader in AI-powered quantitative CAD <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 309.28999999999996pt; position: absolute; text-decoration: none; white-space: pre;">analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 348.73pt; position: absolute; text-decoration: none; white-space: pre;"> with <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 374.24pt; position: absolute; text-decoration: none; white-space: pre;">strong customer relationships <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Attractive revenue model with significant operating leverage potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Large addressable market opportunity with a significant unmet need <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Robust and compelling portfolio of clinical evidence <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Established reimbursement coverage and favorable society support<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">U<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 97.22pt; position: absolute; text-decoration: none; white-space: pre;">nique and scalable AI, data and R&#38;D capabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 327.58000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Experienced leadership team<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our growth strategies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.35pt; position: absolute; text-decoration: none; white-space: pre;">key<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.91pt; position: absolute; white-space: pre;"> strategies will play a critical role in our continued growth&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expand adoption of our Heartflow Platform by new accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Broaden awareness of the CCTA + Heartflow pathway to drive volume at existing accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Launch and drive adoption of our Heartflow Plaque Analysis product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Invest in additional clinical evidence to support adoption and expand our indications <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Extend our technology leadership through continued investment in our platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Leverage our platform to pursue adjacent and international markets<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">10<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risk factors <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 143.97pt; position: absolute; text-decoration: none; white-space: pre;">su<font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 157.97pt; position: absolute; text-decoration: none; white-space: pre;">mmary<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our business is subject to a number of risks and uncertainties, as more fully described in the section titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Risk factors&#8221; immediately following this prospectus summary. You should read these risks before you <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invest in our common stock. These risks include, among others, the following&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We have incurred significant net losses since our inception, we expect to incur additional substantial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">losses in the foreseeable future and we may not be able to achieve or sustain profitability. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our revenue is currently generated almost entirely from the sales of only one product, Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, and we are therefore highly dependent on the success of this product, which makes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">it difficult to evaluate our current business, predict our future prospects and forecast our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance and any growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If healthcare providers are unwilling to change their standard practice regarding the evaluation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD, our business, financial condition, results of operations and prospects will be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If third-party payors, including government payors, do not cover and provide adequate, or any, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement for the Heartflow Platform, or if existing payment amounts are reduced or coding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes, adoption of the Heartflow Platform by healthcare providers will be negatively impacted, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our business, financial condition, results of operations and prospects will be adversely affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with a concentrated customer base.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face significant competition in an environment of rapid technological change, and there is a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">possibility that our competitors may develop products that are more effective, accurate, reliable, cost-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">effective or more advanced than ours, which may harm our financial condition. If we are unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compete successfully or our potential market share is reduced, we may be unable to increase or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sustain our revenue or achieve profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The commercialization of the Heartflow Plaque Analysis product is nascent, and we may not be able <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to achieve or maintain sufficient market acceptance or the levels of utilization we expect from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis product or any other future product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with our use and development of artificial intelligence models, which may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">result in operational challenges, legal liability, reputational concerns and competitive risks.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If we fail to properly manage our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.51pt; position: absolute; text-decoration: none; white-space: pre;">future<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.06pt; position: absolute; text-decoration: none; white-space: pre;"> growth, our business could suff<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.41pt; position: absolute; text-decoration: none; white-space: pre;">er.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our business could be disrupted by catastrophic events.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We depend on our information technology systems, and any failure of these systems could harm our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">business and adversely affect our business and operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our networks and those of our third-party service providers may become the target of bad actors or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">security breaches that we cannot anticipate or successfully defend, which could have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We face extensive, regulatory requirements to bring our products to market, and our failure to receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and maintain regulatory clearances or approvals of our current and future products in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">States or abroad or to comply with medical device regulatory requirements could adversely affect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to obtain and maintain sufficient intellectual property rights, or the scope of our rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">is not sufficiently broad, third-parties could develop and commercialize technology and products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">similar or identical to ours, and our ability to successfully commercialize our technology and products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.81pt; position: absolute; text-decoration: none; white-space: pre;">11<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Our credit agreement contains certain restrictions that may limit our ability to operate our business. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we raise additional capital through debt financing, the terms of any new debt could further restrict our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ability to operate our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The summary risk factors described above should be read together with the text of the full risk factors in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the section titled &#8220;Risk factors&#8221; and the other information set forth in this prospectus, including our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements and the related notes. The risks summarized above or described in full <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elsewhere in this prospectus are not the only risks that we face. Additional risks and uncertainties not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presently known to us, or that we currently deem to be immaterial, may also materially adversely affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, financial condition, results of operations, and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Corporate information<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We were incorporated under the laws of the State of Delaware in 2007. On March 1, 2021, we completed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an internal reorganization in which a newly formed parent holding company was put in place. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previous holders of our common stock and preferred securities became holders of common stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred securities of HeartFlow Holding, Inc. The equity incentive plan, outstanding equity awards, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding warrants and certain other equity-related agreements of HeartFlow, Inc. were assumed by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. Our operations and business activities remained at HeartFlow, Inc., and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">wholly-owned non-U.S. subsidiaries of HeartFlow, Inc. remained in place. On&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated HeartFlow Holding, Inc. into HeartFlow, Inc. and the previous holders of HeartFlow Holding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc. common stock and preferred securities became holders of our common stock and preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities, and the equity incentive plan, outstanding equity awards, warrants and certain other equity-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related agreements of HeartFlow Holding, Inc. were assumed by us. In connection with this consolidation, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we changed our name to Heartflow, Inc., whose name appears on the cover of this prospectus. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal executive offices are located at 331 E. Evelyn Avenue, Mountain View, California 94041, and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">telephone number is (650) 241-1221. Our corporate website address is www.heartflow.com. Information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contained on, or accessible through, our website shall not be deemed incorporated into and is not a part <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of this prospectus or the registration statement of which it forms a part. We have included our website in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus solely as an inactive textual reference.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Implications of being an emerging growth company<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We qualify as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2012 (the &#8220;JOBS Act&#8221;). We will remain an emerging growth company until the earliest of&#58; (i) the last day of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fiscal year following the fifth anniversary of the completion of this offering&#59; (ii) the last day of the fiscal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year in which we have total annual gross revenue of at least $1.235 billion&#59; (iii) the last day of the fiscal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which would occur if the market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the second fiscal quarter of such year&#59; or (iv) the date on which we have issued more than $1.0 billion in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-convertible debt securities during the prior three-year period. An emerging growth company may take <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advantage of specified reduced reporting requirements and is relieved of certain other significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements that are otherwise generally applicable to public companies. As a result, the information that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we provide to our stockholders may be different than you might receive from other public reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies in which you hold equity interests.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As an emerging growth company, we have elected to take advantage of certain reduced disclosure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligations in the registration statement that this prospectus is a part of, and may elect to take advantage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of other reduced reporting requirements in future filings. In particular&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will present in this prospectus only two years of audited financial statements, plus any required <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unaudited financial statements, and related management&#8217;s discussion and analysis of financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">condition and results of operations&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">12<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will avail ourselves of the exemption from the requirement to obtain an attestation and report from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our independent registered public accounting firm on the assessment of our internal control over <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">financial reporting pursuant to the Sarbanes-Oxley Act of 2002&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will avail ourselves of relief from compliance with the requirements of the Public Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Accounting Oversight Board regarding the communication of critical audit matters in the auditor&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">report on the financial statements&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will provide less extensive disclosure about our executive compensation arrangements&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we will not be required to hold stockholder non-binding advisory votes on executive compensation or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">golden parachute arrangements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transition period for complying with new or revised accounting standards. This provision allows an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">emerging growth company to delay the adoption of some accounting standards until those standards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would otherwise apply to private companies. We have elected to use the extended transition period for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any other new or revised accounting standards during the period in which we remain an emerging growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company&#59; however, we may adopt certain new or revised accounting standards early. As a result of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elections, the information that we provide in this prospectus, including our financial statements, may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different than the information you may receive from other public companies in which you hold equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interests. In addition, it is possible that some investors will find our common stock less attractive as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result of these elections, which may result in a less active trading market for our common stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">higher volatility in our share price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Basis of presentation<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certain monetary amounts, percentages, and other figures included elsewhere in this prospectus have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables or charts may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not be the arithmetic aggregation of the figures that precede them, and figures expressed as percentages <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the percentages that precede them.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The consolidated financial statements include the accounts of HeartFlow Holding, Inc. and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiaries. Prior to the completion of this offering, we will complete a consolidation pursuant to which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the previous holders of HeartFlow Holding, Inc. common stock and preferred securities will become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of our common stock and preferred securities and the equity incentive plan, outstanding equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards, the warrants and other equity agreements of HeartFlow Holding, Inc. will be assumed by us. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expect that the consolidation will not have a material effect on our consolidated financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">included elsewhere in this prospectus. The consolidated financial statements of HeartFlow Holding, Inc. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are that of Heartflow, Inc., the registrant whose name appears on the cover of this prospectus. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">13<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1008" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The offering<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="position: absolute; top: 107.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 165pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 300pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock offered by us<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 143.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 146.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 146.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 146.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 146.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 0pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 74.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 17.25pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Option to purchase additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">shares<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.86pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 46.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 47.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 47.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 47.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 17.25pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We have granted the underwriters an option for a period of 30 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.37pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">days to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 39.37pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stock from us at the public offering price, less underwriting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">discounts and commissions on the same terms as set forth in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 63.37pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock to be outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">after this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.78pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 96.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.3pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 94.5pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 12.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares if the underwriters <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 24.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise in full their option to purchase additional shares).<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">14<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 165pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 300pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 501.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Use of proceeds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.36999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 83.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 86.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 0pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We estimate that the net proceeds from this offering will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million (or approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the underwriters exercise in full their option to purchase up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; additional shares of common stock), based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 62.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the midpoint of the estimated price range set forth on the cover <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 74.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">page of this prospectus, after deducting estimated underwriting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 86.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">discounts and commissions and estimated offering expenses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 98.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">payable by us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">In connection with the completion of this offering, we are obligated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to use certain of the net proceeds from this offering to repay $50.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">million (or $55.0 million if the underwriters exercise any portion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">their option to purchase additional shares of common stock) of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">indebtedness outstanding under the amended credit agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and guaranty (as amended, the &#8220;2024 Credit Agreement&#8221;) with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Services, LLP (&#8220;Hayfin&#8221;) and to pay approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of fees in connection therewith. In connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the issuance of the 2025 Convertible Notes (as defined below) in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">January 2025, we entered into Amendment No. 1 to the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Credit Agreement, pursuant to which entities affiliated with Hayfin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">converted $23.0 million of outstanding indebtedness under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024 Credit Agreement in connection with the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conversion (as defined in the section titled &#8220;Certain relationships <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">and related-party transactions&#8221;) and became holders of 5% or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">more of our capital stock as of March 1, 2025. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We expect to use the remainder of the net proceeds from this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">offering, together with our existing cash and cash equivalents, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">fund our sales and marketing efforts, fund research and product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">development activities and for other general corporate purposes, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">including working capital, operating expenses, and capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">expenditures. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We may also use a portion of the net proceeds from this offering to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">acquire complementary businesses, products, services, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">technologies. We periodically evaluate strategic opportunities&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">however, we have no current understandings or commitments to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">enter into any such acquisitions or make any such investments.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">We will have broad discretion in the way that we use the net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">proceeds of this offering. See the section titled &#8220;Use of proceeds&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.63pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 504.75pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Risk factors<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.84pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 62.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 66.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 66.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 66.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.92999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 504.75pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">You should read the section titled &#8220;Risk factors&#8221; for a discussion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">factors to consider carefully, together with all the other information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">included in this prospectus, before deciding to invest in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 300pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 558pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Proposed Nasdaq&#160;trading<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.19pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">symbol<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.61pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 49.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 51.690000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 51.980000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 52.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 52.080000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.09pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 558pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;HTFL&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">15<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 165pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 300pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 156.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 3pt; width: 165pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 165pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lock-up agreements<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.36pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 103.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 105.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 106.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 168pt; position: absolute; top: 3pt; width: 300pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 1.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">In connection with this offering, we, our directors, our executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 13.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">officers, and the holders of substantially all of our common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 25.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">stock options, and other securities convertible into or exercisable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 37.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">or exchangeable for our common stock, have agreed that, without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 49.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the prior written consent of J.P. Morgan Securities LLC, Morgan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 61.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stanley &#38; Co. LLC and Piper Sandler &#38; Co. on behalf of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 73.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">underwriters, subject to certain exceptions more fully described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 85.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">under the section titled &#8220;Underwriting&#8221;, we and they will not, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 97.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">among other things, sell or otherwise transfer or dispose of any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 109.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">our securities during the period from the date of this prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 121.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">continuing through the date 180 days after the date of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 133.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">prospectus. See the section titled &#8220;Underwriting&#8221; for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 145.87pt; width: 300pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">information.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 244.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The number of shares of our common stock to be outstanding after this offering is based on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of our common stock outstanding as of December 31, 2024 and excludes&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">24,930,958&#160;shares of our common stock issuable upon the exercise of outstanding stock options as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of December 31, 2024 under our HeartFlow Holding, Inc. Amended and Restated 2009 Equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Incentive Plan (the &#8220;2009 Equity Incentive Plan&#8221;), with a weighted-average exercise price of $1.62&#160;per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">796,801&#160;shares of our common stock issuable upon the exercise of outstanding stock options granted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent to December 31, 2024 under our 2009 Equity Incentive Plan, with a weighted-average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise price of $4.34&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">4,811,190 shares of our common stock issuable upon the exercise of warrants outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024 held by Hayfin, with an exercise price of $0.01 per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">282,691 shares of our common stock reserved for future issuance under our 2009 Equity Incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plan&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock to be reserved for future issuance under our 2025 Performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Incentive Plan (the &#8220;2025 Plan&#8221;), which will become effective as of the date immediately prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">date our registration statement relating to this offering becomes effective, from which we will grant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restricted stock units (&#8220;RSUs&#8221;) covering approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock concurrently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with this offering (based on the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">midpoint of the price range set forth on the cover page of this prospectus), as well as any future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">increases in the number of shares of common stock reserved for issuance under the 2025 Pla<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.41pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">n&#59; an</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.63pt; position: absolute; text-decoration: none; white-space: pre;">d<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock reserved for future issuance under our 2025 Employee Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Purchase Plan (the &#8220;ESPP&#8221;), which will become effective immediately prior to the date our registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">statement relating to this offering becomes effective, as well as any future increases in the number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of common stock reserved for issuance under the ESPP.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless otherwise indicated, all information contained in this prospectus assumes or gives effect to&#58;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our amended and restated certificate of incorporation, to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in effect immediately prior to the completion of this offering, and the adoption of our amended and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restated bylaws, to be in effect upon the effectiveness of the registration statement of which this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">prospectus forms a part&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the automatic conversion of 122,231,454 outstanding shares of our Series A, Series B-1, Series B-2, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Series C, Series D, Series E, Series F and Series F-1 redeemable convertible preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 688.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(collectively, our &#8220;r<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.34pt; position: absolute; text-decoration: none; white-space: pre;">edeemable convertible preferred stock&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.68pt; position: absolute; text-decoration: none; white-space: pre;">) as of December 31, 2024 into an <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">16<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">aggregate of&#160;149,581,128 shares of our common stock, the conversion of which will occur <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">immediately prior to the completion of this offering (the &#8220;Preferred Stock Conversion&#8221;)&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the automatic conversion of $9<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.1pt; position: absolute; text-decoration: none; white-space: pre;">8.4 million <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.86pt; position: absolute; text-decoration: none; white-space: pre;">of convertible promissory notes with original maturity dates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of 48 months from the dates of issuance into an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which amount includes the $23.0 million aggregate principal amount of notes issued in the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Loan Conversion (collectively, the &#8220;2025 Convertible Notes&#8221;), assuming the assumed initial public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, which is the midpoint of the estimated price range set forth on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cover page of this prospectus, issued by us in January and March 2025, which will be automatically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">converted upon the effectiveness of this offering into an aggregate of&#160; &#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock (the &#8220;Convertible Notes Conversion&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-for- &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reverse stock split of our common stock, which we effected on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025 and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">corresponding adjustment to the ratio of the Preferred Stock Conversion, the Convertible Note <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Conversion and adjustment to our outstanding warrants&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">no exercise, settlement or termination of the outstanding options or warrants described above&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">no exercise by the underwriters of their option to purchase up to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; additional shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">17<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_694" style="position: absolute; top: 72pt;"></div><div style="font-size: 16pt; line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Summary<font style="display: inline-block; height: 11.64pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 144.88pt; position: absolute; text-decoration: none; white-space: pre;"> consolidated financial data<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following tables summarize our consolidated <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 290.87pt; position: absolute; text-decoration: none; white-space: pre;">financial<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 327.53999999999996pt; position: absolute; white-space: pre;"> data for the periods and as of the dates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indicated. The following summary consolidated statements of operations data for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024 and our consolidated balance sheet data as of December 31, 2024 have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been derived from our audited consolidated financial statements and related notes included elsewhere in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus. Our audited consolidated financial statements included elsewhere in this prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">historical results are not necessarily indicative of the results that may be expected for any period in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future. You should read the following summary consolidated financial data together with our audited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements and the related notes included elsewhere in this prospectus and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">section titled &#8220;Management&#8217;s discussion and analysis of financial condition and results of operations.&#8221; The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summary consolidated financial data included in this section are not intended to replace the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statements and the related notes included elsewhere in this prospectus and are qualified in their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entirety by the consolidated financial statements and the related notes thereto included elsewhere in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 263.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 283.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 331.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.42pt; position: absolute; text-decoration: none; white-space: pre;">Year ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 331.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated statements of operations data&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 43.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 43.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 43.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 43.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.77pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 73.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 73.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 73.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.81pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">29,123<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">31,359<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 54.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 56.580000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 57.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 58.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 58.400000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.440000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">58,051<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">94,449<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 136.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 138.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 138.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 138.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">35,854<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">43,517<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 167.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 168.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 168.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 168.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">95,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">112,154<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 125.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 140.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 142.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 143.42000000000002pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 143.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 143.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">130,965<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">155,671<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 139.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 98.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 98.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 98.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.86999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(72,914)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(61,222)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 149.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 151.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 153.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 153.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 153.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(19,237)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(18,702)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 168pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 141.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 143.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 143.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.62pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,957)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(16,449)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 182.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss before provision from income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 182.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 183.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 183.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 183.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 183.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,108)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,373)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 196.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 131.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 132.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 133.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 133.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(547)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(53)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 210.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 38.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 38.870000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 210.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 210.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 225pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cumulative dividends on Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 46.959999999999994pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 48.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 48.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 48.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 48.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 48.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 48.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.709999999999994pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 225pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,239)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 225pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 251.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 90.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 92.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 93.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 93.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 93.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 93.53pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 251.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(26,794)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 251.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 277.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common stockholders<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 202.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 203.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 203.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 203.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 203.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 203.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 277.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(123,688)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 277.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 291.75pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss per share attributable to common stockholders, basic and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 41.08pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 49.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 51.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 52.480000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 53.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 53.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 53.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.410000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 291.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(8.67)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 291.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(6.16)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 318pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used to compute net loss per share attributable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 200.51pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 208.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 208.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 208.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 208.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 318pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">14,265,293<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 318pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">15,661,682<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 344.25pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net loss per share attributable to common stockholders, basic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 60.53pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 68.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 68.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 68.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 68.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 344.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 370.5pt; width: 331.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma weighted-average shares used to compute net loss per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.97pt; width: 331.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 252.72pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 260.65000000000003pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 262.96000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 263.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 263.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 687.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">See <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 105.42pt; position: absolute; text-decoration: none; white-space: pre;">Notes 2<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 131.25pt; position: absolute; text-decoration: none; white-space: pre;"> and 16 to our consolidated financial statements included elsewhere in this prospectus for an explanation of the calculation <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 696.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of our basic and diluted net loss per share attributable to common stockholders and the weighted-average number of shares used in the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 705.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">computation of the per share amounts. <font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">18<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Unaudited pro forma net loss per share attributable to common stockholders, basic and diluted, for the year ended December 31, 2024 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">is c<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 101.24pt; position: absolute; text-decoration: none; white-space: pre;">alculated by giving effect to (i) removal of the effect of interest expense related to the 2024 Term Loan Conversion of $23.0 million <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and the $50.0 million partial repayment of the indebtedness outstanding under the 2024 Credit Agreement, (ii) the Preferred Stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 99pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Conversion, as if the shares resulting from the Preferred Stock Conversion were outstanding as of the beginning of the period <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">presented, (iii) the Convertible Notes Conversion, as if the shares resulting from the Convertible Notes Conversion were outstanding as <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 117pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of the beginning of the period presented, and (iv) stock-based compensation expense related to the grant of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; RSUs concurrent <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with this offering at the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the estimated price range set <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 135pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">forth on the cover page of this prospectus, as if 25% of the shares were vested and outstanding as of the beginning of the period <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">presented. The total stock-based compensation expense related to the concurrent RSU award is estimated to be $&#160;&#160;&#160;&#160;million. The RSUs <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 153pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">will be settled in shares of common stock and vest over four years in annual equal increments, subject to continued service, on the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">anniversary of the grant date. The following table summarizes our unaudited pro forma net loss per share for the year ended <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 171pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Decembe<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 122.08pt; position: absolute; text-decoration: none; white-space: pre;">r&#160;31, 2024&#58;<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="position: absolute; top: 188pt; width: 612pt;"><div style="font-size: 0pt; left: 90pt; position: absolute; top: 0pt; width: 450pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 381.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-top: 1.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000000; border-top: 1.5pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 384.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.15pt; position: absolute; text-decoration: none; white-space: pre;">Year ended <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.14pt; position: absolute; text-decoration: none; white-space: pre;">December 31, <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 381.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 48pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Numerator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 62.25pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 282.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 283.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 283.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 283.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.99pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 384.75pt; position: absolute; top: 62.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 76.5pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to remove interest expense related to debt conversion and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 381.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">repayment<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 58.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 59.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 59.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 102.75pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to add stock-based compensation expense related to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 381.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">RSUs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 37.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 38.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 129pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net loss attributable to common stockholders<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 247.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 248.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 248.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 248.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.93pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 384.75pt; position: absolute; top: 129pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 143.25pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Denominator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 157.5pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used in computing net loss per share attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 189.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 191.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 192.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 193.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 193.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 193.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 193.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.68pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 384.75pt; position: absolute; top: 157.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">15,661,682<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 183.75pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to reflect the Preferred Stock Conversion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 281.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 283.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 283.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 283.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.87pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 198pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to reflect the Convertible Notes Conversion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 291.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 293.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 293.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 293.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.87pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 212.25pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma adjustment to reflect the vesting of RSUs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 230.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 232.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 233.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 233.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 233.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 233.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 233.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 233.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 24.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 226.5pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 1.82pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma weighted-average shares used in computing pro forma net loss per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 13.82pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 252.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 253.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 253.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 251.25pt; width: 381.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 381.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net loss per share attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 372.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 373.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 373.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 373.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 373.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.99pt; position: absolute; text-decoration: none; white-space: pre;"> .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 384.75pt; position: absolute; top: 251.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="position: absolute; top: 469.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 263.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="5"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 201.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 201.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 93.17pt; position: absolute; text-decoration: none; white-space: pre;">As of December 31, 2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 263.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 35.15pt; position: absolute; text-decoration: none; white-space: pre;">Actual<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.02pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.489999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.65pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma as <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.4pt; position: absolute; text-decoration: none; white-space: pre;">adjusted<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 48.36pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(2)(3)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated balance sheet data&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 122.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 124.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 125.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 125.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.33999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">51,367<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 65.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Working capital<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 70.77pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 78.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.44pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">48,683<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 79.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 55.400000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 55.550000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 55.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">118,704<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 93.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 75.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.55pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 93.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">136,431<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 107.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 109.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 109.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 110.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.28pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 108pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 122.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 179.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 180.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 180.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 122.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">768,566<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 136.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated deficit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 89.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 90.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.5pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 136.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(970,959)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 150.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.97pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stockholders&#8217; equity (deficit)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 150.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 150.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(859,484)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 642.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The pro forma column above reflects (a) the issuance and sale of the 2025 Convertible Notes and the 2024 Term Loan Conversion that <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 651.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">occurred subsequent to December 31, 2024&#59; (b) the Preferred Stock Conversion&#59; and <font style="display: inline-block; height: 5.46pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 374.94pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">(c) </font><font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 385.75pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 660.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">amended and restated certificate of incorporation, to be in effect immediately prior to the completion of this offering.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 677.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The pro forma as adjusted column gives effect to (a) the pro forma adjustments set forth in (1) above, (b) the issuance and sale <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 686.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock in this offering at the assumed initial offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, which is the midpoint of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 695.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the estimated price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 704.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">commissions and estimated offering expenses payable by us, (c) the assumed repayment of <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 397.72pt; position: absolute; text-decoration: none; white-space: pre;">$50.0 million<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 439.78pt; position: absolute; text-decoration: none; white-space: pre;"> of the indebtedness <font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="background-image: url(&#39;data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHN0eWxlPSJwb2ludGVyLWV2ZW50czogbm9uZTsiPjxwYXRoIHN0eWxlPSJmaWxsOiB0cmFuc3BhcmVudDsgc3Ryb2tlOiAjMDAwMDAwOyBzdHJva2UtbGluZWNhcDogc3F1YXJlOyBzdHJva2Utd2lkdGg6IDAuNXB0OyIgZD0iTSA0OC4zMyA0OC4zMyBWIDk4My42NyBIIDc2Ny42NyBWIDQ4LjMzIEggNDguMzMiPjwvcGF0aD48L3N2Zz4=&#39;); background-size: 612pt 792pt; height: 792pt; position: absolute; width: 612pt; z-index: -9223372036854775805;"></div><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">19<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding under the 2024 Credit Agreement and payment of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of fees in connection therewith, and (d) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">the Convertible Notes Conversion </font><font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 204.13pt; position: absolute; text-decoration: none; white-space: pre;">at the assumed initial offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, which is the midpoint of the estimated <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">price range set forth on the cover page of this prospectus.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 107pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The pro forma as adjusted information above is illustrative only and will depend on the actual initial public offering price and other terms <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of this offering determined at pricing. Each $1.00 increase or decrease in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 125pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of our common stock, which is the midpoint of the estimated price range set forth on the cover page of this prospectus, would increase <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">or decrease, as applicable, each of our pro forma as adjusted <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 295.78999999999996pt; position: absolute; text-decoration: none; white-space: pre;">cash and cash equivalents, total stockholders&#8217; equity (deficit), and total <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 143pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">capitalization<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 133.32pt; position: absolute; text-decoration: none; white-space: pre;"> by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the number of shares offered by us, as set forth on the cover page of this <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 161pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expenses payable by us. Similarly, each increase or decrease of 1.0 million shares in the number of shares of common stock offered by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">us would increase or decrease, as applicable, each of our pro forma as adjusted <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 357.86pt; position: absolute; text-decoration: none; white-space: pre;">cash and cash equivalents, total stockholders&#8217; equity <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 179pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(deficit), and total capitalization<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 192.86pt; position: absolute; text-decoration: none; white-space: pre;"> by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">share of our common stock, which is the midpoint of the estimated price range set forth on the cover page of this prospectus, remains <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 197pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Working capital is defined as current assets less current liabilities. See our consolidated financial statements and related notes included <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 223pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">elsewhere in this prospectus for further details regarding our current assets and current liabilities.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">20<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_697" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risk factors<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investing in our common stock involves a high degree of risk. You should carefully consider the risks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described below, as well as the other information in this prospectus, including our financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the related notes and &#8220;Management&#8217;s discussion and analysis of financial condition and results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations,&#8221; before deciding whether to invest in our common stock. The occurrence of any of the events <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or developments described below could have a material adverse effect on our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects. In such an event, the market price of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could decline, and you may lose all or part of your investment. Additional risks and uncertainties not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presently known to us or that we currently believe are not material may also impair our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects. Please also see the sections titled &#8220;Special note regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forward-looking statements&#8221; and &#8220;Market and industry data.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to our business and industry<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We have incurred significant net losses since our inception, we expect to incur additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 269.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">substantial losses in the foreseeable future and we may not be able to achieve or sustain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">profitability. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have incurred significant net losses since our inception in 2007, and we expect to incur additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 313.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial losses in the foreseeable future. For the fiscal years ended December 31, 2023 and 2024, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 325.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incurred net losses of $95.7 million and $96.4&#160;million, respectively. As of December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 337.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we had an accumulated deficit of $874.5 million and $971.0&#160;million, respectively. Since inception, we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">spent significant amounts of cash to develop the Heartflow Platform, to fund research and development, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including our preclinical research and development activities and clinical trials related to our products, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scale our commercial operations and to recruit and retain key talent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 393.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The net losses we incur may fluctuate significantly from quarter to quarter and year to year, such that a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 405.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period-to-period comparison of our results of operations may not be a good indication of our future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance. We expect to continue to incur significant research and development, sales and marketing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 429.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory and other expenses as we expand our marketing efforts to increase adoption of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 441.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand existing relationships with our customers, obtain regulatory clearances or approvals for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 453.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">planned or future products, conduct clinical trials to extend applicability of our platform into new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indications or to develop new products or add new features to our existing products. The investments in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business may be more costly than we expect, and&#160;if we do not achieve the benefits anticipated from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these investments, or if the realization of these benefits is delayed, they may not result in increased <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue or growth in our business. In addition to the anticipated costs of growing our business, we expect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our general and administrative expenses to increase following this offering due to the additional costs of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">being a public company. If our revenue growth does not increase to more than offset the anticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increases in our operating expenses, we may not be able to achieve or sustain profitability and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects will be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, our revenue may decline or our revenue growth, if any, may be constrained. Our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase sales is uncertain, and we may never be able to achieve or sustain profitability for many <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reasons, including that&#58; our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 239.74pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 259.15999999999997pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.82pt; position: absolute; white-space: pre;"> Analysis may not achieve widespread adoption among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare providers and we may be unable to increase revenue generated from sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis&#59; our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.28pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.26pt; position: absolute; white-space: pre;">Plaque Analysis may not achieve widespread adoption among healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers and we may be unable to generate sufficient revenue from sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.67pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.65pt; position: absolute; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis&#59; payors, such as insurance companies and government insurance programs, may decide not to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimburse for our products, may set the amount of such reimbursement too low or reduce the amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such reimbursement&#59; healthcare industry trends, including growth in CCTA usage, may move in directions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that do not allow for adoption of our products or that do not provide adequate incentives for the adoption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our products&#59; competitors may develop or acquire a product that successfully competes with ours&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 701.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturers of CT scanners may partner with our competitors or develop or acquire a competing <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">21<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product and integrate one or more products that successfully competes with ours&#59; we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain regulatory approval for future versions of our products (including improved versions of our AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">algorithms), new indications for use of our products or other future products&#59; and there may be changes in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing or anticipated clinical guidelines, including the current ACC and AHA Class 1, Level A guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for CCTA and Class 2a, Level B guidelines for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 277.31pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.28999999999996pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 341.71pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.37pt; position: absolute; white-space: pre;"> Analysis for certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acute chest pain and no known CAD, or the timing of adoption of positive clinical guidelines that support <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the use of the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.31pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.29000000000002pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 199.70999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.37pt; position: absolute; white-space: pre;"> Analysis. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Because of these and the other risks and uncertainties described in this prospectus, we are unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predict the extent to which we will be able to increase sales, if at all, or the timing for when or the extent to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which we will become profitable, if ever. We will need to generate significant additional revenue to achieve <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and sustain profitability, and even if we do achieve profitability, we may not be able to sustain or increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability. Our failure to become and remain profitable would depress the value of our company and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock price and could impair our ability to raise capital, fund our research and development efforts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand our business, diversify our product offerings or continue our operations. A decline in the value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our company could cause you to lose all or part of your investment.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our revenue is currently generated almost entirely from the sales of only one product, Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: bold; left: 91.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 100.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, and we are therefore highly dependent on the success of this product, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">makes it difficult to evaluate our current business, predict our future prospects and forecast our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">financial performance and any growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.08pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.06pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 272.48pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.14pt; position: absolute; white-space: pre;"> Analysis represented 98% of our total revenue. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">second half of 2023, we began limited market education efforts of our second product, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 454.54pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.52pt; position: absolute; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis. Over the next several years, we expect to continue to devote a substantial amount of resources <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to increase sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 178.09pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.07pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 242.49pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.15pt; position: absolute; white-space: pre;"> Analysis and also expand our commercialization efforts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">drive increased adoption of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.98pt; position: absolute; white-space: pre;">Plaque Analysis. However, we may not succeed in increasing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.41pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 190.82999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.49pt; position: absolute; white-space: pre;"> Analysis or in increasing adoption of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 381.69pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.67pt; position: absolute; white-space: pre;">Plaque Analysis. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expect to continue to derive almost all of our revenue from sales of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.15pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.13pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 433.55pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.21pt; position: absolute; white-space: pre;"> Analysis for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreseeable future, so we are highly dependent on its success. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, because we plan to devote substantial resources to increase sales of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.41pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.39pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 495.81pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis and rely on it as our main source of revenue, any factors that negatively impact these efforts, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">Plaque Analysis commercialization efforts or our ability to diversify our products would have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Therefore, it is difficult to predict our future prospects and forecast our financial performance and any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth, and any such forecasts are inherently limited and subject to a number of uncertainties. If our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions regarding the risks and uncertainties we face, which we use to plan our business, are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorrect or change due to circumstances in our business or our markets, or if we do not address these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">risks successfully, our operating and financial results could differ materially from our expectations and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects could suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If healthcare providers are unwilling to change their standard practice regarding the evaluation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">CAD, our business, financial condition, results of operations and prospects will be adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our success depends on physicians, hospitals and other healthcare providers adopting and using the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform to aid in the evaluation of CAD. While we have had some recent success in achieving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">broader adoption of the Heartflow Platform, we have in the past faced, and may in the future face, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenges in achieving higher rates of adoption. Many healthcare providers have extensive experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with existing non-invasive tests for CAD and have established relationships with the companies that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide these tests or in some instances own or manage the equipment for these tests in their offices. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Existing tests are performed in a high enough volume that healthcare providers generate sufficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue from their use and are well versed in their use, reimbursement and outcomes. The outcomes and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">workflow efficiencies that we believe our Heartflow Platform provides may not be valued by healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">22<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers as highly as we expect or at all. In addition, healthcare providers have been, and may continue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to be, slower to adopt or recommend our products because we have a more limited commercial track <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">record and healthcare providers may feel they can generate more revenue from existing tests. Healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers also may not find our clinical data compelling and may not recommend or use our products until <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they receive additional recommendations from other healthcare providers that our products have a clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefit, or at all. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the Heartflow Platform relies on healthcare providers following the ACC and AHA guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by referring certain patients with stable or acute chest pain and no known CAD to undergo a CCTA, with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the CCTA images to be analyzed by our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.67pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.65pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 315.07pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.73pt; position: absolute; white-space: pre;"> Analysis. Although the ACC and AHA guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support CCTA plus our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.12pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.1pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 239.52pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.18pt; position: absolute; white-space: pre;"> Analysis as the preferred pathway for diagnosing and managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD in certain patients with stable or acute chest pain and no known CAD, these guidelines may not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">widely adopted by healthcare providers. Moreover, healthcare providers may choose not to adopt the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform if they are not able to obtain an adequate CCTA. Further, if future studies and trials or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other events, including reimbursement rates of CCTA, adversely impact the rate of use of CCTAs in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practice, then healthcare providers may be less willing to adopt a technology that uses CCTAs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Also, the Heartflow Platform may be more difficult than we expect to integrate into standard practice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">because a provider may be resistant to introduce our embedded information technology and workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">infrastructure. Due to different laws, policies and preferences of healthcare providers regarding patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy both in the United States and abroad, they may be averse to sending data externally (outside of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their facility) or abroad. Furthermore, if healthcare providers using the Heartflow Platform experience what <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they perceive to be false negative result or imprecise readings, including due to user error, they may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine not to continue using our platform going forward.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect that addressing these and similar issues will require a significant amount of our time and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources, and if we are unsuccessful, we would be unable to achieve broader adoption of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform by healthcare providers. If our products do not gain broader acceptance by healthcare providers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, financial condition, results of operations and prospects will be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If third-party payors, including government payors, do not cover and provide adequate, or any, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement for the Heartflow Platform, or if existing payment amounts are reduced or coding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">changes, adoption of the Heartflow Platform by healthcare providers will be negatively impacted, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and our business, financial condition, results of operations and prospects will be adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to grow sales and revenue from our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.73pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.71000000000004pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 344.13pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.79pt; position: absolute; white-space: pre;"> Analysis and to successfully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.88pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.86pt; position: absolute; white-space: pre;">Plaque Analysis depend, in large part, on whether third-party payors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including private health insurers, managed care plans and government healthcare programs, such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicare and Medicaid, cover and adequately reimburse for the use of the Heartflow Platform and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underlying CCTA. Patients generally rely on payors to reimburse all or a significant part of the costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">associated with their treatment. As a result, coverage determinations and reimbursement levels are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">critical to the commercial success of the Heartflow Platform. Reimbursement is obtained from a variety of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sources, including government sponsored and private health insurance plans, and varies by country and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by region within some countries. These payors determine whether to provide coverage and payment for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific products and procedures. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, payors continually review new technologies and can, without notice, deny coverage. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, the coverage determination process is often time consuming and costly, with no assurance that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage and adequate reimbursement will be obtained or maintained if obtained. If payors change their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement policies, including if the current Category 1 CPT codes related to our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.18pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.16pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 510.58pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis or future Category 1 CPT codes related to our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.3pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.28pt; position: absolute; white-space: pre;">Plaque Analysis are not favorably <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">priced, we would be unable to obtain favorable Medicare reimbursement for the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Moreover, physicians, hospitals and other healthcare providers may decline to adopt or reduce usage of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform due to the economic impact a change in reimbursement may have on their <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">23<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business and, as a result, we may experience a significant loss of revenue, which would have a material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Given the evolving nature of the healthcare industry and ongoing healthcare cost reforms, we are and will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continue to be subject to effects of changes in the level of Medicare reimbursement for our products. A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduction in coverage or payment by the Medicare program could cause some commercial third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors to implement similar reductions in their coverage or payment amounts for the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unfavorable coverage or payment determinations at the national or local level could adversely affect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with a concentrated customer base.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although our Heartflow Platform had an installed base of more than 1,100 accounts in the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of December 31, 2024, the decision-making function for some of these accounts is concentrated in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relatively small number of customers, such that the loss of one customer could result in a disproportionate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loss across our accounts. For example, for the year ended December 31, 2024, our top two largest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers collectively represented approximately 8% of our revenue. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We cannot guarantee that that we will continue to generate revenue from these customers, whether due <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to increase in competition, new technologies, our customers&#8217; ability to terminate their contracts with us or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce order volumes, or other factors outside of our control. If we do not increase the number of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers and drive increased use of the Heartflow Platform as the preferred non-invasive testing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">method for assessing CAD, we will continue to face risks associated with a more concentrated customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">base.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue from these customers may fluctuate from time to time due to demand for the Heartflow Platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the timing of which may be affected by seasonality or other factors outside of our control such as CT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scanner capacity, contrast availability and staffing availability. These customers could also potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pressure us to reduce the prices we charge for the Heartflow Platform, which could have a material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse effect on our margins and business. For example, during the year ended December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our average sales price was impacted by customer pricing contracts that included utilization and volume <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rebates and by changes in the mix of customer accounts, which trend we expect to continue in the near <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">term, and it is possible that similar trends in customer pricing contracts may continue to have a negative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact on our average sales price in the future. In addition, if any of our largest customers terminates its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationship with us or otherwise reduces its FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 287.49pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.15pt; position: absolute; white-space: pre;"> Analysis volumes for any reason, we may be unable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to replace them with a customer who refers a similar number of patients for the Heartflow Platform, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such termination or reduction in volume could have a material adverse effect on our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face significant competition in an environment of rapid technological change, and there is a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">possibility that our competitors may develop products that are more effective, accurate, reliable, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">cost-effective or more advanced than ours, which may harm our financial condition. If we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">unable to compete successfully or our potential market share is reduced, we may be unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">increase or sustain our revenue or achieve profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The medical technology industry is highly competitive, subject to rapid change and significantly affected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the introduction of new products and technologies and other activities of industry participants. Because <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the size of the market opportunity for the treatment of CAD, we believe current and potential future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors will dedicate significant resources to aggressively promote their products or develop new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products or treatments. Our principal competition comes from companies that provide traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive tests that aid physicians in the evaluation of CAD, such as SPECT, stress echocardiography and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PET. Established, traditional non-invasive tests for CAD have been used for many years and are therefore <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficult to change or supplement. Many of the companies that sell these traditional non-invasive tests or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the equipment they require have established relationships with healthcare providers. One of the major <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hurdles to adoption of our products is overcoming established testing patterns, which requires education <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of physicians and supportive clinical data. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">24<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The companies that sell the traditional non-invasive tests for CAD include companies that offer&#58; (i) cardiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific tests to primary care and cardiology offices, such as manufacturers of capital equipment for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress echocardiography and SPECT, including GE Healthcare, Siemens Healthineers AG and Koninklijke <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Philips N.V.&#59; and (ii) products used for the invasive FFR testing market.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">With the greater resources of some of these competitors and their more diversified product offerings, it is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possible that they or other entrants into the market may develop competing products or technologies that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could be more effective, accurate, reliable, cost-effective, more advanced or otherwise improved relative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the Heartflow Platform, which could render our products obsolete or less competitive. In addition, one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or more competitors could develop and market an on-premise solution, which may be more appealing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than our cloud-based offering. Moreover, new treatments, such as GLP-1s, may indirectly reduce stenosis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or plaque build-up, which could reduce the market opportunity for non-invasive CAD tests and, as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, our Heartflow Platform. In addition, we currently target our Heartflow Platform for use only on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptomatic patients and expanding the Heartflow Platform for asymptomatic patients may take years, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with potential delays due to the high-risk nature of the effort. Our competitors who offer traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive tests offer those tests to both symptomatic and asymptomatic patients, and this increased market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penetration could create additional price pressure for our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the field of cardiovascular genomics is subject to rapidly changing technology, and others may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invent and commercialize technology platforms such as next generation sequencing approaches that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could compete with our products or could make our products or any product we may sell in the future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obsolete. We also face competition and price pressure from companies that have developed or are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing AI-based platforms that leverage CCTA to diagnose CAD, including earlier-stage companies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as Cleerly, Inc., Elucid Bioimaging Inc. and Keya Medical Technology Co., Ltd. We may also face <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competition from companies developing AI-based platforms, even if they are not currently in the CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market and recent and future advances in AI may allow other companies to quickly create competing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, and they may be able to create such products less expensively and benefit from FDA and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement approvals we and others have obtained. For us to remain competitive, we must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continuously work on our products&#8217; design and features, improve our algorithms, and invest in and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">develop new technologies, including in the rapidly evolving area of AI. If we are unable to introduce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, features and improvements aimed at increasing the value proposition of the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our customers, or if the products, features and improvements we introduce are viewed less favorably <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than our competitors&#8217; products, we may be unable to compete successfully. If we are unable to compete <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">successfully against our current or future competitors, we may be unable to increase market acceptance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our products, which could prevent us from increasing or sustaining our revenue or achieving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability and could cause the market price of our common stock to decline.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the Heartflow Platform relies on a CCTA first being performed, as the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires a CT image from a CT scanner to perform its analysis. A number of companies manufacture CT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scanners, including, among others, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V., Samsung <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Electronics Co., Ltd., Siemens Healthineers AG and Canon Medical Systems Corporation. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies are more diversified than we are and have substantial financial, manufacturing, sales and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing distribution and other resources. Any of these companies or others could determine to develop, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partner with or acquire and offer a product that competes with ours or manufacture CT scanners that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">no longer compatible with our Heartflow Platform. Further, these larger companies have market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penetration in the CT scanner market and understand the market for CAD and, if they are able to develop, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partner with or acquire a competing product, they may offer it as a bundle with the purchase of a CT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scanner, which could prevent us from increasing or sustaining our revenue or achieving profitability. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">past, three of these companies, Siemens Healthineers AG, Koninklijke Philips N.V. and Canon Medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Systems Corporation, considered development of a local workstation-based technology prototype aimed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at deriving CT-based blood flow data without an invasive procedure. If these companies decide to further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursue this technology and obtain regulatory approval or clinical validation, it may become competitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with our products. In addition, we are reliant on these third-party CCTAs and CT scanners continuing to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support standard output file formats that our Heartflow Platform supports. If a CT manufacturer were to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change to a proprietary format or develop a novel method of performing CT scans, we would need to <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">25<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">further develop our existing technology to accommodate the images its scanners output, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">materially affect the ability of physicians to use the Heartflow Platform, increase our R&#38;D expenses, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The size and expected growth of our addressable market may be smaller than we estimate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our estimate of the addressable market for our current products and any future products is subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant uncertainty and is based on assumptions and estimates, including our internal analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">industry experience. While we believe our assumptions and the data underlying our estimates are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reasonable, these assumptions and estimates may not be correct. As a result, our estimates of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addressable market for our current or future products may prove to be incorrect. Moreover, our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">serve a significant portion of this estimated market is subject to many factors, including our success in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promoting the use of CCTA as a non-invasive diagnostic test that can be combined with the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform, which is subject to many risks and uncertainties, and relies on the availability and proximity of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare facilities with active CCTA programs to the patients in our estimated market. Accordingly, if we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are unable to increase the use of CCTA at the rates we estimate, if the actual number of patients who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would benefit from our products is less than we estimate, or if the price at which we can sell future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products or the reimbursement rate received by healthcare providers is less than we estimate, the size <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and expected growth of our addressable market would be smaller than our estimates, which could have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may not be successful in updating or otherwise enhancing the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A part of our strategy is bringing new enhancements to our customers through updates to the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform, which may include offering new products, additional features, applications and improvements to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our technology. We expect to make significant investments to advance these efforts, and enhancing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform is a complex and time-consuming endeavor. New products, additional features, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications and improvements to our technology that initially show promise may fail to achieve the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">desired results or may not achieve acceptable levels of analytical accuracy, utility or user friendliness. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Product development and improvement is expensive, may take months or years to complete and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have uncertain outcomes. Failure can occur at any stage of the development or improvement process <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and may occur only after substantial work has been completed, or after completion. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Even if, after development, an updated product appears successful, we may, depending on the nature of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the update, need to obtain regulatory clearances, authorizations or approvals before we can market the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">updated product. Such regulatory clearances, authorizations or approvals are likely to require significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time and expenditures and the applicable regulatory authority may not clear, authorize or approve any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, update or new product we develop. Obtaining such clearances, authorizations or approvals may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require data from clinical trials, which can be costly and time-consuming to obtain. In certain jurisdictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or in certain cases, clinical data may also be required in order to obtain reimbursement coverage, and this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical data may be in addition to data required to obtain regulatory clearances, authorizations or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approvals. Some clinical studies may fail to meet their endpoints, introducing risk or delay in the ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize a new feature or product. In light of these requirements, we may choose to limit the scope <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any new products, additional features, applications and improvements we seek to develop. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Even if we develop a product update or new product that receives regulatory clearance, authorization or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval, and for which we obtain sufficient commercial third-party and government reimbursement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage, we would need to commit substantial resources to commercialize and market the updated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, new product or new application of our existing product, which may never achieve market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acceptance among various stakeholders or be commercially successful. Further, the applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations or the application of those regulations could change in ways that would impact the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform and our ability to successfully manufacture or market our products. The expenses or losses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">associated with unsuccessful updates to or expansion of the Heartflow Platform could adversely affect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">26<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The commercialization of Heartflow Plaque Analysis is nascent, and we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">achieve or maintain sufficient market acceptance or the levels of utilization we expect from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis or any other future product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We began limited market education efforts for our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.24pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.22pt; position: absolute; white-space: pre;">Plaque Analysis in the second half of 2023, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and we have generated very minimal revenue from this product. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.97pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.95pt; position: absolute; white-space: pre;">Plaque Analysis has taken <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time and significant resources to develop, and we may not be able to achieve customer acceptance or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">broad commercial reimbursement coverage, which could limit its adoption. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The market for alternative plaque analysis products is competitive in terms of development, availability, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing, product quality and time-to-market. We face competition from companies that provide or are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing similar plaque analysis products, which may distinguish themselves from us through, among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other things, perceived product quality, style and visuals, sleek design, enhanced user-friendliness and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">innovative features. In addition, some of these competitors are agile, early-stage companies that may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to respond more quickly and effectively than we can to new or changing opportunities, technologies, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standards or customer requirements in the plaque analysis category. Some of these competitors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercially launched competing plaque analysis products prior to our launch of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.55pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.53pt; position: absolute; white-space: pre;">Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis and may have a first-mover advantage as a result. For more information on risks related to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competition, see the risk factor titled &#8220;We face significant competition in an environment of rapid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technological change, and there is a possibility that our competitors may develop products that are more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective, accurate, reliable, cost-effective or more advanced than ours, which may harm our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition. If we are unable to compete successfully or our potential market share is reduced, we may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to increase or sustain our revenue or achieve profitability.&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our competitors may also be able to offer plaque analysis products similar or superior to ours at a more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attractive price than we can or may be better positioned to serve certain segments of our market, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could create additional price pressure. For example, our competitors have in the past, and may in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future, offer plaque analysis and other products at a more attractive price than we can such that current or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential customers may select our competitors&#8217; products in lieu of purchasing and using our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 481.58pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis. Moreover, our competitors have in the past, and may in the future, suggest that their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque analysis and other products could replace both our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 331.46pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.44pt; position: absolute; white-space: pre;">Plaque Analysis and our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis, which would adversely affect our ability to achieve sufficient market acceptance for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">Plaque Analysis, could affect sales of our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.2pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.18pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 365.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 374.26pt; position: absolute; white-space: pre;"> Analysis and could cause our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis to lose market share. While we believe <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 361.11pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.09pt; position: absolute; white-space: pre;">Plaque Analysis represents a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant long-term opportunity for us, there can be no assurances that we will successfully compete in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such market and our business, financial condition, results of operations and prospects could be materially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face risks associated with our use and development of AI models, which may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">operational challenges, legal liability, reputational concerns and competitive risks. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We use and develop AI and automated analysis and decision-making technologies, including proprietary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AI algorithms and models and computational fluid dynamics (collectively, &#8220;AI Technologies&#8221;) to power the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform. In addition, we use AI Technologies to drive improvements in the performance of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform. We expect that significant increased investment will be required in the future to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">improve our use and development of AI Technologies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">As with many technological innovations, there are significant risks involved in developing, maintaining and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">deploying these technologies. In particular, if the AI Technologies underlying our Heartflow Platform are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">incorrectly designed or implemented&#59; trained or reliant on incomplete, inadequate, inaccurate or otherwise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">poor quality data&#59; used without sufficient oversight and quality control&#59; misused or used outside of scope <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">of applicable regulatory authorizations&#59; and&#47;or adversely impacted by unforeseen bugs, defects, technical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">challenges, cybersecurity threats or material performance issues, the performance of our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Platform and business, as well as our reputation and the reputations of our customers, could suffer or we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">could incur liability resulting from the violation of laws or contracts to which we are a party, regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">27<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">enforcement actions or civil claims. This could result in fines, penalties and damage awards and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">disgorgement of any output, development or technology developed as a result of such violations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we leverage a human-in-the-loop AI system that combines advanced algorithms with an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analyst-based quality inspection and monitoring process to create patient-specific reports based on CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">images. While we constantly work to improve our Heartflow Platform and algorithms, the AI Technologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we work with are novel and complex, and we cannot assure you that our AI Technologies will be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perform as intended under all circumstances, or that our analyst-based review process will identify and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">correct any errors in the outputs of our AI Technologies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The regulatory framework for AI Technologies is rapidly evolving as many federal, state and foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government bodies and agencies have introduced or are currently considering additional laws, regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and guidance. For example, the FDA has issued guidance documents relating to the incorporation of AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Technologies into medical devices and marketing submissions for AI-enabled devices. Specifically, draft <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidance issued on January 7, 2025, titled Artificial Intelligence-Enabled Device Software Functions&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Lifecycle Management and Marketing Submission Recommendations, proposes recommendations for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">design, development and implementation of AI-enabled devices that FDA encourages manufacturers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consider using throughout the total product lifecycle. In addition, the California Privacy Protection Agency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has approved for rulemaking regulations under the CCPA regarding the use of automated decision-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making that may require risks and providing notice and rights to opt-out and access to information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underlying the logic and outputs. Colorado passed the Colorado AI Act, which will go into effect in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">February 2026. This law creates duties for developers and deployers to use reasonable care to protect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consumers from any known or reasonably foreseeable risks of &#8220;algorithmic discrimination&#8221; arising from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the intended and contracted uses of &#8220;high-risk AI systems,&#8221; including those that impact healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services. Such additional laws, regulations and guidance may impact our ability to develop, use and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize AI Technologies in the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">It is possible that further new laws and regulations will be adopted in the United States and in other non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. jurisdictions, or that existing laws and regulations, including competition and antitrust laws, may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpreted in ways that would limit our ability to use AI Technologies for our business, or require us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change the way we use AI Technologies in a manner that negatively affects the performance of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform and the way in which we use AI Technologies. We may need to expend resources to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adjust our&#160;Heartflow Platform in certain jurisdictions if the laws, regulations or decisions are not consistent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">across jurisdictions. Further, the cost to comply with such laws, regulations or decisions and&#47;or guidance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpreting existing laws, could be significant and would increase our operating expenses (such as by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">imposing additional reporting obligations regarding our use of AI Technologies). Such an increase in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating expenses, as well as any actual or perceived failure to comply with such laws and regulations, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could materially and adversely affect our business, financial condition, results of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow Platform and the data and models it generates could have bugs, defects or errors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">including human quality control errors, or otherwise fail to meet the expectations of patients, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">physicians and third-party payors, which could adversely affect our reputation, business and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We cannot provide assurance that the proprietary technology and algorithms used in our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform do not contain undetected bugs, defects or errors or that our analyst-based review process will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identify and correct any errors in the outputs of our AI Technologies. We cannot provide assurance that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limitations of the inbound CCTA images and image quality will always allow a true representation of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient anatomy, and any such limitations in CCTA images could affect the results of our analyses. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have in the past, and may in the future, experience defects or errors in our Heartflow Platform or the data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and models it generates that remain undetected by our analyst-based review process, our reputation, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business and operating results could be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, the success of the Heartflow Platform depends in part on patients&#8217;, physicians&#8217; and third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party payors&#8217; confidence that our platform can provide reliable, high-quality actionable data and analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">28<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that will improve clinical decision making. We believe that patients, physicians and third-party payors are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">likely to be sensitive to product defects and errors in the use of our products, including if the defects and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">errors affect a physician&#8217;s ability to use the CCTA imaging results or result in a misdiagnosis. In the past, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we have experienced software code defects and software release process defects that have resulted in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intermittent interruptions to the physician&#8217;s ability to use our Heartflow Platform, and we may experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such defects in the future. A subset of these defects were reported as part of the FDA&#8217;s Manufacturer and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">User Facility Device Experience (&#8220;MAUDE&#8221;) disclosure. For more information, see the risk factor titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;The Heartflow Platform may be subject to recalls, which could be costly and could harm our reputation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and business.&#8221; As a result, the failure of our Heartflow Platform to perform as expected, including to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce unnecessary invasive testing or fail to enable physicians to optimize treatment planning or provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more efficient care, could significantly impact a physician&#8217;s willingness to use and rely on the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform, which would impair our operating results and our reputation. In addition, we may be subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legal claims arising from any such failures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bugs, defects or errors in the Heartflow Platform or the failure of third-party service providers we rely on, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as AWS or other cloud storage and telecommunications services providers, to block a virus or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prevent a security breach could harm our reputation and adversely impact our results of operations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Defects may cause our products to be vulnerable to security attacks, cause them to fail to produce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurate results or temporarily interrupt our commercial operations. Because the techniques used by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computer hackers to access or sabotage networks change frequently and generally are not recognized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until launched against a target, we or our third party services providers may be unable to anticipate these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">techniques and provide a corrective measure in time to protect the Heartflow Platform and our networks. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Potential defects may further cause the platform to be unavailable for a period of time, affect ability of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer to access information, result in a slow or suboptimal user experience, impact turnaround time of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an analysis, or provide other forms of degradation to the overall service. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">develop, motivate and retain our personnel, including highly qualified, technical personnel, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">may not be able to grow effectively and this could adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To execute our growth plan, we must attract and retain highly qualified, technical personnel. Competition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for these personnel is intense, especially for engineers with high levels of expertise in AI, cloud <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">architecture, 3D visualization, research scientists and senior sales executives with experience in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiology industry. We may experience difficulty in hiring and retaining employees with appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualifications. Many of the companies with which we compete for experienced personnel have greater <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources than we have. We also compete with companies that are believed to have high potential growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunities or that have experienced rapid recent growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our future success depends in part on our ability to continue to retain our executive officers and other key <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees and to recruit and hire new employees, including engineers, research scientists, case analysts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and production team members. We do not maintain &#8220;key person&#8221; insurance for any of our executives or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other employees. The loss of the services of any of these persons could impede the achievement of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development, research and commercialization objectives. Any of our executive officers and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees may terminate employment with us at any time with no advance notice. The replacement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any of our key personnel likely would involve significant time and costs, may significantly delay or prevent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the achievement of our business objectives and may harm our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, job candidates and existing employees often consider the value of the stock awards they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receive in connection with their employment. If the perceived value of our stock awards declines or is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perceived to be less valuable than stock awards of other competing employers, it may adversely affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our ability to recruit and retain highly skilled employees. In addition, many of our employees have become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or will soon become vested in a substantial amount of stock or number of stock options. Our employees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be more likely to leave us if the shares they own or the shares underlying their vested options have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly appreciated in value relative to the original purchase prices of the shares or the exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prices of the options, or if the exercise prices of the options that they hold are significantly below the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">29<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market price of our common stock. If we fail to attract new personnel, or fail to retain and motivate our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current personnel, our business and prospects could be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we fail to properly manage our future growth, our business could suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We intend to continue to grow and may experience periods of rapid growth and expansion, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">place a significant additional strain on our limited personnel, information technology systems and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources. Our future growth will impose significant added responsibilities on management, including the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">need to identify, recruit, train and integrate additional employees. In order to manage our operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth we will need to continue to improve our operational and management controls, administrative and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operational infrastructure, reporting and information technology systems and financial internal control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures. Due to our limited financial resources and the limited experience of our management team in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managing a company with such future growth expectations, we may not be able to effectively manage the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected expansion of our operations or recruit and train additional qualified personnel. Moreover, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected expansion of our operations may lead to significant costs and may divert our management and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business development resources. Any inability to manage growth could delay the execution of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business plans or disrupt our operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, as demand for the Heartflow Platform increases, we will need to scale our capacity, expand <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer service and enhance our internal quality assurance program. We may fail to implement any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increases in scale, related improvements and quality assurance, and we may fail to find appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">personnel to facilitate the growth of our business. Due to our limited resources, we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectively manage this simultaneous execution and expansion of our operations. This may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">weaknesses in our infrastructure, give rise to operational mistakes, legal or regulatory compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">failures, loss of business opportunities, loss of employees and reduced productivity among remaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees. The expansion of our operations may lead to significant costs and may divert financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources from other projects, such as the development of any new products. If our management is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to effectively manage our expected development and expansion, our expenses may increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more than expected, our ability to generate or increase our revenue could be reduced and we may not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to implement our business strategy. Our future financial performance and our ability to compete <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectively and commercialize our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.35pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.33000000000004pt; position: absolute; white-space: pre;">Plaque Analysis or any of our future products will depend in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">part on our ability to effectively manage the future growth and expansion of our company. If we are unable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to manage our growth effectively, it may be difficult for us to execute our business strategy and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our business could be disrupted by catastrophic events.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The occurrence of any catastrophic event, including earthquake, fire, flood, tsunami or other weather <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">event, power loss, telecommunications failure, software or hardware malfunctions, pandemics, political <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unrest, geopolitical instability, severe or prolonged economic downturn, cyberattack (including a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ransomware attack), war or terrorist attack, could result in lengthy interruptions in our ability to serve our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers. In addition, acts of terrorism could cause disruptions to the internet or the economy as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">whole and could disproportionately affect us given our reliance on the internet and cloud-based services. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Specifically, our corporate headquarters are located in Mountain View, California and our production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related computers are currently located in our Mountain View office and in Austin, Texas. California is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered to be an active earthquake zone, is prone to catastrophic fires, severe weather events and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follow-on effects thereof, including tsunamis, mudslides, flooding, power outages and other events that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could disrupt our business. Texas is also subject to severe weather events, power outages and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">events that could disrupt our business. Any event that prevents our access to such facilities, physically or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">virtually, would prevent us from operating our business and have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we rely on our network and third-party infrastructure, including our cloud-based infrastructure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which we outsource to Amazon Web Services (&#8220;AWS&#8221;), and enterprise applications, internal technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems and our website, for our development, marketing, operational support hosted services and sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities. In the event of a catastrophic event, we may be unable to continue our operations and may <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">30<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">endure system interruptions, delays in our ability to generate reports and output them to physicians, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reputational harm, delays in our product development, breaches of data security and loss of critical data, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of which could have an adverse effect on our future operating results. If we are unable to develop <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adequate plans to ensure that our business functions continue to operate during and after a disaster and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to execute successfully on those plans in the event of a disaster or emergency, our business would be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">harmed. Even with our disaster recovery arrangements and insurance coverage, the ability of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers to access and utilize our Heartflow Platform could be interrupted, or we could close critical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">data, which would have a negative impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the occurrence of a catastrophic event could impact providers of CCTAs, contrast agents for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTAs or suppliers of iodinated contrast media or similar supplies that are necessary to perform CCTAs. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For example, in 2022, the shutdown of an iodinated contrast media manufacturing facility led to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant shortage of iodinated contrast media, which resulted in the cancellation or rescheduling of non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">urgent contrast-requiring cardiac procedures and imaging. Any of these events could affect demand for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform, which could have a material adverse effect on our business, financial condition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Consolidation&#160;among healthcare providers could have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the United States, there has been a trend of consolidation among healthcare providers and purchasers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of medical technology devices, often to gain greater market power. As healthcare providers consolidate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they may try to use their market power to negotiate price concessions or reductions for the products and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services they purchase and use, including our Heartflow Platform. As result, it is unknown whether such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchasers will decide to stop purchasing our Heartflow Platform or demand discounts on our prices. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduce our prices in response to these industry trends, our revenue would decrease, which could have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may acquire other companies, solutions or technologies, which could divert our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">management&#8217;s attention, result in additional dilution to our stockholders and otherwise disrupt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our operations and adversely affect our operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may in the future seek to acquire or invest in companies, solutions or technologies that we believe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could complement or expand our products, enhance our technical capabilities or otherwise offer growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunities. The pursuit of potential acquisitions or other investment opportunities may divert the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attention of management and cause us to incur various expenses in identifying, investigating and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuing suitable transactions, whether or not they are consummated. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If we acquire any businesses, we may not be able to integrate the acquired personnel, operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technologies successfully, or effectively manage the combined business following the acquisition. We also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not achieve the anticipated benefits from the acquired business due to a number of factors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#58; inability to integrate or benefit from acquired technologies or services in a profitable manner&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unanticipated costs or liabilities associated with the acquisition&#59; incurrence of acquisition related costs&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficulty integrating the accounting systems, operations and personnel of the acquired business&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficulties and additional expenses associated with supporting legacy products and hosting infrastructure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the acquired business&#59; diversion of management&#8217;s attention from other business concerns&#59; use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources that are needed in other parts of our business&#59; adverse effects to our existing business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationships with business partners and customers as a result of the acquisition&#59; the potential loss of key <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees&#59; and use of substantial portions of our available cash to consummate the acquisition.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, a significant portion of the purchase price of any companies, solutions or technologies that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may acquire may be allocated to acquired goodwill and other intangible assets, which must be assessed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for impairment at least annually. If our acquisitions do not yield expected returns, we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">take charges to our operating results based on this impairment assessment process, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">31<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our operating results and cause the market price of our common stock to decline. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an acquired company, solution or technology fails to meet our expectations and does not complement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand our products, enhance our technical capabilities or otherwise offer growth opportunities, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, financial condition, results of operations and prospects may suffer. In addition, the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement restricts our ability to pursue certain mergers, acquisitions, amalgamations or consolidations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that we may believe to be in our best interest.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sales to customers outside the United States or with international operations expose us to risks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">inherent in international sales.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In our fiscal years ended December 31, 2023 and 2024, sales to customers outside the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounted for approximately&#160;11% and&#160;9% of our revenue, respectively. One element of our growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">strategy is to further expand our international operations and worldwide customer base. Operating in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international markets requires significant resources and management attention and subjects us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory, economic and political risks that are different from those in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have limited operating experience in international markets, and we cannot assure you that our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing presence in the United Kingdom, Europe and Japan or any expansion efforts into other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international markets will be successful. Our experience in the United States and international markets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be relevant to our ability to expand in other markets. Our international expansion efforts may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be successful in creating further demand for our products outside of the United States or in effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">selling our products in the international markets we enter. In addition, expansion into other international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">markets will be costly and will impose additional burdens on our executive and administrative personnel, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finance and legal teams, sales and marketing teams and general managerial resources. If our efforts to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">introduce our products into other international markets are not successful, we may have expended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant resources without realizing the expected benefit. Ultimately, the investment required for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international expansion could exceed the results of operations generated from this expansion.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we operate in an industry which is subject to significant enforcement scrutiny by both U.S. and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-U.S. government authorities. Our international business requires us to comply with U.S. and foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws and regulations, such as various anti-bribery and anti-corruption laws, including the U.S. Foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Corrupt Practices Act (&#8220;FCPA&#8221;), the U.S. Fraud Act and in certain cases the U.K. Bribery Act of 2010. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Compliance with these is costly and exposes us to significant civil and criminal penalties for non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance. Any failure to comply with applicable legal and regulatory obligations could impact us in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">variety of ways that include, but are not limited to, significant criminal, civil and administrative fines, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penalties and disgorgement of profits, including imprisonment of individuals, denial of export privileges, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">seizure of shipments, restrictions on certain business activities and exclusion or debarment from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government contracting. Our international operations expose us to risks inherent in operating in foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions that could adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we do not obtain and maintain international regulatory registrations, clearances or approvals for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our Heartflow Platform, we will be unable to market and sell our products outside of the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any future sales of our products outside of the United States are subject to foreign regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements that vary widely from country to country. While the regulations of some countries may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impose barriers to marketing and selling our products or only require notification, others require that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain the clearance or approval of a specified regulatory authority or a Certificate of Conformity of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notified body. Complying with foreign regulatory requirements, including obtaining registrations, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearances or approvals, can be expensive and time consuming and we may not receive regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearances or approvals in each country in which we plan to market our products or we may be unable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do so on a timely basis. The time required to obtain registrations, clearances or approvals, if required by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other countries, may be longer than that required for FDA clearance or approval, and requirements for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such registrations, clearances or approvals may significantly differ from FDA requirements. If we modify <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">32<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products, we may need to apply for regulatory clearances or approvals before we are permitted to sell <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the modified product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, AI governing regulations around medical devices evolve rapidly and we may not continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meet the quality and safety standards required to maintain the authorizations that we have received. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are unable to maintain our authorizations in a particular country, we will no longer be able to sell the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable product in that country.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulatory registration, clearance, marketing authorization, or approval by the FDA does not ensure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration, clearance, marketing authorization, or approval by foreign regulatory authorities or authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representatives in other countries. Registration, clearance, marketing authorization, or approval by one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more foreign regulatory authorities or authorized representatives do not ensure registration, clearance, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing authorization, or approval by regulatory authorities in other foreign countries or by the FDA. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">However, a failure or delay in obtaining registration or regulatory clearance or approval in one country <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may have a negative effect on the regulatory process in others.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to data privacy and information technology<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Failure to comply with laws and regulations affecting the transmission, security and privacy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">personal information (including health information) could result in significant penalties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Federal, state and foreign government bodies and authorities have adopted, are considering adopting, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may adopt laws and regulations regarding the collection, use, processing, storage and disclosure of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">personal information obtained from consumers and individuals. In the United States, federal, state, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">local governments have enacted numerous data privacy and security laws, including data breach <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notification laws, personal data privacy laws, consumer protection laws (e.g., Section 5 of the Federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Trade Commission Act), and other similar laws (e.g., wiretapping laws). Under these laws we may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required to obtain certain consents to process personal data. For example, some of our data processing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practices have been, and may in the future continue to be, subject to challenges or lawsuits under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy, security, and communications laws, including, for example, challenges based on wiretapping laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for sharing consumer information with third parties through various methods, such as via third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing pixels or software development kits. Our inability or failure to obtain consent for these practices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could result in adverse consequences, including class action litigation and mass arbitration demands. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, numerous federal and state laws and regulations, including the Health Insurance Portability and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended by the Health Information Technology for Economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), govern the collection, dissemination, security, use and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">confidentiality of patient identifiable health information. HIPAA and the HITECH Act require us to comply <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with standards for the use and disclosure of health information within our company and with third-parties. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Standards for Privacy of Individually Identifiable Health Information (&#8220;Privacy Standards&#8221;), and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Security Standards for the Protection of Electronic Protected Health Information (&#8220;Security Standards&#8221;), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under HIPAA establish a set of basic national privacy and security standards for the protection of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">individually identifiable health information by health plans, healthcare clearinghouses and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare providers, referred to as covered entities, and the business associates with whom such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">covered entities contract for services. As a result, both covered entities and business associates can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to significant civil and criminal penalties for failure to comply with the Privacy Standards or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Security Standards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA, the HITECH Act and the Affordable Care Act (&#8220;ACA&#8221;) also include standards for common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare electronic transactions and code sets, such as claims information, plan eligibility, payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information and the use of electronic signatures, unique identifiers, operating rules. Companies that bill <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors for healthcare-related services and device use are required to conform to the transaction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standards. CMS, on behalf of HHS, has the authority to investigate complaints and audit for compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the HIPAA standards for transactions, code sets, unique identifiers and operating rules, including the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrative Simplification provisions of HIPAA and the ACA. Failure to comply with these standards, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and any investigation or audit and penalties imposed may have an adverse impact on our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA requires covered entities and business associates to develop and maintain policies and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">33<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures with respect to protected health information that is used or disclosed, including the adoption of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative, physical and technical safeguards to protect such information. The HITECH Act expands <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the notification requirement for breaches of patient identifiable health information, restricts certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosures and sales of patient identifiable health information and provides a tiered system for civil <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">monetary penalties for HIPAA violations. The Final HIPAA Omnibus Rule modifies the breach reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard in a manner that will likely make more data security incidents qualify as reportable breaches. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The HITECH Act also increased the civil and criminal penalties that may be imposed against covered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entities, business associates and possibly other persons and gave state attorneys general new authority <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attorney fees and costs associated with pursuing federal civil actions. Additionally, states have adopted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comparable privacy and security laws and regulations that differ somewhat from federal and other states&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws, and that govern where more stringent than federal law.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a business associate under HIPAA, if we do not comply with the requirements of HIPAA, the HITECH <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act or applicable state privacy and security laws, we could be subject to criminal or civil sanctions that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our financial condition. The costs of complying with privacy and security related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legal and regulatory requirements are substantial and could have an adverse effect on our business. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, we are unable to predict what changes to the HIPAA Privacy Standards and Security Standards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">might be made in the future or how those changes could affect our business. Any new legislation or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulation in the area of privacy and security of personal information, including personal health <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information, could also adversely affect our business operations. In addition, a security breach could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require reporting to federal and state government entities, notification to affected individuals, expensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigation and remediation and mitigation. Government agencies could, in their discretion, impose fines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and penalties relating to the breach, that would have an adverse effect on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Foreign data privacy regulations, such as the General Data Protection Regulation (E.U.) 2016&#47;679 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;GDPR&#8221;), the European Union&#8217;s Data Protection Directive (Directive 95&#47;46&#47;EC), and the country specific <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations that implement Directive 95&#47;46&#47;EC, also govern the processing of personally identifiable data, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and a number of these regulations are stricter than U.S. laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, many states have laws, regulations and other authorities that govern data privacy, security <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and breach notification. While some of these laws exempt protected health information subject to HIPAA, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">they may apply to other personal information we collect, including personal information collected from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees or from visitors to our website. Failure to comply with these authorities may have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect to expend significant resources to comply with these laws and regulations. The functional and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operational requirements and costs of compliance with such laws and regulations may adversely impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, and failure to enable our solutions to comply with such laws and regulations could lead to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant fines and penalties imposed by regulators, as well as claims, lawsuits and contractual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnification obligations by or for our customers or third-parties and significant reputational harm. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We depend on our information technology systems, and any failure of these systems could harm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our business and adversely affect our business and operating results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Information technology and telecommunications systems are vulnerable to damage from a variety of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sources, including telecommunications or network failures, failures during the processes of upgrading or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">replacing software, power outages, hardware failures, user or human errors and natural disasters. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Moreover, despite network security and back up measures, some of our servers are potentially vulnerable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to cybersecurity incidents, including phishing attacks by computer hackers or other malicious human acts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computer viruses, ransomware, malware and similar disruptive problems or other methods of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compromising employee or customer administrator credentials to access protected health information and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our internal data. Failures or significant downtime of our information technology or telecommunications <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems could prevent us from operating our business. Any disruption or loss of information technology or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">telecommunications systems on which critical aspects of our operations depend could have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect on our business and our operating results may suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">34<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, our brand, reputation and ability to attract, retain and serve our customers are dependent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon the reliable performance of our Heartflow Platform, including our underlying information technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems and infrastructure. Our technical infrastructure may not be adequately designed with sufficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reliability and redundancy to avoid performance delays or outages that could be harmful to our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If our Heartflow Platform is unavailable when physicians attempt to access it, or if it does not load as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quickly as they expect, physicians may not use our Heartflow Platform as often in the future, or at all. As <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our customer base continues to grow, we will need an increasing amount of technical infrastructure, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including network capacity and computing power, to continue to satisfy the needs of our users. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We rely upon AWS to operate our cloud offering&#59; any disruption of or interference with our use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">AWS would adversely affect our business, results of operations and financial condition.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We outsource all of our cloud-based infrastructure to AWS. Our customers need to be able to access our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cloud-based infrastructure at any time, without interruption or degradation of performance. AWS runs its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">own platform that we access, and we are, therefore, vulnerable to service interruptions at AWS. We may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience interruptions, delays and outages in service and availability from time to time as a result of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">problems with our AWS provided infrastructure. For example, in September 2015, AWS suffered a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant outage that had a widespread impact on cloud-based software and services companies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although our customers were not affected by that outage, a similar outage could render our cloud offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inaccessible to customers. Additionally, AWS has suffered outages at specific customer locations in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">past, rendering the customer unable to access our offering for periods of time. Lack of availability of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AWS infrastructure could be due to a number of potential causes including technical failures, natural <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disasters, fraud or security attacks that we cannot predict or prevent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, if the security of the AWS infrastructure is compromised or believed to have been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compromised, our business, results of operations and financial condition could be adversely affected. It is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possible that our customers and potential customers would hold us accountable for any breach of security <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affecting the AWS infrastructure and we may incur significant liability from those customers and from third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties with respect to any breach affecting AWS systems. For more information, see the risk factor titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Failure to comply with laws and regulations affecting the transmission, security and privacy of personal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information (including health information) could result in significant penalties.&#8221; Because our agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with AWS limits AWS&#8217; liability for damages, we may not be able to recover a material portion of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities to our customers and third-parties from AWS. Customers and potential customers may refuse to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do business with us because of the perceived or actual failure of our cloud offering as hosted by AWS and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our operating results could be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our agreement with AWS allows AWS to terminate the agreement by providing 30 days&#8217; advance notice, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and allows AWS to terminate in case of a material breach of contract if such breach is uncured for 30 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days following receipt of notice of such breach, or to terminate immediately upon notice to us (i) if AWS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has the right to suspend our account&#59; (ii) if AWS&#8217; relationship with a third-party software or technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provider terminates, expires or requires AWS to change the way it provides its services&#59; or (iii) in order to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comply with the law or requests of governmental entities. Although we expect that we could receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar services from other third-parties, if any of our arrangements with AWS are terminated, we could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience interruptions on our platform and in our ability to make our platform available to customers, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">well as delays and additional expenses in arranging alternative cloud infrastructure services.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we fail to offer high quality customer support, our business and reputation could suffer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our customers rely on our customer support teams to resolve technical and operational issues if and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">when they arise. We may be unable to respond quickly enough to accommodate short-term increases in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer demand for customer support. We also may be unable to modify the nature, scope and delivery <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our customer support to compete with changes in customer support services provided by our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors or to adapt to product and industry developments. Increased customer demand for customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support, without corresponding revenue, could increase costs and harm our results of operations. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, as we continue to grow our operations and reach a large global customer base, we need to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to provide efficient customer support that meets our customers&#8217; needs globally at scale. The number <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">35<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our customers has grown significantly, and that growth has and will continue to put additional pressure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our support organization. As our business scales, we may need to engage third-party customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support service providers, which could negatively impact the quality of our customer support if such third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties are unable to provide customer support that is as effective as that we provide ourselves. Our sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are highly dependent on our business reputation and on positive recommendations from our existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers. Accordingly, high quality customer support is important for the renewal and expansion of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with existing customers and any failure to maintain such standards of customer support, or a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market perception that we do not maintain high quality customer support, could harm our reputation, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ability to sell product to existing and prospective customers and our business, financial condition, results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We invest significantly in research and development, and to the extent our research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">development investments do not translate into new products, features or improvements to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">current products, or if we do not use those investments efficiently, our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">condition, results of operations and prospects would be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A key element of our strategy is to invest significantly in our research and development efforts to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">introduce new products, features and improvements aimed at increasing the value proposition of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform for our customers. For the years ended December 31, 2023 and 2024, our research <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and development expenses were 41% and&#160;35% of our revenue, respectively. If we do not spend our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development budget efficiently or effectively on compelling innovation and technologies, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business may be harmed and we may not realize the expected benefits of our strategy. Moreover, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development projects can be technically challenging and expensive. The nature of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development cycles may cause us to experience delays between the time we incur <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses associated with research and development and the time we are able to offer compelling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">solutions and generate revenue, if any, from such investment. For example, investments made to expand <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform to asymptomatic patients may be expensive, technically challenging, experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delays and may not be successful. Additionally, anticipated customer demand for a product or feature we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are developing could decrease after the development cycle has commenced, and we would nonetheless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be unable to avoid substantial costs associated with the development of any such product or features. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we expend a significant amount of resources on research and development and our efforts do not lead to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the successful introduction or improvement of products or features that are competitive in our current or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future markets, it would harm our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our networks and those of our third-party service providers may become the target of bad actors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">or security breaches that we cannot anticipate or successfully defend, which could have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">adverse impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform involves the storage and transmission of our customers&#8217; personal information or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identifying information of their patients. Increasingly, we and other companies are subject to a wide variety <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of attacks on their networks on an ongoing basis. In addition to attacks from traditional computer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;hackers,&#8221; malicious code (such as viruses and worms), employee theft or misuse, ransomware attacks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and denial of service attacks, sophisticated nation state and nation state supported actors now engage in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intrusions and attacks (including advanced persistent threat intrusions), and add to the risks to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal networks and the information they store and process. Additionally, such bad actors frequently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attempt to fraudulently induce employees or customers into disclosing sensitive information such as user <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">names, passwords or other information in order to gain access to our customers&#8217; data, their patient&#8217;s data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or our data, including our intellectual property and other confidential business information, or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information technology systems. Because techniques used to obtain unauthorized access or to sabotage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">systems change frequently and generally are not recognized until successfully launched against a target, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may be unable to anticipate these techniques or to implement adequate preventative measures. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Despite significant efforts to create process and security barriers to such threats, it is virtually impossible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for us to entirely mitigate these risks. Any such breach could compromise our networks, creating system <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disruptions or slowdowns and exploiting security vulnerabilities of our products, and the information stored <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our networks could be accessed, publicly disclosed, lost or stolen, which could subject us to liability <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">36<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and cause us significant financial harm. Such breaches often result in reputational damage, negative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publicity, loss of industry data security certifications, customers and sales, increased costs to remedy any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">problem, costly litigation and contractual indemnification obligations by or for impacted customers or third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties any of which could adversely affect our business. In addition, although we have, and intend to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintain, insurance with respect to any such indemnification obligations, the coverage limits of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance policies may not be adequate and one or more successful claims brought against us may have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also rely on third-party service providers, such as cloud storage and telecommunications services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providers. Such service providers are also potentially vulnerable to cybersecurity incidents that could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result in the interruption of their services to us or unauthorized access, use or disclosure of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">confidential information and confidential information of our customers and protected health information of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their patients. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our products are also targets for malicious cybersecurity acts. While some of our products contain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">encryption or security algorithms to protect third-party content or patient information or other data stored <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in our products, these products could still be hacked or targeted by malicious software programs or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attacks or the encryption schemes could be compromised, breached or circumvented by motivated or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sophisticated hackers, which could harm our business and our reputation. In addition, see the risk factor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">titled &#8220;Our Heartflow Platform and the data and models it generates could have bugs, defects or errors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including human quality control errors, or otherwise fail to meet the expectations of patients, physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and third-party payors, which could adversely affect our reputation, business and operating results&#8221; for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more information on bugs, defects or errors in the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to legal and regulatory matters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We face extensive, regulatory requirements to bring our products to market, and our failure to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">receive and maintain regulatory clearances or approvals of our current and future products in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">United States or abroad or to comply with medical device regulatory requirements could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In order to market any product, we must establish and comply with numerous and varying regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements that vary by country and by region within certain countries. Approval, clearance or marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorization in the United States by the FDA or by a regulatory authority or other body in another country <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not ensure approval by the regulatory authorities in other countries or jurisdictions or ensure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval, clearance or other marketing authorization for the same conditions of use. Approval processes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vary among countries and can involve additional product testing and validation and additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative review periods. In general, unless an exemption applies, in the U.S. current and future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">versions of our products must receive pre-market notification (&#8220;510(k)&#8221;), de novo classification (&#8220;de novo&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or pre-market approval (&#8220;PMA&#8221;) from the FDA before they can be marketed in the United States. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cannot provide assurance that any of our future products, to the extent required, will be cleared, approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or otherwise authorized by the FDA through any of its pre-market review processes, or that the FDA will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide export certificates that are necessary to export certain products to certain countries. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the national health or social security organizations of certain foreign countries, including those outside <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Europe, require our products to be qualified before they can be marketed in those countries. Failure to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receive, or delays in the receipt of, relevant foreign qualifications in the European Economic Area or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign countries could have an adverse effect on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pre-market notification, de novo classification request or PMA applications may require support by data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from clinical trials. We are subject to requirements to publicly register and report the results of our clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trials. We must also abide by good clinical practice (&#8220;GCP&#8221;) requirements in the conduct and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">documentation of our clinical trials and report to the FDA significant financial interests of investigators in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any clinical trials we submit to support marketing applications for our products. We, the FDA or an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">institutional review board (&#8220;IRB&#8221;), may suspend or terminate clinical trials at any time on various grounds, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including a finding that patients are being exposed to an unacceptable health risk or that the treatment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not have any effect. If the FDA considers data from our clinical trials to be actually or potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">37<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">biased due to investigators&#8217; financial interests, or unreliable due to GCP noncompliance, it can require us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to implement extensive data analyses or other corrective actions, or exclude data from consideration in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support of our marketing applications. These outcomes could result in delay or denial of FDA clearance or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval and could result in the need to conduct additional, costly and time-consuming clinical trials. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Additionally, we are required to obtain pre-market clearance or approval to market significantly modified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">versions of our currently cleared Heartflow Platform, as well as to market the existing product for new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indications. The FDA requires us to make and document a determination as to whether or not a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modification requires a new 510(k) clearance, de novo classification or PMA approval&#59; however, the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">can review and disagree with our decision. Although we have received 510(k) clearance from the FDA for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the current version of the Heartflow Platform, we may not be successful in receiving clearances, de novo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classifications or approvals in the future or the FDA may not agree with our decisions not to seek <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearances, de novo classifications or approvals for any new products or particular product modifications <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or updates. The FDA may require us to obtain a new 510(k) clearance, de novo classifications or approval <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for any past or future modification or a new indication for our existing products. Such submissions may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require the development and submission of additional data, may be time consuming and costly, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ultimately may not be cleared or approved by the FDA.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the FDA requires us to obtain pre-market clearances, de novo classifications or approvals for any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketed modification to a previously cleared version of the Heartflow Platform, we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cease manufacturing and marketing of the modified product or to recall the modified product until we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain such FDA marketing authorization. The FDA may not clear, grant or approve such submissions in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">timely manner, if at all. The FDA also may change its policies, adopt additional regulations, or revise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing regulations, each of which could prevent or delay pre-market clearance, de novo classification or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval of our devices, or could impact our ability to market a device that was previously cleared. Any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the foregoing could adversely impact our business and financial condition.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the FDA and other comparable foreign regulatory authorities may delay, limit or deny <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearance, de novo classification or approval of future versions of or future indications for our products or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any other potential product for many reasons, including, among others&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the results of our clinical trials may not meet the level of statistically significant and clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">meaningful efficacy with an acceptable safety profile as required by FDA, or other comparable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">regulatory authorities in other countries, for marketing approval&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA or other comparable regulatory authorities in other countries may disagree with the number, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">design, size, conduct or implementation of our clinical trials&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA or other comparable regulatory authorities in other countries may disagree with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">interpretation of data from our clinical trials&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA or other comparable regulatory authorities in other countries may not accept data generated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at one or more of our clinical trial sites&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">if our 510(k) notifications, de novo classification requests, PMA applications, or similar notifications or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications, if and when submitted, are reviewed by the FDA or other comparable regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">authorities, as applicable, the regulatory authorities may have difficulties scheduling the necessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">review meetings in a timely manner, or may recommend against clearance or approval of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">application&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA may determine that our 510(k) notifications for new indications, if and when submitted, must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">follow a different regulatory pathway than we have attempted, and there may be potentially extended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">standards, timelines, reviews (such as by an FDA Advisory Committee) and costs in order to pursue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">approval. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any of these factors, many of which are beyond our control, could jeopardize our ability to obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory clearance, de novo classification or approval for current or future versions of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">38<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform and could result in difficulties and costs for us. If we fail to comply with regulatory requirements in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international markets or to obtain and maintain required marketing authorizations, or if marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorizations in international markets are delayed, our ability to realize the full market potential of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new potential products will be limited.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Healthcare policy changes, including recently enacted legislation reforming the U.S. healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">system could have an adverse effect on our business, financial condition, results of operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the United States, there have been and continue to be a number of legislative and regulatory initiatives <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to contain healthcare costs. Federal and state lawmakers regularly propose and, at times, enact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legislation that would result in significant changes to the U.S. healthcare system, some of which are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intended to contain or reduce the costs of medical products and services, including our own products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current and future legislative proposals to further reform healthcare or reduce healthcare costs may limit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage of or lower reimbursement for the diagnostic tests associated with the use of our products. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cost containment measures that payors and providers are instituting and the effect of any healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reform initiative implemented in the future could impact our revenue from the sale of our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect additional state and federal healthcare policies and reform measures to be adopted in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future, particularly in light of the recent changes in the White House and Congress, any of which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limit reimbursement for healthcare products and services or otherwise result in reduced demand for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products or additional pricing pressure and have a material adverse effect on our industry generally and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our customers. We cannot predict what other healthcare programs and regulations will ultimately be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implemented at the federal or state level or whether any future legislation or regulation in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States may negatively affect our business, financial condition, results of operations and prospects. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continuing efforts of the government, insurance companies, managed care organizations and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors of healthcare services to contain or reduce costs of healthcare may adversely affect our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">set a price that we believe is fair for our products, our ability to generate revenue and achieve or maintain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability and the availability of capital.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any changes of, or uncertainty with respect to, future coverage or reimbursement rates could affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demand for our products, which may prevent us from being able to generate additional revenue or attain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to many laws and governmental regulations affecting our marketed products, both <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">domestically and internationally, and any adverse regulatory action may adversely affect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform is subject to regulation by numerous government authorities, including the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and comparable foreign authorities, after clearance or approval of current and future versions of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product. To varying degrees, each of these authorities requires us to comply with laws and regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governing the development, design, testing, manufacture, labeling, advertising, promotion, distribution, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">import and export of our products. The Heartflow Platform (also referred to as Heartflow Analysis, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consists of three main functions, the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 298.57pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.23pt; position: absolute; white-space: pre;"> Analysis, the Heartflow Plaque Analysis and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow RoadMap Analysis) has been cleared by the FDA (K213857), and only the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.96pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.94pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 511.36pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 520.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis function of the Heartflow Platform is CE Marked in the European Economic Area, the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Kingdom and Australia, received medical device licensing in Canada and has been approved for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing authorization in Japan by the Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;), all for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific indications for use. The Heartflow Platform has also been cleared by the equivalent regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities in Israel, Saudi Arabia, United Arab Emirates, and licensed in Bahrain.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We currently have ongoing responsibilities under U.S., U.K., European Economic Area, Switzerland, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Canada, Australia, Japan, Saudi Arabia, United Arab Emirates, Bahrain and Israel (registered or licensed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regions) regulations, including requirements related to product and facility registration, device listing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse event reporting, reporting of recalls and field corrective actions, manufacturing, advertising, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promotion, distribution, import, and export. In certain jurisdictions outside of the United States, we <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">39<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contract with third parties (i.e., notified bodies, authorized representatives, manufacturing authorization <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders) who either oversee regulatory compliance or assume regulatory responsibilities for our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distributed by those third parties. We are subject to periodic inspections and audits by the FDA, notified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bodies, authorized representatives and comparable foreign authorities to determine compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory requirements, including good manufacturing practices such as the Quality System Regulation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the FDA, Medical Device Single Auditing Program, ISO 13485&#58;2016, and EN ISO 13485&#58;2021 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">concerning the EU, establishment registration and device listing, medical device reporting, vigilance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting of adverse events, notification of corrections, recalls, field safety corrective actions and product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">labeling and marketing. These inspections and audits can result in inspectional observations or reports, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warning letters or other forms of enforcement action. If the FDA or comparable foreign authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conclude, as a result of these inspections or audits or from any other source of information, that we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not in compliance with applicable laws or regulations, or that our products are ineffective or pose an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unreasonable health risk, such authorities could ban these products, suspend or cancel our marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorizations, impose &#8220;stop sale&#8221; and &#8220;stop import&#8221; orders, refuse to issue export certificates, detain or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">seize adulterated or misbranded products, order a recall, repair, replacement, correction or refund of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, require us to conduct post-market surveillance studies or change the labeling for our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or require us to notify health professionals and others that the products present unreasonable risks of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial harm to the public health. Failure to comply with regulatory requirements may also subject us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to additional administrative and judicially imposed sanctions, warning letters, civil and criminal penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">injunctions, interruption of manufacturing or clinical trials, total or partial suspension of production and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resulting adverse publicity. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Discovery of previously unknown problems with our products&#8217; design or manufacture may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restrictions on the use of the Heartflow Platform, restrictions placed on us or our suppliers or withdrawal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the existing regulatory clearance of the Heartflow Platform. The FDA or comparable foreign authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may also impose operating restrictions, enjoin and restrain violations of applicable law pertaining to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical devices, assess civil or criminal penalties against our officers, employees or us or recommend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">criminal prosecution of our company. Adverse regulatory action of a certain magnitude may restrict us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from effectively marketing and selling our products. In addition, negative publicity or product liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claims resulting from any adverse regulatory action could have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In many of the foreign countries in which we market our products, we are subject to extensive medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device regulations that are similar to those of the FDA, including those in Europe. The regulation of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products in Europe falls within the European Economic Area, which consists of the 27 member states of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the European Union, as well as Iceland, Liechtenstein and Norway. Only medical devices that comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain conformity requirements of the Medical Devices Regulation (E.U.) 2017&#47;745 (&#8220;MDR&#8221;) concerning <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medical Devices, or the E.U. Medical Devices Directive, Directive 2006&#47;114&#47;EC are allowed to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketed within the European Economic Area. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Foreign governmental regulations have become increasingly stringent and more extensive, and we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">become subject to even more rigorous regulation by foreign governmental authorities in the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Penalties for a company&#8217;s noncompliance with foreign governmental regulation could be severe, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revocation or suspension of a company&#8217;s business license and civil or criminal sanctions. In some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions, such as Germany, any violation of a law related to medical devices is also considered to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a violation of unfair competition law. In such cases, governmental authorities, our competitors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business or consumer associations may then file lawsuits to prohibit us from commercializing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform in such jurisdictions. Our competitors may also sue us for damages. Any domestic or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign governmental law or regulation imposed in the future may have an adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">40<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Delays in the commencement or completion of future or ongoing clinical testing could result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">increased costs to us and delay our ability to market the Heartflow Platform for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">indications. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are currently enrolling patients for our DECIDE clinical trial to evaluate our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.92pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.9pt; position: absolute; white-space: pre;">Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in a real-world setting. We do not know whether our DECIDE clinical trial will be completed on schedule, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or at all. The commencement or completion of clinical trials can be disrupted for a variety of reasons, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including difficulties in&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">recruiting and enrolling patients to participate in, and investigators to conduct, a clinical trial&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reaching agreements on acceptable terms with prospective clinical research organizations and trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sites&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">obtaining approval of an investigational device exemption (&#8220;IDE&#8221;), application from the FDA or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">equivalent authorization from foreign regulatory authorities, if required&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">obtaining IRB approval to conduct a clinical trial at a prospective site.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A clinical trial may also be suspended or terminated by us, an IRB, the FDA or other regulatory authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">due to a number of factors, including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">failure to conduct the clinical trial in accordance with regulatory requirements or in accordance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our clinical protocols&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the imposition of a clinical hold&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">safety or effectiveness issues&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">lack of adequate funding to continue the clinical trial.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, changes in regulatory requirements and guidance may occur, and we may need to amend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical trial protocols to respond to such changes, which could impact the cost, timing or successful <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of a clinical trial. If we experience delays in the commencement or completion of our clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trials, the commercial prospects for additional indications for our products will be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interim, &#8220;top-line&#8221; and preliminary data from our clinical trials that we announce or publish from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">time to time may change as more patient data become available and are subject to audit and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">verification procedures that could result in material changes in the final data. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">From time to time, we may publicly disclose interim, top-line or preliminary data from our clinical trials, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including our DECIDE clinical trial, which is based on a preliminary analysis of then-available data, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the results and related findings and conclusions are subject to change following a more comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review of the data related to the particular trial or additional data collected at a later time. We also make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have received or had the opportunity to fully and carefully evaluate all data. As a result, the interim, top-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">line or preliminary results that we report may differ from future results of the same trial, or different <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conclusions or considerations may qualify such results, once additional data have been received and fully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluated. Interim, top-line or preliminary data also remain subject to audit and verification procedures <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that may result in the final data being materially different from the interim, top-line or preliminary data we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previously announced. As a result, interim, top-line and preliminary data should be viewed with caution <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until the final data are available. Adverse differences between interim data and final data could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could result in volatility in our share price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, others, including the FDA and other regulatory authorities or other bodies, may not accept or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">41<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the importance of data differently, which could impact the value of the particular trial, or the approvability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or potential for commercialization of the particular medical device. In addition, the information we choose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information, and others may not agree with what we determine is material or otherwise appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information to include in our disclosure. The interim, top-line or preliminary data that we report may differ <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from final results, and regulatory authorities and other bodies may disagree with the conclusions reached, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may harm our ability to obtain marketing authorization for, and commercialize, our future products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which could harm our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may face product liability claims that could result in costly litigation and significant liabilities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may not be able to maintain adequate product liability insurance.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Development, marketing and clinical testing of our products may expose us to product liability and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tort claims. Although we have, and intend to maintain, liability insurance, the coverage limits of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance policies may not be adequate and one or more successful claims brought against us may have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our business, financial condition, results of operations and prospects. For example, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the U.S. Supreme Court declined to hear an appeal where the U.S. Court of Appeals for the Ninth Circuit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ruled that the 1976 Medical Device Amendments to the Federal Food, Drug and Cosmetic Act did not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preempt state laws in a product liability case involving a medical device company. If other courts in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States adopt similar rulings, we may be subject to increased litigation risk in connection with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products. Product liability claims could negatively affect our reputation, product sales, and our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain and maintain regulatory approval for our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, although we have product liability and clinical study liability insurance, this insurance is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to deductibles and coverage limitations. Our current product liability insurance may not continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be available to us on acceptable terms, if at all, and, if available, coverage may not be adequate to protect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us against any future product liability claims. If we are unable to obtain insurance at an acceptable cost, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on acceptable terms with adequate coverage, or at all, or otherwise protect against potential product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities could have an adverse effect on our reputation, business, financial condition, results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow Platform may be subject to recalls, which could be costly and could harm our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reputation and business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are subject to ongoing medical device reporting regulations that require us to report to the FDA or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar governmental authorities in other countries if our products cause, or contribute to, death or serious <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">injury, or if they malfunction and would be likely to cause, or contribute to, death or serious injury if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">malfunction were to recur. We could voluntarily elect to, or the FDA and similar governmental authorities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in other countries could require us to, perform a correction, field safety corrective action, removal or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recall of our products in the event of material deficiencies or defects in design, manufacturing or labeling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that could cause harm. Our products have been in the past, and may in the future, be the subject of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical device reports of adverse events with the MAUDE database, including reports of false negative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results and incorrect or imprecise results or readings. Between 2017 and 2025, 116 Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MAUDE reports were made, with 104 of those reports due to false negative results, 11 reports due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorrect, inadequate or imprecise results or readings, and one report due to an adverse event without an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identified device or use problem. While none of these MAUDE reports resulted in a mandated or voluntary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">correction, field safety action, removal or a recall, a government mandated or voluntary correction, field <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">safety corrective action, removal or other recall could occur as a result of manufacturing errors or design <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defects, including defects in labeling. Any correction, field safety corrective action, removal or other recall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would divert managerial and financial resources and could lead to a substantial loss of physician and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient confidence in our products and, consequently, have an adverse effect on our growth prospects or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating results. A correction, field safety corrective action, removal or other recall could also result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial litigation, including product liability claims, with liabilities well in excess of our insurance <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">42<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage limits. Any of these events could have an adverse effect on our reputation, business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Off-label or other unlawful promotion of our products could result in costly investigations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">sanctions from the FDA and other regulatory bodies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform (also referred to as Heartflow Analysis, which consists of three main functions, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis, the Heartflow Plaque Analysis and the Heartflow RoadMap Analysis) has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cleared by the FDA (K213857), and only the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.16999999999996pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 333.59pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.25pt; position: absolute; white-space: pre;"> Analysis function of the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is CE Marked in the European Economic Area, the United Kingdom and Australia, received medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device licensing in Canada and has been approved for marketing authorization in Japan by the PMDA, all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for specific indications for use. The Heartflow Platform has also been cleared by the equivalent regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities in Israel, Saudi Arabia, United Arab Emirates, and licensed in Bahrain. We may only promote <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or market our products for their specifically cleared or approved indications. We train our marketing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales force against promoting our products for uses outside of the cleared or approved indications for use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;off-label use&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the FDA determines that our promotional materials or training constitute promotion of an off-label use, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or of claims that are not adequately substantiated or that are otherwise false or misleading, it could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">request that we modify our training or promotional materials or subject us to regulatory or enforcement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">criminal penalties. It is also possible that other federal, state or foreign enforcement authorities, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Federal Trade Commission or Department of Justice, might take action if they consider our business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities to constitute promotion of an off-label use or other unlawful promotion, which could result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant penalties, including criminal, civil and administrative penalties, damages, fines, disgorgement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exclusion from participation in government healthcare programs and the curtailment of our operations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any of these events could significantly harm our business, results of operations, financial condition and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, the advertising and promotion of our products are subject to European Economic Area Member <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States laws implementing the Medical Devices Directive concerning misleading and comparative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advertising, and Directive 2005&#47;29&#47;EC on unfair commercial practices, as well as other European <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Economic Area Member State legislation governing the advertising and promotion of medical devices. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">European Economic Area Member State legislation may also restrict or impose limitations on our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advertise our products directly to the general public. In addition, voluntary E.U. and national codes of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct provide guidelines on the advertising and promotion of our products to the general public and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may impose limitations on our promotional activities with healthcare professionals harming our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to numerous federal, state and foreign healthcare fraud and abuse, compliance, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">transparency and privacy laws and regulations, and a failure to comply with such laws and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">regulations could have an adverse effect on our business&#59; similarly, an investigation, inquiry or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">audit by a government agency that alleges violations of law or regulations may have an adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">effect on our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our operations are, and will continue to be, directly and indirectly affected by various federal, state and&#47;or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign healthcare laws, including those described below. In particular, because the use of our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are directly or indirectly reimbursed by U.S. federal health care programs, for example Medicare, we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the federal Anti-Kickback Statute, a criminal law that prohibits, among other things, any person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or entity from knowingly and willfully offering, paying, soliciting or receiving any remuneration in cash or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in-kind (including any kickback or bribe, but also common forms of remuneration, such as service or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consulting fees, service fees, meals, travel expenses, discounts or rebates), directly or indirectly, overtly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or covertly, in cash or in kind, in return for or to induce the referring, ordering, leasing, purchasing or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arranging for or recommending the referring, ordering, purchasing or leasing of any good, facility, item or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">service, for which payment may be made, in whole or in part, under federal healthcare programs, such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Medicare and Medicaid programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">43<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">anything of value. Although there are a number of statutory exceptions and regulatory safe harbors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protecting certain common activities, the exceptions and safe harbors are drawn narrowly. Failure to meet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of the requirements of a statutory exception or regulatory safe harbor does not make the conduct per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">se illegal under the Anti-Kickback Statute. Instead, the arrangement will be evaluated on a case-by-case <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis based on a cumulative review of all of its facts and circumstances. Several courts have interpreted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remuneration is to induce referrals of (or purchases, uses or recommendations of prescriptions, uses or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchases related to) federal healthcare program covered business, the Anti-Kickback Statute has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implicated and potentially violated. Our practices may not in all cases meet all of the criteria for safe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">harbor protection from Anti-Kickback Statute liability. Further, the ACA, amends the intent requirement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the federal Anti-Kickback Statute and certain criminal healthcare fraud statutes. A person or entity no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">longer needs to have actual knowledge of the statute or specific intent to violate it. In addition, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government may assert that a claim for payment by a government health care program including items or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services resulting from a violation of the Anti-Kickback Statute constitutes a false or fraudulent claim for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purposes of the false claims laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The U.S. civil False Claims Act prohibits, among other things, any person or entity from knowingly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presenting, or causing to be presented, a false or fraudulent claim for payment or approval to the federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government or knowingly making, using, or causing to be made or used a false record or statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material to a false or fraudulent claim to the federal government. A claim includes &#8220;any request or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demand&#8221; for money or property presented to the U.S. government. The civil False Claims Act also applies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to false submissions that cause the government to not receive a benefit to which it is entitled, such as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discounted sales price for products covered by federal healthcare programs. Intent to deceive is not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required to establish liability under the civil False Claims Act. In addition, the civil False Claims Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes a whistleblower provision that allows private citizens to bring claims on behalf of the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government alleging violations of the law. Whistleblowers may be entitled to up to as much as thirty <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">percent (30%) of the government&#8217;s financial recovery resulting from such claims. This incentivizes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential whistleblowers to file complaints in federal court, which complaints are relied upon heavily by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government to investigate and prosecute allegations of violations of both the civil False Claims Act and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Anti-Kickback Statute. U.S. enforcement authorities or private whistleblowers acting on behalf of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. government may file complaints under the civil False Claims Act alleging that we have caused one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more of our customers to submit false submissions for reimbursement from federal health care programs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including Medicare, Medicaid, or the Veterans Affairs program due to alleged kickbacks, the sale of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adulterated or misbranded products, or the provision of false or misleading information to our customers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or other third-parties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Additionally, under the federal Civil Money Penalty Statute, the Department of Health and Human <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Services (&#8220;HHS&#8221;) may impose civil money penalties against entities that make offers to transfer or transfer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remuneration, including gifts, payments or routine waivers of co-payments or deductibles, to any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicare beneficiary in order to influence such individual to order or receive any item or service for which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment may be made, in whole or in part, under Medicare and&#47;or a State health care program.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Violations of these laws and regulations may result in significant criminal and&#47;or civil fines and penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as well as potential exclusion from participation in federal health care programs, that could significantly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact our business and operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to other federal and state fraud and abuse laws, including HIPAA&#8217;s fraud provisions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which among other things, are criminal laws that prohibit, among other actions, knowingly and willfully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executing, or attempting to execute, a scheme or artifice to defraud any healthcare benefit program, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including private payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully preventing, obstructing, misleading, delaying or attempting to delay a criminal investigation of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare offense and knowingly and willfully falsifying, concealing or covering up a material fact or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making any materially false, fictitious or fraudulent statement or representation in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delivery of or payment for healthcare benefits, items or services. Many of these state laws closely mirror <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the federal Anti-Kickback Statute or civil False Claims Act, but apply more broadly to products and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">44<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services that are paid for in any way, whereas the federal law pertains only to those reimbursed by federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health care programs. In addition, many states have also adopted laws prohibiting fee-splitting (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sharing of professional fees with non-state licensed persons or entities), restricting marketing activities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with physicians and&#47;or prohibiting the practice of medicine (or the direction of the practice of medicine) by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporations or others that are not specifically licensed to practice medicine within the state. While under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our model, licensed practitioners independently are providing any and all medical treatment and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnostic services for which a state license is required, these state laws still may apply to us. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also are subject to foreign fraud and abuse laws and regulations, which vary by country, and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prohibit many of the same activities addressed by U.S. laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to the federal and state transparency reporting laws and regulations, gift bans and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance reporting provisions. The Physician Payments Sunshine Act (also known as Open Payments) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires manufacturers of drugs, devices, biologics and medical supplies for which payment is available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under Medicare, Medicaid or the State Children&#8217;s Health Insurance Program to report annually to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Centers for Medicare and Medicaid Services information related to payments and other transfers of value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided directly or indirectly to physicians (defined to include doctors, dentists, optometrists, podiatrists <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and chiropractors), other healthcare providers (such as physician assistants and nurse practitioners) and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">teaching hospitals. Such manufacturers are also required to annually report certain ownership and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment interests held by such U.S. physicians and their immediate family members. Certain states, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">like Massachusetts and Vermont have similar reporting requirements. Some states, like Vermont, prohibit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">gifts and certain benefits from being provided to physicians licensed within that state. Other states, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as California and Nevada mandate implementation of compliance programs to ensure compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fraud and abuse laws and regulations, as well as with industry codes of conduct, such as the AdvaMed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Code of Ethics on Interactions with Health Care Professionals. Our business is subject to these many <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, which can be nuanced and lacking in clear guidance. Our failure to comply with these laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or regulations could result in substantial fines or penalties. Further, our reports made pursuant to these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws may be used by enforcement authorities or whistleblowers to raise or substantiate allegations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to the federal physician self-referral prohibitions, commonly known as the Stark Law, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which prohibits, among other things, physicians who have a financial relationship, including an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment, ownership or compensation relationship with an entity that submits claims for payment to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicare or Medicaid programs, from referring Medicare or Medicaid patients for certain &#8220;designated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health services,&#8221; which include diagnostic imaging services related to our products, unless an exception <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applies. Similarly, entities may not bill Medicare or any other party for services furnished pursuant to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prohibited referral. Many states have their own self-referral laws as well, which in some cases apply to all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors, not just Medicare and Medicaid.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If our operations are found to be in violation of any of the laws described above or any other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental regulations that apply to us now or in the future, we may be subject to significant penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including civil and criminal penalties, damages, fines, disgorgement, exclusion from governmental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare programs and the curtailment or restructuring of our operations, any of which could adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our ability to operate our business and our financial results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also note that there is risk of our being found in violation of these laws by the fact that many of them <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have not been fully, clearly or consistently interpreted by the regulatory authorities or the courts, and their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions are open to a variety of interpretations. Any action against us for violation of these laws, even if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we successfully defend against it, could cause us to incur significant legal expenses and divert our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management&#8217;s attention from the operation of our business. Moreover, to achieve compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable federal and state privacy, security and electronic transaction laws, we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modify our operations with respect to the handling of patient information. Similarly, to achieve compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with other applicable federal and state anti-fraud, open payments or other healthcare regulations, we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be required to modify our operations. Implementing any of these modifications may prove costly. At this <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">45<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time, we are not able to determine the full consequences to us, including the total cost of compliance, of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these various federal and state laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to U.S. and foreign anti-corruption and anti-money laundering laws with respect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our operations and non-compliance with such laws can subject us to criminal and&#47;or civil liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and harm our business.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: bold; left: 184.68pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are subject to the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S.&#160;Travel Act, the USA PATRIOT Act, the U.K. Bribery Act of 2010 and Proceeds of Crime Act 2002 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possibly other state and national anti-bribery and anti-money laundering laws in countries in which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees and third-party intermediaries from authorizing, promising, offering or providing, directly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirectly, improper payments or benefits to recipients in the public or private sector. We use third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representatives to support sales of our products abroad. In addition, as we increase our international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales and business, we may engage with additional business partners and third-party intermediaries to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sell our products abroad and to obtain necessary permits, licenses and other regulatory approvals. We or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our third-party intermediaries may have direct or indirect interactions with officials and employees of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government agencies or state owned or affiliated entities. We can be held liable for the corrupt or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and agents, even if we do not explicitly authorize or have actual knowledge of such activities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Noncompliance with anti-corruption and anti-money laundering laws could subject us to whistleblower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">media coverage and other collateral consequences. If any subpoenas or investigations are launched, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation, our business, results of operations and financial condition could be materially harmed. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, responding to any action will likely result in a materially significant diversion of management&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attention and resources and significant defense and compliance costs and other professional fees. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain cases, enforcement authorities may even cause us to appoint an independent compliance monitor, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which can result in added costs and administrative burdens. As a general matter, enforcement actions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and sanctions could harm our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to governmental export and import controls that could impair our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">compete in international markets due to licensing requirements and subject us to liability if we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">not in compliance with applicable laws. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our products are subject to export control and import laws and regulations, including the U.S. Export <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administration Regulations, U.S. Customs regulations and various economic and trade sanctions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control. Exports of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products must be made in compliance with these laws and regulations. If we fail to comply with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws and regulations, we and certain of our employees could be subject to substantial civil or criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">penalties, including&#58; the possible loss of export or import privileges&#59; fines, which may be imposed on us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and responsible employees or managers&#59; and, in extreme cases, the incarceration of responsible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees or managers. Obtaining the necessary authorizations, including any required license, for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particular sale may be time consuming, is not guaranteed and may result in the delay or loss of sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunities. In addition, changes in our products or changes in applicable export or import regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may create delays in the introduction and sale of our products in international markets, prevent our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers with international operations from deploying our products or, in some cases, prevent the export <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or import of our products to certain countries, governments or persons altogether. Any change in export or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">import regulations, shift in the enforcement or scope of existing regulations or change in the countries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governments, persons or technologies targeted by such regulations, could also result in decreased use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products, or in our decreased ability to export or sell our products to existing or potential customers <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">46<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with international operations. Any decreased use of our products or limitation on our ability to export or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sell our products would likely adversely affect our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, we incorporate encryption technology into certain of our products. Various countries <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulate the import of certain encryption technology, including through import permitting and licensing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, and have enacted laws that could limit our ability to distribute our products or could limit our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers&#8217; ability to implement our products in those countries. Encrypted products and the underlying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology may also be subject to export control restrictions. Governmental regulation of encryption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology and regulation of imports or exports of encryption products, or our failure to obtain required <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">import or export approval for our products, when applicable, could harm our international sales and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our revenue. Compliance with applicable regulatory requirements regarding the export of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products, including with respect to new releases of our products, may create delays in the introduction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our products in international markets, prevent our customers with international operations from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deploying our products throughout their globally distributed systems or, in some cases, prevent the export <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our products to some countries altogether.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Moreover, U.S. export control laws and economic sanctions programs prohibit the shipment of certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products and services to countries, governments and persons that are subject to U.S. economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">embargoes and trade sanctions. Any violations of such economic embargoes and trade sanction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations could have negative consequences, including government investigations, penalties and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reputational harm.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Any future litigation against us could be costly and time-consuming to defend.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have been in the past, and we may become in the future, subject to legal proceedings and claims that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arise in the ordinary course of business, such as claims brought by our third-party vendors, our customers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or their patients in connection with contractual disputes or the use of our Heartflow Platform, claims <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">brought by us or by competitors related to intellectual property or employment claims made by our current <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or former employees. Litigation might result in substantial costs and may divert management&#8217;s attention <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and resources, which might seriously harm our business, financial condition, results of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects. Insurance might not cover such claims, might not provide sufficient payments to cover all the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs to resolve one or more such claims, and might not continue to be available at all or on terms <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acceptable to us (including premium increases or the imposition of large deductible or co-insurance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements). A claim brought against us that is uninsured or underinsured could result in unanticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs, potentially harming our business, financial condition, results of operations and prospects. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, we cannot be sure that our existing insurance coverage will continue to be available on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acceptable terms or at all or that our insurers will not deny coverage as to any future claim.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to our intellectual property <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to obtain and maintain sufficient intellectual property rights, or the scope of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">rights is not sufficiently broad, third-parties could develop and commercialize technology and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">products similar or identical to ours, and our ability to successfully commercialize our technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and products may be adversely affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our commercial success will depend, in part, on our ability to continue obtaining and maintaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property protection for our technology and products, in both the United States and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other countries, successfully defending this intellectual property against third-party challenges and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">successfully enforcing this intellectual property to prevent third-party infringement. We rely upon a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combination of patents, trade secrets, know-how, copyrights, trademarks, license agreements and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractual provisions to establish our intellectual property rights and protect our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to protect our technologies and products from unauthorized or infringing use by third-parties <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depends in substantial part on our ability to obtain and maintain valid and enforceable patents in both the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States and certain other countries. The patent positions of medical technology and software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies can be highly uncertain and involve complex legal, scientific and factual questions for which <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">47<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">important legal principles remain unresolved. In addition, the patent prosecution process is expensive, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce, defend or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">license all necessary or desirable patents or patent applications at a reasonable cost or in a timely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manner, or in all jurisdictions. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We cannot guarantee that any patents will issue from any pending or future patent applications owned by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or licensed to us, or if issued, the breadth of such patent coverage. In particular, during prosecution of any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent application, the issuance of any patents based on the application may depend upon our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generate additional preclinical or clinical data that support the patentability of our proposed claims. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be able to generate sufficient additional data on a timely basis, or at all. It is also possible that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may fail to identify patentable aspects of inventions made in the course of our development and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial activities before it is too late to obtain patent protection on such inventions. If we fail to timely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file for patent protection in any jurisdiction, we may be precluded from doing so at a later date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The issuance of a patent is not conclusive as to its inventorship, ownership, scope, validity or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enforceability, and our owned or licensed patents may be challenged in the courts or the patent offices of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States or abroad. Such challenges may result in a loss of exclusivity or in the patent&#8217;s claims <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third-parties from using or commercializing similar or identical products, or limit the duration of patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection for our technology and products. In addition, changes in either the patent laws, implementing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations or interpretations of patent laws in the United States or foreign countries may diminish the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of our patent rights.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Even if unchallenged, our owned or licensed patents may not provide us with exclusivity or commercial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value for our products or any significant protection against competitive products or prevent others from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">designing around our claims. Our competitors might conduct research and development activities in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">countries where we do not have patent rights (or in those countries where we do, under safe harbor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions) and then use the information learned from such activities to develop competitive products for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale in our major commercial markets. Further, if we encounter delays in regulatory approvals, the period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of time during which we could market our products under patent protection could be reduced. Any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these outcomes could impair our ability to prevent competition from third-parties, which may have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Patent applications are generally maintained in confidence until publication. In the United States, for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, patent applications are maintained in secrecy for up to 18 months after their filing. Similarly, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publication of discoveries in scientific or patent literature often lag behind actual discoveries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Consequently, we cannot be certain that we or our licensors were the first to invent, or the first to file <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent applications on our products. There is also no assurance that all of the potentially relevant prior art <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relating to our patents and patent applications has been found, which could be used by a third party to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenge validity of our patents or prevent a patent from issuing from a pending patent application. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to patents, proprietary trade secrets and unpatented know-how are important to our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For information about risks related to these intellectual property rights, see the risk factor titled &#8220;If we are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to protect the disclosure and use of our confidential information and trade secrets, the value of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products and technologies and our business and competitive position could be harmed&#8221; below. We also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rely on the trademarks we own to distinguish our products from the products of our competitors. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cannot guarantee that any trademark applications filed by us will be approved. Third-parties may also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">oppose or attempt to cancel our trademark applications or trademarks, or otherwise challenge our use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the trademarks. In the event that the trademarks we use are successfully challenged, we could be forced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to rebrand our products, which could result in loss of brand recognition, and could require us to devote <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources to advertising and marketing new brands. Competitors or other parties may adopt trade names <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market confusion. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, we cannot provide assurance that competitors will not infringe the trademarks we use, or that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will have adequate resources to enforce these trademarks. If we attempt to enforce our trademarks and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">48<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assert trademark infringement claims, a court may determine that the marks we have asserted are invalid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or unenforceable, or that the party against whom we have asserted trademark infringement has superior <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights to the marks in question. In this case, we could ultimately be forced to cease use of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trademarks. We may license our trademarks and trade names to third-parties, such as distributors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Though these license agreements may provide guidelines for how our trademarks and trade names may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be used, a breach of these agreements or misuse of our trademarks and trade names by our licensees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Over the long term, if we are unable to establish name recognition based on our trademarks and trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">names, then we may not be able to compete effectively and our business may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For information about risks related to our inability to protect our intellectual property rights outside the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States, see the risk factor titled &#8220;We may not be able to adequately protect our intellectual property <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights throughout the world&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to protect the disclosure and use of our confidential information and trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">secrets, the value of our products and technologies and our business and competitive position <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">could be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to patent protection, we also rely on other intellectual property rights, including trade secrets, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">know-how, and&#47;or other proprietary information that is not patentable or that we elect not to patent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">However, trade secrets can be difficult to protect, and some courts are less willing or unwilling to protect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade secrets. Although we have taken steps to protect our trade secrets and unpatented know-how, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including by entering into confidentiality agreements with third-parties, and proprietary information and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invention agreements with our employees, consultants and advisors, third-parties may still obtain this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information or we may be unable to protect our rights. There can be no assurance that binding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements will not be breached, that we would have adequate remedies for any breach, or that our trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets and unpatented know-how will not otherwise become known or be independently discovered by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our competitors. We also seek to preserve the integrity and confidentiality of our data and trade secrets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by maintaining physical security of our premises and physical and electronic security of our information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology systems. While we have confidence in these individuals, organizations and systems, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">security measures may be breached, and we may not have adequate remedies for any such breach. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would have no right to prevent them, or those to whom they communicate it, from using that information to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compete with us. Any exposure of our trade secrets and other proprietary information would impair our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitive advantages and could have a material adverse effect on our business, financial condition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results of operations and prospects. In particular, a failure to protect our proprietary rights may allow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors to copy our products or technologies, which could adversely affect our pricing and market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or technologies that we consider proprietary. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Costly and time-consuming litigation could be necessary to enforce and determine the scope of our trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secret rights and related confidentiality, non-disclosure and non-use provisions, and outcomes of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation are unpredictable. Enforcing a claim that a party illegally disclosed, used or misappropriated a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. While we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use commonly accepted security measures, trade secret claims are often based on a combination of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal and state law in the United States, and the criteria for protection of trade secrets can vary among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different jurisdictions. If the steps we have taken to maintain our trade secrets are deemed inadequate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may have insufficient recourse against third-parties for misappropriating the trade secret. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement terms that address non-competition are difficult to enforce in many jurisdictions and might not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be enforceable in certain cases. Even if we were to be successful in the enforcement of our claims, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be able to obtain adequate remedies. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">49<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Reliance on third-parties requires us to share our trade secrets, which increases the possibility <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">that a competitor will discover them or that our trade secrets will be misappropriated or disclosed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to others. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any collaboration or other engagement with third-parties for the development of our products may require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us, at times, to share trade secrets with them. We may also conduct joint research and development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs that may require us to share trade secrets under the terms of our research and development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partnerships or similar agreements. We seek to protect our trade secrets and other proprietary technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in part by entering into confidentiality agreements with third-parties prior to beginning research or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosing proprietary information. These agreements typically limit the rights of the third-parties to use or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclose our confidential information, including our trade secrets. Despite the contractual provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employed when working with third-parties, the need to share trade secrets and other confidential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information increases the risk that such trade secrets become known by our competitors, are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inadvertently incorporated into the technology of others, or are disclosed or used in violation of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements. Given that our proprietary Heartflow Platform is based, in part, on our know-how and trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets, a competitor&#8217;s discovery of our trade secrets or other unauthorized use or disclosure could have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, these agreements typically restrict the ability of our advisors, employees, third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractors and consultants to publish data potentially relating to our trade secrets. Despite our efforts to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protect our trade secrets, we may not be able to prevent the unauthorized disclosure or use of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technical know-how or other trade secrets by the parties to these agreements. Moreover, we cannot <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guarantee that we have entered into such agreements with each party that may have or have had access <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to our confidential information or proprietary technology and processes. Monitoring unauthorized uses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and disclosures is difficult, and we do not know whether the steps we have taken to protect our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proprietary technologies will be effective. If any of the collaborators, scientific advisors, employees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractors and consultants who are parties to these agreements breaches or violates the terms of any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these agreements, we may not have adequate remedies for any such breach or violation, and we could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lose our trade secrets as a result. Moreover, if confidential information that is licensed or disclosed to us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by our partners, collaborators, or others is inadvertently disclosed or subject to a breach or violation, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be exposed to liability to the owner of that confidential information. Enforcing a claim that a third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party illegally obtained and is using our trade secrets, like patent litigation, is expensive and time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consuming, and the outcome is unpredictable. In addition, courts outside the United States are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sometimes less willing to protect trade secrets, and we may need to share our trade secrets and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proprietary know-how with current or future partners, collaborators, contractors and others located in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">countries at heightened risk of theft of trade secrets, including through direct intrusion by private parties or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign actors, and those affiliated with or controlled by state actors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Obtaining and maintaining our patent protection depends on compliance with various procedural, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">document submission, fee payment and other requirements imposed by governmental patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">agencies, and our patent protection could be reduced or eliminated for noncompliance with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">requirements. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) and various foreign governmental patent agencies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require compliance with a number of procedural, documentary, fee payment and other similar provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">during the patent application process. In addition, periodic maintenance fees, renewal fees, annuity fees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and various other government fees on patents and&#47;or applications will be due to be paid to the USPTO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and various governmental patent agencies outside of the United States over the lifetime of our patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and&#47;or applications and any patent rights we may obtain in the future. We have systems in place to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remind us to pay these fees, and we employ outside firms to remind us to pay annuity fees due to patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agencies on our patents and pending patent applications. In many cases, an inadvertent lapse can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cured by payment of a late fee or by other means in accordance with the applicable rules. However, there <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are situations in which noncompliance can result in abandonment or lapse of the patent or patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">event, our competitors might be able to enter the relevant market, which would have an adverse effect on <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">50<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business. Noncompliance events that could result in abandonment or lapse of a patent or patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application include failure to respond to official actions within prescribed time limits, non-payment of fees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and failure to properly legalize and submit formal documents.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Changes in patent law, precedents and policies in the United States and other jurisdictions could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">diminish the value of patents in general, thereby impairing our ability to protect our products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to obtain patents is highly uncertain because, to date, some legal principles remain unresolved, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and there has not been a consistent policy regarding the breadth or interpretation of claims allowed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents in the United States. Furthermore, the specific content of patents and patent applications that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary to support and interpret patent claims is highly uncertain due to the complex nature of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relevant legal, scientific, and factual issues. The United States Supreme Court has ruled on several <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent cases in recent years, either narrowing the scope of patent protection available in certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances or weakening the rights of patent owners in certain situations. Changes in either the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws or interpretations of patent laws in the United States or other jurisdictions may diminish the value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our intellectual property. In the United States, in certain circumstances, court rulings may narrow the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scope of patent protection and weaken the rights of patent owners. We cannot predict how decisions by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the courts, the U.S. Congress, the USPTO or changes in the patent laws of other jurisdictions may impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the value of our patents. Changes in the laws, regulations, precedents and procedures governing patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our intellectual property in the future, which could have a material adverse effect on our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, patent coverage in medical devices and technologies is a subject of evolution and differences <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">between countries. This is especially true of the definition of patentable subject matter which affects both <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computer related inventions and biological inventions. This evolution may cause current granted patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to be considered non-patent eligible or prevent us from protecting future inventions. U.S. Supreme Court <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Federal Circuit decisions interpreting and&#47;or limiting the scope of patentable subject matter under 35 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S.C. &#167; 101, in addition to examination guidelines from the USPTO, have made it more difficult for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patentees to obtain and&#47;or maintain patent claims in the United States that are directed to medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technologies involving computer-implemented applications. Several precedential decisions regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patentable subject matter are of particular relevance to patents in the computer-implemented applications <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">space. Our efforts to seek patent protection for our technologies and products may be impacted by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evolving case law and guidance or procedures issued by the USPTO or authorities in other jurisdictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on such evolving case law.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, changes in patent laws and regulations in other countries or jurisdictions, changes in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental bodies that enforce them or changes in how the relevant governmental authority enforces <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent laws or regulations may weaken our ability to obtain new patents or to enforce patents that we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain in the future. For example, the complexity and uncertainty of European patent laws have also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increased in recent years. In Europe, a new unitary patent system took effect June 1, 2023, which will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly impact European patents, including those granted before the introduction of the new unitary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent system. Under the unitary patent system, European applications have the option, upon grant of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the Unitary Patent Court <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;UPC&#8221;). As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any litigation. Patents granted before the implementation of the UPC have the ability to opt out of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction of the UPC and remain as national patents in the UPC countries. The UPC will provide our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitors with a new forum to centrally revoke European patents, and allow for the possibility of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitor to obtain pan-European injunctions, since patents that remain under the jurisdiction of the UPC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be potentially vulnerable to a single UPC-based revocation challenge that, if successful, could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invalidate the patent in all countries who are signatories to the UPC. We cannot predict with certainty the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">long-term effects of any potential changes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Further, the laws of some foreign countries do not protect proprietary rights to the same extent or in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">same manner as the laws of the United States and Europe. As a result, we may encounter significant <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">51<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">problems in protecting and defending our intellectual property both in the United States and abroad. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, if the issuance in a given country of a patent covering an invention is not followed by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance in other countries of patents covering the same invention, or if any judicial interpretation of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">validity, enforceability or scope of the claims or the written description or enablement, in a patent issued in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">one country is not similar to the interpretation given to the corresponding patent issued in another country, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our ability to protect our intellectual property in those countries may be limited. Changes in either patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws or in interpretations of patent laws in the United States and other countries may materially diminish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the value of our intellectual property or narrow the scope of our patent protection.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, on September 16, 2011, the Leahy-Smith America Invents Act (the &#8220;Leahy-Smith Act&#8221;) was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Assuming that other requirements for patentability are met, prior to March 16, 2013, in the United States, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the first to invent the claimed invention was entitled to the patent, while outside the United States, the first <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to file a patent application was entitled to the patent. On or after March 16, 2013, under the Leahy-Smith <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act, the United States transitioned to a first inventor to file system in which, assuming that other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements for patentability are met, the first inventor to file a patent application will be entitled to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent on an invention regardless of whether a third-party was the first to invent the claimed invention. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under this system, a third-party that files a patent application in the USPTO before us could be awarded a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent covering an invention of ours even if we had made the invention before it was made by such third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party. Since patent applications in the United States and most other countries are confidential for a period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of time after filing or until issuance, we cannot be certain that we or our licensors were the first to either (i) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file any patent application related to our products or (ii) invent any of the inventions claimed in our or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licensors&#8217; patents or patent applications.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Leahy-Smith Act also changed the way patent applications are prosecuted, including by allowing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third-party submission of prior art to the USPTO during patent prosecution and additional procedures to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenge the validity of a patent by USPTO administered post-grant proceedings to attack the validity of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a patent. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard in U.S. federal courts necessary to invalidate a patent claim, a third-party could potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">same evidence might not be sufficient to invalidate the claim if presented in a district court action. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, third-parties may use USPTO proceedings to invalidate our patent claims that would not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been invalidated if first challenged in a district court action. Therefore, the Leahy-Smith Act and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implementation could increase the uncertainties and costs surrounding the prosecution of our patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications and the enforcement or defense of our issued patents, which could have a material adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect on our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may not be able to adequately protect our intellectual property rights throughout the world. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our patent portfolio includes patents and patent applications in countries outside of the United States, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including Japan, Korea, China, Canada, Australia, Israel, India and countries in Europe. The requirements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for patentability differ from country to country, the breadth of allowed patent claims can be inconsistent, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the scope of coverage provided by these patents varies and the laws of some foreign countries may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protect our intellectual property rights to the same extent as laws in the United States. In addition, filing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prosecuting and defending patents on our products in all countries throughout the world would be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prohibitively expensive. For those countries where we do not have granted patents, we may not have any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ability to prevent the unauthorized sale of our products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we may decide to abandon national and regional patent applications before they are granted. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The examination of each national or regional patent application is an independent proceeding. As a result, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent applications in the same family may issue as patents in some jurisdictions, such as in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, but may issue as patents with claims of different scope or may even be refused in other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions. It is also quite common that depending on the country, the scope of patent protection may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vary for the same product or technology. For example, certain jurisdictions do not allow for patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection with respect to methods of treatment.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">52<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Consequently, we may not be able to prevent third-parties from practicing our inventions in all countries <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outside the United States. Competitors may use our technologies in jurisdictions where we have not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtained patent protection to develop their own products and, further, may export otherwise infringing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products to territories in which we have patent protection that may not be sufficient to terminate infringing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">world may be inadequate to obtain a significant commercial advantage from the intellectual property that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we develop or license.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licenses to third-parties, government agencies or government contractors. In these countries, the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owner may have limited remedies, which could materially diminish the value of such patent. If we or any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our licensors is forced to grant a license to third-parties with respect to any patents relevant to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, our competitive position may be impaired, and our business, financial condition, results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and prospects may be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not seek or have patent rights in certain foreign countries in which a market may exist. Accordingly, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our efforts to protect our intellectual property rights in such countries may be inadequate, which may have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an adverse effect on our ability to successfully commercialize our products in all of our expected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant foreign markets. Moreover, in foreign jurisdictions where we do have patent rights, proceedings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to enforce such rights could result in substantial costs and divert our efforts and attention from other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent applications at risk of not issuing. Additionally, such proceedings could provoke third-parties to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remedies awarded, if any, may not be commercially meaningful. Thus, we may not be able to stop a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitor from marketing and selling in foreign countries products that are the same as or similar to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, and our competitive position in the international market would be harmed.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may be involved in lawsuits to protect or enforce our patents or other intellectual property, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the patents of our licensors, which could be expensive, time consuming and unsuccessful. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Competitors or other third-parties may infringe, misappropriate or otherwise violate our owned or licensed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents, trade secrets or other intellectual property. To counter infringement or unauthorized use, we may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be compelled to file infringement or misappropriation claims, which can be expensive and time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consuming. We do not carry intellectual property insurance that would cover such claims. In certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances it may not be practicable or cost effective for us to enforce our intellectual property rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fully, particularly in certain developing countries or where the initiation of a claim might harm our business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationships. If we initiate legal proceedings against a third-party to enforce a patent covering our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, the defendant could counterclaim that our patent(s) are invalid and&#47;or unenforceable. In patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation in the United States, counterclaims alleging invalidity and&#47;or unenforceability are common, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">there are numerous grounds upon which a third-party can assert invalidity or unenforceability of a patent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In an infringement proceeding, a court may decide that a patent we own or license is not valid, is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unenforceable or is not infringed, or may refuse to stop the other party from using the technology at issue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the grounds that our patents do not cover the technology in question. The outcome following legal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, we cannot be certain that there is no invalidating prior art. If a defendant were to prevail on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">legal assertion of invalidity and&#47;or unenforceability, we may lose some, and perhaps all, of the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection covering our products. An adverse result in any litigation or defense proceeding could put one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or more of our patents at risk of being invalidated or interpreted narrowly, could put our patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications at risk of not issuing and could have a material adverse impact on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our defense of litigation may fail and, even if successful, may result in substantial costs and distract our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and other employees. Even if we establish infringement, the court may decide not to grant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an injunction against further infringing activity and instead award only monetary damages, which may or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be an adequate remedy. For example, the amount of any monetary damages may be inadequate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to compensate us for damage as a result of the infringement and the proceedings. We may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">53<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prevent, alone or with our suppliers, misappropriation of intellectual property rights important to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, particularly in countries where the laws may not protect those rights as fully as in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, because of the substantial amount of discovery required in connection with intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property litigation, there is a risk that some of our confidential information could be compromised by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosure during this type of litigation. There could also be public announcements of the results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hearings, motions or other interim proceedings or developments. If securities analysts or investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perceive these results to be negative, it could have an adverse effect on the price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Third-party defendants may challenge any patent we own or in-license through adversarial proceedings in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the issuing offices, which could result in the invalidation or unenforceability of some or all of the relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent claims. If a third-party asserts a substantial new question of patentability against any claim of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. patent we own or license, the USPTO may grant a request for reexamination, which may result in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loss of scope of some claims or a loss of the entire patent. The adoption of the Leahy-Smith Act has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">established additional opportunities for third-parties to invalidate U.S. patent claims, including inter partes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review and post grant review, on the basis of lower legal standards than reexamination and additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">grounds. Outside of the United States, patents we own or license may become subject to patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opposition or similar proceedings, which may result in loss of scope of some claims or loss of the entire <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent. Participation in adversarial proceedings is very complex, expensive and may divert our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management&#8217;s attention from our core business and may result in unfavorable outcomes that could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our ability to prevent third-parties from competing with us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may be subject to claims challenging the inventorship or ownership of our patents and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">intellectual property rights or alleging that we have violated the intellectual property rights or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">other proprietary rights of third-parties. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our commercial success depends, in part, upon our ability to develop, manufacture, market and sell our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products and use our proprietary technologies without infringing the proprietary rights and intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property of third-parties. The medical device industry is characterized by extensive and complex litigation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding patents and other intellectual property rights. We may be exposed to, or threatened with, future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation by third-parties having patent or other intellectual property rights alleging that our products or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proprietary technologies infringe on their intellectual property rights. There is a risk that third-parties may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">choose to engage in litigation with us to enforce or to otherwise assert their patent rights against us. Even <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">if we believe such claims are without merit, a court of competent jurisdiction could hold that these third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party patents are valid, enforceable and infringed, which could have a negative impact on our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialize our products. This includes litigation, or threatened litigation, with non-practicing entities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that have no relevant product revenue and against whom our own patent portfolio may have no deterrent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect. The legal threshold for initiating litigation or contested proceedings is low, so that even lawsuits or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceedings with a low probability of success might be initiated and require significant resources to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defend. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may also be subject to claims that former employees, collaborators or other third-parties have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ownership interest in our patent rights or other intellectual property, for example, based on conflicting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligations of consultants or others who are involved in developing our products. Although it is our policy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to require our employees and contractors who may be involved in the conception or development of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property to execute agreements assigning such intellectual property to us, we may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unsuccessful in executing such an agreement with each party who, in fact, conceives or develops <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property that we regard as our own, and we cannot be certain that our agreements with such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties will be upheld in the face of a potential challenge, or that they will not be breached, for which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not have an adequate remedy. The assignment of intellectual property rights may not be self-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executing or the assignment agreements may be breached, and litigation may be necessary to defend <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against these and other claims challenging inventorship or ownership. If we fail in defending any such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">54<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material adverse effect on our business. Even if we are successful in defending against such claims, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">litigation could result in substantial costs and be a distraction to management and other employees. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We employ individuals who were previously employed at other medical technology companies. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, we use publications that are subject to copyright, as well as proprietary information and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">materials from third-parties in our research. Some of the information and materials we use from third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties may be subject to agreements that include restrictions on use or disclosure. Although we strive to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ensure proper safeguards, we cannot guarantee strict compliance with such agreements, nor can we be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sure that our employees, consultants and advisors do not use proprietary information, materials or know-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">how of others in their work for us. In addition, we may be subject to claims that we or our employees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consultants or independent contractors have inadvertently or otherwise used or disclosed alleged trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets or other proprietary information of former employers or other third-parties. Although we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures in place that seek to prevent our employees and consultants from using the intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property, proprietary information, know how or trade secrets of others in their work for us, we may in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future be subject to claims that we caused an employee to breach the terms of his or her non-competition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or non-solicitation agreement, or that we or these individuals have, inadvertently or otherwise, used or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosed the alleged trade secrets or other proprietary information of a former employer or competitor. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may also be subject to claims that former employers or other third-parties have an ownership interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in our future patents. In addition, we may be subject to claims that we are infringing other intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property rights, such as trademarks or copyrights, and to the extent that our employees, consultants or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractors use intellectual property or proprietary information owned by others in their work for us, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disputes may arise as to the rights in related or resulting know-how and inventions. Litigation may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary to defend against these claims. There is no guarantee of success in defending these claims, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and even if we are successful, litigation could result in substantial cost and be a distraction to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and other employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">An unfavorable outcome for any such claim could require us to cease using the related technology or to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party does not offer us a license on commercially reasonable terms. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If a third-party claims that we infringe its intellectual property rights, we may face a number of issues, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">infringement and other intellectual property claims which, regardless of merit, may be expensive and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">time consuming to litigate and may divert our management&#8217;s attention from our core business&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">substantial damages for infringement, which we may have to pay if a court decides that the product at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issue infringes or violates the third-party&#8217;s rights, and if the court finds that the infringement was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">willful, we could be ordered to pay treble damages and the patent owner&#8217;s attorneys&#8217; fees&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a court prohibiting us from selling or licensing the product unless the third-party licenses its product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">rights to us, which it is not required to do&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">if a license is available from a third-party, we may have to pay substantial royalties, upfront fees or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">grant cross licenses to intellectual property rights for our products&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redesigning our products or processes so they do not infringe, which may not be possible or may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">require substantial monetary expenditures and time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In order to successfully challenge the validity of a U.S. patent in federal court, we would need to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">overcome a presumption of validity. As this burden is a high one requiring us to present clear and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of competent jurisdiction would invalidate the claims of any such U.S. patent. Foreign courts will have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar burdens to overcome in order to successfully challenge a third-party claim of patent infringement.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than we can because they have substantially greater resources. In addition, any uncertainties resulting <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">55<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from the initiation and continuation of any litigation could have an adverse effect on our ability to raise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional funds or on our business, financial condition, results of operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The terms of our patents may not be sufficiently long to effectively protect our products and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Patents have a limited lifespan. In the United States, the natural expiration of a patent is generally 20 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">years after its first effective non-provisional filing date, but can be shorter due to terminal disclaimers or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar term reductions in other jurisdictions. Although various extensions may be available, the term of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent, and the protection it affords, is limited. Even if patents covering our technologies or products are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtained, once the patent term has expired, we may be open to competition. In addition, although upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance in the United States, a patent&#8217;s term can be increased based on certain delays caused by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">USPTO, this increase can be reduced or eliminated based on certain delays caused by the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicant during patent prosecution. Given the amount of time required for the development, testing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory review of products, patents protecting such potential products might expire before or shortly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after such products are commercialized. If we do not have sufficient patent life to protect our technologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and products, our business, financial condition, results of operations and prospects will be adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we do not obtain additional protection under the Hatch-Waxman Amendments or similar foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">legislation, our business may be materially affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Depending upon the timing, duration and specifics of FDA marketing approval for our future products, one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or more of our U.S. patents may be eligible for limited patent term restoration under the Drug Price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Competition and Patent Term Restoration Act of 1984 (the &#8220;Hatch-Waxman Amendments&#8221;). The Hatch-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Waxman Amendments permit a patent term extension of up to five years beyond the normal expiration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the patent as compensation for patent term lost during product development and the FDA regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review process, which is limited to the approved indication (or any additional indications approved during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the period of extension). This extension is limited to one patent that covers the approved product, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved use of the product, or a method of manufacturing the product. A patent term extension cannot <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extend the remaining term of a patent beyond a total of 14 years from the date of product approval, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only those claims covering such approved product, a method for using it or a method for manufacturing it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be extended. However, the applicable authorities, including the FDA and the USPTO in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, and any equivalent regulatory authority in other countries or areas, may not agree with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment of whether such extensions are available, and may refuse to grant extensions to our patents, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or may grant more limited extensions than we request. We may not be granted an extension because of, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for example, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scope of patent protection afforded could be less than we request. If we are unable to obtain patent term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extension or restoration of the term of any such extension is less than we request, our competitors may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain approval for competing products following our patent expiration, and our ability to generate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenues may be adversely affected. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Open-source software licenses often impose unanticipated or unclear restrictions on us or could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">expose us to litigation, and using open-source software has inherent risks, any of which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">impair our ability to successfully commercialize the Heartflow Platform.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology platform implements software modules licensed to us by third-parties under &#8220;open source&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licenses. The terms of many open source licenses have not been interpreted by U.S. courts, and there is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a risk that these licenses could be construed in ways that could impose unanticipated conditions or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restrictions on our ability to commercialize our products. Moreover, we cannot be certain that our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">processes for controlling our use of open-source software in connection with our products will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective. From time to time, we may face claims from third-parties asserting ownership of, or demanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">release of, the open-source software or derivative works that we developed using such software (which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could include our proprietary source code), or otherwise seeking to enforce the terms of the applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">open source license. These claims could result in litigation. If we are held to have breached the terms of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">56<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an open source software license, we could be required to seek licenses from third-parties to continue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering our products on terms that are not economically feasible, to re-engineer our proprietary code, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discontinue the sale of our products if re-engineering could not be accomplished on a timely or cost <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective basis, or to make generally available, in source code form, our proprietary code, any of which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect our business, financial condition, results of operations and prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The use of open-source software may entail greater risks than the use of third-party commercial software, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as open source licensors generally do not provide warranties or other contractual protections regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">infringement or the quality or ownership of the code. Many of these risks cannot be eliminated, and could, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">if not properly addressed, negatively affect our business. We cannot be sure that all open source software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is submitted for approval prior to use in connection with our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, some open-source licenses contain requirements that we make available source code for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modifications or derivative works we create based upon the type of open-source software we use. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combine our proprietary software with open-source software in a certain manner, we could, under certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">open-source licenses, be required to release portions of the source code of our proprietary software to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public. This would allow our competitors to create similar products with less development effort and time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and ultimately could result in a loss of sales for us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Intellectual property rights do not necessarily address all potential threats to our competitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">advantage. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The degree of future protection afforded by our intellectual property rights is uncertain because <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property rights have limitations and may not adequately protect our business or permit us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintain our competitive advantage. The following examples are illustrative&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">others may be able to make products that are similar to or otherwise competitive with our potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products but that are not covered by the claims of our current or future patents&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an in-license necessary for the manufacture, use, sale, offer for sale or importation of one or more of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our potential products may be terminated by the licensor&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we or future collaborators might not have been the first to make the inventions covered by our issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">or future issued patents or our pending patent applications&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we or future collaborators might not have been the first to file patent applications covering certain of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our inventions&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">others may independently develop similar or alternative technologies or duplicate any of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">technologies without infringing our intellectual property rights&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">it is possible that our pending patent applications will not lead to issued patents&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issued patents that we own or in-license may be held invalid or unenforceable as a result of legal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">challenges by our competitors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issued patents that we own or in-license may not provide coverage for all aspects of our new potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products in all countries&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our competitors might conduct research and development activities in countries where we do not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">have patent rights and then use the information learned from such activities to develop competitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products for sale in our major commercial markets&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">we may not develop additional proprietary technologies that are patentable&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the patents of others may have an adverse effect on our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Should any of these events occur, they could significantly harm our business, results of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">57<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to financing and tax matters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may require additional capital to support business growth, and this capital might not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">available on terms favorable to us, or at all, and may dilute ownership of our common stock for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our stockholders, including purchasers of common stock in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We intend to continue to make investments to support our business growth and may require additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">funds to respond to business challenges and opportunities, including the need to develop new products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enhance our existing products, enhance our operating infrastructure, potentially expand internationally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and potentially acquire complementary businesses and technologies. In order to achieve these objectives, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may make future commitments of capital resources. Accordingly, we may need to engage in equity or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt financings to secure additional funds. If we raise additional funds through further issuances of equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or convertible debt securities, our stockholders, including any purchasers of common stock in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, could suffer significant dilution, and any new equity securities we issue could have rights, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferences and privileges superior to those of holders of our common stock. In addition, our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incur indebtedness is subject to limitations under the 2024 Credit Agreement and, if incurred, would <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase our fixed obligations and could include covenants or other restrictions that would impede our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ability to manage our operations. Further, if additional financing is needed, we may not be able to obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional financing on terms favorable to us or at all. Our inability to obtain adequate financing or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financing on terms satisfactory to us, when we require it, could significantly limit our ability to continue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supporting our business growth and responding to business challenges and opportunities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our operating results may fluctuate significantly, which makes our future operating results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">difficult to predict and could cause our operating results to fall below expectations or any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">guidance we may provide.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our quarterly revenue and results of operations may fluctuate from quarter to quarter due to, among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">others, the following reasons&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the level of physicians&#8217; acceptance and adoption of our products, and changes in the rates at which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians order our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 247.18pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.84pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis or the percentage of CCTA scans for which our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is ordered&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">determinations, including the timing of determinations, by payers concerning coverage and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement of our products&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in coverage amounts or government and payers&#8217; reimbursement policies&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the timing, expense and results of research and development activities, clinical trials and any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">additional regulatory approvals&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in AHA or ACC guidelines, or guidelines in other countries, that lower support for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products or elevate alternative products as the preferred pathway for diagnosis and management of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">fluctuations in our expenses associated with expanding our commercial operations and operating as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a public company&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients meeting their annual health insurance deductible later in the calendar year&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the introduction of new products and technologies by our competitors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in our pricing policies or in the pricing policies of our competitors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the productivity of our sales and marketing teams, and their ability to identify physicians who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">consistently refer appropriate patients for CCTAs in accordance with AHA and ACC guidelines&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quality problems with our products or the Heartflow Platform&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">58<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the impact of catastrophic events such as a pandemic.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Because of these and other factors, it is likely that in some future period our operating results will not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meet investor expectations or those of public market analysts. Any unanticipated change in revenue or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating results is likely to cause our stock price to fluctuate. New information may cause investors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analysts to revalue our business, which could cause a decline in our stock price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our credit agreement contains certain restrictions that may limit our ability to operate our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">business. If we raise additional capital through debt financing, the terms of any new debt could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">further restrict our ability to operate our business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The terms of the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.51pt; position: absolute; text-decoration: none; white-space: pre;">2024 Credit Agreement<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.29pt; position: absolute; white-space: pre;"> and related collateral documents contain, and any future debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements would likely contain, a number of restrictive covenants that impose significant operating and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial restrictions on us, including restrictions on our ability, and the ability of our subsidiaries, to take <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">actions that may be in our best interests, including, among others, disposing of assets, entering into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change of control transactions, mergers or acquisitions, incurring additional indebtedness, granting liens <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our assets and declaring and paying dividends. Our ability to meet covenants can be affected by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">events beyond our control, and we may not be able to continue to meet such covenants. We have in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">past, and may in the future, breach our covenants under the 2024 Credit Agreement. In March 2023, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered into an agreement with Hayfin to temporarily waive certain covenant requirements that had not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been met pursuant to our prior credit agreement with Hayfin. In the future, a breach of the covenants or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the occurrence of other events (including, among others, a material adverse effect or the inability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generate cash to service our obligations under our debt agreements) specified in the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement and&#47;or the related collateral documents or a future debt agreement could result in an event of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">default. Upon the occurrence of an event of default, our lenders could elect to declare all obligations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owing under the debt documents, if any, to be immediately due and payable, terminate all commitments to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extend further credit and&#47;or proceed against the collateral, if any, pledged to them to secure such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indebtedness. For example, we have pledged substantially all of our assets, including, among others, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property, all of Heartflow&#8217;s ownership interests in Heartflow, Inc. and our foreign subsidiaries <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as collateral under the 2024 Credit Agreement and related collateral documents. For additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information on the 2024 Credit Agreement, see the section titled &#8220;Management&#8217;s discussion and analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of financial condition and results of operations&#8212;Liquidity and capital resources&#8212;Hayfin credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement.&#8221; If lenders accelerate the repayment of borrowings, if any, we may not have sufficient funds to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repay our existing debt and the lenders could seize collateral that was pledged as guarantee for the loan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which would harm our business and financial condition. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amounts borrowed under the 2024 Credit Agreement can be repaid at any time, subject to applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prepayment fees, prior to the June 14, 2028 maturity date, at which time all obligations owing under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt documents will be due and payable. The 2024 Credit Agreement contains customary affirmative and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">negative covenants, indemnification provisions and events of default. The affirmative covenants include, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">among others, covenants requiring us to deliver certain financial reports and to maintain our legal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existence, regulatory authorizations and certain intellectual property rights. The negative covenants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">include, among others, restrictions on changing our business activities, incurring additional indebtedness <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and creating liens on our assets, requirements to maintain certain levels of liquidity and minimum net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales, restrictions on making investments, paying dividends, issuing securities, engaging in mergers or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acquisitions, licensing our assets or making other distributions, in each case subject to customary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exceptions. If we default under the 2024 Credit Agreement, Hayfin will be able to declare all obligations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable and take control of our pledged assets, which may require us to renegotiate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our agreement on terms less favorable to us or to immediately cease operations. Any event of default by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us could significantly harm our business, financial condition, results of operations and prospects and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could cause the price of our common shares to decline. Further, if we are liquidated, Hayfin&#8217;s right to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repayment would be senior to the rights of the holders of our common shares to receive any proceeds <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from the liquidation.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">59<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we are obligated to repay indebtedness outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the 2024 Credit Agreement in an amount equal to the lesser of (i) net cash proceeds in excess of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$150.0 million and (ii) $50.0 million (or $55.0 million if the underwriters exercise any portion of their option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to purchase additional shares). While we currently anticipate paying off $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indebtedness under the 2024 Credit Agreement immediately following the completion of this offering, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">portion of the indebtedness under the 2024 Credit Agreement will remain outstanding and we will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the ongoing requirements of the 2024 Credit Agreement and related collateral documents. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are subject to risks associated with currency fluctuations, and changes in foreign currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">exchange rates could impact our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">All of our revenue and the majority of our expense and capital purchasing activities through the year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended December 31, 2024 were transacted in U.S. dollars. Approximately&#160;11% of our 2023 revenue and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 9% of our 2024 revenue was generated from customers outside the United States. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">However, because a portion of our operations consists of business activities outside of the United States, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we have foreign currency operating expenses as well as asset and liability balances. During the year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended December 31, 2024, we were exposed to foreign currency risks in connection with our non-U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations, and we anticipate that, over time, an increasing portion of our international agreements may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide for payment denominated in foreign currencies. Changes in the exchange rates between such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign currencies and the U.S. dollar could therefore materially impact our reported results of operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and distort period-to-period comparisons. Fluctuations in foreign currency exchange rates also impact the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting of our receivables and payables in non-U.S. currencies. As a result of such foreign currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fluctuations, it could be more difficult to detect underlying trends in our business and results of operations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, to the extent that fluctuations in currency exchange rates cause our results of operations to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">differ from our expectations or the expectations of our investors, the trading price of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could be adversely affected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not currently engage in currency hedging activities to limit the risk of exchange rate fluctuations. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the future, we may engage in exchange rate hedging activities in an effort to mitigate the impact of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange rate fluctuations but we may not be successful in doing so. If our hedging activities are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective, changes in currency exchange rates may have a more significant impact on our results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our ability to use our net operating losses and tax credits to offset future taxable income and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">taxes may be subject to certain limitations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, we had net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $542.9 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million and $435.5&#160;million for federal and state income tax purposes, respectively, which may be utilized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against future federal and state income taxes. Federal NOL carryforwards we generated in tax years <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through December&#160;31, 2017 generally may be carried forward for 20 years and may fully offset taxable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income in the year utilized, and federal NOLs we generated in tax years beginning after December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2017 generally may be carried forward indefinitely but may only be used to offset 80% of our taxable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income annually for tax years beginning after December&#160;31, 2017.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In general, under Section 382 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its pre-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change NOLs, carryforwards and other tax attributes, such as research and development tax credits, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offset future taxable income and taxes. In general, an ownership change occurs if the aggregate stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ownership of certain stockholders, generally stockholders beneficially owning five percent or more of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, applying certain look through and aggregation rules, increases by more than 50% over <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such stockholders&#8217; lowest percentage ownership during the testing period, generally three years. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Purchases of our common stock in amounts greater than specified levels, which will be beyond our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control, could create a limitation on our ability to utilize our NOLs for tax purposes in the future. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.41pt; position: absolute; text-decoration: none; white-space: pre;">We are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">currently completing a Section 382 study of our historic ownership changes through December 31, 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to determine whether the use of our NOLs is impaired<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.16999999999996pt; position: absolute; white-space: pre;">. We may have previously undergone an &#8220;ownership <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change.&#8221; In addition, this offering or future issuances or sales of our stock, including certain transactions <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">60<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involving our stock that are outside of our control, could result in future &#8220;ownership changes.&#8221; &#8220;Ownership <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes&#8221; that have occurred in the past or that may occur in the future, including in connection with this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, could result in the imposition of an annual limit on the amount of pre-ownership change NOLs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and other tax attributes we can use to reduce our taxable income, potentially increasing and accelerating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our liability for income taxes, and also potentially causing those tax attributes to expire unused.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If we are limited in our ability to use our NOLs and tax credits in future years in which we have taxable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income, we will pay more taxes than if we were able to fully utilize our NOLs and tax credits, and we could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be required to pay taxes earlier than we would otherwise be required, which could cause such NOLs to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expire unused. This could adversely affect our results of operations. Furthermore, we may not be able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generate sufficient taxable income to utilize our pre-2018 NOLs before they expire beginning in 2030. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any of these events occur, we may not derive some or all of the expected benefits from our NOLs, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business, financial condition, results of operations and prospects may be adversely affected as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our international operations subject us to potentially adverse tax consequences.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We currently report our taxable income in various jurisdictions based upon our business operations in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">those jurisdictions, including in the United States, United Kingdom, and Japan. We may in the future be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to reporting requirements in other foreign jurisdictions. The international nature and organization <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our business activities are subject to complex transfer pricing regulations administered by taxing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities in various jurisdictions. The relevant taxing authorities may disagree with our determinations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as to the income and expenses attributable to specific jurisdictions. If such a disagreement were to occur, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and our position were not sustained, we could be required to pay additional taxes, interest and penalties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which could result in one time tax charges, higher effective tax rates, reduced cash flows and lower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">overall profitability of our operations. We believe that our consolidated financial statements reflect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adequate reserves to cover such a contingency, but there can be no assurances in that regard.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our effective tax rate may vary significantly from period to period. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Various internal and external factors may have favorable or unfavorable effects on our future effective tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate. These factors include, but are not limited to, changes in tax laws, regulations or rates, both within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and outside the United States, structural changes in our business, new accounting pronouncements or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes to existing accounting pronouncements, non-deductible goodwill impairments, changing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpretations of existing tax laws or regulations, changes in the relative proportions of revenue and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income before taxes in the various jurisdictions in which we operate that have different statutory tax rates, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the future levels of tax benefits of equity-based compensation, changes in overall levels of pretax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">earnings or changes in the valuation of our deferred tax assets and liabilities. Additionally, we could be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">challenged by state and local tax authorities as to the propriety of our sales tax compliance, and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results could be materially impacted by these compliance determinations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, our effective tax rate may vary significantly depending on the market price of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock. The tax effects of the accounting for share-based compensation may significantly impact our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective tax rate from period to period. In periods in which the market price of our common stock is higher <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than the grant price of the share-based compensation vesting in that period, we will recognize excess tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefits that will decrease our effective tax rate. In future periods in which our stock price is lower than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the grant price of the share-based compensation vesting in that period, our effective tax rate may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase. The amount and value of share-based compensation issued relative to our earnings in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particular period will also affect the magnitude of the impact of share-based compensation on our effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tax rate. These tax effects are dependent on the market price of our common stock, which we do not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control, and a decline in our stock price could significantly increase our effective tax rate and adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our financial condition.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">61<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Taxing authorities may successfully assert that we should have collected or in the future should <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">collect sales and use, value added or similar taxes, and we could be subject to tax liabilities with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">respect to past or future sales, which could adversely affect our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not collect sales and use, value added and similar taxes in all jurisdictions in which we have sales, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on our belief that such taxes are not applicable or that we are not required to collect such taxes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with respect to the jurisdiction. Sales and use, value added and similar tax laws and rates vary greatly by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction. Certain jurisdictions in which we do not collect such taxes may assert that such taxes are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable, which could result in tax assessments, penalties and interest, and we may be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">collect such taxes in the future. Such tax assessments, penalties and interest or future requirements may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Risks related to our common stock and this offering<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">There may not be an active trading market for our common stock, which may cause shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">common stock to trade at a discount from the initial public offering price and make it difficult to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">sell the shares of common stock you purchase. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to this offering, there was no public market for our common stock. It is possible that after this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, an active trading market will not develop or, if developed, that any market will not be sustained, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which would make it difficult for you to sell your shares of common stock at an attractive price or at all. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The initial public offering price per share of common stock was determined by agreement among us and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the representatives of the underwriters and may not be indicative of the price at which shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock will trade in the public market, if any, after this offering. The market value of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock may decrease from the initial public offering price. It is possible that in one or more future periods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our results of operations may be below the expectations of public market analysts and investors, and, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a result of these and other factors, the price of our common stock may fall. Furthermore, an inactive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market may also impair our ability to raise capital in the future by selling shares of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The market price of our common stock may be volatile, which could cause the value of your <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">investment to decline and could result in substantial losses for investors purchasing shares in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">this offering. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This initial public offering price may vary from the market price of our common stock after the offering. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market price of our common stock may be highly volatile and could be subject to wide fluctuations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities markets worldwide experience significant price and volume fluctuations. This market volatility, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as well as general economic, market or political conditions, could reduce the market price of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock regardless of our operating performance. These fluctuations may be even more pronounced in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trading market for our stock shortly following this offering. You may be unable to resell your shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock at or above the initial public offering price or at all. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We are an emerging growth company, and the reduced reporting requirements applicable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">emerging growth companies could make our common stock less attractive to investors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. We will remain an &#8220;emerging growth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company&#8221; until the earliest to occur of&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the last day of the fiscal year during which our total annual revenue equals or exceeds $1.235 billion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(subject to adjustment for inflation)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the last day of the fiscal year following the fifth anniversary of this offering&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the date on which we have, during the previous three-year period, issued more than $1 billion in non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible debt&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Exchange Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">62<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result of our &#8220;emerging growth company&#8221; status, we may take advantage of exemptions from various <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting requirements that would otherwise be applicable to public companies including, but not limited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements and exemptions from the requirements of holding a nonbinding advisory vote on executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation and stockholder approval of any golden parachute payments not previously approved. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investors may find our common stock less attractive because we may rely on these exemptions. If some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors find our common stock less attractive as a result, there may be a less active trading market for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock and the market price of our common stock may be adversely affected and more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volatile.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We will incur increased costs and become subject to additional regulations and requirements as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">result of becoming a public company, which could lower our profits or make it more difficult to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">run our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a public company, we will incur significant legal, accounting and other expenses that we have not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incurred as a private company, including costs associated with public company reporting requirements. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have also incurred and will continue to incur costs associated with the Sarbanes-Oxley Act and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related rules implemented by the SEC and the listing requirements of the Nasdaq Global Select Market. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The expenses generally incurred by public companies for reporting and corporate governance purposes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been increasing. We expect these rules and regulations to increase our legal and financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance costs and to make some activities more time-consuming and costly, although we are currently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unable to estimate these costs with any degree of certainty. These laws and regulations also could make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">it more difficult or costly for us to obtain certain types of insurance, including director and officer liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">higher costs to obtain the same or similar coverage. These laws and regulations could also make it more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">difficult for us to attract and retain qualified persons to serve on our board of directors, on our board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">committees or as our executive officers. Furthermore, if we are unable to satisfy our obligations as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public company, we could be subject to delisting of our common stock, fines, sanctions, other regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">action and potentially civil litigation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If we are unable to design, implement and maintain effective internal control over financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reporting in the future, investors may lose confidence in the accuracy and completeness of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">financial reports and the market price of our common stock may decline.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a public company, we will be required to maintain internal control over financial reporting and to report <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any material weaknesses in such internal controls. In addition, beginning with our second annual report <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on Form 10-K, we will be required to furnish a report by management on the effectiveness of our internal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control over financial reporting, pursuant to the rules and regulations of the SEC regarding compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with Section 404 of the Sarbanes-Oxley Act. The process of designing, implementing and testing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal control over financial reporting required to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.75pt; position: absolute; text-decoration: none; white-space: pre;">comply<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.41999999999996pt; position: absolute; white-space: pre;"> with this obligation is time consuming, costly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and complicated. We<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.14pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> have in the past and may in the future identify control deficiencies, including </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">material weaknesses in our internal control over financial reporting. In connection with the preparation of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">our consolidated financial statements, material weaknesses in our internal control over financial reporting </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">were identified as of and prior to December 31, 2023, which were remediated in connection with the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">preparation of our consolidated financial statements as of and for the year ended December 31, 2024. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any failure to maintain effective internal control over financial reporting could severely inhibit our ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurately report our financial condition, results of operations or cash flows. Further, if we identify one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more material weaknesses in our internal control over financial reporting, if we are unable to comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner or if we and, if required, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our auditors, are unable to assert that our internal control over financial reporting is effective, investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may lose confidence in the accuracy and completeness of our financial reports and the market price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock could decline, and we could also become subject to investigations by the stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange on which our common stock is listed, the SEC or other regulatory authorities, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require additional financial and management resources. Failure to remedy any material weakness in our <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">63<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal control over financial reporting, or to implement or maintain other effective control systems <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required of public companies, could also restrict our future access to the capital markets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon effectiveness of the registration statement of which this prospectus forms a part, we will become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to the periodic reporting requirements of the Exchange Act. Our disclosure controls and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures are designed to reasonably ensure that information required to be disclosed by us in reports <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we file or submit under the Exchange Act is accumulated and communicated to management and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded, processed, summarized and reported within the time periods specified in the rules and forms of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the SEC. We believe that our disclosure controls and procedures as well as internal control over financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting, no matter how well conceived and operated, can provide only reasonable, not absolute, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assurance that the objectives of the control system are and will be met. These inherent limitations include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the realities that judgments in decision making can be faulty and that breakdowns can occur because of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the inherent limitations in our control system, misstatements due to error or fraud may occur and not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">detected.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If our estimates or judgments relating to our critical accounting policies are based on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">assumptions that change or prove to be incorrect, our operating results could fall below our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">publicly announced guidance or the expectations of securities analysts and investors, resulting in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">a decline in the market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The preparation of financial statements in conformity with the United States generally accepted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reported amounts of assets, liabilities, revenue, expenses and related disclosures. We base our estimates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on historical experience and various other factors that we believe are reasonable under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances, the results of which form the basis for making judgments about the carrying value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assets and liabilities that are not readily apparent from other sources. Actual results may differ from these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates under different assumptions or conditions and any such differences may be material. If our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions change or if actual circumstances differ from our assumptions, our operating results may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affected and could fall below our publicly announced guidance or the expectations of analysts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and investors, resulting in a decline in the market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our principal stockholders and management own a significant percentage of our stock and will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">able to exert significant control over matters subject to stockholder approval.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to this offering, as of December 31, 2024, our executive officers, directors, owners of more than 5% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our capital stock and their respective affiliates beneficially owned approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding shares and, upon the completion of this offering, that same group will beneficially own <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our outstanding shares (assuming no exercise of the underwriters&#8217; option to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase additional shares). Therefore, even after this offering, these stockholders will have the ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">influence us through this ownership position. These stockholders may be able to determine all matters <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requiring stockholder approval. For example, these stockholders may be able to control elections of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, amendments of our organizational documents, or approval of any merger, sale of assets or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offers for our common stock that you may feel are in your best interest as one of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">A significant portion of our total outstanding shares is restricted from immediate resale but may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">be sold into the market in the near future, and any sales of a substantial number of shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">common stock in the public market could cause our stock price to decline significantly, even if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our business is doing well.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Sales of a substantial number of shares of our common stock in the public market could occur at any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time. These sales, or the perception in the market that the holders of a large number of shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">64<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock intend to sell shares, could reduce the market price of our common stock. If our existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market after the lock-up agreements, market standoff and other legal restrictions on resale discussed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus, including as described under the section titled &#8220;Shares eligible for future sale&#8212;Lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements,&#8221; lapse, the trading price of our common stock could decline. Based upon the number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares outstanding as of December 31, 2024 and assuming (i) the Preferred Stock Conversion, (ii) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes Conversion, (iii) no exercise of the underwriters&#8217; option to purchase additional shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock, and (iv) no exercise of outstanding options or warrants, upon the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, we will have outstanding a total of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock. Of these shares, all of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of our common stock sold in this offering, plus any shares sold upon exercise of the underwriters&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option to purchase additional shares, if any, will be freely tradable, without restriction, in the public market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately following this offering, other than shares purchased by our &#8220;affiliates&#8221; (as such term is defined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in Rule 144 under the Securities Act). See the section titled &#8220;Shares eligible for future sale&#8221; in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus for restrictions applicable to our affiliates. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We and each of our directors, our executive officers and substantially all of our other securityholders have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered or will enter into lock-up agreements with the underwriters prior to the completion of this offering, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which are described in the section titled &#8220;Underwriting&#8221;. After the expiration of the lock-up agreements, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of December 31, 2024, up to approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;million additional shares of common stock will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">eligible for sale in the public market, approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of which shares are owned by directors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executive officers and other owners of more than 5% of our outstanding common stock, stock options, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants and securities convertible into our common stock and will be subject to Rule 144 under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, an additional approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our outstanding common stock, stock options, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants and other securities convertible into or exercisable or exchangeable for our common stock are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to market standoff restrictions with us that include restrictions on the sale, transfer or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disposition of shares, among other things and subject to certain exceptions, for a period of 180 days <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commencing on the date of this prospectus. As a result of the foregoing, substantially all of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding common stock, stock options, warrants and other securities convertible into or exercisable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchangeable for our common stock are subject to a lock-up agreement or market standoff provisions for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a period of 180 days commencing on the date of this prospectus. See the section titled &#8220;Shares eligible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for future sale&#8221; for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After this offering, based upon the number of shares outstanding as of December 31, 2024, the holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million shares of our common stock, or approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our total outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, will be entitled to rights with respect to the registration of their shares under the Securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act, subject to the lock-up agreements and market standoff restrictions described above. Registration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these shares under the Securities Act would result in the shares becoming freely tradable without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restriction under the Securities Act, except for shares purchased by affiliates. Any sales of securities by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these stockholders or any perception that these shares may be sold could have a material adverse effect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the trading price of our common stock. In addition, a security holder who is not subject to market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standoff restrictions with us nor a lock-up agreement with the underwriters may be able to sell, short sell, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer, pledge or otherwise dispose of their equity interests at any time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our amended and restated certificate of incorporation will provide that the Court of Chancery of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the State of Delaware (or, if such court does not have jurisdiction, Delaware federal district court) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">will be the exclusive forum for certain disputes between us and our stockholders, which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">directors, officers or employees. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will provide that, unless we consent in writing to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">selection of an alternative forum, the Court of Chancery of the State of Delaware (or, in the event that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware) is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">65<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claim of breach of fiduciary duty owed by any of our current or former directors, officers, employees or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders to us or to our stockholders, any action asserting a claim against us arising pursuant to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Delaware General Corporation Law, our amended and restated certificate of incorporation, or our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended and restated bylaws (as either may be amended from time to time) or as to which the Delaware <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">General Corporation Law confers jurisdiction on the Delaware Court of Chancery, or any action asserting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a claim against us that is governed by the internal affairs doctrine of the State of Delaware. Our amended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and restated certificate of incorporation will also provide that the federal district courts of the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Securities Act. Further, our amended and restated certificate of incorporation will provide that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foregoing choice of forum provisions will not apply to suits brought to enforce any liability or duty created <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the Exchange Act, or any other claim for which the federal courts of the United States have exclusive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will also provide that any person or entity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notice of and consented to the foregoing provisions of the amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation. Although our amended and restated certificate of incorporation will contain the choice of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forum provision described above, it is possible that a court could find that such a provision is inapplicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for a particular claim or action or that such provision is unenforceable. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe these provisions may benefit us by providing increased consistency in the application of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Delaware law and federal securities laws by chancellors and judges, as applicable, particularly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experienced in resolving corporate disputes, efficient administration of cases on a more expedited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">schedule relative to other forums, and protection against the burdens of multi-forum litigation. However, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may discourage lawsuits with respect to such claims, although our stockholders will not be deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to have waived our compliance with federal securities laws and the rules and regulations thereunder. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, the enforceability of similar choice of forum provisions in other companies&#8217; certificates of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation has been challenged in legal proceedings, and it is possible that a court could find these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">types of provisions to be inapplicable or unenforceable. While the Delaware courts have determined that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a venue other than those designated in the exclusive forum provisions, and there can be no assurance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that such provisions will be enforced by a court in those other jurisdictions. If a court were to find the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">choice of forum provision that will be contained in our amended and restated certificate of incorporation to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such action in other jurisdictions, which could adversely affect our business, financial condition, results of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and prospects. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">General risk factors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We will have broad discretion in the use of net proceeds to us from this offering and may not use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">them effectively. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we are obligated to use certain of the net proceeds from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering to repay approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of the indebtedness outstanding under the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Credit Agreement and to pay approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of fees in connection therewith. We expect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use the remainder to fund our sales and marketing efforts, fund research and product development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities and for other general corporate purposes, including working capital, operating expenses, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital expenditures. We may also use a portion of the net proceeds from this offering to acquire <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">complementary businesses, products, services, or technologies. See the section titled &#8220;Use of proceeds&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for additional information. We periodically evaluate strategic opportunities&#59; however, we have no current <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">understandings or commitments to enter into any such acquisitions or make any such investments. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected use of net proceeds from this offering represents our intentions based upon our present plans <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and business conditions. We cannot predict with certainty all of the particular uses for the proceeds of this <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">66<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering or the amounts that we will actually spend on the uses set forth above. Accordingly, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management will have broad discretion in applying the net proceeds of this offering, including for any of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the purposes described in the section titled &#8220;Use of proceeds,&#8221; and you will not have the opportunity as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">part of your investment decision to assess whether the net proceeds are being used appropriately. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">timing and amount of our actual expenditures will be based on many factors, including cash flows from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and the anticipated growth of our business. Pending their use, we intend to invest the net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds of this offering in a variety of capital-preservation investments, including government securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and money market funds. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If we do not use the net proceeds that we receive in this offering effectively, our business, financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations and prospects could be harmed, and the market price of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock could decline. Pending their use, we intend to invest the net proceeds of this offering in a variety of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital-preservation investments, including government securities and money market funds. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments may not yield a favorable return to our investors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Investors in this offering will experience immediate and substantial dilution. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The initial public offering price of our common stock is substantially higher than the pro forma as adjusted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net tangible book value per share of our common stock. Therefore, if you purchase shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock in this offering, you will pay a price per share that substantially exceeds our pro forma as adjusted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net tangible book value per share after this offering. Based on the initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share, you will experience immediate dilution of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, representing the difference between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our pro forma as adjusted net tangible book value per share after giving effect to this offering and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">initial public offering price. In addition, purchasers of common stock in this offering will have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contributed&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the aggregate price paid by all purchasers of our common stock but will own only <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our total equity outstanding after this offering. Furthermore, you will experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional dilution if the underwriters exercise their option to purchase additional shares, outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options and warrants are exercised, upon the vesting of outstanding restricted stock awards or when we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise issue additional shares of common stock. For a further description of the dilution that you will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience immediately after this offering, see the section titled &#8220;Dilution&#8221; included elsewhere in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We do not intend to pay dividends in the foreseeable future. As a result, your ability to achieve a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">return on your investment will depend on appreciation in the market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available funds and any future earnings, if any, to fund the development and expansion of our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and we do not anticipate paying any cash dividends in the foreseeable future. Any future determinations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding the declaration and payment of dividends, if any, will be at the discretion of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, subject to applicable law, and will depend upon then-existing conditions, including our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations, contractual restrictions, general business conditions, capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, and other factors our board of directors may deem relevant. In addition, our ability to pay <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash dividends is currently restricted by the terms of the 2024 Credit Agreement. Our ability to pay cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dividends on our capital stock in the future may also be limited by the terms of any preferred securities we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may issue or agreements governing any additional indebtedness we may incur.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If our operating and financial performance in any given period does not meet any guidance that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">we provide to the public, the market price of our common stock may decline. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may, but are not obligated to, provide public guidance on our expected operating and financial results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for future periods. Any such guidance will be comprised of forward-looking statements subject to the risks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and uncertainties described in this prospectus, including in the section titled &#8220;Risk factors,&#8221; and in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future public filings and public statements. Our actual results may not always be in line with or exceed any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidance we have provided, especially in times of economic uncertainty. If actual circumstances differ <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from those in our assumptions, our operating and financial results could fall below our publicly announced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidance or the expectations of investors. If, in the future, our operating or financial results for a particular <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">67<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period do not meet any guidance we provide or the expectations of investment analysts or investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generally, or if we reduce our guidance for future periods, the market price of our common stock may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decline. Even if we do issue public guidance, there can be no assurance that we will continue to do so in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">If securities or industry analysts do not publish research or reports about our business, or if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">issue an adverse or misleading opinion regarding our stock, our stock price and trading volume <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">could decline. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The trading market for our common stock will be influenced by the research and reports that industry or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities analysts publish about us or our business. We do not currently have and may never obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research coverage by securities and industry analysts. If no or few securities or industry analysts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commence coverage of us, the market price for our stock would be negatively impacted. In the event we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtain securities or industry analyst coverage, if any of the analysts who cover us downgrade their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluations of our stock or issue an adverse opinion regarding us, our business model, our intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property or our stock performance, or if our results of operations fail to meet the expectations of analysts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our stock price or trading volume to decline. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We may be subject to securities litigation, which is expensive and could divert management <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">attention.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the past, following periods of volatility in the overall market and the market price of a company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities, securities class action litigation has often been instituted against these companies. Because of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the potential volatility of our stock price, we may become the target of securities litigation in the future. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These events may also result in or be concurrent with investigations by the SEC. We may be exposed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such litigation or investigation even if no wrongdoing occurred. Such litigation, if instituted against us, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could result in substantial costs and a diversion of our management&#8217;s attention and resources, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could seriously harm our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Provisions in our charter documents and under Delaware law could discourage a takeover that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">stockholders may consider favorable and may lead to entrenchment of management. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">O<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.77pt; position: absolute; text-decoration: none; white-space: pre;">ur amended and restated certificate of incorporation, to be in effect immediately prior to the completion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">of this offering, and our amended and restated bylaws, to be in effect upon the effectiveness of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">registration statement of which this prospectus forms a part, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.13pt; position: absolute; white-space: pre;">will contain provisions that could delay or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prevent changes in control or changes in our management without the consent of our board of directors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These provisions will include the following&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a classified board of directors with three-year staggered terms, which may delay the ability of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholders to change the membership of a majority of our board of directors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our directors may be removed by our stockholders only for cause&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">no cumulative voting in the election of directors, which limits the ability of minority stockholders to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">elect director candidates&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the exclusive right of our board of directors to change the size of the board of directors and to elect a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">director to fill a new directorship created by the expansion of the board of directors or a vacancy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">created by the resignation, death or removal of a director, which prevents stockholders from being <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">able to change the board&#8217;s size or fill new directorships and vacancies on our board of directors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the ability of our board of directors to authorize the issuance of shares of preferred stock and to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">determine the price and other terms of those shares, including preferences and voting rights, without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholder approval, which could be used to significantly dilute the ownership of a hostile acquiror or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adopt a stockholder rights plan&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">68<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the ability of our board of directors to alter our amended and restated bylaws without obtaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholder approval&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the required approval of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">then-outstanding shares of capital stock entitled to vote generally in the election of directors to adopt, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">amend, alter or repeal our amended and restated bylaws and certain provisions of our amended and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restated certificate of incorporation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an annual or special meeting of our stockholders&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the requirement that a special meeting of stockholders may be called only by our secretary at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">request of our board of directors, the chairman of our board of directors, or our chief executive officer, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which may delay the ability of our stockholders to force consideration of a proposal or to take action, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including the removal of directors&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">advance notice procedures that stockholders must comply with in order to nominate candidates to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting, which may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">own slate of directors or otherwise attempting to obtain control of us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are also subject to the anti-takeover provisions contained in Section 203 of the Delaware General <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Corporation Law (&#8220;Section 203&#8221;). Under Section 203, a corporation may not, in general, engage in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business combination (as defined in Section 203) with any interested stockholder (generally defined by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Section 203 to include holders of 15% or more of our capital stock) unless the interested stockholder has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">held the stock for three years or, among other exceptions and exclusions, the board of directors has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved the business combination transaction or the transaction that resulted in the stockholder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">becoming an interested stockholder. For a description of our capital stock, see the section titled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Description of capital stock.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">69<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1039" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Special note regarding forward-looking statements<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus, including the sections titled &#8220;Prospectus summary,&#8221; &#8220;Risk factors,&#8221; &#8220;Management&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discussion and analysis of financial condition and results of operations,&#8221; and &#8220;Business,&#8221; contains express <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or implied forward-looking statements about us and our industry that involve substantial risks and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">uncertainties. All statements other than statements of historical facts contained in this prospectus, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including statements regarding our strategy, future financial condition, future operations, projected costs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospects, plans, objectives of management, and expected market growth, are forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements. In some cases, you can identify forward-looking statements by words such as &#8220;may,&#8221; &#8220;will,&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;shall,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;intends,&#8221; &#8220;target,&#8221; &#8220;projects,&#8221; &#8220;contemplates,&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;goal,&#8221; &#8220;objective,&#8221; &#8220;seeks,&#8221; or &#8220;continue&#8221; or the negative of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these words or other similar terms or expressions that concern our expectations, strategy, plans, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intentions. Forward-looking statements contained in this prospectus include, but are not limited to, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements about&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 259.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our business model and strategic plans for our products, technologies and business, including our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">implementation thereof&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 291.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to continue improving our products and technologies, including our AI Technologies&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 311.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectations regarding government and third-party payer coverage and reimbursement&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the implementation of our business model and strategic plans&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to commercialize, manage and grow our business by increasing our sales to existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">customers or introducing our products to new customers&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to compete with other companies engaged in the development of products, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">algorithm-based diagnostic analysis products, that provide existing non-invasive tests that aid in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluation of CAD&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectations regarding the potential addressable market size for our products&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectation about market trends&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to attract, hire and retain key personnel and additional qualified personnel&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to effectively manage our growth&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including potential effects of evolving and&#47;or extensive government regulation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to obtain, maintain and expand regulatory clearances for our products and any new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products we create&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to establish and maintain intellectual property protection for our products or avoid claims of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">infringement&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our expectations regarding the use of the net proceeds from this offering and our existing cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cash equivalents&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">estimates of our expenses, future revenue, capital requirements, needs for additional financing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to obtain additional capital&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our ability to expand internationally&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">general economic, industry, and market conditions, including rising interest rates and inflation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our future financial performance&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">70<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other risks and uncertainties, including those listed under the caption &#8220;Risk factors.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should not rely on forward-looking statements as predictions of future events. We have based the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forward-looking statements contained in this prospectus primarily on our current expectations, estimates, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forecasts, and projections about future events and trends that we believe may affect our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial condition, results of operations, and prospects. Although we believe that we have a reasonable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis for each forward-looking statement contained in this prospectus, we cannot guarantee that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future results, levels of activity, performance, or events and circumstances reflected in the forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements will be achieved or occur at all. The outcome of the events described in these forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements is subject to risks, uncertainties, and other factors described in the section titled &#8220;Risk factors&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and elsewhere in this prospectus. Moreover, we operate in a very competitive and rapidly changing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all risks and uncertainties that could have an impact on the forward-looking statements contained in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus. The results, events, and circumstances reflected in the forward-looking statements may not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be achieved or occur, and actual results, events, or circumstances could differ materially from those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described in the forward-looking statements. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The forward-looking statements made in this prospectus relate only to events as of the date on which the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements are made. We undertake no obligation to update any forward-looking statements made in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus to reflect events or circumstances after the date of this prospectus or to reflect new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information or the occurrence of unanticipated events, except as required by law. We may not actually <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not place undue reliance on our forward-looking statements. Our forward-looking statements do not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may make.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relevant subject. These statements are based upon information available to us as of the date of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus, and while we believe such information forms a reasonable basis for such statements, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information may be limited or incomplete, and our statements should not be read to indicate that we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements are inherently uncertain, and you are cautioned not to unduly rely on these statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should read this prospectus and the documents that we reference in this prospectus and have filed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as exhibits to the registration statement, of which this prospectus is a part, completely and with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">understanding that our actual future results may be materially different from what we expect. We qualify <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of the forward-looking statements in this prospectus by these cautionary statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">71<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1064" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Market and industry data<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus contains estimates, projections, and other information concerning our industry and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business, as well as data regarding market research, estimates, and forecasts prepared by our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management or third parties, including but not limited to, Clarivate and the publications listed below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Information that is based on estimates, forecasts, projections, market research, or similar methodologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is inherently subject to uncertainties, and actual events or circumstances may differ materially from events <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and circumstances that are assumed in this information. These data and the industry in which we operate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the section titled &#8220;Risk factors.&#8221; These and other factors could cause results to differ materially from those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expressed in these estimates, publications, and reports made by third parties or us.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless otherwise expressly stated, we obtained such industry, business, market, and other data from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reports, research surveys, studies, and similar data prepared by market research firms and other third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">parties, industry and general publications, government data, and similar sources. In some cases, we do <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 259.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more sources of this type of data in any paragraph, you should assume that other data of this type <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appearing in the same paragraph is derived from sources which we paid for, sponsored, or conducted, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unless otherwise expressly stated or the context otherwise requires. The content of these third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sources, except to the extent specifically set forth in this prospectus, does not constitute a portion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus and is not incorporated herein.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 339.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The sources of certain statistical data, estimates and forecasts contained in this prospectus are from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">following publications&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Martin et al., Circulation 149&#58;e347, 2024 (the &#8220;Martin paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 391.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Bhatt et al., JAMA 327&#58;662, 2022 (the &#8220;Bhatt paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 411.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Kofoed et al., Journal of the American College of Cardiology 77&#58;1044, 2021 (the &#8220;Kofoed paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hoffmann et al., Circulation 135&#58;2320, 2017 (the &#8220;Hoffman paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Yang et al., BMJ Open 2017&#59;7&#58;e011684, 2017 (the &#8220;Yang paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">MacDonald, Current Developments in Nutrition 6&#58;925, 2022 (the &#8220;MacDonald paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 491.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Nakanishi et al., The International Journal of Cardiovascular Imaging 33&#58; 2067, 2017 (the &#8220;Nakanishi <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 503.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 523.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Yokota et al., Netherlands Heart Journal 26&#58;192, 2018 (the &#8220;Yokota paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Patel et al., American Heart Journal 167&#58;846, 2014 (the &#8220;2014 Patel paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Patel et al., New England Journal of Medicine 362&#58;886, 2010 (the &#8220;2010 Patel paper&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Wang et al., American Journal of Roentgenology 191&#58;409, 2008 (the &#8220;Wang paper&#8221;)&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Ni et al., American Heart Journal 157&#58;46, 2009 (the &#8220;Ni paper&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Forecasts and other forward-looking information with respect to industry, business, market, and other data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are subject to the same qualifications and additional uncertainties regarding the other forward-looking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements in this prospectus. See the section titled &#8220;Special note regarding forward-looking statements.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">72<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1089" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Use of proceeds<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate that the net proceeds from this offering will be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million (or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million if the underwriters exercise in full their option to purchase up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of common stock), based on the assumed initial public offering price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the estimated price range set forth on the cover page of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus, after deducting estimated underwriting discounts and commissions and estimated offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses payable by us.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 187.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each $1.00 increase or decrease in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 199.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, which is the midpoint of the estimated price range set forth on the cover page of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 211.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus, would increase or decrease, as applicable, the net proceeds to us from this offering by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the number of shares offered by us, as set forth on the cover <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">page of this prospectus, remains the same, and after deducting estimated underwriting discounts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commissions and estimated offering expenses payable by us. Similarly, each increase or decrease of 1.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 259.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million shares in the number of shares of common stock offered by us would increase or decrease, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable, the net proceeds to us from this offering by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of our common stock, which is the midpoint of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the estimated price range set forth on the cover page of this prospectus, remains the same, and after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deducting estimated underwriting discounts and commissions and estimated offering expenses payable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 339.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we are obligated to use certain of the net proceeds from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering to repay <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.12pt; position: absolute; text-decoration: none; white-space: pre;">$50.0 million (or $55.0 million if the underwriters exercise any portion of their option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 363.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">to purchase additional shares of common stock) o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.53999999999996pt; position: absolute; white-space: pre;">f the indebtedness outstanding under the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement and to pay approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of fees in connection therewith. In connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 387.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the issuance of the 2025 Convertible Notes in January 2025, we entered into Amendment No. 1 to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 399.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Credit Agreement, pursuant to which entities affiliated with Hayfin converted $23.0 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 411.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding indebtedness under the 2024 Credit Agreement in connection with the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 423.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conversion and became holders of 5% or more of our capital stock as of March 1, 2025. The 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement bears interest equal to the sum of (i) 7.0% (or 6.0% if the alternative base rate is in effect) plus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(ii) the greater of (x) the forward-looking term rate based on the Secured Overnight Financing Rate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;SOFR&#8221;) for a respective tenor (or the alternative base rate, if applicable), and (y) 2.0%. The alternative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">base rate equals to the sum of (i) 6.0% plus (ii) the greater of (1) the Wall Street Journal Prime Rate, plus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">0.5%, (2) the Federal Reserve Bank of New York rate plus 0.5% or (3) CBA Term SOFR for one month <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tenor plus 1.0%. The 2024 Credit Agreement matures on June 14, 2028. Borrowings under the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Credit Agreement were used to refinance outstanding indebtedness. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 527.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect to use the remainder of the net proceeds from this offering, together with our existing cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash equivalents, to fund our sales and marketing efforts, fund research and product development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities and for other general corporate purposes, including working capital, operating expenses, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital expenditures. With respect to funding research and product development activities, we plan to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 575.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deploy net proceeds from this offering into three main areas of research and development&#58; (i) new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products to drive greater efficiency and reduce manual involvement by the imaging physician, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">software tools that reduce imager time spent reading and reporting on CCTA images&#59; (ii) new features <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that enhance the clinical utility and ease of use of our existing products, including a more intuitive and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">simplified user interface&#59; and (iii) new clinical evidence to support expanded indications of our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform into high risk asymptomatic patients and longer term, lower risk asymptomatic patients. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may also use a portion of the net proceeds from this offering to acquire complementary businesses, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products, services, or technologies. We periodically evaluate strategic opportunities&#59; however, we have no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current understandings or commitments to enter into any such acquisitions or make any such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 691.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">73<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our current operating plan, we estimate that our existing cash and cash equivalents as of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date of this prospectus, together with the estimated net proceeds from this offering, will be sufficient to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fund our planned operations through&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. We have based this estimate on our current <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions, which may prove to be wrong, and we may exhaust our available capital resources sooner <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than we expect. The expected use of net proceeds from this offering represents our intentions based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon our present plans and business conditions. We cannot predict with certainty all of the particular uses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the proceeds of this offering or the amounts that we will actually spend on the uses set forth above. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, our management will have broad discretion in applying the net proceeds of this offering, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors will be relying on the judgment of our management regarding the application of these net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds. The timing and amount of our actual expenditures will be based on many factors, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash flows from operations and the anticipated growth of our business. Pending their use, we intend to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invest the net proceeds of this offering in a variety of capital-preservation investments, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government securities and money market funds.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">74<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1114" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dividend policy<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available funds and any future earnings, if any, to fund the development and expansion of our business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and we do not anticipate paying any cash dividends in the foreseeable future. Any future determinations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding the declaration and payment of dividends, if any, will be at the discretion of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, subject to applicable law, and will depend upon then-existing conditions, including our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">condition, results of operations, contractual restrictions, general business conditions, capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements, and other factors our board of directors may deem relevant. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.59pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">our ability to pay </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">cash dividends is currently restricted by the terms of our 2024 Credit Agreement. Our ability to pay cash </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">dividends on our capital stock in the future may also be limited by the terms of any preferred securities we </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">may issue or agreements governing any additional indebtedness we may incur.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">75<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1139" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Capitalization<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table sets forth our cash and cash equivalents and our capitalization, as of December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024&#58;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 139.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">on an actual basis&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 159.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">on a pro for<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.1pt; position: absolute; text-decoration: none; white-space: pre;">ma basis, to give effect to&#58; (i) the issuance and sale of the 2025 Convertible Notes and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 171.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan Conversion that occurred subsequent to December 31, 2024&#59; (ii) the Preferred Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 183.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Conversion&#59; and (iii) the adoption, filing, and effectiveness of our amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 195.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">incorporation, to be in effect immediately prior to the completion of this offering&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 458.42pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">on a pro forma as adjusted basis, giving effect to (i) the pro forma adjustments discussed above, (ii) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the issuance and sale of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock in this offering at the assumed initial offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the estimated price range set forth on the cover <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">page of this prospectus, after deducting estimated underwriting discounts and commissions and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 263.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">estimated offering expenses payable by us, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 284.81pt; position: absolute; text-decoration: none; white-space: pre;">(iii) the repayment of $50.0 million of the indebtedness <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 275.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding under the 2024 Credit Agreement and payment of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of fees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 287.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in connection therewith, and (iv) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares issuable in connection with the Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 299.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Conversion at the assumed initial offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, which is the midpoint of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 311.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">estimated price range set forth on the cover page of this prospectus<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.84pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should read this table together with the sections titled &#8220;Summary consolidated financial data,&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 343.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Management&#8217;s discussion and analysis of financial condition and results of operations&#8221; and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 355.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements and the related notes included elsewhere in this prospectus. The pro <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 367.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forma as adjusted information below is illustrative only and our capitalization following the completion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 379.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering will depend on the actual initial public offering price and other terms of this offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 391.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined at pri<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.99pt; position: absolute; text-decoration: none; white-space: pre;">cing.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 411.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 263.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="5"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 201.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 201.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 93.17pt; position: absolute; text-decoration: none; white-space: pre;">As of December 31, 2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 263.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 263.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 35.15pt; position: absolute; text-decoration: none; white-space: pre;">Actual<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.15pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.65pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma as <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.53pt; position: absolute; text-decoration: none; white-space: pre;">adjusted<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 122.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 124.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 125.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 125.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.33999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">51,367<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 36.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 75.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 75.55pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.97pt;"></font></font><font style="left: 25.599999999999998pt; position: absolute;">136,431<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 65.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 107.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 109.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 109.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 110.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.28pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 65.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 62.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 79.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock, $0.001 par <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">value&#59;&#160;122,231,454&#160;shares authorized&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454&#160;shares issued and outstanding, actual&#59; no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">shares authorized, issued or outstanding, pro forma and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">pro forma as adjusted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 108.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 109.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 110.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 110.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 110.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.41pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">768,566<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 79.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 51.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stockholders&#8217; equity (deficit)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 74.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Preferred stock, $0.001 par value&#59; no shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">authorized, issued and outstanding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">actual&#59;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares authorized, no shares issued or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">outstanding, pro forma&#59;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">authorized and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares issued and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 62.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">outstanding, pro forma as adjusted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 177.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 179.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 180.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 180.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 180.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 180.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 63.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">76<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 263.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 86.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock, $0.001 par value&#59;&#160;210,300,000&#160;shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">authorized,&#160;17,877,051&#160;shares issued and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">outstanding, actual&#59;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares issued and outstanding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 50.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">pro forma&#59;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 62.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares issued and outstanding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 74.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">pro forma as adjusted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 120.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 120.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 120.58999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 75.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">18<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 86.25pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Additional paid-in capital<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 122.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 125.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 125.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.36999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 86.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">112,229<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 100.5pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated deficit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 101.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 103.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 104.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 105.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 105.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 100.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(970,959)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 114.75pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stockholders&#8217; equity (deficit)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 150.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 150.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(859,484)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 129pt; width: 263.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 263.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total capitalization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 84.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 85.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 85.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 85.5pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 129pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">45,513<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 129pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 129pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 223.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Each $1.00 increase or decrease in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of our common stock, which is the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 232.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">midpoint of the estimated price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, each of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 241.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our pro forma as adjusted cash and cash equivalents, additional paid-in-capital, total stockholders&#8217; equity (deficit), and total <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 250.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">capitalization by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the number of shares offered by us, as set forth on the cover page of this <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 259.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 268.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expenses payable by us. Similarly, each increase or decrease of 1.0 million shares in the number of shares of common stock offered by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 277.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">us would increase or decrease, as applicable, each of our pro forma as adjusted cash and cash equivalents, additional paid-in-capital, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 286.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">total stockholders&#8217; equity (deficit), and total capitalization by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the assumed initial public offering <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 295.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of our common stock remains the same, and after deducting estimated underwriting discounts and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 304.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">commissions and estimated offering expenses payable by us.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 321.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the underwriters exercise in full their option to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 333.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, pro forma as adjusted cash and cash equivalents, 2024 Term Loan, additional paid-in capital, total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 345.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders&#8217; equity (deficit), total capitalization, and shares of common stock outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 357.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2024 would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 369.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The number of shares of our common stock to be outstanding after this offering, pro forma and pro forma <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as adjusted, in the table above is based on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2024, after giving effect to (i) the issuance and sale of the 2025 Convertible Notes and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 425.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Term Loan Conversion that occurred subsequent to December 31, 2024, (ii) the Preferred Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conversion, (iii) the Convertible Notes Conversion and (iv) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.51pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">amended and restated certificate of incorporation, to be in effect immediately prior to the completion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 461.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.47pt; position: absolute; white-space: pre;">, and excludes&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">24,930,958&#160;shares of our common stock issuable upon the exercise of outstanding stock options as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of December 31, 2024 under our 2009 Equity Incentive Plan, with a weighted-average exercise price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of $1.62&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">796,801&#160;shares of our common stock issuable upon the exercise of outstanding stock options granted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent to December 31, 2024 under our 2009 Equity Incentive Plan, with a weighted-average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise price of $4.34&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">4,811,190&#160;shares of our common stock issuable upon the exercise of warrants outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024 held by Hayfin, with an exercise price of $0.01 per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">282,691 shares of our common stock reserved for future issuance under our 2009 Equity Incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plan&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock to be reserved for future issuance under the 2025 Plan, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">will become effective as of the date immediately prior to the date our registration statement relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this offering becomes effective, from which we will grant RSUs covering approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of common stock concurrently with this offering (based on the assumed initial public offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">price of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the price range set forth on the cover page of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this prospectus), as well as any future increases in the number of shares of common stock reserved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 705.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">for issuance under the 2025 Plan&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">77<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock reserved for future issuance under the ESPP, which will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">become effective on the date immediately prior to the date our registration statement relating to this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering becomes effective, as well as any future increases in the number of shares of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reserved for issuance under the ESPP.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">78<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1164" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dilution<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If you purchase shares of our common stock in this offering, your ownership interest will be immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and substantially diluted to the extent of the difference between the initial public offering price per share of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock and the pro forma as adjusted net tangible book value per share of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately after this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 163.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, our historical net tangible book value (deficit) was $(872.2)&#160;million, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 175.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$(48.79)&#160;per share of our common stock. Our historical net tangible book value (deficit) is the amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 187.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our total tangible assets less our total liabilities and the carrying values of our redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 199.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock. Our historical net tangible book value (deficit) per share represents historical net tangible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 211.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">book value (deficit) divided by the aggregate number of shares of our common stock outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2024. Total tangible assets represents total assets less capitalized internal-use software, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capitalized contract costs, deferred debt financing costs, unamortized debt discount and issuance costs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and deferred initial public offering costs. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 267.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our pro forma net tangible book value (deficit) as of December 31, 2024 was $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 279.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share. Pro forma net tangible book value per share represents total tangible assets, less total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 291.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities, divided by the total aggregate number of shares of our common stock outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 303.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2024, after giving effect to&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 323.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the issuance and sale of the 2025 Convertible Notes and the 2024 Term Loan Conversion that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 335.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">occurred subsequent to December 31, 2024&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 355.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Preferred Stock Conversion&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Convertible Notes Conversion&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our amended and restated certificate of incorporation, to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in effect immediately prior to the completion of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After giving further effect to the issuance and sale by us of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 439.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering at the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated price range set forth on the cover page of this prospectus, and after deducting estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 463.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriting discounts and commissions and estimated offering expenses payable by us <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.71pt; position: absolute; text-decoration: none; white-space: pre;">and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.16pt; position: absolute; text-decoration: none; white-space: pre;">the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 475.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">repayment of $50.0 million of the indebtedness outstanding under the 2024 Credit Agreement and to pay <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 487.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million of fees in connection therewith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.88pt; position: absolute; text-decoration: none; white-space: pre;">,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.65pt; position: absolute; white-space: pre;"> our pro forma as adjusted net tangible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 499.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">book value (deficit) as of December 31, 2024 would have been $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This represents an immediate increase in pro forma net tangible book value to existing stockholders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 523.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share and an immediate dilution in pro forma net tangible book value to new investors of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 535.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share. Dilution per share represents the difference between the price per share to be paid by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 547.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new investors for the shares of our common stock sold in this offering and the pro forma as adjusted net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 559.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tangible book value per share immediately after this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">79<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.65pt; position: absolute; text-decoration: none; white-space: pre;">table illustrates this dilution on a per sh<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.83000000000004pt; position: absolute; white-space: pre;">are basis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 92pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assumed initial public offering price per share<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 204.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 206.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 206.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 206.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.60999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 26.25pt; left: 0pt; overflow: hidden; position: absolute; top: 14.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Historical net tangible book value (deficit) per share as of December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 45.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 46.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 46.739999999999995pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 32.83pt; position: absolute;">(48.79)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 38.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 40.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma increase in net tangible book value per share as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024 attributable to the pro forma adjustments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 27.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">described above<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 96.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 99.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 100.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 101.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 101.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.41pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma net tangible book value per share as of December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 324.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 326.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 326.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 326.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.61pt; position: absolute; text-decoration: none; white-space: pre;"> .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 93pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Increase in pro forma net tangible book value per share attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">new investors participating in this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 206.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 206.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.81pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 119.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Pro forma as adjusted net tangible book value per share after this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 327.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 330.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 331.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 133.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Dilution per share to new investors participating in this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 277.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 279.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 280.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.44pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 255.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The dilution information discussed above is illustrative only and may change based on the actual initial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 267.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public offering price, the number of shares we sell, and other terms of this offering that will be determined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 279.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at pricing. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 299.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each $1.00 increase or decrease in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 311.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the midpoint of the estimated price range set forth on the cover page of this prospectus, would increase or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 323.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decrease, as applicable, our pro forma as adjusted net tangible book value per share after this offering by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 335.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share and the dilution per share to investors participating in this offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 347.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assuming that the number of shares of common stock offered by us, as set forth on the cover page of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 359.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus, remains the same, and after deducting estimated underwriting discounts and commissions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and estimated offering expenses payable by us. Similarly, each 1.0 million share increase in the number <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of shares offered by us would increase our pro forma as adjusted net tangible book value per share after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share and decrease the dilution per share to investors participating in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, and each 1.0 million share decrease in the number of shares offered by us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would decrease our pro forma as adjusted net tangible book value per share after this offering by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share and increase the dilution per share to investors participating in this offering by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, in each case assuming the initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share remains the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 455.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">same, and after deducting estimated underwriting discounts and commissions and estimated offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses payable by us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the underwriters exercise in full their option to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 499.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, the pro forma as adjusted net tangible book value (deficit) per share of our common stock after this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, and the dilution per share to investors participating in this offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 523.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, assuming the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 535.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is the midpoint of the estimated price range set forth on the cover page of this prospectus.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes, as of December 31, 2024, on a pro forma as adjusted basis as described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, the number of shares of our common stock, the total consideration and the average price per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share (i) paid to us by existing stockholders and (ii) to be paid by new investors acquiring our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 591.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock in this offering at the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, the midpoint of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated price range set forth on the cover page of this prospectus, before deducting estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriting discounts and commissions and estimated offering expenses payable by us. As the table <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 627.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">below shows, investors participating in this offering will pay an average price per share substantially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 639.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">higher than our existing stockholders paid.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">80<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 156pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 32.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 156pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 22.31pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.42pt; position: absolute; text-decoration: none; white-space: pre;">Shares purchased<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 282pt; position: absolute; top: 0pt; width: 123pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 22.31pt; width: 123pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.46pt; position: absolute; text-decoration: none; white-space: pre;">Total consideration<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 408pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.93pt; position: absolute; text-decoration: none; white-space: pre;">Weighted- <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.38pt; position: absolute; text-decoration: none; white-space: pre;">average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.39pt; position: absolute; text-decoration: none; white-space: pre;">price per <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.38pt; position: absolute; text-decoration: none; white-space: pre;">share<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.4pt; position: absolute; text-decoration: none; white-space: pre;">Number<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.39pt; position: absolute; text-decoration: none; white-space: pre;">Percent<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.42pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 32.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.39pt; position: absolute; text-decoration: none; white-space: pre;">Percent<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Existing stockholders<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 96.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 98.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 98.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.36pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.72pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.36pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.72pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">New investors<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 65.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 67.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 68.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 68.08999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 59.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 5.4pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 26.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 27.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 27.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 27.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 27.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 27.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 27.939999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 30.35pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 30.35pt; position: absolute;">100<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.72pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 30.35pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 30.35pt; position: absolute;">100<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 50.36pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 73.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.72pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 175.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each $1.00 increase or decrease in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 187.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the midpoint of the estimated price range set forth on the cover page of this prospectus, would increase or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 199.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decrease, as applicable, the total consideration paid by new investors and total consideration paid by all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 211.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming that the number of shares of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offered by us, as set forth on the cover page of this prospectus, remains the same, before deducting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated underwriting discounts and commissions and estimated offering expenses payable by us. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, each 1.0 million share increase or decrease in the number of shares offered by us would <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 259.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase or decrease, as applicable, the total consideration paid by new investors and total consideration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">paid by all stockholders by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the assumed initial public offering price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of common stock remains the same, before deducting estimated underwriting discounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and commissions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 315.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Except as otherwise indicated, the above discussion and tables assume no exercise of the underwriters&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 327.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option to purchase additional shares. If the underwriters exercise in full their option to purchase up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 339.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of common stock, our existing stockholders would own&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, and our new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors would own&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the total number of shares of our common stock outstanding upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The foregoing tables and calculations (other than historical net tangible book value) are based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock outstanding as of December 31, 2024, after giving effect to (i) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance and sale of the 2025 Convertible Notes and the 2024 Term Loan Conversion that occurred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsequent to December 31, 2024, (ii) the Preferred Stock Conversion, (iii) the Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conversion and (iv) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.44pt; position: absolute; text-decoration: none; white-space: pre;">the adoption, filing, and effectiveness of our amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">incorporation, to be in effect immediately prior to the completion of this offering<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.2pt; position: absolute; white-space: pre;">, and excludes&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 463.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">24,930,958&#160;shares of our common stock issuable upon the exercise of outstanding stock options as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 475.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of December 31, 2024 under our 2009 Equity Incentive Plan, with a weighted-average exercise price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of $1.62&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">796,801&#160;shares of our common stock issuable upon the exercise of outstanding stock options granted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent to December 31, 2024 under our 2009 Equity Incentive Plan, with a weighted-average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise price of $4.34&#160;per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">4,811,190&#160;shares of our common stock issuable upon the exercise of warrants outstanding as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024 held by Hayfin, with an exercise price of $0.01 per share&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">282,691 shares of our common stock reserved for future issuance under our 2009 Equity Incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plan&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock to be reserved for future issuance under the 2025 Plan, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 627.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">will become effective as of the date immediately prior to the date our registration statement relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 639.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this offering becomes effective, from which we will grant RSUs covering approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of common stock concurrently with this offering (based on the assumed initial public offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">price of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the price range set forth on the cover page of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this prospectus), as well as any future increases in the number of shares of common stock reserved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">for issuance under the 2025 Plan&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">81<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock reserved for future issuance under the ESPP, which will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">become effective on the date immediately prior to the date our registration statement relating to this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering becomes effective, as well as any future increases in the number of shares of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reserved for issuance under the ESPP.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To the extent that any outstanding options are exercised, new options or other equity awards are issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under our equity incentive plans, or we issue additional shares in the future, there will be further dilution to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new investors participating in this offering. In addition, we may choose to raise additional capital because <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of market conditions or strategic considerations, even if we believe that we have sufficient funds for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current or future operating plans. If we raise additional capital through the sale of equity or convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt securities, the issuance of these securities could result in further dilution to our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">82<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_533" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Management&#8217;s discussion and analysis of financial condition <font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 16pt; line-height: 11.64pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and results of operat<font style="display: inline-block; height: 11.64pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 230.12pt; position: absolute; text-decoration: none; white-space: pre;">ions<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You should read the following discussion and analysis of our financial condition and results of operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in conjunction with our consolidated financial statements and the related notes and other financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information included elsewhere in this prospectus. This discussion and analysis and other parts of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus contain forward-looking statements based upon our current plans and expectations that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expectations, intentions and beliefs. Our actual results and the timing of events could differ materially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from those anticipated in these forward-looking statements as a result of various factors, including those <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">set forth under the section titled &#8220;Risk factors&#8221; and elsewhere in this prospectus. You should carefully read <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the section titled &#8220;Risk factors&#8221; to gain an understanding of the important factors that could cause actual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results to differ materially from our forward-looking statements. Please also see the section titled &#8220;Special <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">note regarding forward-looking statements.&#8221; Our historical results are not necessarily indicative of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results that may be expected for any period in the future.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive solution for diagnosing and managing coronary artery disease (&#8220;CAD&#8221;), a leading cause of death <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">worldwide. As of December 31, 2024, our Heartflow Platform has been used to assess CAD in more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">400,000 patients, including 132,000 in 2024 alone. We believe that we are the most widely adopted AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered test for CAD. Our novel platform leverages AI and advanced computational fluid dynamics to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized 3D model of a patient&#8217;s heart from a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;), a specialized type of scan that provides detailed images of the heart&#8217;s arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition thereby overcoming the limitations of traditional non-invasive imaging tests which rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures of coronary disease and lead to higher false negative and false positive rates as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated by our PRECISE trial. We believe the differentiated accuracy and clinical utility of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, along with its ability to enhance workflows, will continue to support our growth and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advance the &#8220;CCTA + Heartflow&#8221; pathway as the definitive standard for the non-invasive diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have developed three software products<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.65999999999997pt; position: absolute; text-decoration: none; white-space: pre;"> under the Heartflow Platform<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.61pt; position: absolute; white-space: pre;"> that provide physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the critical insights needed to effectively diagnose and manage CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: absolute; text-decoration: none; white-space: pre;"> offers a highly intuitive anatomic visualization of the coronary arteries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">helping physicians quickly identify clinically relevant areas to focus their review.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 163.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.05pt; position: absolute; text-decoration: none; white-space: pre;"> calculates blood flow and pinpoints clinically significant CAD, which is CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with a f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.64pt; position: absolute; white-space: pre;">ractional flow reserve (&#8220;FFR&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.58pt; position: absolute; text-decoration: none; white-space: pre;"> value of 0.80 or below, at every point in the major coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">arteries. FFR measures the severity of blood flow restriction in the coronary arteries on a scale of 1.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(no restriction) to 0.0 (complete blockage) by assessing pressure differences across a stenosis during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">induced stress, guiding decisions on whether a patient requires invasive revascularization.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.09pt; position: absolute; text-decoration: none; white-space: pre;"> provides a comprehensive assessment of coronary plaque, enabling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimized medical treatment strategies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform has an existing commercial presence and regulatory approval in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, United Kingdom, European Union, Australia, Canada and Japan.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.41pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.18pt; position: absolute; white-space: pre;">We have developed a highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scalable, capital efficient commercial model that combines Territory Sales Managers (&#8220;TSMs&#8221;) who drive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new account adoption with Territory Account Managers (&#8220;TAMs&#8221;) who focus on increasing utilization by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">educating referring physicians. Our commercial team does not cover cases or otherwise spend time in an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating room or lab setting, which enables them to focus solely on driving commercial adoption and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">83<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">educational activities. We also have small, direct commercial teams in our international markets. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future, we may expand our international presence beyond these markets. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology is simple and intuitive and does not require the purchase of any capital equipment. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">onboarding process seamlessly integrates the Heartflow Platform into the customer&#8217;s daily workflow. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These unique attributes of our business model afford our commercial organization a differentiated level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency and scalability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have experienced considerable revenue growth since we <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.06pt; position: absolute; text-decoration: none; white-space: pre;">began commercializing<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.3pt; position: absolute; white-space: pre;"> the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform in 2015<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.76pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.3pt; position: absolute; white-space: pre;">driven primarily by growth in our account base and increasing test volumes at accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in our installed base. We recognized revenue of $125.8&#160;million for the year ended December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to revenue of $87.2 million for the year ended December 31, 2023. Substantially all of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue is generated on<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> a &#8220;pay per click&#8221; basis </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.99pt; position: absolute; white-space: pre;">each time a physician chooses to review either our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.04000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.02pt; position: absolute; white-space: pre;">Plaque Analysis, or both and we recognize usage-driven fee revenue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon delivery of the requested analysis to the physician. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.09000000000003pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 368.07pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 387.49pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.15pt; position: absolute; white-space: pre;"> Analysis has served as our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial foundation, representing 98% of our total revenue as of December 31, 2024. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.85pt; position: absolute; text-decoration: none; white-space: pre;">In the second <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">half of 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.22pt; position: absolute; white-space: pre;">, we initiated limited market education efforts for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 338.39pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.37pt; position: absolute; white-space: pre;">Plaque Analysis, our second <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial product.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.99pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Our </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.17pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">RoadMap Analysis is generally provided as a workflow efficiency tool </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">to drive customer retention and loyalty and is not a stand-alone product. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have primarily funded our operations with proceeds from sales of shares of our redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock, common stock and convertible promissory notes, borrowings under our term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loans and revenue received from our customers. As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.19pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 401.98pt; position: absolute; white-space: pre;">, we had $51.4&#160;million in cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and cash equivalents. In January and March 2025, we issued $98.4 million in aggregate principal amount <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the 2025 Convertible Notes to investors, including related parties, with original maturity dates of 48 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months from the dates of issuance. The consideration for the issuance of the 2025 Convertible Notes was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprised of $75.4 million in cash and the exchange of $23.0 million of outstanding indebtedness under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2024 Credit Agreement (as defined below).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have incurred significant operating losses and negative cash flows since our inception. Our net loss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.88pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.67pt; position: absolute; white-space: pre;"> and 2024 was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.45pt; position: absolute; text-decoration: none; white-space: pre;">$95.7 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.56pt; position: absolute; white-space: pre;"> and $96.4 million, respectively. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024, we had an accumulated deficit of $874.5 million and $971.0&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.33pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">respectively.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Key factors affecting our results of operations and performance <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe there are several important factors that have impacted and that we expect will continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impact our operating performance and results of operations for the foreseeable future. These factors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">include, among others&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Rate of adoption of CCTA in the market and our ability to increase adoption of the CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway among both referring and reading physicians.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Ability to successfully introduce our Heartflow Plaque Analysis and other new products and the rate at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which they are adopted by physicians. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Ability to automate an increasing number of the manual components of our production process and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the rate at which we hire and train analysts to full productivity. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We experience seasonality throughout the year b<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 307.03999999999996pt; position: absolute; text-decoration: none; white-space: pre;">ased on a number of factors, including staff <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">availability, vacations, weather and other macro economic events.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Publications of clinical results by us and third-parties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Heartflow revenue cases</font><font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We regularly review a number of operating and financial metrics to evaluate our business, measure our </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708.8pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">performance, identify trends affecting our business, formulate our business plan and make strategic </font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">84<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">decisions. Substantially all of our revenue is generated on a &#8220;pay per click&#8221; basis each time a physician </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">chooses to review either our </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 199.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.74pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 264.15999999999997pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT</font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.82pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.8pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.78pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis, or both and we </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">recognize usage-driven fee revenue upon delivery of the requested analysis to the physician. We define a </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">&#8220;Heartflow revenue case&#8221; as each time an account orders and we deliver the requested analysis to the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">physician. For example, the ordering of both an </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.61pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 348.03pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.69pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis and a </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 426.68pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.66pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis from a single CCTA counts as two revenue cases. We define an &#8220;account&#8221; as any individual </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">facility that orders a </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.4pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.38pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 225.8pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT</font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.46pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.41999999999996pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis, or both. Accounts may have </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">more than one reading physician or CT machine. The following </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.16pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">table</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.83pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> lists these revenue cases in each of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">the three month periods as indicated&#58;</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 188pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 465.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 60.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 33.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 60.75pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q1 2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q2 2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 128.25pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q3 2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q4 2022<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 195.75pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q1 2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 229.5pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q2 2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 263.25pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q3 2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 297pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q4 2023<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330.75pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q1 2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 364.5pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q2 2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 398.25pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q3 2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432pt; position: absolute; top: 0pt; width: 33.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: bold; left: 4.29pt; position: absolute; text-decoration: none; white-space: pre;">Q4 2024<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 11.25pt; width: 60.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.68pt; width: 60.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue cases<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 54.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 54.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 54.370000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.46pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 54.38pt; position: absolute; text-decoration: none; white-space: pre;"> .<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 60.75pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">12,316<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">12,701<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 128.25pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">14,865<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">16,697<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 195.75pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">19,537<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 229.5pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">21,769<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 263.25pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">23,195<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 297pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">24,897<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330.75pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">28,803<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 364.5pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">33,039<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 398.25pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">34,970<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 432pt; position: absolute; top: 11.25pt; width: 33.75pt;"><div><div style="line-height: 5.46pt; position: absolute; top: 2.72pt; width: 33.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.46pt; width: 4.95pt;"></font></font><font style="left: 7.58pt; position: absolute;">37,805<font style="display: inline-block; height: 5.46pt; width: 2.49pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 226.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">The period-to-period change in Heartflow revenue cases is an indicator of our ability to drive adoption and </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">generate sales revenue, and is helpful in tracking the progress of our business. We believe that Heartflow </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">revenue cases are representative of our current business&#59; however, we anticipate this metric may be </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.5pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">substituted for additional or different metrics as our business grows.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 282.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Components of our results of operations<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Substantially all of our revenue comprises usage-driven fees from accounts who <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.63pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">order either our </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> Analysis, </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.04000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.02pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis, or both</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.23pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 347.77pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We recognize usage-driven fee revenue </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 348.9pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">upon delivery of the requested analysis to the physician. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 323.09000000000003pt; position: absolute; text-decoration: none; white-space: pre;">Key factors that drive our revenue include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 360.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">revenue case growth from our installed base and the success of our sales force in expanding adoption of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 372.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the Heartflow Platform to new accounts and expanding the utilization of our system by accounts in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 384.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">installed base. We consider an account that has our Heartflow solution deployed with the ability to send <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 396.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">us CCTA images for processing as being part of our installed base. New accounts generally take 12 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 408.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">months to reach steady state revenue case volumes. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.64pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">For purposes of managing our business, we do not </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 420.9pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">separately track increases in revenue solely attributable to new accounts. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue cases generated from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 432.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">clinic or office-based accounts typically carry a lower pricing than hospital-based accounts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 444.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">commensurate with their lower reimbursement levels. We expect the percentage of our revenue cases <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 456.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">generated from clinic or office-based accounts to increase over time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 476.9pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">While a single customer may include multiple accounts, no</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.85pt; position: absolute; text-decoration: none; white-space: pre;"> single <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.51pt; position: absolute; text-decoration: none; white-space: pre;">customer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.62pt; position: absolute; text-decoration: none; white-space: pre;"> accounted for 10% or more of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 488.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our revenue during the years ended December 31, 2023 and 2024. However, the decision-making <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 500.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">function for some of these accounts is concentrated in a relatively small number of customers, such that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 512.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the loss of one customer could result in a disproportionate loss across our accounts. For example, for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 524.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">year ended December 31, 2024, our top two largest customers collectively represented approximately 8% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 536.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">of our revenue. As we expand the adoption of the Heartflow Platform to new accounts, we expect this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 548.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">customer concentration risk to decrease.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 568.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our revenue has fluctuated, and we expect it to continue to fluctuate from quarter-to-quarter due to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 580.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">variety of factors includ<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.19pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ing the number of </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.73pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">accounts in our installed base</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.4pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">, the volume of Heartflow Platform </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 592.9pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">usage by accounts in our installed base, changes in the mix of customer accounts and seasonality. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 510.67pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.9pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">may experience fluctuations in the volume of Heartflow Platform usage by our customers based on </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.9pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">seasonal factors that impact the number of radiologists and support staff available to conduct CCTAs at </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.9pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">customer accounts. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue and gross margin<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cost of revenue consists of personnel and related expenses, including stock-based compensation costs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily related to our production team. Additional costs include third-party hosting fees, amortization of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capitalized internal-use software, amortization of contract fulfillment costs as well as royalties associated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with technology licenses used in connection with the delivery of our product and allocated overhead, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">85<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which includes facilities expenses, equipment, depreciation and technology services. The role of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">production team is to support our patient case volume revenue by performing defined quality-related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities on CCTA scans submitted by our customers for analysis. The portion of these costs that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supports patient case volume revenue is recorded as cost of revenue. The production team also supports <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities in our clinical trials and research and development, which are allocated as research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development expense. We expect cost of revenue to increase as we hire additional personnel in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">production team to support our increasing patient case volume.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We calculate gross margin as gross profit divided by revenue.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.56pt; position: absolute; text-decoration: none; white-space: pre;"> Our gross margin has been and will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">continue to be affected by a variety of factors, primarily by our production team costs, the timing of hiring <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">new production team members and training them to full productivity, the timing of our acquisition of new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">customers and pricing and commercialization of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.87pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.85pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis and other new products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although, we expect our gross margin to fluctuate from period to period, based upon the factors described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, we believe our gross margin will increase over the long term as we leverage the AI-based nature <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our software platform to automate an increasing number of the manual components of our production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">teams&#8217; p</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.4pt; position: absolute; white-space: pre;">rocess, thereby lowering the cost of revenue per analysis. We also expect increased revenues <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.97999999999999pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.95999999999998pt; position: absolute; white-space: pre;">Plaque Analysis, to positively impact our gross margin, as it runs on the same CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scan as <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.2pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 173.62pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.28pt; position: absolute; white-space: pre;"> Analysis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Research and development expenses are incurred in connection with the advancement of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform with the goal to introduce products, features and improvements aimed at increasing the value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proposition for our custome<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.1pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">rs by expanding its applicability to additional disease states and patient </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">populations. Research and development expenses </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 299.26pt; position: absolute; white-space: pre;">consist primarily of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.01pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.78pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">engineering, product development, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">consulting services, clinical studies to develop and support our products, regulatory activities, medical </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">affairs,</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 104.57pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and ot</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.35pt; position: absolute; text-decoration: none; white-space: pre;">her costs associated with products and technologies that are in development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.67pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 476.21pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Rese</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 499.55pt; position: absolute; white-space: pre;">arch and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development expenses consist of personnel and related expenses, including stock-based compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs, clinical trials, third-party consulting costs, the portion of the costs incurred by our production team <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to support clinical trials and research and development efforts, and allocated overhead, including facilities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses, equipment and depreciation. Our research and development team is comprised of PhD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research scientists with expertise in AI-based algorithms and medical imaging, alongside software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">engineers skilled in cloud architecture, AI algorithms, machine and deep learning and 3D visualization, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">well as product managers and designers who ensure optimal customer experience and design. We record <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development expenses in the periods in which they are incurred. We expect our research <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and development expenses to increase as we conduct clinical studies for expanded indications for use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and to hire additional personnel to develop new product offerings and product enhancements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Selling, general and administrative expenses consist of personnel and related expenses, including stock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based compensation costs, related to selling and marketing, commercial operations, reimbursement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finance, legal, information technology and human resources functions. Other expenses include sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commission, marketing initiatives, professional service fees (including legal, audit, accounting and tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fees), market access work to secure reimbursement for our technologies, travel expenses, conferences <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and trade shows, and allocated overhead, which includes facilities expenses, software licenses, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depreciation and other miscellaneous expenses.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect that our selling, general and administrative expenses will increase in the future as a result of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expanding our operations, including hiring personnel, to both drive and support anticipated growth as well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as various incremental costs associated with operating as a public company. We expect that our costs will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase related to legal, audit, accounting fees, consulting fees, regulatory and tax-related services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">associated with maintaining compliance with exchange listing and SEC requirements, director and officer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance costs, investor and public relations costs and other expenses that we did not incur as a private <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">86<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. However, we expect selling, general and administrative expenses to decrease as a percentage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of revenue primarily as, and to the extent, our revenue grows.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Interest income (expense), net consists primarily of interest expense on our 2024 Term Loan and related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortization of debt discount and debt issuance costs. Interest income is primarily interest earned on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash and cash equivalents. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other income (expense), net consists primarily of changes in fair value related to our Convertible Notes, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock warrant and derivative liability as well as foreign exchange transaction gains or losses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from transactions and asset and liability balances denominated in currencies other than the U.S. dollar. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We will continue to record adjustments to the estimated fair value of the common stock warrant liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until the warrants are exercised or expire.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Provision for income taxes consists of income tax expense in foreign jurisdictions. To date, we have not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded any U.S. federal or state income tax expense. We have net deferred tax assets for U.S. federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income taxes for which we provide a full valuation allowance. Due to our history of net operating losses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">since inception, we expect to maintain a full valuation allowance in the foreseeable future due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">uncertainties regarding our ability to realize these assets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Results of operations<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Comparison of years ended December 31, 2023 and 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes our results of operations for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.61pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.4pt; position: absolute; white-space: pre;"> and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 418.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 201pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 64.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 64.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 64.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 64.5pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 201pt; position: absolute; top: 0pt; width: 132pt;"><div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 2.81pt; width: 132pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.92pt; position: absolute; text-decoration: none; white-space: pre;">Year ended <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 70.89pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 336pt; position: absolute; top: 0pt; width: 132pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 132pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 96.41pt; position: absolute; text-decoration: none; white-space: pre;">Change<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 201pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 201pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(dollars in thousands)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 12.75pt; width: 64.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 41.87pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 12.75pt; width: 64.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 41.87pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 12.75pt; width: 64.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 56.87pt; position: absolute; text-decoration: none; white-space: pre;">$<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 12.75pt; width: 64.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.87pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 43.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 25.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 21.66pt;"></font></font><font style="left: 29.849999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 25.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.31pt;"></font></font><font style="left: 24.5pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 25.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 21.87pt;"></font></font><font style="left: 30.06pt; position: absolute;">38,634<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 25.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 40.62pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 40.62pt; position: absolute;">44<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.739999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 73.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 73.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 73.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.36pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 39.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.22pt;"></font></font><font style="left: 29.849999999999998pt; position: absolute;">29,123<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 39.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.43pt;"></font></font><font style="left: 30.06pt; position: absolute;">31,359<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 39.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 32.99pt;"></font></font><font style="left: 35.620000000000005pt; position: absolute;">2,236<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 39.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 46.18pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 46.18pt; position: absolute;">8<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.74pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 54.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 56.580000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 57.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 57.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 57.970000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 57.99pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 54pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.22pt;"></font></font><font style="left: 29.849999999999998pt; position: absolute;">58,051<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 54pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.22pt;"></font></font><font style="left: 29.849999999999998pt; position: absolute;">94,449<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 54pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.43pt;"></font></font><font style="left: 30.06pt; position: absolute;">36,398<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 54pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 40.62pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 40.62pt; position: absolute;">63<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.739999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 136.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 138.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 138.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 138.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.24pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.22pt;"></font></font><font style="left: 29.849999999999998pt; position: absolute;">35,854<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.43pt;"></font></font><font style="left: 30.06pt; position: absolute;">43,517<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 32.99pt;"></font></font><font style="left: 35.620000000000005pt; position: absolute;">7,663<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 82.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 40.62pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 40.62pt; position: absolute;">21<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.739999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 167.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 167.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 168.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.28pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.22pt;"></font></font><font style="left: 29.849999999999998pt; position: absolute;">95,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.87pt;"></font></font><font style="left: 24.5pt; position: absolute;">112,154<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.43pt;"></font></font><font style="left: 30.06pt; position: absolute;">17,043<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 96.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 40.62pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 40.62pt; position: absolute;">18<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.739999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 113.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 116.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 117.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 117.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 117.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 111pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.66pt;"></font></font><font style="left: 24.29pt; position: absolute;">130,965<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 111pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 21.66pt;"></font></font><font style="left: 24.29pt; position: absolute;">155,671<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 111pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.43pt;"></font></font><font style="left: 30.06pt; position: absolute;">24,706<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 111pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 40.62pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 40.62pt; position: absolute;">19<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.739999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 125.25pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 97.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 98.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.14999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 125.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 23.89pt;"></font></font><font style="left: 26.52pt; position: absolute;">(72,914)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 125.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 23.89pt;"></font></font><font style="left: 26.52pt; position: absolute;">(61,222)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 125.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.43pt;"></font></font><font style="left: 30.06pt; position: absolute;">11,692<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 125.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 37.29pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 37.29pt; position: absolute;">-16<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.739999999999995pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 139.5pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 137.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 138.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 138.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 138.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 139.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 23.89pt;"></font></font><font style="left: 26.52pt; position: absolute;">(19,237)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 139.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 20.77pt;"></font></font><font style="left: 23.4pt; position: absolute;">(18,702)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 139.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.32pt;"></font></font><font style="left: 43.95pt; position: absolute;">535<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 139.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 42.85pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 42.85pt; position: absolute;">-3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.74pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153.75pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 129.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 131.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 132.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 132.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 132.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.99pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 153.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 29.45pt;"></font></font><font style="left: 32.08pt; position: absolute;">(2,957)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 153.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 20.77pt;"></font></font><font style="left: 23.4pt; position: absolute;">(16,449)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 153.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 20.77pt;"></font></font><font style="left: 23.4pt; position: absolute;">(13,492)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 153.75pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 35.06pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 35.06pt; position: absolute;">456<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.74pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 168pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss before provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 173.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 176.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 177.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 177.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.93pt; position: absolute; text-decoration: none; white-space: pre;"> . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 168pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 23.89pt;"></font></font><font style="left: 26.52pt; position: absolute;">(95,108)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 168pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 23.89pt;"></font></font><font style="left: 26.52pt; position: absolute;">(96,373)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 168pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 29.45pt;"></font></font><font style="left: 32.08pt; position: absolute;">(1,265)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 168pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 37.64pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 37.64pt; position: absolute;">1.3<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 54.86pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 182.25pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 119.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 122.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 123.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.03pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 182.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 37.78pt;"></font></font><font style="left: 40.410000000000004pt; position: absolute;">(547)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 182.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.34pt;"></font></font><font style="left: 45.970000000000006pt; position: absolute;">(53)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 182.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.11pt;"></font></font><font style="left: 43.74pt; position: absolute;">494<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 182.25pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 37.08pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 37.08pt; position: absolute;">-90<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 54.86pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 196.5pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 201pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 41.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 42.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 42.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.93pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 201pt; position: absolute; top: 196.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 18.33pt;"></font></font><font style="left: 26.52pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 268.5pt; position: absolute; top: 196.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 18.33pt;"></font></font><font style="left: 26.52pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 336pt; position: absolute; top: 196.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 29.1pt;"></font></font><font style="left: 37.29pt; position: absolute;">(771)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 403.5pt; position: absolute; top: 196.5pt; width: 64.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 64.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 37.85pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 37.85pt; position: absolute;">0.8<font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.74pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 645.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue increased $38.6&#160;million, or&#160;44%, to $125.8&#160;million during the year ended December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 677.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">$87.2 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.44pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.22pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.01pt; position: absolute; white-space: pre;">. The increase in revenue was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily attributable to an increase in revenue cases, partially offset by a modest reduction in average <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">87<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales price due to a higher percentage of revenue cases generated from clinic or office-based accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and to a lesser extent, the impact of rebates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Cost of revenue and gross <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 200.79pt; position: absolute; text-decoration: none; white-space: pre;">margin<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cost of revenue increased $2.2&#160;million, or&#160;8%, to $31.4 million during the year ended December 31, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">$29.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.44pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 289.22pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.01pt; position: absolute; white-space: pre;">. This increase was attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$0.8&#160;million in allocated overhead, $0.5&#160;million in personnel and related expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.01pt; position: absolute; text-decoration: none; white-space: pre;">,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.78pt; position: absolute; white-space: pre;"> $0.5&#160;million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortization of capitalized internal-use software, $0.4&#160;million in third-party hosting fees and a net change <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of $0.3 million in capitalized and amortized contract fulfillment costs, partially offset by a $0.6&#160;million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decrease in royalties. Personnel and related expenses included $0.3&#160;million and $0.4 million of stock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based compensation costs during the year ended December 31, 2024 and 2023, respectively. Gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">margin for the year ended December 31, 2024 increased to&#160;75% as compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 431.43pt; position: absolute; text-decoration: none; white-space: pre;">67%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 451.44pt; position: absolute; white-space: pre;"> for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;">. The gross margin increase during the year ended December 31, 2024 was primarily <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">driven by increased revenues and through the launch of a major new algorithm that significantly increased <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the automation of manual components of the production teams&#8217; process, which lowered the cost of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue per analysis. We expect that future new algorithm launches will have significantly less impact on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automation increases and associated gross margin expansion.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Research and development expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Research and development expenses increased $7.7&#160;million, or&#160;21%, to $43.5&#160;million during the year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.23pt; position: absolute; text-decoration: none; white-space: pre;">$35.9 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 310.34000000000003pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.12pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 500.91pt; position: absolute; white-space: pre;">. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase in research and development expenses was primarily attributable to an increase of $3.7&#160;million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 530.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">in personnel and related expenses directly associated with an increase in headcount, $2.0&#160;million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consulting and professional fees, $1.2&#160;million in software-related costs, $0.5&#160;million in clinical trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">expenses and $0.5 million of capitalized internal-use software costs, partially offset by a $0.6 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">decrease in allocated overhead<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.92pt; position: absolute; white-space: pre;">. Personnel<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.47pt; position: absolute; text-decoration: none; white-space: pre;"> and related expenses included $2.2&#160;million and $3.3 million o<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 534.25pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">f </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">stock-based compensation costs during the year ended December 31, 2024 and 2023, respectively. </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Selling, general and administrative expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Selling, general and administrative expenses increased $17.0&#160;million, or&#160;18%, to $112.2&#160;million during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.45pt; position: absolute; text-decoration: none; white-space: pre;">$95.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.56pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.34pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.13pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The increase in selling, general and administrative expenses was primarily attributable to an increase of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$13.5&#160;million in personnel and related expenses directly associated with an increase in headcount, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$5.3&#160;million in professional fees, including legal, audit and consulting fees, and $1.7&#160;million in marketing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses, partially offset by a decrease of $1.0 million in software-related costs and $2.9 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capitalized commission costs. Personnel and related expenses included $7.8&#160;million and $8.7 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock-based compensation costs for the year ended December 31, 2024 and 2023, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Interest income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Interest income (expense), net decreased to expense of $18.7&#160;million during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December&#160;31, 2024, compared to expense of $19.2 million during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.22pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 522.01pt; position: absolute; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This decreased expense was attributable to more favorable interest rates under the 2024 Term Loan. As <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of December 31, 2024 and 2023, the aggregate outstanding principal balance (including interest paid-in-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">kind) under our 2024 Term Loan was $138.1 million <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 301.82pt; position: absolute; text-decoration: none; white-space: pre;">and $138.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.94pt; position: absolute; white-space: pre;">, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Other income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 206.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other income (expense), net increased to an expense of $16.4&#160;million during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December&#160;31, 2024, compared to expense of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.33000000000004pt; position: absolute; text-decoration: none; white-space: pre;">$3.0 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.88pt; position: absolute; white-space: pre;"> during the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.66pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.45pt; position: absolute; white-space: pre;">. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase was primarily attributable to the remeasurement and recognition of the change in fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related to our common stock warrant liability of $14.1 million. Other income (expense), net also included <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the remeasurement and recognition of the changes in fair value related to our Convertible Notes through <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">88<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their conversion in March 2023 and to the derivative liability through the 2024 Term Loan Refinancing (as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defined below) in June 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Provision for income taxes was $547,000 and $53,000 for the years ended December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively, related to our foreign taxes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selected quarterly results of operations data<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth selected unaudited quarterly statements of operations data for each of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 190.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">four fiscal quarters ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.54000000000002pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.33000000000004pt; position: absolute; white-space: pre;"> and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.55pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 319.78999999999996pt; position: absolute; white-space: pre;">. The unaudited information for each of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quarters has been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the same basis as our audited annual consolidated financial statements included elsewhere in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus and includes, in the opinion of management, all adjustments, consisting only of normal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recurring adjustments, necessary for the fair statement of the results of operations for these periods. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">data should be read in conjunction with our consolidated financial statements and related notes included <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elsewhere in this prospectus. These historical quarterly operating results are not necessarily indicative of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our operating results for the full year or any future per<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.05pt; position: absolute; text-decoration: none; white-space: pre;">iod.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 294.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 90pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 51.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 48pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 50.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 48pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 11.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="15"><div style="left: 90pt; position: absolute; top: 0pt; width: 378pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.66pt; width: 378pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 311.51pt; position: absolute; text-decoration: none; white-space: pre;">Three months ended <font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td></tr><tr style="height: 18.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 11.25pt; width: 90pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 90pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 90pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 7.18pt; position: absolute; text-decoration: none; white-space: pre;">March 31, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 22.68pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 132.75pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 11.14pt; position: absolute; text-decoration: none; white-space: pre;">June 30, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 22.68pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 11.25pt; width: 51.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 4.75pt; position: absolute; text-decoration: none; white-space: pre;">September 30, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 34.68pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 230.25pt; position: absolute; top: 11.25pt; width: 48pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 3.16pt; position: absolute; text-decoration: none; white-space: pre;">December 31, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 30.93pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 281.25pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 7.18pt; position: absolute; text-decoration: none; white-space: pre;">March 31, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 22.68pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324pt; position: absolute; top: 11.25pt; width: 39.75pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 11.14pt; position: absolute; text-decoration: none; white-space: pre;">June 30, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 22.68pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 366.75pt; position: absolute; top: 11.25pt; width: 50.25pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 3.25pt; position: absolute; text-decoration: none; white-space: pre;">September 30, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 33.18pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 420pt; position: absolute; top: 11.25pt; width: 48pt;"><div><div style="line-height: 4.73pt; position: absolute; top: 3.36pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 3.16pt; position: absolute; text-decoration: none; white-space: pre;">December 31, <font style="display: inline-block; height: 4.73pt;"></font></font></div><div style="line-height: 4.73pt; position: absolute; top: 11.16pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 30.93pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 4.73pt;"></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 30pt; width: 90pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 90pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 30.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 31.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 31.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 31.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 90pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">18,844<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 132.75pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">21,412<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 30pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 20.76pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">22,753<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 230.25pt; position: absolute; top: 30pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 17.01pt;"></font></font><font style="left: 23.529999999999998pt; position: absolute;">24,165<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 281.25pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">26,843<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324pt; position: absolute; top: 30pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 8.76pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">31,054<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 366.75pt; position: absolute; top: 30pt; width: 50.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 19.26pt;"></font></font><font style="left: 25.779999999999998pt; position: absolute;">32,934<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 420pt; position: absolute; top: 30pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 17.01pt;"></font></font><font style="left: 23.529999999999998pt; position: absolute;">34,977<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 90pt;"><div><div style="line-height: 6.4pt; position: absolute; top: 2.86pt; width: 90pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 38.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 41.080000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 41.370000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 41.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 41.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 41.580000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . .<font style="display: inline-block; height: 6.4pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 90pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">11,314<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 132.75pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">13,978<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 41.25pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">15,851<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 230.25pt; position: absolute; top: 41.25pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.9pt;"></font></font><font style="left: 23.529999999999998pt; position: absolute;">16,908<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 281.25pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">19,423<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">23,839<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 366.75pt; position: absolute; top: 41.25pt; width: 50.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 23.15pt;"></font></font><font style="left: 25.779999999999998pt; position: absolute;">24,937<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 420pt; position: absolute; top: 41.25pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.9pt;"></font></font><font style="left: 23.529999999999998pt; position: absolute;">26,250<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 90pt;"><div><div style="line-height: 6.4pt; position: absolute; top: 2.86pt; width: 90pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 80.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 83.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 83.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 83.55pt; position: absolute; text-decoration: none; white-space: pre;"> .<font style="display: inline-block; height: 6.4pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 90pt; position: absolute; top: 54pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">31,764<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 132.75pt; position: absolute; top: 54pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">32,528<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 54pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 24.65pt;"></font></font><font style="left: 27.279999999999998pt; position: absolute;">30,731<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 230.25pt; position: absolute; top: 54pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.9pt;"></font></font><font style="left: 23.529999999999998pt; position: absolute;">35,942<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 281.25pt; position: absolute; top: 54pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">35,481<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324pt; position: absolute; top: 54pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 12.65pt;"></font></font><font style="left: 15.280000000000001pt; position: absolute;">38,016<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 366.75pt; position: absolute; top: 54pt; width: 50.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 23.15pt;"></font></font><font style="left: 25.779999999999998pt; position: absolute;">39,866<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 420pt; position: absolute; top: 54pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.9pt;"></font></font><font style="left: 23.529999999999998pt; position: absolute;">43,208<font style="display: inline-block; height: 5.09pt; width: 2.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 11.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 90pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.15pt; width: 90pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 67.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 69.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 69.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 5.09pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 69.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . .<font style="display: inline-block; height: 5.09pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 90pt; position: absolute; top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(20,450)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 132.75pt; position: absolute; top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(18,550)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 66.75pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 22.32pt;"></font></font><font style="left: 24.95pt; position: absolute;">(14,880)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 230.25pt; position: absolute; top: 66.75pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 18.57pt;"></font></font><font style="left: 21.2pt; position: absolute;">(19,034)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 281.25pt; position: absolute; top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(16,058)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324pt; position: absolute; top: 66.75pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 10.32pt;"></font></font><font style="left: 12.95pt; position: absolute;">(14,177)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 366.75pt; position: absolute; top: 66.75pt; width: 50.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 20.82pt;"></font></font><font style="left: 23.45pt; position: absolute;">(14,929)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 420pt; position: absolute; top: 66.75pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 3.19pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 5.09pt; width: 18.57pt;"></font></font><font style="left: 21.2pt; position: absolute;">(16,058)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 90pt;"><div><div style="line-height: 6.4pt; position: absolute; top: 2.86pt; width: 90pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 27.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 30.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 30.779999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 30.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 31.009999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.4pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; left: 31.05pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.4pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 90pt; position: absolute; top: 78pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(30,755)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 132.75pt; position: absolute; top: 78pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(22,710)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 78pt; width: 51.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 51.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 18.43pt;"></font></font><font style="left: 24.95pt; position: absolute;">(19,599)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 230.25pt; position: absolute; top: 78pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 14.68pt;"></font></font><font style="left: 21.2pt; position: absolute;">(22,591)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 281.25pt; position: absolute; top: 78pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(20,932)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324pt; position: absolute; top: 78pt; width: 39.75pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 6.43pt;"></font></font><font style="left: 12.95pt; position: absolute;">(23,379)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 366.75pt; position: absolute; top: 78pt; width: 50.25pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 16.93pt;"></font></font><font style="left: 23.45pt; position: absolute;">(19,140)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 420pt; position: absolute; top: 78pt; width: 48pt;"><div><div style="line-height: 5.09pt; position: absolute; top: 4.69pt; width: 48pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 7pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 5.09pt; width: 14.68pt;"></font></font><font style="left: 21.2pt; position: absolute;">(32,975)<font style="display: inline-block; height: 5.09pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 401.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Quarterly</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 116.43pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> trends</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Revenue</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 441.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Our quarterly revenue increased sequentially in each of the periods presented primarily due to revenue </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 453.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">growth from the expansion of revenue cases volume within our existing installed base and the addition of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">new customers.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 485.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Cost of revenue and gross margin</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">With the exception of the three months ended September 30, 2023, cost of revenue generally increased </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 517.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">sequentially in each of the quarters presented, driven by increased sales. During the three months ended </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 529.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">September 30, 2023, cost of revenue decreased as we introduced the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.65pt; position: absolute; white-space: pre;">automation of certain manual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 541.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">components of our production <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">teams p</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 242.55pt; position: absolute; white-space: pre;">rocess thereby resulting in decreased <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.44pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">personnel and related </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 553.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">expenses and allocated overhead.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Our quarterly gross margins have fluctuated between</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.98pt; position: absolute; white-space: pre;">&#160;60<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.87pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">% and</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.21pt; position: absolute; white-space: pre;">&#160;77<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.1pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">% in each period presented.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Total operating expenses have generally increased sequentially in each period presented with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exception of the three months ended September 30, 2023 and March 31, 2024. Operating expenses <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fluctuate due to t<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.86pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">iming of consulting projects, legal expenses, clinical studies, stock-based compensation </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 649.15pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.11pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">capitalization of internal-use software costs</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.63pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">89<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidity and capital resources<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sources of liquidity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Since inception, we have primarily funded our operations with proceeds from sales of shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock, common stock and convertible promissory notes, borrowings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under our term loans and revenue received from our customers, which we expect to be our primary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">source of future liquidity. As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.31pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.1pt; position: absolute; white-space: pre;">, we had $51.4&#160;million in cash and cash equivalents, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accumulated deficit of $971.0&#160;million and $138.1&#160;million outstanding under our 2024 Term Loan. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.36pt; position: absolute; text-decoration: none; white-space: pre;">On <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">January 24, 2025 and January 31, 2025, we reduced our outstanding indebtedness under our 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Loan by $23.0 million and received $25.4 million in cash in exchange for the issuance of $48.4 million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">aggregate principal amount of 2025 Convertible Notes, as described below. In March 2025, we issued an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">additional $50.0 million in aggregate principal of the 2025 Convertible Notes to investors. As of March 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025, we had $&#160; &#160; million in cash and cash equivalents, which included the $75.4 million in proceeds from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">our January and March 2025 convertible promissory notes offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 105.31pt; position: absolute; text-decoration: none; white-space: pre;">credit agreement<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On June 14, 2024, we entered into a Credit Agreement and Guaranty for a $138.1 million term loan to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">refinance the outstanding obligations under the initial credit agreement we entered into with Hayfin on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January 19, 2021 and the additional term loans entered into with Hayfin on March 17, 2022 in exchange <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the payment of exit fees and early prepayment fees in the aggregate amount of $8.3 million payable in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sixteen equal quarterly installments, or immediately upon the occurrence of a financing event, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but not limited, to the completion of this offering. On January 24, 2025, in connection with the issuance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2025 Convertible Notes as further described below, we entered into Amendment No. 1 to the Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement and Guaranty (as amended, the &#8220;2024 Credit Agreement&#8221;) to amend the terms and conditions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governing the term loan outstanding thereunder (as amended, the &#8220;2024 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.05pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan&#8221;). In connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the refinancing of the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.09pt; position: absolute; text-decoration: none; white-space: pre;">original 2021 Credit Agreement with Hayfin<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.51pt; position: absolute; text-decoration: none; white-space: pre;"> with the 2024 Term Loan (the &#8220;2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan Refinancing&#8221;), we remeasured the fair value of the derivative liability immediately before the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan Refinancing and recognized a $0.2 million loss from the change in fair value in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consolidated statements of operations and comprehensive loss for the year ended December 31, 2024. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The associated current fair value of the derivative liability of $1.1 million, as remeasured at the date of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan Refinancing, was derecognized and recorded as a debt discount to the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">on the consolidated balance sheet.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Term Loan matures on June 14, 2028 and bears interest equal to the sum of (i) 7.0% (or 6.0% if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the alternative base rate (&#8220;ABR&#8221;) is in effect) plus (ii) the greater of (x) the forward-looking term rate based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on Secured Overnight Financing Rate (&#8220;SOFR&#8221;) for a respective tenor in effect on such day (or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alternative base rate, if applicable), and (y) 2.0%. The ABR equals to the sum of (i) 6.0% plus (ii) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">greater of (1) the Wall Street Journal Prime Rate, plus 0.5%, (2) the Federal Reserve Bank of New York <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate plus 0.5% or (3) CBA Term SOFR for one month tenor plus 1.0%. We have an option to pay interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in-kind at the rate equal to the cash interest rate plus 1.0% through the last interest period ending before <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 18th month anniversary of the 2024 Credit Agreement. We have an option to prepay the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan subject to a prepayment fee of 1.5% for prepayments after the second anniversary but on or prior to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the third anniversary of the 2024 Term Loan and a prepayment fee of 3% for prepayments thereafter. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Term Loan must be repaid in full immediately upon the occurrence of a change in control. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with the completion of this offering, we are obligated to use certain of the net proceeds from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering to repay the 2024 Term Loan in an amount equal to the lesser of (i) the net cash proceeds of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering in excess of $150.0 million and (ii) $50.0 million (or $55.0 million if the underwriters exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any portion of their option to purchase additional shares).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Credit Agreement contains customary representations and warranties, events of default and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affirmative and negative covenants, including, among others, covenants that limit or restrict our (and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiaries) ability to incur additional indebtedness, grant liens, merge or consolidate, make acquisitions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pay dividends or other distributions or repurchase equity, make investments, dispose of assets and enter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into certain transactions with affiliates, in each case subject to certain exceptions. Financial covenants <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">90<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require us to maintain a $15.0 million minimum liquidity balance in cash and cash equivalents at all times <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and minimum net sales for twelve consecutive month periods ending on the last day of a fiscal quarter, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which is not tested as long as the we maintain minimum liquidity of at least $60.0 million and there has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been no decline in net sales for two-consecutive fiscal quarters at the end of such fiscal quarter. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">minimum twelve months trailing net sales covenant increases each quarter and is $78.8 million for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quarter ended June 30, 2024 up to a minimum net sales amount of $110.0 million for the quarter ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">June 30, 2025 and each quarter thereafter. Events of default in the 2024 Credit Agreement include, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representations and warranties, bankruptcy and insolvency events, material judgments, cross-defaults to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material contracts and events constituting a change of control. Upon the occurrence of an event of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">default, the interest rate applicable to the 2024 Term Loan shall increase by 3.0% per annum and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding principal balance, along with any accrued interest, shall become immediately due and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payable. As of December 31, 2024, the aggregate outstanding principal balance under the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan was $138.1 million and the effective interest rate was 16.0%. As of December 31, 2024, we were in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliance with the 2024 Credit Agreement covenants.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the period from September 2022 through December 2022, we issued convertible promissory notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Convertible Notes&#8221;) to certain investors, with an aggregate principal amount of $40.0 million. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes bore interest at a rate of 8% per annum, compounded monthly. The aggregate principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount and interest accrued on the Convertible Notes was due September 30, 2026, and could not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prepaid by us without the consent of a majority of the Convertible Note investors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, we completed a Qualified Financing (as defined in the Convertible Notes) and all of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes, including principal and interest, were converted into 21,465,064 shares of our Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">F-1 redeemable convertible preferred stock. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.64pt; position: absolute; text-decoration: none; white-space: pre;">In connection with the conversion of the Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">into the shares of our Series F-1 redeemable convertible preferred stock, we derecognized the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes in our consolidated balance sheet. We remeasured the fair value of the Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notes immediately before the conversion and recognized a $5.1 million loss from the change in fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">in the consolidated statements of operations and comprehensive loss for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.76pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January and March 2025, we issued convertible promissory notes to various investors and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees (the &#8220;Requisite Holders&#8221;) in the aggregate amount of $98.4 million,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.85pt; position: absolute; text-decoration: none; white-space: pre;"> which was comprised of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$75.4 million in aggregate principal amount of notes issued for cash consideration and $23.0 million in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregate principal amount of notes issued in the 2024 Term Loan Conversion (collectively, the &#8220;2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes&#8221;). <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 163.45999999999998pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Th</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 175.12pt; position: absolute; white-space: pre;">e 2025 Convertible Notes are due and payable in full 48 months from the issue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date. Upon completion of an IPO transaction, the 2025 Convertible Notes shall automatically convert into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of our common stock at the IPO price per share at the lower of a 20% discount and a valuation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cap of $2.0 billion on a pre-money basis. In the event we complete a sale of shares of our preferred stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Requisite Holders may elect to convert the outstanding 2025 Convertible Notes into shares of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">series of preferred stock at the same terms. Further, upon a change of control transaction, the Requisite <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holders may elect to convert the outstanding 2025 Convertible Notes into shares of our common stock at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lower of a 20% discount to the implied price per share of common stock in the change of control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction and a valuation cap of $2.0 billion on a pre-money basis, or receive payment of all principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and any accrued but unpaid 2025 Convertible Notes paid in-kind (&#8220;PIK&#8221;) interest. The 2025 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes do not accrue interest for one year following the date of issuance. Following the one-year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">anniversary of the issue date and for the remainder of the term, the 2025 Convertible Notes interest will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accrue on an annual basis at the rate of 7.0% per annum. All PIK interest accrued and payable will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">paid by capitalizing such interest on an annual basis and adding it to the outstanding principal amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2025 Convertible Notes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the issuance of the 2025 Convertible Notes, we entered into Amendment No.1 to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Credit Agreement, in which our lender, Hayfin, converted $23.0 million of principal under the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">91<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Term Loan to 2025 Convertible Notes under the same terms as the other purchasers of the 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes our cash flows for each of the periods presented&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 144pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.42pt; position: absolute; text-decoration: none; white-space: pre;">Year ended <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 72.39pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 334.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.75pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 42.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in operating activities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 162.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 164.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 166.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 166.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 166.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(76,434)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 15.96pt;"></font></font><font style="left: 24.15pt; position: absolute;">(69,001)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in investing activities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 160.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 161.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 161.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 161.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(6,105)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.08pt;"></font></font><font style="left: 29.709999999999997pt; position: absolute;">(4,357)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash provided by financing activities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 180.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 181.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 181.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">169,318<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.74pt;"></font></font><font style="left: 36.370000000000005pt; position: absolute;">2,237<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 228.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in operating activities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 248.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in operating activities was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.3pt; position: absolute; text-decoration: none; white-space: pre;">$76.4 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 311.40999999999997pt; position: absolute; white-space: pre;"> for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 398.06pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.85pt; position: absolute; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 260.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable to a net loss of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.95pt; position: absolute; text-decoration: none; white-space: pre;">$95.7 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 248.06pt; position: absolute; white-space: pre;"> and a net change in operating assets and liabilities of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.59pt; position: absolute; text-decoration: none; white-space: pre;">$8.5 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 272.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.33pt; position: absolute; white-space: pre;">, partially offset by non-cash charges of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.77pt; position: absolute; text-decoration: none; white-space: pre;">$27.8 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.88pt; position: absolute; white-space: pre;">. Non-cash charges primarily consisted of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 284.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$11.9 million in stock-based compensation expense, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 305.71000000000004pt; position: absolute; text-decoration: none; white-space: pre;">$5.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 356.26pt; position: absolute; white-space: pre;"> of change in fair value of convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 296.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">note, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.99pt; position: absolute; text-decoration: none; white-space: pre;">$4.7 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.54000000000002pt; position: absolute; white-space: pre;"> of depreciation and amortization, $2.8 million of amortization of debt discount and debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 308.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance costs, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.1pt; position: absolute; text-decoration: none; white-space: pre;">$2.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.65pt; position: absolute; white-space: pre;"> of change in fair value of common stock warrant and $0.9 million of non-cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 320.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest charges, partially offset by <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 226.21pt; position: absolute; text-decoration: none; white-space: pre;">$4.2 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276.76pt; position: absolute; white-space: pre;"> of change in fair value of derivative liability. The net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 332.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes in operating assets and liabilities primarily consisted of an increase of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 421.41pt; position: absolute; text-decoration: none; white-space: pre;">$9.4 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 471.96pt; position: absolute; white-space: pre;"> in accounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 344.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receivable and a decrease of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.12pt; position: absolute; text-decoration: none; white-space: pre;">$1.8 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.67pt; position: absolute; white-space: pre;"> in operating lease liabilities, partially offset by an increase of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 356.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$3.8 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.55pt; position: absolute; white-space: pre;"> in accrued expenses and other current liabilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in operating activities for the year ended December 31, 2024 was $69.0&#160;million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable to a net loss of $96.4&#160;million and a net change in operating assets and liabilities of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$10.9&#160;million, partially offset by non-cash charges of $38.3&#160;million.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.43pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> The non-cash charges primarily </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">consisted of $10.2 million in stock-based compensation expense, $16.4 million of change in fair value of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">common stock warrant, $5.4 million of depreciation and amortization, $2.7 million of amortization of right-</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">of-use asset, $2.0 million of non-cash interest charges and $1.6 million of amortization of debt discount </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and debt issuance costs. The increase in net operating assets was primarily due to an increase of $3.8 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million in accounts receivable, a $1.0 million increase in prepaid expenses and other current assets, a </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">$2.7 million increase in other non-current assets and a $3.2 million decrease in operating lease liabilities.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in investing activities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 512.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash used in investing activities for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.4pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 404.19pt; position: absolute; white-space: pre;"> was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 427.51pt; position: absolute; text-decoration: none; white-space: pre;">$6.1 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.06pt; position: absolute; white-space: pre;"> consisting of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchases of property and equipment.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash used in investing activities for the year ended December 31, 2024 was $4.4</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 446.96pt; position: absolute; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.73pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million consisting of </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">purchases of property and equipment.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net cash provided by financing activities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 596.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Net cash provided by financing activities for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336.41pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.2pt; position: absolute; white-space: pre;"> was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.52pt; position: absolute; text-decoration: none; white-space: pre;">$169.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.19pt; position: absolute; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 608.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily attributable to net proceeds of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 247.51pt; position: absolute; text-decoration: none; white-space: pre;">$169.0 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.18pt; position: absolute; white-space: pre;"> from the issuance of our Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Net cash provided by financing activities for the year ended December 31, 2024 was $2.2</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.97pt; position: absolute; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.74pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million primarily </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">attributable to $4.6</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.76pt; position: absolute; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.53pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million in proceeds from the exercise of stock options offset by payments of $2.3 </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.25pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">million in exit, prepayment penalty and lender fees related to our 2024 Term Loan Refinancing.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">92<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Future funding requirements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our current operating plan, we believe that the expected cash generated from revenue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions with customers and our cash and cash equivalents of $&#160; &#160; million as of March 31, 2025, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes the $75.4 million in proceeds from our January and March 2025 convertible promissory notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.69pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">will be sufficient to fund our planned operating expenses and capital expenditure requirements </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">for at least the next 12 months. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 211.94pt; position: absolute; white-space: pre;">Our losses primarily resulted from the costs incurred in the development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and sales and marketing of our products and providing general and administrative support for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations. We expect to continue to incur losses and to expend significant amounts of cash in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreseeable future as we continue to scale our business, invest in research and development activities, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase sales and marketing efforts to support commercial expansion, and increase general and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative expenses to support being a publicly-traded company. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 377.92pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">We </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 395.5pt; position: absolute; white-space: pre;">have based our estimate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future funding requirements on assumptions that may prove to be wrong, and we could deplete our capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resources sooner than we expect. We may experience lower than expected cash generated from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating activities or greater than expected capital expenditures, cost of revenue, or operating expenses, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and may need to raise additional capital to fund operations, further research and development activities, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or acquire, invest in, or in-license other businesses, assets, or technologies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our future funding requirements will depend on many factors, including the following&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the market acceptance of our products&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the timing, scope, rate of progress, results and costs of our research and development activities&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the number, scope and duration of current or future clinical studies and additional regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clearances or approval&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the effect of competing technological and market developments&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the costs and timing of future commercialization activities, including marketing and sales, f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 487.68pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">or </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.98pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Plaque Analysis and any other new products&#894;</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the amount of revenue, if any, received from commercial sales of our Heartflow Plaque Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">any other new products&#894;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the impact of competitors&#8217; products and technological advances and other market developments&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the expenses needed to attract and retain skilled personnel&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the size of the markets and degree of market acceptance of any products in territories in which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">receive regulatory approval, including product pricing, product coverage, and the adequacy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reimbursement by third-party payors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Whether we acquire third-party companies, products or technologies&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Restructuring, refinancing or repayment of debt&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the increase in the number of our employees to support growth initiatives&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the cost of attaining, defending and enforcing our patents and other intellectual property rights&#894;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the timing of when we pay our operating expenses&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the costs associated with being a public company&#894; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other factors, including economic uncertainty, geopolitical tensions, healthcare reform <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.21pt; position: absolute; text-decoration: none; white-space: pre;">and changes in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">administration<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.22pt; position: absolute; text-decoration: none; white-space: pre;">, which may exacerbate the magnitude of the factors discussed above.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, our operating plans may change, and we may need additional funds to meet operational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">needs and capital requirements for clinical trials and other research and development expenditures.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">93<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contractual obligations and commitments<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our contractual commitments will have an impact on our future liquidity. These commitments include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future payments on non-cancellable facility leases, purchase obligations related to research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development and professional services under non-cancellable contracts, royalty obligations for exclusive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology licensing agreements and future payments on our 2024 Term Loan. Where applicable, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calculate our obligation based on termination fees that can be paid to exit the contract. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Lease agreements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have operating lease arrangements for office space in Mountain View, California, Santa Rosa, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 194.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">California, Austin, Texas, and Tokyo, Japan. As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.69pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.48pt; position: absolute; white-space: pre;">, we had total lease payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligations under non-cancelable leases of $30.0&#160;million, including $5.6&#160;million payable through <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2025. See Note 6 to our consolidated financial statements included elsewhere in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Royalty payments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We entered into various exclusive technology licensing agreements that requires us to make annual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">royalty payments in fixed amounts as well as certain milestone and revenue-based payments. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;">, we had total royalty obligations under these agreements of $0.3 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 477.52pt; position: absolute; text-decoration: none; white-space: pre;">, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$50,000 payable through December 31, 2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 273.15pt; position: absolute; white-space: pre;">. See Note 7 to our consolidated financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The principal balance on debt outstanding under our 2024 Term Loan as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 405.16pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 492.95pt; position: absolute; white-space: pre;"> was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$138.1&#160;million. In January 2025, principal outstanding under the 2024 Term Loan was $115.1 million after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">conversion of $23.0 million in principal to 2025 Convertible Notes and approximately $13.8 million of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">interest is payable through December 31, 2025.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.55pt; position: absolute; white-space: pre;"> See Note 8 and Note 18 to our consolidated financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recently issued accounting pronouncements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A description of recently issued accounting pronouncements that may potentially impact our financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">position, results of operations or cash flows is disclosed in Note 2 to our consolidated financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Critical accounting policies and estimates<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 515.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 527.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preparation of these consolidated financial statements requires us to make estimates and assumptions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates are based on our historical experience and various other factors that we believe are reasonable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 575.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the circumstances, the results of which form the basis for making judgments about the carrying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of assets and liabilities that are not readily apparent from other sources. Actual results may differ <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from these estimates under different assumptions or conditions and any such differences may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">While our significant accounting policies are described in more detail in Note 2 to our consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statements included elsewhere in this prospectus, we believe that the following discussion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addresses our most critical accounting policies, which are those most important to our financial condition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and results of operations and require our most difficult, subjective and complex judgments.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">94<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrants<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have issued freestanding warrants to purchase shares of common stock in connection with our 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Term Loan. We classify these warrants as a liability because they do not meet the equity indexation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">criteria. We record the fair value of the warrant on the consolidated balance sheet upon issuance and is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to remeasurement at each balance sheet date. The changes in the fair value of the warrants are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded in the consolidated statements of operations and comprehensive loss. We utilize the Black-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Scholes option-pricing model, which incorporates assumptions and estimates, to value the common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrant liability. Significant estimates and assumptions impacting fair value include the stock price, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contractual term, expected volatility and weighted average risk-free interest rate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The estimated aggregate fair value of the warrants issued in connection with the 2024 Term Loan in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">January 2021 and March 2022 was $4.3 million and $3.5 million, respectively. We recognized a $2.3 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million and $16.4 million loss from the change in fair value in the consolidated statements of operations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and comprehensive loss during the years ended December 31, 2023 and 2024, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to the 2024 Term Loan Refinancing in June 2024, we determined that our 2024 Term Loan contained <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain prepayment features, default put option and default interest adjustment features that were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined to be embedded derivatives requiring bifurcation and separate accounting as a single <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compound derivative. The impact of bifurcation of the embedded derivative on the date of issuance was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reflected as a debt discount. The instrument was classified as a liability on the consolidated balance sheet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and is subject to remeasurement at each balance sheet date. Any change in fair value of the derivative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability is recognized in the consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We utilize both the Black-Scholes-Merton and option-pricing method, which incorporates certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions and estimates, to value the derivative liability. These include the estimated time and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">probability of a business combination or IPO, default, change of control and incurrence of new debt, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">weighted common stock value, debt yield, expected volatility and risk-free interest rate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The estimated fair value of the derivative liability was $2.1 million at the issuance date in January 2021. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We recognized a <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.59pt; position: absolute; text-decoration: none; white-space: pre;">$4.2 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.14pt; position: absolute; white-space: pre;"> gain and $0.2 million loss from the change in fair value in the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 399.78pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 487.57pt; position: absolute; white-space: pre;"> and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.&#160; In connection with the 2024 Term Loan Refinancing on June 14, 2024, the associated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current fair value of the derivative liability of $1.1 million, as remeasured at the date of 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Refinancing, was derecognized and recorded as a debt discount to the 2024 Term Loan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stock-based compensation related to share-based awards granted to employees, consultants and to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">members of our board of directors is measured at fair value. Compensation expense for those awards is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized on a straight-line basis over the requisite service period, which is generally the vesting period. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For performance-based stock options, we assess the probability of performance conditions being <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieved in each reporting period. The amount of stock-based compensation expense recognized in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">one period related to performance-based stock options can vary based on the achievement or anticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achievement of the performance conditions. We account for forfeitures of stock-based awards as they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">occur. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate the fair value of each option award on the date of grant using the Black-Scholes option -<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing model. This model requires the use of highly subject assumptions to determine the fair value, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Fair value of common stock.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.95999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> See the subsection titled &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.7pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">&#8212;</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.7pt; position: absolute; text-decoration: none; white-space: pre;">Determination of fair value of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">95<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expected term.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157.2pt; position: absolute; text-decoration: none; white-space: pre;"> The expected term represents the period that the stock-based awards are expected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">be outstanding. The expected term for our stock options was calculated based on the weighted-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">average vesting term of the awards and the contract period, or simplified method.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.75pt; position: absolute; text-decoration: none; white-space: pre;"> Since we are not yet a public company and do not have any trading history for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock, the expected volatility was estimated based on the average historical volatilities of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock of comparable publicly traded entities over a period equal to the expected term of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock option grants. The comparable companies were chosen based on their size, stage of their life <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cycle or area of specialty. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Risk-free interest rate.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.29000000000002pt; position: absolute; text-decoration: none; white-space: pre;"> The risk-free interest rate is based on the U.S. Treasury yield in effect at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the expected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">term of the awards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expected dividend yield.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.78pt; position: absolute; text-decoration: none; white-space: pre;"> The expected dividend yield is zero as we have not paid dividends nor do we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">anticipate paying any dividends on our common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We expect to continue to grant equity-based awards in the future, and to the extent that we do, our stock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based compensation expense recognized in future periods will likely increase.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on the assumed initial public offering price per share of $&#160; &#160; &#160; , which is the midpoint of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated offering price range set forth on the cover page of this prospectus, the aggregate intrinsic value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our outstanding stock options as of December 31, 2024 was $&#160; &#160;  million, with $&#160; &#160;  million related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vested stock options.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">See Note 14 to our consolidated financial statements included elsewhere in this prospectus for further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">details.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Determination of fair value of common stock<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As there has been no public market for our common stock to date, the estimated fair value of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock underlying our share-based awards was estimated on each grant date by our management and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved by our board of directors. Our board of directors exercised reasonable judgment and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered a number of objective and subjective factors, as well as valuations prepared by independent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third-party valuation firms. The methodologies used to estimate the enterprise value are performed using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methodologies, approaches and assumptions consistent with the American Institute of Certified Public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accountants Accounting and Valuation Guide, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 276.8pt; position: absolute; white-space: pre;">Valuation of Privately-Held-Company Equity Securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Issued as Compensation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.01pt; position: absolute; white-space: pre;"> (the Practice Aid).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to considering the results of independent third-party valuations, our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considered various objective and subjective factors to determine the fair value of common stock as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each grant date, including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">contemporaneous valuations performed by independent third-party specialists&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the prices, rights, preferences and privileges of our redeemable convertible preferred stock relative to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">those of our common stock&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the prices of common or preferred stock sold to third-party investors by us and in secondary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">transactions or repurchased by us in arms-length transactions&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">lack of marketability of our common stock&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our actual operating and financial performance&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">current business conditions and projections&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our stage of development&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">96<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">likelihood of achieving a liquidity event, such as an initial public offering or a merger or acquisition of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our company given prevailing market conditions&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the market performance of comparable publicly traded companies&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the U.S. and global capital market conditions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For our valuations performed, the allocation of these enterprise values to each our share classes utilized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the hybrid method. The hybrid method considered the stay private scenario and IPO exit scenario. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stay private scenario, three market methodologies were employed including (i) a market indexing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">valuation analysis based on the Series F Preferred financing round, (ii) a guideline public company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analysis based on historical and forecast operating metrics for us, and (iii) a guideline transaction analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on historical and forecast operating metrics for us. In the IPO exit scenario, the total equity value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was estimated based on the expected timing, offering size and pre-money valuation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The assumptions underlying these valuations represented management&#8217;s best estimate, which involved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inherent uncertainties and the application of management&#8217;s judgment. As a result, if we had used <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly different assumptions or estimates, the fair value of our common stock and our stock-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation expense could be materially different.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Once a public trading market for our common stock has been established in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering, it will no longer be necessary for our board of directors to estimate the fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of our common stock in connection with our accounting for share-based payments, as the fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock will be based on the quoted market price of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Off-balance&#160;sheet&#160;arrangements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the periods presented we did not have, nor do we currently&#160;have,&#160;any&#160;off-balance&#160;sheet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arrangements as defined in the rules and regulations of the SEC.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Quantitative and qualitative disclosures about market risks<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest rate risk<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 444.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; white-space: pre;">, we had cash and cash equivalents of $51.4&#160;million. Our cash and cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalents are held for working capital purposes. We do not enter into investments for trading or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">speculative purposes. Due to the short-term nature of our cash equivalents, we have not been exposed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to, nor do we anticipate being exposed to, material risks due to changes in interest rates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our exposures to market risk for changes in interest rates relate primarily to our 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(described above) which bears floating interest rates and a rising interest rate environment will increase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the amount of interest paid on these loans. Each 100 basis point increase in these initial rates would <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase annual interest expense by approximately $1.2&#160;million assuming the 2024 Term Loan remain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding for the annual period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Credit risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our cash and cash equivalents, which at times may exceed federally insured limits, is maintained with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">large financial institutions. As of the issuance date of the financial statements included in this report, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have not experienced any losses on our deposits and all of our cash deposits have been accessible to us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our accounts receivable primarily relate to revenue from the sale of our products to medical providers.&#160;No <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer represented 10% or more of our accounts receivable as of December 31, 2023 and 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency exchange risk<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The vast majority of our cash generated from revenue is denominated in U.S. dollars, with a small amount <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">denominated in&#160;other foreign currencies. Our expenses are generally denominated in the currencies of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the jurisdictions in which we conduct our operations, which are primarily in the United States, United <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">97<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Kingdom&#160;and&#160;Japan. Our results of operations and cash flows are, therefore, subject to fluctuations due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes in foreign currency exchange rates. The effect of a hypothetical 10% change in foreign currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange rates applicable to our business would not have had a material impact on our consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statements during the year ended December 31, 2024. As the impact of foreign currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchange rates has not been material to our historical operating results, we have not entered into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative or hedging transactions, but we may do so in the future if our exposure to foreign currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">becomes more significant.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Effects of inflation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inflation generally affects us by increasing our cost of labor and overhead costs. We do not believe that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inflation has had a material impact on our business, results of operations, or financial condition, or on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements included elsewhere in this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Emerging growth company status<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are an &#8220;emerging growth company&#8221; under the JOBS Act, which permits us to take advantage of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extended transition period to comply with new or revised accounting standards applicable to public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies. We have elected to use this extended transition period until we are no longer an emerging <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth company or until we affirmatively and irrevocably opt out of the extended transition period. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, our consolidated financial statements may not be comparable to companies that comply with new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or revised accounting pronouncements applicable to public companies. The JOBS Act also exempts us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from having to provide an attestation and report from our independent registered public accounting firm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2002.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We will remain an emerging growth company until the earliest of&#58; (i) the last day of the fiscal year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following the fifth anniversary of the completion of this offering&#59; (ii) the last day of the fiscal year in which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we have total annual gross revenue of at least $1.235 billion&#59; (iii) the last day of the fiscal year in which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the Exchange Act, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the last business day of the second fiscal quarter of such year&#59; or (iv) the date on which we have issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more than $1.0 billion in non-convertible debt securities during the prior three-year period.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">98<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1189" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Business <font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 129.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 141.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">invasive solution for diagnosing and managing coronary artery disease<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.25pt; position: absolute; white-space: pre;"> (&#8220;CAD&#8221;), a leading cause of death <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 153.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">worldwide. As of December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.76pt; position: absolute; text-decoration: none; white-space: pre;">, our Heartflow Platform has been used to assess CAD in more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 165.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">400,000 patients, including 132,000 in 2024 alone. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.13pt; position: absolute; white-space: pre;">We believe that we are the most widely adopted AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 177.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered test for CAD. Our novel platform leverages <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.6pt; position: absolute; text-decoration: none; white-space: pre;">AI<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.03pt; position: absolute; white-space: pre;"> and advanced computational fluid dynamics to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 189.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized 3D model of a patient&#8217;s heart from a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 201.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;), a specialized type of scan that provides detailed images of the heart&#8217;s arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 213.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 225.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition thereby overcoming the limitations of traditional non-invasive imaging tests which rely on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 237.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures of coronary disease and lead to higher false negative and false positive rates, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 249.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated by our PRECISE trial. We believe the differentiated accuracy and clinical utility of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 261.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, along with its ability to enhance workflows, will continue to support our growth <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 504.63pt; position: absolute; text-decoration: none; white-space: pre;">and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 273.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">advance the &#8220;CCTA + Heartflow&#8221; pathway<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 255.38pt; position: absolute; white-space: pre;"> as the definitive standard for the non-invasive diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 285.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally. In the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alone, the Centers for Disease Control (&#8220;CDC&#8221;) estimates that approximately 805,000 people suffer a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">heart attack each year. Despite significant advancements in therapeutic and interventional treatments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD remains a leading cause of death globally because healthcare systems generally lack scalable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methods to efficiently detect, diagnose and quantify CAD at a personalized level. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 409.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on our analyses using Clarivate&#8217;s ProcedureFinder data repository, we estimate that there were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 9.5 million non-invasive tests (&#8220;NITs&#8221;) in the United States in 2023 for patients experiencing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stable or acute chest pain, which we refer to as symptomatic CAD patients. These NITs primarily include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress tests, such as single-photon emission computed tomography (&#8220;SPECT&#8221;), echocardiography and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positron emission tomography (&#8220;PET&#8221;), which infer the presence of heart disease based on how well <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood is supplied to the heart, and do not measure the actual disease itself. Accordingly, these tests have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been shown to be unreliable and inconsistent. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA has emerged as a leading non-invasive imaging method for evaluating CAD, offering direct and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">detailed visualization of the coronary arteries. Unlike traditional stress-based NITs, CCTA enables <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physicians to identify the presence and extent of coronary blockage. As a result, CCTA has become the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred first-line test for patients with suspected CAD, as evidenced by the AHA and ACC guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elevating CCTA to Class 1, Level A. However, while CCTA provides superior anatomical imaging, it does <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not independently quantify the severity of CAD, assess blood flow limitations, or characterize plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition&#8212;critical factors for determining the most appropriate, personalized course of treatment for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform builds upon the well established strengths of CCTA by going beyond its limitations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and providing new quantified insights and compelling visualizations of data. By applying our advanced AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">powered technology to a single CCTA scan, we generate a precise, patient-specific analysis that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quantifies blood flow, measures plaque burden, and characterizes plaque composition&#8212;at every point in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the major coronary arteries. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.44pt; position: absolute; text-decoration: none; white-space: pre;">99<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To date, we have developed three software products under the Heartflow Platform that provide physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the critical insights needed to effectively diagnose and manage CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.32pt; position: absolute; text-decoration: none; white-space: pre;"> offers a highly intuitive anatomic visualization of the coronary arteries, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">helping physicians quickly identify clinically relevant areas to focus their review.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 163.06pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.05pt; position: absolute; text-decoration: none; white-space: pre;"> calculates blood flow and pinpoints clinically significant CAD, which is CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with a f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.64pt; position: absolute; white-space: pre;">ractional flow reserve (&#8220;FFR&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.58pt; position: absolute; text-decoration: none; white-space: pre;"> value of 0.80 or below, at every point in the major coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">arteries. FFR measures the severity of blood flow restriction in the coronary arteries on a scale of 1.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(no restriction) to 0.0 (complete blockage) by assessing pressure differences across a stenosis during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">induced stress, guiding decisions on whether a patient requires invasive revascularization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.09pt; position: absolute; text-decoration: none; white-space: pre;"> provides a comprehensive assessment of coronary plaque, enabling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimized medical treatment strategies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe we are the first and most widely-adopted AI-powered test for CAD. With over a decade of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial presence, we have established a competitively differentiated data set of over 100 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">annotated images, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 157pt; position: absolute; text-decoration: none; white-space: pre;">which is <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.32pt; position: absolute; white-space: pre;">primarily sourced from our commercial relationships with customers, driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">training and refinement of our algorithms for over 10 years and the ability to train new AI models for future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe our Heartflow Platform delivers the following key benefits&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 282.68pt; position: absolute; text-decoration: none; white-space: pre;">, clinically validated to provide superior assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">blood flow, plaque volume and plaque characterization compared to traditional non-invasive methods. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments, personalized care, and better risk stratification<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 452.03pt; position: absolute; text-decoration: none; white-space: pre;">, positively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">impacting physician decisions on which patients should receive an intervention, supporting more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficient intervention planning and driving more personalized medical management.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency and enhanced interventional treatment planning<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 460.25pt; position: absolute; text-decoration: none; white-space: pre;">, accurately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifying more patients who need interventional treatment while reducing unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures&#8212;significantly improving the efficiency of the catheterization lab and therefore hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">economics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Proprietary, secure bi-directional data communication with customers <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 425.31pt; position: absolute; text-decoration: none; white-space: pre;">that feeds a growing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">database of over 100 million annotated CCTA images that we leverage to improve the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Platform&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.01pt; position: absolute; text-decoration: none; white-space: pre;">accuracy, automation and clinical utility and seamlessly deliver new features and workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficiencies to our customers. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.03pt; position: absolute; text-decoration: none; white-space: pre;"> through our Heartflow RoadMap Analysis that, as demonstrated in our SMART-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CT study, reduces CCTA interpretation times by approximately 25% and reduces variability between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviewing physicians by approximately 40%, leading to more consistent diagnoses and standardized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patient care. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 272.66999999999996pt; position: absolute; text-decoration: none; white-space: pre;">, by leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in approximately 20 minutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. By providing a definitive diagnosis upfront, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform eliminates the need for layered testing, streamlining the patient journey and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reducing anxiety associated with uncertain or inconclusive results.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.65pt; position: absolute; text-decoration: none; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.65pt; position: absolute; white-space: pre;">9.5 million unique stable chest pain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients receive NITs in the United States annually. In addition, based on our FORECAST randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trial, we further estimate that 33% of patients have stenosis levels between 40% and 90%, which results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in approximately 2.8 million patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 363.02pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.68pt; position: absolute; white-space: pre;"> Analysis in the stable setting. Based <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">100<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the Martin paper, where there were approximately 577,000 hospital discharges in the United States in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020 due to a principal diagnosis of acute chest pain, and the Bhatt paper, where No ST Elevation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;NSTE&#8221;) related acute chest pain accounted for approximately 70% of acute chest pain, we further <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that the annual incidence of patients who have acute chest pain with NSTE is approximately 0.4 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million patients. Of these approximately 0.4 million patients, we estimate based on the Kofoed paper that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 70% have obstructive disease and are eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 439.17pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.83pt; position: absolute; white-space: pre;"> Analysis, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">results in approximately 0.3 million acute chest pain patients eligible for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 470.78pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.44pt; position: absolute; white-space: pre;"> Analysis. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Therefore, we believe there is a market opportunity of approximately 3.1 million patients eligible for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis, which, at a U.S. average sales price of $1,067, translates to an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market opportunity of approximately $3.3 billion in the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we believe our Heartflow Plaque Analysis is applicable to approximately 60% of those 9.5 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million NIT patients annually and the majority of patients experiencing acute chest pain. Based on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PROMISE trial and the Hoffmann paper, we estimate that approximately 60% of CCTA patients have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque and are eligible for plaque analysis, which translates to approximately 5.1 million patients eligible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our Heartflow Plaque Analysis in a stable setting. Based on our internal analysis and the findings in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Wang paper, where less than 5% of patients were expected to be contraindicated for CCTA, we also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate that all of the approximately 0.4 million patients with acute chest pain with NSTE referred to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above will be eligible for our Heartflow Plaque Analysis. Therefore, we believe there is a market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunity of approximately 5.5 million patients eligible for our Heartflow Plaque Analysis, which, at an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated U.S. sales price of $300, translates to an estimated market opportunity of approximately an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incremental $1.7 billion in the United States. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Beyond the commercialization of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 283.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.26pt; position: absolute; white-space: pre;"> Analysis and Heartflow Plaque Analysis in symptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, we see a significant market opportunity for our technologies in at-risk individuals who show no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptoms, a segment comprised of approximately 200 million people globally, based on data from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Census Bureau, CDC, Eurostat, United Kingdom Office of National Statistics, the Yang paper and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the MacDonald paper. To unlock this potential, we are continuing to evaluate new product opportunities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and appropriate clinical evidence supporting eventual regulatory approval, payor coverage and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercialization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the Heartflow Platform is the most extensively studied AI-enabled test for CAD. Our belief is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">grounded in our analysis, including that the Heartflow Platform and its accuracy, clinical utility and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic benefits have been evaluated in over 100 clinical studies and more than 130,000 patients, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including our PRECISE and FORECAST trials, each a large randomized controlled trial, with results <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">published in over 600 peer-reviewed clinical publications. Our studies, including the PRECISE, NXT and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PACIFIC trials, have consistently demonstrated that the Heartflow Platform is more accurate than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">traditional non-invasive tests and highly concordant to invasive testing, reduces unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">testing, and enables physicians to optimize treatment and ultimately provide more efficient care.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have developed a highly scalable, capital efficient commercial model that combines Territory Sales <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Managers (&#8220;TSMs&#8221;) who drive new account adoption with Territory Account Managers (&#8220;TAMs&#8221;) who focus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on increasing utilization by educating referring physicians. Our commercial team does not cover cases or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise spend time in an operating room or lab setting, which enables them to focus solely on driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial adoption and educational activities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our technology is simple and intuitive and does not require the purchase of any capital equipment. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">onboarding process seamlessly integrates the Heartflow Platform into the customer&#8217;s daily workflow. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These unique attributes of our business model afford our commercial organization a differentiated level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency and scalability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current clinical guidelines strongly support the adoption of the Heartflow Platform. The CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis pathway is supported by the American Heart Association (&#8220;AHA&#8221;) and American College of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiology (&#8220;ACC&#8221;) guidelines, with CCTA identified as a Class 1, Level A test and Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 500.55pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis identified as a Class 2a, Level B test for the diagnosis of CAD in certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acute chest pain and no known CAD. The AHA and ACC guidelines utilize Classes and Levels to indicate <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">101<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strength of a recommendation and the quality of supporting evidence, respectively. Class 1 represents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the strongest recommendation, followed by Class 2a, which represents a moderate recommendation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, Level A signifies the highest quality of evidence, while Level B indicates moderate quality.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe current reimbursement policies support the adoption of the Heartflow Platform. Our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis is reimbursed under a dedicated Category 1 Current Procedural Terminology (&#8220;CPT&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">code, effective as of January 1, 2024, and has established coverage policies representing approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">99% of covered lives in the United States. A Category 1 CPT code was also recently established for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis, which will take effect in January 2026, and it is covered by all seven Medicare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative contractor (&#8220;MACs&#8221;). A Category 1 CPT code designates a procedure or service that has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received Food and Drug Administration (&#8220;FDA&#8221;) clearance, is frequently performed by physicians across <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States for its intended clinical use, aligns with current medical practice, and has documented <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficacy in literature. The established Category 1 CPT code for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 431.32pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 439.98pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis validates its widespread use and distinguishes it from emerging technologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that are assigned a Category 3 CPT code.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We primarily generate revenue on a &#8220;pay per click&#8221; basis each time a physician chooses to review either <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 134.2pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 153.62pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.28pt; position: absolute; white-space: pre;"> Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.26pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.24pt; position: absolute; white-space: pre;">Plaque Analysis, or both. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 364.99pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.97pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 429.39pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 438.05pt; position: absolute; white-space: pre;"> Analysis has served <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as our commercial foundation, representing 98% of our total revenue as of December 31,&#160; 2024. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">second half of 2023, we initiated limited market education efforts for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.4pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.61pt; position: absolute; white-space: pre;"> Plaque Analysis, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">second commercial product. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 219.2pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.18pt; position: absolute; white-space: pre;">RoadMap Analysis is generally provided as a workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency tool to drive customer retention and loyalty and is not a stand-alone product. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have experienced significant revenue growth since we began commercializing the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in 2015. We recognized revenue of $125.8&#160;million for the year ended December 31, 2024, compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue of $87.2 million for the year ended December 31, 2023, representing&#160;44% year-over-year growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The software-based nature of our Heartflow Platform produces an attractive gross margin profile, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continues to expand as we leverage AI to automate an increasing portion of our &#8220;human-in-the loop&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality control process, where learnings are fed back into our algorithms to make them smarter and more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficient. For the twelve months ended December 31, 2024, we generated gross margins of&#160;75%, an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increase of&#160;8&#160;percentage points year-over-year from December 31, 2023. Our net losses were $95.7 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million and $96.4&#160;million for the years ended December 31, 2023 and 2024, respectively. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accumulated deficit was $874.5 million and $971.0 million as of December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our success factors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the continued growth of our company will primarily be driven by the following suc<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.53pt; position: absolute; text-decoration: none; white-space: pre;">cess factors&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Differentiated approach to the non-invasive diagnosis and management of CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.25pt; position: absolute; text-decoration: none; white-space: pre;"> We are the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">first medical technology company authorized for marketing in the United States to leverage software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and AI to accurately and non-invasively diagnose and manage CAD using a single CCTA. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024, our Heartflow Platform has been used to assess CAD in more than 400,000 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients, including 132,000 in 2024 alone. Our Heartflow Platform applies AI and advanced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">computational fluid dynamics to generate a personalized 3D model of a patient&#8217;s heart, delivering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">actionable data on blood flow, stenosis, plaque volume and plaque composition. This enables <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians to diagnose CAD, assess risk and develop individualized care plans without requiring an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">invasive procedure. Unlike traditional NITs that use surrogate measures to diagnose heart disease, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which results in higher rates of false negatives and false positives, as demonstrated by our PRECISE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">trial, the Heartflow Platform measures and quantifies the actual disease and has been proven to more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accurately diagnose CAD. Our proprietary database of more than 100 million annotated CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">images, which is <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.09pt; position: absolute; white-space: pre;">primarily sourced from our commercial relationships with customers and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.59pt; position: absolute; text-decoration: none; white-space: pre;">growing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">daily, has fueled ongoing AI-driven algorithm refinement for over a decade&#8212;enhancing our platform&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">value for patients, physicians, and payors. Our<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.52pt; position: absolute; white-space: pre;"> standard commercial agreements provide us with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">right to use submitted images for product support and development. We perform regular updates and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">upgrades to the Heartflow Platform and don&#8217;t charge customers for the rollout of those <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">102<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">enhancements. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.12pt; position: absolute; text-decoration: none; white-space: pre;">We believe the unique software technology attributes of our Heartflow Platform will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continue to support our commercial presence and help us establish the CCTA + Heartflow pathway as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the standard of care for the non-invasive diagnosis and management of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Market leader in AI-powered quantitative CAD analysis with strong customer relationships&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 521.35pt; position: absolute; text-decoration: none; white-space: pre;"> We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">believe our Heartflow Platform is the most widely adopted AI-powered test for CAD, to date, with an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">installed base of more than 1,100 accounts in the United States as of December 31, 2024, reflecting a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAGR of 44% from December 31, 2021, including leading academic institutions, integrated delivery <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">networks, physician offices and outpatient imaging centers. Our value proposition resonates across <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">multiple subspecialties, including radiology, cardiology, and interventional cardiology. Our deep <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">integration into customer workflows and IT infrastructure, including electronic medical record systems, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensures seamless utilization and efficiency. We believe our long-standing customer relationships, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continuously improving AI-powered software and the highly embedded nature of our customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">integrations will continue to support the rapid adoption of our Platform. Additionally, as we expand our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">AI capabilities, introduce new applications such as Heartflow Plaque Analysis, and further optimize <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">workflow integration, we expect our Platform&#8217;s value proposition to grow&#8212;deepening customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reliance on our solutions and accelerating broader market penetration.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Attractive revenue model with significant operating leverage potential&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.19pt; position: absolute; text-decoration: none; white-space: pre;"> We primarily generate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revenue on a scalable &#8220;pay per click&#8221; model, in which we charge per physician review of our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, Heartflow Plaque Analysis, or both. Utilization rates for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 470.7pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.36pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">typically scale rapidly after onboarding, approaching approximately 33% of eligible CCTA tests within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an account&#8212;a level that is generally sustained over time. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.52pt; position: absolute; white-space: pre;">Utilization rates for an account are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">calculated as the number of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 279.94pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.6pt; position: absolute; white-space: pre;"> Analysis ordered divided by the total number of CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">tests performed at an account. Our TAMs measure this utilization rate in the first twelve months <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">following the onboarding of a new account to ensure onboarding was successful. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.89pt; position: absolute; text-decoration: none; white-space: pre;">As CCTA + <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow referral volumes increase, these stable utilization rates translate into increasing Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revenue cases.These aspects of our revenue model afford us significant predictability and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">consistency. Additionally, the AI-based nature of our software platform produces an attractive gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">margin profile that has improved over time as we have leveraged AI to automate an increasing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">number of the manual components of our &#8220;human-in-the loop&#8221; quality control process thereby <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">lowering the cost of revenue per analysis. For the twelve months ended December 31, 2024, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">generated gross margins of&#160;75%, an increase of&#160;8% year-over-year from December 31, 2023. Given <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our established relationships and bi-directional data sharing infrastructure with customers, we also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">have the opportunity to add and rapidly scale revenue streams from new software products or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">indications, such as Heartflow Plaque Analysis, with minimal additional setup and installation cost and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">effort for our customers. Since Heartflow Plaque Analysis runs on the same CCTA scan as Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, we expect favorable operating and gross margin leverage as its adoption increases. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We have also developed a highly scalable enterprise commercial model that combines TSMs who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">focus on driving new account adoption with TAMs who educate referring physicians and drive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">increased volumes at accounts in our installed base. Unlike traditional medical technology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">companies, our software is fully cloud-based, simple to implement, and does not require case <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">coverage or on-site support. This streamlined, capital-light model enables us to scale efficiently while <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">maintaining a lean commercial footprint. We believe these structural advantages will enable us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continue investing in growth while advancing towards profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Large addressable market opportunity with a significant unmet need&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 418.07pt; position: absolute; text-decoration: none; white-space: pre;"> CAD is a leading cause of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">death and a highly prevalent condition worldwide with well-established pathways for diagnosis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">primarily through NITs. In the United States alone, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.25pt; position: absolute; white-space: pre;">based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.22pt; position: absolute; text-decoration: none; white-space: pre;">approximately 9.5 million NITs were performed for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">diagnosis of CAD in 2023. However, the majority of these tests measure only surrogate markers for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD and are therefore often inaccurate leading to missed diagnosis or unnecessary invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures. By contrast, CCTA imaging combined with our Heartflow Platform provides a more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accurate and actionable NIT for CAD, driving rapid adoption. We believe this approach will ultimately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">become the standard of care. Accordingly, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 278.68pt; position: absolute; white-space: pre;">based on our FORECAST randomized trial, our PROMISE <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">103<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">trial, the Wang paper and the Hoffman paper, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.18pt; position: absolute; text-decoration: none; white-space: pre;">we believe our market opportunity represents the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155pt; position: absolute; text-decoration: none; white-space: pre;">8.6 million patients non-invasively tested for CAD in 2023 that are indicated for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis and Heartflow Plaque Analysis products based on their stenosis and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">levels, respectively, representing a market value of approximately $5&#160;billion in the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">alone. While we have rapidly scaled the adoption of our Heartflow Platform to achieve $125.8&#160;million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of revenue in 2024, we believe the Heartflow Platform analyzed only approximately 10% of U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA volumes and represented less than 1% of all NITs in 2023, highlighting a substantial runway for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">growth. Looking ahead, we see the potential to expand both our geographic footprint and clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications. Beyond symptomatic CAD, we believe our technology can play a pivotal role in risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stratification and preventive therapy optimization for the approximately 200 million asymptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">individuals globally considered high risk for a cardiac event, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.54pt; position: absolute; white-space: pre;">based on data from the U.S. Census <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Bureau, CDC, Eurostat, United Kingdom Office of National Statistics, the Yang paper and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">MacDonald paper<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.36pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Robust and compelling portfolio of clinical evidence&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.39pt; position: absolute; text-decoration: none; white-space: pre;"> We believe the Heartflow Platform is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">most extensively studied AI-enabled test for CAD. Our belief is grounded on our analyses, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 489.36pt; position: absolute; white-space: pre;">including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">that the Heartflow Platform and its <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 243.25pt; position: absolute; text-decoration: none; white-space: pre;">accuracy, clinical utility and economic benefits have been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluated in over 100 clinical studies and more than 130,000 patients, including our PRECISE and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FORECAST trials, each a large randomized controlled trial, with results published in over 600 peer-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviewed clinical publications. Our studies, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.52pt; position: absolute; white-space: pre;">including the PRECISE, NXT and PACIFIC trials,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 496.12pt; position: absolute; text-decoration: none; white-space: pre;"> have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">consistently demonstrated that the Heartflow Platform is more accurate than traditional non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tests and highly concordant to invasive testing, reduces unnecessary invasive testing, and enables <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians to optimize treatment and ultimately provide more efficient care. As a result, the clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evidence demonstrates that the Heartflow Platform reduces unnecessary invasive testing, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">enables physicians to make more informed revascularization decisions, delivering more efficient, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cost-effective care. For example, our PRECISE randomized controlled trial showed that our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.77pt; position: absolute; text-decoration: none; white-space: pre;">Analysis was 78% more likely than traditional testing to identify patients in need of intervention <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and 69% less likely to progress patients to unnecessary invasive testing, leading to 2x the yield of ICA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">leading to revascularization such as percutaneous coronary intervention (&#8220;PCI&#8221;) or coronary artery <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">bypass grafting (&#8220;CABG&#8221;), compared to standard care. This reduction in unnecessary diagnostic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedures and higher rate of revascularization procedures represents a clinical benefit for patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and significant economic benefit for providers. We believe that our extensive body of clinical evidence <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">will drive continued adoption, and we expect to continue to invest in evidence generation that will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expand the applicability of our Heartflow Platform into new indications. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Established reimbursement coverage and favorable society support&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.92pt; position: absolute; text-decoration: none; white-space: pre;"> Our rapid growth is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">underpinned by a favorable reimbursement landscape and strong clinical guidelines that drive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adoption of the Heartflow Platform. Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 330.43pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 340.78pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is reimbursed under a dedicated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Category 1 CPT code, effective as of January 1, 2024, and has established coverage policies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">encompassing approximately 99% of covered lives in the United States. In addition, a Category 1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CPT code was also recently established for our Heartflow Plaque Analysis, set to take effect in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">January 2026. Heartflow Plaque Analysis is already covered by all seven local MAC regions, with five <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of the seven MACs issuing final local coverage determinations (&#8220;LCD&#8221;). We expect to leverage our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">experience in establishing commercial policies for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 376.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.96pt; position: absolute; text-decoration: none; white-space: pre;">Analysis to efficiently establish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">commercial coverage for our Heartflow Plaque Analysis. In addition, CCTA combined with our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is supported by the AHA and ACC guidelines, with CCTA a Class 1, Level A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">test and FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 147.74pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.09pt; position: absolute; text-decoration: none; white-space: pre;">a Class 2a, Level B test for the diagnosis of CAD in <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 387.44pt; position: absolute; white-space: pre;">certain patients with stable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">acute chest pain and no known CAD<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.66pt; position: absolute; text-decoration: none; white-space: pre;">. We believe our favorable reimbursement and society support <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provides a strong foundation and tailwind for our continued growth. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Unique and scalable AI, data and R&#38;D capabilities&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.90999999999997pt; position: absolute; text-decoration: none; white-space: pre;"> We designed our AI-powered software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">platform to be high quality, highly scalable, integrate seamlessly with physician workflows and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improve as we ingest more data, and leverage that data to improve our algorithms&#8217; performance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our business efficiency. Our proprietary technology stack includes secure data transfer software, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">scalable cloud database, a web and mobile interface, quality review tools and an AI algorithm pipeline <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">104<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that delivers diagnostic accuracy, utility, workflow efficiency, and operational scalability. By harnessing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">AI to process massive volumes of cases while maintaining a &#8220;human-in-the loop&#8221; quality control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">process, where learnings are fed back into our algorithms to improve their performance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficiency, we have been able to rapidly grow our platform while delivering accurate, timely results for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians and patients. We have also built a substantial and growing data asset that has driven <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ongoing refinement of our algorithms for more than 10 years with over 100 million annotated CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">images. Additionally, our bi-directional data sharing relationship with our customers enables us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deliver even greater value by ensuring they benefit from ongoing feature additions, workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">enhancements and performance improvements. Unlike traditional CAD diagnostic tools, our AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">platform can be updated with improved features, better performance and can improve from one of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">largest CCTA datasets globally, creating a competitive advantage that continues to grow over time. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">We believe our differentiated AI, data and R&#38;D capabilities and proven dedication to improvement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensures that Heartflow remains at the forefront of precision coronary care. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Experienced leadership team&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.6pt; position: absolute; text-decoration: none; white-space: pre;"> Our senior management team consists of seasoned executives with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deep industry expertise across various disciplines, including biomedical and software engineering, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clinical evidence, medical technology and medical imaging, AI, data science and sales and marketing. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">With backgrounds at leading medical technology companies, our leadership has a proven track <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">record of scaling businesses, securing market adoption and driving innovation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The convergence of AI advancements, cutting-edge imaging technologies, and broad-based guideline <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adoption is accelerating a shift toward more precise, personalized approaches to cardiovascular care. By <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integrating anatomical and physiological insights, our technology enables physicians to tailor therapies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more effectively, optimizing treatment decisions and improving patient outcomes. With Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 518.1600000000001pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.8199999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis reimbursement firmly established, growing physician acceptance, and a proven track record of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">real-world impact, Heartflow is well-positioned to lead the transformation of coronary care on a global <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scale.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our growth strategies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the following strategies will play a critical role in our continued growth&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Expand adoption of our Heartflow Platform by new accounts&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.27pt; position: absolute; text-decoration: none; white-space: pre;"> We believe that all accounts with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an active CCTA program would benefit from adopting the Heartflow Platform into their workflow in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">order to improve efficiency and patient care. We estimate that as of December 31, 2023, there were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">approximately 2,700 hospitals and outpatient facilities in the United States that perform CCTA, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this target account base has grown at a 10% CAGR from 2018 to 2023, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.26pt; position: absolute; white-space: pre;">based on our analyses using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">Clarivate&#8217;s ProcedureFinder data repository<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.84000000000003pt; position: absolute; text-decoration: none; white-space: pre;">. As of December 31, 2024, we have successfully <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deployed our Heartflow Platform in more than 1,100 accounts in the United States. Our TSMs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">responsible for acquiring new accounts. Our TSMs engage with physicians to communicate the value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">proposition of the Heartflow Platform, leveraging our large base of clinical evidence to extoll its clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and economic benefits. Once onboarded, providers typically reach utilization rates approaching 33% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of CCTAs eligible for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 248.05pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.4pt; position: absolute; text-decoration: none; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.62pt; position: absolute; text-decoration: none; white-space: pre;">. Unlike traditional sales models, our TSMs are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">required to support case coverage or ongoing account maintenance, allowing them to focus on new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">account acquisition efficiently. We intend to drive further adoption by leveraging our existing 40 TSMs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">as of December 31, 2024, while selectively expanding our team to capture additional geographic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">opportunities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Broaden awareness of the CCTA + Heartflow pathway to drive volume at existing accounts&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 523.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">While we have achieved significant commercial adoption to date, including 132<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.76pt; position: absolute; text-decoration: none; white-space: pre;">,000 patients <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.75pt; position: absolute; text-decoration: none; white-space: pre;">on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Platform in 2024 alone, we believe this represented less than 1% of our overall market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">opportunity of 9.5 million total NITs, and approximately 10%, of current U.S. CCTA volumes. To <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expand adoption, we are actively educating physicians on the AHA and ACC chest pain guidelines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that support CCTA plus Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 259.73pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 268.39pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis as the preferred pathway for diagnosis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">management of CAD. Our commercial team includes TAMs who are responsible for educating the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cardiologists who refer patients to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.63pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">accounts in ou</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.08000000000004pt; position: absolute; text-decoration: none; white-space: pre;">r installed base and driving increasing Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">105<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Platform volumes. These TAMs utilize our extensive clinical compendium to educate and train <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians on the benefits of our platform. Similar to our TSMs, our TAM model is highly efficient and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">scalable. We also invest in robust medical education, including peer-to-peer discussions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">symposiums, podium presentations, and other educational events. These initiatives, combined with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">strong society support, our leading field presence, and continued technology investment, contribute to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the expansion of both the CCTA market and the CCTA + Heartflow pathway.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Launch and drive adoption of our Heartflow Plaque Analysis product&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.66pt; position: absolute; text-decoration: none; white-space: pre;"> We initiated l<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 479.44pt; position: absolute; text-decoration: none; white-space: pre;">imited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.1pt; position: absolute; text-decoration: none; white-space: pre;"> market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">education efforts for our second product, Heartflow Plaque Analysis, in the second half of 2023. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">believe there is broad recognition among the cardiology physician community of the importance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quantifying and characterizing plaque composition as a key indicator of cardiovascular risk. Existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clinical trials have demonstrated plaque volume and plaque composition correlate with heart attack <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">risk. There are also multiple pharmaceutical therapies that have proven to slow or halt plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">progression and reduce the risk of cardiovascular events. However, current non-invasive risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">assessment methods are often inadequate due to their reliance on manual, time-consuming, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">largely visual assessments, leaving physicians with limited actionable data for prescribing optimal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">therapies. Our Heartflow Plaque Analysis fills this critical gap in care by enabling rapid and precise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quantification of plaque volume and composition at the vessel and patient level, down to the cubic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">millimeter. We believe that broad commercial reimbursement coverage will be important for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">widespread adoption of Heartflow Plaque Analysis and are working to secure coverage. In 2024, CMS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">assigned Heartflow Plaque Analysis a Category 1 CPT Code, which will be effective as of January <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2026, and as of December 2024, Heartflow Plaque Analysis is covered by all MACs. We intend to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">leverage our learnings from the successful reimbursement coverage expansion and commercial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">launch of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 197.73000000000002pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 208.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Analysis to drive commercial coverage and adoption of Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis. Since Heartflow Plaque Analysis runs on the same CCTA scan as Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 489.13pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 497.79pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis, we expect favorable operating and gross margin leverage as its adoption increases.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Invest in additional clinical evidence to support adoption and expand our indications&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.66pt; position: absolute; text-decoration: none; white-space: pre;"> We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">believe we have developed the largest clinical evidence base supporting a non-invasive AI-powered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">diagnostic for CAD and that our extensive evidence demonstrates the superior accuracy, clinical utility <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and economic benefits of our Heartflow Platform relative to other non-invasive methods. We expect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continue to invest in clinical evidence to extend our leadership position. For example, we are currently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conducting the DECIDE registry, a 20,000-patient study which aims to demonstrate how Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis impacts physician decision-making. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 322.77pt; position: absolute; text-decoration: none; white-space: pre;">Beyond the commercialization of Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and Heartflow Plaque Analysis in symptomatic CAD, we see a significant market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">opportunity for our technologies in at-risk individuals who show no symptoms, a segment comprised <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of approximately 200 million people globally, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.14pt; position: absolute; text-decoration: none; white-space: pre;">based on data from the U.S. Census Bureau, CDC, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Eurostat, United Kingdom Office of National Statistics, the Yang paper and the MacDonald paper<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 516.02pt; position: absolute; text-decoration: none; white-space: pre;">. To <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unlock this potential, we are continuing to evaluate new product opportunities and appropriate clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evidence supporting eventual regulatory approval, payor coverage and commercialization. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Extend our technology leadership through continued investment in our platform<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 470.71pt; position: absolute; text-decoration: none; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.04pt; position: absolute; text-decoration: none; white-space: pre;"> Our ongoing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">research and development initiatives are focused on introducing products, features and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improvements to maximize customer value. We prioritize advancements in four key areas including&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">improving our algorithms by leveraging extensive clinical data to improve accuracy and efficiency&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">optimizing clinical utility to better support physicians in diagnosis, patient management, and treatment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">planning&#59; enhancing ease of use through seamless workflow integration to improve operational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">efficiency&#59; and expanding our platform&#8217;s applications to serve a broader patient population. By <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">executing on these priorities, we aim to deepen engagement with existing customers, attract new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ones, and further solidify our leadership in AI-driven cardiovascular diagnostics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Leverage our platform to pursue adjacent and international markets&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.77pt; position: absolute; text-decoration: none; white-space: pre;"> We believe our installed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">base and deeply integrated <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.35pt; position: absolute; white-space: pre;">platform technology approach allows us to add on new analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">insights within the same product experience<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.88pt; position: absolute; text-decoration: none; white-space: pre;">. Our relationships with referring and imaging physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provide us with insights into unmet clinical and workflow needs, while our extensive database of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">106<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA images and AI capabilities enable us to develop and integrate new algorithm-based solutions. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Additionally, while our current commercial focus is on the U.S. market, we have an existing presence <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the United Kingdom, European Union, Australia, Canada and Japan. In the future we may choose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to selectively expand our geographic footprint by strengthening our presence in existing international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">markets, entering new international markets, or exploring adjacent market opportunities in the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and abroad.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Market overview and opportunity<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Overview of CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular disease is the leading cause of death worldwide, with CAD being the most lethal form. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD occurs when plaque&#8212;a buildup of cholesterol, fat, calcium and other substances&#8212;accumulates on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the walls of the coronary arteries, restricting blood flow and increasing the risk of heart attack or stroke. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This condition is responsible for half of all cardiovascular-related deaths globally. Key risk factors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including high cholesterol, hypertension, smoking, diabetes, obesity, physical inactivity, and genetic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predisposition, accelerate plaque formation and destabilization. In the United States alone, the CDC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates that approximately 805,000 people suffer a heart attack each year<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.9pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.26pt; position: absolute; white-space: pre;">T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 419.36pt; position: absolute; text-decoration: none; white-space: pre;">he CDC estimates that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 1 in 20 adults over the age of 20 have CAD, which is approximately 12.5 million individuals <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">with CAD in the United States. The CDC also estimates that CAD killed 371,506 people in 2022. Given its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">morbidity and mortality, CAD places a significant cost burden on the healthcare system and is projected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">reach $215 billion by 2035.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD is caused by the build-up of calcified and non-calcified plaque in the coronary arteries.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.29pt; position: absolute; text-decoration: none; white-space: pre;"> This plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">build-up results in a narrowing of the arteries, or stenosis, which may require an intervention<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.04pt; position: absolute; white-space: pre;"> if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduction in blood flow caused by the stenosis is determined to be clinically significant. Effectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnosing CAD in order to inform the optimal treatment pathway requires a measurement of the blood <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">flow through the stenosis as well as quantifying the amount and type of plaque causing the stenosis. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, the foundational FAME 1 and FAME 2 randomized controlled trials showed that deferring <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention is superior when blood flow, as measured by FFR, was greater than 0.80 but that when FFR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was below this same level, intervention was superior to optimal medical therapy. Similarly, a follow-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analysis to the foundational SCOT-HEART trial showed that plaque volumes greater than 238 mm<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 503.77pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">3<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 507.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resulted in a 7x greater risk of heart attack than lower plaque volumes and higher concentrations of low-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attenuation plaque burden were associated with a nearly 5x greater risk of heart attack. This is due to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unstable nature of low-attenuation plaque, which can result in a higher risk of rupture leading to occlusion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of coronary blood flow. Based on these trials, the cardiology community has recognized the importance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurately measuring FFR values and characterizing plaque, and has supported this perspective with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical guidelines that stratify treatment recommendations based on FFR values and plaque metrics.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Traditional methods for the non-invasive diagnosis of CAD and their limitations<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When patients present with symptoms of CAD, such as chest pain, they are typically referred for a NIT. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are two primary types of NITs&#58; stress-based tests, which measure surrogate markers for CAD to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">infer the presence of heart disease based on blood perfusion, or CCTA which directly images the patient&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary arteries. Based on the output of a patient&#8217;s NIT, the imaging physician and managing physician <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine the appropriate next step which can include sending the patient home with only lifestyle <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modifications if the disease is not determined to be significant, initiating pharmaceutical therapy if there is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumed plaque burden without significant stenosis, or sending the patient to catheterization lab for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention if there is significant stenosis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When appropriately diagnosed and managed, CAD can be effectively treated with well-established <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">therapeutics and devices. These therapeutics, which include statins, PCSK-9s and GLP-1s, among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">others, have been proven to effectively manage CAD by reducing plaque progression, changing plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition, and reducing the risks of a major adverse cardiovascular event. Similarly, when indicated, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedures to open the arteries, including percutaneous coronary intervention with intravascular <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">107<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lithotripsy, atherectomy and&#47;or stenting, and coronary artery bypass grafting, have been shown over <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decades to be highly efficacious in reducing mortality risk and relieving the symptoms of CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stress tests<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stress-based NITs include SPECT, PET and stress echocardiography. These tests use imaging to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluate heart function under exercise or pharmacologically-induced stress. The tests image the heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">muscles and identify the differences in blood perfusion to the myocardium between the rest and stress <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">state images to infer the presence of CAD. Stress-based NITs rely on surrogate markers of CAD to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deduce the disease in the coronary artery without actually assessing the coronary arteries or the disease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">itself. According to the 2010 Patel paper, which determined patterns of non-invasive testing and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnostic yield of catheterization among patients with suspected coronary artery disease, these NITs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inaccurate a majority of the time, and often result in either missed CAD diagnoses or unnecessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive procedures as demonstrated by our PRECISE trial. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result, approximately 20&#8211;50% of patients who undergo stress-based NITs go home with false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">negatives, or undetected CAD that should have required an intervention, based on the Nakanishi paper <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the Yokota paper. In addition, based on the 2014 Patel paper, up to 55% of patients receive false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positives and are sent to the cardiac catheterization lab for an invasive diagnostic angiography when an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention was never needed exposing patients to unnecessary risks including vascular injury and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bleeding complications. This results in significant additional costs to the healthcare system and poor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient experience.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 332pt; width: 612pt;"><div style="left: 144pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 146.06pt; width: 324pt;" src="business1aa.jpg" alt="business1aa.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 491.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 3&#58; Traditional non-invasive tests. Left&#58; Stress echocardiogram. Right&#58; SPECT and PET<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">CCTA<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA is a high-resolution 3D imaging method that uses X-rays to produce detailed pictures of the heart&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">arteries and other structures. CT imaging itself has been widely available and its use in cardiology is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growing rapidly. The analyses performed by our Heartflow Platform rely on CCTA images from third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CT manufacturers. Because CCTA images are used across multiple medical practices, by different <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 579.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical professionals and others, CT scanners have historically and currently output CCTA images in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 591.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard file formats rather than proprietary formats. In October 2021, the AHA and ACC elevated CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a first line Class 1, Level A test in the guidelines for certain patients with stable or acute chest pain and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">no known CAD, above stress testing which is Class 1, Level B. This made CCTA a first line test for CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 627.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owing to the strong evidence supporting its differentiated clinical utility. As of December 31, 2023, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 639.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimate there were approximately 2,700 sites with an active CCTA program in the United States. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similarly, CCTA now has guideline support from the European Society of Cardiology Clinical Practice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidelines on Chronic Coronary Syndromes (1B), is included in the National Institute for Health and Care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Excellence guidelines in the United Kingdom, and in the Japanese Circulation Society 2022 Guidelines in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Japan. We believe these guidelines further support the growth of CCTA tests outside the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 699.06pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and specifically in the European Union, United Kingdom and Japan. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">108<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unlike stress-based NITs that rely on indirect functional assessments of heart muscle activity to infer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, CCTA enables direct visualization of the patient&#8217;s coronary anatomy and can allow for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive assessment of coronary stenosis and plaque burden. CCTA has been clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated in the SCOT-HEART trial to have the highest diagnostic performance of all traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive imaging tests for CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The foundational SCOT-HEART randomized controlled trial, highlighted the clinical superiority of CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">over traditional stress-based NITs. The study found a significant 41% reduction in the rate of death or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-fatal heart attacks after five years in patients who underwent CCTA evaluations. The study also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated that patients in the CCTA group were more likely to be started on lipid lowering, anti-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hypertensive, anti-platelet, and anti-anginal medication, which improved outcomes in patients with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disease that may not have been detected with stress-based testing alone. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 220pt; width: 612pt;"><div style="left: 193.51pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 144pt; width: 224.98pt;" src="business2ba.jpg" alt="business2ba.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 377pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 4&#58; CCTA image<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 397pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">With the elevation of CCTA to a Class 1, Level A guideline recommendation by the AHA and ACC <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 409pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidelines in 2021, CCTA test volumes have grown at a 22% CAGR from 2018 to 2023 while SPECT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volumes have grown at a 2% CAGR over the same time period, based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 433pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.59pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217.36pt; position: absolute; white-space: pre;"> We believe CCTA test volumes will continue to grow rapidly, ultimately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">replacing other NIT methods based on increasing awareness of the superior diagnostic accuracy, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">workflow efficiencies and clinical guideline recommendations. Furthermore, favorable reimbursement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trends are expected to accelerate adoption. In 2025, CMS reimbursement levels for hospital outpatient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA are set to increase by 104% based on the OPPS final rule, published in the Federal Register on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">November 27, 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Catheterization lab-based invasive diagnostics for CAD<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 533pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Invasive methods of diagnosing CAD are typically performed in the catheterization lab and provide highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurate assessments of blood-flow and plaque. However, they are not practical or cost-effective as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">first-line diagnostic due to procedural risks, patient discomfort, as well as cost and availability of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">catheterization lab time. As a result, these technologies are utilized downstream in the catheterization lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after a patient has been identified as having suspected CAD based on an NIT and referred for an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interventional procedure. Because of the invasive nature of these tests, they serve as valuable reference <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">points for validating the accuracy of our technology, however, we do not directly compete with them.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These invasive catheter-based procedures, which include FFR and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 370.87pt; position: absolute; text-decoration: none; white-space: pre;">Intravascular ultrasound (&#8220;IVUS&#8221;),<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 519.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been the reference standard for obtaining FFR values and assessing plaque burden for decades. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FFR requires inserting a pressure wire into the coronary arteries under stress conditions to assess the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">109<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">severity of blood flow restriction and IVUS uses a catheter-based ultrasound probe to directly image <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">plaque within the arteries.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our symptomatic CAD market opportunity<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate our current market opportunity in the United States for our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 452.77pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.43pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is approximately $5 billion. Based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, we estimate that there were approximately 9.5 million NITs performed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the diagnosis of CAD in the United States in 2023. This includes an estimated 6.8 million SPECTs, 0.8 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million PETs, 1.2 million stress echocardiograms, and 0.7 million CCTAs, based on our analyses using <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Clarivate&#8217;s ProcedureFinder data repository.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 206.4pt; width: 612pt;"><div style="left: 201.6pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 224.1pt; width: 208.8pt;" src="business3ba.jpg" alt="business3ba.jpg"></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 443.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Based on our analyses using Clarivate&#8217;s ProcedureFinder data repository<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 460.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#126;73,000 Heartflow tests billed in FY23<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Figure 5&#58; Pie chart of U.S. non-invasive test market<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 497.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA testing volumes have grown 22% between 2018 and 2023, based on our analyses using Clarivate&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 509.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ProcedureFinder data repository, and we believe they will continue to outpace the broader NIT market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 521.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">growth driven by the recently established Class 1, Level A guidelines, due to superior clinical utility <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 533.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compared to stress-based tests, and improved reimbursement. Of the approximately 9.5 million NITs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performed for the diagnosis of CAD in the United States in 2023, we believe, based on our FORECAST <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">randomized trial and the Wang paper, there were approximately 8.6 million patients that were addressable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for CCTA after accounting for layered testing due to the inconclusive nature of traditional tests and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">need for multiple re-tests and contraindications to CCTA.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform, which requires a CCTA image from a CT scanner to perform its analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly improves the clinical utility of CCTA and addresses the limitations of traditional non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD testing by combining existing CCTA images with our AI algorithms to provide actionable data on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">blood flow, stenosis, plaque volume and plaque composition. This delivers superior clinical utility relative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to other NITs and compelling economic benefits, which are supported by extensive clinical evidence. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result, we believe the CCTA + Heartflow pathway will become the standard of care for the non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 673.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnosis of CAD over time.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">110<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Addressing the limitations of traditional CAD testing<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 92pt; width: 612pt;"><div style="left: 144.42pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 144pt; width: 323.15pt;" src="business4ba.jpg" alt="business4ba.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 249pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 6&#58; Image of SPECT test result on left&#59; image of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 376.25pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 384.91pt; position: absolute; white-space: pre;"> Analysis result on right<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 269pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.49pt; position: absolute; white-space: pre;"> Analysis is reimbursed for use on any CCTA showing 40% to 90% stenosis, which, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on our FORECAST randomized trial, we estimate to be approximately 33% of all CCTAs annually. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 293pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 245.14pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.8pt; position: absolute; white-space: pre;"> Analysis therefore is applicable to 33% of the NIT market and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">majority of patients experiencing acute chest pain, which represents 3.1 million patients and an estimated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market opportunity of approximately $3.3 billion in the United States. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.35pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 441.33pt; position: absolute; white-space: pre;">Plaque Analysis is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursed for plaque identified on CCTA with 1% to 69% stenosis, which, based on our PROMISE trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the Hoffmann paper, we estimate to cover approximately 60% of all CCTAs annually and a majority of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patients experiencing acute chest pain. We believe that CCTA + Heartflow Plaque Analysis is therefore <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable to 60% of the NIT market, which represents 5.5 million patients and an estimated market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">opportunity of an incremental approximately $1.7 billion in the United States. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 397pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">While our current focus is on the United States and the Heartflow Platform has been cleared by the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 409pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(K213857), our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.44pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.42000000000002pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 205.84pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.5pt; position: absolute; white-space: pre;"> Analysis has commercial presence and regulatory approval in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Kingdom, European Union, Australia, Canada and Japan. The Heartflow Platform has also been cleared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the equivalent regulatory authorities in Israel, Saudi Arabia, United Arab Emirates, and licensed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bahrain. In the future we may expand our international presence beyond these markets and extend our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">platform to additional indications.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Asymptomatic CAD market opportunity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 497pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For asymptomatic patients, current clinical practice guidelines (Class 1, Level B) recommend using risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 509pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">factors such as age, sex, smoking status, hyperlipidemia, hypertension, and diabetes, among others, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 521pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">calculate a risk score, called an ASCVD score, for assessing overall cardiovascular event risk and guiding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 533pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventive therapy. However, this approach does not account for the actual disease state of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">individual&#8217;s arteries leading to imprecise risk assessment and suboptimal management. As a result, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">despite the widespread availability of proven, preventative pharmaceutical treatments, up to 25% of heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attacks occur in those with no symptoms and approximately 50% of sudden heart deaths occur without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any prior diagnosis or testing according to the Ni paper. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe there is a significant opportunity for our Heartflow Platform to materially improve risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stratification and patient management. Clinical data supports our belief that AI-based risk calculation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predicated on the combination of individual-specific CAD measures enables more accurate and effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and preventative measures as compared to those based on an ASCVD score alone. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, our EMERALD 2 study showed that combining certain CCTA-derived quantitative features from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary physiology via <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.23000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.21pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 243.63pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.29pt; position: absolute; white-space: pre;"> Analysis and from plaque metrics via <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 420.03pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.01pt; position: absolute; white-space: pre;">Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 673pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predicted future plaque rupture more accurately than CCTA alone. Serial AI-based risk assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 685pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">asymptomatic patients can also capture temporal changes in disease state and cardiovascular risk, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 697pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">can be used to personalize preventative medical therapy over time. We estimate that there are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 709pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately 200 million patients globally with a high risk of cardiovascular events, of which 71 million <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.4pt; position: absolute; text-decoration: none; white-space: pre;">111<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">live in the United States<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.95999999999998pt; position: absolute; text-decoration: none; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 182.5pt; position: absolute; white-space: pre;">based on data from the U.S. Census Bureau, CDC, Eurostat, United Kingdom <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Office of National Statistics, the Yang paper and the MacDonald paper. In the future, we believe certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sub-segments of this population may be appropriate candidates for our platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Beyond the commercialization of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 283.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 293.95pt; position: absolute; white-space: pre;">Analysis and Heartflow Plaque Analysis in symptomatic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CAD, we see a significant market opportunity for our technologies in at-risk individuals who show no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">symptoms, a segment comprised of approximately 200 million people globally. To unlock this potential, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are continuing to evaluate new product opportunities and appropriate clinical evidence supporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">eventual regulatory approval, payor coverage and commercialization.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our technology<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow enhances CCTA, the most advanced non-invasive imaging modality for assessing CAD, with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AI-powered analysis to deliver more accurate and clinically actionable insights for diagnosing and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managing CAD. The Heartflow Platform applies deep learning, an advanced form of AI, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computational fluid dynamics to CCTA images to create a personalized 3D model of a patient&#8217;s heart <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on a single CCTA image. This model provides actionable insights into blood flow, stenosis, plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume and plaque composition allowing precise diagnosis, risk stratification, and treatment planning &#8211; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without the need for an invasive procedure. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The CCTA + Heartflow pathway addresses the limitations of traditional non-invasive tests that only assess <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirect measures for coronary disease and therefore result in higher rates of false negative and false <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positive CAD diagnoses, as demonstrated by our PRECISE trial. We believe the differentiated accuracy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and clinical utility of the CCTA + Heartflow pathway will continue to support our growth and advance the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard for the non-invasive diagnosis and management of CAD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We designed our AI-powered software platform to be highly scalable, seamlessly integrate into existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physician workflows for diagnosing CAD, and improve as we ingest more data over time. By leveraging AI <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to process massive volumes of cases and a &#8220;human-in-the loop&#8221; quality control process, where learnings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are fed back into our algorithms to improve their performance and efficiency, we have rapidly scaled our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">platform to deliver accurate, timely results to benefit physicians and patients alike. Our cloud-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology has enabled us to rapidly scale to an installed base of more than 1,100 accounts in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States as of December 31, 2024, reflecting<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.4pt; position: absolute; text-decoration: none; white-space: pre;"> a CAGR of 44% from December 31, 2021<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.57pt; position: absolute; white-space: pre;">. We have also built <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a substantial and growing data asset that has driven refinement of our algorithms for over 10 years and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of December 31, 2024, we have analyzed and annotated over 100 million annotated CCTA images. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Additionally, through our bi-directional data sharing relationship with our customers we ensure platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enhancements, delivering immediate and tangible benefits through new features, workflow efficiencies, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and improved performance.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The CCTA + Heartflow pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When a patient presents with symptoms of CAD and their physician follows the AHA and ACC Class 1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level A chest pain guidelines by referring the patient for a CCTA, the patient will undergo standard CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">imaging at the relevant hospital or outpatient facility. At Heartflow-enabled accounts, CCTA images are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securely transmitted directly to our cloud-based platform through our embedded software in the hospital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or outpatient imaging center. Leveraging proprietary AI and advanced computational fluid dynamics, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">create a personalized, 3D digital model of the patient&#8217;s coronary arteries, unlocking critical insights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beyond what is visible on standard imaging.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">112<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 121.27pt; width: 468pt;" src="figure2a.jpg" alt="figure2a.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 206.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 7&#58; The CCTA + Heartflow pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform includes a suite of innovative, AI-powered products designed to deliver <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive coronary artery assessment&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">1)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.47pt; position: absolute; text-decoration: none; white-space: pre;"> Coronary anatomy modeling that enables clinicians to interpret CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accurately, efficiently and consistently while identifying whether the patient requires further evaluation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with our other products. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 157.72pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 168.18pt; position: absolute; text-decoration: none; white-space: pre;">Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.61pt; position: absolute; text-decoration: none; white-space: pre;"> Accurate 3D model of blood flow that identifies clinically-significant CAD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at the lesion level to inform whether the patient requires revascularization and identifies which lesions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">should be addressed. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">3)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.25pt; position: absolute; text-decoration: none; white-space: pre;"> Precise quantification of plaque volume and plaque composition down <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to the cubic millimeter to help assess risk and determine optimal medical treatment.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These analyses provide the critical complementary data that are lacking from other non-invasive tests but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that we believe physicians need to diagnose, assess risk and make optimal, patient-specific decisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.27pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about medical and interventional therapies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 422.27pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 234.12pt; width: 468pt;" src="productportfolioa.jpg" alt="productportfolioa.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 669.39pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 8&#58; The Heartflow Portfolio<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.39pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform seamlessly integrates into our customer workflows, providing clinically actionable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 701.39pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insights directly to the account in a median turnaround time of 1.6 hours, which we believe is sufficient for <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">113<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the workflows of our customers. We deliver the Heartflow RoadMap Analysis automatically to the imaging <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiologist or radiologist for every acceptable CCTA patient at our accounts to help drive more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA interpretation and workflows. In conjunction with the Heartflow RoadMap Analysis, we also provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physicians with a case list that catalogs all their CCTAs and identifies the cases where our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 472.26pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.53pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 189.51pt; position: absolute; white-space: pre;">Plaque Analysis or both would enable them to accurately diagnose clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant CAD and plan treatment. With a single click, Physicians can access these analyses on-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demand, and we bill the account directly for each product selected. Because <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.96pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.94pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 476.36pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 485.02pt; position: absolute; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.45pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.43pt; position: absolute; white-space: pre;">Plaque Analysis have distinct clinical indications and dedicated billing codes, our workflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">helps ensure physicians can order the most appropriate analyses for each patient, supporting both high-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality care and efficient reimbursement processes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 200pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 197.95pt; width: 468pt;" src="business8ba.jpg" alt="business8ba.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 410.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 9&#58; The Heartflow Platform and workflow<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow Platform portfolio<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 450.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 120.3pt; position: absolute; text-decoration: none; white-space: pre;">RoadMap Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.14pt; position: absolute; text-decoration: none; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.5pt; position: absolute; text-decoration: none; white-space: pre;">The<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.72pt; position: absolute; text-decoration: none; white-space: pre;"> Heartflow RoadMap Analysis provides a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 130.9pt; left: 426.75pt; position: absolute; top: 453.3pt; width: 115.2pt; z-index: 3;"><div><div><div style="position: absolute;"><img style="height: 130.9pt; width: 115.2pt;" src="business9ca.jpg" alt="business9ca.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 462.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">highly intuitive anatomic visualization of the patient&#8217;s coronary anatomy based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">on CCTA images. It rapidly orients the imaging physician to clinically relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">areas of the patient anatomy and provides a preview of what they will review <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">in the native CCTA images to aid the physician in accurately, efficiently and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">consistently identifying stenosis in the coronary arteries. Heartflow RoadMap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis supports more efficient radiology workflow, improving CCTA read <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">times by 25% and increasing consistency between reviewing physicians by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 40%, as demonstrated in our SMART-CT study. Physicians use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Roadmap Analysis as a first-line assessment tool along with CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">interpretation to determine whether to order our more detailed Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 582.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; text-decoration: none; white-space: pre;">Analysis or Heartflow Plaque Analysis reports. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 308.2pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow RoadMap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 594.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Analysis was cleared by the FDA in October 2022, and we began providing it to our customers in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 606.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">second quarter of 2023. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">We generally provide Heartflow RoadMap Analysis to accounts as an integrated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">feature to enhance the efficiency and consistency of their CCTA programs and it is not a stand-alone <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">product. We believe the efficiency that Heartflow RoadMap Analysis provides our customers has resulted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.95pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">in enhanced customer loyalty and retention.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">114<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: bold; left: 139.72pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 150.18pt; position: absolute; white-space: pre;">Analysis&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197.38pt; position: absolute; text-decoration: none; white-space: pre;">Our<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.04pt; position: absolute; white-space: pre;"> flagship product, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.90999999999997pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.89pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 357.31pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.66pt; position: absolute; white-space: pre;">Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 133.07pt; left: 425.55pt; position: absolute; top: 70.33pt; width: 115.2pt; z-index: 1;"><div><div><div style="position: absolute;"><img style="height: 133.07pt; width: 115.2pt;" src="ffrctanalysis.jpg" alt="ffrctanalysis.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consists of a patient-specific, interactive, 3D anatomical reconstruction of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary anatomy that identifies <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.42pt; position: absolute; text-decoration: none; white-space: pre;">clinically <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.40999999999997pt; position: absolute; white-space: pre;">significant CAD at every point in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">major coronary arteries to determine the need for intervention. The model is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">color-coded along vessel length, indicating Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 327.52pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 337.87pt; position: absolute; white-space: pre;">Analysis values <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which assist the physician in rapidly and precisely assessing blood flow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through the coronary arteries. Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.3pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.28pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 289.7pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.05pt; position: absolute; white-space: pre;">Analysis has the highest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diagnostic accuracy for a non-invasive CAD test and has demonstrated a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">high level of concordance to invasive FFR, as seen in our PRECISE, NXT <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and PACIFIC trials. Our product can measure the FFR value and determine <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">whether a lesion is clinically significant &#8211; a &#8220;clinically significant lesion&#8221; means <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an FFR value of 0.80 or below. Because FFR values <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 306.37pt; position: absolute; text-decoration: none; white-space: pre;">are the guideline <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">directed measure to determine <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 210.32pt; position: absolute; white-space: pre;">the need for invasive revascularization, this data offers a more clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurate, non-invasive basis for determining the need for interventional treatment. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current AHA and ACC guidelines support CCTA + <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.26pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.24pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 358.66pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.01pt; position: absolute; white-space: pre;">Analysis as a more efficient care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pathway. The guidelines designate CCTA as a Class 1, Level A test for CAD in certain patients with stable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or acute chest pain and no known CAD, with our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 288.62pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.6pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 353.02pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.37pt; position: absolute; white-space: pre;">Analysis given a Class 2a, Level B <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognition to help physicians guide patient treatment decisions. This CCTA + <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.84pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 461.82pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 481.24pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.59pt; position: absolute; white-space: pre;">Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pathway enables physicians to identify lesions that require revascularization&#160;in less than two hours, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">guidelines recommend patients with positive <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.32pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.3pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 334.72pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.07pt; position: absolute; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 382.29pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 384.09pt; position: absolute; white-space: pre;">findings be sent directly to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiac catheterization lab for possible treatment. Comparatively, AHA and ACC guidelines provide stress-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based testing a Class 1, Level B recommendation, suggesting patients with suspected CAD and positive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stress-based test findings first initiate guideline directed medical therapy. Only if symptoms are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resolved by medical therapy, which can last weeks or months, are patients then sent to the cardiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">catheterization lab.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 388pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 155.4pt; width: 482.4pt;" src="figure10a.jpg" alt="figure10a.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 556.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 10&#58; AHA and ACC chest pain guidelines<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 155.82999999999998pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.18pt; position: absolute; white-space: pre;">Analysis is indicated for patients with stenosis levels between 40% and 90% in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vessel because a physician&#8217;s review of a CCTA alone may not appropriately identify the need for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treatment in these cases. For example, in the figure below, two patients with &#62;70% stenosis based on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CCTA alone would likely be referred for invasive coronary angiography (&#8220;ICA&#8221;). However, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 511.17pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 530.5899999999999pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 539.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis reveals that while Patient A has an FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 286.37pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.03pt; position: absolute; white-space: pre;"> value &#62;0.80&#8212;indicating no need for intervention&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">115<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Patient B has an FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 167.5pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.16pt; position: absolute; white-space: pre;"> value &#60;0.80 and should be referred for revascularization. As of December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.78pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.76pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 164.18pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 172.84pt; position: absolute; white-space: pre;"> Analysis represented 98% of our total revenue.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 202.01pt; width: 468pt;" src="business12ba.jpg" alt="business12ba.jpg"></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 319.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Figure 11<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 114.22pt; position: absolute; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.75999999999999pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 164.74pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 184.16pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT&#160; <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 196.42000000000002pt; position: absolute; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 233.64pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 235.44pt; position: absolute; white-space: pre;">Significantly Improves CCTA &#8211; anatomy from CCTA + Physiology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.01pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 139.74pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 159.16pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 169.62pt; position: absolute; white-space: pre;">Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 206.84pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 208.64pt; position: absolute; white-space: pre;">better informs clinical decisions<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">116<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.92000000000002pt; position: absolute; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 202.46pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 244.67pt; position: absolute; white-space: pre;"> Plaque Analysis transforms coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="height: 131.27pt; left: 425.55pt; position: absolute; top: 72.5pt; width: 115.2pt; z-index: 2;"><div><div><div style="position: absolute;"><img style="height: 131.27pt; width: 115.2pt;" src="plaqueanalysis.jpg" alt="plaqueanalysis.jpg"></div></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque assessment from a time-consuming and variable manual process, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which is seldom clinically used, into a rapid, automated, and highly precise AI-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">driven solution. The Heartflow Plaque Analysis automatically provides a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive 3D assessment of a patient&#8217;s coronary plaque, including a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">characterization of plaque types and quantification of plaque volumes at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">every point in the major coronary arteries. The Heartflow Plaque Analysis has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been validated against the reference standard of invasive IVUS and shown to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have a 95% agreement with IVUS in quantifying total coronary plaque volume <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in our REVEALPLAQUE study. Because coronary plaque volume is a strong <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predictor of a patient&#8217;s risk of having a heart attack regardless of ASCVD risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">score, calcium score, or stenosis, this data offers incremental predictive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">power over risk factors and stenosis alone and can aid the physician in optimizing medical management. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, only quantified plaque analysis based on CCTA can assess non-calcified plaque, which has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a higher risk for causing a heart attack as compared to calcified plaque. We believe that our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.96pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis is applicable to the approximately 60% of CCTA patients identified as having 1% to 69% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stenosis and adds significant value over review of CCTA alone, which is unable to precisely quantify or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">characterize the type or volume of plaque that would impact a physician&#8217;s treatment plan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow Plaque Analysis guides medical man<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 295.18pt; position: absolute; text-decoration: none; white-space: pre;">agement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 316pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 202.5pt; width: 468pt;" src="figure12a.jpg" alt="figure12a.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 531.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Figure 12&#58; Plaque is critical to guide medical management, regardless of FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: normal; left: 414.14pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 422.8pt; position: absolute; white-space: pre;"> results<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to its comprehensive plaque assessment capabilities, Heartflow Plaque Analysis incorporates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a nomogram derived from an extensive international cohort of over 11,000 patients. This nomogram <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 575.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stratifies coronary atherosclerotic plaque volumes by age and sex, providing physicians with a valuable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reference to contextualize individual patient data against population-based benchmarks. By leveraging <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this tool, clinicians can more precisely assess a patient's CAD risk, facilitating personalized treatment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">strategies. This integration of large-scale data enhances the actionable insights delivered by Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis, supporting more informed clinical decision-making.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.43pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.41pt; position: absolute; white-space: pre;">Plaque Analysis was cleared by the FDA in October 2022. We began our limited market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">education efforts in the second half of 2023, and we expect to broaden our market education efforts as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 667.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">payor<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.01pt; position: absolute; white-space: pre;"> coverage for <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.11pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.09pt; position: absolute; white-space: pre;">Plaque Analysis increases. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">117<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Key benefits of our Heartflow Platform<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the unique features of our technology allow us to offer superior clinical utility and economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value to our customers and the broader healthcare system. The key benefits offered by our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform include&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More accurate non-invasive test for CAD&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 286.01pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow products have been clinically validated to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provide a more accurate non-invasive assessment of blood flow, plaque characterization and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">volume compared to traditional non-invasive tests, parameters that have been established to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">highly clinically relevant. Our prospective, core-lab adjudicated NXT trial demonstrated that Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.77pt; position: absolute; text-decoration: none; white-space: pre;">Analysis is able to accurately calculate lesion-specific FFR values with a high level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">concordance to the invasive reference standard of FFR. In addition, our retrospective, core-lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adjudicated PACIFIC trial demonstrated that our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 369.14pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 379.49pt; position: absolute; text-decoration: none; white-space: pre;">Analysis offered superior diagnostic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accuracy relative to CCTA alone as well as SPECT and PET. Individually and collectively, these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">studies support the differentiated level of precision that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 398.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.96pt; position: absolute; text-decoration: none; white-space: pre;">Analysis offers relative to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other non-invasive tests as well as its clinical reliability. Similarly, our prospective REVEALPLAQUE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">study validated our Heartflow Plaque Analysis relative to the invasive reference standard of IVUS, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demonstrating 95% agreement for overall plaque volume and excellent agreement in identifying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">plaque volume and sub-types at the lesion level. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">More informed assessments and personalized care&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 336pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 422.6pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.95pt; position: absolute; text-decoration: none; white-space: pre;">Analysis has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clinically demonstrated in multiple studies to positively impact physician decisions on intervention and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patient management. The ADVANCE prospective registry which included over 5,000 patients globally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">showed that in 67% of cases physicians changed their patient management plans, predominantly with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">respect to revascularization, based on review of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 368.26pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.61pt; position: absolute; text-decoration: none; white-space: pre;">Analysis relative to CCTA alone. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Similarly, our DECODE study, which included 100 patients, demonstrated that in 66% of cases <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">physicians changed preventative medical therapy plans based on a review of Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Analysis relative to CCTA alone. Further supporting the value of our Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">product, among patients with a calcium score of 0, physicians revised their management plan in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">nearly 50% of cases after reviewing our Heartflow Plaque Analysis report. In 63% of cases in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">DECODE study, physicians increased the dosage of the patient&#8217;s medication, indicating that patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">were being under-treated based on conventional non-invasive testing methods that fail to both <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quantify and characterize plaque volumes. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Superior economic efficiency&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.68pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 319.28pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 329.63pt; position: absolute; text-decoration: none; white-space: pre;">Analysis has been clinically demonstrated to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reduce rates of false positive CAD diagnoses relative to other non-invasive tests and more accurately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identify the patients that actually need an invasive procedure. Our PRECISE prospective randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">controlled trial which enrolled over 2,100 patients and compared Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 440.5pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.85pt; position: absolute; text-decoration: none; white-space: pre;">Analysis with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">standard of care, demonstrated that our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 332.7pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 343.05pt; position: absolute; text-decoration: none; white-space: pre;">Analysis was 78% more likely to identify <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients in need of revascularization and showed a 69% reduction in false positives, or unnecessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ICA tests. It also showed 2x the yield of ICA leading to a revascularization procedure such as a<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 508.24pt; position: absolute; text-decoration: none; white-space: pre;"> PCI or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CABG.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.08pt; position: absolute; text-decoration: none; white-space: pre;"> These are economically important procedures for our customers which, when done in place of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a diagnostic only catheterization, result in more efficient use of valuable cardiac catheterization lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">facilities and staff time. As a result, our calculations based on the PRECISE trial indicate that net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">average cardiac catheterization lab revenue increase<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.47pt; position: absolute; text-decoration: none; white-space: pre;">d 20%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Improved workflow&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.36pt; position: absolute; text-decoration: none; white-space: pre;"> Our Heartflow Platform offers significant workflow benefits, including improving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">workflow efficiency and reducing CCTA interpretation times. Our SMART-CT study demonstrated that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the use of our Heartflow RoadMap Analysis reduced read time by approximately 25%. In addition to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reducing read times, our Heartflow RoadMap Analysis enhances consistency across a radiology <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">program resulting in a more than 40% increase in inter-reader agreement. Given the intense <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demands on radiologist time resulting from an increasing number of images to review on a daily <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">basis, we believe this added efficiency and consistency strengthens the competitive differentiation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our platform.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">118<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Enhanced interventional treatment planning<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 298.7pt; position: absolute; text-decoration: none; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.03pt; position: absolute; text-decoration: none; white-space: pre;"> Once the patient is diagnosed with clinically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">significant CAD and referred to the catheterization lab for an intervention, our Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">provides information that is useful to interventional cardiologists in planning for the most efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">treatment based on individual anatomy and disease s<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.12pt; position: absolute; text-decoration: none; white-space: pre;">tate.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.55pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 348.14pt; position: absolute; text-decoration: none; white-space: pre;">The Heartflow Platform enables early, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">detailed pre-operative planning, allowing physicians to triage patients to the most appropriate site of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">service&#8212;whether a hospital-based catheterization lab or an outpatient interventional center. By <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifying the complexity and severity of disease in advance, our technology ensures that high-risk <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients receive care in fully equipped facilities, while lower-risk cases can be efficiently managed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outpatient settings, reducing strain on hospital resources. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.52pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow&#8217;s 3D model provides a precise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">preview of the anatomy corresponding to specific views used in invasive catheterizations. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.62pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.42pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.08pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.74pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.72pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis provide quantitative and visual insights on lesion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">severity, plaque burden and type, and hemodynamic significance, which enable more precise pre-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">selection of interventional tools. This allows catheterization labs to be better prepared with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">necessary guidewires, catheters, and adjunctive devices before the procedure, thereby reducing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">inefficiencies. With growing demand for complex structural heart procedures&#8212;such as transcatheter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">aortic valve replacemen<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 195.56pt; position: absolute; text-decoration: none; white-space: pre;">t, left atrial appendage c<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 302.2pt; position: absolute; text-decoration: none; white-space: pre;">losure, and transcatheter mitral interventions&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">catheterization lab capacity is increasingly a constraint for hospitals. By reducing unnecessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">diagnostic angiograms and increasing the efficiency of PCI planning, we believe the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Platform frees up catheterization lab time for these higher-acuity, resource-intensive procedures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Better patient and provider experience&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 276pt; position: absolute; text-decoration: none; white-space: pre;"> By leveraging a single CCTA for all of our products, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">patients complete their test in approximately 20 minutes with significantly lower radiation exposure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to nuclear imaging tests such as SPECT and PET that take multiple hours and require <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">radioactive tracers to be injected into the bloodstream. A fundamental challenge with traditional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stress-based testing is the lack of a definitive diagnosis, which often results in a cascade of follow-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tests. Stress tests frequently produce inconclusive or false-positive results, requiring additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">imaging studies such as cardiac catheterization to confirm or rule out disease. This layered testing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">approach prolongs the diagnostic journey, delays appropriate treatment, and adds unnecessary costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and inconvenience for patients. The Heartflow Platform offers an entirely digital and non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">experience that better serves both patients and providers. The CCTA + Heartflow Pathway provides a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">fulsome array of insights with only a single patient exam. All results can then be viewed and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">distributed digitally to all of the patient&#8217;s care providers. In addition, our platform offers the flexibility to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">add new visualizations, insights and updates as the technology evolves, and physicians can receive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the benefits of these updates conveniently through the same software platform. For example, when <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow RoadMap Analysis and Heartflow Plaque Analysis were introduced, our accounts were able <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to access these technologies through the same connection infrastructure and platform that they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">utilized for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 202.70999999999998pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.06pt; position: absolute; text-decoration: none; white-space: pre;">Analysis without the need to buy new equipment or establish new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">connections. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our production process<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our production process involves a sophisticated and highly refined system that combines advanced <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">machine learning algorithms with &#8220;human-in-the loop&#8221; quality control process, where learnings are fed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">back into our algorithms to improve their performance and efficiency. After the CCTA test is complete, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient&#8217;s images are securely transferred to our cloud-based system through our established software that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integrates directly into the account&#8217;s infrastructure. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">When the images arrive, we leverage multiple machine learning algorithms which have been trained from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a database of millions of annotated CCTA images to precisely segment CCTA data and extract patient-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific 3D anatomy, which includes the coronary tree, myocardium and other anatomic features. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality of CT images and the anatomy extracted by our algorithms is inspected through propriety software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that guides quality-oriented production analysts through each step to review and potentially correct the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">segmentation, as needed. Our machine learning algorithms then utilize any analyst inputs to generate a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">final 3D model of the coronary vessels. Our algorithms then compute stenosis, plaque volumes and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plaque characteristics as well as blood flow simulation with computational fluid dynamics over the entire <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.03pt; position: absolute; text-decoration: none; white-space: pre;">119<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coronary tree. The simulated blood flow and pressures allow calculation of quantitative <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.21pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 501.19pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 520.61pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis values at every point on the coronary tree. Once complete, our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 391.38pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 436.36pt; position: absolute; white-space: pre;">RoadMap Analysis, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.75pt; position: absolute; white-space: pre;">Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.19pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.17pt; position: absolute; white-space: pre;">Plaque Analysis are securely delivered directly to the physician in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">multiple formats&#58; an interactive web experience where they can explore the data in detail, PDF <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summaries, and direct delivery into the electronic medical record. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The corrections and changes from the analyst quality inspection step are stored in a database as labels <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for training our algorithms. New and improved versions of our algorithms using the latest machine <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">learning methodologies are trained with incrementally more labels and released over time and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporated into our platform. The core algorithms for the 3D coronary anatomic model and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.08pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.77pt; position: absolute; white-space: pre;">Analysis are now on their 3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 221.75pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;">rd<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.52pt; position: absolute; white-space: pre;"> generation with improvements over time. This iterative approach of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combining improved algorithms with human quality control processes continues to enhance the accuracy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and efficiency of our technology. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have also invested significantly in automating our production process through improved algorithm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance, visualization, and internal workflow enhancements, which have materially reduced our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">analyst processing times from 69 minutes in 2021 to 26 minutes in the fourth quarter of 2024, significantly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enhancing our margin profile.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Our data security<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our Heartflow Platform relies on industry-leading security controls, including encryption at rest and in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transit, multi-factor and single-sign on authentication, granular authorization and a secure development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lifecycle. We have designed the Heartflow Platform to de-identify data for processing, ensuring the most <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">identifiable sensitive data (including PHI) remains segregated, encrypted, and within source regions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limiting privacy and security risk. Our commitment to information security is demonstrated by our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HITRUST, ISO 27001, and SOC 2 Type II certifications.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our clinical results and economic evidence<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the Heartflow Platform is the most studied AI-enabled test for CAD. The accuracy, clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utility and economic benefits of our Heartflow Platform have been evaluated in over 100 clinical studies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and more than 130,000 patients, including our PRECISE and FORECAST trials, each a large randomized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">controlled trial, with results published in over 600 peer-reviewed clinical publications. Collectively, this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extensive body of clinical evidence has supported regulatory approvals for our products, established <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">broad payor coverage and society guideline inclusion for our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.46pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 386.44pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 405.86pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.52pt; position: absolute; white-space: pre;"> Analysis, and is driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rapid commercial adoption of our portfolio of products. We have sponsored 50 of the 100 clinical studies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and are continuing to invest in evidence that highlights the clinical utility and economic benefits of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.97999999999999pt; position: absolute; white-space: pre;">Plaque Analysis to support expansion of payor coverage and commercial adoption. In the future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we may also invest in clinical studies of the Heartflow Platform to expand indications to broader <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">populations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our clinical programs have been focused on (i) validating the accuracy and reproducibility of our product <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offerings relative to invasive reference standards and non-invasive alternatives, (ii) establishing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">differentiated clinical utility of our products relative to non-invasive alternatives, and (iii) demonstrating the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic benefits associated with our products including reduced costs for payors and improved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">efficiency for providers. Our studies, including the PRECISE, NXT and PACIFIC trials, have consistently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrated that the Heartflow Platform is more accurate than traditional non-invasive tests and highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">concordant to invasive testing, reduces unnecessary invasive testing, and enables physicians to optimize <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treatment and ultimately provide more efficient care. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.35pt; position: absolute; text-decoration: none; white-space: pre;">The &#8220;p-values&#8221; noted below indicate the measure of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the study&#8217;s &#8220;statistical significance,&#8221; which refers to the likelihood that a result or relationship is caused by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">something other than random chance or error. The &#8220;p-value&#8221;&#160; indicates the probability value that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">results observed in a study were due to chance alone. A p-value of &#60; 0.05 is generally considered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">statistically significant, meaning that the probability of the results occurring by chance alone is less than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">five percent. The lower the p-value, the less likely that the results observed were random.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">120<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">None of the studies discussed below that collected adverse event data related to the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reported adverse events related to the Heartflow Platform.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: italic; font-weight: bold; left: 160.25pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 168.91pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;">Accuracy and reproducibility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 197pt; position: absolute; white-space: pre;">&#58; Numerous foundational clinical trials in cardiology, including the FAME 1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and FAME 2 RCTs have demonstrated that FFR values are the most accurate predictors of the need for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intervention in patients with CAD. Key clinical studies that have supported the accuracy and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reproducibility of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 147.54000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 192.51999999999998pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 211.94pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.6pt; position: absolute; white-space: pre;"> Analysis relative to invasive FFR testing and non-invasive alternatives <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">include&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">NXT (2014)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 144.98pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.97pt; position: absolute; text-decoration: none; white-space: pre;">-sponsored<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.99pt; position: absolute; text-decoration: none; white-space: pre;"> NXT trial was the was the basis for de novo 510(k) FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">clearance of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 211.62pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.28pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis. It was a prospective, blinded, core-lab adjudicated trial in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which CCTA was performed prior to non-emergent <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 314.77pt; position: absolute; text-decoration: none; white-space: pre;">ICA<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 330.87pt; position: absolute; text-decoration: none; white-space: pre;"> in stable patients with suspected CAD. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 154.4pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.75pt; position: absolute; text-decoration: none; white-space: pre;">Analysis values based on the CCTA were compared to invasive FFR values. The trial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">also compared the efficacy of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 286.97pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.63pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis relative to CCTA alone for predicting FFR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">values. NXT studied 254 patients who were scheduled to undergo clinically indicated ICA and who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">had CCTA performed within 60 days before ICA or who agreed to undergo CCTA within 60 days <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">before ICA and studied 484 vessels at 10 centers in Europe, the United Kingdom, Japan, Korea, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Australia. The results showed that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 307.5pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 316.15999999999997pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis is highly accurate compared to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reference standard of invasive FFR, with a per vessel accuracy of 86% compared with 65% for CCTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">alone (p &#60; 0.001). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">PACIFIC (2019)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.95999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> The PACIFIC trial was an investigator-initiated, prospective study funded by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Company to evaluate in a head-to-head manner the diagnostic performance of several non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tests commonly used to identify functionally significant CAD. At a single site in the Netherlands, a total <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of 208 patients with suspected stable CAD underwent CCTA, SPECT and PET, and then used ICA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">with invasive FFR as the reference standard. The Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 375.26pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.92pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was not initially included <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in the PACIFIC study, but the investigators subsequently undertook a retrospective PACIFIC FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 517.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 526.27pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sub-study to evaluate the diagnostic performances of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 391.6pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.26pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis compared to CCTA, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">SPECT, and PET. Using invasive FFR as the reference standard, the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 460.95pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 469.61pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">demonstrated the highest diagnostic performance for vessel-specific ischemia of all tested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">noninvasive tests, with an AUC (Area Under the Curve) of 0.94 compared with PET (0.87), CTA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(0.83), and SPECT (0.70) (p &#60; 0.001 for all).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: underline; white-space: pre;">Differentiated utility, improved clinical and economic outcomes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.59pt; position: absolute; white-space: pre;">&#58; Numerous studies have demonstrated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that use of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.42pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 166.4pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 185.82pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.48000000000002pt; position: absolute; white-space: pre;"> Analysis favorably impacts clinical management, supporting physicians in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making more informed and better patient-specific decisions about intervention which drives more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use of resources. Key company-sponsored clinical studies that demonstrated the impact of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.28pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.42pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> Analysis on clinical decision-making, outcomes and provider and payor economics include&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ADVANCE (2018)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.42000000000002pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored ADVANCE prospective registry studied 5,083 patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at 38 centers across the United States, United Kingdom, Europe, and Japan whose CCTA showed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CAD, in order to determine whether the incremental addition of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 434.33pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 442.99pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis resulted in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">change in patient management.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 230.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.78pt; position: absolute; text-decoration: none; white-space: pre;">Results at 90 days showed that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 438.82pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 447.48pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis findings <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">drove a change in management plan for 67% of patients and that Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 444.38pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 453.04pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis values <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#62;0.80 did not have any reported major adverse cardiovascular events compared to those with values <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">0.80 or below who experienced higher rates of major adverse cardiovascular events (p &#60; 0.01) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">despite overwhelmingly non-invasive patient management. Additionally, CCTA-based stenosis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">severity was determined to be a poor predictor of Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 373.8pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 382.46pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis values, demonstrating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that CCTA alone was not as effective for clinical decision-making. A review of outcomes at one year <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">showed that physician management decisions were safe and durable and that deferral of an invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">procedure based on Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 246.09pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.75pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was safe and appropriate, as it was highly unlikely to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">result in a later revascularization or adverse clinical event.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">121<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">PRECISE (2023)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.85pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored PRECISE trial was a prospective randomized controlled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">study conducted at 65 centers across the United States, Canada, the United Kingdom, and Europe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which compared decision-making and outcomes based on a CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 460.04pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 468.7pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway with the &#8220;usual care&#8221; pathway which involved alternative non-invasive or invasive testing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">methods chosen by the clinician, such as <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.43pt; position: absolute; white-space: pre;">exercise electrocardiogram, stress echocardiogram, stress <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">nuclear myocardial perfusion imaging (single-photon emission CT or positron emission tomography), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">stress cardiovascular magnetic resonance imaging, or catheterization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.66pt; position: absolute; text-decoration: none; white-space: pre;">. The study included 2,103 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">participants without known CAD or prior testing and had a median follow up of 11.8 months. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">study found that, compared with the &#8220;usual care&#8221; pathways, CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 456.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 464.73pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">78% more likely to identify patients in need of revascularization (p &#60; 0.001), and resulted in a 69% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reduction in diagnostic-only ICA. The net effect of this pathway was 2x the yield of ICA leading to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">revascularization procedure, from 30.5% of cases to 71.9% of cases. As a result, our internal analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">based on the PRECISE data demonstrated a 20% increase in net revenue for the cardiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">catheterization lab, on average. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">PLATFORM (2015)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 180.5pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored PLATFORM trial was a prospective controlled study of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sequential cohorts that enrolled 584 patients across 11 centers in the United Kingdom and Europe. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The study assessed the clinical and economic impacts of using a CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 481.09pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 491.44pt; position: absolute; text-decoration: none; white-space: pre;">Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway to select patients with stable, new onset chest pain for ICA. The study compared outcomes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">between cohorts with a &#8220;usual care&#8221; invasive pathway to a CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 450.53pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 459.19pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pathway. The study found that the CCTA + Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 344.05pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.71pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis pathway reduced the rate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary ICA by 83% from 73% to 12% (p &#60; 0.0001) and showed a 23% reduction in costs at 90 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">days and a 32% reduction (p &#60; 0.0001) in costs at one year based primarily on the avoidance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary invasive procedures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Our Heartflow Plaque Analysis<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our clinical portfolio includes 10 studies and over 25 peer-reviewed publications specific to <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 474.74pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plaque Analysis. These studies and publications, which include large, multi-center, international trials, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document the performance, accuracy and clinical utility of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.62pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.6pt; position: absolute; white-space: pre;">Plaque Analysis as well as its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">positive impact on the physician&#8217;s ability to assess risk and manage outcomes. By providing more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accurate and detailed information on plaque types and volumes than can be achieved with traditional non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invasive tests or risk measures, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.18pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.15999999999997pt; position: absolute; white-space: pre;">Plaque Analysis supports more appropriate, precise medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 135.89pt; position: absolute; text-decoration: none; white-space: pre;">Key studies that support the clinical benefits of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.16pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 389.14pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis include&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">REVEALPLAQUE (2024)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 207.15pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored REVEALPLAQUE study demonstrated the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accuracy of Heartflow Plaque Analysis relative to IVUS, the accepted reference standard for coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">plaque measurement and characterization. REVEALPLAQUE was a prospective, blinded, core-lab <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adjudicated trial that enrolled <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.54pt; position: absolute; text-decoration: none; white-space: pre;">237 patients<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 274.99pt; position: absolute; text-decoration: none; white-space: pre;">, with 432 lesions, in the United States and Japan and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared coronary plaque quantification and characterization between Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and IVUS. The study showed that Heartflow&#8217;s Plaque Analysis results for total plaque volume, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">calcified plaque, and non-calcified plaque were strongly correlated with IVUS measurements, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">achieving 95% agreement with IVUS.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">DECODE (2024)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.75pt; position: absolute; text-decoration: none; white-space: pre;"> Our Company-sponsored DECODE study evaluated the impact of the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis on clinical decision-making using data from 100 patients who underwent CCTA. For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each case, three cardiologists with expertise in reading CCTA and preventive therapies aligned on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">management plan based on patient demographics, clinical history, and the CCTA alone. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cardiologists were then provided with Heartflow Plaque Analysis for the same patients and asked to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">determine a management plan. The results showed that the use of Heartflow Plaque Analysis led to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">changes in treatment plans for 66% of patients, including 63% of patients who had medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">management up-titrated. The likelihood of changing the management plan increased with higher <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">coronary artery calcium scores and was more pronounced in patients with significant coronary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stenosis, however even 50% of patients with a coronary artery calcium score of 0 had a revised <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">management plan with Heartflow Plaque Analysis.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">122<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ADVANCEPLAQUE (2024)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 212.72pt; position: absolute; text-decoration: none; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.05pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.64pt; position: absolute; text-decoration: none; white-space: pre;">The ADVANCEPLAQUE<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.16999999999996pt; position: absolute; text-decoration: none; white-space: pre;"> study is a retrospective analysis of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ADVANCE trial after 1-year follow up (see above for more information related to our Company-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">sponsored ADVANCE trial). In a multi-variate analysis of the data, high total plaque volume as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identified by Heartflow Plaque Analysis was shown to be an independent predictor for the risk of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adverse clinical cardiac events. In addition, the risk of an adverse cardiac event was shown to be 2x <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">higher in patients where Heartflow Plaque Analysis showed a higher total plaque burden compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">those with a lower plaque burden.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">EMERALD 2 (2024)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 179.41pt; position: absolute; text-decoration: none; white-space: pre;">&#58; The EMERALD 2 study, funded by the Company, enrolled 351 patients who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">presented with acute coronary syndrome, including specifically-identified culprit plaque rupture, within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">3 years following a CCTA across the United States, Canada, Denmark, Italy, Hungary, Belgium, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Australia, Japan and South Korea. The study sought to investigate the additive value of AI&#8211;enabled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">quantitative coronary plaque analysis together with hemodynamic&#160;analysis as predictors of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subsequent plaque rupture. The study showed that adding the CCTA-derived, AI-enabled measures <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">derived from FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 167.74pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.4pt; position: absolute; text-decoration: none; white-space: pre;"> and Plaque Analyses predicted plaque rupture more accurately the reference <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">model of CCTA alone (p &#60; 0.001).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">DECIDE<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.75pt; position: absolute; text-decoration: none; white-space: pre;">&#58; Based on the success of our DECODE study, which supported CMS coverage for Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plaque Analysis, we initiated in March 2025 the DECIDE registry, a prospective real world analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">measuring the impact of Heartflow Plaque Analysis on changes in treatment decisions compared to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA alone or alternative non-invasive tests. In contrast with DECODE in which physicians <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">retrospectively identified revised patient management plans, physicians in our DECIDE registry will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">use Heartflow Plaque Analysis information to implement real world patient management changes. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">study&#8217;s primary endpoint is change in medical management following Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compared to CCTA alone, and the secondary endpoint will examine changes in key outcomes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including death, heart attack, revascularization, cardiovascular medication changes and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">cardiovascular hospitalizations at both 90-days and one-year follow-up. DECIDE was initiated in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">March 2024 and we expect to enroll approximately 20,000 patients across approximately 40 sites in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the United States. As of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.39pt; position: absolute; white-space: pre;">&#160;March 18<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.83pt; position: absolute; text-decoration: none; white-space: pre;">, 2025, we have enrolled over 10,000<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.28pt; position: absolute; white-space: pre;">&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.05pt; position: absolute; text-decoration: none; white-space: pre;">patients. We believe that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outcomes of the DECIDE registry will support expanded commercial payor coverage and continued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">adoption of Heartflow Plaque Analysis.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">123<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other Company sponsored or funded clinical studies<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The table below summarizes the results of additional clinical studies of the Heartflow Platform that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have sponsored or funded to date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 124pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 85.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 76.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 306.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 85.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Reference<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 0pt; width: 76.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Source<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 0pt; width: 306.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 306.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Study summary<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 249pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Koo et al. (2011)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 12pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal of the <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">American <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">College of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 36.83pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cardiology<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 12pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">DISCOVER-FLOW study<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; Bon-Kwon Koo, James K. Min, Bjarne L. N&#248;rgaard, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Seoul National University Hospital<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 60.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 103<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 80.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; Prospective, multicenter trial sponsored by the Company, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">aimed at evaluating the diagnostic performance of non-invasive <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">fractional flow reserve derived from CCTA in assessing the functional <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">significance of coronary artery disease. The study involved patients <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">with suspected CAD who underwent CCTA and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.47pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 248.45pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 266.90999999999997pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 275.13pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 137.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Analysis, with results compared to invasive FFR as the reference <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 149.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">standard.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study concluded that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.13pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 213.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 231.57pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 239.79pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 180.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">demonstrated high diagnostic accuracy in identifying functionally <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 192.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">significant coronary stenosis, with improved diagnostic discrimination (p <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 203.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">&#60; 0.001) compared to CCTA alone. These findings support the potential <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 13.169999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 58.150000000000006pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 76.61pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 84.83pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis as a reliable non-invasive method for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 226.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">assessing coronary artery disease, offering a promising alternative to <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 238.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">invasive FFR for guiding clinical decision-making.<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 305.25pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 261pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Morris et al. (2024)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 261pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cardiovascular <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computed <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 36.83pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Tomography<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 261pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">SMART-CT 2.0<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; Michael F. Morris, Mahesh Chandrasekhar, Harish Gudi, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Banner University Medical Center, Phoenix<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 60.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 120<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 80.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; The Company-sponsored SMART-CT 2.0 study (also <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">referred to as the SMART-CT study) was designed to evaluate the <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">effectiveness of an AI-informed coronary stenosis quantification tool, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">known as AI-CSQ, in assisting the interpretation of CCTA. This tool, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">aims to reduce the time required for CCTA interpretation, while <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 137.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">maintaining or enhancing the accuracy and confidence of the readers. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 148.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The study involved 120 CCTAs from patients at 2 sites with stable chest <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 160.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">pain or symptoms of CAD. These were analyzed by six readers of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 171.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">varying experience levels, including cardiologists and radiologists, to <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 182.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">determine the impact of AI-CSQ on interpretation time, diagnostic <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 194.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">accuracy, and inter-reader variability.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 213.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study concluded that the use of AI-CSQ significantly <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 225.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">decreased the overall time required for CCTA interpretation by 25.8%, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 236.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">regardless of the reader's experience level (p &#60; 0.001). It also improved <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 247.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">inter-reader agreement and boosted reader confidence in diagnosing <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 259.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">coronary artery disease. These findings underscore the potential of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 270.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">advanced AI tools like AI-CSQ to enhance the efficiency and reliability <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 282.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">of CCTA interpretation in clinical practice, addressing challenges such <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 293.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">as time-consuming post-processing and variability in reader accuracy.<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">124<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 85.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 76.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 306.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 85.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Reference<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 0pt; width: 76.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Source<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 0pt; width: 306.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 306.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Study summary<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 318pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Curzen et al. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 85.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(2021)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 12pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">European Heart <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 12pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">FORECAST<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; Nick Curzen, Zoe Nicholas, Beth Stuart, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Multiple centers across the United Kingdom<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 60.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 1,400<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 80.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; The FORECAST (Fractional Flow Reserve Derived from <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computed Tomography Coronary Angiography in the Assessment and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Management of Stable Chest Pain) study, funded by the Company, was <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">a prospective, randomized controlled trial across 11 sites, designed to <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">assess the clinical and economic impact of using CCTA combined with <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 137.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis in the management of patients presenting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 149.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">with stable chest pain. The study compared this approach to standard <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">care pathways that did not include <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 148.76pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 193.74pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 212.2pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 220.42pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis, aiming to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 172.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">determine its effectiveness in reducing unnecessary invasive <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 184.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">procedures and improving patient outcomes.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 203.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study concluded that the integration of CCTA with <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis into the diagnostic pathway for stable chest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 226.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">pain resulted in a significant reduction in the need for ICA and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 238.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary procedures, without an increase in adverse patient <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 249.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">outcomes. It found that random assignment to the study arm using <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 261.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">CCTA and our <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 64.71pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 109.69pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 128.15pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 136.37pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis was associated with a 22% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 273.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">reduction in the need for ICA, a 52% reduction in the frequency of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 284.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">unnecessary ICA, 40% fewer layered non-invasive tests, and no <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 295.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">increase in adverse patient outcomes or in costs (in the United <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 307.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Kingdom).<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">125<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 85.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 76.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 306.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 85.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Reference<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 0pt; width: 76.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Source<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 0pt; width: 306.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 306.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Study summary<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 434.25pt;"><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12pt; width: 85.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 85.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Min et al. (2012)<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 85.5pt; position: absolute; top: 12pt; width: 76.5pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Journal of the <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">American <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Medical <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 36.83pt; width: 76.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Association<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-left: 1pt solid #000; border-right: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 162pt; position: absolute; top: 12pt; width: 306.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">DeFACTO study<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 22.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authors&#58; James K. Min, Jonathon Leipsic, Michael J. Pencina, et al.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 41.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Institution&#58; Multiple international centers (United States, Belgium, <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 52.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Canada, Latvia and South Korea)<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 72.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">N&#58; 252<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 91.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Description&#58; Multicenter diagnostic performance study, sponsored by <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 103.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the Company, involving 252 stable patients with suspected or known <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 114.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">CAD from 17 centers in 5 countries who underwent CT, ICA, FFR, and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 125.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis between October 2010 and October 2011. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 137.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computed tomography, ICA, FFR, and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.01999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 212pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 230.46pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 238.68pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 149.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">interpreted in blinded fashion by independent core laboratories. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 161.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accuracy of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 54.85pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 99.83pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 118.28999999999999pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 126.50999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis plus CT for diagnosis of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 173.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">ischemia was compared with an invasive FFR reference standard. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Ischemia was defined by an FFR or <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.54999999999998pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 199.53pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 217.99pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 226.21pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis of 0.80 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 196.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">or less, while anatomically obstructive CAD was defined by a stenosis <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 208.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">of 50% or larger on CT and ICA. The primary study outcome assessed <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 219.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">whether <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.03pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 84.00999999999999pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 102.47pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 110.69pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis plus CT could improve the per-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 231.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">patient diagnostic accuracy such that the lower boundary of the 1-sided <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 242.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">95% confidence interval of this estimate exceeded 70%.<font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 262.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Conclusions&#58; The study did not meet its primary goal for per-patient <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 273.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">diagnostic accuracy, as it resulted in diagnostic accuracy of 73%, with a <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 285.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">lower bound of the 95% CI of 67%. However, the use of noninvasive <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 47.61pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 66.07pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 74.28999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis combined with CT in stable patients with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 308.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">suspected or known CAD showed improved diagnostic accuracy and <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 319.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">discrimination compared to CT alone for identifying hemodynamically <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 331.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">significant CAD, using invasive FFR as the reference standard. This <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">suggests that <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.71pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 106.69pt; position: absolute; text-decoration: none; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.175pt; font-style: normal; font-weight: normal; left: 125.14999999999999pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 133.37pt; position: absolute; text-decoration: none; white-space: pre;"> Analysis could enhance the noninvasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 354.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">assessment of CAD by providing physiologic insights that CT alone <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 366.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">cannot offer, potentially reducing unnecessary invasive procedures. <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 377.43pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Following the completion of the DeFACTO study, we substantially <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 388.83pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">redesigned our technology, which improved product performance. The <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 400.23pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">results of this improvement were validated in the NXT study, which <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 411.63pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">resulted in a per vessel 86% accuracy and was the central evidence for <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 423.03pt; width: 306.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the initial De Novo 510(k).<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 531.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other clinical studies<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following summarizes the results of additional clinical studies that were not supported, sponsored, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">funded by the Company. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 583.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">SCOT-HEART (2015)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.5pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 193.26999999999998pt; position: absolute; white-space: pre;">SCOT-HEART was a foundational open-label, multi-center, parallel group <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">randomized controlled trial that compared the standard of care against the standard of care with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">CCTA. The study registered 4,146 patients across 12 sites in Scotland. Enrollment was open to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients aged 18&#8211;75 years who had been referred by a primary-care physician to a dedicated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">cardiology chest pain clinic with suspected stable angina due to coronary heart disease. The study <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">highlighted the clinical superiority of CCTA over traditional stress-based NITs, finding a significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">41% reduction in the rate of death or non-fatal heart attacks after five years in p<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 440.46pt; position: absolute; text-decoration: none; white-space: pre;">atients who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">underwent CCTA evaluations. The study also demonstrated that patients in the CCTA group had <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">higher rates of preventative therapies throughout follow-up&#58; antiplatelet therapy use fell from 48% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 691.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(baseline) to 41% (at 1 year) in the standard of care group (p &#60; 0.001), whereas it increased from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 703.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">49% (baseline) to 52% (at 1 year) in those in the CCTA group (p &#61; 0.017). Statin use increased in <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">126<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">both groups, from 43% to 50% (at 1 year) in the standard of care group and from 44% to 59% (at 1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">year) in the CCTA group (p &#60; 0.001 for both groups), but this was greater in those assigned to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CCTA group (p &#60; 0.001).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FAME 1 (2009)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.64pt; position: absolute; text-decoration: none; white-space: pre;"> T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.32999999999998pt; position: absolute; white-space: pre;">he foundational FAME 1, a prospective randomized controlled trial, enrolled 1,005 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients with multi-vessel CAD across 20 sites in the United States and Europe. The study, along with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">FAME 2, showed that deferring intervention is superior when blood flow, as measured by FFR, was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">greater than 0.80 but that when FFR was below this same level, intervention was superior to optimal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">medical therapy. In FAME 1, patients diagnosed with CAD by ICA and planned ICA had rates of major <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">adverse cardiovascular events that were lower with deferral of FFR negative lesions than with angio-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">guided PCI of all lesions independent of FFR (18.3% vs. 13.2%) (p &#61; 0.02). In addition, 78% of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients in the angiography group were free from angina at 1 year, as compared with 81% of patients <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">in the FFR group (p &#61; 0.20).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">FAME 2 (2014)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.64pt; position: absolute; text-decoration: none; white-space: pre;"> T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.32999999999998pt; position: absolute; white-space: pre;">he foundational FAME 2, a prospective randomized controlled trial, enrolled 1,220 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">patients across 28 sites in Europe and North America. The enrolled patients were appropriate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">candidates for PCI in stable condition who had angiographically assessed one-, two-, or three-vessel <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">CAD suitable for PCI. The study demonstrated that patients diagnosed with CAD by ICA and with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">invasively-measured positive FFR had rates of major adverse cardiovascular events that were lower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">with PCI and medical management than with medical management alone (8.1% vs. 19.5%) (p &#60; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; white-space: pre;">0.001)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 118.34pt; position: absolute; text-decoration: none; white-space: pre;">. This reduction was driven by a lower rate of urgent revascularization in the PCI group (4.0% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">vs. 16.3%) (p &#60; 0.001), with no significant between-group differences in the rates of death and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">myocardial infarction.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sales and marketing<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">We believe the Heartflow Platform adds significant value across all the subspecialties that impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">cardiovascular care including referring cardiologists, imaging physicians, and interventionalists. We have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">structured our sales force to efficiently call on these key physician stakeholders, with a primary focus on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">the imaging physicians who are instrumental in new account adoption and the referring physicians who <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">are critical to driving volume growth at accounts in our installed base. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We market and sell our Heartflow Platform in United States through a direct sales organization. As of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2024, our U.S. commercial team included 40 TSMs focused on opening new accounts, 48 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">TAMs who are focused on broadening referring physician awareness of the CCTA + Heartflow pathway <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and driving increased volumes at accounts in our installed base, and our customer success organization <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that supports seamless onboarding, implementation and ongoing utilization at our accounts. We support <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our direct commercial efforts with a marketing team that generates demand for the CCTA + Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pathway and highlights clearly defined value propositions for the various stakeholders across our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer base including cardiologists, radiologists and interventional cardiologists.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our TSMs engage with physicians to communicate the value proposition of the Heartflow Platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">leveraging our large base of clinical evidence to highlight its clinical and economic benefits as well as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lack of any new capital equipment purchase to drive new account adoption. Our TSMs have substantial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience selling into cardiology and radiology practices as well as engaging with broad stakeholders to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">establish new diagnostic and therapeutic solutions, employing an enterprise sales strategy. Our TAMs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utilize our extensive clinical compendium to educate and train physicians on the benefits of our platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ultimately driving more referrals to our accounts. Our TAMs have strong backgrounds in establishing new, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disruptive therapies and growing a cardiology referral base. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">127<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="left: 72pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 172.32pt; width: 468pt;" src="business15ba.jpg" alt="business15ba.jpg"></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 257.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Figure 13&#58; Overview of Heartflow call points<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 277.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our software is simple, intuitive and does not require case coverage by our sales reps, which affords our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 289.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial organization a differentiated level of efficiency relative to most other medical device <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology companies. We intend to drive further adoption of our Heartflow Platform by leveraging our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 313.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">existing and highly efficient cohort of TSMs and TAMs to continue opening new accounts and driving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 325.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume growth. We expect to selectively add additional TSMs to grow our geographic presence where we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 337.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">see areas of opportunity and modestly grow our team of TAMs to continue to drive awareness of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefits of our technology and broaden our referring physician population as our installed base grows. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 369.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that all accounts with a CCTA program would benefit from adopting the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 381.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate that as of December 31, 2023, there were approximately 2,700 hospitals and outpatient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 393.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">facilities in the United States that perform CCTA, and this target account base has grown at a 10% CAGR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 405.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from 2018 to 2023 as accounts increasingly recognize the benefits of a guideline directed CCTA program, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on our analyses using Clarivate&#8217;s ProcedureFinder data repository. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also have small, direct commercial teams in the United Kingdom and Japan. We may continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand our commercial activities outside the United States in areas where we see potential opportunity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 461.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and supportive reimbursement dynamics. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 481.32pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 503.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have invested significantly in research and development efforts over more than a decade to establish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 515.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the first and most widely adopted AI-enabled non-invasive test for CAD that is authorized for marketing in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 527.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States. We have built sophisticated AI-based algorithms and established an intuitive, easy to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use web and mobile customer interface, developed secure data transfer software, a scalable cloud <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">database, and quality review software, all while facilitating operational scalability. Our highly skilled and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">focused research and development (&#8220;R&#38;D&#8221;) team has been pioneering AI-based coronary imaging for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 575.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">over a decade and remains uniquely positioned to continuously advance our Heartflow Platform. Our R&#38;D <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">team is comprised of PhD research scientists with expertise in AI-based algorithms and medical imaging, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alongside software engineers skilled in cloud architecture, AI algorithms, machine and deep learning and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">3D visualization, as well as product managers and designers who ensure optimal customer experience <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and design. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are continuing to invest in research and development efforts with the goal of driving improvements to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Heartflow Platform and expanding its applicability to additional disease states and patient populations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our near to medium term research and development priorities include&#58; (i) continuing to train and improve <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our AI algorithms to drive greater quality and efficiency and reduce manual involvement&#59; (ii) enhancing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 691.72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product features for both <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 183.64pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 228.62pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 248.04pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.7pt; position: absolute; white-space: pre;"> Analysis and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 318.36pt; position: absolute; text-decoration: none; white-space: pre;">Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 363.34pt; position: absolute; white-space: pre;">Plaque Analysis&#59; (iii) developing <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">128<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional workflow enhancements for our customers&#59; and (iv) expanding indications for our platform, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including asymptomatic risk prediction.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Reimbursement <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ability of our customers to obtain third-party payor coverage and payment for the use of our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform products for their patients is important to our business. Demand for our existing and new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products is, and will continue to be, affected by the extent to which government healthcare programs such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as Medicare and Medicaid and private health insurers reimburse our customers for the use of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products with their patients in the countries where we do business. We have successfully engaged with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third-party payors in major markets throughout the world to obtain coverage, coding, and payment rates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our products. Nonetheless, not all third-party payors reimburse our customers for our products in all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">situations. Third-party payor reimbursement for the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 363.38pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 372.04pt; position: absolute; white-space: pre;"> Analysis is broad&#59; however, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Plaque Analysis is our second commercial product and we continue to work to expand <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage and payment for its use. Even if we develop or acquire a promising new product that has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cleared for commercial distribution by the FDA, demand for the product may be limited unless our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers are reimbursed at favorable rates by private health insurers and government health care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs. Our Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 203.6pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 212.26pt; position: absolute; white-space: pre;"> Analysis is reimbursed under a dedicated Category 1 CPT code effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of January 1, 2024, and has established coverage policies representing approximately 99% of covered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lives in the United States. A Category 1 CPT code was also recently established for our Heartflow Plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis, which will take effect in January 2026, and it is covered by the MACs, with five of the seven <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MACs issuing final LCDs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the United States, our customers purchase Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 339.68pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.03pt; position: absolute; white-space: pre;">Analysis and Heartflow Plaque Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reports generated by our products for their patients. These customers then submit a claim to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable third-party payor for reimbursement. To the extent that coverage is denied on such claims, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the reimbursement paid does not exceed the customer&#8217;s cost for our products, demand for our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will wane or the charges for our products would have to be materially reduced. Internationally, healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement systems vary significantly. In some countries, our customers, such as hospitals, are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">constrained by fixed budgets, regardless of the volume and nature of patient treatment. Other countries <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require application for, and approval of, government or third-party payor reimbursement. Without both <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">favorable coverage determinations by, and the financial support of, government and private third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors, the market for of our products would be adversely affected. We cannot be sure that third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payors will maintain the current level of coverage and payment to our customers for use of our existing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products. Adverse coverage determinations, or reductions in the amount of reimbursement, could harm <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business by discouraging customers&#8217; ordering of, and reducing the prices they are willing to pay for, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">It is our intent to complete additional clinical studies and analyses, as needed, to obtain and continue to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expand coverage and payment at favorable rates for our products in countries or regions where it makes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic sense to do so. Nonetheless, coverage and payment for our products can differ from third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payor to third-party payor. Further, as a result of their purchasing power, third party payors have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implemented, and are continuing to implement, cost cutting measures such as seeking discounts, price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reductions or other incentives from medical products manufacturers, and imposing limitations on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">coverage and payment for medical technologies and procedures. These trends could compel us to reduce <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prices for our products and could cause a decrease in the size of the market or a potential increase in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competition that could negatively affect our business, financial condition and results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to uncertainties surrounding insurance coverage policies, there are periodic changes to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement levels by government payors and private health insurers. Third-party payors regularly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">update reimbursement amounts and also from time to time revise the methodologies used to determine <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursement amounts. This includes routine, annual updates to payments to hospitals under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outpatient prospective payment system (&#8220;OPPS&#8221;). These updates could directly impact the demand for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">129<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The overall escalating cost of medical products and services being paid for by the government and private <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health insurance has led to, and may continue to lead to, increased pressures on the healthcare and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical device industries to reduce the costs of products and services. Third-party payors are developing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increasingly sophisticated methods of controlling healthcare costs through prospective reimbursement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and capitation programs, group purchasing, redesign of benefits, and exploration of more cost-effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">methods of delivering healthcare. In the United States, some insured individuals enroll in managed care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs, which monitor and often require pre-approval of the services that a member will receive. Some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managed care programs pay their providers on a per capita (patient) basis, which puts the providers at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial risk for the services provided to their patients by paying these providers a predetermined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment per member per month and, consequently, may limit the willingness of these providers to use <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our products.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Competition<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We consider our primary competition to be traditional non-invasive tests for CAD including primarily stress <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tests such as SPECT, stress echocardiography and PET. The primary providers of imaging systems that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">perform these tests include Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V. and Canon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medical Systems Corporation. These companies also manufacture CT scanners and therefore have a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vested interest in growing the CCTA market in addition to protecting their share of the non-invasive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market. These are large, multi-national, commercial organizations with significant resources and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distribution capabilities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also face competition from companies that have developed or are developing AI-based platforms that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">leverage CCTA to diagnose CAD, including earlier-stage companies such as Cleerly, Inc., Elucid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bioimaging Inc. and Keya Medical Technology Co., Ltd. We may also face competition from companies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing AI-based platforms, even if they are not currently in the CAD market. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe the primary competitive factors in our market include&#58; (i) the accuracy, reliability, and utility of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the test as demonstrated by the strength and quality of clinical data directly utilizing the test and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supporting it&#59; (ii) speed and efficiency of achieving a definitive diagnosis at scale&#59; (iii) per patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economics including reimbursement rates and relative costs&#59; (iv) availability and ease of use including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integration within hospital systems and clinical workflows as well as customer support&#59; and (v) effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketing and physician education efforts as well as ability to impact physician mindshare and historical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practice patterns<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.88pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Intellectual<font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 134.64pt; position: absolute; text-decoration: none; white-space: pre;"> property<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our success depends in part on our ability to obtain, maintain and defend our patent and other proprietary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights for the Heartflow Platform, the validity and enforceability of our patents, our ability to operate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without infringing the valid and enforceable patents and proprietary rights of third-parties and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continued confidentiality of our know-how and trade secrets. We are actively involved in research and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development and therefore seek to protect the investments we have made into the development of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform and our proprietary technology by relying on a combination of patents, trademarks, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade secrets, and licenses, as well as through internal compartmentalization processes, confidentiality <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements and proprietary information agreements with suppliers, employees, consultants and others <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who may have or gain access to our proprietary information. We seek patent protection in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States and key markets internationally for the Heartflow Platform, and any other inventions to which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have rights, where available and appropriate. We also rely upon trademarks to build and maintain the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">integrity and identity of our brand, and we seek to protect the confidentiality of trade secrets that may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">important to the development of our business, especially where we do not believe patent protection is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate or obtainable. We license from third parties certain patent rights and proprietary know-how <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that we believe to be useful to our business. We have non-exclusively licensed some patents in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent portfolio to a small number of licensees in a limited field of use that is outside of CCTA, and we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">believe that those licensees' product offerings covered by our patent portfolio are complementary to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product offerings.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">130<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our patent portfolio, described more fully below, includes claims directed to the Heartflow Platform and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delivery, as embodied in various systems, computer programs, computer implemented methods and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related methods of use. These claims are directed to various aspects of deriving anatomical and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">physiological information from image data for the Heartflow Platform, aspects of the Heartflow Platform <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">user interface, machine learning methods for generation of the 3D models used for our FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 476.37pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 486.72pt; position: absolute; white-space: pre;">Analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Plaque Analysis products, and methods of deriving blood flow, anatomy, plaque and organ tissue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information from the image data. A number of our issued patents also cover indications other than CAD, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as peripheral artery disease, stroke, or aneurysms as well as technical applications related to image <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">data analysis and processing, and platform-related PHI and data transfer methodologies and a number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued patents cover alternative methods such as deriving FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 350.85pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 359.51pt; position: absolute; white-space: pre;"> using purely machine learning methods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or from other imaging modalities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, our owned and licensed patent portfolio includes approximately five hundred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and eighty-six (586) issued patents and one hundred and three (103) pending patent applications globally, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of which nine (9) are allowed. In the U.S. this includes three hundred and nine (309) issued U.S. patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and fifty-six (56) pending non-provisional U.S. patent applications (of which three (3) are allowed). In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign jurisdictions our owned and licensed patent portfolio includes two-hundred and eighty (280) issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign patents and forty-seven (47) pending foreign patent applications (of which five (5) are allowed). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The two-hundred and eighty (280) issued foreign patents include one or more issued patents in Europe, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Japan, Korea, China, Australia, Canada, India, Hong Kong, and Israel. We also filed twenty-three foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utility models between 2011 and 2014, having ten-year terms, all of which have expired. The forty-seven <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(47) pending foreign patent applications include one or more pending applications in jurisdictions such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Europe, Canada, China, and Japan. We own all of our issued patents except for 7 issued U.S. patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and 8 issued foreign patents, for which we have exclusive licenses. All of the issued U.S. patents in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">portfolio are utility patents. Assuming payment of all appropriate maintenance, renewal, annuity or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governmental fees, as applicable, our owned and licensed issued U.S. patents expire between 2018 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2041. If issued, our last to expire pending patent application (without accounting for potentially applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent term adjustments or extensions) is expected to expire in 2045. One of our U.S. patents expired in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2018 and we do not expect any additional expirations in the near-term. The next expiration of a Heartflow-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licensed patent is expected to be in 2028. The next expiration of a Heartflow-owned patent is expected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be in 2031. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our patents and applications generally fall into three broad categories&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications and patents relating to our Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 309.40999999999997pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 328.83000000000004pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 339.18pt; position: absolute; text-decoration: none; white-space: pre;">Analysis, including claims directed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">segmentation, determining blood flow characteristics using artificial intelligence and&#47;or fluid dynamics, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and visualization generation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications and patents relating to our Heartflow Plaque Analysis, including claims directed to plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and vessel visualization and characterization&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">applications and patents relating to our Heartflow RoadMap Analysis, including claims directed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">image quality and annotation, segmentation, and vascular tree generation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The term of individual patents depends upon the legal term of the patents in the countries in which they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are obtained. In most countries in which we file or intend to file, including the United States, the patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">term is 20 years from the earliest date of filing a non-provisional patent application. Additionally, a U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisional patent application expires twelve months from its filing date, and its subject matter can only be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claimed in an issued patent if, among other things, we timely file a non-provisional patent application <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making a valid priority claim to that provisional patent application before it expires. In the United States, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative delays by the USPTO in examining and granting a patent, or may be shortened if a patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is terminally disclaimed over an earlier filed patent. The coverage sought in a patent application can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">denied or significantly reduced either before or after the patent is issued. We cannot be sure that patents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be granted with respect to any current pending patent application or with respect to any patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applications filed by us in the future, nor can we be certain that any current pending or published patent <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">131<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application will be granted with the current claims or that any current or future patents will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercially useful in protecting the Heartflow Platform and our proprietary technology. In addition, any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patents that we may hold, whether owned or licensed, may be challenged, circumvented or invalidated by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">third-parties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The success of our business strategy also depends in part on our continued ability to protect our brand. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We own registered trademarks for the Heartflow Platform. We also own and maintain registration for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">number of domain names. As of December 31, 2024, we have registered the trademarks &#8220;HEARTFLOW&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">word mark and logo with the USPTO. Although we own registered trademarks and domain names in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">United States and certain other countries, and have filed trademark applications and secured domain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">name registrations in the United States and in certain other countries, we do not have assurance that our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trademark portfolio will be adequate to secure or protect all necessary trademarks that we use. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Heartflow Platform also implements software modules licensed to us by third-party authors under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;open source&#8221; licenses. The use of open source software may entail greater risks than the use of third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party commercial software. Please see &#8220;Risk factors&#8212;Risks related to our intellectual property&#8221; for more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">description of these risks. We have established a review process for screening requests from our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development organizations for the use of such software that is designed to help us mitigate risks related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the quality of any open source software implemented in our technology platform. We also review any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">open source software used to support our software development, but not directly incorporated into the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform, as part of our general quality management processes. While these review processes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">help us mitigate risks associated with the quality of the open source software incorporated into or used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developing the Heartflow Platform, we cannot be sure that all open source software is submitted for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval prior to use in connection with the Heartflow Platform. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We also rely on trade secrets, including know-how, unpatented technology and other proprietary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information, to strengthen our competitive position. We seek to protect trade secrets and confidential and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unpatented know-how, in part, by entering into non-disclosure and confidentiality agreements with parties <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who have access to such knowledge, such as our employees, collaborators, manufacturers, consultants, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advisors and other third parties. We also seek to enter into confidentiality and invention or patent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assignment agreements with our employees and consultants that obligate them to maintain confidentiality <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and assign their inventions to us. We also seek to preserve the integrity and confidentiality of our data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and trade secrets by maintaining the physical security of our premises and physical and electronic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">security of our information technology systems.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our ability to stop third-parties from making, using, selling, offering to sell or importing the Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform depends on the extent to which we have rights under valid and enforceable patents, trade <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">secrets or other intellectual property and proprietary rights that cover these activities. We pursue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property protection to the extent we believe it would advance our business objectives. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notwithstanding these efforts, there can be no assurance that we will adequately protect our intellectual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">property or provide any competitive advantage. For more information regarding risks relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intellectual property, see &#8220;Risk factors&#8212;Risks related to our intellectual property.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Government regulation<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">United States regulation of medical devices<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our products are medical devices subject to extensive and ongoing regulation by the United States Food <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Drug Administration (&#8220;FDA&#8221;), the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;), the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Department of Health and Human Services Office of Inspector General (&#8220;OIG&#8221;) and regulatory bodies in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States and other countries. Regulations govern virtually every critical aspect of a medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device company&#8217;s business operations, including research activities, product development and testing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing and production, contracting, reimbursement, product messaging, medical communications, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales, marketing and advertising. In the United States, the Federal Food, Drug and Cosmetic Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;FDCA&#8221;) and the implementing regulations of the FDA govern product design and development, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preclinical and clinical testing, premarket clearance or approval, product manufacturing, product labeling, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">132<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product storage, advertising and promotion, product sales and distribution, import, export and post market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical surveillance. Our business is subject to federal, state, local, and foreign regulations, such as ISO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">13485&#58;2016, ISO 14971&#58;2019, FDA&#8217;s Quality System Regulation (&#8220;QSR&#8221;) contained in 21 CFR Part 820, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the EU&#8217;s Medical Devices Directive 93&#47;42&#47;EEC and its replacement, Regulation (EU) 2017&#47;745. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Platform consists of three main analyses&#59; Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 366.32pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT <font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.67pt; position: absolute; white-space: pre;">Analysis, Heartflow Roadmap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Analysis, and Heartflow Plaque Analysis. All three are authorized for clinical use in the United States, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bahrain, Israel, Saudi Arabia, and the United Arab Emirates. Only the FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 399.65pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408.31pt; position: absolute; white-space: pre;"> Analyses is authorized for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical use in the European Economic Area, United Kingdom, Australia, Canada, and Japan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">FDA premarket clearance and approval requirements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless an exemption applies, each medical device commercially distributed in the United States requires <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">either FDA clearance of a 510(k) premarket notification, grant of a de novo classification request, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval of a premarket approval (&#8220;PMA&#8221;) application. Our Heartflow Platform is regulated in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States by the FDA as a Class II medical device. The FDA classifies medical devices into one of three <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classes. Devices deemed to pose low to moderate risk are designated as either Class I or II. Class I <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices are subject to general controls such as establishment registration and device listing, labeling, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adherence to current good manufacturing practices outlined in the QSR, maintenance and investigation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product complaint records, and adverse event reporting, but are usually exempt from premarket <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notification requirements. Class II devices are subject to the same general controls and may be subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">special controls such as performance standards, post-market surveillance, particularized labeling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements and&#47;or clinical testing prior to clearance. Manufacturers of Class II devices, absent an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exemption, are required to submit to the FDA a premarket notification prior to commercial distribution. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Devices are designated as Class III, which requires approval of a PMA application, if they are deemed by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the FDA to pose the greatest risk. These high-risk devices include life sustaining or life supporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices, certain implantable devices, and other devices that are intended for a use that is of substantial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">importance in preventing impairment of human health or that present a potential unreasonable risk of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">illness or injury. The PMA approval process is more comprehensive than the 510(k) clearance process <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and typically takes several years to complete.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">510(k) clearance marketing pathway<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A 510(k) notification requires the sponsor to demonstrate that a medical device is substantially equivalent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to another marketed device, termed a &#8220;predicate device,&#8221; that is legally marketed in the United States and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for which a PMA was not required. A device is substantially equivalent to a predicate device if it has the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">same intended use and technological characteristics as the predicate, or has the same intended use but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">different technological characteristics that do not raise new questions of safety and effectiveness, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information submitted to the FDA demonstrates that the device is at least as safe and effective as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">predicate device.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If the FDA agrees that the device is substantially equivalent to a predicate device currently on the market, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">it will grant 510(k) clearance to commercially market the device. If there is no viable predicate device for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new device because, for example, of a new intended use, the device is automatically designated as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Class III device. Unless the De Novo pathway is available for the new device, the device sponsor must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fulfill more rigorous PMA requirements. The PMA process requires that the manufacturer demonstrate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that the device is safe and effective for its intended uses, which generally requires the submission of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extensive data, including results from pre-clinical studies and human clinical trials. A PMA must also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contain a full description of the device and its components, the methods, facilities, and controls used for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing, and proposed labeling. The PMA process is burdensome, and in practice, the FDA&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review of a PMA application may take up to several years following initial submission. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After a device receives 510(k) clearance, any modification that could significantly affect its safety or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectiveness, or that would constitute a new or major change in its intended use, requires a new 510(k) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearance, or depending on the modification, could require the filing of a de novo classification request or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a PMA application, which would require the submission to the FDA of clinical trial data, among other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information. We are required to determine, for each modification to our cleared products, whether to <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">133<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">submit a new 510(k) notification for the modification, based on the nature of the modification. If we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine a new 510(k) submission is not required, the decision and justification are documented in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;letter to file.&#8221; If the FDA disagrees with our determination, the FDA can require us to cease marketing or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recall the modified device until 510(k) clearance, grant of a de novo classification request or approval of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">PMA is obtained. We have made, and we plan to continue to make, minor product enhancements to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cleared products that we believe do not require new 510(k) clearances and that we document in letters to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file. We also intend to make product enhancements from time to time that we expect may require new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">510(k) clearances.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">De novo classification process<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A manufacturer can request a risk-based classification determination for a novel device in accordance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the &#8220;de novo&#8221; process. Medical device types that the FDA has not previously classified as Class I, II, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or III are automatically classified into Class III regardless of the level of risk they pose. The Food and Drug <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administration Modernization Act of 1997 established a route to market for low-to-moderate risk medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices that are automatically placed into Class III due to the absence of a predicate device, called the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Request for Evaluation of Automatic Class III Designation,&#8221; or the de novo classification procedure. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">procedure allows a manufacturer whose novel device is automatically classified into Class III to request <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">down-classification of its medical device into Class I or Class II on the basis that the device presents low <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or moderate risk, rather than requiring the submission and approval of a PMA application. Pursuant to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Food and Drug Administration Safety and Innovation Act (&#8220;FDASIA&#8221;), manufacturers may request de novo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classification directly without first submitting a 510(k) pre-market notification to the FDA and receiving a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not-substantially-equivalent determination. De novo classification requests, like PMA applications and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">510(k) notifications, are subject to the payment of user fees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under the FDASIA, the FDA is required to reach a decision within 120 days following receipt of the de <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">novo request, although the process may take significantly longer. If the manufacturer seeks <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reclassification into Class II, the manufacturer must include a draft proposal for special controls that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary to provide a reasonable assurance of the safety and effectiveness of the medical device. If the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FDA grants the de novo request, the device may be legally marketed in the United States. However, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FDA may reject the request if the FDA identifies a legally marketed predicate device that would be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate for a 510(k) notification, determines that the device is not low-to-moderate risk, or determines <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that General Controls would be inadequate to control the risks and&#47;or special controls cannot be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developed. After a device receives de novo classification, any modification that could significantly affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its safety or efficacy, or that would constitute a major change or modification in its intended use, will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require a new 510(k) clearance or, depending on the modification, another de novo request or even PMA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We obtained initial marketing authorization for Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 341.73pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 350.39pt; position: absolute; white-space: pre;"> Analysis through the FDA&#8217;s &#8220;de novo&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">classification process, supported by clinical data from our NXT clinical trial. Through this process, the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreed that special controls provide reasonable assurance of the safety and effectiveness of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 136.4pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.06pt; position: absolute; white-space: pre;"> Analysis and therefore it can be classified as a Class II device. We received a de novo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorization on November 26, 2014 for version 1.4 of the Heartflow FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 394.7pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.36pt; position: absolute; white-space: pre;"> Analysis. We received the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">510(k) clearance for version 2.x of the FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 261.94pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.6pt; position: absolute; white-space: pre;"> product in January 2015, and 510(k) clearance for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modification to the intended use language in August 2016. Additional clearances were received for a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">strategic architecture scope change in December 2018, which is the device we refer to as Heartflow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Platform. The Heartflow Platform version 3.0 received FDA clearance in January 2021, and the newest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product generation, Heartflow Platform version 3.18, adding Roadmap and Plaque functions, received <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FDA clearance in October 2022.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Medical device clinical trials<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Clinical trials are sometimes required to support 510(k) or de novo submissions. All clinical investigations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of devices to determine safety and effectiveness must be conducted in accordance with the FDA&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigational device exemption (&#8220;IDE&#8221;) regulations which govern investigational device labeling, prohibit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promotion of the investigational device, and specify an array of recordkeeping, reporting and monitoring <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">134<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibilities of study sponsors and study investigators. If the device presents a &#8220;significant risk&#8221; to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">human health, as defined by the FDA, the FDA requires the device sponsor to submit an IDE application <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the FDA, which must become effective prior to commencing human clinical trials. If the device under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluation does not present a significant risk to human health, then the device sponsor is not required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">submit an IDE application to the FDA before initiating human clinical trials, but must still comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">abbreviated IDE requirements when conducting such trials. A significant risk device is one that presents a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential for serious risk to the health, safety or welfare of a patient and either is implanted, used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disease or otherwise preventing impairment of human health, or presents a potential for serious risk to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient in some other way. An IDE application must be supported by appropriate data, such as animal and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laboratory test results, showing that it is safe to test the device in humans and that the testing protocol is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">scientifically sound. The IDE will automatically become effective 30 days after receipt by the FDA unless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the FDA notifies the company that the investigation may not begin. If the FDA determines that there are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trial to proceed under a conditional approval.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regardless of the degree of risk presented by the medical device, clinical studies must be approved by, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and conducted under the oversight of, an Institutional Review Board (&#8220;IRB&#8221;) for each clinical site. The IRB <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is responsible for the initial and continuing review of the clinical study, and may pose additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements for the conduct of the study. If an IDE application is approved by the FDA and one or more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IRBs, human clinical trials may begin at a specific number of investigational sites with a specific number <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of patients, as approved by the FDA. If the device presents a non-significant risk to the patient, a sponsor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may begin the clinical trial after obtaining approval for the trial by one or more IRBs without separate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval from the FDA, but must still follow abbreviated IDE requirements, such as monitoring the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements. Acceptance of an IDE application for review does not guarantee that the FDA will allow the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IDE to become effective and, if it does become effective, the FDA may or may not determine that the data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derived from the trials support the safety and effectiveness of the device or warrant the continuation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical trials.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During a study, the sponsor is required to comply with the applicable FDA requirements, including, for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">example, trial monitoring, selecting clinical investigators and providing them with the investigational plan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ensuring IRB review, adverse event reporting, record keeping and prohibitions on the promotion of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigational devices or on making safety or effectiveness claims for them. The clinical investigators in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the clinical study are also subject to FDA&#8217;s regulations and must obtain patient informed consent, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rigorously follow the investigational plan and study protocol, control the disposition of the investigational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device, and comply with all reporting and recordkeeping requirements. Additionally, after a trial begins, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, such as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">strategic business decisions or a belief that the risks to study subjects may outweigh the anticipated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">benefits.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Expedited development and review programs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Following passage of the 21st Century Cures Act, the FDA implemented the Breakthrough Devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Program, which is a voluntary program offered to manufacturers of certain medical devices and device-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">led combination products that may provide for more effective treatment or diagnosis of life-threatening or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">irreversibly debilitating diseases or conditions. The goal of the program is to provide patients and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare providers with more timely access to qualifying devices by expediting their development, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment and review, while preserving the statutory standards for PMA approval, 510(k) clearance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">de novo classification. The program is available for medical devices that meet certain eligibility criteria, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including that the device provides more effective treatment or diagnosis of a life-threatening or irreversibly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debilitating disease or condition, and that&#58; (i) the device represents a breakthrough technology, (ii) no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approved or cleared alternatives exist, (iii) the device offers significant advantages over existing approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or cleared alternatives, or (iv) the availability of the device is in the best interest of patients. Breakthrough <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Device Designation provides certain benefits to device developers, including more interactive and timely <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">135<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">communications with FDA staff&#59; use of post-market data collection, when scientifically appropriate, to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">facilitate expedited and efficient development and review of the device&#59; opportunities for more efficient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and flexible clinical study design&#59; and prioritized review of premarket submissions. When reviewing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Breakthrough Device Designation requests, the FDA may require a combination of literature or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preliminary bench, animal or clinical data to demonstrate a reasonable likelihood of clinical and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technological success. Receiving a Breakthrough Device Designation from the FDA does not guarantee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that the FDA will grant marketing authorization for the device.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Post-market regulation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After a device is approved or cleared and placed in commercial distribution, numerous FDA regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements apply. These include, but are not limited to, requirements to&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">register establishments and list devices with the FDA&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">maintain a quality system that is compliant with the QSR, which governs design, development, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">manufacture of devices&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">establish various specifications and controls for incoming components and finished devices&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensure that devices are designed to meet user needs&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">verify that finished devices are manufactured to the appropriate controls and that they meet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">specifications&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensure that devices are assigned and labeled with a Unique Device Identifier (&#8220;UDI&#8221;) and that certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">UDI information is provided to FDA&#8217;s Global Unique Identification Database (&#8220;GUDID&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ensure that labeling and advertising and promotional activities are consistent with cleared&#47;approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">uses, adequately substantiated, and truthful and not misleading&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">analyze quality data to identify and correct quality problems&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">submit notifications or applications for clearance or approval of product modifications that could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">significantly affect safety or effectiveness or that would constitute a major change in intended use&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">review, evaluate and investigate complaints and report adverse events to the FDA when a device may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">have caused or contributed to a death or serious injury or malfunctioned in a way that would be likely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to cause or contribute to a death or serious injury if the malfunction were to recur&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">report to FDA corrections and removals undertaken to reduce a risk to health posed by the device or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to remedy a violation of the FDCA that may present a risk to health. In addition, FDA may order a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">mandatory recall if there is a reasonable probability that the device would cause serious adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">health consequences or death&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">comply with any post-approval restrictions or conditions, including requirements to conduct post-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">market surveillance studies to establish continued safety data&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conduct clinical studies in accordance with good clinical practices and applicable regulations, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">including requirements for clinical trial registration and results reporting on ClinicalTrials.gov.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Manufacturing processes for medical devices are required to comply with the applicable portions of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">QSR, which cover the methods and the facilities and controls for the design, manufacture, testing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">production processes and controls, quality assurance, labeling, packaging, distribution, installation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">servicing of finished devices intended for human use. The QSR also requires, among other things, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintenance of a device master file, device history file, device history record and complaint files. As a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturer, we are subject to periodic scheduled or unscheduled inspections by the FDA. Failure to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintain compliance with the QSR requirements could result in the shutdown of, or restrictions on, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing operations and the recall or seizure of marketed products. In February 2024, the FDA <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">136<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued the Quality Management System Regulation Final Rule (&#8220;QMSR&#8221;) to amend the QSR, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporating by reference the international standard for medical device quality management systems, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ISO 13485&#58;2016. The rule becomes effective on February 2, 2026. Until then, manufacturers are required <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to comply with the QSR. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The FDA polices these requirements by inspection, review of required reports or submissions, and market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surveillance, and the agency has broad enforcement powers to address any violations. The FDA may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct announced or unannounced facility inspections to determine compliance with the QSR and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations, and these inspections may include our manufacturing facilities. Failure to comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable regulatory requirements can result in enforcement action by the FDA or other regulatory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities, which may result in sanctions and related consequences, including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">untitled letters or warning letters or it has come to our attention letters&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">injunctions or consent decrees&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">fines or civil penalties&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">recall, detention, or seizure of our product&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">operating restrictions, partial suspension, or total shutdown of production&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA&#8217;s refusal of or delay in granting 510(k) clearance or premarket approval of new or modified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">products&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">withdrawal of 510(k) clearances or PMA approvals&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the FDA&#8217;s refusal to grant export certificates&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">criminal prosecution&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">unanticipated expenditures to address or defend such actions&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reputational harm resulting from such actions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other regulatory authorities overseeing the implementation and adherence of applicable state, federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and analogous foreign regulatory authorities may also conduct unannounced inspections. Such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inspections may result in similar administrative, civil and criminal penalties. The discovery of previously <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unknown problems with marketed medical devices, including unanticipated adverse events or adverse <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">events of increasing severity or frequency, whether resulting from the use of the device within the scope <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of its clearance or off-label by a physician in the practice of medicine, could result in restrictions on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">device, including the removal of the product from the market or voluntary or mandatory device recalls.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">International regulation &#8212; European Union, United Kingdom, Japan and Canada<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In order to market and sell our product outside of the United States, we must comply with numerous and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">varying regulatory requirements of other countries and jurisdictions regarding quality, safety, and efficacy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and governing, among other things, clinical trials, marketing authorization, commercial sales and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distribution of our product.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although many of the regulatory issues we face in the United States are similar to the issues in other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">geographies, the approval or certification process varies between countries and jurisdictions and can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involve additional testing and additional administrative review periods. The time required to obtain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approval or certification in other countries and jurisdictions might differ from and be longer than that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">required to obtain clearance from the FDA. Regulatory approval or certification in one country or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction does not ensure regulatory approval or certification in another, but a failure or delay in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obtaining regulatory approval or certification in one country or jurisdiction may negatively impact the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulatory process in others.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">137<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">European Union<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The primary regulatory environment in Europe is that of the European Union, which includes most of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">major countries in Europe. The law regarding medical devices is harmonized in the European Union. Until <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a few years ago, medical devices were governed by the Medical Devices Directive 93&#47;42&#47;EEC (&#8220;MDD&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the Active Implantable Medical Devices Directive 90&#47;385&#47;EEC (&#8220;AIMD&#8221;), implemented by the member <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">states of the European Union into their national law. However, on May 26, 2021,the Medical Devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulation (EU) 2017&#47;745 (&#8220;MDR&#8221;) entered into application, repealing and replacing the MDD and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AIMD. As a Regulation, the MDR is directly applicable in all member states of the European Union and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not require further implementation into national law. The MDR and its associated guidance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">documents and harmonized standards govern, among other things, device design and development, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preclinical and clinical or performance testing, premarket conformity assessment, registration and listing, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturing, labeling, storage, claims, sales and distribution, export and import and post-market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surveillance, vigilance, and market surveillance. The MDR is based on very similar general system as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDD, but adds obligations on manufacturers and distributors of medical devices. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Since May 26, 2021, medical devices placed on the European Union market must conform to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements set out by the MDR. Medical devices must comply with the General Safety and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Performance Requirements (&#8220;GSPRs&#8221;) set out in Annex I of the MDR. Compliance with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements is a prerequisite to be able to affix the CE mark to devices, without which they cannot be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">marketed or sold in the European Union. To demonstrate compliance with the GSPRs provided in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDR and obtain the right to affix the CE mark, medical devices manufacturers must undergo a conformity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment procedure. The conformity assessment procedure varies depending on the class of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product, but most cases involve an assessment by a Notified Body. Depending on the relevant conformity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment procedure, this assessment may consist of a review of the technical file submitted by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturer, an audit of the quality system of the manufacturer, and testing of the product of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">manufacturer. Even though a Notified Body is a private organization in one of the member states of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">European Union, all Notified Bodies in the European Union are designated and accredited by a national <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government of the European Union based on stringent criteria. Only such accredited Notified Bodies may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">give a CE Certificate of Conformity following successful completion of a conformity assessment procedure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted in relation to the medical device and its manufacturer and their conformity with the GSPRs. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The CE Certificate of Conformity confirms the conformity of the device to the GSPRs and allows the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicant to affix the CE mark on the assessed medical device and to commercialize it in the European <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Union after having prepared and signed a related European Union Declaration of Conformity. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a general rule, demonstration of conformity of medical devices and their manufacturers with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">GSPRs must be based, among other things, on the evaluation of clinical data supporting the safety and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance of the products during normal conditions of use. Specifically, a manufacturer must <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demonstrate that the device achieves its intended performance during normal conditions of use and that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against the benefits of its intended performance, and that any claims made about the performance and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">safety of the device (e.g., product labeling and instructions for use) are supported by suitable evidence. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This assessment must be based on clinical data, which can be obtained from (i) clinical studies conducted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the devices being assessed, (ii) scientific literature from similar devices whose equivalence with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessed device can be demonstrated or (iii) both clinical studies and scientific literature. The conduct of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clinical studies in the European Union is governed by detailed regulatory obligations. These may include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the requirement of prior authorization by the Competent Authorities of the country in which the study takes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">place and the requirement to obtain a positive opinion from a competent Ethics Committee. This process <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">can be expensive and time-consuming. After a device is placed on the market in the European Union, it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remains subject to significant regulatory requirements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The MDR also establishes transitional provisions, amended by Regulation (EU) 2023&#47;607, permitting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain devices that have been CE marked in accordance with the MDD or the AIMD to continue to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">placed on the European Union market under strict conditions and for a specific period of time depending <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the risk classification of the device and the date of issuance of any related CE Certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">138<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conformity. Accordingly, CE Certificates of Conformity issued by Notified Bodies in accordance with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDD or the AIMD from May 25, 2017, and which remained valid on May 26, 2021 and have not since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">been withdrawn will, with certain exceptions, remain valid until December 31, 2027 for Class III and Class <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IIb implantable medical devices and until December 31, 2028 for other Class IIb, Class IIa and Class I <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices with a measuring function or which are sterile. Class I medical devices, for which the conformity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assessment procedure in accordance with the MDD or the AIMD did not require the involvement of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notified Body but will require the involvement of a Notified Body in accordance with the MDR and for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which an European Union Declaration of Conformity was issued in accordance with the MDD or the AIMD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to May 26, 2021, can continue to be placed on the European Union market until December 31, 2028. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Manufacturers of medical devices may only benefit from the above extended transitional provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deadlines if the following conditions are fulfilled&#58; (i) the devices continue to comply with the requirements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the MDD or AIMD, as applicable, (ii) there are no significant changes in the design and intended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purpose, (iii) the devices do not present an unacceptable risk to the health or safety of patients, users or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other persons, or to other aspects of the protection of public health, (iv) the manufacturer implements a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality management system by May 26, 2024 which complies with the requirements of the MDR, (v) by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">May 26, 2024 an application is lodged with a Notified Body for conduct of the conformity assessment of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the devices covered by the CE Certificate of Conformity, or the devices intended to substitute for such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">devices, in accordance with the MDR and a related written agreement is signed with the Notified Body by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">September 26, 2024, and (vi) from May 26, 2021, compliance with the MDR relating to post-market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">surveillance, market surveillance, vigilance, registration of economic operators and of devices is ensured <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in place of the corresponding requirements in the MDD or AIMD.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, CE Certificates of Conformity issued by Notified Bodies in accordance with the MDD or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">AIMD from May 25, 2017, which were valid on May 26, 2021 and have not been withdraw since but which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expired before March 20, 2023, will only continue to be valid in accordance with the extended transitional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deadlines above if either (i) the manufacturer signed a written agreement with a Notified Body for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conformity assessment of the device covered by the expired CE Certificate of Conformity, or the device <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">intended to substitute that device, in accordance with the MDR before the date of expiry of the CE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certificate of Conformity, or (ii) a competent authority of an European Union Member State has granted a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derogation from the application conformity assessment procedure in accordance with Article 59(1) or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Article 97(1) of the MDR.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On July 26, 2011, our Notified Body at the time, TUV Nord, issued a CE Certificate of Conformity for, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thus allowed us to affix the CE mark, version 1.0 of the Heartflow Platform (July 26, 2011). The CE <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certificate of Conformity was subsequently reviewed for version 2.x of the Heartflow Platform and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">confirmed in March of 2017. Our current version, version 3.x is also CE marked under the MDD <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(November 20, 2019). We currently rely on the transitional provisions of the MDR to continue to place <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">version 3.x of the Heartflow Platform on the market in the European Union.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, TUV Nord assessed the conformity of our quality management system (&#8220;QMS&#8221;) with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">industry standard, EN ISO 13485, and TUV Nord issued the certificate confirming that we meet all EN ISO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">13485 requirements. Based on the EN ISO certificate, TUV Nord also issued a certificate under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDSAP (Medical Device Single Audit Program), stating that the requirements of EN ISO 13485&#58;2016 for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality management systems are met in Australia, Canada, USA and Japan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the second half of 2024, we changed Notified Bodies from TUV Nord to BSI by an agreement between <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">TUV Nord, BSI and us. BSI has taken over Notified Body responsibilities concerning all MDD&#47;MDR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements. BSI has also taken over our QMS certifications. After this transfer, all certificates issued by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">TUV Nord remain valid and in effect. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The advertising and promotion of medical devices in the European Union is subject to the national laws of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the individual European Union Member States that implemented the MDD, the AIMD and that apply the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MDR, Directive 2006&#47;114&#47;EC concerning misleading and comparative advertising, and Directive 2005&#47;29&#47;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">EC on unfair commercial practices, as well as other national legislation of individual European Union <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Member States governing the advertising and promotion of medical devices. European Union Member <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">139<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States&#8217; national legislation may also restrict or impose limitations on our ability to advertise our products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directly to the general public. In addition, voluntary European Union and national industry Codes of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conduct provide guidelines on the advertising and promotion of our products to the general public and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may impose limitations on our promotional activities with healthcare professionals.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, other countries, such as Switzerland, have voluntarily adopted laws and regulations relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">medical devices that mirror those of the European Union. Medical devices certified by a Notified Body and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CE marked in the European Union may be placed on Swiss market.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The United Kingdom left the European Union in January of 2020 and the transitional period ended on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2020. In light of the fact that the CE Marking process is set out in European Union law, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which no longer applies in the United Kingdom, the United Kingdom has devised a new route to market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">culminating in a UKCA Mark to replace the CE Mark. Northern Ireland will, however, continue to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">covered by the regulations governing CE Marks. The United Kingdom Medicines and Healthcare products <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulatory Agency (&#8220;MHRA&#8221;) has established transitional provision to recognize the acceptance of certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CE marked medical devices on the Great Britain market until June 30, 2030, at the latest, depending on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the type of device and its classification. Accordingly, medical devices which, for example, meet all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements of the European Union MDD and have a valid CE Certificate of Conformity and European <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Union Declaration of conformity issued under the MDD prior to May 26, 2021, may be placed on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market until the sooner of expiry of the CE Certificate of Conformity or June 30, 2028. Medical devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which meet all requirements of the European Union MDR may be placed on the market until June 30, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2030. Manufacturers of medical devices located outside the United Kingdom, including manufacturers of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">CE marked medical devices, need to appoint a United Kingdom Responsible Person before the devices <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be placed on the United Kingdom market. The United Kingdom government plans on introducing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">new legislation governing medical devices which will be delivered though secondary legislation. The first <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">piece of legislation was laid in 2024 and updates post-market surveillance requirements. Additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">instruments will follow in 2025 and 2026 to introduce new pre-market requirements including international <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reliance, and further enhancements to the regulations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Japan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We applied for marketing authorization with the PMDA in Japan in February 2015, which was approved in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">November 2016. As a result, we are able to commercially market the product in Japan. Our initial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">SHONIN application is still current and includes a minor change notification.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Canada<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow received our initial Canadian Medical Device License in August 2015. This remains current and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">updated frequently with amendments for every minor software release. As well, Canada recognizes the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow Mobile application as a separate device identified within our Heartflow device family and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires amendments for Mobile updates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other regulations &#8212; federal and state fraud and abuse, data privacy and security and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">transparency laws<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to FDA restrictions on marketing and promotion of medical devices, there are numerous U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal and state laws, regulations, and guidance documents pertaining to healthcare compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protections against fraud and abuse, including anti-kickback laws, payment transparency laws, patient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">inducement laws, and false claims laws, and, in some states, prohibitions against the corporate practice <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of medicine and the unlicensed practice of medicine (collectively, fraud and abuse laws and regulations). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our relationships with physicians, hospitals and other healthcare providers and referral sources for our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products are subject to scrutiny under these laws. Violations of these laws may be punishable by criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and civil sanctions, including, in some instances, imprisonment and exclusion from participation in federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and state healthcare programs, including the Medicare, Medicaid and Veterans Administration health <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">140<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs. Because of the breadth and far-reaching nature of these laws, we may be required to alter or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discontinue one or more of our business practices to be in compliance with these laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These healthcare fraud and abuse laws and regulations are complex, and even minor departures from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">what is expressly permitted under the laws and regulations can potentially give rise to claims that a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statute or regulation has been violated in a manner that could result in serious criminal or civil <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consequences. Several of the more significant healthcare fraud and abuse laws and regulations that may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our business or ability to operate are summarized below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The federal Anti-Kickback Statute is a criminal law that prohibits, among other things, knowingly and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully offering, paying, soliciting, or receiving any remuneration in cash or in-kind (including any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">kickback or bribe, but also common forms of remuneration, such as service or consulting fees, service <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fees, meals, travel expenses, discounts, or rebates), directly or indirectly, overtly or covertly, to induce or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in return for purchasing, leasing, ordering or arranging for or recommending the purchase, lease or order <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any item or service reimbursable, in whole or in part, under Medicare, Medicaid or other federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Although there are a number of statutory exceptions and regulatory safe harbors protecting some <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common activities, the exceptions and safe harbors are drawn narrowly. Practices that involve <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remuneration that may be alleged to be intended to induce prescribing, uses, purchases, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recommendations of prescriptions, uses, or purchases of our products may be subject to scrutiny if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis based on a review of all relevant facts and circumstances. Several courts have interpreted the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to induce referrals of (or purchases, uses, or recommendations of prescriptions, uses, or purchases) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal healthcare program covered business, the Anti-Kickback Statute has been implicated and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potentially violated.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Additionally, the Anti-Kickback Statute was amended by the ACA. Specifically, as noted above, under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Anti-Kickback Statute, the government must prove that a defendant acted &#8220;knowingly&#8221; to prove a violation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ACA added a provision that clarifies that with respect to violations of the Anti-Kickback Statute, &#8220;a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person need not have actual knowledge&#8221; of the Statute or specific intent to commit a violation of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Statute. This change effectively overturns case law interpretations that set a higher standard under which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prosecutors had to prove the specific intent to violate the law. In addition, the ACA codified case law that a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claim including items or services resulting from a violation of the federal Anti-Kickback Statute may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">constitute a false or fraudulent claim for purpose of the federal civil False Claims Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The federal civil U.S. False Claims Act prohibits, among other things, any person or entity from knowingly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presenting, or causing to be presented, a false or fraudulent claim for payment or approval to the federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government or knowingly making, using or causing to be made or used a false record or statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material to a false or fraudulent claim to the federal government. A claim includes &#8220;any request or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">demand&#8221; for money or property presented to the United States government. The civil False Claims Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also applies to false submissions that cause the government to not receive a benefit to which it is entitled, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such as a discounted sales price for products covered by federal healthcare programs. Intent to deceive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is not required to establish liability under the civil False Claims Act. In addition, the civil False Claims Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes a whistleblower provision that allows private citizens to bring claims on behalf of the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States government alleging violations of the law. Whistleblowers may be entitled to up to as much as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thirty percent (30%) of the government&#8217;s financial recovery resulting from such claims. This incentivizes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">potential whistleblowers to file complaints in federal court, which complaints are relied upon heavily by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government to investigate and prosecute allegations of violations of both the civil False Claims Act and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Anti-Kickback Statute.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Many medical device, pharmaceutical, biotech and other healthcare companies have been investigated or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prosecuted under these healthcare fraud and abuse laws and regulations. Investigations, prosecutions <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">141<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(and settlements) relate to a wide range of activities, including among other things, improper clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">studies, provision of consulting fees to physicians for services that were not commercially reasonable, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">providing free product to customers to induce them to do business with the manufacturer, providing high <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value meals to customers to induce them to do business with the manufacturer, or providing non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compliant discounts or rebates to customers, with the expectation that the customers would bill federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">programs for the product or the medical services that involve the product. Other companies have been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigated or prosecuted for causing false claims to be submitted by, among other things, marketing of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">products for unapproved, and thus noncovered, uses, or for promotion of uses inconsistent with approved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">labeling (&#8220;off label&#8221; promotion).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The United States government may further prosecute conduct constituting a false claim under the criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">False Claims Act. The criminal False Claims Act prohibits the making or presenting of a claim to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government knowing such claim to be false, fictitious, or fraudulent and, unlike the civil False Claims Act, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requires proof of intent to submit a false claim.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to the Anti-Kickback Statute and the civil and criminal False Claims Acts, the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal government has the authority to seek civil monetary penalties, assessments and exclusions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against an individual or entity based on a wide variety of prohibited conduct. For example, the Civil <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Monetary Penalties Law authorizes the imposition of substantial civil money penalties against an entity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that engages in activities including&#58; (i) knowingly presenting or causing to be presented, a claim for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services not provided as claimed or which is otherwise false or fraudulent in any way&#59; (ii) knowingly giving <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or causing to be given false or misleading information reasonably expected to influence the decision to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discharge a patient&#59; (iii) offering or giving remuneration to any beneficiary of a federal healthcare program <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">likely to influence the receipt of reimbursable items or services&#59; (iv) arranging for reimbursable services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with an entity which is excluded from participation from a federal healthcare program&#59; (v) knowingly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully soliciting or receiving remuneration for a referral of a federal healthcare program beneficiary&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(vi) using a payment intended for a federal healthcare program beneficiary for another use.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are other federal anti-fraud laws, including the Health Information Portability and Accountability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act&#8217;s fraud provisions, that prohibit, among other actions, knowingly and willfully executing, or attempting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to execute, a scheme to defraud any healthcare benefit program, including private payors, knowingly and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material fact or making any materially false, fictitious or fraudulent statement in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">delivery of or payment for healthcare benefits, items or services.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Finally, many states and foreign countries have similar healthcare fraud and abuse statutes or regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that may be broader in scope and may apply regardless of payor, in addition to items and services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reimbursed under Medicaid and other state programs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Violations any of these laws or any other governmental regulations that may apply to us may result in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exclusion of devices from government-funded healthcare programs, such as Medicare and Medicaid or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comparable foreign programs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Physician Payment Sunshine Act<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Transparency laws regarding payments or other transfers of value provided to certain licensed healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">professionals and teaching hospitals may also impact our business practices. The federal Physician <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Payment Sunshine Act requires most medical device manufacturers, including Heartflow, to track and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">report annually to the Secretary of the United States Department of Health and Human Services (&#8220;HHS&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial arrangements, payments, and other transfers of value made by that entity to physicians (defined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to include doctors, dentists, optometrists, podiatrists, and chiropractors), other healthcare providers (such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as physician assistants and nurse practitioners) and teaching hospitals, as well as ownership and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment interests held by such physicians and their immediate family members. The payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information is made publicly available in a searchable format on the CMS Open Payments website. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">142<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Similar laws have been enacted or are under consideration in several states and foreign jurisdictions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including states such as Massachusetts and Vermont, and countries like France, which has adopted the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loi Bertrand, or French Sunshine Act, which became effective in 2013. We will need to dedicate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant resources to establish and maintain systems and processes in order to comply with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations. Failure to comply with these federal reporting requirements can result in significant civil <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">monetary penalties. In addition, information reported to HHS, since it is publicly reported, can potentially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be used by a whistleblower to bring claims under the civil False Claims Act alleging that certain payments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or transfers of value gave rise to kickbacks or false claims.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Foreign Corrupt Practices Act<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;) prohibits any U.S. individual or business from promising, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, paying, providing or authorizing the provision of money or anything else of value, directly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirectly, to any foreign official, political party candidate or certain other persons (including health care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">professionals of state-funded hospitals) for the purpose of influencing any act or decision of the foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entity in order to assist the individual or business in obtaining, retaining or directing business. The FCPA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also obligates companies whose securities are listed in the United States to comply with accounting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions requiring them to maintain books and records that accurately and fairly reflect all transactions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the corporation, including international subsidiaries, and to devise and maintain an adequate system of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal accounting controls for domestic and international operations. Activities that violate the FCPA, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">even if they occur wholly outside the United States, can result in criminal and civil fines, imprisonment, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disgorgement, oversight, and debarment from government contracts. In addition, several other domestic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and international anti-corruption or anti-bribery laws within and outside the United States apply to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Privacy, security and breach notification<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other federal and state laws and regulations restrict or otherwise impact our business practices. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws include, without limitation, data privacy, security and breach notification authorities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA, as amended by HITECH, requires health plans, certain healthcare providers and healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearinghouses, referred to as &#8220;Covered Entities,&#8221; to protect the privacy and security of certain types of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health information, referred to as protected health information (&#8220;PHI&#8221;). HIPAA also imposes various <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements on &#8220;Business Associates&#8221; &#8212; entities performing services for, or on behalf of, a Covered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Entity that has access to the Covered Entity&#8217;s PHI in connection with providing those services as well as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their covered subcontractors. Three key sets of federal regulations implementing HIPAA &#8212; the Privacy, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Security Breach Notification and Omnibus Rules (collectively, &#8220;HIPAA Rules&#8221;) set forth a number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standards that Covered Entities and Business Associates must meet with respect to protecting the privacy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and security of PHI. HIPAA also regulates standardization of data content, codes and formats used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">healthcare transactions and standardization of identifiers for health plans and providers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our customers are Covered Entities under HIPAA, and, in some cases, Heartflow may be considered a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Associate to such Covered Entities when they pay Heartflow for certain services that involve the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sharing of PHI with Heartflow. When Heartflow bills payors directly for the services, Heartflow is acting as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a Covered Entity. Whether acting as a Business Associate, covered subcontractor, or a Covered Entity, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow has obligations to comply with HIPAA and the HIPAA Rules, and either contractual obligations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to its Covered Entity Customers or statutory and contractual obligations to ensure that any sub-Business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Associates comply. This requires risk assessments and a wide range of compliance policies, procedures <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and practices to safeguard.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Penalties for violations of HIPAA regulations include civil and criminal penalties. Our failure to comply with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HIPAA could result in significant criminal and civil penalties and other damages which could adversely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">affect our results of operations, financial position or cashflows. We have developed and implemented <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">processes designed to comply with HIPAA and are continuing to assess the need for additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">safeguards, policies, procedures, and programing and to develop them where necessary. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements under HIPAA may change periodically and could have an effect on our business operations <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">143<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">if compliance becomes substantially more costly than under current requirements. Additionally, a breach <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of unsecured PHI, such as by employee error or an attack by an outsider, could have an adverse effect on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our business in terms of potential penalties and corrective action required, in addition to reputational <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">damage.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to HIPAA and other federal privacy regulations, there are a number of state laws governing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy, confidentiality and security of health information that apply to our business. Most states also have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities governing breach notification. New laws governing privacy, security, and breach notification <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be adopted in the future as well. We have undertaken measures to comply with health information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy requirements to which we know we are subject. However, we can provide no assurance that we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are or will always remain in compliance with diverse and changing privacy, security, and breach <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notification requirements in all of the jurisdictions in which we do business. Failure to comply with privacy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">security or breach notification requirements could result in civil or criminal penalties, which could have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse effect on our business. Our failure to adequately protect personal or health related information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could have an adverse effect on our business. A wide variety of provincial, state, national and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">international laws and regulations apply to the creation, collection, use, retention, protection, disclosure, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer, and other processing of personal information, including protected health information. These data <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">protection and privacy and security related laws and regulations are evolving and being tested in courts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and may result in ever increasing regulatory and public scrutiny and escalating levels of enforcement and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sanctions. Our failure to comply with applicable laws and regulations, or to protect such data, could result <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in enforcement action against us, including fines, imprisonment of company officials and public censure, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">claims for damages by end customers and other affected individuals, damage to our reputation and loss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of goodwill (both in relation to existing end customers and potential end customers), any of which could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have an adverse effect on our operations, financial performance, and business. Evolving and changing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">definitions of personal data and personal information, within the European Union, the United States and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">elsewhere, especially relating to classification of IP addresses, machine identification, location data, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other information, may limit or inhibit our ability to operate or expand our business. Even the perception of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">privacy concerns, whether or not valid, may harm our reputation and inhibit adoption of our product by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current and future end customers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Healthcare reform<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Current and future U.S. legislative proposals to further reform healthcare or reduce healthcare costs may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result in low, or even no, reimbursement for our product, or for the procedures associated with the use of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our product, or limit coverage of our product. The cost containment measures that payors and providers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are instituting and the effect of any healthcare reform initiative implemented in the future could <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significantly reduce our revenues from the sale of our product. Alternatively, the shift away from fee-for-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">service agreements to capitated payment models supports the value of our product, as they are intended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to reduce longitudinal resource utilization, which can be cost saving for both payors and providers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The ACA was enacted in March 2010. As a U.S.-based company with anticipated sales in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States, these healthcare reform laws will materially impact our business. Certain provisions of the ACA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are still set to become effective in future years and the administrative agencies responsible for issuing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations that implement some aspects of the laws have yet to do so.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There have been numerous legal challenges and Congressional actions and amendments to certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aspects of the ACA. For example, on August 16, 2022, the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;) was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">signed into law, which, among other things, extends enhanced subsidies for individuals purchasing health <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insurance coverage in ACA marketplaces through plan year 2025. The IRA also eliminates the &#8220;donut <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maximum out-of-pocket cost and creating a new manufacturer discount program. Further, it is unclear <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">whether the Trump administration and Republicans in the Congress and the states who oppose these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">policies may try once again to repeal the ACA outright or pare back its subsidies and enrollment periods.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The uncertain fate of the ACA notwithstanding, we expect that the ACA, as well as other healthcare <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reform measures that may be adopted in the future, particularly in light of the recent changes in the White <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">144<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">House and Congress, may result in more rigorous coverage criteria and in additional downward pressure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the price that we may receive for our products. Any reduction in payments from Medicare or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">government programs may result in a similar reduction in payments from private payors. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implementation of cost containment measures or other healthcare reforms may prevent us from being <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">able to generate additional revenue or attain profitability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Employees and human capital resources<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, we had 626 full-time employees globally. We believe the success of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business will depend, in part, on our ability to attract and retain qualified personnel, in particular highly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">skilled technology personnel. Our employees are not subject to a collective bargaining agreement, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we believe that we have good relations with our employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our human capital resources objectives include attracting and retaining top talent, investing in our talent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with leadership development and job-related technical training, and increasing diverse representation in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our employee base through inclusivity initiatives that build on our culture of inclusion and belonging. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal purposes of our equity incentive plans are to attract, retain and motivate employees, consultants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and directors through the granting of stock-based compensation awards and cash-based performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bonus awards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Facilities<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our corporate headquarters and research and development facilities are located in Mountain View, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">California, where we lease approximately 61,500 square feet of office space under a lease agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that expires in August 2030. We also lease and occupy approximately 26,400 square feet in Austin, Texas <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">primarily for additional production personnel under a lease agreement that expires in December 2025. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do not own any real property. We believe that these facilities are adequate for the foreseeable future.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 388.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Legal proceedings<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 411.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have become, and we may become in the future, involved in various legal proceedings arising from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 423.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the normal course of business activities. We are not presently a party to any litigation the outcome of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which, we believe, if determined adversely to us, would individually or taken together, materially and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adversely affect our business, financial condition, or results of operations. However, we may from time to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time be involved in various claims and legal proceedings of a nature we believe are normal and incidental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a business such as ours. These matters may include employment, contract, intellectual property, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">product liability and other general claims. Regardless of outcome, litigation can have an adverse impact <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on us because of defense and settlement costs, diversion of management resources and other factors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 515.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Corporate information<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We were incorporated under the laws of the State of Delaware in 2007. On March 1, 2021, we completed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an internal reorganization in which a newly formed parent holding company was put in place. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previous holders of our common stock and preferred securities became holders of common stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred securities of HeartFlow Holding, Inc. The equity incentive plan, outstanding equity awards, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding warrants and certain other equity-related agreements of HeartFlow, Inc. were assumed by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. Our operations and business activities remained at HeartFlow, Inc., and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">wholly-owned non-U.S. subsidiaries of HeartFlow, Inc. remained in place. On&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025, we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated HeartFlow Holding, Inc. into HeartFlow, Inc. and the previous holders of HeartFlow Holding, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc. common stock and preferred securities became holders of our common stock and preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities and the equity incentive plan, outstanding equity awards, outstanding warrants and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other equity-related agreements of HeartFlow Holding, Inc. were assumed by us. In connection with this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidation, we changed our name to Heartflow, Inc. Our principal executive offices are located at 331 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">E. Evelyn Avenue, Mountain View, California 94041, and our telephone number is (650) 241-1221. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporate website address is www.heartflow.com. Information contained on, or accessible through, our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 705.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">website shall not be deemed incorporated into and is not a part of this prospectus or the registration <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">145<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statement of which it forms a part. We have included our website in this prospectus solely as an inactive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">textual reference.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">146<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1233" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Management<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth information regarding our executive officers and directors, including their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ages as of December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 139.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 189.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 30pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 242.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 189.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 189.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 0pt; width: 30pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.51pt; position: absolute; text-decoration: none; white-space: pre;">Age<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 0pt; width: 242.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Position(s)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Executive officers and employee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 91.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.08pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 39pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">52<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 39pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">President, Chief Executive Officer and Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 53.25pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 80.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 53.25pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">40<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 53.25pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Financial Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 67.5pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Tim A. Fonte<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 58.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 61.190000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 61.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.81pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 67.5pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">42<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 67.5pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Technology Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81.75pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 128.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 131.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 131.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 81.75pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">63<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 81.75pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Medical Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Non-employee directors<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 110.25pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 87.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 110.25pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">76<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 110.25pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director and Chair of the Board of Directors<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 124.5pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.99pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 124.5pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">71<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 124.5pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 138.75pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 73.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 75.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 76.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 76.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 76.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.75pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 138.75pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">58<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 138.75pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.27pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 117.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 119.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 121.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 121.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 121.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 153pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">39<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 153pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 167.25pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 167.25pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">65<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 167.25pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 181.5pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wayne J. Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 96.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 96.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.91pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 181.5pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">65<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 181.5pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 195.75pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 195.75pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">80<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 195.75pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 210pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 81.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 81.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 210pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">67<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 210pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 224.25pt; width: 189.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 189.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Charles A. Taylor, Jr., Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 124.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 126.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 126.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 126.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 126.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.83pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 224.25pt; width: 30pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 30pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.44pt; position: absolute; text-decoration: none; white-space: pre;">60<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 225.75pt; position: absolute; top: 224.25pt; width: 242.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 242.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 385.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Member of our audit committee. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 402.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Member of our compensation committee. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 419.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Member of our nominating and corporate governance committee. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 436.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Dr. Downing and Mr. Smith have each notified us that they will resign from our board of directors immediately prior to the effectiveness <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 445.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of the registration statement of which this prospectus forms a part.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 462.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Executive officers and employee director<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 485.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.79000000000002pt; position: absolute; white-space: pre;"> has served as our Chief Executive Officer and as a member of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 497.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors since March 2022, and as our President since January 2022, and he served as our Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 509.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Operating Officer from July 2021 to March 2022. Prior to joining the Company, from March 2008 to July <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 521.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2021, Mr. Farquhar held numerous positions of increasing responsibility across the cardiovascular and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 533.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diabetes portfolios of Medtronic plc (&#8220;Medtronic&#8221;), a global medical technology company, most recently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">serving as a President and General Manager from June 2018 until July 2021. Prior to that, Mr. Farquhar <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served as a Marketing Manager at General Mills, Inc., a multinational manufacturer and marketer of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">branded processed consumer foods, from January 2004 until March 2008. He received a B.A. in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Psychology and History from Duke University and an M.B.A. from Northwestern University&#8217;s Kellogg <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">School of Management. We believe that Mr. Farquhar&#8217;s extensive experience in the medical sector <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualifies Mr. Farquhar to serve on our board of directors and his role as our Chief Executive Officer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provides a vital link between our board of directors and our management team.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.09pt; position: absolute; white-space: pre;"> has served as our Chief Financial Officer since June 2023. He joined the Company in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until July 2021 in various <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 673.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">leadership roles spanning global marketing, regulatory and clinical affairs and business development. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 685.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 697.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 709.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">University of Pennsylvania&#8217;s The Wharton School. He is also a CFA charter holder. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">147<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Timothy A. Fonte<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.57pt; position: absolute; white-space: pre;"> has served as our Chief Technology Officer since November 2023. Mr. Fonte joined <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company in 2010 and held various roles spanning product, technology, and commercial leadership <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to becoming the Company&#8217;s Chief Technology Officer. Prior to joining the Company, Mr. Fonte led <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">design engineering at Cameron Health, Inc. (acquired by Boston Scientific Corporation), a cardioverter-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defibrillator medical device company, from 2006 until 2010. Mr. Fonte also co-founded Bespoke, Inc. (d&#47;b&#47;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a Sculpt), a company developing custom-fit healthcare products, and was a researcher in blood flow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modeling from medical image data at Stanford University from 2004 through 2005. He received a B.S. in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mechanical Engineering from Rensselaer Polytechnic Institute and an M.S. in Mechanical Engineering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from Stanford University. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Campbell D.K. Rogers, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 203.55pt; position: absolute; white-space: pre;"> has served as our Chief Medical Officer since March 2012. Prior to joining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company, Dr. Rogers was the Chief Scientific Officer and Global Head of Research and Development <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at Cordis Corporation (&#8220;Cordis&#8221;), a medical device company that was formerly part of the Johnson &#38; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Johnson family of companies, from July 2006 until February 2012, where he was responsible for leading <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments and research in cardiovascular devices. Prior to Cordis, Dr. Rogers was an Associate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Technology from July 1994 until July 2006, and a director of the Cardiac Catheterization and Experimental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular Interventional Laboratories at Brigham and Women&#8217;s Hospital in Massachusetts from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">October 2000 until June 2006, where he was responsible for clinical care, education and research. Dr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rogers served as a Principal Investigator for numerous interventional cardiology device, diagnostic, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pharmacology trials, is the author of numerous publications in the area of coronary artery and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiovascular diseases, and was the recipient of research grant awards from the National Institute of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Health and American Heart Association. He received an A.B. in English from Harvard College and an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M.D. from Harvard Medical School.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Non-employee directors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 158.55pt; position: absolute; white-space: pre;"> has served as Chair of our board of directors from June 2017 to May 2019 and since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020, and also as a member of our board of directors since September 2014. Mr. Weldon is the former <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chairman of the board and Chief Executive Officer of Johnson &#38; Johnson (Nasdaq&#58; JNJ), a global <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">developer and manufacturer of healthcare products, having served in those positions from 2002 until his <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">retirement in 2012. Mr. Weldon previously served in a variety of senior executive positions during his 41-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year career with Johnson &#38; Johnson until his appointment as Chairman of the board and Chief Executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Officer. Mr. Weldon previously served as a director of CVS Health Corporation (NYSE&#58; CVS) until his <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">retirement from that board in May 2023, Exxon Mobil Corporation (NYSE&#58; XOM) until his retirement from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that board in May 2021, JPMorgan Chase &#38; Co. (NYSE&#58; JPM) until his retirement from that board in May <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2019, and The Chubb Corporation until its acquisition by ACE Limited in January 2016. He is a member of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">various not-for-profit organizations and is also a member of the Board of Trustees for Quinnipiac <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">University. Mr. Weldon received his B.A. in Biology from Quinnipiac University. We believe that Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Weldon&#8217;s knowledge of the healthcare industry and his experience as chief executive officer and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">chairman of the board at Johnson &#38; Johnson and on the boards of other publicly traded companies, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which have exposed him to reporting and governance requirements, qualify him to serve on our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 160.26999999999998pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since January 2022. Mr. Barabe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served as the Chief Financial Officer and Executive Vice President at Affymetrix Inc. (acquired by Thermo <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Fisher Scientific, Inc.), a provider of life science productions and molecular diagnostic products, from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2010 until his retirement in June 2013. Prior to that, Mr. Barabe served as Senior Vice President and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chief Financial Officer of Human Genome Sciences, Inc., a biopharmaceutical company, from July 2006 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until March 2010. From 2004 until 2006, he served as Chief Financial Officer of Regent Medical Limited, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.K.-based, privately held surgical supply company, and with Novartis AG, a pharmaceutical company, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from 1982 until August 2004 in a succession of senior executive positions in finance and general <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management, most recently as the Chief Financial Officer of Sandoz GmbH, the generic pharmaceutical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiary of Novartis AG. Prior to that, Mr. Barabe served as the President of the Specialty Lens <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 706.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Franchise and Group Vice President and Chief Financial Officer of CIBA Vision Corporation, a <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">148<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contact lenses and lens care product manufacturer, until 2003. Mr. Barabe has served on the board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors of Cartesian Therapeutics, Inc. (Nasdaq&#58; RNAC) since 2016 and previously served on the board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors of Veeva Systems Inc. (NYSE&#58; VEEV) from September 2015 until June 2021, ArQule, Inc., <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from 2001 until January 2020, and Opexa Therapeutics, Inc. from 2014 until 2017. Mr. Barabe also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">currently serves on the board of directors of Vigilant Biosciences, Inc., a private company. Mr. Barabe <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received a B.B.A. in General Business, Finance from the University of Massachusetts at Amherst and an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M.B.A. from the University of Chicago. We believe that Mr. Barabe&#8217;s extensive finance experience, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">his service on the board of directors of several other publicly traded companies, qualifies Mr. Barabe to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">serve on our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.14pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since November 2020. She has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served as a Special Advisor to Brighton Park Capital, L.P., an investment firm specializing in software, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information services and technology-enabled services, since June 2020, and previously served as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chief Technology and People Officer at Forescout Technologies Inc. (&#8220;Forescout&#8221;), a network security <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">software company, from June 2017 until January 2021. Prior to joining Forescout, Ms. Cullivan served as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Executive Vice President, Business Operations and Chief Information Officer of FireEye, Inc., an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">enterprise cybersecurity company, from January 2013 until May 2017, and as a Senior Vice President at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">McAfee Corp., a global computer security software company, from April 2008 until October 2011. Earlier in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">her career, Ms. Cullivan held executive roles at Autodesk, Inc., EMC Corporation, and Oracle Corporation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Ms. Cullivan has served on the board of directors of Axon Enterprise, Inc. (Nasdaq&#58; AXON) since 2017, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cobalt Labs Inc. (dba Cobalt.io) since 2022 and OPSWAT Inc. since 2021, and previously served on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">boards of Astra Space Inc. (Nasdaq&#58; ASTR), AaDya Security Inc. (dba Judy Security) and SADA, Inc. Ms. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cullivan received a B.S. in Finance from Santa Clara University. We believe that Ms. Cullivan&#8217;s extensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience in the technology sector, including her past roles at leading technology, cybersecurity and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">digital infrastructure companies, qualifies Ms. Cullivan to serve on our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.2pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since March 2023. Since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2018, Dr. Downing has worked at Bain Capital, a private investment firm, currently serving as a Managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Director on the Bain Capital Life Sciences team. Prior to joining Bain Capital, Dr. Downing was a Resident <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Physician at the Brigham and Women&#8217;s Hospital in Boston from 2015 until 2018. Dr. Downing is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">author of over 40 peer-reviewed scientific articles. Prior to his medical career, Dr. Downing was a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Consultant at McKinsey and Company, a global management consulting firm, where he worked with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clients in the pharmaceutical, hospital and financial services industries. Dr. Downing received an A.B. in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chemistry from Harvard College and an M.D. from Yale University School of Medicine. We believe that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Dr. Downing&#8217;s extensive investment and financial experience, particularly in the medical sector, as well as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">his medical background qualifies Dr. Downing to serve on our board of directors. Dr. Downing has notified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us that he will resign from our board of directors immediately prior to the effectiveness of the registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statement of which this prospectus forms a part. Dr. Downing&#8217;s resignation is not due to any disagreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with us or any matters relating to our operations, policies or practices.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.94pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since December 2011. Since <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2007, Mr. Lightcap has served as a Senior Managing Director at HealthCor Partners Management, L.P. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;HealthCor Partners&#8221;), a venture capital investment manager focused on late-stage venture and early <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commercial stage healthcare companies in the diagnostic, therapeutic and medtech sectors. Since 2019, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Lightcap has also served as a Senior Managing Director at Healthcare Venture Partners, LLC, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">venture capital investment manager focused on healthcare companies. From 1997 until 2006, Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Lightcap served as a Senior Managing Director at JLL Partners, a leading middle-market private equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">firm. Prior to JLL Partners, from 1993 until 1997, Mr. Lightcap served as a Managing Director in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">mergers and acquisitions group at Merrill Lynch &#38; Co., Inc. (&#8220;Merrill Lynch&#8221;), a global financial services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. Prior to joining Merrill Lynch, Mr. Lightcap was a Senior Vice President in the mergers and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acquisitions group at Kidder, Peabody &#38; Co., a brokerage company, and at Salomon Brothers, a global <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial institution. Mr. Lightcap currently serves on the board of directors of Careview Communications, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc. (OTC&#58; CRVW), RTI Surgical Inc. and KellBenx, Inc. Mr. Lightcap also previously served on the board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors of a number of HealthCor Partners&#8217; portfolio of private companies, including AccessClosure, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc., Sadra Medical, Inc., Practice Partners in Healthcare, Inc. and Paradigm Spine, LLC. Mr. Lightcap <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">149<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received a B.E. in Mechanical Engineering from the State University of New York at Stony Brook and an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M.B.A. from the University of Chicago. We believe that Mr. Lightcap&#8217;s extensive experience in the medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sector, including his service on the boards of directors of multiple healthcare companies, qualifies Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Lightcap to serve on our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Wayne J. Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.59pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since November 2021. Dr. Riley <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has served as the President of the State University of New York Downstate Health Sciences University <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">since April 2017, where he is also a Tenured Professor of Internal Medicine and Health Policy and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Management. From 2013 until 2017, Dr. Riley was an Adjunct Professor of Healthcare Management at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Owen Graduate School of Management, Vanderbilt University and a Clinical Professor of Medicine at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Vanderbilt University School of Medicine. From 2007 until 2013, Dr. Riley served as President and Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Executive Officer of Meharry Medical College, and from 2003 until 2006, served as Vice President and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Vice Dean of Health Affairs and Governmental Relations at Baylor College of Medicine. Dr. Riley has <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">served on the board of directors of Compass Pathways, plc (Nasdaq&#58; CMPS) since 2021 and HCA <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Healthcare, Inc. (NYSE&#58; HCA) since 2012, where he also serves as the chair of the patient safety and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quality committee and as a member of the audit and compliance committee and nominating and corporate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governance committee. Dr. Riley previously served as a director of Vertex Pharmaceuticals Inc. (Nasdaq&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">VTRX) from 2010 until 2015, Pinnacle Financial Partners, Inc. from 2007 until 2013, and the Federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Reserve Bank of Atlanta, Nashville Branch Bank Board from January 2013 to June 2013. He is President <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Emeritus of the American College of Physicians and an elected member of the National Academy of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Medicine. Dr. Riley is also a commissioner of the Medicare Payment Advisory Commission, chair of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Board of Trustees and of The New York Academy of Medicine since 2019. Dr. Riley received a B.A. in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Anthropology from Yale University, an M.P.H. in Health Systems Management from the Tulane University <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">School of Public Health and Topical Medicine, an M.D. from the Morehouse School of Medicine, and an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">M.B.A. from Rice University&#8217;s Jesse H. Jones Graduate School of Business. We believe that Dr. Riley&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience as a practicing physician and his leadership, executive management and patient care skills at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other leading medical and educational institutions, as well as his prior public company board service, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualify him to serve on our board of directors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.12pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since September 2011. From 1997 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">until April 2020, Mr. Smith was the President and Chief Executive Officer and then Chairman of Intuitive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Surgical, Inc., a developer and manufacturer of surgical robotic products designed to improve clinical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outcomes of patients. From 1978 until 1997, Mr. Smith was Senior Executive Vice President of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hillenbrand Industries, a manufacturer and provider of products and services for the health care and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">funeral services industries. During his tenure at Hillenbrand Industries, he was a member of the executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">committee, the office of the president and the board of directors. Mr. Smith has also held positions at The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Boston Consulting Group, a management consulting firm, and International Business Machines Corp, a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">technology and consulting company. Mr. Smith served as chairman of the board of Tandem Diabetes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Care, Inc. (Nasdaq&#58; TNDM), from 2013 until 2015. Mr. Smith received a B.S.E.E. from Utah State <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">University and an M.B.A. from Harvard Business School. We believe that Mr. Smith&#8217;s extensive medical, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management and directorship experience in the medical sector qualifies him to serve on our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors. Mr. Smith has notified us that he will resign from our board of directors immediately prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectiveness of the registration statement of which this prospectus forms a part. Mr. Smith&#8217;s resignation is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not due to any disagreement with us or any matters relating to our operations, policies or practices.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.54000000000002pt; position: absolute; white-space: pre;"> has served as a member of our board of directors since August 2010. Since 2005, he <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has served as a General Partner of U.S. Venture Partners, a venture capital firm. From 2001 until 2004, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Tansey served as the Chief Executive Officer and President of Epicor Medical, a medical device <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. Prior to Epicor Medical, Mr. Tansey was Chief Executive Officer and President of Heartport, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Inc., a medical device company, which is now part of the Johnson &#38; Johnson family of companies. Prior <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to that, he was with the cardiovascular division at Baxter Edward, a medical technology company, for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">nearly ten years, holding various sales and marketing positions. Mr. Tansey currently serves on the board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors and as a member of the organization and compensation committee of Inspire Medical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Systems, Inc. (NYSE&#58; INSP) and previously served on the board of directors of Intersect ENT, Inc. from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 708pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2006 until 2017. He also serves on the board of directors for a number of U.S. Venture Partners&#8217; portfolio <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">150<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of private companies, including Cagent Vascular LLC, Dstillery, HighLife Medical Inc., Luminopia, Inc., <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">MicroTransponder Inc., Neochord, Inc., Neuros Medical, Inc., ShiraTronics, Inc. and Shoulder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Innovations. Mr. Tansey received a B.S. and an M.B.A. from the Notre Dame De Namur University. We <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">believe that Mr. Tansey&#8217;s extensive experience as a venture capital investor and as a member of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">boards of directors of multiple companies in the medical sector qualify him to serve on our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Charles A. Taylor, Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.23000000000002pt; position: absolute; white-space: pre;"> is one of our founders, and has served as a member of our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">since July 2007. He is currently the W.A. &#8220;Tex&#8221; Moncrief, Jr., Chair in Computational Medicine, and a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Professor in the Department of Internal Medicine and the Oden Institute for Computational Engineering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Sciences at the University of Texas at Austin. Dr. Taylor served as the Chief Technology Officer from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">April 2010 to February 2022 and then Chief Scientific Officer of the Company from February 2022 through <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 2023. Prior to joining the Company, Dr. Taylor was an Associate Professor in the Department <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of Bioengineering and Surgery at Stanford University from July 1997 until August 2010, where he held <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">courtesy faculty appointments in the Departments of Mechanical Engineering and Radiology. He received <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a B.S. in Mechanical Engineering, M.S. in Mechanical Engineering and M.S. in Mathematics from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rensselaer Polytechnic Institute and a Ph.D. in Mechanical Engineering from Stanford University. Dr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taylor has published over 450 publications in scientific journals and conference papers related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cardiovascular bioengineering and patient-specific modeling of blood flow in the cardiovascular system <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and is also an inventor on more than 300 issued patents worldwide. In 2024, Dr. Taylor was inducted into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the U.S. National Academy of Engineering. We believe that Dr. Taylor&#8217;s extensive knowledge of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company as its founder, Chief Technology Officer and Chief Scientific Officer, experience as an inventor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and knowledge of our industry qualifies him to serve on our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Family relationships <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There are no family relationships among any of our executive officers or directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Board composition and election of directors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our business and affairs are managed under the direction of our board of directors. Our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">currently consists of ten members&#58; Mr. Barabe, Ms. Cullivan, Dr. Downing, Mr. Farquhar, Mr. Lightcap, Dr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Riley, Mr. Smith, Mr. Tansey, Dr. Taylor, and Mr. Weldon. Dr. Downing and Mr. Smith are expected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resign from our board of directors immediately prior to the effectiveness of the registration statement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which this prospectus forms a part. Under our amended and restated voting agreement (&#8220;Voting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement&#8221;), which would terminate at the completion of this offering, the stockholders who are party to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Voting Agreement have agreed to vote their respective shares to elect&#58; (i) one director designated by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">BCLS Fund III Investments, LP, currently Nicholas Downing, (ii) two directors designated by the holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our Series A, Series B-1, Series B-2, Series C, Series D and Series E redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, currently Casey M. Tansey and Jeffrey C. Lightcap, (iii) our Chief Executive Officer, John Farquhar, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(iv) one director designated by our founders, currently Charles A. Taylor, and (v) Timothy C. Barabe, Julie <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A. Cullivan, Wayne J. Riley, Lonnie M. Smith and William C. Weldon, as directors designated by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">majority of the foregoing directors. In connection with this offering, the Voting Agreement will terminate. As <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a result, following this offering there will be no contractual obligations regarding the election of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">After this offering, the authorized number of directors may be changed by resolution of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, subject to the terms of our amended and restated certificate of incorporation that will become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective upon the completion of this offering. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Director independence<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 671.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have applied to have our common stock listed on&#160;the Nasdaq Global Select Market and this offering is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contingent upon obtaining such approval. Under the listing rules of&#160;the Nasdaq Global Select <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Market&#160;(&#8220;Listing Rules&#8221;), independent directors must comprise a majority of a listed company&#8217;s board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors within a specified period following completion of this offering. In addition, the Listing Rules <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">151<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and nominating and corporate governance committees be independent. Under these rules, a director will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only qualify as an &#8220;independent director&#8221; if, in the business judgment of the company&#8217;s board of directors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that person does not have a relationship that would interfere with the exercise of independent judgment in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">carrying out the responsibilities of a director. Under the Listing Rules, certain types of relationships <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generally occurring within the last three years will automatically disqualify a director as independent, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as if the director is one of our employees, is in receipt of direct compensation from us in excess of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$120,000 in a twelve-month period, or is engaged, directly or indirectly in certain business dealings with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">us in excess of specified thresholds. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our board of directors has determined that none of Mr. Barabe, Ms. Cullivan, Mr. Lightcap, Dr. Riley, Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Tansey, Dr. Taylor or Mr. Weldon has a relationship that would interfere with the exercise of independent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">judgment in carrying out the responsibilities of a director, and that each of such individuals are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;independent directors&#8221; in accordance with the Listing Rules. In making these determinations, our board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors reviewed and discussed information provided by the directors and us with regard to each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">director&#8217;s business and personal activities and relationships as they may relate to us and our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">management. Mr. Farquhar is not considered independent by virtue of his position as our Chief Executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Officer, and Dr. Taylor is not considered independent by virtue of his former employment with us within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">last three years.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Classified board of directors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In accordance with our amended and restated certificate of incorporation, which will be effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately prior to the completion of this offering, our board of directors will be divided into three classes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with staggered three-year terms. At each annual general meeting of stockholders, the successors to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors whose terms then expire will be elected to serve from the time of election and qualification until <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the third annual meeting following election. Our directors will be divided among the three classes as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follows&#58;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Class I directors will be &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and their terms will expire at the first <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">annual meeting of stockholders following the completion of this offering&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Class II directors will be &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and their terms will expire at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">second annual meeting of stockholders following the completion of this offering&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Class III directors will be &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and their terms will expire at the third <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">annual meeting of stockholders following the completion of this offering. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The division of our board of directors into three classes with staggered three-year terms may delay or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prevent a change of our management or a change in control.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Leadership structure of the board<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our corporate governance guidelines to be in place immediately prior to the completion of this offering will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide our board of directors with flexibility to combine or separate the positions of Chair of the board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors and Chief Executive Officer and to implement a lead independent director in accordance with its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination regarding which structure would be in the best interests of our company.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Weldon currently serves as our Chair of the board of directors and Mr. Farquhar serves as our Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Executive Officer. Our board of directors has concluded that our current leadership structure is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate at this time. However, our board of directors will continue to periodically review our leadership <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">structure and may make such changes in the future as it deems appropriate.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Board committees<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 691.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our board of directors has established an audit committee, a compensation committee, and a nominating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 703.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and corporate governance committee. Our board of directors may establish other committees to facilitate <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">152<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the management of our business. The composition and functions of each committee are described below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Members serve on these committees until their resignation or until otherwise determined by our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors. Each committee intends to adopt a written charter that satisfies the applicable rules and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and Listing Rules, which we will post <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on our website at www.heartflow.com upon the completion of this offering.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Audit committee<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our audit committee oversees our corporate accounting and financial reporting process and the quality <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and integrity of our financial statements, the qualifications and performance of our independent registered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public accounting firm, our internal audit function and our risk management program. Among other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">matters, the audit committee&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees our independent registered public accounting firm, and has sole responsibility for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">appointment, compensation, retention and oversight of the work of our independent registered public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accounting firm&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluates the independent registered public accounting firm&#8217;s qualifications, independence, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves the scope of the annual audit and pre-approves all audit and non-audit fees <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and services to be performed by our independent registered public accounting firm&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews with management and our independent registered public accounting firm the results of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">annual audit and the review of our interim financial statements, and reviews our financial statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and our management&#8217;s discussion and analysis of financial condition and results of operations to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">included in our annual and quarterly reports to be filed with the SEC&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees our internal audit function&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees our risk management program and reviews risks related to major financial risk exposures, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">information security, regulatory compliance, and the steps our management has taken to monitor and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">control these risks and exposures&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">establishes procedures for the receipt, retention, and treatment of any complaints received by us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">regarding accounting, internal accounting controls, or auditing matters&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves all related person transactions&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews the audit committee charter and the audit committee&#8217;s performance on an annual basis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our audit committee consists of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Our board of directors has determined that all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">members are independent under the Listing Rules and Rule 10A-3(b)(1) of the Exchange Act. The chair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our audit committee is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Our board of directors has determined that&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;are each an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;audit committee financial expert&#8221; as such term is currently defined in Item 407(d)(5) of Regulation S-K. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our board of directors has also determined that each member of our audit committee can read and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">understand fundamental financial statements as required by the Listing Rules. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Compensation committee&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our compensation committee oversees our compensation policies, plans and benefit programs, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particularly as they apply to our executive officers. Among other matters, the compensation committee&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves corporate goals and objectives relevant to compensation of our Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Executive Officer, evaluates the performance of the Chief Executive Officer in light of those goals and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">objectives and approves the compensation of Chief Executive Officer based on such evaluations&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves the compensation of our other executive officers&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">153<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and makes recommendations to our board of directors regarding non-employee director <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">compensation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews and approves or makes recommendations to our board of directors regarding the issuance of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock options and other equity awards under our performance incentive plans&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">engages in risk assessments of our compensation programs&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">reviews the compensation committee charter and the compensation committee&#8217;s performance on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">annual basis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our compensation committee consists of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors has determined that all members are independent under the Listing Rules and are non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee directors, as defined by Rule 16b-3 promulgated under the Exchange Act. The chair of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation committee is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Nominating and corporate governance committee&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our nominating and corporate governance committee oversees the nomination process for our directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and policies relating to our corporate governance. Among other matters, the nominating and corporate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governance committee&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">identifies individuals qualified to be members of our board of directors, including candidates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">recommended by stockholders, consistent with criteria approved by our board of directors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">evaluates and makes recommendations to our board of directors of candidates for membership on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our board of directors and on each of the board&#8217;s committees&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">develops and reviews the adequacy of our corporate governance guidelines and code of business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conduct and ethics and recommends and proposed changes to our board of directors&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees the process of evaluating the performance of our board of directors&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">oversees management succession planning&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">assists our board of directors on corporate governance matters and board of directors performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">matters, including recommendations regarding the size, structure and composition of our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">directors and its committees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our nominating and corporate governance committee consists of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors has determined that all members are independent under the Listing Rules. The chair of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">nominating and corporate governance committee is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Compensation committee interlocks and insider participation&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">None of the members of our compensation committee (&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or has been during the past fiscal year one of our employees or has been at any time one of our officers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and none of such individuals has any relationship requiring disclosure under SEC rules applicable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related person transactions. None of our executive officers currently serves, or has served during the last <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fiscal year, as a member of the board of directors or compensation committee (or other board committee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performing equivalent functions) of any entity that has one or more executive officers serving as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">member of our board of directors or on our compensation committee.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Code of business conduct and ethics&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 671.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, our board of directors intends to adopt a written code of business conduct <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and ethics that applies to all of our directors, executive officers, and employees, including our principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executive officer, principal financial officer, and principal accounting officer or controller, or persons <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performing similar functions. The full text of our code of business conduct and ethics will be posted on our <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">154<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">website at www.heartflow.com upon the completion of this offering. The nominating and corporate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">governance committee of our board of directors will be responsible for overseeing our code of business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct and ethics. We intend to disclose any future amendments to or waivers of our code of business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conduct and ethics applicable to our directors and officers, including our principal executive officer, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal financial officer, principal accounting officer or controller, or persons performing similar functions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the extent required by applicable rules of the SEC or the Nasdaq Global Select Market, on our website <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at the address identified above. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Limitations on liability and indemnification matters&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation, which will become effective immediately prior to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the completion of this offering, limit our directors&#8217; and officers&#8217; liability to us and our stockholders for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">monetary damages for breach of fiduciary duty as a director or officer to the fullest extent permitted under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;). Such provision will not eliminate or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limit the liability of&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director or officer for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the corporation or its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholders&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director or officer for any act or omission not in good faith or that involves intentional misconduct or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a knowing violation of law&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director for an unlawful payment of dividends or redemption of shares&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a director or officer for any transaction from which the director or officer derived an improper personal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">benefit&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an officer in any action by or in the right of the corporation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These limitations of liability do not apply to liabilities arising under federal securities laws and do not affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the availability of equitable remedies such as injunctive relief or rescission. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As permitted by the DGCL, our amended and restated certificate of incorporation provides that we will, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain situations, indemnify our directors and officers and may indemnify other employees and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limitations, to payment of expenses (including attorneys&#8217; fees) in advance of the final disposition of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeding. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, we have entered, and intend to continue to enter, into separate indemnification agreements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with our directors and officers. These indemnification agreements, among other things, require us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnify our directors and officers for certain expenses, including attorneys&#8217; fees, judgments, fines, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement amounts incurred by a director or officer in any action or proceeding arising out of their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services as a director or officer, or any other company or enterprise to which the person provides services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at our request. We also maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and officers are insured against liability for actions taken in their capacities as directors and officers. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that these provisions in our amended and restated certificate of incorporation and these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnification agreements are necessary to attract and retain qualified persons as directors and officers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers, or control persons, we have been advised that, in the opinion of the SEC, such indemnification is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">against public policy as expressed in the Securities Act and is therefore unenforceable.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">155<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1258" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Executive and director compensation<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This section discusses the material components of the executive compensation program for our executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers who are named in the &#8220;Summary Compensation Table&#8221; below. In 2024, our &#8220;named executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers,&#8221; comprised of our principal executive officer and the two most highly compensated executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers (other than our principal executive officer) and their positions with the Company, were as follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 163.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar, President and Chief Executive Officer&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 183.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese, Chief Financial Officer&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Timothy A. Fonte, Chief Technology Officer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 223.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As an &#8220;emerging growth company&#8221; as defined in the JOBS Act, we are not required to include a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 235.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 247.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements applicable to emerging growth companies. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 267.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 summary compensation table<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 289.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.65pt; position: absolute; text-decoration: none; white-space: pre;">table<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: absolute; white-space: pre;"> sets forth information concerning the compensation of our named executive officers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for the year ended December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 321.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 133.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name and principal position<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 136.5pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.37pt; position: absolute; text-decoration: none; white-space: pre;">Salary<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 46.39pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 199.5pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 28.41pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 26.38pt; position: absolute; text-decoration: none; white-space: pre;">awards<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 39.26pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 50.239999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 262.5pt; position: absolute; top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.19pt; position: absolute; text-decoration: none; white-space: pre;">Non-equity <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.17pt; position: absolute; text-decoration: none; white-space: pre;">incentive plan <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.18pt; position: absolute; text-decoration: none; white-space: pre;">compensation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 49.01pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 59.989999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 335.25pt; position: absolute; top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.66pt; position: absolute; text-decoration: none; white-space: pre;">All other <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.18pt; position: absolute; text-decoration: none; white-space: pre;">compensation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 49.01pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 59.989999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.42pt; position: absolute; text-decoration: none; white-space: pre;">Total ($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 133.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 91.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 93.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 95.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 95.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 95.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.46pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 136.5pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 19.79pt; position: absolute;">590,480<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 199.5pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,030,400<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 262.5pt; position: absolute; top: 45pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.91pt;"></font></font><font style="left: 29.54pt; position: absolute;">654,369<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 335.25pt; position: absolute; top: 45pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.03pt;"></font></font><font style="left: 40.660000000000004pt; position: absolute;">5,200<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 45pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">2,280,449<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 23.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 133.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 0.4pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">President and Chief <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 12.4pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Executive Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 133.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.82pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 79.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 80.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 80.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 136.5pt; position: absolute; top: 82.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 19.79pt; position: absolute;">400,548<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 199.5pt; position: absolute; top: 82.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,067,295<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 262.5pt; position: absolute; top: 82.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.91pt;"></font></font><font style="left: 29.54pt; position: absolute;">222,338<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 335.25pt; position: absolute; top: 82.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.03pt;"></font></font><font style="left: 40.660000000000004pt; position: absolute;">5,200<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 82.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,695,381<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 98.25pt; width: 133.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.9pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 11.4pt; position: absolute; text-decoration: none; white-space: pre;">Chief Financial Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 114pt; width: 133.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.82pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy A. Fonte<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 77.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 80.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 80.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 136.5pt; position: absolute; top: 114pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 19.79pt; position: absolute;">358,750<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 199.5pt; position: absolute; top: 114pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 19.79pt; position: absolute;">998,784<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 262.5pt; position: absolute; top: 114pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 26.91pt;"></font></font><font style="left: 29.54pt; position: absolute;">202,125<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 335.25pt; position: absolute; top: 114pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.03pt;"></font></font><font style="left: 40.660000000000004pt; position: absolute;">5,200<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 114pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.87pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,564,859<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 129.75pt; width: 133.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 4.9pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 8.63pt; position: absolute; text-decoration: none; white-space: pre;">Chief Technology Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 475.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts reflect the grant date fair value of stock options granted during 2024 computed in accordance with ASC Topic 718, rather than <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 484.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the amounts paid to or realized by the named individual. See Note&#160;14&#160;of the consolidated financial statements elsewhere included in <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 493.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">this prospectus for a discussion of valuation assumptions made in determining the grant date fair value and compensation expense of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 502.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our stock options.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 519.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts represent annual bonuses earned by each named executive officer in 2024 which were paid by us after certification of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 528.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">performance achievement in early 2025. See &#8220;2024 Bonuses&#8221; below. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 545.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts disclosed reflect Company contributions to our 401(k) plan.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 562.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Narrative to the summary compensation table<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each of our Named Executive Officers will participate in our forthcoming severance plan, as described in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Executive compensation arrangements&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Elements of compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 636.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 salaries<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In 2024, the named executive officers received an annual base salary to compensate them for services <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rendered to the company. The base salary payable to each named executive officer is intended to provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">156<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For fiscal year 2024, Mr. Farquhar&#8217;s annual base salary was $594,881&#160;effective as of&#160;March 3, 2024&#160;(and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">it was $572,000&#160;prior),&#160;Mr. Verghese&#8217;s base salary was $404,250&#160;effective as of&#160;March 3, 2024&#160;(and it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was $385,000&#160;prior) and&#160;Mr. Fonte&#8217;s base salary was $367,500&#160;effective as of&#160;March 3, 2024&#160;(and it was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$350,000&#160;prior). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 bonuses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In 2024, Mr. Farquhar, Mr. Verghese and&#160;Mr. Fonte&#160;were eligible to earn annual cash bonuses targeted at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">100%, 50% and 50%, respectively, of their annual base salaries. Pursuant to our annual cash bonus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">program, each named executive officer was eligible to earn his annual cash bonus based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attainment of pre-established annual company objectives. These pre-established objectives include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue, with a target of $&#160; &#160; million (weighted 40%), gross margin, with a target of&#160; &#160;  % (weighted 20%), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interactive product validation (weighted 20%), asymptomatic strategy (weighted 10%) and patient care <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(weighted 10%). The actual achieved bonus amount was paid in 2025 based on achievement of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">objectives.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Equity compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each of our named executive officers currently holds outstanding stock option awards granted pursuant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company&#8217;s 2009 Equity Incentive Plan as described in more detail in the section titled &#8220;&#8212;Outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equity awards at year end&#8221; below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, we intend to adopt the 2025 Plan (as defined below) in order to facilitate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the grant of cash and equity incentives to directors, employees (including our named executive officers) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and consultants of our company and certain of our subsidiaries (if any) and to enable us to obtain and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">retain the services of these individuals, which is essential to our long-term success. We expect that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Plan will be effective as of the date immediately preceding the date on which this offering is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completed. For additional information about the 2025 Plan, please see the section titled &#8220;&#8212;2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance incentive plan&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other elements of compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Retirement plans <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We maintain a 401(k) retirement savings plan for our employees, including our named executive officers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">401(k) plan on the same terms as other full-time employees. We anticipate that, following the completion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of this offering, our named executive officers will continue to participate in this 401(k) plan on the same <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terms as other full-time employees. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Employee benefits and perquisites <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">All of our full-time employees, including our named executive officers, are eligible to participate in our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">health and welfare plans, including&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">medical, dental, and vision benefits&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">medical and dependent care flexible spending accounts&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">short-term and long-term disability insurance&#59; and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">life insurance.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We believe that the employee benefits described above are necessary and appropriate to provide a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competitive compensation package to our named executive officers. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">157<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No tax gross-ups<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We do not make gross-up payments to cover our named executive officers&#8217; personal income taxes that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may pertain to any of the compensation or perquisites paid or provided by the Company.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding equity awards at fiscal year-end<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 146.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 133.65pt; position: absolute; text-decoration: none; white-space: pre;">table<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: absolute; white-space: pre;"> summarizes the number of shares of common stock underlying outstanding equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incentive plan awards for each named executive officer as of December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 178.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 462.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 107.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 14.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 107.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 80.81pt; width: 107.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 110.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 80.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.66pt; position: absolute; text-decoration: none; white-space: pre;">Grant date<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 192.75pt; position: absolute; top: 0pt; width: 270pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 270pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 204.92pt; position: absolute; text-decoration: none; white-space: pre;">Option awards<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 78pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.67pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.64pt; position: absolute; text-decoration: none; white-space: pre;">securities <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.86pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.67pt; position: absolute; text-decoration: none; white-space: pre;">underlying <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">unexercised <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.68pt; position: absolute; text-decoration: none; white-space: pre;">options - <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.63pt; position: absolute; text-decoration: none; white-space: pre;">exercisable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.51pt; position: absolute; text-decoration: none; white-space: pre;">(#)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.489999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.67pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.64pt; position: absolute; text-decoration: none; white-space: pre;">securities <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.86pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.67pt; position: absolute; text-decoration: none; white-space: pre;">underlying <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">unexercised <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.68pt; position: absolute; text-decoration: none; white-space: pre;">options -<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.65pt; position: absolute; text-decoration: none; white-space: pre;">unexercisable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.51pt; position: absolute; text-decoration: none; white-space: pre;">(#)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.489999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.66pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 26.62pt; position: absolute; text-decoration: none; white-space: pre;">exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 27.65pt; position: absolute; text-decoration: none; white-space: pre;">price ($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.46pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.66pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 57.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.66pt; position: absolute; text-decoration: none; white-space: pre;">expiration <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 68.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.14pt; position: absolute; text-decoration: none; white-space: pre;">date<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 90.75pt; width: 107.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 107.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 91.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 93.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 94.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 94.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.33pt; position: absolute; text-decoration: none; white-space: pre;"> . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">8&#47;24&#47;2021<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 90.75pt; width: 14.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 14.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.69pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">166,666<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">33,334<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 90.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">8&#47;24&#47;2031<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2022<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 105pt; width: 14.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 14.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.69pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">206,250<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">93,750<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 105pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2032<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 119.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2023<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 119.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">1,367,644<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 119.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">4,482,084<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 119.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 119.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2033<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2024<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.79pt; position: absolute; text-decoration: none; white-space: pre;">11,666<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">548,334<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">3.28<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 133.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2034<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 147.75pt; width: 107.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 107.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 79.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 79.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 79.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.53pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2022<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 175.5pt; position: absolute; top: 147.75pt; width: 14.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 14.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 3.69pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">22,917<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">3&#47;23&#47;2032<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 162pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2023<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 162pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 162pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">226,042<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 162pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 162pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2033<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;24&#47;2023<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">325,963<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 176.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;24&#47;2033<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 190.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2024<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 190.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 190.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">576,916<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 190.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">3.28<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 190.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2034<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 204.75pt; width: 107.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 107.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy A. Fonte<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 77.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 78.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 79.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 79.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 79.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 79.46pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 204.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.9pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;11&#47;2017<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 204.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">15,000<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 204.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 204.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 204.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.9pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;11&#47;2027<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 219pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">9&#47;20&#47;2019<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 219pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.61pt; position: absolute; text-decoration: none; white-space: pre;">5,000<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 219pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 219pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 219pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">9&#47;20&#47;2029<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 233.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">2&#47;28&#47;2020<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 233.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">20,000<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 233.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 233.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 233.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">2&#47;28&#47;2030<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 247.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;22&#47;2020<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 247.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.61pt; position: absolute; text-decoration: none; white-space: pre;">3,600<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 247.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 247.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 247.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;22&#47;2030<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 261.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.72pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;2&#47;2021<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 261.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.61pt; position: absolute; text-decoration: none; white-space: pre;">9,166<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 261.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.94pt; position: absolute; text-decoration: none; white-space: pre;">834<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 261.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 261.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.72pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;2&#47;2031<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 276pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;12&#47;2021<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 276pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.61pt; position: absolute; text-decoration: none; white-space: pre;">4,264<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 276pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.94pt; position: absolute; text-decoration: none; white-space: pre;">186<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 276pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 276pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">4&#47;12&#47;2031<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 290.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2023<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 290.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">46,041<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 290.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">83,959<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 290.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 290.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7&#47;10&#47;2033<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 304.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;24&#47;2023<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 304.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 32.05pt; position: absolute; text-decoration: none; white-space: pre;">31,048<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 304.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">293,974<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 304.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 304.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;24&#47;2033<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 110.25pt; position: absolute; top: 318.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2024<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 192.75pt; position: absolute; top: 318.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261pt; position: absolute; top: 318.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">539,883<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 329.25pt; position: absolute; top: 318.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">3.28<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 397.5pt; position: absolute; top: 318.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12&#47;26&#47;2034<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 519.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Amounts disclosed in this column reflect the number of options granted to our named executive officers that were subject to time-based <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 528.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">vesting and have vested.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 545.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Unless otherwise noted, the stock option vests and becomes exercisable as to 1&#47;48th of the total number of shares underlying the stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">option monthly following the vesting commencement date, subject to the applicable named executive officer&#8217;s continued service through <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 563.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the applicable vesting date.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 580.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 102.92pt; position: absolute; text-decoration: none; white-space: pre;"> stock option vests and becomes exercisable as to 1&#47;4th of the total number of shares underlying the stock option on the first <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 589.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">anniversary of the vesting commencement date and 1&#47;48th monthly thereafter, subject to the applicable named executive officer&#8217;s <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">continued service through the applicable vesting date.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 615.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Executive compensation arrangements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we intend to enter into a new severance plan covering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each of our named executive officers that will set forth the terms and conditions of such executive&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employment with us and any benefits payable upon a qualifying termination of employment. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">158<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2024 non-employee director compensation table <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have paid certain of our non-employee directors, Mr. Weldon, Mr. Barabe, Mr. Riley, Mr. Smith, Mr. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taylor and Ms. Cullivan, cash fees as set forth in the table below for their service on our board. We have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also reimbursed our directors for expenses associated with attending meetings of our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and committees of our board of directors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mr. Taylor, one of the Company&#8217;s founders, served as our Chief Technology Officer from April 2010 to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">February 2022 and as our Chief Scientific Officer from February 2022 through December 2023. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with his termination of employment, we entered into a separation agreement with Mr. Taylor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with an employment termination date of December 1, 2023, which provided for certain benefits in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consideration for his execution of a general release of claims and adherence to the protective covenants <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">set forth therein. Those benefits include (i) severance payments equal to $658,341.76, payable 50% on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the effective date of the agreement and 50% on June 1, 2024, (ii) payment of COBRA benefits for 12 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months, (iii) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.41pt; position: absolute; text-decoration: none; white-space: pre;">i<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.63pt; position: absolute; text-decoration: none; white-space: pre;">f the Company paid bonuses with respect to the 2023 fiscal year<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 411.93pt; position: absolute; white-space: pre;">, payment of Mr. Taylor&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">target bonus for such year, payable 50% in April 2024 and 50% in June 2024 and (iv) acceleration of 25% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of his then-unvested options.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In addition to his service on the board, since December 2023, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 346.41pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Mr. Taylor has served as a consultant to us </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and was paid cash fees of $3,178 in 2024 in consideration of his consulting services.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 130.88pt; position: absolute; text-decoration: none; white-space: pre;"> table<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.32pt; position: absolute; white-space: pre;"> sets forth information regarding the compensation of our non-employee directors for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fiscal year ended December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 342.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 190.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 190.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">Fees earned <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 53.63pt; position: absolute; text-decoration: none; white-space: pre;">or<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.66pt; position: absolute; text-decoration: none; white-space: pre;">paid in cash <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 51.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.66pt; position: absolute; text-decoration: none; white-space: pre;">Option <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 31.63pt; position: absolute; text-decoration: none; white-space: pre;">awards<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.51pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 55.489999999999995pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 0pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.66pt; position: absolute; text-decoration: none; white-space: pre;">All other <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.18pt; position: absolute; text-decoration: none; white-space: pre;">compensation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 56.14pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 41.15pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 51.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 87.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 87.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">65,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 45pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">65,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 87.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 87.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 59.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 73.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 75.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 76.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 77.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 77.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 73.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 87.75pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 109.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 111.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 112.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 112.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 112.53pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 87.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 102pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 87.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 87.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.67999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 102pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 116.25pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wayne J. Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 94.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 97.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 116.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 116.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 130.5pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 77.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 77.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 130.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 130.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 130.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 130.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 144.75pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 81.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 82.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 82.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.52pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 144.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 144.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 144.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 53.04pt;"></font></font><font style="left: 55.67pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 144.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 159pt; width: 190.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 190.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Charles A. Taylor, Jr., Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 124.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 126.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 126.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 127.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 127.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 127.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 127.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.52pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 193.5pt; position: absolute; top: 159pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">40,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 261.75pt; position: absolute; top: 159pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 330pt; position: absolute; top: 159pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 23.06pt; position: absolute; text-decoration: none; white-space: pre;">571,082<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 59.19pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 159pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">611,082<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 523.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The aggregate number of stock option awards (whether exercisable or unexercisable) held as of December 31, 2024, by Mr. Weldon, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 532.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Barabe, Ms. Cullivan, Dr. Downing, Mr. Lightcap, Mr. Riley, Mr. Smith, Mr. Tansey and Mr. Taylor was&#160;520,730, 100,730, 87,188, 0, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 541.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">0,&#160;185,000, 135,000, 0&#160;and 460,301, respectively.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 558.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">This amount includes&#58; (i) $329,171 in severance payme<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 274.13pt; position: absolute; text-decoration: none; white-space: pre;">nts&#59; (ii) $40,015 in COBRA payments&#59; (iii) $198,718 a<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 450.3pt; position: absolute; text-decoration: none; white-space: pre;">s a target bonus for 2023&#59; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 567.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and (iv) $3,178 in consulting fees.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the completion of this offering, we intend to approve and implement a compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">program for our non-employee directors that consists of annual retainer fees and long-term equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 628.65pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">2025 performance incentive plan</font><font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following summarizes the material terms of our Amended and Restated 2009 Equity Incentive Plan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;2009 Plan&#8221;), under which we have previously made periodic grants of equity and equity-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards to our named executive officers and other key employees. In addition, we intend to adopt a 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 687.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Performance Incentive Plan (the &#8220;2025 Plan&#8221;) and an employee stock purchase plan (the &#8220;ESPP&#8221;), which <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">159<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will become effective in connection with the completion of this offering. The terms of the 2025 Plan and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the ESPP have not yet been finalized.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Amended and restated 2009 equity incentive plan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan was adopted by the board of directors of Heartflow, Inc. in 2009 and was amended and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restated effective March 1, 2021 in connection with a reorganization of Heartflow, Inc. in which the 2009 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan and all outstanding award agreements thereunder were assigned to and assumed by HeartFlow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holding, Inc. As of December 31, 2024, a total of&#160;24,930,958&#160;shares of common stock were then subject <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to outstanding awards granted under the 2009 Plan, and an additional&#160;1,079,492&#160;shares of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">were then available for new award grants under the 2009 Plan. With respect to the stock options then-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding on this date, the weighted-average exercise price of such options was $1.62&#160;per share, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the weighted-average remaining term of these options was&#160;7.96&#160;years.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Purpose<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The purpose of the 2009 Plan is to attract and retain the best available personnel for positions of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantial responsibility, to provide additional incentive to employees, directors and consultants, and to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promote the success of our business. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Administration<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan is administered by our board of directors (the &#8220;Board&#8221;) or a committee thereof (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Administrator&#8221;). The Administrator has the discretion to (i) determine the fair market value of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, (ii) select the employees, directors and consultants to whom awards may be granted under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2009 Plan, (iii) determine the number of shares of our common stock to be covered by each award <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted under the 2009 Plan, (iv) approve forms of award agreements for use under the 2009 Plan, (v) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine the terms and conditions of any award granted under the 2009 Plan, (vi) institute and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determine the terms and conditions of an award exchange, (vii) construe and interpret the terms of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2009 Plan and awards granted thereunder, (viii) prescribe, amend and rescind rules and regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relating to the 2009 Plan, (ix) modify or amend outstanding awards granted under the 2009 Plan, subject <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to certain restrictions set forth in the 2009 Plan, (x) determine procedures for recipients to satisfy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">withholding tax obligations, (xi) authorize any person to execute on our behalf any instrument required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effect the grant of an award previously granted by the Administrator, (xii) allow a recipient to defer the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receipt of the payment of cash or the delivery of shares that otherwise would be due to such recipient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under an award, (xiii) establish additional rules to accommodate the rules or laws of applicable non-U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions and afford recipients who are foreign nationals or are employed outside the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">favorable treatment under such rules or laws, and (xiv) make all other determinations deemed necessary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or advisable for administering the 2009 Plan. All decisions, or actions taken, by the plan administrator or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in connection with the administration of the 2009 Plan shall be final, conclusive and binding on all persons <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">having an interest in the 2009 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Eligibility<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our employees and consultants, employees and consultants of our parents or subsidiaries (if any), and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-employee members of our Board are eligible to receive awards under the 2009 Plan, provided that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only employees may be granted awards intended as incentive stock options.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.22pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> As of December 31, 2024, </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">approximately&#160;606&#160;of our and our subsidiaries&#8217; officers and employees (including all of our named </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">executive officers), and each of the nine non-employee members of our Board, were considered eligible </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">under the 2009 Plan. In addition, approximately 13&#160;individual consultants and advisors engaged by us </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">and our subsidiaries were then considered eligible under the 2009 Plan.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Share reserve<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, a total of&#160;30,787,082&#160;shares of our common stock had been authorized for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 694.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance under the 2009 Plan,&#160;24,930,958&#160;shares were subject to stock options then-outstanding under <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">160<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the 2009 Plan,&#160;no&#160;shares were subject to restricted stock and restricted stock unit awards then-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding under the 2009 Plan, and&#160;1,079,492&#160;shares were available for issuance under the 2009 Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Types of awards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan authorizes the grant of stock options, stock appreciation rights, restricted stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted stock units. Awards granted under the 2009 Plan are generally not transferable by the recipient <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other than by will or the laws of descent and distribution and are generally exercisable, during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recipient&#8217;s lifetime, only by the recipient. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Stock Options<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 152.2pt; position: absolute; text-decoration: none; white-space: pre;">. A stock option is the right to purchase shares of our common stock at a future date at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a specified price per share (the &#8220;exercise price&#8221;). The per share exercise price of an option generally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">may not be less than the fair market value of a share of our common stock on the date of grant. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">maximum term of an option is ten years from the date of grant. An option may either be an incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock option or a non-qualified stock option. Incentive stock option benefits are taxed differently from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">nonqualified stock options, are subject to more restrictive terms, and are limited in amount by the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Internal Revenue Code and the 2009 Plan. Incentive stock options may only be granted to our and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our subsidiaries&#8217; employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Stock Appreciation Rights<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 204.42000000000002pt; position: absolute; text-decoration: none; white-space: pre;">. A stock appreciation right is the right to receive payment of an amount <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">equal to the excess of the fair market value of share of our common stock on the date of exercise of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the stock appreciation right over the base price of the stock appreciation right. The base price will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">established by the Administrator at the time of grant of the stock appreciation right and generally may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">not be less than the fair market value of a share of our common stock on the date of grant. Stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">appreciation rights may be granted in connection with other awards or independently. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Restricted Stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 162.75pt; position: absolute; text-decoration: none; white-space: pre;">. A share of restricted stock is granted subject to vesting, transfer restrictions and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other restrictions as determined by the Administrator, or is a share issued pursuant to the early <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">exercise of a stock option. Recipients of restricted stock, unlike recipients of stock options and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restricted stock units, have voting rights and the right to receive dividends, if any, prior to the time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restrictions lapse with respect to such shares, however, extraordinary dividends will generally be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">placed in escrow, and will not be released until restrictions are removed or expire.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Restricted Stock Units<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 188.29000000000002pt; position: absolute; text-decoration: none; white-space: pre;">. A restricted stock unit is a bookkeeping entry representing an amount equal to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the fair market value of a share that is granted subject to vesting, transfer restrictions and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">restrictions as determined by the Administrator. Unlike restricted stock, shares underlying restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock units will not be issued until the restricted stock units have vested, and recipients of restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock units generally have no voting or dividend rights prior such conditions being satisfied.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Adjustments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As is customary in incentive plans of this nature, the share limit, the number and kind of shares available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the 2009 Plan, any outstanding awards as well as the exercise or purchase prices of awards, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance targets under certain types of performance-based awards, are subject to adjustment in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">event of certain reorganizations, mergers, combinations, recapitalizations, stock splits, stock dividends, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other similar events that change the number or kind of shares outstanding, and extraordinary dividends or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distributions of property to the stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Assumption and termination of awards<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If an event occurs that results in a change in control of us or in which we otherwise do not survive (or do <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not survive as a public company in respect of our common stock), including, without limitation, a merger, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">combination, consolidation, conversion, exchange of securities, or other reorganization, or a sale of all or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantially all of our business, stock or assets, awards then-outstanding under the 2009 Plan will not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automatically become fully vested pursuant to the provisions of the 2009 Plan so long as such awards are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumed or substituted. However, if awards then-outstanding under the 2009 Plan are to be terminated in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such circumstances (without being assumed or substituted), such awards would generally become fully <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">161<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vested (with any performance goals applicable to the award being deemed met at the &#8220;target&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance level and all other terms and conditions met), subject to any exceptions that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrator may provide for in an applicable award agreement. The Administrator also has the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discretion to establish other change in control provisions with respect to awards granted under the 2009 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan. If we are wound up pursuant to a dissolution or liquidation, awards then-outstanding under the 2009 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan will terminate immediately prior to such event.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No limit on other authority<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2009 Plan does not limit the authority of the Board or any committee thereof to grant awards or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorize any other compensation, with or without reference to our common stock, under any other plan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or authority.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Termination of or changes to the 2009 plan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Board may amend or terminate the 2009 Plan at any time and in any manner. Stockholder approval <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for an amendment will be required only to the extent then required by applicable law or deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">necessary or advisable by the Board. Unless terminated earlier by the Board, the authority to grant new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">awards under the 2009 Plan will terminate on March 21, 2031. Outstanding awards, as well as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrator&#8217;s authority with respect thereto, generally will continue following the expiration or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">termination of the 2009 Plan. Generally speaking, outstanding awards may be amended by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Administrator (except for a repricing), but the consent of the award holder is required if the amendment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or any plan amendment) impair the rights of the holder.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">162<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1286" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Certain relationships and related-party transactions<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following includes a summary of transactions since January 1, 2022 and any currently proposed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions to which we were or are expected to be a participant in which (i) the amount involved <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exceeded or will exceed $120,000, and (ii) any of our directors, executive officers, or holders of more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">5% of our capital stock, or any affiliate or member of the immediate family of the foregoing persons, had <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or will have a direct or indirect material interest, other than compensation and other arrangements that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described under the section titled &#8220;Executive and director compensation.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 187.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2025 convertible promissory notes financing<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 209.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January and March 2025, we entered into note purchase agreements with various investors, pursuant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 221.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to which we issued an aggregate of $98.4 million&#160;in principal amount of subordinated convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 233.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promissory notes (the &#8220;2025 Convertible Notes&#8221;) to investors, including related parties, with original <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 245.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maturity dates of 48 months from the initial issuance of the notes. Pursuant to the January 2025 note <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase agreement, (i) the first closing occurred on January 24, 2025, at which time we issued $44.7 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 269.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million in principal amount of the 2025 Convertible Notes and (ii) the second closing occurred on January <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2025, at which time we issued $3.7 million in principal amount of the 2025 Convertible Notes. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 293.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to the March 2025 note purchase agreement, the closing occurred on March 25, 2025, at which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time we issued $50.0 million in principal amount of the 2025 Convertible Notes. The aggregate principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount outstanding under the 2025 Convertible Notes will be automatically converted upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effectiveness of this offering into shares of our common stock without interest.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following related parties, or their respective affiliates, participated in the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 107.92pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="position: absolute; top: 381.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 384.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 384.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 27.119999999999997pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.17pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.66pt; position: absolute; text-decoration: none; white-space: pre;">purchase price <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 66.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.91pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 138.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 141.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.81pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 35.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">23,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.76999999999998pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 150.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 151.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 151.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 151.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 151.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 49.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">6,595,648.51<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Entities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 81.5pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 89.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 91.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 91.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.86999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">2,078,516.75<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 93.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 96.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 96.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 78pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">2,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 92.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(6)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 92.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">1,822,713.44<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 106.5pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 72.58999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(7)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 106.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">1,460,234.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 120.75pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">U.S. Venture Partners Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.36pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(8)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 138.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 141.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 141.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 120.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">811,558.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 135pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(9)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 87.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 135pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">250,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 149.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(10)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 90.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 91.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 149.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">144,650.88<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 553.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For additional information regarding these stockholders and their equity holdings, see the section titled &#8220;Principal stockholders.&#8221; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 570.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited and entities affiliated with Hayfin HeartFlow UK Limited own more than 5% of our outstanding capital. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 579.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited is an entity affiliated with Hayfin Services, LLP, which is the lender under our 2024 Credit Agreement.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 596.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP owns more than 5% of our outstanding capital. Dr. Nicholas Downing, M.D. is a member of our board of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 605.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">directors and is a managing director of Bain Capital Life Sciences.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 622.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of $1,929,687.95 in principal amount of the 2025 Convertible Notes purchased by Capricorn Healthcare Special Opportunities <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 631.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">II, L.P., $57,996.00 in principal amount of the 2025 Convertible Notes purchased by The Skoll Foundation, $52,169.37 in principal <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 640.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">amount of the 2025 Convertible Notes purchased by Capricorn Healthcare Special Opportunities II-A, L.P., and $38,663.43 in principal <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 649.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">amount of the 2025 Convertible Notes purchased by The Skoll Fund. Capricorn Entities own more than 5% of our outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 666.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Timothy C. Barabe is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 683.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(6)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Lonnie M. Smith and entities affiliated with Mr. Smith own more than 5% of our outstanding capital. Mr. Smith is a member of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 692.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">163<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(7)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC and entities affiliated with HCPCIV 1, LLC own more than 5% of our outstanding capital. Mr. Jeffrey C. Lightcap is a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors and is a controlling member of HCPCIV 1, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 98pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(8)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of $786,399.92 in principal amount of the 2025 Convertible Notes purchased by U.S. Venture Partners X, L.P. and $25,158.30 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 107pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in principal amount of the 2025 Convertible Notes purchased by USVP X Affiliates, L.P. U.S. Venture Partners Funds own more than 5% <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of our outstanding capital. Mr. Casey M. Tansey is a member of our board of directors and is a controlling member of U.S. Venture <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 125pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Partners Funds.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(9)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Casey M. Tansey is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 159pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(10)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Vikram Verghese is our Chief Financial Officer.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Amendment No. 1 to 2024 Credit Agreement and related matters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 24, 2025, in connection with the issuance of the 2025 Convertible Notes, we entered into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amendment No. 1 to the 2024 Credit Agreement, pursuant to which our lender, Hayfin, converted $23.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million of outstanding indebtedness under the 2024 Term Loan to 2025 Convertible Notes (the &#8220;2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan Conversion&#8221;) under the same terms as the other purchasers of the 2025 Convertible Notes, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described above. As a result, Hayfin became a holder of 5% or more of our capital stock. For more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information about the 2024 Credit Agreement, as amended, see &#8220;Management&#8217;s discussion and analysis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of financial condition and results of operations&#8212;Liquidity and capital resources&#8212;Hayfin credit agreement&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Note 18 to our consolidated financial statements included elsewhere in this prospectus. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the prior credit agreement with Hayfin that was refinanced by the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement, we issued warrants to purchase an aggregate of 541,389 shares of common stock to Hayfin. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result of the Series F redeemable convertible preferred stock financing referred to below, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">antidilution adjustments of these warrants resulted in the issuance to Hayfin in March 2023 of additional <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants to purchase an aggregate of 4,269,801 shares of our common stock. The warrants have an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise price of $0.01 per share of common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Series F and Series F-1 redeemable convertible preferred stock financing<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, we entered into a Series F and Series F-1 redeemable convertible preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase agreement with various investors, pursuant to which we issued an aggregate of 61,344,029 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of Series F redeemable convertible preferred stock at a cash purchase price of $2.8505 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for gross proceeds of $174.9 million in multiple closings and 21,465,064 shares of Series&#160;F-1 redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock at a purchase price of $1.9098 per share for gross proceeds of $41.0 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Series F and Series F-1 redeemable convertible preferred stock financing&#8221;). The Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 476.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock was issued upon conversion of the indebtedness under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding subordinated convertible promissory notes issued by the Company from September 30, 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 500.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to December 16, 2022, in the aggregate principal amount of $40.0 million.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">164<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The table below sets forth the number of shares of our Series F and Series F-1 redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock purchased by our executive officers, directors, holders of more than 5% of our capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock at the time of the transaction, and their affiliated entities or immediate family members. Each share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of Series F and Series F-1 redeemable convertible preferred stock in the table below will convert into one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share of our common stock upon the effectiveness of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 140pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 248.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 248.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 27.119999999999997pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 27.63pt; position: absolute; text-decoration: none; white-space: pre;">Series F <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.64pt; position: absolute; text-decoration: none; white-space: pre;">redeemable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.66pt; position: absolute; text-decoration: none; white-space: pre;">convertible <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.15pt; position: absolute; text-decoration: none; white-space: pre;">preferred <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">stock (#)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19.64pt; position: absolute; text-decoration: none; white-space: pre;">Series F-1 <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.64pt; position: absolute; text-decoration: none; white-space: pre;">redeemable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.66pt; position: absolute; text-decoration: none; white-space: pre;">convertible <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 23.15pt; position: absolute; text-decoration: none; white-space: pre;">preferred <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 25.66pt; position: absolute; text-decoration: none; white-space: pre;">stock (#)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.17pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.66pt; position: absolute; text-decoration: none; white-space: pre;">purchase price <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 59.51pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 70.49pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.76999999999998pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 150.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.34pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">35,081,564<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 56.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">99,999,998.18<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The Lonnie and Cheryl Smith Family Trust<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 189.24pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 197.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 199.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 200.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 200.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 200.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.29999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,068,125<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 70.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">15,408,505.15<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.91pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 140pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 140.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.46pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,508,156<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">2,689,375<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 84.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">15,136,167.06<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 72.58999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(6)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,905,025<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">1,321,383<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 99pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">13,654,851.50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wellington Investors<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 92.42999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(7)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 100.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 100.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 100.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 100.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,169,444<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 113.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">11,885,000.12<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">U.S. Venture Partners Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.36pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(8)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 140.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 140.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,508,156<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 127.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">9,999,998.68<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Entities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 81.5pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(9)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 89.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 90.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 90.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 90.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 90.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.52pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,013,904<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 141.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">8,591,133.35<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The Schiehallion Fund Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 137.06pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(10)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 148.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 149.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 150.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 150.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.44pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">2,490,791<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 156pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">7,099,999.75<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 170.25pt; width: 248.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 248.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(11)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 95.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 95.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 95.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 251.25pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">73,469<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 319.5pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">80,898<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 170.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">363,922.46<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 332.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For additional information regarding these stockholders and their equity holdings, see the section titled &#8220;Principal stockholders.&#8221;<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 349.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The consideration for the Series F-1 redeemable convertible preferred stock was funded through the conversion of outstanding <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 358.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">subordinated convertible promissory notes.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 375.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP owns more than 5% of our outstanding capital. Dr. Nicholas Downing, M.D. is a member of our board of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 384.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">directors and is a managing director of Bain Capital Life Sciences.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 401.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Lonnie M. Smith and entities affiliated with Mr. Smith own more than 5% of our outstanding capital. Mr. Smith is a member of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 410.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 427.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited and entities affiliated with Hayfin HeartFlow UK Limited own more than 5% of our outstanding capital. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 436.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited is an entity affiliated with Hayfin Services, LLP, which is the lender under our 2024 Credit Agreement.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 453.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(6)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC and entities affiliated with HCPCIV 1, LLC own more than 5% of our outstanding capital. Mr. Jeffrey C. Lightcap is a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 462.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors and is a controlling member of HCPCIV 1, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 479.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(7)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 3,176,720 shares of Series F redeemable convertible preferred stock held by Hadley Harbor Master Investors (Cayman) II <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 488.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">LP and 992,724 shares of Series F redeemable convertible preferred stock held by Texas Hidalgo CoInvestment Fund, L.P. Wellington <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 497.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investors own more than 5% of our outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 514.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(8)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 3,399,403 shares of Series F redeemable convertible preferred stock held by U.S. Venture Partners X, L.P. and 108,753 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 523.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares of Series F redeemable convertible preferred stock held by USVP X Affiliates, L.P. U.S. Venture Partners Funds own more than <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 532.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">5% of our outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 549.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(9)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 1,402,222 shares of Series F redeemable convertible preferred stock held by Capricorn Healthcare Special Opportunities II, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 558.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">L.P., 37,909 shares of Series F redeemable convertible preferred stock held by Capricorn Healthcare Special Opportunities II-A, L.P., <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 567.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">12,729 shares of Series F redeemable convertible preferred stock held by Carthage, LP, 1,142,851 shares of Series F redeemable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 576.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock held by Pacific Sequoia Holdings, LLC, 223,661 shares of Series F redeemable convertible preferred stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 585.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">held by The Skoll Foundation, and 194,532 shares of Series F redeemable convertible preferred stock held by The Skoll Fund. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 594.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Entities own more than 5% of our outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 611.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(10)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Schiehallion Fund Limited and Baillie Gifford Funds affiliated with The Schiehallion Fund Limited own more than 5% of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 620.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding capital.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 637.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(11)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. William C. Weldon is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 654.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2022 convertible promissory notes financing <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In September 2022, we entered into a note purchase agreement with various investors, pursuant to which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we issued an aggregate of $40.0 million in principal amount of subordinated convertible promissory notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;2022 Convertible Notes&#8221;) to investors with original maturity dates of 48 months from the dates of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">165<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance. The 2022 Convertible Notes automatically converted into shares of Series F-1 convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock on March 2, 2023. For more information, see the subsection titled &#8220;&#8212;Series F and Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">F-1 redeemable convertible preferred stock financing.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following related parties, or their respective affiliates, participated in the 2022 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering&#58;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 107.92pt; position: absolute; top: -2.548pt; vertical-align: super; white-space: pre;"> <font style="display: inline-block; height: 4.732pt;"></font></font></div><div style="position: absolute; top: 148pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 384.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 384.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 5.8500000000000005pt; font-style: normal; font-weight: bold; left: 27.119999999999997pt; position: absolute; text-decoration: none; top: -2.2925pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.2575pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.17pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.66pt; position: absolute; text-decoration: none; white-space: pre;">purchase price <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 66.64pt; position: absolute; text-decoration: none; white-space: pre;">($)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">The Lonnie and Cheryl Smith Family Trust<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 189.24pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 197.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 199.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 200.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 201.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 201.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 201.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 201.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 201.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 35.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 4.07pt;"></font></font><font style="left: 12.260000000000002pt; position: absolute;">15,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.91pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 138.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 141.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.81pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 49.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">5,000,000.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 72.58999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 63.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 9.63pt;"></font></font><font style="left: 17.82pt; position: absolute;">2,458,284.00<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 384.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 384.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 78pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.96pt;"></font></font><font style="left: 26.15pt; position: absolute;">150,501.65<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 248.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For additional information regarding these stockholders and their equity holdings, see the section titled &#8220;Principal stockholders.&#8221; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 265.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. Lonnie M. Smith and entities affiliated with Mr. Smith own more than 5% of our outstanding capital. Mr. Smith is a member of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 274.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 291.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited and entities affiliated with Hayfin HeartFlow UK Limited own more than 5% of our outstanding capital. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 300.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin HeartFlow UK Limited is an entity affiliated with Hayfin Services, LLP, which is the lender under our 2024 Credit Agreement.&#160; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 317.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">HCPCIV 1, LLC and entities affiliated with HCPCIV 1, LLC own more than 5% of our outstanding capital. Mr. Jeffrey C. Lightcap is a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 326.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors and is a controlling member of HCPCIV 1, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 343.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mr. William C. Weldon is a member of our board of directors.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 360.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Investors&#8217; rights agreement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are party to an amended and restated investors&#8217; rights agreement, as amended, dated March 2, 2023 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Investors&#8217; Rights Agreement&#8221;), with the purchasers of our outstanding redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock, including the following directors, holders of more than 5% of our capital stock and entities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with which certain of our directors are affiliated&#58; BCLS Fund III Investments, LP, Lonnie M. Smith, Hayfin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow UK Limited (an entity affiliated with Hayfin Services, LLP, which is the lender under our 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Credit Agreement), HealthCor Partners Funds, Wellington Investors, U.S. Venture Partners Funds, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Capricorn Entities, Baillie Gifford Funds, William C. Weldon and Charles A. Taylor, Jr., Ph.D. Following the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering, the holders of approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million shares of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuable upon the conversion of our outstanding redeemable convertible preferred stock are entitled to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights with respect to the registration of their shares under the Securities Act. For a more detailed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">description of these registration rights, see the section titled &#8220;Shares eligible for future sale&#8212;Registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 534.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Voting agreement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are party to an amended and restated voting agreement, as amended, with certain holders of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock and redeemable convertible preferred stock, including the following directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executive officers, holders of more than 5% of our capital stock, and entities with which certain of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 593.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors are affiliated&#58; BCLS Fund III Investments, LP, Lonnie M. Smith, Hayfin HeartFlow UK Limited (an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 605.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entity affiliated with Hayfin Services, LLP, which is the lender under our 2024 Credit Agreement), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HealthCor Partners Funds, Wellington Investors, U.S. Venture Partners Funds, Capricorn Entities, Baillie <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Gifford Funds, William C. Weldon and Charles A. Taylor, Jr., Ph.D. Pursuant to the amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">voting agreement, BCLS Fund III Investments, LP has the right to designate one member to be elected to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our board of directors, which designee is currently Nicholas Downing. Upon the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, the amended and restated voting agreement will terminate. Members previously elected to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">board of directors pursuant to this agreement will continue to serve as directors until they resign, are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">removed or their successors are duly elected by holders of our common stock. The composition of our <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">166<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">board of directors after this offering is described in more detail in the section title &#8220;Management&#8212;Board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Right of first refusal and co-sale agreement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are party to an amended and restated right of first refusal and co-sale agreement with certain holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock and redeemable convertible preferred stock, including the following directors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of more than 5% of our capital stock, and entities with which certain of our directors are affiliated&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">BCLS Fund III Investments, LP, Lonnie M. Smith, Hayfin HeartFlow UK Limited (an entity affiliated with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin Services, LLP, which is the lender under our 2024 Credit Agreement), HealthCor Partners Funds, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Wellington Investors, U.S. Venture Partners Funds, Capricorn Entities, Baillie Gifford Funds, William C. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Weldon and Charles A. Taylor, Jr., Ph.D. This agreement provides for rights of first refusal and co-sale <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relating to the shares of our common stock and convertible securities, other than Series F and Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock and the common stock issuable upon conversion of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock, held by certain parties to the agreement. Upon the completion of this offering, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended and restated right of first refusal and co-sale agreement will terminate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Management rights letters<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with the issuance of our Series F and Series F-1 convertible preferred stock, we entered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into management rights letters with certain purchasers of our redeemable convertible preferred stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including holders of more than 5% of our capital stock, U.S. Venture Partners X, L.P., Baillie Gifford Funds <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and HealthCor Partners Funds, pursuant to which such entities were granted certain management rights, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including the right to consult with and advise our management on significant business issues, review our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating plans, examine our books and records and inspect our facilities. These management rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">letters and the rights granted to the parties thereto will terminate upon completion of this offering. Certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our obligations under the management rights letters will remain in effect after the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, including certain tax reporting and financial disclosures.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Letter agreement with Bain Capital Life Science<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 427.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with our Series F redeemable convertible preferred stock financing, we entered into a letter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 439.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with BCLS Fund III Investments, LP (the &#8220;BCLS Letter Agreement&#8221;), which holds more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">5% of our outstanding capital stock. Pursuant to the BCLS Letter Agreement, BCLS Fund III Investments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 463.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">LP was granted the right to designate a board observer in a nonvoting capacity, which right will terminate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 475.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon the completion of this offering. Certain of our obligations under the BCLS Letter Agreement will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 487.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remain in effect after the completion of this offering,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.77pt; position: absolute; text-decoration: none; white-space: pre;"> including our obligation to obtain the consent of Bain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 499.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Capital prior to making certain public disclosures about Bain Capital or certain of its affiliates and certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 511.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">pro rata lock-up release rights of Bain Capital which provide that, in the event we or the managing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 523.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">underwriter waive or terminate the lock-up restrictions contained in the Investors&#8217; Rights Agreement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 535.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">certain lock-up agreements (including certain lock-up agreements for this offering), then such restrictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 547.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">applicable to Bain Capital under the Investors&#8217; Rights Agreement or any lock-up agreement will be waived <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 559.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">or terminated, as applicable, to the same extent and with respect to the same percentage of securities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 579.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Letter agreement with Wellington Investors<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 601.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with our Series F redeemable convertible preferred stock financing, we entered into a letter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 613.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with the Wellington Investors (the &#8220;Wellington Letter Agreement&#8221;), which collectively hold more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 625.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than 5% of our outstanding capital stock. Pursuant to the Wellington Letter Agreement, the Wellington <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investors were granted the right to designate a board observer in a nonvoting capacity, which right will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 649.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminate upon the completion of this offering. The Wellington Letter Agreement will terminate by its terms <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 661.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in connection with the completion of this offering and the Wellington Investors will not have any continuing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 673.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights following this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">167<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Letter agreement with Capricorn Entities<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with our Series F redeemable convertible preferred stock financing, we entered into a letter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with the Capricorn Entities (the &#8220;Capricorn Letter Agreement&#8221;), which collectively hold more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than 5% of our outstanding capital stock. Pursuant to the Capricorn Letter Agreement, the Capricorn <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Entities were granted the right to designate a board observer in a nonvoting capacity. The Capricorn <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Letter Agreement will terminate by its terms in connection with the completion of this offering and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Capricorn Entities will not have any continuing rights following this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023 Taylor Trust repurchase<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 29, 2023, we entered into a common stock repurchase agreement in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series F and Series F-1 redeemable convertible preferred stock financing, pursuant to which we <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repurchased 300,000 shares of common stock from the Taylor Family Revocable Trust, a family trust held <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by Charles A. Taylor, Jr., Ph.D., one of our directors, at $2.8505 per share for an aggregate purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price of $855,150.00.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 264.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 287.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Michael Smith, a relative of Mr. Lonnie M. Smith, one of our directors, has been one of our non-executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 299.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">employees since 2014. His overall cash compensation for each of 2022, 2023 and 2024 did not exceed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 311.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$300,000. He did not receive any equity compensation in 2024, and has received an aggregate of less <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 323.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">than 50,000 incentive stock options during his employment with us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 343.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Executive officer and director compensation<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Please see the section titled &#8220;Executive and director compensation&#8221; for information regarding the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 377.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">compensation of our directors and executive officers and the new severance plan we intend to enter into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 389.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">prior to this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 409.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Indemnification agreements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have entered into indemnification agreements with certain of our current directors and executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers and intend to enter into new indemnification agreements with each of our current directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">executive officers before the completion of this offering. Our amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation and our amended and restated bylaws will provide that we will indemnify our directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers to the fullest extent permitted by applicable law. Further, we have purchased a policy of directors&#8217; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and officer&#8217; liability insurance that insures our directors and officers against the cost of defense, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement or payment of a judgment under certain circumstances. See the section titled &#8220;Management&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Limitations on liability and indemnification matters.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 536pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Policies and procedures for related-party transactions<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to the completion of this offering, our board of directors will adopt a written related-party transaction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">policy, to be effective upon the completion of this offering, setting forth the policies and procedures for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">review and approval or ratification of related-party transactions. This policy will cover, with certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exceptions set forth in Item 404 of Regulation S-K, any transaction, arrangement, or relationship, or any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">series of similar transactions, arrangements, or relationships, in which we were or are to be a participant, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">where the amount involved exceeds $120,000 and a related person had or will have a direct or indirect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material interest, including without limitation purchases of goods or services by or from the related person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and employment by us of a related person. In reviewing and approving any such transactions, our audit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">committee is tasked to consider all relevant facts and circumstances, including but not limited to whether <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an unrelated third party and the extent of the related person&#8217;s interest in the transaction. All of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions described in this section occurred prior to the adoption of this policy.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">168<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1309" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Principal stockholders<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth, as of March 1, 2025, information regarding beneficial ownership of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital stock by&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 139.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 151.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 171.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each of our named executive officers&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">each of our directors&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 211.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">all of our executive officers and directors as a group.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 231.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The percentage ownership information under the column titled &#8220;Beneficial ownership prior to this offering&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 243.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is based on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock outstanding as of&#160;March 1, 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 255.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including&#160;149,581,128&#160;shares of our common stock resulting from the<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.09pt; position: absolute; text-decoration: none; white-space: pre;"> Preferred Stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 450.28pt; position: absolute; white-space: pre;"> Conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 267.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.45pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock resulting from the conversion of the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 279.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(based on the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, which is the midpoint of the price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 291.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">range set forth on the cover page of this prospectus)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.63pt; position: absolute; white-space: pre;">, in each case as if such conversion had occurred as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 303.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of&#160;March 1, 2025. The ownership information under the column titled &#8220;Beneficial ownership after this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 315.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering&#8221; assumes the foregoing and the issuance of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock in this offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 327.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and assumes no exercise of the underwriters&#8217; option to purchase additional shares. In addition, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 339.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following table does not reflect any shares of common stock that may be purchased in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 359.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have determined beneficial ownership according to the rules and regulations of the SEC, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 371.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">generally means that a person has beneficial ownership of a security if they or it possesses sole or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shared voting or investment power of that security. In addition, shares of common stock issuable upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 395.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of stock options or warrants that are currently exercisable or exercisable within 60 days <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 407.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of&#160;March&#160;1, 2025 are included in the following table. These shares are deemed to be outstanding and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beneficially owned by the person holding those options or warrants for the purpose of computing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">percentage ownership of that person, but they are not treated as outstanding for the purpose of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">computing the percentage ownership of any other person. The information contained in the following table <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 455.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not necessarily indicate beneficial ownership for any other purpose. Unless otherwise indicated, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">persons or entities identified in this table have sole voting and investment power with respect to all shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 479.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shown as beneficially owned by them, subject to applicable community property laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 499.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unless otherwise noted below, the address for each beneficial owner listed in the table below is c&#47;o <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 511.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Heartflow, Inc., 331 E. Evelyn Avenue, Mountain View, California 94041.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">169<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="position: absolute; top: 72pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 195pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 198pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 40.94pt; position: absolute; text-decoration: none; white-space: pre;">Beneficial ownership <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.98pt; position: absolute; text-decoration: none; white-space: pre;">prior to this offering<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 40.94pt; position: absolute; text-decoration: none; white-space: pre;">Beneficial ownership <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 56.96pt; position: absolute; text-decoration: none; white-space: pre;">after this offering<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 45pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 195pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 195pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name of beneficial owner<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.67pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.63pt; position: absolute; text-decoration: none; white-space: pre;">shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.65pt; position: absolute; text-decoration: none; white-space: pre;">beneficially <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 34.15pt; position: absolute; text-decoration: none; white-space: pre;">owned<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.17pt; position: absolute; text-decoration: none; white-space: pre;">Percentage of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.15pt; position: absolute; text-decoration: none; white-space: pre;">beneficial <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.66pt; position: absolute; text-decoration: none; white-space: pre;">ownership<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.67pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.63pt; position: absolute; text-decoration: none; white-space: pre;">shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.65pt; position: absolute; text-decoration: none; white-space: pre;">beneficially <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 34.15pt; position: absolute; text-decoration: none; white-space: pre;">owned<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.17pt; position: absolute; text-decoration: none; white-space: pre;">Percentage of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.15pt; position: absolute; text-decoration: none; white-space: pre;">beneficial <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.66pt; position: absolute; text-decoration: none; white-space: pre;">ownership<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">5% and greater stockholders&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 83.25pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">BCLS Fund III Investments, LP<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.76999999999998pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 150.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 151.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 151.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 151.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 151.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.93pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 83.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 97.5pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HealthCor Partners Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 118.72pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 126.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 127.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 127.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 97.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111.75pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wellington Investors<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 92.42999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(3)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 100.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 101.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 102.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.19pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12,890,317<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 76.52pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(4)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 84.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 87.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.08999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 140.25pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Entities affiliated with Hayfin Services, LLP <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(5)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 19.560000000000002pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 21.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 22.020000000000003pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 22.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 166.5pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(6)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 166.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 180.75pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">U.S. Venture Partners Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 130.36pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(7)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 138.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 140.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.99pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 180.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 195pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Baillie Gifford Funds<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 92.41pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(8)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 100.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 101.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 102.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 102.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.19pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 195pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">8,777,530<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 195pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 209.25pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Named executive officers and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">directors&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 235.5pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 91.5pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(9)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 99.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 101.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 102.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 102.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.08999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 235.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">3,509,166<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 235.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 249.75pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 78.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(10)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 90.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 92.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.16pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 249.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 264pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy A. Fonte<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 77.77pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(11)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 88.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 91.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 92.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.03pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 264pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">584,691<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 264pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 278.25pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.07pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(12)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 96.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 278.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">813,327<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 278.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 292.5pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.56pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(13)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 97.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 97.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.36pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 292.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 306.75pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 73.17pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(14)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 84.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 87.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 87.11999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 306.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">124,062<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 306.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 321pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 109.27pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(15)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 120.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 121.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 122.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 122.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.24pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 321pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.62pt; position: absolute; text-decoration: none; white-space: pre;">&#8212;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 321pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 335.25pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 85.75999999999999pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 93.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 96.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.02pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 335.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 349.5pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Wayne Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 84.25pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(16)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 95.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 97.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 97.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 97.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.24pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 349.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; text-decoration: none; white-space: pre;">101,770<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 349.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 363.75pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(6)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 86.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 363.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 378pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 79.11pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(17)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 90.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 92.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 92.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 92.22pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 378pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 392.25pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Charles A. Taylor, Jr., Ph.D.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 124.05pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(18)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 135.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 136.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 137.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 137.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 392.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">3,282,801<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 392.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 406.5pt; width: 195pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">All current directors and executive officers <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 195pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">as a group (13 persons)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 117.75pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(19)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 129.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 131.89000000000001pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 132.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 132.08pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 406.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;">%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 512.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Indicates beneficial ownership of less than 1% of the total outstanding common stock.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 529.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 118.74pt; position: absolute; text-decoration: none; white-space: pre;"> of&#160;(A) 35,081,564&#160;shares of our common stock issuable upon conversion of our redeemable convertible preferred stock and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 538.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by Bain Capital Life Sciences <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 547.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Fund III, L.P. Bain Capital Life Sciences Investors, LLC (&#34;BCLSI&#34;) is the manager of Bain Capital Life Sciences III General Partner, LLC, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 556.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which is the general partner of Bain Capital Life Sciences Fund III, L.P., which is the managing member of BCLS Fund III Investments <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 565.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">GP, LLC, which is the general partner of BCLS Fund III Investments, LP. As a result, BCLSI may be deemed to share voting and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 574.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">dispositive power with respect to the securities held by BCLS Fund III Investments, LP. The principal address for BCLS Fund III <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 583.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investments, LP is 200 Clarendon Street, Boston, Massachusetts 02116. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 600.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) shares of our common stock issuable upon conversion of our redeemable convertible preferred stock expected to be <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 609.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">held by the following entities, collectively referred to as &#8220;HealthCor Partners Funds&#8221;&#58; (i)&#160;9,328,973&#160;shares of common stock issuable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 618.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon conversion of our redeemable convertible preferred stock held by HCPCIV 1, LLC&#59; (ii)&#160;2,166,846&#160;shares of common stock issuable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 627.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon conversion of our redeemable convertible preferred stock held by HealthCor Partners Fund, L.P&#59; and (iii)&#160;2,166,846&#160;shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 636.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by HealthCor Partners Fund II, L.P. and (B) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 645.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by HCPCIV 1, LLC. Mr. Lightcap, a <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 654.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">member of our board of directors, is a controlling member of each of the HealthCor Partners Funds. Mr. Lightcap disclaims beneficial <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 663.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">ownership of these shares except to the extent of his pecuniary interest therein. The address for the HealthCor Partners Funds is 186 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 672.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Seven Farms Drive, Suite F-371, Daniel Island, South Carolina 29492. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 689.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(3)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (i) 9,894,486 shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 698.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hadley Harbor Master Investors (Cayman) II LP and (ii) 2,995,831&#160;shares of our common stock issuable upon conversion of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 707.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock expected to be held by Texas Hidalgo Co-Investment Fund, L.P. (each a &#8220;Wellington Investor&#8221; <font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">170<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and, collectively, the &#8220;Wellington Investors&#8221;). Wellington Management Company LLP, a registered investment adviser under the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investment Advisers Act of 1940, as amended, is the investment adviser to each Wellington Investor, and Wellington Alternative <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investments LLC is its general partner. Wellington Management Investment, Inc. is the managing member of Wellington Alternative <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 99pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investments LLC. Wellington Management Company LLP is an indirect subsidiary of Wellington Management Group LLP. Wellington <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Management Group LLP and Wellington Management Company LLP may be deemed beneficial owners with shared voting and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 117pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">investment power over the shares held by each Wellington Investor. The address for each Wellington Investor and the Wellington <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">entities is 280 Congress Street, Boston, Massachusetts 02210. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 143pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(4)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) shares of our common stock issuable upon conversion of our redeemable convertible preferred stock held by the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">following entities, collectively referred to as the &#8220;Capricorn Funds&#8221;&#58; (i)&#160;2,503,776&#160;shares of common stock issuable upon conversion of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 161pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our redeemable convertible preferred stock held by Capricorn Healthcare and Special Opportunities, LP&#59; (ii) 3,090,809 shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by Capricorn Healthcare and Special <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 179pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Opportunities II, LP&#59; (iii)&#160;83,561&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by Capricorn Healthcare and Special Opportunities II-A, LP&#59; (iv)&#160;208,016&#160;shares of common stock issuable upon conversion of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 197pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock held by Capricorn S.A. SICAV&#8201;&#8212;&#8201;SIF&#8201;&#8212;&#8201;Global Non-Marketable Strategies Sub-Fund&#59; (v) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">92,058&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by Carthage, LP&#59; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 215pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(vi)&#160;121,595 shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by CHSO CIG, LP&#59; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(vii)&#160;148,543&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by CHSO SFP, LP&#59; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 233pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(viii)&#160;222,117&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by CHSO TSF, LP&#59; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(ix) 3,395,959&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by Pacific Sequoia <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 251pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Holdings, LLC&#59; (x)&#160;632,386&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Skoll Foundation&#59; and (xi)&#160;556,593&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 269pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock held by The Skoll Fund and (B) (i) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">purchased by Capricorn Healthcare Special Opportunities II, L.P., (ii)&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 287pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes purchased by The Skoll Foundation, (iii)&#160;  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2025 Convertible Notes purchased by Capricorn Healthcare Special Opportunities II-A, L.P., and (iv)&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 305pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuable upon conversion of the 2025 Convertible Notes purchased by The Skoll Fund. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CHSO Partners, LLC, is the general partner of Capricorn Healthcare and Special Opportunities, LP, CHSO CIG, LP, CHSO SFP, LP, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 331pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and CHSO TSF, LP. CHSO Partners, LLC has sole investment and voting authority over the shares held by these funds. Voting and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 340pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">dispositive decisions on behalf of CHSO Partners LLC are made by the separate decisions of Barry Uphoff, the Principal Manager of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 349pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CHSO Partners LLC and a majority of the CIG Managers of CHSO Partners. Messrs. Eric Techel and Ion Yadigaroglu are the CIG <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Managers of CHSO Partners LLC. Messrs. Uphoff, Techel and Yadigaroglu may be deemed to have shared voting and investment <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 367pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">control with respect to the shares held by the funds managed by CHSO Partners LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">CHSO Partners II, LLC, is the general partner of Capricorn Healthcare and Special Opportunities II, LP and Capricorn Healthcare &#38; <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 393pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Special Opportunities II-A, LP. CHSO Partners II, LLC has sole investment and voting authority over the shares held by these funds. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Voting and dispositive decisions on behalf of CHSO Partners II, LLC are made by the separate decisions of Barry Uphoff, the Principal <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 411pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Manager of CHSO Partners II, LLC and one designated representative of Capricorn Investment Group, LLC. Mr. Uphoff and Capricorn <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investment Group may be deemed to have shared voting and investment control with respect to the shares held by the funds managed <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 429pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by CHSO Partners II, LLC.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 446pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Capricorn Investment Group, LLC is the general partner of Carthage, LP and the investment manager of Pacific Sequoia Holdings, LLC, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 455pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Skoll Foundation and The Skoll Fund.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The address for each of the Capricorn Funds is c&#47;o Capricorn Investment Group LLC, 250 University Avenue, Palo Alto, California <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 481pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">94301. CHSO Partners, LLC and CHSO Partners II, LLC&#8217;s address is 2020 K Street NW, STE 720, Washington, DC 20006<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(5)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) (i)&#160;6,197,531&#160;shares of our common stock issuable upon conversion of our redeemable convertible preferred stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 507pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expected to be held by Hayfin Heartflow UK Limited and (ii)&#160;4,811,190&#160;shares of our common stock subject to warrants exercisable by <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Tourmaline Luxco S.a.r.l. within 60 days of&#160;March&#160;1, 2025 and (B)&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 525pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the 2025 Convertible Notes purchased by Hayfin HeartFlow UK Limited. The principal address for the Hayfin Services, LLP and its <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 534pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">affiliates is 65 Davies Street, London W1K5JL. Hayfin Services, LLP is the lender under our 2024 Credit Agreement. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 551pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(6)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) (i)&#160;8,068,125&#160;shares of our common stock issuable upon conversion of our redeemable convertible preferred stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">expected to be held by Lonnie M. Smith HeartFlow IV Grantor Retained Annuity Trust u&#47;a June 24, 2023, (ii)&#160;645,161&#160;shares of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 569pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by Lonnie M. Smith HeartFlow GRAT III, <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(iii)&#160;248,653&#160;shares of our common stock issuable upon conversion of our redeemable convertible preferred stock held by McKram <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 587pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Investment Capital II LLC, (iv)&#160;100,000&#160;shares of our common stock held directly by Mr. Smith and (v)&#160;59,062&#160;shares of our common <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock subject to options exercisable by Mr. Smith within 60 days of&#160;March&#160;1, 2025 and (B)&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 605pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon conversion of the 2025 Convertible Notes purchased by Lonnie M. Smith. Mr. Smith has voting and investment power over the <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 614pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares held by McKram Investment Capital II LLC. Mr. Smith has notified us that he will resign from our board of directors immediately <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 623pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">prior to the effectiveness of the registration statement of which this prospectus forms a part.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(7)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A) shares of our common stock issuable upon conversion of our redeemable convertible preferred stock expected to be <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 649pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">held by the following entities, collectively referred to as the &#8220;U.S. Venture Partners Funds&#8221;&#58; (i)&#160;8,821,387&#160;shares of common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 658pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuable upon conversion of our redeemable convertible preferred stock held by U.S. Venture Partners X, L.P. and (ii) 237,522&#160;shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 667pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by USVP X Affiliates, L.P. and (B) (i) <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by U.S. Venture Partners X, L.P. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 685pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and (ii) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased by USVP X Affiliates, L.P. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 694pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Presidio Management Group X, L.L.C. (&#8220;PMG X&#8221;) is the general partner of the U.S. Venture Partners Funds. The managing members of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 703pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">PMG X are Irwin Federman, Steven M. Krausz, Rick Lewis, Paul Matteucci, Jonathan D. Root and Casey Tansey, all of whom may be <font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">171<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 5.46pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">deemed to share voting and investment power over these shares, but disclaim beneficial ownership except to the extent of their <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 81pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">pecuniary interests therein. The address for the U.S. Venture Partners Funds is 2735 Sand Hill Road, Menlo Park, California 94025. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 98pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(8)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of shares of our common stock issuable upon conversion of our redeemable convertible preferred stock expected to be held <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 107pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by the following entities, collectively referred to as &#8220;Baillie Gifford Funds&#8221;&#58; (i)&#160;435,065&#160;shares of common stock issuable upon conversion <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of our redeemable convertible preferred stock held by Host-Plus Pty Limited, (ii)&#160;127,704&#160;shares of common stock issuable upon <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 125pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">conversion of our redeemable convertible preferred stock held by Interventure Equity Investments Limited, (iii) an aggregate <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of&#160;4,206,596&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred stock held by Scottish <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 143pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Mortgage Investment Trust plc, (iv)&#160;227,051&#160;shares of common stock issuable upon conversion of our redeemable convertible preferred <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock held by The Board of Trustees of the Saskatchewan Healthcare Employees' Pension Plan, (v)&#160;3,292,034&#160;shares of common stock <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 161pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">issuable upon conversion of our redeemable convertible preferred stock held by The Schiehallion Fund Limited, (vi) 249,613 shares of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common stock issuable upon conversion of our redeemable convertible preferred stock held by The States of Jersey Public Employees <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 179pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Contributory Retirement Scheme, (vii) 194,237 shares of common stock issuable upon conversion of our redeemable convertible <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">preferred stock held by Vision Super Pty Ltd, and (viii)&#160;45,230 shares of common stock issuable upon conversion of our redeemable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 197pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock held by Warman Investments Pty Limited. Baillie Gifford Overseas Limited has been appointed to act for and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">on behalf of, as direct investment manager, for each of the Baillie Gifford Funds with full voting and investment power. The address for <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 215pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Baillie Gifford Funds is Calton Square, 1 Greenside Row, Edinburgh EH1 3AN, Scotland, United Kingdom. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(9)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (i) 1,090,272 shares of our common stock and (ii) 2,418,894 shares of our common stock subject to options exercisable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 241pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">within 60 days of&#160;March&#160;1, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(10)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A)&#160;(i) 335,260 shares of our common stock and&#160;(ii) 123,925 shares of our common stock subject to options exercisable <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 267pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">within 60 days of&#160;March&#160;1, 2025 and (B)&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">purchased by Vikram Verghese.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 293pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(11)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of&#160;(i) 359,143 shares of our common stock and (ii) 225,548&#160;shares of our common stock subject to options exercisable within <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">60 days of&#160;March&#160;1, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 319pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(12)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (i)&#160;164,270&#160;shares of our common stock, (ii) 398,016&#160;shares of our common stock issuable upon conversion of our <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 328pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred stock and (iii) 251,041 shares of our common stock subject to options exercisable within 60 days <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 337pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">of&#160;March&#160;1, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(13)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of (A)&#160;(i) 91,978 shares of our common stock and (ii) 7,709&#160;shares of our common stock subject to options exercisable within <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 363pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">60 days of&#160;March&#160;1, 2025 and (B)&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon conversion of the 2025 Convertible Notes purchased <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by Timothy C. Barabe.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 389pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(14)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of&#160;(i) 112,812 shares of our common stock and (ii) 11,250 shares of our common stock subject to options exercisable within 60 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 398pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">days of&#160;March&#160;1, 2025.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 415pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(15)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Does not include shares of our common stock issuable upon conversion of our redeemable convertible preferred stock held by BCLS <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Fund III Investments, LP or our 2025 Convertible Notes purchased by BCLS Fund III Investments, LP. Dr. Downing is a managing <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 433pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">director of Bain Capital Life Sciences. Dr. Downing, a current member of our board of directors, has notified us that he will resign from <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our board of directors immediately prior to the effectiveness of the registration statement of which this prospectus forms a part.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 459pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(16)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of 101,770 shares of our common stock subject to options exercisable within 60 days of&#160;March&#160;1, 2025. <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 476pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(17)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Includes (A) the shares described in footnote 7 and (B)&#160; &#160; &#160; &#160; &#160; &#160; &#160;  shares of common stock issuable upon conversion of the 2025 <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 485pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes purchased by Casey M. Tansey.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(18)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consists of&#160;(i) 400,000 shares of our common stock and (ii) 460,301 shares of our common stock subject to options exercisable within <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 511pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">60 days of March&#160;1, 2025, and includes&#160;(iii) 2,305,280&#160;shares expected to be held by various family trusts established by Dr. Taylor and <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(iv) 117,220 shares expected to be held by various family members. Dr. Taylor may be deemed to beneficially own such <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 529pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares.&#160;600,000 shares expected to be held by Dr. Taylor and his trust have been pledged to Section Capital Partners, LP.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 5.46pt; position: absolute; top: 546pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(19)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Includes the shares described in footnotes <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 232.49pt; position: absolute; text-decoration: none; white-space: pre;">1, 2, 6 and 9 through <font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 303.74pt; position: absolute; text-decoration: none; white-space: pre;">18<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 312.08000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> above<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 334.59000000000003pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">172<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1337" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Description of capital stock<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following descriptions are summaries of our capital stock and the material terms of our amended and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restated certificate of incorporation and our amended and restated bylaws, which will become effective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately prior to the completion of this offering. Because the following descriptions are only <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summaries, they do not contain all of the information that may be important to you. Reference is made to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the more detailed provisions of, and the descriptions are qualified in their entirety by reference to, these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">documents, copies of which are filed with the SEC as exhibits to the registration statement of which this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus is a part, and applicable law.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 199.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">General<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 221.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering and the filing of our amended and restated certificate of incorporation, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 233.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our authorized capital stock will consist of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of capital stock, par value $0.001 per share, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 245.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of which&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 265.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares are designated as common stock&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 285.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares are designated as preferred stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, there would have been &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of common stock outstanding, held of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">record by&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;stockholders, assuming the conversion of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 341.32pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.9pt; position: absolute; text-decoration: none; white-space: pre;"> of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 408pt; position: absolute; white-space: pre;"> our outstanding redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock and 2025 Convertible Notes into&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately prior to the completion of this offering, based on the assumed initial public offering price of $&#160; &#160; &#160; &#160; &#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">per share, which is the midpoint of the price range set forth on the cover page of this prospectus. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025, we consummated a &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-for-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reverse stock split of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 385.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Common stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Voting rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holders of our common stock are entitled to one vote per share on all matters submitted to a vote of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will not provide for cumulative voting for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">election of directors. Subject to the rights of the holders of one or more series of preferred stock, director <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">candidates standing for election will be elected by a plurality of the votes cast by our stockholders present <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in person or represented by proxy at the meeting and entitled to vote thereon. Our amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certificate of incorporation will retain a classified board of directors, divided into three classes with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">staggered three-year terms. Only one class of directors will be elected at each annual meeting of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders, with the other classes continuing for the remainder of their respective terms. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dividend rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subject to preferences that may be applicable to any preferred stock, the holders of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be entitled to receive ratably, on a per share basis, any dividends declared by our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">out of assets legally available.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidation rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subject to preferences that may be applicable to any preferred stock, in the event of any voluntary or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involuntary liquidation, dissolution or winding up, after payment or provision for payment of our debts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other liabilities, the holders of shares of our common stock will be entitled to receive, ratably in proportion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the number of shares held by the holder, all our remaining assets available for distribution to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">173<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No preemptive or similar rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 92pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holders of our common stock will not be entitled to preemptive, subscription or conversion rights. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">There will be no redemption or sinking fund provisions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 124pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Preferred stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Immediately prior to the completion of this offering, all outstanding shares of our redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock will be converted into shares of our common stock. Our amended and restated certificate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of incorporation will authorize&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of preferred stock and will provide that preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be issued from time to time in one or more series. Our board of directors will be authorized to fix the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">voting rights, if any, designations, powers, preferences, the relative, participating, optional, special and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">series. These rights, powers and preferences could include dividend rights, conversion rights, voting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rights, terms of redemption, liquidation preferences, sinking fund terms, and the number of shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">constituting, or the designation of, such series, any or all of which may be greater than the rights of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock. Our board of directors will be able to, without stockholder approval, issue shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock with voting and other rights that could adversely affect the voting power and other rights of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the holders of the common stock and could have anti-takeover effects. The ability of our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to issue shares of preferred stock without stockholder approval could have the effect of delaying, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deferring or preventing a change of control or the removal of existing management.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock options<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of&#160;December 31, 2024, we had outstanding&#160;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 280.31pt; position: absolute; text-decoration: none; white-space: pre;">24,930,958&#160;shares of our common stock issuable upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">exercise of outstanding stock options<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.88pt; position: absolute; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 241.42pt; position: absolute; text-decoration: none; white-space: pre;">with a weighted-average exercise price of $1.62&#160;per share<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 498.08pt; position: absolute; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.56pt; position: absolute; text-decoration: none; white-space: pre;">nd&#160;16,500,139&#160;shares were unvested, with a weighted average exercise price of $1.41&#160;per share. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 509.21pt; position: absolute; white-space: pre;">For <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional information regarding the terms of our equity incentive plans, see the section titled &#8220;Executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and director compensation&#8212;2025 Performance incentive plan.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 412.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Warrants<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, we had outstanding warrants to purchase an aggregate of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 449.19pt; position: absolute; text-decoration: none; white-space: pre;">4,811,190 <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 495.68pt; position: absolute; white-space: pre;">shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock, with an exercise price of $0.01 per share, issuable upon the exercise of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding warrants. The warrants will terminate on the ten-year anniversary of the issuance date, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">however, the warrants will automatically net exercise immediately prior to termination if the fair market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of one share of common stock exceeds the then current exercise price per share of common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with certain change of control transactions, which include SPAC combinations, mergers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidations and the sale or lease of substantially all of the assets of the Company, the warrants will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">also automatically net exercise if the fair market value of one share of common stock exceeds the then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current exercise price per share of common stock. The warrants do not automatically net exercise in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with an initial public offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 563.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Registration rights<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering and subject to the lock-up agreements entered into in connection with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering and federal securities laws, holders of shares of our common stock that will be issued upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the conversion of our redeemable convertible preferred stock in connection with this offering and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holder of shares of our common stock issuable or issued upon exercise of certain outstanding warrants to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase shares of our common stock will initially be entitled to certain registration rights under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act. These securities are referred to as registrable securities. The holders of these registrable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities possess registration rights pursuant to the terms of the Investors&#8217; Rights Agreement and are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described in additional detail below. The registration of shares of our common stock pursuant to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of the registration rights described below would enable the holders to trade the registered shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without restriction under the Securities Act when the applicable registration statement is declared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 705.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective. We will pay the registration expenses, other than underwriting discounts, selling commissions, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">174<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock transfer taxes, and fees and disbursements in excess of $100,000 to one counsel for the holders, of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the securities registered pursuant to the demand, Form S-3 and piggyback registrations described below. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conditions and limitations, to limit the number of securities the holders may include. The demand, Form <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">S-3 and piggyback registration rights described below will terminate upon the earliest to occur of (i) a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Liquidation Event (as defined in the amended and restated certificate of incorporation, dated March 2, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2023, of HeartFlow Holding, Inc.) where the stockholders receive cash and&#47;or publicly traded securities or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the holders receive reasonably comparable registration rights, (ii) with respect to each holder, such time <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">after the completion of this offering after which Rule 144 of the Securities Act (&#8220;Rule 144&#8221;) or another <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar exemption under the Securities Act is available for the sale of all of such holder&#8217;s shares without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limitation, during a three-month period without registration and such holder holds less than 1% of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding capital stock of the company or (iii) the date three years after the completion of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Demand registration rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering, holders of up to approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock issued upon conversion of our redeemable convertible preferred stock and the holder of warrants to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase up to an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock will be entitled to certain demand <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration rights. Beginning six months after the effectiveness of the registration statement of which this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus is a part, holders holding, collectively, at least a majority of the registrable securities held by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the holders of common stock issued upon conversion of our redeemable convertible preferred stock then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding may, on not more than two occasions, request that we register at least 40% of the registrable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities held by the holders of common stock issued upon conversion of our redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock then outstanding on a Form S-1 registration statement, subject to certain specified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exceptions. If we determine that it would be seriously detrimental to us and our stockholders to effect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such a demand registration, we have the right to defer such registration, not more than twice in any 12-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">month period, for a period of up to 120 days. In addition, we will not be required to effect a demand <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration during the period beginning 60 days prior to our good faith estimate of the date of the filing of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and ending on a date 180 days following the effectiveness of a registration statement relating to a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration initiated by us or if registration on Form S-3 is available.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Form S-3 registration rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering, holders of up to approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock issued upon conversion of our redeemable convertible preferred stock and the holder of warrants to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase up to an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock will be entitled to certain Form S-3 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration rights. At any time when the company is qualified to file a Form S-3 registration statement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders holding, collectively, at least 30% of the registrable securities then outstanding may request that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we register registrable securities having an anticipated aggregate offering price of at least $10.0 million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net of underwriting discounts and certain other expenses. These holders may make an unlimited number <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of requests for registration on Form S-3&#59; however, we will not be required to effect a registration on Form <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">S-3 if we have effected two such registrations pursuant to such requests within the 12-month period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preceding the date of the request. In addition, if we determine that it would be seriously detrimental to us <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and our stockholders to effect such a registration, we have the right to defer such registration, not more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than twice in any 12-month period, for a period of up to 120 days. Lastly, we will not be required to effect a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration on Form S-3 during the period beginning 30 days prior to our good faith estimate of the date <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the filing of and ending on a date 90 days following the effectiveness of a registration statement relating <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a registration initiated by us. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Piggyback registration rights <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to the Investors&#8217; Rights Agreement, if we register any of our securities either for our own account <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or for the account of other security holders, other than through this offering, holders of up to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million shares of our common stock issued upon conversion of our redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock and the holder of warrants to purchase up to an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">175<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock will be entitled to customary &#8220;piggyback&#8221; registration rights allowing them to include <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their securities in such registration, subject to specified conditions, limitations and exceptions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Anti-takeover effects of provisions of the proposed amended and restated <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">certificate of incorporation and bylaws and applicable law<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will contain provisions that could have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the effect of delaying, deferring or discouraging another party from acquiring control of us. These <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions and certain provisions of Delaware law, which are summarized below, could discourage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">takeovers, coercive or otherwise, and as a consequence, they might also inhibit temporary fluctuations in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the market price of our common stock that often result from actual or rumored hostile takeover attempts. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These provisions are also designed, in part, to encourage persons seeking to acquire control of us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">negotiate first with our board of directors. It is also possible that these provisions might have the effect of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventing changes in our management and could make it more difficult to accomplish transactions that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders might otherwise deem to be in their best interests.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Classified board of directors<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will provide that our board of directors be classified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into three classes of directors, with each class serving a staggered three-year term. As a result, in most <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances, a person can gain control of our board of directors only by successfully engaging in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proxy contest at two or more annual meetings of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Authorized but unissued shares<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our authorized but unissued common stock and preferred stock will be available for future issuances <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without stockholder approval and could be utilized for a variety of corporate purposes, including future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but unissued and unreserved common stock and preferred stock could render more difficult or discourage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Written consent&#59; special meeting of stockholders<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will provide that stockholder action may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not be taken by written consent, which forces stockholder action to be taken at an annual or special <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meeting of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will provide that, subject to the rights of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any holders of preferred stock, special meetings of our stockholders, for any purpose or purposes, may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be called only by (i) the chair of the board, (ii) the chief executive officer or (iii) the secretary at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">direction of our board of directors pursuant to a resolution adopted by a majority of our board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Advance notice requirements for stockholder proposals and director nominations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated bylaws will provide that stockholders seeking to bring business before the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">annual meeting of our stockholders or to nominate candidates for election as directors at the annual <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meeting of our stockholders or, in certain instances as provided in our bylaws, a special meeting of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders must provide timely notice of their intent in writing. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To give timely notice, the notice must be delivered to the secretary at our principal executive offices not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">later than the close of business on the 90th day nor earlier than the 120th day prior to the first anniversary <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the preceding year&#8217;s annual meeting. However, if the date of the annual meeting is more than 30 days <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">before or more than 70 days after such anniversary date, the notice must be delivered not earlier than the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">120th day prior to such annual meeting and not later than the close of business on the later of the 90th <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">day prior to such annual meeting or the tenth day following the day on which public announcement of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date of the annual meeting is first made or sent by us.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">176<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated bylaws will also specify certain informational and other requirements as to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">form and content of the notice. These provisions, if not satisfied on a timely basis or at all, may preclude <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our stockholders from bringing business or director nominations before the meeting of our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Election and removal of directors<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will contain provisions that establish <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">specific procedures for appointing and removing members of the board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under the amended and restated certificate of incorporation, our directors may be removed from office, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but only for cause, which requires approval by the holders of a majority of our outstanding capital stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">then entitled to vote in the election of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Vacancies and newly created directorships on our board of directors may be filled only by a majority vote <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the directors then in office, even if less than a quorum, or by a sole remaining director (and not by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 236pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders). Any new director shall hold office for the remainder of the full term of the class of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 248pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to which the new directorship was added or in which the vacancy occurred and until his or her successor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 260pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has been elected and qualified, subject, however, to such director&#8217;s earlier death, resignation, retirement, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disqualification or removal. The treatment of vacancies has the effect of making it more difficult for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders to change the composition of the board of directors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">No cumulative voting<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The DGCL provides that stockholders are not entitled to cumulate votes in the election of directors unless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a corporation&#8217;s certificate of incorporation provides otherwise. Our amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation will not authorize cumulative voting rights for our stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The absence of cumulative voting makes it more difficult for a minority stockholder to gain a seat on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">board of directors to influence a decision by our board of directors, including regarding any potential <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">merger, tender offer or other potential takeover transaction.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Amendments to our certificate of incorporation and bylaws<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation and bylaws will provide that the affirmative vote of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 444pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all then-outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of capital stock entitled to vote generally in the election of directors is required to amend certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions of our certificate of incorporation, including provisions relating to the size of the board, removal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors, special meetings, actions by written consent and cumulative voting. The affirmative vote of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all of the then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding shares of capital stock entitled to vote generally in the election of directors will be required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amend or repeal our bylaws, although our bylaws may be amended by a simple majority vote of our board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of directors. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Delaware anti-takeover statute <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Section 203 prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a business combination with an interested stockholder for a period of three years following the date the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person became an interested stockholder unless&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">prior to the date of the transaction, our board of directors approved either the business combination or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the transaction that resulted in the stockholder becoming an interested stockholder&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">upon completion of the transaction that resulted in the stockholder becoming an interested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding at the time the transaction commenced, excluding for purposes of determining the voting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (A) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares owned by persons who are directors and also officers and (B) shares owned by employee <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">177<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock plans in which employee participants do not have the right to determine confidentially whether <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">shares held subject to the plan will be tendered in a tender or exchange offer&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">at or subsequent to the date of the transaction, the business combination is approved by our board of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">directors and authorized at an annual or special meeting of stockholders, and not by written consent, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">by the affirmative vote of at least sixty-six and two-thirds percent (66-2&#47;3%) of the outstanding voting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock that is not owned by the interested stockholder.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Generally, a business combination includes a merger, asset or stock sale, or other transaction resulting in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a financial benefit to the interested stockholder. Subject to certain exceptions, an &#8220;interested stockholder&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is a person who, together with affiliates and associates, owns or, within three years prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination of interested stockholder status, owned 15% or more of our outstanding voting stock. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provision is expected to have an anti-takeover effect with respect to transactions our board of directors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not approve in advance. Moreover, Section 203 may discourage attempts that might result in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">premium over the market price for the shares of our common stock held by stockholders.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Choice of forum <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will generally designate, unless we otherwise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consent in writing, the Court of Chancery (or, if such court does not have subject matter jurisdiction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thereof, the federal district court of the State of Delaware) as the sole and exclusive forum for (i) any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fiduciary duty owed by any current or former director, officer, employee or agent to us or our stockholders, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or any claim for aiding and abetting any such alleged breach, (iii) any action asserting a claim arising <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or bylaws or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware or (iv) any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">action asserting a claim governed by the internal affairs doctrine of the law of the State of Delaware. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will also provide that the federal district courts of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the United States will be the exclusive forum for the resolution of any complaint asserting a cause of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">action arising under the Securities Act. Further, our amended and restated certificate of incorporation will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide that the foregoing choice of forum provisions will not apply to suits brought to enforce any liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or duty created by the Exchange Act, or any other claim for which the federal courts of the United States <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have exclusive jurisdiction. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our amended and restated certificate of incorporation will also provide that any person or entity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 480pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">notice of and consented to the foregoing provisions of the amended and restated certificate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation. Although our amended and restated certificate of incorporation will contain the choice of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forum provision described above, it is possible that a court could find that such a provision is inapplicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for a particular claim or action or that such provision is unenforceable.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This choice of forum provision may limit a stockholder's ability to bring a claim in a judicial forum that it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may discourage lawsuits with respect to such claims, although our stockholders will not be deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to have waived our compliance with federal securities laws and the rules and regulations thereunder. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Furthermore, the enforceability of similar choice of forum provisions in other companies' certificates of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporation has been challenged in legal proceedings, and it is possible that a court could find these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">types of provisions to be inapplicable or unenforceable.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Limitations on liability and indemnification<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For a discussion of liability and indemnification, see the section titled &#8220;Management&#8212;Limitations on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability and indemnification matters.&#8221;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">178<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Transfer agent and registrar<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The transfer agent and registrar for our common stock will be Fidelity Stock Transfer Solutions LLC. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer agent&#8217;s address is&#160;245 Summer Street, Boston, MA 02210.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Nasdaq listing <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have applied to list our common stock on the&#160;the Nasdaq Global Select Market&#160;under the symbol <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;HTFL,&#8221; and this offering is contingent upon obtaining such approval. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">179<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1360" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Shares eligible for future sale<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to this offering, there has been no public market for our common stock, and a liquid trading market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our common stock may not develop or be sustained after this offering. Future sales of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, including shares issued upon the Preferred Stock Conversion, the Convertible Notes Conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and the exercise of outstanding options or warrants, in the public market after the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, or the perception that those sales may occur, could adversely affect the prevailing market price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for our common stock from time to time or impair our ability to raise equity capital in the future. Although <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">we have applied to have our common stock listed on&#160;the Nasdaq Global Select Market, we cannot assure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">you that there will be an active public market for our common stock. As described below, only a limited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 203.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">number of shares of our common stock will be available for sale in the public market for a period of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 215.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">several months after the completion of this offering due to contractual and legal restrictions on resale <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described below. Future sales of our common stock in the public market either before or after restrictions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lapse, or the perception that those sales may occur, could adversely affect the prevailing market price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock at such time and our ability to raise equity capital at a time and price we deem <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 263.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sale of restricted shares<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Based on the number of shares of our common stock outstanding as of December 31, 2024, upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering and assuming (i) the Preferred Stock Conversion, (ii) the Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conversion, (iii) no exercise of the underwriters&#8217; option to purchase additional shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock and (iv) no exercise of outstanding options or warrants, we will have outstanding an aggregate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Of these shares, all of the&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock to be sold in this offering will be freely <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tradable in the public market without restriction or further registration under the Securities Act, unless the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 397.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares are held by any of our &#8220;affiliates&#8221; as such term is defined in Rule 144 or subject to lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 409.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements. All remaining shares of common stock held by existing stockholders will be &#8220;restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 421.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities,&#8221; as such term is defined in Rule 144. These restricted securities were issued and sold by us in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">private transactions and are eligible for public sale only if registered under the Securities Act or if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualify for an exemption from registration under the Securities Act, including the exemptions provided by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Rule 144 or Rule 701 of the Securities Act (&#8220;Rule 701&#8221;), which rules are summarized below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As a result of the lock-up agreements referred to below and the provisions of Rule 144 and Rule 701, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on the number of shares of our common stock outstanding (calculated as of December 31, 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the basis of the assumptions described above and assuming no exercise of the underwriters&#8217; option to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase additional shares, if any, and no exercise of outstanding options), the shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock (excluding the shares sold in this offering) that will be available for sale in the public market are as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 557.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 84.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 380.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 21.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 84.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.15pt; width: 84.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Approximate <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 84.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">number of shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 87.75pt; position: absolute; top: 0pt; width: 380.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 380.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">First date available for sale into public market<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 33.75pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 21.75pt; width: 84.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 84.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">shares<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="height: 33.75pt; left: 87.75pt; overflow: hidden; position: absolute; top: 21.75pt; width: 380.25pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 2.63pt; width: 380.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">181 days after the date of this prospectus, upon expiration of the lock-up market stand-off <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 14.03pt; width: 380.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">agreements referred to below, subject in some cases to applicable volume, manner of <font style="display: inline-block; height: 6.91pt;"></font></font></div><div style="line-height: 6.91pt; position: absolute; top: 25.43pt; width: 380.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">sale and other limitations under Rule 144 and Rule 701.<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 629.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We may issue shares of common stock from time to time as consideration for future acquisitions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments, or other corporate purposes. In the event that any such acquisition, investment, or other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction is significant, the number of shares of common stock that we may issue may in turn be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">significant. We may also grant registration rights covering those shares of common stock issued in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with any such acquisition and investment.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 697.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, the shares of common stock reserved for future issuance under the 2025 Plan will become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 709.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">180<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up agreements, a registration statement under the Securities Act, or an exemption from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration, including Rule 144 and Rule 701.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Rule 144<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under Rule 144, as currently in effect, once we have been subject to the public company reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements of the Exchange Act for at least 90 days, and we are current in our Exchange Act reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at the time of sale, a person (or persons whose shares are required to be aggregated) who is not deemed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to have been one of our &#8220;affiliates&#8221; for purposes of Rule 144 at any time during the 90 days preceding a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months, including the holding period of any prior owner other than one of our &#8220;affiliates,&#8221; is entitled to sell <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">those shares in the public market (subject to the lock-up agreement referred to below, if applicable) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without complying with the manner of sale, volume limitations, or notice provisions of Rule 144, but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to compliance with the public information requirements of Rule 144. If such a person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has&#160;beneficially owned the shares proposed to be sold for at least one year, including the holding period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any prior owner other than &#8220;affiliates,&#8221; then such person is entitled to sell such shares in the public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market without complying with any of the requirements of Rule 144 (subject to the lock-up agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to below, if applicable).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In general, under Rule 144, as currently in effect, once we have been subject to the public company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting requirements of the Exchange Act for at least 90 days, our &#8220;affiliates,&#8221; as defined in Rule 144, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">who have beneficially owned the shares proposed to be sold for at least six months, are entitled to sell in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the public market, upon expiration of any applicable lock-up agreements and within any three-month <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period, a number of those shares of our common stock that does not exceed the greater of&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">1% of the number of shares of common stock then outstanding, which will equal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock immediately upon the completion of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offering (calculated as of December 31, 2024 on the basis of the assumptions described above and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">assuming no exercise of the underwriters&#8217; option to purchase additional shares and no exercise of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">outstanding options or warrants subsequent to December 31, 2024)&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the average weekly trading volume of our common stock on the&#160;Nasdaq Global Select Market during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Such sales under Rule 144 by our &#8220;affiliates&#8221; or persons selling shares on behalf of our &#8220;affiliates&#8221; are also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to certain manner of sale provisions, notice requirements, and requirements related to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">availability of current public information about us. Notwithstanding the availability of Rule 144, the holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of substantially all of our restricted securities have entered into lock-up agreements as referenced above, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and their restricted securities will become eligible for sale (subject to the above limitations under Rule <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">144) upon the expiration of the restrictions set forth in those agreements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Rule 701<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In general, under Rule 701 as currently in effect, any of our employees, directors, officers, consultants, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advisors who acquired common stock from us in connection with a written compensatory stock or option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plan or other written agreement in compliance with Rule 701 before the effective date of the registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statement of which this prospectus is a part (to the extent such common stock is not subject to a lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement) and who are not our &#8220;affiliates&#8221; as defined in Rule 144 during the immediately preceding 90 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days, is entitled to rely on Rule 701 to resell such shares beginning 90 days after the date of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus in reliance on Rule 144, but without complying with the notice, manner of sale, public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information requirements, or volume limitation provisions of Rule 144. Persons who are our &#8220;affiliates&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may resell those shares beginning 90 days after the date of this prospectus without compliance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">minimum holding period requirements under Rule 144 (subject to the terms of the lock-up agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to below, if applicable).<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">181<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 8.73pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Lock-up and market stand-off agreements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 94.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, we, our directors, our executive officers, and the holders of substantially <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 106.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all of our common stock, stock options, and other securities convertible into or exercisable or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 118.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exchangeable for our common stock, have agreed, that without the prior written consent of J.P. Morgan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 130.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co. on behalf of the underwriters, subject <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to certain exceptions more fully described under the section titled &#8220;Underwriting&#8221;, we and they will not, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">among other things, sell or otherwise transfer or dispose of any of our securities during the period from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the date of this prospectus continuing through the date 180 days after the date of this prospectus. See the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">section titled &#8220;Underwriting&#8221; for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition to the restrictions contained in the lock-up agreements described above, we have entered into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with certain securityholders, including the Investors&#8217; Rights Agreement, our standard form of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option agreement and warrants that contain market stand-off provisions or incorporate market stand-off <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provisions from our equity incentive plan imposing restrictions on the ability of such securityholders to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offer, sell, or transfer our equity securities for a period of 180 days following the date of this prospectus.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Following the lock-up periods set forth in the agreements described above, and assuming that J.P. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co. do not release any parties <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from these agreements, all of the shares of our common stock that are restricted securities or are held by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our affiliates as of the date of this prospectus will be eligible for sale in the public market in compliance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with Rule 144 under the Securities Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Registration rights<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon the completion of this offering, the holders of approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be entitled to rights with respect to the registration of their shares under the Securities Act, subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up agreements described under &#8220;&#8212;Lock-up agreements&#8221; above. Registration of these shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the Securities Act would result in the shares becoming freely tradable without restriction under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act, except for shares purchased by affiliates, immediately upon the effectiveness of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relevant filed registration statement, subject to the terms of the lock-up agreements described above. Any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales of securities by these stockholders could have a material adverse effect on the trading price of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Equity incentive plans<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We intend to file with the SEC a registration statement on Form S-8 under the Securities Act to register <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 495.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our shares issued or reserved for issuance under our equity incentive plans. Such registration statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is expected to be filed and become effective as soon as practicable after the completion of this offering. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 519.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, shares registered under such registration statement will be available for sale in the open <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market following its effective date, subject to Rule 144 volume limitations, vesting restrictions, and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lock-up agreements described above, if applicable.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 563.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Rule 10b5-1 trading plans<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Following the completion of this offering, certain of our officers, directors, and significant stockholders may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adopt written plans, known as Rule 10b5-1 trading plans, in which they will contract with a broker to buy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or sell shares of our common stock on a periodic basis to diversify their assets and investments. Under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these Rule 10b5-1 trading plans, a broker may execute trades pursuant to parameters established by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 633.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officer, director, or stockholder when entering into the plan, without further direction from such officer, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 645.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">director, or stockholder. Such sales would not commence until the expiration of the applicable lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements entered into by such officer, director, or stockholder in connection with this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">182<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1408" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Material U.S. federal income tax consequences to non-U.S. <font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 11.64pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">holders<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following discussion is a summary of the material U.S. federal income tax consequences to Non-U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holders (as defined below) of the purchase, ownership, and disposition of our common stock issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">1986, as amended (the &#8220;Code&#8221;), Treasury Regulations promulgated thereunder, judicial decisions, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each case in effect as of the date hereof. These authorities may change or be subject to differing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interpretations. Any such change or differing interpretation may be applied retroactively in a manner that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">could adversely affect a Non-U.S. Holder. We have not sought and will not seek any rulings from the IRS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regarding the matters discussed below. There can be no assurance the IRS or a court will not take a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contrary position to that discussed below regarding the tax consequences of the purchase, ownership, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and disposition of our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This discussion is limited to Non-U.S. Holders that hold our common stock as a &#8220;capital asset&#8221; within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">address all U.S. federal income tax consequences relevant to a Non-U.S. Holder&#8217;s particular <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances, including the impact of the Medicare contribution tax on net investment income and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">alternative minimum tax. In addition, it does not address consequences relevant to Non-U.S. Holders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to special rules, including, without limitation&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">U.S. expatriates and former citizens or long-term residents of the United States&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">persons holding our common stock as part of a hedge, straddle, or other risk reduction strategy or as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">part of a conversion transaction or other integrated investment&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">banks, insurance companies, and other financial institutions&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">brokers, dealers, or traders in securities&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">accumulate earnings to avoid U.S. federal income tax&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">purposes (and investors therein)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tax-exempt organizations or governmental organizations&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 546.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">persons deemed to sell our common stock under the constructive sale provisions of the Code&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">persons who hold or receive our common stock pursuant to the exercise of any employee stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">option or otherwise as compensation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">tax-qualified retirement plans&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;qualified foreign pension funds&#8221; as defined in Section 897(l)(2) of the Code and entities all of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">interests of which are held by qualified foreign pension funds.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If an entity treated as a partnership for U.S. federal income tax purposes holds our common stock, the tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treatment of a partner in the partnership will depend on the status of the partner, the activities of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">partnership, and certain determinations made at the partner level. Accordingly, partnerships holding our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">federal income tax consequences to them.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">183<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, AND DISPOSITION OF OUR <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">THE LAWS OF ANY STATE, LOCAL, OR NON-U.S. TAXING JURISDICTION OR UNDER ANY <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">APPLICABLE INCOME TAX TREATY.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Definition of a Non-U.S. Holder<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For purposes of this discussion, a &#8220;Non-U.S. Holder&#8221; is any beneficial owner of our common stock that is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">neither a &#8220;U.S. person&#8221; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an individual who is a citizen or resident of the United States&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a corporation created or organized under the laws of the United States, any state thereof or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">District of Columbia&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an estate, the income of which is subject to U.S. federal income tax regardless of its source&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">a trust that (i) is subject to the primary supervision of a U.S. court and all substantial decisions of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">which are subject to the control of one or more &#8220;United States persons&#8221; (within the meaning of Section <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">7701(a)(30) of the Code), or (ii) has a valid election in effect to be treated as a United States person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">for U.S. federal income tax purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Distributions<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As described in the section titled &#8220;Dividend policy,&#8221; we do not anticipate paying any cash dividends in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreseeable future. However, if we do make distributions of cash or property on our common stock, such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 404.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current or accumulated earnings and profits, as determined under U.S. federal income tax principles. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 428.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and first be applied against and reduce a Non-U.S. Holder&#8217;s adjusted tax basis in its common stock, but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not below zero. Any excess will be treated as capital gain and will be treated as described under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsection titled &#8220;&#8212;Sale or other taxable disposition&#8221; below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subject to the discussion below regarding effectively connected income, dividends paid to a Non-U.S. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or such lower rate specified by an applicable income tax treaty, provided the Non-U.S. Holder furnishes a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">valid IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) certifying qualification for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lower treaty rate). A Non-U.S. Holder that does not timely furnish the required documentation, but that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their entitlement to benefits under any applicable tax treaties.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder&#8217;s conduct of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trade or business within the United States (and, if required by an applicable income tax treaty, the Non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 612.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Holder maintains a permanent establishment in the United States to which such dividends are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 624.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 636.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Form W-8ECI, certifying that the dividends are effectively connected with the Non-U.S. Holder&#8217;s conduct <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a trade or business within the United States.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at the regular rates applicable to U.S. persons. A Non-U.S. Holder that is a corporation also may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">184<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">treaty) on such effectively connected dividends, as adjusted for certain items. Non-U.S. Holders should <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consult their tax advisors regarding any applicable tax treaties that may provide for different rules.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Sale or other taxable disposition<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A Non-U.S. Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other taxable disposition of our common stock unless&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the gain is effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">permanent establishment in the United States to which such gain is attributable)&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Non-U.S. Holder is a nonresident alien individual present in the United States for 183 days or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">more during the taxable year of the disposition and certain other requirements are met&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our common stock constitutes a U.S. real property interest (&#8220;USRPI&#8221;) by reason of our status as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">U.S. real property holding corporation (&#8220;USRPHC&#8221;) for U.S. federal income tax purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income basis at the regular rates applicable to U.S. persons. A Non-U.S. Holder that is a corporation also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income tax treaty) on such effectively connected gain, as adjusted for certain items.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A Non-U.S. Holder described in the second bullet point above will be subject to U.S. federal income tax at <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale or other taxable disposition of our common stock, which may be offset by certain U.S. source capital <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">losses of the Non-U.S. Holder (even though the individual is not considered a resident of the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such losses.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">With respect to the third bullet point above, we believe we currently are not, and do not anticipate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">becoming, a USRPHC. Because the determination of whether we are a USRPHC depends, however, on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fair market value of our USRPIs relative to the fair market value of our non-U.S. real property interests <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and our other business assets, there can be no assurance we currently are not a USRPHC or will not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other taxable disposition of our common stock by a Non-U.S. Holder will not be subject to U.S. federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income tax if our common stock is &#8220;regularly traded,&#8221; as defined by applicable Treasury Regulations, on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an established securities market, and such Non-U.S. Holder owned, actually and constructively, 5% or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">less of our common stock throughout the shorter of the five-year period ending on the date of the sale or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other taxable disposition or the Non-U.S. Holder&#8217;s holding period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for different rules.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Information reporting and backup withholding<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Payments of dividends on our common stock will not be subject to backup withholding, provided the Non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">U.S. Holder certifies its non-U.S. status, such as by furnishing a valid IRS Form W-8BEN, W-8BEN-E, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">W-8ECI, or otherwise establishes an exemption. However, information returns are required to be filed with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the IRS in connection with any distributions on our common stock paid to the Non-U.S. Holder, regardless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of whether such distributions constitute dividends or whether any tax was actually withheld. In addition, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds of the sale or other taxable disposition of our common stock within the United States or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted through certain U.S.-related brokers generally will not be subject to backup withholding or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information reporting if the applicable withholding agent receives the certification described above or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Non-U.S. Holder otherwise establishes an exemption. Proceeds of a disposition of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conducted through a non-U.S. office of a non-U.S. broker that does not have certain enumerated <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">185<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationships with the United States generally will not be subject to backup withholding or information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Copies of information returns that are filed with the IRS may also be made available under the provisions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of an applicable treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resides or is established.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be allowed as a refund or a credit against a Non-U.S. Holder&#8217;s U.S. federal income tax liability, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided the required information is timely furnished to the IRS.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Additional withholding tax on payments made to foreign accounts<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to as the Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;)) on certain types of payments made to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds from the sale or other disposition of, our common stock paid to a &#8220;foreign financial institution&#8221; or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a &#8220;non-financial foreign entity&#8221; (each as defined in the Code), unless (i) the foreign financial institution <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">undertakes certain diligence and reporting obligations, (ii) the non-financial foreign entity either certifies it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not have any &#8220;substantial United States owners&#8221; (as defined in the Code) or furnishes identifying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information regarding each substantial United States owner, or (iii) the foreign financial institution or non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial institution and is subject to the diligence and reporting requirements in (i) above, it must enter <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into an agreement with the U.S. Department of the Treasury requiring, among other things, that it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">undertake to identify accounts held by certain &#8220;specified United States persons&#8221; or &#8220;United States owned <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign entities&#8221; (each as defined in the Code), annually report certain information about such accounts, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with the United States governing FATCA may be subject to different rules.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under applicable Treasury Regulations and administrative guidance, withholding under FATCA generally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applies to payments of dividends on our common stock. While withholding under FATCA would have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applied also to payments of gross proceeds from the sale or other disposition of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beginning on January 1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">final Treasury Regulations are issued.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospective investors should consult their tax advisors regarding the potential application of withholding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under FATCA to their investment in our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">186<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1434" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Underwriting<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We are offering the shares of common stock described in this prospectus through a number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters. J.P. Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co. are acting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as joint book-running managers of the offering and as representatives of the underwriters. We have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered into an underwriting agreement with the underwriters. Subject to the terms and conditions of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 155.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 167.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 179.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the cover page of this prospectus, the number of shares of common stock listed next to its name in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 191.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following table&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 211.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 390.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 74.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 21.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 390.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 390.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Name<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 393.75pt; position: absolute; top: 0pt; width: 74.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 12.75pt; width: 74.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 3.7pt; position: absolute; text-decoration: none; white-space: pre;">Number of shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 21.75pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">J.P. Morgan Securities LLC<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 117.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 117.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 117.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 117.85pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 36pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Morgan Stanley &#38; Co. LLC<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 115.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 116.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 117.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 117.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 117.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 117.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 50.25pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Piper Sandler &#38; Co.<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 86.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 88.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 89.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 89.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 64.5pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stifel, Nicolaus &#38; Company, Incorporated<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 175.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 177.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 178.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 179.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 179.18pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78.75pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Canaccord Genuity LLC<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 103.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 106.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 107.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 107.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 108.03pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 93pt; width: 390.75pt;"><div><div style="line-height: 6.91pt; position: absolute; top: 3.79pt; width: 390.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 22.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 22.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 23.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 23.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.91pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.5pt; font-style: normal; font-weight: normal; left: 23.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.91pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 334.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters are committed to purchase all the shares of common stock offered by us if they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase any shares. The underwriting agreement also provides that if an underwriter defaults, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase commitments of non-defaulting underwriters may also be increased or the offering may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminated.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters propose to offer the shares of common stock directly to the public at the initial public <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering price set forth on the cover page of this prospectus and to certain dealers at that price less a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">concession not in excess of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share. After the initial offering of the shares to the public, if all of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the shares of common stock are not sold at the initial public offering price, the underwriters may change <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the offering price and the other selling terms. Sales of any shares made outside of the United States may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be made by affiliates of the underwriters.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters have an option to buy up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of common stock from us to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cover sales of shares by the underwriters which exceed the number of shares specified in the table <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above. The underwriters have 30 days from the date of this prospectus to exercise this option to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional shares. If any shares are purchased with this option to purchase additional shares, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters will purchase shares in approximately the same proportion as shown in the table above. If <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any additional shares of common stock are purchased, the underwriters will offer the additional shares on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the same terms as those on which the shares are being offered.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriting fee is equal to the public offering price per share of common stock less the amount paid <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the underwriters to us per share of common stock. The underwriting fee is $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following table shows the per share and total underwriting discounts and commissions to be paid to the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">187<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters assuming both no exercise and full exercise of the underwriters&#8217; option to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional shares.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 66.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 29.18pt; position: absolute; text-decoration: none; white-space: pre;">Without <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.61pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.19pt; position: absolute; text-decoration: none; white-space: pre;">option to <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.41pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.65pt; position: absolute; text-decoration: none; white-space: pre;">purchase <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.21pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.17pt; position: absolute; text-decoration: none; white-space: pre;">additional <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.01pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.63pt; position: absolute; text-decoration: none; white-space: pre;">shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 56.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 26.62pt; position: absolute; text-decoration: none; white-space: pre;">exercise<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 27.17pt; position: absolute; text-decoration: none; white-space: pre;">With full <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.61pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.19pt; position: absolute; text-decoration: none; white-space: pre;">option to <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.41pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.65pt; position: absolute; text-decoration: none; white-space: pre;">purchase <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.21pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.17pt; position: absolute; text-decoration: none; white-space: pre;">additional <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.01pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 33.63pt; position: absolute; text-decoration: none; white-space: pre;">shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 56.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 26.62pt; position: absolute; text-decoration: none; white-space: pre;">exercise<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Per Share<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 47.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 49.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 51.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 51.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 51.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.470000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 26.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 26.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 26.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 26.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 4.43pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 215.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We estimate that the total expenses of this offering, including registration, filing and listing fees, printing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 227.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 239.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. We have agreed to reimburse the underwriters for expenses relating to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">clearance of this offering with the Financial Industry Regulatory Authority, Inc. in an amount up to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">A prospectus in electronic format may be made available on the web sites maintained by one or more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocate a number of shares to underwriters and selling group members for sale to their online brokerage <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">account holders. Internet distributions will be allocated by the representatives to underwriters and selling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">group members that may make Internet distributions on the same basis as other allocations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 339.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have agreed that we will not, subject to certain exceptions, (i) offer, pledge, sell, contract to sell, sell <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any option or contract to purchase, purchase any option or contract to sell, grant any option, right or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrant to purchase, hedge, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">file with, the SEC a registration statement under the Securities Act relating to, any shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 387.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock or any securities convertible into or exercisable or exchangeable for any shares of our common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 399.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, or (ii) enter into any swap, hedging, or other agreement that transfers, in whole or in part, any of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 411.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic consequences of ownership of any shares of common stock or any such other securities, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 423.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publicly disclose the intention to undertake any of the foregoing (regardless of whether any of these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions are to be settled by the delivery of shares of common stock or such other securities, in cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or otherwise), in each case without the prior written consent of J.P. Morgan Securities LLC, Morgan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stanley &#38; Co. LLC and Piper Sandler &#38; Co. for a period of 180 days after the date of this prospectus, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other than the shares of our common stock to be sold in this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 491.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The restrictions on our actions, as described above, do not apply to certain transactions, including (i) the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 503.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance of shares of common stock or securities convertible into or exercisable for shares of our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 515.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock pursuant to the conversion or exchange of convertible or exchangeable securities or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 527.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise of warrants or options (including net exercise) or the settlement of RSUs (including net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement), in each case outstanding on the date of the underwriting agreement and described in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus&#59; (ii) grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 563.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the issuance of shares of our common stock or securities convertible into or exercisable or exchangeable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 575.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for shares of our common stock (whether upon the exercise of stock options or otherwise) to our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plan in effect as of the closing date of this offering and described in this prospectus, provided that such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recipients enter into a lock-up agreement with the underwriters&#59; (iii) the issuance of up to 5% of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding shares of our common stock, or securities convertible into, exercisable for, or which are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise exchangeable for, our common stock, immediately following the closing date of this offering, in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acquisitions or other similar strategic transactions, provided that such recipients enter into a lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 659.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement with the underwriters&#59; or (iv) the filing of any registration statement on Form S-8 relating to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 671.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities granted or to be granted pursuant to any plan in effect on the date of the underwriting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement and described in this prospectus or any assumed benefit plan pursuant to an acquisition or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar strategic transaction.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">188<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our directors and executive officers, and substantially all of our securityholders (such persons, the &#8220;lock-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">up parties&#8221;) have entered into lock-up agreements with the underwriters prior to the commencement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this offering pursuant to which each lock-up party, with limited exceptions, for a period of 180 days after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the date of this prospectus (such period, the &#8220;restricted period&#8221;), may not and may not cause any of their <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">direct or indirect affiliates to, without the prior written consent of J.P. Morgan Securities LLC, Morgan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Stanley &#38; Co. LLC and Piper Sandler &#38; Co., (i) offer, pledge, sell, contract to sell, sell any option or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or any securities convertible into or exercisable or exchangeable for our common stock (including without <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limitation, our common stock or such other securities which may be deemed to be beneficially owned by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up party in accordance with the rules and regulations of the SEC and securities which may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued upon exercise of a stock option or warrant) (collectively with our common stock and any common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock of HeartFlow Holding, Inc. prior to the consolidation of HeartFlow Holding, Inc. into HeartFlow, Inc., <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the &#8220;lock-up securities&#8221;), (ii) enter into any hedging, swap or other agreement or transaction that transfers, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in whole or in part, any of the economic consequences of ownership of the lock-up securities, whether <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any such transaction described in clause (i) or (ii) above is to be settled by delivery of the lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities, in cash or otherwise, (iii) make any demand for or exercise any right with respect to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration of any lock-up securities, or (iv) publicly disclose the intention to do any of the foregoing.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Such persons or entities have further acknowledged that these undertakings preclude them from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">engaging in any hedging or other transactions or arrangements (including, without limitation, any short <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or any other derivative transaction or instrument, however described or defined) designed or intended, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up party or any other person) of any economic consequences of ownership, in whole or in part, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directly or indirectly, of any lock-up securities, whether any such transaction or arrangement (or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">instrument provided for thereunder) would be settled by delivery of lock-up securities, in cash or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The restrictions described in the immediately preceding paragraph and contained in the lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements between the underwriters and the lock-up parties do not apply, subject in certain cases to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">various conditions, to certain transactions, including (a) transfers of lock-up securities&#58; (i) as a bona fide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">gift or gifts or charitable contribution, or for bona fide estate planning purposes, (ii) by will or intestacy or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any other testamentary document, (iii) to any member of the lock-up party&#8217;s immediate family or to any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trust for the direct or indirect benefit of the lock-up party or the immediate family of the lock-up party, or if <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the lock-up party is a trust, to a trustor, trustee or beneficiary of the trust or to the estate of a trustor, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">trustee or beneficiary of such trust (for purposes of the lock-up agreement, &#8220;immediate family&#8221; means any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relationship by blood, current or former marriage, domestic partnership or adoption, not more remote than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">first cousin), (iv) to a corporation, partnership, limited liability company, investment fund or other entity (A) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of which the lock-up party and&#47;or the immediate family of the lock-up party are the legal and beneficial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owner of all of the outstanding equity securities or similar interests, or (B) controlled by, or under common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control with, the lock-up party or the immediate family of the lock-up party, (v) to a nominee or custodian <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, (vi) in the case of a corporation, partnership, limited liability company, trust or other business <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 592pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entity, (A) to another corporation, partnership, limited liability company, trust or other business entity that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is an affiliate of the lock-up party, or to any investment fund or other entity controlling, controlled by, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">managing or managed by or under common control or common investment management with the lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party or its affiliates or (B) as part of a disposition, transfer or distribution to limited partners, members or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shareholders of the lock-up party&#59; (vii) by operation of law, such as pursuant to a qualified domestic order, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">divorce settlement, divorce decree or separation agreement, (viii) to us upon death or disability of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lock-up party, or, if the lock-up party is an employee of ours upon death, disability or termination of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employment, in each case, of such employee, (ix) as part of a sale or transfer of lock-up securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">acquired (A) from the underwriters in this offering or (B) in open market transactions after the completion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of this offering, (x) to us in connection with the vesting, settlement, or exercise of restricted stock units, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">189<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options, warrants or other rights to purchase shares of our common stock (including, in each case, by way <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), including for the payment of exercise price and tax and remittance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">warrants or rights, provided that any such shares of our common stock received upon such exercise, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vesting or settlement shall be subject to the terms of the lock-up agreement, and provided further that any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such restricted stock units, options, warrants or rights are held by the lock-up party pursuant to an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement or equity awards granted under a stock incentive plan or other equity award plan, each such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreement or plan which is described herein, or (xi) pursuant to a bona fide third-party tender offer, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">merger, consolidation or other similar transaction that is approved by the Board of Directors and made to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 180pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">all holders of our capital stock involving a Change of Control (for purposes hereof, &#8220;Change of Control&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">means the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction or a series of related transactions, to a person or group of affiliated persons, of shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capital stock if, after such transfer, such person or group of affiliated persons would hold more than 50% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our outstanding voting securities (or the surviving entity))&#59; provided that in the event that such tender <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offer, merger, consolidation or other similar transaction is not completed, the lock-up party&#8217;s lock-up <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities shall remain subject to the restrictions in the immediately preceding paragraph&#59; (b) exercise of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the options, settlement of RSUs or other equity awards, or the exercise of warrants granted pursuant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plans described in this prospectus, provided that any lock-up securities received upon such exercise, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">vesting or settlement be subject to restrictions similar to those in the immediately preceding paragraph&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(c) the conversion of outstanding preferred stock, warrants to acquire preferred stock, or convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities into shares of our common stock or warrants to acquire shares of our common stock, provided <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that any common stock or warrant received upon such conversion would be subject to restrictions similar <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to those in the immediately preceding paragraph&#59; and (d) the establishment by lock-up parties of trading <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">plans under Rule 10b5-1 under the Exchange Act, provided that (1) such plans do not provide for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transfer of lock-up securities during the restricted period and (2) any required public announcement or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">filing under the Exchange Act made by any person regarding the establishment of such plan during the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 384pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted period shall include a statement that the lock-up party is not permitted to transfer, sell or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise dispose of lock-up securities under such plan during the restricted period in contravention of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 408pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lock-up agreement and no public filing, report or announcement by any party shall be made voluntarily in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 420pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with such trading plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 440pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">J.P. Morgan Securities LLC, Morgan Stanley &#38; Co. LLC and Piper Sandler &#38; Co., in their sole discretion, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 452pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may release the securities subject to any of the lock-up agreements with the underwriters described <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 464pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, in whole or in part at any time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have applied to have our common stock approved for listing on the Nasdaq Global Select Market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under the symbol &#8220;HTFL&#8221; and this offering is contingent upon obtaining approval of such listing.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">making bids for, purchasing and selling shares of common stock in the open market for the purpose of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventing or retarding a decline in the market price of the common stock while this offering is in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">progress. These stabilizing transactions may include making short sales of common stock, which involves <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the sale by the underwriters of a greater number of shares of common stock than they are required to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase in this offering, and purchasing shares of common stock on the open market to cover positions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">created by short sales. Short sales may be &#8220;covered&#8221; shorts, which are short positions in an amount not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">greater than the underwriters&#8217; option to purchase additional shares referred to above, or may be &#8220;naked&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shorts, which are short positions in excess of that amount.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters may close out any covered short position either by exercising their option to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional shares, in whole or in part, or by purchasing shares in the open market. In making this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination, the underwriters will consider, among other things, the price of shares available for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase in the open market compared to the price at which the underwriters may purchase shares <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">190<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">through the option to purchase additional shares. A naked short position is more likely to be created if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters are concerned that there may be downward pressure on the price of the common stock in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the open market that could adversely affect investors who purchase in this offering. To the extent that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters create a naked short position, they will purchase shares in the open market to cover the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">position.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The underwriters have advised us that, pursuant to Regulation M of the Securities Act, they may also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">engage in other activities that stabilize, maintain or otherwise affect the price of the common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including the imposition of penalty bids. This means that if the representatives of the underwriters <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase common stock in the open market in stabilizing transactions or to cover short sales, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">representatives can require the underwriters that sold those shares as part of this offering to repay the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriting discount received by them.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These activities may have the effect of raising or maintaining the market price of the common stock or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preventing or retarding a decline in the market price of the common stock, and, as a result, the price of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the common stock may be higher than the price that otherwise might exist in the open market. If the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters commence these activities, they may discontinue them at any time. The underwriters may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">carry out these transactions on the Nasdaq Global Select Market, in the over-the-counter market or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to this offering, there has been no public market for our common stock. The initial public offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price will be determined by negotiations between us and the representatives of the underwriters. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determining the initial public offering price, we and the representatives of the underwriters expect to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consider a number of factors including&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the information set forth in this prospectus and otherwise available to the representatives&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our prospects and the history and prospects for the industry in which we compete&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 396pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an assessment of our management&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 416pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">our prospects for future earnings&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the general condition of the securities markets at the time of this offering&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 456pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the recent market prices of, and demand for, publicly traded common stock of generally comparable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 468pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">companies&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 488pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other factors deemed relevant by the underwriters and us.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Neither we nor the underwriters can assure investors that an active trading market will develop for shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of our common stock, or that the shares will trade in the public market at or above the initial public offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 552pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other relationships<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certain of the underwriters and their affiliates have provided in the past to us and our affiliates and may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provide from time to time in the future certain commercial banking, financial advisory, investment banking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and other services for us and such affiliates in the ordinary course of their business, for which they have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received and may continue to receive customary fees and commissions. In addition, from time to time, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain of the underwriters and their affiliates may effect transactions for their own account or the account <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of customers, and hold on behalf of themselves or their customers, long or short positions in our debt or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equity securities or loans, and may do so in the future.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 666.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Selling restrictions<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other than in the United States, no action has been taken by us or the underwriters that would permit a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">191<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may this prospectus or any other offering material or advertisements in connection with the offer and sale <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of any such securities be distributed or published in any jurisdiction, except under circumstances that will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 120pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">possession this prospectus comes are advised to inform themselves about and to observe any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 132pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restrictions relating to the offering and the distribution of this prospectus. This prospectus does not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 144pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 156pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdiction in which such an offer or a solicitation is unlawful. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the European Economic Area<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In relation to each Member State of the European Economic Area (each a &#8220;Relevant State&#8221;), no shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">publication of a prospectus in relation to the shares which has been approved by the competent authority <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in that Relevant State or, where appropriate, approved in another Relevant State and notified to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offers of shares may be made to the public in that Relevant State at any time under the following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exemptions under the Prospectus Regulation&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(i)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Regulation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(ii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the Prospectus Regulation), subject to obtaining the prior consent of the underwriters&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(iii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in any other circumstances falling within Article 1(4) of the Prospectus Regulation,<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided that no such offer of shares shall require us or any underwriter to publish a prospectus pursuant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus Regulation. and each person who initially acquires any shares or to whom any offer is made <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be deemed to have represented, acknowledged and agreed to and with each of the underwriters and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to us that it is a &#8220;qualified investor&#8221; within the meaning of Article 2(e) of the Prospectus Regulation. In the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">case of any shares being offered to a financial intermediary as that term is used in the Prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulation, each such financial intermediary will be deemed to have represented, acknowledged and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreed that the shares acquired by it in the offer have not been acquired on a non-discretionary basis on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which may give rise to an offer of any shares to the public other than their offer or resale in a Relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">State to qualified investors as so defined or in circumstances in which the prior consent of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters have been obtained to each such proposed offer or resale. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to shares in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Relevant State means the communication in any form and by any means of sufficient information on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subscribe for any shares, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017&#47;1129.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the United Kingdom<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prior to the publication of a prospectus in relation to the shares which (i) has been approved by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Conduct Authority or (ii) is to be treated as if it had been approved by the Financial Conduct <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Authority in accordance with the transitional provisions in Article 74 (transitional provisions) of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus Amendment etc (EU Exit) Regulations 2019&#47;1234, except that the shares may be offered to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the public in the United Kingdom at any time&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(i)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Regulation&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">192<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(ii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the UK Prospectus Regulation), subject to obtaining the prior consent of underwriters for any such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">offer&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(iii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in any other circumstances falling within Section 86 of the FSMA,<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided that no such offer of the shares shall require the Issuer or any Manager to publish a prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to Section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus Regulation. For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relation to the shares in the United Kingdom means the communication in any form and by any means of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">decide to purchase or subscribe for any shares and the expression &#8220;UK Prospectus Regulation&#8221; means <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulation (EU) 2017&#47;1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act 2018.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any offer subsequently made may only be directed at persons who are &#8220;qualified investors&#8221; (as defined in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Prospectus Regulation) (i) who have professional experience in matters relating to investments falling <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended (the &#8220;Order&#8221;) and&#47;or (ii) who are high net worth companies (or persons to whom it may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">otherwise be lawfully communicated) falling within Article 49(2)(a) to (d) of the Order (all such persons <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">together being referred to as &#8220;relevant persons&#8221;) or otherwise in circumstances which have not resulted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Services and Markets Act 2000.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any person in the United Kingdom that is not a relevant person should not act or rely on the information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">included in this document or use it as basis for taking any action. In the United Kingdom, any investment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or investment activity that this document relates to may be made or taken exclusively by relevant persons.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 400pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Canada<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements of applicable securities laws.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for rescission or damages if this prospectus (including any amendment thereto) contains a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">province or territory for particulars of these rights or consult with a legal advisor.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">underwriter conflicts of interest in connection with this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 626.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Switzerland<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus does not constitute an offer to the public or a solicitation to purchase or invest in any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares. No shares have been offered or will be offered to the public in Switzerland, except that offers of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares may be made to the public in Switzerland at any time under the following exemptions under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Swiss Financial Services Act (&#8220;FinSA&#8221;)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(i)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to any person which is a professional client as defined under the FinSA&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">193<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(ii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">to fewer than 500 persons (other than professional clients as defined under the FinSA), subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">obtaining the prior consent of the representatives of the underwriters for any such offer&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(iii)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">in any other circumstances falling within Article 36 FinSA in connection with Article 44 of the Swiss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Financial Services Ordinance,<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided that no such offer of shares shall require the Company or any investment bank to publish a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus pursuant to Article 35 FinSA.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 168pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be listed or admitted to trading on a trading venue in Switzerland.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 188pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Neither this document nor any other offering or marketing material relating to the shares constitutes a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 200pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus as such term is understood pursuant to the FinSA and neither this document nor any other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 212pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering or marketing material relating to the shares may be publicly distributed or otherwise made publicly <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 224pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available in Switzerland.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the Dubai International Financial Centre<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This document relates to an Exempt Offer in accordance with the Markets Law, DIFC Law No. 1 of 2012, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as amended. This document is intended for distribution only to persons of a type specified in the Markets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Law, DIFC Law No. 1 of 2012, as amended. It must not be delivered to, or relied on by, any other person. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Dubai Financial Services Authority (DFSA) has no responsibility for reviewing or verifying any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">nor taken steps to verify the information set forth herein and has no responsibility for this document. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities to which this document relates may be illiquid and&#47;or subject to restrictions on their resale. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospective purchasers of the securities offered should conduct their own due diligence on the securities. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If you do not understand the contents of this document you should consult an authorized financial advisor.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In relation to its use in the DIFC, this document is strictly private and confidential and is being distributed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to a limited number of investors and must not be provided to any person other than the original recipient, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and may not be reproduced or used for any other purpose. The interests in the securities may not be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offered or sold directly or indirectly to the public in the DIFC.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the United Arab Emirates<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been, and are not being, publicly offered, sold, promoted or advertised in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Arab Emirates (including the Dubai International Financial Centre) other than in compliance with the laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the United Arab Emirates (and the Dubai International Financial Centre) governing the issue, offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and sale of securities. Further, this prospectus does not constitute a public offer of securities in the United <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities and Commodities Authority, Financial Services Regulatory Authority (FSRA) or the Dubai <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Services Authority (DFSA).&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 564.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Australia <font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">does not constitute a disclosure document or a prospectus under Chapter 6D.2 of the Corporations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Act 2001 (Cth) (the &#8220;Corporations Act&#8221;)&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 639.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">has not been, and will not be, lodged with the Australian Securities and Investments Commission <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(&#8220;ASIC&#8221;), as a disclosure document for the purposes of the Corporations Act and does not purport to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">include the information required of a disclosure document for the purposes of the Corporations Act&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 675.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">and<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">194<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">may only be provided in Australia to select investors who are able to demonstrate that they fall within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">one or more of the categories of investors, available under section 708 of the Corporations Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(&#8220;Exempt Investors&#8221;).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares may not be directly or indirectly offered for subscription or purchased or sold, and no <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">invitations to subscribe for or buy the shares may be issued, and no draft or definitive offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">memorandum, advertisement or other offering material relating to any shares may be distributed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Australia, except where disclosure to investors is not required under Chapter 6D of the Corporations Act <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">application for the shares, you represent and warrant to us that you are an Exempt Investor.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As any offer of shares of our common stock under this prospectus will be made without disclosure in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities for resale in Australia <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Chapter 6D.2 if none of the exemptions in section 708 applies to that resale. By applying for the shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">our common stock you undertake to us that you will not, for a period of 12 months from the date of issue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the shares, offer, transfer, assign or otherwise alienate those shares of our common stock to investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in Australia except in circumstances where disclosure to investors is not required under Chapter 6D.2 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 280pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Japan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Instruments and Exchange Act. Accordingly, none of the shares nor any interest therein may be offered or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sold, directly or indirectly, in Japan or to, or for the benefit of, any &#8220;resident&#8221; of Japan (which term as used <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">herein means any person resident in Japan, including any corporation or other entity organized under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to or for the benefit of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">regulations and ministerial guidelines of Japan in effect at the relevant time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Hong Kong<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document, other than (a) to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(Cap. 571 of the Laws of Hong Kong) (the &#8220;SFO&#8221;) of Hong Kong and any rules made thereunder&#59; or (b) in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 484.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 496.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong) (the &#8220;CO&#8221;) or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 508.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which do not constitute an offer to the public within the meaning of the CO. No advertisement, invitation or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 520.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document relating to the shares has been or may be issued or has been or may be in the possession of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 532.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 544.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 556.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 568.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 580.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">SFO and any rules made thereunder.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 600.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Singapore<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, no shares have been or will be offered or sold and no shares have been or will be made the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 647.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject of an invitation for subscription or purchase, and no prospectus or any other document or material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 659.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in connection with the offer or sale, or invitation for subscription or purchase, of the shares, has been or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 671.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be circulated or distributed, whether directly or indirectly, to any person in Singapore other than (i) to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an institutional investor (as defined in Section 4A of the Securities and Futures Act 2001 of Singapore, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modified or amended from time to time (the &#8220;SFA&#8221;)) pursuant to Section 274 of the SFA, (ii) to a relevant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">195<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provision of the SFA.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Singapore SFA Product Classification &#8212; In connection with Section 309B of the SFA and the CMP <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Regulations 2018, unless otherwise specified before an offer of shares of our common stock, we have <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined, and hereby notify all relevant persons (as defined in Section 309A(1) of the SFA), that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock are &#8216;&#8216;prescribed capital markets products&#8217;&#8217; (as defined in the CMP Regulations <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 164pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12&#58; Notice on the Sale of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 176pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investment Products and MAS Notice FAA-N16&#58; Notice on Recommendations on Investment Products).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Bermuda<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Shares may be offered or sold in Bermuda only in compliance with the provisions of the Investment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Act of 2003 of Bermuda which regulates the sale of securities in Bermuda. Additionally, non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bermudian persons (including companies) may not carry on or engage in any trade or business in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Bermuda unless such persons are permitted to do so under applicable Bermuda legislation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 274.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Saudi Arabia<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This document may not be distributed in the Kingdom of Saudi Arabia except to such persons as are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">permitted under the Rules on the Offer of Securities and Continuing Obligations Regulations as issued by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the board of the Saudi Arabian Capital Market Authority (&#8220;CMA&#8221;) pursuant to resolution number <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 332.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">3-123-2017 dated 27 December 2017, as amended (the &#8220;CMA Regulations&#8221;). The CMA does not make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">any representation as to the accuracy or completeness of this document and expressly disclaims any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 356.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 368.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospective purchasers of the securities offered hereby should conduct their own due diligence on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 380.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accuracy of the information relating to the securities. If you do not understand the contents of this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 392.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">document, you should consult an authorised financial adviser.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 412.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in the British Virgin Islands<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 435.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares are not being, and may not be offered to the public or to any person in the British Virgin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 447.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Islands for purchase or subscription by or on behalf of us. The shares may be offered to companies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incorporated under the BVI Business Companies Act, 2004 (British Virgin Islands), &#8220;BVI Companies&#8221;), but <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 471.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only where the offer will be made to, and received by, the relevant BVI Company entirely outside of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 483.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">British Virgin Islands.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 503.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in China<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus will not be circulated or distributed in the PRC and the shares will not be offered or sold, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and will not be offered or sold to any person for re-offering or resale directly or indirectly to any residents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the PRC (for such purposes, not including the Hong Kong and Macau Special Administrative Regions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or Taiwan), except pursuant to any applicable laws and regulations of the PRC. Neither this prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">nor any advertisement or other offering material may be distributed or published in the PRC, except under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances that will result in compliance with applicable laws and regulations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 605.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Korea<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be registered under the Financial Investments Services and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Capital Markets Act of Korea and the decrees and regulations thereunder (the &#8220;FSCMA&#8221;), and the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">have been and will be offered in Korea as a private placement under the FSCMA. None of the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be offered, sold or delivered directly or indirectly, or offered or sold to any person for re-offering or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and regulations of Korea, including the FSCMA and the Foreign Exchange Transaction Law of Korea and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the decrees and regulations thereunder (the &#8220;FETL&#8221;). Furthermore, the purchaser of the shares shall <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">196<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comply with all applicable regulatory requirements (including but not limited to requirements under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">FETL) in connection with the purchase of the shares. By the purchase of the shares, the relevant holder <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 96pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thereof will be deemed to represent and warrant that if it is in Korea or is a resident of Korea, it purchased <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 108pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the shares pursuant to the applicable laws and regulations of Korea.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Malaysia<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No prospectus or other offering material or document in connection with the offer and sale of the shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">has been or will be registered with the Securities Commission of Malaysia (&#8220;Commission&#8221;) for the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Commission&#8217;s approval pursuant to the Capital Markets and Services Act 2007. Accordingly, this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus and any other document or material in connection with the offer or sale, or invitation for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indirectly, to persons in Malaysia other than (i) a closed end fund approved by the Commission&#59; (ii) a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holder of a Capital Markets Services Licence&#59; (iii) a person who acquires the shares, as principal, if the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offer is on terms that the shares may only be acquired at a consideration of not less than RM250,000 (or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its equivalent in foreign currencies) for each transaction&#59; (iv) an individual whose total net personal assets <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or total net joint assets with his or her spouse exceeds RM3 million (or its equivalent in foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">currencies), excluding the value of the primary residence of the individual&#59; (v) an individual who has a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">gross annual income exceeding RM300,000 (or its equivalent in foreign currencies) per annum in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preceding twelve months&#59; (vi) an individual who, jointly with his or her spouse, has a gross annual income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of RM400,000 (or its equivalent in foreign currencies), per annum in the preceding twelve months&#59; (vii) a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corporation with total net assets exceeding RM10 million (or its equivalent in a foreign currencies) based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the last audited accounts&#59; (viii) a partnership with total net assets exceeding RM10 million (or its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalent in foreign currencies)&#59; (ix) a bank licensee or insurance licensee as defined in the Labuan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial Services and Securities Act 2010&#59; (x) an Islamic bank licensee or takaful licensee as defined in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Labuan Financial Services and Securities Act 2010&#59; and (xi) any other person as may be specified by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Commission&#59; provided that, in the each of the preceding categories (i) to (xi), the distribution of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares is made by a holder of a Capital Markets Services License who carries on the business of dealing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in securities. The distribution in Malaysia of this prospectus is subject to Malaysian laws. This prospectus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">does not constitute and may not be used for the purpose of public offering or an issue, offer for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subscription or purchase, invitation to subscribe for or purchase any securities requiring the registration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a prospectus with the Commission under the Capital Markets and Services Act 2007.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Taiwan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The shares have not been and will not be registered with the Financial Supervisory Commission of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taiwan pursuant to relevant securities laws and regulations and may not be sold, issued or offered within <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Taiwan through a public offering or in circumstances which constitutes an offer within the meaning of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorised to offer, sell, give <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advice regarding or otherwise intermediate the offering and sale of the shares in Taiwan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in South Africa<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Due to restrictions under the securities laws of South Africa, no &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 355.79pt; position: absolute; white-space: pre;">offer to the public<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 432.43pt; position: absolute; white-space: pre;">&#8221; (as such term is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 607.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defined in the South African Companies Act, No. 71 of 2008 (as amended or re-enacted) (the &#8220;South <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 619.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">African Companies Act&#8221;) is being made in connection with the issue of the shares in South Africa. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 631.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accordingly, this document does not, nor is it intended to, constitute a &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 384.5pt; position: absolute; white-space: pre;">registered prospectus<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 480.62pt; position: absolute; white-space: pre;">&#8221; (as that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">term is defined in the South African Companies Act) prepared and registered under the South African <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Companies Act and has not been approved by, and&#47;or filed with, the South African Companies and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Intellectual Property Commission or any other regulatory authority in South Africa. The shares are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offered, and the offer shall not be transferred, sold, renounced or delivered, in South Africa or to a person <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">197<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with an address in South Africa, unless one or other of the following exemptions stipulated in section 96 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(1) applies&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 480.75pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 94.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 386.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 94.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 94.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Section 96 (1) (a)<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 0pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the offer, transfer, sale, renunciation or delivery is to&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 19.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(i) persons whose ordinary business, or part of whose ordinary business, is to deal in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">securities, as principal or agent&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 51pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(ii) the South African Public Investment Corporation&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 70.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(iii) persons or entities regulated by the Reserve Bank of South Africa&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 90pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(iv) authorised financial service providers under South African law&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 109.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(v) financial institutions recognised as such under South African law&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 129pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(vi) a wholly-owned subsidiary of any person or entity contemplated in (c), (d) or (e), <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">acting as agent in the capacity of an authorised portfolio manager for a pension fund, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">or as manager for a collective investment scheme (in each case duly registered as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">such under South African law)&#59; or <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 184.5pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">(vii) any combination of the person in (i) to (vi)&#59; or<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 5.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 50.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 204pt; width: 94.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 94.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Section 96 (1) (b) <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 94.5pt; position: absolute; top: 204pt; width: 386.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">the total contemplated acquisition cost of the securities, for any single addressee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">acting as principal is equal to or greater than ZAR1,000,000 or such higher amount as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">may be promulgated by notice in the Government Gazette of South Africa pursuant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 38.63pt; width: 386.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">section 96(2)(a) of the South African Companies Act.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 371.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Information made available in this prospectus should not be considered as &#8220;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 406.43pt; position: absolute; white-space: pre;">advice<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 435.33pt; position: absolute; white-space: pre;">&#8221; as defined in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 383.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">South African Financial Advisory and Intermediary Services Act, 2002. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 403.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Notice to prospective investors in Israel<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 425.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">This prospectus does not constitute a prospectus under the Israeli Securities Law, 5728-1968, or the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Israeli Securities Law, and has not been filed with or approved by the Israel Securities Authority. In Israel, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this prospectus is being distributed only to, and is directed only at, and any offer of the shares is directed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 461.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only at, (i) a limited number of persons in accordance with the Israeli Securities Law and (ii) investors <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 473.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">listed in the first addendum, or the Addendum, to the Israeli Securities Law, consisting primarily of joint <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 485.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 497.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 509.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equity in excess of NIS 50 million and &#8220;qualified individuals,&#8221; each as defined in the Addendum (as it may <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 521.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be amended from time to time), or, collectively referred to as qualified investors (in each case, purchasing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 533.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for their own account or, where permitted under the Addendum, for the accounts of their clients who are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 545.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investors listed in the Addendum). Qualified investors are required to submit written confirmation that they <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 557.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fall within the scope of the Addendum, are aware of the meaning of same and agree to it.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 297.66pt; position: absolute; text-decoration: none; white-space: pre;">198<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_1505" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Legal matters<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The validity of the issuance of our common stock offered in this prospectus will be passed upon for us by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">O&#8217;Melveny &#38; Myers LLP. King &#38; Spalding LLP is acting as regulatory counsel to us in connection with this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering and will pass upon certain legal matters. Certain legal matters in connection with this offering will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 143.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be passed upon for the underwriters by Cooley LLP, San Francisco, California.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1531" style="position: absolute; top: 163.2pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 163.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Experts<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The financial statements as of December 31, 2024 and 2023 and for the years then ended included in this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prospectus have been so included in reliance on the report of PricewaterhouseCoopers LLP, an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">independent registered public accounting firm, given on the authority of said firm as experts in auditing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and accounting.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1578" style="position: absolute; top: 254.4pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 254.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Where you can find additional information<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 289.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have filed with the SEC a registration statement on Form S-1, including exhibits and schedules, under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 301.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Securities Act, with respect to the shares of common stock being offered by this prospectus. This <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 313.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prospectus, which constitutes part of the registration statement, does not contain all of the information in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 325.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the registration statement and its exhibits. For further information with respect to us and the common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 337.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contained in this prospectus as to the contents of any contract or any other document referred to are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">summary in nature and not necessarily complete, and in each instance, we refer you to the copy of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contract or other document filed as an exhibit to the registration statement. Each of these statements is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 385.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualified in all respects by reference to the full text of such contract or other document.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 405.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">You may read our SEC filings, including this registration statement, over the Internet at the SEC&#8217;s website <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at www.sec.gov. Upon the completion of this offering, we will be subject to the information reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 429.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requirements of the Exchange Act, and we will file reports, proxy statements, and other information with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 441.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the SEC. These reports, proxy statements, and other information will be available for review at the SEC&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 453.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">website referred to above. We also maintain a website at www.heartflow.com, at which, following the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completion of this offering, you may access these materials free of charge as soon as reasonably <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accessible through our website is not a part of this prospectus or the registration statement of which it <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forms a part, and the inclusion of our website address in this prospectus is an inactive textual reference <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">only. You should not consider the contents of our website in making an investment decision with respect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to our common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-1<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_77" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 151.75pt; position: absolute; text-decoration: none; white-space: pre;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="position: absolute; top: 113.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 428.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 39.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 0pt; width: 39.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 39.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.63pt; position: absolute; text-decoration: none; white-space: pre;">Page<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_113">Report of Independent Registered Public Accounting Firm</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 257.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 259.90999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 260.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 260.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 260.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.34pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 12.75pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_113">F-2</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 428.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Financial Statements&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_461">Consolidated Balance Sheets as of December 31, 2023 and 2024</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 311.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 313.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 314.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 314.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 315.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 315.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 41.25pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_461">F-3</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_447">Consolidated Statements of Operations and Comprehensive Loss for the years ended </a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_447">December 31, 2023 and 2024</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 152.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 155.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 155.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.35999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 55.5pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_447">F-4</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81.75pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_432">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; </a><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_432">Deficit for the years ended December 31, 2023 and 2024</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 272.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 274.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 275.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 275.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 275.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 275.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 81.75pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_432">F-5</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_418">Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2024</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 422.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 424.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 425.15999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 425.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 425.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 425.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 108pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_418">F-6</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 122.25pt; width: 428.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 428.25pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.63pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_129">Notes to Consolidated Financial Statements</a><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 215.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 215.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 215.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 215.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 215.57999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 122.25pt; width: 39.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 39.75pt;"><font style="color: #0000ff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.13pt; position: absolute; text-decoration: underline; white-space: pre;"><a style="color: inherit; text-decoration: inherit; z-index: 1;" href="#i2341357d54884756b9e9172f0a83cd6b_129">F-7</a><font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-2<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_113" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Report of Independent Registered Public Accounting Firm<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">To the Board of Directors and Stockholders of HeartFlow Holding, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 127.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Opinion on the Financial Statements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 147.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have audited the accompanying consolidated balance sheets of HeartFlow Holding, Inc. and its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 159.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiaries (the &#34;Company&#34;) as of December 31, 2024 and 2023, and the related consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 171.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss, of redeemable convertible preferred stock and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 183.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders&#8217; deficit and of cash flows for the years then ended, including the related notes (collectively <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 195.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">referred to as the &#34;consolidated financial statements&#34;). In our opinion, the consolidated financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 207.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements present fairly, in all material respects, the financial position of the Company as of December <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 219.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2024 and 2023, and the results of its operations and its cash flows for the years then ended in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 231.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conformity with accounting principles generally accepted in the United States of America.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 251.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">Basis for Opinion<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 271.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 283.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 295.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 307.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(United States) (PCAOB) and are required to be independent with respect to the Company in accordance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 319.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the U.S. federal securities laws and the applicable rules and regulations of the Securities and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 331.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Exchange Commission and the PCAOB.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 351.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We conducted our audits of these consolidated financial statements in accordance with the standards of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 363.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the PCAOB and in accordance with auditing standards generally accepted in the United States of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 375.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">America. Those standards require that we plan and perform the audits to obtain reasonable assurance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 387.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about whether the consolidated financial statements are free of material misstatement, whether due to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 399.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">error or fraud.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Our audits included performing procedures to assess the risks of material misstatement of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements, whether due to error or fraud, and performing procedures that respond <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 455.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosures in the consolidated financial statements. Our audits also included evaluating the accounting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principles used and significant estimates made by management, as well as evaluating the overall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 479.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">presentation of the consolidated financial statements. We believe that our audits provide a reasonable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 491.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">basis for our opinion.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 531.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#47;s&#47; PricewaterhouseCoopers LLP<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 543.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">San Jose, California<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 555.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">March 26, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 575.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">We have served as the Company&#8217;s auditor since 2009, which includes periods before the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">became subject to SEC reporting requirements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-3<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_461" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 222.02pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Balance Sheets<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 105.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 181.92pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 133.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assets<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Current assets&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 122.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 123.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 124.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 124.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 124.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 124.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">122,767<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">51,367<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts receivable, net of allowance for credit losses of $1,058 and $814 at <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023 and 2024, respectively<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 195.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 196.23pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 196.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 196.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 196.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">20,546<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">24,639<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 87.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Restricted cash, current<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 109.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 110.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 111.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">150<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 100.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid expenses and other current assets<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 186.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 187.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 187.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 187.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 187.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 187.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 100.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">5,134<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 100.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">6,132<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total current assets<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 104.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 106.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 106.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">148,447<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">82,288<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment, net<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 116.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 118.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 119.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 119.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 119.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 119.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">9,921<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">8,920<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 138.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease right-of-use assets<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 142.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 142.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 142.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 142.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 142.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 142.85999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">20,961<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 138.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">18,805<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 151.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Restricted cash, non-current<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 115.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 115.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 115.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 115.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 115.86pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 151.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,467<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 151.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,325<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 164.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current assets<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 102.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 102.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 102.36pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">1,255<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 164.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,366<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 177pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total assets<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 74.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 75.27pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 177pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">185,051<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 177pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">118,704<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 204pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Liabilities, redeemable convertible preferred stock and stockholders' deficit<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 216.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Current liabilities&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 229.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts payable<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 85.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 87.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 88.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 88.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 229.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">2,887<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 229.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">2,870<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 242.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued expenses and other current liabilities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 196.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 196.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 196.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 196.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 242.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">24,790<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 242.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">25,319<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 255pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities, current<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 147.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 149.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 150.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 151.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 151.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 151.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 151.46pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 255pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">5,138<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 255pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">5,416<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 267.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total current liabilities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 112.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 114.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 115.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 115.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 115.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 115.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 267.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">32,815<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 267.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">33,605<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 280.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.26pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Term loan<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 42.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 43.260000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 43.550000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 43.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 43.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 280.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">134,008<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 280.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">136,431<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 294.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrant liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 124.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 124.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 124.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 124.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 294.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,440<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 294.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">20,835<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 307.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 72.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 74.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 75.06pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 307.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">903<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 307.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 320.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities, non-current <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 156.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 156.29999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 156.34pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 320.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">21,454<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 320.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">18,537<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 333pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current liabilities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.22999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 111.25pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 333pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">429<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 333pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">214<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 345.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total liabilities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 82.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 83.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 83.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 84.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 84.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 84.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 84.16pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 345.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">194,049<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 345.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">209,622<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 358.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Commitments and contingencies (Note 7)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 45.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 371.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.31pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock issuable in series, $0.001 par value&#59; <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 14.11pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454 shares authorized, issued and outstanding as of <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 257.58pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 24.91pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 31.630000000000003pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024&#59; aggregate liquidation value of $951,917 as of <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 258.57pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 35.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 31.630000000000003pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 71.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 73.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 74.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 74.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 75.02pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 371.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">768,566<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 371.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">768,566<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 417pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stockholders&#8217; deficit&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 45.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 429.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.31pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock, $0.001 par value&#59; 210,000,000 and 210,300,000 shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 14.11pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">authorized as of <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 78.11pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 157.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, respectively&#59; 14,427,925 and <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 24.91pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">17,877,051 shares issued and outstanding as of <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 205.6pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 284.57pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">respectively<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 59.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 61.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 61.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 61.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 61.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 429.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 48.88pt;"></font></font><font style="left: 51.510000000000005pt; position: absolute;">14<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 429.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 48.88pt;"></font></font><font style="left: 51.510000000000005pt; position: absolute;">18<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 475.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Additional paid-in capital<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 100.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 101.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 101.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 102.16pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 475.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">97,456<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 475.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">112,229<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 488.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated other comprehensive loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 159.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 160.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 160.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 160.75pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 488.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(501)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 488.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(772)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 501pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated deficit<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 80.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 83.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 83.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 84.02pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 501pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(874,533)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 501pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(970,959)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 513.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stockholders&#8217; deficit<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 126.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 128.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 128.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 128.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 129.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 129.08pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 513.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(777,564)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 513.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(859,484)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 526.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.16pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Total liabilities, redeemable convertible preferred stock and stockholders&#8217; <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.96pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 35.63pt; position: absolute; text-decoration: none; white-space: pre;">deficit<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 59.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 61.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 61.57000000000001pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 61.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 526.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">185,051<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 526.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">118,704<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 700.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 130.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-4<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_447" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 118.73pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Statements of Operations and Comprehensive Loss<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 105.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 181.92pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 133.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 38.620000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 39.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 39.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 39.300000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 39.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">87,174<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">125,808<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 66.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 66.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 66.36pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">29,123<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">31,359<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 51pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Gross profit<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 49.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 51.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 51.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 52.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 52.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 52.510000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 52.52pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">58,051<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 51pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">94,449<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating expenses&#58;<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 85.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 87.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 88.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 88.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 76.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 124.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 124.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 124.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 124.86pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 76.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">35,854<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 76.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">43,517<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 89.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 152.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 154.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 155.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 155.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 155.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 155.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">95,111<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 89.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">112,154<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 102pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total operating expenses<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 102.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 104.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 106.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 106.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 106.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">130,965<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">155,671<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 114.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 86.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 87.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 88.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 88.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(72,914)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 114.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(61,222)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest income<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 65.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 65.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 66.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 66.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 66.16pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">5,457<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,066<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 140.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest expense<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 69.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 70.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 70.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 70.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 70.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 70.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 70.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(24,694)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(22,768)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of convertible note<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 158.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 159.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 160.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 160.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 160.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 153pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(5,120)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 153pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 165.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of common stock warrant liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 214.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 217.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 218.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 218.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 218.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 218.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 218.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 218.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 165.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(2,320)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 165.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(16,395)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 178.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of derivative liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 163pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 164.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 165.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 165.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 165.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 165.16pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 178.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,158<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 178.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(222)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 191.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other income, net<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 74.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 74.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 75.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 75.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 75.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 75.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 75.27pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 191.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 47.62pt; position: absolute; text-decoration: none; white-space: pre;">325<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 191.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">168<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 204pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss before provision for income taxes<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 156.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 158.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 160.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 160.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 160.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 160.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 160.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 160.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 204pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(95,108)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 204pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,373)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 216.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 108.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 111.06pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 216.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(547)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 216.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 45.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">(53)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 229.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 35.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 37.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 38.580000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.870000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 38.970000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 229.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(95,655)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 229.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 242.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cumulative dividends on Series C redeemable convertible preferred stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 295.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 298.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 299.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 299.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 299.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 299.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 299.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 242.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(1,239)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 242.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 255pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of redeemable convertible preferred stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 312.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 313.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 313.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 313.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 313.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 255pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(26,794)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 255pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 267.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common stockholders<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 182.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 183.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 183.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 183.25pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 267.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 18.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(123,688)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 267.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 280.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Comprehensive loss&#58;<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 86.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 87.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 88.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 88.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 88.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 88.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 293.25pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 35.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 37.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 38.580000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 38.870000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 38.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 38.970000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 293.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(95,655)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 293.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 306pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other comprehensive loss&#58;<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 109.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 110.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 111.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 318.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 144.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 146.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 147pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 147.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 147.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 147.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 318.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(504)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 318.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(271)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 331.5pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total comprehensive loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 103.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 106.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 106.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 331.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,159)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 331.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,697)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 360pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss per share attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 294.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 295.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 295.71999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 295.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 360pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 41.02pt; position: absolute;">(8.67)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 360pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 41.02pt; position: absolute;">(6.16)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 372.75pt; width: 334.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.16pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used to compute net loss per share attributable to <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.96pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">common stockholders, basic and diluted<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 171.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 173.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 174.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 174.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 174.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 372.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 13.88pt;"></font></font><font style="left: 16.51pt; position: absolute;">14,265,293<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 372.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 13.88pt;"></font></font><font style="left: 16.51pt; position: absolute;">15,661,682<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 546.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 130.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 612pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 792pt;"><div style="left: 0pt; position: absolute; top: 540pt;"><div style="width: 666pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 388.5pt; position: absolute; text-decoration: none; white-space: pre;">F-5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 666pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_432" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 307.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 91.2pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 125.11pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Deficit<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 105.6pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 271.92pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands, except share and per share amounts<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 516.75pt; position: absolute; white-space: pre;">)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 133.6pt; width: 792pt;"><div style="font-size: 0pt; left: 63pt; position: absolute; top: 0pt; width: 666pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 171pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 62.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 50.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 47.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 51pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 72.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 62.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 29.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 171pt; position: absolute; top: 0pt; width: 115.5pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 10.65pt; width: 115.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.14pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable Convertible <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 20.25pt; width: 115.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 28pt; position: absolute; text-decoration: none; white-space: pre;">Preferred Stock<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-right: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-left: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 292.5pt; position: absolute; top: 0pt; width: 110.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 20.25pt; width: 110.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.82pt; position: absolute; text-decoration: none; white-space: pre;">Common Stock<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 405.75pt; position: absolute; top: 0pt; width: 51pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 5.97pt; position: absolute; text-decoration: none; white-space: pre;">Additional <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.18pt; position: absolute; text-decoration: none; white-space: pre;">Paid-In <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 12.18pt; position: absolute; text-decoration: none; white-space: pre;">Capital<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 459.75pt; position: absolute; top: 0pt; width: 72.75pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3.45pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 11.29pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 25.72pt; position: absolute; text-decoration: none; white-space: pre;">Other <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.41pt; position: absolute; text-decoration: none; white-space: pre;">Comprehensive <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 9.3pt; position: absolute; text-decoration: none; white-space: pre;">Income (Loss)<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 535.5pt; position: absolute; top: 0pt; width: 62.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.04pt; position: absolute; text-decoration: none; white-space: pre;">Accumulated <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 18.92pt; position: absolute; text-decoration: none; white-space: pre;">Deficit<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="2" colspan="1"><div style="left: 600.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 13.05pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 23.08pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 22.65pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 6.21pt; position: absolute; text-decoration: none; white-space: pre;">Stockholders&#8217; <font style="display: inline-block; height: 5.82pt;"></font></font></div><div style="line-height: 5.82pt; position: absolute; top: 32.25pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 20.42pt; position: absolute; text-decoration: none; white-space: pre;">Deficit<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 29.25pt; width: 62.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 17.8pt; position: absolute; text-decoration: none; white-space: pre;">Shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 29.25pt; width: 50.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 10.03pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 29.25pt; width: 60pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 16.68pt; position: absolute; text-decoration: none; white-space: pre;">Shares<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 29.25pt; width: 47.25pt;"><div><div style="line-height: 5.82pt; position: absolute; top: 3pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 8pt; font-style: normal; font-weight: bold; left: 8.53pt; position: absolute; text-decoration: none; white-space: pre;">Amount<font style="display: inline-block; height: 5.82pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at January 1, 2023<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 117.08pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 119.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 121.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 122.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 122.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 122.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 123.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 123.02pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 41.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 10.88pt;"></font></font><font style="left: 13.510000000000002pt; position: absolute;">39,422,361<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 41.25pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 6.38pt;"></font></font><font style="left: 14.010000000000002pt; position: absolute;">538,423<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 41.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 8.63pt;"></font></font><font style="left: 11.260000000000002pt; position: absolute;">14,436,169<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 41.25pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 25.88pt;"></font></font><font style="left: 33.51pt; position: absolute;">14<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 41.25pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 12.13pt;"></font></font><font style="left: 19.759999999999998pt; position: absolute;">58,427<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 41.25pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 56.38pt;"></font></font><font style="left: 64.01pt; position: absolute;">3<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 41.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 15.39pt;"></font></font><font style="left: 23.02pt; position: absolute;">(752,084)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 18.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(693,640)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of common stock upon <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise of stock options<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 122.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 122.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 123.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 123.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 123.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 123.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 123.27pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 54pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 54pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 54pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 21.13pt;"></font></font><font style="left: 23.759999999999998pt; position: absolute;">291,756<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 54pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 54pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 29.63pt;"></font></font><font style="left: 32.26pt; position: absolute;">589<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 54pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 54pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">589<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 45.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.31pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of Series F redeemable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.11pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock at <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.91pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.8505 per share, net of issuance <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.71pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">costs of $5,904<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 84.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 87.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 87.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 78pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 10.88pt;"></font></font><font style="left: 13.510000000000002pt; position: absolute;">61,344,029<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 78pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 11.38pt;"></font></font><font style="left: 14.010000000000002pt; position: absolute;">168,957<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 78pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 78pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 78pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 35.63pt;"></font></font><font style="left: 38.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 78pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 78pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 56.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.01pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of Series F-1 redeemable <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.81pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock at <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.61pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">$1.9098 per share upon conversion <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.41pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">of convertible notes and accrued <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.21pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">interest<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 53.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 55.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 55.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 55.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 123.75pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 10.88pt;"></font></font><font style="left: 13.510000000000002pt; position: absolute;">21,465,064<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 123.75pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 16.38pt;"></font></font><font style="left: 19.009999999999998pt; position: absolute;">61,186<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 123.75pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 123.75pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 123.75pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 35.63pt;"></font></font><font style="left: 38.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 123.75pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 123.75pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 35.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 180pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.66pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.46pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">redeemable convertible preferred <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.26pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 44.629999999999995pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 45.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 46.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 46.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 180pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 180pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 180pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 180pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 180pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 17.13pt;"></font></font><font style="left: 19.759999999999998pt; position: absolute;">26,794<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 180pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 180pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 25.39pt;"></font></font><font style="left: 28.02pt; position: absolute;">(26,794)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 180pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 215.25pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Repurchase of common stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 133.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 135.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 215.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 215.25pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 215.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 18.14pt;"></font></font><font style="left: 20.77pt; position: absolute;">(300,000)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 215.25pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 215.25pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.64pt;"></font></font><font style="left: 29.27pt; position: absolute;">(228)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 215.25pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 215.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 215.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(228)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 228pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 159.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 161.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 163.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 163.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 163.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 163.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 163.47pt; position: absolute; text-decoration: none; white-space: pre;"> .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 228pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 228pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 228pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 228pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 228pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 17.13pt;"></font></font><font style="left: 19.759999999999998pt; position: absolute;">11,874<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 228pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 228pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 228pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">11,874<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 240.75pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 144.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 145.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 145.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 145.75pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 240.75pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 240.75pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 240.75pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 240.75pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 240.75pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 35.63pt;"></font></font><font style="left: 38.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 240.75pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 48.39pt;"></font></font><font style="left: 51.02pt; position: absolute;">(504)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 240.75pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 240.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(504)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 253.5pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 47.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 49.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 50.580000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 50.870000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 50.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 50.970000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 253.5pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 253.5pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 253.5pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 253.5pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 253.5pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 35.63pt;"></font></font><font style="left: 38.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 253.5pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 253.5pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 25.39pt;"></font></font><font style="left: 28.02pt; position: absolute;">(95,655)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 253.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(95,655)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 266.25pt; width: 171pt;"><div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 50.1pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 131.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 133.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 135.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 136.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 266.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 5.88pt;"></font></font><font style="left: 8.51pt; position: absolute;">122,231,454<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 266.25pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 11.38pt;"></font></font><font style="left: 14.010000000000002pt; position: absolute;">768,566<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 266.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 8.63pt;"></font></font><font style="left: 11.260000000000002pt; position: absolute;">14,427,925<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 266.25pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 30.88pt;"></font></font><font style="left: 33.51pt; position: absolute;">14<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 266.25pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 17.13pt;"></font></font><font style="left: 19.759999999999998pt; position: absolute;">97,456<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 266.25pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 48.39pt;"></font></font><font style="left: 51.02pt; position: absolute;">(501)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 266.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 20.39pt;"></font></font><font style="left: 23.02pt; position: absolute;">(874,533)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 266.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(777,564)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 24pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 279pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 171pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Issuance of common stock upon <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 171pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">exercise of stock options<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 122.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 122.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 123.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 123.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 123.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 123.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 123.27pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 279pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 279pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 279pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 13.63pt;"></font></font><font style="left: 16.26pt; position: absolute;">3,449,126<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 279pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 35.88pt;"></font></font><font style="left: 38.510000000000005pt; position: absolute;">4<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 279pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 22.13pt;"></font></font><font style="left: 24.759999999999998pt; position: absolute;">4,560<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 279pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 279pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 279pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,564<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 303pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 159.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 161.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 163.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 163.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 163.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 163.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 163.47pt; position: absolute; text-decoration: none; white-space: pre;"> .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 303pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 303pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 303pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 303pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 303pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 17.13pt;"></font></font><font style="left: 19.759999999999998pt; position: absolute;">10,213<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 303pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 303pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 303pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">10,213<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 315.75pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign currency translation loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 144.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 145.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 145.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 145.75pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 315.75pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 315.75pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 315.75pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 315.75pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 315.75pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 35.63pt;"></font></font><font style="left: 38.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 315.75pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 48.39pt;"></font></font><font style="left: 51.02pt; position: absolute;">(271)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 315.75pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 315.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(271)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 328.5pt; width: 171pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 47.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 49.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 50.580000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 50.870000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 50.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 50.970000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 328.5pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 46.88pt;"></font></font><font style="left: 49.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 328.5pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 34.88pt;"></font></font><font style="left: 37.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 328.5pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 44.63pt;"></font></font><font style="left: 47.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 328.5pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.88pt;"></font></font><font style="left: 34.51pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 328.5pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 35.63pt;"></font></font><font style="left: 38.260000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 328.5pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 57.38pt;"></font></font><font style="left: 60.010000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 328.5pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 25.39pt;"></font></font><font style="left: 28.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 328.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 341.25pt; width: 171pt;"><div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 2.71pt; width: 171pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 50.1pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2024<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 131.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 133.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 135.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 136.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 171pt; position: absolute; top: 341.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 5.88pt;"></font></font><font style="left: 8.51pt; position: absolute;">122,231,454<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 236.25pt; position: absolute; top: 341.25pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 6.38pt;"></font></font><font style="left: 14.010000000000002pt; position: absolute;">768,566<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; border-right: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-left: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 292.5pt; position: absolute; top: 341.25pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 8.63pt;"></font></font><font style="left: 11.260000000000002pt; position: absolute;">17,877,051<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 355.5pt; position: absolute; top: 341.25pt; width: 47.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 47.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 25.88pt;"></font></font><font style="left: 33.51pt; position: absolute;">18<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 341.25pt; width: 51pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 51pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 7.13pt;"></font></font><font style="left: 14.760000000000002pt; position: absolute;">112,229<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 459.75pt; position: absolute; top: 341.25pt; width: 72.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 72.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 43.39pt;"></font></font><font style="left: 51.02pt; position: absolute;">(772)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 535.5pt; position: absolute; top: 341.25pt; width: 62.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 62.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 15.39pt;"></font></font><font style="left: 23.02pt; position: absolute;">(970,959)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 600.75pt; position: absolute; top: 341.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 18.39pt;"></font></font><font style="left: 26.02pt; position: absolute;">(859,484)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 503.6pt; width: 792pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 220.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 751.5pt;"><div style="width: 504pt;"><div style="line-height: 7.28pt; position: absolute; top: -9.38pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 504pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_418" style="position: absolute; top: 49.5pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 49.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 68.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 191.71pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated Statements of Cash <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 386.29pt; position: absolute; text-decoration: none; white-space: pre;">Flows<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 83.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 271.59pt; position: absolute; text-decoration: none; white-space: pre;">(in thousands)<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 95.1pt; width: 612pt;"><div style="font-size: 0pt; left: 59.25pt; position: absolute; top: 0pt; width: 493.5pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 360pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 360pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows from operating activities&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 37.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 35.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 37.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 37.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 37.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 37.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.05pt;"></font></font><font style="left: 30.68pt; position: absolute;">(95,655)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 37.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 23.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(96,426)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Adjustments to reconcile net loss to net cash used in operating activities&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 61.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Depreciation and amortization<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 134.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 136.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 136.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 61.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.04pt;"></font></font><font style="left: 38.67pt; position: absolute;">4,744<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 61.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">5,358<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation expense<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 159.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 161.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 163.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 163.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 163.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 163.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 163.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.04pt;"></font></font><font style="left: 33.67pt; position: absolute;">11,874<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">10,213<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 85.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Amortization of debt discount and debt issuance costs<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 229.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 230.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 231.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 231.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 231.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.04pt;"></font></font><font style="left: 38.67pt; position: absolute;">2,777<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">1,609<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 97.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.21pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Amortization of right-of-use asset<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 146.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 149.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 149.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 149.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 150pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 150.01999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 97.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,889<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 97.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">2,735<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of convertible note<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 170.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 171.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 172.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 172.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 172.66pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.04pt;"></font></font><font style="left: 38.67pt; position: absolute;">5,120<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of common stock warrant liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 226.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 229.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 230.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 230.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 230.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 230.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 230.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 230.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.04pt;"></font></font><font style="left: 38.67pt; position: absolute;">2,320<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">16,395<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 135.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value of derivative liability<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 175pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 176.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 176.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 177.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 177.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 177.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 177.16pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 135.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.05pt;"></font></font><font style="left: 35.68pt; position: absolute;">(4,158)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 135.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">222<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 147.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Paid-in-kind interest<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.22pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 95.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 96.16pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.54pt;"></font></font><font style="left: 46.17pt; position: absolute;">144<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 147.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 159.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Non-cash interest charges<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 119.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 121.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 122.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 122.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 122.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 122.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 123.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 123.02pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 159.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.54pt;"></font></font><font style="left: 46.17pt; position: absolute;">865<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 159.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">2,016<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 172.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in allowance for credit losses<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 163.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 163.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 163.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 172.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.04pt;"></font></font><font style="left: 38.67pt; position: absolute;">1,190<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 172.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(244)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 184.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Changes in assets and liabilities&#58;<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 145.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 145.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 145.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 145.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 196.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts receivable, net<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 124.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 126.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 127.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 127.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 127.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 127.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.05pt;"></font></font><font style="left: 35.68pt; position: absolute;">(9,350)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(3,849)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 208.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid expenses and other current assets<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 198.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 199.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 199.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 199.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 199.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 199.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 208.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.55pt;"></font></font><font style="left: 43.18pt; position: absolute;">(357)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 208.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(998)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 220.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current assets<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 126.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 127.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 127.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 127.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 127.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 220.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.55pt;"></font></font><font style="left: 43.18pt; position: absolute;">(402)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 220.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(2,698)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 232.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounts payable<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 97.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 99.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 100.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 100.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 100.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 232.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.55pt;"></font></font><font style="left: 43.18pt; position: absolute;">(623)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 232.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(327)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 244.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued expenses and other current liabilities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 208.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 208.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 208.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 208.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 244.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.04pt;"></font></font><font style="left: 38.67pt; position: absolute;">3,759<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 244.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">426<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 256.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 126.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 127.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 127.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 127.75pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 256.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.05pt;"></font></font><font style="left: 35.68pt; position: absolute;">(1,761)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 256.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(3,218)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 268.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Other non-current liabilities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 134.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 136.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.61pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 268.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.54pt;"></font></font><font style="left: 46.17pt; position: absolute;">190<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 268.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(215)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 280.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 38.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in operating activities<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 182.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 184.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 185.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 185.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 185.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 185.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 186.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 186.01999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 280.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.05pt;"></font></font><font style="left: 30.68pt; position: absolute;">(76,434)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 280.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(69,001)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 9pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 301.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows from investing activities<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 313.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Purchase of property and equipment<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 160.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 162.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 162.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 163.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 163.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 163.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 163.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 163.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 313.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.05pt;"></font></font><font style="left: 35.68pt; position: absolute;">(6,105)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 313.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(4,357)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 325.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 38.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash used in investing activities <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 183.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 185.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 185.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 186.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 186.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 186.06pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 325.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.05pt;"></font></font><font style="left: 35.68pt; position: absolute;">(6,105)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 325.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(4,357)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 8.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 345.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash flows from financing activities<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 357.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.21pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Proceeds from issuance of Series F redeemable convertible preferred shares, net of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.01pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 23.63pt; position: absolute; text-decoration: none; white-space: pre;">issuance costs<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 82.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 82.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 82.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 82.86pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 357.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.04pt;"></font></font><font style="left: 28.669999999999998pt; position: absolute;">168,957<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 357.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 381.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Proceeds from exercise of stock options<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 174.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 176.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 176.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 177.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 177.06pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 381.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 43.54pt;"></font></font><font style="left: 46.17pt; position: absolute;">589<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 381.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">4,564<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 393.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Payments of exit, prepayment penalty and lender fees<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 229.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 230.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 231.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 231.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 231.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 231.21pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 393.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.54pt;"></font></font><font style="left: 52.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 393.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 33.39pt;"></font></font><font style="left: 36.02pt; position: absolute;">(2,327)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 406.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Repurchase of common stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 133.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 135.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 406.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.55pt;"></font></font><font style="left: 43.18pt; position: absolute;">(228)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 406.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 49.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 418.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 38.63pt; position: absolute; text-decoration: none; white-space: pre;">Net cash provided by financing activities <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 201.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 203.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 203.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 204.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 204.06pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 418.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.04pt;"></font></font><font style="left: 28.669999999999998pt; position: absolute;">169,318<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 418.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 36.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">2,237<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 430.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Effect of foreign exchange rates<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 129.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 132.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 132.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 132.09pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 430.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.55pt;"></font></font><font style="left: 43.18pt; position: absolute;">(504)<font style="display: inline-block; height: 6.55pt; width: 0.34pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 430.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 43.52pt; position: absolute;">(271)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 442.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net increase (decrease) in cash, cash equivalents and restricted cash<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 280.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 280.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 280.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 280.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 280.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 442.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.04pt;"></font></font><font style="left: 33.67pt; position: absolute;">86,275<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 442.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 28.39pt;"></font></font><font style="left: 31.02pt; position: absolute;">(71,392)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 454.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance, beginning of period<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 128.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.89000000000001pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 131.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 131.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 131.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 132.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 132.02pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 454.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 31.04pt;"></font></font><font style="left: 33.67pt; position: absolute;">40,959<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 454.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 29.009999999999998pt; position: absolute;">127,234<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 466.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance, end of period<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 104.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 105.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 105.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 105.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 105.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 466.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 21.04pt;"></font></font><font style="left: 28.669999999999998pt; position: absolute;">127,234<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 466.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">55,842<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 478.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Supplemental disclosure of cash flow information&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 490.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash paid (refunded) for taxes<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 136.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 136.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 490.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 38.54pt;"></font></font><font style="left: 46.17pt; position: absolute;">405<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 490.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 40.89pt;"></font></font><font style="left: 48.52pt; position: absolute;">(72)<font style="display: inline-block; height: 6.55pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 502.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash paid for interest<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 100.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 100.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 100.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 100.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 100.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 100.81pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 502.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.04pt;"></font></font><font style="left: 33.67pt; position: absolute;">20,800<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 502.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.38pt;"></font></font><font style="left: 34.01pt; position: absolute;">19,163<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 514.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Supplemental disclosure of non-cash investing and financing activities&#58;<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 12pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 526.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Purchases of property and equipment included in accounts payable<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 282.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 284.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 285pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 285.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 285.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 285.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 526.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 38.54pt;"></font></font><font style="left: 46.17pt; position: absolute;">808<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 526.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 44.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 538.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.71pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Derecognition of derivative liability in connection with debt refinancing<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 290.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 293.25pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 293.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 293.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 294.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 294.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 294.05pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 538.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 44.54pt;"></font></font><font style="left: 52.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 538.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 31.38pt;"></font></font><font style="left: 39.010000000000005pt; position: absolute;">1,125<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 551.25pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Right-of-use asset obtained in exchange for lease obligation<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 253.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 253.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 253.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 253.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 551.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 44.54pt;"></font></font><font style="left: 52.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 551.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 38.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">579<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 564pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.76pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Unpaid deferred offering costs<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 134.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 136.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 136.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 564pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 44.54pt;"></font></font><font style="left: 52.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 564pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 38.88pt;"></font></font><font style="left: 46.510000000000005pt; position: absolute;">413<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 576.75pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Reduction in right-of-use asset and lease obligation due to amendment in lease terms<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 354.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 356.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 356.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 356.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 357.14pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 576.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 31.04pt;"></font></font><font style="left: 38.67pt; position: absolute;">1,776<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 576.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 44.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 589.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 360pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of redeemable convertible preferred stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 324.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 325.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 325.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 325.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 325.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . .<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 589.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.04pt;"></font></font><font style="left: 33.67pt; position: absolute;">26,794<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 589.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.63pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 44.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 601.5pt; width: 360pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 360pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Conversion of convertible note into Series F-1 redeemable convertible preferred stock<font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 355.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 356.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 357.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 360pt; position: absolute; top: 601.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 26.04pt;"></font></font><font style="left: 33.67pt; position: absolute;">61,186<font style="display: inline-block; height: 6.55pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 428.25pt; position: absolute; top: 601.5pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 6.55pt; width: 44.88pt;"></font></font><font style="left: 52.510000000000005pt; position: absolute;">&#8212;<font style="display: inline-block; height: 6.55pt; width: 2.99pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 6.55pt; position: absolute; top: 725.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: italic; font-weight: normal; left: 130.82pt; position: absolute; text-decoration: none; white-space: pre;">The accompanying notes are an integral part of these consolidated financial statements.<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-7<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_129" style="position: absolute; top: 90pt;"></div><div style="line-height: 0.72pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 1pt; font-style: normal; font-weight: normal; left: 306pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 0.72pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_161" style="position: absolute; top: 91.2pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 91.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">1. Business Overview<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 113.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Description of Business<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 133.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware in July 2007 as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 145.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. On March 1, 2021, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 157.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company completed an internal reorganization in which a newly formed parent holding company, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 169.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">HeartFlow Holding, Inc., was established. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 189.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company is a <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 155.87pt; position: absolute; text-decoration: none; white-space: pre;">commercial-stage<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.76pt; position: absolute; white-space: pre;"> medical technology company that has pioneered the use of software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 201.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease (&#8220;CAD&#8221;). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 213.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s novel HeartFlow Platform uses AI<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 292.31pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.08000000000004pt; position: absolute; white-space: pre;">and advanced computational fluid dynamics to create a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 225.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">personalized 3D model of a patient&#8217;s heart based off a single coronary computed tomography <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 237.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">angiography (&#8220;CCTA&#8221;). This results in actionable data on blood flow, stenosis, plaque volume and plaque <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 249.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">composition.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 128.11pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> The Company&#8217;s HeartFlow FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 271.02pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT </font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 281.37pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis and Plaque Analysis software assists physicians </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 261.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">in diagnosing, managing and delivering precision care to patients with CAD.</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 406.42pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 409.01pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">The Company was awarded </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 273.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Conformit&#233; Europ&#233;ene Mark (&#8220;CE Mark&#8221;) for its HeartFlow FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 350.2pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT </font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.55pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis in July 2011. Th</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 470.16pt; position: absolute; text-decoration: none; white-space: pre;">e Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 285.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">received clearance from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) in November 2014 for its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 297.6pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">HeartFlow FFR</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 139.73000000000002pt; position: absolute; text-decoration: none; top: 2.548pt; vertical-align: sub; white-space: pre;"><font style="background-color: inherit;">CT </font><font style="display: inline-block; height: 4.732pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 150.07999999999998pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Analysis and in October 2022 for its Plaque Analysis</font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 381.15pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s United States (&#8220;U.S.&#8221;) headquarters is located in Mountain View, California, and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company also has offices in Santa Rosa, California, Austin, Texas, and Tokyo, Japan. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 349.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company had the following wholly-owned subsidiaries as of December 31, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 424.2pt; position: absolute; text-decoration: none; white-space: pre;">2024&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 369.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 234pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 234pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 234pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 91.02pt; position: absolute; text-decoration: none; white-space: pre;">Entity Name<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 0pt; width: 234pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 64.07pt; position: absolute; text-decoration: none; white-space: pre;">Country of Incorporation<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 69.25999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 70.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 71.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 71.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.17999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 12.75pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United States<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Japan G.K.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 100.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 101.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 101.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 101.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 101.33999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 27pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Japan<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow U.K. Ltd<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 87.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 89.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 90.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 90.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 90.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 90.94999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 41.25pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Technology U.K. Limited<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 158.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 160.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 160.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 161.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 161.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 234pt; position: absolute; top: 55.5pt; width: 234pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 234pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 455.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Effective July 2024, HeartFlow International Sarl, a wholly-owned subsidiary in Switzerland, was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 467.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dissolved.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidity<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has incurred operating losses and negative cash flows from operations since its inception <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 519.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and has an accumulated deficit of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 223.65pt; position: absolute; text-decoration: none; white-space: pre;">$874.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.22pt; position: absolute; white-space: pre;"> million and $971.0 million as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.41pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 484.2pt; position: absolute; white-space: pre;"> and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively. The Company expects to incur losses for the foreseeable future. Historically, the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 543.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">activities have been financed through sales of shares of redeemable convertible preferred stock, common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 555.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock and convertible promissory notes, borrowings under term loans and revenue received from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 567.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 587.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Management believes that the Company&#8217;s existing unrestricted cash and cash equivalents of $51.4 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 599.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million as of December 31, 2024, the expected cash generated from revenues along with the $75.4 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 611.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in cash proceeds from the convertible promissory notes issued in January and March 2025 (see Note 18) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will provide sufficient funds to allow the Company to continue its planned operations for at least the next <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">12 months from the date of the issuance of these consolidated financial statements. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_403" style="position: absolute; top: 655.35pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 655.35pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2. Summary of Significant Accounting Policies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Basis of Presentation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 697.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The accompanying consolidated financial statements include the accounts of the Company as well as its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 709.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">wholly owned subsidiaries and have been prepared in accordance with accounting principles generally <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-8<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accepted in the United States of America (&#8220;U.S. GAAP&#8221;). All significant intercompany balances and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions have been eliminated in consolidation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Reclassification of Prior Period Presentation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Certain prior year amounts have been reclassified for consistency with the current year presentation.&#160; A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reclassification was made to the Consolidated Statements of Cash Flows for the year ended December <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">31, 2023 to identify non-cash interest charges of $865,000. This change in classification does not affect <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">previously reported cash flows from operating activities in the Consolidated Statements of Cash Flows <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and had no effect on the reported results of operations.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Use of Estimates<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The preparation of financial statements in conformity with U.S. GAAP requires management to make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates and assumptions that affect the amounts reported in the financial statements and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accompanying notes. Management used significant judgement when making estimates in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determination of the fair value of its common stock and stock options, deferred income tax valuation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allowance, capitalized internal-use software, depreciation of property and equipment, allowance for credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">losses, revenue recognition, valuation of operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities, and the fair value of convertible debt, warrants to purchase common stock and embedded <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivatives. Management evaluates its estimates and assumptions on an ongoing basis using historical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience and other factors and adjusts those estimates and assumptions as facts and circumstances <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">dictate. Actual results could materially differ from those estimates.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Segment <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 116.97pt; position: absolute; text-decoration: none; white-space: pre;">Information<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company operates and manages its business as one reportable and operating segment, which is the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">business of non-invasive coronary artery disease detection solutions. The Company&#8217;s Chief Executive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Officer, who is the Chief Operating Decision Maker (&#8220;CODM&#8221;), reviews financial information, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue and net loss, presented on a consolidated basis for purposes of making operating decisions, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocating resources and evaluating financial performance. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company's measure of segment profit or loss is consolidated net loss, which is used by the CODM to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">measure actual results versus expectations, set performance metrics, and develop the annual budget to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">achieve the Company&#8217;s long-term objectives. Significant segment expenses within consolidated net loss <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">includes cost of revenue, research and development, and selling, general and administrative expenses, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which are each separately presented on the Company&#8217;s consolidated statements of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive loss. Other expense items that are presented on the consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations include interest income, interest expense, changes in fair value of warrant liability, other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income, net, and provision for income taxes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table is representative of the significant expense categories regularly provided to the CODM <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">when managing the Company&#8217;s single reporting segment and includes a reconciliation to the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 574pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">net loss shown in the consolidated statements of operations and comprehensive loss for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023 and 2024 (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.5pt; position: absolute; text-decoration: none; white-space: pre;">F-9<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="position: absolute; top: 90pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 42.650000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 44.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 46.120000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 46.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 46.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.470000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Less<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 23.75pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.68pt; position: absolute; text-decoration: none; white-space: pre;">&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 85.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 86.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">29,123<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">31,359<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 148.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 151.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 151.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 151.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 151.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.59pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">22,330<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">25,983<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Regulatory and clinical<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 127.19pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 129.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 131.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.39000000000001pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.43pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">13,524<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">17,534<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative expenses&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 125.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Sales<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 51.629999999999995pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 51.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.86pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">53,374<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">66,895<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 139.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">Marketing<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 70.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 71.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 71.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 71.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.75pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,949<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">14,470<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.63pt; position: absolute; text-decoration: none; white-space: pre;">General and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 146.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 146.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">31,788<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">30,789<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 168pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Loss from operations<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 96.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(72,914)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 168pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(61,222)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 182.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 141.28pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(2)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 149.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 151.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 151.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.62pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(22,194)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 182.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(35,151)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 196.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.87pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(547)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 196.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(53)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 210.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Segment net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 79.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 81.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 81.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 81.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 210.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 210.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 323pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 332pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(2)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Other income (expense), net represents the consolidated amounts for interest income, interest expense, change in fair value of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 341pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible note, change in fair value of common stock warrant liability, change in fair value of derivative liability and other income, net <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">as shown on the consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 367pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company derives revenue and has long-lived assets primarily in the United States of America. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 379pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue by geography is further described in Note 3.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 399pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cash, Cash Equivalents and Restricted Cash<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 419pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company considers all highly liquid investments that are readily convertible to known amounts of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 431pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash and purchased with an original maturity of three months or less to be cash equivalents. Cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 443pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalents consist primarily of amounts invested in money market accounts. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 463pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table provides a reconciliation of cash, cash equivalents and restricted cash within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 475pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated balance sheets to the total shown in the consolidated statements of cash flows (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 487pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 507pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cash and cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 122.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 124.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 126.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 126.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 126.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">122,767<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">51,367<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Restricted cash<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 71.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 71.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,467<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,475<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total cash, cash equivalents and restricted cash<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 214.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 216pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 216.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 216.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 216.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">127,234<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">55,842<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 591.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2023 and 2024, restricted cash represents deposits held as security in connection <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 603.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the Company&#8217;s facility lease agreements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 623.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Fair Value of Financial Instruments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 643.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is an exit price, representing the amount that would be received to sell an asset or paid to transfer a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 667.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability in an orderly transaction between market participants. As such, fair value is a market-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 679.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">measurement that should be determined based on assumptions that market participants would use in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 691.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing an asset or a liability.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-10<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company discloses and recognizes the fair value of its assets and liabilities using a hierarchy that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">priority to valuations based upon unadjusted quoted prices in active markets for identical assets or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that are significant to the valuation (Level 3 measurements). The accounting guidance establishes three <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">levels of the fair value hierarchy as follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level 1 -<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.33pt; position: absolute; white-space: pre;"> Observable inputs, such as quoted prices in active markets for identical assets or liabilities&#59; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level 2 -<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.33pt; position: absolute; white-space: pre;"> Observable inputs other than Level 1 prices, such as quoted prices for similar assets or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corroborated by observable market data for substantially the full term of the assets or liabilities&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Level 3 -<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 110.33pt; position: absolute; white-space: pre;"> Unobservable inputs that are supported by little or no market activity and that are significant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fair value of the assets or liabilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">particular input to the fair value measurement in its entirety requires management to make judgments and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">considers factors specific to the asset or liability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; white-space: pre;"> and 2024, the carrying amounts of the Company&#8217;s financial instruments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value due to their relatively short maturities and market interest rates, if applicable. Management believes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">that the Company&#8217;s Term Loan bears interest at the prevailing market rates for instruments with similar <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">characteristics&#59; accordingly, the carrying value of this instrument approximates its fair value. Fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounting is applied to the convertible notes, common stock warrant liability and derivative liability. No <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible notes or derivative liability were outstanding as of December 31, 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Concentration of Credit Risk and Significant Customers<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equivalents, restricted cash and accounts receivable. The Company maintains bank deposits in federally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">insured financial institutions and these deposits may at times exceed federally insured limits. To date, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company has not experienced any losses on its cash deposits. The Company currently has full control of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its cash and cash equivalents balance. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 10, 2023, Silicon Valley Bank (&#8220;SVB&#8221;) was closed by the California Department of Financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">receiver. On March 13, 2023, the FDIC announced that it had transferred all insured and uninsured <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deposits and substantially all assets of SVB to a newly created, full-service FDIC-operated &#8220;bridge bank&#8221; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">called Silicon Valley Bridge Bank, N.A. (&#8220;SVBB&#8221;), where depositors would have full access to their money <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately. On March 27, 2023, First Citizens BancShares, Inc. (&#8220;First Citizens Bank&#8221;) acquired SVBB <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">from the FDIC and operated SVBB as Silicon Valley Bank, a division of First Citizens Bank. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">successfully transferred all funds to another financial institution and did not incur any losses on its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deposits as a result of SVB&#8217;s closure.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No single customer represented more than 10% of the Company&#8217;s revenue during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No single customer represented more than 10% of the Company&#8217;s accounts receivable as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 662pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 296.09pt; position: absolute; text-decoration: none; white-space: pre;">F-11<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Accounts Receivable<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company performs ongoing credit evaluations of its customers&#8217; financial conditions and generally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">extends credit to customers without requiring collateral. Accounts receivable are recorded at the amounts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">billed less estimated allowances for credit losses for any potential uncollectible amounts. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">continually monitors customer payments and maintains an allowance for estimated losses resulting from a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customer&#8217;s inability to make required payments. The Company considers factors such as historical <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">experience, credit quality, age of the accounts receivable balances, geographic related risks and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">economic conditions that may affect a customer&#8217;s ability to pay. Accounts receivable are written-off and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">charged against an allowance for credit losses when the Company has exhausted collection efforts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.43pt; position: absolute; text-decoration: none; white-space: pre;">success<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 142.55pt; position: absolute; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Property and Equipment<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Property and equipment are stated at cost less accumulated depreciation or amortization. Depreciation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and amortization is computed using the straight-line method over the estimated useful lives of assets, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which generally ranges from two to five years. Leasehold improvements are amortized over the lesser of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">their useful life or the remaining life of the lease. Upon sale or retirement of assets, the cost and related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in results from operations in the period realized. Maintenance and repairs are expensed as incurred.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Impairment of Long-Lived Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company reviews its long-lived assets, including property and equipment, for impairment at least <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">annually and whenever events or changes in circumstances indicate that the carrying amount of an asset <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may not be recoverable. When factors indicate that long-lived assets should be evaluated for possible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">impairment, the Company uses an estimate of the related undiscounted future cash flows over the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remaining useful life of the long-lived assets in measuring whether they are recoverable. If the carrying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of the asset exceeds the estimated undiscounted future cash flows, a loss is recorded as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">excess of the asset&#8217;s carrying value over its fair value. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.41999999999996pt; position: absolute; text-decoration: none; white-space: pre;">No<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.2pt; position: absolute; white-space: pre;"> assets were determined to be impaired during <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.45pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.24pt; position: absolute; white-space: pre;"> and 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Deferred Offering Costs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company capitalizes certain legal, accounting and other third-party fees that are directly associated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with in-process equity financings as deferred offering costs until such financings are consummated. After <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consummation of the equity financing, these costs are recorded as a reduction of the proceeds from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering, either as a reduction of the carrying value of preferred stock or in stockholders&#8217; deficit as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reduction of additional paid-in capital generated as a result of the offering. Should the in-process equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financing be abandoned, the deferred offering costs would be expensed immediately as a charge to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating expenses in the consolidated statements of operations and comprehensive loss. No deferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">offering costs were capitalized as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 232.89pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 320.68pt; position: absolute; white-space: pre;">. As of December 31, 2024, deferred offering <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs of $413,000 were capitalized within other non-current assets in the consolidated balance sheets.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Internal-Use Software<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company capitalizes certain costs related to internal-use software during the application <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development stage. Costs related to planning and post implementation activities are expensed as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">incurred. Capitalized internal-use software is amortized on a straight-line basis over the estimated useful <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">life, which is generally two years, after the product is deployed and ready for use. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or changes in circumstances occur that could impact the recoverability of these assets. Capitalized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal-use software costs are classified as a component of property and equipment, net.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-12<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Leases<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">At the inception of a contractual arrangement, the Company determines whether the contract contains a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lease by assessing whether there is an identified asset and whether the contract conveys the right to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">control the use of the identified asset in exchange for consideration over a period of time.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">An <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.99pt; position: absolute; text-decoration: none; white-space: pre;">ROU<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.2pt; position: absolute; white-space: pre;"> asset and corresponding lease liability are recorded on the consolidated balance sheets based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the present value of lease payments over the lease term. An ROU asset represents the right to control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the use of an identified asset over the lease term and a lease liability represents the obligation to make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lease payments arising from the lease. Leases with an initial term of 12 months or less are not recorded <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in the consolidated balance sheets. The Company uses its incremental borrowing rate to determine the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">present value of lease payments, as the discount rate implicit in the lease is not readily available. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lease terms used to calculate the ROU asset and related lease liabilities include options to extend or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminate the lease when it is reasonably certain that the Company will exercise that option. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company elected to account for contracts that contain lease and non-lease components as a single lease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">component. For the years ended December 31, 2023 and 2024, the Company&#8217;s only leases were for its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">facilities, which are classified as operating leases with lease expense recognized on a straight-line basis <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">over the lease term. Variable lease costs, which primarily consist of common area maintenance, taxes, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and utility charges are expensed as incurred. The Company does not have any finance leases.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Term Loan is accounted for at amortized cost. Original debt issuance costs are deferred and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">presented as a reduction to the carrying value of the Term Loan. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.89pt; position: absolute; white-space: pre;">Debt discount and debt issuance costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are amortized using the effective interest method and recorded in interest expense within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated statements of operations and comprehensive loss. Refer to Note 8 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company issued Convertible Notes from September 2022 to December 2022, which were all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">converted to Series F-1 redeemable convertible preferred stock in March 2023. Refer to Notes 9 and 10 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for additional information. The Convertible Notes contained embedded features that provided the Note <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Investors with multiple settlement alternatives. Rather than accounting for the embedded features that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">qualified as derivatives separately, the Company elected to account for the Convertible Notes at fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each reporting period. Debt issuance costs were expensed as incurred. Until their conversion in March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2023, the Company recognized the changes in fair value (including interest) as change in fair value of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible note within the consolidated statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Common Stock Warrants<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s warrants to purchase common stock that were issued in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.13pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do not meet the equity indexation criteria and are classified as a liability. The warrants are recorded at fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value upon issuance and are subject to remeasurement to fair value at each balance sheet date, with any <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes in fair value recognized as change in fair value of common stock warrant within the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 586pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss. Refer to Note 12 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Embedded Derivative<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to its refinancing in June 2024, the Term Loan contained certain prepayment features, default put <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option and default interest adjustment features that were determined to be embedded derivatives <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">requiring bifurcation and separate accounting as a single compound derivative, as discussed in Note 13. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The impact of bifurcation of the embedded derivative on the date of issuance was reflected as a debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discount. The fair value of the derivative liability related to the Company&#8217;s Term Loan, as discussed in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Note 8, was estimated using a scenario-based analysis comparing the probability-weighted present value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the Term Loan payoff at maturity with and without the bifurcated features. This method isolates the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of the embedded derivative by measuring the difference in the host contract&#8217;s value with and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-13<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without the isolated features. The resulting cash flows are discounted at the Company&#8217;s borrowing rate, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as adjusted for fluctuations in the market interest rate from the inception of the Company&#8217;s comparative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">borrowings to the reporting date, to measure the fair value of the embedded derivative. Until its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derecognition in June 2024, t<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 200.34pt; position: absolute; text-decoration: none; white-space: pre;">he derivative liability was remeasured to fair value at each reporting period <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">and the related change was reflected as change in fair value of derivative liability on the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">statements of operations and comprehensive loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable Convertible Preferred Stock<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company records redeemable convertible preferred stock at fair value on the dates of issuance, net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of issuance costs. The redeemable convertible preferred stock is recorded outside of stockholders&#8217; deficit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">because the preferred shares are contingently redeemable upon the occurrence of an event that is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outside of the Company&#8217;s control. The Company has elected not to adjust the carrying values of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock to the liquidation preferences of such shares because it is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">uncertain whether or when an event would occur that would obligate the Company to pay the liquidation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferences to holders of shares of redeemable convertible preferred stock. Subsequent adjustments to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the carrying values to the liquidation preferences will be made only when it becomes probable that such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liquidation event will occur. The redemption value of each series of redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 298pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock is equal to their respective original issue price plus accrued but unpaid dividends on Series C <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred shares and all declared but unpaid dividends (if any) for other series of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred shares. In connection with the Series F redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock financing, the cumulative dividends payable to holders of Series&#160;C redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock upon a liquidation event were capped from $6.66 to $8.25 per share depending on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time of issuance, with an aggregate total of $88.5 million as of December 31, 2023 and 2024. Refer to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Note 10 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Revenue <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 116.43pt; position: absolute; text-decoration: none; white-space: pre;">Recognition<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Compa<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.22pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">ny sells its </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 173.07999999999998pt; position: absolute; white-space: pre;">HeartFlow Platform<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 258.59000000000003pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> to medical providers in the United States and in select </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">international markets. </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 170.13pt; position: absolute; white-space: pre;">The Company determines revenue recognition through the following steps&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Identification of the contract, or contracts, with a customer&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Identification of the performance obligations in the contract&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Determination of the transaction price&#59;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Allocation of the transaction price to the performance obligations in the contract&#59; and<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#8226;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Recognition of revenue when, or as, the Company satisfies a performance obligation.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company identified a single performance obligation, which is comprised of a highly interdependent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bundle of goods or services that are not distinct on their own but are as a group and consists of providing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implementation services and the requested analysis, including an image file and related licenses and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">support. Revenue recognition commences only after completion of installation, implementation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">training for new customer accounts. The Company&#8217;s service consists of providing a visualization of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">patient&#8217;s coronary arteries and enables physicians to create more effective treatment plans. This service <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">is normally billable upon delivery of the analysis to the physician. Payment terms are generally net 30 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">days.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">Substantially all of the </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.95999999999998pt; position: absolute; white-space: pre;">Company&#8217;s revenue is from usage-driven fees and generated on<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 456.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;"> a &#8220;pay per click&#8221; </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">basis </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 98.11pt; position: absolute; white-space: pre;">each time a physician <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.99pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">orders the Company&#8217;s HeartFlow </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 345.67pt; position: absolute; white-space: pre;">FFR<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 365.09pt; position: absolute; top: 2.548pt; vertical-align: sub; white-space: pre;">CT<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.75pt; position: absolute; white-space: pre;"> Analysis and Plaque Analysis. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 670pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company also derives revenue from <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 235.33pt; position: absolute; text-decoration: none; white-space: pre;">subscription fees from customers accessing the Company&#8217;s hosted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 682pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">software service during the subscription period. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 283.64pt; position: absolute; white-space: pre;">During the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 390.31pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 478.1pt; position: absolute; white-space: pre;"> and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-14<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">98.1% and 98.8% of revenue was from usage-driven fees, respectively, and the remainder was from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subscription fees.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue is recognized when control of these services is transferred to the customer, at an amount that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reflects the consideration the Company expects to be entitled to receive in exchange for those services. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company recognizes usage-driven fee revenue <font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 304.8pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">upon delivery of the requested analysis to the </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">physician, which is when </font><font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.20999999999998pt; position: absolute; white-space: pre;">control of these services is transferred to the customer. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognizes revenue on a straight-line basis over the contract term for subscriptions where the customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pays a fixed amount upfront for unlimited analyses. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.28999999999996pt; position: absolute; text-decoration: none; white-space: pre;">Contracts with customers typically include a fixed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">amount of consideration and are generally cancellable with <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 334.78pt; position: absolute; text-decoration: none; white-space: pre;">30 days&#8217;<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.64pt; position: absolute; text-decoration: none; white-space: pre;"> written notice<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 433.28pt; position: absolute; text-decoration: none; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The transaction price consists of fixed consideration and variable consideration related to utilization and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">volume rebates for reimbursement claims from government and commercial payers which are known and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determinable based on the number of analyses delivered within each quarterly period. The transaction <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">price (inclusive of both fixed consideration and variable consideration that is not constrained) is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized as revenue when control transfers. The Company uses a portfolio approach to estimate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">variable consideration using the expected value method. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Unbilled Receivables<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unbilled receivables generally represent revenue in which the Company has satisfied its performance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligation prior to invoicing. The Company records unbilled receivables within accounts receivable, net on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the consolidated balance sheets, based on the Company&#8217;s unconditional right to payment at the end of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the applicable period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contract Costs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Costs associated with product revenue include a flat rate commission per analysis and new customer site <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commissions as well as implementation and onboarding costs. The Company capitalizes new customer <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">site commissions and certain implementation and onboarding costs that are considered to be incremental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the acquisition of new customer contracts.&#160; Capitalized implementation and onboarding costs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortized over an estimated period of benefit of two years and capitalized new site commission costs are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortized over an estimated period of benefit of three years. The estimated period of benefit is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined by evaluating average customer life, the nature of the related benefit, and the specific facts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and circumstances of its arrangements. The Company evaluates these assumptions at least annually and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 486pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">periodically reviews whether events or changes in circumstances have occurred that could impact the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 498pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period of benefit.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company expenses flat rate commissions when incurred as commensurate with its usage-driven fee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revenue recognition and amortizes capitalized new customer site commissions to selling, general and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">administrative expense in the consolidated statements of operations and comprehensive loss. During the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">year ended December 31, 2023, new site commission costs were not capitalized as the amount was not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material. The Company amortizes capitalized implementation and onboarding costs to cost of revenue in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the consolidated statements of operations and comprehensive loss. Short-term capitalized contract costs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are included in prepaid expenses and other current assets and the long-term portion is included in <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 506.99pt; position: absolute; text-decoration: none; white-space: pre;">other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 602pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">non-current assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.78pt; position: absolute; white-space: pre;"> in the consolidated balance sheets.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Remaining Performance Obligations<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenue allocated to remaining performance obligations represents the transaction price allocated to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">performance obligations that are unsatisfied, or partially unsatisfied. It includes contract liabilities and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amounts that will be invoiced and recognized as revenue in future periods and does not include contracts <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">where the customer is not committed. The customer is not considered committed when they are able to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">terminate for convenience without payment of a substantive penalty under the contract. Additionally, as a <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-15<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">practical expedient, the Company has not disclosed the value of unsatisfied performance obligations for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">contracts with an original expected length of one year or less.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contract Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company records contract liabilities when billings or payments are received in advance of revenue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognition from subscription services. The contract liabilities balance is reduced as the revenue <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognition criteria are met, generally within 12 months. Once services are available to customers, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company records amounts due in accounts receivable, net and contract liabilities within accrued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expenses and other current liabilities on the consolidated balance sheets. To the extent the Company bills <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">customers in advance of the billing period commencement date, the accounts receivable and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">corresponding contract liabilities amount are netted to zero on the consolidated balance sheets, unless <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">such amounts have been paid as of the balance sheet date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Cost of Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cost of revenue includes, but is not limited to, personnel and related expenses, stock-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation costs, third-party hosting fees, amortization of capitalized internal-use software, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amortization of contract fulfillment costs as well as royalties associated with technology licenses used in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with the delivery of the Company&#8217;s HeartFlow Platform and allocated overhead, including rent, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">equipment, depreciation, technology services and utilities, related to the Company&#8217;s production team. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">role of the production team is to support the Company&#8217;s patient case volume revenue by performing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 338pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defined quality-related activities on CCTA scans submitted by its customers for analysis. The production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 350pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">team also supports activities in the Company&#8217;s clinical trials and research and development, which are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocated as research and development expense.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Research and Development<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Costs related to research, design, development, clinical studies, regulatory activities, and medical affairs <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are charged to research and development and are expensed as incurred. These costs include, but are not <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limited to, personnel and related expenses, clinical trials, stock-based compensation costs, third-party <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 438pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consulting costs, the portion of the costs incurred by the production team to support clinical trials and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 450pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">research and development efforts, and allocated overhead, including rent, equipment, depreciation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">utilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Clinical Trials <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company accrues and expenses costs for its clinical trial activities performed by third parties, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including clinical research organizations and other service providers, based upon estimates of the work <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completed over the life of the individual study in accordance with associated agreements. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determines these estimates through discussion with internal personnel and outside service providers as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to progress or stage of completion of trials or services pursuant to contracts with clinical research <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">organizations and other service providers and the agreed-upon fee to be paid for such services. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Advertising Costs<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company expenses advertising costs as incurred. Advertising costs includes design and production <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">costs, including website development, testimonial videos, written media campaigns and other items. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Advertising costs of $778,000 and $1,538,000 was expensed during the years ended December 31, 2023 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and 2024, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock-Based Compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company accounts for share-based payments at fair value. The grant date fair value of options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted is measured using the Black-Scholes option pricing model. Option awards vest based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">satisfaction of a service requirement and stock-based compensation expense is recorded on a straight-<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-16<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">line basis over the applicable service period, which is generally four years. For performance-based stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options, the Company will assess the probability of performance conditions being achieved in each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting period. The amount of stock-based compensation expense recognized in any one period related <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to performance-based stock options can vary based on the achievement or anticipated achievement of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the performance conditions. Forfeitures are recognized in the period in which the forfeiture occurs.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Income Taxes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company accounts for income taxes under the asset and liability method. Under this method, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deferred tax assets and liabilities are determined based on the temporary differences between the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">which the differences are expected to reverse. As a result of the history of net operating losses, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company has provided for a full valuation allowance against the deferred tax assets for assets that are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">not more-likely-than-not to be realized.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company applies a comprehensive model for the recognition, measurement, presentation and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosure in the consolidated financial statements of any uncertain tax positions that have been taken or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected to be taken on a tax return using a two-step approach. The first step is to evaluate the tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">position taken or expected to be taken in a tax return by determining if the weight of available evidence <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indicates that it is more likely than not that the tax position will be sustained upon examination by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">relevant taxing authorities, based on the technical merits of the position. For tax positions that are more <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">likely than not to be sustained upon audit, the second step is to measure the tax benefit in the financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements as the largest benefit that has a greater than 50% likelihood of being sustained upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settlement. Significant judgment is required to evaluate uncertain tax positions. Changes in facts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances could have a material impact on the Company&#8217;s effective tax rate and results of operations. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">component of provision for income taxes in the consolidated statements of operations and comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">loss.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Comprehensive Loss<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Comprehensive loss is comprised of net loss and foreign currency translation loss. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 462pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Foreign Currency <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 482pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The functional currency of the Company&#8217;s f<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 261.78pt; position: absolute; text-decoration: none; white-space: pre;">oreign subsidiaries is the local currency except for<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 482.87pt; position: absolute; white-space: pre;"> HeartFlow <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">International Sarl, which was the U.S. Dollar. For all non-functional currency balances, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remeasurement of such balances to the functional currency results in either a foreign exchange <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transaction gain or loss, which is recorded within other income, net within the consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 530pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and comprehensive loss. The Company recognized foreign exchange transaction losses of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$172<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;">,000 and $269,000 during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 285.38pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 373.17pt; position: absolute; white-space: pre;"> and 2024, respectively. During the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">years ended December 31, 2023 and 2024, the Company recognized $504,000 and $271,000 of foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">currency translation loss, respectively, in the statements of comprehensive loss related to foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subsidiaries which have local functional currencies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Net Loss Per Share Attributable to Common Stockholders<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Basic net loss per common share is calculated by dividing the net loss attributable to common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stockholders by the weighted-average&#160;number of shares of common stock outstanding during the period, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the net loss attributable to common stockholders by the weighted-average number of shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share calculation, the redeemable convertible preferred stock, common stock warrants and stock options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">are considered to be potentially dilutive securities.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-17<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Basic and diluted net loss attributable to common stockholders per share is presented in conformity with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the two-class&#160;method required for participating securities as the redeemable convertible preferred stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and common stock subject to repurchase are considered participating securities. The Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">participating securities do not have a contractual obligation to share in the Company&#8217;s losses. As such, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the net loss is attributed entirely to common stockholders. Diluted net loss per share is the same as basic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net loss per share because the effects of potentially dilutive items were anti-dilutive given the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net loss position during the years ended December 31, 2023 and 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 8.73pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recent Accounting Pronouncements<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Board (&#8220;FASB&#8221;) or other standard setting bodies and adopted by the Company as of the specified <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">effective date. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Business Startups Act of 2012 and has elected not to &#8220;opt out&#8221; of the extended transition related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">complying with new or revised accounting standards, which means that when a standard is issued or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">revised and it has different application dates for public and nonpublic companies, the Company will adopt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 276.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the new or revised standard at the time nonpublic companies adopt the new or revised standard and will <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">do so until such time that the Company either i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period or ii)&#160;no longer qualifies as an emerging growth company. The Company may choose to early <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adopt any new or revised accounting standards whenever such early adoption is permitted for nonpublic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">companies.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 344.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recently Adopted Accounting Pronouncements<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In August 2020, the FASB issued Account Standards Update (&#8220;ASU&#8221;) 2020-06, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 421.36pt; position: absolute; white-space: pre;">Debt-Debt with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Equity (Subtopic 815-40)&#58; Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Equity<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.77pt; position: absolute; white-space: pre;">. The amendment simplifies the accounting for certain financial instruments with characteristics of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. The new <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">standard requires entities to provide expanded disclosures about the terms and features of convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">instruments, how the instruments have been reported in the entity&#8217;s financial statements, and information <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about events, conditions, and circumstances that can affect how to assess the amount or timing of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entity&#8217;s future cash flows related to those instruments. On January 1, 2024, the Company adopted ASU <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2020-06, which had an immaterial impact on its financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In November 2023, the FASB issued ASU 2023-07, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 301.39pt; position: absolute; white-space: pre;">Segment Reporting (Topic 280)&#58; Improvements to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Reportable Segment Disclosures<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 218.11pt; position: absolute; white-space: pre;">. The amendment expands segment disclosures by requiring disclosure <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of significant segment expenses that are regularly provided to the chief operating decision maker <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;CODM&#8221;), the amount and description of other segment items, permits companies to disclose more than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">one measure of segment profit or loss, and requires all annual segment disclosures to be included in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interim periods. The amendments do not change how an entity identifies its operating segments, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">aggregates those operating segments, or applies quantitative thresholds to determine its reportable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">segments. During the year ended December 31, 2024, the Company adopted ASU 2023-07, which had a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 588.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosure only impact on its financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Recent Accounting Pronouncements Not Yet Adopted<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In December 2023, the FASB issued ASU 2023-09, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 301.39pt; position: absolute; white-space: pre;">Income Taxes (Topic 740)&#58; Improvements to Income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Tax Disclosures<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.1pt; position: absolute; white-space: pre;">, which requires enhanced income tax disclosures, including specific categories and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disaggregation of information in the effective tax rate reconciliation, disaggregated information related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income taxes paid, income or loss from continuing operations before income tax expense or benefit, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 676.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">income tax expense or benefit from continuing operations. This guidance is effective for annual periods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 688.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">beginning after December 15, 2024, with early adoption permitted. The Company is currently in the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-18<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">process of evaluating the impact of this pronouncement on the disclosures in its consolidated financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In November 2024, the FASB issued ASU 2024-03, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 301.39pt; position: absolute; white-space: pre;">Income Statement &#8211; Reporting Comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40)&#58; Disaggregation of Income Statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115.9pt; position: absolute; white-space: pre;">, which requires more detailed disclosures about specified categories of expenses (including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee compensation, depreciation, and amortization) included in certain expense captions presented <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">on the face of the income statement. This ASU is effective for fiscal years beginning after December 15, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2026, and for interim periods within fiscal years beginning after December 15, 2027, with early adoption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">permitted. The amendments may be applied either (i) prospectively to financial statements issued for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reporting periods after the effective date of this ASU or (ii) retrospectively to all prior periods presented in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the financial statements. The Company is currently evaluating the impact of this pronouncement on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">disclosures in its consolidated financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_388" style="position: absolute; top: 250pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">3. Revenue and Contract Balances<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 272.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Disaggregation of Revenue<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes total revenue from customers by geographic region (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 312.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United States<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 62.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 66.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">77,725<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,036<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United Kingdom<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 73.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 76.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 76.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 76.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 76.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,492<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,185<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Japan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 29.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 31.029999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 31.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.689999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,003<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,297<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Rest of Europe<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 69.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 71.58999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 71.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">954<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,290<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 62.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 66.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 66.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 66.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">87,174<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">125,808<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 425.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Revenues by geography are determined based on the region of the Company's contracting entity, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">may be different than the region of the customer.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contract Balances<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Unbilled receivables included within accounts receivable on the consolidated balance sheets as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 489.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024 was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.57pt; position: absolute; text-decoration: none; white-space: pre;">$342<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 249.81pt; position: absolute; white-space: pre;">,000 and $574,000, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 509.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table provides the breakdown of capitalized contract costs on the consolidated balance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 521.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sheets (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 541.15pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 471pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 337.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 337.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 337.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 337.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 138.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 139.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 139.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 139.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 139.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 139.68pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,077<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,941<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 337.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 337.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs capitalized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 116.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 118.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 119.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 119.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 119.55pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,081<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,952<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 337.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 337.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs amortized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 113.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 114.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 114.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 114.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 114.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,217)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(3,739)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 337.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 337.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 113.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 114.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 114.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 114.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.5pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 337.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,941<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 405.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,154<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 639.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table provides the breakdown of contract liabilities included within accrued expenses and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 651.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other current liabilities on the consolidated balance sheets (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-19<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="position: absolute; top: 90pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 141.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 141.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">118<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">498<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract liabilities added<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 111.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">470<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract liabilities recognized as revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 184.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 186.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 186.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 186.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(90)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(316)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 111.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">498<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">182<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_373" style="position: absolute; top: 188.5pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 188.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">4. Fair Value Measurement<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes the Company&#8217;s financial assets and liabilities measured at fair value on a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recurring basis by level within the fair value hierarchy (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 242.9pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 198pt; position: absolute; top: 0pt; width: 270pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 270pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 94.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 1<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 2<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 3<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.89pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Money market funds included in cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 86.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 88.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 89.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 89.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 89.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">115,636<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 80.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrant liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.18pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derivative liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 79.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 80.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 80.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 80.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 80.33pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">903<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">903<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,343<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,343<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="position: absolute; top: 396.15pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 198pt; position: absolute; top: 0pt; width: 270pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 270pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 94.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 1<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 2<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Level 3<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.89pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Money market funds included in cash and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">cash equivalents<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 86.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 88.39999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 89.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 89.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 89.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.97pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">36,882<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 80.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrant liability<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.15pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 139.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 140.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 140.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.18pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 94.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 108.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 25.189999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.209999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.22pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 108.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 535.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 89.22pt; position: absolute; white-space: pre;"> following tables present a reconciliation of the Company&#8217;s financial liabilities measured at fair value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 547.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.43pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 184.22pt; position: absolute; white-space: pre;"> and 2024 using significant unobservable inputs (Level 3), and the change in fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 559.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 579.15pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.9pt; position: absolute; text-decoration: none; white-space: pre;">Convertible <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.14pt; position: absolute; text-decoration: none; white-space: pre;">Notes<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of January 1, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 149.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 149.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.68pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">56,066<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 93.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 94.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,120<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derecognition of convertible notes upon conversion into redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 34.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 35.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(61,186)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78.75pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 163.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 164.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 164.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 78.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 688.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Convertible Notes, which are not regularly traded, are classified as Level 3, since their values cannot <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 700.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be determined by using readily observable inputs or measures, such as market prices (see Note 9). The <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-20<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value of the Convertible Notes was estimated as the sum of its components (conversion features and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the debt component) as of the issuance dates and as of the subsequent balance sheet dates. To value <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">each of the conversion features, a &#8220;with and without&#8221; methodology was employed. The debt component <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">was valued using a discounted cash flow method that measured the net present value of the principal and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest payments to be received by the holders of the Convertible Notes (excluding the conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">features) through the estimated maturity date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 170pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 45pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.66pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.14pt; position: absolute; text-decoration: none; white-space: pre;">Common <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.46pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.38pt; position: absolute; text-decoration: none; white-space: pre;">Stock <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Warrant <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Liability<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 45pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of January 1, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 149.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 149.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.68pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 45pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,120<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 59.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 93.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 94.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 59.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,320<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 73.5pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 163.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 164.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 164.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 73.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 87.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 93.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 94.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 87.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">16,395<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 102pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 163.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 164.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 164.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 102pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,835<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 302.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In determining the fair value of the common stock warrant liability, the Company used the Black-Scholes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">option pricing model to estimate the fair value using unobservable inputs including the expected term, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 326.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected volatility, risk-free interest rate and dividend yield (see Note 12).<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 346.25pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.13pt; position: absolute; text-decoration: none; white-space: pre;">Derivative <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Liability<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of January 1, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 145.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 147.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 148.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 149.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 149.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.68pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,061<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 93.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 94.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,158)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 73.71pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 163.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 164.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 164.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">903<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in fair value<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 91.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 93.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 94.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">222<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Derecognition in connection with debt refinancing<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 220.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 222.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 223.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 224.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 224.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 224.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 224.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 224.68pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,125)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value as of December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 161.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 163.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 164.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 164.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.98pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 471.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In determining the fair value of the derivative liability, a two-step valuation approach was employed, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 483.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">included a probability-weighted scenario valuation method, the Black-Scholes-Merton method, and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 495.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">option pricing method, using unobservable inputs (see Note 13), which are classified as Level 3 within the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 507.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">fair value hierarchy, and then comparing the instrument&#8217;s value with and without the derivative features to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 519.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">estimate their combined fair value. The debt instrument is carried at amortized cost, which approximates <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 531.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">its fair value.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_358" style="position: absolute; top: 551.75pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 551.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">5. Balance Sheet Components<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 574.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Allowance for Credit Losses<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.15pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table presents a reconciliation of the allowance for credit losses (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 614.15pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 141.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 141.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">212<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,058<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Additions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 43.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 46.050000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 46.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 46.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 46.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.580000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,190<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Write-offs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 45.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 46.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 46.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 46.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 46.690000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 46.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(344)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(244)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 111.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,058<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">814<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-21<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid Expenses and Other Current Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prepaid expenses and other current assets are comprised of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 130pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Prepaid expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 82.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 84.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 86.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,583<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,017<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs, current<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 103.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 106.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 106.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.52pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,953<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,453<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 29.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 31.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 31.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 31.459999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">598<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">662<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total prepaid expenses and other current assets <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 218.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 221.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 221.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 221.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 221.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.57999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,134<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,132<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 229.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment, net<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 249.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Property and equipment consisted of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 269.25pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment at cost&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Computer equipment and software<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 155.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 156.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 156.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 156.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 156.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,842<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,489<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Furniture, fixtures and equipment<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 149.26999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 151.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.62pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,095<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,233<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Capitalized internal-use software<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 147.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 149.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 151.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 151.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 151.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">48,535<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">52,606<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Leasehold improvements<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 114.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 115.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 116.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 116.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 116.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 116.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 116.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.64999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,057<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,057<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Construction in progress<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 111.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">57<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">27<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Total property and equipment <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 146.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.87pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">60,586<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">60,412<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 125.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Less&#58; Accumulated depreciation and amortization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 220.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 221.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 221.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 221.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(50,665)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 125.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(51,492)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 139.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Property and equipment, net <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 131.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,921<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 139.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,920<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 439pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company capitalized certain internal-use software costs totaling <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 376.95pt; position: absolute; text-decoration: none; white-space: pre;">$4.6<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 396.4pt; position: absolute; white-space: pre;"> million and $4.1 million, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 451pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including stock-based compensation of $408,000 and $393,000 related to internal-use software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 463pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">development efforts, during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 270.14pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 357.93pt; position: absolute; white-space: pre;"> and 2024, respectively. Amortization of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 475pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">capitalized internal-use software totaled <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.31pt; position: absolute; text-decoration: none; white-space: pre;">$3.2<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 269.76pt; position: absolute; white-space: pre;"> million and $3.7 million for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 465.28pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 487pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;"> and 2024, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 507pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Depreciation and amortization expense related to property and equipment, excluding capitalized internal-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 519pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">use software, was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 154.75pt; position: absolute; text-decoration: none; white-space: pre;">$1.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.2pt; position: absolute; white-space: pre;"> million and $1.7 million for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 369.72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 457.51pt; position: absolute; white-space: pre;"> and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 531pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 551pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other Non-Current Assets<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Other non-current assets are comprised of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 591pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contract costs, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 85.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 86.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">988<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,701<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred offering costs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 103.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 105.85pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 106.42999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 106.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">413<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 29.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 31.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 31.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 31.459999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">267<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">252<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total other non-current assets <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 137.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 141.07999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 141.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,255<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,366<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-22<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Accrued Expenses and Other Current Liabilities<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 110pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Accrued expenses and other current liabilities are comprised of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 130pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued payroll and related expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 169.87pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 171.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 171.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">15,228<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,206<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Customer contract and rebate liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 175.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 176.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 176.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 176.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 176.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,109<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,041<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued royalty<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 71.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 71.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,604<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">736<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued professional fees<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 117.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 119.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 121.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 121.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,188<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 68.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,672<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 82.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accrued clinical trial expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 136.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.79999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,148<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 82.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,215<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 96.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 29.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 31.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 31.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 31.459999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,513<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 96.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,449<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total accrued expenses and other current liabilities <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 229.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 231pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 231.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 231.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 231.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 231.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">24,790<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 111pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">25,319<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_343" style="position: absolute; top: 271.25pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 271.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">6. Leases<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 293.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company leases office space in Mountain View, California, Santa Rosa, California, Austin, Texas, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Tokyo, Japan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 325.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Mountain View, California<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 345.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In August 2021, the Company entered into a facility lease agreement with MV Campus Owner, LLC. (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 357.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">&#8220;Landlord&#8221;), for approximately 61,000 rentable square feet in Mountain View, California through August <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 369.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2030. T<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 105.7pt; position: absolute; text-decoration: none; white-space: pre;">he Company received a tenant improvement allowance <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 352.37pt; position: absolute; text-decoration: none; white-space: pre;">of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 360.7pt; position: absolute; text-decoration: none; white-space: pre;"> $1.8 million, in which the remaining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 381.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">unused amount of $1.4 million was credited against rent expense <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 362.54pt; position: absolute; white-space: pre;">during the year ended December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 393.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2023. In connection with the lease, the Company established a standby letter of credit for the benefit of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 405.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the landlord in the amount of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.42pt; position: absolute; text-decoration: none; white-space: pre;">$4.3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.87pt; position: absolute; white-space: pre;"> million in August 2021, which is classified as non-current restricted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 417.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">cash on the consolidated balance sheets as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.78pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 367.57pt; position: absolute; white-space: pre;"> and 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Santa Rosa, California<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In October 2024, the Company entered into an agreement to sublease approximately 4,000 rentable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">square feet of office space in Santa Rosa, California for 29 months commencing on November 1, 2024. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with this sublease, the Company paid a security deposit of $8,000 and recorded an ROU <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">asset and lease liability of $169,000.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Austin, Texas<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 533.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">In January 2023, the Company amended its facility lease agreement in Austin, Texas, which provides for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 545.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">approximately 26,000 square feet of space, to extend the lease term which expired in November 2023 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 557.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">with a five-year renewal option to December 2025 with no renewal option<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.19pt; position: absolute; white-space: pre;">. In connection with the lease <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 569.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amendment, the Company recorded a reduction of $1.8 million in ROU asset and lease liability from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 581.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remeasurement that previously included the renewal option during the year ended December 31, 2023. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 593.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; white-space: pre;"> and 2024, a security deposit of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 326.96000000000004pt; position: absolute; text-decoration: none; white-space: pre;">$150<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.2pt; position: absolute; white-space: pre;">,000 was recorded as non-current <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 605.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">restricted cash and current restricted cash, respectively, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.2pt; position: absolute; text-decoration: none; white-space: pre;">on<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 332.32pt; position: absolute; white-space: pre;"> the consolidated balance sheets related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">this lease. Refer to Note 18 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 637.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Tokyo, Japan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has one non-cancellable operating lease for its facility in Tokyo, Japan which was set to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expire in November 2024. In April 2024, the Company entered into an agreement to extend the lease for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an additional three years through November 2027. In connection with the new lease agreement, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company recorded an ROU asset and lease liability of $420,000.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-23<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Operating lease cost consisted of the following (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 110pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease cost<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 94.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,906<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,900<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Variable lease cost<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 86.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 86.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 86.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.83pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,120<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,597<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total lease cost<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 71.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 71.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 71.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,026<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,497<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 197.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Cash paid for amounts included in the measurement of operating lease liabilities during the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 209.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024 was $4.1 million and $5.2 million, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 229.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes the maturities of the aggregate lease payments under the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 241.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating lease liabilities as of December 31, 2024 (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 261.25pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 14.06pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Year ending <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 56.59pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.39pt; position: absolute; text-decoration: none; white-space: pre;">Operating <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.38pt; position: absolute; text-decoration: none; white-space: pre;">Leases<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,647<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2026<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,109<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2027<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,177<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2028<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,155<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2029<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,309<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Thereafter<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 48.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 49.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.970000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,645<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total minimum lease payments<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 139.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 139.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 140.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.10999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">30,042<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Less&#58; Amount of lease payments representing interest<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 252.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 254.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 254.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 254.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 254.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 254.93pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,089<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 138pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Present value of future minimum lease payments<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 219.26pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 219.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 219.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 220.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 220.04999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 138pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">23,953<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 152.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Less&#58; current portion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 105.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 108.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 109.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 109.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 109.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 109.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 152.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,416<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 166.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities, net of current portion<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 211.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 213.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 214.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 214.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 214.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 214.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 214.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 166.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,537<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 458pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes additional information related to the Company&#8217;s operating leases (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thousands, except weighted-average data)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 490pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Right-of-use assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 88.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 91.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.47999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 91.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.74pt;"></font></font><font style="left: 27.93pt; position: absolute;">20,961<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 25.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.74pt;"></font></font><font style="left: 27.93pt; position: absolute;">18,805<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average remaining lease term (years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 214.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 216.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 216.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.60999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">6.5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 39.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">5.5<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average discount rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 144.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 146.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 146.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 146.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 146.60999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">9.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 54pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">9.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_328" style="position: absolute; top: 574.25pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 574.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">7. Commitments and Contingencies<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Royalty Commitments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has entered into various exclusive technology licensing agreements and other software <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">licensing agreements. The terms of the agreements require the Company to make annual royalty <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 640.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payments in fixed amounts as well as certain milestone and revenue-based payments. The revenue-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based royalty percentage is in the low single digits, subject to reductions and offsets in certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 664.65pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">circumstances with a minimum royalty commitment of $50,000&#160;annually. Future minimum royalty <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-24<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commitments due under the terms of these exclusive agreements as of December 31, 2024 are as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 122pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 35.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 402.75pt;"><div><div style="font-size: 12pt; line-height: 6.55pt; position: absolute; top: 25.31pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Year ending <font style="display: inline-block; height: 6.55pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 56.59pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.89pt; position: absolute; text-decoration: none; white-space: pre;">Minimum <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.39pt; position: absolute; text-decoration: none; white-space: pre;">Royalty <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 25.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.65pt; position: absolute; text-decoration: none; white-space: pre;">Commitments<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 35.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 35.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 49.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2026<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 49.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2027<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 63.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2028<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 78pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 92.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2029<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 24.869999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 25.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 25.099999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25.11pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 92.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 106.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Thereafter<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 48.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 49.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 49.970000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 49.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 106.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">50<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 120.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total minimum royalty commitments<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 161.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 163.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 164.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 164.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 164.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 164.76999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 120.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">300<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 273pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company incurred royalty expense of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 260.32pt; position: absolute; text-decoration: none; white-space: pre;">$2.1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 279.77pt; position: absolute; white-space: pre;"> million and $1.5 million for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 475.29pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 285pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;"> and 2024, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Purchase Commitments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 325pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Open purchase commitments consist of agreements to purchase of goods and services entered into in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 337pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the ordinary course of business. These amounts were not recorded as liabilities on the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 349pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">balance sheets as of December 31, 2024 as the Company had not yet received the related goods or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 361pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">services. As of December 31, 2024, the Company had estimated open purchase commitments for goods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 373pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and services of $5.2 million over the next four years.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 393pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Contingencies<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company is not involved in any pending legal proceedings that it believes could have a material <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 425pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adverse effect on its financial condition, results of operations or cash flows. The Company may pursue or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 437pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be subject to litigation and other legal actions from time to time arising in the ordinary course of business, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 449pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">including intellectual property, products liability, breach of contract, commercial, employment, and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 461pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">similar claims which could have an adverse impact on its reputation, business and financial condition and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 473pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">divert the attention of its management from the operation of its business. The Company accrues a liability <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 485pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for such matters when it is probable that future expenditures will be made, and such expenditures can be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 497pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">reasonably estimated. There were no contingent liabilities requiring accrual or disclosures as of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 509pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 31, 2023 and 2024.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 529pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Indemnifications<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company provides general indemnifications to management and the members of the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">board of directors (the &#8220;Board of Directors&#8221;) when they act, in good faith, in the best interest of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company. The Company is unable to develop an estimate of the maximum potential amount of future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payments that could potentially result from any hypothetical future claim, but expects the risk of having to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">make any payments under these general business indemnifications to be remote. The Company also <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">maintains insurance coverage that would generally enable the Company to recover a portion of any future <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amounts paid.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_313" style="position: absolute; top: 641pt;"></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 641pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">8. <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 85.33pt; position: absolute; text-decoration: none; white-space: pre;">Term Loan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 663.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Initial Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 683.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 19, 2021, the Company entered into a Credit Agreement with Hayfin Services, LLP (&#8220;Hayfin&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 695.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">for total borrowings of up to $70.0 million (the &#8220;Initial Term Loan&#8221;). The Company received net cash <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 707.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">proceeds of $68.1 million, after deducting $1.3 million of lender fees as a discount to the debt, and <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-25<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$629,000 of debt issuance costs. The Company also issued a warrant to the lender to purchase a total of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">315,810 shares of its common stock. The fair value of the warrant was $4.3 million as of the issuance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">date, which was accounted for as a debt discount. Refer to Note 12 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">New Money Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 17, 2022, the Company entered into Amendment No. 1 to the Credit Agreement with Hayfin for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an additional $50.0 million term loan (the &#8220;New Money Term Loan&#8221;), collectively with the Initial Term Loan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(the &#8220;Term Loan&#8221;). Additionally, certain terms of the Initial Term Loan were amended. The Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">received net cash proceeds of $49.2 million, after deducting $820,000 of lender fees as a discount to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">debt. The Company also issued an additional warrant to the lender to purchase a total of 225,579 shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of common stock. The fair value of the warrant was $3.5 million&#160;as of the issuance date, which was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounted for as a debt discount. Refer to Note&#160;12 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Other Amendments<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company entered into Amendments No. 2 and No. 3 to the Credit Agreement in September 2022 and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">December 2022, respectively, which enabled the Company to issue Subordinated Convertible Promissory <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Notes and to increase the aggregate principal of the Subordinated Convertible Promissory Notes that can <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be issued to $42.0 million (see Note 9). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the first quarter of 2023, the Company entered into three amendments to the Credit Agreement with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin. In March 2023, the Company entered into Amendment No. 4 and Waiver to Credit Agreement with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin to temporarily waive various covenant requirements that had not been met through the waiver date <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and to enable the Company to amend certain terms of the Credit Agreement. Under Amendment No. 4, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">part of the Series F redeemable convertible preferred stock financing closing (see Note 10), the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued to Hayfin 4,269,801 warrants for shares of common stock for no consideration and committed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sell 2,689,375 and 3,508,156 shares of Series F-1 and Series F redeemable convertible preferred stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respectively. These shares were issued to Hayfin Heartflow UK Limited upon Convertible Note conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and upon the initial closing of Series F redeemable convertible preferred stock with the same terms as all <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other investors. In March 2023, the Company entered into Amendment No. 5 to the Credit Agreement with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin, which required the Company&#8217;s securities at JPMorgan Chase Bank to become a &#8220;Controlled <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Account&#8221;, as defined by the Credit Agreement. Also in March 2023, the Company entered into <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amendment No. 6 to the Credit Agreement with Hayfin, which permitted the reacquisition of 300,000 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock from an employee&#47;founder of the Company. In connection with these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amendments, the Company paid $94,000 in lender fees, which were recorded as a debt discount. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Amendments No. 4 through No. 6 were accounted for as debt modifications for accounting purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; white-space: pre;">2024 Credit Agreement<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 542pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On June 14, 2024, the Company entered into a Credit Agreement and Guaranty (the &#8220;2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement&#8221;) with Hayfin for a $138.1 million term loan (the &#8220;2024 Term Loan&#8221;) to refinance its outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loan obligations under the 2021 Credit Agreement, as amended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 355.34pt; position: absolute; text-decoration: none; white-space: pre;">(the &#8220;2021 Credit Agreement&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 488.1pt; position: absolute; white-space: pre;">. In <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">addition, in connection with the 2024 Term Loan, the Company entered into several other adjoining <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with Hayfin. The 2024 Term Loan extended the maturity date from January 19, 2026 to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">June&#160;14, 2028. The 2024 Credit Agreement was accounted for as a debt modification for accounting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purposes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Prepayment Terms and Other Fees<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 654pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Any prepayment or repayment of the principal balance are subject to an exit fee. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 428.98pt; position: absolute; text-decoration: none; white-space: pre;">The Company is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 666pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">accreting the exit fee over the loan term using the effective interest method. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 407.83pt; position: absolute; white-space: pre;">Under the 2024 Term Loan, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company has the option to prepay the 2024 Term Loan subject to a prepayment fee of 1.5% for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prepayments after the second anniversary but on or prior to the third anniversary of the 2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 702pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and a prepayment fee of 3% for prepayments thereafter. The Company must repay the loan in full <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-26<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately upon the occurrence of a change in control. In addition, immediately upon the consummation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of an IPO or SPAC, as defined in the terms of the 2024 Credit Agreement, the Company shall repay the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024 Term Loan in an amount equal to the lesser of (i) the net cash proceeds of such IPO or SPAC in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">excess of $150.0 million and (ii) $35.0 million. Refer to Note 18 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On June 14, 2024, concurrently with entering the 2024 Credit Agreement, the Company signed a fee <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">letter agreement with Hayfin under which the Company agreed to pay $9.2 million in fees to Hayfin, which <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consists of a 3% exit fee and 3% early prepayment fee due under the 2021 Credit Agreement in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount of $8.3 million payable in sixteen equal quarterly installments of approximately $518,000 through <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 31, 2028, agent fees of $150,000, due in annual installments of $30,000 through March 31, 2028 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and an upfront fee of $721,000. The Company paid the $721,000 upfront fee and $30,000 agent fee upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the closing of the 2024 Term Loan. The exit fee and early prepayment fee must be repaid in full <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 230pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately upon the occurrence of a financing event, including, but not limited to, any IPO, SPAC, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance of convertible notes or equity. Refer to Note 18 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The Initial Term Loan had an interest rate equal to the sum of the applicable margin of 6.0% plus the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">higher of SOFR and 1.0%, and the New Money Term Loan had an interest rate equal to the sum of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">applicable margin of 15.25% plus the higher of the adjusted term for such interest period and 1.0%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Interest payments are due quarterly. The Company may elect to pay the quarterly interest in-kind (&#8220;PIK&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">through the last interest period ending before the second anniversary of the original Credit Agreement. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">However, if the Company elects to pay interest in-kind after the first anniversary, the applicable margin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">increases by 1.0%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">With respect to the New Money Term Loan, the Company may elect to pay PIK Interest, provided that, (i) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">prior to December 31, 2023, a minimum of 3% per annum shall be payable in cash and (ii) on or after <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 398pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023, a minimum of 6% per annum shall be payable in cash. During the year ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 410pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; text-decoration: none; white-space: pre;">, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 165.32999999999998pt; position: absolute; text-decoration: none; white-space: pre;">$144<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 187.57pt; position: absolute; text-decoration: none; white-space: pre;">,000 of interest was paid-in-kind and was added to the outstanding principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 422pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">balance of the Term Loan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Term Loan bears interest at a floating per annum rate in an amount equal to the sum of (i) 7.0% <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or 6.0% if the alternative base rate (&#8220;ABR&#8221;) is in effect) plus (ii) the greater of (x) the forward-looking term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate based on SOFR for a respective tenor (or the alternative base rate, if applicable), and (y) 2.0%. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ABR equals to the sum of (i) 6.0% plus (ii) the greater of (1) the Wall Street Journal Prime Rate, plus <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">0.5%, (2) the Federal Reserve Bank of New York rate plus 0.5% or (3) CBA Term SOFR for one month <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tenor plus 1.0%. The Company has the option to pay interest in-kind at the rate equal to the cash interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">rate plus 1.0%. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Debt Issuance Costs and Debt Discount<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Debt issuance costs include third-party costs incurred in connection with the original Credit Agreement. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Debt discount includes fees paid to the lender, warrants issued to the lender and the embedded derivative <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liability as described below.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 598pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to the refinancing of the 2021 Credit Agreement with the 2024 Term Loan (the &#8220;2024 Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 610pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Refinancing&#8221;), certain prepayment features of the Term Loan, default put option and default interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adjustment features were determined to be embedded derivatives requiring bifurcation and separate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accounting for at fair value as a single compound derivative. The fair value of the derivative liability was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$2.1 million, as of the issuance date in January 2021, and is remeasured to fair value at each reporting <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period. In connection with the 2024 Term Loan Refinancing, the associated current fair value of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 670pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative liability of $1.1 million was remeasured at the date of refinancing and was derecognized and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 682pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recorded as a debt discount to the 2024 Term Loan. Refer to Note 13 for additional information.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-27<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The debt issuance costs and debt discount are classified as an offset to the Term Loan on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated balance sheets, and is accreted over the loan term using the effective interest method.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; text-decoration: none; white-space: pre;">, the effective interest rate of the Initial Term Loan and the New Money Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Loan was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 117.56pt; position: absolute; text-decoration: none; white-space: pre;">16.1%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 145.9pt; position: absolute; text-decoration: none; white-space: pre;"> and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 168.12pt; position: absolute; text-decoration: none; white-space: pre;">26.8%<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.45999999999998pt; position: absolute; text-decoration: none; white-space: pre;">, respectively. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.03pt; position: absolute; white-space: pre;">As of December 31, 2024, the effective interest rate of the 2024 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Term Loan was 16.0%.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 166pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Collateral and Covenants<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2024 Term Loan is collateralized by substantially all of the Company&#8217;s assets. The 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement contains certain customary representations and warranties, covenants, events of default, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">termination provisions and affirmative and negative covenants, including, among others, covenants that <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">limit or restrict the Company&#8217;s (and its subsidiaries) ability to incur additional indebtedness, grant liens, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">merge or consolidate, make acquisitions, pay dividends or other distributions or repurchase equity, make <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">investments, dispose of assets and enter into certain transactions with affiliates, in each case subject to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain exceptions. Events of default include, among others, non-payment of principal, interest or fees, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">violation of covenants, inaccuracy of representations and warranties, bankruptcy and insolvency events, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">material judgments, cross-defaults to material contracts and events constituting a change of control. Upon <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the occurrence of an event of default, the interest rate applicable to the 2024 Term Loan shall increase by <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">3.0% per annum and the outstanding principal balance, along with any accrued interest, shall become <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable. The Company is subject to financial covenants which requires the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company to maintain a $25.0 million minimum liquidity balance in cash and cash equivalents at all times <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(Refer to Note 18 for additional information) and minimum net sales for twelve consecutive month periods <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ending on the last day of a fiscal quarter, which is not tested as long as the Company maintains minimum <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 366pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liquidity of at least $60.0 million and there has been no decline in net sales for two-consecutive fiscal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 378pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">quarters at the end of such fiscal quarter. The minimum twelve months trailing net sales covenant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">increases each quarter and is $70.0 million for the quarter ended March 31, 2024 up to a minimum net <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 402pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sales amount of $110.0 million for the quarter ended June 30, 2025 and each quarter thereafter. Other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">non-financial covenants are outlined in the 2024 Credit Agreement. As of December 31, 2024, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company was in compliance with the 2024 Term Loan covenants.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Debt Components<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The components of the Term Loan are as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 486pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31, <font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Principal value of Term Loan<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 128.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 131.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 27pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">120,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 27pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">138,137<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">PIK interest added to principal<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 135.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 136.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 136.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 136.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">18,118<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accreted exit fee<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 77.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 79.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 80.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 81.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 81.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 81.41pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,819<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">567<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt discount<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 63.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 66.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 66.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(5,664)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,095)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt issuance costs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 92.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 96.11999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.41pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(265)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 84pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(178)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 98.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total Term Loan <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 76.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 76.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 76.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 76.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.83pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 98.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">134,008<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 98.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">136,431<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 614.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The 2024 Term Loan was classified as long-term on the consolidated balance <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 416.81pt; position: absolute; white-space: pre;">sheets as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 473.46pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 626.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.24pt; position: absolute; white-space: pre;"> and 2024.&#160; As of December 31, 2023, the estimated fair value of the Term Loan was $132.4 million. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, the Company believes the fair value of the 2024 Term Loan approximates its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">carrying value due to the relatively close proximity of the 2024 Term Loan Refinancing to the balance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sheet date.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-28<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_298" style="position: absolute; top: 90pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">9. Convertible Notes<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 112.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">During the period from September 2022 through December 2022, the Company issued convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promissory notes to certain investors (the &#8220;Note Investors&#8221;), with an aggregate principal amount of $40.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 136.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million&#160;(the &#8220;Convertible Notes&#8221;). The Convertible Notes bore interest at a rate of 8% per annum, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 148.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compounded monthly. The aggregate principal amount and interest accrued on the Convertible Notes was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">due September&#160;30, 2026, and could not be prepaid by the Company without the consent of a majority of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Note Investors.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 192.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The principal and accrued interest on the Convertible Notes was subject to automatic conversion upon a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 204.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Qualified Financing (defined as a transaction or series of transactions in which the Company sells shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 216.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of its capital stock for cash proceeds of at least $100 million, including the Convertible Notes) at a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 228.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conversion price equal to 67% of the price per share paid by the investors purchasing such capital stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 240.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in such Qualified Financing. Upon a Non-Qualified Financing, whereby the cash proceeds are less than <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 252.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$100&#160;million, upon the written consent of a majority of the Note Investors, the Convertible Notes shall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 264.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convert on the same terms as a Qualified Financing.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 284.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Convertible Notes were also subject to repayment upon a Change of Control. A Change of Control is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 296.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">defined as a sale of all or substantially all of the Company&#8217;s assets, a merger or business combination <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 308.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with a change in more than 50% of the voting interest, or after a person or group, directly or indirectly, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 320.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">owns more than 35% of the capital stock of the Company after the Company becomes publicly traded.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, the Company completed a Qualified Financing and all of the Convertible Notes, including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">principal and interest, were converted into 21,465,064 shares of Series F-1 redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock and the Company derecognized the Convertible Notes from its consolidated balance <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">sheets. The Company remeasured the fair value of the Convertible Notes immediately before the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 388.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conversion and recognized a loss of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.23pt; position: absolute; text-decoration: none; white-space: pre;">$5.1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 253.68pt; position: absolute; white-space: pre;"> million from the change in fair value within the consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 400.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statements of operations and comprehensive loss for the year ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 378.65pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 466.44pt; position: absolute; white-space: pre;">.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_283" style="position: absolute; top: 420.4pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 420.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">10. Redeemable Convertible Preferred Stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, the Company issued 61,344,029 shares of Series F redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock to existing and new investors at a price per share of $2.8505 for an aggregate cash consideration of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$174.9 million, net of $5.9 million&#160;issuance costs. Contemporaneously with the issuance of the Series F <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock, the Company converted all of the outstanding Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issued by the Company from September 30, 2022 to December 16, 2022, in the aggregate principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amount of $40.0 million plus accrued, unpaid interest of $994,000&#160;into 21,465,064 shares of Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock at a price per share of $1.9098, which represents a discount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">33% from the cash purchase price per share. Additionally, in connection with the Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock financing, the cumulative dividends payable to holders of Series C redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock upon a liquidation event were capped from $6.66 to $8.25 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 562.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depending on the time of issuance, with an aggregate total of $88.5 million.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The issuance of the Series F redeemable convertible preferred stock triggered the anti-dilution protection <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provision for Series B-1, Series B-2, Series C, Series D and Series E stockholders. As a result, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company recorded a $26.8 million deemed dividend in the amount equal to the change in fair value of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">abovementioned series of convertible preferred stock before and after the anti-dilution adjustment. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 630.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value of the Series B-1, Series B-2, Series C, Series D and Series E redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 642.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock was determined using a &#8220;with-and-without&#8221; model under which the equity value of the Company was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 654.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">allocated using a hybrid method, whereby the enterprise value in the IPO scenario is allocated to each <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 666.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">class of shares using the fully-diluted shares outstanding and whereby the enterprise value in the non-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">IPO scenario is allocated using an option-pricing model to reflect the full distribution of possible non-IPO <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 690.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outcomes, both before and after the anti-dilution adjustment. The following table summarizes information <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-29<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">about the significant Level 3 unobservable inputs used to estimate the fair value of the Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock at the modification date&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 122pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.13pt; position: absolute; text-decoration: none; white-space: pre;">March 2, 2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 98.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 99.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 99.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 99.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 99.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">4.8<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 82.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 83.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 84.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 84.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 84.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 84.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 84.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.89999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 27pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">88.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected term (in years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 111.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 113.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 114.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 114.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 114.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 114.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">2.0<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 107.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 108.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 109.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 109.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 109.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 109.89999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 38.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 38.39pt; position: absolute;">0.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 207.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Redeemable convertible preferred stock consists of the following as of December 31, 2023 and 2024 (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 219.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thousands, except share amounts)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 239.75pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 198pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="7"><div style="left: 198pt; position: absolute; top: 0pt; width: 270pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 270pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 74.02pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2023 and 2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 56.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 12.75pt; width: 198pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.63pt; position: absolute; text-decoration: none; white-space: pre;">Shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.15pt; position: absolute; text-decoration: none; white-space: pre;">Authorized<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.15pt; position: absolute; text-decoration: none; white-space: pre;">Number of<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 17.63pt; position: absolute; text-decoration: none; white-space: pre;">Shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.38pt; position: absolute; text-decoration: none; white-space: pre;">Issued <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.63pt; position: absolute; text-decoration: none; white-space: pre;">and <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.16pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.14pt; position: absolute; text-decoration: none; white-space: pre;">Carrying <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.63pt; position: absolute; text-decoration: none; white-space: pre;">Value<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.41pt; position: absolute; text-decoration: none; white-space: pre;">Liquidation <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 20.63pt; position: absolute; text-decoration: none; white-space: pre;">Value<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series A<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 40.13pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 40.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 40.32pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 40.330000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 69pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">4,082,965<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 69pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">4,082,965<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 69pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,041<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 69pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,041<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 83.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series B-1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 49.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 50.150000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 50.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 50.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.28pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 83.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">1,954,846<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 83.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">1,954,846<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 83.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,940<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 83.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,940<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 97.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series B-2<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 49.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 50.150000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 50.230000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 50.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.28pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 97.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">2,848,263<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 97.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">2,848,263<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 97.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 97.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 111.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series C<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 40.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 43.260000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 44.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 44.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 44.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 44.940000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 13.34pt; position: absolute; text-decoration: none; white-space: pre;">11,343,434<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 13.34pt; position: absolute; text-decoration: none; white-space: pre;">11,343,434<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">104,378<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 111.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">193,167<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series D<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 40.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 43.260000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 44.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 44.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 44.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 44.940000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7,151,873<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 18.16pt; position: absolute; text-decoration: none; white-space: pre;">7,151,873<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">110,756<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 126pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">110,854<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 140.25pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series E<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 40.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 42.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 43.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 44.440000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 44.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 44.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 44.900000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12,040,980<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">12,040,980<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">304,197<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 140.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">305,018<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 154.5pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series F<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 39.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 40.120000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 40.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 40.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 40.330000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 154.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">61,344,029<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 154.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">61,344,029<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 154.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">168,957<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 154.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">262,295<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 168.75pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Series F-1<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 48.720000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 49.88pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 50.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 50.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 50.220000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 168.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">21,465,064<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 168.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 12.6pt; position: absolute; text-decoration: none; white-space: pre;">21,465,064<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 168.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">61,186<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 168.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">61,491<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 183pt; width: 198pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 198pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 26.509999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 28.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 29.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 30pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 183pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.04pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 183pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 7.04pt; position: absolute; text-decoration: none; white-space: pre;">122,231,454<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 183pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">768,566<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 183pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">951,917<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 453pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The significant rights and obligations of the Company&#8217;s redeemable convertible preferred stock are as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 485pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Dividends<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holders of Series A, Series B-1, Series B-2, Series C, Series D, Series E, Series F and Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 517pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock are entitled, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 303.09000000000003pt; position: absolute; text-decoration: none; white-space: pre;">on a pro rata, pari passu basis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 437.52pt; position: absolute; white-space: pre;">, when and if declared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 529pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the Board of Directors, to non-cumulative dividends out of the Company's assets legally available <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 541pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">therefore at the rate of $0.030, $0.284, $0.284, $0.7384, $1.24, $2.0265, $0.2281 and $0.1528 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 553pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">per annum, respectively. No distributions will be made with respect to the common stock until all declared <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 565pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">but unpaid dividends on redeemable convertible preferred stock have been paid or set aside for payment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 577pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to the convertible preferred stockholders. Except with respect to the rights of the holders of Series C <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 589pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock upon a liquidation event, the right to receive dividends on shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 601pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of redeemable convertible preferred stock are non-cumulative, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 349.76pt; position: absolute; text-decoration: none; white-space: pre;">and<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 366.44pt; position: absolute; text-decoration: none; white-space: pre;"> no right to such dividends accrues to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 613pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">holders of redeemable convertible preferred stock by reason of the fact that dividends on such shares are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 625pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">not declared or paid in any years<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 217pt; position: absolute; text-decoration: none; white-space: pre;">. At <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 234.19pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 321.98pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 371.98pt; position: absolute; text-decoration: none; white-space: pre;">no<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 383.1pt; position: absolute; text-decoration: none; white-space: pre;"> dividends had been declared or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 637pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">paid.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 657pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Dividends are payable to preferred stockholders in the order of&#58; first, the Series F and Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 669pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock, then the Series E redeemable convertible preferred stock, then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 681pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Series D redeemable convertible preferred stock, then the Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 693pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock, then the Series B-1 and B-2 redeemable convertible preferred stock, and then finally, the Series A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 705pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock. After payment of the full amount of any dividends described <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-30<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">above, any additional dividends shall be distributed among all holders of common stock and all holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock on an as-converted basis.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holders of Series C redeemable convertible preferred stock are the only preferred stockholders <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entitled to cumulative dividends upon a liquidation event. In connection with the Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock financing, the cumulative dividends payable to holders of Series C redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">convertible preferred stock upon a liquidation event were capped from $6.66 to $8.25 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 170pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">depending on the time of issuance, with an aggregate total of $88.5 million, provided, however, that the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company shall be under no obligation to pay such Series C preferred accruing dividends until a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liquidation event&#59; provided further, that a holder of shares of Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock shall automatically forfeit any then accrued but unpaid Series C redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 218pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accruing dividends with respect to such shares upon conversion of such shares into shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 230pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock. As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 125.85pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 213.64pt; position: absolute; white-space: pre;"> and 2024, the total accumulated, but not yet declared or paid, dividends <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.1pt; position: absolute; text-decoration: none; white-space: pre;">$88.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 108.11pt; position: absolute; white-space: pre;"> million related to the Series C redeemable convertible preferred stock was not recorded in the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 254pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consolidated financial statements as an accrued dividend as such an event was not considered probable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 266pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to occur.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Liquidation Rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the holders of Series F, Series F-1, Series E, Series D, Series C, Series B-1, Series B-2 and Series A <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock are entitled to liquidation preferences in the amount of $4.2758, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$2.8647, $25.3317, $15.50, $9.23, $3.55, $3.55, and $0.50 per share, respectively, for each outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 354pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">share plus all declared but unpaid dividends, if the shares are not converted to common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 374pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Payment of liquidation rights to preferred stockholders are in the order of&#58; first, the Series F and Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 386pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">F-1 redeemable convertible preferred stock, then the Series E redeemable convertible preferred stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 398pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">then the Series D redeemable convertible preferred stock, then the Series C redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock, then the Series B-1 and B-2 redeemable convertible preferred stock, and then finally, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series A redeemable convertible preferred stock. The remaining assets, if any, shall be distributed to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">holders of common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">If upon the liquidation, dissolution or winding up of the Company, the assets of the Company legally <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">available for distribution to the holders of the Series F, Series F-1, Series E, Series D, Series C, Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">B-1, Series B-2 and Series A redeemable convertible preferred stock are insufficient to permit the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payment to such holders of the full liquidation preferences to which they are entitled, then the holders of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Company&#8217;s common stock will receive nothing in respect of their equity holdings in the Company. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Upon such an event, the assets of the Company legally available for distribution shall satisfy the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">respective liquidation preferences of the preferred stockholders with equal pro rata priority in the same <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferential order as described above.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Conversion Rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Each share of Series A, Series B-1, Series B-2, Series C, Series D, Series E, Series F and Series F-1 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock shall automatically be converted into fully-paid, nonassessable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares of common stock at the then effective conversion rate per share (currently $0.50, $3.0161, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 614pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$3.0161, $5.4841, $8.2085, $12.4806, $2.8505 and $1.9098, respectively) for such share prior to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 626pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">closing of a firm commitment underwritten IPO pursuant to an effective registration statement filed under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 638pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the Securities Act of 1933, as amended, or SPAC transaction covering the offer and sale of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s common stock, provided that (i) the aggregate gross proceeds to the Company are not less <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 662pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than $100,000,000 and (ii)&#160;the per share price of the shares sold in the public offering shall be no less <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">than $4.9884 per share or $5.7010 per share (subject to adjustment from time to time for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Recapitalizations and as otherwise set forth elsewhere herein) so long as a certain investor holds at least <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">11,693,855 shares of Series F redeemable convertible preferred stock (a &#8216;&#8216;Qualified Public Offering&#8217;&#8217;) shall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automatically be converted into fully-paid, nonassessable shares of common stock at the then effective <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-31<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conversion rate for such share upon the written consent of the holders of a majority of the Series F and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">F-1 redeemable convertible preferred stock (voting as a single class and on an as-converted basis). The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">conversion rates per share for previously issued preferred stock were amended as a result of the Series F <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock financing from the original conversion rates per share for Series <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">B-1, Series B-2, Series C, Series D and Series E redeemable convertible preferred stock ($3.55, $3.55, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$9.23, $15.50 and 25.3317,&#160;respectively). Upon a Qualified Public Offering, shares of each series of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding redeemable convertible preferred stock are convertible into the number of shares of common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock determined by dividing the original issue price for the relevant series of redeemable convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">preferred stock by the conversion price for such series. As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 342.49pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 430.28pt; position: absolute; white-space: pre;"> and 2024, shares of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series A, Series B-1, Series B-2, Series C, Series D, Series E, Series F and Series F-1 outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">redeemable convertible preferred stock are convertible into shares of common stock on a 1&#58;1, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">1.177017&#58;1, 1.177017&#58;1, 1.683047&#58;1, 1.888287&#58;1, 2.029686&#58;1, 1&#58;1, and 1&#58;1 basis, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 242pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Voting Rights<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The holder of each share of Series A, Series B-1, Series B-2, Series C, Series D, Series E, Series F and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Series F-1 redeemable convertible preferred stock is entitled to one vote for each share of common stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 286pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">into which it could be converted.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_268" style="position: absolute; top: 306pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">11. Common Stock<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Under the Company&#8217;s Amended and Restated Certificate of Incorporation, the Company is authorized to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issue 210,300,000 shares of $0.001 par value common stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Common stock reserved for issuance, on an as-converted basis, consisted of the following&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 380.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 179.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 181.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 181.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 181.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options to purchase common stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 159.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 161.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 161.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.62pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">24,146,541<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">24,930,958<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrants<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,811,190<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,811,190<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 71.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 26.509999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 26.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">151,189,185<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">151,973,602<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_253" style="position: absolute; top: 481.9pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 481.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">12. Common Stock Warrant Liability<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 19, 2021, in connection with entering into the Credit Agreement, the Company issued Hayfin&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">a warrant to purchase 315,810 shares of common stock at an exercise price of $0.01 per share. On <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">March 17, 2022, upon amendment to the Credit Agreement, the Company issued Hayfin a warrant to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">purchase 225,579 shares of common stock at an exercise price of $0.01 per share. On March 3, 2023, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 552.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">upon Amendment No. 4 to the Credit Agreement and as a result of antidilution adjustment provisions in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 564.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with the Series F redeemable convertible preferred stock financing, the Company issued <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 576.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Hayfin a warrant to purchase 4,269,801 shares of common stock at an exercise price of $0.01 per share <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 588.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(collectively, the &#8220;Warrants&#8221;). As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 225.8pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 313.59000000000003pt; position: absolute; white-space: pre;"> and 2024, all warrants remained outstanding.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Warrants have a net exercise provision under which their holders may, in lieu of payment of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise price in cash, surrender the warrant and receive a net amount of shares based on the fair market <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value of the Company&#8217;s stock at the time of exercise of the Warrants after deduction of the aggregate <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 644.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">exercise price. The Warrants contain provisions for adjustment of the exercise price and number of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 656.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shares issuable upon the exercise of the Warrants, if upon the issuance of next round securities, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 668.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Warrants are then currently exercisable and the next round price is less than $25.3317 per share (as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">adjusted for any stock splits, recapitalizations, and the like). In such case, the number of exercise shares <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">shall be increased to equal the quotient obtained by dividing (a) $8.0 million by (b) the next round price. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Warrants also have customary antidilution protection provisions. The Warrants will terminate on the <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-32<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ten-year anniversary of the issuance date, however, the Warrants will automatically net exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately prior to termination if the fair market value of one share of common stock exceeds the then <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">current exercise price per share of common stock. In connection with certain change of control <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions, which include SPAC combinations, mergers, consolidations and the sale or lease of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">substantially all of the assets of the Company, the Warrants will also automatically net exercise if the fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">market value of one share of common stock exceeds the then current exercise price per share of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock. The Warrants do not automatically net exercise in connection with an initial public offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 182pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The aggregate fair value of the Warrants issued in connection with the initial Credit Agreement and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 194pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">amended Credit Agreement was $4.3 million and $3.5 million, respectively, at issuance and was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 206pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized as a debt discount and recorded as a warrant liability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The warrant liabilities were remeasured to fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 328.04pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 415.83pt; position: absolute; white-space: pre;"> and 2024, resulting in a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">loss of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103.65pt; position: absolute; text-decoration: none; white-space: pre;">$2.3<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 123.1pt; position: absolute; white-space: pre;">&#160;million and $16.4 million, respectively, within the consolidated statements of operations and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comprehensive loss. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the common stock warrant liability was determined using the Black-Scholes option <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">pricing model based on the following weighted average assumptions&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 302pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock price<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 52.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 54.370000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 55.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 56.11pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 56.400000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 56.410000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">0.93<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">4.34<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercise price<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 65.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 66.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 66.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 66.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">0.01<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.86pt;"></font></font><font style="left: 39.050000000000004pt; position: absolute;">0.01<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Contractual term (in years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 121.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 121.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 121.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 121.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 42.73pt; position: absolute; text-decoration: none; white-space: pre;">7.6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.73pt; position: absolute; text-decoration: none; white-space: pre;">6.6<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 71.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 82.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 84.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 86.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 86.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 86.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 86.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">84.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">72.1<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 85.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 178.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 180.84pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 181.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 181.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 181.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">3.88<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 32.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 32.83pt; position: absolute;">4.44<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 55.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 66.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 66.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 39.65pt;"></font></font><font style="left: 42.28pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 39.65pt;"></font></font><font style="left: 42.28pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 12.22pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_238" style="position: absolute; top: 432pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 432pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">13. Derivative Liability<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Prior to the 2024 Term Loan Refinancing in June 2024, the Term Loan contained certain prepayment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 466.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">features, default put option and default interest adjustment features that were determined to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 478.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">embedded derivatives requiring bifurcation and separate accounting as a single compound derivative, as <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discussed in Note 8. The fair value of the derivative liability was recorded at the issuance date as a debt <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 502.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">discount and reduction to the carrying value of long-term debt on the consolidated balance sheets. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 514.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">derivative liability is remeasured to fair value at each reporting period and the related changes in fair <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 526.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value are recorded on the consolidated statements of operations and comprehensive loss. Through the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time of the 2024 Term Loan Refinancing in June 2024, t<font style="display: inline-block; height: 7.28pt;"></font></font><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 317.35pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">he Company continued to adjust the derivative </font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.4pt; width: 612pt;"><font style="background-color: #ffffff; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;"><font style="background-color: inherit;">liability for changes in fair value of the Term Loan.</font><font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Estimating fair values of the derivative liability requires the development of significant and subjective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 582.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates that may, and are likely to, change over the duration of the instrument with related changes in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 594.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">internal and external market factors. Since the derivative financial instrument is initially and subsequently <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 606.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">carried at fair value, the Company&#8217;s income will reflect the volatility in these estimate and assumption <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 618.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">changes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 638.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The derivative liability was remeasured to fair value as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 325.82pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 413.61pt; position: absolute; white-space: pre;"> and June 14, 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 650.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">resulting in a gain of $4.2 million and a loss of $222,000, respectively, within the consolidated statements <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 662.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of operations and comprehensive <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222.57pt; position: absolute; text-decoration: none; white-space: pre;">loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 240.35pt; position: absolute; white-space: pre;">. In connection with the 2024 Term Loan Refinancing on June 14, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 674.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024, the associated current fair value of the derivative liability of $1.1 million as remeasured at the date <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 686.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of refinancing was derecognized and recorded as a debt discount to the 2024 Term Loan.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-33<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the derivative liability was estimated using a scenario-based analysis comparing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">probability-weighted present value of the Term Loan payoff at maturity with and without the bifurcated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">features. The Company used both the Black-Scholes-Merton and option pricing method to estimate the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value of the derivative liability because it believes these techniques are reflective of all significant <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumption types and ranges of assumption inputs that market participants would likely consider in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions involving compound embedded derivatives. The option pricing method was employed as part <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a back-solve analysis to the Company&#8217;s Series F Preferred round of financing. The Company&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">assumptions used in determining the fair value of the derivative liability is as follows&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 194pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 304.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 80.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.88pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 0pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 80.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.13pt; position: absolute; text-decoration: none; white-space: pre;">June 14,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 12.75pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.12pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 12.75pt; width: 80.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 30.12pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Debt yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 47.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 49.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 50.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 51.120000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.410000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 27pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 47.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 47.83pt; position: absolute;">17.7<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 27pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 47.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 47.83pt; position: absolute;">18.5<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of business combination or IPO (with feature)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 252pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 254.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 255.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 256.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 256.34000000000003pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 256.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 256.40000000000003pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.41pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 41.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 47.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 47.83pt; position: absolute;">70.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 41.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 47.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 47.83pt; position: absolute;">80.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of business combination or IPO (with feature)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 253.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 255.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 256pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 256.29pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 256.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 256.52pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 55.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 55.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of Default<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 94.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 96.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 96.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 69.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 47.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 47.83pt; position: absolute;">10.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 69.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 53.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 53.39pt; position: absolute;">5.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of Default<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 95.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 96.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 96.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 96.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 96.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 84pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">9&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 84pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">9&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 98.25pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability to incur new debt<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 128.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 130.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.04999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 131.34pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 131.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 131.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.51999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 98.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 53.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 53.39pt; position: absolute;">0.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 98.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 53.39pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 53.39pt; position: absolute;">0.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 112.5pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date to incur new debt<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 129.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.57999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.62pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 112.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.61pt; position: absolute; text-decoration: none; white-space: pre;">n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 112.5pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.61pt; position: absolute; text-decoration: none; white-space: pre;">n&#47;a<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 126.75pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Probability of change of control<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 47.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 47.83pt; position: absolute;">10.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 126.75pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 47.83pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 47.83pt; position: absolute;">10.0<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 70.61pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date of change of control<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.94pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 141.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.79999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 141pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 141pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">6&#47;30&#47;2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 155.25pt; width: 304.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 304.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Event date (without feature)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 125.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 126.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 126.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 126.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 304.5pt; position: absolute; top: 155.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">1&#47;19&#47;2026<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 387.75pt; position: absolute; top: 155.25pt; width: 80.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 80.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 33.16pt; position: absolute; text-decoration: none; white-space: pre;">1&#47;19&#47;2026<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 379.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Debt yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.44pt; position: absolute; white-space: pre;"> &#8212; Discount rate that reconciles the total fair value of the Warrants and 2021 Credit Agreement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 391.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">with the transaction value. Debt yield reflects a change in the credit benchmark for a &#8220;CCC&#8221; rated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 403.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">obligation. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_223" style="position: absolute; top: 423.5pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 423.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">14. Equity Incentive Plan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In 2009, the Company adopted its 2009 Equity Incentive Plan (the &#8220;Plan&#8221;) which provides for the grant of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock options to the Company&#8217;s employees, members of the Board of Directors and consultants. Options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">granted under the Plan may be either incentive stock options (&#8220;ISOs&#8221;) or nonqualified stock options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(&#8220;NSOs&#8221;). ISOs may be granted only to employees. NSOs, Stock Appreciation Rights, Restricted Stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and Restricted Stock Units may be granted to employees, members of the Board of Directors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">consultants. As of December 31, 2024, the Company reserved 30,787,082 shares for issuance under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 517.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Plan.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Options under the Plan have a term of ten years from the grant date. The option exercise price will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">determined by the Board of Directors, but will be no less than 100% of the fair market value per share on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the date of grant. In addition, in the case of an ISO granted to an employee who owns stock representing <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">more than 10% of the voting power of all classes of stock of the Company, the per share exercise price <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will be no less than 110% of the fair market value per share on the date of grant. Through December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2024, options granted generally vest over (i) four years with 25% vesting on the first anniversary of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">issuance date and 1&#47;48th per month thereafter or (ii) vesting monthly in equal installments over four <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">years.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-34<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 96.99pt; position: absolute; white-space: pre;"> option activity under the Company&#8217;s 2009 Equity Incentive Plan is set forth below (in thousands, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">except share and per share amounts)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 122pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 156pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 60pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15pt; position: absolute; text-decoration: none; white-space: pre;">Shares <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 3.02pt; position: absolute; text-decoration: none; white-space: pre;">Available for <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18.01pt; position: absolute; text-decoration: none; white-space: pre;">Grant<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.52pt; position: absolute; text-decoration: none; white-space: pre;">Number of <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.02pt; position: absolute; text-decoration: none; white-space: pre;">Options<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 13.76pt; position: absolute; text-decoration: none; white-space: pre;">Awards <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.28pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.26pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.5pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 19pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.28pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.26pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.02pt; position: absolute; text-decoration: none; white-space: pre;">Remaining <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.03pt; position: absolute; text-decoration: none; white-space: pre;">Contractual <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 5.52pt; position: absolute; text-decoration: none; white-space: pre;">Life (Years)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 0pt; width: 60pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.77pt; position: absolute; text-decoration: none; white-space: pre;">Aggregate<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 12.51pt; position: absolute; text-decoration: none; white-space: pre;">Intrinsic<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 60pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 18pt; position: absolute; text-decoration: none; white-space: pre;">Value<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at December 31, 2022<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 142.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 143.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: absolute; text-decoration: none; white-space: pre;"> . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">4,312,292<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">9,420,310<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">9.77<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">6.17<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 56.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.72pt;"></font></font><font style="left: 30.91pt; position: absolute;">3,561<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authorized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 50.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 52.720000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 53.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.09pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">16,018,730<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 70.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options granted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 73.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 76.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 77.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 77.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 77.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 77.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 2.63pt; position: absolute;">(16,881,199)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">16,881,199<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 84.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options exercised<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 83.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 13.83pt;"></font></font><font style="left: 16.46pt; position: absolute;">(291,756)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 99pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">2.02<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options canceled<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 79.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 82.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 82.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 83.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 83.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.05pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,863,212<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 5.5pt;"></font></font><font style="left: 8.129999999999999pt; position: absolute;">(1,863,212)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 113.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">6.11<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 156pt;"><div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.620000000000005pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; text-decoration: none; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 143.18pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 143.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 143.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.35999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">5,313,035<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">24,146,541<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">1.41<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">8.19<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 127.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 42.17pt;"></font></font><font style="left: 50.36pt; position: absolute;">&#8211;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Authorized<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 50.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 52.720000000000006pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 53.010000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.09pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 141.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 141.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 141.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 37.73pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options granted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 73.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 76.05pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 77.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 77.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 77.86999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 77.91pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 77.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 77.94pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 156pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 5.5pt;"></font></font><font style="left: 8.129999999999999pt; position: absolute;">(6,533,982)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 156pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">6,533,982<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 156pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">2.21<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 170.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options exercised<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 83.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 83.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.31pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 170.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 43.29pt;"></font></font><font style="left: 45.92pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 170.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 5.5pt;"></font></font><font style="left: 8.129999999999999pt; position: absolute;">(3,449,126)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 170.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">1.32<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 184.5pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Options canceled<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 79.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 82.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 82.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 82.89999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 82.97999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 83.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 83.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 83.05pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 184.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">2,300,439<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 184.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 5.5pt;"></font></font><font style="left: 8.129999999999999pt; position: absolute;">(2,300,439)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 184.5pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">1.64<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 198.75pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 140.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 142.72pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 143.01pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 143.09pt; position: absolute; text-decoration: none; white-space: pre;"> . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 156pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">1,079,492<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">24,930,958<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">1.62<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.84pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">7.96<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 198.75pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">68,256<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 213pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vested and exercisable, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 99.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 101.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 102.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 102.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.83pt;"></font></font><font style="left: 11.46pt; position: absolute;">8,430,819<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">2.01<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.84pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">6.22<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 213pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">19,989<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 239.25pt; width: 156pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Vested and expected to vest, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 156pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">December 31, 2024<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 99.42pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 101.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 102.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 102.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 103pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 219pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 3.27pt;"></font></font><font style="left: 5.9pt; position: absolute;">24,930,958<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 282pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 28.28pt;"></font></font><font style="left: 36.470000000000006pt; position: absolute;">1.62<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 345pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.92pt; position: absolute; text-decoration: none; white-space: pre;">7.96<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 408pt; position: absolute; top: 239.25pt; width: 60pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 60pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 17.16pt;"></font></font><font style="left: 25.349999999999998pt; position: absolute;">68,256<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 403.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The weighted-average grant date fair value of options granted during the years ended December 31, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 415.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2023 and 2024 was $0.43 and $1.23 per share, respectively. The total grant date fair value of options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 427.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">vested was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 124.77000000000001pt; position: absolute; text-decoration: none; white-space: pre;">$3.2 million and $2.0 million <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 250.86pt; position: absolute; text-decoration: none; white-space: pre;">during the years ended December 31, 2023 and 2024, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 439.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 459.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table summarizes information about stock options outstanding as of December 31, 2024&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 479.5pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 126.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 56.25pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 126.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Range of<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercise Prices<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Number <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 6.16pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.11pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 9.64pt; position: absolute; text-decoration: none; white-space: pre;">Remaining <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.65pt; position: absolute; text-decoration: none; white-space: pre;">Contractual <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 8.14pt; position: absolute; text-decoration: none; white-space: pre;">Life (Years)<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.62pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 15.64pt; position: absolute; text-decoration: none; white-space: pre;">Number <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 7.63pt; position: absolute; text-decoration: none; white-space: pre;">Exercisable<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 13.91pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 10.9pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-<font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 24.71pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.88pt; position: absolute; text-decoration: none; white-space: pre;">Average <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 35.51pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 14.12pt; position: absolute; text-decoration: none; white-space: pre;">Exercise <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 46.31pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 21.62pt; position: absolute; text-decoration: none; white-space: pre;">Price<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 56.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$0.76 - $0.76<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.57pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">13,209,195<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">8.38<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,582,603<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 56.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.76<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 70.5pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$0.93 - $0.93<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.870000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">2,446,710<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.31<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.93<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">103,119<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 70.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">0.93<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 84.75pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$1.74 - $1.74<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.57pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">466,500<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.70<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">1.74<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,791<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 84.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">1.74<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$2.85 - $2.85<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.57pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">5,234,099<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">4.99<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,538,001<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.85<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$3.28 - $3.28<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.870000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">3,395,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">9.99<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">3.28<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">23,305<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 113.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">3.28<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$4.20 - $4.20<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.57pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">15,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">0.60<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">4.20<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">15,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">4.20<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 141.75pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$4.24 - $4.24<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.57pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">104,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">1.41<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">4.24<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">104,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 141.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">4.24<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$9.58 - $9.58<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.57pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">60,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">3.86<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">9.58<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">60,000<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 156pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">9.58<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 170.25pt; width: 126.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 126.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">$0.76 - $9.58<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 61.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 63.830000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 64.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 65.57pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 129.75pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">24,930,958<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 198pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 43.17pt; position: absolute; text-decoration: none; white-space: pre;">7.96<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 266.25pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">1.62<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">8,430,819<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 170.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 41.720000000000006pt; position: absolute;">2.01<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 680pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stock options and the fair value of the Company&#8217;s common stock for stock options that were in-the-money <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-35<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">at each reporting period. The aggregate intrinsic value of stock options exercised for the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024 was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 227.57pt; position: absolute; text-decoration: none; white-space: pre;">$4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 238.69pt; position: absolute; white-space: pre;">,000 and $1.7 million, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Stock-Based Compensation<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 142pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company estimated the fair value of stock options using the Black-Scholes option-pricing model <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 154pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">based on the following assumptions&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 174pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 325.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 325.5pt; position: absolute; top: 0pt; width: 142.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 142.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 16.02pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 12.75pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 325.5pt; position: absolute; top: 12.75pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.87pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 398.25pt; position: absolute; top: 12.75pt; width: 69.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 24.87pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 25.5pt; width: 325.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 325.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected life (in years)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 104.27pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 106.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 107.16pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 107.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 107.53pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 325.5pt; position: absolute; top: 25.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.23pt; position: absolute; text-decoration: none; white-space: pre;">6.0<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 398.25pt; position: absolute; top: 25.5pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 53.23pt; position: absolute; text-decoration: none; white-space: pre;">6.0<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 39.75pt; width: 325.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 325.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 82.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 82.75999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 82.83999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 82.86pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 325.5pt; position: absolute; top: 39.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 8.99pt; position: absolute; text-decoration: none; white-space: pre;">54.7%-55.7%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 398.25pt; position: absolute; top: 39.75pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 8.99pt; position: absolute; text-decoration: none; white-space: pre;">53.7%-55.0%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 54pt; width: 325.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 325.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 98.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 100.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 101.61999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 102.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 102.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.42999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 325.5pt; position: absolute; top: 54pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 42.89pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 42.89pt; position: absolute;">4.2<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 60.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 398.25pt; position: absolute; top: 54pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 20.11pt; position: absolute; text-decoration: none; white-space: pre;">3.5%-4.5%<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 68.25pt; width: 325.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 325.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 64.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 67.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 67.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 67.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 67.58pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 67.58999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 325.5pt; position: absolute; top: 68.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 51.22pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.22pt; position: absolute;">&#8211;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 60.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 398.25pt; position: absolute; top: 68.25pt; width: 69.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 69.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 51.22pt; position: absolute;"><font style="display: inline-block; height: 7.28pt;"></font></font><font style="left: 51.22pt; position: absolute;">&#8211;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font><font style="left: 60.11pt; position: absolute;">%<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 272.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The significant assumptions used in these calculations are summarized as follows&#58; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 292.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Fair value of common stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 194.19pt; position: absolute; white-space: pre;">. Because there has been no public market for the Company&#8217;s common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 304.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the fair value of common stock shares underlying stock options has historically been determined by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 316.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Board of Directors at the time of option grant by considering independent valuation performed by third-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 328.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">party valuation firm as well as a number of objective and subjective factors, including valuation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">comparable companies, sales of convertible preferred stock to unrelated third parties, operating and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financial performance, the lack of liquidity of capital stock and general and industry specific economic <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 364.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outlook, among other factors. The fair value of common stock was determined in accordance with <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 376.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">applicable elements of the American Institute of Certified Public Accountants Practice Aid, Valuation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 388.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Privately-Held-Company Equity Securities Issued as Compensation. In 2023, the Company considered <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 400.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the stay private scenario and IPO exit scenario. In the stay private scenario, three market methodologies <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 412.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">were employed including (i) a market indexing valuation analysis based on the Series F Preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 424.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">financing round, (ii) a guideline public company analysis based on the Company&#8217;s historical and forecast <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 436.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operating metrics, and (iii) a guideline transaction analysis based on the Company&#8217;s historical and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 448.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forecast operating metrics. In the IPO exit scenario, the total equity value was estimated based on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 460.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expected timing, offering size and pre-money valuation. A hybrid method was used to allocate equity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 472.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">value to common stock under the stay private and IPO scenarios.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 492.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expected term<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.43pt; position: absolute; white-space: pre;">. The expected term of stock options represents the weighted-average period the stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 504.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options are expected to remain outstanding. The Company does not have sufficient historical exercise <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 516.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and post-vesting termination activity to provide accurate data for estimating the expected term of options <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 540.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of the vesting term and the original contractual term of the option. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expected volatility<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.98000000000002pt; position: absolute; white-space: pre;">. As the Company is not publicly traded, the expected volatility for the Company&#8217;s stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">options was determined by using an average of historical volatilities of selected industry peers deemed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be comparable to the Company&#8217;s business corresponding to the expected term of the awards. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 604.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Risk-free interest rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 167.51999999999998pt; position: absolute; white-space: pre;">. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 616.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 628.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the awards. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 648.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Expected dividend yield<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 177.01pt; position: absolute; white-space: pre;">. The expected dividend rate is zero as the Company currently has no history or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 660.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expectation of declaring dividends on its common stock. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 680.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company also issues stock options with vesting based upon completion of performance goals. The <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 692.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value for these performance-based awards is recognized over the period during which the goals are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 704.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">to be achieved. Stock-based compensation expense recognized at fair value includes the impact of <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-36<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimated probability that the goals would be achieved, which is assessed prior to the requisite service <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">period for the specific goals.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 122pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Total stock-based compensation expense is as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 142pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cost of revenue<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 73.17999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 75.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 76.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 76.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 76.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 76.52pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">440<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">307<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 6.5pt; font-style: normal; font-weight: normal; left: 124.88pt; position: absolute; text-decoration: none; top: -2.548pt; vertical-align: super; white-space: pre;">(1)<font style="display: inline-block; height: 4.732pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 132.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 135.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 136.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 136.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.49pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,339<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">2,151<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Selling, general and administrative<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 155.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 156.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 156.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 156.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,722<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,755<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 71.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total stock-based compensation expense <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 188.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 191.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 191.35999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 191.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 191.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 191.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.57999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">12,501<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">10,213<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 235.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(1)<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Includes stock-based compensation expense of $627,000 during the year ended December 31, 2023 related to a repurchase of <font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 244.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">common shares from one employee, as described below.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 261.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 97.53pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 185.32pt; position: absolute; white-space: pre;"> and 2024, total unrecognized stock-based compensation costs related to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 273.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unvested stock options was <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 196.99pt; position: absolute; text-decoration: none; white-space: pre;">$20.7<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 222pt; position: absolute; white-space: pre;"> million and $16.5 million, respectively, which is expected to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 285.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">recognized over a remaining weighted-average period of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 324.8pt; position: absolute; text-decoration: none; white-space: pre;">3.22<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 344.25pt; position: absolute; white-space: pre;"> years and 2.79 years, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January 2023, the fair value of the Company&#8217;s common stock declined from $14.27 to $0.76 per share, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">prompting the Company to reduce the exercise price of certain stock options to $0.76, effective July&#160;10, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2023. No other changes to the stock options&#8217; terms were made. The Company calculated the incremental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">fair value by calculating the fair value of the award immediately before and immediately after the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">modification. The fair value of the award immediately before the repricing is based on assumptions <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(including volatility, expected term and risk free interest rate) that reflect the facts and circumstances on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the modification date and therefore, differ from the fair value calculated on the grant date. The average <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">additional compensation per award from the modification was $0.09 and the aggregate incremental <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 401.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">expense was $649,000, of which $340,000 was immediately recognized on the modification date and the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 413.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">remaining amount is recognized over the options&#8217; remaining requisite service period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 433.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In March 2023, the Board of Directors approved a repurchase of 300,000 common shares from an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 445.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee of the Company at a purchase price of $2.8505 per share for total consideration of $855,000. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 457.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The fair value of the repurchased common shares was $228,000, and the difference between the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 469.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repurchase price and fair value of the common shares of $627,000 was recorded as stock-based <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 481.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensation expense within research and development expense in the consolidated statements of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 493.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">operations and comprehensive loss during the year ended December 31, 2023.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_207" style="position: absolute; top: 513.5pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 513.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">15. Employee Retirement Plan<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 535.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has a qualified retirement plan under section 401(k) of the Internal Revenue Code (&#8220;IRC&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 547.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">under which participants may contribute up to 100% of their eligible compensation, subject to maximum <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 559.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">deferral limits specified by the IRC. The Company may make matching contributions of up to 4.0% of an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 571.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employee&#8217;s eligible compensation, subject to conditions specified by the IRC. During the years ended <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 583.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 159.79000000000002pt; position: absolute; white-space: pre;"> and 2024, the Company&#8217;s matching contributions totaled <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 414.59pt; position: absolute; text-decoration: none; white-space: pre;">$1.4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 434.04pt; position: absolute; white-space: pre;"> million and $1.5 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 595.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-37<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_193" style="position: absolute; top: 90pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">16. Net Loss Per Share Attributable to Common Stockholders<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 112.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth the computation of basic and diluted net loss per share attributable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 124.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stockholders (in thousands, except share and per share amounts)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 144.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 5.81pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 15.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 15.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 30pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Numerator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 44.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 38.730000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 41.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 41.330000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 41.480000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 41.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.580000000000005pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 44.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,655)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 44.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 58.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Cumulative dividends on Series C redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 328.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 331.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 331.33pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 331.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 331.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 58.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,239)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 58.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 72.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deemed dividend upon down round of redeemable convertible preferred <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 34.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 36.12pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 36.410000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 36.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 36.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 36.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 36.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 36.71pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 72.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 24.64pt;"></font></font><font style="left: 27.27pt; position: absolute;">(26,794)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 72.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss attributable to common stockholders <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 204.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 205.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 206.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 206.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 206.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 206.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(123,688)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,426)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 113.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Denominator&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 26.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Weighted-average shares used to compute net loss per share, basic and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 15.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 11.63pt; position: absolute; text-decoration: none; white-space: pre;">diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 41.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 41.660000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 41.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 41.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 41.800000000000004pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.81pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">14,265,293<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 127.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 15.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">15,661,682<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 153.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss per share attributable to common stockholders, basic and diluted<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 327.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 329.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 331.06pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 331.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 331.43pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(8.67)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 153.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 38.39pt; position: absolute;">(6.16)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 328.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following outstanding shares of potentially dilutive securities were excluded from the computation of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 340.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">diluted net loss per share attributable to common stockholders for the period presented because including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 352.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">them would have been antidilutive&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 372.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 12.75pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 2.81pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 12.75pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 27pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Redeemable convertible preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 179.85999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 181.01999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 181.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 181.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 181.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 27pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 27pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">122,231,454<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 41.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Outstanding options to purchase common stock<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 213.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 216.04pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 216.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 216.48pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 216.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 216.57999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">24,146,541<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 41.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 8.52pt;"></font></font><font style="left: 11.149999999999999pt; position: absolute;">24,930,958<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 55.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Common stock warrants<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 110.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,811,190<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 55.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 14.08pt;"></font></font><font style="left: 16.71pt; position: absolute;">4,811,190<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 69.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 26.509999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 26.8pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 26.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">151,189,185<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 69.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 2.96pt;"></font></font><font style="left: 5.59pt; position: absolute;">151,973,602<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div id="i2341357d54884756b9e9172f0a83cd6b_178" style="position: absolute; top: 472.4pt;"></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 472.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">17. Income <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 137.32pt; position: absolute; text-decoration: none; white-space: pre;">Taxes<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The components of net loss before income taxes are as follows (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 514.8pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">United States<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 62.61pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 64.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 66.08pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 66.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 66.45pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 66.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,634)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,422)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">International<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 57.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 59.940000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 61.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 61.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 61.470000000000006pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">526<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">49<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Net loss before income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 131.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 131.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 131.82999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.84pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(95,108)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(96,373)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 602.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">For the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.20999999999998pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, the Company did <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 380.33pt; position: absolute; text-decoration: none; white-space: pre;">not<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 394.22pt; position: absolute; text-decoration: none; white-space: pre;"> record any federal or state <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 614.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">provision for income tax expense. For the years ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 315.86pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 403.65pt; position: absolute; text-decoration: none; white-space: pre;"> and 2024, the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 626.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">recorded an income tax provision of $547,000 and $53,000, respectively, from international jurisdictions.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 646.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table presents a reconciliation of the statutory federal rate and the Company&#8217;s effective tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 658.05pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">rate (in thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-38<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="position: absolute; top: 90pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Tax at federal statutory rate<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 123.69999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 126.00999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 126.3pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 126.44999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 126.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 126.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,003)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 19.08pt;"></font></font><font style="left: 27.27pt; position: absolute;">(20,027)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">State taxes, net of federal benefit<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 149.24pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 151.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 151.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 151.60999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 151.62pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,032)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(2,247)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Change in valuation allowance<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 138.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 140.51999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 141.1pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 141.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.47pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 141.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.53pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,418<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">16,563<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 71.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 123.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 125.50999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 126.08999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 126.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 126.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 126.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 126.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.53pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,722<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,706<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 85.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Fair value remeasurement<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 119.28999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 121.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.61999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,075<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,482<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">R&#38;D credits<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 55.940000000000005pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 56.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 56.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 56.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 56.79pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 56.800000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(391)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(281)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 114pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Foreign rate differential<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 105.19999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 106.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 106.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 106.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 106.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 106.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 114pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(50)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 114pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 47.42pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">41<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 128.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 27.619999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 29.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 31.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 31.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 31.459999999999997pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 128.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(192)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 128.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">816<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 142.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Provision for income taxes<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 119.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 120.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 121.57pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 121.64999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 142.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 36.3pt;"></font></font><font style="left: 44.49pt; position: absolute;">547<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 142.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 50.050000000000004pt; position: absolute;">53<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 262.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Significant components of the net deferred tax assets for federal and state income taxes are as follows (in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 274.75pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">thousands)&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 294.75pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 11.52pt; position: absolute; text-decoration: none; white-space: pre;">Year Ended December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred tax assets&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Net operating loss carryforwards<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 158.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 160.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 161.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 161.54pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.54999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">142,089<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 16.85pt;"></font></font><font style="left: 25.04pt; position: absolute;">143,066<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Research and development credits<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 169.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 171.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 171.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 171.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.60999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,586<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,111<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 71.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Stock-based compensation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 135.2pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 136.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 136.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 136.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 136.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 136.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,316<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">1,611<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 85.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Interest limitation<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 90.14999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 91.67999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,551<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 85.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,964<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 99.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Accruals and reserves<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 113.52pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 115.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 116.41pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 116.49pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 116.53pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 116.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 116.56pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">3,493<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 99.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">9,502<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 114pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Fixed asset and intangible asset basis<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 183.51pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 185.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 186.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 186.54999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 114pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,250<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 114pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">4,615<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 128.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 125.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 126.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 126.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 126.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 126.77pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 128.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">6,791<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 128.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 33.53pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">5,955<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 142.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Section 174 research and development capitalization<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 249.09pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 251.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 251.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 251.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 251.60999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 142.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">12,432<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 142.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 30.599999999999998pt; position: absolute;">20,675<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 156.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total deferred tax assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 111.5pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.83pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.83999999999999pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 156.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">184,508<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 156.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">201,499<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 15.75pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 186.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred tax liabilities&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 201pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Capitalized implementation costs<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 160.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 161.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 161.6pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 161.75pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 161.76999999999998pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 201pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(756)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 201pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(1,556)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 215.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Operating lease right-of-use assets<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 170.17pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 171.32999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 171.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 171.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.72pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 215.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(5,346)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 215.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(4,653)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 229.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">Other<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 39.62pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 40.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 41.36pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 41.65pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.660000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 229.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 229.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 44.09pt;"></font></font><font style="left: 46.720000000000006pt; position: absolute;">(66)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 243.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total deferred tax liabilities<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 120.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 121.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 121.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 121.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 121.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 243.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(6,102)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 243.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 30.2pt;"></font></font><font style="left: 32.83pt; position: absolute;">(6,275)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 258pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Deferred tax assets, net<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 108.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 111.02pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.31pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 111.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 111.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.58pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 258pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">178,406<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 258pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 22.41pt;"></font></font><font style="left: 25.04pt; position: absolute;">195,224<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 272.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Valuation allowance<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 90.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 91.36999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 91.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 91.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 91.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 272.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(178,406)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 272.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 13.52pt;"></font></font><font style="left: 21.709999999999997pt; position: absolute;">(195,224)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 597.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As the Company has incurred annual net operating losses since inception, a full valuation allowance is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 609.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provided against U.S. net deferred tax assets due to uncertainties regarding the Company&#8217;s ability to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 621.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">realize these assets. The valuation allowance increased by $20.4 million and $16.8 million for the years <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 633.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">ended <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 102.57pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 190.36pt; position: absolute; white-space: pre;"> and 2024, respectively.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 653.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">As of December 31, 2024, the Company had net operating loss carryforwards of approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 493.61pt; position: absolute; text-decoration: none; white-space: pre;">$542.9<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 524.1800000000001pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 665.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million&#160;and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 122.55pt; position: absolute; text-decoration: none; white-space: pre;">$435.5<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 153.12pt; position: absolute; white-space: pre;"> million available to reduce future taxable income, if any, for federal and state income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tax purposes, respectively. Of these amounts, $355.9 million of federal net operating losses are carried <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">forward indefinitely, and $187.0 million are limited to 80% of future taxable income. The remaining federal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 701.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">net operating losses will expire starting in 2030. Utilization of net operating loss carryforwards may be <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-39<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to an annual limitation in certain situations where changes occur in the stock ownership of a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">company. In the event the Company has undergone or undergoes a change in ownership, utilization of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the carryforwards could be limited.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 134pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company also had federal and California research and development credit carryforwards of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 146pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">approximately <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 137pt; position: absolute; text-decoration: none; white-space: pre;">$9.4<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.45pt; position: absolute; white-space: pre;"> million and <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 209.77pt; position: absolute; text-decoration: none; white-space: pre;">$7.0<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 229.22pt; position: absolute; white-space: pre;"> million, respectively, as of December 31, 2024. The federal credits <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 158pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">will expire starting in 2030, if not utilized. The California credits have no expiration date.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 178pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Deferred income taxes have not been provided for undistributed earnings of the Company&#8217;s consolidated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 190pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign subsidiaries because of the Company&#8217;s intent to reinvest such earnings indefinitely in active <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 202pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">foreign operations. The Company believes that future domestic cash generation will be sufficient to meet <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 214pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">future domestic cash needs. The Company has not recorded a deferred tax liability on the undistributed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">earnings of non-U.S. subsidiaries. The foreign withholding taxes would not have a material impact on the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Company&#8217;s financial position and results of operation. As of December 31, 2023 and 2024, the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 250pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">had $0.6 million and $1.1 million, respectively, in unremitted earnings that were indefinitely reinvested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 262pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">related to its consolidated foreign subsidiaries.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 282pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company&#8217;s gross unrecognized tax benefits as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 312.90999999999997pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 400.7pt; position: absolute; white-space: pre;"> and 2024 was $8.2 million and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 294pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$8.6 million, respectively, all of which would affect the Company&#8217;s income tax expense if recognized <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 306pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">before consideration of the Company&#8217;s valuation allowance. The Company does not expect its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 318pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 330pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest and penalties accrued on any unrecognized tax benefits as a component of provision for income <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 342pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">taxes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 362pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">The following table summarizes the activity related to unrecognized tax benefits as follows (in thousands)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 535.81pt; position: absolute; white-space: pre;">&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 382pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 334.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 334.5pt; position: absolute; top: 0pt; width: 133.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 133.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">December 31,<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2023<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 14.25pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 22.62pt; position: absolute; text-decoration: none; white-space: pre;">2024<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 28.5pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at beginning of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 137.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 139.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 141.10999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 141.4pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 141.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 141.46pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 141.47pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">7,371<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 28.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,188<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 42.75pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Increase related to current year tax positions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 199.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 200.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 201.56pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 201.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 201.68pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 201.69pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">817<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 42.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 41.86pt;"></font></font><font style="left: 44.49pt; position: absolute;">558<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 57pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Changes related to prior year tax positions<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 190.39pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 191.54999999999998pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 191.7pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 191.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 48.54pt;"></font></font><font style="left: 51.17pt; position: absolute;">&#8212;<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #cceeff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 57pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;"><font style="display: inline-block; height: 7.28pt; width: 38.53pt;"></font></font><font style="left: 41.160000000000004pt; position: absolute;">(149)<font style="display: inline-block; height: 7.28pt;"></font></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 71.25pt; width: 334.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 334.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Balance at end of period<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 110.96pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 111.53999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 111.69pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 111.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 111.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 111.8pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 334.5pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,188<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="background-color: #ffffff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 71.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 2.63pt; position: absolute;">$<font style="display: inline-block; height: 7.28pt; width: 27.97pt;"></font></font><font style="left: 36.160000000000004pt; position: absolute;">8,597<font style="display: inline-block; height: 7.28pt; width: 3.33pt;"></font></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 483.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company files income tax returns in the U.S. federal jurisdiction, various state and certain foreign <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">jurisdictions. In the normal course of business, the Company is subject to examination by their respective <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 505.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">taxing authorities. The Company has been selected for audit by the Internal Revenue Service for its 2022 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 517.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">tax year. The examination is at its early stages. However, no tax adjustments are anticipated. The statute <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 528.3pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of limitations remains effectively open for the U.S. federal and state tax jurisdictions for all tax years from <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 539.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2010 through 2024. Tax years outside the normal statute of limitations remain open to examination by tax <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 550.7pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">authorities due to tax attributes generated in earlier years which have been carried forward and may be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">examined and adjusted in subsequent years when utilized.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_144" style="position: absolute; top: 581.1pt;"></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 581.1pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">18. Subsequent <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 163.98000000000002pt; position: absolute; text-decoration: none; white-space: pre;">Events<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 603.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Company has reviewed and evaluated subsequent events as of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 375.9pt; position: absolute; text-decoration: none; white-space: pre;">December&#160;31, 2023<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 463.69pt; position: absolute; white-space: pre;"> through March <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 615.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">26, 2025, the date that the consolidated financial statements were available to be issued.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 635.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Convertible Notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 655.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">In January and March 2025, the Company issued convertible promissory notes to various investors and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 667.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certain employees (the &#8220;Requisite Holders&#8221;) <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 267.53pt; position: absolute; text-decoration: none; white-space: pre;">in the aggregate amount of $98.4 million<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 445.85pt; position: absolute; text-decoration: none; white-space: pre;">,<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 448.62pt; position: absolute; text-decoration: none; white-space: pre;"> which was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 679.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">comprised of <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.99pt; position: absolute; text-decoration: none; white-space: pre;">$75.4 million in aggregate principal amount of notes issued for cash consideration and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 691.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">$23.0 million in aggregate principal amount of notes issued in the 2024 Term Loan Conversion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="font-size: 12pt; line-height: 7.28pt; position: absolute; top: 703.5pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(collectively, the &#8220;2025 Convertible Notes&#8221;)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 259.56pt; position: absolute; text-decoration: none; white-space: pre;">. <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 264.91999999999996pt; position: absolute; white-space: pre;">The 2025 Convertible Notes are due and payable in full 48 <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 295.72pt; position: absolute; text-decoration: none; white-space: pre;">F-40<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"><div style="line-height: 11.64pt; position: absolute; top: 36pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 217.17pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc.<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 55.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 180.72pt; position: absolute; text-decoration: none; white-space: pre;">Notes to Consolidated Financial <font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 366.64pt; position: absolute; text-decoration: none; white-space: pre;">Statements<font style="display: inline-block; height: 8.73pt;"></font></font></div></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 90pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">months from the issue date. Upon completion of an IPO transaction, the 2025 Convertible Notes shall <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 102pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">automatically convert into shares of the Company&#8217;s common stock at the IPO price per share at the lower <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 114pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">of a 20% discount and a valuation cap of $2.0 billion on a pre-money basis. In the event the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 126pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completes a sale of shares of preferred stock, the Requisite Holders may elect to convert the outstanding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 138pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Convertible Notes into shares of such series of preferred stock at the same terms. Further, upon a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 150pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">change of control transaction, the Requisite Holders may elect to convert the outstanding 2025 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 162pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Convertible Notes into shares of the Company&#8217;s common stock at the lower of a 20% discount to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 174pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">implied price per share of common stock in the change of control transaction and a valuation cap of $2.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 186pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">billion on a pre-money basis, or receive payment of all principal and any accrued but unpaid PIK interest. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 198pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The 2025 Convertible Notes do not accrue interest for one year following the date of issuance. Following <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 210pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the one-year anniversary of the issue date and for the remainder of the term, the 2025 Convertible Notes <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 222pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">interest will accrue on an annual basis at the rate of 7.0% per annum (PIK Interest). All PIK Interest <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 234pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">accrued and payable will be paid by capitalizing such interest on an annual basis and adding it to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 246pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">outstanding principal amount of the 2025 Convertible Notes. The Company is currently analyzing the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appropriate accounting treatment and financial statement impact related to the 2025 Convertible Notes on <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 270pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its consolidated financial statements.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Amendment to 2024 Credit Agreement<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 310pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On January 24, 2025, in connection with the issuance of the 2025 Convertible Notes, the Company <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 322pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">entered into Amendment No.1 to the 2024 Credit Agreement, in which its lender, Hayfin, converted $23.0 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">million of principal under the 2024 Term Loan to 2025 Convertible Notes under the same terms as the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other purchasers of the 2025 Convertible Notes. The principal balance outstanding under the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan, as amended, is $115.1 million. The minimum liquidity cash balance covenant under the 2024 Term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Loan was reduced to $15.0 million from the previous $25.0 million. In addition, the amount immediately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 382pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">payable upon the consummation of an IPO or SPAC, as defined in the terms of the 2024 Credit <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 394pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Agreement, was amended where repayment of the 2024 Term Loan will be at an amount equal to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 406pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">lesser of (i) the net cash proceeds of such IPO or SPAC in excess of $150.0 million and (ii) $50.0 million <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 418pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">(or $55.0 million if the underwriters exercise any portion of their option to purchase additional shares). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 430pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The exit fee and prepayment fee remaining under the original terms of the 2024 Term Loan, which were <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 442pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable upon issuance of the 2025 Convertible Notes was also amended to be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 454pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">immediately due and payable upon the next occurrence of a financing event as described in Note 8.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 474pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">2025 Facility Lease Amendment<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 494pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">On March 12, 2025, the Company amended the lease for its Austin, Texas facility to extend the lease term <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 506pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">an additional 12 months through December 31, 2026. The monthly lease payments are approximately <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 518pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">$57,000 per month during the one-year extension period.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 538pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Grant of Option Awards<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 558pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Subsequent to December 31, 2024, the Company granted options for 796,801 shares of common stock, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 570pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">subject to service-based vesting conditions, with an exercise price of $4.34 per share to employees.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_706" style="position: absolute; top: 72pt;"></div><div style="font-size: 12pt; line-height: 13.1pt; position: absolute; top: 179.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 214.48pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="position: absolute; top: 287.2pt; width: 612pt;"><div style="left: 140.4pt; position: absolute; top: 0pt;"><div style="position: absolute;"><img style="height: 57.28pt; width: 331.2pt;" src="heartflowlogoa.jpg" alt="heartflowlogoa.jpg"></div></div></div><div style="line-height: 13.1pt; position: absolute; top: 409.48pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: italic; font-weight: bold; left: 241.01pt; position: absolute; text-decoration: none; white-space: pre;">Common stock<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="line-height: 13.1pt; position: absolute; top: 491.08pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 18pt; font-style: normal; font-weight: bold; left: 205.99pt; position: absolute; text-decoration: none; white-space: pre;">Preliminary prospectus<font style="display: inline-block; height: 13.1pt;"></font></font></div><div style="position: absolute; top: 592.68pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 96pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 125.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 69pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 108.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 96pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 96pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">J.P. Morgan<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 165pt; position: absolute; top: 0pt; width: 125.25pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 125.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 3.1pt; position: absolute; text-decoration: none; white-space: pre;">Morgan Stanley<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 359.25pt; position: absolute; top: 0pt; width: 108.75pt;"><div><div style="line-height: 11.64pt; position: absolute; top: 3.75pt; width: 108.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 3.04pt; position: absolute; text-decoration: none; white-space: pre;">Piper Sandler<font style="display: inline-block; height: 11.64pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="position: absolute; top: 625.93pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 42pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 282.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 143.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 20.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 42pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 42pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Stifel<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 324.75pt; position: absolute; top: 0pt; width: 143.25pt;"><div><div style="line-height: 10.92pt; position: absolute; top: 4.68pt; width: 143.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 15pt; font-style: normal; font-weight: bold; left: 3.15pt; position: absolute; text-decoration: none; white-space: pre;">Canaccord Genuity<font style="display: inline-block; height: 10.92pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 7.28pt; position: absolute; top: 701.18pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.78pt; position: absolute; text-decoration: none; white-space: pre;">II-1<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_709" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Part II<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Information not required in prospectus<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1386" style="position: absolute; top: 127.2pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 127.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Item 13. Other expenses of issuance and distribution.<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 149.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The following table sets forth the costs and expenses, other than the underwriting discounts and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 161.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">commissions, payable by Heartflow, Inc. (the &#8220;Registrant&#8221;) in connection with the sale of the Registrant&#8217;s <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 173.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), being registered. All amounts are <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 185.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">estimates except for the Securities and Exchange Commission (the &#8220;SEC&#8221;) registration fee, the Financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 197.6pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Industry Regulatory Authority (&#8220;FINRA&#8221;) filing fee, and the&#160;Nasdaq Global Select Market listing fee.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 217.6pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 402.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 65.25pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 0pt; width: 65.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 4.7pt; position: absolute; text-decoration: none; white-space: pre;">Amount to be <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 65.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 44.14pt; position: absolute; text-decoration: none; white-space: pre;">paid<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">SEC registration fee<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 92.03999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 94.35pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 94.64pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 94.78999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 94.83pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 24pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 3.31pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">FINRA filing fee<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 72.03pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 74.33999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 74.63pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 74.78pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 74.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 74.83pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 38.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.73pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Nasdaq listing fee<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 82.07pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 84.38pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 84.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 84.82pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 84.83pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 52.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.73pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 66.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Transfer agent&#8217;s fees and expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 160.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 163.28pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 164.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 164.59pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 164.67pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 164.71pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 164.73pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 164.74pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 66.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.73pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 81pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Printing and engraving expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 148.21pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 149.37pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.6pt; font-style: normal; font-weight: normal; left: 149.66pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 149.81pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 149.89pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 149.93pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 149.95pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 149.96pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 81pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.73pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 95.25pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Legal fees and expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 113.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 114.92999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 114.97pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 114.99pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 115pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 95.25pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.73pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 109.5pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Accounting fees and expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 138.76pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 139.92pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 140pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 109.5pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.73pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #ffffff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 123.75pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Miscellaneous expenses<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 9.24pt; font-style: normal; font-weight: normal; left: 111.55pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 2.32pt; font-style: normal; font-weight: normal; left: 113.86pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 1.18pt; font-style: normal; font-weight: normal; left: 114.44pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.16pt; font-style: normal; font-weight: normal; left: 114.72999999999999pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.04pt; font-style: normal; font-weight: normal; left: 114.77pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 114.78pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #ffffff; border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 123.75pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 58.73pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="background-color: #cceeff; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 138pt; width: 402.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.32pt; width: 402.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Total<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 4.64pt; font-style: normal; font-weight: normal; left: 23.74pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.32pt; font-style: normal; font-weight: normal; left: 24.9pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 0.08pt; font-style: normal; font-weight: normal; left: 24.98pt; position: absolute; white-space: pre;"> <font style="display: inline-block; height: 7.28pt;"></font></font><font style="color: #b4b4b4; font-family: &#39;Times New Roman&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 25pt; position: absolute; text-decoration: none; white-space: pre;"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="background-color: #cceeff; border-bottom: 3pt double #000; border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 402.75pt; position: absolute; top: 138pt; width: 65.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 65.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 3.31pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 3pt double #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 377.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">*<font style="display: inline-block; height: 5.46pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">To be filed by amendment.<font style="display: inline-block; height: 5.46pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1458" style="position: absolute; top: 394.85pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 394.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Item 14. Indemnification of directors and officers.&#160;<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 417.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Section 145 of the General Corporation Law of the State of Delaware (the &#8220;Delaware General Corporation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 429.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Law&#8221;) provides that a corporation may indemnify directors and officers as well as other employees and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 441.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">individuals against expenses (including attorneys&#8217; fees), judgments, fines, and amounts paid in settlement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 453.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">actually and reasonably incurred by such person in connection with any threatened, pending, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 465.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">completed actions, suits, or proceedings in which such person is made a party by reason of such person <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 477.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">being or having been a director, officer, employee, or agent to the Registrant. The Delaware General <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 489.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Corporation Law provides that Section 145 is not exclusive of other rights to which those seeking <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 501.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 513.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors, or otherwise. Article&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of the Registrant&#8217;s amended and restated certificate of incorporation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 525.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provides for indemnification by the Registrant of its directors, officers, and employees to the fullest extent <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 537.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">permitted by the Delaware General Corporation Law. The Registrant has entered into indemnification <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 549.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">agreements with each of its current directors, executive officers, and certain other officers to provide <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 561.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these directors and officers additional contractual assurances regarding the scope of the indemnification <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 573.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">set forth in the Registrant&#8217;s amended and restated certificate of incorporation and amended and restated <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 585.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">bylaws and to provide additional procedural protections. There is no pending litigation or proceeding <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 597.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">involving a director or executive officer of the Registrant for which indemnification is sought.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 617.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 629.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">certificate of incorporation that a director or an officer of the corporation shall not be personally liable to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 641.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or an <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 653.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officer, except for liability (i) for any breach of the director&#8217;s or officer&#8217;s duty of loyalty to the corporation or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 665.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 677.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">knowing violation of law, (iii) in the case of directors, for unlawful payments of dividends or unlawful stock <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 689.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">repurchases, redemptions, or other distributions, or (iv) for any transaction from which the director or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 701.25pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officer derived an improper personal benefit&#59; provided that officers may not be indemnified for actions by <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.78pt; position: absolute; text-decoration: none; white-space: pre;">II-2<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">or in the right of the corporation. The Registrant&#8217;s amended and restated certificate of incorporation <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provides for such limitation of liability.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The Registrant maintains standard policies of insurance under which coverage is provided (a) to its <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">directors and officers against loss rising from claims made by reason of breach of duty or other wrongful <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">act and (b) to the Registrant with respect to payments that may be made by the Registrant to such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers and directors pursuant to the above indemnification provision or otherwise as a matter of law.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The proposed form of underwriting agreement to be filed as Exhibit 1.1. to this registration statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">provides for indemnification of officers and directors of the Registrant by the underwriters against certain <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">liabilities.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1483" style="position: absolute; top: 204pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 204pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Item 15. Recent sales of unregistered securities.<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 226.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Since January 1, 2022, to the date of this registration statement, the Registrant made sales of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 238.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">following unregistered securities&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 258.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(a) Equity plan-related issuances<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 278.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">1.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Since January 1, 2022, the Registrant granted to its directors, employees, consultants, and other <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 290.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">service providers options to purchase an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of its Common Stock under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 302.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">its HeartFlow Holding, Inc. Amended and Restated 2009 Equity Incentive Plan (&#8220;2009 Equity Incentive <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 314.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Plan&#8221;), with a weighted-average exercise price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 334.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Since January 1, 2022, the Registrant issued and sold to its directors, employees, consultants, and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 346.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">other service providers an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of its Common Stock upon the exercise of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 358.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">stock options under its 2009 Equity Incentive Plan, with a weighted-average exercise price of&#160; <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 370.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 390.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(b) Sales of preferred stock<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 410.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">3.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">In March 2023, the Registrant sold an aggregate of (i) 61,344,029 shares of its Series F redeemable <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 422.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">convertible preferred stock to 29 accredited investors at a purchase price of $2.8505 per share and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 434.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">(ii)&#160;21,465,064 shares of its Series F-1 redeemable convertible preferred stock to 19&#160;accredited <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">investors at a purchase price of $1.9098 per share, for an aggregate purchase price of $215.9&#160;million. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">The Series F-1 redeemable convertible preferred stock were issued upon conversion of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">indebtedness under outstanding subordinated convertible promissory notes.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(c) Warrants<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 510.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">4.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">On March 17, 2022, the Registrant issued a warrant to Hayfin Tourmaline Luxco S.a.r.l. to purchase <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 522.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">an aggregate of 225,579 shares of its Common Stock at a purchase price of $0.01 per share (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 534.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;2022 Hayfin Warrant&#8221;). <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 554.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">5.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">On March 2, 2023, the warrant issued to Hayfin Tourmaline Luxco S.a.r.l. on January 19, 2021 (the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 566.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">&#8220;2021 Hayfin Warrant&#8221;) was adjusted in connection with the Series F and Series F-1 Convertible <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 578.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Preferred Stock Financing, allowing Hayfin Tourmaline Luxco S.a.r.l. to purchase an aggregate of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 590.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">2,806,525&#160;shares of its Common Stock at a purchase price of $0.01 per share pursuant to the 2021 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 602.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Hayfin Warrant.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 622.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">6.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">On March 2, 2023, the 2022 Hayfin Warrant was adjusted in connection with the Series F and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 634.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Series&#160;F-1 Convertible Preferred Stock Financing, allowing Hayfin Tourmaline Luxco S.a.r.l. to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 646.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">purchase an aggregate of 2,004,665 shares of its Common Stock at a purchase price of $0.01&#160;per <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 658.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">share pursuant to the 2021 Hayfin Warrant. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 678.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(d) Convertible notes<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 698.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">7.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">From September 30, 2022 to December 16, 2022, the Registrant issued $40,000,000 principal <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 710.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">amount of the 2022 Convertible Promissory Notes to investors, including related parties, with original <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.78pt; position: absolute; text-decoration: none; white-space: pre;">II-3<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">maturity dates of 48 months from the dates of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 291.03999999999996pt; position: absolute; white-space: pre;"> issuance<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 333.27pt; position: absolute; text-decoration: none; white-space: pre;">. The 2022 Convertible Notes automatically <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">converted into shares of Series F-1 convertible preferred stock on March 2, 2023. <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">8.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">In January and March 2025, the Registrant issued an aggregate of $98.4 million principal amount of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">the 2025 Convertible Promissory Notes to investors, including related parties, with original maturity <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">dates of 48&#160;months from the dates of<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 252.73pt; position: absolute; white-space: pre;"> issuance<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 294.96000000000004pt; position: absolute; text-decoration: none; white-space: pre;">. The 2025 Convertible Promissory Notes will be <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">automatically converted upon the effectiveness of this registration statement into shares of Common <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 152pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Stock.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 172pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">No underwriters were involved in these transactions. The offers, sales, and issuances of the securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 184pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">described in paragraphs (1) through (2) were deemed to be exempt from registration under Rule&#160;701 <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 196pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) as transactions under <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 208pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">compensatory benefit plans and contracts relating to compensation, or under Section&#160;4(a)(2)&#160;of the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 220pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act as a transaction by an issuer not involving a public offering. The recipients of such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 232pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities were our directors, employees, or bona fide consultants and received the securities under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 244pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Registrant&#8217;s equity incentive plans. Appropriate legends were affixed to the securities issued in these <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 256pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">transactions. Each of the recipients of securities in these transactions had adequate access, through <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 268pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">employment, business or other relationships, to information about the Registrant.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 288pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The offers, sales, and issuances of the securities described in paragraphs (3) through (8) were deemed to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 300pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">be exempt under Section 4(a)(2) of the Securities Act or Rule 506 of Regulation D under the Securities <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 312pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Act as a transaction by an issuer not involving a public offering. The recipients of securities in each of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 324pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these transactions acquired the securities for investment only and not with a view to or for sale in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 336pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">connection with any distribution thereof and appropriate legends were affixed to the securities issued in <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 348pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">these transactions. Each of the recipients of securities in these transactions was an accredited investor <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 360pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">within the meaning of Rule&#160;501 of Regulation&#160;D under the Securities Act and had adequate access to <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 372pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">information about the Registrant.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1555" style="position: absolute; top: 392pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 392pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Item 16. Exhibits and financial statement schedules.<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 414.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(a)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Exhibits.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 131.62pt; position: absolute; text-decoration: none; white-space: pre;"> See the Exhibit Index attached to this registration statement, which Exhibit Index is <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 426.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">incorporated herein by reference.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 446.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">(b)<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">Consolidated financial statement schedules.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 300.96000000000004pt; position: absolute; text-decoration: none; white-space: pre;"> Schedules not listed above have been omitted <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 458.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">because the information required to be set forth therein is not applicable or is shown in the financial <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 470.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">statements or notes thereto.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_1603" style="position: absolute; top: 490.4pt;"></div><div style="line-height: 8.73pt; position: absolute; top: 490.4pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Item 17. Undertakings.<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 512.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 524.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">officers, and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 536.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Registrant has been advised that in the opinion of the SEC such indemnification is against public policy <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 548.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 560.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 572.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">paid by a director, officer, or controlling person of the Registrant in the successful defense of any action, <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 584.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 596.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 608.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 620.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">indemnification by it is against public policy as expressed in the Securities Act and will be governed by the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 632.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">final adjudication of such issue.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 652.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">The undersigned Registrant hereby undertakes that&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 672.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">1.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For purposes of determining any liability under the Securities Act, the information omitted from the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 684.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">form of prospectus filed as part of this registration statement in reliance upon Rule&#160;430A and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 696.8pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">contained in a form of prospectus filed by the Registrant pursuant to Rule&#160;424(b)(1) or (4) or 497(h) <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"><div style="line-height: 7.28pt; position: absolute; top: 22.12pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 298.78pt; position: absolute; text-decoration: none; white-space: pre;">II-4<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="-sec-extract: summary; left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">under the Securities Act shall be deemed to be part of this registration statement as of the time it was <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">declared effective.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 104pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">2.<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">For the purpose of determining any liability under the Securities Act, each post-effective amendment <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 116pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">that contains a form of prospectus shall be deemed to be a new registration statement relating to the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 128pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">securities offered therein, and the offering of such securities at that time shall be deemed to be the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 140pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">initial <font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 115.53999999999999pt; position: absolute; text-decoration: none; white-space: pre;">bona fide<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 156.66pt; position: absolute; text-decoration: none; white-space: pre;"> offering thereof.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div id="i2341357d54884756b9e9172f0a83cd6b_2217" style="position: absolute; top: 160pt;"></div><div style="font-size: 12pt; line-height: 8.73pt; position: absolute; top: 160pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Exhibit i<font style="display: inline-block; height: 8.73pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 118.64pt; position: absolute; text-decoration: none; white-space: pre;">ndex<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="position: absolute; top: 182.4pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 50.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 414.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 24pt;"><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 50.25pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 3.26pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Exhibit <font style="display: inline-block; height: 6.55pt;"></font></font></div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">number<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; border-top: 2pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 0pt; width: 414.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 14.06pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 166.91pt; position: absolute; text-decoration: none; white-space: pre;">Exhibit description<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 24pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">1.1*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 24pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Form of Underwriting Agreement.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 38.25pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">3.1*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 38.25pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Amended and Restated Certificate of Incorporation, as amended, currently in effect.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 52.5pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">3.2*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 52.5pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Form of Amended and Restated Certificate of Incorporation, to be in effect immediately prior <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">to the completion of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 78.75pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">3.3*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 78.75pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Amended and Restated Bylaws, currently in effect.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 93pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">3.4*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 93pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Form of Amended and Restated Bylaws, to be in effect immediately prior to the completion <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">of this offering.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 119.25pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">4.1*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 119.25pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Form of Common Stock Certificate.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 133.5pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">4.2++<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 133.5pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Warrant to Purchase Common Stock, dated January 19, 2021, between Hayfin Tourmaline <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Luxco S.a.r.l. and HeartFlow, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 159.75pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">4.3++<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 159.75pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Warrant to Purchase Common Stock, dated March 17, 2022, between Hayfin Tourmaline <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Luxco S.a.r.l. and HeartFlow Holding, Inc.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 186pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">4.4++&#8224;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 186pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Amended and Restated Investors&#8217; Rights Agreement, dated March 2, 2023, by and among <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc. and the investors listed therein.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 212.25pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">5.1*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 212.25pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Opinion of O&#8217;Melveny &#38; Myers LLP.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 226.5pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">10.1#++<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 226.5pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc. Amended and Restated 2009 Equity Incentive Plan and forms of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">award agreements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 252.75pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">10.2#*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 252.75pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025 Performance Incentive Plan, to become effective on the date the registration statement <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">is declared effective, and forms of award agreements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 279pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">10.3#*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 279pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">2025 Employee Stock Purchase Plan, to become effective on the date the registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">statement is declared effective, and forms of award agreements.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 305.25pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">10.4++&#8224;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 305.25pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Lease, dated August 9, 2021, by and between MV Campus Owner, LLC and HeartFlow, Inc. <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 26.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 319.5pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">10.5++&#8224;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 319.5pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Credit Agreement and Guaranty, dated June 14, 2024, by and among HeartFlow, Inc., <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HeartFlow Holding, Inc., Hayfin Tourmaline Luxco S.a.r.l. and Hayfin Services, LLP.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 38.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 345.75pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">10.6++<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 345.75pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Amendment No. 1 to Credit Agreement and Guaranty, dated January 24, 2025, by and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 14.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">among HeartFlow, Inc., HeartFlow Holding, Inc., Hayfin Tourmaline Luxco S.a.r.l. and Hayfin <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 26.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Services, LLP.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 17.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 384pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">10.7#*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 384pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Form of Indemnification Agreement for Directors and Officers.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 401.25pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">21.1++<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 401.25pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">List of Subsidiaries.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 415.5pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">23.1*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 415.5pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 429.75pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">23.2*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 429.75pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Consent of O&#8217;Melveny &#38; Myers LLP (included in Exhibit 5.1).<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 444pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">24.1*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 444pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Power of Attorney (reference is made to the signature page to the Registration Statement).<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 458.25pt; width: 50.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 50.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">107.1*<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 53.25pt; position: absolute; top: 458.25pt; width: 414.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 2.63pt; width: 414.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">Filing Fee Table.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr></table></div></div></div><div style="line-height: 5.46pt; position: absolute; top: 662.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 72pt; position: absolute;">*<font style="display: inline-block; height: 5.46pt; width: 15.09pt;"></font></font><font style="left: 90pt; position: absolute;">To be filed by amendment.<font style="display: inline-block; height: 5.46pt;"></font></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 671.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 72pt; position: absolute;">#<font style="display: inline-block; height: 5.46pt; width: 13.83pt;"></font></font><font style="left: 90pt; position: absolute;">Indicates management contract or compensatory plan.&#160;<font style="display: inline-block; height: 5.46pt;"></font></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 680.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 72pt; position: absolute;">+<font style="display: inline-block; height: 5.46pt; width: 13.63pt;"></font></font><font style="left: 90pt; position: absolute;">Filed herewith.<font style="display: inline-block; height: 5.46pt;"></font></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 689.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 72pt; position: absolute;">++<font style="display: inline-block; height: 5.46pt; width: 9.26pt;"></font></font><font style="left: 90pt; position: absolute;">Previously filed.<font style="display: inline-block; height: 5.46pt;"></font></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 698.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; text-decoration: none; white-space: pre;"><font style="left: 72pt; position: absolute;">&#8224;<font style="display: inline-block; height: 5.46pt; width: 13.83pt;"></font></font><font style="left: 90pt; position: absolute;">Annexes, schedules and&#47;or exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish <font style="display: inline-block; height: 5.46pt;"></font></font></font></div><div style="line-height: 5.46pt; position: absolute; top: 707.9pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 7.5pt; font-style: normal; font-weight: normal; left: 90pt; position: absolute; text-decoration: none; white-space: pre;">supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.<font style="display: inline-block; height: 5.46pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div id="i2341357d54884756b9e9172f0a83cd6b_712" style="position: absolute; top: 72pt;"></div><div style="line-height: 11.64pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 16pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Signatures<font style="display: inline-block; height: 11.64pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 107.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 119.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 131.2pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Mountain View, State of California on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025.&#160;<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 151.2pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 237.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 15pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 14.25pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 201pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="3"><div style="left: 237.75pt; position: absolute; top: 0pt; width: 230.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 230.25pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: bold; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">HEARTFLOW, INC.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="2"><div style="left: 237.75pt; position: absolute; top: 28.5pt; width: 29.25pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 29.25pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">By&#58;<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 267pt; position: absolute; top: 42.75pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 201pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 14.25pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 267pt; position: absolute; top: 57pt; width: 201pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.4pt; width: 201pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 2.63pt; position: absolute; text-decoration: none; white-space: pre;">President and Chief Executive Officer<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div><div style="line-height: 8.73pt; position: absolute; top: 235.45pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 12pt; font-style: normal; font-weight: bold; left: 72pt; position: absolute; text-decoration: none; white-space: pre;">Signatures and power of attorney<font style="display: inline-block; height: 8.73pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 257.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 269.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">appoints Vikram Verghese, Angela Ahmad and Mhairi L. Jones, and each of them, as their true and lawful <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 281.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">attorneys-in-fact and agents, each with the full power of substitution, for them and in their name, place, or <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 293.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">stead, in any and all capacities, to sign any and all amendments to this registration statement (including <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 305.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">post-effective amendments), and to sign any registration statement for the same offering covered by this <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 317.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">registration statement that is to be effective upon filing pursuant to Rule 462(b) promulgated under the <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 329.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Securities Act, and all post-effective amendments thereto, and to file the same, with exhibits thereto and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 341.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">other documents in connection therewith, with the Securities and Exchange Commission, granting unto <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 353.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 365.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">every act and thing requisite and necessary to be done in and about the premises, as fully to all intents <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 377.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 389.85pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div><div style="--justify: justify; --position: absolute; background-color: #FFFFFF; border: 1px solid #CCCC; content-visibility: auto; float: none; font-size: 0; height: 792pt; margin: 10px auto 10px auto; overflow: hidden; padding: 0; position: relative; width: 612pt;"><div style="left: 0pt; position: absolute; top: 720pt;"><div style="width: 468pt;"></div></div><div style="left: 0pt; position: absolute; top: 0pt;"><div style="width: 468pt;"></div></div><div><div style="line-height: 7.28pt; position: absolute; top: 72pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed <font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="line-height: 7.28pt; position: absolute; top: 84pt; width: 612pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 72pt; position: absolute; white-space: pre;">by the following persons in the capacities and on the dates indicated.<font style="display: inline-block; height: 7.28pt;"></font></font></div><div style="position: absolute; top: 104pt; width: 612pt;"><div style="font-size: 0pt; left: 72pt; position: absolute; top: 0pt; width: 468pt;"><div><table style="border-collapse: collapse; display: inline-table; width: 100%;"><tr style="height: 0;"><td style="padding: 0; width: 151.5pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 225.75pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 3pt;" rowspan="1" colspan="1"></td><td style="padding: 0; width: 84.75pt;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 0pt; width: 151.5pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 151.5pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 55.02pt; position: absolute; text-decoration: none; white-space: pre;">Signature<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 0pt; width: 225.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 103.63pt; position: absolute; text-decoration: none; white-space: pre;">Title<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 0pt; width: 84.75pt;"><div><div style="line-height: 6.55pt; position: absolute; top: 4.31pt; width: 84.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 9pt; font-style: normal; font-weight: bold; left: 32.63pt; position: absolute; text-decoration: none; white-space: pre;">Date<font style="display: inline-block; height: 6.55pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 17.25pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 9.67pt; position: absolute; text-decoration: none; white-space: pre;">President, Chief Executive Officer and Director <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 31.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 31.31pt; position: absolute; text-decoration: none; white-space: pre;">John C.M. Farquhar<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 31.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 51.23pt; position: absolute; text-decoration: none; white-space: pre;">(<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 54.559999999999995pt; position: absolute; text-decoration: none; white-space: pre;">Principal Executive Officer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 171.18pt; position: absolute; text-decoration: none; white-space: pre;">)<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 31.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 48.75pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 63.82pt; position: absolute; text-decoration: none; white-space: pre;">Chief Financial Officer <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 63pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.78pt; position: absolute; text-decoration: none; white-space: pre;">Vikram Verghese<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 63pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 52.9pt; position: absolute; text-decoration: none; white-space: pre;">(<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 56.23pt; position: absolute; text-decoration: none; white-space: pre;">Principal Financial Officer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 169.52pt; position: absolute; text-decoration: none; white-space: pre;">)<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 63pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 80.25pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 59.37pt; position: absolute; text-decoration: none; white-space: pre;">Chief Accounting Officer <font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 94.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 41.86pt; position: absolute; text-decoration: none; white-space: pre;">Mhairi L. Jones<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 94.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 48.17pt; position: absolute; text-decoration: none; white-space: pre;">(<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: italic; font-weight: normal; left: 51.5pt; position: absolute; text-decoration: none; white-space: pre;">Principal Accounting Officer<font style="display: inline-block; height: 7.28pt;"></font></font><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 174.24pt; position: absolute; text-decoration: none; white-space: pre;">)<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 94.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 127.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 35.03pt; position: absolute; text-decoration: none; white-space: pre;">William C. Weldon<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 127.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 45.4pt; position: absolute; text-decoration: none; white-space: pre;">Chair of the Board of Directors<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 127.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 160.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 34.28pt; position: absolute; text-decoration: none; white-space: pre;">Timothy C. Barabe<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 160.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 160.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 193.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 40.48pt; position: absolute; text-decoration: none; white-space: pre;">Julie A. Cullivan<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 193.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 193.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 226.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 22.43pt; position: absolute; text-decoration: none; white-space: pre;">Nicholas Downing, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 226.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 226.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 259.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 34.18pt; position: absolute; text-decoration: none; white-space: pre;">Jeffrey C. Lightcap<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 259.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 259.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 292.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 29.67pt; position: absolute; text-decoration: none; white-space: pre;">Wayne J. Riley, M.D.<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 292.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 292.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 325.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 39.65pt; position: absolute; text-decoration: none; white-space: pre;">Lonnie M. Smith<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 325.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 325.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 358.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 37.51pt; position: absolute; text-decoration: none; white-space: pre;">Casey M. Tansey<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 358.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 358.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr><tr style="height: 3pt;"><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 15.75pt;"><td style="border-bottom: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td></tr><tr style="height: 14.25pt;"><td style="border-top: 1pt solid #000; font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 0pt; position: absolute; top: 391.5pt; width: 151.5pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 151.5pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 16.42pt; position: absolute; text-decoration: none; white-space: pre;">Charles A. Taylor, Jr., Ph.D<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 154.5pt; position: absolute; top: 391.5pt; width: 225.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 225.75pt;"><font style="color: #000000; font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 95.38pt; position: absolute; text-decoration: none; white-space: pre;">Director<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"></td><td style="font-size: 0; text-align: left; vertical-align: top;" rowspan="1" colspan="1"><div style="left: 383.25pt; position: absolute; top: 391.5pt; width: 84.75pt;"><div><div style="line-height: 7.28pt; position: absolute; top: 3.37pt; width: 84.75pt;"><font style="font-family: &#39;Arial&#39;, sans-serif; font-size: 10pt; font-style: normal; font-weight: normal; left: 14.63pt; position: absolute; text-decoration: none; white-space: pre;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025<font style="display: inline-block; height: 7.28pt;"></font></font></div></div></div></td></tr></table></div></div></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>business12ba.jpg
<TEXT>
begin 644 business12ba.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" <($$H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLGB6]=20<X*F7!'L>#7]"'P#^*UG\;_@UX0\<V6T1ZUI\=Q)&ISY4V-LL?\
MP&177\*Z.1N#FNCM]_\ PS.?GM-0[G?T445F:!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !117Y>_MB_\%0_BI^SW^T7XL\ ^'= \'WNCZ2UN
M()]4LKJ2X;S+>.5MS)<HI^9SC"CC'UJ7)*2CW+47).2Z'ZA45^*W_#ZOXW_]
M"M\/_P#P77W_ ,F4?\/J_C?_ -"M\/\ _P %U]_\F51!^U-%?BM_P^K^-_\
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M2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCTK[HD_X(D_#$QL(_'OBU9,':S"U(![$CRAG\Z\,_P"")'_);OB!_P!BZO\
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M23O6)0WZ@UO5M4BH3E%;)G/2DYTXR>[2"BBBLS4**** "BBB@ HHHH ****
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M]>DO_H!K^6FOZEO$W_(MZK_UZ2_^@&OY::XX_P >7HOSD=<OX4?5_DC]_/\
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M!0 0P( P:WC%5$W!F$I.F[31]B_$CX;^&_BYX*U3PEXNTJ'6M U*/R[FSF)
M;!!#!E(96! (92"" 0:^5/ ?_!)+X"^!?&T'B)H/$'B);>83P:3K5]'+9(P;
M*Y1(D9P"/NNS ]P:U?\ @JY_R9%XT_Z^]._]+8:_!>V_X^(O]\?SJ,+^\K\L
M='=*_P!VORN;U(^XD]4]?T_0_JC50J@ 8 X %+4%E_QYP?\ 7-?Y5^0/_!1+
M_@I!XJUCQYK7PT^%VM7'AWP[I$SV.IZQI[F*[O[A&*R)'*#NCB5AM^4@L0V3
MM(%93GRR4%JV327M(<^RT_'H?J]XK^*'@WP&R+XE\6Z%X=9SA5U;4H;4GZ>8
MPJUX7\>>&?&]N9_#GB+2=?@Z^;I=]%<K^:,17\X7PI_9R^*?[0<E]=>"/!^K
M>*4@<_:KZ-0L(D."5::0JA<[@=N[=@YQ6=X]^%_Q%_9W\76EOXHT/6?!&O1'
MS[2:0- QVG_60S*<-@G[R,<'O6GPV4]+B^*[AT/Z:Z*_+/\ X)J_\%%_$GC'
MQEIWPF^*6I/K4]^/*T/Q!<<W!E52?L]P_P#RTW ':Y^;=P2VX$?J96DX<MGN
MG_7W_P!;&<9\S:ZH****S- HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M? /4M0O_  !XEN/#=WJ$2P74MO%$YE13N"D.K#@^E>I?\/'OVD/^BIZE_P"
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M9\0OVMM8LI_%L]K8Z/IY9K'1-+1H[6%FX,AW,S/(1@;F/'.T*"17JW_!./\
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MFOTK_P""H'P?_P"%L_LC^)IK>'S=4\,,FOVN!SMA!$X_[\O*<>H%?EI^Q?\
MMUO^QOI'B6#3_ =IXFU#79XGFO[C4&MV2.-2$B"B-N,N[9S_ !>U?0^K_P#!
M;#5==TF]TV^^$&EW%E>0O;SQ/K4A#QNI5E/[GH0375BOWE)4Z>Z5_P#M[?\
MR7R.;#_NZKJ3ZO\ \EVM^;^9^>'PZ\<:C\,_'WA[Q9I+[-2T6_AOX.2 6C<,
M%..QQ@^Q-?TS_#_QIIWQ'\#:!XJTF02Z9K5C#?V[9_@D0. ?<9P?<5_+S.R/
M-(T2&.(L2J%MQ49X&>_UK]JO^".WQM_X3SX :CX$O;CS-3\'7FV%6;+&RG+2
M1]?[L@F7V 45T0_>47'JM?T?Z?<S&?N55);/3]5^OWGO7[?W_)FOQ8_[ S?^
MAI7\[%?T3_M_?\F:_%C_ + S?^AI7\[%>7'_ 'F?^&/YR.^7\&/J_P HG]*O
M[,/PO\-?"3X&>#M#\,:9%IUFVF6]S,R*/,N)GB5GEE8#YG8GDGV P !7RC_P
M68^'>DZU^SGI'B][2$:YHFLPP17FT>9]GF5U>+/4J6"-CU6OMCX5_P#),/"'
M_8'L_P#T0E?*7_!7K_DS>_\ ^PU8?^A-71F3]^3_ +Z_]*2_(YLO_AQ_PO\
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M!W*@J /6OSQ_X(I_!G^TO%OC3XH7D.8=,@71-/=AQYTN))V'NJ",?24U^M[
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MEL-?@O;?\?$7^^/YU^]'_!5S_DR+QI_U]Z=_Z6PU^"]M_P ?$7^^/YUG@?\
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MAB'>?K_2,Z<9T%:']7\S]9_ /_!''PK\/_'7AWQ19?$K7)+S1=1M]1AC:QA
M9X9%D )!X!*XK]#Z_-G_ ()__P#!3S4_B]XLT_X:_%86Q\1WQ\K2O$5M$L"7
MD@&?)GC7"K(V#M9 %8X7:#@G])JTFI1BE>ZZ?K^1$7&4F^O]6"BBBL34****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY6/R8^+O[(_Q@^!&E)JGCGP%J>B:4S!#J'[NXMD8X"J\L+.J$DX 8C)Z5A_
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MZ5XW\)V^MPZ[IHE$#76I-+$1)&T;!EVC/RN?QP:Q/^"KG_)D7C3_ *^]._\
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M+,_ Z^T<W.H:3XNTN^1 6LC80REV[A'6;! ]6V_2OC_]N?\ X*>3_M)^$9?
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M^5#C"GG'UKBK1<H67=?FCMH24:B;/YQ*_I_^%?\ R3#PA_V![/\ ]$)7X_\
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M]%%%<YN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,UI4DWY?J>E4445R&Y^9W_!;SP;+>?#SX:^*8T8QZ?J=SITK#H//B5US_P"
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M7]+OQXL9M3_9V^(5G;EEGN/"VH11LO4,UI(!C\37\T5M_P ?$7^^/YU_4O\
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M!(/%>5?&[_@LQX6\.>/-"T_X;:))XL\-P70;6M5O(WMC<08P4M$;#!AG=OD
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M^!^VG_!&VSFM_P!DN\EDC*1W'B2\>)C_ !*(H%)'XJ1^%?D_^V!_R=7\7O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P 3[3/7_KYK]]K5&CM848894 (_"I:*U]HW!4^B=_OM_D1RKFYCX\_X*??
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M/5_&&FZYJ5MK%T]I NAP0RNKJFXEQ++& ,>A- 'N%%? '_#ZOX(?]"M\0/\
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M_P F4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\
M\F4 ??\ 17P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\
M)E 'W_17P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E
M 'W_ $5\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90
M!]_T5\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]
M_P!%? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??
M]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4 ??\
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M_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E 'W_17P!_P^K^"'_0K?$#_ ,%UC_\
M)E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\ 0K?$#_P76/\
M\F4?\/J_@A_T*WQ _P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ _P#!=8__ "91
M_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%? '_  ^K^"'_ $*WQ _\%UC_ /)E
M'_#ZOX(?]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\
M#ZOX(?\ 0K?$#_P76/\ \F4 ??\ 17P!_P /J_@A_P!"M\0/_!=8_P#R91_P
M^K^"'_0K?$#_ ,%UC_\ )E 'W_17P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K
M^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_
M@A_T*WQ _P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A
M_P!"M\0/_!=8_P#R90!]_P!%? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?
M]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\
M0K?$#_P76/\ \F4 ??\ 17P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K
M?$#_ ,%UC_\ )E 'W_17P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*W
MQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ
M_P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/
M_!=8_P#R90!]_P!%? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\
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M4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4
M??\ 17P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E '
MW_17P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_
M $5\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90!]_T
M5\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%
M? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??]%?
M'_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4 ??\ 17P!
M_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E 'W_17P!_P
M^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\
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M?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\
M0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ
M_P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%? '_  ^K^"'_ $*W
MQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\0/\
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M_P F4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\
M\F4 ??\ 17P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\
M)E 'W_17P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E
M 'W_ $5\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90
M!]_T5\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]
M_P!%? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??
M]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4 ??\
M17P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E 'W_17
MP!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\
M ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90!]_T5\ ?
M\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%? '_
M  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??]%? '_#Z
MOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4 ??\ 17P!_P /
MJ_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E 'W_17P!_P^K^"
M'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX
M(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90!]_T5\ ?\/J_@A_T
M*WQ _P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%? '_  ^K^"'_
M $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\
M0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4 ??\ 17P!_P /J_@A_P!"
MM\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E 'W_17P!_P^K^"'_0K?$#_
M ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\ 0K?$
M#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ _P#!
M=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%? '_  ^K^"'_ $*WQ _\
M%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\0/\ P76/
M_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4 ??\ 17P!_P /J_@A_P!"M\0/_!=8
M_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E 'W_17P!_P^K^"'_0K?$#_ ,%UC_\
M)E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\ 0K?$#_P76/\
M\F4?\/J_@A_T*WQ _P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ _P#!=8__ "91
M_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%? '_  ^K^"'_ $*WQ _\%UC_ /)E
M'_#ZOX(?]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\
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M]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\
M0K?$#_P76/\ \F4 ??\ 17P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K
M?$#_ ,%UC_\ )E 'W_17P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*W
MQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ
M_P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/
M_!=8_P#R90!]_P!%? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\
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M4 ??]%? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4
M??\ 17P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E '
MW_17P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_
M $5\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90!]_T
M5\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%
M? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??]%?
M'_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F4 ??\ 17P!
M_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E 'W_17P!_P
M^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\
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M?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E 'W_ $5\ ?\ #ZOX(?\
M0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "90!]_T5\ ?\/J_@A_T*WQ
M_P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R90!]_P!%? '_  ^K^"'_ $*W
MQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F4 ??]%? '_#ZOX(?]"M\0/\
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M=TA\9_$?0M*ME8%DT*UFO7=<\@&40A3CO@X]#7OG_#ZOX(?]"M\0/_!=8_\
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M'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H
M^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^
M/^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P
M0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X
M@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ
M_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC
M_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$
M/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^(
M'_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K
M'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H
M^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^
M/^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P
M0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X
M@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ
M_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC
M_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$
M/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^(
M'_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K
M'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H
M^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^
M/^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P
M0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X
M@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ
M_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC
M_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$
M/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^(
M'_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K
M'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H
M^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^
M/^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P
M0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X
M@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ
M_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC
M_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$
M/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^(
M'_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K
M'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H
M^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^
M/^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^=/V5_VZ
M/ ?[7FK>(-/\':1XCTV;1((I[AM<MK>)761F50GE3R9.5.<@=J^BZ "BBB@
MHHHH **** "BBB@ HHHH *_-7_@MY_R2SX:?]AFX_P#1 K]*J^:OVWOV-?\
MALKPKX:T;_A+_P#A$/[%O9+SSO[,^V^=O39MV^='MQUSDT ?SV45^JG_  XQ
M_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6
MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\
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MT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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M,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
MEJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M '
MY5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_
M ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1
M_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
M=M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717Z
MJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_
M ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ
M_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E
M717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .
M,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_
M  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9
M_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!V
MT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI
M_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\
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MT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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M,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
MEJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M '
MY5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_
M ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1
M_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
M=M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717Z
MJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_
M ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ
M_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E
M717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .
M,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_
M  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9
M_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!V
MT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI
M_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\
M#C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_
M ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0
M!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_
M  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9
M_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!V
MT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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M,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
MEJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M '
MY5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_
M ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1
M_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
M=M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717Z
MJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_
M ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ
M_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E
M717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .
M,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_
M  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9
M_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!V
MT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI
M_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\
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MT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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M,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
MEJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M '
MY5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_
M ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1
M_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
M=M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717Z
MJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_
M ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ
M_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E
M717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .
M,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_
M  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9
M_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!V
MT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI
M_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\
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MT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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M,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
MEJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M '
MY5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_
M ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1
M_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
M=M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717Z
MJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_
M ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ
M_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E
M717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .
M,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_
M  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9
M_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!V
MT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI
M_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\
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MT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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M,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
MEJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M '
MY5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_
M ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1
M_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!^5=%?JI_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
M=M 'Y5T5^JG_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ?E717Z
MJ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!^5=%?JI_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'Y5T5^JG_  XQ_P"JV?\ EJ?_
M ';1_P .,?\ JMG_ ):G_P!VT ?E717ZJ?\ #C'_ *K9_P"6I_\ =M'_  XQ
M_P"JV?\ EJ?_ ';0!@_\$/?^1Z^*O_8-L?\ T;+7ZY5\C?L/?L"?\,9ZYXKU
M'_A._P#A,/[=MH+?R_['^P^1Y;.V<^?)NSOZ8&,5]<T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4453U+6+#181+J%];6,1X#W,RQJ?Q8B@"Y17++\5/
M!32%!XPT$N.JC4X,C_QZI/\ A9GA#_H:]$_\&,/_ ,50!TM%<X?B1X249/BG
M10/7^T(?_BJ='\1?"DW$?B?1G/\ LZA$?_9J .AHK#;QUX:7KXATH?6]B_\
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M_P#CE+_PTI\(O^BJ>"O_  HK/_XY0!Z/17G4?[1_PEF.(_BCX+<^B^(+0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***H2>(-+BD>-]2M$D0
ME61IU!4CJ",\&FDY;(5[%^BL_P#X2+2O^@G9_P#@0G^-'_"1:5_T$[/_ +_I
M_C5^SGV8N9=S0HK/_P"$ATK_ *"=G_W_ $_QH_X2'2O^@G9_]_T_QH]G/LPY
MEW-"BL__ (2+2O\ H)V?_?\ 3_&C_A(M*_Z"=G_W_3_&CV<^S#F7<T**S_\
MA(M*_P"@G9_^!"?XTG_"1:5_T$[/_P "$_QI>SGV#F7<T:*SO^$BTK_H)V?_
M ($)_C1_PD>D_P#04L__  (3_&CDGV#F7<T:*SO^$BTK_H)V?_@0G^-'_"1:
M5_T$[/\ \"$_QHY)]@YEW-&BL_\ X2+2O^@G9_\ @0G^-'_"1:5_T$[/_O\
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M .>B_P#?0H\^/_GHO_?0H DHJ/SX_P#GHO\ WT*//C_YZ+_WT* )**C\^/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "LKQ1XJTCP3X?O=<U[4;?2=(LH_-N+RZ<)'&OJ3]< #J20!6
MK7XN_P#!2#]L;4OC!\2KWP)X;NBO@?P[=&'="W&H72@!Y6QU56W*HZ<;NIX
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M;^-_>>H?\+S\;?\ 04-._P"%Y>-O^@H:X!6!QBGAJ]99?@O^?,?N1Q_6*_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD"+G;6E>->0Q#862NFL_#ZQS#<@7\*T]2\/Q26XP>U 'G46H7</S2$O5VQU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5'L]%%%?C9^G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\P_P#!0J58?@KI
M!89!U^ ?^0+BOS[DACDCW "OOC_@HZXC^!FCLQP/^$AM_P#TGN:_.^WUO=&$
M0$=LF@">21H6Q@8IT,8N#D<FF-;H\9EED&>N,UG"[E\PK V%H T[S?"F !6:
MMF;A\^6&8^U/<7#?,V6^E6+.^FAD'RX^HH&6[;PG/(H=HPH]JEN-+DMTPO6M
M)_$AAM\,1G%84_B-GE]LT"(X[.<L2Z\5(L)5A@FKJ:G%)#EB :IF^5F.WF@"
MRUX;./U-4GU W3<\"DF4S?>X%4YHX[<Y#9/UH T(Y$CZC=4%TOVJ0!#L'M4<
M;LT?RC-+$R1'=(#NH V-/LXX8\LV3[U7OE#2?(U027C>3E00*IVTMQ--PIQ0
M!T5F\2P[7)S5>\A@C;>K')JO)=K:J!(P#>E,:<W297D4 6(?+D7+N:JWTR1J
M1'5>0..AQ5-FFW=>* )+?S)),YQ5B5A9_.W)JND^SA8VD;_9I\D,\Z_/&RK[
MB@!]M>17CXD/RUI2);B'$ ^;UQ69#:HG\!%:VFP@L,]* ,:2V9'W2N<5%-<!
M>+?EO6MO6K=)/E3BLB.V2WZG=0!8TVQNKKYIY&"^F:OR21V Q'@GUID<A\KY
M59![TD6F)>-EI/UH R]2BEO$+@@#ZURUYYL&50 M71^(+>6W7RXCQ7,W"/9Q
M%V/S4 <OJ27(D+2@8^M4%5I/X0!6A=72W,QWFJLS[5(BYH L:1<+#>(,GK7U
M-\']3C-O&IY-?)=C<-#<#/7/2OIGX)PFXC1Y,J* /HJ.\VQ#"C&.M9'B;6HD
MTV16;!Q39[HQH$C/&*Y7Q<RMI\K-(-V/6@#YR^*$JW5_+CD9KS=;2!6/.&KK
M_&MVW]H2J3D9KBY8\R;LXH S=77$@ )85<TJWBBBWO\ *:N_98WCW;=Q%9%Z
MLC96-&% &E'JL=K+G?P*K:IJS:I\D<IQ]:Y^ZL9XU+LV15.WO LFTG;0!>NK
M%8P=S;FJA&UQ"_/"5?33I;AO,63Y:@U"WEVE=P H ;-&URGRR8/L:JQV=Q"V
M2VX?6HX+=U))D_"I6DD&5!R* ,?7FFVL<\X]:XF0DN<]<UW>I0R-$V 3Q7"S
M*4D8,,'- #**** "OZ4_V3O^36?@W_V)FC?^D,-?S65_2G^R=_R:S\&_^Q,T
M;_TAAH ]5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \]^.NF'5/AUJ<0&<1,
MWZ5^&VH$P>(M7C;^&Z<?J:_?+QA9KJ'AG4X6&=UNX_2OPO\ BIX??PW\1-4M
MG79YEP[#\S7WO"]36=,\',X_#(P(YJF62H# R]!5B.RGV[MO%?I$>;:Q\X[$
MJR\"G>95<(ZGD5,L9ZUM'F9&A)NI=U-,9%)M-::]2= -)2[33&#<^E2RD,;K
M4,O>IL&F-&6-8R3915;FF"W+&KH@!J:.U/I6:HN3*Y[%2.UZ5:CM:M1VV,5:
M6'IQ7;"@8RJ%6.UVTYH]M6VCVU&5]:Z'"R,^:Y JU,O%)M IF[FI7NCW+*R=
MJ?YN!559,T\R#%:J9'*/:0L:?'SUJ'K4T?%7%WU!EI32[J@\W%(TWRUOS&?*
M%Q(%6LZ2\^;&:?=7 (/-8]U<;<G->=7K6V.BG"Y]'?L8ZTUE\4  V-Q4?K7Z
M[6[;K>(^J@_I7XN_L@WK2?%2$+_?7^=?L_8_\>5O_P!<U_E7Y!Q1)3Q,9+L?
M797'EIM$]-=%D4JPRIX(-.HKXH]H^!_VX?V=UC_XJ/2+?).9)MHKX9M;J2-@
MC@J<X(/6OW)\3>'+3Q3H]QI]Y&KQ3*5.X9Q7YD_M1?LNZG\/];NM8T^V)TV1
MB5P.U?I'#^;KE6&K/5;'Q6<9>T_;TUIU/")-.6^L25&6 S3O!=XT-QY+'!!I
M/#>H+DQ2<?PD-3=1C_LK65F3B,U^G74>3$1Z;GP$KM2HR^1ZC)']KL".M>W?
MLD?%]?!VN-HMU)MCNI .>E>&>'[L75JO/!%5XIWTO6%F@8I,&RI!KTLSPE',
ML-[*IM+\SQ<OQU3 8CGANC]>;6ZCO+=)HF#QN,@BIJ\ _9;^*G_"6Z$--NI1
MY]J@'S&O?Z_FC,,%4R_$SP]3='] 8'%PQU"->&S"BBBO..X**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M )-9^#?_ &)FC?\ I##0!ZK1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ^!?\ @M)_R:IX=_['"T_]([VOQ25BK C@U^UO_!:3_DU3
MP[_V.%I_Z1WM?BC0!NZ7XRU#3-H23*#M7<:%\25O)$CN#L/<M7E5 )4Y'!H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M445D^*=4;1M#N;M1N:-<XH U<TM?($?[0=\/$UU&UXP17XBS7M'@SXSVVJQH
MET/+)_B8T >KT55L=2M]0C#P2K(I]#5AF$:EF.%'4T .HKB_%'Q<\,^%4;[9
MJENDB_P%^:\H\1?ME^&M)5_(,=P5Z;7KT\/EN+Q6M*FVCCJXRA1TG-(^BZSM
M3\06&CQL]W<I$%Y.37P5X^_;HU+5Y'M](MY;7L)$->.ZU\9O&GB0MYVL3[&Z
MJ2:^QP'!>.Q5I57RH\#$\0X>CI!7/T)\6?M/>"O"ZN&U2%Y5_A+5XAXV_;J1
MH9(M'M(YNP96KXMU**?4I-][(9V)Y+&I[.S@MU&U0M??8+@? T6G6;DT?-XC
MB+$U%^[T.O\ '7Q0U[XB:I]LN9I8,'A=U<R3<R?ZVX9QW!-#3*O&<56FOE3/
M-?H.'P>$P<5&E!*Q\U4Q%:N[SDV7/+C5<8J&22.,?* *S)M810?FQ6)J'B1(
MP0'K:IBJ-+70JG1G+0Z"ZU18U/S5S.K^)TC!&_\ 6N9U3Q,S9 /%<S+<W.KW
M AM5:>5C@*O6OE\;G5DU%GM8? _S&AK7BC?GYN*U_A3\'/$7QJ\0PV>G6LLE
MJSA9)E!^4>M>V?LZ?L0Z_P#$V_@O-9BDT^R)!Q,APPK]-?@_\!O#?P?TN.WT
MNRA6X  >95QN/K7Y/FV?7;C!WD?98/+]FU9'#?LY_LH^'_A+X7BBO+.&\OI(
MP)&E09KQO]KW]CA-<BN/$'ANWQ./F:&%>@%?=%1SPI<0O%(NZ-QM93W%?$X;
M,:^&K^WC+4]RIAZ=2'(T?@7J5C<Z'J4EC?1&&XC)!1AZ4S-?I;^U;^QK8>*K
M"YUSP_;K#>CDI&O)K\X_$/AO4?!^J2V&J6SVTJ,0/,&,^]?L&69G1S"G>+L^
MJ/D<3AIX>5GL9V:=NH"AN12E:]PX1I--(S2T4F,$4+3F8>M1MG%022$5',HH
M=KDDDE4Y9NM$DQQ5*:0\UQU*AO&(LDN:;YP'>JS,:9N-<#GJ;\I>6?G@U*MP
M:HPU8Q6D9,EI$S77O2>?[U5D^4U&TFT4O:,.4GFN?>J<C;\YJ*:X"<LV*[7X
M9_!_Q+\5=6@M=,L)VMW8 SHI(KCKXF$$Y3>AO"FY.T48'@_P;J7Q"\00:/I-
MN]Q/(PX0<XK]:?V/_P!D/3?@_H,.HZE"MSJ<P$@,B_-&?2K?[+/['>C_  ?T
MVWU#4(8[K5R PE*_,N>U?4( 5< 8 K\WS+,I8J7)#2)]%AL,J2O+<  HP!@4
MDDBQJ68X [FN0\:?$O2_"-K(\L\;2*/NYKP#Q!\<-:\5W3P:+%*ZDX_=\UX!
MWGTO<>+=,MYA$URH<G &:UHI5F0.IRIKY:\*_#_Q;X@U&WN[V>:!%<,5<&OI
M[3;=K6RBC8Y95 )H M4444 %%%% !2$XYI::^-IR<#'- 'E/Q&_:$T+X?:HM
MA<S1FY89",>:\!\3^)8?B-XHMM4C<*L;9 6N?_;:\,V(UR/4[6[22Y1?]6IY
MKQ#P#XPO])DB\UFV<=:X\33IUH^SF[7/*S"C1Q5%X>K/EN?6DL9FL]A'RD<U
MX1XVT.;PMX@.HQ@^3.^#Z5Z[X.\21ZU8+E@Q84GB#P]#KUO/:S@$[?W>?6O-
MHTOJ52W1GY)@8XGAG-U2KN].?7R.<^'/C :/JT-\LFZ*0A67/'O7T7XN^#_A
M/XV>&!(MI;Q3NF/.503G%?%21W7A'7GTJ[W!5.59J^DO@;\3GT62.QNI"UNW
M.XGBOHZ=6=*7-!V9^USA"M&TE=,^7_BU^PIXC\.W4\^APS7L.21M'%?/.O?#
MWQ;X'D<ZCIDL"KU9@:_<.SO(-4M1)$RR1N/K7+>+/A)X8\96LL.H:7#,7&-S
M+7T]#/ZT;*JKGS.(R&E-/V3L?BSI/C9X7 D)7'K7=>'_ (F&&4;;DQX]#7V3
M\1O^">.EZU<2W&D7$5FK'(C5>E?,GQ,_8F\6^"O,DT])K]1_SS4U]AA.(H.R
M4_O/B<9PW+5RA\T0Q?'9-,O PN_/D]":Z1?VD+N1D"2E..S5\OZU\'?'FGW+
MRMHEY\O?8:Y>[/B31YPEQ;3Q2CC8P.:X,QJX;,ZGM,3';L>EEM'$Y72]GAI;
M]S]&/A;^TK>VNH1":=I$SRK-7VYX$\;6GC+2H[B!U:3:"R@]*_%'X4:?X[U3
M6()(](O'M<Y,@4XK]!_V:?&USI.IQ:=<LR.S!71NU?G^+HPHU&J;NC]"P=:=
M:DI5%:1]G44V.02(&4Y!YIU<1VA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX0<UJ6.E%N"<"@#)UZ6WEX  JAI>H0V\FT8KH=0\,&?.%KG;GP[+:R<*<>M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ JO?6,.I6LEO.N^)Q@K5BHY[B*UC,DTBQ(.2S' H
M\$\:?LLZ=JUY->:3LM;ESNW,>]>)^)M,U/X7:A]GU*;SHU; 9>E>D?'3]L?2
M? \TVF:5+YE\I*;EY&:^,_'_ ,>_%'CZ9S>RQF G(P,&OK,OX;Q>.C[1^['S
M/G<9GF'PDN1>\SZ]\"_%R2U1&AO%,7]T'FD^,_QTUZ;P^Z:#))#,1C*C-?"&
ME_%:[\,W042L5SZUZSX=^/%O?0*MPP)]ZYJN7XC*<0IU(<\5]QT4L91S"C:$
MN5O[SSSQ)JGBCQ%>RRZR9YF)Z\BN4O+62/@12LWIDU]%OXXT'5%_TE5*GKM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'P+_P %I/\ DU3P[_V.%I_Z1WM?BC7[7?\ !:3_ )-4\._]CA:?
M^D=[7XHT %%%% !1110 4444 %%%% %[2)H8+M&F^[GTKTO3+BUNH5\DD?A7
MDZL58$=:Z'0_$$L+!78;10!Z7)&88MQ'%9<UU'(Q55W'W%/T_6I+Y5C X]ZU
M+G3U6'>J?-0!SDC/&VXIM'M4\>L1E-C"I)V9<AEK/DDC5CE: 'W&JQ19V(,^
MN*LZ;?0R\R56ALH;CG8QI[6*QJ=@*?6@"?4E2Y4B$"LF&TEM6W,Y'T--GD>-
MMJMD^U-\YH^7R30!>^UNO5LCW-0F[CE8 #YJBAL)=2;Y6P*FDT]]+&YOF- &
MO:R&.')>HI+N:<E5 (^M81OYKI@NUE6M6U:.UBW9W-0 UD:-_P!XHQ5RUC^T
M,$B7)-5X6:]D^8?+77^&=+62XC6*)BQ- '6?#7X?1W-[%+<#N#TKZ\\)^';>
MUTV-(F*<>E><_#'P+*MO'/(F..XKU&XNCH]J2SJH44 6+BQ%DI<S$X]:\R^(
MGQ&_L6UD2-LMC%97C;XO?9W>&-\]N*\2\8>/!J&X.W+>M &1XI\8G6;B1YY6
MZ\#->::Q/)-(1$6(]JW+K3VU20LAR#Z5O:'X'GN%&T#_ ($* .-T*VE4[GW'
MZUHWTKGCH/05U6L:(^AQ%I2OX"N4^U)-(3CI0!8TZTEF 91M6N@L=:&EL 78
MFN9_M>YC.R/&WV%3P7RR']]&V: .IU#7I-0AP&VCZUR=U',9,J=WOFEO[B/:
M?+8H?<UA37]W'G:"X]10!Z#X;NFMH_FC4FNBM?$4<5TH=MI]!7E^C>(+DD(5
M(_"NJM[B+<CR=: /H+PKJ7]J682/D$5QGQ0\,R>4\B$@UJ?"_7+.:1(0PW?6
MO2_%GAF"_P!++DAB10!\/ZI:WMO.PW' /K4$5]<HA#?./1C7K7BCP7%'=2$*
M0,UQ6J:"ENAPP/L* .#U"9+J0B6WC'O7*ZE;PPR'8W/I7:ZEIL<>YBC"N&U!
M2MPW'':@"K1110 4444 %?TI_LG?\FL_!O\ [$S1O_2&&OYK*_I3_9._Y-9^
M#?\ V)FC?^D,- 'JM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<
MC\0?B9H_PXL4N=5N$A5_NAF S6E.G*K)0@KMD3G&G%RF[(ZUF"J6/0#-?GU^
MV]\=+W_A(G\+Z?<-#%MW%D:N\^+7[=&G6NDW-OHT#^85*B56S7Y\>,/'E[X^
M\1S:K>NTDS$@%O2OM\FRJKAZRKXF-ET1\?FN9TZ])T</*[ZLDU9%N82Q.YVY
M9O4UCV\(CJQ',\B_,>*KWE[':1,S' K]"J24GSGP].+BN5%+6-6&GPLR\L!P
M*^L/V./V75^+$<6OZVGEV.!(BR+D-[5YC^SG^S7JOQM\46UW+$R:3"X:3>IV
MNM?K5\/? >F_#KPS::/ID"PP0KC"BOS[.LVDG[&C+U/NLIRU->UJHM>$?!VE
M^"=(BT[2K6.V@08VH,9K<HHKX1MO5GV"5M$%%%%(84444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444V218U+.=JCDD
MT .JCJ>M66CPF6\G6%!SEC7G/Q(^/&C>"8Y(HY%NKC'W8VY%?)?C_P"-.N>,
M+R1OMCV]GG_5L>U?693PYBLS:FURP[L^*SKBK!Y2G!/GJ=D?3/CS]I;2?#Z2
MQ6#1WDHX&UJ^;?'7QYU?7+>\N/[0DT] "57=7B_B3QS8:6K.TJR3?[W>O-[=
MO$GQC\20:-HJS)#))LD902 #7VN+RG+LKP<X4W>HUN?G^#SC,\ZQL)UHVI)_
M#L?1'[.'@T_&KQ\]S?W_ -L\DB0LW.<&OT<T?2;?1=/BM+:,1Q1J!A:\6_9=
M_9ZM_@SX6MS.%DU61/WDH')S7NU?D=3EYO=/V^CS<GO!11161L%%%% !1110
M 5SOCOQ!)X<\/7-W#&9)%7@"NBJKJ&FV^J6[07,8DC88(- 'P#XMUS5OB!XH
M:T3S)9)Y-H7_ )YU]5? OX.VW@71X;JYB5M1D7YV8<BMO0?@OH6AZ])J<=LG
MFE]Z\=*]#H ***R=>\36/A^W:2ZF5"/X2<4 :U<'\6/&]AX9\*WQDG3[1L^6
M//)K@O&'[0UO;B2.U!BQD!LU\T^.?B3<>(+N5KVX^T1DG SVK*K)P@Y(X,=6
MEA\/.K!7:.7TB0ZMXQU&_8;1,^X?G7L.DMY=J,>E>*:+K%N-0_=84$UZ]HMZ
MLEJ.>U?*5FY.[/Y]S)SJS=274H0:JUIXTMG'!,BC]:^Y]*D\[3+5_P"]$I_2
MO@75Y4M_$%I+W\Y?YU]T>"[S[;X=LWSG]VH_2O9R]^ZT?IG!TE["<#=HHHKU
MS]%"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ^!?^"TG_)JGAW_ +'"T_\ 2.]K\4:_:[_@
MM)_R:IX=_P"QPM/_ $CO:_%&@!54MTI*** "BBB@ HHHH **** "A6*G(.#1
M10!V?@W4)(G'F_,O8FO0#J0GC 45X[HNJ?V;=*[@LGH*]9T%H_$%J&1&C7WX
MH JW,;L2<9%9=Q F<NVT^E=1-H;1G:C<?[1K*OM'6'YG;<?8T 944CPC]V>*
M2XO97&T#/K4OV5YOE7Y5IQ5;&-AE6- &;'(BL?,&&ITD,<OS%^*J7$4EQ-E6
M44-8S!<O(-OL: -BPAF;Y;;D^M32Z;>*^;DEAZ$UFV-Z]CQ$>?>IGUZY\P%_
MFH ==V[(OR)MJM9VLDT@W-@5>N)I;NWW$8&*QHKXV=Q_$>: -R2&>WP(\FO6
M/@MIT^H:M#YL9*YKA_"BV^KS1B8XR>]?3_PGT.UM?+," GUQ0![]X;T^"VTJ
M/HI"UY-\8]?>RCD2)RH]J]<AC,=B,-SCI7@/QH6YD60JN%]Q0!X1J=\+J9V>
M0LWO7%ZU8O<S ASC/2N@NE>.9B_K5WPYH[:QJ4:E<J3S0!K_  R^'][K.S;
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M-?S65_2G^R=_R:S\&_\ L3-&_P#2&&@#U6BBB@ HHHH **** "BBB@ HHHH
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M8+^3S+B-L?*>]?HG^PG\$;?P[X?'B&[MU=[I T98=Z^$O%D,G_">WA*\+/\
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M_$;6KCYXQ+\O3@UXAJ<+7$S$@N<]Z ,6XU*:^F)8<9ZTGG8;!&:O-;M;KN=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X%_P""TG_)JGAW_L<+3_TCO:_%&OVN_P""TG_)
MJGAW_L<+3_TCO:_%&@ HHHH **** "BBB@ HHHH MZ=I-WJTPBM(&F<G&%%>
MU?#_ /9SGU*-;O6I1;0=3&XQ7D_AOQ;/X9D\RWA1WSD%JZ+5/C5XBU*U,'VA
MH$Z?(QH ]RNM%^'7P_A^:2"6X7^$-S7G?B;XV:7',8=-TX^6.CAABO&KS4+G
M4)#)<3/,Y[L<U7H ]+;XPR3*5,!0'W%9Z^-X[JXW,-I)[UPE'TH ];BUS[1
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MYKAY;>292Q&&H Q+Y45BP3YO6N>OKCD]SZ5TUYISLI+NRBN2U"X2UF:-!O\
M<T 4)'+DEAMJ"G22&1LFFT %?TI_LG?\FL_!O_L3-&_](8:_FLK^E/\ 9._Y
M-9^#?_8F:-_Z0PT >JT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(Y[>1H9HV#))&<%2.A!K[[_9)_:N'CA;?P?XMN57747;9WLAQ]J 'W6/]_\
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M5O0H[@@_44 =[167X=\4:-XPTM-2T'5['6].<E5N].N4N(6(Z@.A()_&M2@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFO(L:,[L$11DLQP
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M/(L4$2&221C@*H&23[ 4FU%78U=Z(EHKY6;_ (*B_LQ*Q!^)HR#CC0=3(_\
M2:O3/@?^UG\*/VD+_5;+X=>+%\0W>EQ)-=P_8+JU:-')"L//B3<,@CY<XXSC
M(JDG+8EOEW/7:***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR=_R:S\&_P#L3-&_](8: /5:*** "BBB@ HHHH **** "BBB@ HHHH ****
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MC];J*KZ??0ZI8V]W;.);>=%DC=3D%2,@U8K^1&G%V9\R%%%%( HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH **** "BBB@
MHHHH **** "DV@]A2T4 ,,,;=44_A5>?2[.Y7$EM$_U05;HIW%9&.WA+26SF
MQA_[X%9E]\,?#VH B6PC.?1175T5:J36S(=.$MT>3:U^S'X'UQ6$]@P+=U(%
M>5>+OV$O#5]O;2T9&/3<]?5U%=E+,,51?N39Q5<NPM;XZ:/S>\8?L(^++"1F
MTMD\O/&6S7C7C3]G_P ?>"HR]U$TD8_YYJ37["LH;J ?K5#4M!L-6MWAN;2&
M5&&/F0&O:I\18N"M+4\2IPW@YN\=#\G/A7X#M]65?[;62-LX(8XKW"Q_9_\
M!>I*N2^3_MU]&>,/V5]"U>9[JR:2"8\A$^45YKJO[/\ XLT'<=.5I$'0LU>?
M+.,;*3DJC/1ADN!C%1=-,S="_99^'Y96N0Y'^_7I_AS]G_X7:2J-'"Q<?WC7
MDLGA;XA:?D-;\#WI@;QK:+F6%@!UQFN6IF&*J?%49U4\NPE+X::/J71O!_@_
M2T46L$.!TW 5UEG#IL*A8$@4?[(%?&D/C'7;+'GB88] :U;7XP7-F0'>8$>H
M-<4IRE\3.Z,(QTBK'V&K)V*_@:=N'K7RI:_'JXC489C_ +P-;%C^T%=[A]W'
MO4%GTI17C>B_'*.X*BY9 *] T7QYI>L!1',-YH Z2BFJZNN5((]J=0 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8%Q(KG=N"MR-G3'>OA?3/^"W.O:AJ5I:GX4:<@GE2+=_;4AQN8#/^I]ZY/\
M;X_X*-_#7]J;X%IX+\*:)XJT_5%U6WOO.UFTMHH/+C60$9CN)&W?.,?+CKS7
MYXZ3=I8:K97,@8QPSI(P7J0&!./?BEA=:S57X>9?=97_ !N57LJ:]GO9_?=_
MI8_J;C;?&K=,C-)(I>-U5BC$$!AV]Z^ 8_\ @M3\$4C53X6^(&0 /^0=8_\
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M<Q7.ZH+RQ&=[#(H K27PNFS\V*V-*DAR 0!]:R8[JTC^7 +5I6]LERNX'8*
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M*WO+2XA>X:+S=.U:'!VY'W6]5/<=J_,1A7M7[-_[1VH_!?6197C27OA:Z?\
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M4_\ '2!^%?0E?G]_P3X\4MIWQ%UK1'?$6H6?FJI/&Z-NWN=P_*OT!K^1>,\
MLOSNM""M&7O+_M[5_C<\S$Q4:KL%%%%?$',%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJT.#MR/NMZJ>X[5^;_C[P%K'PX\276B:W:M;7D#8Y'RNO9E/<'UKT_\ 9O\
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MZ-NWN=P_*OS_ ([P"QV25)V]ZG:2^6C_  ;.NNU4HOR/T!HHHK^3SQ HHHH
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 -?[K?2OY=/''_(Z^(/\
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M#G;E2<<9. ?2-+_X+;Z-H^FVEA:?!BXAM;6%((HT\0J%1%4*H ^S=  *M?\
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M /8T+_Z27%?C[X3\37W@OQ5HWB'3&1-1TF\AOK9I%W*)8G#ID=QE1Q7[!?\
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M=V/T -?S,_&#XD7WQ?\ BEXJ\::B3]KUS49KTHQSY:LQ*(/95VJ/917[1_\
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M!M^FZY0_510!^2OQ!\>:U\4/&VM^+/$=XU_K>L73W=U.V>78YPH[*!A57H
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M9"/P5R:_!;]L7Q%HGB[]J+XF:UX<O[?5-%U#6IKFVO;5P\4RL02RL.H))YH
M\HT76+SP_K%CJNGSM:W]C/'<V\Z'#1R(P9&'N" ?PK^G;X8^,T^(WPU\)^+(
MXO(CU[2+35%BSG8)X4E"_AOK^7VOZ0/V+;A[G]DGX0.YW,/"]@GX+ JC] *
M(OVV_P#DT7XN_P#8M7G_ *+-?SB5_1W^VW_R:+\7?^Q:O?\ T6:_G$H [SX!
M?\EV^''_ &,FF_\ I5'7]-E?S)_ +_DNWPX_[&33?_2J.OZ;* "BBB@ HHHH
M **** /RK_X+G?\ -$_^XW_[85^5=?JI_P %SO\ FB?_ '&__;"ORKH ^O/^
M"4?_ ">[X+_Z]-1_](IJ_>ROP3_X)1_\GN^"_P#KTU'_ -(IJ_>R@ HHHH _
M++_@N7_QX_!C_KIK'\K*ORDK]6_^"Y?_ !X_!C_KIK'\K*ORDH *^[?V;_\
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M:R:3.\ARW^C2O#'D]SY:1G/O7\]-?N-_P1WNGN/V0?+;I!XAO8U^A6%OYL:
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MOV9/B'XNCF:"^M=+DMK&13\RW<Y$$##UVR2HQ]E/3K7LM?F=_P %LOBL--\
M^ OAU:S 3:M?2ZS>HCD,L,"^7$K#NKO,Y'O![4 ?D17K/[*/P;;X^?M#^!O
M[1M)8ZCJ"OJ&UBN+.(&6X^;L?*1P/<@=Z\FK]2?^")OP:\_4O'?Q4O(,I;HG
MA[39#R-[;9KDX[$*+8 CL[CZ@'ZNQQK%&J(H1%&%51@ #L*=110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U_NM
M]*_ET\<?\CKX@_["%Q_Z,:OZBW^ZWTK^73QQ_P CKX@_["%Q_P"C&KE?^\+_
M  O\T=,?X$O5?E(_37_@CW\&_ 'Q-^&?Q NO&'@;PWXKNK75X8H)M<TBWO'B
M0PY*JTJ,5!/.!7Z!_P##)_P0_P"B-_#_ /\ "7L?_C5?%G_!$/\ Y)/\2?\
ML-P?^B*_2BO2KZ35NT?R1YU#6#]9?^E,Q?"_@GP[X'LOL?AS0=+T"S_Y]]+L
MX[:/_OE% K:HHK#?<Z-CYN_;_P#VE+W]F#]GG4?$6B^6/$VI7":3I+RJ&6*:
M169I2IX.Q$=@#QN"YXK^?_6-:UWX@>*)M0U2]OM?\0:I.#)<7,C3W%S*Q &2
M<EB3@#\!7[*?\%GO".H:Y^S1H&KVD<DMMHOB&&:\"?=2.2&6(.P]G9%S_M^]
M?C;X*\2R>#/&6@^((H5N)=)O[>_2%C@.8I%<*3V!VXK##J,Z\N=Z72]%9/\
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M_DWOP/\ ]C0O_I)<5^2GPB_Y*QX*_P"PW9?^CTK]:_\ @ME_R;WX'_[&A?\
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M(N^&UDP5LU/K_M_RKYS/<^PV0X;VU;63^&/5O_+NSZO*\+5Q]3DI[+=]B/\
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MKW[5)^R_^RY#\/[6'Q1XJ@27Q#(N^&UDP5LU/K_M_P JX;]JK]JK[4UUX/\
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M2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'Z@5X%7KO[(?BJ'P3^U%\*]8N76*U@\1V23R-T2-Y5C=C]%<G\* /Z2Z***
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M(MK50#^"_K7WG7YS?\$2_%T-]\#?'GAD'-UIGB%;]AGI'<6T:)_X]:R5^C-
M!117Q)^TQ_P5$\,_LT_&+6?A]J/@C5-;O--CMY'O+2\B1&\V%)0-K#((#@4
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MV,_ECV05^)'[ WP9_P"%Y_M5>!]#N(//TBQNO[8U,$97[/;8D*M_LNXCB/\
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MP_>^&_%UFK'R?L]ZUK<.O8LDRJBGV$C#WKGO#O\ P2-_:)UNY\J\T70_#Z9
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MAM8R9-B&**0EC(L74 8!KZ&HK*45-6?]6U-8R<'='XK?\.5/C?\ ]#3\/_\
MP8WW_P AU^N7P1^&-I\&?A%X1\$691XM#TV&S:5!@2R*H\R3_@3EF_X%7;T5
MMS-1<.C_ $O_ )F/*G)2ZK];?Y!1114%GY^?\%!_^"<OBO\ :F^*6B^-/ NJ
M^'M)NETT6&IIK=Q/#YK(Y,3IY4,F3M=E.<<*N,UXU^S_ /\ !*WX\_ OXT>#
M_'=KXH\!N=$U".XFBBU&]W2P'Y9HQFS RT;.O/K7ZT444?W#3AT=_O=PJ_OD
MU+JK?A8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;QMM7)- %^.25L!CFM"$Q2+M9!FL:.2>9AL7Y?I4\DS6ZYP=U &A<6*1KE
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M_E?T_4;O2+ZWO;&YFLKVW<2PW%O(8Y(W!R&5@<@@]Q7MUU^W9^T#=Z6NGO\
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M,;UK%:W\YB"<>U=3XCB#+Y:-L/Y5DZ7IZI)F0[J ,)M'19-S1[JN;+6VAS(
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MI7QK\>_^"5/P9^,U]<ZMI%O=?#[79V:22?0=OV65R22SVS#:.3_RS*5]F44
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M_A&OMW72OMOVC[1]G_Z;1[-OV?WSN[8Y^4_^'&4G_1:E_P#"6/\ \F5^K%%
M'P-^R?\ \$L7_9B^.&B_$,_$Q?$@TV*YB_LX:#]E\SS87BSYGVE\8WY^Z<XQ
MQ7WS110 4444 ?*_[='[#K?MH0>"XU\:#P?_ ,(XUXV3I?VW[1YX@_Z;1[=O
MD^^=W;'/R?\ \.,I/^BU+_X2Q_\ DROU8HH ^+?V)?\ @G,_['GQ*UGQ8WQ
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M_$;Q/;,LD,VI0K%8V\@P0\=L"P+ ]Y&?'! !&:^V*** "BBO OVG/VUOA_\
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MRR6^\?,FGP[EB^F]VD?W7RSZ4 ??-%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP,>6C'Y]0HHHKY\] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX7SFF[>QO_V]'_,^9C32*^P/#O[ MZTB_P!O:U;K'_%_9UPS'\-\(KUOPO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"E@0/K4RR2>8$6V50.];^GVXF #)D^E '+K87/V@!6&WVKJ]-T^181N-:?\
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M"+]!0!XCJ%B]W&6SSZ5Q>H6=Q',0$;%>^:QX3$:GR4_2N(NO"DSW'+L>?NT
M<+I5C-<2*BV[,<]0*]@\,^'(K.R$UP #C[IK2\)^"65%/E*#_>KIKCPV(XBK
M/N/I0!Q=YXTL]'8H$'%9$GQ"ANY,!>*O>)OA;=ZKODBR@Z\5YQ=> M6L+KRD
M+D9H U?%5\FIQ'RQS7ZI_ M2GP2^'RGJ/#VGC_R6CK\M;#PG<0V^;G.:_5+X
M.Q^3\(O \8Z+H=BOY6Z4 =A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\.Z>Q_&VCH [BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLS+>#[QQ6?-_HN0H+5+:LJ1+M.2:U8;5IHLF,_6@#*L[I>L@Q]:;=R),W[O
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MO64F1A[9K]@_@C$(/@OX C7E4\/Z>H_"VC%?D<NE/:RKD[%]Z_7/X)C;\&O
M0SG_ (D%AS_V[QT =I1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !117S_^U]^V1X0_9'\$_;]79=6\47R,-)\.PRA9KIAQO<\^7$#U<CV
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MH ]4TC6@TR MD5Z19ZQ;_95'RYQ7S;'XA?3VX.6%=#H/C:X:=3*3MS0![;/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?D%_P6)_:AE\2>,K+X,:%=XT
MG13'?ZXT3?ZZ\9<Q0G!Y6-&#$?WG&>4%?J/\;/BA9?!?X1^+?'.H!7M]"TZ:
M\$3''G2*O[N+/J[E$'NPK^>KX4^#-=_:R_:0T_3=2O))M1\3ZK)?:OJ/>*(L
MTUS-SP"$#[0>,[5[TF[*[ _0?_@DO^S+9^!?"5U\=?%MJ$U+4$DM?#D<XP8;
M;E9K@ CK(044_P!Q6/(DKZV\;?&R]UU9;/2#MC)*DD8KE_'GB2VNH=.\*^&H
MA8Z#I,$5I:6\.0L4,:A$0>P4 ?A6;^YTNU#87..2:_"N+^-*E"K]1RUZ]67R
MZ790TG2S:7#W%P=TK'<2>:S_ !MXU^QV_P!DM26N'X55YK"\6_$>&Q4Q0MNF
M;@*.:]"^ OP1O/%&I0^(M=1A&K;XE/0BOA\AX?Q6>8M5J^V[9DT=I^SA\&FT
MZ/\ X2+5(]T]SB2,-VKZ.J&UM8[.W2&%0D:# 45-7]1X3"T\'1C0I*R0TK!1
M1176,*^7?VQIA)<:/:?\]5Z?C7U%7S-^U!X7U3Q%XV\-"RA\R!!^\/IS0![3
M\(;?[+\-]!BZ;;<"NPK"\#V3Z=X4TVV<;7CB"D5NT %%%% !1110!^97_!8#
M]DU->\/P?&WPU8YU3352T\1QPJ29[7A8;D@#K&2$8_W&4\".O-_^".W[4,OA
MOQE>_!C7;O.DZT9+_0VE;_4WBKF6$9/"R(I8#^\AQRYK];O$&@V'BG0=2T75
M;9+W2]1MI+.[MI/NRPR*4=#[%21^-?SD_&/P#XB_8^_::U31;.ZEM]6\*:O'
M>:3J'0R1!EFMIN, Y0H6 XSN7M0!_2+17$_!/XH67QI^$?A+QSIX5+?7=.AO
M#$ISY,C+^\BSZHX=#[J:[:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#XX_X*G;_ /AG?0]G7_A)K;_T
MFNJ_*]9O)Y<9-?J5_P %6IVM_P!G/0V7K_PD]L/_ "5NJ_+'39UN%^?DT 6H
MYDN.V*F7]UPB?C4<DEK <G</]VE37+5?E5')]UH ?)H[7PW%ME6;&V^P_*S[
MQ389#=8*EE'I4[6(<<LP- #+F!9I,HNTU(+4K"?FYJK/;26_*LQJNVH7#*5P
M* *MW&&E(,E-_LGSX\*^#5B*WFF;<%!J]'<);_(Z_-["@#D[[PS*JDER_M6!
M-I_V6;+)BO19W;EMI*_2L:^5)LY0?E0!S9U"2&,"-]M26^H+,096RWK3YH(6
M<A>M5[C35'S _E0!Z=\.O$CVM[&D4I49%?4_AJ^@O-+!G8.Q7O7QS\.;%&U"
M/)?K7UWX)TM#8)PYX[B@#Q_XS::C2.\0VKS7AFVU61E< O7T9\<66SMW!7 P
M>U?+TU[#->$ D-F@#H(8IX_FA&%K5T^:\,@#H=OK6%I]J[X(F;'UK;L[@Q,%
M+Y/UH Z1I$:WP!\U9L-K*9LM)M7TJ["KO#\N,T6]J5DW2M0!;CMX&0 J&/K4
M=Q88C)3I5II(FCQ#G=5,V]U(W)POUH SX[.1YL!RO->E>!?-M60(W-<K9K9V
M_$K,7K=TB-KJ91;R[!GUQ0!]!>&[J[FC09W#%=)= 10EI!AL5QW@'3YK6%"\
MVXX_O5>\;:E-;VK!#\V.U &3JTT\EWB-R%S79^$;.=H5+DD5X]H.J7!U+-SO
M9,_6O<?#VN6:V:*H8-C^(4 7KVW5.C\^E11S97;MS5Z-4OCG(%4M0TV53^[;
M\C0!BZUH_P!N4@2[?;%5M)T1])^82UTME:%$_>%2U*8HHI,S_<]J ,UM6N%.
M$):GPM)>/F=>/>KM_J6GM#M@3YO7%9]GEF.6(H U(&M+5L)$"WK3KQ3=)\AV
M5F7"!>1(OYTD4V!R['Z&@!LT;V:G<^:BLYI&DRK5+*KS=B1[U-#;Q1C+97Z4
M 6_.:0!7-031&+YE&:;L60XB8D^]/^SRK]\\>QH JS:@TBE"O/I6:PE23)C(
M6N@%N NX*I^M9UU>1K)M(Y]A0!=T^X58Q\F/>G7U]9V\#O*0&Q3+>XB$/(Q^
M%<_K%J;W<$;CZT >2_$N^EUBZ:.UD.W/:JG@C1!:S*93YCYZ8KH]:\+SB8E5
M'X59T/1Y[-P[)DB@#LH;3R[3<5V+BO./&EY;1LPWC=76ZYXA:&Q:,G:<5XUK
M-Q)>7S%GRN?6@"]8ZV\#_NW)K]<O@M*9O@[X$D;[SZ#8,?QMXZ_([3[&W:,<
MD-[5^N/P541_!OP&HZ+H%@!_X#QT =G1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C,%4DG '
M4TCNL:EF(51U)KP[XS?'"+0XWTS3)-UT^4++R!7!CL=0R^C*OB)62+C%S=D=
M=X^^+^G^$XVBB(N;CIMC.2*\<U#QYKOBR8LMRT$#?P-7 6=P]U(U]J,N^X;D
MDGBH]3\>):M]GM$::4\ 1C-?S#Q#Q?F>>5GAL!>,/+=GM4L/"DKSW.TDL[6
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MUKVCX)_!A-/6/6-4C#W##Y58<U#\%?@WY6W5]9C#NPRJGUKWV.-8T"J-J@8
M%>IY$@JB-0JC"@8 IU%% 'QC_P %"-7EC;PMI*L?*OV*.N>O-?0/[.&BQ>'_
M (/Z#91($1(^@KYV_P""A-G(=6\%7H'[JWD+.>PYKZ4^ NH1ZG\*]$N(R&1H
MN"* /E+]O_15TS6_#NLVX\NY?4(@SKU(W"OL_P  ZA_:7A'2IN_V>,'_ +Y%
M?'G_  4*U1)&\-V2'=+_ &C%\HZ_>%?7GPVL6T_P7I4;]3;H?_'10!T=Q'YT
M$D?]Y2OYBOSKA\70_LO_ !XO9=47[1!JUXTP_P!D9K[_ /%VNKX;\/W=^PR(
ME/\ *OA+X1_#>/\ :P^(WB#5/%9%QI^DW92-5.#MSTH V/VB?VN=!\?:'!X5
MTJ F?5085?<#M)KZ-_97\#R^!?A#I%E</OEVY)^M>0?&[]C7P9X8\'WGB7PU
M:/:ZGI,1GC,C[AD=ZM? #X_WM_\ !2^:_#7&IV-J[AHQW .* $_;$^,\A6W\
M$^'Y2^K33JDPB.2$;@\5\]_&[X-P?"3P/IT+HIO+JXBN&?OECDUE?!3XO:+J
M'QFO?&OC'3+R>0[D4%3V/'%:O[9O[3WAKQO'9)8V5S&(I(_OKC@&@#]%_AO_
M ,B#X>_Z\8?_ $$5TE>+_LZ?&_1?B5X,T:#3K>>%X;6.)O,&!D*!Q7M% !7'
M_&3P]%XN^$/CC0IEW0ZGH=]9.,9XDMW0_P#H5=A5;4DBDTZZ2<XA:)P_^[@Y
M_2@#^>'_ ()_Z[+X=_;+^$]U"VUY-86S)_V9XWA8?E(:_HGK^;3]C]Y8_P!J
M[X.F$9?_ (2[2@?]TW<8;],U_270 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!\H_\%)(S)\"=' X_P"*
MAM__ $GN:_,^X@ECY(XK],/^"DDAC^!.CD=?^$BM_P#TGN:_-.>]=AAEXH 2
M"<R+M\HD_2G+I)FDW%=HI;;4(;5<L>:)-8\YCM?:/:@#1$0@AVIUK-N"\;9/
M2I[6X:9@BG)-=+8^ [W5D#(C/GL!F@#F;26)OO+DT^Z6&;@L![9K<UCP3J.B
MQEFM6 ]2*XB[AG:4CE6H ORZ;&RD(P!JBVAK#F1GY^M.M4GA8>8Q(JU>;Y(<
M@<8H YVZNYXY-D9RM0R23NG/7Z4^9W60@)BI8\NN#0!AW4+,#N<9K6\(:#=S
M7R,HW+GTJK>0"%MQ&17>_#:^62Z1 @H ]7\/M<:3I>77&%]*\2^+GBJ>XNG1
M9,#/3->\:_.]KHY(3^&OEWQ[J'VB^E4PY.: .?TNYCDD+32\_6NNTS5+=<*F
M&^O->>Q:/-/)O7Y177^'-)VLN3DT =<EN;G## %3NRPKMZU:M88H80&;GTJM
M>6<EQ_J10!3D6%EX!S5,K)&V0<"M&+1[E>67BH+JUE4X(H :8);J/ D'T%9<
MVGRV\FXAJV;=7MUW;>*/[425]CIF@""S62Z 1%)-=GX=T6ZML.J$-]*;X4TZ
M*ZG4JF.?2O5+73UM;=3L[4 <[9W5W:L//!V_2NU\/W4%YM^7!]ZY^:X@DFV.
M!G-=KX7\-K+&LH.%H U3HEE>1XD0'--M? ]A%()$4CZ&NCM=(4X P14\VGQQ
M\"<J?04 4[>-;!-L2,?H:FCB:Y.YU8TR19X1B(>9[FG+--;QY?@^E $C206_
M!B;-59[Z%N"/PJ);I[F4JW%2W&G11IO)R: *JRNS?(,"BXM9+C&[@5)#)MZ+
MQ4DC2R#Y* %M;6.)0":O_:%MTP@S66A.<.<&K*RJBX;&WZT 6H]0L^?.^]]:
MI7$D<[_N2"*9)IMM>-D28JQ;:.D(^60@^PH @\D+_K*?]H%O]U":I:EOLY,L
M[-]:?97:WB@=#0!;6ZO9O]6GR_2M*QE6-LW3<^AJ*V>XA&V-,KZTVYC67EA\
MU $VH217"D1CY:RXPB28'6FW,WD+@';3+"$R2>87)^M &G]O^SKC.#6;) +N
M;>TH_.I;O$C[0H)J&33I(8_,/'M0!)JUT;/3VVAF&.U>;1^(KE=2^0./F[UT
MVK7UU<1F(;D3UKDKB:WTURSR;G]Q0!Z=I.K//9@S,I..E?>_PY8-\/?"[#H=
M+M3_ .05K\LF\9^7Q'*17Z@_!^<W7PE\$S$Y,FAV+Y^MNAH ZZBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH-)CA"Z"V'XG[0?R/I7[HT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/I6O-<7=RW[O*+0!TTEBY3*2*1]:Q=0>2URQVFGZ?=31+M;+FF7UK+??PG%
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MW-?K)\&4\OX/^!4_NZ#8C_R72OS6?39>CG!K]+_A*OE_"GP8O]W1;(?^0$H
MZRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-'<6TZ++%-$P9'1AD,".H((.:FH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OS _X+9_%Z.U\-> _AC;2_Z3>7#>(+Y%."L48>& 'U#,\Y^L0K].;R
M\@T^TFNKF:.WMH$:66:5@J(BC)8D]  "<U_.?^U=\9;_ /:L_::\0>(]-AFN
MH-2O4TS0K-5.\VR$16ZA>S/]\C^](U 'Z#_\$3?A;)I/P^\??$"ZMRIUB^AT
MJRD<<F*W5GE*^S/,H/O%[&OTOKS+]FCX/P? 7X#^"O D2QB;2=.C2[>/[LET
M^9+AQ[&5W(]B*]-H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%(S!>6( ]Z %HJ$WD"]9HQ_P(55O=>L+!"TMU$ /]L5G*I""O)V
M&DWL<MXJ^#WAWQ?J$5YJ%H)9XWWAO>N>^,W@726\#N@5(%A&Y2W'05:\6_M
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M1110 4444 %%%% !1110 4444 %%%% !7P+_ ,% OV1;W7+BY^)W@NS>ZNV
M;6]-@3+N  HN(U'4@ ;P!_M>M??5% 'X&:?NA7YCBK4FK10M\YXK]/?C_P#\
M$_O"/Q6N[W7/#5Q_PB/B2X)D?RDW6<[XZM&/N$]RGKG!-?$7CK]@;XU>$KK
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MS\ ?B5_#\.?%9^FAW/\ \10!Y5JD@,6V/('M69:V:2$E@2?<5ZS)\!/B8/\
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MZ1Z-<,?T2@#YCM;I54*IRU=+I+2L@W#BKG_#-OQ?LKLE/AAXSD7/\/AZ[/\
M[3KJ-+^!_P 7-H#_  Q\8Q_[WA^['_M.@#"&GJR@D<U);PBV?(6N\LO@9\4?
MX_ASXL'UT.Z_^-U<G^!/Q),1(^'7BLM[:)<__$4 >;WUX0OS' KGKBZC:7]V
M26KT&^^ 7Q4NIBO_  K3QCM]?[!NL?\ HNB']G/XFQ,&'PU\7Y_[ 5U_\;H
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MAI\W_P 30!YOJ"^7<_N@6 /I6OI^I2QQ@"/%=CI'PT\4!OWWA/6A[MITP_\
M9:TKSX8^)=O[KPSJP_[<)?\ XF@#B/+DU#AZ='I*P2BNUL_ACXH4'=X<U8'W
ML91_[+4A^'?BB&3*^&M8;_MPE/\ [+0!CV\BV]O@KS4$DSR G'%=))X#\421
M\^&=8S[6$O\ \35,^ ?%@.!X7UK'_8/F_P#B: .'U&[,<G YI;;5)%7CBNQF
M^%OB>?YF\,ZQG_KPE_\ B:SY/A/XN9OE\,ZP%_[!\W_Q- &;'?0R0D3<G'I4
M44<,C?NUP/I6ROPS\6PL!_PBNMM[C3IO_B:OQ_#;Q4R CPQK"G_L'R__ !-
M&/;VZ0_,.M9VKQM,"<"NQ7X=^+57!\.:N1_UX2__ !-#_#'Q/,OS>'-7'_;C
M+_\ $T <%H]ONN!N?'MFM3Q%=0:?8LS,.G:M>;X4^)H&W)X7UMC_ +-A-_\
M$UC:Y\'?'6MPM%;^%]8R>,26<B?JP% 'SUXXUX7EPZQRMC-9'@_P]=>)-9MK
M&TMYKV\N'"100H7=V/8 5]$^%OV#?B#XLO(I=42T\-6#M\\EY,))@N>JQIGG
MV8K7V-\$?V9_"'P,A:;2H9+_ %J5-DVJWF#(1SD(.B YY Y/<F@"M^S7\!X/
M@OX59KD+)XAU!5:\D7!$8&2L2GT&>3W/T%>QT44 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDB-ST!92&4_4 &OI7]E/]I"]^(4S^%/$\PFUN*(R6E]@*;I%'S*X'\8'.1U
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MQDGCWKWN:))XGCD7<CJ593W!ZBORU\'_  ?\9>/M-DU#P_H-QJEE'*86FA9
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M^(D\31Z6LDTD/V=K(RD;#C.[S!U^E<;^TM_R73QA_P!?8_\ 1:U[S^S%\?O
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MX0FG9],U&"2XAA8\1SH 25],H&SZ[1Z5]Q5\&?L0^#;O6/BA+X@\MA8:1;2
MS8^4RR*45/KM+G\*^\Z]7#W]A#F[?J[?UV/7X#E7ED_[W92?+_AT_P#;N8**
M**W/T4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"&\MTN[:6%QN5U*\^XK\]OVA_@RWA/QS]M%MOL927=\<#)K]
M#ZX[XF_#^U\?>';BREC4RL/E<]J\/.,N68X9TUI);'=@\1]7J*3V/B[X9ZW<
M>#;BWNK*5A!PQ1>E?:'P_P#B!:>+M-B82*+@+\RYYKXAUK1+_P"'&O2Z=J",
M;=GQ&Q& !76>#_&%UX8OHKJUF/D,V653VK\/RW-\7PWC94<0FX-ZK]4?=8C!
M4<RH*=/?H?<E%<CX!\=VOB[3(G61?.QRN>:ZZOZ!PN*I8RE&M1=XL_/:U*="
M;IS5F@HHHKK,0HHHH **** "BBB@ HHHH **** /*_V@OV9?A]^TUX5&A^.M
M%6\\K)M-2MB(KVR8_P 44N"1[J05.!E3@5^/?[4/_!+?XH? JXN]6\+6TWQ$
M\')ND%YID!-[;)R<36X)8X Y>/<O&3MZ5^[%% '\^7[//_!0SXS?LW^3IECK
M7_"2>&X#L_X1_P 1![B*(#C;$^1)#CG"JVW/537Z'?!O_@LE\*/&4,5OX\TK
M5/A_J. 'G"-J%D3T)#Q+Y@^ACP/4U]!?'?\ 87^#/[1$T]]XI\)0V^NRCG7-
M';['>$\_,[+\LIY_Y:*]?!7Q7_X(F>([&:>X^''CW3]6M?O1V'B.%K:91_=\
MZ(.KGW*(/IUH _2[X?\ [17PO^*ENDOA/Q_X>UPMC]Q;:A'YZYZ!HB0ZGV(%
M>B5_/'XX_P""=_[0_@.XE2[^&.K:G$G2;0]FH*X]0(69OP(!]JX6/_A=?POS
M91_\)]X2\OK;K]MLMO\ P'Y<4 ?TK45_-7_PT;\;_P#CR_X6A\0/^O?_ (2"
M^_\ 0?,ILG_"Z_BABRD_X3[Q;YG2W;[;>[O^ _-F@#^A+X@?M%?"_P"%=N\O
MBSQ_X>T,KG]Q<ZA'Y[8ZA8@2['V -?(GQD_X+)?"CP;#+;^ ]*U3X@:C@A)R
MC:?9 ] 2\J^8?H(\'U%?G%X'_P""=_[0_CRXB2T^&.K:9$_6;7-FGJ@]2)F5
MOP )]J^JOA1_P1,\1WTT%Q\1_'NGZ3:_>DL/#D+7,S#^[YTH14/N$<?7K0!\
MR_M#?\%#?C-^TAYVF7VM?\(WX;G.S_A'_#H>WBE4\;97R9)L\95FVYZ**[3]
ME[_@EO\ %#XZW%IJWBFVF^'?@Y]LAO-3@(O;E.#B&W)##(/#R;5YR-W2OU;^
M!'["_P &?V=YH+[PMX2AN-=B'&N:PWVR\!X^9&;Y8CQ_RS5*]]H \K_9]_9E
M^'W[,OA4Z'X%T5;/S<&[U*Y(EO;UA_%++@$^R@!1DX49->J444 %%%% !111
M0 4444 %%%% !1110!\V_MV?\DMTK_L*)_Z+>O%?V(?^2SO_ -@R?_T)*]J_
M;L_Y);I7_843_P!%O7BO[$/_ "6=_P#L&3_^A)7C4?\ D82^?_I!^*Y]_P E
M=@_^W/\ TIG6_MG_  1.FWI\>:/!_HMPP34XD'W)#PLN/1NA]\'O7(_LD_&X
M?#KQ5_PC^K7&SP]J\@&]S\MM<'A7]E;A6_X">U?>.L:19Z_I5WINH0)=65U$
MT,T,@R'5A@BOS.^.'PGN_A!XZNM)D#2:?+F:PN6'^LA)XY_O+T/T]ZSFG@:Z
MG!>Z_P"FOU7_  "N*LNK9+CH9_E^FOO+I=]7Y2V?GYLS/BY_R5+Q;_V%+C_T
M8U?HE\!/^2,>#?\ L&0_^@U^8=Q<2W4SS32-+*YW-(Y)9CZDGK7Z>? 3_DC'
M@W_L&0_^@UME<>6E./;E_4X^!ZZQ6<XJNE;G4G;UFF?"/[3FM3:U\<O%+ROO
M6WN!:QC^ZJ*% _//YUVWPE_:Z/PI\"V'ANW\(0WOV8R.]U]N,9F9G+;BOEGG
M! Z_PBN2_:H\.S>'OCAXB\U<1WKK>Q-C *NHS_X\&'X5]'?LH^'_  %X]^$]
MDMYX8T#4=:TZ1[>]>YTZ"28Y=F1F)7)!4@ G^Z?2N3 QJR4E"5GU^_7\3S\+
M2Q]3BC%T\+65*JW4LVD[KFO9)I]-5Y(\O\??MH-X^\&ZOX>N?!L4$6H6[0^<
M-1+&,GHP'E<D'!_"O'_@=JDVC?&#P=<P,4?^U((CCNKN$8?BK$?C7WOX[\&_
M#7X?^$=4\07_ (&\.O;6$)E:--*M@SGH%7*8R20!]:\9\"_'KX4^(O&>AZ9I
M7PKM++4KJ\BBM[E-.M%,+EAA\J,C:><CD8KKC3Y<5"4YWE=?GH>KF^4XMXJA
M/-<PASKX?=L]U_*EU[G:?ML:+>:I\'5N+5'DCL;Z*>=5!.$(9=Q]@6'YUX!^
MQ?XTT?PC\3[N/5[F&R&I61M;>XG8*@DWJP4L>!N"GKW '>OKSX[?$G2/AC\/
M[R_UBP&K177^AQZ>V MPS _*Q/1< DG!KX>^&7P+OOCC)K%_HNH:)H"13E8M
M-N+ERXS@@*N&;8 <;CU(QZXA\U/&2G27,^J[:6_([N*:<Z>>X3$X&TZZ7P>2
M;=[[:ZK>^EU<^WOCUXXT7P=\+]>?5+J%7O+*6WMK9F&^=W0JH5>IZY)[ 5\%
M_L]:+=ZY\:/",-FK%X;^.Y=E_ACC.]R?P4_G7JNG?L%^,9;I%O\ 7]#MK?/S
M26[33./HIC0'\Q7TM\%OV?\ P]\%K.5[%I-1UBX0)<:G<* S+UV(H^XN1G&2
M3W)P,;4Z52IB5B*BM:WX:K\7]Q6*P&;<3X[#U<5A_84J6]W=O5-VV>ME;2R[
ML[GQ9X=TWQ9X=O\ 2-8C\W2[J/9<)YACRF<GY@01T]:^69O%G[/'P9\66^HZ
M'8WNK:U8,VR33)I;B-&*E3\TD@1N">1FNW_;:\67OA_X5VUA9R/"NK7@MIW0
MD$QA68KGT) _#-?,7[,7POTGXK?$H:;K;,VFVMJ]Y);QN4,^UE4)N'(&6R<<
MX';K4SJ2J8KV=))275[[7_!'9Q-FKCF5#+\+0A.L[6E-)\MWI;M:U[_A<]UU
M#]OS1XV/V'PC?7"YZW%XD1Q^"M7R!XEU8>(/$>JZHL/V=;V[EN1#NW; [EMN
M<#.,XZ5^F4/P@^'7AO37<^$?#]O:VZ%GGN;&)RJ@9)9W!)^I-?FIXRFL[GQA
MKDVG>7_9\E_.]MY*[4\HR,4VCL,8P*XL8IQG%5)7>ORV_/\ 0^4XRH9K1P])
MYCB(S3>D8QM9VU?=]C]-_A$2?A5X.)Y/]D6G_HE:^*_VV?\ DMK_ /8.M_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^*+C6+/Q%=:AY]LUM);RP*BD%E8'()Y!7]:ZK]H3_DB7C/\ [!TE>?\ [/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO;?^"0OP_P!5\4?M96OB&TB_XE?AK3;FXO9V' ,T;0QH/]IBY/T1JZ#_ (+
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MC5J;U-O[L5>R_#\EJ?HK\*_C#X+^-WA6/Q'X&\16?B31W;89[1B&C? .R1&
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M[P.T;,WER@ [HG#(W&3@KP2,&OW$_87^,>L_'C]EOP3XO\1/YVNSPRVM[<
M>?)!,\/FD   N$#$  9)QQ6]-1=%RI/2^J^_];^AC4YE42J;]'\O\CWJBBBL
MRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWAB P/+C95W* ,".%" 3_""37[;_  -^$.C_  %^$_AOP'H)>33M%MA")I0
M\\A)>25L<9=V9B!TW5W5%;*2C#V<%9&+BY3YY.["BBBH+"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ).H_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\
MDZC_ (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3
MJ/\ AFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H
M_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_
M (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\
MAFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&
M:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_ (9I
M_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\ AFG_
M (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&:?\
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M ).H_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\
MDZC_ (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3
MJ/\ AFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H
M_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_
M (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\
MAFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&
M:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_ (9I
M_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\ AFG_
M (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&:?\
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M ).H_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\
MDZC_ (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3
MJ/\ AFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H
M_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_
M (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\
MAFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&
M:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_ (9I
M_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\ AFG_
M (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&:?\
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M ).H_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\
MDZC_ (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3
MJ/\ AFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H
M_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_
M (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\
MAFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&
M:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_ (9I
M_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\ AFG_
M (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&:?\
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M ).H_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\
MDZC_ (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3
MJ/\ AFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H
M_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_
M (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\
MAFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&
M:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_ (9I
M_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\ AFG_
M (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&:?\
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M ).H_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\
MDZC_ (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3
MJ/\ AFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H
M_P"&:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_
M (9I_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\
MAFG_ (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&
M:?\ @H9_T%_B!_X<>'_Y.K]J:* /Q6_X9I_X*&?]!?X@?^''A_\ DZC_ (9I
M_P""AG_07^('_AQX?_DZOVIHH _%;_AFG_@H9_T%_B!_X<>'_P"3J/\ AFG_
M (*&?]!?X@?^''A_^3J_:FB@#\5O^&:?^"AG_07^('_AQX?_ ).H_P"&:?\
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M8UN)=K; WS8'&1GFOOJBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/_ 6V_\ DBJ_U9SE_P#,-(7]IX/_ )^(^GZ*^8Q_P4$^';?\P;Q/_P" MO\
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M_C])_P -U> LX_LCQ'_X#6__ ,?KXC52HPPS4<GET ?<Z?MO>!)%R-+\0?\
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M'D6%0_/?%=U7\V8BC+#U94IK5.Q^CTYJI!374****P- HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHK[^_9W\;/XZ^%.D7D\ADO+8&SN&;J7CX!/U7:?QH ]*HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /P!_P""H_\ R?9\3?\ N&?^
MFNTKY5KZJ_X*C_\ )]GQ-_[AG_IKM*^5: "IK.ZDLKA)8SM93FH:* /KGX#_
M !.AEAAAEF!=< @FOI:TU]+R%=IZU^:/@OQ0_AG4DF!(3/-?6WPO^)<6J1Q&
M289],T ?0;+YB9ZU4&FKNW$4S2];ANHE*G-7I93*ORCB@"%EAC&/2H)F21?E
MJ&XMY)&ZX%-\LPKC.: ()OE/ S3H8V;DC%2+LR">:DEN(U7KS0 R>X$*[15
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4(Y%^9_UKG]8:.16V&@"B_C*>U?_ %K?G5B'XE31]9&_.N-U*W"R&LQL=,4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM#G./[+_ /;NOS._X2"1CR:_1?\ X)#ZD=0_X6P#_!_9/Z_;/\* /T5HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#\ ?^"H__ "?9\3?^X9_Z:[2OE6OJK_@J/_R?9\3?^X9_Z:[2OE6@ HHH
MH **** "BBB@ HHHH **** "BBB@"S!J4]N,*Y K0L_$<T#99B:QJ* /1M#\
M2&\VACS7;:?-&R L>:\+L[Z2SD#(:]!\,ZT;I &;YJ .[N)(]IP*Q+B3,AQ4
MY\R1?:JDGRMS0 _+!>M5)&8-4C2$CK5*9^O- %AKH;<54DD.ZDC]2:<R[J $
MC^:K]K9>8P-0V<(9@ ,FNCL;!MH)&* +>EVB1KTKH[& 3.JKR:Q88?F"BN\\
M%^'9;RXC;;QF@#N? GAM@%D*UZ%>,-/M"2=N!5;3HX]%L06P"!7#^-/&A97C
M1O:@#BOB9XLF=I(XW.*\.U+5G:1BYR<UV/BS4FN&<DY)KS6^WR2G/2@"RU_D
MYIC:@*IK$6Z]*>T:CCJ: )?[09ONTY6ED.<&FV]N6;A:ZG2=%>XP2O% %#2U
MFW#Y":[#3K60*"RU<L-'2W4$H,UI*I;Y57B@".&'<!GBKT<6WO1]G,:Y/%5V
MN0I(!H M-M[U7DN(TZ#FJSW0]:@D=6YSB@"\EU&>M.:2.3&!6= A9N.E;>GV
MB$9/)H @,>Y<*N*JO;2;N36Y-"5'RC%496,>210!#"?+7YJBN)%;BH)YFE;C
MBG0V[2<T 5Y-/$N2*R+_ $8M77)&(UQBH9E5NU ' MH,C-A5K]&_^"0VFOIZ
M_%?>,;_[)_3[9_C7P\L809VBOOO_ ()5MN_X6AQC_D%_^W= 'WW1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<U][?\$JH6B_X6AN[_V7_P"W= 'WW1110 4444 %%%% !1110 4444 %%%%
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MIULXQ/LZ]1MOS/(]0^,%O;YVN?RK5\%_M.7WAO5H9K>\DV*PRFXXQ7U9=?\
M!,SP])IY47DYGQW;O7R[\>OV(=>^$L;ZA:H\MB#PV<FO@UQ0\=+V6EGT9]B^
M&X8->TMJNJ/T0_9]_:8T?XI:5!!+.B7P4 KFO>E8, 1R#7X1_#/XF:G\-/$5
MM-%-)&(Y!N&2.AK]AOV=_BY;?%;P-:7R2AYMN&&?05\1G.74Z-L10V>Z[,^M
MRK'5*O[BMNMGW1ZO1117RA]*%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!^ /\ P5'_ .3[/B;_ -PS_P!-=I7R
MK7U5_P %1_\ D^SXF_\ <,_]-=I7RK0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% "JQ5@1P:Z'0=8=7".U<[4]E)Y=PA/3- 'IUO,+A11-"&X4
M\U5T=6FA7:*UUM?+&X]: *4&G.6'-;VE6;K(HJK;L=V *[GP?H;7DZ,PR,T
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M\M4Z9;  P*L".-AG.33XXU'2@":&QBV9<\U'(L$?3%)<*VW.[ K'G:0M@<T
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MXIFEG\/.<\D*S8KYG\8?LQ^/O!4LA^S>9$I_AR:_8&JMUI=I>J5GMHI0?[R
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%?>G_!*J'RA\3_?^R_\ V[KX36,=37WG_P $M65C\3@O;^S/_;N@#[THHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M</B1MT445XYF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW0&K[2KT"_I2I;J>6XH KVMNS'DU?-CM3):J^X1G@X%2F^&W .: *DD(W8/
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M:[ZOYRQ.&K8.M*A7BXSCHTSP91<&XR6H4445S$A1110 4444 %%%% !1110
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MR?$"W<]LU]$P_P"K3Z5]9X5I+(]/YF8XQ6J#Z***_9C@"BBB@ HHHH ****
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M':IO,5>3S0!%&LC= :^_/^"6&[_BYV[_ *A?_MW7P<MTH& ,5]Z?\$LW#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX*C_ /)]GQ-_[AG_ *:[2OE6OJK_ (*C_P#)]GQ-_P"X9_Z:[2OE6@ HHHH
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M59O7PT%:-[KT>J^Z]CQ:\.2HT@HHHKY8P"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "JVHZA#I=G)=7#!(4QN8^Y
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M6WD\V"-_[R@U)5/2'\S3;=LY^0?RJY7YF]S]<6P4444AA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7.?
M$/Q=!X%\%:QKMPV$LK=I![MC@?G71U\Q?MX>+FTKX>Z;H<3X?4KK=(H/.Q!G
M\LU[>2X'^TLQHX1[2DK^BU?X'G9CBOJ>$J5^RT]>GXGPQKVLW7B+6K[5+QS)
M=7DS32,3GECFLZI"*::_L:,5"*C%62/Q2G6<G=LC:FU(132*U/7I52,BO;_V
M0-(\'ZY\5Q:>+HX)TDM6%A#=?ZJ2XW+@'U.W=CWKQ(BECDDMY4EB=HY4(970
MX92#D$'L:X<PPKQV$J8:,W!R5KK='NX7$*G-2:O8^R?VI/V1X8;6?Q7X&L1$
ML:[[S2H!Q@=9(Q_,?C7Q=)&48JP*L#@@]J^]OV5?VJH_&4-OX2\7W*QZX@V6
ME](0%NP.BMZ/_/ZU@?M7_LH"Y6Z\9>#+3$HS)?Z7"OWNYDC'\U_*OS/(\^Q6
M38K^Q,]>OV)O9KI=]NSZ;,^KE&%:/MZ&W5'Q+334KH58JP*L#@@]:97[ ATJ
MI&:::D(I"*H]FE5(J0BGD4VK/8I50AFDMYHYHG:.6-@R.IP00<@BOUC_ &>O
MB,/BC\)]#UIW#7GE>1= =I4^5OS(S7Y-L*^T_P#@G;XR8-XF\+RO\GR7L"D]
MS\K ?D#^-?F'B'EL<9E/UI+WJ3O\GH_T?R-L5:I2OU1]LT445_+IX@4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_-A^UQ_P G
M5?&/_L<-7_\ 2R6O)J]9_:X_Y.J^,?\ V.&K_P#I9+7DU 'ZZ_\ !)3X$?#;
MXG?LUZYJOB_P#X9\4:G'XINK9+S6-)@NIEB%K:,$#R(2%!9CCIECZU]K_P##
M(?P-_P"B.^!/_"<M/_C=?,7_  1;_P"34_$/_8WW?_I)9U]\T ?/GC;]@']G
MWQWITUI>?"W0=-,BD+<:)!_9\L9/1E,!7D>A!'J#7Y(?M[?L&ZC^R+KUGJVD
M7D^N?#W5YC#97UP!Y]I-@M]GGV@ DJ"5< !@K< KS^^5?+__  4P\.V?B+]B
MGXCB[16:RAMKV!VZI)'<Q$$>Y!9?HQH _GWKW7]B'XQW/P-_:?\  GB&.9XK
M">_33-213Q):7#".3([[=PD ]8UKPJG1R/#(LD;,DBD,K*<$$="#0!_5-7FG
M[2'QPTO]G3X+^)O'VJJ)DTNW_P!&M<X-S<N0D,0[X9V7)'1=Q[5WNA7S:GHF
MGWCJ5>XMXYF4C&"R@D?K7Y9?\%M/B].;[P#\,;2YVVZQ2>(-0A4_?8EH;;/T
M"W!P?[P/:@#\S_'7C;6?B1XQUGQ3XAO9-1UK5KI[NZN)"26=CG ST4< #H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :_P!UOI7\NGCC_D=?
M$'_80N/_ $8U?U%O]UOI7\NGCC_D=?$'_80N/_1C5RO_ 'A?X7^:.F/\"7JO
MRD?K+_P1#_Y)/\2?^PW!_P"B*_2BOP3_ &)_^"@DW[&_A3Q)HL7@5/%@UF]C
MO#,VJFS\K;'LVX\F3=GKG(KZ+N/^"Y.H- X@^#EM',1\CR>(V=0?4@6HS^8K
MT*TE*5UV7X)'!1BXQM+N_P 6V>]?\%C+S3H/V288+QXA>S^(+,62O]XN%E+%
M?HF_)]#[U^'U>S_M.?M;>/\ ]K#Q/:ZKXSN[>*SL0RZ?H^G1F.TLPV-Q522S
M,VT99B2< <  "K^RS^SMKO[3GQBT7P?I$$GV)Y5FU6_53LLK-6'F2,<8!Q\J
MCNQ45RX>C*4Y?WG?TT2_2[['37JQC"/]U?JWI]]C]\OV2X[BW_9<^$J7A_?K
MX5TW=N&"/]&CP#[@8K\[/VTO^"LGB6/Q?J?@WX+7-OI.EZ=,UM<^*6A2>>[D
M4X;[.K@HL601O(+-U&WC/Z7_ !1T'5K'X&^*=$\#V>[6HO#]S9:+:1NL?[X6
M[) H9B%&#MY) ]Z_#;_AV/\ M,_]$PF_\'&G_P#R15XB;KXF<EI'?UNW^7ZB
MHQ]EAXW^+;TLE^?3T/+-0^/'QD^).I&WNO'WC3Q%=S,66U&K74^>_P L88@
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MQM_D?SP_&/\ :C^,VE_%WQQ9V?Q<\=VEG;Z[?0PV\'B6]2.)%N'"JJB7
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M8!1M3]*O/H\9DW'DYJ[;V<48^[0!%8NS8W# K7ANM@ 456%NG:I8[<J"1TH
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M  4V_9GNI3&GQ/@5@<9DTC4$'YM;@4 ?4-%>'^&/VW_@)XOE$>G?%GPNLA.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "OAG_@H!?,_CSPU9Y.R/33-M]VE89_\<K[
MFKX)_;Y)/Q=T8=AH41_\F+BOT/@.*EG<&^D9?D?&\63Y,KEYN/YGS,U--2$4
MTU_3Q^.4JI'3:D(IM4>Q2JD9IN*D84TBJ/8I51(9I+:9)8G:.6,AE=3@@CH0
M:^[?V6/VJ(_%\%OX3\6W"IK"*([6]E.!<CLK'^]_.OA$BEAFDM9DFA=HI8V#
M*ZG!!'<&OG\\R/#9]AG0KJTE\,NJ?^7='T6"QDL/+FCL?9_[5W[*(NA=>,?!
MMKB;F2^TV$?>[F1!Z^HKXH="C%6!5@<%2.17Z1_LA?%#Q+\2/ LJ>(;"5DL2
M(8=6<86Z']TYZL.Y'%?/'[<WPU\.^"O%^DZGHWEVMWJZRR7=C'C"E2N) .V[
M)_$5\/POG>*PN.?#V8OGG"ZC):Z)7L_EMU6S/IZL8R@L13T3/F"FFI"*;7Z^
M%*J,--(IY%)5'LTJI'7N'[&OB9O#7QPTOYL)?+]B(['S'117B!%=Y\ YGA^-
MG@79GYM;LE/T,Z9KR<YHQQ&6XBE+9PE^1Z$ZUJ,WY,_6VBBBOXG.(**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _FP_:X_Y.J^
M,?\ V.&K_P#I9+7DU>L_M<?\G5?&/_L<-7_]+):\FH _:_\ X(M_\FI^(?\
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M?^"QW_)W4'_8MV7_ *,GKX9K[F_X+'?\G=0?]BW9?^C)Z^&: /TQ_P""'_\
MR43XH_\ 8*L__1SU^N]?D1_P0_\ ^2B?%'_L%6?_ *.>OUWH **** "BBB@
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M -C&O_I-%7Y3_''_ )+5\0/^QAU#_P!*9*_5C_@B3_R0WQ__ -C&O_I-%6>
M_P!U_P"W%^<2\7_O"_Q/\I'1_P#!9ZYGA_97T2.,'RIO%-JLK!L<"WN2 1WY
M _*OQ2MX);JXBA@C>:>1@D<<:EF9B<  #J2:_?;_ (*??#:X^)'['7B\64+3
MWNAO!K<:+UVPO^]/X1-*?PK\"K.ZEL+N"Y@;9-"ZR(P[,#D'\Q65#E]M-3T5
MT_E9*_X/[CHK7=*#CT37SNW^J/7?^&:?V@/^B5?$K_PG=0_^-T?\,T_M ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBD>K&C3AI&*14CTBQC&%M(0/^N8J06-NO2"(?\ %3T5G=FMD0_9(/^>,?_?
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MO3: /PST7_@C[^T%JD"27,/AG1V;K%>ZMN9?KY4;C\C6S<?\$8/CI#$'37/
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MJ#_L6[+_ -&3U\,U]S?\%CO^3NH/^Q;LO_1D]?#- 'Z8_P#!#_\ Y*)\4?\
ML%6?_HYZ_7>OR(_X(?\ _)1/BC_V"K/_ -'/7Z[T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA[K4?L]?3M_6Q_++7](G[&O_ ":?\(O^Q7T__P!$+5__ (9.^"'_ $1OX?\
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M%_%.I1Q"!+S6M&MKR98P20@>1&(4%F.,XR3ZU@?\,G?!#_HC?P__ /"7L?\
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_X*C_\
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M#H=A;G*6L0/^X*MK"B?=15^@I]%%V%DMA*6BBD,**** "BBB@ HHHH ****
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M _A7/\7/B3INCK&QL(V%Q?2 <+"I&1_P+A?QK]5;.TBL+2&V@01PPH$15'
M& *_$_$C-U&E3RNF]7[TO1;+YO7Y(^CPEY+F)J***_ 3T0HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO@/]HWXI_"^U2T\)_$/Q+H-DHPMG9ZG,EN/^V6[9^E '],=?+W[8W[>?@?\
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M /R43XH_]@JS_P#1SU^N] !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI3:W:0H><GVKZV_X)U7XOI/B&5Z+_9_Z_:: /LVBBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-IMD?_CU?TBPVT-LI$,21#T10/Y5+0!^4/[.O_!&&\DN[;5OC+XABAM5P_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXM=W4XIDD+=!TJE%J!7[[EJMQ:@).@H 18UCZFKEN$D_AJ!O+89ZFIH;I8^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN[1KT'O$W\J_/_4D\OQ]K:#IBOK^&Y6Q+7D?A_BLG_94)+I(^KOV<(Q%X54
M?P5[#7D?[.ZD>&5_W:]<KP,P_P!ZJ>K/TGAC7)L+?^1?D%%%%>>?3A1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!4?\
MY/L^)O\ W#/_ $UVE?*M?57_  5'_P"3[/B;_P!PS_TUVE?*M !1110 4444
M %%%% !1110 4444 %%%:6@Z'/KE]'#$I()Y.* /5_@G]H\Q"H)Y[U]9Z 9#
M9H7!!Q7F'P?^'J:7:Q,Z9..>*]FN%CT^U_NX% '*^*IG\IE&!7EU]:&29LG)
MKKO%GB%"[HK9KCEN'GDZ]: (CI['@8IZZ?MY)Q5^&U<@G=23+Y8Y^8T 00VI
MS][BM&"U3BLT2G/W:MQS-MXXH NF%(^<BH))EZ$X^E0;GDX)J1;>-1N8YH E
MC5<9SQ4$RO(WR'BFRW"+PM2P,I7)XH 1$,2\DDU(C GYNE1374:G ;-)&Z-R
M7H FD</PM+%:CJ6_6F!HR<+UJ=8G(SM.* &S19X4U7:SDDX!(JT4;^ X-/A@
MN&;[V: +6B^&D:0/,^?QKO;"QBAB C4?E6%H6DW,C*2IQ7906OV6'+"@#/FC
MD0$ UC74+%B7;BM34M7BAR!P:Y74=:$FX T ,OKI(5(7DUC^:\TA)X%-FN]Q
M.!S3H-TOWNE $-W=;%('%9;.96ZUMW%B)^IP*@7241A@[J *]O9E\<UM6&FE
MF7DFBST\LP'2NNTG2UC4$K0!J>&;!;?:S+FNQDO4B@PH XKG898X5 #4VZO&
M92 =U &/XHNO.5\\BO-=4QO.U>?I7;ZW-*RL IS7%WGVC<3L)H S8;5V;)J2
M6WE)PH.:3[5.AQL-:>F-<32+E* 'Z%X?NKJ52XXS7L7A+0%M8U)49K&\+Z4\
MJJS+7?6=LT*@#B@"2YS%'A0*^D_V$)GDF\>!A@*;''_DQ7S9=-''&2[5]%_L
M#WR7=U\051LB,V'Z_:?\* /KJBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'X _P#!4?\ Y/L^)O\ W#/_ $UVE?*M?57_  5'_P"3[/B;_P!PS_TU
MVE?*M !1110 4444 %%%% !1110 445<TK2;C6+I(+="[L<=.E #]%T6YUR]
M2WMD+,QKZM^$/P06PMXKBZ3#G!/%5?@S\(TTF".YND!D.#R*]NN-=BT.UVX
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MRC/0$DXKZ7K\)K6ZFL;J&YMY7@N(762.6,E61@<A@>Q!%?MQ\._$$GBSX?\
MAG7)AMEU/2[6]<8QAI(E<_JU>SDN85,?2DJOQ1MKWO?_ "/@_$_@K!<,5:&*
MRV\:56Z<6V^5JST;ULT^K=FM]=.AHHHKZ(_"PHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /P!_X*C_\GV?$W_N&?^FNTKY5KZJ_X*C_ /)]GQ-_
M[AG_ *:[2OE6@ HHHH **** "BBB@ HHI54LP &2: 'V\#W,RQQC<[' %?2?
MP/\ A:0L=U-%AFP<D5Y_\)_ +WU]%<3Q%@2"..E?7'A[38]*T]%4!<+VH N7
M<EIX=T_EAD"O(/%WBZ;4)F2)R%SVKJ/&EXTVY0QQ[FO.VMP9"3R: (;>WGF^
M9G)K3ATQW7D\5';HP8!!6H/,2/EEH SI(X[7^')I]N[2$8&!3V0,Q)(- ;;_
M /6H T(ML:Y-$NH1*,#BJL:O-@*#4W]DL!N8XH B^T>8V0:LP71CY)Q5.6)H
M^ 5Q1&H7EC0!JMJBE<=:;'<>8W6LY65FP%)K5LXU50 M $[99<=:IR6[;LEB
M*VT5-O(P:B733>38!H 9HMB;B50!GFO1=+T=+>-6)[5DZ'X>6W"L3S76V]J%
MC&6P/>@#'U*_:V&U.E9,>L3-)R373W&FI<$Y*FJ$^CQVX)&,T +;ZBQ3IFLS
M48[J\SLSMJ>*']YRW%:,31[=HZT <=-9O:@E_F/I65>7C=%3%=_?6,,D9)%<
M;J]HBY"(<T 8+3 <N:A:=9#A>*FDT^5VHBTV3S!A<GVH 8EBTG(-7+'29)Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^>76UU\*V9^>O_!3G_D=?!'_ &#Y_P#T8*[C_@F/_P B+XU_["4/_HHUP_\
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M]4]WJGH?L'1117Z4?PZ?'7_!3/\ Y);X4_[#)_\ 1$E?&O[.OQL_X4'\0_\
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MX2CPMHVL^1]F_M&RAN_)W[_+\Q ^W=@9QG&<#.*_)/\ :V_Y.0\>_P#80/\
MZ M?KCX>T6#PWH&F:1:O));:?;16D33$%RB(%!8@ 9P!G %?D=^UM_R<AX]_
M["!_] 6HXGMRTK=W^AEX,^S>?XQTOA]F[>G/&Q]1?LE_M5?#'X7_  -T3P[X
ME\0OI^KVTUR\MNMA<2A0\[LOS)&5.00>#75?%C_@H5X"TGPM?1>"Y;OQ!KL\
M+1VSFU>"W@<C >0R!6(&<X4'.,9&<U\L?"/]B;QQ\9O MCXKT35?#]KIUV\B
M1Q7]Q.DP*.4.0D+#JIQSTJ+XL?L2_$CX1>%Y_$%\FF:UI=L-UU)H\\DK6Z?W
MV5XT.WU*@XZG YKAGC<TC@U'V=H**5TM;65GOVZV/M<1PQP'C.(*D\3C7+$3
MJ-RIN:4>=RUC\*>^EN:[VNSS[X,_!W7_ (V>-;/0=$M9&C9U-Y>[,Q6<)/S2
M.>@XS@=6(P*_9;1]+M]#TBQTVT79:V<"6\2^B(H51^0%?F_^R%^UYJ/@'Q!I
M'@SQ!%8-X2O9EMDN+>TBMI+.1L*LC&-5$BDXW%P6YSNXP?TLKWLAIT(89RHR
MNV];Z:KI;Y_/\%^>^,.-S:KF='"XVDH48ING9\W->UVW9:Z)<MO=[N]V4445
M]*?SZ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P G#?\ <(NO_0HZ^Q?VP/@'X@_: \&:)I'AZ\TVSN;'4/M4C:G+)&A7RV7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)_V<9]JYSXW?LE> _CI=?VCJEM/I.O8"G5=,94ED & )%(*N!QR1NP  0*\
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MC@:G/*C149Z25I6BK:I7V>JN@HHHKWS\E"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P I*^,?V(_^3GO!?^_=?^DLU?9W_!1+_DW@_P#87M?Y25\8_L1_\G/>"_\
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M]N:3Y4WY=7\DTNI^D%%?G#X6_P""EGCJPOHSK_AW1-7L?XTLQ+:S'Z.6=?\
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M#)8'NPXS];UZ^'Q-+%0]I1E='PV=Y!F7#N)^JYE2<);KJFNZ:T?Z=0HKQO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH _ '_@J/_P GV?$W_N&?^FNTKY5KZJ_X*C_\GV?$W_N&?^FN
MTKY5H **** "BBMOPOH)UJ\4-_JP>: )?"_AU]2N%D=2(P:]CT>W%C;JBBIM
M!\,V]C @ &0*U+CR+=>!S0!>T2_6VG!->D:9JRS0@9XQ7CL=XOF [L"NETO5
MCL"H] '4Z_=(P(7DUR$P(8\5>N9FDY9LU$A0<MS0!%:_>Y6M)9XMN"/TJHT@
M/W4-.CBD;G&* +S31JGR@&LBZN'+'"U;.V/JV330$E;&* (+69^I.*MR2R.N
M .*>MG&O+'%*V ORF@"I&K;N@-;NFVPX+'%9 #;A@5T6BV+7#+N/% &I;V:R
M* &./:KG]GE$^52Q^E;.GZ7;VZJ68,?2MB,Q"/"K@4 <!/:LK9D2NE\+2>4R
M[(]OOBK%W:PR2?,*T=)MX(2#N7Z4 =;9^9<(-Q.*J:O:H%( W&I(;B5E"Q=*
MM1V.X;I?F- 'G&J:,[2%]G%5K19+:0!1BO1K^WCVD*E<]=://(^8UVCZ4 6-
M-U*?8!FMNWN';!(S]:R--TXV[9F-;2R1,H5!D^U $[7&X8  ^E)';B8YI$M_
MXCP*E\QEX3B@!DUOLX'6B"W&[+"DDE,7+C--74AG&V@#1W*B_(,&L34KAMQR
M>*DN-6 R!P*S9)C<-\JDT 6+63S&J_Y)8?+R:S((9%YSMK0AF>,<'<: )X[6
M1.6P!]:MPXZ U3C\V9N14_,'\)H M/D+Q59E=\DEL5);RM,V A%:7"1_,1F@
M##\L!NA)K1M;8,,L,"I%PS<)^-65CR.2* ".%$Z=*>H5FZYIC,D:\M0MU'_"
M,F@#1CPJ8 Q56X=@>":#<;5S5.2Z:1L#B@"99'/&XU#=2.JYSBF[G5<EJPM:
MU*3!7=Q0 NH:_P#8D)# GZU]'_L#Z])K4WC[?TB-AC\?M/\ A7Q_?6\]X2%S
MS7UC_P $\=+DTYOB"9.LG]G_ *?:?\: /LBBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKQ9KJ?Q#K$8ZV][?(J'\8HD;]:^@_!/@#PY\-]%72?#&C6FBV .XQ6L87>V
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M^2/WG@?_ )-UF'I7_P#39^M=%%%?H!_(Q\@_\%,/^2/^&O\ L.I_Z3S5XO\
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M_#FV_P"/B+_?'\Z_=FOPFMO^/B+_ 'Q_.OW9KS^&OX%3U_0_2/'/?+?^XO\
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M^TUX[NOB)\=/&&J7$K2117\EE:J6R$@A8QH!Z9"[L>K'UK[D_9$_99\&:/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8T[\?** -JZU%+9\2OTJQ9:U:R<'FN7M?#E[JC>9*^T'GFNAL/#"6JC+;FH
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MO_P31_Y+9X@_[%Z7_P!*;>OO;XF?"3PG\8M'MM*\7Z5_:]A;3BYBA^TS0;9
MK+NS&ZD\,PP3CFL7X9_LX_#OX/ZW<:OX1\/?V1J-Q;FTDF^VW$VZ(LK%<22,
M!\R*<@9XKYU9=5_M3Z]=<OSO\-NUM_,_:\NXVR[!\&5N':D)NM/FLTH\FLKJ
M[YK_ /DISG[:7_)LGC?_ *XP?^E,5?GS^QA_R<WX&_Z^)_\ TFEK]5_&G@O1
MOB)X9OO#WB"S_M#1[U56XMO->+>%8,/F1@PY4'@CI7GW@O\ 9-^%/P]\3V/B
M'P_X5_L_6+%F:WN?[1NY-A92I^5Y2IX8CD'K48G+*U;,J>,BURQY>]]&V^GZ
MBX5XVR[(^&L=DV)A-U*_M.5Q47%<U-05VY)[K6R>AZ[7Y7_\% /^3E-7_P"O
M*T_]%"OU0KROX@?LN_#'XI>)9O$'B?PS_:>KS(D;W'V^ZBRJC"C;'*J\#VK;
M.<!5S"C"G2:34KZ^DET3[G@>'_$V#X5S:6/QL92@X.-H)-W;B^KBK:=SAOV
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M/*0N0"?E4 #)S@D CA_V3_\ DXWP#_V$E_\ 06K]2]+^!_@70_ =_P"#-/\
M#=K9^'+^,Q7=I 71K@$8)>4-YC-C^(MGCK7,>$_V1?A+X'\1Z?KVB>$_L6K6
M$HFMKC^TKN38X&,[7E*GKW!I1R7%+&4\5.HI6<7*][W3N[:;6M;]#LP_B9P_
MA,IQ6483!3HTY1E&FHI/XHVYIMSO=O?XM+:L]AHHHK[,_F0**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M NV&,>BC^5 $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU[U10!X%_P ,(? S_H1__*M??_'Z7_AA'X&?]"/_ .5:^_\ C]>^44 >!?\
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MXD@&,CR\YKZ<484"O"_V?_!^H:5_I>H1/%(N5 <5[K0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZ4M)0!^<?[
M5EW)JW[87A/29#NMW@W%3TX-?H7X<A%OH.GQ*,*D" ?D*_/O]KK3)/#_ .U3
MX7\0R@K:Q0["YZ9)K] ?"]TMYX;TR=3E9+=&!_X"* /@3]OU#HGQ6T+5K?Y)
MO,A0LO7DBOO?P;<F\\)Z/,?O/:1$_P#?(KX(_;G8^+?C5HFA6A\V97BD*KST
M-??7A.U^P^&-)@/!CM8U/_?(H UJ;)(L<;.QPJC)-.KS7X__ !&M_AO\.=4O
MY9!',T#K%DX);'&* /C']IW4+[X_?'S2?!VENTMII5Y'/,$Y&W(SFOO[P=X;
MM_"?ARRTRV4)%"@& .^.:^-_V _"$_BC4M4^(^J0EKC4 T:F09Q@\5]C^-=0
MN-*\*ZE=VB&2XBA9D5>I- 'S%^VC\8)8[.V\#:#,7U/56-L_EGE":\U^(GP3
M7X2_LHWC7B;M8N;(_:9&'S$]>:\2T#Q]XLM/V@M:\1>)?#,M]##,)+039PI!
M[5WW[57[7.I^-?ACJ.FR>&FM(Y(2N_)XH ^JOV&?^2"^'O\ KW%?0]? G[!/
M[0M_=^#=!\-'12L(01_:,_K7WAJ&I0:78M=7+B*%!EF/:@"W17"V/QO\$ZC=
M/;PZ];-.AVLF3D&NJL=>T_4E#6UU'*IZ$&@#0HI P;D'(I: "BBB@ HHHH *
MQ?&&DKKGAN_LV7=YL16MJD90RD'I2:NK,:=G<_(_XA:)+X3^).KZ>ZE(5?"C
MMUKN?V:?$K:#\4+*,/M2>8 BMG]L;1X-.^(IGAQOEF^;%>=?"IF3XG:+LX/G
MBORF5+ZKFB4>Y^D0E]8R[F?8_6&*031JZ]&&13ZH:'DZ3:[NNP5?K]66Q^;L
M****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:RAQAAD4ZB@!D<:Q
MC"J!]*?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIG_E TO_ .1J_?ZBLJ<7"-F[FLY*3NE;;\OUW/P!_P"'HW[3O_13/_*!I?\
M\C5])_\ !/3]MSX^_'S]I[0_"WBWQB^O^&#:7=U?VJZ/8P!52%MCL\4"LH$A
MC'#<D@=ZO?\ !:#]H7S[WPW\'=*N?DA"ZUK0C;JQ!6VA;'H-\A!_O1FO3/\
M@C?\ 3X+^$>L?$W4K?9J7BR;[-8%U^9+&%B"1Z;Y=Q]Q&AKHPLE/GJ->ZKKU
MZ?G^"N88F+ARP3UE;Y=?R_.Q];_M/?M(>'/V6OA1?^-?$*O=E7%M8:;"X66^
MN6!*1*3T& 69L':JL<'@'\=?&G_!2[]I/XR^*7M?#>N3Z#'=/BUT+PKIR,X
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M^RO_ ,$\?%_Q(\41;+*?7KNZTFV+;7OY/*A@CC7_ 'I8G&>P5CT!K$_X)E?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% &1XO\+Z?XX\)ZUX<U:-Y=+U>RFL+N.-RC-#
M*A1P&'(.UCR*_,'XT?\ !$W_ %UY\*O'6>ZZ1XJ3\\7,*_D#%]6K]/O%_BG3
M_ _A/6O$>K2/%I>D64U_=R1H7988D+N0HY)VJ>!7Y??&K_@MA(_G67PH\#B,
M=%UCQ4^3W!VVL+<=B&,I]UK&7+S:?%Y?/Y=S9<W)K\/ZZ?\  /DR[\!?M/\
M[!>M3:K!:>)O!-LK!I=1TYA=Z3/SM4RE=\#Y[+*,C(X!K[=_8N_X*N:]\7_B
M)X;^'/Q \)VLFKZS/]EMM>T1S$F_;D>=;N3UP<LCCMA*^&[KQE^TW^WIKDFF
M177B;QW#O DL;("VTJW/+*9%79;QGT:3!/')K[D_8N_X)1Z]\(/B)X;^(WQ
M\66L>KZ-/]JMM!T1#*F_;@>=<.!TR<JB'MAZ[*/-I[;X?T_KL<=;EL_8_%^O
M]=S]+JP/'WC;2_AOX)UWQ5K<_P!GTG1K*6^N9.XCC4L0/4G& .Y(K?K\VO\
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M@9 =&P<#(P>]=%.-J#]F[QNOUM\MU_2,:C;JKVBM+^O^'_$],HHHK,L****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_DU^OW(5.\%/F=W+_-/]/O/G+_@DS_R93X8_["&H?^E+U\\?\%R/^0=\'?\
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M6W]?U<B:E*FZ2>C/AS_@LZH7]E/0@.@\56@'_@-=5\N?\$4?^3B/&7_8L/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!!>S"WLYY"<!48_I7P#\1?$!U[XA7=W(^Y(]RCGC@U]ZZY
M8S:EI=Q;0,J2R(5!<D#D>PKY+U#]C[QO>7UW.NJZ"!,S%=UQ/GGU_<T <+\(
M/#A^(WC^.%QOMH,/[<&OO73[.+3[.*"% B(H& ,=J\(_9W_9]U_X2ZE-=:U=
MZ9=%U('V&61SS_O1K7T!0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5S/CCXG>#OAE:VUUXP\6:'X3MK
MIS'!-KFI0V:2N!DJAE90Q YP*Z:OFK]M[]C7_ALKPKX:T;_A+_\ A$/[%O9+
MSSO[,^V^=O39MV^='MQUSDT >@?\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
MX[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I
M_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[
M7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"H
ML?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV
M?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+
M'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__
M /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,
M?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_
M  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HL
MGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT
M?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP
M_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!
M#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_
M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
MX[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I
M_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[
M7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"H
ML?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV
M?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+
M'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__
M /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,
M?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_
M  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HL
MGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT
M?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP
M_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!
M#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_
M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
MX[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I
M_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[
M7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"H
ML?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV
M?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+
M'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__
M /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,
M?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_
M  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HL
MGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT
M?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP
M_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!
M#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_
M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\
MHLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\
M-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_
MY:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\
M$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W
M_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_
MZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_
MPUC\$/\ HLGP_P#_  J+'_X[7P!_PXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=
MM 'W_P#\-8_!#_HLGP__ /"HL?\ X[1_PUC\$/\ HLGP_P#_  J+'_X[7P!_
MPXQ_ZK9_Y:G_ -VT?\.,?^JV?^6I_P#=M 'W_P#\-8_!#_HLGP__ /"HL?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTN(UFAFC.5=& *L#W!!!K\:/^"U2Z>/VC/"1@\O^T3X9C^U;?O;?M,_E[O\
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MMMW;5SCKM'I7TS_P4<D2/]BGXHEV5 ;&%1N.,DW,6!7QY_P0U_UGQD^FD_\
MMY5876I7O_*OS-:^F'@_[W_R)R/_  5C^.GQ(^'/[3UCI7A/X@^*O"^EMX<M
M)VLM&UJYM(3(9K@%RD;JNXA5!.,\#TJ?5/'G[;7[8'A6RUOX;Z?K?A7P%;V\
M=O926.K0Z;<Z@T:!6G:XDD2:9G.3E3Y>>.2"3P/_  66_P"3M=/_ .Q7L_\
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M$'^YJG\[6OKW_@FG_P F2?#+_KWNO_2N>EA]<-4;_F_^2-L3I5I6_E9\&?\
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M7G?<\KRFW[O;;G-34B\-AE53O*S=_2_^7XHN,E7Q+I-6BFE;KKU_KJF?)/\
MP3G_ &]+G]JS2M3\+^+X+:S\?Z+ MR\UHNR+4K;<%,RI_ ZL5#J/E^=2N 2J
M_FW^WM\)_CA\./$UA>_%KQ'J&N:1JNH:A)X?AO==DU%;:,.A8(CL1%\KQ# Q
MG:!VK<_X))_;O^&T- ^Q@F'^S+_[7C./*\DXS_P/R^O?%?27_!<C_D'?!W_K
MKJO\K2KQ44I4JJW?W;OI_P!NK\2<&W.52D]E?UTC?]?N.&_X)^? G]I6^O/A
M5XUT[Q?JL7P<74!</HZ^)YDMS:I.ZRK]C#[2"P<[<<YSWK#_ ."UO_)R?A#_
M +%2'_TKNJ_0/_@FBZO^Q'\,RI# 6]T.#W%Y/Q7Y^?\ !:W_ ).3\(?]BI#_
M .E=U5XWW*T:2V4WZ[/_ "%@O>I5*CW<5^$E_F:FA^-?VR/VH_A;X;MOA#I&
MJ>$OAWH>F6VE6MSINHPZ9-?R00K&\OVB21)'RRMQ&0B_=.6!-<Y^R-^W'\:/
M@W^T=I7P^^)WB#6O$.D7FL+H>JZ;XCG:[NK&=Y!$)$F<LXV.1E=Q4KNP,D$?
MJQ^R6H7]EOX1 # _X1/2^G_7K'7XS?M9*%_X*5>(0H '_"7:>>!Z_9R:Z'[F
M8^Q>J;=[]?>2_&_RTML<S_W)U%HXI6\M'_E\];[G[XUS/Q-\>67PN^'?B;QA
MJ2/+8Z%IUQJ,T<?WG6*,N5'N<8_&NFKRS]ISXX:-^SK\$_$?CG7+ ZO:V,:Q
MQZ:I ^US2,$CB)(( +,,G!P 3@XQ7!5?+!ZV_K0[*:YII6N?E1X#^-7[6?\
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M ()B_#_X>"[+ZN/$$VDW:$\FSM,7$8^@^T6P'_7,^E:W[;_[+O\ PJ']D/\
M9V\0Q6GV?4+6R:PUAMOS^?= WBAC_LN9U_*NJZHXF=>WN*45;R:;7WWL_P 3
MF2=7#PH7]YQD[^FC_*Z/T'_X*;?&K4O@K^RKK%YH.KW6B>(M9O+?2M/OK&=H
M;B)F;S)&C=2&4^5%(,@\9KQO]@?4OB)J'[$/Q2^(GBWQOXGU[5-4M=1.D7.K
M:Q<W+VL-M;2*)(3(Y,;&;S.5P?W:^@KY._;X_:0E_:'^&W[.VA:?,U[J$V@K
MJ.HPP\[[^1Q:[<?W@]O-_P!_*_4O_A6<'P;_ &)=0\%6X4#1?!-U:RLH^_,+
M1S*__ G+M^-<]:#I8?%3;[Q7_;N]OFO_ "8WHR52OAH6[2?SV3^37S1^>_\
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M%?./[:G_  4BTS]D7Q[I'A*V\'IXVU.ZLOMMXJZQ]B-DI8K&K#R)<E@&;M@
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MQW^)?P[_ &J#I/A3XA^*O#.E?V'9S?8='UNYM(-[-+N;RXW"Y.!DXYQ7,_\
M!&7[;_PU7J_V<-]E_P"$8NOM/7&//M]N?^!8_6LS_@L/_P G@'_L7K'_ -"E
MJL7I.A..G-K^$E^ES/#WY:L7K;_[5_J>LZ5\0_VQ_P!KKQMX:\5>$-,\2^&_
MA=;W]H88[/4(M+6YM4=/,EDD>2-[G>H8MM+)R5 ]?K;_ (*$?MP']D?P=IEC
MH%I;:EX[UX2&QBN\M#:0I@/<2*""W)"JN1DY.<*0?H_X4J%^%_@]5  &C68
M'_7!*_'+_@LPUZ?VKM*6X)^RCPQ:_9NN-OGW&[\=V>GM1B_<FJ$=N9Z]=O\
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MWZ?/;^MOIO\ X)/_  ;^$\WPJTSXI^%=-U*W\<>5/H6LS7M^TRB4-&[A$ 5
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M 3E1\N<BZDKX>\G:2=KKK?;Y_J_(SIJV(2BO=:O9]+?I^B[L_/GX.ZG^V/\
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MD(O[7Z<L=/ZW"M^[P=2:^S^O-+7^MC] _P!G_P"%7QK^%/[+?QML_C7XBO\
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M(+DRF6.21) 7E12FV-N0Q.2./3"7NQYGL;Q]Z7*M]_N/;:*^ /\ A]7\$/\
MH5OB!_X+K'_Y,KW[]E/]M?P/^V WB4>#=*\0:9_8'V?[5_;EO!%O\[S-FSRI
MI,X\ILYQU'7M2BY7:Z$MI;GT#1114C"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S_
M !#&\V@:G'&C22/;2JJJ,DDH< #UK0HK.I#VD'!]58N$N22EV/P__P""<_[/
M7Q4\#_MC> -:\1_#3QAH&C6IOO/U'5-!NK:WBW64ZKND>,*N68 9/)('>OW
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MGJ>&_P#L':A_Z3M7[H^(8WFT#4XXT:21[:5551DDE#@ >M?C5_P3#^ 7Q/\
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M@/XKNOB7\288=-\0-:/9Z9HD<R326RR$>9-*Z$J&*C:%4G 9LX/ \5_X*Q_
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MNO\ PY\+MXXTBX1K3[3IMF=0@U"WW;D$MM&PGC8$ \8P<@,P/+_C)I?[8?\
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M '8_X)#_  4^(?PU^.WBS4/%_@/Q-X5L)O#KP176MZ/<6<4DGVF$[%:1%!;
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MP5X7U7Q/K%D\VDWUKHMA+=S^0X\V)RD:EMJLL@SC&91ZU^D=%9SASV?5._\
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M0YB1MI(!P#UQ7UY_P3Y\+ZUX+_8_^'FC>(=(O]"UBU@N1<:?J=L]O<0DW4S
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M]/N74;1.JHK/$2,=1&Q  8' Q^VU%6_XDJD-.;==/Z_R)7P1A+6VS/Q1T_\
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M0_8'7XO7GP)AUOXT:I>W_B?6+MKRUMM0ACAFM+,HHB1T15VLQ#O@C(#@'!&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
;"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>business15ba.jpg
<TEXT>
begin 644 business15ba.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !@     0
M &     !    1TE-4" R+C$P+C,X   R,#(U.C R.C T(#$Y.C$P.C4Y  $
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M1T(@6%E:( ?I  ( !0 ! "  *V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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MBIG!F%1<DSBIG%"M#^OYN^_)<&JL@                  "@UZ9X?2
M                4F$F1EU         *37Q=3+@  !@R  8,@ &#(
M 48SK?N^1LKH^+-9              Y;+ :&/1DR,  %!9B^  &K3A YQ/2$
MYU.D2QFACT9,@..3L4_0               @YN.7#F0Z?-7G:A:30QZ,F0''
M)V*?H                      48SJOO^3M7SW%JL             !Y=GF
M::0/Z #QT.U#19Z,GDT=MG%QU(<J'5!T(>2Y[MG%9ZPGAT=%G')W$>:AI$]B
M3B$[H.YS=0              !2>))[:'@@;G-!G31Y[FD3V).(3N@[G-U
M                   %$M#>LYN^?)\&NL@             ><ANDY"+6<?F
M^#JPYU.:#8QST=OG/AOD]/3Q_.LS51ZTGCB8:?.70]*#D$Z'/($[]._3=H
M            !!XH'M6>*1L Y7.J3K\Y!.ASR!._3OTW:
M       42UQWG*V/TG$KSD                 "#GLXK/00VJ  :J,5-_@
M %)Q:=HE8              !!S0;:,^   *3BT[1*P
M   "C#57H.9M7SO#KL
M     &#(                        48QH7U?-WUY'AU[
M       $0A@57D                        "F<03C-5@
M          *,-;]WR=E='Q9K(                   $8?G..<??]ETGX/K
M@                        .<?<]CT+X;K_P!YFJL@
M       48SJOO^3M7SW%JL                    QBG&. ON/I>_\ XAYP
M                        #@C[5W_=WQ;I/WUZJKR
M      !1+0WK.;OGR?!KK(                   #&*<8X"^X^E[_\ B'G
M                        ."/M7?\ =WQ;I/WUZJKR
M       !1+7'><K8_2<2O.0                   *81EP']O\ 1=^?#O.S
M2J@                      $84RX*^V=]W=\8Z?]]>BNL@
M           48:J]!S-J^=X==@                   *9Q@7:[^&OM7HO0
MKX1Y>\<;%5Y                       C$_CKOS3_0WHN[_C'4; Z/A?I6
M0                       *,8T+ZOG;Z\CPJ]@                   "
MG#2/K^=YJ_IGU/L1^.?$W")JK(                      $8Q^4;/)C]9>
MO['^-]+U)\QZ>K8                        _-G7/;\C8_1\:O:
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M&ISD@[ +.889X<X&U 80;F-A%E.D#A<P8ZS,#+T<V'29SL?L>I1E@
M  !K8S,UZ?*8T7HQ(N9D1R2>B!Q>;O,<*#,#Z#-CG\V$6 I-RE^
M     *35!]I\A^1^9AQ83:YP">IYS4; .?#<!49";5.3C:A]Y\9:C>P
M        *329<S!2_&<FN399A)\9CILLYZ.PS6Q;#$S-"\ER,W.;S:YCI^IM
M(^H      # ,@&      #(        ""6#+!D     &#(!@      R
M   #!D                          !1+5_IMGG7^E.1I'Z%NM_*MBF:*A
M1DV%RJ%4LF6:ADLS"RHS;-2HS"S)<J@8P&<   3G-TXD= _,.M]&/S3Y;.^F
MXE6:   B<8_S+\\_T?R>9?K6^Q<^F<PM5PI.2V:+*A4*C.99A94*,LW&;E1F
M%F2V ,AG   #.?VB=F>2XW?7YS\STW\OZK]*PR9  &(9M$U;)K\@
M         &99_7.+M6NYIG.='>UKP<_H1MQ+U.YFC8S4*E1L9J%F:<[(SME1
MLA9F%RJELC.PIC+.QFF-JK-A1F,VQF0  !-1B&;V3XK@>^W\Z_G&RO.<0  "
MP<W/@S_03=H/ZIL5L8M62V<PV&R5QFJ6PHMFRRX7"C93FBV*9V,TQ;-LVS1<
M-C&9   #(2_7AX]BOPUX/O;X%YRO)D !!C"[-.R9&3(
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M #)@ #\&-,L[/+\ &3&/FK3]S=924GZ   !DU?SC?U0\-/<1"X73G9-5V?\
M .SWI\EY>K_<Z*N'NPCT.ONCX!S>&_O^G])SE?358>SO%.PSMOQ&R[:JT9])
M;-\-6.>C?ERV]/E&?HW[,CZ?/+WUG?A7H6:='LV9XK5I#W^VGD9WC\^QI[VG
M(LO.SN[P.K2GON1O;YUHY2^\]AI'Z3RBX7"B]F>)U_T;_P Q_"SE5D!&$3/A
M%^^?,\S?;NOA<*I7*XQLGK]GI_\ D_L\(YVSZ]=6+M)U1[?&R/%;<*]*W?\
M-=VM/09NY^^RM=^G;P^;[O-K]8:O93\-;K7RL6#=6E?HVS!.^V?ALSL3RLZ.
M^B;=H^*O+.#KTQ[;;G'FJN_$C5GLN1T5\UC2_P!"W<?_ '[G+HV0J%RJEL]W
MOYL^-ZG^<\&H $&/S=@G:   /"]CK5C0"/L-D&#G2S/+IO<J,)8V0<X&QE>>
M>=?HYC;N)/'3&^#0+/?;/"['4QRUG&W,-)9;0PUNKV77   #)J_G(_JA\[CN
M)++-A79WP'M<^\9R?RG'5_QOG\M?7.-<MM;=^?[K#MK!?1XUU]"T\Q_0Y]*?
MRYSN<?J.O9OC]_5OQ_;YE_K?3D7'F^=3LYN^FNC?DN<XZ?;T3\SSYR?IQZ3?
ME?/-_P!)W737.,]]6(]ANSWS>OH7YMKU#['D:*^BW]_+KA?](<YC8;&:*V;X
MG7_1G_,;Q]=)SD",(C'A%^^O(<S?;NL++++B=E/!V>H'Y/[KX,X_/K]WR]QB
MOK[Z9^<;M(>RQ3KV8YV$5;:^7MF6^;VT\>_*[]H\3V$_%'*\Q/UGJ[E_,F[Y
MN[8MW%??U.=K^-V:O],S3K;N&<\=?6+ZN^4-G^*G6/L,6CO.5^-SYK?KGG+L
MV%EE,7[M_P VO+]3_..%5D (,?F[!.T   >%S%T8WHBSF/L<"9==XSNY6+,?
M G@[.>IL+N7<Q3+9^&O"\9:!.^\9T/G''AW[C/.K&Y#A#+TRPQQ7KLL   R:
MOYROZH?,7<1#9"H67>.HY'Q[%ZZSD_KI6/MJN7$S\N_/T<;95C9\W)NV<QD?
M2;K=S\9;Y[D=A? ^3K;WD\K?9X^3?7X[;N?7;/OX%]Y_G';YO_K+7G?DMF+]
M]5.;RCHZQCNMOZ:V0]+LM_8U;^9NKK-D[FF+9R;*:V;-\4_HS_F-Y:JDYR!&
M$1/A'^^O#\T?;NK+I7"RV+C362]%RJ<9G%4W5+?<>'76WPWL+]P+X;_0G <C
M;3==C? >3?\ KMWGQ^J>)DO2[<9]#G)//[:6SJSXMLT/]-G$NTJQ=M5UX%?O
MINP=MMO'79^KC5\?)V-VR(K'/16JIQ<LTYV4UL-GNY_-KS_4WSCB59 "#'YN
MP3M   &#%1]Y=V,3+:9RS:V?K8_%/P*N!:RL^DM9F1KXR,_8_0PLS8Q4OYBA
MM0P V"   &35_.7_ %0^3.XDJ&38;(7"HQ9;-%FR%1-T8IC9.P;%;(6G+-II
M5S>R(VIIL1G92N<6S4,FPV%FPLS"X7.;A6SO$S_1G_,CHEU.0#&*9QX2_OGP
M/,_V[IRX65*H70N)V,98WSL1C8FHS<8J,U551.RFMA<LQBS8JINHFVNZ=FZ<
M9C&8K8FXHJY6666667"X6S7NU_-OJ>I_G/%G.0!!C\W8)V@
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M;;\EOTE[3.T_-7K?TBG;G;GBMVA?I$[C^>[['V3D']%Z)NE65#)L+8V>[?\
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M%,U2NE<XN-53NN%LVNRS)99L*8V>Z_\ -WE]2?.$T $&/S=@G:
M           9-7\Y_P#4S\Y.XTE%&PV%EPLJ%TK**9V+HV&PLLLS"X5*RJ%E
MFPHLHN%TMD*G-Q=%EEEE#9OA^3_1;_,SLHK-64D$XQ3#PG_?/Q?FG[7YDHHV
M&PLJ&PV0J"%F6;79M+-A191<*+*ALI6;#)L*+*I72N<W%64S1L*++8OW6_F[
MVO4OSC*LS@R@88_B[!.T                     R:OYT?ZE_FJ>VX].;BA
ML++++++*A9<*I5*X6S:MA;.TLIBBH6S<KA="RBRBRRX72N%U*C-0MB]F^)YG
M]%'\T>W\T_T+Z3T,^!]#D?$TZ!]KSM5>IYW:'R'H_"_]Z_#>:/M?F392EG8S
M99L*+*-D++A4**A;-JLLV&QG:Q1@V,["H52V0LLHV%%0J&RE<YJ,TG;"YQGW
M6_G#WFW_ "W.X]^J=SZ!?"O-U5?FQ^A/2^@?POSW[\!89V
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M84;"V+9RQ7NA_-WUU=>AU+ZGE=\?$?.JOS3_ $-Z/L3Y1U&S?&\.PXW
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M6667&;C.8SLC-3BXS3%LV6Q;-EE,4S99LA4+A4++++A7N9_.;[_U#\[](SD
M08_-V"=H                    !DU?SQ?U#_G-';]?&;A1;-EEE%%EFPJ%
MEPNE4KA9:K9N&39&*C-QFS846466666669A<+ALA6RO$=Y_0_P#S9_2<U-6+
M AB)>&?[Q_%'-_V?YB73FV:*+++++++*+A=*X7*X64JF;+A<8J,W.;A<+++*
M*-A19991<+A<+I7[F_SE_0O4'SSU#.0!!C\W8)V@
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M,Q68SL-D*+*E19999<*IS4+EMA149V,T64S=.;A<XNG-3.Z,9O\ T_9>[?\
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M   %!@0' P ! @@6%1<@4!,4,#8W$!$Q0!(A.& R-$AP&$$E)S/_V@ ( 0$
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M>1)D3,^'-ECY2!,D5S22Q$MESNZ&EINL;2S8H\:=-@R9DR80S\&=EQQHDV9
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M:=V^ D DA(+/Y;;_ $U<'Y%]LIK\<6/6\%Y@UE8!7D2VVUOMM^SZWG'8XCI
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M3:.E3#8C83"YX<V@H ,L$*TK7 [/^RFT5WJ,V$(;"Q]SL*C&@PWU0 SV[O\
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MAN!N=LW<,QQXURP6MQ6N<\4+B:;"3]J#SZ_Z(1'4MN-OBUPSKEE_%->:$!Q
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MS47\)"!(?&4/S4;\)=SZ/^,H?FHOX2$#1_QE#\U%_"6HD/C*'YJ-P_Z7KBA
MT?\ &4/S47\)"7T?\90_-1?PD(&C_C*'YJ+^$M1(?&4/S4;\)"!(?&4/S4;\
M):B0^,H?FHW#_I>N*$#1_P 90_-1?PEJ9#XRA^:C?A^N*$'1_P 90_-1OPUJ
M9#XQA^:C?AH09#XRA^:C?A+4R'QC#/\ ^N,/_K0EY#X>SZ$;\)"!H\9S[/H1
MOPT(6COAT/Z$?\-:C1QRGF?0C?AH2\A\.9]"-^&M1)#O9]GT(WX:;#EOAT/Z
M$;\-:J7.4]#^A&_#0@0/AT/Z$;\-:B!\.9]"-^&A @?#V?0C?AKN>7^'L^A&
MX?\ 30@2_P /9]"-^&M1+_#V?1C?A(0('P]GT(W#_I+42]/_ %K'?Y8WX:$&
M!\*9Y(WX:$*#X,Q#)W4B_AH0V_IH?_R_AHL:!770^CW7\-7+66EIXT4L6NAP
M>(Q/^8J0E8390/8X0ZMHXC$T(Q)V\:GJH*!19'19>29NYQ^2?2CHW1>!,RW'
M93%/T9HPTMFF]!_U4M(RL%[7PIECGUP -/25IJ%*OEA> )@# C/L]>C-0ZAQ
M#\7;",J>]@V]"*GW?GLQ^M?Z4'*]!ZN0<KD'*Y!RNXH.5Z#E<@Y7(.0>@]7H
M.5X0<%5!RN0<@\(/'K_HKP@]7H.5R#D'H/XJ]!Z#T'\5>@Y2KSW1!IMB,'55
M0XQEW0WL.-1Z^O2G1(>E(+0XVQ6-KGB.!IF/44)45IA/+;CAAWQ]?OS5QQ-2
M0,L=JT? =/1@U[BT#$DDX4Z\_7+%3DXR3A=QP#6AJYPIGZ]6SH)O>YQQJTKE
MM$_IF(S<UOH"#E<@Y7(.5W%!RO0<@Y!RN0<KT'*Y!R#T'JZJ#E<@Y7A!RN0<
M@^B#T'H/5Z#E>@]!R#U>@]!Z$17\4'*X5;TA2CO<(7!I_:*T?I1\H^E:M>##
M-=@=T^HQWK2,C#$-LY"B W"I:#EMPQ'01F%>\\ZX]'KV($NPN/E/V*1@PY.'
MW7%?<:&VIR)&!S-3Y>&*G9Q\V\W5M& Q]<?7>F8.H,J>]@V]"*T@[\]F/UKO
M2@]7H.5W%!RN0<KT'*Y!R#D'*]!RNXH.5]$'J]!RO0<KT'(.0<KT'H/0>KT'
M*Y!RN0<KR@Y7H.5R#U)1 )F$#X3V@=-52VUSLJ9;E#BOAOO8ZE6T1N>XN<<U
MPZU#CNA$ZLVNX(ASG7O.*&;AZT7+D_T[%/R1Z @Y7(.5Z#E<@]!R#E>@Y7(.
M5R#E>@Y7H/0>@Y7(/5R#E>@Y7(/0B(/0>@Y7E!RO0<@]!ZO0>KT'*[%GS@I*
MAEX7%A_;-/2L!B<:>G8M?&ML+C9N\G\%6E./I1:<PGQHKV-87&C:85W#9ZU3
MN>*-]2H9IS#WV?O8-O0BM)._/YG]:[TH.5W%!R#@M;1!]R$>W!7>%5!ZN0<K
MZ(15?3G(1:HN"#E<@Y5KZ4(E$(E2A$HM;=F@Y!R#E<@Y7H.5W%!RO0>@]!ZO
M0<KD'*Y!RD#6>DQ_^1#]*=X76AD.@>U;X?6N79IIV+\T>@(.5R#U=Q0B46NR
MZ4Y]6IK^:@Y7(.5]$V*K@@Y7(.5W%!RO0<A1W!:P-PK5%XH"#M3HF 3'-<WG
M&BO8,BJW'')-B@8+ "[J0<KD'JY!RO38GKP5<,]OJ4'*Y!RN0<KN<S'P@M'G
M\V@_,/[7MV9]7O8-O0BM)O\ S^9_6O\ 2@Y7<4'(.335V:BP8D*"R+JWACW4
M:XM=:[H<10TPK10I:)%:Z(QCWA@JXM:YP:-I<16@&\HOH;5>KB@]0&.C%UH<
MX-;>ZT$T:-IH,!Q."?@5 :Z*;6@N.X DUZL:I[#")#P6D;' M(\JUB#E<@Y!
MZ::FE4YCFP]9:;:@74PJ=A=ECL3.=2G1OQ46%$@TO8YAW.:6G'@4'*]!ZN0<
M@X[,4'*[BKJ9X*Y!]5>KB,\$'U0>KT'*[B@Y:,/Y_*?KX?[2=X76AD.@>U'A
M="Y?NIIV+OM;Z @Y7H.5RA!T1P8T%SC@&@5))W 8UX*)!=#(;$:6/NI8\%KJ
MY$6G&M>"B0HL&&USV/8'#FE[7-#AO:2!7J37YH.5Z#U+PHD9S@QKW6M+C:TF
MC1F309<5$YCN/KB@_!!RN0=3[U=A]JN*J:5H:;]B#BG/.%#C50-'Q8S;@Q[L
M <&N*B0GPG4>"VFQPIZ5$AQ+&O+'ACA1KBUUKN@Y'J4M*19MI9#8YUN)+033
MI(RVJ+)QI;&(U[1LN! [5!K%<(;02[8!B2<@!TKV-BAMQAQ!_E/W(ES'%A.6
MQ!RN0<KD'53+GUH"0T5-!4 <3L'2BZU"+7!!U%<@Y7H.0=SF?."T:?S:#\T_
MM'V[,^KWL&WH16DW?TE-?K7^E!RN0<M9;SO%QZD;:"8KBYOI4/4SNAM':/CA
M@O@-BP"0 3'!(:V[Y8YN)I4@G):/9"T9+:3T8V"TN?HZ/,S$4T.J<1;;M[S/
M"F+B#WJ@2$E*R0TCI2(Z)#B13"@0V\VK</="ZAZA11- 2;](Z-9#+G26D&PH
M@B9.AMB/M(IM+>W#!0="2<YI&/(Z/B.<R2#W1W$#W5L,Y,:34$Y8G/'#9I/0
M$NZ3?%AP72D:#WU\0.OA95!HT UV?<N3 8R!ID.>'N&C8X:VE>;S<:XXJ6D)
M :&A:0CDW&9U-*]]S6G,][GM#MF"T?)2LAI*"V&329D.[&EU*@&X$=Z03S<"
M*43)27TG,3\Q&)ARLJ7.<*ASHE#D#04KCC3 ;"G:)DIYDI-20=#EVS4.!&8X
MW8'^\#L*C>*8'I4](Z/$^R5DRY_N^HB/. ;C0BF;B-IP'!0M$Z-B3431>L?K
M&N<6QJ8,<W"CFTYU-IYO1M431^CYF7GX4NY[IR08]]QP;&#"!EX!+CO<I+04
M%DM)MC0'F-,LAQW/#P&PFNZ0;SMIAFOR>@PIJ:BQWZR6EF7NL< Z+E;#I7FD
MC,XTXJ._1\70#HTL"R")UL)T-V)8X,?_ 'E.<.-!]IY/R[9J;(']E+$S.^HA
MXTZ\NM<H3&F))DX>861-2"&5KX3*TZ\3N"EM$R@D(42.7Q=>R^+'9_PY.8+
M"76YG$*0T;+NA3$2XS;61##AL'N;BW])S@32@RI6IQ3]%RS9^7EV1W'NBUUA
MAN]RNS;7)Q;O&>&6-)C1,LV%--;K9=\"&YUSA>V,&[, ++LQB=W%2FBI740'
M^Z&%%AAT>.W^ZK@064+G4I4XMPR4C)0?SQ\)SIEC(SH38;18\M_2<X%P'"W,
MI^CI;N^7@PXCF".67%PHZ'<ZEM#@2W?2A[$S1VCXW=D&KM9)07QS,YAPA]\=
M7GT<[';1/E)*;D&1H1<;8C6$._O*COA0"VI&6/2F:(EH+(4-T&(3%AM!BM=5
ML&[A0E]NWG"NQ2VC)25@3<:*7-U,R65!NUN=10][6W/)N.!.",I(PW2TPU[K
M9F+35G-N/C6T^JIN4E(LX)>FJM%3;3W6@% T  -+LMOWSTM A0!%AM?!<(FK
M,%^)(_2!UK<#XM,.*N0<@Y7H.6C3^?R?^(A_M)N1Z"A[5N;U_*&[_:"-\T>@
M(.5Z#D'8CL7)V(?9S1F%;IR"RFP\\+2VC9+3.DGST1S89T?,N9,#!H:R$:WD
M#/FX?.'R@N4D0:5@:+A2S!1T82\%[ &T;4-;NK0 9X[U#T3H;7/T2(KN[FM=
M[L>],Q6W5V[ 3MNZE)Z&E($G-SD['<S43)E[ VM<'85\$F@QZ<#DI+04"++&
M=$-TP(SS#@PPX,LAG*(Y]I!/R:8]BT]HB'HJ;AL9&$762K9@# %I)_LB,<0:
MBNU<G1-2>CX<SW.(D6;FFP77#*4P+NHF@KP*C:)$;3T>5?$LONB0ZM[V"34#
MB0$^!H1T.9A-<^#-2UP:YW.$P&^#:T>YEVS%U-^U=PZ(T9+RO=Q?$CSH;'8&
MFT08+\L:.N(I6G-4+14L\:0?"CF.V#+.F((#;>94"IJ*[<M^\8J7DH,?09GG
M AS9\0.%+"?L471LC![AEC?=,M@1[LQ#$0-N>:8NI4T:-PQ=5/T+#F)2>C,,
M2$R3:\B,\ B+J_!MH+"1B,79%2XD(G)QE\*V+W7:T@BKW6"CKK31I\3KKN9R
M:.IAM<UT1T=@<(X<T-@W9"WP[=N(KL1E84"?$I%-T6',6N->_:#0A:;TA.24
M>#!DA9!A2[.:!05H"7..TI\T[3 EX4S#K'=2$R, 0279--,#0Y'BIR%&BRCI
M$L]RT?)@AUHYT6".?QYU7'R+1\6- T+/1Y?FOVG:*UR6@IN8TQ*3TG/"L.7E
M8LXQSL]9#&%#FM#3,'V1EQJJETPR&,\RX8J)I/24OI=YN)APY@L$/"E@=M&W
M[5,Z,AS6ER(7N8BRPFWVXVN=0D-&&W #9T!1M'0&071M2]NJB6.#G5UHRJ#:
M+3U'LHIZ#(VR4HV 63$<08L.)>,"X4#2T-%QKX1/2%[ .BUAVN!:RICDMM>X
M9BP"H!WWG?38A)R4I+]T3[7$ZPL8UCO[MN;R[G>2BT>W1;IL"7]WA18=UKAW
MM020X.;B1L((&W/ 0NYXK]):FYD.78^D.ZO/:YHYQH*C'*F[<F0I&59+0Y^X
MQINV,RTTM@OP&QU3AEATJ%HR'W9'AO/N#8+YB&X>+;<S?PJ.FAR*$O*3,",]
MMU8&=<G#+(=[CLJ[I5\/$,\$T\B#U<@]!^?0M#FNBX'0?2AD.CVS,^KWB."N
M0-?Z@;>A%:5=_24U^L?Z4'*]!R;$ #@?"%OE3;Z%I/-AMN\BG-.:^2T; EW&
M''EH;>=N()I3?QK3%:)Y0.A.THR<CNB1YJ0C0 *5N<\C&[94YJ7TSH^8T?!T
M5I6$Y@@G60HK.=AAS"W#IK7J4QR@EO9#1KX <R2T>V%#U>;HC8;[BZN%"[R#
M)2NEH4II6:G(;2Z6GFQ&Q&!Q:Y@BG%U<>]S'%:1TEH:'*1&P619F8C9Q'.<S
M50SF  YP<>FG0N3^D9;1T.>=%BEXFY6) AP[>]OH14G&F"F-)0HNBF2<,D6S
MCHQZ"UH%-NP[/*HVGH7=>C"VXF#HMDJ_ZV6.7.VK1>F(<I%GH,S6++31>U]O
M?0ZFMPWTW;0G:8DY2'+RD@YT2 9ADQ&B.%N PU=M33/.IV9;9K2<!VE.ZI0E
MC-?KWM/A&M3C4BJAZ9A#2<:?AN=#:^^K: N(=7C2O05*:2@08>D;GET6<AO:
MQU*4<YP-#Y,]Z;I716D(,FW2+8L*/(0F01JR3W0R'B*T<VPFM*XX*2TUH@34
MW!=#B0I2.QS"+G/,''")5QYQ&T5%:X4R4QI/1L/1,QHV5N?!?,:YL4BE[[2*
MV^#GAB[B5HK2<.2D8Q@U;'B>Y Y$-S..=3@I'E*=1-2TXQT>&^$YL,.-2(W@
MG'[%(Z4E(-L:'K)?5BD6 #>(U-H<YXLNR- 1P4+2>C9E\P9J$Z7<Z(Z-"B0W
M%UE3@+ YK7#C@5$Y0O=.RT6$S70)4-95U&NB!I)J3B1@:4J:<5'TGHTLF8\.
M^),1H;@(3L&P2[;<'<ZARP WJ4TM)VRT1PB2\6##:'AAN;&MVXN%MVW!P4#2
MDH8DU$F&&%%?'=$@S##6UI.$/5U:#ONS]"F-,R\U-RL>)"<6RM@UU><^QU;B
MT'/@794Q4KI1D"/I&((Q<V;E(T%O-VQ,F$5^MZ5+SL&#):ASBXF*QPPH&4!!
M&^N.%!O3M)2D5\%[H<2Z"QM6AU6QK *8U!9=3' HZ3@OE)B" 6F-,AX;LA"C
MMISI44SKM7LC"=+2<,O+^YX]3S;=V1ZL5'TE*=UMCFZ+K&T>,M4<.<TW<^W<
M0*]HGY^#$E1 AO=&)BB)K'\VP4(L#:NWY]BO*O0<KD'+1+JZ1D_U\/\ :";D
M>@H>U;X?7Z%_**ZG**-\QOH:@Y!R#DQV;O$%U.A:+T@R4GY"==WL&;A1#3<T
M@G!3NE)J)I'2$:#%<V7G8D2YM:7![JT(K_HAI]C)31[(=6Q)",(A;F'6FHH?
M3]JAZ<T0(L32=CO9"*]T40Z\UL5QN#KJX@'P;>%=J=IR&='S<I,PB]TQ,]T7
MAV P<#4=8[5(:7T?'D(<EI!SX4.!&UL&(S$N%![F14=1KA4YK3$WH^8FV1Y:
M ^$V&T0A=$>\O:W^\-3F?%&"G^5,8LE&:/BO@R\O(PX3@,*Q6BKHAH=]>I'E
M/*Q8NC)PP2Z:@,9#F7DTUT,&I=OJ:T->&:F)_0@[KCPF.C1YIS[6N%&RS7XW
M U-[F[,&[4W26A]*2\MW?<R/)!L%EO.UT%E2-UE:YXJ2Y0R<&:G&.E]5 F(#
MI1EIK1E1;0;\,<JXE36EI&7T6W1T$.&LGFQ<?FN!RRSRQZ=@&G('LE)3 :7M
ME9:%"H<,88 KM%:XA>S^CH4+23;XE\XR**.'CTPH"?+7H:I324L=$NDG$LMF
M#%AFE276VVD$@@89BO0O931,9D*/,ZYLS 8UH@M<ZV,6  &Z[F74Q%#MHHL=
ML2.^8A<V(Z(7!M:V FHQ.=$W2LA/R[8,^70XT& /=FT.L#10!PP\M>E0-.:/
M90-@TA24%T6 <+HDPT"QQRH,M_6I/E1,.CMBQB\R\6+[LTDXL)YPH>"D]*R$
M.%I&5BEP@S$PY\$@#"'C0$5%#DGZ6DY&5BP) .UL>$6/>Z@]S=FT;,=N/"F*
MT7.Q)6<EHAA@M;$9%=E4 .Q*=I'13IF+/ O?$,4U80&B^M<ZG#?0=84MIS^D
M(\Q,LO9%:Z%:'6^Y.\4_)V>I4;2&CH$)[) /FXL6)K"'UAZD;ASB'<2<.%5,
MZ4EXW<4W$88,U ;#@B%6YK[,G!U<"=U*<4[2FAPYTS&;&=&>PW0;G6![LS<U
MV(!R%O6I?2.CX\NZ6G'/#+W/AD-N]S/@$$M/0:]2EM*Z+A3S#+0]7 @,U9.U
MP&%3AWQK7UJH,_)P3I#5W.9-->&/(H;W.:<14X89XJ#I'1TVV6B:0O$:4M@M
MM%:P65(\6G3CT+V=A=UQHE/<7PG2T(#$AI;8W=PJ5"GI>7@1V9F,!2G2#CMR
M0,,5+,W&J#D'(.5^!Z%H/'14MT._:0]LS/J]XCBK4!3^H&WH16DG?G\WC_?/
M]*#E>@]7H/5W%!V->U7/(<68N#2<?XHQ8K837N\(@'#>M8\5L=4ZJZBA1 ^'
M<YV-,<%!<XPW.<ZT!U&&GD0=&;SRQT0DV!]#0'9P3>Z@07-,5QP ;F/HJ%#C
MP1%=J8E'-)!<UP BGI&SR*'?"@Q&1(]\5]8KF4I:W;0[:;DUQU0A!]['.UEQ
M%I;PKF:(O(+3"=5C6X\7+6.:#&#JNRLI]J9$C.%X-'.\#<-]47 /;S\#2_F^
M5!T5SK&XMKS,NI0M;$BO:_FNH0 -IKP4&)$<7U+KX,2TBPG ;3@FAT36N,:Z
MI=S:45Y%I<RC0VRMWV*%J1!CM,4ASRX@4.U-C4@F&P.<ZRTD GRI[HQA,<VG
M-AAF8K@A!C/U-&NN#&O=S2>E:R(=;"M(-3GAZ48H:6-#2U[&BXYW4V=*=$>8
M32PT]VN<VF)&WC1"*6MN:>83WM/"]*:Z[%:S8@Y7\4'*Y!RNXH.6BG5TG(?X
MJ%^T$?L*.8Z/N]H=G2O#/S2OY2W?[21?U;?0$'*Y!RO0<KD'*Y!R&L=_90]8
M1C2M*#?BKHSL'D-^3@47O +0W'QJ_8N;$8TZRD1N!%,@.CB@2Q[&]\QU"=F:
MAF((T1T.&6PV@W4J[+/+)0WMB..K!=%#K@RAQ]=RB12^(UL>$YA:0[&N!'4H
MO=$-\-VK,.&YP-QVM.W%1"=<U[77 #=A5!S7G613BW%K:TZ.E-CMK4Q"08F5
MI[[I5T,B(UHN)!=2M,>E7,#6G58ZJSOD\CW,,;:=6,:_8FO>^*UI=@QNZ@P0
MB]\UQ(&NK2G;7[$Z-#$1H)J=^.",S#;% O)J*;?(FB9:XN?# @'%IO&/VH1;
M@2< #GP3(S+M5X3^=EX!V_P1P=1K=:0,B:8;\4+R,889_F!1!9B7APW! CH5
MR#D'(.0>@]7H.5^!Z%H#_=4O\T^DH>V9GU>]@V]"*TF[\_FL?[Y_I0<KD'*]
M!RN0>M9$!:V&,7D,ZBM&R7=TQW+&FA+AK2ZI9>!;T9G# #$G#:IO0$"')=U2
MND'33F11"BPW2VH+(9KSZDD.';P7Y+2$)TI BZ;U472$*%%9"$K?_; $ FN
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MJ(<I-6%Q9=<T FT<<,!UD@!0-#!T)\W/3AEY"(]T.6B-@WN>?!- 00*;W9X
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ML)L41/[ 9X8_Q0 82U[Z1.^&T?<@]OAQ>?X/-\BYKQ[I$JZN I3T*'&UM8)
M 9X6^BUC02VZFRM$"UHIK<'89+7:SO(E2SF$%N8'%&-A81JF;?"N^Y!T$,#8
M/6X[T'*Y!RO0<KD'JY!RN7);_<\#H/VK=T?=[9F?5[V#;T(K2SOZ4G_\3$]*
M#E>$'*Y!RN0<KDU]$'(.5P0?Y-R#D'\5<@[_ %5Z#E<@Y7H/5Z#U<@Y7H/54
M';%>@X*Y!RN0<KD'H.0<KT'+01_IG1?^,@_M+:[YR;X73[0[.E;7?-*_E7/^
MU<Q\P?\ B@Y7(.5R#T'(.5Z#D'(/XJ_B@Y7!!_\ IQ5W%!RO0<KD'*Y!ZO37
M4RP5U4'*Y!VU7(.5U,D'*X(/0<@Y7(.5Z#E=Q0<KUR3_ -S2W1]I6[H]LS/J
M][!MZ$5I=W]*3_\ BHOI0<KD'(/0<KD'*]!RO0<KD'J]!ZN0<KD'*[B@Y7(.
M5Z#E<@]7H.5W%!RN0<KT'*Y!RO*#E>@]!Z#ER>=73>C/\9!_;"VN^<4WPNGV
MFY.\+YJ_E9=_M7,?,'H:KE<@Y7H/5Z#T'H/5Z#U<@Y7(.5W%!R#T'*]!RN0>
MKD'*]!RN0<KT'*Y!R#D'*]!ZN0<KD'*[B@Y!RY(_[EE_FGTGV[,^KWL&WH16
MG80@Z7TE!\*%-Q8?T7>T!HKN*:[BJE!R#E<@Y7(.5R#E<@Y7(.5R#T'(.5Z#
ME<@Y7<4'*]!RN0>KD'J]!ZN0<KP@Y!R$6FU<G"Z+IK1M/ FX+ST!P1%V/R:(
M9>T-<*;UWS7-/A5'E"_EAENYN53F>/+L?]GV>T'\P*J@Y!RN0<KD'*Y!RN0>
M@Y!RO0<KD'*[B@Y7H.5R#E>@]7(.5R#E>$'*Y!RN0<KD'K66\[<*KDCS= 29
M.<5MWTL4<QT>V9GU>]@V]"*_E/T$[0_*:;B6D0IU[YEIH;?='5I7;3+Z7M:%
M8A5*J@Y7H.5W%!RN0<KT'*Y!RO*#E<@Y7(.5Z#E<@Y7%!RO0<@Y!RO0>KD'J
MY!R:_P!"!JY?R?:/[ITL7N;S8,'6 D&EU: 5W[>I-YK#TK=T>TK2G'!6EQSR
M=5?RY:!<(DKIMK2;K95Q )VEP).ROV>WJ55 JJ#E>@Y7(.5Y0<KT'(.0<KR@
MY7(.5Q0<KD'*Y!Q5Q0<@Y!RN0<@]!RN0<KR@Y:.A&;G)>7 )UL1K#05P<>"T
M5*"6D9:7& @,8/HCU*.?MF9]7O8-O0B<2OY1>10Y2:,=J #-2SS'@C(Q2T&D
M*[Y6SMPRG)(R4W'EIR&^%-0HA88+@X6EN&>W'R[-JQOYXYM.]1#<PWM5=@YO
M%8^/V+'Q^Q8^/V+'Q^Q8^/V+'Q^Q5^4JGQE<?'0<[Q^Q!SOTG8@YWZ3L0<[]
M)V*YQ_O.Q"[])V*KAD_L0?$\?L0B/\?L0B/\?L6L?X_9T(1'^/V*^)X_8A$?
MX_8A$?X_8A$?X_8M8_Q^Q!S_ -)V(.?^D[$'/\?L5S_'[/X(.?\ I.Q!WCOP
MZ$'P_P!)V*^'^D[$'P_TG8M:!WC\>A-N.)?V+6 $"ZN-.CBM'R4WI.<A2TI#
M=$N< 7@8#&AK_JN3N@8>A9&&TT=,N:-8\"ARRZ!LKQ.%?ZCE#H:'IW1D>0B-
M!UC3:\@.U;MCP#F6[MJY4\F9WDII.-*S,,ED0N,*,!S7L)YKL,*X99[U4-YI
MQ:>=U[U1NQO:J[N;VK'Q^Q8^/V+'Q^Q8^/V+'Q^Q8^/V*ORE4^,KCXZ#G>/V
M*KOTG8FN=^D[$'._2=B#G?I.Q"[])V*YP_O.Q"(_Q^Q"(_Q^Q"(_Q^Q:Q_C]
MG0A$?X_8A$?X_8A$?X_8M8_Q^SH0BO\ '[%K7^/V='KY4(K_ !^Q:QY\/L0<
M_P#2=BN?X_8@Y_Z3L5_CQ,-F"#H?Z3L0?#\?L0?#_2=B#@>\B8]"O>/[SL5Y
M!%SJBN[-.C7N9#8"\NH-6W;UA<@^2T:7(TI'9JVQ(=L."X!Q!P-]3B.'''#:
M!8P!<?;@^](13C_, ?"*Y7_R=:%Y6M=%;";*Z1:*"=8W'?1S,+_*-@X+3/\
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M#;,/<:1Y4J/WG':&V8>XTCRI4?O..T-LP]QI'E2H_><)L&V8]5%D>5:BG_\
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M%:UDS*E?D@_5Z3"FR132)/,-FJI?IY[?2O7TJN(%(@4J(M/AQ&8L+3HW+0"
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MG-OP>5KRCES\<QYZLW?!Y6O*.7/QS'GJS;\'E:\H9;_&\>>K-OP>5KRAEO\
M&\>>K-OP>5KRAEO\;QYZLV_!Y6?*&6_QO'GJS;\'E:\H9;_&\>>K-OP>5GRA
MES\;QYZLV_!Y6?*&7/QO'GKS;\'=9\H9<_',>>O-OP=UGRAES\<QYZ\V_!W6
M?*&7/QS'GKS;\'=9\H9<_',>>O-OP=UGRAES\<QYZ\V_!W6?*&7/QS"9JS;\
M'=9\HY<_',>>G-OP=UKRCES\<^3%#K%;J+[K=2RQ.H;0-Z@>ERJ8^CI*O< ,
M"?,)%1.MQ 2W0JKYFTE43(6;KEIO0*E;A>Z\F/A\O1\N/X/^6,J5>KRI]6D-
M/56GF,BG4=T5030-"I4=2KH?)MU= -#?<%I=5%<=8T[2,N9&KE==7,F=W*?)
MC-@T%*Y53V6J<V38&@A&-A7$)\5%\B<4G74(-)[@& ;79UL?N"=L!4#=HJKR
MNFDJEWD1(Z:/!JNJ8'9WL@$['M ]+)."C,IBJBK[9.3_ .6.UULD$57M@)_&
M:03EU,2X]1*FXX8V;T#*35'JU!IV8DS/1G=)RX#[T&6Q#1\7 -1)AH"9"6(F
MB@X1-*;9NMMBJR5<VBTBA43-E0IN7I?+*>V9+JNI<B>U+O*?OE5>4;CN=[=5
M3^*=4GFW"78(7_@"(EK:9<WCW[RY"_1^S%\525,AQ2?@4UVJ/CT1&7H[+KG]
M0Y;K#%^OTQYM.'==2EF?-B+_ /#RL][^4LNK\O\ +GZ>K'GJS;;_ .'E9\HY
M<_&\>>K-OP>5CRAEW\;QYZ<V?!Y6?*.7OQO'GJS9\'E9\HY=_&\>>K-OP>5C
MRAEW\;QYZLV_!Y6/*&7?QO'GJS9\'E8\H9=_&\>>G-GP>5GRCE[\;QYZ<V?!
MY6?*.7OQO'GJS9\'E8\H9=_&\>>K-OP>5CRAEW\;QYZLV_!Y6/*&7?QO'GJS
M9\'E8\H9=_&\>>K-GP>5CRAE[\;QYZLV_!Y6/*&7?QO'GKS;\'E9\H9<_&\>
M>O-OP>5GRAES\;QYZ\V_!Y6?*&7?!_\ OO'GKS;\'E9^2H9=_&\>>O-OP>5K
MRAES\;QYZLV_!Y6O*.7/QO'GIS;\'E:\HY<_',>>K-WP>5KRCES\<QYZLV_!
MY6O*&6_QO'GJS;\'E:\H9;_&\>>K-OP>5GRAEO\ &\>>K-OP>5KRAEO\;QYZ
MLV_!Y6O*&6_QO'GJS;\'E9\H9<_&\>>K-OP>5GRAEO\ &\>>O-OP=UGRAES\
M<QYZ\V_!W6?*&7/QS'GKS;\'=9\H9<_',>>O-OP=UGRAES\<QYZ\V_!W6?*&
M7/QS'GKS;\'=9\H9<_',>>O-OP=UGRAES\<QY[,W?!W6?*&7?QS#&:<SFZV#
M^0JS';(Q%75G9=- NJ(IDB5S5I%.<N@3.R<T26R+JU-(IW;54XI?H5.GQW_1
MWD3"(2H.EQ5LM[63G_T;KT7[^-K%EVA9AL*"A2F4+CW'Y#%OX^=P^G&SS+>4
M*1D(YE*J+37+:4Y)J68Q1A7V2%MS6ZHO@;<<();Q!COMF$=0-'P)Q7U*5D'9
M-(>-YS:$<EYPB=<<>GTU7#=,E(W")QA2(B)5(KJI$2J2K=5P[L[V1CIT9_1P
ME;U%^74Q$1?:_P 1T^#IPNSC8^N[--H"#T;Q%ETS5?KTJD?]BXI.2MEU,J46
M=3=I#D>3&?%QAX9M+ @45ZU.,K:HJ<TQ<$FG 4FW ("(5V[Y:RK)RZ-;FR6H
M-;C-HU!?$+N5)40C;@.,A8B1Q=1HZJ?DRZWK[I'T.PC<1+AUCT\?'^;J#_(]
M/^*M?J\RR>C1<7_F2?S#:0E\@YP_Y?J:_HBN+BF5*H4:;&J5-D''F074>8=;
M5!,2#O7N)(O$3;<0@=!2;,5$E17'J-MRH>MQUFF;0J5$X*JZ&*A%:NJ)X8YN
MN+U&_">/_>-G^538TF!*?A2+H_%<=C/"I"2A(8-6W 4@4@728DEQ)16UQ546
M^!5>"DJZO&O3U8R7EBH9RK[5$C.@SJ]->E.JB-QX@DB.O$*D*N*WJ% ;%;F9
M"A$VWK<#.V=*9D&CO;/\@O$9)J2O5=LO3G9FE&9+3+O#\H+2@O/MV"(*)'CH
MCH)R02)4UN]T7&U[Z>'0G[]/RVV"(OG"BKU+*FV^>2/\O4$Q?P?S-/Y@O0OB
MQM8%LL^YA!5M>4Q;C;BD*+=<;/-HU2R/42:+>2*--5&:E"U(HO,E83>CZU06
MY0@B>R$'Q3=ND*HTZSM'R32&X+&>,GS&G,OU!P2=B >DH+SBVLV!:2W!.*K3
MD94%V(]S!#<W;C(XKE^))9>:MU2_R)XDOA"+OV6^GY>B^,A97H64:(&T3.<E
M'-*"]EVEMD)NOR[;Z&\0-E8WCTZF&B7=QP17Y!(8JL7/&=JUGFJG5*B[9L+M
M0HHK=B+'O=&VT2R$9?[Y]10WB%.Y:!IML=6[74O2J+:W?O;\W4'^1Z?\5:_5
MZC?OXX8MB^$7^8IZMM,;UY!S;QMIH-2+QVC&ML%J5%$5L26^7$:7+A.#(AO.
MQI3:+NW67#:<%5%172XV0&.I%455%3@2IUXD.R'GD=<(G77E5Q]PR4B-PUU&
M9$2JI$2JJD2JJJO&_'!"B.B5^*\+=2KB+4*A3W5>@2'H9F*LJY'><:<4"5%4
M5-H@)0)134"K9;)WDP:N<XK7*W'CT^%/\OVXZ4$BX<WBG>7&P5"\X<-?8<HG
M(GCY;)]1OA+?NN%3S$7^8IZLO#&UU&SVA9@,.@9C"I\PB:OI3"<55"'AU>/O
M_MPDZ<L<H?*'$A[_ 'G)MXXC*N:=&^5K4C:N:$0->G5IYM[<,(BV)%ZB5;I^
MF_\ I@-2IQ3ATW\."G3I486)+[KC4;6$5DG35MD"[K= 1J+:&J(I:!34J)?
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M2LED7"*AMHJ7XIPOTWX75?"OA6^)4QB!%<E2G6V660)QQQTQ!L!!-1&9GS!
M115(B5$%+E=+8I%5B5B,DN%(8EQC(]W(C/-OL.:#4"T.M$39:'!,"TDNDQ(5
MLJ62RW5<(O?Q;PXZ,7P'6O7Q_?O='?X8*JQ5J(4W?L#+)HWPCJZ ON,MD ..
M@RI[Q6P(VT,Q10$C%%5%)+R'A8;5Q>A$U*O1S?Z7B[^*56*?6&$D4Z7&FL*J
MBC\1]J2P1 NDD1UDC;U"J*A(*]*<4NGJGAZL(J*ET5%3OHMTPG3\GHMI7K"S
M=_8%2^KGCV:^/_+"]U^_?] O1A?8^-,;!?6'$^,S/KDCT%[?+BH3&(,=R1(=
M;88: G7GGC%IIIIL5(W''#5   %%(R)4$115543$&?&GQ@E1GV9##H"XT^PX
M#S+C9BABX+H*8$)A90(5TDBWOT8AUN!,F28<>7&?D1"$)3++[3KT8C34V,AL
M"(VE,44A1Q!4DXIPOZ&JUF#1@CN3I4:,,F0$5KE+[3".O.(6EEO>D*&Z:"6E
ML;FJ(MDX8%P7FD<'B)IJ1?'^M$3H6_7@>Y1?,OB_?QP^3S-:7TW35WKI?]&$
M7OX7C_WM^U,5;-.6,N$'92J1(CCJD@H\^VVIJEM2"AFB<VZ75%NG6G%,0*E#
MJL4)\%]N1'(=0&V8N(:<"O<;HJ*G7WN*+PQ&KM/J$R338\N,<R&@E)BA(:.2
MP)I<%>9$MXVAHEP)T;EQLJIBMYKH.7-RW6JA%@J_J1KE,AII7=&G6H(9@1HW
MJ'4HKI'6.I.<.*3F7+U;'52JG#FHBZ56/(;>L73I7=&2(O%.;TXFR8\*.[+F
M2 C18P$\\\X2 #;;:*1N.&7- 0%%(B+FHB7)42ZXA;0<FU20D&+7J<[(-;--
MA*CDI^!NSO.M_1PW;AI=1P%34/0O#HO=+I;Q*OF(0K>Q(MNFRHMO'YJF*=)(
MGC6V)E2B05BB_)89<F/;B*#KP-')=TJ:MQA,D)YS0)%I;U%I$BM9%7 &C@H7
M@_?]U6^$)%]'M8]?N8_C;7U.-Z-?S=0/Y(I_Q5K_  ^@7'LE'^BJ_L_U\>"=
MF4//&9<W0$><"D5EEFLM-KJ1RBNPHBR#T:277#(%D)IL2M@;:+Z9PS!*GYHK
M^7,Y.HH4HLWTVD48$6R&T#SCLB6EK7&0;0M-71;A&!QLM,A=53S5F2KYCDY9
MRH,2+V,9:D5"?,:>D(I.HXK45I@'8R+W*&X[OK(BV0%5,!M%JX98S,])C1F<
MPY:&6P\ *;T1V0S$22U(%-3;FY?$P504A<%=XWK73K*3GO--$RVE>K3--!*L
M<5FCLBZZ(QSDHNLZE+)O=:0_CE5AD!0=XP*NGNW7,J[3ILK,,.C5"I4RL-5%
MHMU(IC1L+%E-@3I1WF2E3-ZV30FHR =!!(-)-^FBH;5$_+,@JAK?SWT_FKPL
M*,2EOTHG?1.F_0B75,5[,F;#SE)RS0DA( 4F'.&7(!U>3;Z1,;<0F ,>5ZA8
M#= )Q$;7>DX^=A:7-N9,PYBR94&9AQ8\FD9@;HU5!MI[<SDWL,FW6UY2AQVE
M%\.4,N;_ 'B:VD(174KV8:QEBC9=H,%(<O,59(V6'=R]%I\5H <=22ZRCLAU
M=VUNQ5D7_3G5+2XR*\UO.69*'5)=!S*4.3(*DOU:G5"(V<<'A8W8N17(KKLA
M6W!5Q# D?<$VU6Z H6+)^9<XU:DR,QU88$>F]ADD1H[&\-]Z9I%S?*I>EL1W
M NK<:\AT.:IR%+4 ^?[/[>7X.;GF*:E-4H:R(";S>RVGM"F^Q(5U B(>\%68
MSH2E0.+LA'%5H&LX9UAU.A.5F/3NQ.8I:PV8\??#(@N$P[):O),M$YO<QW1-
M>30B$R;44,4+&8-K4]*O5HE.GT:DM4<WHB-5$'Y#U2D,\7$#1(AC#9155E'?
MRLS(3)&T 15U_:?.J%#RTN7X3/9W,3SD0 D.$[%AE&$TF/F;6CE( ;:BR*$P
MKR$ADK5B#%,<K_;2@,U\(YR@RU4-,F)K;9>%R93N=R5PW2CN-V 7!WT@7.#@
MNCJ)AK:?7DH>598M.BDRJJE)BFIH.[>FV9!]>GFQU/?DEN(ME;&RJ;'H>89&
M5H4YN33IL)FJ1QNB:)#:#$G-7]BMPCO61;D;CSB)J0[5;:)F!<S5.G0I5*IK
M]-D)'@4:H@YOZ[9!/>-2M_':C _<F6E%F9Z8!$X@<6QS;M!JU/>HL1>1Y=*H
M05ERZG41*9'C/:6U2FM@Q*C,G(4G"-7%E"UNV7%;WB]S&SS4:;DFH9CS!$9)
M^$1M0UBR */5.:')I31(3BQF)*N)<7]1L)KNK@H+AT/:U4SJ='Y9/H=5;KDE
MB&=-@;UJ52G91 ,==X;[XS1!Q49/TJ*X*D#J(HH3:5+:+F)*]5*=$D4FGOP)
M(QX5&J(.\IK7-!U#8E\I89C-NH:LM*+,TD<;-30?XL<VY]K=,>H$%"A9;[*0
M$F2ZC4D&9&C2%$$['CNI+#)/JKBFKBRQ;1MIQ0WJKS0SEF%G(=9KDN-#&ITI
MF6L22TZDB#41C1U>8FM@V[O&X\A..Y(T,>*(1II<.7G#:+36*!6),>G/0Z_+
M8@,TQ%<;D,/RP3DIG.34P2&=]^V,3TD;"T<I><M+S;FBF9I2AYK" XS,I+]3
MCO0Q=9Y*L=UH'(YBZZ_RA$!]M1?%6%NA?D_%"&9M@J#LB?48=0H<>-$DNMQ:
M/*WJ3ZA'8<42(I(R!;A.R+*K+:PI*!<%<,M:Z*CG_,,Z=ER'EV)%>[/T)RHF
MDDB#DM^1[J2BMEZ>+:22UQQYSRJ&EY@$<=Q3\TYKE#FC+%0.$W6:9%"7'J;3
M#BL.1I(*H-G!Y6K@&F[<2_+.==%141%0LOYLSC0<A-5F1*;J<>1(;BQW9 R2
M. AR'&GIL^4Y(D/2VF+BZHB+"@#9@IZ5%QO(V::S6IYQY<BFUF!R7?,UNF6C
M@+PZ!<I[T$Y<MQ' OJ%X7B @X&+1((FG[/-3S-I7K"S=_8%2^KGA.Z+Q?Y8Z
M_D] O1A>@/&G[<;!?6'$^,S/KDCT.TE$7(^9E+JI-0T654YW)G++=/#C+]>J
MF0Z067=T<HZY"9G95(24C*3-TL\A5%'F\FDF#RDI':+(U(BI&<MLXWF5ZUGE
MZIF;\B!$BU">X2KJD/K&>E27%3G<YUQUPM(JJ#T!9.&#S=GUJEM9RDQH/8%P
M6ZHM(;%Q9C=),4<)[ERN"T;X,\]8ZPP%>+>^%40UK^=\PN5VAT[*L:)(*K4A
MZ?>81"+2BY&W;JHBZG6PWIZV1%#<56M+T<!,L9BVF56G51*%RVE4J5%AL/52
M;+:=>;*>XW<F8,5)D4D;1><KKDES0A"&[<)"+&S[-XYQHYRI ,C-@R3ITER,
MXKD62\T %RB.2HBBV^V;;R 5R;4R;)2MJQM,EP<QYF=HLNHI'@T*C.RF]#@_
MRW*1P(?-3BCT9D'WA6Z*BO-DE[%:B;068^SKSP.-E(?IM/"&XPVMM]5&D2.3
M0K<K-K(5;'SD0/3=)+BC53:3OJ7/G0*=.IM0>%B9$B:HCU+:<6XRM_*F.#.;
M;%-+R-LQGKJA--G91P69LZYAJM>'*04^)3J"\Y -V<R[).H3F0 W&@%'HB1F
MTUZ-\G*+J*F*:;HDS.5?IY9.9GT]JG2ZW4EB5:.ZX$MQD$C/N_D[T5_<<]QF
MZ$0FJLFFIIIU"!',Q3ASV&7Q%KL>N7)555>=ORD,2HC0HAZT!&B!XM0[O5K0
M20T2Z+2,XY]J79R>U!@.TNDS*W%!A'-U(G/0GY#,-F,;A[N+Q: 'W'B=%TE,
MP;C@(ZZ7M*K<:LTB+5*G1*CV7FC!?IL"X2Z2\_J)E=:RGUF,@8*PX91XJH9B
MXG!";Q(E9P:VI2F.R[#<1JC-3N3.1I+C(TWESB&"-!/::28HB:),MJX !1](
M\Y_;'5''ZA4(E3HL:)!DN-QZ-+UI.J##!*BGRA'A"*X^"+N06+(1M5$72OJ0
M:;5NR^78==9#=E,IS4P&[HMT=;W@\4X)<2ZE5%Z1Z[[-LOTW-,>IYFJ\ *C4
M*A6IP*Y),7^1Q DNMM1&$<1=+30@ED2Q$2JI=0C3LMTO(KN8*M3I>X@NQEEN
MTC6VD2,;(KKDL-)9&5<#2CZ#S35L27CC+E78I^8J/G :BV,O,M8>C52'J$U8
M@58Q*FBXMA%5B;N'&([)97'23@18SO$:J.T[*$:8+<F([$J!;IP4< Q08Q+P
M6Z+KM9;HM\9_RY3LJ5#+69LOQ!IDUS,%/ITODG,&9#FO-L/1GV00 =U<TVS,
M55MP 4.=9%VB.[S(F8CW:H1T*??CT(L8[_ZWZ>E>*KB!D/+-3R!3WI%)BR)+
M]"8>5[2#;B/'&3TX741#0AU+I("0A]BJ6Q1-H$O+^SN/*E.#+J+51>R]$D2S
M5EKTF2]&9DRW41ZP-M-[U\UWAN*)(A&Z::J!M.JDBMMT5^JTJL.U2(ZD*93F
MB;&)/$5<%N1&Y;(5]I10RWH/L*BM[MP$1]#;R!5<SQ(^=*S5Z@U+IM)J5;Y2
MR3,G?\HC.(2\G><FO(Q#%L7$&*+);NX"#RIJ0F]LM4;*/57JG1'(+TEM':"Q
M<JA$@FO=\L.0@O2F!76;'(&@)4-D9"61XI6<<S5^O'0\HI$BC"BL2I\Z:P](
MU%)$C9C,1A>BW6PH3CA2!0=:"@J2+C/%1ST.4.53A"@SHU49AOG&>,^7-K+C
MMLRH3\6:#T1EW6A.M/B;RCO(Y@@KO3JD^J06<@]F%IU3E3:T+*R>0DWR=LX4
M]UIV(+LA\HTG=M@T\[O#UB;P@(B::',S9RKE1KB92;@1:907WH+IS6W913Z@
MP#;CC8 #\7DC2:]&^O(52121K2B7F[3Z@N4&JI#@-M5M*U'H<F"\>L.4C4 A
M2V1>101+KODC/%I055MUQGB;2P<VYNI&8J' S$$-V%F'>(RW&%T':>Z#1R1
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M5!H'4D+=H=8M%OD(2%.:9YQS/F*L0\KK5LLK1H<K,U#<C26J@,W4*5&.8A*
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M !B"ASU'4%Y^3ZS(K6T-U(JI"K.74@TZ63C:"](W,L23=@X3@Z%=#4I %_\
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M17.C)TYVF1@]L6<97F5]VB9?%&04&SN]U!Q&*)P&O04J=;S2R01WD"%Y;-P
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M:=6-!8:F=&R:Z0)P2D5CTE4^.=BV3WV2X/TBFRGJ9+I52(+Q373$>2/&B0#
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M/0:\WN'H<@MTGUG?C60++"#JH\Z'-KWB'-@S8R$:,PED"D1WH\1C1RB,%[2
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MZO'BN6GI.^W2;>##L&]Y1JWNRJ.YZ3;GG)8_K>@:C7=W@1),K7R"O-J\?/\
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M^*J3\6<(YV0M(G[$E53Z%^WM0!$_@O;]OA.\X59: \-3&#)!D?N##(83??\
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MVS"P983I !55;&4"R@[S![++.6E7)C-DRC/5\=AVP/,D"QB&U:RDJ$D=5&(
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M<U&8]F]M!$27;T]&E=1UB=+'DVEA5LFI$C*]QT@UL9C3O>5R2' C@1F@YG"
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MN1DE*0\F253'([KXS44CW.5W-&-:Q.:(B,8UK?!G$'_L")_YVPXPK[$6P_\
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M:M?_ --XP#X?T$^1IG'S^%?H\?\ MV_RY9_1B_=_T?J/9!_GJW_YFC\=EO\
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MQ$8C1J1.V'_^X?\ '[%\?]_T<O1H1$:GZWEY/&%5MH-IJZFPF^R2F"<>L2Y
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M58OU#(OMU7R)6_0CCQ@ED2#/:,  C>4I2O5&L8,8_+>]7*G)J(O-?#EP2/*
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M<32YR(YJ*J)[9/0K&6E985KR)S&V?"D0U(B>^QL@8W.1/?7@4>,$DB0<C1!
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MMK<W7(]'/'R=]%B?[9J'Y5B_4,B^W5?(E;]#C'_;==[R+_Z2SX?FOH]_CO\
M0@8+:NRFU>;O;H'T\6J<=T>Z;XIJ=85T;I%_]5+$!G+Q7CL[6OCBB,L)=[75
M47D@QQ8K+6+6U87\M:,V8HXV^NGV^OE\'#L.!/ON_$(6N9;OZ!*9]N!'<Q)
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M+A[()*3R.52"?MN1RM9$OLF-;$=;RY<:JKJ5\,!=JN>@I<V;*FQI01INJ@Q
M0&M41%<KFJ_1$C1WS;ROE5TB1#%+#'$D,_=<\LR#;1Y4-1321VBY1S5ZMCM,
MHRH]R,5B9H>HDW]= K\?'*'&)8 <::_J8HGQ[-8T( Y4;63<$(;6^+!:GNT:
M74ILF+>2;"\ALM1QJ(E> 4"K,][(SS%G /U<HZ,<3:8L<;/$;R^*/(3'IT^1
MW62HD74.RCL8PA82UKI\4[Q/8;VNE!RQM\IRC<@R)J&]E[:4![YDO'>[BR$N
M.[U!81ITGHM8!PQ:H)6%Y%5CI4MNCER,_5JX_B_>^?/[//Z''_\ 2WRY9_1B
M_=_T?HOG\_N^]Z>)1;G$[C+@D[,JL8H=-BQ,K-%*F1S^<HL00BNCM5J/&DK3
MRW"C;S\M.,SS#%<.E8O*HZ^QDCK\DQ0^,.G2:V V4 IX#>AE3(',VRV2P@E<
M]) FE:X2+QAUY?UN()CV47E!0GIZQ]J6_JG9'I!7SEMRF95SE"=S'S(0ZQK1
M^<%'M)3!]4_* 8H*D;)-@.)K*LK]TTT*N$RXR'3HJZ]8TJSE2G.T(/KJZ.%C
M#2#RWO009.9FGT42=E>%6]U0EKJ20Z-77]A70HLV$Z ^P(4E>&<R9%$5LY\E
M8NDA%*<>EG&)5-_?=F=T3*;45++H\0F2W7V-S983DC&.XMQ:):P0GCM@S#O@
MTSQF*,H]7M>,[HL;C89!AXG<18,:WOA7$I9/54=?8I#)65\^,YYD/*>Z18];
M"& 3X@P5=B7JBQZ3*V40BY-?73,0@4C93FUQ,G==RZ!7OF;>\.J4T,\YSU8L
ME(K6"([6Y#.AP\HA8K;TTZ%)>>YQ=DRI=13X[4>V/.@75O-/91IVIXHLRN0)
M@'&CY<, RM<MQ?5F1]EL"NK9%ET&(WUI('F-U&JC&$]22@V@8E'.L^G<6J@O
MI[)K4+%22?SI&@Q&CP"+3I.R;%69O*M<E9,E5M1C[U@C"-L"L+&+8V4N1-VQ
ML[SBB"D=2ZS(\:"[1&Y'%KX]D'%L)"XE4<IZ^<%I\A4,^,R0C94-ID<J/A2-
MTD<S##;+G":*6;LIE6E#8Y+#;6YTCZFJHWY%-,YT.J1A!U8QD<5 +YYY-/F6
MLW/#EP?,<>PFWP3%PX>2DM&7%$/%C9'</LA2HCQT?-A7"JXJ/1+B1'$0CN4%
M%(!&.2T[0LDJZZ\R+*,@O]V3:Q@6;JNLK;>75UU' ZQA&PZ^)&B,=M#&QY=>
MZ5"NV4CY/84+RU]9D AR#8U': -%!L8\=P36-9$"-K(9K >A)S0*T!W!$16;
MC.:83_U"9\/_ +7L/#P^%?!57DB)X\_#CM#A7'9EDV9R2=I.<KUE7V?+DT,H
M33]+8+K,@71&D8O/> >0,8$*PCW(U51<$J;\+HDT?:3B<@560[9+Z:!,SD<J
MOJ721N?NK"B%$Q51RH)?I<7DA;PV##G83B="*L9+-E6<R5(";/(23RJ:VM!=
M4#N<4(1RIT\]AML9)1@0%4;DXR_.(@:4UQBC,FB*L,TBPQRPGX_K44V$1CXT
MDU59#4$H+4DM>@R\ARB<MSC#KR_KL0;CV4WE!0R*BM=:EOJAV1Z8]?/=<%..
MLF[)WL=-AAK6[2;@HUI)8/JWYY18Y%PR##Q.XBP(UM?#N);I'4T<"Q2&2M@3
MXKBE0TEZFLTG10@"Z*,-;8E=),*BRV9CU$>=*RJAIIM5;1^]:H,\&;!QV9.A
MM>H7:Q'"^PJI!?.Q")&(9#*-%+:X3B\3&&1H.,TMXMU>MLB]$2?/M(A6.@P)
M0B6RR.B$D0#35;(Z=7)E3WKL1#9[?Y'4PB7G9]<65#/!3%*&JMID4=>2%*BK
M,<>37Q)"641LI)+I1(;&%)O&'R:F!TN0W>/1H&0=ZS3-Q"HD!D.E4T0-D2FG
M'OIEVAZ8X5.(EI71ZB8Y4$Q>B85[7RYU!6 MK5KXH8T:9,2O@"ZB6(!I]C,5
M'/# K0D).DJUKC&&%0L]T4J56&VF0=G^5/NJJSF!FX*8[2T\RH&&2>#:PS7%
M^KQ3(QWDKYN_"*90$8Z"U51P\HR&K@X+#AXQ<9;$8RQ9=GD7D?&[&:'0$42P
M8*F?TL1 NFF/8I*G(5>ZX<-@72>SM<3JH*Y'VFQX\JK%=F.ZII8G<B7MA-LG
MU[&R)J0P.: 46.Z"260B*TP=MR/QR/E0:5TD'9[E"QK.A64&#8B-=4+G\ZN>
M63,KCQG-:Q['S9XSC<$PY+54D2+]'\_L?0_/^=4\/A^QSXQ*#$;*#+QZ+.$8
MR^2W>D3UEA?$((SCNTMTKK>P#AE\4YISXR>3:NG3I%]CEK4M.CVG,Z;/<!S3
MR3G.CM";3U(7F4O-6: $]'$&@R05J+N>3+D55A2LAF*HI[QEDQ)42>6/J;K8
MA!E85"#UZ2"T:W/Q*3'BS!8]B38H8@"*$ME(",BR),H^EX8W5R".UJ,;D$U&
MIR>O%C8FB/EUEN.S@V$77LR'UMISW$$HW$8R0/FUXT1SVJ1JIJ9S0C)D2CAW
M$ZPF'#HGW8X0.[(L<CW.9"' DR=XTO5H,4KAC43/($URO5V3CDCD$==8Y,J(
MO3M&YK),H@W,*92D8K (@^?F4,[GZ O3GRK*!K)"3(5S/L"E5HT HI4>.%B"
M>A5,ID<-5)J"U.2IY2^ ^,-L7@G[&/8R^EF,8.-NEDNC68=45O6(QT9KYPW:
MBD"K6H1=OGYM]Q57$>1(I;Z,"/.= <%EA&)#,V1%EPU.NR_;)J1XB.&PS5>J
M/;H\H=#CX[0D:1;Q+:XG6PH8))TA+]+0HT:(<X1!'J<5'.DN(\VCEI8Y_$Z]
MCB.R))LV31B,UC9*,1['*CF,,X2$Y,Y)R(Y%5&ZGL]"ERY0SN[B39<A H,'6
MZ)$(D9FIBRD#J1Y$<_3(<W2C^;M>D3\JC'&=[[VG6!%4;&:!F=,#(U2-16*,
M2M$1%T(14=RTCTZE2D#DPKZ+844-E4R32L@2!SZP)'$CM,.?)"Z+*CJ5XMT6
M^-S51[V+R00<EB2:8\+%LC!'!T540+I]>L HRP9 5F*HCE>]CW2QO>%KU._V
MK6,:^9C-)'NE-(MX5DMA9]*WJ$!&*,K7ABR')%0>O2%G.2YR:W%.G(0^+X,!
M\^-D%N2!'!/CN0#8=='*LF2@I(CI*9(DDT#)I&GF&)Y:<N2Y!493/O+F%:UN
MB$I)9; T&TC&0\*0WKI;48%Q&N;)V"*]6-:B#=SXJ9['951V4$8!V(Z @"P[
MI\9RN0Y33)\<T=TM%:.4!028C4YM8/DI$6XGV4&TII\RW+;5]GCQ&&D0AGU[
ME<^.:5! 0+E52=3'>,[2\U\ D5A,=NX )<Q,=A@AK)N2M6TN6,WNH)8ECN*T
M12,D$ 'SLO1Y)B.(CU%Q;&K*Z\F3)\<H(46Y9"'7U#Y+N;Y BPY19,LT-.;8
M;"#C,\I>HW'.=SJ9[79516<$8!V(J$H"Q+IT9[GH<Q9$^,:-U7-HY(.GD14:
MCVC%IU(MQ.LH-I33YMN6VK[/'B"-)A,-KW*Y\8LJ"$@7+S)U(7CD-/K7P"1S
M'XK<[5G(A8V." TR<H#7ELV(8AB29FDVQOHI%8,2RC>0U"*?F32F52S"E.9>
M4M[714&P2O&:T*C@..WJ$8P+.2[BB(9VKGR8Y%7BYH7#D++LK2KF@(U@UCL%
M!:=I-UZF:?6]2-4;6AY+R*BZ$\'0;V_@7W>P@0VV<"#W>6IMS0!#"-[Y$F2*
M7#',$ ;)@F1S(@^:"(1?.+DE2V&2*:YNX%E#"!&K!AQXW4ZHRD>9"^2TS&"T
MB?S:SSCV^"<8U2C'(2532KD\DCV,2.]EF:*42 Y%WGN8@5U[@0ISY;3GIS<A
M+N76W14MHFU:PW.C#[LE)%B@!/IY3)2NF.COCJ] 6(8X7M7R_2C6BQN!(O[=
M$LVV'79'L(^ P0'A9$K0!ES]#7Z]PSM\+$<Q%9'YE(K?FOPKZ?\ 7]#B?[9J
M'Y5B_4,B^W5_(E;]#3VLEI7@K[&)+*P+6N,X8#->]!M>\0U?I1=*/>U%7P]/
M+BY-#D2X\2WER2G TKP]1'+)?)$&6%CWL,UCG-Y#(1S!D3P7GRXPF)#&9MCB
MLBSE&)(&+I2%/9LGQ=O2=2/1&L1#-(P/V-SVS7Y@&!?]^*4UBVH)T"TP[@^X
M]2I/W&SG1&F+O(/HQO5R(QKT:-6)D%7)202QN;BNLD.P;.G^E^I60I51^ZUY
M2'U#8QA.?)S7%9JTK#H,C%;![HE29%38TS8DDNU/5I)<65&FR(PW#4K$($S"
MHJ>+7(YC2..'N*O?7UT:)'BMWW-?+FO$WD6=.46H/4R%\7,C^9:W2GDIS7BH
M@XS9W=-55%/#KD$&:2O=(E#1739L@<"9LJXIR+R(Y[EVTYJC'<N,-OU#+EY'
MC\=\"V?-T/CVD-CC-"O5*]\A9:QI1V'.6/S0KVE3J$'I6Y)45EO,G6D8T6**
M\#6NA4C)"M4DB*\13R9,L&E6P)#QQMI'.*KG^_1CRB/>!GT41E6TU*VO("RK
M N<Z..2R64#H<D.MPE.%IVN3F56.7D,.3]73D@8]DL#NYT&D;%')K1A<)T,L
M9CVBB%,FTKY37N$CR'4J>4B"*7&J"->(KK^/;];;+"4AV#@&BDU,CO:D=Z/>
MUHQ,#(1S$>4DE'/:(./Y&.%(-%J:ZJA'C%:%AG%A5_1'+&Y/DC<H7.4\13.3
M4HVHJB1RN;E#8Y<LMI&0TD^O2;<D@J2.>2YFPQP62C:QN\=Z;U*N&@VB# T*
M1[96-6P[,1F7#KRNF5PXTABR5K^A6-,')D1G#$JM:[=%ND74YXVM<FE8-[?P
M;[O808;;.O@I"+4VI:\;0C<Z1)D-EQ R0A$DL3 R.0M2B74YQED2!1Q1!'.4
MPX@O$4=A"*Y@!ZG.51C32Q/U[FIY:KZ.*[V71+T%O6P@5Z6="L$B6<2.W3%6
M?&L7CT2@L1!OD"74_P#PW@P; 48H%98,H<:;8SJ\9U >QM+Z4!S(\RU<PH(H
M QWN;MLC;[@-9_A$*YH(-A97EW90!RFDGP#V4PX9,,G,<@213'2(KMMQ-M'Z
M6-(C%Y>'-,OHYH\A947EA D5SX *UTX$6!)D'$.2AIK M<J$$Q51Q4>B&\IJ
MIRXM(.'Q+ETV[BK7SKB^= ;)!7/5-^% BP4>+E,\&%*8ZE1K4:%JD>Q6T]K)
M:0@*^QBS#, C5,\0"HYR#:1S&\U:WD/61GO^5SU<2[Q8>864@\V19)63.YH5
M:<YSOD]/(-'-+E)%U.TO1C%<X:M1S]&IC[/(;B+U@+R/+KK2$%ZA7NN:%D?I
MX;O2CX8A!0+GM7<43-:M(KC<3(E)$N)T^:<&FPO&08_=D6.Y7.2$*#+D(8TG
MGH*8ZM&C&\Q@1^I5Q>QB,L8N1X[!J*Y1D& M09E,YY!26R6R4FM>Y58K@]+I
MTZQ:TY)SEY&6IO364U)$HM"?H.Y.]9C'[CW3V'ZU8K#$=)&+IF$1^EFXQ&J+
MB'0Y-'M0]SRY4FHL*,<0Q-F>]KY<*7&G&C,T[HT(([7H]-;1[3=+MRIN*ZE=
M%I*F)W8V,WIF6$V/TDJ&:PG%%ICEL3=2\KWNY([2P:E33K3+8=?WN>)=TK:Z
MO)+C0A21R.JCG(LM@)A1-"Q O1KP[CG^',3/%RTHLF%?1K"DA#JF'I!UT@,Z
ML \A(Z&9..!T:8)"*Q3,ZD3TY%>)?)1)-]*B2 UZ4DRCKX491'+%C=U/@0F.
M<4L=JKS<TLEW/GK(N@?)&(N5U9AR''O8M6&(\;1J$3X5BV65QW.(-XVN&GD[
M33.U\M36^''S]/CS\?2J^C4JHWWO#Z''_P#2WRY9_1B_=_T?HO\ CR^[R_B_
MQN7!<WPQ,,D E8C#QHT3)YUW$*QT>WE6;SA;5U,YKFJA1#YOD,\6GYLXS7',
MG9A4&SNZ>564A**?>'KT=+BF"0EH:=5A.-K"N#HZ&+)\C4FA57C#:R(> ,^/
M91A5W-=))(:$L7'90#S11G#C&<Z01@U;'8081E<J(0H/.*._R]Y8G=MIBU#2
M1Q->?KV2JFPMY4DAA=,R.@'"G@:%Z25(I&O1P6HUCB=K-"^TAPC9]D]A=5<F
M,Z65L>)*@TH!Q+--$4B;SZPP)K8I2CZ*1S!(,Y'C3 GSH_9]CT+#<LJ+IU1C
M'>SPRHD*/)%)+&F'J8'3D5YD'"IUKT$OE'D7:N&P7':!:RRPR1\JR"#:U[([
MSN*&/&HJRK>V:Q\<+ G61#*]$ 24FVHW.(,J*Q*[%GVT.%DE#E,W+J.TBI)F
MUH;-F465[5-EB(*(>3&*":V%8BVQJU7%>/=5B--5W676=#55E+"F"#C^(3[R
M7$N[">)@'SKTMA&JAK&@,:KZZN9"EZ)!-]TUZA:Q;7$\0L\1]CTF99%H[JW?
M;"R'&H]S*/-D"2MB5YZRX+7&F')6D+.K6\MGJX^CF#C&LNQ2SJK&_JL??BUX
M'*R3(D3(*LIXDSJ^LJ8TM:ZU%-C$D(YM=( Y)6E[!(QFK*<MRJQHYC\BI\=@
MAC4H9<<=>^H?9J6(QDMJN-&8DT:@L#272IAUDO?%@"Z:./!,L :$VOQB#E4>
M>$SSI-*2^AQ(\18@^EV'C0@']4LB5&7E[7?X_G\?>3GZ/#['@J>TY:&HO+BW
M_P"3F?BDW';RTEW3Z#,5N8CJ*SL"*:<M+9TT>8\E?-D*\_0RHC4CE=JCE3F5
MI,ARC*[6#9Y5DD6+">.J >/04E7 85D2LJF2MR:5KBE+)G39.V^09XM(!;'&
M/8Q:%B2)]3%D D%@/,2(1Q9\R0W:)(C12>T.UKM0F)NHK?:JI'9."Q-",^ZS
M?)<EBK"(<C60;B2,T89UD18JMEL:U4DC"AP,)[0[^.[ZB7$AV\*VI;VJ+8-(
MZO?/I+./8@CSMEA#-C2-E0O>$;R-U(K1D]S=+S*-#P"QFWM)1P)K+R1=F?BT
MJN$4<MN-G'4/=85<MTA\F1$*F.2)4@8T<4//>3M(PZ194\FVS&TS"; G,25$
MKM.1-1(SYH6QBEA*CT<XL>(RR:#P"(\GDK^,.K(AH(SX]D^%W<QT@DEH2Q<=
ME!D3!17#BG59#V#Y :9L<)%]U.'SB-[0+:46&2/E60P[:N9'(9Y0QXU%6U9&
M3$='$QA>HA%<S8)(8X2C(A$(KFCKL,ZRH[TB9F'(B'WYJP%A"SXF4JQA>[UD
M.EK7N0.A\48UF-T.*P:J5U_E[RQ.[;7%J"ECA80RSF2JN?;RY)"LZ=(R1WLG
MBV7#F$>KT>A!CTLU=K\BPEP1LS;+B2H!Q\RQ(4+)68]C[$R DN.)D2$UPS);
M2(REV*TKB0)?5HU1X88B8'D+LEG1,5B#J9^8FOZFMFL0KY&.^R;*\P9W%":-
M"V<:LCU49L<4=RD\6;4>NK"UJ2X%[47C8%VR2^CN$JI/4=SW#(VL_=TGVSOI
M:4G,8^<4_MN,*RZY]AU9#QJ%D< E'C_>+V@%:0P1HI SY,""MB]SAJXPW0*8
M->-&"$.P.\AN,JQV4> 2;=V><38I EDOBL#DTZQEP$DD?$&9",%,&DM! DM:
M1I-I2)MD=V7]R6%,+-.S2!#C!6P=/?CEJUU"E'<09! C'.''D,1IHDYL%Q *
M%B$B-UH@ZW-\HF8RV/$QBYH4I:/O$G0$FV%;+"]LV?%CDLW&'$?U1R"KFQW)
M&!$KW,61+)\_?]//Z/Y_ GULQ/\ ;-0_*D7Z/Y_#QD7VZOY$K?K9\_@XQ_[=
MM\N67T8OW?\ 1^L! '&,P3,<(H2M:\11O32\91O16$&]JJCV/16N1>2IP^90
M8KC='+*S:))J*.MK9#QZD7;>:%& \C%<B.0;U5$5J*OBB<?/WOA^S_>HH3YL
M:N HSFDSI2KM1X\<+S%?R;YPA%1F@0Q^60CFM14YJO$V]HKPEM&K)D>+8,D5
M1*LPNL<K8LD2=9-9(CF(S1RU!.%5YD#S7FVKKK#,&1IMS%K)$, J4\E1K9B:
M\+)KF2QCBL0SMECQDD$>GTP6-'$X>N^BVD^/4P,7>9MW9[)98Q*R4L(0H<8#
M6OE%E&14CC^E];$74HW-0+K9U7;LMXILHJE0BQ'P98",AR&D%+B/(=&.]#QD
M%).(@W(C7(YCVI7;7NG1V^WR_9]V2]'I\/;<N7/W^,@_Y3M/L?[CG=/U_<V]
MWUR9W;W9T_TSUNO7HT>9U>VY+M*D*KLLA=!OYPXZM@-I)DN!%--8U\.-/MF2
M&-"1[2#;)44,XHKW*A'N:W4E]-NKP5$/';4%7.UPB354A'R!NV&QB(0ID,!!
ML -C1D:Y3/*$:$7AMY97YHE5)M)5=6GC49YZG'$?I=+F,ZZ.RN:34UPHV](.
MY$)M#(J)Q<@+=UPZ6A .7/R '.;%Z:3IZ18P@.:23+E*]&MBN<U6$802D&5.
M3VY!1VZW56V:VNFJ2O)63($MPT-'0L59$K6"0-JZ9(C$8UZ(WR7ZN*JNL,P'
M'FW,:KD0HXJ21*<-UJ-BB'-<V4P4=F\YH!/$225S.4@L6.)1Z[JMM[:)4 QY
M)26$W2^6KGQ9*1-FOCM<!\PQCN\PQ'!8HM>O:5J,3&\@JK1;6JF7\>M>\T!:
MV5&GA(&0H2Q^IFA>-X7;@C ED1WEM>B.:G&6BK;+NH_/)2.D]&&=JCBBG*>,
M@3\F)U(VJ'=14>+5K9XIR6+"6_FP[20I7$CLH.LBQ B5SED&GNMXN@"!:A2O
M(!NA';3D)R1JW$\EXHL<K9_=D>V#5&ER;22NIX6Q*IAQJU%C-4Y'29311VN#
MS0KG*C,?BTTQMI%R=3-K)9HQ:Q[7QB**>R?#>XQ8W1<G$?MNDM='Y$!N<]OB
M]6IR@=R:+C.1".!U9(KMS5 >U35I7GD#FB&3R%1Z1BZ.11C('RVUU=KVUGSH
M<+<].CJ3C!N?:\?)Y^#>2^*<3L>Q,PJ*EI9#JX<>+%AN?)-%7:DS)QY<<QY$
M@QD=S4C]":1H]J\R/+4)#@Q::QG-C1+@VH46J/.5S1DLD$UFF&-X^;Y8D\A%
M1SF*I'N<^[)09*MQ+Q^,^;- ^G-  :$![129$"9UDI2(![D5K3"A/(U'&!S]
M^NNY^2"!(MZR3-KJIM7)-)-(CG,%8[RBDN#'CD5C?IL^E7.>0;8[]!',@U5E
MD+H%_.'&TU[*27,@0SS$1\2-86HY#& (9"#0[@PSBBZN13/1ODRH,ENB3"D&
MBG;S1=)HY%$1OAX.Y.:OE)Y*^V3EJ5/J.)_MFH?E2+]0R'[=7\C5WU.'7L($
M#ID@4?>D/VP"0CT:XAW\ETB8WFXGOZ473Y7+B\)19(MO*H(SYLT#Z<T$!H0"
M-%)D09?62MUH".16M,"*\C$<8+5XHK6XRME:R\BO.*,*H//DB4<M\<G-HY(Q
M=*B-1ZG(<)%>][!Q2JQZLF8TLZ*T5?'?8R[AR$Z8%0V(R:^>\+>9M?3$&W8:
MBN60]&H78YGX[0#4U^VY$M1#$5A:X]7*"O>@G,(V.4\IA8I&IY!62%(QWDG$
M/6/5C'_;E=_YH:^GFG+['O<_!?!> 75,P<8$^TF563>G9I[*KW'2[ WCR#'E
MUH.N$K_!QQ/:J[Q..SJOQJ,P,:27(:VJ8]RC1(4"8",&;)>[SK%?'C+.E:D<
M9CE)J:]_-JVKZ7("6DNFB$GRHQZ.75 /"BJU)9J^68YV'<%7H]@2AC*46I[$
M>C-*=[W60-JQEF/AQ846O=:V!W":QYCDCI-A)'C-W6,<1Q-1G,>UHT]"LHVV
M(GQ"TWL@#:,BR'/-3].X[#!K6O2266K4T-AL52;W/0Y4YN2 :IR$<\4JV'42
M028*UMK",1W)DAU<LN9U$-S$=R.R0--Y-AVV1SE:N%]X\N4\D'O'I-7N07&W
M.EZKR?1RT=2[1[?4[EHXM;>QOA4L*HG0X<AY()YCGMF(;D\ XY4*4VH2-;'1
MCT<CW$>>,,3GHMM97A8=7)G28=,2-2R+&9:CAE5IIJPTDQDA16HHD:LB4\RE
MW1"$J#:]X*+O8+(TVF)>U]LL8C1&@]*62!TB,9XB17N4) R6O4JQG-74PVCD
MLVRK\TBE!3DC]]$DTT^&*."1J09Z_P ^0UCN'8D<$9P(9G.763IT)Y5+84-J
MM]"NYA:N.KH3ZR4*R$X;.E(!TB2SSN^QPBL+I\7(1C5:FLU+'R+?R,(S<X/<
MLP586;$&\LFN!>+(\2L016",^ P!BHB#(W<Y\6EW/O!4T6IFP8I]R"64\B3&
M$7S PNUD.CF-&&.@]M=2E*6.,;B+B!RWCK+'<BF;(2I4GCR#3(D^-'DU4R+U
MZNBB-O(%9PY9MM'/?M:>2\6-'16A>DB+<29CS5ID=7"K3'W8D0#9LB3;E$QH
MQQW,<PAO)<C!\^!V-1?#M1+,)!DQ),+NJUC':QSVE6"LN;NQ",&Y$E,,C6F\
MTX:$5R)]2_?_ -7&/_;MOERR^C%^[_H_4^V#)NDZ_N+M"[2;3HM_I>JZ,XS;
M'4;,C90NG0I-@O)%\6.]"X_9VO9K:@Q[)Y4:NJCQKNNFY%WG8QW%J(TG'=D(
M(P[0@]J.8MPUT159WI&KR[@&!Q#*<1]C<RQIIEW228M]'OHTV-72(\>=$EN%
M KW0+".LR.1[!-E15:\NQ/?I%NW5GC_9J:RBT%S?U4UYLGBP'34H9YXA'T(W
M59R64IX8ZG<"2*MB,D/Z$-E-D#,K,"O:''[#(P]H$X,&N@ ."#8A)(J9MB,;
MV2FDAN*T\3HIB&GQHT1CBRR3MH+E)CV/"PWK,^O8,RTD8TS(HZ5E+50I38QK
M&TR9(!D0+W%"R(D.JDGDRWNCZ&:!D==]]XJZNN<4L<>]E%8ER&7&B8UD$ML0
M>5U%B* B7$&&Y'./#)#KY(G1R,DK"<UKWXIBD.O2QE9&RVFRC]8P+*:FIP#4
MMD5G3'=,WY\F) B1F.CN<8RKN(@%:MKD5'AC;;#:@UANV[\HAP+JRBU!"!MI
MU%CY(!VRX\=T>1T?6VU6>PVE("/YR/N8U48=1+EEWE%,N21(S[,%%7P,<;TO
MZ+6E@>-,*%A7S@!A1(U=),4K3C(@$;S-VBELZ:516 <6PB-+@2#!ELW!GR%=
M^#.#Y%A .U[5C2]$<CFIMR8T:4,T8'9;_P HG1>Q;N_-NL[PZCIM_I:GH]72
M^>U=3HT:??\ 3QD%WV;=QA6KKF^R&96K8\HU>[=E-ZA)O^">M>8OFO%=IR>"
MJB\0<FC]F=F?#+&1&Z.=#N&SLK+3S"C%&N_8=%JB/6&]I6R7QQ6QK 5>O5].
MJ-=I/B.'XRW*+BM@0[*]-,N1X[44\>?O]WA-.Z&WD'L[! D(*)&@:6@YF>9$
M11\9ED[Z,\6XP5+4-_B\J:!I06-7$9+Z5EG'8<)HDV*0)8]G%CN&0)>:A1XB
M!3&)MU@4JGQC*[6KI85H6]AR;B+.NT:.J)98\&&J1H4TRM&A$MB388W:YM=#
M.XD89\0P_&6Y1<5D&)97I9MT+'ZFGCS]Y( #3^@M9$BSGM X@H8*]Z,!S,^2
MC>8US/)WT<B+<8(VU#?XO*F!:4%C5Q&2^F99QAR8YX<V*0)8]E'C/"8)?*"A
M&/"F/V=KV:VH,>R>5&KJH\:[KIN1=YV,=Q:B-)QW9"",.T(/:CF+<-=$56=Z
M1J\NX!@<0RC$?8W-L:>7=TDF->AOXTV/728\>=%E*&O@+!L8W5QR.$-DR&1K
MB-%-?R&I+:[@8Y)A-=GN1T-?CT*P);3+_*).3RX"=.><UJ!?<3]4QX>?301;
MC8Z$:%@WPJ;*<"/1,LX<F3#MJBX]E-4 T1&O+!NY0:BL2GE/8Y'0WD::'+(T
M@HTM\EK!\3;RIP8]KB<"[E4LJ57W;).5MZ.Q+6RYR8>&M?\ 2HC#4^P:X'9K
M"=U:1':M/'\?[_C_ ,4]YVK3X*J-_O,A[ES #?73@09Y8*60JNS(Q.DL20N3
MM] <GZ6H,B[CV+H\.:9'2RLMEY)9S)%2>&Y\&?&@HT,U2R0P>H8QPU&QNN0I
M@5XE=H9'WD9S3&[./)UPH$3%AS#;,EFT^N9'29YMX6G?M;;O<F/1VGDQ'*J.
M3M @SIQ(=/ELLLF)<CAR)/2EBVCY\,A8;$'(6/(8Y4>W1U#%TM<SRN:3\?K;
MLEM92+RNL'N2NFQ(CQABE&[I-YB/<T3GHA''4)'N=Y,=&C<]8UA9R.EACB68
MWEVC%\J1 .$*;8&%,NHA$9S0;D;SU/\ )153^/T+X<OL>//T<_>1WZW1R\(-
MP_M R''@=/#2UQN,MYK:6$-@CCJCU[N[$'8[2JPA2"<QY'$(S6J,9EL3J)'5
MVV1U]E"#,=(ERCQ1.EO*23.Y;13,W6*1YBL>8JO?R<WFJ!6OS2=BUFD@R642
M9#FVE/8">J(*0"%"B3!.D! F@XIXE1[MM!F:+7JRVL;JJJ/)(U6$=K'K^2!L
M*L@RI.6HC>4R'82$,]XHZ.,UI&/<%'.)RE8W46J7LFXLXT^PG#A2X42+'@C=
MT\823QC.4[S.W7/V6M8U-M4=J1>,;LX\K7"KXF+#EGV)#%"^N9&ZQNR0;2O4
M*B=X#&Y'\O,:O%'9S-[Q%6R;:6<^.9#(JBV(H2/L2G)]*NC/DQRS(ZM8A4AN
M)%;J5ZC54YT\!<@GY)9U66"LRGF1I4?>A"B>"PR2FJK8J'Y!&V0HY6YK>L0;
M-+N+/( W/45UQ6W15<L"P$:%-L(!QL@&$L347SSVL8<>Z%R.UJ4>E.9H,?*H
ME3>WJJR]/)J[LLB-6#?YJHAFA03CT27)O6!&&;U":(Q$>C=3+C%AY9,I4=9!
MM:S)JL5N*-)>V(V/)@RXP!Q[087-5KA^;7D8?-6-VQ;N)3._;K+>Z'R"6T^=
M(L>G<E@FP1E3#LW]0%T6([SKB;?6'$%KD&USN+>8++"V2S::X@P!,I+ #1.F
M158%M@0@E=ND>J@:R(UX=?.0>0$2('B/+CN5DB*4,@!/V!H[D(QW/Q5RL>/R
MOV>E&HB)I<U]^;)38M-GZ2VE5*I+"U8.;R3>-"EP45KHY7><:*3M.:Y7KYM'
M\F8WMUB$QJD&R-,DFA#=+N#*A=RTL(J>60?4*QXXA7&7I1Z-'CL<97#G9Q)R
M#O;'K&)6Q@U$^#5 DOT, /8>*.T,HK.:#:*&D,(6$0LI5>QBX9$B'W3U-1)C
M3V;1FK'.2Q.=K=3Q,8;4-4?YI7I[SG(3QX@6[^T#(<> L>&EMC,;OS6AH8F"
M.RJ/7.[N0=AMZF$>4+QO(XI4YKMMG2QK)4<F7(,QTPZRI;F$*Y6NDRG.<Z29
MS>2D-S\LFM>;O3]1Q/\ ;-0_*L7ZAD/VZOY%KOJ=7+NX_4U89&J4-0]0W2HW
MM8\D?_#C$5S"$%R=K8U6Z'^T7*X<[-Y-]WMCUC$K8X*B="JP27JQ@1[#A1VA
ME%;S0;11$AA"PB%E*Y[&+AT6(;=D551(C3A;1F[)RV!RM;K<,;2ZAN1W,*O^
M!RJ1>7%K,?((6CO<;9CTB>$$C<BM/30XA)38I6A,;8E TO'I:YX];A(1S4:N
M6P(F2ON+"XKXX(BCJ)\2)R!8,,@=4@>\LIS6ZWJ]@(H432AC/=Y%%832;,2'
M:0I,DNDA= 1'1Y':1H\C]*<_ :$_?XR<-58%%69!*E]8-C>39L1TDQ0\V&&K
MPZF$5K]E0G<(I!%\'JU>S4S'/E2,</?OMH@F$&\(+.6Y&[17L;&([IGO*Q!D
MT^0T9%#RUI=O7M&R?(1RX<@%54--D4,B$E^2Q]L68K8901A*YIXT?<25S]#6
M.1BPXD+)/8C;AF3"6Q@T\F7-M@E>U\)8EC%&1XNF8UPDBE/ "<SWJ5PT3<2H
ML._;J,(.*P(+;R,PX+&ONQ-+S--:Q'&D-;N_HAW>5^XA5Z:23RM=:V5<@R[(
M8=S&F1[8=0>N?"K(?MH,F9+APILU9)=!-! &0;=;GR%5H4>/-GY3)^F)CICJ
ME*&?NPBFB.&]LN9Y87C"15Y]WLE/.YPT32'F7C(ZI\CE.GW=5+BAVS>=CQNK
MWB[FAPA[>XSENE89_/FB*].(%%[+++#9U1+FD'(C+:N@6D6>7><R1W0TAQ28
MA-:C4@W"=K<U'M>_2!LM]Y;64*-C-A5.N+AUC+--L)-=*'JC!+U,J'#+*/I#
M'+Y(=;GN\'\VYE72#[<VU92)!#M%=O+#L7&D><8)P1[(E0GGBBW.?(>M>,8C
MB(A;.FRR1<DB*PK$Z=!PG 53N'L<C%"X:HS>(-/;C:G/B7=_\HN5=W26R)K,
M5CEOHEB*3(:]S*MDIC^Z@1@2')I*TI&H!B!VO\)QD-24ZML9]Q32HP%8<BD!
M$25OO4Z,V^;-UC5W"M>3GY#':53CL[:I7$D8YD-A96<9@GZQQWV-?+!H(\0H
MY7/$!ZHUA'*Q4TET*J<3K$63V#8=B2QG0[BIC3X4NFL)<@A )+&>..5)$)KE
M;,[O\IS'^2Y">1Q'A2[L&69 VP:0%R*H-7D@5@PO&2'(ES(D&;.<<CFE:-X7
MZ.3M9EY!Y_/[/A]CDG+P^I?O_P"KC'_MV_RY9?1B_=_T?J7S^?\ .OH3FJ\E
M[8<>=6<K?*<A[09M%$ZVO^GHMUXU1=_K.FC=6B>TF$CO%_AD&GI[.HD&'O'H
M<QPRTM6=3&#TD"J:1+ VHIV(;IN;?- <\[^>L8B<]2X?D0(NJGJ\8RRMFS-Z
M*SIYME*HR0A].0[)!=]D4SM88ZB$K$87;5X.>41L<PD.2#DYUV@)56++^OJP
MUYW9//$1+Z-:O#*6. F[+$6H2Q(82=.6/$.W>/V)TL5@[+V$Y!UV13 E" (6
M&H[T<N4(<PXCR1=YV:#&,(W2581"."P;7[-5G^-U3<E0>/2\6N,?;8PZN<L4
MUE'LX=I5R+)P*\[XIQF'*AS)<1I8RIL&>1C6KG.2YK4#I199CL/#H>..EP[2
M3%HXR3BR95I)@$?7NFSI-@]PHL(TEL(0FHLDI'*H[2[SY@^]H-75X/CY$EQI
M;SXW2:WEMWOCG+M%R.:1)DD4I[YD=(PQ26HB#;Q<8X/L7PK-+!9ML_',YL X
M@L9\>TER9<%^3AMVMR+?INI8 K(4>>DT,<0XYAJ[>7$<LQVA@Y*VOPY<*O\
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M1%_O]?M_6S$_VRT7RI%X^?P?1Y#]NL^1J[ZV?/X.*#[=M\N6?T8OW?\ 1_\
MY:Q/]LM%\J1>/G\'T>0_;K/D:O\ K9\_@XQ_[=M\N67T8OW?]'ZW28R^F-(,
M!?\ _"11_P"MB_6S%6-]*9!4E_<QYH3O_D#=]0MG?_60UIT^Y7QX_P#^7^MN
M.M=^N9.*G^3(M)QF?R2)]&/]U_-];K8>VK8U@7O2([]:X<Q5(9&?8%*WP_:&
MWZU_/Y_9X[R>Q5BT48DE2+[3K)#71H@U_P 9463(3_,?4*C(Q,51E$^JF.1$
MY->%7R82K\+B,),:KO>: :?6R/"BC4TF4<4>.)OMB&,]&#8G^4Y43[7/BLJ
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M]6DK[*W) O-=GKPC2:?<RZ+^^NRJJ(LZ-AR$X(!<;YDA)5M9?'5(9@7,D_\
M$JQ--MC!^-=B.FX^*-TZG.0L;+_R&>[8"R"EU4)7F&XG3@<$ZEK@/PY.Z:3X
M_K-H%)T$=(2.";T@1.:O: $5I:J\))[4.Y+WOJ,)( *5949 "W$Q:/J_+DAS
M.VW\;67Y,T><IS,ENZ2 *4@]\Z"SN+;EX%$4G*#518L$4@X*_5:K16\/MW.=
MW]*!9 KOX"@$;N ZCL*:!)Q)6B6UN&_"@6(Z8#XU+:T&-X9LQ#JAAZHP78JH
M.@@8.F(ZD[6]97CP-(F9*[0;IQU&%!0N(^G^$&RYO;3'6+-.RA7),U*@R7K
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M2QN46% $M"I :K1EE,WW^PE4'4%-.^T_YQ.O>N9U.#9:@O+*_BA!\:(+E&]
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M&G%[0S$J:V:^?R[WM>\]=+\I^\DQWTZPR.,K'<6M$5^:->W30()!^ 6(,+8
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M"B KISVBLK8%NQJN@5*)8EOA.D62TGQ'BZ>5ESK,T<!F)=$I.AN#GP9,T9Q
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M.IZ;JTL16BLDQN*HAD"(%BUE+1C2S(MVM]#HH"J84RYN'^<,/^[\";_FD?\
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M(LV$2AM"$$2M0:-*PYFN#,Y-CF(C1]6,W!"R'<F\,OLZ-4 ].ZL[NQ&-RRN
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M"200022"00 0"0       222"22"2 ""0 2  0"0 0#S^?S^?S^?S^?S^?Q
M              "0"22 "02""0 0        "" 00" 0 2"2" 2"0"020(L+
MTL+TL:N.NN.NO!               20"20 2"00""0"           0 2"0
M02022  ""02 52.%2.%2.LJ.LJ.L\@                   20
M            0          "    (  (  (        ?              ""
M0        2"2                "2  "2                       "3
M             """ 00" 0"2 ""                "0" ""
M            !5@               02"0 """0 " 0                0
M"0" 0                      !>                  "20  0    "
M             "0    "                      "0
M                                (                        !_
M                    L                         ">
M             _                     4@
M "*@                       "3                    !>@
M                #/@                       !5@
M    !>@                        #/@                       !>
M                   #"3@                      !R @
M            "0                    "@-@
M _!@                        [                     7@
M                )_@                       "?@
M     ^A@                       U.@                        ?@
M               2   !)"" ""0               0   2"   "0
M       20  0  00"020           2" 20 2                  ""2
M 0  20                02"""022  020          2"202   " 0
M            "2 00 222               "0" "" 2202020      !( )
M)))))(         0A      ( ))))))(         !
M         "EQ8N$T"04&ZT/6N;6VVT7/@  !TH-0-;H:G*P4/6;[6VVVTII
M  A@222222222222222222"#!LX#?-=PB/)@-%$)W$DDE&8@   JLW$]G+@E
M;$I%ID7$DDD$P)   G@                  @ER A$DBU_\ D&D$$@@($A@
M -O@!9!A$DBQ\\;D$ P@DELD!@ /&@ #P                     %@4D$$
M'C ?8D$F@@@@LL!CW9@ 8[6DD  ?#<<_@BB5M$DAA@!R@ 1
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MP?+.*&I;KZ\49L?N< !,   ( *"):)! ))(( )   (6#1 ,B11^@-_N<:)@
M"033IP &2#"3? 8*>7<9L>9A<(20")*: !,                     (622
M#3123N9=[J0JB)*2001IP 'T  03Y=>*^KM GJ4T$JB"0.H !,   (   !
M! (! (!)   (0"402#3*/Y3Z]GB.200:"0-H ("240?S#ZYTOC3:[+$O[G"
M0P !,  ! )8(8))  (8  83(  (>)86000-Y9@S1? F0022::/H $B886<C%
M!@^AK@9'RY<\:(+3J !,   !)0)())  ((!( )   (>2819 &20@4#@T #1:
M4" +5R 'X088*0V0"#3W0R&;32$ 20"H !,                     (>22
M2:!*40" 9":02214"  5]!7H220*(06000!31000+%J02;[T/L
M           (0+2"  *#22"2&,"822237*4&RYC?6"""*)+ "246"12031#S
M6ZVYB                     (9ENE4T"ERF'8*02',FFEOH3,HX,["PVF"
MD_%LC*22X,WENQPTGMWV))))))))))))))))))))!(:43* L"2" ;!206"28
M:8 0?T3Z%" !"_  "0821 &20+080$ \U&^                     (700
M"$BX4  2"+324020)303N(Y$* "5S4&"222: %40 282:#.TMT
M           (0"%@N241<&(R03!!"&6628.4$#0 7\>22O $"0R<N! 02""
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M#(%@D]8-.;-PK<[P$DU3R +H" ##37$%@A75/<!Q?(46>)0 !,      (
M           (00 ""0+20!#G" R6R0*"0"8* $T""0223"2"MU0$"@"R1!("
M'  !,                     (83L""20;1"$EQV00"   :9;* *V3B2"20
M"!"&6;H" "020# &B !,                     (6 #%N20" *#0"3B)L0
M200"_( $, +*." ""032"!#G600 "";(  $                     (2 "
M!$!\"(" 380@F.9822&$R '$D #&#L"(202!"$APW60" ="  -
M           )1RQ)9&# D_DDFE*&]UB*^J8   F;O6TF'ANLTDDVA5KOBJTA
M3H  *&                    6)=Q__ -)IAM'0%$RT1Y%Y4ZG   "QZ?\
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M1L$<B:2(X\O:YW72/>< 2<*IYKU\->F6"13L#;?7C7;M@&$I"B:TVS,\<O7
M&,EHX2_>)ZO'.-13;0%R=O3CXR4H:,A-JNO%_'A$ D%7<N/;7B>.<6P[ W))
M$^7I6+!0IQ5]FVW\U@#&2T<)?O$]7CG&HIMH"Y.WIQ\9*4-&0FU77B_CPB 2
M"KN7'MKQ/'.+8=@;DDB?+TK%@H4XJ^S;;^:P!C):.$OWB>KQSC44VT!<G;TX
M^,E*&C(3:KKQ?QX1*($1(!#"&1I@J50(4<GQ9D):&)6)@0QJ8+,-&M'QQV__
M !02)D)+/L>M3A; 02D 95EE-Q'-01)#F?*/IVU_^**.XAU[^T3Y9-.D@D1
M6!N81:C/FPERB9U4^//A]/\ \3!0-H\[T=?#G'K]"!"$&"DB(Y9B=Y*%>DB4
MIN=ZZ_\ XH A*(2A,=_^R=L8&PKR0$DB9>#IHI@Q4>^(?]UQVO\ _%"RH@(0
M9-Q=9!VBEF1#5U1L.T08%V!+!$"H+WS//;_\4[!2 ;7!YOIMDK#$E<U4"$DP
MP1"\*$#$""!IJ7:+'9Y?'_RCG6G<^T<^-9N$ZR>$/AU_F01%(.LE>^Y\H_\
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M_P#V3MC V%>2 DD3+P=-%,&*CWQ#_NN.U_\ E0 -2K]/^8B1)XV5BI>EG@.
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M%Z;@DE))DL)J5;=( #ND\;L3 C(.MQ"S:G?@&%79OB(Y#TG<3>0ST:#T/SK
M$@Z;)72!Q,S]/^.,DH@]_ 19'3[I%)IN%OIC,JB9=M'3V\?-;OZ\O@S?(6
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M,UUR<,B<Z*DNH>D-W@GPD?#&>,3J2$K=_G48<WC%S< :\O6<EEMP<SQVE\,
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M+::2(1R1H3?4^-U?\Y0:2)'-5,QXHG=\9-*Q BFT.B'24NRX$& 9'P$0JU2
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M1\2+,$I)]2H0YF#2DJ9DT1L[-Z86E)9.\74UJN(O#4"B20,C**"0F5@!6%2
ME @9I(%0*%(9@5'!JQ!M<4WQ#KJU9UR:B53H9 IN$LA"+187+N$8NK7Q)K3?
M.,O<XKM>O;' Z=8CCF OIB!>4"1)&QQ%?.1:%DF=ZKI)KI\X"PGB0<7*>V#A
MS*$=IF9(Z>5XN2,:9X)21(6"8 @;R"R-2HBL2U(,"DN<36NM3='2OC%B"_,M
M],@FX'33)<Q?3ZX%P4H1U,[:0E4@ :S:A1R)7LO\P\Y5@2R50&RU/'>*W51H
M"R]A>^*:W&*!*I:>&]E^6<A''$.NL"SZ=C$&03M&0(I#8K4L'.(7UY[,<1@X
ME)G3K\?9Q6#IQ5AWC^X+6@/'\8Y?7FM>$?W"D[GG7EK)>2N*U7,?WG$ZP!V?
MQTQRYF>:HKB/[A9>R)UN*[?3%,YW_P!'^^_Q?)_X?WU_^/R/QFSXOSA@\=;P
MN.GE3.#N8[6R5VKYRH.AU;X].WMD1,L<%]H9CVSK3$5;V[8:;U4?G6#J8/O4
MP1+[+^=8B*8>L;\HP9W+,SJ"N(O <L^I^,,.SQZ7,>V1IC<1?77&"03,\73X
MQ_,<@O1!FFHOZ8J6$$8 X(L8A-;3EQIV8@K#"FY4!0IN85D# 3VW60!+$*P"
MWL)!@24F-DPSI"QCD2!W$RC00*I*%(X(@5JL2 Z8";"<,C6T*0%I61% B20W
MEQ\+1(A)F%2E390!T]:[B)=6YZP^N)>&F(0F(&PD;*PP$22LQE:YF  01)&4
M)A(.F0/@D6  ),:"A<Q%#** TE85"$8;$#9*8"(9$#))4P&D6*"%-@**DM 4
M0AZN;\/SE^[ZZJN(O &V7K9^,B)?(OM#,>V<[I*M[=NF&F]5'YUD8CB9YWZ8
M8=GCTN8]LY=2;W^,&=RS,Z@KB+QKN69Z?CZQEVUK4M:[<8!SNHO==O+!(.O%
MTO>/YDL1CA\GKY?["7M#[F,C>)ON?W.BI>=[KU[Y?N^NJKB+P'+/J?C"B]<%
M]KF/;.=TE6]NW3#3>JC\ZP=3!]ZF")?9?SK& LR,A$S) !@,AD66MS$J0E92
M')3-R0@-)H(IE+",5D#NRJA6"1*"64C%!"*D2$/8W 2)&#089I;$XB8(4$!E
MN2,L.*#G-:L0=$NW@!B.R"32$[&9&/&&, LA.4$]4.# @ 9&*5TLX4@PW( %
M (F"L:91$!H6D0(BX3+FF:BA#JDH)5. B)VD)%2*-,+DHT4!,F9HDW(0B&(#
MN6B.J)#:=T1/;8KZSCDV$(C2H6"JJO%84(XEM6A1&Y04J58M<%W&> D# " /
M364+U%I"!%*[47+9@$_2S1<!@(@&"43'2E3D)Y&UM621A1325@#*9 L@J-)6
M"(%HJ1*:\0D,S)L(E I!L7%AS$REA440 *$LRP0K8Q7<ZNE9 *)1&WAZ1S5$
M$2*:C@6"!Q+I:T,B-PJ:@6A4"*(1*W4S#4-IPD 1()&$4S0*5#NP/ HY'ZIS
M*7V(]9]S)8"W66_;!(.O%TO>/YD  Q9Y/YO\M9HM&CF]>7EBF_/OKB*_&%X'
MG>JU[X%PQ4\]NI7CCD]4_P![?XOD_P#@_KY_QYKXQ^ SUZ:]]>^LY\C\_?K_
M (6.OHOQDT]CFN/#\>7'^FM]O?.W^/OW[^?\??OWG_,UYG$<]_OA_F_G^9^7
MM]^7_%_;_OW7'^.-]/?]X_?+<NL^U]=_[_(_&;/B_.4+X$]SV\MXK!,1Q5GC
M']R#CX_6.O<X]+F/;)1WG5:ZS&..]U'YU@N6/1_&*A?9?SK%3>JF-M=L2"-<
MM>L1[9!9&HF3MQ'AC3>^"NUS'MDH[SJM=9C$WOVAIZ7BB#9+P?$C$G ) 5"*
M3=H)*7"-84@@6ZB;$FDR()*7)9<1;53 !HU,K##"?'QRJ") D0RM,<F1EC(H
M( FPVJ))12G!<EJVB D)0J"6% &"Q(&4D2L$(1))F[)C-@=EC@-J2+*A*889
M"5 H&@G0$!(1E5*0D)A0P@TKM9;B9<2\O(B28D65#HW1I6$2*A,T7"10!0D6
M$YH$#( G*C;VA'D#\".2600$KL $@ (R((#B 7,)E$W,"$(;E9&-<S^-?CVQ
M0.C%_F(]L4A#C?7VQU[G'I<Q[9*.\ZK768QQWNH_.LG>74ZG;&F]\%=KF/;!
M<L>4_C$@C7+7K$>V!@T^?\[Z[YW)J(U&NU],F!#VBJKPQ-[]H:>EY %[>KAS
M!/\ LQMU_#^0R$L?PDC^9O(<7CQXH'1B_P Q'MBD(<;Z^V.O<X]+F/;)1WG5
M:ZS&..]U'YU@N6/1_&*A?9?SK.JR:(I3IXP^#DR 5.>7P+I-)E!", I#$TB4
M)E"-VSICTL:<VB0"3%66QBS'FF/A!$@U$H!5YS@)+F$##!*6;%HC( L5E"!H
M55*G&06Y;UH@E D@E.8Z 03B&2ZDC+#10B1A,(#"W"2E*+H1"A5-K.($,%>A
MJ2+#95K:)2)+(8$ZD*D(@1T@@H(4:PK C0<I1648[;8! XT3<@DG!IXFW$T3
MVKILAAY9$ #CA,)  $))[%)V00)>"K;2 V0 &#@B7LE!G DJI(TG9B"!,5X4
M""(Y 92"+="9 8,F!B4-+6DP#ECW9$$L^E#;2 A/(4I>J2M652DJ221%188#
MFP!"E;5D5,J- WE8"7&QH9E D%H9#6%PJ'( $@D0H0M3X&)GP$*\W:O6XQQH
M64A( *42;2H(0Y2QX1*D0(!"@ $I@0#EJB 2ED;B+!N&82-+<S-ZU%:P80'C
M9?MB[F>U$-=K^,)Q?E^)C.@P^LE=HP[)[S_,60T5Y]M>^11Q8=?+7OCE.ULK
M\$>\_P"V_P 7R?\ P;]O9G_/G^_7VU/?.9\/:?W_ )^_>?>>_P#GKW^UGW[]
M/]OOWK_C]_F?\Q^??QG/I_E^Z\MYO[T>_P!Z?_'Y'XS9\7YR(QGOO7KJ#YP*
MY:ZUVU[Y!"OET?&+P8&9=^';7&,PN>8U[QY8,!MKR[:]\(Q?2H]ICWPYG1\Z
MK7OGTO\ 6#N8[6R5VKYPTJ![^%Z\/3!U,][(*[7\Y(W-1K^.# [:?#VP8WL[
ME/%&%,%<O?MK/I?ZPBST<E=JGUR8)F&+E>M:\\&+U%/:H(C'\$19/3MAR1LY
MB(".W&:/)VQLZ-=;R6+:YO9VCSP#&UHF7?I6,5*^)=O>/+I@H!7@RQZF&W,1
MS=M<1_,!1MUS;Z8)!UXNE[Q_,3%7VZ><8,!MKR[:]\(Q?2H]ICWPYG1\ZK7O
M@71[OZP8#;7EVU[YJ$]*U'G%Q@ZF>]D%=K^<";9\GYC!W,=K9*[5\X:5 ]_"
M]>'IG',][(*[7UZX$VSY/S&&F]5'YUD:=S?Q'0ZX_;XYH>!\?Z%TZ/D_ ^N
MB;&GJ_''AE1O?>GI?'G@P&VO+MKWP")=!4:?&+C!@9EWX=M<8S"YYC7O'E@P
M&VO+MKWQD!/2NGM<>^!K?M!1TO$)"T=OYBI"J3RL&N'I@G,G2^W;MK(B7R+[
M0S'MD2M@+MN8W7SAPW70DZ6P>5X.I@O]\GUPHUT5/>$R $H>H?S"-33*BE5V
MO*HM)N#TC*)>=%O2YCVR-5N(OKKC(Z%OBR_&/Y@#F)MJ;\8R<VAYPIVC"M-Q
M;<L1V_Y@9[M3;\F1BJ>6-^48;?3F]^$?S(5?2=WUXJ<.9T?.JU[X%T>[^L&
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M[U/?#C4UV[/3N<& H,$.NJT><?\ ,EIF-/@=]W.)"$=:%0=Y77SB#6J\H8'
M0()BWY^6=I#'8>]UW\L%&>697E$^OGG;_P 1[_-Y!?J0U\.7S<)?2KP&_P G
M?>)@@S%1)1=>]-SG /C[2Q&!:W'B>>L& VUY=M>^)3I3,4B)J3K@XQ&"$AQ?
M&],\]<!DM' 0I,%94D56.\1M4HM+ILFA+3,I*PSB@]5!*A(E]&8T8U*#S0,B
M4W.JUMHP""%+!H@VD0E<*M&49PB3N)#UY1FN3K=-RR73I\9EZ:8PP[/'I<Q[
M9-4"5MGI1?MZ8R$MP,NOW>$!>2*D:-Z]L'#.SJ._GFY-J.UIZ9.;S&NFKF,J
MWF==/68R-,WS516N.N"Q*XJ?:ICRG) 3"N5]M>^1\OKPR),U\5:K7OFBW$WK
MKQ<9L#>)F=*UG=>O]9 +Q5R]8CSC!F[+&Y?A'OAG>6HGVYC -O75V[9%2?69
M=N(]\A0UX>\NX\//)!!XX\]Y]^F&"#*_6WJ/%873\]'U[XP# +Z]'U[S@2/7
M[8_+$4@IA[3S>N(-:KRAD$) YCL\?+Z9+3,:? [[N<F,65?@>L\^)UR2*#[E
M=^]82CZ$=]69VD,=A[W7?RR/0=2_USG"Q<<&CKK]X1B4.I4ZTGP\//$<./%*
M=]5[QSD(1:N.8LCBM7@36XM[5+$9(N_,75_I@71[_P QP)3,=CB; KUQP)E/
M%,;+OK40'.1^60%#:RUQ&S<2K";9A#0O*A%&8 \@DJP$L $+(.!,R3>YEP4
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M)&EG&%47$NF!$@)8*RP TNBL1PWZ1@F2JIC1\133*V"ETB8(S \1OF+42)9
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M(_F KK74OTK!()F>+I\8_F$3AVB8[:PV^G-[\(_F HVZYM],$@Z\72]X_F4
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MZFK\)B?/!677,W.JL]\)43ZO'E@0#:^/IJ_'$H2#KC7G%Q[Y'10[205P%_G
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M%LSU?B<&.HXF9KTP4=9N=5Z8K!,1Q5GC']P7''<_6--[X*[7,>V$N8\I^#(
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M+RK@0++M;5XJ-@U*X]XXQ1O.A)"(R[PEMD7QO;P_^*0"<2R0D# 6TSUI-/\
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M &>=2;G?[/.I-SO]GG4FYW^SSJ3<[_9YU)N=_L\ZDW._V>=2;G?[/.I-SO\
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MMLU./GT:YF>,:3@L[/-MJOO\^O\ O67JZ^='\QUS?.LU;M\J6+GX^TUT>O\
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M6&0!@(*IRSP6;41AMKH2-G'2@6+7&%9R"4)2S.^\Q 7!-R!<DQY+V*4!9HF
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M3U[\_%S01UAPYGQYS_%V;9]T^F%\ ,Q&Z$+ FC03%=("@F4:ZD,H$B4C)F*
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MQY7K7&F;7XWI=AG_ !K Z'X^[$Z^S_7=FV?? 8(J"9@G>"?.D'(.MR;[_:@
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M>^/NS>'Y/H+[3I]V)U]G^ZF9O3W/K!B+;5!L5@LLR6+.YL\_2#8Q'AMTH (
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M.S4YHX2 D\#,CLXH>(UX02.%E-L32,,1(+$;=MZ4OQ^$2VMNC62^&B%ELT@
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M%+BQ$K(UEV. I)U-AYG0@O9L@,1<:&<Y<(2IED%.+*:.,1%3,66.J[AC5O4
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M@(@"%F1 @14$*35D!B? ["=AB(B3$WVJ28DG;7R_@DF))VF_E3:[8W;4H"D
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M+X!6 THTPG!AD(?&80=F!U6B++\FGNL.J\:&YU=#0H%)&=H'SH22#[_*)6>
MC!N961 F4BR K5J[)[0N;&M*RN+7'7[Z,"Y4>FUB*#XAQ=#E2R+KSFX#S$FI
ME<LQJ!(5!$K=035*V\ ^$!BHY(Q7;DB"UGL&%DS0G"8%?%'3!4:3&2@G2S@
M4BF>X:AI*S1VIE2)Z?*BX99RRX3M]P#JT%5SM44R1L&O!M;U2!4L->C# @X5
M**:%Q^5MUM]&$JC]&,*TXN0ZU8R!MXQQGOZMJ=0B<-UB0,Z ]*U@-N*PJQ!#
M82TR33985@20UCLI;Z1Y-O;T;"@H7&;269SL$[D-#TBU;GGQ%.F2.DYY^GN3
M[;5*.&%\R [ZHZ7(QNI27Q(G#V-3##,?E;'C]<WI[GU7=UQ7N\?LS>'Y*[CO
M]H(@Q,9M.] JP9(D7,$"%P:S,4()D1&XS<G^*]9AS:2BZAPB0*"EW("F-V<$
M*/0H+IPOS%3Q=XX3[&2\Z ($T-/+$ID5A)/UJ2X!6"54H#,5]54!,(0H"J$7
MG2PUPXZ$:\:4/8D'"@[_ #6_-WBB(E1S=1Y$?04"R)I4!5O0#FR4F%Z00:+U
M(X8,"S9Y-,20;5*PY8,63N+-0(OM3O4N 2BL0H,UW<D$@< BI+R"R#I%&L$%
M\(UT'PU580U6OAJX86:AM2L31D"<HK-<LTEQ05NP"4LP5O0F1\*Y  ;6R(8B
MVWL6!Y)R90RB:54X?1"3=L@3:A\-.P:A&CHXVSXF5KQ':(@<UEL*H'9?4."K
M!.*8PB!*,.EP?0KV2VG"*$9S/^("# J9&I%!A*#ZS9=Z$&5JA>S)(,L]JAN?
MQYVZ(P 2!3A"MJD#S9GCJ@$CM&YH#+"@$+6 (#/U/P]RNPZW.NO6C/>O]V)U
M]G^NG88\712W)DUL'A_M2(B+3G_*@<DT &6 !HMY>+14*$9(*L(HDR$1 F+U
M.M="COB2.DR:1QX,J=A-^*4(J7&I0?\ H ^*XIY=6:/$RV;,E2<TR1-M2Z9%
MQ0%@(QA.16-P$*9O#@H%(]8=2,;0)#M#VTZ=)92U&+,*Z*(AEO6@ L\#30%4
MF*K:0M) <T0>,[0(KEKM'_/A::>,I3I!9(X4#K2@ -36I<3 &=$ F;#C!-69
M&2HG0BMGP!:-<PDH5'(7I>#=>Z(KRI7TD@:MMR8V 1)# [M4;V.K>HS!=%79
M]M?>O2_(/[A[4SJ#3".B(PO;ZW$H"BV.%Q$<A3ED*UOPYG M%\GA70,.)D#R
M8!U!$\C42K*3!:3+4M:^V(2:00G>'P$UKE4C3W#&K L]\Q>U9M:GJ UU;WH4
M#1&J< H+'^EAD9.2)TL"D[M@QPPW9!2;C6H&V2A2VR5Z+1(\*D%R+V".#A?N
M[P]WC]F3O6NX[_042Z.@@\IJVR8SUH#BG*5*N9+=XZXFF02>:.YZ\J6 #<)Q
M[=PJ72:I!-H LU>+494 H.84O?W9YFRL*I7$TL]66".(2D/.2#H;B+]8@4@!
MT\2O""&'(:._G_:F0QY,J0@<PXG!(B2 XT-(/19F,L:2@$LQ_P#8T2E(X61<
M%%%X)&C5LBYR,V ..<;:CHB_9B80G2.&.J06NO;^##!E2$* /+%UD3=--'0-
MM;D!E/*,(4'H\H_0Q=OH@@(#2\IHVHN^I<T+8ZD[P3N7]<-'"M,1!8%>,+A4
M!_+=7+]_+,<-80.D.('(-$*;2(-$DX!,@5AD"5EDTY2V4"+/GF@S2?\ OYA4
M#1PH+]H L81/0I"I\.]Y>>SAD9J-8Z5I*)3^?$>E@MB8=IAYV  5RE:,)LJI
MZ\"R:#$)KHZ-PQ8OK2C4Q[0=+H%]4C?ET.(!GD4"0H.3%F_B'& *&,4P46@+
M6%CD)<!4?J8Z/<^C[\CV^[$Z^S_99!+M%\#^?S3.A!D6+1J=S0G5F-JC7#$3
M%^^*26Q!L#UW=H-ZCU$+-B#.<LZ3)I4.2$B5L0Z 'G6/<U=./.%D+>VUMBI!
M0DT$1$NL76F?' '65C!W$7L BEF:(3L1S>0EVZ3-II 09I(4(L( X!O0@XFI
M0\P07B"5UH8D!>+01$"Z,"SFE.2$T%F#$==+7+10,B)2R[,84>:AQ2TB%Q0W
M+*&\28F&* S$;)>!B88"TS:A1$6.3H2C1U;GCF=2%1UL+%A X64:RB.ATQ8<
MED6;A!2 R#,RIE+2I=+WG2HF S5L3KHY-%6AP1S=2Y%K6C4L7BL5%XA(P"J7
M(O>V**C A<&X'(%U6[X5 6B\[5&P0I$,%K3$VF@= !$*%Q/CM2!12P <FT&M
MY:U[-F1<X93<P+DT=A4A%I$%%\B#2U1!J+%0DD-!-TB;EJ*L[\S" 46LLXSZ
M;?P>?SE.'ME]D3/!+TID>LOA'VZYRPQ;::@; C=@$]?FH7 "ZA$3.P1X_1)B
M\0SOZ5%\3;+$SW>E$ (DP"(ZQ4HV1L1A:QI,$+&]652L#*8"X#/GKI5CS5,4
MMCB8OQ;=)"!760$7F[!IKX2"F=,57$@30N6^;0HE72@=UD$ E3!%XA@$@%<6
M"X(CEE"8:8%F:H!#1:0(PCG6I@P03 $,A2")DO8R32D'<'M@(%29UM?+08BJ
MPC02$A:$49LS1: *R1R!N>RI<B)A(-LWVOUS::@$(DH##.A>&8\=8H!SY+J:
M+M]8,0Q<M5S,-)#;0Z#IIBXTM>!,JPJY&P3)89,V* K O7,0+%M+K40 D %8
MLA*&>#>\UJ $@)LA$7\=[=:68)(I @N'4 NF8N$W9Q4$2 ,+LD#NES5+E82+
M,ZH8:2 HZEJA#$,PRB\D6MG?%07L7NVRN5WFH-C?&N_T@VX\-J@V^U[7)'T,
M]IT^[$Z^S_7=LV?8*8H>M[YV.@4)AI27?6777-$HF9@"06#EQQM,4%1@\ @S
MV4M+$-04[7-C))D/IB]W(XKC&2) :^/4"=;"X;H45^/[@:Q053[NRXN=R^[U
M&@7)DN"!P#JE2+8%X7":!W.\N00$O0 8/$3# N'!J85QX(=%#I(F1+R5$'=>
MPEDJS5K_ #6ZW1%)4$UM$],B/?\ 4*%=$Q%?"X6Z6D:$^JMG^=J7( 3 A;U'
M+3+\TPSR45&3(B38,[3=W  &*H!R2T_X*CK\L^2Q(%P_&E*(!%TJ,$2BKBJ#
MDQ(Y4T"Z@L[&*@N8:/A#<D\8I2R],:9)$AL($E7%)1NI0S5-C14B6.GL-6*(
MN-OKTR4.>UNJ?,LBB-U-40P$H@(KJT8%8;,ZH&/)YH9UOF-3CP_@\GX/Q3C[
M#\CVK'OV^Y((B]C2V/*@ZD>OM4 W,TG1CU]Z;%Y#@\M7&M(B;%,80NUL9^*"
MU;!H!(8:1(%0JQ<NVV9C6%<3J"&(:PI 5%WFX=PB]8@V_A'FH70)99&>)"5&
M!2 PX8Y2$@8* K%#T%P&K987#I@+3V7/OB220PQE26X['!D!M!2&@CUK61X)
M>UWJ>:0&F 6,!8:;+7FA56$2=8'J'(G&,F"8,S-* *KVWC1I"<MC'KN6U$*8
MAM%/0(O: %P&4M$ZA%M5U1:9 5/Q,3HQFJ<O<BNA"\Y \0!#0KI9I4*R"FG'
MSTUYQWV:40O0)%:I_"'$*YT8Q9>&GD&HQ)SP(QE,@L*A!@BQA+^>:A<Y(C;Y
MVI>A'K[4BW=../O] ?A]#?:=/NQ.OL_UW;-G\!8&4P08KHG"QDN9AQ4ZVZ@G
MEB7$DHHY:E+LM)2=)-?1WM7""]"KH33.8/@E#! 780"*NIU,+DBR*S1E%NR0
M:!X<-:(Z1DW-&;!$!A842H!46QWT"7\Y$((E2O8$MPFV +FD?)CJR*A((3A>
MVLF(X(2BT>LK<CTI/>RN=05"](HL.@/& <7'J:(G;_C4BPUZ3Z5P[$)5 DA%
M%K<6DLLP1K@4T&EI=J78DP8J1MKORF&@\3%43:Z2Y3K>>MH0!Y,@'%\BCAT(
MQ"70LA]D  (F2!%Z&N$6.KS@0@168X=,$6B $2G+ G+<@B#6  J/1/ELH4EB
MCH W,PF@2BO'2<J$^7X$19T1C,17(HQ@9;66SSJ:S] 7%0K9S4[6VGG?2TU(
MB(M.?\^SR>E\?=W?9_C26%!0,3&[M+Q4?OJI('$T9#=HF_E</[[P26%2VN;?
M" :=QA<5BS&U'<F4IE2 T/2Z@4<]-*EHZ0SO2*V!30:YF$66ED-%,4&$(3Y'
M&^ #$*(QTW<-HM4[(M\40/=QY59295.-0,<Y[Y!GX!!G5AQ>QRJB6.8J0;S*
M =PP:#-*8AC-T34N1/\ (M*>+3\3(N,8>F4??=,V3E/,T,-1:&K.,%G.2P)(
MBRUU7*_.! U1<=TC;YD%]RAJG$*C)H6"II$T46#C.NG=0QE0*CA(,K[QJ98^
M%9WB_LW&X; 6"N65F[A##"&99)W-_L$HF+30*6)(=0MOZ4O0B^^3;%2(B+3G
M_/KZ(^@;[3I]V)U]G^73Q/?OMI(\A\R?Z@;  # DEP&-* JC(DH%5<\PS)-L
M44/; 0)>9,$M>+WIK#<U)()4F%D"6UM0!A18#!S9.3<LS% LQ',62PA9=92^
M,8J2H.00(: ,#JOZQ8!@(*ID7+:T1 EFE 1'3J9GT0);<HW3AM)!%^0>#.U7
M$) J4#><Q+YAI062I30DN78X28VFE( 0)-\$RKG8OOO4X4U,T(P77$1:,[E,
M4! I,D$H"[&YG*3@VV 0!RA>W699L7J*<@ZRP3)M*UL8@-=TG-%F4F2YIN=:
M4-$@I;.!9:&@,Y2*!Y!9R2+F8<8A;WMFE(LXB$-TFT%C2<DW@"^#?,@ +;$P
M.;N"H![*KA)?09.IBB;%^.> L7-KML7=!AF97$)#"$#FPKB^PR>$< DO(S*;
M&B(2(I!U;!H2#>M,JS>\THV))6;! S):Q;&^*LDAW15<A7B-_H"XZT*6+>%;
MXO$3/^5*-H765N\47&9MC%(6B'.1MY4EF:T]+X^[N^[^-)8AD(LHK*.9AT<Q
MUHH%0+J2BXJD6C7&MYA 620"P)K#K'A4C$ .A6((-PLMHXRP4@8,$H\"^F:0
M$;-MQ()F\9P.+4&4AIDN7DBT3@30<Q0BC,.Y@DS&DLS,8:3)$N49+0!;Z&+9
MIC$$AJ1;@4C&"+SBU)8F"RA4+/07&NR90&X9,(Q(R8LVWS4"807R"/>WE4$(
MN!;+9CI&H_G*RO60A)9-+EKO-0X$ L7)+:"+QG\UG2(@XV608-0@CBIE V#U
M6(\OFK*((DL2M"ZCC%3H8&L22%P"PEI=K%P7TM+<O-AH0;3R@<!*D;HL^8XV
MEI*7-;E@,1"P'3$=*E6V&N5A 9@L#-U=JBT)#D;L.5M@^P)GI->!Y/>*'K?R
M/:A%=2-Y9]*FZGU]ZA<Y(C;YVI@2(M.>3CZ)NTZ?=B=?9_N,L$1!&VGE]<,E
MG?7SJ!927?7Z<ZF':L8USS]2ZV8XQXU981;.9\J$;%_"DGVUAWH$96? /7Z0
M;&(\-NE03,$[Q>@# '2U0;%06L6Q;'3:D&)!BY)AW/I!L8CPVZ?R$'\_M7X'
MO]@Q/)'XK'OVHQUCS;W_ )=C0N&SN;4WS?K6W#)P[FS4N^<_2#8S/COUJ7=J
M4P,6G?;2KDPF)1M^/6@6<8CZ S*CX'Y^@!@#H1]8)F"=X)\Z@F8)B)UC:=OK
M!L;XUW_C,='N?1-^1[?=B=?9_KHA2=[NWH#B.5O+!V49P>+>U*&: X?S_P
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MD%J$@HTA$%-6A5V5Y85S(7R(&31)NKI8?+EL_9;6S#9SSTN@<R&'.X[AT9L
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MG$+8A)+L2V()LHQ@WHWHQ@$2RXO2^:4.U=^&9\%E%-*OT\Z<W4"*J \09_S
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M/Z?)J3<^S^GR:DW[TF_W'O:I-_OU/_E42I#*8)$"@"(00;#I3$1+C9<>;'G
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M%7-T<X\:>L7SYVJ8;D>I\C[%"..S$Z_#V N*49/;O8XF_EF[]UK3/A\_=_\
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MJ\XMO/QV(.>M0)%LZ;\Q%&Z)7B1_[Q[XI B#K%CQO:D@H$BS)F\$V=?"_AI
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M:R)S:9]ZA(&&)AV^]:@3,WC']_ @YH!S9BHUZ_!7N/CNN/'V_A$X@H@9#UC
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M/]E6;+%;G3>"4.C5GXPC\>GW(@5V>(!+A]P=2993&"9<2WZY,)PHHC5"@-\
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M 7:2FZC9K'J]_P#F<CJ>]:?1903'$O*O&S#H\P_;VIQK]W+$9ZM:9\/G[O\
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M%(7 5!0-?U3[V["XB'4E//BUC.U+VG0C!@@@"2%5P"2B7"CC$\6^:12P/$I
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M%L! =Y%,FVCV1$-86@02 *QN5TSJ1@**S><]U!P+7K%Z@%-*&PL#X'^=NO\
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M+"BK$@0@3/:BLNU*232!VE1E![UX&]'^JSW/RW<*2''$IP_/I+:HW[*QYZS
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M'),,^-<7J_NB"QKSS1G,1K1C7R3?I:U.,ZXO;.^?MZ8B[ V\Z4R6"+W;6ZM
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KT98NG#G8M=T2@1!;P(Q9\18UBA.H@LEB:QF2 O-Q0CD( "( 1;IT>S__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>business1aa.jpg
<TEXT>
begin 644 business1aa.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &2 X4# 2(  A$! Q$!_\0
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M_#T;]F+_ **9_P"4#5/_ )&H ^JJ*^5_^'H?[,?7_A9J_P#@BU/_ .1J0_\
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MS0!]0T5\K?\ #T3]F3_HI?\ Y0-4_P#D:E;_ (*A_LR+C/Q,_+0=3/\ [;4
M?5%%?*O_  ]&_9C_ .BF?^4#5/\ Y&H_X>C?LQ_]%,_\H&J?_(U 'U517RK_
M ,/1OV8_^BF?^4#5/_D:C_AZ-^S'_P!%,_\ *!JG_P C4 ?55%?*O_#T;]F/
M_HIG_E U3_Y&H_X>C?LQ_P#13/\ R@:I_P#(U 'U517RK_P]&_9C_P"BF?\
ME U3_P"1J/\ AZ-^S'_T4S_R@:I_\C4 ?55%?*O_  ]&_9C_ .BF?^4#5/\
MY&H_X>C?LQ_]%,_\H&J?_(U 'U517RN/^"H7[,AZ?$O_ ,H.I_\ R-2-_P %
M1/V8U.#\3/\ R@ZG_P#(U 'U317RJ?\ @J-^S$./^%F_^4'4_P#Y&H_X>C?L
MQ?\ 13/_ "@:I_\ (U 'U517RK_P]&_9B_Z*9_Y0-4_^1J/^'HW[,7_13?\
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M:I_\C4?\/1OV8_\ HIG_ )0-4_\ D:@#ZJHKY5_X>C?LQ_\ 13/_ "@:I_\
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M9%CM_/D\M%/ 7<< 'T Q6?N/K3Y6W=L4RDM%8 W'UHW'UHHI@&X^M&X^M%%
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M ([2_P##U#X&?W_$_P#X*5_^.UE_JMG?_0)/_P !9K[>G_,CZ^HKY _X>I?
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M9[N_U*Z8DS3-UV@DX4= *\-_X>H_ S^_XG_\%*__ !VE_P"'J'P,_O\ B?\
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M.-HFW-MW<$5]&Z/^R.GC+36%O;K+O7&43CD>M?@N(^D3++:_L\9@(M7[M/\
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MOBB.R\Z^1E&YV(4"C^*NV^'6CPZA=B66/<1(!GTK]FS7V,<+*M77NT_>_P#
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MC%K^MN!,+6P658BC7CRR4GI\CPL5)2J)H_I(HHHK^7#V3\7/^"U?_)SOA/\
M[$^V_P#2V]K\^F^\:_07_@M7_P G.^$_^Q/MO_2V]K\^F^\:H HHHI@%%%%
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M-F=TB;4///6E+8DY^BG,F#3:Y[%!1110 4444 %?;?[#]Q]F\#>*';;@1/\
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MWD>4T<?PUF^"JQYJ<F[?*[7XI'YIA,=4R_-,+BZ3M*+3_P S]4OA3\5+O7O
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M6+HMQY,B29^:-P175?%JQ>R\57T90JWF,#GZFN&L9/\ 2-AZ=*_UJR[%QIK
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MI5(VN*^RQ$N6%[7U2'3BI-IGWQ^RUK@\2>%]2TF4^8H =>>>?2O3_"=F=/\
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M-O[3_(TQ?\5(_I(HHHK^9CV#\7/^"U?_ "<[X3_[$^V_]+;VOSZ;[QK]!?\
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MGR1KM73U'_ S_A7#[?\ .:-I_P FNSZU5E9-F'L*78W]:\62:QPT(B'H&)K
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M'(X)]#61,NW.>HKK?%(7[6XPT?<+C!9?4UR<S;EK.8B&BBBLB@HHHH ****
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M=%>Y\SQ!PKD>,R^KCN&JC<J6LX-W?*MY+TZF-=:;HT=F^RQA$BX!^7N:\O\
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MAQ?\5'](]%%%?S*>P?BY_P %J_\ DYWPG_V)]M_Z6WM?GTWWC7Z"_P#!:O\
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MU2XMX[B5W :8C!QT'M7*W#?O#CCVJ*C)17;K10W6BL2@HHHH **** "E5BK
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M7-,[TN[L.M3<+ /6F,W-.8[1CO4=9E!1112 _?+_ ()F_P#)A7PR_P![4O\
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M_P!M"YTR8);JURH&3)(^,_H:^5EX<\>XV<:*P+NNZY5\V[(_5UXZ8_$.%/\
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M4^J8O"XF.CC.+_$_;O\ 9I\2+-\,[0LZ@A>=QKX*_P""A>L)J&O311H0&N
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MSW'WC'9*R2OY61_2.!\#\IP_[_.\5*HH]&^57^5CW/PW<6EY9K:Z7$+6VC&
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M)?%&HV]G,1EH/,+/^0!KB_B!^UWX4\&Z1-9^"-SWN2$E-ME1[G<17RE\5/B
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M8_ZD^V_]+;VOBKP7KUS8Z+XGTU&V65]9C[1@9)".&&/QK[5_X+5?\G.^$_\
ML3[;_P!+;VO@O3]1-C'=A8PWVB%HCST!(YZ^U &QJ'C:]:U^QZ?MTZQC)VK
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M.M.NM-6ST^WN1<1R/,3^[C/*_6LR1BQ^;K[U/)[SDV VBBBF,**** "BBB@
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MM'_WU7Q_$&78C-Z3PU.K34/\1WX7V>%BH4TSG]/7-Y%]:^O/^"?''[57A/\
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MLM_0_7+_ ()M_P#)B_PX/_375/\ TZ7=?1E?./\ P38;=^PG\-C_ ---3_\
M3G=U]'5WI65F?,U+<\K=PHHHIF84444 %%%% !1110!^2/\ P5V_Y.0\,_\
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M*R'Y0K$?G[5]%:+\4/\ A9VDO;7UBL\\4>-R2D$YK_./C[PDQW#>.GF=!\V
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M-]XU0!1113 **** "E#L.A-)4MO((FRR*X(Q\U #H[AUA:+/[ICN*^]1/C/
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M%^-&EV6H(=1L8YU#<D9!/O7T3:_M3>$(+.%(G:W(&-K  CZ5_/\ Q3#Q(R[
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MTT*=23W((8G5\L*Z[X8_\E(\+_\ 84MO_1BUS!]B:Z7X8_\ )2O"W_83MO\
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MN_#>O217B,BABB2JO[J53TP>U=+H5]/I=DVG6UP&C<[9(I!V].?2OT[^.7P
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M]\O^"9O_ "85\,O][4O_ $YW=?2=?-G_  3-_P"3"OAE_O:E_P"G.[KZ3K,
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M0_G?)L8Y\]&H[R@[/S&^'3S,/85]5?\ !/7_ ).J\*?[ES_Z):OE3PU]Z?\
MW:^J_P#@GK_R=5X4_P!RY_\ 1+5^NY#_ ,D5+_!5_P#;COQ'\<\2^)7_ "47
MQ1_V%+K_ -&M2^ XEDUDEAD+&QI/B5_R4;Q1_P!A2Z_]&M2>";V*QU5WEX0Q
ML*_7<#O"W9'GUOAD=CJNI&%)"#A5%8=C;WOB"Z6*'S-['A4K2\2B.2QCGMVW
MQNP!Q7N/[,7PW?Q!=&\%LS$L$3*_F:^>\1^-H<!<.3S6*3J7Y8IZ:GUG!'#U
M'/L8XXEVIP5Y>B/+[?X0>*9D!C28,1D;GKJ_"/[-OB'Q'=*MY+*$Z;<$U^@N
MG_!-+73XWG@"# SN%=EX%\+^'-(O )YXDD!P%/ K_//&?2)XVS&'U/#RC2<]
MI-*+7S?^1^NU\'P?EZEB,-AG5E#I=M?@CXIL_P!AX&R61HIF8CN*\*^*7P9O
M/A3?8F5Y=/D.U]R_=STK]R]*TW2KJQ3RUAE3;@$ 8KP+]I3]G.P\>:'=R6=J
M&D9.54<?6OH<CX^XWX3Q=/-L=CY8W#-KVD-=(O=QU=[>2/G_ .U<ISZ+P6-P
ML*'-I&<5K%]+VZ=S\.?%6BMI]T63YHB<JPZ8K$M[P%B&.#7T%\5?A#J7P^OK
MG3]4AE^PR,?)F(^Z?2OG3Q!IEQI=\49&4YP*_J[.,[PF(P5+BG(I^UP]3>W1
M[:]5KT/S;$Y;B<MQ#P&-5I+9])+NB_;S"28@<\9JW6)H98W,@<;6 Q6T*^FX
M7S"6:8%8I]6SS*T/9RL2#O\ 2LB&3=<.#TW=:UUK+4#[00!_%6_$*FJF'E&5
ME=Z=]$31ZG<>"?!UQXFNH[:&T:XDD; QUQ7T1X<_8MGU6&.2[N#89ZB4;:G_
M &+='2ZO+O4Y+<.MG 3N/8]J]4OM4O?%FI7D]YJ;00Q,0L:G%?QEQ[X@\3U.
M)L1D615E0A2TNDKNV]VU?\3['@O@6OQI4KXFKB71HTGRVBKRDSC(_P!BOPG8
MX74/$YW]U5@*GD_8_P#!#Q,EEK9FN"/D#RC&:M);&XN)!;I<7>#]Y6-.GMY;
M49DLKF$G^/)XK\AGQ5Q=.H_:Y[/F72[7Z'[R_!7).10>)J\UM^;]+H\1^+7[
M*^O>#X1=6ENU[9D$^9 -V /7%?.&LZ#+!*XD#)(IY1A@BOT1T'XB:GX?S;F;
M[;9-]Z"<9%0>.O@KX7^-FCSWVB6L.G>(,%S H&UB!7Z%DOBQB.2.6<80]K2>
MGMHOWH^<DMU^/J?DG$GASG/"=-XK#R>)PZZVM.*\UU7H?FK+;F)B&R#]*9MP
M*]"^(/@FY\+ZM=:=>IY5S!(4=?0BN FC,;LO7'>OT3-\IC@7"OAIJ=&HN:$E
MU3U6GH?#X;$1Q$.>)K^&_P#72_2O1/AC_P E(\+?]A2V_P#1BUYWX<SYDOTK
MT/X8_P#)2O"W_84MO_1BU_0_ U_]6X?]O?FSS<3_ !ON/Z2:***_E$]P_%S_
M (+5_P#)SOA/_L3[;_TMO:_/IOO&OT%_X+5_\G.^$_\ L3[;_P!+;VOSZ;[Q
MJ@"IDC7[.9-XW[MOEX[8ZU#13 &^\:GL;I[.Z2:-MK*<@BH**$!Z=X?O-*UB
M\BNX52UNR0);=ONG_:4^IKW;P?I&E7TL:R3FP88:*=#N"L/6ODO3+MK6Y1EQ
MD'//2O4?"?BB2.=6MKAK*X3EH';,4@]B>AKHCJA7/TL^$?C)CI:^'_$;#4M&
MN0%2<GS"AQCA^H^G:O>-!^#>F7%M%J6A74-[:2 (UK=_O$ [C![^]?F9\-OB
MMJNGZM;R1WS1V>0)H2-P5Q7VW\._C%J%_P"'3'::I;HQRRVY3;AASG(J6BX[
MGI?BK]G'1[K3=0CM]$AM%N$+,\$A^5\=0/2N,7]E^>TTG3'CN)WFB8,5$";3
M]2:Z32_VKHHY8M/OX(Y;Z,?O5#A/EQUYZUA:]^TT+OS9X6\I$?F+S@AQZ 8.
M:G4O0[JP_9RTBWO([Z2SN;DOM:6Q,N$5^[#T^E>FV6GG2I(8K.10BK@0RQ\J
M/0-7DGPY^--QXPAF<"3,*$C<ZAOKC)!KU#PSXFL;Z".634;AI&'SQS*-JMVZ
M"@>A7U+X96^M>*+77+F_N#/ 0T:QM@?3%;'B?QA:>%;"2XN TJQC+;R /SK.
M\1^(BEZUMIJ++=HN[=NR%S[ U\C?M(?%*_@MIO/U:2=[=BIMP $4CL0.M))W
M"4K;'6?M'?$N#Q1X5M;JSG6"=7PEMNRQ'KGM7Y_>.&NM1U24JDDEQ-+G>S8V
MCZ5TOB3X^>(?$N@R6%G:V5M:1 F>XC3,C>V3G%>/KJFM:U>H\=O>7;S2[1#;
MJ=Q^I(K5&;=SVKX=>#;[7)%BBF!2W >2)(RJQ_4CK]*YKQW#;>&]0N(YTC$K
M,21'U '0_4U[IX%M]=\#_#60QPIIE_<1EGFNB&9%Q_.OC_XBZ\UYXDG9+N6Z
MF9F\R7&!UZBF2:.H>+[J.^$=J_E0L@7D]!Z5BZOK$E[-F6<E8_NA?:L6VLV5
MD:2Y&]\DOUVU8@U:QLHG!MO.8-P'/+?[1]J!7.N\&PS75KYH5;6VW$O+)P3]
M*Y?XV:AINM1VQL8@)+?Y!(/[O<?7/>LW5/%]Y?0X^T+;PC^&,8''I7!ZEK$]
MYE3(63/7UI:6 RS1117.,**** "BBB@">WD&T@]JOQL0@9>4/WA64N>U7[6Y
M D ?@'C(Z?C6T7T%8Z;PW@76TR^6S<)(#P#]*[K3-0U"U_XE\LD4\6?GC^O]
MVO/;732UN;A P*_Q+R![UK0(\:B<W&'(RA8G/U%:6"Y[;X0DN]-N&ELF9#*N
M/+9\ \]*[[0=8DL/$MGJ26DNEZM:G,EJK I(/[V#7DWP\_M.:%KEO,O;:%=Y
M*@,T8[GZ=*]0T_QA9^*9+)M0*FZMSLCN]F"1_=;UJ;7*/NWP'\4'M_"-HU[%
MA[PAUE@)CD3/MWS7T7H>K6^J>';>Y9R4>,!C(,-^-?!OAWQ<]]J&C:4UPDZ1
M[5A")\RGTKZ&\2_$34-!\-"UN%AMV5.=ZG]X,=<@\&LVBDSU>'QA#),L%D1+
M$K;7G4G"GT*UT45]'<N!'<1R <\#%?,WPT^)WAZ:&]:ZO9/M&>FXH#]>.1[U
MK^(/C)%INEM?Z?)#"B'!>&3>JG/&1WHL5S,]\UK6K/1[5KB\EV(.B\<FOF/X
M\:EXG\0QRW-LTZZ>RXCC5#SS_LURGCKXD:EJ[V<4NHF6^F(\M8>0X/L>E>T^
M#?B!!X!\(VJ^)(98IR-P$TB2,P_#@4!?FW/FKP5^S5XZ^*RW+7=])I,49Q%-
M=(Q+#M@T^X_X)[^(-)\1B>#Q!;FT;F6YD0DL>X KZ$\4?M2:/I]I%/8DVUL3
MAY)%W@#/7 KE[7]L2VGU"2)8%O+&/_E],97 QV6AAH>$_$[]FA/#%\-0OIR=
M,AAQ%\N#(W<A17S)K&A)+?736L;Q)"^U%8D#)/4_X5]!?&[]I#4-2U:X6VG;
M^RV;8I7G'U)KP_6O%%K-IDLB7>\S?,UI"G).>[5J9%%I+31;"2VNBSS1H"&C
M "Y/8@=?K6-XFU%;ZWL=MJC11KS&HP2>V?6L.\\426XF6>..T61@%3[TD@^M
M8T?C9=.A=$B:24'"^9SM!H$2:HT/[VYGD*A?F\L>HZ"N*U+7'OK@>5&8H!]X
M-WINK>(I+KS&DD4JTA*QQ_UJA=ZLDUKA5(P>3TS_ (T"*-Q,MU=R&48BXQBL
MO5KB*6;; ,1+W_O>],O]0:X8A,A.G3%4,FLW(=A6I***Q&?OE_P3-_Y,*^&7
M^]J7_ISNZ^DZ^;/^"9O_ "85\,O][4O_ $YW=?2=2 445XA^UI\?-9_9[\!Z
M3K>A:/8:W?7^JQ::+?4)'2,;U<ALH0<Y4#TY-5&+G)0CNW;[Q2:C%R>R3?R2
MNSV^BOE.X_:J^)?PK\3>'+?XQ?#O2="\/Z]<+:6VK>'M0:Z6&1L$>9DGC!Z#
MFOJ>ZO+>RQ]IN8;<,< S2JF?ID\UI.E*FE)[/MKMN90JQFW%;K77L]G^!+13
M'FCCB\UY$2+&?,9@%QZYZ5B^+/&-CX4\'ZMXB=X[RTT^V>Y989T_>;1G:&SC
M)K!NRNS=:NR-VBN#^"'Q<T_XY?#71_&.G6DFFPZBC/\ 89YDDEAP[+AROKMS
M7>5I.$J<G":LT9PG&I%2B]&?DC_P5V_Y.0\,_P#8HVO_ *67E?$*]:^WO^"N
MW_)R'AG_ +%&U_\ 2R\KXA6O[)X1_P"1%A/\*/!K_P 61UW@FX6SAOYBNYU0
M8/I5GP;H\OCGQK")ANBC<,?PY'\JJ>"H1=6NI1?QF/@=S7:_L\R1Q>,+BVD
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MOY+/=/Q<_P""U?\ R<[X3_[$^V_]+;VOSZ;[QK]!O^"U7_)SGA/_ +$^V_\
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M[F."\A7Y(R%*/GKCTJ2\\?HL-K;-,)-K%I(3%@O]3WKYET?Q9,T8_>[9T/\
M""N*L-\3Y[>XC1IVF96(._YB/H:7*%SZ#C\<2S>(II/[/9V"C[,MNK;Q^5>K
MZ7IWBO6O#3ZA?66I/'G]U&UL[Y'N2.GTKY7\%_$>ZCUZ*YMKK;<Y $:DCGUK
M[A\ _%_Q'XAT.WLPMU=76/\ 5HVU&^N.*-@N>0ZYX<UC3]%D,\CV]N?W@$ML
M?E&?<"O'[74;>[U*X26:>:&(,PDMTPA]BM?:GQ&634-%=O%IBM[%(MLD=J@9
MP/3/K[U\"?$;7[?P_JUY9Z/YEM;.S!8S+R$]?K3T$<%\0/$%O)JL@;SF!/\
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M+X3_ !U\-+&;"_OS&D@QAUP.E>A^&=2\2?#[7G\0>#'COM.F/F.@.<CKBO\
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M]N(K_P <\3^)'_)1/%(_ZBMU_P"C6KB]:4R0*H'.[%=I\2O^2C>*?^PK=?\
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M@9"0<C-=/K"B\DE?H&8D"N:FC\MR.U?WCQ'E/]CX3"9=AXVI48J*?=K=_/\
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M7J_PIN++4+:20&1[E'R&A.''XU\:6'CF\T^Q%K'%$4!SN.X']#71Z#\=-?\
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M.,8/J .<?6O,B<FBI<P-?6_$FH>(K@27]TUPR\*#@*OTQ60>IHHJ+@%%%%(
MHHH&>W6@ HI>:W+/P;KU] DUMH][/$X7;)';NRG()'('L:'9 ?NK_P $S?\
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M_P!%GD_\)C_[LH_X<;P?]%GD_P#"8_\ NRG<#\HZ*_5S_AQO!_T6>3_PF/\
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M_#C>#_HL\G_A,?\ W91_PXW@_P"BSR?^$Q_]V47 _*.BOU<_X<;P?]%GD_\
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M^(<81T2LM/P,)4*<G=H_/7_AS5X$_P"B@>(O_ >#_P")H_X<U^!/^B@>(O\
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MV_\ \37Z%44O]=.(/^@J7W1_R#ZO2_E/ST_X<U> _P#H?_$7_@/!_P#$T?\
M#FKP'_T/_B+_ ,!X/_B:_0NBC_73B#_H*?W1_P A_5Z7\I^>G_#FKP'_ -#_
M .(O_ >#_P")I?\ AS7X$_Z*!XB_\!X/_B:_0JBC_73B#_H*?W1_R#ZO2_E/
MSU_X<U>!/^B@>(O_  '@_P#B:3_AS5X$_P"B@>(O_ >#_P")K]"Z*/\ 73B#
M_H*?W1_R#ZO2_E/ST_X<U>!/^B@>(O\ P'@_^)H_X<T^ _\ HH'B+_P'M_\
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M  'M_P#XFOT*HH_UTX@_Z"G]T?\ (/J]+^4_/7_AS7X#_P"A_P#$7_@/;_\
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MT%/[H_Y!]7I?RGYZ?\.:O ?_ $/_ (B_\!X/_B:/^'-7@/\ Z'_Q%_X#P?\
MQ-?H711_KIQ!_P!!3^Z/^0?5Z7\I^>G_  YJ\!_]#_XB_P# >#_XFM#P_P#\
M$@_!'A[7M.U6+Q[XADELKB.Y5&@@PQ1@P!^7IQ7WW12EQEG\E9XI_='_ "#Z
MO2_E"BBBOBSH"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>business2ba.jpg
<TEXT>
begin 644 business2ba.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !@     0
M &     !    1TE-4" R+C$P+C,X   R,#(U.C R.C T(#$X.C,U.C$Y  $
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M1T(@6%E:( ?I  ( !0 ! "  *V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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MK2!*0]B1*HHR**\I"5+?*T@32XP$767H5!'%WFP)F E"F(DE#8,W2+P.0
M                         "D/G&8-+A+6(T\RO*PCBA)DCCT(@B2%(0PP
M7"9X,KEF&G!I\2QD@HS(1N&9B(<Z%<1)7EU'TY+Z.0
M          :(F@A>I('B3AT(HH#W*L\#S(TMPUP,8EK&/RJK-T6KOVME[L9+
M:]7O:?:F+5OR.G>>G3FRK3N ;0$,="K+B+.+G,]'T&.P
M            /SIFCYF RN7 91+K*<Y*TL0M(AS I:Q;A&E:0Q8DQY=;9R_]
M1Z6U/G<&RGDM*;W,FF7LMS!UJPGR?F5\1O>9Q(HF22+4*PG"US[.G8
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M_+GTFYBWO9K?^=:'A9=Q=Q?1V,.&)S#)^^HY
M    !^? U<)(B"O)4]R/.Q(D&=2WRXR8*L@29F/''>C])L>WMMWS^4\?'=6#
M+7R5%/MC,:]9\OSR_17H\>>!Y]G_ #?F5VI6Y*Q;MDS#'QXEI&*C]^QR
M                        #X*FL9;1T)(KCT!7$:210'D4Y2E(2YP>IWF*
M#UN]2>UWK%\%H6%Y_2O"V7<_VFY&^LSZ/_'.996YCO;Z)U[YV[W/X7G8;\SK
M8JM6JK;N8)+9/W\G(     . $                    $\@^#1JJ1)1DL>Q
MW."N.Q2E:49'E049+D,3Q!E%2(S9FQ_:[MP]K9R]%=S?':UE^<T_GG+'M+05
MYR1-)KW73L'TF:W>/AMKY]S[+P4Q;-O!'[^H<@    XAX1,$M2)X22
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MV6^JF_[J^OL80]?T:[%79;P7+E-7!VM?F0 X+?K> KE
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MZ)C5ND!C1$RB\D?&N:Z_GT\B?FQ+=Z)BC))0IWU6]CXQL>$%OKL8H-ZT@GE
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MD$7(?1@V.,,'S7.Y)%^'J85,]&?S38PR8I(LZ@'[^SD    X+?K> KE
M                 $_.+\D=Z:    S 9"(,H2E*LH#D\B?*,KS;DWU,4'S\
M,*ERGH7<4)2&2S94U:,(%I&/2B /W]G(   !P6_6\!7*
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M3A3$*=3W/(ES(Y]'#R/FJ;#&1#3DA#P*0B#H0Y>H+I-WS4<U4+<*<_?T<@
M  '0BHM31(                    JB45[6C\@9H  #D]C/QEHQ*6P39U*0
MH"L+_-VC/YIB:TFX9B$MTLLLT]2&![%>3QF0R::H&(RSR@/W]G(     ""0
M                  " "?R!&@  .Y[EWEJ%$"^C(YT(8N\^@QF4U&-5#/QL
M@:HDV89,:GN09=A0'H7R;1& #')C(LDZG[]SD
M     'Y C0  'H< ZG!R9F)DC3*9]!RXS0TP 1IN<9@-=2E,4EJ$44A7E6>Y
M6&0B#*TBBRC"9^_ Y                            !^0(T    !V/0RP
M7:9?-^SDP(:>%J'D7B9;+5+!+3+F(([E2>)V(\F"E)<D"Y3&!^W\Y
M                     !^0(T    !ZE\F6#9 W1,;&%")-:BVSJ747R1YC
M@Y+G)PDR2( \"I(XCRB*$\B4/VO'(                            /R#
M'S\  !R=S,I?QN ;F&H9IN6@=R/*PABYBK+P)(FSW*PKSL<%"5!(%.0AY$81
M1^RHY                            !^04^?QP  ":-G#9,W)-!S6TMDN
MP@3U!T,@&3 5Y5%4<'L>A;Q6%*31X'4HBX"-/UNG8
M         'Y!SY^'!V!U ,C&W1OB:PFEYP>1T/,Z$B9*+T*PI"Y"//0B2Z3J
M4AW(XK"I/0@R5(D_78<@                            _((?/X'H=SP!
M4&?#?XV</ER8D+@.Q'E&767^7020($ECN3!:A<94%039%D(59$GL=R&/UT'(
M                            /R('SR  !D$V5/I40)\NB%*XJCJ2I?Q>
MQ&$B29%DZ9>+C+8)LO4%M%CEEE&19U*(\S];)R
M      #\H1\P3@  R:;4GT\-)328CRY2%,B%\E><'L3!4E2;8&9SR*$CB0+;
M(,J2WS$AC JR-* _6T<@                            _*\?*4X /0J3
M-1OR;1'S!+1*8\#R,SDL21X$B=C(AL@9^+2.I81=!=A9),FL):I)ECD0=2TC
M]<IR                            #\PQ\ARD .Q<YGL^GIC0^>A$E83I
M>AD8H"1/8E"\C=4N4]B$)HH"O/(@2--=SR+*)(NPLPM4_58<@
M                 _-<?(TL@Z@]3+YN.;]GS4,!'H31>)D4KR,+@+@)TSP9
M_*PH"3*TBSL4AU+8-?"O+.+&+V,DG8_0^<@
M   _-Z?,TUX. 3IL\?1,M<^?I!%XEX$N>I)$L7893,BF1"\B1*4IR7/,CSJ2
M!;Q"%CEG&/#/!;!C _36<@                            _-D:(&N9"%
M>91-O#9D^=Y9IDHN,O\ *0C"H.YM@;3EA$09 *D[GH48.YT*LCSW.A'%CF42
M%,/'Z SD                            'YFS2<\B".Q5F[!=)\YBX#,A
M?Q%D4=BK*(W%-@BV36\S 9<*TB2-*XH"H.A0$P1I)D*3)KH8,/U''(
M                      /SB&BI0$"6X2AM(;F&@Y9!>A?Q#GJ>17DR;0&:
MST,!E495+@/$I"0/ \"N*8IRO)HCR#,*&LI^J4Y
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MY2^CQ/<E3*!MH7V="A,6EVE\'D5IYE&4))'8HBUC5$EC+A^@$Y
M                  !^:\T].22!;A&%CGH3AO\ EG&FQ,E^E,3Y$&3#= D"
MD,DE$6>7,=R>(DH":* A2?+5-1C9$PP?I,.0
M    ?FK-/R;/(C#R*X@"R2G-]B4/GP7<7X5A(G)=1N2669',M$4510% ="L!
MZGH41P6(6 2YKL?J*.0                            ?G3-3"3(PI#Q.
MY&&.B5/H&8#-3B^R_P IB?+;+B-JRTR^S/8*TZ$">YW.#V.A[E&<GB8,/ _1
M"=@                            ?GN-/R6(X]"**4HRRC(1M0:4%87.=
MBD/8H"]S8LN4H#/QV!U(XD22(XI2J)DH2/),CB&/MP<@
M            _/8:ME4=2WSDAB *$V6+<-0C)QD8ARB*TJ3/1/&;"_SJ=BA/
M$]SV.#R*8KB4(T\RG(0Q<?H3.0                            ?G3-,C
M8(^PY\P35,H"%/$V()LTH,AF0B0+=(TE3:0M0VG+F*8A#W.#H>92%PD"2Q4D
M>4YR=#!)^AXY                            !^>0TS,LGWG,J'RK/F@4
M1;I7&X1C4U(,LDH>A&'B707F;G%PG<CSQ*LHRL)8H"$.2X2&.3D\BR3[O'8
M                           'R6/DD<&>#;H@C0DL4C2W3(IMR:G&/2Z3
M)Y:A2%49#-[B6*<Z%$>I[D621+$4>A!$J>A2EOE]'V#.P
M             +2/SBF(#P/8\B5+7*8LTHS/ALT:,%LF4"E)$HC(YO$29)D2
M4I %XD>3A*$"2Q8I<)"DR8Y/JF;#'(                            .#
M'!\>S3@M\HRN(4ARB(XM@SH95-,B^"^2++6)TS0;-&23@%N%>3)*E(6J>),D
MR1!F<V],XG8                             _\0 ,Q   @(" 00! P(%
M! (# 0   @,!!  %!@<1$A,4""%0("(0%2,P-Q87,3(D)SA 03/_V@ ( 0$
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M)UU^QG$*"P?57W1R>EY5-O68BP,EW>1SDR3,[>!P1%,!$"UGKR[9ATYWS?\
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MJEZ>(Z4=2*75+B/!NO?'.><T_M\.VW7:QU5__?[-#/J;MMK]=M;R$E$K=IM
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MG6;>=%>1<VZJ=.Z?1>YTYW.RY%P/]=#/JC_SK_&O<;6E>],LJ7"D)NE L<S
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MR!,A1"8@?//7 Q)S$Q=24*B RSV>5B!7C;C '9[*)RIY6+&J3\17YOZ@ /\
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MNMW'L9_K2N_O"UQ_&OZTKO[=7;M#C@'@Q6N_MUO8_C)=UG%:[^W6NT.-@?\
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M_#U\'Y=V\KKU^7N=.=B>5KYA?U^GP>MK$\_*+&_(>O#B= 5Z^+E>^OX-R.)
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M7T]_O8:E#6<'ZH;T $T!DBH1W:&N]#"B% %&9V>:-BR4)%)P4[+L"&S[*)'
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M7!*K;&W,04"!-*9"N[Z5Z5%OF,B"$6$?44D$CY\]O[N^6R+3!B^,B0%3/,!
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M1W(-?\AF>+4 *,(FCRPRL6QR%,B9Z$Q:$:TY99#5(!DD&# KA%)B=$%M#!"
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M4-XX6;2$V$AYX;V#Y4PE+.@BE2MC3@0](AA!S_OU! B0 T-(:#BJ*]5"76P
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MWSPT1QA_J.5!N.%D5#>/J &"1YVS!./4XA=9#!V8T&O6)'@"R>&_6&%34,/
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M^)2NH@"J7^X*>H\CB$(A5U#5D?GSW_NQ&6$K3^&C?R(-;@L#D2_P*ZWX4#2
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MZWMS-@+_ !&_*?J$ $N\PU-$\=/W 2L'&@%]HU%*9M3 S6^(" $ ;'?G;,!
M4M"TX4QH @^:8JEH>8;"PDO.'!</<&1@$K[3)#T9,.S8@?1C\1I1Z\>T)EQ9
M?CS2'3!&_"AV:>$ZA@&(TX>A@BP""/S,>;?W9A^GG1Z4%DB3Y_XT:"!H0=D*
MD"%.8&Q.!0Z]TWPN@I,0RG(DFS+)E@,I^T*V>-7"D P6D8!,)>S_ ! Y@UUK
MB%O,8ZQ'YX:MDO/B T!.D/0810=,0","$ %UUA10N)#2:0-VS]1F)R=59FE1
M62'636H '9YQ+LX/P1B7H_V $%FB=X1$*<ZM=Y6->XM.(VQL;;J#()')U'2#
M.*=-YB$30X7^(K75V7O/]\\U_NP)YAQ#BQ>[F>%_-@O8*FL2D?>)\6'>Q^H!
M !%%< ?F&3D0+.IA1.7GH])D6PM1(51QTBB@(]U12OHTJ!"./FL)F1?'[A#-
M[ITN*C#CI^8,;(C;3(E[Y8TY+G: 0;::P(#15Q ->G4:VJG'(3A!4U<REZ=]
MXX$D9'C@2X([_N#@UGK^\PP)'#;[P:/%8445W\Q#PK#1FS"@ GEK\>(!1 0,
M$ZA<ZRP""=*ZW!^?[L%[>XK[X]^(5$&0^G+_ ("H!$ D!JQTK2(5!ICG03%W
MR@S :Q!G&_BX?1BEYS ,#2L\5]S,NTC$AT X8.Z8R8<T8. OHSC C\^)\@<'
MW'X/6,+@EFMB-R8(!%R-HNI@SO  H4[:0%0-140ZS%"XK%!\YEXLWM#MP":>
MS@0V<KCM$6CX7I+8*C\)G(C6.%]- Z(\P,) B@^_A@F*XU$;4T&->=H3U" "
M7G80(4\H1HTUKYS_ '8E+A#YON9V*,Z^'$/U$=+W\S,(N247[A8]\RUPKAJQ
MSQ+#;?Q#+>$K8<+W]H:(0VI.\(1K*N%11_IS",)DUC2+:ZFFT%?,8-+;[A91
M9/2&9.EF#CO9![$P0I8OR;\0NJ" J%=<3,  DT#VZ0$M!6LJY.O,:/1U\YA@
M0,$-*5B/,O@!ZRND>7S-'5V@% QZ.G710QH&NQB:%@1IZPJW@#58HW"C$D!5
M ?&9>RC);&"[F8"'0Y^_G^[+6+0..:"^(+9A2H(W8'I!&P%V0'O"G##@@P0%
M]1!") [=E0 ! $;*%76=<](F"XSQB.!E\8YF%#2IC%#408P5'3WA5;',*,:X
M@"L/D\,(:,GQS,H>%$J! %5K9@DL<92![0.J*!GH'W!?7V$U)*^L2V)V1ZP%
MM.' *1;H@F3]8!3='!%0B=DFB\?N=/4#CYUBX19IK%,(2/2N.>8(28 ?!YA1
M, -LI7#]:=5?<PWV_O#^2.8['U'#GCK&90%#@N?\,($.Q0)A21?N.(?A(W.4
M<%%L5 V<<\2S[+(0U@\6J X/@GSJ](#M"L"$(IGGQP'! "\*9/D[[PJ%:0;'
MUA0H[)4)"3(%7"@A".^(,%%'UP]-Y:$681# .M:/UF<S'<T0*PP9F>.8$ I]
MON$L&1YO!='6(A$ #V>;P H 67;F: -T1S!E04\TA71Z+]RPSUQ\3/ZM7$ V
MJ%GR+@_NWNX^@-^!I!;\O%2"T)AD@#ZPA"3/;F'*_#%E  ]P0M1"+/'GUCUA
MG"\9]X\5  +T?$,(V!>G$,P/N&\(H3#$P L<9ER)M]Q0EA*(V0)ON-7 28HS
M" 0#MO*) _M:QX![H!"G1^X^1H:0H"SOU[0[&#^1+H !/=03 ,<E*+X=/-8-
MJ0=])A4R!+;L</M#4 +,=R .=(#4WOYS* LC:$0P3@51@YH8@!ZP20)-@Y3U
M]_[S/=07K/&DQQ;"[\[*.RIJG]")&F<AA_,-FY!+/?D0%O-OG6..;<Q,4:%@
M<P<%/H.13%_N,/[";+Z=("P5QB*%*!Z2E-5G/QZ1U<%9Z\0YIF $(:0($>=O
MJ%*('7F"Y L![.('%.&[2.#3=]HPDB3K\S;G9\P  L4S!9@P\J<W"/4A0Z1Y
MO$D<XBQX_<(8@H,Z0 7LIJJ!;?F"BMG7_(]>8GMZ3*T(C?>Y7D2<&Y\KPZUN
MB#VY&EP/SG\?W8U@<:>\#:G5=X!@!C;B8LV>R'[ CPVVB.[LG7,Z%$Q\P7(:
M'I8YA*2S$\@OF$K$0B<OS$A&Q<G:8",+.G:$_3KT,LF)]YMP9\)B;)7E0@3=
M(9QH\&#!-3X'I$6H!K_L#@8](4D(20C(+12L_4?DWN /M#E8"/F;BR(;&74V
M87!HW<,"JU]9;0&SPXL B[/:7H@C/EP&PVM;]H<)*=D(;$8/2.5T,1Z@!]Q!
M@QRRW"QT?]X4 +1VYH!2#(UF(1JU>."0(Z!.'O !!'1?B-DWHX#*]L_/U*7
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M6'*'J/\ D?0 :03B(!HK40N 2E%I:\O'?10PHFDU(Z#F'*!$,&=X$S9%K_R
M(M&5*H:_>GHX6E#YS"GRIE\FBS7Q"!0$ZMV(^-L^(XYN>/2(:M3_ #"(Z7FL
MU&6QYVC /O,G%F.(-JKQ1>P*7Y<L"QRVPX@ @7.T 4COW1D@((Y#BL#-H,7E
M[0<\(K,)$0A9)"@&H' R:W!^?[M?$(>SA(,I,$-, +'  :>@(T"LD1LF2($(
MLEIWZP=65JBE^/UJ ,C  2SKH1"7J S'LR\UT(AY(O4W9]EWJ'9G0:[1N5WM
M&P)-0N$.)W"/S>X+( )P4_&0ZBXY(0@-C,*J'=3',0*6,MZA$E:A"MB,"!1J
MJ!\#$^:"#^8-ZDH8F;H/9AB"2$KM>'ZC"A>>D$%,%NHD$Q;8YYC@5=?W!+;*
MX!EFF#UX@3BV ;_R& ;E "4!4V71[ -$X>, "2F!(6R4CJJI$E $20(=?]!7
MU8T/]V7,UVVR<*1AAD:YXDE#MQ\]CF"MQ@9L@;A1!T0C2!!SJ'!^1$FF[A]H
M1K"VO^"!8%@K6UU$P'0)Q^81,%:^C-&*Q-F%<=:A;<4$B\<A%%XZAD_D8ER"
M:@3//&8:!#D'M%D)I9_4?*>\)&PJ!0CN5>D&(4$7P'T0KL=#Z0&6)$+A)LZ0
M6K]8Z2QOOT@#X10=U^I@P%4PK>.D]8AK[02$C]?T(9ZCO$RERA&;H:/O&R[B
M+>M0\40XU_$(7(T?U'.Z*$!3LFAC)^X3>PNA&$'1^B,J9]6H?@^=)2F<!;<5
MR?T^0]?[LA[]B1H1H1OZHY (*Z6I:90CS3#FWGELM:8@K!B8Y<JZWS^ZP(Z2
M6D,X!I$11TZFW5? !*T1^]X(@#=:\1IOGY\XA<KT)AXY:A,]X;$&Z?F5H6*/
MK]0ANPRT1J?J)-8GN,T^GXB@&@#8!X<!\BQ>XXAG945J/\'6I:-3O^X)!PC0
MCCGB(R*<@,#FH:[>H%MQS!C9O4*2:]OB/*'3]2L@S8],]4)YWW'2B8 BCK!7
MDK3CP2=8&2)K3YU4-B?G'HX+TZ9SBJE8&DL\4))RY> <S"1:,GB.4T-90(9:
M!T61$&](SP%>?QI^SD]  /[O_]H # ,!  (  P   ! 0" 20" "000   0"0
M2                               2 2 02" 22 "" "0"2
M                    2""  " 20(2YEX000""
M        0"""0" 2 3K0'$@2"2 0                             0
M"022"(<3"JD.2"00                             2""0"0  2O&P!MQ
M2 "0                             "02"0"""269L 9E0 02
M                      "02 20  3Y@022[B2 0
M           "2" 0   9QT0(&^022"                             "
M0220 2""CZ@ 6!   "0                             "    "" 01X&
MZP SR2"                             0"2"    0 VLG,,".0 0
M " @                   P"2 ""200 "%2!;E *MBH     2&0DDDDDDDD
MDDDDDDDDDDDF:"2 "00"" ""  20"6KZP    !P@
M#@" 02"0 202 "00 >! B,A0 ">                      ;02  " 00 "
M"2 20 "2FM*$  3                      ">0022"22  2"0"0200)8J0
M(K&8                      3@2"0 22 0"000"    " ":=%3
M              "<2"22 0"   ""  0 020 &284AI   022 0 R$$$ $
M   3P" 0"0 2""0"   0"02   "8J9H@"2Q>MLPY#2PP"P2B   "<""202"2
M "2  " "0220   3"](H #\[.T)2]FIX3>F'&D  3B20"0022" 022""2" "
M     3#M "<&FL/ZA"G!> 4G(T  ">"2"2""0"""0    "0 0    "8(, 6$
M0H00$@4.&&V 4JD  3@0"2"2  "0   "222 "     3
M     "<  "20"20 0"222  " 0    "8                      3@  0"
M"00"02220  0 "     3                      "<   2 " 0 2"220"
M000    "(                      3@  "2   00222"  "2"     3
M                   ",  "20" 2"2  "022  0     6D
M       &/   """"2  20"""2020      6@                   "!0
M 0 2 "020 22"""20      $                    $$  "00 0" "0" 0
M"2"2 0                               "00" "002"200 020
M                            ""2 "0"0 0"  20
M           "    020 0"202"  0
M2  "0"022" "0 """0                               02 202""02
M""""02""                             2"2""2202""020 020
M                         "  2 0""02 0222" " 0
M                  00020"2"20"2 02
M   0 2220 2"" 02"000 2                             2  "00" "
M222 " "2                               "  22202" 20""000"00
M                             0 "" 22"""0"02""0
M                 ""0022200022 2 2"""
M     "20 2 2200" 02 2 0"                              22  0"
M22200  0" 2""                              "" 0220 """ 0  "2
M"0                             2"0 222"" 2" ""2200
M                   02""2 2""" 00 ""0"20
M       "" " 00 20  ""00  02                             0  2
M00"  20 2 "2" "                             "0    2 20"22 "0
M0 "0                               "" 0""    "0"02020
M                      022"2  ""   002  ""
M           "" " 2  "  2002  "                              0
M"""200   0 00" "                               2 "" ""000" "
M202"220                             2"0 222"22" " 0"20"
M                        """20 """ 0 2"0"
M            " 2200220 0 0 0022"
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M!VXZ#VPH0! 8",81"W:BH. #*$L()9.3[T7 *)0A3(!P+_@-%IHF@ *4J+L
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ME22!"8,04H20"$BVAHD$ LF92Q&!>&2)N' U'&8S&&CO[,D0%P-L/&P?"FE
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M[?\ ._@/7U G"DC.WOOE(,>9#1Q%PP<Q!N34,0,0$L(!70S[XJB:"2@.D-D
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M !:AK9[N!328,>P'WY-Z%:A'X4B.Z"YD]4?:<*(0 \,LSR]^==3Z%;N?][^
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M/-;N/-;N/-;N/-;N/-;N/-2)F;1CS_\ 0B__Q  J$ $!  (" @(! P0# 0$
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M+,>!69HV###<^*!3W6'&E3'Z]<3VRP$F] XQ%N/#>-U$2(/86]%U,[KR* 1
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MKV!T\V!I6N#-=%AB7.7K@F4D4+"5)[.^]O$O-$*L$N-VF/)YY'(R9XC=?O\
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M27$$.P46X!3K+@26FBQ\8\]X+P5G!B,PW%RY<_.^!#"B;54A*&03RYXP0::
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MP,V\" &XP>KF=]<"T1A:F6Q#K*U,QQG!UK.\&&5&45U"/&;"& .P;8?H<>2
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MZ[G7$!8^+#?C+Q#'0#!<3><SUG@"@N("FV6.=YA-2Z=8ID]1A&*YLI_H"#%
MMO3@^<.NGVX8=Z<Y'=+@L3OCIJ,,+,-]O'V?',N#E4%87NEQC+3OIUQ,U>O&
M]X&GC\-$1&3,T>TUD^\I,MKS(&T\]=N3J[\K8!0G3NY/7S^O&@024N?&SQ\_
MYYEU"(+&*#$/81[WS:XJD"*-GO6<</[0=S.?+Q?Q/8*54S0S_P  GDMJD48I
M8WE)W(PL9XSBC @93+4-^"?KUP4DCF=[BW!$A;<<@> *X0*K3NXUK/&3*J#8
MRW?UYU\<H439G(/:S?7D_,;ZH[W&YAQ^WWPHSV!Y*-,M<9S]]\>,9'6:NW.!
MQC_6QJ-[6BZ?$RW_ #QF M9K#F1DZ_7*<Q414IUFFC> -N4DG(O%PZ&IG"E*
M99M1#:F,3QC;IRI:G04H\';69X0\$+^^;3'Q6)HNHPXB(,TSP%GBY4!\PE<-
MN13>'9R)YB("(+Y4C'&%$=D=0P"R-K\?\1A]"_HG^>4 N+7M'+]7^W&P\OZ
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M,EI'/+>4#@ZH<5O4/F!!* *@&U&M.';AC)>K.:/P_MS7Y?O_ +=V/D_?^@Z
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M"7?G>,&M\L:TBK! \>-8#\\82E"22JC>^S6?3P\(_/KU^9N_U-_7['FGX_\
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MMN$'%#27)[7K23O?D@@T16J T.Q_R\71^4 O8Z#+3=^> P7M0 ,ST3=BS@Y
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MLQP.#XL)".V8]8_;BBN(1@V#/MUS-^W18*S5]3K#>LCIFD%4& 8[==3N\*Q
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M/"\N:A!PF[:1+N^3NAV""74[C0N/.3OB.H"08R/BNC\Y)YJ\, X9N?##6^"
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MSG/K6<]:XV38T4$OA&-P=3Q;1YR.DWAOXXAB! ; (B3 K=_-7 +@O%(%7O\
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M&E87L0(Y:3)TY^>7\2(":K7Z-9YHN$1;/6V?7?T-Q&1#$K+WG/[CV*$4M 7
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L 5.H5/0*/1WPYGAM(85F!ZU'F(:S"(I%@WQ\"*E*G&5@%0"H,?(A7^^$_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>business3ba.jpg
<TEXT>
begin 644 business3ba.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !@     0
M &     !    1TE-4" R+C$P+C,X   R,#(U.C R.C T(#$X.C,Y.C(Y  $
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M1T(@6%E:( ?I  ( !0 ! "  *V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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M!$@") $0"   (D") B            @(0B2(V  D
M 0(%!:;5DO0VFAR/C,_.7TA]H55:UV.ESHNE(G                   (0C
M,010VMCN6]ASY*:29@1($80E$@1$1]H7K%3(\..YTB8A$QD
M   (0M]YQ3/DL>6RY$@     )A"XX8R[#CN^*LT@               1\TXG
MLWQC-DA,@       "!&(ON*N8ZV*IHC8             ! H;3@^WEMV2Z(
M         3-1BKF^MBO%*Q             (0M62V";67X7D           "
M,,TU<60XJ3             M5YP#9S?/)8@            E$9KJ8<BQUB
M         0**6O=S-3WL             !&(SW3PWFD1          !(:YV\
M]!FE              !,?6L['T<%9$          0,/V+8QL9@  $D@$$
M       +MBIL#4Q3*E@       !!%!-M<[N:6T@  :*K7G>E=>EY,M313?L*
M6Q+@        ((SC3Q9!CK$        $(8)M9;'GN   -;UCAZM>F)<I&PDY
MS:W8!/(         5=*[)TL7T0        *&TZVW,D)ND   1@M8UC"]RR"9
MV;,@         ()KG&GCR#'4       "%6';67&=BQ(   &/Q'']6KZM22]3
MK3GM@          NN*FP-/'/,       "5&LMW/37L     $(0B+
M   BNS=+%5U@      !"W7G7&]G                  "6;:>+(<-(R
M  $L,<RVPS<SD                  )9%JX\TU\<T@     !!&%;.;'<]P
M                 M%RP1L/0P1R   %8EE-K7FVH $$8!M9K/FN
M          $JC7K8^KGUUV=D  "$1DF/'T5\5R?I?* ((UUM[%MRR
M $56LK*8) !"80   !)**QEM7G8)H   0.5/2NOU5Y;R)MH ((UMM[%#ED
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MS_&_OF"7+TI+]&$]#Y9-V1ORVZ/;OYRQ>T?X@^5GM( $(<J^D=?JOS#D-@
M+7DOKO;RI      ",,TT,5APY(VD!*^UQ:\IM_%8 !"::99;#F5\7+OJ^KY.
M?L6FEO2=V3+NR3OR6Z4CH^W?\]ODNRO'>3&;  0ARKZ1U^J_,.0V   @:]V\
MMJRY2H     %SQ4O&@MD63(!-0K)6<.KL  !!,U44S>=>\;>+SU_1F?S"_6O
M3Q7Z+KPR;NQOALGZ*_YI? W'!BGN  A#E7TCK]5^8<AL  !!%IO?7V[F
M  @97KTH-*9)DD DK?JX]=UV_B%@($2"I,9O=YPYU.OCG?GRL_6OT7!GZ1^K
M]:?Q;\GZ,_F_Y>*T;  (0Y5](Z_5?F'(;   "!@^:]@V\JI(    %<ST*V3%
MD   ^RD8MAE-B"?*172ZO1<QG%K<BQ38];>EL-C,MTOK[6RZJ'/'WG3WG\;H
MW?6QA( "$.5?2.OU7YAR&P   %-,ZYW,]-8D    A44KE6C6RUR   )7VN/7
MU-NG3A)B*)4; 7UTI?DY35DTMI9].\6I*F7'6:\S2   A#E7TCK]5^8<AL
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M&&&;F4)RE(!%ZO3!-?9I)N)D9Y;6RS+@FD2     !"'*OI'7ZK\PY#8
M(0*6["=J]HR922"%F4Z>.AU<DB0/.]&F4;45N:?0]< GZ*U=6"4V;C?'L++K
M7ACC(D      0ARKZ1U^J_,.0V      "$(BQYK8CL9*+)<A#--&EBQ9(@ !
M ) )*WR<='-LKG'])B(       (0Y5](Z_5?F'(;        2EEO.-;$T62V
M4<Q95R22 "2" 36S6[VI=U?I,102       !"'*OI'7ZK\PY#8        0@
MA\[*"MK6M31--"1,JT43JU!4HKYBXVK4H2$0        "$.5?2.OU7YAR&P
M        $"($! $0 )           0ARKZ1U^J_,.0V
M          A#E7TCK]5^8<AL                 )2!. 2$:(RC8    !"'
M*OI'7ZK\PY'CML+L=BF'%S+D:B.7C4IW(5)N4@9R><)G)B)OPW"<?'0YDICA
M@)CYRP>@9ODXW.Q3GLYJ.H2X&:G!YT24QN,UL>@M&'=3)D6G2ZXH     A#E
M7TCK]5^8<CPFV%E+J8&9^:@/4,Y *@M1@AJ,^!Z/&MS?)R*<N%Q/3@X0*(VP
M;E,?,X.)3I P@YX*0ZJ+H4QCA>2A,$.7#T./8^(\R/T3]7OOS/GUN+$
M)-ZW6?FW%P[)>K+D845).9$8^5I\2SF<&.%]+69@888^5)DQ:#XF2F/%:9:8
M27DLY<3$S(RA(E8496EA+Z#,8BD9/JK]D     0B(1,<4,HF)&X
M        !" D@     (H)Q;8V,CU-?ZV+.#C891F2FPSZ%Q,7)C,#%SG(R,M
MIA)M4S@V\889>8R5QJ4VL8"6HV,;0            !R%Z;U>MO+N7];1-9Q"
M6,LQCI:S?IBQJ$MAN@RTSDYD.DC7IB!:S/3'#51B)TB<;G09IX]&C=!D0
M         /G6C'::Z:\V,IBJ/H6,O)$D,7+F9@:K-BF$F5 D/J"G,2,U+86<
MR4D,C             )*$1&9FN                          &I_H-O:7
MS6I]+0O/GF;=+P=)FDS 2@,^-PGG@=*&JC SMDU:;),4*DP0V28::[.EC:
M             .<?L^CT1\3SOI)9Q"9B<I'6IKPYQ-[F/&W37QI<Z+(E>2&A
MS5AV6<<&R2J-O'91D0              )(K+K3/L3-9   B0    (D   "(
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M(,)&)$;C+WLM7MBV2:*['5G%TI8![:8X&C'BK[5[1@MV\/:/ENVKZ!:P(9*
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M:3;2Z::<@>OK5E+(42(0V[>81P12IPJ<.]0XC.#<:)BI,I<(G*3ME2@&F)?
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MP=,(,T*EL=$616)RX?$71I*B)#1#1$=49': A).DLL/B_]H " $" 0$_ ?\
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MH4J#2M.J,"35:L2^K7AZ@-D421BP_LZB,Z=D'"H)3A 2H FNO^Z.N/,Y*4Y
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MD$;N<,#T2>W_ +OP?5*CYJ:'Y0X,ME?X=L658MH6S,_$K.:6^Y@))0#1AI-
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MOWP_FXT#JK^,;0.KUO\ _\0 :!   00  P0$!P</!P8(# <  P$"! 4&$1(
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MLTB58ISV0XO 0SRIFL1T(X4I "P]7=*UQ7XTPA?+H981 !62&-', =@>'(9
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M_P#H;V\G/96?$=]#NU^G/X"QOQG_ $-3]ZI_1#V_&9G\J*F7Z5^ L;\5F?\
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M7=7=27+O4=C$?EZ])5RVR'90"+EGDR7'>N7GR:_NVTCD@([XK"L<OS-7;O\
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M<*U=R6QDS R77&(DK>,@CCN:](]:R"I$\,K$WZO:QS45Z9/U,0(<3W])?FQ
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MIDN?/9HQM:,8VHQC&(C6,:U,FM:U.36M3)$1.2)W?^9 :PMA"%82&*2/ )*
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M3P0BEEN3[X4<C,E5V6Q<3CQAA^9 ;!?,CBC6L,DV:]!ZQP 06O?-=8%?]C)
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MQ;=$6442A;)X=VO4HM\UC]L8B#C21AZTJ>E#%=+!MHU'03S I*B4@8M2L*9
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MY1DA#)LZ2JYJ=)Y<_NM8A-6BLRN@H@4-VP<GU'SO*TK[$(4M;MG-O+*V9LZ
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M%(2M-PL6%<<9;H6N($UF1P+5UW)(LRX;Y8N2V1-$1,\A2R@(ZKB "T[ETU2
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M-,Z$R&)6A04DQB_*T80ABKL2"(EE"GH.H)5 !@( @  10=/0T MP,@) KBF
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M '[I'5N?DP.=) 6EFH'<(WC#';Y&7J$GCZ"+C6,*</7XZ6'ZKZ[T>$&QVZ?
M=J@^]_FH-OKFH-C[_P *@\8/O#'A!4&QE<:N7FZU!M]S\U 8"H-C[;]':H-C
M3VN=FYMXP;<>I?YO4&Q4'WO\W\(-N'0P?P'_V@ , P$  @ #    $    !
M!) !!()!   ( (  ! ( )    )(!(((()()( ) !!!(!)   (     ())( (
M (! ()())!!)!((!  (   !  ( !) !!! (( )( )() !(      ))!(!!()
M(   !!(! !))(((            0YP"0                     )*%96 X
M                   !C7@3='=@QCA@                ,TG      *,H
M                96*0      +6O@             !*6           _
M           !JF           !C             +@            !F
M        4P0            %\0          #D              #$
M    !>     @         'T         +T   #86,         )P
M \    #XM@         )         (T   "RY          $<        %"
M   /W<          !X       !L     (H@          /0       .P
M              .       )4                   (      !,
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MH  "(      1,  %0@"2AKDP0  !=    =     *T   (F/+V-OLQ(  +H
M #@     ?@   XB$+'* =   !=    (I     @$   ZP D8@$    +H   !:
MH   #96R2@3   '>@    !=    !#I   " B $ 'P$&8@     +H    !8(
M #1$VF0 S@3L@     !=     !2Y$ P@RP& !#Z\@      +H      )S@$0
M 2$@ 4:0       !=        1(X $$$&M($        +H        9-=4@4
M'92         !=          0!+Y)(           +H
M         !=                  0 1(     +J 202 2"22"0 20""2  1
MC@    != 20""  "02 "2 "2 "22 ;__ /\ _P#_ *$D$D $@$@$@D@DDDDD
M$D&$DDDDDVN#                  "DDDDDDD:+0D @ DD @D@DDD@
M       !J D @@@ $$$ @ D             GH@@$$ D$ $@D@
M     3                           /PDD@$ $@D D
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M_P#0=[]E_P#H.]^R_P#T'>_9>5!)D00.5M$LL#/&U[&R!D1R3(5("K>2$&@
MAM%KZ>'V^@]Z ER;>Q3EYOK^DT+,7^:P3?$TD6 YA'K4=O+\T.)A>W^34]SS
M^*GN>?Q4]SS^*4+L7T;Z\*[#78:[#78:[#78:[#78:[#2K96VK;3A4]SS^*
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MYN;-#ESK#M!I%/!YU#,#6YF.T0M"7PR.!>Z(QQ?BDH4[,=+IS%^5")3=3Z7
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M=T_0]![U@\GTK/*6Z,7ZSY5B\_8J)>+,L\"KD2$S;G#MH8Q(3BD&]K>A>.M
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M%399C>,",JB5HQ$B(:0B6*@)$CD1$+$W4/0'P019 6A#"B"!S0B )2E 95R
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MC!I3D>SC7(A0]^%H@WNZGT!7B$2_'OC60!R9E-YV;WL#LE$ $R6<1:VFL1^
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M>YJS\A[,4_\ $>E=I: WB(W7V- ]-*[]?IZ>??\ R*,HZO0:E!;LA+$2$%V
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M)S9;F"<Z_P!=,EVP,N(F*&ZXZWT'7CZN[_8__\0 *Q$!  $# P(%! ,! 0
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M>6>LYK2--M/L-8S\?:ERQLCVN6IBL$ZS_E3VR\OC_K4#,81QY7\OU#8\"H#
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M:ARHM<H%* %7-0HQ 6<*T<*>4@'<R2<&!]!H!OI!0+BDTTBPB1%&E0*4) X
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M[*\OEG(15T A>B!2^77W,HJV[!/ -*Z1$J[!)C?!SV2B,A) VHH88.&E7!8
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MGW,IY/N93R?<RGD^YE/)]S*>3[F4\GW,IY/N93R?<RGD^YD ;::=E-E-]_\
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M-"R4PAEF#_O,FO\ .+D^O3Y4?YQ4?5!T6<'#PV$X-63B>T\8%H(IP"@;=6
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M)-T?84:^OQ*7+/A;AC1)O"J^%Z$N,MIQ:K9":8U2?>K3&;F&UPM<=F*9Q*6
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$_P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>business4ba.jpg
<TEXT>
begin 644 business4ba.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !@     0
M &     !    1TE-4" R+C$P+C,X   R,#(U.C R.C T(#$X.C0S.C4R  $
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M1T(@6%E:( ?I  ( !0 ! "  *V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
M 0    QE;E53    "    !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_" !$( @ $?0,!$0 "$0$#
M$0'_Q  >  $  00# 0$             !P$%!@@#! D""O_$ !T! 0  !P$!
M               ! @,$!08'" G_V@ , P$  A #$    ??PUB/+ W?)%-Q"
MA4% >3QZQ'R?10'D\>LA0XS0XSPDP\<B=3V$*'T?(!4^CZ
M    .G)'MQA68  !'QH>242X;#@ H1^1\:"G6/80H?0!\E3[/H
M           &I9XNF^YY%'L4>4)Z?FH9M$:2D?GI@>9)O^3&><9'Q^IP_/*8
MD8L>TIYRGK^8<:VGD$>GQ&YHL3L;T'IT?8                 !TI)NY-)6
M,0  (?/S&&>'H*><QZJ&HA=3 ":R%364V2/1TT$+R7<^C.#80],3Z
M              !HB><QWB*C)B#C?8VH-(C5XZIG) YZ)'JN?G@.H?I]/SK&
M)$]GM^:3GF*=,S@UN-]3=,\/S;XV4/3T^@                 #I23=R>2J
M(  $0GDX361X:1GI(>4).9GQ["'D <)(Q9B,3=P\7C:8]="$STU/H
M              %"@ !4%"I0 J4*E 5* J4*E "I0%2A4J
M    =*2;N3R51   ^05*    %0 4*E"H*@                     MI@!)
MY]  'R"A0^RH  !AQE1%)+9]  'R5*@                  '2DF[D\E40
M +80J3T?8!TR,B6"H,,+\8D2 ?0      /DJ5                !Y7FA1Z
MF'*:YEU)%+T0H7TN9I8;W':(=/7\\U#%"-#9\T8/0<\8#UL+V:?%^-B"""&S
M<4J8@882>1Z>P)]@               '2DF[D\E40  -=3\_!L0;[$4$IF6$
M&F,D]%X-:C7DXC;LE@@ FXR0Q@B8NQ:B3R"B5RQE2+B/C<0R0W]*@
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M B%0@1(  $2 !$  @*0C6(  @  1   ( $0/DJ50(@  =*2;N3R51
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MEMY^E7HVJE5QJWRUAC=]:::L(7>I22,(CE^E3RV/PN['+<_,E3]>MM-OXF
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MCSMU+K^DN52AO.N9SG<9?;VGS3R6BUJV3&W48ZEG==>.;Q%O-=K^:4X
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M3@>8>8O"6MW%;2*G0+!1D_5O8;/OO&X   Z4DW<GDJB  /S GD" <YGA4
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MMD?R'Y"URT%B=GE[9-D_U!XW>=[9+H  #I23=R>2J(  _,">0(!SF>%0
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MNFCR1+ZGN86]:<<D'SWX@B;SSI$*4]_MEC&VRQ_5#8[GOJK@  =*2;N3R51
M 'Y@3R! .<SPJ     "J'H+P?8<YP5WY@>E]44I4\R6KENU8*3M[UV2MRP6?
M;/B<DRUGT(1M-"K8<;=0'Q+?,LYMM^ME.'H3ZUXG*-?GVL?E7T]JSC[ZS
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M25ZD($HS2'3FSXO)W98YUEM/V^[%XXUJY_Z8TWV3:-HNN:/YV>2NVH$",0
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MZ1W;0UX(]+899=X#V#['X1U$UWL<=<R]6:PY*Q]+_7_%O//RQUO"M5S1,C*
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M/FK+:[>YP["9?'ILM\QJHS?,(_KU4M_8Q   Z4DW<GDJB  /S GD" <YGA4
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MDNMX-Z&]J;'?+_J>Q'AC.:X_1# P+[8\CY;XY\7P]J^RXQ2O?TI8KIF\\F0
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M$:Y?0[R]*'B/PG&>G5\2I9K]%F&ZUN_)DP  .E)-W)Y*H@ #\P)Y @'.9X5
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ME3S#XZCOD&(B3'Y_%[7,_IRL-_WKA=   =*2;N3R51  'Y@3R! .<SPJ
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M,WAWWFEI]R^OOK<^B=_AOF3./)_FC!=>R]WEUZY>ENNXEWOWI/?S\Z9'7I[
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M8  #I23=R>2J(  TS/QREI!SF>%0         >FYH 8.
M8R7<_:23Z8<A^5^,?.*"M-<[C&SCD=%V0RFCY;F\=@UCGH>Q.<^J#8/)Z5<O
M1748J]4^K^Y=YZZ\:X;*7FWS+KWRF]UOPW1H_DV7>66GHW-"Y7,;C'$WACLF
MJXK([K&23<XV0;FPR7(8[MRV>/6L>C;WF25,?E;'="%]&-'8X+QVYZ^V6ZVF
MVR59FP*A8H30[4JY->X:8KK4).FUCLS6]DC=W.M0D:YLLQRMK<<]+3-Y/HY:
M\Y;6TN.*QG>PMA\XJC:\=/CN.RT#8SH'NY9;]ZF27'U&(  '2DF[D\E40 !0
M\Y#P&(9.0S4J        #< G(R \TC&@               5)?/T"F[94H"*
M3&(0^II>PI=V:C]GQ"?JQB2]^:AV+BMT;W*437"TQ_%1Q_2I7-NIW7$J7]+8
MXR_,*E4OW&'TEK&3FC)V(R=A+R0AQ1<*;GA)V8R?4)NM"K;X5^C"LA&L7?2_
M!TH34FAV(TN[&WK&''"?Z.=+RQI\LTG+%]0F^:BJ5++\2U.*6:DE60X5[NJ_
M:%40  .E)-W)Y*H@  4 *@        %  "H               * %0  (0%(
MQ%0A1 (3 5C"D(D$1$5$%"L1"B)"L!&D0J$"(H"H  "%$*H@A1$B0JB0%(*H
MTC+5$410A6*B-0  #I23=R>2J(
M                                    Z4DW<GDJB
M                                                       .E)-W
M)Y*H@
M              #I23=R>2J(                  'R5*@
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M"2ZYH27BI;TEFY)I<!L\SG5YB*QD0FP&WSG<JV&836?U*QF6\RNK8<D8@
M         =*2;N3R51   'P8V8^>4AZ7DW%#4HVW*%#Z!0U)-MP ?)]%"A]%
M "I0J?)]%H+(9B5+01\9R7\X3'3+           0S8['$UOL6W.4YSYBZMZ"
MVDR>C^=.L]EQN:]F6O@;5+5@:WV/:S)\^PZWRW-+/UZN/A7%[YO!L?(=1,#T
MJ4LCJ^'VFR9]7PT16VP>O^X>8]&<+V#&Y9)@JXF.5UAU+,S;<:O8)+K@A7M\
ML<+M\KZC;-PGSQU_ML7T<CLE>Z;CLUQT+7*1'5IRM"2Y1M93O,!MYE^<?<0
M           '2DF[D\E40  ,?/.T]'""SPH)E(.-UR)R9##2-C,R,B4#*#<4
MMQ"I)YJX74DHZYEY$Y*!@14R0CXNAG!N$:($7D]EN+48J2\:J'L.2P
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M*5\2Q^ZDB,:PC26":%($843?2-80I)!6A62:DLQ)5%%2I'X2I*GU&7[/M$
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M.U5%Z@X6,I K^1(5=UYS2PM@,VM;8$%_+!TRDF':91L4,.GQE:#BA,.,:*
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MWK9K!'LBFA?X<@F*+[YP975?]O[843#89Q QOY^X^_?G0QX;^4XVR[4YQ_\
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M)(=0YCY,;CLTCC^9E)0_BFJHD*$DX17M;))-7P#CFG5=)-OM2RM(&$^9&_\
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MFW %03SRLC1$NOFR8=R+<#YZ!@LC!C=JIW,4#=H,A, 17 HL4P*9@W-GH*&
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MH%11S_:L3#F,%.LK$HR9;4W3JKWV\/;X.XF4N42TZT<_&][WY V T]\"KDN
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M$N@C2)HW$3%KPI 487+)(AR76D[I,(3-;066H>V$IG21OK]IA$K.J3<K7[3
MI\XL^>OVF&:,^I._F4;PG#"G/1/O@X0 &<I(A^@.-).S2;B*-.SU(FT**UI
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MK2!]QZ/C\HY^'Z#;*-H=Y/ I_&,/8;FZ\^D,)5LB=5VX1(]#\LZV \I.U*=
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MT/#N*J14ZGAB3<HT[1I=<W.TI<R[.M+E&PLN/M33V^5"W"PU 24#.' #[O\
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M766Y6:4[=S*A4QMF6Q=10I*"K+&*-L>EO#AG@\JF[:5V6U4OJ1F;S92H*5Y
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MNM;$HU264,AMMH@@&[:4F^O&%]*N/5HE$*K[UI%252Q$M))4@H!"<RTRX4Z
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M7DH$9^[4 Z^Z,CFAV*['L"E 'N[1WP4Z;I4H_P!TW'AQ@A80;MN CF4*%_=
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M2&?*!:I,Y4-+4T%M@;.^=&JAK9S"6&Z;@_#,S-R5\15ZK2FHFG1_[3,'/F#
M6$'R>1M2@D%*W <W"]5PGT8X>Q30:+/TN>F5UN4IXRMSCZ699V<F%LIF%.;=
MMPG-^<;"E@(0C(V%E6=W!?1I1<9HPI/R<]4G*JL+DYGK+S+,B'U.)98\FZTX
M]DV=@5)>5=2<[GGE&%>C7#,UC?%]#K##CU.I$F],RJ^L.MK9M925J+2D*7E"
MK!*O. US&YBDX6Z/L:2M<I- DIRGU2BR#LRS4YB8>>^TDL;H=ZL7=FWMB M:
M-BQ9+@#:4&X;P)-X29Z+,1-N4%;BI/K"*NDS+@7./-R;(?=9=S@LH<%DI0TM
MM((5H+DG!&$</U>0Q%C&MR[RJ!2')D2]*9?<#SBVVR^&%.IR.;K:FDMK#PNN
M^U587-0PIA#%6$JGB3!]/F*(NAK=5.2LS-.S27VFF6WUK2IQQXH4$J\D04YE
M!25IL4N)&%>CVD8"H.*ZS3IM^9FIEJ7?9EYE]'6UJ9=40K,X@-)LG:$MEI0<
M0D Y"IM>(<-=%U$D,/XI-*J3M,K$O+_^S-SCN9#C[2YC;J?6\'<R4)V>5$SD
M*K62K548OZ/\,2N)\(-4IY4E0,2M2[SA<<6O8;1:,R Y,**LZ@L(222+D$))
MT.)<"84I J<N[A6=D)%B44NGXDEJC-5-,TXE(45KDF53!E4\1F?;V)RKNI!V
M>=U&1U64Z;2R ."ARU('O /;&]<YA;] ]'Q^4<_#^I.'JW,X>JDM5)95E,*\
MHB]DNLG\XTOB"E0X!0*0H)58Y8Q#6YO%%1F*G..W4\JS*4D[-IE/YMIH:60F
MY.@ *BI=@50D^U&D='M?DL.3F()B>44HJ.&ZA3& $K6>LS*F2@[@-A9"KE5A
MWQ(S.QJ##[RB&4/M*5O$V"7 I1R@ZZ=G'EK"L9236,7ZJV7'*=4)82,W8+S]
M6<:92\$)5D(.=I)OK=(58$D6<E<#4UNI335<?Q N8EIAFGTQ4E.R2I9]TC8N
MO3)*6W=B+Y@$)"CY1"0I"1%*J=$F,)(HLU75X>F6JBY-NJ:I[TSUQ"FU)"5.
M2I2H)3F"0%.9;HWF]&E)KE;H3TEAV2ITZ_-(I,TOK#\RVX%J!=2LOA.6P;-B
M6V[[1+>1"@5!<8JJ<A5*\].R+Q?EE;'*K*ILDH:0A6A&86(4.'#@(QM.4&K,
M4^IT^I*<G4R4K+3-+5*.MF7+259E":/DG+7""E&;FH+(C"U7H[6&ZC1IJH*H
MT].3C;OVDB6<FEF3RHO*V9L]8+2I1LM&8.$;R=HDUFN4!& OX+TNI3-2G4XA
M^TE3$PPZTEU'4DL79"P<C>:PV;BBZ%A9U04*C$=2H%:PY0IA-24Q5J/36*6[
M2C*O*#X82$]8$VD%E%\MPC>.H!"#>)VK89J<AA>HO3RFYVA2TA*35&7)NNIG
MF)5QO:$3))ET)6VAPY%Y\X*0JQT)K>$E8FI^(7,5S;K#$_)3?V,S3IIL2K;#
MK/DTNJ4&5LH(S/);:SN-Y\F9VQ5*8OHQQ/B],R7/L;$QGV.M-H5M95$T\M3<
MR&SO$-(<5F1D4LG+9!U29V1P33*7,B0JZL05!YS9L#J,W3FY/3>?5M'"'5&^
MX@WLH"XRW,2N.TTBG4-FGS76&D2KU/KM,6%AB;EGG4*6RHK3LR5)"@EUNZF2
M3;.VIQ*T_P !$U*;V<Z^S)STL7I1\-SA<HM0))3++;3D,ZVUF!0Z%9MP(4"2
M7CB&NTM.%$4!FMKQ$XNI=>$V[).RRI1(:0V60N94MTYB%E.0Y;+7<)%L^%J@
MBDUJGSSI\@W-MAZ]S>6)ROC0A5]DI=AKO6T5%;Q?07<8TF;II,M095#,L^VV
MVMM(:=6OK;@:RYUI"%A64I"E+1N\;FJ8GHKV-J#/2CZT8>HJJ?+M.EMPVE99
M0*G R1M+Y+(-TE:RT#P.E)Q1297&6)YUQU::37$564;GPTL[-F>F ^V^6+;6
MX0CS,I5F6- +F,-U2@8==Q=+*J)FV*EAZ?D:?,=5?:ZQ-3"?)!3*DE35^U9R
MCMUTPE6*=2Z?BEF=F-B[4J-,R<FA+2G-H^XE:4H*D@Y <PWE638WOH;8*J<K
M1<2T2ISRRW*R<^R],+"5+*6TDYB$I!4K^ZD:BXAS&=!_PL)Q7UA2J+UT/;?9
M/)44=6V?YDHVGG>C8=L4[I#HTCCC$\\H+F</XDVLNMT(<2XAMW* X6S9PI0"
M[F3E4L[I0.(+6(\!8(IM9_@G59NO5*M2O5+3,J]*(D6E!>A*V&0YDS[UB2LA
M"1DWEQ259J[2TJ&\9^4<'9^?0,O9[?&.D5OH]7B;#\QB>IS5,GI&DTYY89E7
M9EF>0V^ZI+*MDATHWD+SZ-70\ %J/YMKI-H<QTE,5^9*V:-3:=]ERBRAQ:WV
M6G2IMS8H25M[3.=U6\$)25A*[H1A3%]%I/2;4<33;BA2IB=J$PVL-.DEN:FM
MJWY-*2L;NIN+]H[,,8^I-'QQBR<FTK?P]B9=2;4M"%9VVYR;<<:>+>CF5#;B
MLZ DN;PRI)T,MB3 >"*97%X3JTW7*I7)5=/;:F91V53)-K2L@J4ME@.9<UEA
M-RLY  @%:Q*XLH3713/X9=F3]N.UCKB6 PZ4!D+;)\ML]E>P) *KWB35+)G&
M'I@&8EP\A;[(46RIG,-HV%BQ25)N H:@ZCOP]C#!6'IMBK4W%]1:DVY%+;F$
MYF1GIYDO!/F(FIC;--)&E@WKG&CVQ);CHKKDS4^DBKSLO3'#0\1JGI><R(M*
MR[,PI3P4^4I4VEP)3DMG2%+?403I?I.K4D[C^5EY12&:/AQ<K((2C?;0F6=2
MIU20D$D)0$H*1=69H@"\8TQ=0*OCS"M:D)I;E.IS5($XX6'FU-]5G%.S%D+0
ME:PE!!&4'-P3<Q7<9T&<Z3*1B61F5O4J3<E=N^IAYM2=DZ^IP!E2=H<H6G@D
M\^<8#K-*K_2)CFJRJ3-4J8HCCJE$.,JR)0A*B4+"5\0=+13L1]'V"VZ]5,/U
M*=GJO5)5Z5:IS\L^V),/*S;/;K92@ALJ"5J4XZ2EK<VBO/Z/\7X;E\.XEPUB
M2<>IJ:R7WDSK3#LTHJ>8;9*0&D.&^9!5F4G+O 74;Q@K%F'*7+XBPC5IIW[
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MANG"I.F7JA,Z5]B,^,*$*3"DPZ*&$@UA$(3"$"$H$(."%O[P81$M(E1Q'GE
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MX3G2NIB6^3S:L^HJ;E%CCW8<^3U;THA90PY5)^SRB].S2\=DXE.RKF%/[O\
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M_*W3>(*N[B ,73GE.V;+MM+[+830<J")69<*4U57+/(0R$JSH*PAM-82 !E
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MUK%HSV^=J%<(2I15%@J_E#>+[0^,7 1\P@-C4"L7NNM^<I0]C)2,Q^]2+$N
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MRRD*< KK'YWEI=-!3*%WFPJ[ R]435YWUIHCW0Y/SLRHJ4XH#2E85A&:CB5
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MS]WZ'&%*"!#D^TWV5$8H7,EW]68E4K*:KUQ0,AZOV/BGQA7?/\/WQ._KW?\
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M>'S2#JPT3V6B,NUS44@T\2( *22= *1>IDKDY9Y.B9I!/K!I\#Y,3MJL&RG
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MFG,DU!H-<Z4%:@&2<9E9F12Z7Y&94IM*PO&XAXG5PE1& *((H,:2,LJ$F?\
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MJJIIA!A054D:E-/PAJ1 1,-$'#,+67,J5"Z TSZ>WPCT0%@2N>Y"$MA/'"D
M<^G^L/V6W,2[;*EE*&5(4SS0IK(*US-*\<JU/"%61CETM*?-&UI<;R&2Q7/7
MJ<N'/F+->F5I]*FBO<NI=: ;0@8DG*H2<]<E5RSRSJ'K->2_OFIM2%K1NUU0
ME:5)-/JDT!!XCAXDJ;L[<L.H*RXI\J+JL.'%BY)!H!X9?<91+S"6G.ZA"4(
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M4Z0G$/ :<=(K4D!&>M<H0%I-<-3XC2#VLRG3KI%,22D=FONAM*D A2L0^[C
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M/E";*?6ZVIUIMMP9K6DH37^RW[ZA1KIA!-64%#8!KIES]9X_L)U@?U(__\0
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M5&&)!:2,&*17R1N4I]D950@062D<!SN;7J@JH 3RJU.U[<E]#:_+O=2*N+6
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MTGF8JM1I50LLJOJ JA-J,]E(E/'<(V2-CVMS+#V;([1'093HKU7CBR+3?;=
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MO2/-+N\>G1YH:8[M-2QS8VV')J4R2NLKU0^B6/6/@/9OYV#<K#J=;B7&.KI
MW-(E2[2[+M^*E:G1NW&_;38/<Y%[9(W;:7*FSS8M3Y1[XLNF4FV#4>COL^#%
MJ'[-5^M5+3H=*SERFTRF21.6:@'0BSH$09=;YQ&MUVW=7*?:-H@L>Y)L:&];
M:EU!:_;O;!BR(9*MODR53Y:I&:1SQQ-DTC@N:IXI'# 3DXHEN4.FW$&\BRQ'
MAO:9*C**.138\*-2IJ5&+ ANE/G:22IH9@(Z9'<W0)[7Q+(N_DZMV;5;F@;Q
M:4"VZF0+G2#E.R.RHU.9/GQ'QP+'**HD8"$HD$Z6)' >-N'\EW*=;=N4FI3J
M0:L463;DB2\3Q"&4[1&WF?/21M0QYB;9FY/&6&[.(\1FE;=:<D-L6?(MRT)Q
MJ6:IW;+J#I5P3H[7.>*C@I<N*R.I=#MVWMQ /"2,8TF.\A(PJKRFV[2842X*
M+5H5$J=%K2'FPHE1)4(,>4S.'*ILHH7Q9K#Q"*X#VN79F$[9N<2V+^JO)];<
M2P:T^D"(Q\V06XY"3H>];V/851\>D!J+!'/3@RX51)%:H(TXKSO1[^2Z13FT
M1E EUF >TG.?4!5"75Y':HIPW"-DA ]K$(Z*@VQVC/LR'17N7)V+7FW#1[9D
M7U<-6?2#LB2)T>SZ:Y'22,FO/(*^8L=L-L12")*"NHDHVW:.-LW"I%VT2SJU
M;]0ISIU.OWDTG3:A:PS-17=KYA9\B01QR(QR(0;@[)[XB;*0.3MF?Z!HM9Y)
MI3#&I<PC[@MS<J1(-6X#M@\2QRU**8K'1U"<)003QY<@4Q7QU<>.-,4:AP.0
M6LVC763X9YEXW+&) W*(P1Q&ALJDRCTDDB U3)+>C3',_=6MCTI\AX5;9O*1
M1K-N'E I,6S@6Y-90PGF3]]CPYT$Q3LBQIL@".$:/*0TD&P.1Q I(0J<V?>]
MT6/4[8@U6S7L!F*3-@1&("FQX<*=6VQATTE9***Z1)A!(U\97;N]FV 5,<MT
MFM4.L4B/5KS672SU2FS8 :E&6I7$_>(!980LF T'"[:Q];-)1N1W.35RJU^7
M0ZO%H=1H,44"LR*9.!2)I4%;.H<.HE V)**U0'16A,YWH!45B:7:(G+#0;3J
MM\T*JT%M#KE,H8UDUJFE:)D5"Q8(4>8XW#CPSM)L3!1=]"=\5'1C+4N6BY;9
MGV10:?0NTMOTNX&[K6SKNVP))E0W:210C&6<4KI#!IG(CAC+(:$YQWM6*)9M
M]W';E;NBLDJO_-QRA#LZPZ^-A-9 "MNKVM.J=0"]A'(0KY+E-M'! (#T<U+(
M)R86M<8[*MBX^T5\\G]%))=5BQ80*<<<(1(JOE5:'L#FUF4)I#I<N-4)<-#
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M.P_N97_[T8^D=A_<RO\ ]Z,?2.P_N97_ .]&/I'8?W,K_P#>C'TCL/[F5_\
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M.((;F)Q]$&%'=#,DX*G5A\ZI'VTAW#@FD8VHJJC!,]8Q%55R[_'TSR\&(/\
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M#'(P8F-[ISWKDUOAU<?%EA*S5M#I+FH0KW=)"=+0"SX['J;EEKRU$U<,/HT
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MD 80LS7UHQ#:G0C4Q"L*RUA K,BGOJ]7K50$^3'H5)VJ1QE##8K&S*@<JKL
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MY=C(&4!=F5C7;,PB#=ED]CF\,4OE%Y4*_P!,RH1ZC6>U7_Z[(IL!FX6]3?:
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MDJ7(%%B@8XACG>T8AL;TN(1ZHUK4Z\U3CEQ3CF*2+:;(XV%9M0ECDTO1')K
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M$$5V\,;*?%)*64^ 67J.2&X#W.TN:B?NPGM0?E'])GS(4 M5EQ8<F1%I@"A
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M*:DVY?P[HI-.I+(3G';39U6M^:)U7292QJ'>8L4$L4L@](Y#T<0CN3VK0JI
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MDC@V$\M40*J"^LHK,)V-MS2E77"DB_E,@*VOO1R6CBI\\JYWZ3ULR4SL;,\
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M%.L"[,'#VK%]@<YV<,K3EKK #'EQ)*&:W0UI2,90FAD!L9P='&Q^8.H9^:2
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M -XQ2S@11#34)L.0#"T86"?GN[=J0DHN9G/?,U-/],S$Z=?;'&<P1>YW%_\
MDB_O\ $_,_?A.WR107%+;R\HELPM-$\(<#@-(H$1A'_%JYB6(122+%,K0=FT
M!_ &^LG5XR$3;YUZS&3Z2AP.&LD(W3Y1<PS70;$4:-**2?T^29_<_G9F)TZ^
MV.,Y@B]SN+_\3.[<1I(===<0&NF]@F\72\CP<-0YS6B)8J+I(328ZR!Y)X5U
M@P$<#"@^,)E=9]7M 4E/@OVCG#'V*T98SKH6B)(N!P%"_L[+UUU7_"B&$QWI
MR+D,;CBCKJ<5F2=Q8;$S\L=M8'Z&,]N;(I#2JTNI!#.L8/NX*FTQ4F<,ZR.&
M2$H%$G/(A-TGJ&J#2_;A[:N*Q2B"@M>&3,] @E3J"&='6-8VQ(0BR!I7!;ZQ
M:O4.%>(D!Z/%]**&.+-,.Y6LE2UBU88./;#\1W)M]RV>SU83QH!.E "^_,L$
M)<%G:PRP>;4+4,CW8.A,&J"YACI0 7V&MS[* H(*S\JW @76L7$G_P".)) H
MKH143<*CJK<@,F+W<9#Y#"J&^PA^;Y316+U3PQAH^IY/0*@B-;\*$,4+#VU<
M0KX=ETVZ##X<DWX2*AODA$Q%TBZ[_AB_O\'IN+%F:<@":5@S0W6I[DZT6[X4
M,@,I'];^UD[SZF'K=:).K$0!.M>JO(U3RJKUU7URE[4R."*16(B2244I;KA"
M8$,PEX!F0:31,\*I7>8)U$3@+I>"J_$YOIFBQ4VZ'N9+'K@9")3:V01#-H&)
MOF%3KGIU&#!16ZE9B$I8 F7QAP12#&H\0/ M5Z\Q4-HL)#:*T:\YC(.CN,>&
M_LZYO@M2%V.^@[%IPW[R3S^)E GK8DDGJQ#'7P9,,1;42QVCQC3,NF!TWL85
MF3601R@\Q9OUJTI(1?\ X4TMZU52UM;M*YM:OPM&P+DW>;05H%E.FC'LKZI4
M>5 QVT92\+X*'OE 0LZE AF,5@QFE$D7NID!'&SRA"7DJ&0C@>UI^M*"46,]
M]]=F33_@M!(Y?I6TGS20DE)*;X=V098&%80.OCQ=E%<97_[0LR1*"S&?"I'D
M/*8E>(E0R<_0,2(%0^9#L^2D*DJ<C! ?&^_'13XM^TN"D#X\M)Z4B 2V!J14
M+.<_TR8?\\)H/K]L%O9R;PH9KR++@SZ%1A5@4&FO;,;>>BU78C*59Z]+HQJR
MP;B^AVP/,B]H2*-"BR2KP(DOI2M@T"9-/>':I8_%D)L87(LB8U(U;<Q7&0 $
MTC%0D[#N$_"VJ4\3:+Q0?;,6 / 5I>7M%KKG"/'/-9" )%ZE*P/Y+2!J0("(
MP0#4H#S*]&M'Q"X@/&)"3Y!4<<U5TAL3XT-14=QNI^8#Y0X/DKIW?;F*3IHD
M,*,XW$.D<I+;@O0?0<;FU$CWFNM,-<!_"4A8L)MZ)5KF,AH;-5^,$WI2B%/M
M9&?C0_7=/Z283"0)P)F,!_PA?W^ AR?*!K$ONAQS/NVG%!8,4"GM??'B$WD3
M 58$"RG[^ PA+N^W22BU-H=P63FEHBD#"<6K<>6EI6-4B%%-K]&T7[&5G:48
MPIO"4P!NM [B+62; DDX- 2"2IHK23RI-L>9E THA"/4N)O>!X**]B KKW\Y
M*E30"0$P*-UX+I.\.K3<#:ST",[*GH29*CF(0TRIN_?I*-@I="LMH!%2.DN$
M.9$VMMESR7C)WI;2-$0+%6 YCJK$;J)FP*2]*X*V1U(&+S<+ LY3&7R"Z BQ
MQ&M3/1B* L&6!$*0D7;"L\>!,TKQ(J48N8DALT*H?MR^!M[_ $)F@S#I#[+.
MS8NH(1D"0XJF<)R8]XZMLD@.WW(*J,;FY0>X0>BR5A#SAM#(%)!M9L8*+_@D
M.29$1PCD39UWJ#;N9][\Z@\Z@>N^NG+A@@C!$# &<6RR\V[NYH P1PTS.,99
MG6M:/.7%[3AFZEUA;A7$*D*13H<YB#:FTVOU,?>@3$K78KGY8*;):@]KZVQ?
M/[US4=R]]\"K401V^]^:N5J#M>?HXVTBD-GO^-S9!+A7 C.+1.8XN$7OFN :
M8MC&-IMLW+U#8WZK=SRG,WH @(#32V+<((VBU0Q'?\(Y6Q4-NNOGFN!JOG,_
MHXU#;X==3&7S=VECOWA+78)<(SG0'%8M8>?8DX"D!IVW][\Z@(MC'"T>U%U.
M@@T*Y?-5K+JY16<70$K@8<?-UZYXYF7*U#XLI[>CDTBH;:SUF5ZMW=OFN!??
M737.AT T*AM'*V6=.*L[KNU!8((B#$<#!C3%]VI"(X\9(AG,D$.1!+A0!BWM
MY:=-9<K_ ,,7]_@0Y!C'"S(V84DT7?P0<Z3Z]^YJU%IAGKB[<67*2.:Q6+7.
M%HMM9?@6J*X!KZ_5N5L5P,$&X6L.0LL;&U01$6[]M-H(Q6T1FQ(79P6F;CD5
M1)3![<[;N7YUK@''CG.^5O-U=:A,Q>TNK$Q.X2V:@[7WS]6K@3DO>SDY<,8M
M8J':WY[QI,QI4)F+WOSSTQ;%N ASTO?W[N[M0V[+G-$LY-*AMW]WGB9F:@VQ
MCS'T0C:+5!$!LX:6VM;X+5#$$=_%N5L5#OCW/.^:AL6L1:#8V*AWWZ5PC;HV
MAW(M&(#8J%[9SK//?:^EL5!WSGWJ'\DX::Q:<E05!WWGCG&U!&/^1!W\[]:@
M[[]:[\[_ )H_Q ],>W_,%_?_ ,9/^L5-2?XOMZ_\UG3\8O[_ /B$GDZ+HZ')
M A;T=\ACB"50M<%D)3*+[7 #M"LPQ^Y'6+2).);C6R]8._J!)YA:E RUBYQT
MSG3HP8;=CKC%&]/=Y@*\ K&Y<O\ $_W_ *EFF28XW4HNPP?*@6&27&X$3$G.
M1MW+.9?@R9 D3)TZ2?XXL+)X*O=\*S(O\$*Y,D1@XFI>P]GTU$))9(S4,V<L
M/#U$V_R78,.@WSU8?$%T[-H^$6#_ #>$\)0MR\()D\&1>)<J]U-F\@"03@S)
M)B8E7RKW%RUUA]@WJ47W]K29@4DE6&^Q^$7]_P"TD8CB,9+W003:+DA(:G^R
MMD5PNU]N4D>R0$*50%&00H&Q0QYN%#FYA*2TE2&XF@!RS#7I7DS^;3ITZ=.G
M3ITZ=.G36U%J]="R!2]86HX*]) 0$JP2/\4Z=.2TCP],(\^BA\AVE3D&Z:5V
M1/*5[\_^%3ITZ=.G3ITZ=.G3ITZ=.G3ITZ=.G3ITZ=.G3ITQFQ10&03(+-OR
M(H?]8E1W;:*B/#KFQ,(%FALV1"DG$Z)#''WN"%@!\'T@4T=PW4^$ +F1K,7"
MVBA40W6OKO/E-_/=HS=#!1(W]: LC W%J\1QZ*<F56!:MN?5$,='Z5"M9T#[
M>M1PC@>/"EWCC4IIKZT$W]:YGK7-]:>)Z_ND.9\W]U,RD\6D02RTX=3!K0R4
M&;YNT(/2MY]51T6H[JCOT-2?U7<6H]FM1+\:9%TTBYG?^U,R]]*6>[VI%A>:
ML9/F_NK\D3QI#1]:T7N_NI<?6B6)0O$MZ$[FBR64DAFYFA-O?ZH(TCA4=_,_
MNH1]OW4.S^ZCOZJQM3-ZW!YUG1ZJAT?6@8'SKG>=(:FC3,#S34]WK6 )<VN=
MYOQ%<WS_ &J/&.;1@Q55U\BB"XAD;D2R,!K">OPIZ?V3,[]SL\/X?@%_?^VN
M2$MC'"R-A"=F4%0#4E(]+G+?6>KEZZ[TJW67=\"A^O8_+W@W';A2V$!7E,%6
M%P,=7U62AE9#JN@ARH;[QHAAVM2>4\P?-"S4+"[=8A3X(<N3,!,+$7<U.IH@
MLI.;%W+0[V<08L-S@.@A)8., B)9R9.&+)_PG9P=]S=@I S!7J/NSNV)<L&Q
M4BLDF#0;N3@UW:%B5=(KB@X B@';/04:7ZMI"'02.2.#3BT&C)AH6W^:E#)P
MX5+&&YP*=:VCM:B&PGAP*O(:X*V46L2_JDEPO>\5N@$*_A21\EKUQ5-&[5Q)
M!.Q2O_/\E6PVVN;7;=U>7E3R\!2T3TH[#H?KP_>P!,T)E;8^V9%M'&CGV@7B
MJ<)!3_0+PE2>/#^M&_;9EL#[<\<NA'RO"[<12W/"!M=X0L!PM75B7:N2L--9
M)T0"4UA)>LAQ]YI#"0R:0W=A#\35CF)M!&.:U7^]2Y%2CB/!!VW/P6&GD4J8
M/0?JD LZ%3IZXHUOK@IM_BKJA<O6BU^E3(+VVXM=[5#F*DQ2>ZEJ>*(OM02%
MI BH7_4^6SQ*9/6.Y9 :'A,*FY/]#IPSH2$"WX1?W_N,!% :RRXI:*26KF<S
MOGKQ]\_X:?7L?A?40@@P+3LO?"&CQ)$U! ,""2YU@_GL2[(A"[AL0S-)$HV)
M))6LN\2FP 0,M"P3P E6I0&XG;$@@Q?$MT1Y!R!2%_%\/-29SH@ 5+V,-VPO
M3B5$A@ J2H9,C%(I?BXYX7H5[B4"B47: ,8JRJQ!@ "D4B&HB0EP@T *,B.)
M'7A*>,_^OUU=V,!P=>A$16 E9X!9LVU((9R*72.$MD"+%E(A,YP@N&H:.Y A
MTMG.,DE=7GU_99YP<O\ 'K-!RFZZ!</,\N5"IDLXA7"YF9@U/E[[UIRYW TQ
M1? L\ Q3-A-K:6>>M6BH-0X4#F"V->VK![?*@ 2^.YHF$,;1/*I(<T\_2E-W
MYLU+Q^RI<R@,F*D$BPUF.EZX).8R[UIALUJ]-FG*I5#XF3:8:[[MUVW=X248
M!/2O9E5QDPXF>)) $-J-?!P%<-)LE"[/5[S!Y]B#HN(('=DT. F FH.<I)+'
M$N&H4TA6Y?@88HS0 2E>#!C[,5(TL:TYEB )"TI89$4:%4GW,TL#=&5T%4D%
M1';>6YQ)DLYJX$'2#TM2!@/6@H1RJ>M1O]4]J)-7P50</::C>U*H%0(WCDZ4
M-A:WZ4 GS\J(7GZ582P#O2CE">E&N9>BS?WRK@;B5C))VB]3'!GU^J88*%0%
M7&I=,4:5F.$5EPB;/>]0[4MO7^;8)WPTJ)@5*O(=!>(0 ?A%_?\ NZ=A$"2%
M;[W##<PJ5S?_  T^O8_!8NV-Y ZK:^+7J VT,>6H4S&9%/!T8QBJ.EQ*449R
MAJ8,@(H2 &RL)L)0V:080-HK-UFKX.5S7U$S$@M:\UF(*EH$RDI!@2$ @/$Y
M$%5,&[E9NE254]\")Q6 2-S(7"J$CZDG*%H6EXD8"7,10S$'008"#-6L>/LK
M<V)8L,Q+9'.X:#">3*:ZN&T 117"J7$R!JUK]8^_=_ZK[9@L;H8WB4#',W1-
M"<K!9.X%67F(IPKB4D.B6F[JLM::S9-/EL4-B[R6;"A2;I.@L:VSHA<QT9O?
M6+O-X>LT3\=\*<W]V_GAGIE\("6<'A[C0A">?(_5 =BH3%PI;2@-S%*&RK.J
MI2;[()>G94/*-:)_2G$T6H+%OTI$"0BV=)J)*>"<P;N]-:II(.)NMRIXS@F,
M]_%$S%*]7?#+J?-=QT;X*L8=S\,:U+4+(;V5*R51@(<93]<*C'3"M&I.?,U)
M10'(UE[!%M3*B<(RP9DVT(10*VF6!F6 Q=^B:L0)A/3*M$/IBR AE/;JS&E*
M=1+5YW,!H.X=U!U(+ @;_"Z0J2%<-FRCJQ9< UK<.Z=!8O9N0\3F<G>]-QHU
MS?GQH;'=Z2=I5JW[7HA:EG#Y-9,TWX5,LTUFK2V#:L8:TEE'RH-P<:.\7VJ1
MY/3VH&PA<)CA2A1#_56P0-5M6FL8?NK4NJ_PSWBI4&T8HYS,/S0,IO4U.=>K
M_#1?W^2>T^O8_P ^G%^..\VK#%5[GXG) W)NPE3=!"PX="S<PDE1$\<UF:/@
MV@*%2;6B7J6SBYTFFMHH!$T;PF Q"3ULS&%E*2ILZU*3%MXM-M=^M?WK7?#R
M\!88VT>8V<ZTUZ;==E*.LA.B9P4-"'F%D>.O&(M$! ]OLE0F(2T(@+T@40K8
M5S<V11 8J.[X6\%B('*2$JE53)!6)JI<B;QJ*29L5B]1#;/1$A7EJ0L92 B&
MV[R0O?'KDGDQ_P"?%^XU.3J88)P1!>%*R&@& B(NIL0G: *5B'.F%7PT/AMG
M976_4 N*%GW/76@@*WUS\Z^[VQX^LT?7B@Q&5_(?BHU!'>U0P.2A;$TIYJ%+
M>Z)TT-\S2HA>DWLS:IDR87.7I6" .2Q^JE0BQC^5&Q.3%YO5BJSH,OQ4N6+-
M$\JN\-0W!;?G-<OQ3>%O:K4$M3AI7"8H7E4S67E\T+NG[GT:=AI/2+0\^E#I
MG0F4MCCM2EL<+4FXQ,"3;RK%T4@3PO)#).)8B:N@!RN=KR,R1;!>&[2.(7YL
MC"V@L1A%D$&\<3=%H?CKK4//A+$2S8=)Z&#%81C:S+I:31U,.LE)DBLL(!*E
M;C,U=@"(9S_(X%B"H$L_75<]ZF%I*]+,VBPX0';32DU]*$F2GZ5.07G46;6?
M6I%\?S2IKJS(D";4E(?=JMFC$@M4HD-Z2$P4R;1BA61D7WUI#, LO#?)&];&
MN[.*FP.;)]9HB8++.M,"8M#+K:[QHRL9MQ#M1DO!::N)B&LADZ4PF2@^QK4:
MN=>M_#1?W^2>T^O8_P WDUA&$@WV>"F9CG>#2@,)!0%9P78(2$)QAMDEBP5O
MH['.^S1-19BCY994\7%>68%"T>'!86<=NN'.Y(E=M05P+CI.M.?\V\FTMK8^
M:)]Z (#68&/VO!;22FV(SZB6]]:$*P):HP"2@"Z<,265@G:F3KCRJ*!8U-'F
M8:ME5/H$L 1T- 0A"R=BP!<(:!1:#&8%O2TNVB3<"H 88$M1E V\@3WR_P#)
MY+):;N0W6^/6A,5](P17.,3:9F@64*8*D4JY0&$BRIQ[1&6 E0#1<+(3/"Z_
MR!GJQT!&'S(7.BLKR73[LY(6Z),) @D#;P]9H^O%.*KZ!^*L?"K);2I!WBBV
MJM1.%I;]E+ &:'G1W+,#E14@0"Q06S@DXTB!=$#;6@R.8AT-.M%)#-!Z*"/*
MB(E-HTHX  L<36(OI%**208;DL/IZ42:/VT+VHK+R^:;!58!_>N1-)R9-M-*
M#@$!ZQ1.LV6OS\5/'T  MO%]Z&&&RO8O:I6!);;.=#AOVC]J$'P\<=E/6-T!
M/K?XO0K@)&)Z?VU0X@;,L8VHTG1<'*VZ4$*XQCXHPD9TJ>L]9II6K4TD%BCE
M;<J*DY>[4B!I;G,%>7:$5 EF]*9[%08;AU$8\Z5&.988?NI]X1(A?YM%%KH$
MGDJ]:6NJEV,"L,TS+80F;ZS;;%,' V7MB'6;TXQ<@RZ$4P.[T3$TJEX+>]'8
MTJ#49N%>K_#1?W^2>T^O8_RDE40H<A$#TITHAS=&G86!2J5:^N5K8QS]2MHM
M:XWPG?7/Q3=A#V/Y)#B<- TGH?/BL?(0[ZAKOK;$#AA9I2R9C#_,(1?=+E[,
M4!4;(;A;K<8WN7HX,!$X#Z07E47X1=2^[V4FFDS%6UJ022/!3SC)P9.%3OZ\
M;U@N'R3E^D4^7G!I[LHWZ\]3HKS**2=#C$29#+$4^5*"Y)[/_&?OVJ)S0(M,
M$QA:BV0%D,2@HEOHM 7I@2EM(ER"+(6"XBAHES+%V8COM5,NTB=.6';A11ZS
MQE<MU[:BV75GP]9H^O%!P3!Y'4=S:A0O1@0A=GI]4N+*]2:@!DH(WB]6 QI.
M,V::@$>@#26(N-BTU,2R@=S?K,=*O+G:+9VF:SP8.A#R*$= )=EH\6E8<;<K
M>=3\I%&YT<(#2A\,()EN^=\!3#-Q$U7:EE(TQ32$?+YJ01A5M3E%1%"P^-.!
M0^<0S2?,8BT<:$&S;E?A/U17W++Q[E-@$;)MC6^F]&/&UVCO:G P:4")>^[X
M4J8ZPL>]*+%LH6\6-21;R2QPL:%;\9#+THP+?#RVX4#"9JG*M*AMU^: &;<*
M= WJ=M?9J+;OP'LT?9ALI#)TY5K,8H\7Q1')YT@@M.9TJ-MD\A0B,O<C$I6I
M<!=;U 05,AM^E!M."8>%2JPQ=-.T>OZIX$XTGG7XI)-C,$3<%IV."H$ N=7=
MZ2B(V*W7!-.T.4'.K+L2M&+MJ=8S30C-7#:?TOBN!3[C\(O[_)/:?7L?@[\L
M>OW5I^XI!S*2D70 DA0[++O&MUP TTBLC P&(S6(-">\^L3.LQ:1D8V_R)3G
M'68*^R+CP$-H71SW33+UL:42"LMLF*G+G$P0L\C*CRQQQ%3@C%12UJ4"K#6=
M49ZU V#3>6M"G<WD+Y*"?*]>N89F95EZS_X^_1K>*V-7W"T!866?QT=*E''%
M)&+ .0!K5]W,YUB)YQ:<L<!!$01>T02LS;1+(4!#WW\[LK=7P]9H^O%)D[(?
M;PBRHCO'L**S?UJ;";B;W?U1J/"#D?%/+"-"EZ I!Q_:@51,]V8-*L8:+;#Z
M5#'.<-Q@67C1JAB2E\*?&JLZ4^(8FB(26ADI>EWV4;N[F./%4%C"]Z@Q5EH5
M?=\Y4>4B)G=QJRQV%6AN#,< BL!-C[4<2('ZI(XD7B-MJAC&)8?WUKAV6LH2
M19$ZJ1R:Z\6I9-=YFD%G1MJTQWO4SN-J$-DUZJBKX@S\\HHL18(\C[IJ9?\
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M*&!7:<S(Q=Q2,XH[FO4 :N,<HS[59#.P>Q6&Q9OY7I1Q'N2C=T,YOI;O-#1
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MU;8J34I";%#(9I!==;%0'E%;-CG,D)[A8F"/R8;DN(08"W*N@<@/0[<_D=/
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M&B5I;4:@A?LPXIA$D$39F)HP;/?=Z@4M&MZAUE/L4ZF18AC>D,N,.<U%G?\
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M-VHMV^:CMQ!K,>?K4 E5+2&VDU"L9".4<VB71&9IG^OFH8;!P_- GG7@4C0
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MJ"H*Q_P8*@[Y1[6J P=X]B/S0>$?XCP@J/\ 4?B@_-!_N/SB_O\ _$!?W_\
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ML045'&%B!MNB\N9$0903/YDC?I.QGIJ[M>O'1-,?\T7]_@$G[H@4#",2TGQ
M3<=1G;8]KC'#IR%(VNVCD5TS];S6+IR=:*-1$8?/(V4FV$60#23=WQDC,81H
M%$$8.*TC))6N#4F?XBFRE5BH?F6WSB?AK<L>]R;!3=5*LVEF;RQP"UNR-91,
M\?&57KAY$R<<!/DQ7:0"O,6;0T-!H%-YV$*>C@)D.%=LJ,#H&%%$0XH0Y^R\
M>8R&O!&QD#\[KQJB&G@WJ4<WIW02;#$(THR/3G<I-RP9*?3Z=TF]7P \,HA8
M,B@L<NOB+HE0UQ#%K*L+B>%V,O I+-1!F9RR#8)(%M&-[!%24;<[;[L\ %5&
M8E-_X) $Z2LL!Q(.!([;):@%)O,TSIY7:30)B%KK2L(0VXJ**YHLS,(ZXHJ9
MDO$@K& 9@"W-Z9='#.2SZ"^^=TMM$7^9M/!GZM'J6PW+E_#2#_U>3(J<(RY$
MQ!"[_P!K$4F)]>'SDO&60K!!:QBUCTMRH!UIMO2WBC8ALU*45 PP1):IF:KY
M0)-!0\3RDTQD78 % 3JK0SM15N>*V/<G*!KC1!SW=S!1X?'AU/VF5>?:@ -I
MI<T7(%M:I0#$&$PEX ]N6#TT]7<L?:PLLK4@LPB4R@.LJHHE_P @K4G'6F+9
M_9"-T947R[=$Y-(.<GRJ&4""VH.>2V1T+F3KAK,DF"O8P+03MM>D#U=::]<&
M5;:VD+- ^YF7:T1L"RB0C<R!6"NVE;:.<.L8&^V#TBC1]*B9!R: @0^)*0FH
MI>>2*Z4,(:$E_P"<+^_P14VF8<N<'.2U\R#D170[VR^0!XL"H5;3I$=)G\,\
M<=S) D3M )FXO91MK ZX3YM?K:)P&F+;,=R]<@1+NLASF$\07H<T@<*AIWVQ
M57?,8C <(Y-L#RFFG/+P^K":JCIZ Y!(]?L'B=-Y?!\ ?8/CDACHJ-VO?,6:
M[9!'05GG6;[I:?5QX6#FE:U/T3+T:U38<?!5OL! <)5,_4J61!2:>9^2<7+_
M )2GP$P2\=QR#::/2AU&.+ \E@K5CP6^S29\@5157&6L+TZ'*4)5'$AQDVU0
M8M=!4#C*.=BB+DR%3Y+295"]DY"W*+J$=U5JB4STHLD8X$J#K=8HS%)+6+XU
M#Q?3Y<6&C#/ D""^PQM4)P6E(/S-L,K@BPR:W%"(^UWUOJ7UQ]*HKGSRC0/5
M(]3G//KK)_\ 1B_O_P")6*/?)KRRA9;A@@4X>HL_+,)>6-H5 9>=:"D+CG$I
ME:'\$J7C)*(F8"9.)Z,0L3N&AQ8&Q*99!MN@+)')J!D!N@UB;!22Z)3"53 )
M&0$(MD)B-,%2P"KF<AB!8(;@W.!DF3.)C$+)*!N[W-(1.8EN1=6"9)E(Y.C&
MCE2H$!&- RL.QJ ZE(,(Q.AJF\8&&YJ@HL+B:HNA)&&!,@7M9LRB;!Q\^CEA
M-M3 ,+39F;6&U++-M+H$1@&MPN!#<)O8C"J,WW1(((<',!2.80+8+CS%H9U-
MMWE%;&!99(@4&H;EDDP:(DS:\)N1DA#DA):<)1V-T8-[,9E"0*68$SI!=)MS
M1:4M=BIV)W.3X'&-@+2X6:I18,XVZ+1,M28.3:&TQ.A'-X\*8\S4((ULF=S?
M%KF8)4:XP6SS119D3 6OV@2,:H06S:;A.EA022ZX;+:C&^LV+WTN?M%YVJ36
M.>+9DMQ"XM-Z%?.3-BS4702BPU@<E)PG(;(2ZH%H%1CI=UY&>#9?2AB%HO.)
MNJR(N665@A4]#UR1;IQ:!(R/@+%W&BIYZGJ1;#2L#,SM;<T#*Q*# V2$D3,N
M(X9,TGT0-O3!4'*:"6GB[M>/-WG_ -HO[_"D2-;8GBO0,J$IF0MCZ4,SX!1X
MIG:4BV!@JD-F4543=27_ &#&IM _*LGSY=9:80U)Q)K,V($UO@=8EH-["[IK
M"$W-^"V2,!9E+>*V4,4)"0Y(&F6I>,$<+9R<Y70=)>CMLQ8F"PV"908$HA$3
M*;:#""SJRROF5G?37K-]W"(T&I1+S+1:V;$760T.[C8B54B LMD#1J@U&814
MHT&@M;' %T4QK#\?N]MK$D\V[HR#@%\@=G3=V79O$.TZ@((PX7%3Q7--[QM+
M,V)UQEDUTB,VLR2AA:-@E91PV^%G1MJ9,,2M*2S:Q,2P3DBAL;$B 0GCILHZ
M3443 ,6XJE,;HWUM8!OE-H3(AI)<TT06\(9(;QAHMJ"<<5"63>T0Q"7+JQ29
MI1?@[2D3MJ";J;+6Y\;1I'HB2P3<5[%[2^]F9#4(0%29Y,!$L;3;5#*,D[DD
M(DF)D4VM9EN@W)51/Z)",XO/5XV0E1Z! "G5")1PVPRN%O0F5GY$SA0$!<6%
MX);9QJWM+*@5*TQ>W/JNM>W!I2EC@V:B*)>R7-362JJBHD)%,B!FX%]=A\CA
M1E.Q,<7-PA6Y-@%3-DJ2=ZCPT><G3F$ @S /QWM($!_YF X0*FSHD@U*'Z"J
MQP<)KZ6$E^GA_,[R<5<+B]Y!E04XB.5!U&O,MAN9ONO,LR6F*GS8KLKRBBS
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M8K2/-NWA-^='==(+%Q54968?37K8/%29-%?]S$\2C 4:S $AEDSI_P!;8F4
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M-@J==8%89Y(^B\74!.=-BJRLW9+\I8%(PA11G26S%5:/KF6P55BA854\7!6
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M$$$$ $D$$D@ @@$D$                  #X   $$  @$D $@
M             $ @ $@@$@DD$D D$                  $X      $$@$
M  @                      $@ $D $$@@@$ @D@                  $
M@   $DD@D @DD$@                     $DD$$ D$ @DD$ D@D
M           $@   @$@D D@$@@@                     $    @    $$
M@  $                   $@      D@ D@       @
M $ D@ @ DD@ D$@$ @D                $@   D   $$$@@$  @$D$
M             @@D@@D$   D$@@@ $                 $@   @@D@ D$
M$D$$@@@@@               $ D $@$D DD$$ @D@@                 $
M@   @  @D D$$D DD $ @                    @      @ D
M           $@                                     $&'I$&$!
M!!!  !&  ! !   !! $@   $@
ME$#/+U8B8WFV02P?JU*VQ2;SS22S2R3    $@   D@@      @  @
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M^9=,L*KQBQ)5HR,?B>"$+UKJ[K9(DD,$   $@  $ $@  FAZ !/]2ZG!:
M     "'1$@$@KJM^JW(C'\I?I$PSZU_V=SU($3>"0!$9   $@  $ $@  ""+
M  'JT;-9]        !>9D $@61;UF=,\D6_\Y+9"S\S3"PK;7-2Q[KJD   $
M@  $ $@   S_ ( !'E<0"34V0      9FX !(-26??3AXC<7X)?_ +RV4&,Y
M,UP3-'YI[(\   2   0 2    ;2  3PJ2V,6OH      +!,  2"H#^)OY;13
M1LX.N\V(+RKN;RP+:0,8N?@   2   0 2    "2[ $Z1NCE[3       .*>
M 2  WIOJ#[+2T!X_O.IE(&//V34T!WV$)(\   2   0 2    55S@>TS!V^=
M+D      $!Z2 2!'4.!L. 2W@9M:XV9!=_N4('CXF;#.E$P   2   0 2
M  U<$.8I4ATWT0      '7V  2"JA_U,%PDE/VP[Q1SI#=C$05QWY,L+5-,
M  2   0 2     "R $9(4'1XJ\      (AX2 2"0+VD2,_*G[34GA&=$;=;F
M1ZG%L%?2 4D   2   0 2      2]L,3U:/B=*      "Z,  2 ;9,YMXL;=
M;H/)EC+>:XV-D925XJ(8'RX   2   0 2      +\$:=)3-AEV      //
M 2!-3@52S$YMK=</#Z[UC[^X?>*BR##;#F\   2   0 2      8UR"ZR$R$
M9(      )E.0 2!LVWD?0#'0H/\ 28ROSG0?]J4?P'Q&QM ]   $@  $ $@
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MX &REIQ,    "D02 2!7%3MO;^#1&O9](/FVSL09\5<U5+UI]S0   2   0
M2  -$XR.!P%*  +*ZX0     "F 0 2 3X4X>'H+Y J+Q%?2CN=QNF"N.5)?.
MVD    2   0 2 "/1+.A,'A^=M0M.DR     "D"2 2 P+&/C=I!@@G5T%MSG
M?^LQ]3^W$&S6#L@   2   0 2""'4N$ %;>H:L!20"      "F0  2 11\\O
MZ\=R)RV9$*=<O[P%8)@3 QE,\+\   2   0 2"2<_NH  ]K7"GT@ 00
M"V0  2 '!.]WD)L.,60/''C'2B)8.8WEUJI'1ZT   2   0 2" 2  2   29
M2*,  "      "T 0 2#=K_Y-1,[=A .=X<,D3UH"TRK[MQS@W!$   2   0
M2    2    2434(  "      #S,0 2 I(F\5PLC,H>4"'5A^/< 4E4,7%<+Z
M58,   2   0 2  "     22*EP          ,[F0 2!O8Q7'.Q0;3\+3"*+[
M!=7S&YND+ASTX?8   2   0 2        0")2L          $M   2"^^8OV
M^ XC)Q=QH)'8$.1"5H%^R:8\+PP   2   2 2        02"0
M     0  '/YT5,3[:+S4'MT6(*XA[2,-,%AK/ @   2   0 2        "
M0                 #!JD^CF*C@K-1-&J3,=V"1)KIE4*LP>UT   2   "0
M2          2                 20"[<-@N81>*>>40;-QU7?G%E&!0G2$
M@G,   2   202         ""                    $QC%IEK%2!N)N2#L
M]^ 2P;B#Y/"><>D   2   ""         " "                0   !N0&
MK.'&B 8&5J0$ 0   <ET4$<4F<P   2
M                                          2
M                                                      2
M
M      2                   "                .TGB@D,4I%]F(
M                  2    0" 0 "" 00"2 00""0              'E?'0
M?FWK%OS*(                     2    2"0 2002"  "" " 00
M       /Q03PI"?RCVA,P                     2   "2 2 " 00 "202
M 20"2                                                 2
M                               "RI<%]\41:Z0"XPO(+A'\0
M      2    " "22 022"2020 0""  0           +1C,R(*Z.YU'KT/%[
MA#BM8             2    "  "0"0"0 020" 02 0"0           )0. J
MFU-*X=QK]$QJ\ZB_\             2   """"0  22"0" 0"2"2" "2
M        6>$96S?'I6DPW_-O^O!P\             2     02 0"020  "
M"002 2""           )Y@  I/A$>K=9U0O>+U-#0/XXXM\       2    2
M202 "0               " " " 2" 0*3M;H[=#K7>0!L'$+<$RK]G(]BQL
M      2    0020"00 ""2 0 22 "0""0""2200220 *J?&-,;=!=$]91AF0
MIC<0M:I5V$(       :   " " "00 " ""2 2"  0"2220 "20"00 3_Q  L
M$0$  0,# P0" @,! 0$    !$0 A,4%187&!\)&AL<'1X3#Q$"! 8%!P_]H
M" $# 0$_$/\ P^'=]X/LM/T>Y/\ ^'EIZR]I5+9XT^/_ ,/,^JOEW_\ P\SZ
MJ^7?_P##S/JKY=__ ,/,^JOEW_\ P\SZJ^7?_P##S/JKY=__ ,/,^JOEW_\
M&WGM/Q'K/^((M,_K\U/=Z_KD]:%28CO-JDF-3K2*V8.DU']!_NC-F#:,]_\
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M) E<1:/3[H27E 09V9A_%0G >XVS:D!L$&EK]H)I+"_.9,-*" ;'.WFEUH3
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MF8)*AJ,T64S&YZ=K8E 0HT9L;>9-*<"-<!9]+_1;%(900BT6(TM\4^.%,HC
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M3J1?0;<>%(;..MDZYO;)CI1H(EPG%],;>M8,;XF$QOV_-J=LR97V#,:1QM1
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MZZR4(/4ZV_A7J".+;^]N:70D)1MGED\]*FXECG'I0I9"%C[Z7G3.T@7 "TW
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M/I'J418:=GC%HF/(L[LSK0Q#X3V*OE +D?G0SBQ3(R)]""T7YDIB(Q*>_P#
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M=\Z%"[@ 7@_#:#7F*SZQ72%S3^:]+#]P_=8'A'ZW\[5"MBF8W=XT>OM48+$
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M@(1Q,NP,/'%-89"T:8--,SVI3WQ*::<3?76F9P(9Q..;_4S5TL&/G5[3%"Y
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MFD49WW<#'XMS-- $HL,Q&CS/EZO@<G8G/QI%J)0;TU)%EO[U L*LW1&_GK1
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M@I$4L@!(+&^:<5.$0IIOYQ2LP ]#,FEW4UVBA9RSJY]R''J5(=:>XXX/Q>A
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MO:\\5U$7U7\??\!GU5\N_P#\%:" 7&LSSZ4P 0H$TEZ39[X:)@=1K;S>K@7
MC-IMOW?2I;A#VZS;E?\ FE9KL3C#6V[K2+(S08 /ZS"K:&GD)))!0$RVGZM3
MN\*\K&\^OK>I<V6/DZ]?8_A>.0@<Z&O%O6^:3K5AI&BVF\45G-G8VF_K4&$F
MA.)B.N.]*A+,6L0VO?'3>U#AB070_;/]TRX&^2V2^.MX_=:><E,:-Q^>.*<
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MMSO^4!-)N#F-,^=Z=I9)*.&&3Y[7H,:^%SO'LU9&+%H>MM-M*@YVC 8_7?-
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M&4I$ ]+2WZ4%^1,9 I&#:45?.NC4<F) 44 A"%V3H9MNW=;S_P!AGU5\N_\
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M 3\0_P##YG3Y:Q>OP?\ X?<#3]GY: ,?_A^'_P#$&'_\08?_ ,08?_Q!A_\
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M5<F[/UMJNPRF;.V>S<]IBI6;LQL6FV!SG^J)Q:<:%M7II^$<@IWSZ_P8?^@
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MQSZ13SXDHUD/QGI0@(+@L:NOWYG^$I4<S:#7S-K>E$1BS/?;^^U3%L?%MQF
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M"ZWV^S1:!2 O$/1YZT42DA&QZ3GQTH%56R$D)1M&=HJTA,+]SC[ZE.>;#>V
M]>W-H?P!MVL6S;[H4 8(\?R8?^HPP2,^;Z5;")NR00WXQW[4GX>(F)>DYGTY
MS8XVD=/C^Z+-T^FGG_ E<+[#\4T\P1CAO+[:.O- 86 F=HS]*F&71E]Z1>=/
MMC?^()!('Q,8[Q_=,<'09(6VGW%($'(CIIGKXI&LVQ 1WI$S_$^D]RO7O\L5
M?<;'\)F3(B]3Z[3404O)\6[_ !11&,3K@+8J4:"2M\OK[8HOS*XKO]M?6DEE
M)1<NGW\RD54QD1).3:;DQ?LBB 0R26'2U$]#$Q&(>VO%J0-@&;E"M_/- H%G
M#4^::PT)<0MQ>?NI0)BAD)3'%^EZ2TW$88>?7>D64$U_5IGOVBCSH-R-I"#+
MK0("![VZPWS:BX="B#U)[R_Y$8?:AZD^GQ0VP3$1,][;_JEQ!EI'U=/N5@91
M8D,AI\_%1)L$D2,;F(F]CFB;J9;B&)Z;6[T-N0)&D,_T]5H>B,!98YC6^GS$
ML,V; ]7;Y:! -!F>FN0P^:5V !/=TFDV-%$40W@S_52"XS*&?K=IV&%@YLC>
M=M;VUJ=ES#MI'#K>SXH20U4\FSR^*A2GO^:)(-9(ZF;OI6@'WO\ G<H)FZ7/
MY3)4TZPO!'W>H$&0F^JF]:)MJ?*L@6^WF>IUH9+'4G!'7'%2&I,_&O[I"M.+
M?')^G5)F*-P269G#]T=Z&(B8!U1LSGVI,LS@D!2HO'VU*3&E%PR#&2<?A?XR
M0JJEV7 Z<XHU(&4'?@,9O?\ =$VV4.[$(O?UHH$6XLMVVT-^*-E(39)=G$>Y
MS)38#%>+.Y?3XHBIJ67$AH7[^U8&EC376[/:BM;HS+GVI!UB8I23$?P8?^))
MB@*=H/G6B3 (,ADC0^WB]!:R7(C)=^\Q0 )1$S#-KQK]WFI]CT$1UG;[-,L[
M(F[F?:,_NE2$SUW.NDUOGNGXM\TRY<QFX?=Z;2Y  ,WX?K3HA$*;DZYWGQ'%
M6\  EO.G&=\T&&^23'06VW_P"HTU/=VQQ3"(!"WW2_UH4#,W69O ?!:#6D'-
M %@C7_1N(QKCYJ3<TU+]JDN$&-<]ZUSC W[U%LV4T_ XUH;C,P1]?)^J@8 F
M:-LL1)/V*>)$L($#%R_VU%@-  Z&*$8?:E7/\3Z3W*]>_P L5?<;'\)P]=_=
MK5@66'VO>D0N@7MBUXI0%W&U[7S2R+C32?N]YB]#U/VX%S9M]FAW5#!$2C!$
M?G:H)TXA= QP^V:NW9# P+-]/6F ";*G6)Q]SD3(E)7R8VGM:GV31DE=OW^-
MZ!C,[IE BV)E(Z4(Q>P!RHNK#^]:6$K,18U>,L9>MJ:3E(WA8RYYR%J@5M/>
MW/O-2'"^]HK,Z?+_ )F>A/K%.2V7XF+.8FK(68<3USK)!Q1.50Q,X^_;N\:!
ME)'4_HS3Q-[@F0Z3IQS1S!Z4$!"&%[9W[E'J $%%T-2(G3]4]0#!UTI=V.F=
MJ=1B+)>(EUMN?!1PB@!LQ,D.^/:]*0B,B5AQKJ.U+%92$E2;6YYOWJQA1'92
M\=/>U'85C87^]^PKR)(PV>G::8@@F">O2'U[5.1ITMGIBV-VE G)GEGK1EYD
M\SUW]':I8'?I'L^EZR[_ #2$,:)OK;DVTK9;43*AH[6YSM*UGOFULZ\QX::1
M)C.^<[ATUM4Z44$=_6.>VE ',-N#7X[L12A@7 9!+]M:-&!$<#0$B-/[KIXF
MY,C)\*-NS#! NLRE"52A@3MS,)/UCK1Q0<+>@YT]9HD=;).![_;%9'R&(I@;
MZ<[58XQ)$ YVM;S:\T< A"+EY SWF>>:06V'V]*LT,B<??(]J0X?MO?7IJ4$
M(=V.G\&'_B.1@0<1O^9XI)5C>#;/6(]+U991;SCKG[M0E:&EBTGWTJ73<+YF
MX6TQKWM4BY>$O;VZTFMP2S",6T^Z%.+.O.+<YSCCFM%A-XTY>>U$1*0+GCG?
M>IH201PS$:?K6CHR#'\-=N*T,>H1-^?U_B^)RB]WHQ3LK)Q?.O&Q4I3F7L?;
M?['>Z]_#21(Y+=+VTWS2!7=(RZ;4(!,)Z1QQ2PC:);ZL:1D-;7MI1O/?7?FD
MB%B(B4^_=TI%+_*^D]RO7O\ +%7W&Q_"X%+S':3WF?&E&#N-N@'V]!(A\.EO
MW12W0/+GVGUVK"1<(8WT_/K3US+ H"N0-(]VBH/+$ +)E$M^Z$1$=,;DSB(-
M'6S1>0<&9D#G/F_6G9I8G8CV)O&D5<)&=D2!<9>O>F"B00&4(+/6:FP_C @B
M6?;5,?&3)*PMSC26^:">(5 $AB=_L-#1+[S:(-L3/]N*DB>$08MQ]WS4'%V5
M,[Z:OW%7NJW2_P#E@I8MI8#Q;ZZ4Y 3:]MKVT].A4<&(!$:S?GIZZT$$K\QB
M1Y'XTJ+>0<+-F;\6VFD]G!:)PQAW[WIVC !,MS0MX_9[ D0;-/G2GT787GU+
M?8T*M$4Q!J;!MBDVWA=0%9LQM31=Z$$/<\XO-7R=.7@LIH4=3(@62-8WW]J7
MPH(,K+B<\<XW(N,23%I3&WCC2AP0[F8MQ$T!!N*&<F/G\UH @@]X^^M('!,&
M,:>OO4</OUFC40O9F\?6E"A222^+VS\9BK>VWQ^?0VHC@M<OW)^]Z-$4]-\:
M6OG7WLYP;CG6_IOVI#I# D7$\.K\TYK99T"/ZSHFD#<C?"9F1!R1I%Z548 )
M,P1$^V"H4,)'!K*=.A:*D0<! 1&EO'V)^X2D-M28VS2P2 E$APH638V3=X!/
MN (5=K>NU&<T)*$LQ),QM-,F3RT.6;GM;S9Y0D+8B8^QZ)4-9 AB9!/%Y[]I
MN(R0GNA\OFEHNNGO^Z557?X/X,/_ !)V0N8EB(DO>T\34K>;+<W8O=G7;\TA
M%A#5UI8)F8DS/C>=/2D02EN0QGI![4]<Y2DOF8^Z68J! @ #;/\ B;1IGZYK
MJ>7C\>K2 !E1NXCO3,3E 7;7+.L_UMAWK&8G4.!_NE!9%9!M..\6+^K M42P
M1N(LI!:V:((6PW>)=5I$#!!^^/\ $Z3>)_=#WF2=@^:F 2$YWX&BFR<O!L;>
M]3EA%BVP)G;6A04))!F<%TT>-+4D+&[2')[TFRSU]ZS_ #OI/<KU[_+%7W&Q
M_"(#ZQ.M??XJ(6L1?;Y5%303OA\:]XG)0DM$\9QUVS15;5GFT:'JL@A)]&/M
MYJV>U+525NYOCFW#* 5@D@'&SF\F8K+-G!1!G%_MLM05[WI#H/SC+K36]41%
MQD&^MW.,% 0:3 %18-/MZ)\:(VS.8B?.=*!(@IA29-6?/%+&R5A:4IMS^+4.
M:DB^1C2I(2&>L=/U27K3WO)?3Q1A#8'O_@>[K^GYH("%AB8L:?OZDK$B$>FW
MW.*=UA(.MSW)[Y:L"J-A>0YMZ4F=F#*8YDOU]FABF22,3/S^VF!2W%/O.=]:
MP:4@#4J),".A:)XF)^;4= 46$EQZ7VCTJ +91!LW(MSS'6I!2@1@6=+S^*2N
MN8E"!G?!'V:M\@R:TAK.VWB&F8_(@*NY',:=9BDP,>++*NWW7C:X7K"XX_=
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MB0;^K;Q2O;A$;',;6G9\5 EB37 7F=;%B=1J-PWJUUV^MB@,]FJV9<F_:UJ
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M[.O'W?[!0P@L;0:[SGO2#9H106%EEFKTWMR\<Z1:HT][^] !!CJT$W69E?\
M633U?S0!8_U0Y/>@"Q_.,8I5RS]^_0_S/3P<_G[!_N@Y]T]NE0V]7\\'BI&+
M#S?&O3_1!B=,?Q8?_P 08?\ \08?_P 08?\ Q0$5<))U)5SMR<(AJ=SPJE)
MAF= RJ*"V<,#!20DZ"EEE,*.H>!)0  G,E[L:4,9E1@,851J"-X,U U9)>0B
M4*($(DODE5!$"C)(%1@H @E(JJ2N2!D!HDF$DD"8I"#]P2"94.%@,@5Z+ZIA
M;06$9!)+Y")2AB9@6"$N6"%01J=TWP8Y8*L*!(+2_*M\F4$DY+$V07(30Q9A
M30*3!8HZ6JZ!J8"@05R@N JB6&%I?Z13<L&76 % ME9EB]&#+DC(D8+3>E^D
M<B#*2<* "2S=N:46,("@'%[2"!:@6\DF<K $D8@@Y6KM940@(LB-H,916A,X
MR%TE99D#"QT*,#P73 2Q((8&-2+0I33DLH)W0"W1@(*)Z;&YGFE,%Y.EU+"@
MPP92%I K@5TE20A93"Z3QCM_\S#_ .*"-(WG>(!E+H  "11J0B2V60@B$N"N
MC6G=W DB_="W3&6I5E?&T7'G-%L3, O?3^VR (2(")5%%@'K86!($R V8YM%
M"Y.99N.-$MV43B"462H#5.Z),A)E#466,R: *%)>)F(6&AOJ,.0*)4 B2;)E
M![)\0%GJ),Q"!0Q;PQ3MA -BV22]Z2+Y%AG#RB6BT@2@+,N:")3D!) 62RA@
M.-5KOD@98%"Y4,T81"(KN-TLO* S:69+,**0P0DH4 *.MG@E-36($@"0,B)7
M*W,UT(9J1*3+(X/#<)EAI%IJ]^:+NV@ E@-V-;1X(A<^(- 96B;+FZP]JL+O
MRF56!DH(\0QR4!@119"4IA%N/$1$0VZB2ZZ43Y9I$PH2A2^Y!$7H9B "VR8C
M3=Y_^9A_\4@6"ZD=F\/:;;-$7"NRKF#'8%66X)';ZOEWHJ0185+(1$%F^L)<
M*!6"*H8%2#<",HB-9@MT5@B  B)B(U!#LSIEI(138))UEIV.,7 , @ YP&2"
M%-2"@,K(K>@)0 *F*-08(*VB3%.5D1$%$;M!3$%""A<0\[Q(<1>!:3%J '"T
MM0R.BGABT12H1MD*L"%MBFUZ0/=%",V;2V#)E)&)7\Y4,FK&C)"V IX@+#$@
MR$ #@6(+4#D $K +&EF:UB"DFI):PQ.5=&9HDPHFL%&H&\"TZJO-7YUH'? (
MPH,6F*. (&\$1 !!"!<"CCB3DH#(H)3$F+MV08!A%"R091:5E1F44*P;5%2
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MEO:0$E2J!95,9*:50(+M*&Z3$ (OO,A!I(""YN S6+RF1<@$6;!JRE6E(H#
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M0T4A 3"$I-D4)#J %"L6.$ $%= ())+B4Q ""\2I9 "Q*=X II(2!:Q 4B4
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MKAE=%[E)56_6!D0 EF1B PZ=(A1%)\*VSA+!;N00$B8 *DI82V4<A00I$0C
MDB66U"8 40994DI$E'6Y4-4VM2"1L%3,SHEJ@'N@<!*! H@6!O5D$3"",QT@
M-X<6J"HP1%$-Z%ERY;(CT$OZ 85Q< DA$0H)Y4"A29 73BBK( !+2(4.(-F\
M42'^-LJ5$$,BV&8L"GRB3G+,0JA8 "(T9Z0+B81"KE8769A2*>D3GEW^[?\
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MA@B2 L6HO%P[@5JV1%*%X*-%XP">BKW  58)%0UX%@*&F.(T4$D*@J$Y'44
M40AH\PD.2:-#B%$+$H$!10!%/^-B*P]9)N/TTX!#18M09A(..#/ROEDW&B#2
MH$NQY3.3N*65A=K#AXFW<LGT_"5XB,KGI/6DEAD(.T,"'B;7,H#ZD:#'Z/P
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MS[* 8NB<6+[_ +Y)DHAS!Y 8L$=_\+ 4=(9S#(8*$QCP!*Q@#,:N25VQ^/\
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MB[D -)AIC@.CNY5S <KL'I!$#@<@$F2C  %VD BHPNN8I[FJ( +="(540(H
MB "1 A*N'J7A%)&<4(D-$H)5$;1%(TF#'%ZU#58)H%@.) &FJ\H<>0GDTJY%
MJY%AP" "K#RE/=%-J557B8@C!:DMDU%BB92R_%B)3.U=Y&5Q #0H AP,@0@
M( -)&9YP+*Z,PYAI@QL U%>S 3(H@42-:(')SDG*ARG$29")A1SMHC5SEE6U
M>*D1WJY)0HED&(I"ERV+C*5P@RYT>QV5X:@,L&A% T*1 *5:KS$$80& - +
MZ0]0PX$(?NJ_*U?=?^'5FOG\G] J$/6ZM3"?(FFJMM3$&H+8@BL"0086H8MQ
M9%,NW"9]=@@8#B#$5(PI#H11),FU7%)B1C(!!&D"T'H"'%^FHP"4DE/6= "
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M(7\#+TLJ_1&)H[!TO[7!([5T_G#ELN*AR%H8XQ9GOUJ.AL@EBF=!">AC$Q0
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M(@> 0@8P8AP)LSC*JX(+5L!5E*6( @@>J[RM:JN5<JJY?^(4:F9'+$S@6 K
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MYY%#AB"U6, \!H.(;L+4N (K"V@@BF D )!$ @+@!(06N4J/\E/#'7F^OKQ
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M6+KPZA)Z\VK'D6HD%D1FY]N,=(!1@AW7;L_]7B:65Z:R[R>.^0  I89O]/\
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MHVOG/!0BJAH#166>I<<#:[\*YRF8DP#9E>7VU55KY4-&3WT3A@U=P0#81=N
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MD"L0!Q.XJEU=\N8]PV(EF?;S.,.5<T@R8)UC!E+Q]I10;)$!050<NSF4# F
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MYDF2 $R'O* MLF\2L@L!A)3WHRM0C7@A&0)E3H3!!WM=\J@D18()^YI.%3C
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M!Y%(-'D0P34[\WB,3!Y-AUK#=_=> DMN+Q 7+-GC_?!:-S!<#/V?MURH8Q7
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M/VC]^: ?1_9?R?&.8=IL9^DQZ._GEU@[P+[TQ-&O.>1DN6+A])C_ .\+(Z0
MG5P,@\S'OQ(A,Y7>P5XN??QQ81:/2/!9\_..+"&0)X^XIG^,O#8,YX'::E_;
MYY<B)$#[>QCG.N87IIDR@9S7 9K^_%IE/)9:.WN>O %;:/33 W'MGR/,FCR
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M?M<H[?K*F-,(#P?'B:%!S,,5:H<:P'8$-L07-[F1XX@031%62C[0)$UN8"K
M"D!H%5 Z-'7U*._C\#FWO_'Z0A$V*=8SSUG^X+KT"%50<#'/IEXZRSL.CZ>?
M)C/!2@F&O5W:4VY4SZ(8  )!T9(GD\?Z,:$)!K+Y7G]N2ME]&5'6%GKPX\R$
M#*M"D^/C5? J 7J9*9-G:S)FV(R 6%8"+=M["$O#<T!Q5\.1MI@C6\O#"R6D
M<%V:F<GF/$R(8G54"ON]?9IRK'K8!+Y6&#7SQUU(1]\_[_Q/WOQ?38R7J?M'
M[_CZL,@>8S]_<X(<'*JAT71/?_?$6"G<"SP!_K"[O*_"&306?$.O.7C&D$M0
M'M143JV80/-EE3HP$VDSG7CA3)"W#1,8,1SF6]R<%"D4FC"?O[<!),W)@QT%
M]_?@,DGAXUCU<WUN^,<(=W#[Y;Z9T<:B') 6;%O;/&'[<6 "1%&%RAN^OVUP
M>G3L9T.?ZR=/*;T=6']_MX985N1#'MC?&$D:/[\$_N[ORO-0,"_'X8R^>%T-
M2SY>$KE<!9G^]6\,I#-)O65YF+?.^-/([ R,I^X7DY&P1(<;SYL[F28X%44+
M$6='_H3K/#HF:*U#O\+K1PP@Z*]=4$TK'_SEV;%Q!WG.6'DL.LLMH0# E&B,
M(R.K<\$#P43N,-F26-WQ-*E"H]UCX?Y7@VVHP@>N;=]P)WM)!!5,D=72\+#;
M1 Z9V>_O[TXC3&#%A? :W>ZEQBNA%M(DQK?(F[\_^'T_9?I(%9KY_)_46'S^
M/TLBT I"U1F1DK %IJ@1^) O3$6A3O!Y=*BE$MI0E$O0(8 XV.BHM"*0X$T)
MBQ0 CY KS)B2AZ!)P1*76R #B4 J0K_&D/NIU7B @XT8)D..2-*4B5I)!Z"<
M6]A^P<45<NU4&M0 5VQ$N#,N#P<K<L".D5- JHP%4*M5=M]7+\NWW?\ 'Q00
M1@*"!55$-CXTHG3'H\91AHX:&]5I(<>H8HWVFB<Q5X14%FP0B1P+P*R566!@
M16\(><BH'";)/?@5<-&1;(%6B/$/[K:Y5\JU5RJJK^GI[G\_1DGMBF5AKW$:
M 022XJS1B"P"!.(@R<.2SU7]Q![R^)/\2COX_ YM[_Q^E3M%D[;9GW+.% VC
M,%5V]^,8UGDL< 0IXB'Y7]N+3!,') ZU-KN[[XYHD' Z]'K;O'K.4"(I=JUF
M&9H.(B9PP-MMOV[]^)5@P!FT )I')F/MR]<HN1"RJ-EN63/(S45 897'@3F*
ML$&!0%<D<Y($85>'AI)=">[6?& UF8)/+G".;3(Y(Z/3@1L6.VE[ \'KB\JK
ML_\ ?Y_Q/WOQ<R^JF_!5 SXU_=<0\)07)JSQ9#IWW,\?"],4ZI0IU)YOO*BG
M,89;#]O>9Y%]I&E!ZHI#SJM;"I008YW &$RUQMG#TW@)974E)([7;7!B,4["
MO5+,]]%Q!D3BFBC@@$#VKV7B1244TP/3S=(^7DG5>T LO9N[S\8X4, Z<LZ
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M1$=L O0I 8!)5ZSZ>3C4QA!LHI@UK%)VFB 5I(/3J)X=@N9)5^B$&. P!Q0
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M<I6>.!("BPU>M)OKM-3FPAU2TS@FR=;UGDP,R>3#C$P/;=KQ?4)D;0C96X,
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M #PY.>.Z;+\#(/2<RH,8&0%8L%)<TPX!D ;HR!B8 ^<4++1_Q*._C\#FWO\
MQ^D8V ++C/\ 8;PD,0.!$+!A JHN<O&$B]0L+A]_QQ,J=/:,)T=)'>.6+!BR
M(R8P0*^:YH''"(8P%@AG$+EPYMXSVB](  "0(;@WOG:ML! PN"R7+V#83"2L
M@ 5N(JJ]ZQX>.FCYU8[I9>[ODH-O C?2YL@W^;CYBVD+ (Y<GMKECCL#HP(0
MJYJX-A"6#'R%!54Y#5QF<M -0O78V:(. 0MX]MJFD4(BFS!KR\80]YAB%"H
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M$40=SO/%-&)M"#T;">DIWQQ5J3&(4+/9WF'+$0H@4!&!-ATU'$O%0M%GQ]B
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M+ $/*JJE=U2O0"L ( ''4-) R();,@T[!Z)JPT(-<**94+D.@-.#FDHO"9&
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M%:5&"CJX1:D8CR1X< "I&$4<8$[)Z0D4M M(6@M#<!$3)Q1J@3:]7.UQC/@
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MYSIIQ4BT!08#'@[,,K)7FK; "J<1*JJDVURYV /.)E1Q.U7K.<YNV[B;([R
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MT?(:400"9+Z+6^8S+Y_*5F-%E=8ES0JM,2(+4UO-+EFC? 6'@BO%7^$)Y&_
M^,EU)RJ79(6XZ:H8/I_A&[U:@@^05EN</7DUXA,<;>\KT CX^L*LG4CR4LPP
MMFH]\"B5@.[0^GUXCS'@56CP% !_/#80@!\F;:U8!=O4=3G+07G?^S+0[/\
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2MC*5"\.6L< ]\RS:WCW_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>business8ba.jpg
<TEXT>
begin 644 business8ba.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !@     0
M &     !    1TE-4" R+C$P+C,X   R,#(U.C R.C T(#$X.C4W.C$R  $
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M1T(@6%E:( ?I  ( !0 ! "  *V%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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M 0             ! @,$!0<&"/_:  P# 0 "$ ,0   !^_@
M                                   !R\?D4,=)            #8!^
MR0V: B4Y8MBC:N38\TRP   $#*#;(
M                 !\_H?DNO79N;'C]9UY2];2T)BX6K,4R?6%HK:T
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MVV)B)ACR?L/P9.@()$2)Y6S:&X]C2\Y+!!'K"X5D!)(G56CU.CJYP
M                                         . S\?X  !?NMJ_0']<>
M0YY]GPJ?1R\.?E7US8F/C^7"YMV^#^OUGO\ <T5EN!Y@$Q<45=E62%KA^VN)
MW^ 01S[-=NV1+K53D)4Q[2E)87.$:O28T,OT"D
M                          #@4_'Z   ;A]!^?[M_7/CN8?0\^R<W:V+]
M%Q_FM^*/;LPXO(RO4Y&&?$^G\Y9NEN!3 9M@8(ES,AM62T2IMZ;!6?V_5;]
M".?D9Y>M?$W>MKV>:V+0J,=*_9UKOCVI@#0">@
M      "4XN->            &YCJTG      .!C\?@  !4YJ=U_J;S'8'W?S
MN>?5<C"_ENKH7\S>F=&^5?#\U\CU2]_:>7<[<CU*VQNYE,:4)01*V8KKUOJ;
M*M)5^V2K?@ .?4;CF*A-UB:4LS%XUO<JQ7Y+^Y. <_G0   !"(EK,)K&;%$2
MD@LG6    $#4:,8A-*9( $"0D/<   @C'9B)!$+3O6MLO@  ,"3^'.T5MJ
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MC'B_&+&?FJ#8A=37Y:S:!JDR0HRTF4%B,G1K37S_ +:,=O0      ^?1^0@
MF1,GI3A\[G#M[W@M+,@1B?>NQO'%W=$['S,@  (HW/LX\ZM2VE&"%;_KQU<O
M1$@('SUU>_WYL\&MBMMO.M,71U97J9_R-"_.;?/H^!K'/S-VZOUEZI8<_G0
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M)FXE6495EO*@HRZEO*TQXNY92L,DAF,1C-ZTF;7\&3',&S5L?BMD*-?:^?\
M;+CMZ      'SO/R)@ $;+BCI&DZ]EAYCI0Q-]BU3&[C%^>      /VTG28!
M YJF=R3.6QAM<7NDQ/"5;6]OF]D1]%Z18 <_G0 ! DH^,7[7^_\ LU^*O/\
M1WW&]QW[1O?3C\N<2:U4DJ:^/Y&_KS\P?7C\??J/5/U7RV-=KG] >>_=@
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M+@4AY%R+:51 \"N*<R)&J-?/^WC';W    (%NO-DR70
M     $2>M<DQU]0 "6(^'/[N](R?BZWM2$1Z5Y?M7Y[VI\]ZT^=]:?/X#]/\
M#W3X'Z-VKXAZG&T@   <\&]$>Y6)@!!-4620202@1B$B2(I@61'J:53T"  #
M5T/Q7YL>\,^*A6]RJ*,JR@*@HRZ%">)0D"XE 2%T(&S3TA83)#6TJB:ZFUMC
M]OF.?8    @:WW<U!>20                      $LOU,64X:  25?#W]T
M>A;>^)T@1&<7I7C>V/A^E>![5XN!]SX_JOR[N=P^%^I36D   2F@#H$
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M4PB4H$0   8L9-$3S( A++=3%EF&@
M             '*WI76ZF\RY,UD90-;;>:ARR2
M!"68:F/*<.,                                            #E;TK
MK=3>9<F:R,D+7D67):,2                      !/$9'BK[@
M                                   '*WI76ZF\RY,UD9!!$+
M                  3;K3C>:WG8        !&%YQ1?L=8BI*@QWQFFQ($@
M       5<TRG-K3S$4E?.LV"N7R0              !$OEJU=JD\K>E=;J;S
M+DS61D                         !KC>RVZ;H         "-Z[.Y^*IB(
M"*X%K[MEQ[ )         1.<[7/O^3 6@6&M\>KF(               %RG'
MEE\<QRMZ5UNIO,N3-9&0                         &LMW-26E,@
M   $(;,T<-9$0(1&OM;?M5<P          S7/HY'DPI0,?K:P5SD     :K+
M2;J +<8Z49D!?P     FX,67Y,<3E;TKK=3>9<F:R,@
M        -9;N:DO)(        !"&S-'#61$"$1K_ %M^TUS0!$ @"(,6)3*R
M!$  @1!FN?1R/)A2@8_6U@KG(     ^8BN7*\C$QEB>YE]1*\<*V=/VQ7ST
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MA<#-<^CD>3"E"(Q[%EL.7,I4 <FF^S-@1!A14&6F/%678$  1 (&(&8&'F8
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M3&QHFB3L<T4=  A          1D@D($2 "         3$  !!(
M      '*WI76ZF\RY,UD9  <#P_)#>N0XZUY44G[\9+8#5\SXCEA6!YGJ9(M
M]"F3TC)AMHYQB=&1JC*LE<4I?))FYIVWH;&]/F-SF3[/G46>NH<&&S9<O[6J
MVWQ%<![6?/N-@FEH%/0$H'.5)^/.+8ZRRX^RK8NE;.>R]FB#6QN4V,= @
M                                         '*WI76ZF\RY,UD9  <$
M0_)S>MQQ5K);[M/T[B_/NRT'MSH?3C4>IC\ST+_-^T]'J6TP7/BUU.OI[+JD
MY5>F*TOFDJQE^^_Y&^]WO\AN_+;]"?*?/WV;YO3F*EBS9OVO5C=V38X(]O[?
M?/B/"]M?%H3+'0"4.:<63\_^IT^VLNO]A=S0HS3IU":2.1#>AFYT"
M                                      <K>E=;J;S+DS61D !P4?DH
M5NT5S&ZSXU;5)D; Z>>FY^#&,+")CIO/7G_6R]/Z76N-K6#)KZKMJ:ZV<'G%
M;U>N*8+9[:]VM/V"_.'VG5GPV]\W/>?F.!/3N%IO'6Q9\W[7J3H/V/K<Q^K]
MOKOQKB=I^4<G0MXZ DAR-2WYY=/I_0_/K_<+8TN9Y;:,_)3GPLQ?SH
M                                        Y6]*ZW4WF7)FLC( #@@_
M)$K?(KYXF29E^NN][R+X#@P^M6/1-[V=?L;;U<2^>^I]+6I<FOI_/J;HZ.#2
MN&MAQUQ;7G9ULF3VMYTG,>7LX+V=:Z8[:!IKV7/E_:YCMO=',OH?4Z:\YYD;
M1H&70-R''%+?GDT^GWCGU_NYGTN<[.EBK)36)BAXG0(
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ML=!ARXC6 !$LMI_:7>_18 .?SH 0XPI;\X>MN_1F^#[X;6O*:H-@EZ .?SH
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MF>ECQ+F5YSL;L(44&2+Y6;G+Q+,5B+<S4;#D2:4TJ=!
M                            '*WI76ZF\RY,UD92FESC4T@:V,?*<\3Q
M*<\3R/)/FMYGB7:$U9]Y+/!7P5LQ5'HGU7]%?96<]"<]3T,B-FF[CO0V4:+*
M4@1%4; (!!,"4SLV2
M  <K>E=;J;S+DS61D($1"G*0\#P/ \3P/ \3R/$\20\R4B3$YZ'L>I['J5![
MGL5![%05AZ@@ 1    02D($0
M        #E;TKK=3>9<F:R,A @1     ! $0  0(@   @1        ($2(
M                                          !RMZ5UNIO,N3-9&4$8
M;LY\;RS"0                      0]3/-3%=Z5
M                          Y6]*ZW4WF7)FLC(C66WL4F60
M            ! RW3Q99CH
M      !RKZ5V>I?,N),F6LX_T,N+9)I;RK(@89!#()70 %/*WEX@  ,>,@E&
M5FA0P&3@6*1"S#*6FF,9A=I7NS'ZMCW*@  D !"66ZF++,-
M                                -%?8;^#=K/-$E>1?5^S]$/SC\[+7
M$2!\R<<8A1[VC$JUVH59J69^D]K_ ##BOO6N4%O-NF!GB5I10Q>7TVR/C_C;
MU,U-!5CZ 9\F4>@=+-.17A/Y'FV.;:.Q)KOJWECXX8*?07).@X6HV":1.OCF
MZ6];.FK6WE:P$)9;J8LLPT
M       A A"66*[V;'RDM9,@:_,VAR]$7RK64LOLOIOQ.ID7@P,K2Y$"G/$R
M6&%2Z.-0%88T5AG\SD^:WM6,"Q1F$N2*QT+,["ER/6,T+M*Z$2PDQX&ISM,C
M,@0EENIBRS#0                                              (0
MAK/?S4EY)  $"(  ! B    "!$      @1! B "$LNU,65X:
M                                   01A6?)CNSD@
M         3TKGNKBO-
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M&ET$PZFSJ'?/TXUO!)&J;EJ]G;AKC(P+%$+6O7Q<<H0SZ6CA;"2RR_AQ(NR
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MY]7[18V57B=>1SRUV#'VM:_IWU.&K=R1/7C:"<5MP9%''W8[W3]5KSW5>O\
MYN7#H*KKK AG.,>)YWIE<&'EO <BQ<$,YQ@V5LGP=[W$552P=PNJ7^ .18F
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M\[LL]:DFLG,DV57-JR-NGJEN:V2MR3NDU64-47QS>XP1OY/:^^[)147,M(N
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M$XU\L8S%T3/+W?=P+D<"Y' N1P+D<"Y' N1P+D<&Y[\L7.!P+K X)SW<"Z'
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MU@W1?<?7XH(34-UJ;D.UU '!IZW?O@K1DVTULFTK,UIO,K PJN2K11#G5!
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M#!1G!@6C=(!4EIN.'\WPE.) %UA.^/BNLUH=<)W(L+A,EL*\&P-*F]H'.5"
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MKBN*XKBN*XKBN*XKBN*XKBN*XBWW]]"9W]2/BPM?9]8OU=-EIM%,765JC6[
MXQZD+9:AHKU!P<O#;7_U%7_DO#;6-%HJ_P#(HVVUG3:*IXN*->J=+R>*+B[R
ML>("=1HOP=2INXM'X(V&QN\JRT#QIM_!?)>3O^BLW_U-_!4:%&SLN4*;*3)F
MZP71/ ?6H$JZ5=*NE7=JA$>8%;L%U=91QBZC9:N:OAH(_=Q]7?W*FZ##@B.M
M,X;.D3"O('H2KRO!7@KP5X*\%>5X*\KRO*\%>"#ACP5&FZJ^!K*JV1]%N<=,
M.D=J*',[0@AI/-H5X*\%>"O!7@I0Z3]7V&!A7U?5]7IYCYADB!5K.-*E6NT7
M&[6%YN&,C][8CE/KG_)V+_A\/ZKY6(=^HV [LU_5'*V/ZC8&_P#XP$<I,%D&
M<996CR@V@+KKY:-79#G;AIZH+WLJOED#7 P'J"@@X](B5=40I0YB)4%75=*N
MJZ5!5TJZ5=5TJ"KI4(,)E66J*3\=2M-K;7IA@&(Q)1T'@F\SM""&D\Q5U05!
M4%73N1$(=)^K[.9+^F?=*BU@Z_[K640#I6G IH T"%K[//(U^:OU?9S)7TW[
MG47H]]JUGCSMT+7V?6+_ +.9*^F_<ZB]'OM6L\>>2@XA7]RO[E?W*_N5_<K^
MY7]RO[E?W*_N5_<K^Y7]RO[E?W*_N5_<K^Y7]RO[E?W*_N5_<K^Y7]RO[E?W
M*_N5_<K^Y7]RO[E?W*_N5_<K^Y7]RO[E?W*_N5_<K^Y7]RO[E?W*_N5_<BXG
M=]G<E?3?N=1>CWVK6>/1C>5&\J-Y4;RHWE1O*C>5&\J-Y4;RHWE1O*C>5&\J
M-Y4;RHWE1O*C>5&\J-Y4;RHWE1O*C>5&\J-Y4;RHWE1O*C>5&\J-Y4;RHWE1
MO*C>5&\J-Y4;RHWE1O*C>5&\J-Y4;RHWGG 5U7>*N\5=XJ[Q5WBKO%7>*N\5
M=XJ[Q5WBKO%7>*N\5=XJ[Q5WBKO%7>*N\41T:=.^Z%X/Q[Q_5>#<5X-O7@V]
M>#;UX-O7@V]>#;UX-O7@V]>#;UX-O7@V]>#;UX-O7@V]>#;UX-O7@V]>#;UX
M-O3[.0)"(CG*"NX*[Q5WBKO%7>*N\5=XJ[Q5WBKO%7>*N\5=XJ[Q5WBKO%7>
M*N\5=XJ[Q5WBKO%7>*N\5=XJ[Q5WBKO%7>*N\5=XJ[Q5U$<^2OIOW.HO1[[5
MK/'ZV \V(1^)YYQ5%N$C2H<NMWE=;O*ZW>5UN\KK=Y76[RNMWE=;O*ZW>5UN
M\KK=Y76[RNMWE=;O*ZW>5UN\KK=Y76[RNMWE=;O*$XRJWE<0AIYVA1A]00G#
MGR5]-^YU%Z/?:M9X_6P6OL\T)/M11T\YU<50\CS>MI]7QZ#?P6KM\9.]3OZ,
MJ5/C-O!/Y\E?3?N=1>CWVK6>/UL%K[/-#JXHHZ><ZN*H>1YO6T^KX]!OX+5V
M^,*E8J=Z',5CW*'?U^,&O@G\^2OIOW.HO1[[5K/'ZV"U]G2/,"KR)6*!Q5Y3
MTBM 1T\QU<4="HNZEW"5J[$XF]WVJ2@XJ_Q1,[5CAB5)VJ]O0=O0QVH A.="
M:^>_]5>XJ]Q5[BKW%7N*OPFN!4 CL580]3S1*ID-/6".)G5XV H"@="!XV)W
M)S0!M_NCS9*^F_<ZB]'OM6L\?K8+7V=.%"NE *$0KJ Z8;>*\">\=72ODZMN
M7R?5&F%9LF9RFX.B=6'9A[\8PD:0+S[,;.^Z>_NT:.Q:NQ1+EF^_<+-K-]^X
M5Q71WA.9L5S<A3/L_#<@(1*+96:C':KG?N%<5Q7%F^_<+-2@R%B< C8ZE4KY
M-K#9[5\G5MRH6"HVH+^+3@K=DS,TS4![[1@#&X@'X,.%W9]08ZDVB^H=/O7R
M=5B0ODZMN5ALE2@VVN?H\$J!>CWVK6>/UL%K[.C*GQQU<5,+/51@'N':L_6_
M:.]:S];]H[UJA;W4V^62[C!W"=G""=>T9Q]5Q<YQ=IT\>_#=T"5>X*]P5[@K
MW!7N"O*2@=JO*_W*OC<KXW*^-R+MB!.U2>;1H56K4:[![A@-?%9^M^T=ZUGZ
MW[1WK5"U/IOOO>XQHG1.\:U5RC4K"Z7$LT 'OZAJ]JUZ/J :^"+W-T.(6?K?
MM'>M9^M^T=ZUDVI4>+:'/)'@=32O1[[5K/'IE7MJO!7MBE2I4J5*E7MJO!7@
MKP5[8I4J4#S$J47PLZ-G?!"H"KP0(/2D#2KPVJ,/$NG4F3>Y@M?9T#BKI0'C
MCJXHHZ>>Z9F=:H^3T'"0KO%7>*N\5=XJ[Q41SW41@H*A0@(0Z%;3ZOCSQ*9&
MO4C=C#Z@&O@G\^2OIOW.HO1[[5K/'IE1*N*['B(E7%<5Q78\1AK4,[]G]%=&
MI7$&QTJC2X8:=*S=0:TP.U](\P4(".8+7V>:'5Q11T\Y^*H>1YE Z-;3ZOCT
M&_@M7;TBL4/'%8[4/$#7P3^?)7TW[G47H]]JUGCTRIC9VJM:6,&+Z8[4RW4G
M" YCS^[BO"F^BFUA4,1&OGA1X[J_.<&C>JSZ#(FM3'\R\*LK6C_,4YGTDZV6
M6,+13_Y*G4I/8+E1KSN,](X*4.D5"B$)YPM?9YH=7%%'3SG5Q5#R.^WS>MI]
M7QZ#?P6KM^H!KX)_/DKZ;]SJ+T>^U:SQZ94C8T_Q*WV:K6;^;;35@R;:*%4U
M*P;<+8$;5FFIC TR.:86<[]RKT^.AA\N['[VA90L8JCJ&GH_'^Z9D>N[YS(3
M\DU6D8LTK)UC=9VESKIF-&Z?QZ1YATY6E:$.9I4A3P4\%/!3P4\%/!3P4\%/
M!3P4\%/!3P4\%/!3P4\%/!3P4C<G'H0J!G"84?O>U:-?M\RTZU<_>]O#\$ &
MZ3*K&7'H-4\%/!3P4\%/!3P4\%/!3P4\%/!3P4\%/!3P4\%/!3P4\%/!3P4\
M%/!3P4\%/!3P4\%/!3P4\%/!7N"<>?)7TW[G47H]]JUGCTAKX(H@'FDG Z.@
M1*S9[_V0;',T7B!MP52RBA3#[UZ1,(LN@5)F\Z[=U!6C)52GD^C;65J$U*XI
M7"[K"1,PGLS;KA,G:-',,4[!,ZY(G0)5*E.M/;<.U4Z1JF)A6FQ9NBUTSB L
MUN[^I"G"+).A,$#=TCS#I'F'1O%2I4J5*E2I4J5*E2I4J5*E2KQ4]$.,X*^_
M:A4<-)6=/I>Y9T^E[EG3Z7N6=/I>Y9T^E[EG3Z7N6=/I>Y9T^E[EG3Z7N6=/
MI>Y9T^E[EG3Z7N6=/I>Y9T^E[EG3Z7N6=/I>Y9T^E[EG7:C[EG7[4:KM94ST
M94E25)4E25)4E25)4E25)4E25)4E25)4E25)4E25)4E25)4E25)4E3T,E?3?
MN=1>CWVK6>/2',>D%*)YKUWCJXHU*_\ JS=5,.%Y[OT8&''<A:JA8T566@V?
M. 4X'5SNI.!SDXQ'SM/-,8HF\F@MDJD72CY?6T(.+<6HUJE0773 ]_.3B@<.
MG"CIPH^S^2OIOW.HO1[[5K/'IGG'.0HX]!@D^Y5*;HZTD;"FTR61\W9J36N<
M!3DW&NO!NH.&OBJX@"<3SZPM7:FF$3KTJE9:EN_1 B-B^2*[&F;VC>@PT7EK
M_:G8ND:$?*0T=B*DZ@GV:LVBVJ1 +P#@1OU[D29B[T:0+G0GT#=/!5:9;18=
M!G3M1PC>)^T>2OIOW.HO1[[5K/'IGG'. GB!T*9A[>*M30*33MA4!- G<K+U
MJA"M;OSI9S#7P1TA:NU!-@R#K"R10HV3)S[2X#03[%8J]"WTGW0-)67+$*9+
M@$PX0CY7?:A\$!>*S-006L.D:CV]Q\%::=49,I=0_I6QACHX)U*KI<V!&OHV
M?R^^Y2"'?PJUQF*?$(S(_A^T>2OIOW.HO1[[5K/'IGHP78"5$-1)G3SZ3B80
M#060Z3>"MGZNS@/<%9OU.J?_ (S[EDW%\[0%7QJU=SW>_F/,$$<"WBLFVEE2
MSYA[I9H+2<$VE3LEZI2>&,=J:8"RI:2\GKEPWE-=)B(1\KOM0^"8[-N!B85/
M+&;@,H4"1Z0G!5LJ6JG8:==U"SECJHNAS21HV>Y6C*;[0+CZ5%K9O"X(@_@G
M&3O^'0L_E]OX)WD/_P!LJU?H;/ONS]I,E?3?N=1>CWVK6>/3/18;I1>B-?,(
MUJN'1U59!6%H%_R=7%6S]79P'N"LWZE6_P!MWN"R9Y0X!5_TM;_<=[^8\P05
MV]@FOKTCU"5X;:GMN$G#BBYSCUT;D8:4?*[[5!.A;C\%=;(^'?%6FVTZV3Z5
MD%X.IU03V=]BPU3(P7?^JW<]G\OM_!.\A_\ MGW*U_H;/_+]I,E?3?N=1>CW
MVK6>/3/BP,0=<JU_H:&\-GV*A^J5NU9._3M&J K7A::HU7G= 0%>"#E>WJ]O
MYC&KF:3X@JS^72WN;*IXFU@X@%X&X*U>19^#$?*^T>2OIOW.HO1[[5K/'IGQ
M>L<5:_T-GX-^"H_JE;M^"R?^G9P;[U;/UFK_ !.]_0B5<5V.D/$%6?RZ7\;5
M2TVSB]6KR+/P8CY7?;]H\E?3?N=1>CWVK6>/3/C*^-DI']UJLO\ [?:3KZ_N
M62_*G7@K1C5JG_Y#\.:)1-W>J%ZN][ V(:3*S50/\HPCTAXFB>MP5*H&O?/S
M@9WJN^\1L&C=P^TF2OIOW.HO1[[5K/'IGQ>U5_U2E_"U63_VZT_S^Y9+T^I6
MC])5_P!QWPYL=29'SE3=1I=<:8/?VIU5KGE$R[I#Q-/!Q[[$22Y1Q^TF2OIO
MW.HO1[[5K/'I 3ANQW!/O8X:/) UH%VL:1)W'9T"L=Z$]")(Q5L:,Q9P#\QJ
MH-BR5&WM+S(5A;=>['#%6ML5W$'#X\P,+2H(UX= K'>A/,/M?DKZ;]SJ+T>^
MU:SQZ7QP/!4WM&+]+?)G7W*M#Z)I#-Q>)O.W'6/%/) P52M4>RB/W6IE9XIO
M;^^53K/893W%[I/-$IH3_)\0/$ 2GX(:/M+DKZ;]SJ+T>^U:SQ\1 V>*C<L?
M5H4;E&[V*-W0TJ-WL4;O-#JXIMT-,CAH[=/OV;"OG=GV?R5]-^YU%Z/?:M9X
M^.'B#T!S'S6]&'?WK?\ 9_)7TW[G47H]]JUGC]8Q]H,E?3?N=1>CWVK6>/\
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M1^2;NFT8G=ZAKP[R%=R-(SAM0;'[DS[D?D@$9LV@\8^"_P J;&.K4C2,]K$
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M@NBB(R]0Y596M#W':A_)XLHC_O%&H>$O2G^ZO\7:R?\ 6*-[);_H7^+M9/\
MK%%]DM_T+_%ULG_6.+[);_I1_D[64!_WCC?^G_Z5_B\V7_K%&_\ 3_\ 0O\
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MQ;T/BN&>D+K&L2\; /7H+UW,Y>Q-'1#3M=(.0HW.P,SLK7.G<O\ Y1M+2?\
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M5]JOM5]JOM5]JOM5]JOM5]JOM5]JOM5]JOM5]J<\4R3S4_2 H?E/_\0 >A
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M8S_['=2S\VN/JL9_]CNI9^;7'U6,_P#L=U+/S:X^JQG_ -CNI9^;7'U6,_\
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MEY]%23"EOR)%,?5;6>".;A+!DM6W'"V+;Z&22V7BV;C)MU$&2;JLTG!GQ2-
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M]VI51-)-L#3FVU;HSM&$Q>1$)EQ>V> 8R*=CU2;ZD>Y6\^YRA /8!\O3^_\
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M\;3@N@?!;B8\>/3X?HP.J!(V:J@'I702AVVDNE?KDZ.C&2/WAB_A/RO4R,.
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MT1%TFYJ;./K041",5U7<$'!3_%F!;,2 '@W\F(3%0,'$LNG28%VI(@BS*DO
MD93;;;?!AI6%+>X#8DP.P-Q4W")ZD,=(=HJX9:BO-$X;*.M1D?:<DHRJ:Q[
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M;FV%4X8:+9G#=805:0A< FU$R<VMGE4EY_.X6OS5PW2Y50=?@,S)%1;AEL]
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M.5ZQKQZ8H+S*&(C/IS?9$%"NDW5YTB3SW?P'[0?P)]#>_=7/QE_RD]_]/_\
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MM>H?C,=JUZA^,QVK7J'XS':M>H?C,=JUZA^,QVK7J'XS':M>H?C,=JW[9/\
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MAS(YZ5#6Q)CPFWF2T$HZFS%=*JG!<#17\J9;>HP23FC27:'3'*8,QPB-R6,
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MZ6%NA B$?:Z-VA724FV[/QFVF^=O!QYTKIITHB; -Q(JJI+:Q"HHAC9Q?/\
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MGFU(.Q*@QG&;!8M.S!)&@]Y;EU CC[L@@!L3?Y,>MTU1Q%<V;#*#SR;<54;
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M?#C3)#B(ZX](3JG4O*JY;DTBH=2YEZ)%R)2WX&6I=8<+,M.5R$@3)\"K5-T
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M4B7L]7#:<G;<0+^=113T>A?,UF#V&J/]F3'F:K_L/4=_@^EU_!@&JC FP'7
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M=[G"F_>.[HMOPXRXR.T:,FSTO 8H8$HE8AN))J1=*WX)?IQW%.]V_@MT(O#
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M:1XP%0N(WQ_P_ GW[JGH>0]4*I.ATV!&%"DS:A*8A0XX*0@A/2I+C3#**1"
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MTA,#UI!:-=5BYBR-SG!!O&H^9B:Z@\SC7,O8">.@R,WBD7.=*H>1&!T[]/&
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MEDR3(R?XD3Q $+7S'OUQ<!1B$$5'DA3&ZW.O=1:>(GQR[\(03 W1$&QQ!@U
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M!V$MD"Z(S6!FEU9F4QPB9A2.F+=^K>O\:#I[]N,H$E 0 (;%)TJ2;N YDX>
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M/XAIH0;GQR;8MD<.,DU"@,$@(VN93&<\TR-XD(CVV#1<=&U8;-N(XLSH)D,
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M>??3#YE.-&0.?PP.%\5/9^TAW(U.2L?_ %
M   .CYL& G<,;3PYGRD&(4F2 IMIA:@!/D,*#IKW^VH+DWD+"GRBQ)&DVK\
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MU4&<;71BE:X=]=',7%0; 9/W 5G]W+%0JC$&*A)^T-PQHV9,8(>NK T3YL_
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MXK2_*Y8$;L/&9_\  ((((((((((((((((((((((((((((((("1CYH]$,  (
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M&"W<H=I)FB\3H< )28Q&N&;GI*"A7=]N($B0H@@_YSS[+MEY]],/FIX/@PN
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MRZ2C*D!W65#*6#$)P+A'24(8$9 96(8"Q'TV\XT=9'P(VP9@&0!!BPQA[K6
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M2?.&T2^7.<Z8'MFSF)7Q7_H>//\ ^B9[^V?_V@ , P$  @ #    $
M                                           ()))))))))))))( 3
MUP                                                      .Q[!
M3C       $/2 %4LKCP#0
M          )!((5@    )H35<@)'\N%\^P
M                       !$$ ,E2EE +4ED8$ 1LLVM[(
M                                     (   #YY]( ) I(X )1$AU $
MT                                                 !  !-??3=3
M  #)=  6"9_O;:                            !))))))))))))((
M   !(   B$];@9  C!H !S!-9X      J#D:     "J  )(   +UI   (%__
M /\ _P#_ /\ _P#_ /\ AH      $ -Q>.9&SH@ CZY!/EA]&:LD   "!)X5
M     EW  $D@ D&]-@   V)I))))))))MLE      $ #N71O]]#  $D&4<5-
MA&6F    JX^A/T8   $F0   C'KLP9V   @A))-MM))))))B@      $ ,I@
MF*>M  WT W%.]5:F^X   &_>R$#<    $    DNF2GR=P   0 D@    D@D
M$T        @3   QP@ "@).0%'HEMPQ   WO</KH!0    @   $(!H AO=
M C  D$$ D@D$D B       @ 2:0 ,9L  P*VV@@ O]#^H  !AIE@^CO    $
M    @'.)%A.@  $X $  $$D $ D$4       @!;C "U$  ' )/0 C^J7:T
M ,ZAM]A,0    @ $D@$OH($E(   'D@ $DDD@M!; &       D @E( 1\
M&R24  >*- 0@  "(3O #GI    $  $@$$    $   $4 @$$ $@&?LMD4
M  $@ $H F5      $@ $L$HM    &5Q7JGY@    @  ]P      @   B  D@
M@@ DB080.       D @2!+ +MP   $$  ]T)C(D  "P.6'U\H    $  BC
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M@  !/(!((( ())!( -    !#)))))))))))))))))))))))!T  &?F80L6
M   V)/5!7*:B)V   $9! (!(() !%-*B    &&2222222222222222222222
M29   @/QWCG0   )          !   !CFVWVV^VVW_\ ]I4    1@
M                9@ # +J]" @    0            22" "   R0B@ "0@
M 0!#^4 !59:8YOVFNDM>GL52VD^A #,            ""            ""
M0""""602&"02  0 64/H !RYFPQHR6@H_(FAUNTU @ 9@
M            " 0      2        !C]@ 135Q 3" " :MHJ:2  2= #,
M                                           "X3(
M          9                                              7!&
M$DDDDDDDDDDDDDDDDDDDDDDFL
M          "X!,                       $-;;;;;;;;;98!)O[;;;;;;
M;;(\@M)))))))))))))))+0 7                          "$DDDDDDD
MDDLH#D$         8@# VVVVVVVVVVVVVVVAT"X
M     -MMMMMMMMMLM":DDDDDDDDDDDL",DDDDDFDDFDTDDDDD, 7
M                  !@    "    !X1"2 "2"20   !@1@     &I6'0
M  !@"X                          ,  08%S0) !!";/<\(P*@M].X(B-
M@     4DPFP     YB7                          !@ (/\ :A7P "*G
M@1$-3(\(PBT3UC%   D@$@)LDD$@  "=EN  $$DDDDDDDDDDDD   @@    $
M#  -@@R@B  0#2IU(P$GCV"'/9[XP  $@  DD@$@D@  3[]P  2.W[3;>R7]
MC;^2$  [H4DDSL8 $[  TB$  > ! "@"3!>MLH 8!8 $DD$D  $$DDD   8
MN  $>66VRV66TRV2[S@  +$$!(E#   "V0F0D #PA  "P$%(!/5 # Q( $)$
M@$   $HL,@ # %P  G:/@9$EI(60$CZH  7T$FQEPX          >$1
M      8$8   )  @D @@)D   8 N  $,YE&O@DD@D$AX/@ !1@@W<2B#;;;;
M;;;;;T8D[;;;;;;;;;:&HM!))))))))))))))):(%P  5N5:IF>5BP#J#\0
M ,\  *8\[_\ _P#_ /\ _P#_ /[X$!M))))))))-FX @VVVVVVVVVVVVVVVV
M( N  %E 6F]BLZP[TD2;@ #*$@#*  &VVVVVVVVVP0$%EMMMMMMMML   (
M               %P  SR?N4@_/"8P9: L(]"DH8@$
M                             N  $JUTUDD[Z 6[5F;+^="5]$ $
M                                          %P  #@E;ZL;^VZ3PO3
M3Z' %3$$D                                               N  $
MNTBW7$W@'#=399(J5 LV  $
M         %P  S44V4 )<*QG#K0SFT@J'< @@
M                       N  &:60 D2-I0V22"Q@ $%3S@ @
M                                    %P  GDB22"8; &LRVV(  @":
MD                                                 N  $(FD@$Q
MOZ%>"T C@ $ $0$@D
M   %P  /H2@R 4N8AS^2 <  @%% $
M                 N  %U"BKDP'D3!&F/#  $!@$$DD
M                              %P@ KY/X#-/,A.<#<GX D6;0@#D
M                                            N $ $@ !)M2! %%$
M@  @ VT $4@                                              %P$
M"V626W_?;^2W^26R2VR22230$
M           N D      D   @   $        $@
M                        %P@X                      "3
M                                      N )
M    $8                                             E3, $BR24
M"222RBR2'VF$"220  S
M    %0"Q AO770B^6RU6;C;O;?6^2< &8
M                  U:38$&LE.-)M)9=-P20^F=)M 8 S
M                                 0X   @@ @@ @ @D  $  $$@D &8
M                                               N-MMMMMMMMMMM
MMMMMMMMMMMMM5
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MO:?6)Z1LG)MOG?*TQ?$V1]0TZ[\Y5MF7LGF_.U;)R8VZ:/.U+%A//W[:^AD
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M:-4X)*^H^S$!BR1<B9O*WPJ;J^!)B8NBXZ3K-QQER22YZ$AF02-[-XIXS P
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M-Y/1G0;WH:Z(O/72,M*GJ=_JD18R6ZG].'T]A7EZ_P"CV'S6'Z>Q_C6(W8I
MK!(^V'EL:@(+(A2$8,(8M@EAA%$$(ZMMR9-FR.9&&8R<:8Q^[FO3^&\B'IGV
MH%E:N,01-\[:X$U H!Q@IF4&!DZ#^AF+$MH+Z[14AD8USC#9MQ1)G?KM]E1H
M\1]E1H\1]E1H\1]E"1P1OLY^F'K_ "&D B4FF,%P#!2X9M"2,9+IOJN,,3AM
M2YG"<;#I3<K8FL990 )5D )4%%OGI8F65\I*\"T LN"P08$96)73,RI 7$\F
M0^8J2D-: 682PFR&)("R09(5.=-S<NK9#:"D0*(6TH$K5NO3D2A: F]Q"(1
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MCF+T!(BS&.4Q J9.7>GE@I&VE[3+AT&:+";N$=O7TJ2U@5P%9&^!C.,X5/\
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M@2U'1[?= 6"?X%*R2]_CY<J@@ K0@E,&2!!)B2@DY^'7$KQ1$#-@+P61!SE
M)!*2%G$4@@KD;&X>_(1&U-2),"!9\!,*I(0* *%H)/5ED(JS/))8 0&<JL3(
M,ZC++$38%JFZ$4C#:Z%R6)$84V7., !>\AE&18;1<I15Q+)TRQ!? IN("PJ"
M+7P0A?$UAM32)"2YG 4F[8WN,2HG\*!+4='M]T!8)_IP^GL*\O7_ $>P^:P_
M3V/[$;VOAC\)YE4T(>V6\&/5K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K
M=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;
MO9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=[-;O9K=
M[-;O9K4]D^&C9<)C"/?^<@& GHL-\L:*W,  $S*@2)5@3"9/X."I@0%@S#U@
MR@]4)VCL3FKXVQ)>&=_FU%YE1^ ]8C%QQFGQ4W6;.\NV.58@D,0L+TQ-NNE$
MHF5F($3<<_6U#R@9$-V='2SZ[U/US(0@"RMF04&]G"*>0V(63L S 64ZS0 1
M!9_W _J@<2:@T."H# #T_@*8*=*#0 F5SEM1919;+GSZ_AOC?K4I$*1AMTTI
M5(5319/Q!@CU: 2B%Q3&^/,U LL8B<XTZ4.^LI[4@LKX)<=?Q XDU!H<%0&
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M63>]8A=0NJX\Q5Z;HA<0,'3;\-"UK_=2ZM-5E6V?I6-Z?)3D3!&>F?:: 2P
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M_@ 8""YT:,FX0VLDIUK!96>B$G2@&:.F3*30 ")4%B1"?Q XDU!H<%2)0PC
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M"7"@HJ;0!$HDOA>;8ZIYNVDCC8:8<@%,JU.*I4%Q!+6 3$T^HGTZVVR]<O\
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M819EF6L6$[>3V%J<@'4#IDB+YV;YXTY20A:WO#=ZPVMC0,QNF:VY)C^D*E8
M-\C+:7$L84T0G(>:8&'3#\X'$FH!8PT-"M&63+'_ &)3!BL7K\_Z:4$8KK&M
M V5P"X*,SIA/K:F    B0*AO<0L25EB*" %@PVJW$H?J/:BTQF([CB.U(I4M
M2U2J1LE<VY/MY@DDX9@"2&(;R6'&5.10<40E@7"[ "#(-S!!P 6UK$@F;WE6
MU0%@$,CT;<07J=+4-^??7.H-/P)(F-7;QVZT,,BSFEM\-SQIO6,;7+=HQKI\
MFWT5T^3;Z*Z?)M]%!681!,(C*^11<9=N"+_JAZ:"Z6 0 G" 91:DUC8YQQW0
M'0H'Q_*@H<:$)0-!( *8%E1/4P2YU/$#>U01[L+4'2L( ,-HZQC 9X4TL <;
M2%S-1T]'&C0RK;!R1&0$,060QHD P0L9 6A?&8A!+)4,@C5+VA!9R*)$20D;
MB)I278RE X"N?F& 26=I\QB0+A$<1#1U'#TBK1@9D6,UEPMSN@"9!,Q)C(F2
M)AC>&(C_  N$F.#9@0XQ>.E]+T+&3 <B1:YW82!YU2J5%Y$(1(&@;P2S2%P6
M8);C#C=72:)&E34D..D,"0462,$<0#Y0,7$@("B#)8@#5D,,\6T*/29O]DP9
MN ,"A:283*E#$F-U#$P1@ES*2$@@0-$M')9I%-W"FDZP%1QU@13/G4H2;*01
M(AO<"8*6J8%FT1A[[?ZD#B3IACZU$(BB*,GTRPUX*DH2Q))$,X)!,C3(I-Y0
M!98+ [.)2Y#BD4I80(9";1<NVN-! O&;7 XF)<M"L%QVL!N"@ WSN#;#%_@)
M?/:&>E+3'Q<MN87;W^"=07-'62\Y3TPS*>B7<;S>TDQ]F%"F\ 9K?-#<E;1C
MDQ9K&><7_!@]/BGEZ_[.+U^?]1$-91SSDC+2]X#!RJ>[L!DP4:7F5D8/4_)!
M,YH.OA1HL[Q>RV^YMI2R%H!;4)89Q+I>AAITS"[=QG0C2+T7)G/U_K1SWQ_)
M%&:1XOE?CVFH"-9F]O(:7;.QGL]DP2:^'7/J\%?#KGU>"OAUSZO!01<*,8XP
M.?6L9YQ:9KHE.(5AFM')QEXP.9% 2Q%P7QN.QWM@K3.%!YNQ9C+N11(IDRD0
M)CI$9X[0T4D M.*(DY1O]U TX*$;1""RCU22,:5ADJ J%(<4GTAM,*;(,Z(B
M&9(K %V0%S5,]'*DLHI% B (4HGK#23 F"4%R)6=:;B]^P&4M(! L0+$U-!P
M;3-H)%-6.XS(;1G& J7M.LC?\W!Z-+%#88Y6.#EJP_N5.T4X2;&+93YI#A-
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ML7.]SK2PDRQWZ8L^7M4A+9P/.,?G^",Y],GSI1'"0F;6]<<\(X<"EI=:9T,
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M8 $0$A= 12$Q<*!)V$FE$8(2 G%$9DHTS0J,,HZ:1G> P:#DB&X9")8P,%F
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MK.)CXQH8$3)BA.&LT7B;WLMHG*YTPUK+?QZ]_N@W,CF+E\:V.!MON\;U:M@
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M)@FC0(O<7: *"%LM0.(/I6&%LO32H-#@K*,M,JEU>7\X'$FH# BD$AN3,.M
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MU+J\M2ZO+4NKRU+J\M2ZO+4NKRU+J\M2ZO+4NKRTU65;:[GX)[A[*P'0]O\
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M+>2O&N 9%K';9]:B2&T$6W7/I2F1>45J6CU>M7VT@4&S(GT_($V"%[_&\^U
M)(&RO>3^WI4(DCTG3/"/=QU_$)]+X3SC62%/K/O]30-##.=C)G"8TG:57 !B
MXK: )<,9Q!)G%9A:(SF,-M'*_)C4$SM'F_\ '8'L_P!; ]'VKNOYP/1]JQ_7
MW?\ 7P>GQ3R]?YPG7X?_  L1U/?\$]P]E8#H>W^"0)278<JG9&$F=#*\9^^U
M S"Q!8-F4G;K77X=OHH!$V1S-#V*Z_+MON\;T+J/5^];5U^^V^Y2.O?;?1FN
MOR[;[O&]=?EVWW>-ZZ_+MON\;UU^7;?=XWKK\NV^[QO77Y=M]WC>NOR[;[O&
M]=?EVWW>-ZZ_+MON\;UU^7;?=XWKK\NV^[QO77Y=M]WC>NOR[;[O&]9\\N$6
MT8D3>7M-3B).#$01)Z6%R"+%HM,A$'7)G.%KT\ 6<@O;>*9 5%&"ZI.'D_+$
MS&&;&GG2H+DP8B7#LNQ#WJ&H[G]L="#C\2WG'>/FTU"R0QF=)_;MAE-0W$-1
MGJ88W.36"YL\4)8YZ4 >I'#,N<]LOXB 5@8@=(RM:[M>*@DQVPWOC6T>.M;1
MXZUM'CK6T>.M;1XZUM'CK6T>.M;1XZUM'CK6T>.M;1XZUM'CK6T>.M;1XZUM
M'CK6T>.M;1XZUM'CK6T>.M:0>.M6V&+.%C-P]C&"EE5S_ 6P!6[T@\BIZG?Z
MJ>IW^JGJ=_JIZG?ZJ>IW^JGJ=_JIZG?ZJ>IW^JGJ=_JIZG?ZJ>IW^JGJ=_JI
MZG?ZJ>IW^JGJ=_JIZG?ZJ>IW^JGJ=_JIZG?ZJ>IW^JGJ=_JDF]]B_-L**1U&
MVEL?P@<2:(%@+Z=?_ (K)-ODJ#0X/P3W#V5@.A[?D)0,1?\ 5**P6F<+1-_3
MFKF!)+!9QSZ^16=GK;;]\;TL 2(6VV_7C>NEY&^[QO2;0@[)LZZR>E3_ +=/
M@48ZR6Z9&K& 5/B#@WU$9Y%-%V*M08N*B91\WCZJ.K+,\1';>F),DFA% _J,
MXSHPXA 1%D!4.((+C$TJQ%@ 22W(^,>*R )@(M"CE..]118V9B&(/NI>.FV[
MQO2E;[1A,6F>9/2:9L$X'73X_11V;20["F(M$++=VH!)\+PP8R0D-IEO$PTQ
MA, HB 4B"'$3$2:(P@I88(MZ9[34/-&P9LDSZW* ,Q?-O+AG'7G:ENKA[!VN
M]J"R3P_?&]!D&)8OEGUM_?Y3FQ+&6,23'CTJ-1Z'Z\QHH$SCF&CII\YY?BY8
MX,D^<NE2N+#>+;WO/ICE476;8^1(XZ-2F#%2N*OK_"ETX9.&<.)U*B/F !Z1
M6WY_=;?G]UM^?W6WY_=;?G]UM^?W6WY_=;?G]UM^?W6WY_=;?G]UM^?W6WY_
M=;?G]UM^?W6WY_=;?G]UM^?W6WY_=28;[0^[5P2U]-9;1??K1)0P#O/M^""-
M\\&/"NGA^JZ>'ZKIX?JNGA^JZ>'ZKIX?JNGA^JZ>'ZKIX?JNGA^JZ>'ZKIX?
MJNGA^JZ>'ZKIX?JNGA^JZ>'ZKIX?JNGA^JZ>'ZKIX?JH'(Z8Y;4 PYS_ !@<
M2:@T."H-#@J#0X*@T."H-#@J#0X*@T."H-#@J#0X*@T."H-#@J#0X*@T."H-
M#@J#0X*@T."H-#@J#0X*@T."H-#@J#0X*@T."H-#@J#0X*@T."H-#@J#0X*@
MT."H-#@J#0X*@T."H# #T_%/</96 Z'M^2(<T=J0E,9%X]=<TCXI66 M.V9W
M/XE8,9XQYC4]7+]5.Y5RQGXV_@$Q@],?6MX\=*1)A/IAZ?P+"*M/5CYI-#$2
MU92G&.?6<[5&E>UTTS]<O6D0!B8QJ;[YN>U!4DJ&!8]6MH\=:&F!&D'PT">E
MX3#G^Z4R ABZ\N%S.BK7KB&PLK+?/I&I2<$G %^V4Z6PMB5+N&D28V,NF%K4
M%0A$G7 QMD1.'M.KQ'V4$M'KT/R5M'CK2%AAE'Q^0%+&9>V/G$U!A=;3$]?4
M<HPSI-A%L(TONYO?\AAFWK4].'IKI:EG(.A^$!@14#B34&AP5!H<%0:'!4&A
MP5!H<%0:'!4&AP5!H<%0:'!4&AP5!H<%0:'!4&AP5!H<%0:'!4&AP5!H<%0:
M'!4&AP5 8 >G\0& 'I_PJ>X>RL!T/;\E2(8E!Z4T06;W]"H&:"ZC>K%@UPZZ
M4J 2,D],\FK"]V+K?C#TI);3> B<\8G'>F;)$+I&4F 6Y>"E6SP!Z8NOX2"B
MEF8S*G@C."'3F2H[Y.$\FG&]2A6X.+$/KYA4)L;Z6>5S:@T."H-#@H@((D%B
MUXK&7(V7*,*0L8"Q<8E(EE$)8:VPC7N4/B4@RQ,)#STH$.%: J&!Q->=@"$
M @G!8@]_6D0)**TB/G+W"B! (G#U:C" 03I,EZO@40DLP"^$83ZOK9QJ$"I?
M/7#>,%MF4TW:*0SF!54DAJ&Q5&X"!ESV3I$>L.($C.??[H*T,DS/7SBH-#@I
M,((N3%K9SM5P&+,WBX_4;:T:9<QQZ6QPO./%,$1#T[V<VKY%L(MO_P!(GN'L
MK =#V_+V'S7NO8IHV8M\M26<3VMWJTF#!O'MO0(+^-*!VLRQ>)Q_=,+&!A>>
M,=L-ZL*20PBT'GE_Y''S'FE.-P0<(TQOTBD,4$F^:_J<IILX9FI.FKO1D,4>
MS[WG^<!T/:L3U?>L;T^2H;>K1,6QM?BH#4 "-!;!3#>,*)GB@R[ED&;1KZTO
M2^?4"&*MLKTLW*5))[^:PNORIH9$6]HC>E%Y8F0)M*D"Y===8:E$.( P[0+$
MO<(1O$*<U"$86%(0D5@%*,*%8*P6))F+F*5B2L4$V%UW[3<(\C RHQ7;?P6(
MW0YJS]4Y/DJ9S<'(='#S4J"V$L^,</6B$VT/0N%BV'D_](GN'LK =#V_.75I
M!=)RPJ&*)@<L;93Z]JDRS#-N_7>#[H3,RZVU^-6F3$DW<)"<[Z4G9(ET,80>
MF,X3?&HQJW5DPF8Z_K<@V(M\M$)P&7H)][T2"T71>?.8J6F_*0LP1.?F>%K%
MF?O]L:O9NR,O6DH*Q(1E$%(.QA$=",&GF$L>^#<QM-*<N#8']QOE\5!D/0:5
MB&4/O6-Z?)3!"!P;/GF2;NC*4PC8SF+4@)G3""W$;9]J1_G @0 @ @,8YHR
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MR?EE';>E0$&&7BWQO70RR\6CMO1XC,SAL9]O[_P^_P#PF>[]FNR_Z1/</96
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M5XTAWDY-"84S+YRP< ^#1Z"!KH-'8UG$.%6: 5TWZP/)U.=+ A+Z+-O?]O\
M)"-P=F^XH^H\8\'H_=^=!24-NAFPN^F]^^)641L.0,)Y,M"&T"E*)CZTG98
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MZ]Z&?=.Z\,A=9>A5X*.6$:42DA(VWM*##0#NT^)"(']+]OF6;>.OM<-HVE0
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M;ANX2*%QP8'\7<9>=-=[PFJPA8S_ #?5@4%]-%XO2N$^RVP L2 B=88BG:)
MS,*P612H?.)MU.Y?3>4&UT#MNT US=:XVW5QXW#R$*-!&,7'+;^\9@5P4R#1
M0Z@H.!00!!- FSD,#J]"?<5;.\4*::&TLZ=B)8^4*V!O"84 -4Q#DJ@EVV"
MAI_) HJX*96@ID8'AP0$'16DD$(0%2"; "FX1I" )P^@%SF6%Y'4J)8E;PD
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MA;0 SGA])*BH<$O"A(BEU0((1$<=!K#>A @*^>CY"BPS:A'M3)A. M58P0/
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MB?O(V+R,@[@P<&R@%>F >RF(*F_$GLF#(=,:?S\":D>GJ1=M=NPZ<!ONF H
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M5""PB&02'/&18V$L"*" 70 BNF)10V-<$K(H*VH EDBPD%*)@(!;==+.@7H
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M0=)3L_J<'T?M^@$V!V(IW$$?"<XL^,%BD+"N2(ANC<EO#;5)%"!85+M[J S
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M+%2U$)9OM8&!:7)8:GP/8&<T <\\M>R9LHZ5GE)?WGA_6@_]I^VAOQK$DU9
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M84M* EQ76MG1>9%/$44JZ(:I(J.H#:-DI!LP)2[P L JK *JJLZJJO55^/\
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M8+-H6"]96=J_I/3<W[S<_; 05,@%;5J6"D#*$EXGP_:\HE1:O$BF%2Q0ZN(
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M^N2>T88CK]'GE/\ V.G)XY1$$AS%ECM-<#"\##ERG<]S%74]_P#?[9"W7O\
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M).BQP('W@/)J1NQ0,.[Y^.%22M<:3)'Z=5V2H<)7@5P+$,P@<]A*X&!(M]0
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M]5V]W;O_ .BJ<,TOJ(/T G9!-AA.'@#P&'8&@X.GS()$$WI*;$>>XH^%,<,
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M<DB:O#V9QO\ ?(3<_P E'R/\?^S6H(B"(B)1'2(Z1.3(%@%:^6!7NP#T Z8
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MSA;>^?D?X_\ MZV'8YO!SW]?/QAV/8_5@\ER'8]C(' 'T^:'8^"#R#Z_H ;
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M#7.O'"*]?,XX5,@*IVT4LC)];8@8OA6A"W3*Q7:LR*BI\.!_YNX7FI"3M_\
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MP=DZ23*G#+SYMOO7N]W( @B"]" DX0==2 ( !  0$-"! >X"A>FL%)&22:@
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M1H@(EB(Z2N_+A! R:$N6N>.AQMW<W=BI$H45,0DKB-X(0I4MS$B33G)SG 5
MO:[6N_U2X!@S$4"Q",P6*:01G*=^)9.^XR=D>'TX/E8EE5*8! D1BQ)L&Z@
M4B+'"Z.?2X!,Z7)(HN2("&;P!-G_ .RRFBU@L)J9NM"A(W958J$^#_L7]ZOJ
MOP4H@[@#=54'.+HZ5Z3!%OL()=KWA5E ";SJ"3;UC$")U(4NH,>C( ".%G9J
M 'U;!#:00]4@^H >8'FH/\;2)WI^=,U'R7\^_P"W_IM<'T?MGW7V/_$5KO?.
MGR6Q^H/J8:4:0$:1(QP"8["58$ @6>*UGJJO=;S\\7@^C]LY_+(IPSTQWSO1
MWVB>FK]4TPT1H>0XTJ:XTJ^JN""+LM:VP1M(H=7 @(03!<&^.,K ^P'@2#N
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M/3B?/7>^=/DMC]0?4S^>?=?=/5.5^8TB:2Q.2BH\E2,Y%.%QV"V  [!  Z
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M/X'OXSRO^G\#W\9Y7_3^![^,.HO^G]'Z^,OU^UWXNW37CUH$RI(5M9/I4V5
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M4' #20SAI@J*BR#_ %P8D1NAL&M"2V=$[Z5N'" 59LH/\&;:C#O@HJC-4<L
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M7#1F6-74+%F4ST4N*F.=+#<*2P&D0-&(I+&VJ,.0['L9#L>QD.Q[&4.CIT,
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&GH_?'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>business9ca.jpg
<TEXT>
begin 644 business9ca.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_X25:17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !* 0   0
M $H!   !    1TE-4" R+C$P+C(T   R,#(U.C S.C$Q(#$Q.C,R.C(Q  $
M : #  $    !          @   $$  $   #A     0$$  $      0   @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   ! )         @ "  ( /_8_^  $$I&248
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MY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ]SU/4[32+"6]O91'#&,DGOZ
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M1_S/KZ>?WFM.KB8U(QL[-N^GF_T/.Z***]T]D*W?!DK1>,]*9>OV@+^!X/\
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MG]8H_P Z^]%JM2_F7WEVEJE_:^F_\_UO_P!_!1_;&F_\_P!;_P#?P4?6:/\
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MAB@#[MHHHH ^+_BC_P E.\0?]?9_D*Y&NN^*/_)3O$'_ %]G^0KD: "BBB@
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M2_IGZ5)_P@GBG_H!WG_?%'_"">*?^@'>?]\4K*]RN>7+R]#GJ*Z'_A!/%/\
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M "  "&%C<W!-4T94                                  #VU@ !
M -,M;&-M<P
M            #61E<V,   $@    0&-P<G0   %@    -G=T<'0   &8
M%&-H860   &L    +')865H   '8    %&)865H   'L    %&=865H   (
M    %')44D,   (4    (&=44D,   (4    (&)44D,   (4    (&-H<FT
M  (T    )&1M;F0   )8    )&1M9&0   )\    )&UL=6,          0
M  QE;E53    )    !P 1P!) $T 4  @ &( =0!I &P =  M &D ;@ @ ',
M4@!' $)M;'5C          $    ,96Y54P   !H    < %  =0!B &P :0!C
M "  1 !O &T 80!I &X  %A96B        #VU@ !     -,M<V8S,@
M 0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #W   P&Y865H@
M;Z   #CU   #D%A96B         DGP  #X0  +;$6%E:(        &*7  "W
MAP  &-EP87)A       #     F9F  #RIP  #5D  !/0   *6V-H<FT
M  ,     H]<  %1\  !,S0  F9H  "9G   /7&UL=6,          0    QE
M;E53    "    !P 1P!) $T 4&UL=6,          0    QE;E53    "
M !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_" !$(!* $$@,!$0 "$0$#$0'_Q  >  $  0,% 0
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M3179$I"XN +%=$@"\J4+%9(!7<FX^=9-9*V "NM,@+8 *ZTR MUDJR162
MMUD@ *ZTR M@ KK3("W62 5D@ *ZTR  5D@ +=9(H*ZZS(  ^957>D@D"VFN
MVJ:6X[OYKI$UGPI\C=ZZ%IWTJJJ  "RF.DMTV."K]!?I+K?=<[6N*2L5DBXN
M +"BLD"\J4+ K) N5W)^=9(K)6P 5UID!; !76F0%NLE62*R0  %NLD !76F
M0%L %=:9 6ZR0"LD !76F0 "LD !;K)H)5JK3( 'S*EZLD 6EJLFM%%T3R?
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M"9*R5L %=:9 6P 5UDI!;K)5DBM$I$$@!;K)  5UID!; (+E:9""BL$@K)
M5UID!!(K!( 6ZR:"5:JTR !\RI>K) %I:K)K2OI "RM2:R2N]-09T_-7"IH_
MA[Y+O3!A][_1^'W>>BUJ"XN +%=$@"\J4+%9-+<9&\CTF0+YGY-5-*IZFWC:
M(ZOI_KO'L][*S>( 5UID!; !76F=;B/#+W\.?.V /TSV'A6=R$G'R+PS&SK&
M]X!_478ZQ7R;!8B6/XH^>ND-ZVJ.7Z[[G6N$ENLD !76F:6XD\^,_G7M#4\-
MTOO&Q[3D/;QC->WB67S6(O?>H+JLS3S6Y7_B?YQT=[T16_:7T<NW   KK3(
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M;WO@Q_1?ZKG'_.CY(Z:WK<8]/I#KOH"_/'Y#B[^J_H''7I^V>@'\[OD*/WZ
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M !76F0 "LD !;K)%!7769  'SA6:[T@ 6TUVU2*TKZ0 LKKI,E9-Y4%I:K)
MJ7BW7\ZY2##XSU"_E5^=>OL>7S@_IM]<=6[SL5Z*RH6!62!<KN3\ZR162M@
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M.376/-YP?TV^NNK=YV.E%-TRM3CQ\Z\IQ&^2>&\6UO%?.W!(
M                                           'TFK?L[D<I?J'Z+R<
M^I?HOZ^WUTFNN)QOJ&_*K\X]=8\WG!_3;ZZZMWG8ZTTZ7$V<'_B7YSZ X)S:
MT%L$
M/I$VU1<=P=;Z7G9]Y?9V[[)FZXGP>H;\JOSCUUCS><']-OKWJ_>=B^>/\^ W
MP9\T='\4Y_2
M           ':/2]]D&_0S[DW&[7ZAORJ_.376/-YPOTV^O>L-YV+$CX_P"$
MXE?*/%_G%)(
M          %ZK(GZ%[5F]]I_6WJ$_*[\YM=8\WG#_3?[!QW\_EC3_-SY.T?C
ML@                         7"8I,\ZL7I#\9E8^LIB>NKEH
M                      5/O>N2%_=WV/ZV?A+X]U]CS><']-_KV-WY8XWC
M+\W\FH                         "L.Q+7OSOPFQR>8G(2%^2=P\WK@ZV
M+ 0=;3I]$@                              )5.Z^E;[[?\ G.F;A:\G
MF\_2GZWAI_/CY<X[KN,                       %Z:(K3/-K/OS@P^W9V
M8/=,PL1L&^^>_P L>3M+T:UR.]B>OWH\DW0^9=*>SP4B4
M                -175[F8GMNBCS!?=_P!(Q!_"7S;8E
M        (<KH]>8F(VW.##[GESB-LW*SZ?K3&X6IU]N-XHHY^Q_;'NU;Z6*8
MNM@P'G5W?GUJ                               !4]7D1)],^5+Z][M%
MK\@\*LF*                    %Y26X47LC/%F\H<?LV66)V[(W';#JJ?1
M\+=5A6W7JJ)W2U;WFVW2EOBQVM<PG.KV V.+WF!W_FN$F6P=$@
M                    #T9$Y1Y0/JWM48?RKQ2E$@
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MYA9L[DIW59Y?<QO8OMUR^BWPCT^;ST;WS^/7*X;:Y@
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MR6-57&KGR[U/AWCV8;&S(X..+8]?C'V'7NK?1Y;4
M  3^D_YY/_JKM48GROQ6E(             7(F+P^W3T8'</G5<VRWZ-O7-,
MK^9\[;1KFW+FU+^PV[_%:/7QVU>T"YHUS3)TQI5?PMS\57Q56EMM4^ENO4VY
MW.VWBVWRBGD5NWR&+.[+>EMSH5S[)W2BGZ>:]'-[MPU%CT<ECR<HCR<HN>'D
M5RQNDV-PKHU"WKJHW2KR<@N>7EE6(^UW&Q&[/JT,FW:-Q^NV
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M!+WEH                    3^D_P">3[ZK[;&+\J\3I$
M#(/SY#UHZ?U;=U.D7]JMWM&O_(^9\#0&R+^P/1QJQZ-@MW]LBO2+FD5_,TY\
MC3VZ_BFQ7\T_"AI5>CJN:29TU#Z4-3#44-PHKUEN?I17;;O[DHZHSVC^?+HO
MS[9,  !#<Z;F6O@V.5+5NBY/87:=TKC>;%OD]/FYO;\$:V?UKST=!Y;9$
M                 3^D_P">3WZK[;&-\J\3I$              #ZU/1!K/
M0Y0L5LMLQMMOT[8]&E7/F6+?Q-J7-@7^.6/1QNW?V>+^@7-,KTA\3Y'RMU_!
M.G5Z9.CEHE>VS<T,S\*BAK+36VVX45[G1.HL-5;O[U79P4VOET/&[\;I   "
MY*8U,5R8Z[N\N^I]/Y1Y/5R>W:YQ&+W*OQ>8+H?+<,,SA$
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MZ<[K+61[GJUWMOV:?"_F_-!%N>BS.:OT?,[#]!^OCN]4Y72X!=TY1PBY9
M             $_I/^>3WZK[?&-\J\1I$              "Z!/>]CU3LZEO
M^<&O[KQJ/=L,^CCZ_P 6N7^)+_')]6QUWMEOV]1-OE\^/E%?BVR;NU1<^-$Z
M=<TB=";?77MTSHSYEJFJCZ+/W1J[=W56+FLMWOI;KJFVJW'7M7)XZ]GY7\E
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MVG=GPKR.L]4Y'6Y3=7Z)J//?BRVSD\0NRZIOWAN<LL4];Y&SHK]-*9M@
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M9>UM9U75>KR1)_77/(*?I+1J3-M(          "?TG_/)[]5]OC&^5>(TB
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M2_(VY;UG=6\G_P!]_,FWW?.          !/Z3_GFJ[1TN%KB_-;4
M"ZJ-_P#%>SUY7MG<V/V^=[H.#^UG+=;V,OBE>\_#<SHDB^K;SBO8R'EAZ;PK
M2Q2     %3>K5Z>76^FYV8?<+*WU6_JH^BND5UIC%#)8&"38^8]*>K%4
M         ,M^>;KZ&^0]M[6Z?K.D\?HZ'YUN4+G3>11_=5Y-?+T6:EUKDF%W
M:!'>^!].^W&6TQW%AO7Z9O@KL/>?/<SM/H]W3?4]I^_U;IO%N+;?AUE-5@E^
MG_G"V()          $_I/^06[-F_.OKF$MH        #-/G.<GV^*>K;[J/1
M^>?7&E=D=?U+JOR9_I*U[X"-VXQQV_CO6[I_1>LL)M/FFWOE6'&6UD     )
M5AN]%V>G6^G2#XG;/M-NH7-BKMQ YW0(H<UH^UUT6Q              ^BJ9
M+6-UF-U;HG6U&3C-V'286]SY3\XI&7'AS4UNI=SQUNX&#'=.)Z6Y10[LU[(>
MA?Y!ZKDQRS<^F_?O?+OK?0--Z+7F3Z3Q/H_-ZW;3(          $_I/^1 'F
M"        +Y9$Z;E/4)^<_9]SP.;ZBZ/L^6'W-Q7K*,QT?C\]BQIE'GP[_\
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M8W3E'PYOG:. UB[=:?*#^B7S7U/EO&3N:J?7#;+(_K^\XTTY/S6;MQ?@-WR
M                        3U8+>) ]7Z-U?8]/EUZ1\^[9<M #<8J]#.H=
MFUF.VF"C=N =0>O&@"LIO]6Z-(KI73O/]T?AV%>6UP          "?TG_(@#
MS!        $I?$=GGP^!^O\ !/3LO(?L/5=!V'&X^\#W[NOY9C=KMGIGO6O^
M5S[:^>]/52!?#NFW[N/1'6M[Q4                         ,_/!G?0[H
MW7L=_+E?,AT_YXX[7Y@!66;N-V*974NWX<>K385=VY H6R%Q(3C=AGBYSW&,
MS9.=PB[IS$          "?TG_(@#S!        &7.F9+T[?G1WCIO-;MDG]U
M<<Q:KVG:_CCH/;_,L)I]GN0=_</!8RNGZ5;,4@!? 62
M        &5GBRGIET'M75GE]_F Z=\^\ O\ D %TKTS[ZQU/N77N@P8;QP?&
M_(8*V N1VO9]WK3Y_P!BZ7IQOD^Z-R2RJD          3^D_Y$ >8(
M  ^T/1S\:]TRW].V\K^B=)QJT7=>1_'^^=A^K7<$?I_D_G_^B>/_ #FD
M                        "2S$;)/ES_KO0ES)^=3I' >A_7B0 !W'9]\\
M&J=DC>R^E1PYK0K)BD!]3T[Z9V'C&.W."S=N ] >_%61          $_I/\
MD0!Y@@       "ZMVQ@\[ZZM.WOHST[9U-R?H&V<^\<>7T'PV+KJG/=LKM$@
M                            39:KO\D&M].X%3ZH-M]X1AGD]>)  O.0
M47] M[;<HM@ )3,1N,I6J=>BES_-8Q=EYS;3(         $_I/\ D0!Y@@
M     "LQFOY<AZE]8Z'AOC=]POOZS!UNO']NO>>B
M       +I#L.QZ,],5FLY\+L_8/CRO=^.S.TV<_T7[[L-&]<!Q0R&"0
M R"\^0])>D=PP>]&+@5WGBEL0@         )_2?\B /,$        5)I<5LL
MU>N[[AQX-QZ"OXCS[;_P3YH                           ^L,PO!EY0]
M5W?,[%;CPAF=L]%G07*-YHCJ5Z]VM4P-]!^>^C_5C      !JZ+GI_TWLNPX
MK8/-QT;Y^XU<\Q(         G])_R( \P0       !4G"Q>T2OZQTG%7S[#U
M[$^>KH7SGQZ;"0                         &NEZ(=0Z;D'KO1.H[_OZT
MR.%QIR6I\9]&/[>\WLD8Q>TX^^3.;S3X_.+T3YWX]<L4      +I3]ZMTG+7
M5.FP?[UQ/ W,:JD         )_2?\B /,$        5)>,7L<M>K=<QL\>P<
M,F_$%O7SOC9[L%H4                          :^9G\UGJ&-$>["'-:+
MCI[==T]-%$_6FOUM:5V?H[&[7Q.YC?-_T?Y]^<4@     "Z4J>$V^;W0.KQ0
M[1S^$O<><@         3^D_Y$ >8(        NA(QX\U.#I?:N@/-G>"7F&V
MP\MBGV/F                  "58FM46T@        !<;]YLAZV].Z[TMX=
MCQ3OXJ![H7"/E%L      5ED]X\KZE^:=CP;RNO^:WH7)T         !/Z3_
M )$ >8(        N1G9X\K/!HO=>G+.5XY[_ "=4WL1 MNW!=--(
M        &YQ5FSC<ISZQ>PVR>+Z?O^>@        !DCC=YD]Y9]H2DYGY_QI
MJ]G3> ['B7M7.XH=^^4=)-D     "LQO%N[ZZ>=]JZ]8[R@=&Y%20
M  G])_R( \P0       !=$9R>3+3U:%W;K6UZM#EO#T]9R,:.S\2P:R^IV*J
M(               W.FN:S6]KD?UG>.3SF.#7/5O%KQ] 7L)@;LFEQ^Y?7ND
M/;XT1:E      7Q/>_FVR;CFGW1LVE;7GSO_ ,A8KTYK@V@_0W),Y<P9Z'\X
M1*[5\T_*JD      >HCG_7,G,5E?(ET_C'";OEI(        "?TG_(@#S!
M      %TLY?!F9Y.<=UB=VS1)9/+G,7/)M6+GOT&'O;^2V(
M  $U.O[G(KJO5(OMEU?%/*Z3CSZ<+SVWZI>==Z?D_A=EYK3Y.)>C 05[=SK"
MS*8&@@    !]54XFA?:>1FE]2V#7HSIZ/\LXBXC>^T,=FN\=TYSNV=P?D7SG
M)NK+V$JG6&A     /0-I_195]5VCRN]*Y7B+DL-2D        !/Z3_D0!Y@@
M       "LS)ABMAG,YKVOS'=.X5Z(L'T#I/P;OC5?UZ%3=>)VJ$2
M     $JG;OF]WI@TKM$7.=UR(G/\MMF!<3TZ;V./C/Z9TU[,+W#8]V,WJQ'7
M5SQ6@     [*\NQ3^<L_0OE6!Q/#\)<S6Z/\S8BZMU?F6/SG?F[\JW_8,%YY
MLSJT>&7Y,F/H?(     EIP&U3UZ!TCS;=$YE'MF]:M@        !/Z3_ )$
M>8(        J3KZYNTA.D]6\KW4^ S;8?<>Y\'U#@=JGS];Y\\['78
M       'V.U_/ZY#\'LDGV W[$#*4PA;7Q[B5SRT!<>E?2NQ><#<.2[/=L(I
M3-H   !]BT^8,T<)V67OF7V5S+#ZWP[$7,K.F_-^*6D]KY]B\KJ,GYN">_<(
MT.H?)<:^Q<-      &8>/ROJCYOU*#;<]&ADV?4+:9         G])_R( \P
M0       !5'I;U+HW9&M=$\MO4/GS(_S^OT4:EV?%[S[)@)GN/QI[#H=
M       "M1$WF>F'S,RVK=#[6\&Q]+>FY%GM>@1V9GG^QU6@ .115QV:0
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M@]FY'Z+6S93W8F[ESV&'>_D7Y50      %2?O6>B]]8'I'G WWY]X3=\@
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M            NF>X/%M4MO'ONB1SW<7X?[,;CWK'7N&^WVQ6]5^0<3<QSJB
M      *F5WDR<^.E=VAOV/F<>&=T*@        )_2?\ (@#S!          "
M4[V$V_(O7^M=/<SWG0=+U?OSC>;[.^1,SVW@=*ZI[QH'GG^U^98H;3XJ
M  %U:07!Y^:O3.OX"YSPPX[;QGB]SRVP%Z:3%"D            +Q$]LX_8O
M61HW6,7K6P;;Y?1!1O\ PS&G-:A8B@      !=#>J;WJ<TGN,=_HQL*^X\:
M        G])_R( \P0         !64WF(VO)SGW:N"_)_;N3=[YI\^BX?O+Y
MPS?*/ER[WGT_F/,OKKF/DRZ-A\3ML\5M,@    #OGS>WTY\R[I"UM^I1B;-R
M_2+=)                2*8[.3VZ-V3#JO-[7<;9?T_S\;WQ;0S2
M!<>ES3.N;1BMK\W?1_GJR:0       !/Z3_D0!Y@@         "LI@\1M6:7
M+NX\'^6>J]R8>QPW[3YEOD3V/\D;/EOO7%>'_/6S]*=IUCR@_=7)]NKH1(
M  N)RM2WN1+4NC>3;J_!=LKL6@                GVUS><S=;Z?B#Z<INT
MT]ZX^U%/M7(HQ]DT=        #T :ET61_5]P\DO3>+==>CQ@       "?TG
M_(@#S!          %3/KQYB8WFO<\=_ECK64O(;?R[3@,?\ ZSU;M?4+O8OP
MOLG:&A8/?-YQD /Z'\+C5Z7@   !60U]%<RFL;C)]IW5L#,UB($=_P"&4D
M             !<BLU^JS2NH<'\6^8<Y''TIHSBQF1VCQ7(0-^X=B+E<!;
M      2?XK8I1]1[1!1NG%L4O?KUH       !/Z3_D0!Y@@         "^(Y
M13?]3.B]JP^^;>Q9/?-N2Y3A\+US]18WJ3Z;UGLOYQV?MSY:]_,_?A< _KSD
M'GY^I.7T2  $-XIN2#8;.S#:ET&GCW+'#W>Z-#;>(X1YG3=--(
M     %4\[M7_ %NZ9V3#"QM4?68T*/S8>9^A[2.W;[Y\]=YL;YS^C<$ZQO\
MCI(      #M6S[/3!H7>X+]LY/@[F-2LBD       "?TG_(@#S!
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M3U4[#Z?#TM[,%P.YC.=*>],=G>[<=G^8^-#+NG&H[]AT^T0
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M%Z7? [W)5KO2]+8H\W_0.$].^O&VQ      5IQ]9WG%3U^6.;,:A9)
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MGRTXK-]+>/9.L;N.\^'0/GO2J !]57H#UCIW;F$W+S9[_P "V>NT
M       !/Z3_ )$ >8(                J4       /I*?S6^BYG:CTCSQ
M;[PW$[*X1          "^J<A?'[)Z=2ZAS/&[?T=E?+'5E]#P1S.C<4K\7IB
MU7J7:.#W;KJU[X&]\X+CC[\#29 ^B,D/+EO1GHO;X/\ :>5Q\9O3P
M        )_2?\B /,$                        70[:L>SU1:-V;BV"R4
M3N\\JB>V/4]MJH        %:GTIJDMPNR3,ZEU'A_HR& V7UJ*K8.8=:>G%V
MQ(DRQFQSAZEUS&SSYN(?<.-8*YC2@ +SU$:1V7J7R9'SK]"X7IYBD0
M        !/Z3_D0!Y@@                       "J4Q-3A-QDQT7L+%^C
MSQ]5X'B!D\"        .2V[LY^L[_F!A>A8@Y?'Q6Y[EV,&0UNR"FFV92[#L
M^GUHZ/V7$+S[7$/MW&\(,QI0  GRUKHV0FK]4AYW+BV"6:TZRJ$2
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M[NF]<A\V?0XV\]H5            3^D_Y$ >8(
M   NF.X;'K],FB]QP:].JP/;ORVB0            .R[/I]8>E=FPCM[1 ?O
M7SMU]<\%)D "IO5-[,WP;)VKY<I;'KR4QNQYK838]!8],<.W<ZB9V+E^VQ;3
M(           G])_R( \P0                        !4NEZ4]4Z7V-JW
M0_,?TWY[XG>\H            &^47?6WI?8<3?%ND6^S\AP#SVAT@  +BDJP
M'V3-5@>B]SXO;//?N'$/C719            "?TG_(@#S!
M            $N6)VJ2#3>SPJ[?Q[!K-:?9             5JCT=:QT?L7"
M=*Z$G&P [[P/X54@    =P6/;Z ];ZKYG-KXZ            !/Z3_D0!Y@@
M                         #N:SZ_2QI/;HUO9A8;MNY#\ZH
M  %24;%[++9JG7^AO-FX,]]^=ND_7B;0    9'^;WS+:]T3SM;5RP
M     "?TG_(@#S!                          %\QZ4M1ZOJ<)N7FNZ/\
M]Z*;8            NJ96^/(>D32>U]+XK98E-UXK'%L6E64P    )2<5LW8
MGCV&'+8><             3^D_Y$ >8(                          K*
M8##[;);I79_/IO'"L7,I@            !<=N6?7ZTM/Z[T_A=EZFKQGFRZ3
MPKBMVT@   !.QK?0\-O9XX\,SI"             G])_R( \P0
M               !=4[2\_K]/^D=OB?R.G1&[;S6D2           !=7'9/E
M]GK8T_KVB\_MX5CLK@'GM%@=W3E]L4TB0  !Z*=5ZA%9F-:PIR.J)
M     "?TG_(@#S!                          %8FLQZ+-;Z#W_K&\^7W
MHW#.*7;            %U<=I>7U^IS4.TXK>79N6Y+1NT\%M$(FW\@CUSNK6
MB   'H_UKJ$$6=T'IV_C4@           !/Z3_D0!Y@@
M          #,[S9/T0:%VV+?+:/"YN/.+$(           7':=KU>JC4>RX*
M8_=H==W^>I8<1L68V WKS2[SP_JOT^.@  !V#3>Z_JLT             )_2
M?\B /,$                           ?27HDU?HN3&I](@6WSB&%&7P(
M          2Y7:N^M#3.T8B^'<8EMOX;B+E=5]+6G]=CP]N%B6V7G*)   J4
M             !/Z3_D0!Y@@                          "XY=;]$_>L
M=1S,U[->=S=>4X7YG!6TS28I          #ZQ5ZP]1ZUTUA]]P^R6EPP;KQJ
M0;'YV1/!;[YX]LY*D                 )_2?\ (@#S!
M            %\32J-WBY-WKV_R8:WN&'^1UR'+9='Q*R&&M$2         -
M3%7KGT_JF.V+WWH/U>"!???GJ^*N66K_  ZYYJ)                 $_I/
M^1 'F"                            !>9>^/-29XG;HKLEJV+V0U^B0
M       !4R]\>6],FJ]0P9L[3TM[\3!?MG!K)                   3^D_
MY$ >8(                             N328JE$6H)         N)DL-N
M.;.$Z1J;?MP?RFJPU[)R*U(                  $_I/^1 'F"
M                               *PK+.G'9N0O%[7%[F=4GZU;L,.6:T
M2.'.<_LBDD                  3^D_Y$ >8(
M                  K+N*U?E_P^WP9YK3>RJ+WIQT[ML)^:TN.+.\]^=-*9
M                  $_I/\ D0!Y@@
M           #ZI]4.G]<PMI]D%VZ<6LH)                  "?TG_ "(
M\P0                                         !=$S-X?=,]M6ZS"A
MM/&\',UJM(                  "?TG_(@#S!
M                    %T3W!9]OI5TSN/77B]<&6Z\4Q=R> L@
M        !/Z3_D0!Y@@
M"LKI>J'3.R]<>+;>)6;$&^\\)Z7]>*                  G])_R( \P0
M                                       !5/(Z:_6OIW7L3_-N/#;?
MJXU=T^![>>*;;732                 $_I/^1 'F"
M                         *DHF-STP6L]<P6]GF[A\.?UOB].">P<OB@V
M?F]$                 3^D_P"1 'F"
M              -P3ZD-2ZM&!D/)%/G>:SF:UTONC#=(V./-Y^M[^>]CN><
M               "?TG_ "( \P0
M        !W99]$O&#Z'!GL'.=JFUV39]OHIT[N'5-K,12;5Q'#O)ZP
M          !/Z3_D0!Y@@
M   ()"^)D[Q6Y9YZUV'#K):#$IM?*;D4F5*T0              $_I/^1 'F
M"                                            +D]ZV/=Z9=/[1UC
MB\OL_KT[&G(X*,#8-3Q@]^+M               )_2?\B /,$
M                                 #Z0]2FH=?ZB\VV='Y+2=OM>R-K/
M\[QK]V"M@              !/Z3_ )$ >8(
M                    G<U[H7<>$ZM!)N?SSTY[,;6F5,6B0
M   G])_R( \P0                                            !*-
MC-DE!U3MD.VQ\JP$S6BV3                $_I/^1 'F"
M                                ,A['O]%VE=SC+RNO1 [-Q^R8
M            G])_R( \P0
M      !]IGT::EUW;\?NT1NT\/Q)RFN$6P               G])_P B,/+L
M                                             72RI\>:FIU3MG&/
M-<AYVWB>+64P-M(              #T%$^1&:>34
M                          D$QNURE:QU_<O',:&Q<JC3V'2K:HL
M         /2439&-QXE
M     "M3,?';)+EK?6J^#+X_Y31H:=KY3QNNS0             'KL)#SYGB
M/,>                                               =PV,A*9@NG
M9"XS:XA]GXIB+D,"             .7GN@.6%2 0\_P
M                             +BLN=6?;P:_X_G3              F#
M/3P5!UD>*,ZL
M             !OY[13)@ $3QY92@
M                             !Z%R>0J #XD ) .
M                                            "7\].Q]P  ?(A//.
MP<?
M !J2=<]"9J0   #%(\\I&B?
M                    'T,]CT)F=X     !CV1GF&QTV;(
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M:@?[3T'&\O40B7)5A#@DL+?0J'0K^(-U[A#2LRP;'J!6O=7:]&&;Z&/?0K^
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M8<H?2;A49PCEGE@^+$S][W8W.:2E21V;SFISZ?0SLUJ^5G0Z7$G:,D_]GF<
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MA0 J>B+#T;L#1I#OW.8+1>-ZZ5.N7<* 7EDY#=01PDIKHY,N;"T[_E*@J-
M+M<HL;1VRK:T1L)%H2274?<V545UNJ^]#:FAKN.8/3!X(='W'%.L%;8*JIEP
MI=%)KM4JIZ,"GQQ8&A%D:/5F961;7,8WKQO*I@2+[EY5*@85H*0LJ>4EL)U8
M*:E(R2=U89%T.MG8# R[@Y$_9TG:=GOR$Z;[<T%ME.(YKB;IQ&.W/9L.$?\
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MK#%$LF7EV$)U0NH" E %, K 4@7J<_PMO7R!W!RARK:_HB>_N[G[L3GX4_\
MK# C17\7K'_Z?+_N"#LZN6.0.0.4,N\;O: Y0R[N><(.L0MM653'"0%IT<F6
MFA>&I=K]&J-4I1 *#6E.V-#JKT7L9O(ILV63_P#4(2+H W"G('('*'* &X<K
M=R!EW.&UV=3I%**0ZZ$<10*(*A@%G8G.+KKH!J\M94/"2M1KNQQC@KT!?>G$
M6[;2%-2K!+DJA:15QWW"B"*I0CPD8!15=4#= OXMI"V,J72-Z(K>Q[@[U4[^
M0.X.4.4.Y;7]$S_]V=\T3GX4_P#K# C17\7K'_Z?+_N)@[.KECD#D#E#O Y
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M1QN3^62_TS7VHXW)_+)?Z9K[4<;D_EDO],U]J.-R?RR7^F:^U'&Y3Y1+'_\
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M%(308E2@D  5.=*1I?IW-VXIR4EEJEY=I104I/.>H2*UP*4J&(&>^F(C';G
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MY:L^X\D*!B<:HHF&%!%.F+7D4SC.6_K]=T/-EIU;9]RHCQ?D'IC_ %?Z,?\
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MV9:TD!5\7Z90N]C=R$."^**B93JUBF^+7E./RM  32E=OJ(F9=Z4<+;@(I4
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M*[8LQ?/ZXM.QFK03B$U/0(MNQ7K->44I);O''=_",%#\[WHTV_JZT4_2D_\
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MQZ(S'?FG2V:@D'>#3U_WC1^V>.-I8<4!JTA(J=W7C"4++V*A<WPMYEM2N,+
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M(8%!Z]$<'EB,.L34U-MI>UH6TF^,@<<*^>.$W@KDYII^?L5%V<:*GW$I!YP
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MLOOM_ <4.ROMVZ595/0!6&9-URG,5V@^OB$6?HN[,D%5:'&E//%FV$U9U"H
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M%WB)FY7;_")6B^:<BW&E+&IM=\9!1)\OF][=&O#]>B)-)4ZE1R32%%+LPD'
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MLA_0YXGV+ >O;%J62[9ZJ+WT.&[UPI /-_+[1]\S,A+T_LKJ3V"'[W%G':>
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M!PT+!P@(!0(& P$" P $!1$2(08Q00<3%")187$0%2 P,E2!D:&QP=+P""-
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M<4VK#RINDV.WJ[EE 5I%IK294(#C4HZBH/@ZM[E5H.HY$;Z6DJ!UI)AII+2
ME.H#(#5X!J^$#JGL!J[ ]@.P/4':CV0[ ]@.P/:AVP_ K=4GL1V6[WHTFC:8
M*G4BS-48$W?.V_H4$.<PXF]>&YVQK-]A22.I[F>C?E58KJDI*4 4]I=N,E9
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MQUK;Q-XZANQ:?5I*T+K[[;!XN\2[#+(0,-@E*TM[\<A;-]1U1*;HVG4DYO\
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M$T.!B3%YRF*6XZ0A&)2WVG'%*7B2-;859219"0L +6% @#7>YU>('TQ[FO\
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MP'&RDGP7N3R"\7XJR-E[1N$2P8T I[B;>_EUTVY=^<)!\)MX(0<:5*M8YI\
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M*5!33@3B&)#B#@5@587;4:SNPZ<5N45(S=;6&%IP/;PTAA;IYW$C&F_Q@T4
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MFG$M@DO2R6U)>0@<HQ[Y9.(J4W@ Q&R4WE'@^V"VZR>*1DI)2;CP@VSBF>Z
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M0J=I'3WZ95Y8OR;X*'&@ZMHD'#F'&E)=3L'%5J@;@FYGFI5$F,6>?7.H?_\
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M=_RGWAGF^GSQUPD._P"4^\,\WT^>.N$AW_*?>&?7CKA(=_RGWAGUXZX2'?\
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M K9"TWU1H_4N!N\'6<G3;.YM?\.:+D#%RB\:\_DO=,_H/W/?ZNE?]O,#NO\
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MPFV4%6'FB>GBM2T Y VA-RJY@P3GRF)>1<?7F%6Z(EZ8TT!B&?M[9PA*49
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MO=^KZ5I+DDE:2C:I.WFM$]I\UI7/229JD-!Q3S?'2<*KWVX1GX8E0$R4L$#
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M@_<^^I2OW PKNA]3\?A,[-7!;2;[/;VUPJY5>%IUPH13I#A2TJ4,A;9#>%I
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MLY "PU >Q\\%15L^&VUXN3**]+,!MIYML"84X$E0&OG)'I@E5RE6L'.-[O%
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MO/!O 5;X<K#E,;F>YNJ66W49Q WLX585#7MMKOGJ)V7Y;7"4H 0FP2D84@9
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M;PPC2"26;*R/I\D-3LH[J6GQV\]HRV:MGP2HU)$FV2+8@-5_/[?QJU9>G%J
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M(RO?.&Z2@#GM#4NRU8I O&:LK6C5E\(T@%VDV]K6AX9'EB:R8MMWST1HVO\
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M)(:(S/7Z1J")!24XU2EP=^4#BL!?BWYA&BFDK&D5-9FDK&_X$XT@YZKZO;9
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MX2%!23G?*X$;KV@PJ03/RK=E-IN]A3K(N57MKB9D=[="2G\R;*%K:HD4 V0
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M!M%(<4Y*()Z/(#\#6ZF6!6L@#7[#E]C$_5]_NAHVZ(2PO%C<.+%GRQ+TX/\
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MMG_"/BCI_;ZH3PED61FHCRQ*2RYQ1>=N!KSB;:"6+ "R4CQ0K)44=-TN'G,
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MQ.CJN1'F[JI 0%VM]E55R.?5NG&7R])"8\05"'VR*BI]]%PU[1.3:SW1UO\
M&$CTG+]SL[_/4S"IB=4#KM2;.?,DS# 6HJB!2GC>(156U7**FJ#=56W'#;TZ
MHU6I--E=8A.,QV'DUYKZL,]D9-?L#[!6YI$H7' G*?A4BEPVVV&MZ;46*RV
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M'V#7]OSZ^DVO:I^#DVL]T=;_ !A)])G4:%-[!F''.*KW8\61=@W&G3;RRF)
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MLM+D<><6Z@I<_$:JTM_L2=$(CC/;MI[=J;9,N=JD XT=VW%Z;?-S<S'HF/\
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MO?ZK=:8:HNTSL>GUT!%N/+-49BU54R  W+1N3K<FT\^*Y87+]ZW#WM/BTPA
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MEEC>.QPK)FKKQ@EFR<BMD&1L3LJB2W6R\W#6RE>?)ZB3Y&6'(<-5<IDQ\CU
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MF17$?8DM!(8>!>:XVZ*."2+WLI(N7#E. 4\M*6!RZ2_EL?,N3D.Z\[=/BID
MCIOLJ8=8>!6W67#:=;)+$#C9*!@J<442145.^G*Q6*.^J6L,R&1%V-.CJO/8
M?;3155+Y"7H+9? K2QJ@S2*QE'?T:I/MQWT=O;ZE=,T;F 2] FBWJ)9'&T7%
ME1<%:]^I>]9;X8?1;D@;LU_E02RX?@//$ 207<*9=J"2.K+BCUH!HB%_)*N*
ML&T*FD^!*=@JPN@QVV#(0;;'N0MSD]=GOZ9\E#X$_I;R4#W?TO\ )W:GTG#H
M;"DU#'ZJJTM+?4E/;5-Z8YM%=<\[8#NC)%Q#HM&B-PJ=!:!IAEL %5R])UU6
M]#?<Z3SI=,U(NO"^+$>&/&0\+:^T5>=\E$-SWL-L"F46@041/8I9+_%@NO'&
MU^N^-HTICKS3[;++LA65)#. #HK):S!JH.\'!'[$A9^4MGIKV:J;+J+ YUS&
M[37.=%<MW21RS-%ZT$:PNF!F4QE'*Q1%=DQPTS2(RC]51TMUJB;QM.[< 4Z\
M&VX) X!$!@8Y2$A6Q"0KJ)(NBCU*EOK[$N*\;$F.X#S#[19'&G6UN!B740DE
M_"F&Z+5R!C::&TB+?1NJ- *#V0S_ /4):[K/62J7(3TAP&6FQ4W''30&P%.Z
M(BX8=ATHOW151NXY(I#V$VXFG;92Z+D+B+>N"2J2]Q3\UVJ7%50B!K<<R=)X
MTX9RX\;>H-&;)Q :JK,VEEF7FD;\<C81?#OVP0?9$/<Y\.-BG--%+_5<;Q44
MV&]2R!HG>Q%E*MV85=8(/ ,AAUGAXU_9-YYE-AJP]F-L2<H+SFMA$2)R![5$
MS&'Q85QK,#C9\5T2_>5?"G<X#;JE,H#,YQMBOLM#S&)ZCNFYMNX"6HB+R]U+
M<\/F$4545145%%5145."I;@J=_ I3-J*H+0VM%E/=FQ;(F@[B8CS:)U<S+IP
MMCMTJG%I9<M.9!5\.G?Q-V:V@=8O-C+)IA V#/U2QSG6]..=OG?<X1$3,1+9
M!ZN^O.ZE3%*VLB-Y6:RTL.H=?^T(@)E>5>OLB-947K-IWTSY*'P)_2WDH'N_
MI?Y.[4^DDQ3GG6+5.N,L5>L/F([Q&WT0X5/%<OG3;5B<#K4S+&9O6.:\U5[A
M?6%W\W%,>\N),M4NU3V+(MM$DO\ YQ9%5_K,%KU85$7&0?NU_-B93W1[74(<
MF$?7I)8-I?[R8J=./I09TN*7CCOFTO\ =Y*95B-4ITDD@5=ON3A250"-?7*P
MMG1[Q"N&I<8T=8DM"\PX*W0VW!1P21>M"$D6^+*FBZ65+I:V']L-F(:)* 5<
MK,&.'[Y%5<,Z@TV.JR+JO9"=VV&?&OU^/4*;*>A38IHXQ)8-0<;-.L53XE1=
M%\.$86?3Y!(ENR7Z<T4@M+7,A,1)>NY NN-U6ZW)=CI_!8_U+%7QLLV$O?\
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MPK89R(Q52=7FXYRJJ7U7K7Q8!P>M$YI%95.^N7Q6YV-IY K<?+5]L%X\UBS
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M!P<])PIS.CT*5'E-K[..Z#H6MUW#7%)K#.K=2IL.:*CKS9#(&O'7NNO7$QU
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MPW@-;UFWAWC>"%>(JJ+XT])^2A\"?TMY*![OZ7^3NU/I?:^CKTI=.B36]?\
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MO@G9DR-&%$NJOR&VN'>13P>]KK3K@KT8S$F1KWA)MO=W\.]MX<94:K3XCT7
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MD1_JRG-]C[0LMISG8HK>-4,OKF>VA*/[4+2^FFHT5ER1(>,0:99 G''#+00
M!%24E7O8:J^W;[M!IZHAC2F\B59\="3?Y\R0T).DVX*2/ A)C<[,TJ+#,T3-
M)(>R)CJ(EKO2WT1Q>_P15[V"5TMXM^;X%[^'950G,PXR(JJX^X((ENH4+G'?
MO)@&J7#?J8"XF]D[SL1K1><3.A&=AMTB 5\&(LZ^;LF(T^&J+S'FA<'5+HNA
M<46V'/'S?"J]6*Q2W$L50I[P, O%'@%763_[UO+XL^'&G$RN-&39BO$3 LI)
M[RI;S/[?LG?O@:%4'<]:V>8".\I**N2J<%FHTA474L@[MEXUZ3BJ77BL;.RD
M50J41]ALEX Z0KNS]L)Y"][$N%('*_#DO1G17J<8<)HT]XA7U"\E#X$_I;R4
M#W?TO\G=J?5)/_CWTQ^Y*J/9JS06T2*1+SY=+3SI?YR*I(TGL4Q)BRQ1R&^V
MY&DQR2[;[+HJVXT7L"!5R^R7#K(-NN4&HF4BBSU!=VXP1%]3.%P25'RKO&O6
MJ!</3'8='C*W#9L50K$@2&GP&NM77ER@3RIYW&$T==[FR:X1VFL)5*WE1)%<
MFM!OBT1'!B-V,8K>:]ASF=M%(EU6PGFU152_5@I<Z0W$BM N9UXU$=.I+ZD2
M]R@Z=[#D;9F-F6ZCY8RTTZTS,1]%TXH;AZ\5#JPLBJSY,UQ?MKBJ(^ 0T 1[
MPBB"G!-.2BNYLTJDLI2)XWNK;D6R-FOL38W63"DZ/1.X^%.J_BP!"O0)++X4
M5=?%H@EBN,,-[J-)?&H1Q3H(U. 9',]AG,LO@\U1*DIY(KTA*?4$O83A3E['
M=S][=YQ<1>XR[SN<=E*=D*RAEZQXW7V))K[^&J_%#_9^T3>],D3F-U%H<LAO
MQF(B?O+ZA>2A\"?TMY*![OZ7^3NU/JG3-H8"KO(3R*\U?21&);2&%_G6E4<4
MW:"E.([#J<=B:R2:\UP4+*OA$M,2=GJ_";FTV4-K+;?,.)T)$8U\X?#G$VZ'
M >:6)<C9*NT^J1<RG$@3U6)4,B\&R>3>1G#!-!),F<DME2^)$24V3,F*ZXR^
MT:6)MUHU!P"3J43117Q>E+(EU7@B755UM9$3K5<,5W:IYR@T U$V8ZMJE2J+
M>G.: ["Q'+AO2+,2+<1PW1*!!9@06!01;;1,[JZ7<D'H;[Y6NCQ(A#W6N W2
MINU2ZVYN6W&_@PXR!>6E1UM$CEVII>Y62_P#(OV-"4N^&#DU*4X3>=58B(9=
MBQAUL+;.@9D317+9SXEX.61LQ)<M"VD:RM(2\T9\<2-JWA=;S![V+CS4LJ'W
MT_\ G"KWU);?=8I+PIJ[1&D-;6NK3[XI][S7[?LB\,;.U92SO%3VH<E;W7LJ
M#>*]F7K*[:77K7%4HAV[/90IU()>XF1Q4D!"[D7Q10).Z/#C+HJVZRX;3K9)
ME(' )1,"3J(22RIU+Z@^2A\"?TMY*![OZ7^3NU/JH_Y'E5?U[;,V?)PK<ZV>
M3#OWNF^ ^"W5@N*(B_GPCB3'6S);Y.*731<OY\;0((B*2RCSTR)E0UE1VS-U
M>^3CN<U7K5?2<>FTN(_.FR2%MEB.V;ADI+;@-[#K<R+FBFJV3$>O;9C'J]?L
M+S--\]@4TK(0[R_-DR!7K30"33%VC7(G-T6]D1+)IX,;ZIR=X^8KV/!8RG)?
M7JS@O0#V1_<8<C,/%2Z8JJB18QEO' _^H?Z17]:-DOA5)54E5555U557K6^N
MOF:!41516)5X#UT6RY!D-Y_C"^$=3HN +J?=AF_/@O'BEM?:*(ROONR)!?F_
MT3IKYJJ4HEN[2ZPZ>3FYMS.9!T?N<S1\?N^;N<;Q 1<I7%+7X<$]^ZX;VB@L
M*W3-HD5XT1+ S4A3ZI;\&^&SH^N-'E]0?)0^!/Z6\E ]W]+_ "=VI]5*?6*>
MYNIE.E,2XY_RC#B.(A(G%LK97$[H54._BD;4P;;NIP&I!!>^YDZ@_'+^49D"
M8%X1P):94<$;7L=N^@]>-IS=4EW$T8K*'W+##+0 /B74K>'TE"I<!HGYM0DL
MPXC(\7'Y!HVV'BS%KAEL!9E[3R6D*JU<D%2;)13>1H6;G,L!J)6\_MGZ\$#:
M+JG'N^%U-2[UM2P]3=GS:FU)%47)?GD.&7!4;$M'GT^)M<.SI\AR3*?+.XZX
MMU7O(GK13@B)P3S<<N.5YI;>(T6V(AF-C6!&(D[RJP"JGO+A43O]_P .*B/5
M#CPH?OM1@(O_ #'"\W6J$^]E6MTP#B 2\PY,$U<4!_EG&7"R^ +]Q@CM=4)=
M5X<<2MFZMS=Z0O09J#VR#-#1EYM>]Q:/^2-S#T:90Y\ID.>U4*=%>F09#-L^
M];?8 T'FW4A/*HV._#&5^.\P5[6=:-M;IQ3GHGF)0TTV*?38(IV75YPN]B X
M71CM[L.VR%2Y94704OCRIJALRVG0WT&I1+]B364T(F\W.$@70@+4?'Z:\E#X
M$_I;R4#W?TO\G=J?56H; 3BU;WU5I.9>DBY>RXR>_E?\2'AP<O-;-53PKB1*
MW9MA5J=3Z@%QMF7=+%<4"[OML4K_ &OH=7I*@;1&SOPI%2CS3:2UW!:),PCF
MTS95N/APY(9.K*9IF2.L'MJ+:^[5Q31I>=IFT1.*$*<W#L*$)4FDDJH3+;JE
M+DA?^%/CE'*OVMIL43@KCG%?K%-8^W3X;7?\\D-C^? -^M8:&_B;1,:EW6OB
MNB7^_C:"0BYL]5F(BKW@>)M/O#YN!5Z>ZK,RGR&Y+!IHJ$VM[>U,;@7L2+#<
MIDVHU98!/+2G9Q%6W,J;YYL2YSL4RLJ&G0T'%[E<.<G5KXL#S$YUD%24D6W=
M:=>-Q,IT">'$TF0F)")=17@XTYQRBNNMQ##B2-GV:%-=OEJ5"^H70->BJQ1$
MXKR7Z0[B_P#-\$=K=-?#:#9E'+=F1QRS88$FBU")KDL5QWC).C=+J+:89DNL
M.TC9T3%956E@;8FW?G!#%4N\9(ED+H)=%OB/L]LXP,2GQ075$#?RGK=L>D*'
MGDA]4X]6N*-3&W$>J%/[)=D**B?8[4E 5E@S37>DH[U177=JUU^FO)0^!/Z6
M\E ]W]+_ "=VI]5:'M"TI9:?.:.2B:[R&2H$D%'NDW1$N3[(N5,,52.O^S)#
M#$ELP7-O1?!##+]RJ9L4_:2&*'(V=<5B4@-V+RLEJ//+P,/BFOA_E/3NS3;G
M0.N4H3\79K-_O8)$TL.!4O7)U^&Z_@3%=C/(J.-U6;>_'G2'#$O$0JBIX/K#
M<N#)?B26ENV_'<)IP5O?I!K9>Z'@7=)@&JG#I]7R*/;C$HDDD3UY,=K)5[^Z
MP(_N70<J);+4?!K_  7"=E;/S&US:DQ.9<YOB-EBZ^!2]_#,-J:Y3YQV1J/4
MQ2.AJFN5'TSL$7K1WB+CBI,KYX!Y7&W&U%+W$KHHKX%M@&@W;<8@RM-,B@--
MJB65L 30;\5MI@Z529(/U@[@X8KF:IX>R7NI6O:_6)AR1)=-Y]XU<==<7.X9
MKQ(BX^FO)0^!/Z6\E ]W]+_)W:GU5_;QX99><1R9L\\[2BUYR,MMHY$S>#<D
M.7%2HD[GQJI&?A.@O5OP,1+Q@2BX/\J*8J5(DI9ZGS'XSG>7=&2(8^ P1"3P
M*GIR#/;Z<.7'E![:.Z#J?W<4NKQU0VJE2XLP%1<R+OV0-17UI"Y>Z=2X)1'H
MJNO>TQ"VDCM_4U7:1B2J<!GQDRZ^%UG=G]<1;JB_MP7!['5N0AU*"TI4Q]XN
MV388\XHREUFPEQ%/M*#BM#39!PYC41Z1&=3IHC29G 3UN<!77!&9$9DJD1$N
M8E5=555ZU7K7K]-^2A\"?TMY*![OZ7^3NU/JMM'LN^X(A5H 3XHEQ65 7MEO
M^SG?Q">"XISK?GP-59:4&:] 8F%WBEM?4TDD]DX32.%X2].M4UU<TS9J0]2C
M3OQ#^J(*_(-6/8JR!?9L.E:U[K[ZXJM"/(LQQE9%.NFOEC&%7(XCX7TS1_N[
M_8\$!IE,"(21>*$*V5%\2_7-F)C1D!-UJGBJBJHJ@[(;:<%>^AMF06\.-H9/
M!$I$[5$MJ\VK8Z=6<R1OW_3GDH? G]+>2@>[^E_D[M3ZK4&O-$J)#G,[]$6V
M:,X:-2!7^J-5\:#AF:QJS)8:DM$/ FG@1QM4\"B2*F&JF *4B@314EMKV),[
M6=_ )Y?['IVI[/&=F*]2C, 4K(LNF+OVU%/7;DGU7VM_L>-V(\.OPX%2OJH+
MIWLR7UZN&-HX:Z)Y92'V[];4H^R UZ^:YQZ_KFR-/M</+=B4[_,P;S'?[#"X
MK8"HBL@H,37BJ.S 4_[ +Z<\E#X$_I;R4#W?TO\ )W:GU7H;I.[R72!<HDW,
MO.0X5MP1>Q**;2B?>$VOL.*Y1WA56ZC3I4<1Z]\K2FR8^$7 $</1W447&77&
MC$N(FV:@2+X45%1?3FQ\C-E!RH]AN]Y0F,/1[%WN<8K?N,N\[G%T]?XL":^!
M>&*?7 :5(E7IS+6\3H=E0T)LQ]L0V+WC^N5BNF-VZ+1B:;NEQ[(J+HM<>I=P
MTZGW>*53D5$[-J+TDDS7,@A-(*>\CDA/3GDH? G]+>2@>[^E_D[M3ZK[0['R
M'!1*BT%5IXFNA28B;J4">$HQ"7W%N[PENX-+_&JI\:HN*LVV&6/4""IQO:3$
MSDGO.[Q/3FR@CH2[04I$ZM>S&5'[^$:6RD2#]TM_S8RW6_7B709=DDH)R:3)
M70HM1$%W']5(5-R_[$BQ-I%28*/-@/N,/M'HJ$V2IF3O@2:@O6/UO:.K?9:A
M6NQT_FX41NW]MYS_ /GP:HT8OL-,=?X]U)EFG]UI/3GDH? G]+>2@>[^E_D[
MM3ZKT7:&.I9J;-9><$=-Y'S(DAO[MI31/9VPW5(SR.QYT>/-8<;\[[&DL ^R
MX'MVS$D\>-G]IHP*;;6]I$Q[K359$5'$ZK+OT%>O,7IS9DFELYY>TI 7PK-9
M1,,KU#S5OUYM;X4A5+VX80TX7O@MJZ''']T-)97RP8;1+U2GL-$1.94U*9%R
M"(#Q= K=7UNEJZB"DZ=5)R^R;.3NA7WVV1QNT7][4N&UXLQ//6][>>G/)0^!
M/Z6\E ]W]+_)W:GU8;V?-Z]5V=181MDMR\K2<4X;J)W0AO281>Y0=SW.*QLS
M43&U28,(Y+P8EM]LC/"O<[MU!]LB'B=2)[1,RX$@X[K9)9>:NB^U<!4-/ OI
MO95#OD_=#1\UN]V>Q?O]7@+^;<Z!(;2+F;,<GLK)JG%>'C7QX(A)-5550M>!
M6M?JQ(V-F.]@UZ(+*-A(44CU W&$D$,9Y?L@"7G9^(,(^:9KG<075%334O 6
M@X_=-2(I#LW6GC<4!&X4N<1H3D4O6,N;P5BWZ7/#N?K6S;C3H"D&*]#FEFMN
M7(SKA/J[X$3GIXL5RJ,GGCO3#"*::BL=A$89(? 3;8DGC].>2A\"?TMY*![O
MZ7^3NU/JQ3),H\E+JR+1ZBM^: 2U06'R[^Z?R(2Z;ILS=[G&\:+*WH8.KP6^
MJ+[_ !PSMW3LKLJ!'W%>;9^RPV^<Q4/;,W="3X-VOV/TWLJJ#FMM!2%MW[3F
M/P8SEP94R+XE3"Y1X$5OCUQ6GFC-AUJ2SNG&R5LP48S&4P-%N*WUSB7CR]'#
M6RVTKK?[I(H7@3BL'ELRWG)1)+('9;(;M+(EWM3XW1)VSM581R#4(IPGVN)
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MUQ5SR*NFE6A"J"NA<16'HBBTONEQ=P84LKPJI<8!TXXUOB8FRF'=)<69L&&
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M(.CA""2R0S1J(R!LG5VV$P;7/>.NE4<O>!)0SB32)N?9EOQONU*6E>5YBH.
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MWZ_1?>K<:636BP,FNL26#<QU@*5!S FH"HW4'5%X3$@=0,"PD=>R5$LID $
M:0 !&  :05+RY4+S,TF1I:FZTC:^M J;XI2Q@I+D8I/"TUO&->T4A@GC0$,\
M*Q%,AFDG0WJP.U0R.U*QS'Q4YHUJ0^@TE:ZM9%.//7^@=[GX\^_7Z+!8:-B3
M46&!B8S4V;(<>4DH83CDE1>S!K$@BE-?E4%/U # #E@ 5<I*U=$N/SQIQ7,R
MQ4]]ZP)M4Q3$X:1CE0Q:F3+B:<OV[Y5!+-PO\OO3?33W*97QP,M+ 1:K!)SH
M!LVTY:4Y#,WSM10F\ ?:C.YCPO:M"1.;?BC@]:ODHK?9S%3;'KD,(;R>TC?
MN7Z_WN?C./T"**P$ .*+C""ZSBGL&9@DQEI*]"78\O!109* 1<8Z #B)H P<
MDJY76B94.S#^$>P;*I^<*:RQO6;[U*+7OBK[LQ1M F)HV.U:C-UY5OS?S2&,
M:U87Q-<V%:;HS:*1>?>LN=*27(C]*X(@]Z)0J-JO6!FF>#=&8J".VIV&/BLJ
M,XY48+B!%,],W(-%>(A.>Y 80*9*7F?KW>Y^/:^O*TB;X^A"&31H%1#TC#LJ
M*-FY#(FH<.S(%QLUPHPFB(4 000<@;AM-RFG-XJ0X;5#BBLUJ*6G)27UHIXZ
M\Z!>TYJRF<+D,E7RR@]J0<6BW%5KFW^:1+-JZ#\*L_:D6--Z+M50;>YQ60F8
M9G>M7;YI2 P6>E+"[LH=E2'6\STK:T:D3PBB#9'XKHKQRTI=#0!4FWBG7A5^
M$!C6YY.*[DU M,R(RD%D2'0;?7>]S\>U];>U)W0-80('T6$J5<[R>RS*&^%@
M+"*VG( 5%XN8$JN:FNJNZRO-UYN:N=*35.SG0=ZU6K:L[;TD7S\5=10B88WI
MVOG2DGA%(&6IEBH2'G3.5:1_TJ&W=JNN:TJMM6A.=*F3L%!3?/Q6F,.FU%IL
MQ[4B9##?G4,'M741K4$X40VYY*(IQA2<E_>KN52A!#0LH4^<+)N!?PO"E"3-
MF9Q)&1@4;"D<7 Y+>P;%8LV4UDJ1( XFPN0&(MI5Q!P686^I00F61*M=76B=
M84^QRTJ**FNM14</J7>Y^/:^M#'<7*GE)3>,5HO( 1%,R\-9^]U]WFU[&M//
MVJU3[JA2>^3:A[*#77XHS*8X;U>V5#BM)8FF<85?S=+=:EDFR@UJXFNF(C9U
MX[U"V\TR6;I;U!&!O-72.-#&(W6SD:MWR%_]JR=8CI7+&E!%MZC4RVI0WO0G
MBVX5-VT0M"7)#0@Z^=9UH4R,Z631J>-!&H#7K0 U% 3*.B:N&7D9WJ^F@0R4
MW%O"HL8)3WI*XBF6XUD4G;6;V@>$0;162%!U+T!T(;6FM-R]';PEPZ3-Q:Z^
M+!I"2V,DBRMI6O8C'L">'(C,"ZI*H(TSBZ!H%DHY?J/>Y^/:^M)QR][?JA%/
ME*;_ $4\W522[DU:IIK7W*[??P+!'ORH-+&CPK/Y^:S;RT;IW;[5DB]J8E:>
M;ZHK(FTH^]*Z3-.(*3F8I'54H=(HRJVDXW4FBA=>#;XIBQLFK:J)Y,UU$E,H
M;C8[49WF^CK5A#M-;N*MS2&D$!I[U*"8X;<**$[VJ&YX58Z]HHP):.&?@GVI
M*E<^Z*:#LIK;U]E(PS[4R(P"K6==7JL<:726[%Z,NL7.*O&M@ 2?(:!SF[S:
MU8-("S"-LR7&9H8!E+086TOM;+4N5$4G@LA(J&P+;[T_3>]S\>=]:4Q*!=H8
MW^G-26]YTK'G37M)K67*T4DK>=BE^ZGCBK@0KM]2MK6\P%(PD48E<-&^@M$9
MC2I2W8TC$?+>L&-_>HIJ4(J.J';>KA$Y?S4"U_:G$;?:M(+7N;[TEW2C4AQV
MU &D:;_[3A98EZ*>91ILP[.M XD$TG\$I[JU072*O,C>G&6T5.ZB 2S<J(("
M'70=%3\1LC&-\TJ$IB2Y6ID#E.&A!JM2T%NTE(;36ETJA8:]RS1I0-J6'87I
M&D8!GC4-Q""CFR-VYHH\(!8AS:WO"D4CJ4F"R-&;&0$S]-[W/QYW]?/KG0!,
MP.DY-TJ_NE:-S0R#BJXMAU:,#?,UFDI_Y6(>-&4K[U6L8J8\?FF3D?FE -K/
M2KD&"]2XN%1$Q?=B]6M^%+['XI)PB=:M2&&GV?-,"39EIBW*K1^:LSR$59$-
M;W XJ 2KF8O1AG05?9F7Y4)HRI $VE* D*W91ML4:XI>W55B'IW_ -K H^S+
M^RGC(I$[6HPE3OJI^[HSUXT-$8&%FB(7L)[5=UODZ5@7?=3-W"G&^W*K!1;<
MPM!E:@1D/E6=(L]VW2HA$D.7_'EJ)9I"F G(AT!YJR6[$T[]_>_O]+[W/QYW
M]?/KMGEC1"K!<G)(1:7)0L'YS0-J)=CA1CXKV:UESK@S4DS;=R\ 6(B2B'>.
M#-Z2CZJ%R17NV*E1 G-\5+<+6,E2&,-*+-;E-H*=#:LY+EJ=\3:\749&;PV?
M\J 0WEC;A09PUC:I\:-Z]RG4:5!K^*U:VS52(B##!HX4TE<E%9F:SGK2,-OB
MK*K,U#\.:.FZX_Q>%2-D3(I&H!LGPUE%\[J[I F>&B!V5=S)S :;*:\ #-X!
M#F,YUI,SHA";HY'&B($V"P9Y#/,'<FK04AP=*$1+1M>2HWH8R 'H25>26*%I
M-IPYY-W\O.L0@3,;A5U?$6I:@7OIF@ZS$T3)"03(GS0&D1=T.GK<,5@UDD\X
M$PMP$TJ/I7>Y^-7IU]>;"&7V\\3Y=:,U^8U5DK)7L?->]KSJ6(FIAYE$S(9*
M$BN<NM<'"MK&M)+:2]7JTG-P_P"4(4PTI!9+Q[*3$S/+\M:N=B3?'&MYI5T.
MQMO3_CE4 YK<5(Q GCM2-;N./^5>'0_-0 ,#^:468DVWT4DY$:XIEU_M1F)D
MH6C4MM)_U1(O%#O#IORK4>N]/25>I$5&H\78I"9F&?E,I(2Z4U#5%5U?X%QV
MAW<(%4N!"7!,S"B"0TS#\FPW.;  :RDM,VD[? /8&P%J82D-#,M%9D,3."@0
M\8T>/6G70'%.H(&SD;,G':T1Y;Z7^E=[GXZ>G7U\BYPPPSD9XN]L.?&T0WI:
MCF^G&I5EILE_\K FGWH(#72G#(J;71)%3\/:U#7K0L.,\Z*]LT(EBS1EQF]2
MVBKU#CR*;-1G:FY&:D6''S0 OVTIY SBL@P,4)+,BO5R[1%3G$_:G7:7I83O
M25DP4!M.4E;C7P":V6;TH!J Z!3)&\35HW4GBTM**F#NZ#VTV?X)XU;C2A(&
M7"A+$CD32AVRL6J^&!N62@M6R)DQ:,0-B8*=S)M=(7BFE$166R*&H?* ,.94
MD--,)R(9.D8L,.7Z3WN?CIZ=?7_JK8 :E49I3//\IK:L74*!/4U,\9I)#C3P
MZWQ4Y9Q0&]7B(%Z2KK>"K+%SM'2M WF<]M*+G0WS46\WCP.)RJXSFU%)+KYJ
M5UW-.J4VW*05&#?WI>-ZCAG<7:EOE3P!G4;*7$ZC$TN!QGA1N]FF0RB&_$KW
M3-$I(LS[4]5WXHD'1PI&".-'U,;TF3CI-\5@=-YGVKL_C>C67)&##)9*9$(O
M^5W5D%(W5A9126G>[^8BU,TE")2[#/LG6BC-@V&=6JIE) =,]@-FU+&/WBGZ
M/WN?CIZ=?7EZN?;FRZ<DJ LY&31NU)7",.IO,]=>=3::6\%+&(+&],ERB4(X
M4)+XJ%BG)O3Y',5"6\VZ.-7 F:9O+#3$=036$&D*;M69&PHL=^%:YJ"Y,A/6
MD,RQ%XU4,KT7+\I_=:4XF.M62#*?FF1I.^*F77,NM$+&/RJ9F-:;B#6D,:[-
M7I7()J_C0U&V8HAQ)-W11*%&D&]4(:04VZ2DPAH0I,ME.O/[Z_Q_JGJX(0 =
M+,35!$I7 !^VATGN!!<4!86M>TKNZ3O2C3,+U:8VHZ"AG+)%JZU!,-"&QV0[
M$K*>FM4.7F[_ #?WOO\ 1^]S\=,_?Q]!N^. P?PB&L4UZ(+%UU"+ZYJ(W-6\
MU*>UJ,*A69BN=4<"Z328>%-U(EFM>NEZ$7<:Z+1XT5RB;?\ &G+2NQ^JX[*<
M,ZV*EX$_>N%J_P#: '2<UKMK<J#>-J0*\U)RT5@%UB.=,N*+\'6@R7F:1:&&
M#I0JK20>WA&&S!O4=FK//_M<W;VI8AF*)3G6#=#.*CG7HA:G(E;)J!6[>8<F
MCR:)/Y642:,.Z0B:%PL:PS#[/!OPY1YJX-[3J'W;T,/*M%W+L15++/H@5-Y(
M;5&_O?FHA<;(&_(U=>??'Z-WN?C''[^/H(IB=$31*N5HCDM4< A0E/27\UN)
M+FI1G,4 BH7 #2[)+L <*3')-W4;T,8%J-W'C%"8<)>A-3HN#E3F2I1OSIZ#
MF^:G9DNJ1?9\4M'.:47=;TD4'"K",'C4]4PXID6ZSOK7NM66'1DJ\P7,SM5A
M=X<ZR>3]/M0ES;0X5I)$,VI#*%B.=.1OKSU^]0QKQVJUG*(-TH[E?X"@:?@P
M.I.J_F)^QH;X!3E_C!QE4+$M\ <:%DPE ='VT/FLC0(2?"&<1J;=3DR!F9^^
MO,H)YMVMT8?BH2J06WAJ7Y;T2U2=-XR4TT*=A,R*S3 $;8<OT7O<_&4WZ_0?
M^T#>S0O0^-TSQ422X)&CQ9&E16+T!2OU._FBB%N-U]^.]<@.]/(2H)B=2IQL
M7*7,N<5*"6)G$4I.]M\GS5Y.!8_!75&*NDXM-)9XMOPIB)Y*RX-LU&>YIMTV
MTY5Q\U<WMNI*49EFG$#?:DKG022M&=O^5+93KOQZTDZ8US_C:KW[S7,%=(K'
MABYV3091)KP4%QM9: '1/;P3R6+4K:5WDRQO<"1"-SP_C+/. -!*Q@'YFL8N
M,L#E7MF@@!)R^I/Q .$P!4HC"$45);SO^53QYN\J2&#!9@*@V@@I6/E7TQL6
M078B/KTFO)]G%N\VE/S**%"N;GZ&I4'FR^3(%7/) W%*ILY+#3 &&2:<OT/O
M<_&4WZ_00H#9BV !$JH#*6";5$^W,S)1*.#$2LG]J?9N<GK5Y;IH)AV_X5'2
MA=L\5EHYLHUY"DQIXXFC*KN&+[?%:9#/6B$0S,<M*!:,E+!O6X3M5XYWK9ID
MZT>K-ZN1.E0)W4VN;=Q3,"+JRVMK1A%Y"A%EKS3@?JI?=5KC0I+80H@D^^*P
M3BBTV][ F=DG0*L-0*/ RFN)-YANR^_\;:& VK7=W&%]0%(A<$="VCP5A;%1
MJ (2@Q)@L=+;41<W5WBB4SPH*7",7/6YXFN;@IO-,\-&@$DRW+^Z^,47JF&)
MC-B&P\(C>:]1"%YGDF1]T$4$NN0:\3/L6H*N98/(VG%3[M^^(<<3N?N_?M<1
MOH]^(^A][GXZ>G7U\8O6N::)7* XDXF;&Z*+?B ?IFW$&@!H#+ P"$ +!A 6
M(MM4Q*TM-+6*2J\EI;\*:<WA2UQ4/2DB&[3U"TMW&*3@O>C@(*B?93"@G2N2
MD#2(YI1<YO4E]=J;E9JQ=T7WJ2$)QUJXH]J";D&:'&[5B=:-V,4F:*)07KDR
M_%1,P/\ 57F"CEF>P-'\.E-#O(B""WJ,T2I5RJW7CUI_C%P0C;<)-#RK+00U
MD!!;)=WKG--X8!NB2BN9E\4LG],B$@P,J26@E#?9 GET R49#) U[!32#[MM
M[??--/>EYB$+82Y"^:TF*URD[)I6/F><LZ%Q&E("V#>/&^]$V: NG>ZTPU4,
M2G;O;G:32X*BR:KL *DD"5K79] [W/QT].OKTE%&60)[DT  K0]9UV&1HW$%
M\TI7!^P7&1,IFZ:=S*Z$(3M%DY4V%C_M(.A*.M"##O3(%^CE3[O\4E@:G[C?
M;_E.3"+_ #6S"9:PB=FD"-4(K!=*29"%$)ADFK$N:FC:6GI-R_6GSJD5#:(B
MTUUJ:;X8>U/W*FD\:6#[<M*:TXUK!%]N6E;@GV.]0 (@3-26"=:+'6^O.BDM
MZYCM6:&YTJ.9AP"BF8!'*P@FM6TZ]\:TQ;^,K7=3$.Z)T@*;MGZ*A4YO8[F(
MHRVCE^RQ2+I5NU>E5D%(T$M &RL;D70OGKQWJX'7E5^8(WF.WXHT]ZX5<6T#
MO[EO:E!;DSBQ4D-U#$->X1;U((7# .=C'Q1MUDF[NFD$'-!N@Z&P1B1%(1DJ
M/S3GU_>Y^.GIU]:7;^32<V8 56"BY#*UH"A.":J%%8[-2+.?IU'U!FGE_O\
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MD@F2JK*7+^:GC3Z(HR]--&Y,S-LS3"*DQ,E$$SQ8T]M2S(K7S.<C6#L[2B#
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MYFV?3=[GZ3%:'('V)G;+%CIC2"4ZN/OIH+/WU8T?/F3S0AL:VO:-HP<M?K#
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M[E]Z-LP=4N^]2^<I'=67.O6AF-+?4E479QRLT[T>(W=,  -FP"VSR +$J7$
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M "<Z6J>CC088DY%V%'"HN>H7F[@"Z0NA8K=1;L]%*1-3DINUHMN"BS^P(%(
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MSC,YA$F%HKHI. 3($2S,0C!=3Z%WN?U7%5!'$))S8+IWEM5P!=:SO9JXE-"
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M  "  &!F  !+WKDX    !7<OH$ (0!  0 1@0@(P @ P P@0   P  P @ P
MP 0  P  0  Q@P !)VX2-    &;& @@ * ! " "!B$ * $ & &$"   &  &
M$ & & "  &  "  &!F  !*" &/\ )   >>D$  "$ 0 $ $8$(", ( , ,($
M  ,  , ( , , $  ,  $  ,8,  2$  $$Z9 "DM @  "@ 0 @ @8A "@! !@
M!A @  !@ !@! !@!@ @ !@  @ !@9@  2@ !@8! +@<K,$  "$ 0 $ $8$("
M, ( , ,($   ,  , ( , , $  ,  $  ,8,  2$  $8 $)D"$ @  "@ 0 @
M@8A "@! !@!A @  !@ !@! !@!@ @ !@  @ !@9@  2@ !@8 !K@@6P$  "$
M 0 $ $8$(", ( , ,($   ,  , ( , , $  ,  $  ,8,  2$  $8  $<V"@
M@  "@ 0 @ @8A "@! !@!A @  !@ !@! !@!@ @ !@  @ !@9@  2@ !@8 !
M@R"=>   "$ 0 $ $<$(", ( - ,(E @ ,  ,@(!,!L@$  , ($@ ,8,$ 2$
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M.0$ ! !&!" C " # #"!   #  # !TV # !  #  !  #&#"]"A  !&  !%@
M! @% AB4 ( (&(0 H 0 8 80(   8  8 0 0 8 (  8  (  8&8  &H  8&
M 8,@ ( @> $,6 ! !&!" C " # #"!   #  # " # # !  #  !  #&#  $A
M  !&  !%@ ! @%  A"0( (&(0 H 0 8 80(   8  8 0 8 8 (  8  (  8&
M8  $H  8&  8,@ ( @>  !$2! !&!" C " # #"!   #  # " # # !  #
M!  #&#  $A  !&  !%@ ! @%  $(I( (&(0 H 0 8 80(   8  8 0 8 8 (
M  8  (  8&8  $H  8&  8,@ ( @>  ,)!) !&!" C " # +"!   #  + "
M+ # )  +  !  #&#  $A  !&  !%@ ! @$  %#(H0(;21(QM))  !):222("
M28   :2"(882:0 ::23?(8 $@:2($22!-X ))K(1V4 0!P!&&)4H "24DC.Q
M  "UJ_X "24DEMK;9)#;?_\ _P#_ /))))+;;;;;;;>VW_\ _)O9D"@*H).Z
M                                                       !$91
M!5S@?
M  ^P*@(S  @
M         @R!#U0
M              !L@)R                          *7A0
M                    ,>!*@                         N)$"P
M                          H!5Z                       $5<2N0&
M0                               $E&                       F:
MA0L=-P                                E$6
M #\=DP'_ (1Y!@                                >@
M      " ]4><(-+<$/:                                 T
M          !1_2 AGCV9[5<D'                               0&@
M                2*YH &6>Y)>AR_@
M "!T              #  ;"*WC%R7=#K_P!B4OX
M        $'H              47A;5WKD/ N\'72K)N(P  0
M              @F              VM](=F0, ,,8*6&[,;R$9J\"#0
M                   $$P             "-:HCOGGD%!!'VTS9H%9.$Q[S
M* 0                      @]              _\ 58&:&+2)=1%/LG[6
M8]A'&16*"X                     ! :              8JB([9IS0*K
MIUE_!Q"32ZZ&6[!<                     ($@             '(;K( /
M2#0&#$&)@H$:8=^?*G>4?&                    ! D             !@
MW]0!)A0*)Y8@X(PI@D[/9 7?ZH(8                    ($@
M     .N4" " J9)/*$?,@**\,  !S9%, N                   !!D
M           5KH 83/")!Y9#Y(E1U@P  !@=)PI                    (
M,@              +$NM*1"G!"*+('4-UP=M8    ,''/H
M    !!D               ^I^Q2#=99PP9 2HF B3 @    TIVE@
M          (,@               *D&MT!M9**&**%!K<)_H     &\3B\
M               !!4                *KD?#$[C18Y89Y43TX8@     U
M(,)0                 (!@               (F\4*,&1/"5+ "&S[L-@
M  $-0#R#7Z                ! ,               !^V--=LCAH*A919N
M?Y5*    "C0_OD+(@               (.@              /N_)(ZH;@^(
M/ *)$N\:H@   *SY/.O>@(L              !!T               ZX183
MXP3KA8Q ::N$9G     B7XH-#V"H@@             (.@            $!
M@G4.'+7K)39()0+".',     !R&[[83O2O)"H           !!T
M    LM4,ADY'N;[;8((0F5HH       @UI8_UL_GTL            (.@
M        (#A1$O!S*H<"*6+./$$D        *]:=L!CY&/9,           !
M!T           !:LVNCALX&)@X9(Y:/0E         ;<94$ ML[>#Y@
M     ()            '='/   P420" .</ZQP         /#ZA1G9><LXJD
M          !!8           ,MG)    ]ZH!!XK*Y3^@         TRPPV5K
M;@^,'0          (%8          !C-5>    ')-8'>6(Y           &$
M</H-@*8;S]H          !!^          !W6B8P    J728;27E
M    TU$$USQ1K,_$@          (/H        +WZT0F0     (9A 4;P
M          /%6'<;'/!NEN          ! /         %(%S==      )[X[
MF4              FMWPQ6+=0R+@          (,        / 4BR!;<0
M  (O1'               *A>.,6E$B:%(          !!         !XB8S!
MM4      @GO'P              K1? '^( ,+P@          ((        /
MB*2A[$?                         !'.@ "PX!$&0          !!
M     8TZR)P2A                          D\@!F[0 -R0
M((        $/L]0H ]P                         #%  $D@@,RD
M     !!         9*O4:  W                         !SZ@!J;; X\
M@          ((        +M\2                              "L
M"YR 7.0         !!        !,K!K0                           $
MAK+0  +Q !$:@         ((        ':#8@
M   !6=UN,  $    !          !!        !MF=@
M        'B5=R)P      D=P         ((        !<0L
M             #$9PO)&      !&L         !!        !%7K8
M                  !8@#K6A@     !/+0         ((        -.7H
M               -4,       0 .M'4      (I*         !!        !
M>@W8                !!Z@        !CT'(      (8P         ((
M     &FI3$               #$( KUD     %!/M]<     !-CX
M!!        ![?(1@              !<1G*.,      Z<CWB0(     N!
M      ((        *-WIJ             ,.-.(%U9      "UN(+-
M+G8        !!        !B9=[@           %  S6 !/<(    ( ^Y[MG0
M     !^;         ((        .PYQF           %.K+C  +        '
M_P F;5      "^<         00        =EL+N           !G!*(
M      $Z"!#<      #VP        ""        !GVZ_&@        ");?-Q
M           "#=TU       "+6         00        :(DC6H)
M72#X3            &[HR[8       MP        ""         "!*HM@1
M    "4_]R:X           "S;:?       "=U         00          (C
M(R.H      *]# #Z            #\G.$       ;)(        ""
M    0]X6ZO      N9 "(             3O6L        2Z@        00
M         !BX'5'<     1V0                ?LK0        9V
M  ""          ##I\>Y?@  #?!W@               !YEP]"@       0$
M        00          -NE!_P"C @2Z]%=@0              $O!.U6
M    %($        @@          $?N9E"\2JUJG=&80              %/3
M)4;(      ^Z        $$           #FAC,&-E.A^&^ L
M  &$A_/&A      ![&        @@           7B46;VN<TOHG_ .D
M        *G'O4,PA      %P8       !!            **[V_ES2Z3@!O#
MX            (7,]$1T+"@     'FP       ((             ! *G(
M    MC<          /?OUKT0 .C\               !!
M !        X_@          ")''UTP 9Q$               ((
M               -$A\        %K@\P*%( ).YH              !!
M                    !(:*@       !WWQ-A9#  !R'0$
M((                         +?\       $# *( '@^  +"#P#^
M     !!                         !<X0      !OA&P !NI@  B%.-,
M           ((                         "_R             'P^  (
MCH@B>           !!                         !Z5(            !
ML<0 !!6C:S0           ((                          %<L
M     +1G     *Z            !!                          !;Q0
M           ,Y4    !'@            ((
M .@              UJ4    !L            !!
M       *-            !!07    !=0            ((
M            +FB            +AG)P   !L            !!
M                 !GO8           !7/RP   ))@            ((
M                          X           !CDS    $0
M!!                           !6K0          !+%O#0  !
M      ((                           'CE?X         )MRIN
M           !!                            2;C#0        !)$1<P
M                 ((                            !<5\
M"D8@                  !!                              M9P
M     !Z_$                   ((
M          .@('*                  !!
M               !.V9!P                  ((
M                      +,"^                  !!
M                            !I0                   ((
M                                   :9D                 !!
M                                       !ZLA
M ((                                          /1K+P
M      !!                                           EQ2M@
M            ((                                          %P$^
M>                !!
M  K"&;$                ((
M       !P)!^ZX              !!
M                Q)M@              ((
M                    !SA-H              !!
M                           ;T/@              ((
M                                '/Z               !!
M                                      =<D               ((
M                                           #"KJ
M !                                               <-G
M        !                                              $4N8
M            !!(
M!YZP@             !)(
M       #V<             )(!
M            ![B              (!!
M                                 !
M                                       !  (
M                                            )   !!
M                                                 !     !
M                                                     )(
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MLP.QX^[ ['C^# ['C[,#L>/LP.QX_@P.QX^[ ['C^# ['C[,#L>/LP.QX^[
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MJ,;%6-DED!B&)8Q-=MOJ_)J"2J  [%&'%['8&&X6D%51,": @)2,2F,9Z?3
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MP.QX^S ['C^# ['C[ 28N8G>.)XZ:)'!$L1O&^_7136DN$@[$;&\SG;*YD0
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M1%2#$R2;C/?KI;JJ)8Q1:@6,G#>BP,6@EB)M( @=\LT/1@.C"&X!&;G000<
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M(F()5M-:M^#Z:F2LPWZ:6'Y89%Z80E<L!U D'J=!C<4NRT.W9[BZQ"5 D@*
M-"E0$9>D 2\ +8 :=$89@2(P27K*M"!88P3/6BCWC28J9B*'KRC.]TQSIHJ,
MO-@R!HF4E$PFAG.U"0""V\P@%9'(A^R/<R)8&"B7JI0C82,D'("('1F[C8&T
M%"BUX_.CIC91-S+)S?70 RQB"@$\;7I2=D(*&TCC9NLZ,(@BR8J@(SC=>^FE
M 51LUL #&W3C4L<J8G/$_KG,:6SN@- V BP?CB=CZ"XJ )$V  6IYB?M)<D#
M@)$HE49C3D"#E;I-EL6UR(A"" "),S(!/$3.2 XA U4[+E61-,D:A@L1!R@F
M1S.=YY@K8DC)"AS.Z>-** !<[&B;1YB?7!0]J "HD@D :5NAKWDY JB3$*)#
M"X.!3R"4@#)0"#9,ZFU?"JHB1(W,MN""#@;T,(W2  E1F=5*-"%*4+,MC*36
M@\;K$:XJ%"@+0F;M@($(!!*U:0#C)+&0@P,T)-S+,Z78OJ5<R*Q+$LK#;II,
M8SUO?^:RR\6J*A2DF<]]]-"29@"%$9,ER>CJ/S,KZ*Y(8$H,Q.LM4G($4JI2
MU@$*R5=J<7D88C>^4K5P[$T3(MTK+G%JQZ6L(/0R"E HRZPTD"B!AB-D6K2F
MHV3*EJ$&40-ZE.N0P^)B2RD0A RFB>T#D@,W<J1#$3OMH&-Q!D0&UF #0D28
M$HB9Q.1=S3%+:;,A+-23<]5.=&'H259"1OQ1M3J/MYLF* P-"[&$#0<A-V1
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M\WJ7EUO._._OJ#,7SH$#!,%QT^@L#<N&S#$ES%\G.C"0 Q?[8J-()1$A8*F
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M#$,B0!"@TH/$BU(&@$@H4$#3(# E@&1 U(0D2%3@UQQF88UR+:8 :%)60H
M%8V(B W7+L1M<._W8'8\?3 ['C[L#L>/L^2X:^!YU@=CQ],F)W_3]<#L>/X,
M#L>/LP.QX^GY3I@R@1RU>*]^F=*0Q$=SK>=_:(SHPXQ3%0YCOSQ'&A"BI4B
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MB1*.SP0V4$[+E*,*P,DZ! TLPQ4")8E,A3?C(8*389@F(*$P&$ X= X2Q!1
M@PW06E],,H<A$\JJ;E+1,Z,(@2:,P:FQ%DW Y"T-VC9FAC"U!+,*RC<QB%'0
M*8)E(!8I$(402T1"F4 D957(%"%!+N"8[S@!JNG.@'L##2GE,"J) (A$G(-"
MK1RE59!FXN8VG2'I!$TIUO&8;0[P(*E#$*%;-[03^2=!D6;N(,R$"[RG5-U+
M:C#NV[=-01$5,QM/,8GKJP,!D]8*SP6Q[T:A,J"JI%,&<>D1C1)+* 3$ Z(*
M,\WJ44N;+&<Q),S3>F#*;;0LP% H:D J"AEH($($2+8A)-*FW'8$&4"0B@K
M1:&Y*#("MT3'5#,@M2%-GE$SZ,5J#,"I<S5<3D[>FIXA**&6(9F5EPMK)TTN
ME.[7$-A(34)[%94R!1:495( )U* F[J 2!&XV<FD7&G H0""(*E%%I]P^DQ>
MW;U]=>6^8^F!V/'V*(A4+B!BYX<XJC3'R4,J,H" (2,(I.G$'N2,EX"J46R2
MZ0HH2MI$+/)>([&D:8)"0FTB2,W'))PE(,)I#=21B6%&DR&F1E?:*1"4QP#)
M6C\40#F"&8Z25JB1F=0ISF9G'ZT$!)#2LE&\;[*7J  #2@[)+K*%;<3H$"*4
M94ZIS!HJ7TN,[DH1O1^(#QHTFAB+0DD3 4K! 0>D**BB#Q"1$9%FF,9.3 (6
M*(IR4!+2]E FR!(S)$+<.I%9K<$K"&\._?;5XI&P3,LH9)Q/62VO)DP!4H,:
MB+3"2!/=N ,9!$9$(,1J"B/7N!&CLA4"$3 $$J3 0PL3/+FIT:X<64<"PXJ:
MA,#2$*9;"H'.-IAK8XT3V%9,H4H6KFHB:2^*@TQ=DP]"L8WT&QLU Z)0-;)"
M$V\!<K($X1<$R-3AC8&(D62[#B&=.)8:BH!(DEA93$#V;K%E8 )>*$ SDBPE
MB]%H(*W@QHT&AF QZ^F*S%:,>QXELA'>F<<3,J8E2G$H$K<2HS(+^,D:"DUD
MI*+0 "81>H@Z@#:@,Z%4RLY2 6(53Q(U#CHJ*(Q6BJ)I/)%VX,JW)K'V8'8\
M?3 ['C[L#L>/N^2X:^!YU@=CQ]+61W//\.!V/'V8'8\?8PENHIDVE+<<5RZA
MV',=L0 <X29#),IBA'C.:  3[.-M;6.HHP$K*A&?)J!!5.!@Y'8/3,:@;8 Q
MP (B89!R#1F3=(DT%/E$A-09TM)CS0AEL07!:3*S:!#$D$Q:$.)VBJ7PX1(!
M"23DPNA CI'A2<DLL/1)%:)D 1D0!S"F7&H$1&AB $I 9(*F!:T?0(;,TMM$
MS[DVFCUZ2,BE+*H30(D-3)U0!W(!U [LH+T7AC/"Q(5@@71F7"->:H47@ BC
M*@&SI JFI99HD*8H 8$8%P@$3#(#/'7>=(*9*<E%+0($#$#(D(^PH*2@0 -#
M!@@E)\3G!%D69441%8- *,HC/A@!40"@ C3YJK&IO%? 0( :8J-TZPEH6!0'
M(0="!&*9%!@+L:5VY5[4X,Q$$IDL%B0H>3GU^BHSL#1A4G1/W&MVHR 'G8F4
MD05"-21+<F&CC6E$P@0;=T/)!E.66"*52]M':%!A1;))>9E,PX82"!8@9-<!
ML#,KT9!P20] #"@8H(TV'2I-0/S*JJRP&DJ?I8H2'0 LF45G2+I-@2Q,4QL'
M-U?+=20JF2:K9=YGV=%;IB97) VD4@(@D:*%JM"D*+)T762Z4 (M(K(8DB!@
M2C_GM$BJH*P;$S6\/A-Z7LQUC$8WF:  ,0?3 ['C[%(D/6@EPP0"BF09 675
M)0B6 R[X<QB0ZVH22 LDR+X#3JL(.BW6ZUC3H0VIQ)9()C$[SG4R24& P14A
MF1)8QI>4@1N[LBB%M;C&D3GP0=3#8KG2\IA,5N0A L&HSZ:4KHW$N,E!*3#6
MI4_)1&8@NT\G74>@,@DX 0@P "!#TLJ2 204A)9854I9FYA3TBD/ORZI"$EA
M92J3<4@+J-'B&D9HB() #<!T$!XQ&B,$LF&!&Q>RHR""20 XP!,9U/$((;N:
M !(4*,EAEK$ E 01-G#,0=V^H<K%=SLIP<I)=5PY"BXE19 <%!=)P?0YB%)2
M'),\1I^-9D4-XD@5(@= 1;&Q@, 1*!4XPNUX9CGJLM,D5571'P <P<HJ*WB\
MQN_+S0"51(*R&8#]#(G,EBI&2&D,J%9+!2"=(9@3D,AR,X([:U)!TV4(@H$3
MAG0 1\$ @#:O;08###$F1$$%L$$9U]5!U;<93Z[Z9PHK0FJ)"Q90IU$E481R
M8WG:^F(1[)MSD0 ( P*(TH@,LHI",F#!6$T;5\(C0%P"0-E"BABT4/0!(4<S
M3H &SOGJO[,#L>/I@=CQ]V!V/'W?)<-? \ZP.QX^@?P/W]^!V/'V8'8\?9@=
MCQ](,Q?.H# 'IJ7E]WZ  ! A(8>YJ"9@F(F+CB>-2U;1!>#@Z:@A((64V7E.
M>NL8K4 R$/.^H%E)>=_H62NC-Z;9;<2VQQ/U+";H;YYU Y)^@IAC:JKBM&#L
M?3&--YOO?G3<3<63</)QK#)3SO[YU+R^[J#@]M8'8\?44PIV4\:5<J]]==XB
M>G';IH$""(/&MHVXV]M<=,=(Q&D,$QB;CWU'4@0H8-QB2^*O.D,(@S!<Q?H&
M\&=4A(1#6XB,3ZQCJX.HPT+AON=-W;2X5*G3)6I>7W=2S,WSO[YUSUSU[ZP.
MQX^S ['CZ0<:EY><[\Z5<JP03<'';7_GIQH $ 4.#,9[ZQ9EI>3C7]1Z<=NF
MBK*<2<<:ENV\WGOSJ#@Q&#'';4 X!P9C/?16*[:VC;C;VU+ST]./I+R^^BY-
MH$+;SG.;^F\[\[^^MYWYWT   ""Q4L9[Z58%4+!</)QZ:(,CC4$L&TRPKRN(
M,95M3L"@7J,UE@G%0PIHP)!#&ZR(OB !$++%S53:O8U0/*3>W0XTW39PWH$%
M&#;IJ7E]]"F%.RGC4KEG4'!6*U*84]=%A-T-\\Z;MMQ+QQJ#C&.FI1D6>=]=
M1>;=%,E/)3[GUP.QX^F!V/'W8'8\?=@=CQ]/C..O@>=8'8\?2-X'[^_ ['C[
M,#L>/LP.QX^[ ['C^# ['C[,#L>/LP.QX_@P.QX^[ ['C[$D4(*%34SWB.(T
MZ=ZLQ !4&Y$B:IU"1,&R((8P7TZ:#)T@B'!! @  (U>^=^^_V8'8\?9@=CQ]
MV!V/'W8'8\?=@=CQ]F!V/'T+[6Q%H+(("@2N5=/KD):DDF$HD:HF(-1P@!]'
M001"#F)>YH0;3)Q!@3!ZBIQRT#"5'!M],#L>/NP.QX_@P.QX^F!V/'W8'8\?
M=@=CQ]/C..O@>=8'8\?2-X'[^W ['C[,#L>/LP.QX^[ ['C^# ['C[,#L>/L
MP.QX_@P.QX^[ ['C^ $#!,%P3CG[,#L>/LP.QX^[ ['C[L#L>/NP.QX^S ['
MC[(.-2\Z@F8LP[ZQ9EI>3C6!V/NP.QX_@P.QX^F!V/'W8'8\?=@=CQ]GQG'7
MP/.L#L>/I&\#]_;@=CQ]F!V/'V8'8\?=@=CQ_!@=CQ]F!V/'V8'8\?P8'8\?
M=@=CQ_!@=CQ]F!V/'V8'8\?=@=CQ]V!V/'W8'8\?9@=CQ_!@=CQ]V!V/'\&!
MV/'TP.QX^[ ['C[L#L>/L^$XZ^!YU@=CQ](W@?OZX'8\?9@=CQ]F!V/'W8'8
M\?P8'8\?9@=CQ]F!V/'\&!V/'W8'8\?P8'8\?9@=CQ]F!V/'W8'8\?=@=CQ]
MV!V/'V8'8\?P8'8\?=@=CQ_!@=CQ],#L>/NP.QX^[ ['C[OE..OCN7ZQO _?
MUP.QX^S ['C[,#L>/NP.QX_@P.QX^S ['C[,#L>/X,#L>/NP.QX_@P.QX^S
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M8.WCGC8*[@N@(F[*E-HS>HTJ "F*_(XDZ90 @5+,I)F,5UOM*TX,9Y8XC/\
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MQ4(-J!-;K'6]!P69@+N*@F(G;G3S%6B617;%PY )DT,@\@WF[N;]_P#X)X$
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M_,Z!M[1[:Q\-_I@=CQK ['C22#<7Z$5_W2DB,D^*TC)<&]X-8O3P:P.QX^S
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M]/\ /!9O:>\:G 5A!B<A]R>L1PJXR5ES;.]S1I-K$XY)/Q^.F-*.H1[N@([
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MR4JS#R_CT_&G8$&?S,?N=2D,LV!,!5-8/.L\KD00M9D7L$W*9:E>S"+T)U;
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M.?F<Z>$5P8Y(E@XWVT5-!$HX5::EQFE/=2EW(WXG1%T2(@(5-V%(6X]]":O
M&6%*4D9U<391TSZP8KU=0EE;=O.Y7]:-G;:ZQX_.F1#(0#[1ML-:0'0Z_#)[
M:L3.??G8GO\ ]TLW[?\ D:9)=Y]=*K%C/3.V=%!V-8O?]&L7O^C6/K_6A,;0
M#[16I-_B*_[KI?E_O70_+_>BL+!7/$U_W4C'6<\S7YTY>[Y^@5(%A)BXO>,:
M9(DFJF_;.E4]@4,A+OQYTH8":2D3 *K302@D9T3=\$S)N: G "+),#294IB9
MN;[S;>CK?^$*G&$ "1!8$X$A7B%(L7@0P19W]HB>2F'L2=YH],"^SIU"BR0'
M$TPC:D1Q>G3,Y2@8B&+--Q5 &F^2]T: H!D0;0<LH" Y&&2+&Y''9QIF?$O3
M+^..L[:G4FQ,5C=S4=YU( 8DS<3BJ17;%1H3EAU3E5S"QAI]946X%6B+,T.,
M=(04IFL+M23)MGK>G";4T,<OIM.,]= G8@G B[*L(0'5;@0@T*R+576)JM3@
MZ9V/>D[6Z RS"(B;8E$F(6,JFIT9A#"84H&0)LTD86 11S,L]&$>WCW?\QY\
MO3_+=V4,%"25W J7$$<&C0*)H(L#(9B6A6&HG3)(!@& IK8]]O34(@X<1=5G
MF?6=&!M*<H&4&"]NG33L.!F#+K!#X.-3[@P(O(LF>-W;2=JLC ,#08=GB\1I
MRR ))F$L1)Q<3]$8U$<)DED&%.5VT2P,",";O[?6M*4)0H5N/5UTOR?WIR&(
M!GVG;G6"7;W*Z5/OHT&*(N;8Z;\Z0<^77=^/^Z[OQ_W2 53%_N)_&EBKOH<=
M=10.Z3ZQ6C J]OQ'_N=+)-1>W]Z4IB:C2BW,>/UOI9A^)_YH(3<WSSZ=<Z=<
MT7/2_P#W67<?2?@NNDY_\>F-($KDH$CHO<QCMIZ=B""(DM P .2#+IH2$U$R
M22%T.88%SJ1L(&PX&P_PDE%BO$0;9HTS))-Q  #OC..L3$6@5 H(K=B\#)E8
M6"JP>>!$WGEJ=2E,D(@K%638HJ%RQH)#JJ* 3NJE.J,(BF!ZE[%BL!P!55H<
MQ8,))!V2#NY07,:<;.-0WS80AH9G9EO9!Z2N7:.8H0&BVD29'=DQV:D_]U H
M@E6+"3+G?B-&'P*MQ,(S0\Q8:" ""8ZF_P"^<Z)1(,H+B-P&*$JP9HCPM%HN
M.<5C'&I!@)BE(0)MH]FC&J'R7 "T>#&)LP0!S8+"H;1>>>9.LYK8ENY83VL/
M5W>Q! LF  I#.*88"V9TC-E0 TB"J2$([HFC($BF:9PU7XQZZHG XNH@S?3I
MYUG_ "GGR]/\F>_LZD&#@*[4=66[B,7J;T$DH!.I&%(PW4M+$22:?KMM^<Z%
M#PJ(:F[X]8J=1"D1"K <Y8)O&ISNT:#D5+=)3[:IG5"[*6('F%&[>D=[G"IG
M+KQ!."(=7@%?;F;9;#+^]?GYZ?00&2%-<35Q@FD\C,-'.G& $55)*HB\QH@(
M"R)/7.-"<0]D?WIX&+0GXIXU!&\!7&.MQI,"V#]5H2"E >]:)@SDG'_==WX_
M[H9.9+O/,3H.,J]OWH1C=8[$XS<: '4J>D&F ,YVU# )S-?./<TI9H-M_P )
MM6D7/[XZ,])]-/)G&_3LS_>D72?=N_\ FOU:AX=7Q%*2Q4DD1[SMW%I"(S@D
ML1M1%J(&9%!5,@J;JWUO.-"$=I5!6(KMZ'34!1@H[&/Q_A-%$2O;^[C?4)$)
M'%B)* 8AF "R ,*#; \4Y)288T:],GHE4C(F$I(C4U5"&2"A.\043LFB]ZB#
M=Y2&134S&+ 3>!*8B%PP0\C#LWJ*B,D)J,=V=-*YK0I2H6HNF6L843/4$88!
M!QN#/_--+85L$5N^34]\ U/#B*SM[8C8K@4&HJ8S41=MJJ&]3+.Q,IO(3H>H
MF)!*"SEV9@(W9U& R@!4-E><%XC9T6NS!"#%/YS,^NIBB)6*)#?1Q^-!+HF)
M!2"!R ABJ<S(J) A!@D&$D)SQ.FEX).*6[%%7OMC10 ! TI(I$PJ5)J\1,NT
M](H+RJPB4!26VT(ASE)F)+)O'=T4!Q_E<_EZ?Y-(3$&\K/& KK!D--4@(,U(
M6'=1+%61J0PA""$-%8M8]UG+,Z5 DC&9Y#?I>H0("4" .[ B-Z]]-JI@5@2W
M>X$;[.P_UI8*FD@[&.?O1E<B5[D.D@I"K(P!9*Q%HL3+6EFG"[-;4X^8-B,N
M%]?9\WA$(:MW]^OS.@O( O>N- [;3OFM#@@J*LQ[ZZ7Y/[U"!+ F]=GY_P":
M*EQ6(Q^-?*/^:')P1..G ?G1SGMTXJ-JS&.FCA%]L_@S#S6@7,<=O;\TUH,Y
MG8V_,:4PG_CH@WAN(4A9(SE_[INB!03,2$2L>DOE+8E0RJ$$32,3!<@!9FV,
M[KGUZCL_XL4+X3N_LTWV#'P%&5"BDRKFDT<T,!.%5W,L\Z"8"&@40 $4T*!=
M9!%G5E&TY.^D14,&)'W$>HS(7H'C9.95JL*9*H0*P*7!1(ELB[G][7IE&027
M=+I+XKNZ4$)QP$WLHD5 (IID6 "1WAZQ[?FHU8$$E)23=!@0VP82+J5%9#"F
M[.2)]_1),U@+K-1/SKR,U<HJ=MWPYNM(ABC($5AB=DA*ZZ7$!(0",JJS&>>=
M3I8 (F0+&PVDGMHR047@0I*,6KF?UH/T @P8/,P2E'(D*J))1@AQ?K'R-0@9
M80GI7+H"C826#)C,8Q<7"IID++F2)GQMV_RBX6X.NOY>G^0"L!*T!:O%:&(H
MS2E@FA!H00QJKI "JXE>W7'-:AJ1FV@B#(-1CCH: ))C;''?1N[(R"!'*,D[
M&)B]-3;9IM#!. G?<ES+BN.L_G?OO_ -IMXFO^=O[T';V%23:TX>I"[3-:4>
M\A48B5=J,XGU-,)Y$0%>+CW8@C44U!<A$3%,^BZC8;9*[:0G8Y_I\Z^%_P!:
MMM^?^:[/S_S3=N+Q&/QKY1_S4$V9CY )/<UU/_:X/$9+O4B!F'OQT>F^EM)/
MSMIR+5Q#!N=/^[Z,! &I4 *WZ:+A:R@$&*I)60C9HTV7#G$1( [F5+"8QI*X
M8V[<7#7?38%!L;3^_'^*HB&&9/3_ -T K* !,*U3,$.49%A-FMCPD#8HS'6*
MP2NIY'&J,KZB"JG;TT7P2 F8*J3-,B9/;12+CV,9XK_W4K1SL]2J>^CEIYMD
MEK'+J<\D; 7N?D9TQ<A)0IERI6)=M07L"&XI4FZU+\>!D;N0Q$+6\3M&BA'-
M"=FY;,!O3>%DT%E<9SG&9]=/6%$8F82RX@22+6E"DE@&58B!RY_Y.SJ3QBP@
MBD&9BVM[T@2C@H"+!J<2-889-MD90$MEQEOG!J7[8=(%HF"E8+%3 AX!*A0&
M&,@S-Q$ZP)1328C&WCUT:$5MDK9%U$4J;1:U A$,J**@0;(5!F)-&"<P3_DT
M"EX(N"A@EN'IQ>G+W?/^.:02S*)8F '99J!9GKI4!"$2*0%PF7( J\N@2 D4
M!LZ4.9*-9R$)4A>U_N>-')D6L]8Y3N]]2),S%+>3J\5ZZ1G*J& "\%\35- ^
M2HC$'F6YW7:]! '!'M_$!.02<YV^>=$8A@*@2P%(79!BH7."< W6B,G2]ZK3
MPB713#O.8BS.+YT=!M%WMOC06HECM^M-W])_,7KY1_S1AG:'KRXGVT)8^G_I
M/MJ%I2LYG^X_.-M,G,>DW[=O;1"8;IZ\;5OZSJX#!B(D<.E &5 IDW/_ #;1
MDX3"52"4C C$C9,2.EHL2U1LD..P';_($8$GL7JNF"S(J ;GEQ((DB512&\R
M*LREZ(,1N8D><3X]76Q ]:UVGGG=719"$.-_2)QIBDAC.28[>V^-(@-+<')R
M,?O.^C &VX,B(B3Y[Z@Z$$,RQ3,YZZ-Q8$&A0:.6Z,",(A,@ FS).UH-^DIH
M5F;.[;]&B".T3DF6V:*Y%ZKOI@JG+6B81">43HS4FM5%!0!-5=%VZ(M) !0@
M F4J5:<Z*)"# Y4SD[9TIQ4%MAEVYN?3,&*L\P"("9B&R,).AY1N[;HV]?;1
MCF((;8<[8^*U@ 5QB2[$YK/7-:F;YOW_ ,E4PAT(PX8*F\>B;$06*.,HKH'?
M;_'. @2D0>(VLT)58!8D0"%&*D/29<2LSL:H$: "&^WKQI<18/(W/3_PYTA#
M-,&:8"",1<^D:@";@I>.+VBV-)=[MU)=;,9AB"2GT*1',%>E>SM.EE7E7W_B
MF+^?/F-2S*=X:]MIU$6Q0TG"ZV_&Q&E1"42&B9>6QF=N02!,B$,C)R4R=ET,
M$T,6UG>$_&EEOYZWJ?#\?-SWUG)LGU]B/>8T\1ASW_$;;Z)B\POSIJ7)-YQ7
M:;U:)J3?8COZWL:7M K",Q*V\"\9VC3$F(* J":&"66V!C2Z96IEG#LE=WG$
M:* X_P B.3B?'CC\Z0I@,#$K$[R0 3#?(II!$4(I6"02;)"!2&331H I(0A:
M#=Y(BYB-2+*@&3  9Q^8A[:GR(5@)X0@HB90U4681 JM1$S8J[F'.F7(+ :E
MR@[7GF=/;@8)1"5$*25*B=++'95,)%":@)*A)7,F88(067N1N3Q-FD0D).+E
M:$QTG$;Z8EC$UV^B:NXPV6J 3N#QD9%U61X0 1"))A23 "QH02*J492DB"FR
M2:T,E$+9B6QXC@G%]ZG,P6C)/4B=_&H",* X6^*GG^QZL>4ZN:XQ^=0?A20E
MD;B?C.JGH5LM5>V0VJ-.YM7%LD\R^T1_E50S9L4&T!B[8WT.I)F[N3I/%?K/
M^$64=Y=XK^MO[T1<D*DY$X@,6-$+%&DJ(MDT1!M-;9C"5H?L&:-! JW&(25!
M"FB% [ &  E."S-VDAHPR8S"O?;CC]Z(GB"0<'A,[;>^A&WX"0D+Y:.NJ?W(
M*$@ Z(PD!"B ZMLE)+-5\ZQ6E%%1J3F&.DS'Y='E&\%M>E?S$2J2=P6T8B2P
M!%S-AI<B8 '-3+4V4AQ.B(<J+"-"J>Z^O,DLD+J4_P!SI"(4?U\#VTLVZP.Q
MXT22,[X)<PU\_$ZG"83=J>.-NW3360DC))$P+M)/$VQ>@A@D!P;)PA-D XFV
M,,Q4S,Q655[J]W_,=_F]A1EA@ D\@)$6L1A$0:FAC#R2 ;P25D@$1"$CY&%J
M-(3!$K8,588B8;3TT,."X3A)!2-$Q4S (TV\GZ%() BH0+"PE'2(E55E2WRM
MSH5"D3"*)V2]._3;MT";1_N<S$R^/!0B82*25PS.DXCG(D+ .8!OFN4! !8
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M=! DIGO"V=\U_P"_<DPNUPB0T"-5&,F31^  HL(!.9&3(Y)T7X!)8BZFR/\
MIQHY)9L01.4MAJX)@J@B$0S-EW_Y[.C!O]-SLWMDU=Q )6#(588B7!&9!T*I
M-R%:A8 $G=2@,B**<BP,HS2I"@IB)60$10Y(6G'C_5R#4@I-*ZNG$7RZ H(K
M*:)N[@2TN+U+I,?9%E+B=PL+"22)@N>B5\YT,X!),276,_\ FARB-%P &Q4?
M)G0#BH JPMDS&)@V-&HH9(,V*1M^")472$$Q%6595OW_ -XER(&03([[P'QT
M]E#2PH;?O>DI- $LPFRU.,[_ "=5<@BC&[!!@(Q]XJD8)(3A<P# $N3#)!J$
M*Q8,RB1,6R/$.CL;*@JFZ)7:5+WE@5LX1TE!/K%:4J\J^[]11D43"4GKHM%M
MR603/+WG?.C!2# A(%D1SZ1@TQJ60H9**&F&-UY- 2$4$,3\^;'^IS\XKOI=
M!F4+N($3%XA4-I=,C!\(@U3,,HQE"#-:)63M79,])Z[K.8TRXA(7AA15T%>V
MA>K $C%4492HOJFFCFHT&U0&),I#P@@@Z:84DF,%E2R15O#HP;5CC_>'(@8$
M3C#!O)OA!G5,JGQN;]:]]7(6W>W<?W^-'&BG3@B_*X@Q.C!M6./N 2*0)Y=W
MUKG&I]G4"[&J!&,3O,MN(6J6QQ",.P;R+>H@CBN<>\_O[82D:*A$ $U:*ASU
ML$5$ ]WF^:_LT+B L8-Y4X41U&HTX)N_(_U1OWKV/W.A"A&82V(1JRWTT0(
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M#.$C' (:#"7$I-OXS/A5[$P[#WX]/QJ.X$<K5Z,]#?3E$$U#<96^U\=),U@
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MRC+*5]?H<.F<4P[)".)-RDNCPB "0;AWR,01.\Q@9@V#"_0OC8&"Y+#_ "0
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M=)-,0<QO[43W70#)@SA7ONYY- G$<$B0B(<X,3/>=8'8\?9("%(#Q89Z9]M
M6 ),5"Z_/1F8G00P%&9(,XNO?WTY0"042R*@F\,NQC_Y8HG"Q/!Z:("!184@
MYVL10)8&+=!-ILLPQQ?RC0N0#$!;'?/,3UYTS>*2A![J5F$5;9C1(HL9[P,>
MCMMJ9MRV^O\ A$3;!NZ) 1=@EX*!<XS!&EB^B,W-B]_S>4&;(!,SB&\\S[P0
M&F#FBR'=(GCCL:6$5!)%P9 )N5"HM0T_,2E9&5A)RHB0'(0JLKE^JOD)EL61
M]HB_$:?RDD>IMNQTT\-2#%399_/OJ @DC $MRQE7U9=.7_W\[_:*,C"6)D>=
M"))NA23+D[OYSI(VF+ S%Y_)I.0P8F24V\7;ZSJ4-BIVC_Y2X0Y)]_\ S49Z
M:B4(D D($# \87JS.E3(1^8/D9WWB426I:AF$OWYVT 05 -L%2)6 +H!VQ_A
M,/9@8$$PK% LYF:#9$HD68$=)6.>?:BH1":! ;H'7.V^C01B:,P"6>D8G3JF
M%K*N8P!FS)49TW4D6ZE7>^>O_-1MSA7G-!CUZ::54O'L9[:B*XKV^BB(LL8A
MD/I*N9L::75DSY"W$Z<ONI^6^'V=)1(P;",),/"25(]3)\^8^Y!F$,N8 MJ!
M'LD5J9Z*Y-G.,=W_ *)*3 HR\KV$$$(9T%A].T_G)OHP=C_Y5<47<@,I2=LP
MU8W09X0PVH,[SP?G&KF)F49;F(OUXO1JC !$C9"JN>Q%VU^?\"1/3?\ [.@.
M1*=YS8P$-VAU8T10_"9!"V7&7GTTK14#9 C@Q&_/OJ?&6'1:@-L#.Y R3&M5
M()N K 2A4PI*Y(@C$5M7W$'+6*L^%GTT*3_L2'@TIW!,]Y,UQZ8U91!,K 20
MM!$],&G+W<8]/NCKEE5 @K'!!8JB!T) ($1QM,EXZ]M3")H8M"#$,O,SVT)V
M<1H4#9LFQ7U:+R%1,Z.RI[_D- K$.-Y[)&?D:*D";7V-\7ZL8WTQCDR?^>CT
M30_6&8;&J=S-\U<0&K0$A(9F1Q7$5.2T192OJS_\?2G*>L5^*\Z!-4+8)0=H
MQQB]]2JX3A<8<77<N=.64L $T4Y8DG 4WLY>_;_ SH%:#H+;49=]KK&FMRH@
MA04F:[KO19I8#WH,"*RRO#.I$@R:55N-RLMSWX Q50]1Z,W^>=)%$)D9@<7V
M^Z;VJEPEQT1Q6@/E_(_+SI&(7&S1?GZTSZPBJT"PVQZ^VC!^L>GW2PI;Y2"'
M<HXN+31DH),(!EZO.(22'0J,1 +(XF9HKEU//1>6=YKG++[:8Y C/D7<<QVZ
MZCGGB!$Z4D>^FD$B)447<[C4@P8T)-%%1)AF!-YV)3J/G%X&"66GOQ#G4@-+
M9# +&2"0=IA#=)F^;_\ CZ6AE8]8_.KP"!""NI<S<%J1OJ%I2,I;#+/4^7I+
M=E4L3!"< 1O1EF"P['^8<Q,RSP(KTFNYR: /B68C!^U](TD+CAC!Z?'K*_$I
M[D9@G:6 GTJR$3+8\I7WR-ZX6,S<,Q/!;OAU*]6I)&6<S"29XG4<77#%>=MK
MDS.316@0(,W<!X>^Y "4%"HU,2$A-\.^)>H;,20M9.-LW:SI#IJP%-LTQ/\
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MMMYEB::[8B@[\^=0HPZ379SIX%P#H2Q/&_LZC[8D@P,XB^4\Z;D?(,*U1@;
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M# 9'-+:S40>L3(@ C@C&WS&-'*"8;1L$?F= E!9$]!KYWU=,J7V6\T)%=O\
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M0'V)AER9DFQ69S>H8X3'SW/_ +V'6@P2,0J8<1Q#F3B&XI[*A(MN!*VKB-/
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M)9X;.J&VFC&=&9:#731 &NSFP31,^S]V#<64@*U1JFBT@D0!%D\@@6>ODSM
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MI21'/>-3&)_ K!JA9:"1C5*,FX19*A);G<O3D2:+ZSO$ 1J]H05[=P5E1LK
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MWW^[ ['M]BL$B%&)@(/S?AHJ-1?1U9!(QI0 $5$! IC4S.S5Z)-WKND,0($
M%:&0:LVQX?9D]WW_ $L#L>WZF3W??Z K!I.-J=XJ=8'8]OI$K#8Q%9B2BP 3
M+$SY0(]54F$EHJ:JHFP 0)94$=B=602C0RA#.[<R;M]$ 20$>1PW?Z4%&?;Y
M\Z_8 3NA^Q^<XZ^$Y^J'@]GVU@=CV_3P.Q[?7)[OO]D&'0$^>FB@./KD]WW^
MS ['M]F3W??Z8'8]OTLGN^_W8'8]OLR>[[_3_GAQK:-N-O+0$"*@KP^S)[OO
M^E@=CV_4R>[[_4%8-%!T/;6?K Y-08BN-0<&H,01Q&L8^XDJXE@YOV]^V?I!
M1GV^?.OV8'8]OULGN^^L#L>WU^<XZ^$Y^J'@]GVU@=CV_2P.Q[?9D]WW^S [
M'M]F3W??[,#L>WV9/=]_I@=CV_2R>[[_ '8'8]OLR>[[_9@=CV^S)[OO^E@=
MCV_4R>[[_0%8-)QM3O%3K ['M^P@HS[?/G7[ "=T/V?SG'7PG/U0\'L^VL#L
M>WZ.!V/;ZY/=]_L@PZ GSTT4!Q]<GN^_V8'8]OLR>[[_ $P.Q[?I9/=]_NP.
MQ[?9D]WW^S ['M]F3W??]+ ['M^ID]WW^H*P:*#H>VL_JDE7$L'-^WOVS](*
M,^WSYU^S ['M^MD]WWU@=CV^WY3AKX3GZH;A[.L#L>WZ&!V/;[,GN^_V8'8]
MOLR>[[_9@=CV^S)[OO\ 3 ['M^ED]WW^[ ['M]F3W??[,#L>WV9/=]_TL#L>
MWZF3W??Z K!I.-J=XJ=8'8]OV$%&?;Y\Z_8 3NA^V[?"<_5A)"[ ^?S/Z&!V
M/;ZY/=]_L@PZ GSTT4!Q]<GN^_V8'8]OLR>[[_3 ['M^ED]WW^[ ['M]F3W?
M?[,#L>WV9/=]_P!+ ['M^ID]WW^H*P:*#H>VL_JDE7$L'-^WOVS](*,^WSYU
M^S ['M^MD]WWU@=CV^\1U4\_\Z^$Y^KC\O#[\#L>WV9/=]_LP.Q[?9D]WW^S
M ['M]F3W??Z8'8]OTLGN^_W8'8]OLR>[[_9@=CV^S)[OO^E@=CV_4R>[[_0%
M8-)QM3O%3K ['M^P@HS[?/G7[ "=T/V4F)OC[I_A.?J2;_C?6!V/;['%,>$^
MFA269W:]'G^M2,UU #Q@]0-]."2I[K,B&@E+641C(Q_6G<VWE(PJS4KR1XO<
MY:*>CXO]C1###BSQ'P^.SHKZ/I_'^.OD_'Q_CKY/Q\?XZOCXI^1KTWQ8_!ZZ
M]-\6/P>NO3?%C\'KH_R?CGX\'7R?CX_QU\GX^/\ '7R?CX_QU?'Q3\C7IOBQ
M^#UUZ;XL?@]=>F^+'X/77POC^W];/POC^WS/POC^WS/POC^WS/POC^WS/POC
M^WS/RCC\S7PGC\S4N?A^>%\8NM? N_K8\.-,F&_D[_D7Z#X_]OR+]!\?^WY%
M^@^/_;\BR([/E]'SQU\C^;]^'7R/YOWX=?(_F_?AU?'Q3\C7IOBQ^#UUZ;XL
M?@]=>F^+'X/74^>/RC?@OKQ?S[,?D^O#/H'I_D^O%^@>G^3Z\6S_ (7VZSSG
M;7Q?/^':>AKYIQ^1KYIQ^1KX)\T:^;?-'EHX[Q-S^WE&^O3_ $/[=X>=>@_)
MU>CRZ*NC\G5[\NO2?'^#MKTGQ_@[:^+_ !GYGXO\Y^%_%_G/POXO\Y^%_+/A
M+Y='7H?P=3Y='7H?P=3Y='7H?P=3Y='7H?P=3Y='7H?P=3Y='4]L[;S?9NW;
MN$G"/@ZG/'>2GH?!W>3UDJJQZ/YOP=>D>C^;\'7I'H_F_!UZ1Z/YOP=>D>C^
M;\'7R7CX_P =>D^C_;X.O2/1_-^#]HJ5*E3,N?CW.?CL.OD_'Q_CKY/Q\?XZ
M^;\?V^%_9=NW;I7T?3^/\=?)^/C_ !U\GX^/\=>D^E^7R'1Y7Z'Y/POTOT/R
M?7B_2_0_)]>+/DVWY?(9^3\?'^.OD_'Q_CKY/Q\?XZ^3\?'^.OF_']OA>I2>
M?YQY_.\:0!6,G016A8UM<%0*DQBYAU*E,X@7IB7SP@N2Y14JVB\&:O;;5)ZB
ME1]*2;VK1*"D.Y,QX[_;/\)S]03$^<.@H0+1[:4,H=Z^J]:.8**,F&$R#0%M
M\A2QA;&147(A2<,35I):!$IR8X7"W(J1M&;F(@HZ:E%EV"*+RE>\3I#AF+<R
M.O@T@\'X>(;>G5UZ#Z'X>G5U\/X_MW\:^%_.?C7POYS\:^%_.?C7P+CY[=M>
M@>EZ?C&O0/2]/QC7H'I>GXQKX7\Y^-?"_G/QKX7\Y^-?"_G/QJ[L?-V=XZWZ
M1\W9Y=2?3_2_ \GQ]/\ 2_ \GQ^;<<]/R6/F7S7]Y8^9?-?WECYE\U_>6/F7
MS7]Y8^9?-?WECYWQST^G5UZ=Z?X^G5U\^X^/]=?/N/C_ %U\%XYZ/;ECX+B/
MQ/3ECX+B/Q/3ECX+B/Q/3ECY]Q\?ZZ^?<?'^NOGW'Q_KKY]Q\?ZZ^"_"/3KK
MT'XML>G77H/Q;8].NO0?BVQZ==?/N/C_ %U\^X^/]=?/N/C_ %U\^X^/]=7^
MMYKR>,==>F?%LCTZZ],^+9'IUUZ9\6R/3KKYAQ\?ZZ^8<?'^NOF''Q_KKYAQ
M\?ZZ^<_"/3KKTSXMD>G77IGH^B#RZWZ1Z/X'D^/S#CX_UU\PX^/]=?,./C_7
M7S#CX_UU\PX^/]=?,./C_77S#CX_UU\PX^/]=?,./C_77S#CX_UU\PX^/]=?
M,./C_77S#CX_UU\PX^/]=? ./[=_%KX)\9[WRU\$^,][Y:^"?&>]\M?!/C/>
M^6O@GQGO?+7P3XSWOEKX)\9[WRU\$^,][Y:^"?&>]\M?,./C_77S#CX_UU\P
MX^/]=?,./C_77S#CX_UU\PX^/]=?,./C_77S#CX_UU\PX^/]=?,./C_77S#C
MX_UU\PX^/]=?,./C_77S#CX_UU\PX^/]=?,./C_77R'CGYCJZ^2_/O%Y=?)?
MGWB\NODOS[Q>77S#CX_UU\PX^/\ 77S#CX_UU\PX^/\ 77S#CX_UU\PX^/\
M73S_ $[79\Y73XT6.)K S?GC2,,")TPG:QD-NNE9DHR!*6T#$2A69 <D@% *
M1[20;PO4='H )B10#."A8. @#CF]2*@BF2;.Y]D_PG/U0\'L^VA&0BXP4+DX
M&_/1XR4 LO&XR1?'CHKDLDI0 -6R]IJ"M'#1+D!*1<B(Z2/*3GJB0@3"4J5
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M?^YTXSTA"DW=@"H92^;G41B(@ #6"-VG=732S2!@Y3'6_G)@_.?'_P  LP<
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M>2L=[.7G4)CB#O'4X@V,.F/L,DIDO;+>^8CC3OF)E*B14T YN8IA=)#'%?\
M@TL0AO(OR^.@78E.'@G'#?YQ_#R<_2'C6[!B GS30SL6Z IM,52@CL;Z<181
M"%N25N=J@@@+=-)K,F;6[6^V7?49I<RXN.N;U9 E*F]H>'GWT<Y=_ W,;XV7
M;4)81*CI],GN^_TR>[[ZS.WY=9/=]]9/=]]6JF^==GK_ )J0C.]$'ECUU"9B
M6;QQ([5V-YT[=Y05TC^J\=+%H3,\)&3'-V.;C2NB0I1 87=)AJW_ ,'A;2QU
MSZK!4B?+^%#6(HQ#Y77E_>A%$GAV_L\^NC+#E8(&9XGWVBM1*9LV3=DDN:A:
MO!(B*C-"$,$R VH9(-E@3MK4@@EP" = "B(C2KBMF4MVS/KHK%=J^DO+\_X>
M6B,5M$S_ )TUV>O^:9F]WG^M=;T?ZU*;W>==;T?ZU:?C?6)W_#K![/MK![/M
MK)[OO])"KU>%:AAQO.>*B-(AFTQSZZD8ARI5DS@^3J+8%#$;FT'(4*--*6%E
M.O&<)AEQIR]WW_\ !9RX=GL?T^7\*+<K,C'>%WS%]-5A%E*.=X%9"B")1$T
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MN_W1("[&W3OIY"%9>7KS/D$(:IT2 !#(&EXAZU0W6E75"1A: 69J8GBT$5(
M&T.#9#??OH()!9C-&28[WESHL@T(69*C%S ]>:43QG V D$F1Z/A)](7 O\
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M_P#&_?61F9([MUC_ #60*"89OL,Z@D,*5 %%R$>&\$SJ<0:!E4N"OD=Y:$!
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M_P T^"*N.L8Z8\YU+A4[=L,3UU*Q*"@/3CC?,<Z+(+$HPPSNV9C##C:-$!(
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M]MO/3RP189@&8&+V@JM"PPV70UV>O^:50I229NXHEJ]0)"YF\T[>/I.^J65
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M!$-%Y_.@4:W A-[F>L2X[Z" * (J#<+C RO!$EH  1!5;/[\6G"GO9HE"31
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M>GS.@1F1[K[:0&)0Q.8_7@<D_:J@J!MVFGO.VV_>%RE&@!8CF@P$#*Q+I81
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M(#I02WTSN8-_UBEE$<+(Q-A"JN6)3!J?:+(B3(2[;*$UTTJ3$VV(:-#$E\[
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M(6H&0[QY5JRR!A5<L3' %$%K@[D\E@-A,D,QE>!"JJY5GO\ H$R1EXAS5?\
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M)(@,$#4T[B;Z&0>2?_?KP6#/<A/,3C#6F)*+:XWBYDNJQB=*2IF\(8SQ)/\
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MY-YQ-Z% @C#$=58,5QH*[T5%P<>'?PU:HA8!IB54N"'9C-&C!^,>&H>'R?\
MW<$S!/._G]9$>#',*D_G,FIL[@Q;J(.;2\CPFIP*(QL&_CSG52"Q*&4W0*!/
M$FI$S#14A!!G\3UO5&"?'HB+*^.D5"3-A-;SB\>.^A(G>9+((7Y#OFYT"# P
M=O\ W<T#TDXB3?00!.3J!:MD3 S+&'0PP!$/2+O%]?/4JF1P-Y^=]!K\@@P"
M"9$[2CM )HL3B4"E82!'>UUI'(7$-B4(6@Q)@@&!I@REQO5XKCPCMID>5_\
MO$'(/>_?2J$#M3$*\,XT(^A4XC-<^NH!2H6B )BZF50BM2YG;,PXJ9Z3G;4Q
MV) 27=V,[YO=<3 <'9CKU/\ WT"C):[*/;BKU/,F :EQ6TP_]U3Q5*DIG,51
M,0B&#22 ].GI_=Z7L"-O7C\:<,JYEZ?X:,$8@C_WLI"8R@6PBYVOQ>^C!N9W
M,1W[=,Z)0JMA+(!&IC+"<$P6D*K9-1#,5'=)G%W_ / ([$G<P78K+IB$QAO4
ME?UXZA($%B4M!/6'HW=:4EFIANEG/B.?BY8Y=0\/S_IY_P#OH*W $:(B,D5$
MZCW))FL3M.U"9SIA5*L$D.T?%S>F1C"701$J[D(2,RQI"D#%"/%;GYG4A>.Q
MT]2'-_\ OI(S<7FYF,8G_=0-(#C*A%\SLA;43!IGD18'9ZG7/OI.J@R!+1>!
M?&N=.PD$LJEL*);)$@3(T$=B\I/[WVU,WS?_ +^$T!0$*\.9FS-4B8E0<L"3
MX6,17AZ@S,@BE9HEC;L>6CA  0*HB&R/ 0U SJ*<E",$1(HI$2$IVU-A(3<"
M)VW=N-_.9OF_/R_]ZL#"(SV[\[G&Y&D$1=Q!51F5I!>C6,Z&$* 5@6L>>>M:
M!QO(<>'.(_O0\PB3BT2D04S"," $*6%JR7*!-!7>$1G$)"F(:[;?^_- 00 F
M3Q,<QO9IH815DD2-L(LX8K;0E4RD&8F,^N<Z%FR-"4XDSPH#VZDK*O/_ +\K
MD&<7S=Y\8UMK4F"$PB.;Z](WTQ$*R,;%ANQ1EZR:A M.M"7^ #CF9_\ TQ__
MQ  K$ $  @(! P,#! ,! 0     !$2$ ,4%187&!L? 0D:$@0,'14.'Q,&#_
MV@ ( 0$  3\0_0Q"/6/+V^=<B$:-'/VW'XQ;'4\'B&86^E\](PK:/&T@+!#V
MH*P=Y N92S0285R*K59E;2*1:VHIS8SF8)*E#$R1@--^J9313LE4? 08HSN2
MHF0'8B\U73L?@4>"C16:%\A_?Z)I.C]_TZ'@]OIZAS?Z="^0_OZ;/E]_UW!]
M1^?G&U>O_P % 2\0?\P<\V^]P?+S7ZMGR^^1S=IA>MJKM8;N\>3#2%()3)B
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ME#?$^?SA<[Z;E,@UD>0@"&&2E)@EHCB6S^87RI"<N_FEPRSTP0XB10BQ&PH
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M@#*=[QQ%#3)F39AHV&6/:'!DF"IB1#0J@$R(Q\W3T>;Z:L]FN%-=%1IQK)+
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M_OV\Z_1);KW^?.WTV?+[_J]H_18#WJ'-_IT+Y#^_IL^7W_7<'U'Y^<;5Z_\
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MDA+*RREI1(^>GU=<84>6X$M\V3/.[Q>"#0:@-$<05% Y4@B1#UU"^G\DXL2
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MI]*MU)4U.L8F.L,2]/$^961@!FQC'K I,B'C;^9KT!H8,"!8I2 YI)IE$"A
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M(R[1NXDY.6U]#@\ <9.20$H0LW*+SSJ/3(SJT>%G\SU9^V76 *>O?>OFXP@
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MV\G?_078LAIN..#LZZ;< -!#GI$-*1IJ<8287B:UZ3#TQLC 7X!><#&HQY+
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M;])YF<.4]SWU)DWK?.^F74D88PVQ!R<FF,,[&0 8".#=5!/7#PHM\<I8=M_
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M,/OO_?\ Y!0KJ(.G3N\>O7%E7]@R!N"&#(U<6Y$>04<A"K4P8E1 ;J9AX)0
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M 9%MSC.5@9C:@%=L%M!HG*2$$U***_\ ;\3AP@ @U;B>C&[V,5LDFG&5FN&
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MZC.O+OZ3D)H%";A CN7J=,=OE]_V_L?3P3".B?A_,8!2&+.TO[_9P]'ZP]'
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M0 %8(;,@L6)I9DCB^NN(G#(QS7,=_+KJ9$M S$\0?]7>16Q#(:&UJRWS$],
M5(91';";3;RI3U9^@ILX[8D.)3&HL 4JV.27$@3T=-D3UI0U;LJ23D)YA)_>
M31>/=DUX08MF'FER F-J]_G3_)A]<PFIYP#(,7 87[(12'H 42O=S@-'#Y,U
M,G[,<9I]U>;/6A?TOB+@GP"& B82P54["0,JO 5=,K%&[04:\%0" XAA0F3E
M:O)R\(QLSU>_YR'H_6*II0MJ6W[:TXF .=).]5*BRTI%SF:(4%< WI7;)OL7
M5.^YNQ"9$RQ(4Z,?M_8_:=28$K4CLLLD!(@E"R[02()3?,&[-$<8$,8:'$!W
MG7%5@W>K 4*@ Z!WP8YDM%1D)Q#4;(C@P$LC69F3,U_N<'.I3[(_%3Q#&!'>
MW@)&^=1_Q<V6VQC80I@IR5DQ<M:L\/- 32VD*=/J(1"%$4X1JV#I!@N#8.)J
M[B2EBOB@#2H'HYSM"C!: ,<M$2J@+FX  )T !H#7^4A#DLOL258@+T1Q'(<:
M4RY0N2Y6;O#Q$SG7<FD<@RTXY77.PW=/Z09#J=>.G/SC'.'!L2<W$[-ICB&V
MUS'\$!0=Y,=<L 3FY,(,4Q.Y2THB\\U%\[UBP*W'>?3OFOIRZ1X6?S7\XR^
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M7ZH@I'.E'B,/!"!8F),7Z=MP6O'0KD5E93?,B5(4WUU8GJE%7)>K_P U]O\
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M_P"DX& 0%B1(YB(>O?$NV*UC'U SC9#I-(TE[M/3FI],MY1IPHCKO",8C$6
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MV.*D982MUV3(J659F7;7XX\<?27J_? Z8*5I@*"QE8,24E3<N*=()5Q!01R
MHZ*U]4#?;5:)QQW90<!72-<EA(57!)UF:4I BH$%FFB^/W@&E*6[\F2J)_'7
MGK_SG+%U"DI1,^@9S& TZH18FQOHN43Z-HM!.VP=(' XH(R%-DY@Q/,3MI/L
MQA$"X!-@@P%RJ1@R*E@PNV.?OC/,UUR4TQC?><%UP$Z)$$J08)%@GP#B=I)F
M%"$>Q8TGR1YQRU"I]U!RF%)(X_H8/9IG")#AJ2+ P1* I.P6*V2A</.+*O5G
M_P!6N0675H@&9+1:AQ%<2LD(2]#-.A!T">-1$GBD?&+*O?\ 8^Q^ZZFT# PZ
MYB-]7G?7S@%L1;JNL,@]!Q'2Z=J0 !0JBC&*L-EFR6=HB#/G[F)HLSJ!,7 X
M]2IH:^N4<R4Z8H*8I8G96[*YFHK"-X8B%7;0DP $]K.:R;*-#%10O##?J?#)
M8XB!4<KD1".S3WS!6]O9*6'P+.0AO";&!RA#L 3PI!PRJ)Q7$8< A^R1HX1I
M^,N9AE/A)\J0%-\W )>432B%7$7:SC@A'H%E"Q-QV2>@-\1>'0\G[DCUXZ\\
M]2%BNA\_GSCMGJ_HA!,2E(T[@3\7WE&,-;6X[@$KR!%00]*33J1;0,10JX3E
M<KA'5Q3I.XEP4!VP/"A9EF=N]SS/?K^ZAW#'6,GDEFEXO.1*'RX$4\I$AN8X
MIAF?V E<I,')N^DB:N93O9BA,KAZSB -Q8,Y/1-]$T-8-6HG=4<:?QS@*A4V
M,4,$[Q3C4*JLJ)656Q>5M=_?-WS@^@D26MZ3L(:_K=XB"&"ST:A5Q2S=2)(_
M0O;WJQ@U:)./P"X .;WDV1S@/W^!?2BH?%T#< DH@A4"290& O11=U?_ *:P
M!JC9LFC 54+ X,1"HB88:')RMK\IY5-]Y'[IFS]C['[_ *F5VKZ_27JY*:7[
MXL9T:!(Z7R(DN @!%8@AR2$@D!! QQIR)()*-*2E0J[;FV[OO=WWOK^J7J_J
MEZOTVM'8:$SMV:0C']Y<UEPED=@OK80,*250+'!>((I0$()B8)YGM-:<$(W?
M^^*_;'$LL4'!^..OYRFV9>0H>#N_WZX'L7U""D+:F"%(;U'VVSUQG-9'P[,L
M2(@$QL2''JA,20%&BBD5THMP5@:EK@NJ)L,@@:O1+$H<4"38<J7P5:J&M4X4
M-AGM@J;N4)#<^G0T><S/)VR-YQ9Z\%%T<&DBL2%.C'Z$!!(^8"!KA$/$*DPK
MQ5![0 &1H-F%D?TG\37%31-.?=><^F2NXD0)'';Q;1HO_P!98B6.G'[3V/\
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M_-=2E"9K5%'K?;#P,2("9*3_ "K(0O;/&-!&&C($<7%X49+7=2N@,8P 3_D
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M?*=3:$9&,/J9^R8W2\2IK*/#L4*:2S(V0X$0PQHD7$O*\=#A='L*8R !\R6
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M4A3/$9)(S)&5CE&BHA6I8O<16)5GA]/3_ ^Q_P#/=2^4IIE=.6 Q$ER91I,
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M;-F*H/$MPR),KH4] 5 F<,B3$(P%A8D4@((H#R(.OC4UX[8D*1%ZZ?O8B_[
M+QP5X7F<-59QS^><:SCVEX%3@:40*-K<VWJ>_K_\Z1'5$C.^1\SQOIVG"_51
M)*?6U!Y(M>F;?%,$1@-EXO1<J0<8HJ,T]2OD0" 8!,/H>C;: ISZD8U1957
M3?0 /  ?O8:M260+%R&$*2I1$$,D$,S)%,\SUR$)B01&*ZE+J%'%W+U/VJN1
M4,H(AV*.MC>J^U=/_G98B6.G&&E>A3DC!I9(E91J?,QF7-$,,,!O@F:C&Z!,
M*+@!(_DUJ5E^S>Y-)"G13]X 4D&2$E"0H1<T4NXI7O,*6:3A0$1 5TK7IKZ0
M#&5%B/8.)5L",41 6TI%Z&9'1EDN7?\ \\B+-1%)/A_,^8R5'A8J^RDV)9 T
M@Y2'&DESX[20E&2LSMB&39]0JE7-_O&'!W/1BGI-.LK@T;T;(?4@A[0>#ZM?
MG97OZ="'2L#F_%<B[JU(/'';$1+$3'I-QTF^M_\ W@JJ8ZV*(^ 4$:PR=XT;
M[<B16LE =OG7]$<VOS:08 -+% H"(A&9$41D&1ID&=G_ -Y-*)MF2J=#,3KH
MI**;%:9,C3)Z&/TR0@M,FQ!M=(2:VF5,P^ I!*W^.Q.W6^+/1ED]7S_]T!C,
ME]$WOS$7!_6-M/\ G KZ?J<(@%!0@0MP0,V;L'/T:0XWLWF:SL]VHHAAN(PI
ME" 9D0R(T\C8]FSF_P#[8<H&)#%74,>PGHB0;T$CHI5#2.Q'I0P33]_XFS%I
M,*>+RQ'GYCH@J$G\&8I3_;6_@CI.[@_^R@5-I"2BI0@<" 3!7#A ,,19TD!P
M5OLGKA'1(P)H( -!!QKQ7V_]8(Y2!V?K;2EE+5-[&BKP&;L3J9=$U(AH7'09
MFV,1K,Q$XK"!<H4^$_PI/57O_P#6''''''''''''''''''''''''''''''''
M''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''
M'''''''''''''''&@BL>%$"<MS H.V#WN-Z!%+1D0".!Q%$C5!?F^0LPNT)^
7PN^:JA!*D,S(,B(UN0!G<@#P'_A__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ffrctanalysis.jpg
<TEXT>
begin 644 ffrctanalysis.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 2G! <# 2(  A$! Q$!_\0
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M[Y#5\_\ BS_@H7XSU4-'H&B:9H49/$DVZZE ^IVK_P".U\J4X#%?L. X$R3
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M>C6][(A'XAJPP*4FLITX5-)Q3]4)3E'9V/5-$_:D^*.@2(8?%]Y<JO5+Y4N
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MG=*.E(!W-!  =S2T44$A1112(;"BBBD9MA1112,VPHHIP%!( 4A-!-*!02V
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MV%+]VC[M)2(;"BBB@D*=THZ4G6@AL.M+1109MA112T$-A11100%%% &:"&P
MS3NE'2D [F@@ .YI:**"0HHHI$-A1112,VPHHHI&;8444X"@D *0F@FE H);
M "EHHH,VPHHHH("BBB@D***=TH,VPZ4G6CK2@8H,VP Q1112("EHHI""BBBD
M9MA11100V% &: ,TI.*"&P)Q2=:.M.H("DZT=:6@@****" HHHH("E H I2:
M1#8$T@&: ,TZC8S;"BBBD0%%%%!(4444$-A11100%=[\&_B_K'P9\5QZOIK&
M:V?"7=BS82XC]#Z$=CVK@^G)I*YL1AZ6+I2H5X\T)*S3*IUIT9JI3=FC]>/!
M?C+2_'WAFPU[1K@7-A>1AT;HRGNK#LP/!%;=?G?^R/\ '67X:^+HM U2?_BF
MM7E"-O/%K,>%D'H"<!O;GM7Z(5_)_$F1U,AQKH/6$M8ONO\ -;/[^I^S95F,
M<RPZJ+22T:\_\F%%%%?*GLA7R7^WI\:'\,^&[;P+IDVV^UB,RW[*1F.V!P$_
MX&0?P7WKZKU+4+?2=/NKZ[D$-K:Q--+(>BHH)8_@ :_(CXM?$.[^*?Q"UGQ-
M=[E-Y,3#$QSY4(XC3\% _'-?J/A_DJS+,?K557A1L_63^'[M7\D>C@J7M*G,
M]D<ATI**<!BOZB/?; #%(3VH)[4H&*"  Q11100%%%%!#84M%+]V@D/NTE%.
MI$!11100V%%%%(S;"BBBD0V%%%%! 4M%%!+84 9H S2]*#-L.E)UY-'7DTZ@
M@****" HHHH(;"E H H)I$ 30!0!2TB0HHHH(;"BBBD9MA11100%%%%! 4O2
MCI24$!3@,4 8H)["@@">PH Q0!BEH)"BBB@AL****1FV%+]VC[M)2(;"BBB@
MD*=THZ4G6@AL.M+1109MA112T$-A11100%%% &:"&P S3NE'2D [F@@ .YI:
M**"0HHHI$-A1112,VPHHHI&;8444X"@D *0F@FE H); "EHHH,VPHHHH("BB
MB@D***=TH,VPZ4G6CK2@8H,VP Q1112("EHHI""BBBD9MA11100V% &: ,TI
M.*"&P)Q2=:.M.H("DZT=:6@@****" HHHH("E H I2:1#8$T@&: ,TZC8S;"
MBBBD0%%%%!(4444$-A11100%+TY-'3DTE! 4X"@"B@AL*_1G]D'XP/\ $SX=
M_P!G:C,'US0]MM,6;YI82/W<GZ%3[K[U^<U>J?LU_$Y_A?\ %;2KV20IIEZX
ML;Y<G'E.0-Y'^RV&_ U\7Q;DZSC+)QBKU(>]'U6Z^:T];'N9)CW@<9%R?NRT
M?^?R/T]HI**_E _:SY[_ &X?B$?!GP7N-,@?;>Z_*+%?^N0^:4_D O\ P.OS
M4KZL_P""A?B[^U/B9HGA^-V,6DV'FNN>!+,V3Q_NHGYU\J@8K^L>!, L#DE*
M;7O5+S?ST7X)'T6$CR45Y@!BD)[4$]J4#%?H1U@!BBBB@@****"&PI:*7[M!
M(?=I**=2("BBB@AL****1FV%%%%(AL****" I:**"6PH S0!FEZ4&;8=*3KR
M:.O)IU! 4444$!11100V%*!0!032( F@"@"EI$A11100V%%%%(S;"BBB@@**
M**" I>E'2DH("G 8H Q03V%! $]A0!B@#%+02%%%%!#84444C-L*7[M'W:2D
M0V%%%%!(4[I1TI.M!#8=:6BB@S;"BBEH(;"BBB@@*** ,T$-@!FG=*.E(!W-
M!  =S2T44$A1112(;"BBBD9MA1112,VPHHIP%!( 4A-!-*!02V %+1109MA1
M1100%%%%!(444[I09MATI.M'6E Q09M@!BBBBD0%+112$%%%%(S;"BBB@AL*
M ,T 9I2<4$-@3BDZT=:=00%)UHZTM! 4444$!11100%*!0!2DTB&P)I ,T 9
MIU&QFV%%%%(@****"0HHHH(;"BBB@@*7IR:.G)I*" IP% %%!#8444M!#844
M44$'ZA_LX>/C\1?@_H.I2OOO88OL5T3_ ,]8OE)_$;6_X%17A7_!/OQ5NM/%
M?AN1C\CQ:A"N>Q&Q_P"4?YT5_(7$N!679M7P\5:-[KTEJONO8_=<GQ+Q>!I5
M7O:S]5H?,?[3VM_\)!\?O&]T'\P)?M:ALYXA58L?^.5Y<3VK9\:7C:AXPUVZ
M9M[3W\\I;U+2,<_K6.!BOZ^R^BL-@Z-!;1C%?<DC]"BN6*0 8HHHKO ****"
M&PI:*7[M!(?=I**=2("BBB@AL****1FV%%%%(AL****" I:**"6PH S0!FEZ
M4&;8=*3KR:.O)IU! 4444$!11100V%*!0!032( FO2_V?_@S_P +S\;S^'O[
M8_L3RK*2\^T?9?M&=KHNW;O3KOZY[=*\T KZ7_8!_P"2W7W_ &!9_P#T;#7S
M_$&*K8'*L1B,/*TXQ;3T>OSNC.3LM#O?^'</_50__*)_]T4?\.X/^JA_^43_
M .Z*^TZ\*UC]M#X9:#J]]IEW>Z@EW9SR6TRK8N0'1BK 'OR#7\^8/BCBS,&X
MX2I*;6_+3@[?^2C/(?\ AW#_ -5#_P#*)_\ =%'_  [A_P"JA_\ E$_^Z*]2
M_P"&YOA5_P _^H_^ #T?\-S?"K_G_P!1_P# !Z]3^U..OY9_^"H__($Z'YZ^
M./#?_"&^,M<T'[3]L_LR]FL_M&S9YGEN5W;<G&<9QD_6OI;X=_L'_P#"?>!=
M"\1_\)Q]A_M2TCNOLW]D>9Y6X9V[O/&<>N!7SI\3->M/%'Q&\3ZQ8,S65_J5
MQ=0,Z[6*/(S*2.QP17Z>?L[_ /)#/ O_ &"+?_T 5]SQAG.991EN&K8:IR5)
M-*6D7]F[T::6I$N7VSC';7\SYP_X=P_]5#_\HG_W11_P[A_ZJ'_Y1/\ [HKZ
M@^*7Q:\/?![1+75O$DT\%G<7 M8V@A,I\PJS 8';"FO,?^&YOA5_S_ZC_P"
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MPV4CBZN-6COIXX^KVT#*SI_P(LH_ U[_ *?8P:786UE:QK#;6\2PQ1J,!54
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M8_".35X-0L)]9T6:.6W:&=&D:.1U21.#DCY@WU05\<)\?/B1&BHOCG7E51@
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MP'X0^#]C:^%M 2&TN;B-K@K*X:ZN]FT/*YZM@NH[ ;@ !TKI?$__ "+>K?\
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M***"0IW2CI2=:"&PZTM%%!FV%%%+00V%%%%! 444 9H(; #-.Z4=*0#N:"
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M*/[0QG_/Z7_@3_S Z#_A8GBK_H9M8_\  ^7_ .*H_P"%B>*O^AFUC_P/E_\
MBJY^BC^T,9_S^E_X$_\ ,#H/^%B>*O\ H9M8_P# ^7_XJC_A8GBK_H9M8_\
M ^7_ .*KGZ*/[0QG_/Z7_@3_ ,Q6.@_X6)XJ_P"AFUC_ ,#Y?_BJ/^%B>*O^
MAFUC_P #Y?\ XJN?HH_M#&?\_I?^!/\ S"R.@_X6)XJ_Z&;6/_ ^7_XJC_A8
MGBK_ *&;6/\ P/E_^*KGZ*/[0QG_ #^E_P"!/_,+(Z#_ (6)XK_Z&;6/_ ^7
M_P"*H_X6)XJ_Z&;6/_ ^7_XJN?HH_M#&?\_I?^!/_,+(Z#_A8GBO_H9M8_\
M ^7_ .*H_P"%B>*_^AFUC_P/E_\ BJY^BC^T,9_S^E_X$_\ ,++L=!_PL3Q7
M_P!#-K'_ ('R_P#Q5'_"Q/%?_0S:Q_X'R_\ Q5<_11_:&,_Y_2_\"?\ F+E7
M8Z#_ (6)XK_Z&;6/_ ^7_P"*I?\ A8GBO_H9]9_\#Y?_ (JN>HH_M#&?\_I?
M^!/_ ##E78Z#_A8GBO\ Z&;6/_ ^7_XJC_A8GBO_ *&;6/\ P/E_^*KGZ*/K
M^,_Y_2_\"?\ F'+'L=!_PL3Q7_T,VL?^!\O_ ,52_P#"Q/%?_0SZS_X'R_\
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MH^OXS_G]+_P)_P"8>SAV.A_X6-XL_P"AGUG_ ,&$O_Q5'_"QO%G_ $,^L_\
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M3?\ Q5<[11]?Q?\ S^E_X$_\P]A2_D7W(Z+_ (61XM_Z&C6O_!A-_P#%4?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MZ3X?^.+WX?>)K;5;-B54[9H<_++&>JG^GO7W/X=U^S\4:'9ZK82>9:W48D0]
MQGJ#[@\?A7YZ5[Y^RW\1&T_5Y/"M[)_HEYF6T+'[DHZJ/9AD_4>]?J? N?/
MXI9?7?[NH]/*73[]O6Q^>\79.L7A_KM)>_#?SC_P-_2Y]1 44$T5_19^&W/-
M/BIXL/@SP/J.H1MMN2ODV_\ UT;@'\.3^%?%K,TC%F)9F.22<DFO=?VI/$)D
MU#2-$1_DBC-U*H_O,=J_H&_.O":_F_Q S-XW-GAHOW:*M\WK)_DOD?UO-ZA1
M117YB0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !5G3=1N-(U"VOK60Q7-O(LL;CLP.1
M5:BJC)Q:E%V:%**DG%[,_07P?XBB\6^%],UB'A+R!9"O]UNC+^!!'X45X_\
MLF^)3>^&=4T61\M8SB:)?]B3.?\ QY3_ -]45_7^1YA_:F74<7UDM?5:/\4S
M^8,WP?\ 9^.JX9;1>GH]5^!XA\:-5?5OB9KCLVY89OLZ^P0!<?F#7$UH>(;I
MK[Q!J=PQRTUU+(3[ER:SZ_D_,<0\5C:U=_:E)_>VS^H HHHKS@"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBNTO?@WXRL4WOH%XZXSF.,M_(5SM_P"&M6TL9O--NK4>LT++_,5Q5,)B*/\
M$IM>J9M&M2J?#)/YF;1117(;!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW:FO_;RW_P _F?IN1XGVV&5.6\?RZ$5%%%?GI]&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD.99/C<IGR8J%K[/H_F?:X/,,/CHWHRO;IU*E%%%>*>B%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"Q&'5H3Z=G_DS]7X>S&>+HNC6=Y1Z]U_P#*HHHK\\/K@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *FL[R;3[J.XMW,<T9W*R]C4-%--Q=UN+?1GT?\ #CXC
M6GBBR6WNF$5_&,,O][WKT*WA6=08SY@]5KXVL+^?3;J.YMY#'+&<AA7OOP_\
M>#Q)8Y$GDWT0Q+&#U]Q7ZUD/$'UE+#XCXUU[_P#!/D\?E_LVZE/;\CU1;<#M
M4JQHO4US=OJ<Z[SOR77;D]O>G_;9S&$\T[ <[?>ONHXN/2)X#HRZLZ/S(E[T
MOVQ%]!7,1LX))<MSG!J62?>K 1JI/<$UI]<?1$^P75G1?V@.Q%1R:D%R3(!Q
MGK7-[F]325$L9,KZO$U;C7CTB!8^IK+N=2N9NLA ]J8PIC5Q5*U2>[.B-.$=
MD5I-S'DEJF@C& :%B9NW%6H;<\<5SQ@VS5O0L6\8XXK0ACS4%O">.*TK>/IQ
M7L4:9PU)#HHZNPQ].*(8_:KD<?M7L4Z9P2D-CBZ586'GI4D<9]*LQP^U=T:9
M@Y#(8AFK]NF*9''CM5B-:[J<;'/)W+4?"BI<U#'TI^[%=9B/R:,FF;O>C=[T
M"'[J<K5&&HW4K 3[J-U1;O>C)J;!8G5ZE5ZJ!J<)*3B!:\SWI&YJ!9*<9.*G
ME&BK==*Q;SN:V+HY6L6\/6LJNQO$IM)S4$DF<TDSX8U6>3WKRY3.I1&74GRF
MN<U@F3[/'UW3(<?C6Q<3#!YK$N&$NIV:_P"UFO"S"=Z37<[*:Y4V>J^&;;RX
MHSCM72W\GD6V>G%87A]OW<8K=UJ$-I<S_P!U,U[.'?+1T/@*TKU=3YN^/WQ"
M&CZ:T$3@W$QVA<\_6O/OA7\1].9DL[I!9WQ/RRDY5_Q[&N ^*WB"7Q!XTU%F
M<F*&5HD7L,'&:Y!6*D$'!'0BOY^QV?UWF4L1#6,=+'[=@LIIPP4:4MWJ?>?A
MGQ(695=N:[^TU$31  Y!KXV^#WQ&EN)DTB_FS*!_H\K'DX_A-?2'AK7#)&$8
M\CBOV#(L[IXZBFO^&/@LURV6%J,Z?4(=TASR#7S_ /M(?!]]4LCXLTE2]Q H
M2\ME7EES_K!ZGGGV%?0PD6XCYZU'%A)"DB"2)AM9&&0P]#7I9IEM'-</+#U=
MGL^SZ,\W!8VK@:T:U/INNZ['YNT5[M^T+\!Y_"=_/XCT2)I]"N7+R1J,M;.>
M2"/[N>GTKPFOYJS# 5\MQ$L-B%9K\5W1^SX/&4L=15:B[I_AY,****\X[0HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXM.DGQ$UMDQC[0V<>N37(5T?Q(8MX^\0ACDK?3+^3D5SE?SWBI<^(J275O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&R]K=>:3_'?\3X5U;]E?X@:6I9=-CO5'_/K(7/\ *O/O$'@?7_"LFS5M)NK
M]O.B(!]Z_2Z*!E^Y-@_6FS!EPT\$,^.GFQJ_\Q7S^)X!PLU_LU9Q?GK_ )'T
M%#B[%1?[ZFI+RNO\S\MZ*^]?%W[/G@/Q@LS'2_[)O)6+M=61.XD^Q./TKP?X
M@_LD:[X?CDN_#TW]NV:C)CX$RCW' KX3,.$,TR].?+SQ76.OX;GUN#XCP.*:
MC)\C_O?Y['@5;G@KP?J/CSQ)9:+I<+375RX48&0H[D^U9\VCW]O=&UDLYTN
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MO[SW?]=L=3HV=*,I]]5^'_!/C+PC^P?XXUR-9=3NK'28SSM>7+C\,"MO6O\
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M *]N^ /BRRM]1M=.FU+^RYP_R;^$E]L] ?K7B-*K-&P92593D$=10!^IL/\
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M<>1<_,%/WE.:^3+?XZ>+K= @OHV'3YHES^=077QH\67>WS-07Y3D;8P*Z/\
M6K"P:E2A*+_KS*I\-8U^YB)QDOQ_(^\='\707*C+C\ZZJTN+:X4$D<]Q7PEX
M9_:'GMO+CU6TW8',\)P3_P !KU'PS^T=HMPZ(+YK<G_GZ&P?GFOL,%Q7@L1%
M*<[/[CYO'<,8NDVZ<;_B?52VI^]#)D_6LS7/#.G>(8]NK:;#=D#:LK)\ZCV-
M>?\ AWXO66J+F"YCN57&6A;<!7<:;XVM[I1B56SV)KZ95\-C(6NI)]SY"IA<
M3A9W:::^1YQXD^ H#-/X8N0C$Y-M.<'\&X%:=CIMU;Z,- \5:"NM::V"T$L1
ME0'L01WKTE;ZWO &!"G_ &:?]OFM_NR$K]<UY<LCPZDYT7RWW6Z^XNKC\17I
MJG6]ZVJ>TE\T?'OQB_96C6WNM=\""2:",&2?2)?];$.Y3ID>P%?,DL3PR-'(
MC1R*<,K#!!]"*_6"WUB%)=YAB\SNZJ Q_&O /CI^RWIWQ&U"77?"LL.EZM(,
MS6DGRQ2M_>!_A/X5\!G7"-2*]O@8W[Q7Z?Y?<?=\/\5U*4OJN9OW>DWNO*7?
MU^_N?#E%=%XT^'NO_#[4FLM=TZ:RDR0CLIV28[J>XKG:_+ZE.=*3A-6:Z,_7
MJ=2%:"G3=T^J"BBBLS0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH NZ)K%UX?U:UU&SD,5S;R"
M1&![@YK]%/@/\4;'Q]X?MKA91YCKMFA8_-')WS]>37YO5VGPK^)VH?##Q$E_
M;$RVK_+/;YX=?4>A]Z /MK]I_P#95F^*.F#Q%X9@3_A)+9/WL"\?;$'/'^UU
MK\_-6TB]T+4)['4+66SNX&*20S+M92#@BOU0^ W[0FA^.-)MY4N%8\!D8_.A
M]"*Z?XV? GX<_&;17O\ 7=.2.[C&X:G8E8[EL=%+D'(_"KIPE4DH05VS.I4A
M1A*I4=DE=GP]\#]6?4_!5NDG+P,4SZ\FNLUC]W&Q]*B\,^"[#P3->6&E/-)I
MXF;RFF;<Q )')Q5O7XS]G;Z5^K8=3IX2,*GQ)6/R:M6IU<6YTOAD[KYGS[\7
M-6$L:VR]&8'\J\NKN?BK(%U:.(')7)/XUPU?FN.FYXB39^G8&*CAXV"BBBN
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M'%SK%P;*PW.S'&5KV#7OV2_C9KLVS_A&EMX">7:]@( ]\252OOV7O%/@/29
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M^_DSVJF2XFC@*=3%OFG]K[]'I^(D6I!?WD1^8UXW^TE\/4\3:6?%>G0DZC;
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M110 4444 %.CD:&170[74Y!'8TVB@#[G^#?CC_A8G@.VN#A+VRQ!,H]AP?Q
MKU(>%;?Q9HUSH^H0+/IMY$8W1AG![,/3!P?PKXW_ &5O'"Z#XMFT:YF6.UU!
M?W8/>88 'Y9K]#/!XLGTT,K!I"O3N*Z8:H_ .)J,LJQ4O9JR;O'R_P"&9^6'
MQ6^'EY\+_'&H:!>#/DMNAD_YZ1$G8WXBN1K[4_;8^$]QK%E%XOT^!I9[$>5>
MA>3Y?\+ >@ .:^*ZPDK,_8,CS)9I@*==OWMI>O\ P=PHHHJ3WPHHHH ****
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ+_MCG/J!7P/<6\MI/)!/&T,T;%7C<$,I'4$5^PLUXUC,MQ V#WQ7R3^V1\
M8-8M)OB'X8M0DJ8&JV4*]?\ IJH'XEJ:?0^BX6X@G3E' 8M^Z](OM_=?EV^X
M^+****L_7PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *DCN)8_N2,OT-1T4TVM@'O<2R
M?>D9OJ:9110VWN 4444@"BBB@ HHHH **** "BBB@ HHHH MZ/JDNBZK9ZA
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M">C'_/>OJ3]NGX9CQEX!L/&&FQAY[##3,HR7C; Q^!.:V,3\^:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /4_@%XTGT+Q5;Z<TI^R7+Y"GHK>OZ5^B'AZZ%UHZDG.5&*
M_*O0;V73]9LKB%MLB2J0?QK]7/@[X8?7/!NG7,L_EM+&&"]>HK](X8SJA@:4
MZ>+G9=.I^5<7Y#B<RJTZF"A>77H>)_M&Z8-<^'NM6/D?:+B.(SP+W#@CD>^,
MU\ $%20>M?IC\7M'ETCQ UBY#^9;NRL!P1TK\VM:LWT_5KNWD&UXY64C\:X^
M*I4\34I8NB[QDFK^G_#GH\'1K8:E5P=>/+*+3MZZ?H4Z***^#/T0**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@">QU"YTVX6>TN)+:9>DD3%6'XBOH']G?XQ7EYX@3P[XAG-[;W0(@N9
MVRZ/V7)ZYKYWJ6SNY;&ZBN(',<T3!T=>H(Z&IE'F5CAQF#I8RDZ<UJ]GV/U=
M\*V.G0::57:KCMWS6;XN^!G@#XV6<UKXDL_L&L*NVVUFU^5T]-X'WQ[$UY%\
M$?BM'\1/"D4L;^5J]D!%<Q$]<#AAZ\"O7/!]Y<:]K$5A+<16;2''G3$A%^I%
M>!)5(RWU/R.IAL1A*[4).,T^G];'PA\=/V8?%OP.U&5[VW.I: SG[/J]JI:)
MTSP7Q]QB.V:\?K]PM)\!SFUDT_4-8T'5]-E!62WF8NK#\5X_"O#OC9_P2_\
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M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF0E7C8,"/:OM'P]K*>)_"%EJ$08":$'Z'I7Q37V1^S:AU#X:Q0NAEVN0HQG
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M5^7'[RWE(^:*1#@CD$$5]+E67++:'LKW;U;/7P6%6$I\F[ZGZV?$?X ?#?\
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MMZZ+%I/@&5XT"_Z3$OYDU^?E?I!_P4455^&\IZ9O80/S-?F_0 4444 %%%%
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M5>UR^.H:M=7!.=\A(^F:HUZM./+%(_$,=6^L8JI5[MA1116APA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7ZG?L*6!L?A)I+N,%TW?K7Y8KU%?;?P8_:
MHG\"^#]!TS3-/MY(+>/9.TTA7=_DT =I_P %'=8-OX-L[$!<7ETLG(Y^0]C^
M-?GA7U9^V;\8+?XHZ+X;8I'!>0O*S1PON4@[:^4Z "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O9O@7^T5J_PPU*WMKF:2YTAF V[OFBYZCVKQFB
M@#]G_A3\5K'QGI%O*EPDRR*"&4\$>M<Q^T]^R[HWQ^\.>="(M/\ $]LA-GJ(
M7A^_ER8Z@_X5\#_LQ?'2;P/K$.C7]R4L)&_<2,W$;?W3[']*_37X=^/+?Q#I
ML1+JX91WS0!^,7B_P?J_@/Q#>:)KMC)I^I6CE)89!T/J#T(]Q6/7ZN?M>?LL
MVWQTT$:KHPBMO%M@A,+8 %V@Y\MCZ]<&ORQUS0[_ ,-:M=:9J=K+97]JYCE@
MF4JRL#@@@T 4:**5<%@"<#/)H O:+H.H>(KY+33K62ZN'. J#^9[5]6_!WX"
MVW@KR-6U-VN-8V9\L'Y(_I[UL_!GP1HWA_P?8WFFE)6NH5DGN^"2Q&2,^WI7
M._%G]H:P\*Q3Z5H#+>ZIC8UQU2+W]_I0!ZU'X@TE?$5OH\VHP6EQ(K2/N;HJ
M@DCZG&*\TE$%QK&HW-ON-O+.[1LW4IGC/X5\Z>"SJ7C/QS'>W5Q+-*&+RS;C
MD#GCZ5]$96SM>N !7F8N>T#]>X$P&M3'U%HM%^ID>+-:CTK3I99'"A5ZU\R:
MSJ3ZMJ4URY/SMD ]A7M_Q2\$^+]:\#R>*;33))/#,4WE27*Y+9YYVX^Z,8+=
M,UX'6V&I\L>9[L^<XLS;^T,6Z4'[L?S/;OV8_CM>_"KQ9;6T\[G2+EPK)NXC
M8GK]/6OT(^*GP_T7]H_X5S6<AA^T21>;:7;#/D2XX?CVR/QK\B:^Z_V&_CN]
MW$_A?5KK?/$,0[_XH_7/MP*[3X0^*/%'AK4/!_B"^T;5;=K6_LY3%+$W4$5E
MU]Q_\% O@W&([7QWIEN6DSY5^R?=V?PN?<DXKX<H **** "BBB@ I\,+W$R1
M(-SN0J@=R:97J7[-?@<^.OBQH]H\>^W@?[1)D9!"D'!^M U:^I]#?LR^%;63
MQKX.TFX@6:":X5986'#94D@_C7#_ +5.L6^A^)/$%C9!;='NFCBC3H%&.!7Z
M$_#7X(^%;7XA>&M3CM)+6]BN-Z"%]J9V-U7%?EI^U1J4=U\9O$5M!=?:H;>Z
M=2V,#=GFO.CAY*5Y=S]-QW$N&J8)T<)>+Y%&S[W=]O(\AHHHKT3\Q"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ IXFD5=H=@OIFF44 *SLWWF)^I
MI*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ !*D$'!%?5
MW[+/[1TNBW5MH.KW!#@[;>9VX<?W3[U\HTJLT;!E)5@<@CJ* /VT\*^-[77K
M.,K,-V 0<\BO*_VE/V3] ^/FGS:E:!-)\911GR+R,82Z('"2#W_O<FOBGX(_
MM2W_ (5G@T_7IY);?("7G=1Z-[5^A7PO^)MEXPTN%XKA90Z@AE.<T ?D)XQ\
M&ZOX!\17FB:Y9R66HVKE)(W'Y$>H/6L6OU._;,_9UM_C-X%GU_2XE3Q9HD+2
M1A%YNXAUC_WN<@GTK\LI(VBD9'!5U."IZ@B@#?TGQ]K^AZ3<:99:E-!93C#Q
M \?AZ?A6$JR7$N!NDD<_4DT^SLYKZX2""-I97.%5:]S^'/PLCT3R[Z_"RWG5
M5QPE8U*L:2U/?RC)L3G%;V=%>[U?1%KX3^#'\.Z6;BY7%U/\S _PCTJ;XE>-
M(]!T]D5@\[\*F>M=+XCUJ#0=-EFD8*%6OF?Q-X@G\1:I+<RL2N?D7T%>=2@Z
M\W.6Q^H9[CJ/#N7QRW"/WFO^'9^B7[)OQVT#XB^"&\-:G:V]L+:(Q36L@!C=
M3U//7-?'O[4WPRT#X=_$B[_X1:^AN="NW,D,"/N:W/=/<#UKRWP[XGU/PG?&
M\TJ\DLK@J4+QGJI[55U/5;O6+M[F]G>XG<Y9W.37KGXBVV[LJUT'@+Q9<>"?
M%>GZO;.RFWD!95/WE[BN?HH$?L)X9BT;X]?"-[.ZVW=O>6VPC/?'!_ \_A7Y
M5_%OX=7WPK\?:KX<OX6B>VE)A+]7B).QOQ%?4'[ ?QK;1]6E\)7TI\ISOMBQ
M_-:Z+_@I%X&L+B/2/%ENL45^O[BX^8!Y4.-G&<D#G\Z /@VBBB@ HHHH *^X
M/^">7P\-P-2\1RQY\QQ#$Q'3;G./SKXCM;=[RYB@B&Z25PBCU).!7Z^_LQ>
M(_A]\*=(MFA\F;[.LDRX_P"6A W?K0!Z%8^)(M'^)?A.S,@5I[IHPOJ?*?\
MPK\7?B)=O?>.M?N)&W/)>RDMZ_,:_1/Q%\0FU+]LGX6:##+\B:BT\@!](I!C
M]:_-_P 52>;XGU9_6[E_]#- &71110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $/(?'DWVCQSXBEZ^9J-RWYRL:PJO:]-]HUS49>OF7,C_FQ-4:]$_.PHHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO\&])UJS\37-QX[FNY([S0VC BAA!&QPVWJ1GOVH ^JXM:\ _LI_LIZ1X?\
M$&AW'B3QCX^'V[4K&"Z>U7[""5$;3)\P!^0[<8.,UXU\9/@WX*O/@_H_Q:^&
M+W\.BSWS:=JFBWF7;3+A5#<2$DNAW* 3BNMU[5? W[5WPZ\&KJ?C2P\!>/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ J6SM7O;J.",;GD;:!45=U\*]#_M#4Y+MURD(PO\
MO5G4ER1<CNP.%EC,1"A'JSU3P;H<6AZ3# @P0N6;N3ZU'XVUY-'TJ:0MR!P/
M4UIR3_8[<EN !7B7Q$\3-K&H&WC?,,9YQW->32@ZL[L_7LTQU/*L![*GH[61
MR=U<-=7$DKG+.Q)S4=%%>T?BC;D[L****!!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5[7\);=(="1B,-(Q)_.O%*]\\ V36VCVP(Q\N?SKCQ3]RQ]EPK"^-<[;(?X^
MU#[%I,S*<';C-> R.9'9F.2QR2:]E^*TA31Y/4D#]:\9I856A<?%-5SQB@^B
M"BBBNT^,"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH EM$\RZB0]&8#]:^D/#"!=
M/A Z!0/TKYRT_P#X_K?_ *Z+_.OHSP[_ ,>,?^Z*\[%[(_1.#[>UJ/T.-^,+
MA=-4="6XKQVO6OC Y^QQ _WJ\EK?#?PT>)Q++FS&7H@HHHKJ/E@HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** +&G_P#'];_]=%_G7T?X< -A'_NBOFZQ81WD#'@!
MP?UKZ'\/W.VU09X*@C\J\_%]#]#X1DHU*E_(Y#XOP;M/#@CY&YR:\AKU+XN3
M^9!"!TW5Y;6^'_AH\+B*2EF$VO(****Z3YD**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ 'M7T'X:4R6$!_Z9K_(5X)IT/VB^MXL9W.!^M?0FAQ_9;-%_NJ!^E<&
M*>B1][PK!^TJ2>VAPWQ7MR+-&QT;FO+*]&^+&H>8\$ /.<FO.:VP]_9JYX>?
M2C+'SY0HHHKI/G@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -OP;")O$%N",XYK
MW"&;9:GMQ7C7P]A\SQ C8R%1J]?F4QVK?2O,Q.LTC](X<3AA93\V>/>/;PW6
MN.,Y"C%<W6GXFD\S6KGV;%9E>A35HI'PF,FZF(G)]V%%%%6<04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% '9?#%<ZO(?]FO7[R,&S) [5Y)\+XRVI3-V  KU^\P
MEBW^[7E8C^(?J_#L?^$]W\SY\\2+MUV] Y_>&LVM#Q Q;6KPGKYAK/KTX_"C
M\OQ'\:?J_P PHHHJC **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#LOAC<"/5I82
M<,ZY'X5ZS>3&:S90.U>$^%KYM/UVTD7^)PA^A.*]Y@B%Q:D@]17F8E6FF?IG
M#=5U,+*BMT>!>(E\O6[Q?20UG5TGC^Q6Q\0.%8-YB[S@8QR>*YNO0@[Q3/S[
M%P=/$5(/HV%%%%6<@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #HI&AD5U.&4Y%
M?17A.Y6\TN%^NY%_ES7SG7M?PJU,7.CPQYR\9*M^?'Z5Q8J-XIGVW"E=4\6Z
M;ZHYKXP:;Y-Y;W07AOW>?IS7G->Z_%+16U'0970?/#\X'\Z\*J\-+FIV['%Q
M)AGA\?)VTEJ%%%%=1\L%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5WWPFU0V^I
M2VI/RN/,_+BN!K8\):@--UZUD9MJ%MK'VK*I'F@T>GEM?ZOBZ=3S/I&ZMDO+
M,A^592I^A&*^;?%6C-H6N7-J5VH&+1_[I/%?1VBW2W4 5SVKEOB[X+&KZ(+^
MVCS=6@SA1RR=_P L5YF'J>SG9]3];XARMYI@?K-!7E#7U74\#HHZ<'@T5[!^
M(A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 2WELUG=SV[_?B=HV^H.*BKJOBQHTGAWXI>,M
M)F79+8:S>6KKZ,D[J1^8KE: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH * <'(ZT44 >W>"=3GO/#]M<@-N7]VS8R"
MPKZ?_9HCTN^U*YE\162LC*$@%POR,3UKYX_95UI)9-1T>X59(E(N%5AW) /\
MJ^H_%BQV^@@VA2WE50$;'"GM7*L/%3YCZV7$6)^I_5:>C:LW<\E_:9_8ANK&
MXO?%7P]B^V:=(3+/I"DF2+/):/U7ZGO7QI<6\MG,\,\;0RH=K(XP0?0BON/X
M&_MG>1J#:#XJ=$ECF:%9_P#EFV&('TX]:]0^*O[.G@+]HC3[C5]-FBTOQ',
MR:A;XV.?611]X8]*ZCY(_,BBO4?B]^SEXQ^#NH-'J=BUYI[$^5J%JI:-U'<@
M9*_C7EU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEV2KC*Y!ZC/:HJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MLZ?IMSJEQY%K'YLN,[=P'<#N?<5Z;X'_ &6?BA\1[Z*S\.^&/[1N9?N)_:%K
M%GG'5Y5':BB@#Z/\"_\ !'GX[^)KB/\ MT^'_!]N1EVOM1%S(/8+ '!/_ @/
M>OJCX2_\$6? 'AV2*Z\?^+M4\83*,M9:?&-/MLYZ$Y>1A]&6BB@#[B^%OP.\
M ?!/37L? WA'2O#,$@Q*UC;A99?^NDAR[]!]XFNYHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>figure10a.jpg
<TEXT>
begin 644 figure10a.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 5<$*,# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOC@J,=U<^K+K_@HGXZ?/V;P[X>B]/-2=_P"4HJM_P\.^(W_0%\+_ /@)<_\
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MQ%[:+X7_ / 6Y_\ DBOF#V%%'^J>1_\ 0+'^OF1RQ['U!_P\*^(O_0%\+_\
M@+<__)%'_#PKXB_] 7PO_P" MS_\D5\P44?ZIY'_ - L?Z^9/*CZ?_X>%?$7
M_H"^%_\ P%N?_DBC_AX5\1?^@+X7_P# 6Y_^2*^8**/]4\C_ .@6/]?,AI'T
M_P#\/"OB+_T!?"__ ("W/_R11_P\*^(O?1?"_P#X"W/_ ,D5\P^YI.M+_5/(
M_P#H%B0?3_\ P\*^(O\ T!?"_P#X"W/_ ,D4O_#PCXB_] 7PO_X"W/\ \D5\
MP@8HH_U3R/\ Z!8DGT]_P\)^(O\ T!?"_P#X"W/_ ,D4?\/"/B+_ - 7PO\
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M .@6)'M)=SZ=_P"'@_Q$_P"@+X8_\!;G_P"2*/\ AX/\1/\ H"^&/_ 6Y_\
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M_F/IO_AX)\1/^@-X8_\  6X_^/T?\/!/B)_T!O#'_@+<?_'Z^9**7^JF1_\
M0+$AXRO_ #L^F_\ AX)\1/\ H#>&/_ 6X_\ C]'_  \$^(G_ $!O#'_@+<?_
M !^OF2BC_53)/^@6)'US$?SL^F_^'@GQ$_Z WAC_ ,!;C_X_2_\ #P+XA]]&
M\,_^ MQ_\?KYEZ<FDZT?ZJ9)_P! L2?KN(_G9]-_\/ _B)_T!O#'_@+<?_'Z
M7_AX%\0_^@-X9_\  6X_^/U\R 8I:/\ 53)/^@6)'U[$?SL^FO\ AX%\0_\
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M2?\ YXR?]\&NFHHL',<S]DG_ .>,G_?!H^R3_P#/&3_O@UTU%%@YCF?LD_\
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M9^R3_P#/&3_O@T?9)_\ GC)_WP:Z:BBP<QS/V2?_ )XR?]\&C[)/_P \9/\
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MBBP<QS/V2?\ YXR?]\&C[)/_ ,\9/^^#73446#F.9^R3_P#/&3_O@T?9)_\
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M2?\ YXR?]\&NFHHL',<S]DG_ .>,G_?!H^R3_P#/&3_O@UTU%%@YCF?LD_\
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M9^R3_P#/&3_O@T?9)_\ GC)_WP:Z:BBP<QS/V2?_ )XR?]\&C[)/_P \9/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *9)&DR[74,OH:?10!CWFCE<O!\P_N'K^%5;6]EL
MVP.5SRAKHJI7VG+=*67"R^OK]:15^Y/;7*748=#]1W%35S<<DMC/QE7'!4]Z
MWK6Z2ZB#K^(]*!-$U%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1
MSS1VT,DTKK%%&I=W8X"J!DDGTK\N/VH_CE<?&CX@SM;3M_PC>FLUOIT(/RN
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M****Y2 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+Y)./.EIW.VHHHKC("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"GJ%B+
MM,KQ*O0^OM6/:W#V5QG!X.&6NDK+U>S!7ST'(^]_C2*3Z&E'(LL:NIRK#(IU
M8VCW?ER>2Q^5ON_6MFF)Z!1110(**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[&N"7<^RJ&8_2OU;^%_POT'X1^$[;0M!M5AAC ::X8#S;F3'S22-W)_(# &
M *^-O^"=OAJ&_P#'?BC7)%W2:;8QV\>>@,SDD_7$1'XFOI?]K+QM=>!/@3XA
MO+&8P7UTJ6$,BDAE\U@KD$="$WX/8UYO'&-Q&:YS2R*C*T4XI]G*5M7Y)-?B
M8U&ZU;V?1?\ #W//OBG^WEX8\$ZW/I7A[2)?%<]NYCFNEN1;VV1U"/M<O@\9
MP!Z$UE>!_P#@H9X?UK5X[3Q+X:N/#UM(P5;ZWNA=HF>[KL1@H]5W'VKX*HK[
MJ/A_D4</[&5-N5OBYG>_>U^7\#65&G:R1^R'B#P_H?Q$\+3Z;J=O;ZOHNHP@
ME3ADD0C*NK#H>A##D<$5^?>D7$/[&?[2&I#4;2ZUC38;:1;1HRJR2PR@%')/
M&1@J?=3BK/PP_;@\0?#?P+I/AK^P+/5TTZ,PQW5Q<.KE-Q*J0!C"@A1[**\T
M^/'QKN?CKXHLM<O-)M])N+:S6SV6\A<.H=V!)(Z_.17S?#G"^:9=B,1@<9'F
MPE123]Y:]I))W3:W_'8RITWRN%3;];GU3_P\6\,?]"EJW_?Z+_&OJ7PSKD?B
M;PWI6L11-#%J%K%=)&YRRAT# 'W&:_&>OV ^$_\ R2WP?_V![/\ ]$I7S'''
M#N79'0H3P4'%R;3NV]DNYS5HJ$HI=;_H>._%+]M30?A9X\U;PM>>'=1O;G3V
M17G@EC"/NC5Q@'GHX'X5\]?M+?M7:/\ '+P+9:%I^AWVFS07Z7AEN9$92JQR
M+CY>_P X_*N)_; _Y..\9?\ 72W_ /2:*O'@*_1N'>$\JI8?"9E"F_:\L97Y
MGNXIO2]NIU**@[HZGX6>")OB-\1/#_AN('.H7:12,IP5B'S2-^"!C^%?KC)/
M8>&]-MTDDBL;*,PVL6XA5!9ECC0?5F51]17Q%_P3U^'QU#Q-KWC*XCS#I\0L
M+5B!@RR8:0CW5 H^DE>A_M\?$BX\+^$?#F@Z?<-;W]]?"^9TQE4MR&7Z?O&0
MC_<-?&<7<_$/$-#)J+TAOY-KFD_E%+YG+9U*C\OZ_P" =O\ MD_#_P#X3KX'
MZK-#'OOM%8:I#Z[4!$H_[]ESCU45^9-?L'X'\26GQ'^'^CZT(U>UU>PCFDA;
M! WI\Z'Z$E3]*_*CXK^!Y?AM\1O$'AN4-ML+MDB9CDO"?FC8_5"I_&O6\.,=
M*,,1E-;25-\R7X27R=OO-*<N>FFNGZG)T445^TDMA7KW[+_P@T?XU?$6XT'7
M+F^M;./3Y;L/I\B))O5XU RZ,,8<]O2LOPK^SC\1_&V@VFMZ+X8FO]+N@6AN
M%GA4. Q4\,X/4'J.U?17['/P)\=_#7XK7>K>)?#TVEZ>^E36ZS/-$X,ADB(7
M"N3T5ORKXGB'/,+A\NQ*P^)BJT4[)2CS)KI:][F,I75T>5_M9?L_^'O@3=>&
M(] O-3O!JB7#3?VE+&^WRS'MV[(TQ]\YSGM7@(&*^_/VW/A#XO\ BE=^#W\+
M:+)JZV*78N#'+&GE[S%M^^PSG:W3TKY7U;]ESXI:+I=YJ-[X2N+>RM(7N)YC
M<P$)&BEF; ?/ !/%<7"^?8>OE-!X[%1]L[WYI14OB=M+WVM8MZNR/*Z***_0
M3%L^W?\ @G-_R#/'/_7:T_\ 09:Z3_@H9_R270/^PVG_ *(FKF_^"<W_ "#/
M'/\ UVM/_09:]@_:J^#.N?&[P/I>C:#<6-M=6NHK=NVH2.B%!%(F 51CG+CM
MZU_.&8XBEA.-W7KRY81E&[?3W$11^%_,_,*M3PO_ ,C-I'_7Y#_Z&*^A_P#A
MWW\1_P#H*^&O_ N?_P",5<T;]@?XAZ=K%C=R:IX<:.">.5@MU/DA6!./W/7B
MOUZIQ5DCA)+%1V[G/6A*5.22ULS[_K\@OBG_ ,E.\7_]AB\_]'O7Z^U^07Q4
M_P"2G>+_ /L,7G_H]Z_+?#'_ 'G%?X8_FSJJ? <O5O3='OM8F,5A97%]*!GR
M[>)I&QZX -?3W['_ .S#8_$:!O&/BR W&A0RF.QL"<+=NIPSOC^!3QC^(@YX
M&#]7^.OC)\.O@';V6DZG=V^CEHMUMI>G6I++&#@'9&,(O7&<9P<9P:^YS;C.
M.$QKR[+\.Z]5;I;)]M$V[==DNYS1BYJ_0_++4M,O=(N#!?6D]E/C/EW$31M^
M1%50*_5?P7\6?AS^T#87FEZ?<VFN*J;KC2M1ML/LR!N,<@^89(Y&0"1WKX__
M &O/V:;3X3W%OXF\,QNGAN]E\F6T9B_V.8@D!2>=C '&>A&,\C%9/QE''8S^
MSL?0="L]D]GY:I--]-+/OL-T[QO!W/FFE52[!5!9B<  <FNE^&O@>Y^)7CS1
M/#-I(()M1N!$9F&1&@!9WQWPH8X[XK]._"?P]\#? 'P?//96=KI-E8V_F7FJ
MSJ#/(J\EI),;F.<X4<<X4#@5Z'$7%5#()0HJFZE6>T5IIMJ[/=Z)).YA3@ZD
MN5'Y:3>$==M[3[5+HNHQVN WG/:R!,'H=V,8K)K])]&_;<^&&L^(DTH7NH6B
M2.(X]0NK39;,Q.!R"64>[* .^*ZGXW?L^^&OC)X>O$GL+>U\0>439ZO#&%F2
M0 [0[#ETSP5/8DC!P:^9_P!>J^#KPI9O@I48SV=^GHTKVZV=UV-%1C/2,M3\
ML *":EO+6:PO)[6XC,4\#M')&W564X(/XBOU2_9J_P"2#>"/^P;'_6OJN)>(
MO]7L-3Q"I>TYG;XK=&[WLSDA!SJ>S>F_X6/RGJW?:1?:8L#7EE<6BSKOB:>)
MD$B^JY'(Y'3UK]2;?X<^"?AWXN\1?$#79=.MM3U.Y$G]I:I(D:6JA%14C9R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,BO=5XOR;LU]^OW'C8Q/G4NA^5GQ"L)-)\>^)+*88FM]2N8FR,<K*P_I7/\
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M."I*HG*,7+FZOXMD[\JW]&<4:_/4Y%MW_,\@_P"";\R+>>/XB?G:.Q8#V!N
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MK6JW-EHNH7ENV0LUO:R.AP<'! QUJKJFBZAHDJ1:C87-A(Z[E2ZA:,L.F0&
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MC>*%N]4O7\NW@:QN8M[8)QN>,*.AZGVJ;]I/X>_\++^#7B'2HHO-OHH?MMF
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MT)4W)J"/R-^*0"_$[Q< , :Q>8'_ &V>OTQ_9J_Y(-X(_P"P;'_6OS/^*?\
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M3/&);>]U2V@E0]#&TJAO_'<U^AW[9&GW&H?L]>)1;Q-*T+6\[*@R0BSH6/T
MR3["OSK^'FO)X5\>^&]:F++#I^HV]U)MZ[$D5F_0&OG^ 7*608B-+XN:=O7D
MC8TS/XDWM;]6?KM?72Z;IUQ<$82WB:3&.R@G^E?CUK^N7GB;7+_5M0E:>]OI
MWN)I&ZEF))_G7["W$<6K:;+&&#P7,14,O(*LO4?@:_(/QAX5U#P/XHU/0=4@
M:WOK"=H9%8$9P>&'JK#!![@@UXWABZ2GBXOX_=];>]?\;7^1T9C?V47':_\
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MI^:W[._QN_X4)XUO?$']B_V[]IT][#[/]J^S[=TD3[]VQ\_ZO&,=^O%?0_\
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MYGB?_#R;_JG7_E<_^YZ/^'DW_5.O_*Y_]SU[9_PQ?\&_^A._\J=Y_P#'J/\
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M_JG7_E<_^YZ/^'DW_5.O_*Y_]SU[9_PQ?\&_^A._\J=Y_P#'J/\ AB_X-_\
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MX#_GV_Z^9XG_ ,/)O^J=?^5S_P"YZ/\ AY-_U3K_ ,KG_P!SU[9_PQ?\&_\
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MD&O-.L5EY.-_FO\ *NW/0Y;@]NM?L#J'_(MW/_7HW_H!K\G?@/\ \EJ\#?\
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MW_7S/$_^'DW_ %3K_P KG_W/1_P\F_ZIU_Y7/_N>O;/^&+_@W_T)W_E3O/\
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M[7 ?\^W_ %\SQ/\ X>3?]4Z_\KG_ -ST?\/)O^J=?^5S_P"YZ]L_X8O^#?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 R:,31.AZ,,5SUI(;>[C8\8;!_D:Z2N<U!/+O)1[Y_/FDRHG1T4R%_,AC;
M^\H/Z4^F2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<Y7&_76[OZW=R*V)E5K>V>^GX'ZQWGQT^'=G:3S_ /"<^')?*1G\N+5K=G;
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M&D0J,_:;;CFOT'K[WQ#:>>R:_EB>AF7\=^B"BBBOS,\L**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M"UA<7A/JH-;M8FM?\?2_[@_F:3*CN:6GMNLHOIBK-5-+_P"/&+\?YFK=,044
M44""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KQ/]L[_ )-K\8?]N?\ Z605[97B?[9W_)M?
MC#_MS_\ 2R"O>X?_ .1Q@_\ K[3_ /2D:T?XD?5'Y>T445_:I]&V%%%.^[]:
M" ^[]:3K1UIU! 4G6CK2TC-L****1FV%%%%(@***6@@*2BG 4$-@!1["CV%%
M!FV%+1100V%%%%!FV%+[FCW-)UI$!UIP&* ,44B6PHHHH,VPHHHI&;84444&
M;84M%%! 4H% %!-!#8$T 4 4M! 4444&;8444H%(AL *":":2D9A113ONT$M
MA]VDZT=:6@S;"BBEH,VPHHHH("BBB@AL*7[M'W: .YH( #N:6BB@AL****1F
MV%%%%(S;"BBBD9MA3NG)HZ<FDZT$AUI0,4 8I:#-L****"&PHHHH(;"BBG?=
MH,VP^[2?>H^]3J#-L*3K1UI:1!];?L#_ /,]?]N'_MQ7VEHG_'J_^^?Y"OBW
M]@?_ )GK_MP_]N*^TM$_X]7_ -\_R%?RCQO_ ,E#B?\ MS_TB)^B95_N,/G^
M;-"BBBOACU HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "L36_\ CZ3_ '!_,UMUB:W_ ,?2
M?[@_F:3*CN:&E_\ 'A%^/\S5NJFE_P#'A%^/\S5NF)[A1110(**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1RR['D%+7KW_  R3\5_^A5_\J-I_\=H_X9)^*_\ T*G_ )4;3_X[1_;^4?\
M093_ /!D?\R>678\AI0*]>'[)/Q7[^%?_*C:?_':7_ADOXK_ /0J?^5&T_\
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MS(]G4_E?W'D-%>O?\,E_%?\ Z%7_ ,J-I_\ ':7_ (9+^*P_YE7_ ,J-I_\
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M_E1M/_CM']OY1_T&4_\ P./^9/L*W\C^YGD0'<TM>N_\,F_%;_H5?_*C:?\
MQVC_ (9-^*W_ $*O_E1M/_CM']OY1_T&4_\ P./^9'L*W\C^YGD5%>N_\,F_
M%;_H5?\ RHVG_P =H_X9-^*W_0J_^5&T_P#CM']OY1_T&4__  ./^9#P];^1
M_<SR*BO7?^&3?BM_T*O_ )4;3_X[1_PR;\5O^A5_\J-I_P#':7]OY1_T&4__
M  ./^9#P]?\ D?W,\BHKUW_ADWXK?]"K_P"5&T_^.T?\,F_%;_H5?_*C:?\
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M_,]?]N'_ +<5]I:)_P >K_[Y_D*^6_V1?A/XJ^%__"6?\)-I7]F?;OLGV?\
MTB*7?L\[=_JW;&-Z]<=:^I-$_P"/5_\ ?/\ (5_,_&&(HXK/,16H34XOELTT
MT_<BMUIN?>99"=/!0C-6>N_JS0HHHKXX](**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K$U
MO_CZ3_<'\S6W6)K?_'TG^X/YFDRH[FAI?_'A%^/\S5NJFE_\>$7X_P S5NF)
M[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "O$_VSO^3:_&'_;G_P"ED%>V5XI^V=_R
M;7XP_P"W/_TL@KWN'_\ D<8/_K[3_P#2D:4OCCZH_+[[OUI.M'6G5_:I[P4G
M6CK2TC-L*?##)<3)%%&TLKG:J("68^@ ZUZ=\&_V>_$OQCNQ)9QC3M%0D2ZI
M<J?+X_A0=7;Z<>I%?<OPH_9_\)?".W1]-LA>:MC$FJ78#3'(&0O9!QT7]:^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ
M3]L[_DVOQA_VY_\ I9!7M=>*?MF_\FU^,/\ MS_]+(*][A__ )'&#_Z^T_\
MTI&E/XX^I^7])UHZTM?VH>TV%?3/[-O[*DWC1K?Q+XN@DMM!4A[>P;*O>>[=
MUC_4TW]E7]FW_A.+B+Q;XFMO^)!"_P#HEI(/^/QQ_$1_SS!_,^U?="J$4*H"
MJ!@ =!7XCQIQH\(Y99EDO?VG)?9\EY]WTZ:[<=6K]E%?3=-M='L8+*QMX[2T
M@4)%#"H544=@!5FBBOYZE)R;;=VSB"BBBI **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K;T3_CU?\ WS_(5B5M
MZ)_QZO\ [Y_D*:%+8T****HS"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%R;,T**16#*"IR#T(I:8@HHHH *\3_:3_9L_P"&A?\ A'?^*B_L#^R/M/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *V]$_X]7_ -\_R%8E
M;>B?\>K_ .^?Y"FA2V-"BBBJ,PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _+O\ YO4_[J#_ .Y*OU$K\N_^;U/^Z@_^
MY*OU$K]<\0/^8#_KTOT/8S'_ )=^@4445^1GCA1110 4444 %%%9.J:CUAB/
M^\P_E0/<DOM6$>8X>6Z%NPK(DD:1BS$LQ[FFT5)I:P4444@"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** )[6\EM6RC?+W4]#6Y:7B7:Y7AAU4]:YRGQ2M#('0X84Q-7.HH
MJM97BWD61PP^\M6:HS"BBB@ HHHH **** /$_P!M#_DVGQC_ -N?_I9!7B?_
M  39_P":B_\ <._]NJ]L_;0_Y-I\8_\ ;G_Z605XG_P39_YJ+_W#O_;JOUS+
M?^2%QW_7U?G2/8I?[A4]?\C[8HHHK\C/'"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *Q-;_P"/I/\ <'\S6W6)K?\ Q])_N#^9I,J.YH:7_P >
M$7X_S-6ZJ:7_ ,>$7X_S-6Z8GN%%%% @HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-_".!]*KU)H@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH FM;AK697
M'3N/45T<<@D164Y5AD5RU:^BW&Y&A/5>1]*:)D:E%%%40%%%% !1110!XG^V
MA_R;3XQ_[<__ $L@KQ/_ ()L_P#-1?\ N'?^W5>V?MH?\FT^,?\ MS_]+(*\
M3_X)L_\ -1?^X=_[=5^N9;_R0N._Z^K\Z1[%+_<*GK_D?;%%%%?D9XX4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !15:ZOXK7ACN?\ NKUK+GU>:3(3]VOMU_.@=KFX2%Y)P*C-U"O6
M5!_P(5S;R-(<LQ8^YS3:5RN4Z7[7!_SVC_[Z%'VN#_GM'_WT*YJBBX<ITOVN
M#_GM'_WT*/M<'_/:/_OH5S5%%PY3I?M<'_/:/_OH4?:X/^>T?_?0KFJ*+ARG
M2_:X/^>T?_?0H^UP?\]H_P#OH5S5%%PY3I?M<'_/:/\ [Z%'VN#_ )[1_P#?
M0KFJ*+ARG2_:X/\ GM'_ -]"C[7!_P ]H_\ OH5S5%%PY3I?M<'_ #VC_P"^
MA1]K@_Y[1_\ ?0KFJ*+ARG2_:X/^>T?_ 'T*/M<'_/:/_OH5S5%%PY3I?M<'
M_/:/_OH4?:X/^>T?_?0KFJ*+ARG2_:X/^>T?_?0H^UP?\]H_^^A7-447#E.E
M^UP?\]H_^^A1]K@_Y[1_]]"N:HHN'*=+]K@_Y[1_]]"C[7!_SVC_ .^A7-44
M7#E.E^UP?\]H_P#OH4?:X/\ GM'_ -]"N:HHN'*=+]K@_P">T?\ WT*/M<'_
M #VC_P"^A7-447#E.E^UP?\ /:/_ +Z%'VN#_GM'_P!]"N:HHN'*=+]K@_Y[
M1_\ ?0H^UP?\]H_^^A7-447#E.E^UP?\]H_^^A1]K@_Y[1_]]"N:HHN'*=+]
MK@_Y[1_]]"C[7!_SVC_[Z%<U11<.4Z7[7!_SVC_[Z%'VN#_GM'_WT*YJBBX<
MITOVN#_GM'_WT*/M<'_/:/\ [Z%<U11<.4Z7[7!_SVC_ .^A1]K@_P">T?\
MWT*YJBBX<ITOVN#_ )[1_P#?0H^UP?\ /:/_ +Z%<U11<.4Z7[7!_P ]H_\
MOH4?:X/^>T?_ 'T*YJBBX<ITOVN#_GM'_P!]"C[7!_SVC_[Z%<U11<.4Z7[7
M!_SVC_[Z%'VN#_GM'_WT*YJBBX<ITOVN#_GM'_WT*/M<'_/:/_OH5S5%%PY3
MI?M<'_/:/_OH4?:X/^>T?_?0KFJ*+ARG4+-&_P!V16^A%/KE*EBNIH?N2,!Z
M9XHN'*=-161;ZT>DRY']Y:U(IDF7<C!A[4R;#Z***!!1110 4444 %%%% !1
M110 4444 %%%% !1110 5B:W_P ?2?[@_F:VZQ-;_P"/I/\ <'\S294=S0TO
M_CPB_'^9JW532_\ CPB_'^9JW3$]PHHHH$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7C?[
M8%G)J'[/'BBUA&Z6>2QB0>K->P ?J:]DKC?BYHRZ_P""_L3C,;:GILCCU5+Z
M!R/R4UZF55EALPP]=_9G%_=),J/Q(J>&M$A\->'=+TFW"B&QMH[9-HP,(H7^
ME:5%%>7.<JDG.3NWJ:!1114""BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNT/QEXC\<:5#XEOM-NXK*VTRXE810(T98RLBL-Q8Y4;N!L..>GDG_!0CX/\
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M7_N'?^W5?KF6_P#)"X[_ *^K\Z1[%+_<*GK_ )'VQ1117Y&>.%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M5J&J;28X3SW?_"G:K?>6/)C/S'[Q';VK'I%I!G/)Y-%%%24%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *R_$EO\ :M)9,9Q+"_\ WS*K
M?TK4JIJG_'A+^'\Q33<7=#6YS]%%%9F@4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6WHG_
M !ZO_OG^0K$K;T3_ (]7_P!\_P A30I;&A1115&84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5R7Q*^*7AWX3Z ^J^(;Y;:/D0P+S+.W]
MU%[G]!WKF?CU\?M$^!_A_P ZZ*WFMW"G[%IJM\SG^\W]U!Z]^@K\UOB)\2=>
M^*7B2?6M?O7NKF0X2/I'"O9$7L*_2.%^#Z^>-8G$7A077K+R7EW?W>6-6HX+
M3<]1^-_[67BCXL23:?8R/H/APD@6=NY#S+_TU<=?]T<5Y'X9\*ZQXRU6/3=%
MTZXU.^D^[#;H6/U/H/<\5[%^S_\ LFZ[\6_)U;5#)HOAG.1<.O[VY'I&I[?[
M1X],U]]?#WX7^&OA=HZZ=X=TR*RCP/,FQNEF/J[GDFOTC,N)LIX5I?4,LIJ4
MUT6R?]Y[M_CW:/#E@JF+ES5'9'R9\,OV"+^^6&[\::H-/C/S&PL"'E^C.>!^
M /UKZ>\"_ 7P)\.XXSH_AZU6Y08^UW"^=,?^!MDC\*] KP_]JCXW:E\'?"]B
M-%CC_M749&1)YDW+"JC)8#H3]:_)ZF<9UQ1BHX3VOQO2*?+'YV[+O=FM6G@L
MIH2Q-2.D>N[/;E544*H"J.@ P*PM4\?^&-#9EU#Q%I=DZ]4GO(T;\B<U^87B
M[XR>-?&SO_;'B34+J)NL'G%(A]$& /RKB9I'D;<[,Q]6.:^VPOAK.2OBL39]
MHQO^+:_(^>CQ5&L[4:6GF_T7^9^J,_[0/PXMVVOXQTH'_9FW?RJS8_'#X?ZB
MP6#QCHQ/^W=HG_H1%?DZRD]!FH&!%>O_ ,0SP36F(E?T1[^%S*=?>*/V4TO6
M].UJ+S=.O[6_C_OVLRR#\U)J2^TVTU.%H;RUANHF&&29 P(^AK\;;/5[_2;A
M9K.\N+29#E7AD9"/Q!KU_P"''[7_ ,1/ ^I6BW>M3:[I:N!+:ZB?-+)GD!S\
MP..G->)C/#3%T4ZF"Q"FUT:Y7\G=K\CZ:EAWB(Z'W%XL_9H\(>(-\MA;MH5V
M>0UF<1Y]T/'Y8KQ;Q?\  OQ-X(WSK"-6T]>?M%H"64?[2=1^&:^M]'U)-8TF
MROXE9([J!)U5NH#*& /YU;Z\&OS["<0YA@GR5)<\5TEK^.Y\MC,AP>)NXQY)
M=U_EL?#V@ZQ=:7=1W-G<26UPAR)(VP17T'\/?C?'J'E66O[89SA5O%&$;_>'
M8^_2M7Q_\$=)\5^9>6"KI>JGGS(UQ'(?]I?ZBO!M5\/ZCX4U)K'4[<P3K]T]
M5<>JGN*^I=7 <04[-6FOO7IW1\RJ>-R2I=.\']S]>S/L%7610RD,K#(8'((I
MU>!?#?XG3^'VCL;]FGTT\#/+0^X]O:O>+:YBO+>.>"198I!N5U.017Y_CL!5
MP-3EGJNC[GW&#QM/&0YH:/JB6BBBO-/0"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R[_ .;U
M/^Z@_P#N2K]1*_+O_F]3_NH/_N2K]1*_7/$#_F _Z]+]#V,Q_P"7?H%%%%?D
M9XX4444 %96N](?^!?TK5K,UQ?W43>C$4F-;F/1114F@4444 %%%% !1110
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M*GK_ )'VQ1117Y&>.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %174XMX'D/8<?6I:R=;F^:.(?[QH&C,=S(Q9CDD
MY--HHJ#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "KFEW7V
M>X"D_(_!JG13 ZNBH;.;[1;1OW(Y^M351D%%%% !1110 4444 %%%% !1110
M 4444 %8FM_\?2?[@_F:VZQ-;_X^D_W!_,TF5'<T-+_X\(OQ_F:MU4TO_CPB
M_'^9JW3$]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !535/^/"7\/YBK=5-4_X\)?P
M_F*!K<Y^BBBH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9:9I4?;;$96_$L?Z5^DPR;BS.ESUY247_-+E7_@*U_ ^9^LY/EBY:45\E?\
M'_@GWA#H>FVR[8M/M8U]%A4?TJIJ'@W0-50I>:+872GJ);9&'ZBOSNG_ &O_
M (H7$A8>(!'_ +*6T8'\JOZ;^V=\3;$_/JEO=CTGM4/\A6G^H&=0]^-6-_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %5-4_P"/"7\/YBK=5-4_X\)?P_F*!K<Y^BBBH- HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110!JZ%_P M_P#@/]:UJR="_P"6_P#P'^M:U4C-[A1113$%%%%
M!1110 4444 %%%% !1110 5B:W_Q])_N#^9K;K$UO_CZ3_<'\S294=S0TO\
MX\(OQ_F:MU4TO_CPB_'^9JW3$]PHHHH$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !535/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M49!5Q-%.56'+[UWJ^=)Z7MU:MT]3OQ>%I4<.YPW5OS29]D4445^ GBA1110
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M_<E7ZB5^N>('_,!_UZ7Z'L9C_P N_0****_(SQPHHHH **** "BBB@ HHHH
M*9)#'+]]%;_>&:?10!6;3;9NL0_ D4W^R[7_ )Y?^/'_ !JW10.[*G]EVO\
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M-6Z* NRI_9=K_P \O_'C_C1_9=K_ ,\O_'C_ (U;HH"[*G]EVO\ SR_\>/\
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M?\FT^,?^W/\ ]+(*\3_X)L_\U%_[AW_MU7MG[:'_ ";3XQ_[<_\ TL@KQ/\
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MOG]Q]J_\%*/VF/BA^SGX9\*3_#ZTCM+/4IIEO]?ELQ<BU9-GEQ ,"BEPSG+
MYV<8YKVO]D'XF^,/C!^S_P"&/%?CK2ETGQ%?+*9(T@:!9HUD98YA&Q)4.@5O
M0YR."!7D7_!0S]L/QG^R9:^!I?"&F:%J+:X]XMS_ &W;S2A/)$)79Y<T>,^8
MV<YZ#I7KO['_ ,9M:_: _9Z\+^._$-K86>KZH;H30Z9&\=NOEW,L2[5=W8?*
M@)RQY)^E315Z4Y;Z_=O_ )>GE?4TK:2IO:Z^_?\ R_I:'LM%?G]^TS_P5,7X
M<_$:_P# /PT\)1^+M<L;G[!-J%Y(Y@-T&VF&*&/YY2&^7.Y?F! !ZUYCJ'_!
M3[]H;X87-E>?$KX+6>DZ/</MC6XTG4=(><XR526=Y%)QS]TU$9*:4EL^HY+E
M?*]S]3Z*\P_9S_:"\._M+?"^Q\9^'%EMH9)&M[JQN"#+:7"8WQMC@\%6![JR
MG S@?,?[47_!3:#X6_$2X^'7PT\*_P#"<^+X)_L4\\C.;>.Z) $$<48WSN"=
MI *X;@%CG%33A-4VM7_7]/\ S%%J<>=;'W717Y6?%#_@HE^T]\+_  Y<P^.O
MA7IO@Z35[62#3-633KJW\B8KPX,LLJ.ZC)\LX/0D8Z^E?\$W?V?_ !#=:Q9?
M'W6_B6GC>37M)GL7MY&GGN()&EC++)-*<[D,14KMQW!(P34(N3?9=?/73\/Q
M)E)12[O\N_\ 78_0FBOS(U#_ (*H>-/"O[36J>#/$FF^%+#P)I?B*YTV[U&.
MRNFO$M(IG0N"+@J9-JCHF"3TKF/B-_P60\:3:U-)X"\!Z-9^'4D,<4_B)9[B
M>89X8^3+&L9(Q\N7Q_>-9Q:E&,ELRY+EG*#W7]?H?J]17RK^P_\ MS6'[6EA
MJNF:AI$?AWQCI$237%G!,9(+F$G;YT61N4!N"ASC<OS'/'H'[4G[5W@_]E/P
M;#J_B/S;_4[XM'IFBVA GO'4#)R>$C7(W.>F1@$D U47LK<W7\2:;]I\)[51
M7Y)7_P#P5Z^,>M7-YJ'AOX<>'8]!MCND%Q;7EX\*]?GF26-1QGDH*^F?V1/^
M"F'AK]HCQ);>#O$VCCP=XONOELMD_G6=\P7)1&(#1N<'"-D''#$G%5&$I:+<
MF4XQU>Q]J45YQ^T%\>/#?[.'PSU#QIXG,SV=NRP06EL 9KJ=\[(D!(&3@DD\
M *3VK\_+?_@J!^T!\4+F\O/AA\$[?4]%MFV2>7I>H:P\38SAY;=HU!QS@J*R
M4E)M+IN:M<J3?4_4JN7^)GQ+\._!_P $:GXN\5WS:9H&FA&NKI8))B@>18U^
M2-68Y9U' /6OC/\ 95_X*?Q?%KXB67P^^(OA:/PAXEO9C:6UY:R/]GDN<D>1
M)%)\\+$C:,LV6.#BO./^"HO[2?Q%TO4/%7PEM?#5A+\/[VPLIKC6FL+EKB-S
M(DN!,)/*'SHHP4Z''4@TJK=-1:^UMV[_ )?IW"ERSDU+IOWM<^Z_@?\ M,?#
MK]HR'5YOA_KKZW'I31I>%K*>V\LR!BG^M1<YV-TSTKSG]O[XX>/_ (!? S_A
M(_A]IJ7.H/?);7>H26WVA=.@9')F*=/O*BY8%1NY!R*_*?\ 9'_:H^)_[-]I
MXEA^'?A33O$L>K/ ]XU]IUU=&$QAP@7R94VYWM][.<<5^H'[6G[5GC+X!?LP
M^#/B)HVE://XAUB>PAN[35+>9K>+SK6260*BRHX(9 !EC@9SD\UKB()0YHNR
MO%?-_INO0SH3<I\DEK:3^2_4O_\ !/?XZ_$']H#X)W/B#XA6$<=[#J#6UEJ4
M=K]F74(!&A\S9]TD.67<@"G&,9!KZ?KYH_8'_:8\3_M3?"/6/%/BNPTG3]0L
M]:ETV./1H98HC&L$,@)$DDAW9E;G., <5Q/[7W_!2CPU^S?XBG\'^']'_P"$
MP\90 ?;(VG\FTL"R[E61P"7?!4[% P#RP/%7B&H32:LVEI\D*BG*#=[VO^9]
MFT5^2%A_P5\^,6DW%GJ/B#X=^&Y= N23%]GMKRT:=?\ 8G>612?<(?I7Z _L
MJ?M9>%/VK_!=QK&@Q2Z9JVGLL6J:+=,&EM'8$J0PX>-L-M? SM.0""*E0;3:
MZ!SJZ7<]NK'\8>,-%^'_ (8U+Q%XBU&#2=%TZ$SW5Y<-A(T'?W).  .22 ,D
MUL5^6G_!9#XS7_\ ;7A'X7V5R\.GBV_MO48T; G=G:.!6]0NR1L=,L#V%<]2
M3C91W;M_7R-X13NWLM2]\7_^"RS6VJ7-E\,O!,%U:1-MCU;Q)*X$V#C(MHBI
M53U!,F<'E1TKB?"O_!9OXBVFH!_$O@3PQJMCWATI[FQE_P"^Y))A_P".U[]_
MP33_ &._"'ASX.Z)\2/$V@V>M^+M?4WEI+J$*S+86VXB+RE8$*[ ;RX&[#@
MXSGZH^,W[.7@#X[>$[W1/%/AO3[EIH6CM]02W1;NS8CY7AEQN4@@<9P<8((R
M*WJ1="Z^)K?_ "_JVIA3E[;5Z)[?Y_UT,#]F/]KCP+^U3X>N+SPO/-9:M8A?
MM^B7X"W-MG@-P2'0D'#*?J%/%>V5^8/[)?\ P3Y^-_[.O[07ASQC+?\ A\Z'
M;RO;ZBEMJ$ADGM)%*L-AB )^ZP!/51SQ7W5^TG^T5X;_ &8_AG<>+_$BS72^
M:MK9:?;$"6\N&!*QJ3P!A68L>@4]3@%U94XQ4UIY>?\ P>GGH%-3<G!].O\
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M_P M_P#@/]:UJR="_P"6_P#P'^M:U4C-[A1113$%%%% !1110 4444 %%%%
M!1110 5B:W_Q])_N#^9K;K$UO_CZ3_<'\S294=S0TO\ X\(OQ_F:MU4TO_CP
MB_'^9JW3$]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGC.W'Y 5]YXFT74P>&Q,=E)K_P "5U^1Z6,C:S/4Z***_GH\P**** "BBB@
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M7_QT?X54HH"Q;_M2Z_YZ_P#CH_PH_M2Z_P">O_CH_P *J44!8M_VI=?\]?\
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M?G7^]W%:\<BS(&0[E/>J)M8?1110(**** "BBB@ HHHH \3_ &T/^3:?&/\
MVY_^ED%>)_\ !-G_ )J+_P!P[_VZKVS]M#_DVGQC_P!N?_I9!7B?_!-G_FHO
M_<._]NJ_7,M_Y(7'?]?5^=(]BE_N%3U_R/MBBBBOR,\<**** "BBB@ HHHH
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M%F)]L"OPQ_X)WZ=<Z]^VE\/GM82PBNKF[EVCA(UMI22?0<@?B*Z3]H#_ (*
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MP#U4D8-5_P!M']JKXN?&;X%WNC>*O@#K'@#PV][;SG6M4AN<0LK_ "*&D@C
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MKOB]^P;K^J>#]2T!CIS3^==^&?$$,D)CDZ&6!Q@IN"CYAN1@ <'@UZ/\:/\
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M_#^8H&MSGZ***@T"BBB@ HHHH **** /*OVE/A2_Q:^&=W8V:!M8L7^VV/\
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M ,/6_5OROINPQF(A.G&E!WMU^1L5E>*/%&E^"]!O-:UF[2QTVT3?+-)VYP
M.222  .22!6K7G_QX^'^H_%#X7ZMX;TJ:UM[Z[:$I)>,RQ#9*CG)56/13VK\
M>P-.A6Q=*GB9<M-R2D^ROJ_DCS*:C*:4W9'P[^T!^T=JWQFU)K.W\S3/"T#Y
MM[#=\TQ'22;'5O1>B]LG)-S]GFU^%&BWB:_\0?$,3W<+YMM%^PW,L:D'AY2L
M95O902/7/0='_P ,%_$#_H,>&_\ P)N/_C%'_#!?Q _Z#'AO_P ";C_XQ7]-
MRS+AF.7_ -FX7&JC3V]QVEYZN+WZO?S/HI5,-*G[*,[+R/I$?M=?"10 /%>
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M?2?[@_F:3*CN:&E_\>$7X_S-6ZJ:7_QX1?C_ #-6Z8GN%%%% @HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *J:I_QX2_A_,5;JIJG_'A+^'\Q0-;G/T445!H%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M -"K'_X$S?\ Q=?KV=\895D^+>$KTW.:2;LD[7Z.[6MA8GE4G$_-1?%FM?\
M06O?^_[_ .-/_P"$LUK_ *"UY_W_ &_QK]*?^&0?A/\ ]"JG_@3-_P#%T?\
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M45^,GZN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_<#B@#&U2Y\^X*@_(G ^O>J5!.>3UHJ34****0!1110 4444 %%%% !1110
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MW"6Z.?HHHKSQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M -5%_P#*'_\ =%']F\"_]!U7[G_\J#V6 _Y^/^OD>V?\-H?!O_H<?_*9>?\
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M;H>,<\\>V_\ !0G]MWQ[^RKXT\)Z3X0T_0;RVU73Y+J=M8M9I75UDV@*4E3
MQZ@U\^?L.?\ !/KQ)K#?#KXSQ^*M*CTN;S+T:8T,OGA?WD6W=]W.>:^8OVM/
MV2]9_9*\2:#H^L:[8Z])JUH]W')8QN@C"OM((;O6N(?+4C3ORI2>GR>E_E?Y
M'/1]Z#J;W2U^?;YV^9^Y/P&\=:A\3O@KX(\6ZM';Q:GK>D6U_<QVB%8EDDC#
M,$!)(7)XR3]:[ROS&_8#_8#\1>#_ !C\,_C=-XITNXTF:P;41I<<,@G"W%I(
MBKN/RY'F@GZ&OTYK>O%1F[:;Z=M7H*E)N*ZZ+7N?F3_P6L_Y!_PD_P"NNJ?R
MM:^=O^";/[4A^ ?QD30-;N_*\%^*G2TNS(WR6ESG$-Q[#)V,>/E;)^X*^B?^
M"UG_ "#_ (2?]==4_E:UX#XR_99_X2[_ ()__#CXO^';3=J^AI?6^MQQ+\T]
MG]ON-DV!U,1."?[C9)PE<N'E[*$JKUCS6?H[_P"7RWZ'3B(>T5."W:T]4Y/^
MN^W4_:G5]7LM!TF\U/4;F.ST^SA>XN+F9MJ11JI9F8]@ ":_G\_;$_:-O/VF
MOC9JWB<O+'H-N?L6BVDA(\FT0G:Q'9G)+M[MCH!7JGQ$_P""@?B7XC?LC>'O
MA+MNSXF:3[!J^J@Y-Y8Q[?(0$'<7<X5_41=_,(%K]J7]F-/V:_V1?A9#J5LL
M?C'7M7FU#67P-T;&W'EV^?2-3@]MS.>]15AR.55ZQBTEYN32O\D_S75$PJ<T
M537Q23;\DNGWK\GW/NO_ ()0?\F@Z9_V%[[_ -#%?8M?'7_!*#_DT'3/^PO?
M?^ABOGC]O#QU\??BY^T$_P ,O!.G^*-&\%V]S;Z;%<Z=;W,%K>S2A-\T]PBX
M,2L^W!)4!"<9KJKMNK&$5=M+\D<^'LJ4IR=DG+_TIGZF45^0_P 7O^"6/B?X
M&_"O6_B+I?Q234=9T&T;4KFUAT^2S;:@W2&.X$[,6 !(RBYQVKW7_@E'^TYX
MP^+VD>*_!?C+5;GQ!<:#'#=V&IWTADN#"Y96BD<\OM8*0S$GYB,X Q$8J;E%
M/5:V_K^M"Y2<$I-:/0D_;8_X)R^,?VE?C9!XU\.^+M)LK&XM(+2ZM-9,P>U$
M>1F (C!P02VTE/F)YYX^Y?!/AT^#_!NA:"UY-J+:78P61O)_]9/Y<:IO;W.W
M)^M?C=_P5O\ ^3LS_P!@"R_]"EK])/CI_P F%^+/^Q#?_P!(Q6-.?)A)SCLF
M]/\ P+K\G]_D:2CS8J$'NUO_ . ]/N^X^AZ*_ W]C"Z^,>J^)/$O@[X,+]CU
MWQ)9QP7VM;_*_LVT1\O)YO\ RRR6 W %^R#<16]^TU^QS\8/V5;;3/B%XA\4
M6VK2W=\(3K6BZC<O=6]R0SJ7>1$<$[6PP)Y'..,ZR7)9RT3_ ,[?UYZ$QDYW
M4=U_E?\ KRU/W4HKY;_X)Q_'S6_C]^SK;W_B:Y:_\0:)?2:1=7TA^>Z"(CQR
M/ZMLD52>Y4GO7U)5U(.G+E?]7U0J<^>/,?C!_P %?/\ DZJP_P"Q9L__ $=<
M5D>"/^"5OQ@^('@/0O%FE:KX2.GZSI\&I6L$U_<)-Y<L:NJL/L^T-AAGYL9[
MUK_\%?/^3JK#_L6;/_T=<5^IO[*__)LWPH_[%73/_26.L\/%?5Y3ZJ5OO<O\
MBJS_ 'RCTY?TB?CQ?:]^TQ^P+XLTZ#4+_6O#]J[%K>TN+K[=H]\H/S +N:(D
MC&<;9%# _+D5^LG['O[4VD_M6?"U/$%O FG:_8N+76-+5B1;SXR&3/)C<<J3
MZ$')4U1_;X^'NF_$3]D_X@P7]NDLVEZ?)K%G*P&Z&>W!D#*3TRH93ZAR.]?G
M[_P1R\37FG_M >*-#C<_8-2\/O/-'GCS(9XMC?@)9!_P*M*$G5<Z,]TKI_>_
MT:^YF=6"IJ-6&S=FON_S7Y'TG^W9_P $]_&'[4'Q6TGQAX8\5:58PI81Z?<V
M.M-,HA5'=M\)C1]V=YRI"\C.>>/LKX6^"G^&_P -?"WA234)-6?1=,M]/:^F
M&&G,4:IO(R<9QTR<5^2G_!8;_DYG0O\ L6;?_P!*+BOT#OOB=?\ P9_8&TSQ
MII=LMWJ>D>"K&:UCD4L@E-O$B,P[JI8,1Z UC"2AA)U/LJ6J_P# O\G]_D;5
M(\V*A3ZN._\ X#_FON/I"BOPM^!'@#Q+_P % /B-K%EX_P#C4VCZC"BSVT>L
ML;I[IW8YCM;<RQH%7;DJA& 1A<=/3KKX"_M+_L-_&"PA^&LOB7X@>'%2.\/]
MCZ?<R:==H6*O!<6X+HCX4]"6 96# GC11LXJIIS;=49N5^;V:O;Y'["45Y9\
M=/CI:_ _X":U\1M2L9%DL[&.:'39\H[7,NU8H6[CYW4-QP ?2ORO^$/PI^-/
M_!3+Q-XAUOQ-X_ETWPUI\ZK*]P))+6&5@2L-M:*RI\JXR20<$$EB:A<TIR@E
M\._E_7^7<OFBH*;>^W]?U^!^T=%?B_\ &3X,?&;_ ()HZUX?\2>%OB')J/AR
M_N3$LEJ)(;>295W&&YM&9D8,H;!RWW6/RD U^IO[.GQTL_CY\"_#_P 0;>V-
ML][;.;NSCRWDW$1*2QKW(W*=OJ"*KW7!U(O2._E_7];DWDIJ#6^QZG17XU3>
M%?VB/V^OCM<Z1XDG\1^!O"MP9;A(=2L[J#3;"U0_*BPD(LLOS*.2&8Y)( XR
M?VG?V-O&O[!6CZ#XV\+?%"[O8;R]^PO=:;%)I5S!*49UX29]Z$1MGYAT P<U
M"=HQE4TO\RWK*48:M'[5T5\]?L(_';6/V@_V;]$\3>(BLVOVTTVG7UPB!!<2
M1$8EV@  LC(3@ ;LX '%?ECXT^-WC?\ ;._:*'A?Q7\1F\!>$]2U&6U@@OKA
MH=-TZ%-YC5X@ZJ\AVA=SG)=@,@8 N49*LJ*U;U^7_!N1&494G6>RT^>O^3/W
M3HK\>OBI^P#\8OV58=$\5_!_QIKGC6:YN!')_P (K83VUU#\I97:.*2421';
M@DG&2H((-?I1^S3\0O%WB[X!Z%X@^)FC77ACQ5!!*FJP7]JUJV8F9?/,9 VA
MU4/@#')QQ1[O)*=_AW"\N91MOL>NT5^,OBKXS_%[_@HW^T%/X&\':_/X;\'.
M9GM[!;A[>VBLHR 9[H1\RNWR_*<@,X48&36Q\9/^"=GQ+_9)\#WWQ*\#?$Z:
M_?1T$]__ &9'-I=U%%N +H5E<2*,Y8$KP"<'I4)\L%4J>ZF6]9NG#5H_8*BO
MD?\ X)S_ +6VI_M-?#74[+Q2\<OC+PW)'#>74:!!>0R!O*F*@ !LHZL!QE0<
M#=@?7%:S@Z;LS.$U-704445F6%%%% !1110 4JL58,.H.:2B@#JE;<H(Z$9I
M:BM3FUA/^P/Y5+5F04444 %%%% 'B?[:'_)M/C'_ +<__2R"OFK]AWXG>&OA
M1HOC[5_%6I?V7I\UQIEK'-Y$LV92MXP7$:L>B,<XQQ7TK^VA_P FT^,?^W/_
M -+(*^0OV8?@C_POOP5XX\/_ -M?V%]FU#2[_P"T?9?M&[;'?)LV[TQ_K,YS
MVZ<U^V\.0PE3A#%0QTW&DZJYFMTKTMM'^3/=PR@\'-5'97_R/KW_ (;0^#?_
M $./_E,O/_C-'_#:'P;_ .AQ_P#*9>?_ !FO$_\ AVS_ -5%_P#*'_\ =%'_
M  [9_P"JB_\ E#_^Z*\[^S>!?^@ZK]S_ /E1E[+ ?\_'_7R/;/\ AM#X-_\
M0X_^4R\_^,T?\-H?!O\ Z''_ ,IEY_\ &:\3_P"';/\ U47_ ,H?_P!T4?\
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M_P"5![+ ?\_'_7R/;/\ AM#X-_\ 0X_^4R\_^,T?\-H?!O\ Z''_ ,IEY_\
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M/[-X%_Z#JOW/_P"5![+ ?\_'_7R/;/\ AM#X-_\ 0X_^4R\_^,T?\-H?!O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKJG\K6OHS_@F_IMKK'[#/@BPOK>.[LKJ/4H)[>90R21M>W 96!Z@@D8K@/\
M@J#^S5\2/VB;/X=I\/?#G_"0/I,E^UZ/MUM;>4)!!L_UTB;L[&^[G&.>U>X?
ML,_#'Q+\'?V7_!_A+Q?IO]D>(=/-Y]IL_/BG\O?=S2)\\3,ARKJ>">OK6%%+
MZO5A+K+;RU.BNWS47'HONUD>&?"3_@E'X4^%_P =+/QW-XLDUS0].O9+[3O#
M<^F!!"^28!).9F\P1G!^XNXJI/<'D_\ @M%_R33X<?\ 87N/_1(K]&*^+?\
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M_P %"/B;JUA8_%*Z\!:)IT0NKMM%EDLX;2-V*I&B0LLDS$@_ZQ^BDEN@.?\
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MTENNVWB'HH'Z5)24M69!1110 4444 >)_MH?\FT^,?\ MS_]+(*\3_X)L_\
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M^+WQ0M?B/\8[#4-,T&*[_M&6#7-PU#6+@-N >-_G6,L,LS@%A@*""67]>>G
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MX!T^234YV=UV8,HAC6*/!RV1CA22-M?M512^)*-36WR\Q_"VZ>E_F>$?L2?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"OFV_]!DKSO]N[_DL6G_\ 8'A_]&S5Z)_P3]_Y ?C/_KYMO_09*_HK,_\
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M>S:O\_0^-OV0?B9\./!NHBPO[&YTOQ-J&(/[8O)5E@;)&(U("^4"<=0<GJW
MK[@K\C_%VFVVC^*M:T^RD\ZSM;V:"&3.=R+(RJ<]\@"OTO\ V?\ 7+OQ)\&/
M"5_?.TMU)9*CR/\ >?82@8^Y"@_C7SOB'DM.@Z>;TIM^U=FI.]M+JU]4K)Z=
M.AS9A05.:FGN>@T445^+'DA1110 4444 %%%% !6WHG_ !ZO_OG^0K$K;T3_
M (]7_P!\_P A30I;&A1115&84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !11535M4MM#TN[U"\E6&TM8FFED8\*JC)-5&+DU&*U8'SI^W!\9!X$
M^'Z^&M/GV:QK@*-M/S1VX^^WMG[H_&O@3P%X-OOB!XPTO0-/0O=7TZQ#_9!/
M+'V R:W?C=\3;GXM?$C5O$$[-Y$DGEVL9)Q'"O"#\N?J37U=^P+\&_[.TR[\
M?ZE!B>[!MM.##E8_XY!]3\H^AK^G</&GP/PVZD_XTM?6<MEZ1_1GU4;8##7?
MQ?J?5/@?P?8^ ?"6EZ!IL8CM+"!8EP/O$=6/N3D_C6[117\R5*DZTY5*CO)N
M[?FSY9MR=V%%%%9B"BBB@ HHHH **** "BBB@ KY=_;?^$I\1>%H?&.GP[KW
M2ALNPHY> G[W_ 3^A-?455]0L(-4L;BSNHUFMKB-HI(V&0RD8(KV,HS*IE.-
MIXRG]EZKNNJ^:.#'X.&.P\\//K^#Z,_*+X7^/+SX:^.-*\063$/:RCS$SQ)&
M>'0^Q&:_5/PYK]GXIT&PU>PD$MG>0K-&P]".GU'3\*_,#XX?#.?X4_$34M%=
M6^R;_-M)#_'"W*G\.GX5]*?L,_%P75K=>!=1F_>Q W.GECU7^.,?3[WYU^S\
M;9;3S;+Z><837E5WYP?^3_4_-N&\9/+\;/+J^BD_NDO\_P#(^O:***_ #]8"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /R[_YO4_[J#_[DJ_42OR[_P";U/\ NH/_ +DJ_42O
MUSQ _P"8#_KTOT/8S'_EWZ!1117Y&>.%%%% !3)HQ-$Z'HPQ3Z* .6=3&[*>
M"IP:;6EK%KMD$RCY6X/UK-J34****0!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %7]'@\RYWGH@S^-4.O%=%I]K]EMPI^\>6IH3+-%%%49A1110 4444 >
M)_MH?\FT^,?^W/\ ]+(*\3_X)L_\U%_[AW_MU7MG[:'_ ";3XQ_[<_\ TL@K
MQ/\ X)L_\U%_[AW_ +=5^N9;_P D+CO^OJ_.D>Q2_P!PJ>O^1]L4445^1GCA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7,W?_'U-_OM_.NFKF;O_ (^IO]]OYTF5$BHHHJ2PHHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_9!\6?%R^3Q+X]O+K3]/G/F8N&9[JX'4<'[J$'KGZ"OM[P'\-?#?PUTE-/\
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M%](%_P#'"I_6OU:OQ'PCF&(68XS"S]LK-I;-K;[23^:5^IZ3Q&$E/VLH._\
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M=C4-2:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 445H:?IAF(DE&(^P]:8#])L=
MS":0?*/N@]_>MBD "@ # I:HS;N%%%% @HHHH **** /$_VT/^3:?&/_ &Y_
M^ED%>)_\$V?^:B_]P[_VZKVS]M#_ )-I\8_]N?\ Z605XG_P39_YJ+_W#O\
MVZK]<RW_ )(7'?\ 7U?G2/8I?[A4]?\ (^V****_(SQPHHHH **** "BBB@
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MHH U="_Y;_\  ?ZUK5DZ%_RW_P" _P!:UJI&;W"BBBF(**** "BBB@ HHHH
M**** "BBB@ K$UO_ (^D_P!P?S-;=8FM_P#'TG^X/YFDRH[FAI?_ !X1?C_,
MU;JII?\ QX1?C_,U;IB>X4444""BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHHH *J:I_QX2_A_,5;JIJG_'A+^'\Q0-;G/T445!H%%%%
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M?_0'L?\ P&3_  H_X1'0_P#H#V/_ (#)_A7Q%_P\6\2?]"KI7_?R7_XJG?\
M#Q3Q)_T*VE?]]R__ !5+_4?B/^3_ ,G7^9R2H5(_$C[;_P"$3T3_ * ]C_X#
MI_A1_P (GHG_ $"+'_P'3_"OB8?\%$?$G_0K:5_WW+_\53A_P40\1_\ 0KZ5
M_P!]R_\ Q5+_ %(XC_D_\G7^9QRE&/Q'VO\ \(GHG_0(L?\ P'3_  H_X1/1
M/^@18_\ @.G^%?%(_P""AWB,_P#,KZ7_ -]R_P#Q5.'_  4,\1_]"QI?_?<O
M_P 52_U)XB_D_P#)U_F<<L70C\7Y'VK_ ,(GHG_0(L?_  '3_"C_ (1/1/\
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MP71E45J_V%_TW_\ '/\ Z]']A?\ 3?\ \<_^O18+HRJ*U?["_P"F_P#XY_\
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MT6"Z,JBM7^PO^F__ (Y_]>C^PO\ IO\ ^.?_ %Z+!=&516K_ &%_TW_\<_\
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MG735S-W_ ,?4W^^W\Z3*B14445)84444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX6_#_P 0^+]5AN;C3-#L9M0N8K-5:9XXU+,$#,H+8'&2![U\:?\ #Y#X+_\
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MU"UU72[R,2V][93++#,AZ,KJ2"/I5\KM<CF3=B_1114E!1110 4444 %%%%
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M.O\ H-:+_P!_)/\ XBOT(HH_XB'GO\\?_ 4']I8CNON/SV_X=Y^.O^@UHO\
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M**S_ .VH/[LGY#_&GKJ]LW5F7ZB@+,NT5%'<Q3?<D5O;/-2T""BBB@ HHHH
M**** "BBB@ HHHH \3_;0_Y-I\8_]N?_ *605XG_ ,$V?^:B_P#<._\ ;JO;
M/VT/^3:?&/\ VY_^ED%>)_\ !-G_ )J+_P!P[_VZK]<RW_DA<=_U]7YTCV*7
M^X5/7_(^V****_(SQPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KF;O\ X^IO]]OYUTU<S=_\?4W^^W\Z3*B14445
M)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &KH7_+?_
M (#_ %K6K)T+_EO_ ,!_K6M5(S>X4444Q!1110 4444 %%%% !1110 4444
M%8FM_P#'TG^X/YFMNL36_P#CZ3_<'\S294=S0TO_ (\(OQ_F:MU4TO\ X\(O
MQ_F:MTQ/<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !K^)EE\&_A/XJ\:7Y7R-&L);E48X\R0#$<8]V<JH_WJ[:OSI_X+%?&;^Q?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 :NA?\M_\
M@/\ 6M:LG0O^6_\ P'^M:U4C-[A1113$%%%% !1110 4444 %%%% !1110 5
MB:W_ ,?2?[@_F:VZQ-;_ ./I/]P?S-)E1W-#2_\ CPB_'^9JW532_P#CPB_'
M^9JW3$]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<S\2/'VF_#'P7J?B/5
M9-EK91%@F?FD<\(B^[' _&NFKX(_:8\=:G^T1\:--^&GA9S-I6GW/DNZ<I+<
M=))2?[L8RH_X%UR*^HX=R?\ MC&<E1\M*"YIR[16_P WLOOZ'7AJ/MIV>RU?
MH0_L[?#W4_VEOB]J7Q$\7QM/I-K<"7RWR8Y)!S'"O^P@QD?XFOOQ0%  & .
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MO4@Z<N5^7XJYA3G[2/-Z_@['XP?\%?/^3JK#_L6;/_T=<5^PW@O_ )$W0?\
MKPM__1:U^//_  5\_P"3JK#_ +%FS_\ 1UQ7[#>"_P#D3=!_Z\+?_P!%K48?
M_=Y?XOUD56_WB/\ A_2)LDXY/ K\//B[\7O"7QY_X* ?\)!XUUN/3_ASINKI
M:?:I8WFC^PVA)"A8PQ(F=&Z#_EMFOU+_ &X/C,/@9^S3XOU^"?R-7NK?^S-,
M(.&^TSY167W12\G_   U^<7[ ?[ 'AS]J+P+XA\6>-M2U[2].@OEL=-&C30Q
M&9E3=,SF6&3(&^,#&.0V<U-'F=?VD?\ EWK\VU^6GWEUK*CR/>>GR_X/Z'Z
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M HHHH **** "BBB@ KX,_P""QW_)N7AC_L9H?_2:XK[SKX,_X+'?\FY>&/\
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M -V51_X(J_\ (<^*_P#U[Z;_ .A7%?J;7=6BH\MNJ1R4_><K]'^B/SO^$/\
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MG_'J_P#OG^0IH4MC0HHHJC,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_)GJ5O\ 9J*HKXI:O]$/HHHK\T/+"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *J:I_QX2_A_,5;JIJG_'A+^'\Q0-;G/T445!H%%%% !1110 4
M444 %%%% !1110!@>/? >A?$[P?JOA?Q+I\>J:)J<!@N;67HRGH0>JL#@AAR
M" 1R*_*3XE_\$^_CE^RSX]D\9? [5-0U_38"SP3Z7*J:G!'D'RIH#Q<+P!A
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH **** "BBB@ HHHH **** "OFW]N'XN2>!?ANOA[3I_+U7Q 3"Q4_,EL/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@>#WKZ"HJ8^ZY-?:LONO_F5+WE%/HV_O5@HHHI %%%% !1110 4444 %%%%
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MKCDHISQ7X\_ /XS?$7_@F;\===L/%/@Z:9;R 6NI:+=2FW%U&KDQ7%O/M8,
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M\D5\=_\ 8PK_ .DT5=%_P4FO=0U+]@K2[O5H);75+B?29;N"=2LD<S)EU8$
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M"1YG_P $[_&7[/'C:XUN^^%7@Z3P%XT6T6/5=(NKV:X=H-P.^-GD99(P^!N
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M1?C_ #-6Z8GN%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO_P5*^#7Q<^$.J:%KWPPUG5M:O+&2..QU""UELH;AD(#+.9/,7:QR'6,-P,
M&OTSNK6&]MY(+B&.>"1=KQ2J&5@>H(/!%>?Q_LX?"6'4!?Q_"[P6E\&WBZ7P
M_:"4-Z[O+SGWKGY+P=*>JUUZZFW-::J1T:MZ:?UJ?FS_ ,$@?@SXHD^*6K_$
MF>PGLO"EOI<VG07DR%5O)Y)$)6+/W@@C;<1P#@=>A_P5&_9E\4^$_BZWQH\+
MV-S=:'?B";4+JS0NVFWD*JJR. /E1E1"'Z!@0<97/ZT0PQV\211(L<: *J(,
M!0.@ [4YE#*58 J1@@]#6U23E*$H:..W]?UT,J<5&,XSU4M_Z^7YGYI>$_\
M@LYHT/@> >(_A_J5QXMA@V2?V?=1K97$H&-^YOGC#'DC:^WU:N7_ &(_BO\
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M ()L_P#-1?\ N'?^W5?KF6_\D+CO^OJ_.D>Q2_W"IZ_Y'VQ1117Y&>.%%%%
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MO_XY_P#7HL%T95%:O]A?]-__ !S_ .O1_87_ $W_ /'/_KT6"Z,JBM7^PO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %;>B?\ 'J_^^?Y"L2MO
M1/\ CU?_ 'S_ "%-"EL:%%%%49A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!^7?_ #>I_P!U!_\ <E7ZB5^7?_-ZG_=0
M?_<E7ZB5^N>('_,!_P!>E^A[&8_\N_0****_(SQPHHHH **** .>U*W^SW38
M'RM\PJK717]K]JA('WUY6N>92K$$8(X-2:)B4444AA1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %;6CV_EPF4]7Z?2LVQM3=S!>BCEC71*H50 , <52)D^@
MM%%%,@**** "BBB@#Q/]M#_DVGQC_P!N?_I9!7B?_!-G_FHO_<._]NJ]L_;0
M_P"3:?&/_;G_ .ED%>)_\$V?^:B_]P[_ -NJ_7,M_P"2%QW_ %]7YTCV*7^X
M5/7_ "/MBBBBOR,\<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK$UO_CZ3_<'\S6W6)K?_ !])_N#^9I,J.YH:7_QX1?C_ #-6ZJ:7_P >$7X_
MS-6Z8GN%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG[]MWQ,V@_!.XM8
MVVRZE<I;XSU3DM_2OH&OC[_@HAJ#)H?@^S4\//<2-^"IC^M?6\)X=8G.\-3E
MMS7_ / 4W^AC6ERTVSX=(KTK]G'P6/'7QD\.Z=(F^V2;[1-[(G/\]M>;U]0?
M\$_])6Z^*&L7[+DVNG[![;V'_P 17].\0XN6"RG$UX[J+MZO1?F<5&=VD?H
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M$C'/JHKZ!_:R\>_\(!\#?$$\;[+S44_LRWYP=TH(;![$1B0CW K!_8C\!_\
M"&_ ZQO9H]E[KLSZC)N'/EGY(AGTV*&'^^:_0,K_ .$S(<7C]IUFJ,?3>?WK
M3U/1I?NL/.IUEHOU/?Z***_/SS@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *J:I_P >$OX?S%6ZJ:I_QX2_A_,4#6YS]%%%0:!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %;>B?\ 'J_^^?Y"L2MO1/\ CU?_ 'S_ "%-"EL:
M%%%%49A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!^7?_ #>I_P!U!_\ <E7ZB5^6E]?6VE_MC7%Y>7$5I9V_CUIIKB=P
MD<2+J!+,S'@  $DG@ 5^BO\ PO#X<?\ 0_\ A?\ \'-M_P#%U^R\=X:O76!=
M*#E:FMDWV['M9A&4O9V70[:BN)_X7A\./^A_\+_^#FV_^+H_X7A\./\ H?\
MPO\ ^#FV_P#BZ_*?[/QG_/F7_@+_ ,CR?9S_ )6=M17$_P#"\/AQ_P!#_P"%
M_P#P<VW_ ,71_P +P^''_0_^%_\ P<VW_P 71_9^,_Y\R_\  7_D'LY_RL[:
MBH;.\M]1LX+NTGCNK6=%EBGA<.DB,,JRL.""""".N:FKA::=F9A6=J6G^=F6
M,?O.X]:T:*0SE.G!HK>OM-2ZRZ?))^AK%FMY+=MLB[3^AJ2T[D=%%%(84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5+;V[W4@1!]3Z5-::;)=88C9'_>/]*V[>W2UCVH,
M#N>YIB;$M;9;6((OXGUJ:BBJ,PHHHH **** "BBB@#Q/]M#_ )-I\8_]N?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%@YCF?LD_\ SQD_[X-'V2?_ )XR?]\&NFHHL',<S]DG_P">,G_?!H^R3_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#$5/:592\PHHHKY\YPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *J:I_QX2_A_,5;JIJG_'A+^'\Q0-;G/T445!H%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5MZ)_QZO_ +Y_D*Q*V]$_X]7_ -\_R%-"EL:%%%%49A1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %8FM_P#'TG^X/YFMNL36_P#CZ3_<'\S294=S0TO_ (\(
MOQ_F:MU4TO\ X\(OQ_F:MTQ/<****!!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%#2/ZOY_E8\?$UO;3TV04445\.<@4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5\8?M89^(?[2'PZ\$PDNL1CDGB8_(0\FYOQV(:^SZ^,/
MAN!\2OVYO$NL,/MECH:RK$YZ1%%$2_\ CQ:ONN$_W%;$Y@_^7-*;7^)KE7YG
MH8/W92J?RIGV9%&L,:1H-J* JCT I]%%?"GGA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %5-4_X\)?P_F*MU4U3_CQE_#^
M8H&MSGZ***@T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *V]$_X]7_ -\_R%8E;>B?\>K_
M .^?Y"FA2V-"BBBJ,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L36_P#CZ3_<'\S6W6)K
M?_'TG^X/YFDRH[FAI?\ QX1?C_,U;JII?_'A%^/\S5NF)[A1110(**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8R_3^M6:CN$\RWD7U4B@9S%%%%0:!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %;.AG_1Y!
M_M?TK&K5T-_]<OT--">QK44451F%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5=TF3R[P#LP*U2IT;F.17'53FF!U
M-%-CD$D:N.C#(IU49!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 (3M!)Z5S7-U=>\C_ ,S6
MWJDWDV;8ZM\HK-T>'S+K=V09I%+:YN#@8'2EHHIDA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9U5!W\DQG^;BE+@W/8J_U9_>O\S58JC+:1]:45\]:'^W+\--495N[F^TG/\
MS\6KN!_WP&KU7PO\7_!?C-4_L?Q-IMW(_P!V'[0JR_\ ?!(;]*\/%9+F6"5\
M1AY17=Q=OOV.B-2,MF=A1117C%A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!\:_M*R?\))^UY\+O#\HWVL(MI67_ '[ABWZ1K7V5
M7QMJ#KXH_P""AUK;RC?'I5LH7V*VAE'_ (\]?9-?<\2?NL-EV'[45+_P-MG?
MBM(TH_W?S"BBBOAC@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** (+VW^TV[)WZCZUS9&#@]:ZNL75[3RI/-4?*QY^M
M)E19G4445)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% &SHUSOC:$GE>1]*TJYBWF:WF61>
MH/YUTD,JS1JZG*L,U2(D/HHHIDA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !11574+K[+;DC[[<+_ (T
M9FK7/G7&P'Y8^/Q[UH:5;^1:@D?,_P Q_I6586IN[@ _='+&NBI(I]@HHHID
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%,EF6&,NYVJ* ":988R[G"BN>N)WOKC.,DG
M"K_2GWU\UY(.,(/NK6AIFG^0!+(/WAZ#T_\ KTMR]BQ8V@M(0O5CRQJS113(
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'%O-U*_1N2/H:^<,5_7&6YAA\XP<<31UA-;?FF<,9.G+E9^JW[/OQ@M?C)X
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MW*?\LB?H0:Z&BE8KF9S1LYQ_RQ?_ +Y-)]DG_P">,G_?!KIJ*+!S',_9)_\
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M8?\ C_\ ]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\ C_\ ]:C^W?\
MIA_X_P#_ %JF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_ *8?^/\ _P!:C^W?
M^F'_ (__ /6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?^F'_ (__ /6H_MW_
M *8?^/\ _P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F'_C_ /\ 6H_M
MW_IA_P"/_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA_P"/_P#UJ/[=
M_P"F'_C_ /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\ IA_X_P#_ %J/
M[=_Z8?\ C_\ ]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\ C_\ ]:C^
MW?\ IA_X_P#_ %JF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_ *8?^/\ _P!:
MC^W?^F'_ (__ /6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?^F'_ (__ /6H
M_MW_ *8?^/\ _P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F'_C_ /\
M6H_MW_IA_P"/_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA_P"/_P#U
MJ/[=_P"F'_C_ /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\ IA_X_P#_
M %J/[=_Z8?\ C_\ ]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\ C_\
M]:C^W?\ IA_X_P#_ %JF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_ *8?^/\
M_P!:C^W?^F'_ (__ /6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?^F'_ (__
M /6H_MW_ *8?^/\ _P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F'_C_
M /\ 6H_MW_IA_P"/_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA_P"/
M_P#UJ/[=_P"F'_C_ /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\ IA_X
M_P#_ %J/[=_Z8?\ C_\ ]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\
MC_\ ]:C^W?\ IA_X_P#_ %JF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_ *8?
M^/\ _P!:C^W?^F'_ (__ /6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?^F'_
M (__ /6H_MW_ *8?^/\ _P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F
M'_C_ /\ 6H_MW_IA_P"/_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA
M_P"/_P#UJ/[=_P"F'_C_ /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\
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MJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA_P"/_P#UJ/[=_P"F'_C_ /\
M6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\ IA_X_P#_ %J/[=_Z8?\ C_\
M]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\ C_\ ]:C^W?\ IA_X_P#_
M %JF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_ *8?^/\ _P!:C^W?^F'_ (__
M /6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?^F'_ (__ /6H_MW_ *8?^/\
M_P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F'_C_ /\ 6H_MW_IA_P"/
M_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA_P"/_P#UJ/[=_P"F'_C_
M /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\ IA_X_P#_ %J/[=_Z8?\
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M8?\ C_\ ]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\ C_\ ]:C^W?\
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M_MW_ *8?^/\ _P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F'_C_ /\
M6H_MW_IA_P"/_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA_P"/_P#U
MJ/[=_P"F'_C_ /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\ IA_X_P#_
M %J/[=_Z8?\ C_\ ]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\ C_\
M]:C^W?\ IA_X_P#_ %JF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_ *8?^/\
M_P!:C^W?^F'_ (__ /6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?^F'_ (__
M /6H_MW_ *8?^/\ _P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F'_C_
M /\ 6H_MW_IA_P"/_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA_P"/
M_P#UJ/[=_P"F'_C_ /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\ IA_X
M_P#_ %J/[=_Z8?\ C_\ ]:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_Z8?\
MC_\ ]:C^W?\ IA_X_P#_ %JF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_ *8?
M^/\ _P!:C^W?^F'_ (__ /6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?^F'_
M (__ /6H_MW_ *8?^/\ _P!:IO[$@_OR?F/\*/[$@_OR?F/\*-0T(?[=_P"F
M'_C_ /\ 6H_MW_IA_P"/_P#UJF_L2#^_)^8_PH_L2#^_)^8_PHU#0A_MW_IA
M_P"/_P#UJ/[=_P"F'_C_ /\ 6J;^Q(/[\GYC_"C^Q(/[\GYC_"C4-"'^W?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ***X_XM^*#X0^'NM:BC;)E@,<+>DC?*I_,BMZ%&6(JQHPWDTE\S&O
M6CAZ4JL]HIO[CXV_:"\;-XZ^(E_-')OL;1C;V^#QM4X+#Z]:\MDCK6G4NS,>
M2QR:72]'FUK5;2PMDWSW,JQ(H[L3@"OZBPE.G@</&C#2,%^1_,6+J5,;B)59
M:RF_S/H7]CWX7+-)<>,;Z'(0F&RW#N.&<?CD?A7U?6+X-\,VW@WPQINC6H'D
MV<*Q;@/O$#EC[D\UM5_.6=9E+-<;/$-Z;+R2V/Z(R;+HY7@H8=;[OS;W"BBB
MO#/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .:^(_@:Q
M^(_@O4_#]^BM#=Q%59A]QQRK#Z'%?DWXP\+W?@SQ/J6B7\9CNK*9HG#=>.A_
M$8/XU^Q-?"G[?7PW72O$6D^+[6+;#J"FUN648'FJ,H?J1N_[YK]>\.\X>&QL
MLNJ/W*FJ\I+_ #7Y(X<5'W>==#Y(_2OTW_9(^)9^(WPDLA<R^9J6EG[)<9.6
M.!\K'ZC/Y5^9-?3G[!?C@Z'\3KOP]+)BWUBV;8I/'FQC>#_WR&'XU^E\<Y:L
MPR>=1+WJ7O+T^U^&OR,Z%36Q^@M%%%?RL>D%%%% !1110 5XAXM_9!\!^,_$
MVI:YJ$%P;W4)VGF*R8&X]:]OHKT,'F&+R^3GA*C@WH[.VAI"I.F[P=CYY_X8
M;^&__/"Z_P"_M'_##?PW_P">%U_W]KZ&HKUO]9LY_P"@J?WFWUJO_.SYZ7]A
MSX;A@3;W1]O--6_^&*?AE_T#)O\ O\W^->]45+XDSE[XJ?\ X$P^M5_YV>"_
M\,4_#+_H&3?]_F_QJIJW[%_PUM=+O)H]-F#QPNZGS6ZA21WKZ%JIJR^9I=XO
M]Z%Q_P".FG#B+-^97Q4__ F"Q-:_QL^4_P#@G3)GP#XI3^[J*'\X_P#ZU?6]
M?'O_  3CD+>%?&<?9;RW/YH_^%?85>AQHN7/\4O-?^DHTQW^\3_KH%%%%?%'
M"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %>!_M;:R8?#&EZ8C8-Q/YCC
MU50?ZXKWROEW]K>8R>)]$@SPEFSX^KD?^RU]1PS353-*5^EW]R/F.)*CIY95
MMULOO9\ZR1UZI^S'X7&N?%"VN9$W0Z>AN#[-_"?SKS:2/-?2'['^DA8=?U';
M\VY;?/X!J_7L_P 4\/E=:2W:M]^A^29#A5B,SHQ>R=_NU/I&BBBOYY/Z""BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR/\ :J\'
M+XR^"/B"$1[[FR1;V'C[K(?F/_?!>O7*S_$&FC6-!U*P8;ENK:2 C_>0K_6N
M_+\3+!XNEB8[PDG]S(G'FBX]S\<,5U?PF\1OX3^)GAG54;8+?4(2Y_V"X#_^
M.DUA:U:_8=8OK;&/)GDCQ]&(JD"48,IP0<@U_:=2G'%494Y;237R:/FJ=2S/
MV:@F$\,<J_==0P_$9J2N8^&>N?\ "2> ]%U'.?.MQ_XZ2O\ 2NGK^(ZU-T:L
MJ4MXMK[CZ:,E))KJ%%%%8E!1110 4444 %%%% !1110 4R:/S(9$_O*1^E/I
M#30'QK_P3A8KI/CR(_>2XM"1]5F']*^RZ^._V$\:3X\^*^CG&8[R/_R'+.O_
M +-7V)7V_&SYL^KSZ2Y']\(G?CO]XD_3\@HHHKX<X HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
MR91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^
MK^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0
MK?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P
M76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\
MF4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]
M%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#
MZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]
M"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_
M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
MR91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^
MK^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0
MK?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P
M76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\
MF4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]
M%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#
MZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]
M"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_
M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
MR91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^
MK^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0
MK?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P
M76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\
MF4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]
M%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#
MZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]
M"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_
M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
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M9B68G))Y)I* )KR\N-0NI;F[GDN;F5B\DTSEW=CU))Y)J&BB@ HHHH ****
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M%'V2#_GC'_WP*FHH A^R0?\ /&/_ +X%'V2#_GC'_P!\"IJ* (?LD'_/&/\
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M?LD'_/&/_O@4?9(/^>,?_? J:B@"'[)!_P \8_\ O@4?9(/^>,?_ 'P*FHH
MA^R0?\\8_P#O@4?9(/\ GC'_ -\"IJ* (?LD'_/&/_O@4?9(/^>,?_? J:B@
M"'[)!_SQC_[X%'V2#_GC'_WP*FHH A^R0?\ /&/_ +X%'V2#_GC'_P!\"IJ*
M (?LD'_/&/\ [X%'V2#_ )XQ_P#? J:B@"'[)!_SQC_[X%'V2#_GC'_WP*FH
MH A^R0?\\8_^^!1]D@_YXQ_]\"IJ* (?LD'_ #QC_P"^!1]D@_YXQ_\ ? J:
MB@"'[)!_SQC_ .^!1]D@_P">,?\ WP*FHH A^R0?\\8_^^!1]D@_YXQ_]\"I
MJ* (?LD'_/&/_O@4?9(/^>,?_? J:B@"'[)!_P \8_\ O@4?9(/^>,?_ 'P*
MFHH A^R0?\\8_P#O@4?9(/\ GC'_ -\"IJ* (?LD'_/&/_O@4?9(/^>,?_?
MJ:B@"'[)!_SQC_[X%'V2#_GC'_WP*FHH A^R0?\ /&/_ +X%'V2#_GC'_P!\
M"IJ* (?LD'_/&/\ [X%'V2#_ )XQ_P#? J:B@"'[)!_SQC_[X%'V2#_GC'_W
MP*FHH A^R0?\\8_^^!1]D@_YXQ_]\"IJ* (?LD'_ #QC_P"^!1]D@_YXQ_\
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M^^!1]D@_YXQ_]\"IJ* (?LD'_/&/_O@4?9(/^>,?_? J:B@"'[)!_P \8_\
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M'_/&/_O@4?9(/^>,?_? J:B@"'[)!_SQC_[X%'V2#_GC'_WP*FHH A^R0?\
M/&/_ +X%'V2#_GC'_P!\"IJ* (?LD'_/&/\ [X%'V2#_ )XQ_P#? J:B@"'[
M)!_SQC_[X%'V2#_GC'_WP*FHH A^R0?\\8_^^!1]D@_YXQ_]\"IJ* (?LD'_
M #QC_P"^!1]D@_YXQ_\ ? J:B@"'[)!_SQC_ .^!1]D@_P">,?\ WP*FHH A
M^R0?\\8_^^!1]D@_YXQ_]\"IJ* (?LD'_/&/_O@4?9(/^>,?_? J:B@"'[)!
M_P \8_\ O@4?9(/^>,?_ 'P*FHH A^R0?\\8_P#O@4?9(/\ GC'_ -\"IJ*
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M* (?LD'_ #QC_P"^!1]D@_YXQ_\ ? J:B@"'[)!_SQC_ .^!1]D@_P">,?\
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M_? J:B@"'[)!_P \8_\ O@4?9(/^>,?_ 'P*FHH A^R0?\\8_P#O@4?9(/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF@:CX;U<1+,;'5+9[>8(PRK%' .#_2AZ6OU#?8P**** "BBB@ HHHH ****
M"BBB@ HHHH *ZWX2_#'6OC-\2/#_ (*\/P^=JNL72V\9(^6->6>5O]E$#.?9
M37)5^I/_  1Y_9_6WT_Q!\7]4@!EN"VC:+O'W8P0;B8?5@D8/4;)!T- T?H)
M\&/A+HOP7^'/A[P/X<@$>G:7;K K[0&GDZR3/_M.Y9S[L>U>K6]NMM"L:]!U
M/K5#1;;:K3,.6X7Z5J4D-]@HHHIDA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !5>^M1=PE?XARI]ZL44 <W:W#6=P&/8X
M9:Z-6#*&!R",@UCZS;;)!,HX;@_6K&CW'F0F(GYDZ?2D4]5<T:***9(4444
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MFG6UF(=7CCCGW1ALDB-W7'(Q\U?NS^TGX3TSQS^S_P#$31-86,Z?=:%>;WE
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ/GVZU^T&C_#_P *:+X=CT72_#>CV6A^7L73[6QB2VV>@C5=N/PK\U?VX/\
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M*:HTQGG-FL$[D8S+'\C_ *J:]'KY._X)]^*))?"/B?PI<NQN-(OA*J'[J1R
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M=_".M:=;Z;<:G9V$.G:O:K"GF6UY%&J2*RXR V-ZYZJP-?$?QZ_X(S^+-?\
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ME?T@>$O^15T;_KRA_P#1:T4Y*I0YX[.WY,B<7&NHOHG^:/YJ?C]_R7?XC_\
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MN-XF\-^'/CM\)1HWC[PT]II'B&U07>@ZTZ)/"[88(6C<A958 AD;(*@@Y%>
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M_JX#_P KE'_&;W_5P'_E<H _?ZBOP!_XS>_ZN _\KE'_ !F]_P!7 ?\ E<H
M_?ZBOP!_XS>_ZN _\KE'_&;W_5P'_E<H _?ZBOP!_P",WO\ JX#_ ,KE'_&;
MW_5P'_E<H _?ZBOP!_XS>_ZN _\ *Y1_QF]_U<!_Y7* /W^HK\ ?^,WO^K@/
M_*Y1_P 9O?\ 5P'_ )7* /W^HK\ ?^,WO^K@/_*Y1_QF]_U<!_Y7* /W^HK\
M ?\ C-[_ *N _P#*Y1_QF]_U<!_Y7* /W^HK\ ?^,WO^K@/_ "N4?\9O?]7
M?^5R@#]_J*_ '_C-[_JX#_RN4?\ &;W_ %<!_P"5R@#]_J*_ '_C-[_JX#_R
MN4?\9O?]7 ?^5R@#]_J*_ '_ (S>_P"K@/\ RN4?\9O?]7 ?^5R@#]_J*_ '
M_C-[_JX#_P KE'_&;W_5P'_E<H _?ZBOP!_XS>_ZN _\KE'_ !F]_P!7 ?\
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M_P!7 ?\ E<H _?ZBOP!_XS>_ZN _\KE'_&;W_5P'_E<H _?ZBOP!_P",WO\
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MWO\ JX#_ ,KE'_&;W_5P'_E<H _?ZBOP!_XS>_ZN _\ *Y1_QF]_U<!_Y7*
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M;W_5P'_E<H_XS>_ZN _\KE '[_45^ /_ !F]_P!7 ?\ E<H_XS>_ZN _\KE
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M;W_5P'_E<H_XS>_ZN _\KE '[_45^ /_ !F]_P!7 ?\ E<H_XS>_ZN _\KE
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M;W_5P'_E<H_XS>_ZN _\KE '[_45^ /_ !F]_P!7 ?\ E<H_XS>_ZN _\KE
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MBE_P15\%0^!=1F^'_C'Q&/%4$#2VT6O26\UK<.HSY9\N&-DW'C=EL9Z&H_\
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M*:EHVG:V\'B3PGJ"36.KVBF/S$*K)%)M.>'C==R'(Y93N'7Z5_X99_X*!?\
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MLKW.D^(_Q&\1?%OQMJOB[Q9J']J^(=4D66\O/(CA\U@BH#LC54'RJHX Z5]
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MH!9VELW]J>,-=FO[PQ#<MK%)*TL\A/\ =1"QYZX ZFOW7_;#LXM/_8]^*]K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OQ6_P""U?\ R=-X6_[$RU_]+KZOVIK\5O\ @M7_ ,G3>%O^Q,M?
M_2Z^H _53]D[_DUGX-_]B9HW_I##7JM>5?LG?\FL_!O_ +$S1O\ TAAKU6@
MHHHH **** "BBB@ K)UW_EA_P+^E:U9.N_\ +#_@7]*3&MS*HHHJ30ZNBBBK
M,@HHHH **** "BBB@#X>_P""N'P3U;XJ?LWVVN:':R7U]X1O_P"TI[>%2SM:
M-&R3, .NWY'/^RK'M7Y(_LM_M#:M^R_\9='\>:5:1ZD+97M[S3Y'V"ZMI!B2
M/=@[3P&#8.&4$@C(/])KHLB,CJ&5A@JPR"/2OAC]H#_@D9\*OBUJUYK?A._N
M_AOK%TV^2'3X%N-.9R<EOLQ*E"?1'51_=K*GS4:CG'K_ )6^ZW]=M)\M6FH2
MZ?YW^]/^M-;GAW_@L#\ -8T<W>H3^(M!NU7)L+S2C)(3CHK1,Z'V)(_"OA+_
M (*(?\% ]+_:RL=#\*>$-&OM,\)Z7=&_DNM65$N;NXV,BX1&8(BJS]6)8MR%
MQ@^I7_\ P0_\71W>VR^*.BW%M_STN-,FB?K_ '0[#I_M5Z+\-?\ @B/X8TO4
MH[GQU\1M0\06JD-_9^C6"V 8@]&E=Y25/3Y54^AK24%4:OHOZ^9$9.FG;5GA
M'_!''X0:IXH_:$OO'IMG30?#&GS1&Z9?E>ZG7RTC![D1F1CCIA<_>%?4_P#P
M6B\)WNL_LW^&]9M8FEM]&\0QO=%1Q''+#)&&/MO*+]6%?;?PU^&/A;X/^#K'
MPKX-T6VT'0;)<0VEL#C)ZNS$EG<]2S$L3U)JSX\\"Z'\3O!NK^%?$NGQZIH6
MK6[6UW:R$@.A]".5(."&!!! (Y%/%?O81C#[-K>=GS?F+#I4YN4_M7O\U;_@
MGX)_\$]?VH-&_97^.[:_XEM[B;PWJNGR:5?36J;Y;8,Z.LP7JP#1@%1SAB1D
M@ _H_P#%_P#X*_?!CPCX3N)_ L]]XZ\1.A6ULUL9[.W1\<--),B$+[(&)Z<=
M1XCX_P#^"(=PVN3S>"?B9#'I$CDQ6FNV#&:%>RF6)L2'WV)]*]/_ &>?^".W
M@;X;>(8-=^(?B!OB)<6[K);Z2MG]DL%8<YE4N[3#.."54\AE85;?MHQC)V2^
M_O\ J_\ ,FRI2<HJ]_N[?U^1^/GC?Q5J/CKQEKOB35]G]JZO?37]UY:;%\V5
MR[X7L,L<"OZ*OV-?^33_ (1?]BOI_P#Z(6OC[XP?\$;8?BE\4_%GC"#XL_V+
M%KNIW&HKIW_"-"86WFN7\L.+M-P&< [1]*^\_@W\._\ A4GPG\(^"O[0_M7_
M (1_2[?3?MWD^3Y_E($W[-S;<XSC<<>IITI*.'Y+6=XZ>B?Y7'53=?FO=:Z]
M]5^9^3G[0?\ P4H_:-^#/QN\;>"Y;[1K>/1]5GM[99M(C+-;[RT#YSSNB*-G
MOFOT&^#7[?'P3^*7P_TK6;SXC>&_#FIRV\8O]+U_4H=/G@GVCS$VS,N]0V<,
MN5/K2?M7?L&_#C]K-8=0UU+K0O%=K%Y-OX@THJ)B@SMCF1@5E0$Y .&'(# $
MY^'];_X(>^)(;@#2/BKI5[!DY:^TB6W8>G"RR9_.L*3E&G[.:N^_]=^OGU[Z
M5$I3YX.R[?UVZ>1\_P#_  4U\3_"3Q7^T+'>?"8Z5<6O]GJ-8O="15L[F],C
MDNA3Y';84W.O!/<D&ONC_@BUX3U31OV>?%.LWD4D-AK&O,UCO&!(L4*(\B^H
MWY7/K&?2N6^%/_!$WPSHNL07WQ \?WGB:SC(9M)TBR^PI(0<[7F:1V*$<$*$
M;T85^CGA;PMI'@CP[IV@Z!IUOI.C:?"MO:V5J@2.&-1@* /\GK6U%1HTI0O=
MO\-;_P# 7D956ZU2,K62_P K?\%_U;\E/^"WG_)5OAK_ -@6X_\ 1]>,?\$[
M_P!N*']DOQ=JFE>)+2:^\">('C:\:T4-/93H"%G1?XUP<,N<X (Y7:WL_P#P
M6\_Y*M\-?^P+<?\ H^J__!-W]ECP/^U9^SC\1O#_ (QM9HYK77H9=/U:R8)=
M64AMP"48@@JP #(P(.!W (YL$Y1I3E%7LY:=_?M^M_5&N*Y74A&6E[:]O<O^
MEO1]=CZZ^)__  5?^ OA/P-?ZGX7\2R^,?$'DM]AT>UTZZ@,DI'R^8\L2*B
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M[3R3&9;O.G:M#Y:3_#\3T:/[VA.EU7O+]3[FHHHK\_/."BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY5_X*C_\ )B?Q-_[AG_IT
MM*^JJ^5?^"H__)B?Q-_[AG_ITM* /P!HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/@/_ ,)FR_\ C5'_  RS\%_^B0^ _P#PF;+_ .-47#E/YTJ*_HM_X99^"_\
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MD/@/_P )FR_^-4?\,L_!?_HD/@/_ ,)FR_\ C5%PY3^=*BOZ+?\ AEGX+_\
M1(? ?_A,V7_QJC_AEGX+_P#1(? ?_A,V7_QJBX<I_.E17]%O_#+/P7_Z)#X#
M_P#"9LO_ (U1_P ,L_!?_HD/@/\ \)FR_P#C5%PY3^=*BOZ+?^&6?@O_ -$A
M\!_^$S9?_&J/^&6?@O\ ]$A\!_\ A,V7_P :HN'*?SI45_1;_P ,L_!?_HD/
M@/\ \)FR_P#C5'_#+/P7_P"B0^ __"9LO_C5%PY3^=*BOZ+?^&6?@O\ ]$A\
M!_\ A,V7_P :H_X99^"__1(? ?\ X3-E_P#&J+ARG\Z5%?T6_P##+/P7_P"B
M0^ __"9LO_C5'_#+/P7_ .B0^ __  F;+_XU1<.4_G2HK^BW_AEGX+_]$A\!
M_P#A,V7_ ,:H_P"&6?@O_P!$A\!_^$S9?_&J+ARG\Z5%?T6_\,L_!?\ Z)#X
M#_\ "9LO_C5'_#+/P7_Z)#X#_P#"9LO_ (U1<.4_G2HK^BW_ (99^"__ $2'
MP'_X3-E_\:H_X99^"_\ T2'P'_X3-E_\:HN'*?SI45_1;_PRS\%_^B0^ _\
MPF;+_P"-4?\ #+/P7_Z)#X#_ /"9LO\ XU1<.4_G2HK^BW_AEGX+_P#1(? ?
M_A,V7_QJC_AEGX+_ /1(? ?_ (3-E_\ &J+ARG\Z5%?T6_\ #+/P7_Z)#X#_
M /"9LO\ XU1_PRS\%_\ HD/@/_PF;+_XU1<.4_G2HK^BW_AEGX+_ /1(? ?_
M (3-E_\ &J/^&6?@O_T2'P'_ .$S9?\ QJBX<I_.E17]%O\ PRS\%_\ HD/@
M/_PF;+_XU1_PRS\%_P#HD/@/_P )FR_^-47#E/YTJ*_HM_X99^"__1(? ?\
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M5TF^A6XM;VTD$D4T;#*LK#@@BA>]'F6P/1\KW-&BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ^%_C=:R?LZ_M4:+X[M(7CT/
M6)!+<^7P"2=MPOX@AO<FON*RO(=0LX+JW<203(LD;CHRD9!_(UX]^UG\+5^)
MWPAU)(8]VJ:6#?VFT9)*@[E_%<_I7-_L1_%3_A.OA:NBWER)=6T BV96/S&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "MO1/^/5_P#?/\A6)6WHG_'J
M_P#OG^0IH4MC0HHHJC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO_CH_P */[4NO^>O_CH_PJI10%BW_:EU_P ]?_'1_A1_:EU_SU_\='^%5**
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M?Z!:W7G>5O\ +_U\3[<>8_W<9SSG K]JO^";/QL\:?'[]G$^*?'FL_V[KO\
M;-U:?:_LL%O^Z18RJ[(41>-QYQGFNZ454O*"LHI7_!/\6<G-R22E]IZ?=?\
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M^8_[-O\ P5.^*UK\8-'N/BUX_DU+P###=RZA9PZ+8QR3%;65H41HH$;<THC
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M[KCO7V?"N/I8?&2PF+_@UUR2\K[/Y/KTU.["5%&?)/X9:,]UBE2:-)(V#QN
MRLIR"#T-/KYW_8K^,@^(WPV70K^7.O>'PMO(&/S2V_\ RRD_#&T^Z@_Q5]$5
MX&9Y?5RO&5,'6^*#MZKH_FM3FJTW1FX2Z!1117EF04444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7RK_ ,%1_P#DQ/XF_P#<,_\ 3I:5]55\J_\
M!4?_ ),3^)O_ '#/_3I:4 ?@#117V#_P3H_8_P#^&B_B(_B+Q%;[O OAV9'N
M8WR!?7'WDMQZKP"WM@=Z /<O^";?[ J:E_9OQ:^)&FB2TPMQX?T2Z3*RY&5N
MI5/5<8**>#PQ[5^I5,@@CM88X88UAAC4(D<:A550,  #H *?4FNP4444@"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "MO1/\ CU?_ 'S_ "%8E;>B?\>K_P"^?Y"FA2V-"BBBJ,PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CGG2WC+N< ?
MK3F8(I9C@ 9)KG[Z\:[E)Z(/NBD-*XEY>O>/D\(.BU7HHJ30**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ I\,SP2!T.TBF44 =#8WRWB?W7'5:M5R\,K0R!
MT.&%=%:7*W4(<=>A'H:HAJQ-1113)"BBB@ HHHH **** "LG7?\ EA_P+^E:
MU9.N_P#+#_@7]*3&MS*HHHJ30ZNBBBK,@HHHH **** /PM_X*]>9_P -D7^_
M=M_L6PV;LXV[6Z>V<_CFOJ__ ((BBW_X4[\12H7[7_;T7F>NS[.NS\,[_P!:
M\M_X+7_"2YL?'7@CXDV\#-8:A9-HEW*H^6.:)FEBS[LDCX_ZY&N"_P""0_[1
M.E_"?XT:OX+\07L=AI?C.*&&UN)GVQI?1,WE(2>!YBR.N>[!!WI8!>Y4I]7S
M?^E<WXK;U08S24*G16_+E?W/?T9^V5%%<_\ $#QUHOPQ\%ZSXJ\0WL>G:+I-
ML]U<W$K8 51T'JQ.  .22 .32E)0BY2V148N345NSH**_GVUK_@I1^T/?ZQ?
MW-E\2-0L+.:XDDAM5M;5A"A8E4!,63@$#GTK]P?@7J.O:?\ L_\ @W4_'NHO
M<>(1H4%[K%[<A482F(22E@H &W)!P!TJU_"=:6B5K_--_A8B6E14EJW?\+?Y
MGYI?\%JOC1_:WC3P;\,+*?,&DV[:SJ"*<CSY<I"I]"L:N?I,*[S_ ((G_"/^
MS_"/CKXE7<&)=2N4T6QD8?\ +*("28CV9WC'UC-?FM^T5\6;CXY?'#QGXYN&
M<KK&HR36ZR=8[<'9 G_ 8U0?A5#PO\=/B3X)T>'2/#OQ!\5:!I,)9H['2]:N
M;:!"Q+,5C1PHR22<#DFL\+)TZ<I27O2_"_\ DO=]#3%1YYJ*>D?QM_P=3]!?
M^"V7PA^P^*/ GQ+M(,1W\$FAW\BC@21DRP$^[*TH^D8KI/\ @BC\:1<:7XV^
M%=[/^\MW77M-1F.2C;8KA1[!A"W_  -J_-#Q=\9_B#\0-+33?%/CKQ+XDTY)
M1,MGJ^KW%U") " X21R-P#$9QGDUWG[%_P :#\!?VEO!'BR6<P:6MX++4CNP
MIM)OW<I;V4-O^J"M\'#EE*ETG?\ '5?^3?@8XJ7-%5$M8V_#3_TG3U/Z.Z_F
M-^./_):OB!_V,.H?^E,E?TXJP90RD%2,@CO7\QWQQ_Y+5\0/^QAU#_TIDKAE
M_O$/27YQ.F/\*7JOR9_0%^P__P FA_"+_L7+3_T 5[A7A_[#_P#R:'\(O^Q<
MM/\ T 5[=)(D,;22,J1J"S,QP !U)->CB/XT_5_F<6'_ (,/1?D?F]_P6Z,7
M_"G?AT#M\_\ MZ7;_>V_9VW8]L[?TKY/_P""0OVC_ALC3O)QY?\ 8M_YV<_<
MV+C&/]K;U_PJY_P56_:HT7X__%O2?#GA*_CU3POX1BEA_M"W;=#=WDI7SFC;
M^)%"(H8<$AR,@@GUC_@BA\'[NZ\8>-_B;=0.FGV=H-#LI6'RRS2,DLV/=%2(
M?]M:PP*]ZI5>SYG_ .2\J^]VMZFV-^&%/JN7_P!*YOP6_HS];Z***!GXH_\
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M5^K%=&)^*/\ AC^2,*>\_7]$?SJ_M\_\GD?%G_L-2?\ H*U^UG[ _P#R9O\
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M>2!=6^?YC\Z_9VNVM\%+_#_[=(YZ7QU/7_VU!1117(=(4444 %%%% !1110
M4444 %(RAE*L,@\$&EHH ^ ?'=E=_L@?M-VGB*RBD/A'6':4QQC@P.P\^(#^
M]&2&4>FSGDU]ZZ;J5KK&G6M_93I<V=U$LT,T9RKHP!5A[$$5YQ^T9\(8?C+\
M,K_2%1?[5MP;K3I#@%9U!PN?1AE3]:\._89^,DPAN_AGX@D:'4=/=VT]9^&V
M@GS(>>ZG) ]S7Z9CE_K)DT<RCKB,.E&IWE#[,_EU^?9'J5/]IHJJOBCH_3N?
M8-%%%?F9Y84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7RK_P %
M1_\ DQ/XF_\ <,_].EI7U57RK_P5'_Y,3^)O_<,_].EI0!^#7@OPCJGC_P 6
MZ/X;T6W:[U;5;J.SMH5!.Z1V"C.!TYR3V -?T0_ #X*Z-^S[\*-"\$Z(-\%A
M%F>Z*@-=7#<R3-CNS?D,#M7YG?\ !('X&0^*_B3KWQ*U*W66T\-Q"ST_>H(^
MV3*=S\CJD>?QE![5^NE2RXA1112*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K;T3_CU?\ WS_(
M5B5MZ)_QZO\ [Y_D*:%+8T****HS"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBFR.(T9CT49- &9K%UT@4^[?X5DT^60S2,[=6.:94F
MJ"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5;TVZ^RW S]QN
M#_C52BF!U=%5--N//M5R<LORFK=49!1110 4444 %%%% !63KO\ RP_X%_2M
M:LG7?^6'_ OZ4F-;F51114FAU=%%%69!1110 4444 >?_'CX)^'?VAOA;K?@
M;Q/$S:=J4>$N(P/-M9E.8YHR>C*V#Z'D'@FOP*_:<_8Y^(W[*_B2>V\2Z5+>
M>'FEVV/B:RB9K*Z4_=RW_+*3UC?!R#C<,,?Z-:AO+.WU"UEMKJ".YMI5*20S
M('1U/4$'@BLN2TN>._7S_P"#Y_GH:*?N\LC^?+P+_P %'?VB/A[H%MHNF?$:
MZN=/ME"0KJEE;7TB*.@\V:-I"!T +' &!7#_ !L_:T^+7[1$$%KX^\:7NM:?
M _F1Z?''':VH;LQAA5$9ADX9@2,GGFOW=U[]B3X">))O.O/A)X460G<39Z:E
MKD^I\H+G\:W?!'[+GP@^&]];WWAKX:>%])U"WYAOH=+A-S&<8RLK*7!_&M7:
M;O,S7N*T#\HO^"?/_!.CQ+\5?&6C>/?B)HD^B_#_ $^5+R"SU&(QS:RZG<BK
M&>1!G!9V&&'"YR2OWO\ \%0?C,/A#^R;X@M+680ZMXI9=!M%'79("9R/80K(
M,]BRU];UR_CCX6^"_B=#:1>,?"&@^+(K-F:V37-,@O5A+8#%!*K;2<#..N!1
MB+UJ:I+1?U?[UH.C^ZJ>T>K_ *M]SU/Y[?V*_@Z?CI^TUX%\+2P&?36OEO=1
M&W*_98/WL@;T#!=GU<5_1R %  & .@KB?!GP-^&_PXU9]4\)_#[PMX7U-HC
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M[\]+?Y?<?SY?M\_\GD?%G_L-2?\ H*U^UG[ _P#R9O\ ";_L"1_^A-7<:_\
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M45]'D&<2R7&QQ%KP?NSC_-%[K]5YG3AZSH5%+IU]#G/@S\4M/^+W@+3]?L6
ME=1'=0=X9@/F4_CR/8UW-?GK\-?$FJ?L=_':^\,^())&\,7SA'F/W&B)_=W
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
MWHG_ !ZO_OG^0K$K;T3_ (]7_P!\_P A30I;&A1115&84444 %%%% !1110
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MR&!K3H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.L2^7:%<\N<5>K(UQO
MFB7V)I#6YET445)H%%%% !1110 4444 %%%% !1110!YY^T/\1-2^$OP/\;>
M,M(@M;G5-$TR:]MX;Y&:%W49 <*RL1]&'UK\M/\ A\A\:/\ H6/ ?_@OO?\
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M?J*!HQ:***@T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *V]$_X]7_ -\_R%8E;>B?\>K_
M .^?Y"FA2V-"BBBJ,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^C1<.4Z:BN9^US_\]I/^^C1]KG_Y[2?]]&BX<ITU%<S]KG_Y[2?]]&C[7/\
M\]I/^^C1<.4Z:BN9^US_ //:3_OHT?:Y_P#GM)_WT:+ARG345S/VN?\ Y[2?
M]]&C[7/_ ,]I/^^C1<.4Z:BN9^US_P#/:3_OHT?:Y_\ GM)_WT:+ARG345S/
MVN?_ )[2?]]&C[7/_P ]I/\ OHT7#E.FHKF?M<__ #VD_P"^C1]KG_Y[2?\
M?1HN'*=-17,_:Y_^>TG_ 'T:/M<__/:3_OHT7#E.FHKF?M<__/:3_OHT?:Y_
M^>TG_?1HN'*=-17,_:Y_^>TG_?1H^US_ //:3_OHT7#E.FHKF?M<_P#SVD_[
MZ-'VN?\ Y[2?]]&BX<ITU%<S]KG_ .>TG_?1H^US_P#/:3_OHT7#E.FHKF?M
M<_\ SVD_[Z-'VN?_ )[2?]]&BX<ITU%<S]KG_P">TG_?1H^US_\ /:3_ +Z-
M%PY3IJ*YG[7/_P ]I/\ OHT?:Y_^>TG_ 'T:+ARG345S/VN?_GM)_P!]&C[7
M/_SVD_[Z-%PY3IJ*YG[7/_SVD_[Z-'VN?_GM)_WT:+ARG345S/VN?_GM)_WT
M:/M<_P#SVD_[Z-%PY3IJ*YG[7/\ \]I/^^C1]KG_ .>TG_?1HN'*=-17,_:Y
M_P#GM)_WT:/M<_\ SVD_[Z-%PY3IJ*YG[7/_ ,]I/^^C1]KG_P">TG_?1HN'
M*=-17,_:Y_\ GM)_WT:/M<__ #VD_P"^C1<.4Z:BN9^US_\ /:3_ +Z-'VN?
M_GM)_P!]&BX<ITU%<S]KG_Y[2?\ ?1H^US_\]I/^^C1<.4Z:BN9^US_\]I/^
M^C1]KG_Y[2?]]&BX<ITU%<S]KG_Y[2?]]&C[7/\ \]I/^^C1<.4Z:BN9^US_
M //:3_OHT?:Y_P#GM)_WT:+ARG345S/VN?\ Y[2?]]&C[7/_ ,]I/^^C1<.4
MZ:BN9^US_P#/:3_OHT?:Y_\ GM)_WT:+ARG345S/VN?_ )[2?]]&C[7/_P ]
MI/\ OHT7#E.FHKF?M<__ #VD_P"^C1]KG_Y[2?\ ?1HN'*=-17,_:Y_^>TG_
M 'T:/M<__/:3_OHT7#E.FHKF?M<__/:3_OHT?:Y_^>TG_?1HN'*=-17,_:Y_
M^>TG_?1I1>3C_EM)_P!]&BX<ITM%<_'JMS'_ ![QZ,*O6^M(_$J[#ZCD47%9
MFE13599%#*0P/<4ZF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q=;/^D(/]C^IK:K$U
MO_CZ3_<_J:3*CN9]%%%26%%%% !1110 4444 %%%% !1110!XG^VQ_R:9\5O
M^P!<_P#H-?G5_P $;/\ DO\ XO\ ^Q;?_P!*8*_17]MC_DTSXK?]@"Y_]!K\
M:?V._P!JJ3]DKQ]J_B:/PROB@ZAIIT_[*U\;39F1'W[O+?/W,8P.O6C#24,3
M-O\ E_-31.(BY48)?S?DXL_H"K\0_P#@JQXFLO$7[76J6]G(DK:3I=G87#1_
M\]0K2D$^H$JC\,=J]&^(W_!9#Q[XAT>:S\(>#-)\)7,R,AO[JZ?4)8LC&Z,%
M(T# \C<K#V-<A^Q;^Q'XT_:2^)5KX_\ B#97]MX*%W_:=W?:LK";7)"WF;(]
M_+H['YY.F-P!ST4:+JU8MZ1CK?\ #\K^KL5*K&G3:6LGT_K^NY^@'CC1[KP[
M_P $U;_2[Z,Q7EG\-E@FC/576P (_,5\8_\ !&/_ )+-X\_[ "_^E,=?HC^V
M$H7]E/XL*HPH\,WP ';]RU?G=_P1C_Y+-X\_[ "_^E,==-.I[7&5:G>+?WJ9
MS5H^SPM*#Z27YP/;/^"BOB;]FG0_'5C<?$S0M8\9_$"/3D@ATO1;^2W$%ON=
MT,S!U5 69N@9^0=N,&LSPQ_P4$^+6O>#["#P)^ROKMQX;CLUM[*9#=75L850
M(FUDM%5E  X!YKY>_P""D?@?7OAW^V)J_BK6=*:^T+69[74=/EN%)M[N..*)
M'@+8QD&,J5Z@$'N"?JVZ_P""L-EX\T>S\,_";X8>(-6^(.HH+:SL+Q(OLL$A
M7&X>4[-(J=<$1C ))4"N*G[^&=M6[^[_ %ZM?>]+G55?+6UT27Q/^MM%^"Z'
MR%_P3(D?_AM;PH2GD%HM0W1KP!_HLORX]OZ5[E_P66^'>O?\)MX)\<)!-/X:
M.FG27E0$I;W"RO( W92ZR<>OEGTKQ'_@FK;W-G^W#X9@O$\N\B74DF7CAQ;2
MAAQQUS7T[_P5]UOXA:*W@SRIY'^%5R!'?Z?#<-$MY>K(7\NXV$.R&-5VX. 0
MQX;::WQ-G##-/Y]-Y?IMYV%2?[W$?T^C^_OY7/4_A9_P47^!&A_L[:"][KJZ
M;J6E:-#93>&%LY3/YT<(3R8P$VLK%>&SMP1N*\@?(_\ P29\#ZWXE_:9U/QE
M964EIX<TG3[E;J9 ?)WSX$=N#W/5L>D?/:O-X/VC_P!G5;B&YE_92M7N8POW
M/'=^L1(]8S&5/XYSWK[G_92_X*/?!?Q%>:+\/;/P:_PH:ZE$%C:P1Q-IIF=@
M%3S(PI#N3]YHP">K9//1'WJTJUKRE=6];_/KI_5^65HT8T6[133^[8\4_P""
MTW_(\?##_L'7O_HV*OL/_@G?\/?#G@W]E?P1J6C:1;6.HZY8K>ZE>1I^^NI2
MS<NYY( X S@=@*^//^"TW_(\?##_ +!U[_Z-BK[E_86_Y-$^%G_8&C_]":N7
M"Z8:;_O/\Y&V(UQ,%_=_2)^3'_!1/2;/PK^VQXV72;>.P4SV5YMA4*OG/;0R
M.^.F2Y+'U))K[W_X*W>++_0_V5])TZU>1(=:UNUMKMEZ-&L4DVT_5XT/_ :^
M$_\ @IE_R>UXU_W-._\ 2*"OU1_;1_9[N/VE/V=-1\,:88QX@MC%J6E&5MJM
M<1@_(3VWHSID\ L">E9M?\)]/3:7X+E_0ZY66,[7C^+BOU>_S/GC_@CCX!TB
MS^#GBKQB+6&37K[6'T]KHJ#)';Q11,(P>P+2,QQU^7/050_X+*^ -'F^&?@S
MQH+2*/7[?5O[+-VJ /);R0R2;&/<*T8(STW-CJ:^8?V2_P!L;Q/^PCJ_B;P/
MXP\%WMWIUQ=">YTJ=C9WEC<A I=0RD,KJ$X.,X5@?6+]JS]K;Q;^WQXG\,>"
M_!W@N\M=/M9VEL](MW-W=W=PR[?-<JH"JJ$C'106+-C[N^)_?N'LM?A_"U_O
MUVWOZG+A_P!RI^TT^+\;V^[3?MZ'V]_P2HURY\<?L@W>B:F\LEIIVK7NE0EC
MR('CCE(4^@,[_3\*^%_$GP!^/G[ _P 7)/%OAG2+R]L=/:46OB2PL?MMG/:M
MP1.H#>5E>&#[2""5)P&K]1?V5/V>=4_9Z_9BL_!,%_%:^+IK>XN[F^C59(X;
M^9201D$,(_D7D$'9G'.*^$OA]_P4:^-/[/OQEU+0/V@HM2U_3X(WMYM.ATVS
ML[BWD##;<0E(HQ,A"L!E@K!MP/'-59)XIN#L[)7Z.RU_&_WZ^44X_P"S>_&Z
MNWYJ[T_KR.9U#_@HQX2^/":+IO[0?P=T[Q78:?,[Q7WA^^N+26VW !BL)D^<
MG:,@RJ.*_4S]GB7X?S?!KPS)\+O*7P*\#/IL<4DCB-2[%T/F$N&#EP58Y!!'
M:OR2_;L_:L^&W[6$GAF'X?\ @#4;#Q+'='[1J]]9017ETK+M2W"P/(906((W
M'((P!\QK])/^"?/PF\0?!K]EWPSH?BBW>QUF>2?4);&08>V69RR1N.S;<$CL
M21U%.G[U.;:MK]_]+KY>:";M4@D[Z?=_3_,_,GX)?\I.;?\ ['S4?_1\]?MI
MXD_Y%W5/^O67_P! -?AC\9'\0?LF_MW:MXFOM)DGDT_Q/+K]G#,3$E_:RS-(
MNU\'AE9EW '# @@X(K]6/V:_VKM-_:T^%OBW7],T"Z\/QZ8\EC)!=SK*78P!
M]P*@<?-C\*X_BRU)=$[_ ')?F=*]W'MOJU;[V_R/S#_X)6_\GC>'?^P??_\
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MR1G!!KKJ35/-(SELF_\ TI/]&84XNIELH1W=ORDOU1^Z,O\ JW^AK\#OV'_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ IDLJPQEW.%%.K!U&]-U)M7B->GO[T#2N)>Z@]TV!\L?9?7ZU4HHJ30
M****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %BTO)+1
MLJ<KW7M6];W"748=#]1Z5S-6+.[:TF##E3]X4Q-'1T4U'$BAE.01D4ZJ,PHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M< #)'05T=%+NNX^WD</X5^!7PU\"ZS'J_AKX>^%?#VK1JR)?:5HEM:SJK##
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5-4_X\)?P_F*!K<Y^BBBH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'HH4=J]5H \Q_P"&7_A!_P!$Q\)_^":W_P#B*/\ AE_X0?\ 1,?"?_@FM_\
MXBO3J* /SW_X*<?L=:'J7[.W]O?#?P1I6F:MX<OEO[R/1M/CAEGL]C++]Q06
MV$H^/16/:OQP\/\ B/5?">K0:IHFI7>D:E!DQ7EC,T,L>00=KJ01D$C\:_J6
M90RD$9!X(-?,_C[_ ()O?L]?$;Q!/K6I> (;._N&+S-I-Y/91R,3DDQQ.$!S
MZ 4 ?AK_ ,-(?%?_ **7XM_\'5S_ /%T?\-(?%?_ **7XM_\'5S_ /%U^TO_
M  ZA_9M_Z$Z^_P#!W=__ !RC_AU#^S;_ -"=??\ @[N__CE 'XM?\-(?%?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCXK]M/\ @JO_ ,F5>+_^OJQ_]*4K\3O@'_R73X=_]C%I_P#Z4QT ?TV4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME XAEC8G9(2#A@<$D+M4XS]Z^'-)LM!\/Z9IFG0QV^GV=M';V\,0 5(U4*H
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M\:M4^)FK?&[4;SXC17 ^)$D]O]JCN;2&&0R".,0@Q1J(_N"/@+@]^IK]3O\
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MVTMQ9Q;?^6L4*$R2;ER=A("8.68#GQ75/^"A7[5GP;\<6O\ PGR2VZR#S_\
MA'_$'AV*Q2:(G&498HY<<$!@YY'.<8KW'_@BUI=F?#GQ/U$VL)OUN[*W%UL'
MF",I*Q0-UVY ./4"C_@M/9PMX;^%ET8E^T+=W\0DQSM*0DCZ9 HQ#^KSBUK>
MWIJNB^8L/_M$&GHES>ONWW?R/O;X,_%33OC7\)_#GCG28V@M-9LEN1 [;FA?
ME9(R>Y5U9<]\5^3GPC_X*C_%GPQ\3'N?'_B&;Q;X8ABNU_L>WTRRMVGF\MQ
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M8]3M;=;K[-#<8C=F##9*C+S@<XS7Y<_\% K2'P3^W%XTG\/@64T=[9:BAM\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %;>B?\>K
M_P"^?Y"L2MO1/^/5_P#?/\A30I;&A1115&84444 %%%% !1110 4444 %%%%
M !1110 4444 ?(G_  57_P"3*O%__7U8_P#I2E?B=\ _^2Z?#O\ [&+3_P#T
MICK]L?\ @JO_ ,F5>+_^OJQ_]*4K\3O@'_R73X=_]C%I_P#Z4QT ?TV4444
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M ']!G_!/7_DR_P"%/_8*/_HZ2OHBOG?_ ()Z_P#)E_PI_P"P4?\ T=)7T10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% '/ZI_Q_P OX?R%5*MZI_Q_
MR_A_(54J35;!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"6T_X^H?]]?YUTU<S:?\ 'U#_ +Z_SKIJI$2"BBBF2%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !6)K?_ !])_N?U-;=8FM_\?2?[G]3294=S/HHHJ2PHHHH ****
M "BBB@ HHHH *_.;_@IM^P_XE^*FN0?%'X?:<VLZK':+;:QH]L ;B=8P?+GB
M7_EHP7Y"@^8A4V@\U^C-%1*'-9]47&7+==&?CGX3_P""I/QJ^%/A*U\#ZWX0
MTV_\0Z;"ME!=ZU;7,5YA1M3SHMR[W&,9^4G'.3DFU^R+^QS\3/VB/CM#\5_B
MKIM_IF@IJ0UBZGU> P3ZK<!@Z1Q1, 1%G;EL!=HVKGM^P5%=$9VJ>V:O+O\
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M&.UK?@[ETE[*4GO>_P"5C\W/^"+/_(D_%#_L(67_ *+EJ/\ X+3?\BA\+_\
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M*** "LG7?^6'_ OZ5K5DZ[_RP_X%_2DQK<RJ***DT.KHHHJS(**** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^OR;_P!#- ']!G_!/7_DR_X4_P#8*/\ Z.DKZ(KYW_X)Z_\ )E_PI_[!1_\
M1TE?1% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <_JG_'_+^'\A52
MK>J?\?\ +^'\A52I-5L%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** );3_CZA_WU_G735S-I_Q]0_[Z_P ZZ:J1$@HH
MHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5B:W_Q])_N?U-;=8FM_\?2?[G]3294=S/HHHJ2PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** );7_CZA_WU_G73
M5S-K_P ?4/\ OK_.NFJD1(****9(4444 %%%% !63KO_ "P_X%_2M:LG7?\
MEA_P+^E)C6YE4445)H=71115F04444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY>RB:*61G0]%<^6%!/3<<<XKZ[KFOB-\-_#7Q;\':AX5\7:1;ZWH-^@6>TN
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M^BJ^-/\ P?W7_P <K]D/^'27[.?_ $+^L?\ @YG_ ,:/^'27[.?_ $+^L?\
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M(54JWJG_ !_R_A_(54J35;!1112 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"6T_X^H?\ ?7^==-7,VG_'U#_OK_.NFJD1
M(****9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M([O4+6UD/1)IE0G\":NHZR*&5@RGD,IR#0 M%%% !117Y[_M$?\ !6[P_P"
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M2=#NS&>V.1S7EG_#Y#X+_P#0L>//_!?9?_)=?)__  5\_P"3JK#_ +%FS_\
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M1110 4444 %%%% 'R)_P57_Y,J\7_P#7U8_^E*5^)WP#_P"2Z?#O_L8M/_\
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MR0RNI'_?+1_G7[1U^:G_  6X\&_;_AC\.O%*1EGTS5;BP=P.B3Q*W/XP#\Z
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M$ZAE=2.H(((/O5ROGO\ X)]W$EQ^QE\*'E=I&&D; 6.3M65U4?0  ?A7T)0
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MATNTU/2KZVU/3;N)9K:\LY5EAFC895T=20RD<@@X-7*>VC$%%%%( HKA=/\
MCS\,]7\2)X=L?B)X3O?$#SM;+I5OK=M)=-,I(:,1!]VX$'*XSP:ZS7==T[PQ
MHU[J^KWUOIFEV433W-Y=2".*&-1EF9CP !W-%U;FZ#Z\O4O45YU\)?VA_AQ\
M=?[0'@3Q;8^(I-/(%S#;[TEB!. Q1U5MI(.& P?6O1:=FMR;I[!1112&%%%%
M !1110 44V21(8VDD94C4%F9C@ #J2:\Q_X:F^"__17O ?\ X4UE_P#':/(9
MZA17G&G?M)_"/6+R.TL/BGX*O;J0X2"W\0VDCL?0*),FO18Y%EC5T8.C#(93
MD$>HI^8KK8=12,P522< <DFO+O G[4GPH^)WC6[\(^%O'6DZUXAMMVZRMY#F
M3:,MY3$!9< $GRRV *%J[+<'HKO8]2HHHI %%%% !1110 4444 %%%% !111
M0 4444 %%%1W%Q%:P2332)##&I=Y)&"JJ@9))/0 47MJQDE%<1X3^.7PX\?:
MPND^&/B!X6\1ZHR-(+'2=:MKJ<JOWFV1N6P.YQQ7;TQ7"BL;Q9XT\/> =';5
MO$^NZ9X<TM76,WVK7D=K &;[J[Y&"Y/89YK(\&_&3P!\1M0FL/"?CGPWXGOH
M8_.DM=&U>WNY4CR!O98W8A<D#)XR126NB!Z;G8445SWC/XB>%/AQ8P7OBWQ/
MHWA>SN)/)AN-:OXK2.1\$[5:1E!. 3@<X% SH:*YGP5\4/!OQ*2[?PCXMT+Q
M4EH5%PVBZE#>"$MG:'\MFVYP<9ZX-=-3U6XKWV"BBBD 4444 %%<5XN^-_PY
M^'^K?V5XH\?^%_#>J>6LOV+5]9MK6;8V=K;)'#8.#@X[5TUWKVF6.ARZU<ZA
M:P:/%;F[DU"291 L(7<9"^=NS;SNSC'-%U;FZ#Z\O4OT5YM\*?VD/AG\<+[4
M;+P-XQT_Q#>:?S<6UN6215SC>%=5+)D@;U!7D<\UZ33LUN*Z>P4444@"BBB@
M HHK"\8>//#/P[TM-3\5>(M)\,Z<\H@2\UB^BM(6D()"!Y& +$*QQG/!]*![
MF[16#X-\?^&/B+ILNH^%/$>D^)]/BE,$EWHU]%=Q)( &*%XV(# ,IQG.&'K6
M]3LUN(**\^UW]H?X5>%]8NM)UGXF>#M(U2T?R[BQOM?M()X6_NNC2!E/L15#
M_AJ;X+_]%>\!_P#A367_ ,=I+570]M&>H45YC'^U%\&II%CC^+?@5W8A55?$
MMD22>@ \VMWQE\9OA_\ #O4(;#Q7XZ\->&+Z:(3Q6NLZO;VDKQDD!U61P2N5
M89'&0?2F([&BJ^G:E::QI]M?V%U#>V-U&LT%S;R"2*6-@"KHP.&4@@@C@@U8
MH=UHPO?5!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH EM/^/J'_?7^==-7,VG_'U#_OK_ #KIJI$2"BBBF2%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%?DW_ ,%+/CA^T/\  7]IO2?$>C^(-4T/X>QI V@1V4K#3KMUC0W$
M5W&#ME?S/,^63/R%2N.37UO^Q+^W]X5_:UT@:5=Q0^&?B+:1%[O0C*6CN44#
M=/;,1\R'.2ARR=#N #L ?5M8FM_\?2?[G]36W6)K?_'TG^Y_4TF5'<SZ***D
ML**** "BBB@ HHHH **** "BBB@ HHHH **** "OQY_X+)?\G$^$_P#L5XO_
M $JN:_8:ORJ_X*P?!GX@?$;X\>&=0\)^!O$GB>PA\.10276C:1<7<22"YN&*
M%HT8!L,IP><$>M8U/CAZ_HSHI_PZGI_[=$_0/]E50O[,OPH &!_PBVF=/^O6
M.OR _:H 7_@HOK^!C_BJK#_VA7[%?LV:5>Z%^SS\,]-U*SN-/U&T\-:=!<VE
MU$T4L,BVT89'1@"K @@@C((K\K_VE/@-\3->_;TUOQ!IOP[\6:CH,GB6QG35
M+71+F6U:-?(W.)50J5&#DYP,&N^H_P#A44NEY?\ I43S9)_V?*/6R_\ 26?0
M7_!:!KW_ (5;\.U3_D'G69S-U_UOD?N_;IYE>E_\$FUT]?V1;$V?E_:CK%Z;
MW;U\W<NW=[^7Y?X8KW+]J#]GO2?VFOA#JG@K4Y_L,TC+<V&H*@<VETF=DF.X
MY96&1E68 @\U^7OA#X:_M@?L-ZUJMAX.\.:IJVDWTN9!HMA_;-C=,HPLH159
MXS@]2J,< $$ 5R4)>S=6,OM;?^2_Y'56BZBIRC]G?\?\SW/_ (+2KI__  B/
MPP9_+_M7[=>B/^_Y/EQ[_P -WE_I7N'_  2Q^U_\,;^&?M(/E?;K_P"S9S_J
M_M#_ /L^^OB*/]EG]J#]N+XBV.N?$VTOO#>FQ@0MJ&OVHLDLX-V62"S 5RQR
M2/E 8@;G'6OUL^&/PZT?X2?#_0?!V@0M#I&CVJ6L <@NV.KL1U9F)8GN6-:T
M8.C3FY/63V[+^E^+,ZDO:S@H[1Z_?_G^!^,/P48)_P %.+8L0H_X3W4!R>YG
MG K]QJ_';]JG]C/XT?"7]I+5_B5\-- U+7M.N-8.O:9?Z%"+JXM+AY#*8WMP
M"YVN3_ RLI&3DD#[R_84^)?QA^)O@'Q!>_&30K[0M:MM2$%G%?Z,^F-)!Y2$
ML$=5W#<6^8#'&*FAKA80ZQW_ /)4.JN7$RETEM_Y,SZ7K\)]54-_P4R<$9!^
M*2Y!_P"PF*_=BOQBU'X"_$V3_@H<WB1?AUXL;P[_ ,+(6^_M8:'=&T^S_P!H
M!_.\WR]GE[?FW9QCG.*K#:8ZBWM_P8FE;_<ZB]/RD?L[7X'?M*:7X@U?]O#Q
M?I]OJ4>C:_=>,!#8ZC-*\26K/,HMY2Z@LH53&VY02,9 Z5^^-?GG_P %#/\
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M*** "BBB@ K)UW_EA_P+^E:U9.N_\L/^!?TI,:W,JBBBI-#JZ***LR"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ JIJG_'A+^'\Q5NJFJ?\ 'A+^'\Q0-;G/
MT445!H%%%% !1110 4444 %%%% !1110!^:W_!:#QU/:>%_ASX.BD*P7UU<Z
MI<*#U,*I''GV_?2?E7SI_P $I_A;9_$+]J"+5-1MUN;7POITNJQI(,K]HW)%
M$2/53(SCT* U[!_P6GLY5\5?"R[*_N'LK^(-_M+)"2/R85S_ /P1GUJWM?C-
MXYTN1@MS>:$DT0)ZB.= P_\ (@_*JP&\I=??_!-+[DD9XV_+&/3W5][5_P V
M?KI1114FA\2_%;_@E+\./BI\1O$/B^?Q+K^CW&M7;WLUEIXMQ!'(_+E=T9/+
M9;D]2:^B_P!G+X#:9^S;\+[3P/H^JWVKZ=:W$T\4^H[/-'F-N*_( ,;B3T[U
MWUSXDTBSG>&XU2R@F0X:.2X167Z@FK-EJ%KJ4/G6ES#=19V^9#('7/ID40]R
M/+'8)>_+FEON?A+_ ,%*/^3T/B'_ +]G_P"D<%?J#_P3-_Y,K^'_ -;_ /\
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M6?&G]ACXJ7&BQ:EJ'A/6["19;C2_/\ZQO$895FC!,<J,O1NHYP58<>@?L_\
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MIUMI-REK.NM7,\3LS)N!41PR C'J12PS:IS2\[_^!?YDXA+VL&]]+?\ @/\
MD?>7[87_  4B^$FK? [Q1X6\":S)XNU_Q!8RZ:HALYX(;6.52CRR/*BYPI;"
MKDDXS@<U^?W[&7[.>N_M%?&K0].LK&9O#VFW<-YK6HE#Y-O;JP8H6Z;WVE57
MJ22<84D>R>(O^"0WQRT/29[RTO?".OSQJ66QT[4IEFD]E,T$:9^K"O)_@O\
MM8?&']D'Q1+H-I?74-AIUXT>H>$=:0M;[PQ$B;6^:%LY.Z,KS@G<.#KAW"G6
MYV_>Z?+;Y*Y-93J4N2WN_P"?ZNQ^_(&!@# HKAO@C\7M&^._PM\/^.="#I8:
MM!YGD2$%X)%)62)L=U=67/?&>]=S2E%PDXRW149*45*.P4445!04444 %%%%
M !1110 5MZ)_QZO_ +Y_D*Q*V]$_X]7_ -\_R%-"EL:%%%%49A1110 4444
M%%%% !1110 4444 %%%% !1110!\B?\ !5?_ ),J\7_]?5C_ .E*5^)WP#_Y
M+I\._P#L8M/_ /2F.OVQ_P""J_\ R95XO_Z^K'_TI2OQ.^ ?_)=/AW_V,6G_
M /I3'0!_39116+KOC;P[X74MK.O:9I"CJ;Z\CA _[Z84 ;5%>?0_M#?"RXN/
M(C^)7A&2;./+77+4M^6^NQTGQ!I?B"'S=+U*SU*+&?,M)TE7'U4F@#0HHHH
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M5KEIXH_81N=9L(WBL=1ETJ[MXY%"LL<DB.H(!(! (X!KSK_@B_\ \DM^(O\
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M@F+QM\(_C59Z_J6F7,+2Z6^M6<]]RX"S6[VY5@R,5)&TG&6W#;@_>G_!-O\
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MTO:M*UG]_P /^9^Q/BGXC^$_ VEV^I>)/%&B^'].N,>3>:IJ$-M#)D9&UW8
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MQ#'.<']NC]A3X=_LV_#C3O%'@CQIJ&IW9U%;*YTS5[NVGE8,K'?'Y4<9&TJ
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MT10 '+!PN!CKBOQE_P"&I/VO?^AF^('_ ( 2?_&JI$2/W_HK\ /^&I/VO?\
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M\31_PM+]L[_H)_&#_P !]0_^)H _?ZBOP!_X6E^V=_T$_C!_X#ZA_P#$T?\
M"TOVSO\ H)_&#_P'U#_XF@#]_J*_ '_A:7[9W_03^,'_ (#ZA_\ $T?\+2_;
M._Z"?Q@_\!]0_P#B: /W^HK\ ?\ A:7[9W_03^,'_@/J'_Q-'_"TOVSO^@G\
M8/\ P'U#_P")H _?ZBOP!_X6E^V=_P!!/XP?^ ^H?_$T?\+2_;._Z"?Q@_\
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M3G[Q787^<M294=SW*BBBI+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH EM?^/J'_?7^==-7,VO_ !]0_P"^O\ZZ:J1$@HHHIDA1110
M4444 %9.N_\ +#_@7]*UJR==_P"6'_ OZ4F-;F51114FAU=%%%69!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^'/[*_\ 9]MXLGOK_6;]/.M]'T>%9;DQ D>:V]T1$R"!N8$X. <''O%?EO\
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M$+1M&UGP_K4,VF+'KUI%<VT5PX!A<K*I4$N@0'_IIUZU^SO_  RS\%_^B0^
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M;T3_ (]7_P!\_P A30I;&A1115&84444 %%%% !1110 4444 %%%% !1110
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M(_X'7MG[6O\ P2ETG]H;XJW?CSPYXP_X1+4-597U6TN+$W,,L@ 4S1D.I5B
M,J<@GG(R:^J?V;?V??#_ .S)\)],\"^'99KNWM6>>XOK@ 2W5PYR\K <#.
M.P4#G&: /4:*** "BBB@""^_X\;C_KFW\C7\N7BK_D9]8_Z_)O\ T,U_4;??
M\>-Q_P!<V_D:_ER\5?\ (SZQ_P!?DW_H9H _H,_X)Z_\F7_"G_L%'_T=)7T1
M7SO_ ,$]?^3+_A3_ -@H_P#HZ2OHB@ HHHH XKQM\$?AU\2M5BU/Q=X \+^*
MM2AA%M'>:WHUM>3)$&9A&'D1B%#.YVYQEB>YKG_^&3O@A_T1OX?_ /A+V/\
M\:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU
M6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#
MRK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_A
MD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(
M?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;
M^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__
M (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]
MC_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\
M&J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^
M&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@
MA_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1
MOX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_
M /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+
MV/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\
M\:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU
M6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#
MRK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_A
MD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(
M?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;
M^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__
M (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]
MC_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\
M&J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^
M&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@
MA_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1
MOX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_
M /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+
MV/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\
M\:KU6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU
M6B@#RK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#
MRK_AD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_A
MD[X(?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(
M?]$;^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;
M^'__ (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__
M (2]C_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]
MC_\ &J/^&3O@A_T1OX?_ /A+V/\ \:KU6B@#RK_AD[X(?]$;^'__ (2]C_\
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MS&[NOM?V<7@GV;?L^SS-O&-^,_Q8YKIC)?VC"K]E-Z_]O(F,6LO=+[5HZ?\
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ME"OM.,$!,D=&%?I1;V\5G;Q001K##$H1(T&%50,  =@!6Z?+2Y9.[;OY=?\
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M[[&49QTWBOI/]M#]M_2OV0[;P[$-!B\6ZUJ[R'^RUU,6;P0(!^^8^5)P6(4
M@9PV#P:^7?BY_P $=]0C\22ZK\)O&]KIMJTWFP:;K_FQM9]\)<Q*[, >F4!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $MK_P ?
M4/\ OK_.NFKF;7_CZA_WU_G7352(D%%%%,D**** "BBB@ K)UW_EA_P+^E:U
M9.N_\L/^!?TI,:W,JBBBI-#JZ***LR"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<W4=V8P@H*R"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P F7_"G_L%'_P!'25]$5\[_ /!/7_DR_P"%/_8*/_HZ2OHB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .?U3_C_E_#^0JI5O5/\ C_E_#^0JI4FJ
MV"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM/\ CZA_WU_G735S-I_Q]0_[Z_SKIJI$2"BBBF2%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)K?_'T
MG^Y_4UMUB:W_ ,?2?[G]3294=S/HHHJ2PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** );7_CZA_WU_G735S-K_Q]0_[Z_P ZZ:J1$@HH
MHIDA1110 4444 %9.N_\L/\ @7]*UJR==_Y8?\"_I28UN95%%%2:'5T4459D
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !535/\ CPE_#^8JW535/^/"7\/Y
MB@:W.?HHHJ#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '/ZI_Q_R_A_(54JWJG_ !_R
M_A_(54J35;!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"6T_X^H?\ ?7^==-7,VG_'U#_OK_.NFJD1(****9(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %8FM_P#'TG^Y_4UMUB:W_P ?2?[G]3294=S/HHHJ2PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** );7_ (^H?]]?YUTU<S:_
M\?4/^^O\ZZ:J1$@HHHIDA1110 4444 %9.N_\L/^!?TK6K)UW_EA_P "_I28
MUN95%%%2:'5T4459D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX+-?#J&]":=X$\3W=IG!FN7MX'QZA [@_P#?0J%)-V1;32NS]":*^9?V>_\
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MF\&ZPXU2W3S+G1=1C$%[ N0-Q3)#KD@%D9E!(!.3346U="<DG9L]FHHKQ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 <_JG_'_ "_A_(54JWJG_'_+^'\A52I-5L%%%%( HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** );3_CZA_WU_G735S-I
M_P ?4/\ OK_.NFJD1(****9(4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %8FM_\ 'TG^Y_4UMUB:W_Q]
M)_N?U-)E1W,^BBBI+"BBB@ HHHH **** "BBB@ HHHH ***I:WKFF^&=)N]5
MU?4+72M+M(S+<7M],L,,*#JSNQ"J!ZDT;:L9=HKR_P#X:F^"_P#T5[P'_P"%
M-9?_ !VM7PW\>OAGXRU)-.\/_$7PGKFH/]VTTW7+6XE;Z(CDG\J=F]A71W=%
M%%( HKD?%WQA\!?#^Y2W\4^-_#GAJX<96'5]6M[5R/82.#5WPC\1?"GQ MWG
M\+^)]&\20)]Z72-0BNE7ZF-B!0M=@>FYT-%%<7XP^-GP[^'NJKI?BGQ[X8\-
M:FT0G%GK&L6]I,8R2 X21P=I*D9QC@^E SM**JZ5JUEKNF6FI:;>6^H:==Q+
M/;7=K*LL4T; %71U)#*0000<$&K5-IIV8@HHHI %%%% !1110 445!>WUMIM
MK+=7=Q%:VT2[I)IG"(@]23P!0,GHKSF']I+X27%^MC%\4O!<MZS;!;)XAM#(
M6]-HDSGVKT.&>.YA26&198G&Y70@JP/0@CJ*?2XNMA]%%9OB+Q+I'@_1;G5]
M>U6RT32;4!I[_4;A+>"($@ O(Y"J"2!R>I%*]MQ[Z(TJ*XSP=\:OA[\1-4DT
MWPKX[\,^)M1CB,[V>CZQ;W<RQ@@%RD;DA0649QC)'K79T[,045ROC;XL>"/A
MK):1^+O&/A_PK)>!FMEUO5(+,S!<;B@D==V-RYQTR/6N9_X:F^"__17O ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW^?]?J?B_KCZ'\2O^"G&JVOQ?N$C\.'Q1<V<Z:A-Y<(AA#K:1,Q( C8I"IZ
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M4444 %%%% !1110 4444 %%%% !1110 4444 %;>B?\ 'J_^^?Y"L2MO1/\
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MT 5_^'V'Q2_Z$GPK_P"3'_QRC_A]A\4O^A)\*_\ DQ_\<JQ_PY)^)?\ T/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .?U3_C_E_#^0JI5O5/^/\ E_#^0JI4FJV"BBBD 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $MI_Q]0_[Z_SK
MIJYFT_X^H?\ ?7^==-5(B04444R0HHHH **** "BBB@ HHHH **** "BBB@
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M2):1C:&\H21K&&(+$[BS$G(' K]:_"^B_P#"-^&M)TCSOM'V"TAM?.V[=^Q
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M[0'Y%/LTK C_ *Y&OT#T31;#PWH]CI.EVD-AIEC EM;6MNH6.&)%"JB@=
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MVO\ Q]0_[Z_SKIJYFU_X^H?]]?YUTU4B)!1113)"BBB@ HHHH *R==_Y8?\
M OZ5K5DZ[_RP_P"!?TI,:W,JBBBI-#JZ***LR"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JIJG_ !X2_A_,5;JIJG_'A+^'\Q0-;G/T445!H%%%% !1110
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M':PQPPQK%#&H1(T "JH&  !T %:02ITI0OK)W]+)HRE>I4C.UE%6];L_,?\
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MZ26E_P"OO-ZEO;RK;J73YM_J>/\ _!._2+WQU^W%X8U.PAD2WM;B^U:Y*_\
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M7WQL_9>\2:9I-LUWK6EO'K%E;HNYY7ASO11W8Q-* .Y(%?GA_P $O_VJ- ^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 54U3_CPE_#^8JW535/^/"7\/YB@:W.?HHHJ#0*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K;T3_CU?\ WS_(5B5MZ)_QZO\ [Y_D*:%+8T**
M**HS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH RM<AXCE';Y363737$(N(7C/\ $*YN2-HI&1AAE.#4
MLN(VBBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !110 6( Y- &CHL.ZX:0]%&/Q-;55K&V^RVZJ?O'EJLU1F]PHHHIB"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K$UO_CZ3_<_J:VZQ-;_ ./I/]S^II,J.YGT445)84444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% $MK_Q]0_[Z_SKIJYFU_X^
MH?\ ?7^==-5(B04444R0HHHH **** "LG7?^6'_ OZ5K5DZ[_P L/^!?TI,:
MW,JBBBI-#JZ***LR"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JIJG_'A+^'
M\Q5NJFJ?\>$OX?S% UN<_1114&@4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6WHG_'J_\
MOG^0K$K;T3_CU?\ WS_(4T*6QH44451F%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 54U3_CPE_#^8JW535/^/"7
M\/YB@:W.?HHHJ#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;B5N,9R!S7Z(5I*#BHM]=?Q:_0E24FTN@4445F4%%%% !1110 4444 %%%%
M!117A_[:7P4U[]H;]G'Q1X"\-7%A:ZSJC6IAEU*5XX!Y=Q'(VYD1B/E0XPIY
MQ42;BKI7+@E*23=CW"BOP3^.'_!,'XL? #X6ZYX]\1ZOX3N=&T=8FN(M-OKB
M2=O,E2)=JM;J#\T@SEAQFO-/V6_V/_&O[7&I^(+'P9?:+93:)##/<G6KB6%6
M61F5=GEQ/DY0YSCM5Q]YN,=U_P .1+W8J3V>G]?>C^C>BOA7_@G!^P]X^_9'
M\1>-[[QGJ&@7L.MVMK!;#1;J:9E:-Y&;?YD28&'&,9[U]U54DDDT]R4VVTT%
M%%%24%%%% !117YE_$+_ (*4?%+PK^VM-\([/2O"S^&4\56NB"XFLK@W?D22
MQHQWB<+OPYP=N.G%*/OU8T5O+;[TOU02]VFZCV7_  ?\C]-****8!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD']^3\Q_A1_8L']Z3\Q_A6A10%V5(]+MH_X-Q_VCFK2J%&%  ]J6B@04444
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ML,FOUA_:8_:P^%OP\^"_B*[N/&.CZK=:EID]OIVGZ5?17,]V\D95-BHQ^7+
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MYGXH?&WX7:O\%?VAM0\$:WJQUR[T6]M;:*_+,?-MPD9@X8DKB(QC;DA<8!(
MK^A^#_4Q_P"Z/Y5_/]^U1\5M$^-G[6GB+QAX;:670[[4K5+6:9"C2I%'%%YF
MT\@,4+ '!P1D \5_0#!_J8_]T?RKI@Y/!TW+>[_*)C-16*DH[67YCZ***P-0
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"6TYNH?\ ?'\Z
MZ:N<T]=][$/?/Y5T=4B)!1113)"BBB@ HHHH *R==_Y8?\"_I6M63KO_ "P_
MX%_2DQK<RJ***DT.KHHHJS(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JFJ
M?\>$OX?S%6ZJ:I_QX2_A_,4#6YS]%%%0:!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %;>B
M?\>K_P"^?Y"L2MO1/^/5_P#?/\A30I;&A1115&84444 %%%% !1110 4444
M%%%% 'Y+_P#!57]B7QQX@^*%S\7?!.BW7B;2]1M88]7LM.C::ZM9HD$8E$2C
M<T;(J9*@[2K%L#FO*/@'_P %;_BI\'=%T_P[XHTG3_'^BZ=$+>)KUVM-01%
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MF.12W.T$,>!P'K4H5%"6W?[/]7U[W3%91JTW*._;[7]6_!KU_*#PWXY\<?\
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MWT-OGRC/#(T;N@/(5MNX DXW8R<9/ME=%96J/2WIM\O(YZ3O!:W_ . ?+O\
MP4V_Y,>^)G_7*R_]+K>OC+_@AY_R.OQ7_P"P?8?^C)J^S?\ @IM_R8]\3/\
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MOVT_X)X?M0:U^U-\!CKOB:"%/$FD7[Z5?7%N@2.[98T=9@@X4E9 & XW*2
M0!^7/QLF2W_X*E7DDC;47X@V!9CV'VB&NGEMF$*4EI/5VZ_ KKMH]CFYO]CE
M-;QT7_DWWZGZ2?\ !/O]B#7OV.&\<'6_$FG>(?\ A(!9>5]@ADC\KR//SNW]
M<^<,8]#7V%111*;F[R\E]PU%1O;J%%%%04%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %4-9CWVH;^X<U?IDT8FB=#T88H&<O1
M2NIC8JPP0<&DJ#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *^'?VI?\ @F9_PTM\9M1\>_\ "R/^$<^V06\/]G_V%]JV>5&$SYGVE,YQ
MG[O'O7W%12LN93ZK8I2:37<\[^,WPB_X6[\$?$'P\_M;^R?[6T\6']I?9O.\
MK&WY_+WKN^[TW#KUKQ?]BO\ 85_X8_UGQ3?_ /";_P#"6_VY;P0>7_9/V+R?
M+9VSGSY-V=_MC%?5E%4M)NHMWH_Q_P V1RIP5/HMOP_R1X+^V/\ LL_\-:?#
MG3/"G_"3_P#"*_8M334?M?\ 9_VS?MBD39L\V/'^LSG/;IS5G]D#]F7_ (92
M^%MSX._X23_A*?.U*74/MOV'['C>D:[-GF2=/+SG=WZ5[C11%N'-R_:W_#_)
M#E[_ "\WV=OQ_P V?(7[4W_!-CP)^TAXEN/%=GJMUX*\6W0475Y:0+<6UT0
M \L!927P -RNN>X)YKC/@S_P21\ ?#N\N-1\4^(;CQWJ7DR1VB7%BMK90.RE
M1*T D<R,N<C+A?;."/O"BHC%1BXK9_UIV^0Y/F:;_K_,^*_V1O\ @F__ ,,K
M_%AO&O\ PL/_ (2?.GS6'V'^Q/LG^L9#OW_:).FSIM[]:Z?]M+]A/_AK_7/"
M^H_\)O\ \(E_8EO-;^7_ &3]M\[S&5LY\^/;C;TP<YKZMHJI>_R\WV=OQ_S9
M,4H\UNN_X?Y(X3X%_"__ (4K\(?"O@?^T_[9_L.S6T^W_9_(\_!)W>7N;;UZ
M;C7SG^T5_P $O_AI\<O$5]XETF]O/ GB*]<RW4FG1)-9W$A.6D>W.,.>Y1U!
M))())-?8]%$_WDN>6XX+V<>2.Q^<_@+_ ((Q^$M'UB.Y\7?$/4_$MA&P;[#I
MVG)IWF8.=KN993M/0[=IYX(ZU^@'@_P?HW@'PQIOAWP]IT.DZ+IT*V]K9VZX
M2-!V]2>Y)Y)))R36Q15\SMR]">6*?-U/A#X]_P#!)?P3\5O&=_XE\+>*;OP)
M<ZC.US=V0L%O;0R,<LT2>9&T>222-Q&3P .*3PC_ ,$C/AWX:\!^(M.NM?O-
M<\6:I8O:6VNWUHI@TYS_ ,M8;4.,M_O2$^A7FOO"BLE%1@Z:V>GR_3Y%R?-+
MG>Y\O_L4_L2_\,>MXO/_  F?_"7?\) +4?\ (+^Q>1Y/F_\ 3:3=N\WVQM[Y
MXZ_]J;]D/P9^UAX>T^R\2R7FFZGI;.]AJVGE1-#O W(P8$.A*J2O!RHP1S7N
M-%74?M;<^MK?AL*'[N[CU/B#]EK_ ()FI^S/\9[#Q['\1F\1):07$ TYM$^S
M%A+&4R9?M#],Y^[S[5[K^TI^R+\/OVIM'MK;Q;9SV^J68*V6MZ:XCN[=2<E,
MD%70G^%@1R2,'FO:J*)_O$E+IM_7S%!*FVX]=_R_0_,N3_@BG8G4"\?Q=N%L
M=V1"WAY3+M]/,^T@9]]OX5]=?LQ?L7_#S]E:WNYO#,-UJ6OWL8BNM<U1U>X:
M/(/EH%4+&F0#A1DX&XM@8]ZHJHR<59"<5)W9Y%^TE^R[X)_:D\(P:)XOMYXY
M[-VEL-4L7"75F[ !MA((*L -RL"#@'J 1\=^&?\ @B[X;L?$4=QKWQ-U'5]%
M5]QL+/24M)G7/"F8RR#ZX0>V*_2&BHBE%\R+E[RY6?GY\3_^"1N@>,/B8WB+
MPOXUA\%:'&MJEMH,&A&Y6$0Q1H293<J69RA8L5SECG)Y/Z QKLC5>N!BG457
M,^50OHM?O)Y5S<UM;6^2"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 :&BQ[KAG_NK_.MNJ6DP^3:AB,,YS_A5VJ,WN%%%%,04444
M %%%% !63KO_ "P_X%_2M:LG7?\ EA_P+^E)C6YE4445)H=71115F04444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %5-4_X\)?P_F*MU4U3_CPE_#^8H&MSGZ*
M**@T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9!Y,L6"1\[#*_*5.,G!\<_LO_MW_ +5%G9>&?BCJ%G9>'X)Q<*=2O=-AMQ(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &-K%KMD$RCAN&^M9M=1+&L
MT;(PRK#%<[=6S6LQ1NG8^HJ67%D-%%%(H**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *L6-J;JX5?X1RWTJ!5+L%49)Z"NAL;,6D./XSRQIB;+ &T
M#I2T451F%%%% !1110 4444 %9.N_P#+#_@7]*UJR==_Y8?\"_I28UN95%%%
M2:'5T4459D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !535/^/"7\/YBK=5-
M4_X\)?P_F*!K<Y^BBBH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MO1/^/5_]\_R%8E;
M>B?\>K_[Y_D*:%+8T****HS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ J"ZM4NXRK<'LWI4]% ',W%N]K(4<?0^M15T\T"7";77
M(K%N]+DM\LG[Q/;J*FQHF4J***0PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *55
M,C!5&6/ %3VMC+=-\JX7NQZ5M6=C':+Q\S]V-,39%I^GBU7>_,I_2KU%%49A
M1110 4444 %%%% !1110 5DZ[_RP_P"!?TK6K)UW_EA_P+^E)C6YE4445)H=
M71115F04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %5-4_P"/"7\/YBK=5-4_
MX\)?P_F*!K<Y^BBBH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MO1/\ CU?_ 'S_ "%8
ME;>B?\>K_P"^?Y"FA2V-"BBBJ,PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@"M<:?#<<LF&_O+P:H2Z&PSY<@/LW%;
M%% [LYY],N4_Y9Y_W2#49LYQ_P L9/\ ODUTM%*P^8YG[)/_ ,\9/^^#1]DG
M_P">,G_?!KIJ*+!S',_9)_\ GC)_WP:/LD__ #QD_P"^#73446#F.9^R3_\
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MIJ*+!S',_9)_^>,G_?!H^R3_ //&3_O@UTU%%@YCF?LD_P#SQD_[X-'V2?\
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MO_+#_@7]*3&MS*HHHJ30ZNBBBK,@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *J:I_QX2_A_,5;JKJ8S8R_A_,4#6YSU%%%0:!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%;6B'_17'^W_ $%8M:^AM\DJ^A!IH3V-2BBBJ,PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LG73S"/][^
ME:U8VN-F>-?1<_K294=R@L99<T5HV=F9;9&QUS_.BBQ5S7HHHIF84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %0WB^9:RC_9-34C#<"#T- '*T4Z6,QR.AZJ
M<4VH-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "K^BR;;HK_>6J%26\QAF20?PG-,#IZ*1
M6#*".0>12U1D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5SVIR>9>2>B_+^5;TTHAA=ST49KG;>,W5TJGG
M<V3_ %I,J/<W[./RK6)3U"\T5-13)"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** ,+6(?+NMXZ.,_C5&N@U*V^T6QP/F7YA7/U+-%L%%%%(8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% &[I-SYUOL)^:/C\.U7JYJSN3:SJXZ="/45T:L)%#*
M<J>0:I$-#J***9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445'-,MO$SMT44 9^M7.U5A!Y;EOI3=%M_OS$?[*_UJA^
M\OKKU=S70PQ"")8UZ*,4BWHK$E%%%,@**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *P-3M/LTV5'[MN1[>U;]17%NMS$4;OT/I2&G8YFBI)X6M
MY"CC!'ZU'4F@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !6CI=_Y+>5(?D)X/H:SJ*8'5T5
MD:=JFT"*8\=%;T^M:U49["T444""BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHI&8*I+' '4F@ )"@D\"L'4K[[5)M7_5KT]_>GZAJ1
MN,QQ\1]S_>I^EZ?YA$TH^3^%3W]Z1:TU98TFR\E/-<?.PX'H*T:**9(4444"
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M>V:WD>#PX
M^ZU8$T+V\A1Q@BNHJ"ZM([I<..>S#J*129S=%6;NQDM6Y&Y.S"JU26%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5<LM2>UPK?/'Z=Q]*IT4P.FM[J.Y7,;9]1W%2URJLT;
M!E)4]B#6A!K,D>!(HD'KT-.Y'*;5%4XM4MY.K[#Z,*M+(LGW65OH<TR1U%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !113'F2/[SJOU.* 'T52FU:WC^Z3(?]
MD5GW&L32Y"?NE]NOYTAV9JW5[%:K\[9;LHZUBWE])>-@_*G9!26]G-=ME5..
M[MTK7L]-CM<,?GD_O'M]*"M$5+#2LXDG''9/\:UJ6BF2%%%% @HHHH ****
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M7/\ \]I/^^C73446#F.9^US_ //:3_OHT?:Y_P#GM)_WT:Z:BBP<QS/VN?\
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M118.8YG[7/\ \]I/^^C1]KG_ .>TG_?1KIJ*+!S',_:Y_P#GM)_WT:/M<_\
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M7/\ \]I/^^C73446#F.9^US_ //:3_OHT?:Y_P#GM)_WT:Z:BBP<QS/VN?\
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M118.8YG[7/\ \]I/^^C1]KG_ .>TG_?1KIJ*+!S',_:Y_P#GM)_WT:/M<_\
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?'!(\QO5O\*N44"NQ*6BBF(**** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>figure12a.jpg
<TEXT>
begin 644 figure12a.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" <($$ # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/!_['_Q$UG0=6OM$UBUL(GM]0TZY>WN(6,\0)21"&4X)&0>YK\+O^&L?C?\
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MTH@;1VFSY1L?*78(L\;0WF9Q_'O[DUE*=IQAWO\ A^O^3-8QO&4NW]?=_P
M_=WP?XX\._$+18]8\+:]IOB/29&*I?:3=QW,)8=1O0D9'<9XK;K\C/\ @B3:
M>+1XZ^(-S$+I? QTZ..X+!O(:_\ ,4Q;>Q<1^;G'.&7/45^N===2')RM=5?^
MOS]#EIS<N9/H[!1116)J%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445\3_P#!1S]MCQQ^R#-X$3P;I7A_4AKRWAN?[<MYY=GD
MF';L\J:/&?,;.<]!TJ924;)]2XQ<KVZ'VQ17XK?\/J_C?_T*WP__ /!=??\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !14$-];7$TL,5Q%+-%Q)&C@LGU Z5/0 4444 %%1W%Q%:6\
ML\\B0P1*7DDD8*J*!DDD] !WKR[_ (:Q^"'_ $63X?\ _A46/_QVE?H!ZK16
M7X9\4:-XTT.UUGP]J]CKNCW0)M]0TRY2XMY@"5)21"5;!!'!Z@UJ5336C%OL
M%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%06U];7AD%O<13F-
MMKB-PVT^AQT-3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\4)^QG\5E484:,P _P"!I7N-GXBTK4IQ!::G9W4Q&1'#<([8'7@&O#_V_O\
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MXCM+6VCT'4]TLLC!409ML9+$#GUK\\?^"ROQ7_X2[]H;1O!EM,'L_">EKYJ
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M0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\%M/^2Y^ O^Q=/_ *4R5[I_P1)6Z_X4E\0&<G[&?$*"(=M_V:/?^FRO"_\
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MP>$!X\\=IJW@V34H8=6M9-(L( ;=VV.^^.!778&W\,/NXZ5\;^./^1U\0?\
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MUC\$/^BR?#__ ,*BQ_\ CM3Y%:[GJM%8FL>./#GA[PN?$FJ:_I>F^'?*6?\
MM:[O(XK3RV *OYK,%VD$8.<'(Q7B,G_!0S]G2+7!I+?%;1C=%MGF*D[6^?\
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M*_H7_P""C'_)E?Q2_P"O"+_THBK^>BN"'\>?HOU.V7\"'K+\HA17],/[-O\
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MY)1<JBFWM^;_ *_%GJO_  5^^$(\ _M-Q>*K6'R]/\8V"7A8#Y?M4.(I@/\
M@(B8^[FNB_X(U_&S_A#?C?K?P]OKC9IWBRS\ZU1VX%[;@L !ZM$9<^NQ:^1/
MC#^TS\3?C]:Z9;?$#Q7<>)8=-=Y+07%O"AA9P ^"B*>0JY!XX%<O\,?'VH_"
MOXB>&_&&DN4U'1+^&_APQ 8QN&*''9@"I]B:C!KV3Y)OW7=?)_Y=/1%XI^U7
M-%:JWWK_ #Z^K/Z@J_#?_@L/_P G@'_L7K'_ -"EK]K?!/B[3_'_ (-T/Q-I
M,HGTS6+*&_MI!WCD0.OXX-?BE_P6'_Y/ /\ V+UC_P"A2URXB+A5IQENI/\
M])D;49*5.4ELU^J.W_X(EVL,GQU\=SO#&\\7AT".1E!9 ;F+(![9P,_2OV1K
M\<_^")'_ "6[X@?]BZO_ *4QU^QE>E6^"GZ?^W2."C\=7U_]MB?SK_M_:7;Z
M/^V3\5[>UC$43:PTY50 -TD:2.?Q9F/XU]S_ /!#NZD;PS\6;8G]TMYI\@'N
M4G!_]!%?$?\ P40_Y/2^*O\ V$D_])XJ^U_^"'/_ " _BY_U\:;_ .@W%<N7
M?[H_\"_.)T8[^.G_ 'G^I^@_Q(^ OPX^+EY:WWC?P7HOB>YLXC%!/JMHDS0Q
MD[BJEAP,\U\M:U^T-^Q5^RIXPFO-"M_#5OXOLXWA/_"':3]IF4'*O'Y\:^4#
MQ@J9 1WKR/\ X+#?M4:[X3DTCX/>&;^;3(]2L?[1UVXMG*230.S)';;AR%;8
M[./XAM'0D'\_/V3OV9-<_:P^+=KX,T>\CTJW2!KW4=4FC,BVELI4,X0$;V+,
MJJN1DMR0 2,Z/-5DU3T6OZW_ %]36KRTXIU-7I_P/T/U&D_X+4? ^.1E7PSX
M^D /#+IUE@_G> U^07Q@\5Z=X\^+'C/Q+I%O-:Z5K&LWFH6L%RJK+'%+,\BJ
MX4L P##(!(SW-?K]IO\ P1<^"5M9QI>>(O&UY<@?O)A?6L:L>^%%N<#VR?K7
MY#?&KP?8_#WXP^-_"VF/-)IVBZU>:=;-<L&E,<4SHI8@ %L*,D ?2E+E]HN]
MG^E_T*CS>S;Z77ZV_4_6G_@BC(S?LY^,4+$HOBB0A>P)M;?/\A7G_P#P7(_Y
M!WP=_P"NNJ_RM*[[_@BA_P F[^,_^QH?_P!);>N!_P""Y'_(.^#O_775?Y6E
M;8_^)3_[=_\ 24+ ;R])_P#MQ\9?\$Z/^3UOA7_V$)?_ $FFK^@+Q?X7L/&_
MA36?#VJ0K<:;JMG-8W,3#(:.1"C#\B:_G]_X)T?\GK?"O_L(2_\ I--7]#-:
M5(J>'49;-R_)'+3DXUW);I+\V?R_?%#P#?\ PK^(WB7P?JBD7^AZA/82MC&_
MRW*AQ[, &'L17[9?\$K_ (R0^-OV.["WU&Y G\&3W&EW,DAQM@0>=$Q]A'(%
M_P" &OB7_@LA\&?^$*^/VD^.[.W$>G^+[$>>ZCC[9;A8WSZ9C,!]R&KP']G'
M]IZY^!OPH^-?A2-Y0WC/0H[*SV=([CS!&S?[/[B:<Y]44>E<U"K)X:<7K*S_
M / H_P">MO4Z:U./MX26D;K_ ,!?^77T/./CI\2I_C%\9/&?C6<L3K>J3W<:
MOU2)G/E)_P !0*OX5^P?_!('X,_\*^_9KG\77EN(]3\97S7:LRX;[)#F*$'V
M+><X]I!7XQ?#WP5J'Q(\=^'O"NE(7U'6K^"P@&"</(X0$^PSD^P-?TU^!/!V
MG_#WP3H/A?28A#INCV,-A;H!TCC0(/QP*ZJ,%0P]EUM%>BLW^GXG/6DZU>[\
MY/Y[?K]Q^5/_  6M^$>L1>.O!GQ*@MY)]!GTX:)<S(,K;SI))*@;TWK(V/>,
M^U?(_P"QA^UEJ/[(7Q4F\3V^D1Z_I>H6AL-2TYI?*=XBZN&CDP=KJR@\@@C(
MXR"/Z$O&'@[0_B!X;O\ P]XDTJUUO1+^/RKFQO8A)%*O7D'N" 0>H(!'(K\Y
M/C=_P15\/ZU>76H_"SQC+X<+[G31->C:YME8GA4N%/F(@_VEE;WKDHN>'D[;
M:_CNG][V_P""=57EKI<V^GX;/\$>W_#G_@J_^SWX]6"*_P!>U'P;>3-L^SZ_
MI[JH/O+#YD:CW9A[XKK/#/['/[+?Q'TM=>\.^!?"'B/3;IF9;_2Y_M$+MGG#
M)(5SGMVK\D_C5_P35^._P1TN[U:^\-0>)=#M(_-GU+PU<?:UC7N3$0LV .2W
ME[0.2:\8^#/QS\;?L_\ C*V\3>!]=N=&U"-E\V)&)@NT!_U<\?W9$/H>G48(
M!&T73E+71_U\S&2J1CIJC^D;X=?#3PQ\)?"\'AOP?HUOH&AP.\D5C:Y\M6=B
MS$9)ZDDU^%__  50_P"3X?'W_7+3O_2&"OVD_9C^.5I^T=\#O"WC^UMQ9/JE
MN1=6@)(@N8V,<R GJH=6P3U4@U^+?_!5#_D^'Q]_URT[_P!(8*QK1E&O&,MU
M?]#HPTE*E4<>W_MR/H?_ ((>?\CK\5_^P?8?^C)J]@_X+.?"/6/&?P9\*>,]
M+MI+RW\*7TPU!(ADQ6]PJ+YQ']U7B0'TWYZ UX__ ,$//^1U^*__ &#[#_T9
M-7ZT7UC;:G9SV=Y;Q7=I<1M%-!.@>.1&&&5E/!!!((-;XF#G3IVW2O\ ^3/_
M (8YL-/V=2;\[??%(_FF_9V^.&J_LY?&+P[\0-'M(-0NM)E??9W)*I<1.C1R
M1EARI*,V&YP<'!Q@_K_\,_\ @K]\"O&=K OB276? FH%5$L>HV+W4 <CD)+;
MAR5!_B9$^@KEOC]_P1R^'WQ U*YUCX=Z[/\ #V^F8R/ICP?;-.+')Q&NY7AR
M3V9E X" 5\3?%3_@E#\?OAK8S7UGH^F^-[*%&DD;PU>&695'/^IE6.1V/]V-
M7-3[9\JC-;?UN5[)<W-![GZEZ1\ ?V6_VE+[4_&>D^'_  ?X[N[Z<SWVHV-S
MY[F9N3YH1_D8]<, ?:O7_A5\#_ GP/T^^L? GAFR\,VE]*L]S#9!@LK@;0QR
M3SCBOYL_"/C+Q3\)?&$.L>'M4U'PQXCTZ4JMQ:NT$\3 X9&'ID89&&#R"*_>
M_P#8!_:GN?VK/@9'KFL0Q0>*M)N3IFKB!=D<L@5629%[!U8$CH&# <8K6,%R
M-T]ET\O\MOP,Y2?.E46KZ^?]7/I:BBBLC0**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *_*;_@N/\ \?/P@_W-4_G:U^K-?E-_P7'_ ./GX0?[
MFJ?SM:YZOQ0]?T9TT/M>C/SL^!/Q6F^!OQ>\+>/+?3H]6FT*[%VME)*8EF(4
MC:6 ..O7!K] /^'XFO\ _1)=-_\ !W)_\9KX$_9_^$__  O3XS>$_ 7]J_V)
M_;UX+3^T/L_VCR,J3N\O>F[ITW#K7Z)_\.,?^JV?^6I_]VUV/FY%?:[^_2_Z
M'$N7G=M[+[M;?J>+_'?_ (*[?%'XM>$[[PYX>T;3? 5A?PF"ZN[*62XOBC##
M*DK;5C!!(R$W#LPKXI\)^$]8\=>)--\/^'].N-7UK49EM[2RM4+R2R'H /U)
MZ  D\"OU;\*_\$/?#-G>!O$OQ5U;5K7O%I6D16+_ /?<DDP_\=K[/_9]_8^^
M%?[,MJW_  A'AN.'59(_*GUR^?[1?S+QD&5ON*< E8PJDC.*B$(1?-+_ (/]
M?U8N4IM<J_K^OZ94_8N_9U'[,'[/^@^#)Y(I];)>_P!6N(>4>[EP7"G'*H J
M ]P@/>OSB_X+:?\ )<_ 7_8NG_TIDK]D*_&__@MI_P ES\!?]BZ?_2F2N?%3
M=2K3D_YO_;9&^'BH4JD5V_\ ;D>>_P#!(/\ Y/(L/^P)??\ H*U^PG[2'P'T
MW]I3X3ZGX!UC5;_1M-U"6&2:XTW9YI$4BR!?G!&"RC/':OQ[_P""0?\ R>18
M?]@2^_\ 05K]?_VFOC[I/[,_P9U[QYJT7VO[$BQ6=BK[6N[ISMBB!P< GDG!
MPH8X.*ZL2XJE!SVM_P"W.WXG)AE)U:BCO?\ ]M1\>Q_\$5?A38R)<W'CKQ4\
M$+!Y%F:U5&4')#'RA@?C7V)+^T1\%_!<<.CS?$[P+HJV:+;QV,WB"S@,*H H
M0(9!@  #&.*_ /X\_M2_$S]I;Q#->^,_$=W>VLDNZVT2U=H["VY^58H =N1G
M&XY<]V-?0GPS_P""0GQQ^('AFTUK4)O#W@Y;J,2QZ?KEU,+Q5/(+QQ1.$R/X
M68,.A -*/M)0U5D:24%/35E#_@J_KG@/Q9^TK8^(? >O:'XBM]2T*W?4;S0;
MZ&[B-TDLL?SO$S#?Y:1<$YP%K?\ ^"-.J7%G^U?J-I&Y$%YX:NUE3/!VS0,#
M]01^IKYX_:I_97\2_LD^.M-\*^*-4TK5KV_TY=2CFTAY6C6-I)(PI\Q$.[,9
M[8P1S7OG_!'3_D[R3_L7+W_T.&G@THMJ+Z3_ "E_PP8QMVYE;X/_ &W\]S[&
M_P""S7Q#N/#/[-^A^&;68Q-XDUI$N%!P7MX$:4CZ>9Y)_"OR*^"?PYE^+WQ>
M\'>"H7:(Z[JMO8O*@R8XWD =Q_NKN/X5^F7_  7%BG/AGX22*V+5;O45=?5R
MEN5/Y!OSKXA_X)XR0Q?MI?"IIRH3^TV4;AD;C!*%_'<166!2EB'S:WFOT1>,
M;CATT_LO\Y'] /@7P/H?PU\(Z5X8\-Z=#I6AZ7 MO:VD"X5% ZGU).26/)))
M/)K\U_\ @MC\-/#EKX;\"^.[?38K?Q/<Z@^EW-]"H5KB 0EU$F/O%2ORD\@,
M1Z8_4:OSA_X+<?\ )%?A]_V,+_\ I-)6.*DY)3>_-'7U:3_!FE!*-XK:S_(_
M-C]C?_DZ[X2?]C/8?^CUK]WOVT/^32OB_P#]BOJ'_HAJ_"']C?\ Y.N^$G_8
MSV'_ */6OW>_;0_Y-*^+_P#V*^H?^B&KJQ?^X?\ @?\ Z3$Y\-_OG_@/YR/Y
MOJ_I1_9,_P"37/A%_P!BEI?_ *21U_-=7]*/[)G_ ":Y\(O^Q2TO_P!)(ZZ8
M_P"[3_Q1_*1E+^+'T?YH\G_X*D_\F0^/_P#?L/\ TM@K\"K;_CXB_P!\?SK]
M]?\ @J3_ ,F0^/\ _?L/_2V"OP*MO^/B+_?'\ZY<#_O?_;T?T.ZI_!C\S^H'
MQ;XJM_ OP]UGQ)=_\>NCZ7-J$O\ N11%S^BU_,IXU\7:EX_\8:UXEUB=KG5=
M7O);ZZE8YW22.6;\,G@=A7]$W[7/G?\ #(OQ5\C/F_\ ")W^,?\ 7LV?TK^;
M^N=ZXB5^B7XMW_)?<9TM,)"W7]$K?FS]U/\ @E7^SUH_PK_9OT?QE)81'Q9X
MPC-_<WS*#(EJ7(@A4]DV .0.K/SG Q[S^U5\$]#^/WP+\5>%M9LX;B5[*6XT
M^XD4;[2[1&,4J'J"&P#SRI8'@FOP%T'X _&W7]%LM2T7X;^/M2TBZB6:UN[#
M0KZ6":,C*M&Z1E64CH0<5>/[-/[0!&#\*OB21_V+NH?_ !NNC%7KJ4=NB\NW
MW?F9X?\ <N,M^K\^_P!_Y'D$,TEO,DL3M'+&P974X*D'((/K7]+?[,_Q#F^+
M'[/WP^\773;KW5M%MI[EO6?8%E/_ 'V&K^??_AD[XW_]$;^('_A+WW_QJOW7
M_8.\-ZOX/_9%^&NC:]I5[HFKVEA(EQI^HV[V]Q"QGE.'C<!E."#@CN*Z(_P)
M+S7Y/_@'/+^/'T?YQ/?****YCI,WQ+XAL?"/AW5-<U2=;73=-M9;RYF8X"11
MH7=C] #7\S?QF^)=_P#&3XK>*_&VI%OM6N:A->%&.?+1F_=QY]%0*H]EK]F_
M^"MGQL_X5C^S'-X:L[CRM7\:7(TU55L,+5,27#?0@)&?^NM?AD/?I7-#WZSE
M_+I]^K_3[F=$O<I)?S:_=HOU_ _=?_@DU\'_ /A6O[*=AK=S#Y>I^+[N35Y"
MP^80#]U /H40N/\ KJ:^$/\ @K]\'_\ A ?VF8O%=M#Y>G>,;!+LL!\OVJ$"
M*8?]\B%OJYKOO"/_  6>O_!/A71_#VE?"#38-,TFSAL;6(:U)\L4:!$'^I]%
M%>(?MF?M_2_MB>#]!T?4? %GX<O-'OFN[?4H-1:X?8R%9(MIC7ACL;.>L8KI
MQ7[RJJE/H[?]N[?E9_(Y\+^[IN$^J_'?\]/1GK'_  1G^-W_  B/QFU[X<WU
MQLL/%5G]ILU=N!>6X+8 ]6B,F?\ KFM?LS7\P/PI^(>H_";XE>&?&6E,5O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW87JUL^8YU_&-W'UK^BWXD?$C2_AS\+?$'CF[F672M)TN74]ZGB5%C+J%/\
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M:Z8)1P\DMKQ_*1SU).6)BWO:7YQ/,/\ @I1^W-<_LQ^%[/PEX,FB_P"%AZ]
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M 2-\$H_B1AZ]#@C! (_HD_:(\,V7C+X#?$/1M0B2:TN] O4977(!\ARK?4,
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MCO\ X)__ /)Y?PG_ .PPO_HMZ,O_ (ZGWG^3M^2%CG:@XKI'\[O]3^B8 *
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MLQ^%[/PEX,FB_P"%AZ] TJW+*'&EVN2OG[3P9&8$(""/E8G. #Z!_P $T_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6%G' 7 CBP&*@9_&M[_@C-X'\.>*/@KX[GUGP_I>KSQ^(%1);ZRCG95^S1G
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ML=#N)Y0@B$H;?YL,>,^8,8ST/2L,#^[PSA/1\J7SO$VQ?OU>:.JYK_F?#/\
MP65\%ZCHO[3VE^(9HI#I>MZ' +:8_=\R%G22,>X!C;_MH*\R_P""<_[5&A?L
MK_&ZZU7Q5#,WAG6[ Z9>75M&9)+3]XCI-L'+*"N& YPV1DC!_:?]I3]FGP=^
MU)\.Y?"GBZWD4(_GV.I6N%N;&;&!)&2".1P5/##WP1^3_P 2O^".?QK\*ZC/
M_P (I=:%XWTW?B"2&[%E<E?62.;"*?99&Z=:QP\I8>35N_\ Y->_IO\ KZ;5
MXQKQ3]/PM;\C[D^*/_!6OX#>#_"=U>^%M;N_'6N^6?LNE6>GW-J&<CY?,EGC
M143.,XW,/[IK\1_'7B^^^('C77_$^IB-=1UJ_GU&X6%=J"261G8*.PRQQ7WM
M\$/^",_Q%\1ZU:7/Q-UC3O"&@J0UQ9Z=<"\U"09&44J/*3(S\^Y\?W375?'3
M_@C3XPUOXGZO??"_5_">C>"9A%]@T_6+Z\6Y@Q$BNK%;>0-EPQW;B3NYJG!1
MFI/5O\/^'_3T$IMQ<5M^?_#?J>N?\$3Y%;]GOQJ@8%U\3L2OH#:P8_D:X/\
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M- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS2;BS29A,250RHH8@<X%?6O[=O[&]E^U[\,[>RM;J'2O&6BN]QHVH3@^42P
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M9T2YM+<RPLZ-'YDB*NYEF! SR$/I1A(QA2E2C_+9?]NM?HF3BN:=2-5][_\
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M6(UV82:E:NMDN;_+\6CEQ47&]%[MV_S_  N?IYTX%?G7_P % OV^OB]^R?\
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M;JWY2,J<54Q5.$MG?\XGX=?MA_MD^+_VK/'U]<7FH7-EX*MKAAH_A]'*PPQ
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M:LOAKQG(VK6=PH^07!Q]IB)_O"0E_I(OO47_  3K_;<@_9-\::GIGB:&XN_
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MF6JBU]W(C2BHK#RY=FT_OYF?>?\ P0]_Y$;XJ_\ 81L?_14M?I9JW_(*O?\
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M1]3_ !<_Y)3XT_[ M[_Z(>OY@Z_I\^+G_)*?&G_8%O?_ $0]?S!USQ_WF?\
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M8>.O%NHV<EM8V6DL9[>-G4IYLTR_(%7.=H;<>   =P_"ZN&*?MI2Z62^YO\
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ML(]5SC\*]7KHK15.K*"V3:,*4G.G&3ZI!1116)J%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=([E?G@<GVD5#],U^+>@_P#!*W]I'4-<TZUU'P"NEZ?-<1QW-\VMZ=(+>(L
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M9>?%!YA2[AD;YY65!A48\L.GK7O-%:5_]H<G+J[_ (W)HOV#BX_9M^!^ /\
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MG!\NR5M>OEZO_@]#XR\8?L ?M">"=2^QWGPKUZ^8DA9M'A&H1,,]=\!<#/\
MM8/M7JWPI_X)9_$O5- UWQ9\3H1\/O"VCZ;<:@\4\T<E]=>7$SA512PB7*_,
MTF".RGM];_#_ /X+6_#74- MSXS\&^)=&UP+B>/1T@O+5CZH[RQN,]<%>.F3
MU/A?[:O_  5:MOC;\.]1\ _#30M3T32-63R-3U?6/+2YE@/WH8XHV<*K\ L6
MR5)&T9S15YHPE&.LGHGV\_EO^G0*?+*2<M(]?\OZ^_J?G)7]#O\ P3OC>+]B
MWX5!U9#_ &8[888X,\I!_$$&OP0^$WPM\0?&KXAZ)X,\+V;7NLZM<+#$H!VQ
MKU>1SV1%RS'L :_I3^&'@*Q^%OPY\,^#]-+-8:'IT&GPNW5UC0+N/N<9/UKN
M7NT'?JU;Y)W_ #1QO6NFNB?XM?Y&%\>/@-X0_:.^'=[X.\9V!N].G/F0SQ$+
M<6DP!"S0O@[7&3V(()!!!(/Y"_'#_@D-\8?A_JUQ+X&2T^(F@%R87MIX[6]C
M3J/-AE95)[?NV;.,X'2OV^HKAY%?F6C.SG=N5ZH_G&M_V'_C[<:H-/3X1>+!
M.6V[Y--=(<_]=2 F/?=BOIS]G?\ X([_ !$\8ZM;7_Q5NH/ WA]'#2Z?:W$=
MUJ5PH(^52A:*($9^8LQ']ROV=HK>,N76QE)<VESG/AW\._#WPG\%Z5X3\*:9
M#H^@Z7"(;:TASA1U))/+,222Q)))))R:_(+]KO\ X)Z_M ?%#]I;XA>*_#/@
M'^T] U75'N+.[_MG3XO-C*J VR2X5EZ'@@&OV@HK&4>>HJLGKK^-O\C2,N6'
MLTM-/PO_ )GPK_P2M_9I^)'[-_A7X@6?Q%\.?\([<ZI>VDUFGVZVNO-5(Y Q
MS!(X&"PZXZU]Q:A$\^GW,:#<[Q,JCU)! JQ16E9^V34NUON5C.E%4?A[M_>[
MGX"W7_!+O]IR2YE=?AGE6<D'^WM,]?\ KYK];_\ @G_\)_%?P1_9:\+>$/&N
ME?V+XBLIKQY[/[1%/L$ES(Z'?$[(<JP/![U]%T549.,'!;/]!S_>2YWWN>/?
MM?\ @'7OBE^S/\0O"GABP_M/7]5TUK>SM/.CB\V0NIQOD957@'DD"OQB_P"'
M7'[3O_1,_P#ROZ7_ /)-?O\ 45@J:4W4ZM)?=?\ S-.9N*AVO^-O\CE?A/HE
M[X9^%O@[2-2A^S:CI^C6=I<P[U?RY8X$5UW*2#A@1D$CTKAOVGOV6/!?[5G@
M/_A'?%D$D%U;,TNFZQ:8%S8RD<LA(P5; #(>& '0@$>QT5K6?MY2E-;NYE17
ML(QC![*WZ'X3_&#_ ()-_'7X<ZE/_P (]I=K\0=%4LT=]H]PD4VT'C?;RLK!
MCZ(9!_M5Y#I/[#?Q_P!:U+[#;_"/Q5'-DC==Z>UM%P<?ZR3:GZU_1M14Q5MW
M<N3OMH?D-^S'_P $<O$NK:Q9:U\:;V#0]&B99&\-Z9<B>[N<'[DLR$I$IXR8
MV=B"1E#S7ZT^'_#^F^%-#L-&T>Q@TW2K"!+:UL[9 D<,2 !44#H  *T**U<V
MUR[(S44GS=3\'_B!_P $S/VE-<\>>)-1LOAOYUG>:E<W$$G]NZ:N^-Y693@W
M((R".",U^H7_  3G^#7C'X#_ +,]AX4\=:/_ &'K\6I7=P]G]IAN,1NX*'?"
M[KR.V<U]/45E17L*?LH[62^ZW^1=7]]/VDM[W^^_^9SWQ$TJZU[X?^)]-L8O
M/O;S2[JW@BW!=\CQ,JKDD 9)').*_"+_ (=<?M._]$S_ /*_I?\ \DU^_P!1
M4*FE-U.K27W7_P R^9N*AVO^-O\ (\5_8Q^'?B'X3_LP> /"7BK3_P"RO$.E
MV3PWEGYT<WE,9I& WQLR'A@>">M9/[:W[*-C^UO\'Y/#1NX]+\06$WV[1]1E
M4E(IPI4I)CGRW4E3C)'#8.W!^@**TK_[0Y2GU=_G>_YF=%?5XQC'HK?A8_GB
M\>?\$\_VA/A_J4EK=?#/5]7C$A2.ZT%!J$4H!.''DEF4'&?G53SR >*^Q_\
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M4961O#>CW'G7,_<QS3K\D:]CY9<D$X93S7ZO>&O#6E>#?#^G:'H=A!I>CZ?
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M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_
MZ*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^
M'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_
MZ%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?
M^"ZQ_P#DRC_A]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?
M_DRC_A]7\$/^A6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A
M]7\$/^A6^('_ (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^
MA6^('_@NL?\ Y,H ^_Z*^ /^'U?P0_Z%;X@?^"ZQ_P#DRC_A]7\$/^A6^('_
M (+K'_Y,H ^_Z*^ /^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\
MY,H ^_Z^=?VHOV$?AC^U8JWWB&RGT?Q3%'Y</B+2"L=SM'1)005E4>C#(&0K
M+DUX5_P^K^"'_0K?$#_P76/_ ,F4?\/J_@A_T*WQ _\ !=8__)E3**EN5&3C
ML?._C+_@B/\ $*SOMOA/XA^&=8L_^>FLPW%A(/\ @,:3@_F*N>!?^"(OC.[N
MD/C/XCZ%I5LK LFA6LUZ[KGD RB$*<=\''H:]\_X?5_!#_H5OB!_X+K'_P"3
M*/\ A]7\$/\ H5OB!_X+K'_Y,JH^Z2]3Z/\ V9_V./AK^RGI,T/@[3))M8ND
MV7FO:FXFOKA<YVE@ J)D#Y$50< G)YKW"O@#_A]7\$/^A6^('_@NL?\ Y,H_
MX?5_!#_H5OB!_P""ZQ_^3*J4G+5DQBH['W_17P!_P^K^"'_0K?$#_P %UC_\
MF4?\/J_@A_T*WQ _\%UC_P#)E24??]%? '_#ZOX(?]"M\0/_  76/_R91_P^
MK^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0
MK?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P
M76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\
MF4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]
M%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#
MZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]
M"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_
M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
MR91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^
MK^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0
MK?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P
M76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\
MF4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]
M%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#
MZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]
M"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_
M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
MR91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^
MK^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0
MK?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P
M76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\
MF4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]
M%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#
MZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]
M"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_
M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
MR91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^
MK^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0
MK?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P
M76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\
MF4 ??]%? '_#ZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]
M%? '_#ZOX(?]"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#
MZOX(?]"M\0/_  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]
M"M\0/_!=8_\ R91_P^K^"'_0K?$#_P %UC_\F4 ??]%? '_#ZOX(?]"M\0/_
M  76/_R91_P^K^"'_0K?$#_P76/_ ,F4 ??]%? '_#ZOX(?]"M\0/_!=8_\
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M]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\
M+4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5
ML_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ
M*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_
M "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\
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M#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\
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M[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\
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M]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\
M+4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5
ML_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ
M*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_
M "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\
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M#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\
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M[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\
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M]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\
M+4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5
ML_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ
M*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_
M "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\
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M#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\
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M[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\
M+4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53
M_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/
M_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_
M "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU
M4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M
M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S
M_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK
M]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\
M+4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5
ML_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ
M*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_
M "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\
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M#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\
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M[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\
M+4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53
M_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/
M_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_
M "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU
M4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M
M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S
M_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK
M]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\
M+4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5
ML_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ
M*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_
M "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\
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M#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\
M5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<
M8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[M
MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_
M %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^
M'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^
M[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC
M_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC
M_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/
M_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<
M8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[M
MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M
M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^
M'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\ +4_^
M[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5L_\
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M]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ*_53_AQC_P!5L_\
M+4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_ "U/_NVC_AQC_P!5
ML_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\ 5;/_ "U/_NV@#\JZ
M*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\ 5;/_
M "U/_NVC_AQC_P!5L_\ +4_^[: /RKHK]5/^'&/_ %6S_P M3_[MH_X<8_\
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M#\JZ*_53_AQC_P!5L_\ +4_^[:/^'&/_ %6S_P M3_[MH _*NBOU4_X<8_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\O\ VI?^38_B
M[_V)^K_^D4U>H5Y?^U+_ ,FQ_%W_ +$_5_\ TBFH _G4HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]/_ &6O^3G/
MA%_V.&D?^EL-?T65_.G^RU_R<Y\(O^QPTC_TMAK^BR@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %>7_M2_\FQ_%W_L3]7_ /2*:O4*\O\ VI?^38_B[_V)^K_^D4U '\ZE%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'I_[+7_)SGPB_P"QPTC_ -+8:_HLK^=/]EK_ ).<^$7_ &.&D?\ I;#7]%E
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4V21(8WDD98XT!9F8X  ZDFG5\1?\ !2#]I>3P7X;3X7>&
MKMHO$&NP>9JMQ"V&L[$Y&S(Z/+@CV4-_>!KJPN'GBJL:,-V95:D:4'.1\R?M
MO?M0R?M%>/?^$>T"Y<?#_09V6)E.%U&Y'RM.?51R$]B3WKP:UC"*JJ, =JH6
M-NEO$L<:[548 K5MUZ5^V9=@X8.DJ<$?#XFM*M-RD7(%K1@7I5.W7I6C O2O
MJ*,3RYLM1+5N-:@B6K<:UZM-'))DT:U:C6H8UJW&M=\(G/(GA49Y_E6=-<>9
M,SDY).:NWEPMG9N[#<6!51G')'7\.OX5SZ3&1J5:HHM0"$;ZFY;R9Q6A"W2L
M:U:K\<A[5T4IZ&<HFFKTV9LCCK44;,W:K$:>M=U[HPV*_DENIH:V"1LW<"KJ
MK2M&&1AZBIY4+F,32+54$K]W;)-7W7RQ[5FZ;>"WO);=SC![U<U"8>660\^E
M<U.453TZ&DD^;4E%ZB#!/-96IZPL*D[L5R^L^(C8L0<UQNM>*YID(' ]S7@X
MS-H4DX]3NHX*4VF=+JWC#:Q5'R?8US6I>)KB1<%]J_6MKX-_!#Q[^T'X@&F^
M#M&DNXE<+=:K<9CLK0'J9)<8S_LKECV%?I'\$O\ @FU\.OA[;VM]XPW>/=?3
M#L;P%+&-O1( ?F _Z:%L]<"OS3,>)84FU*5WV1]1ALK<[-+0_,KPMX3\3_$*
M\^S^&- U3Q'<KU33;62?;_O%1A?Q(KWSPM_P3[^-WB*.&:?0;#08Y,'_ (FF
MH1AP#W*1[R/H<&OUGT?1-.\.V$5CI5A:Z991#$=M9PK%&@] J@ 5=KXNKQ+B
M9/\ =12]=3W(9722]]W/S&F_X)D_%&WMF>/Q!X6N) ,B%9[A2?;)AQ7GOBS]
MB/XS^$89)IO"#:K G632+J.Y/X("'/\ WS7Z]T5%/B;'0?O6E\O\BI95AY;7
M1^#=Q#J'AW5);.\MKC3KV%MLMI=Q-%(A]&1@"#]171Z+XL*LJ2':?<U^O'QG
M_9\\%?';139>)]+5[M%Q;:I; 1W=L?5),<C_ &6RI[BOS*_:/_9%\7_L]R-J
M,A_MWPDTFR+6;9"#$3]U9TY\L]MV2I/<'BON\GXFA7DH7Y9]GL_1GSV.RJ5-
M<V\>Y!INI+>1@@YJY+'N&Y>M>8>$?$11EBE;YO>O3+.Z6XC!!SQ7ZY@\5'%4
MU);GP^(I.C(9-(SVY 7>Z#(7U]JHV.K6EQRC[#Z9K2N(BOSC]*Y2\^'GB;Q!
MJEU=^%=(OM8\N+[1=6^GPF9XAG!?8OS$$D= >36&.KO!Q]O]E;_YAAZ:KOV?
M5['8V6I7.GSK<65S)!*O(DA<HP_$5ZIX/_:B^(WA)D":[+J=NN,P:FOV@$>F
MX_,/P-?*K>+-4T&Z-M?V\MM.APT4Z&-QCU5@#6O8?$=9"!*I3W/2O+J8G+LP
MCRXJ"DO-)G3&CBL*^:C)I^3L?H7X._;NTFZ6.+Q-H%Q8R<!KC3W$L?UV-AA^
M9KVOPC\>/ ?C;RTTSQ)9_:'Z6URWD2Y]-KXS^&:_)]?'FFM@/(N?8U?LO$EE
M=8\N?GWKY+&<(9+BFWAINF_)W7W/7\4>U1SW,:"_>I27FK/[U_D?L<&# $'(
MI:_+CPE\:O&OA6W$6D>);^"V[1+,70?16R!6]JW[1'C?Q-8O8:IXCO'M9.)(
MXF$6X>AV $CVKYF7A_C.?W*\7'OK?[O^">K_ *UT5'WJ4N;Y6^__ (!]V>-O
MCGX(^'[M%JVNVXNUSFTMLS2@CL57.W_@6*\XN/VWO ,,Q5+36)5[.+= #^!?
M-?G1\2_B-%X,E'VDE(IANCD.<.>XSW-<3IOBWQ?XDW7FG>%=9N[ ' FCL)60
M_B%KNEPYD67_ +K%593J==;?@E^K.2.;YKBU[2A!1C]_X_\  /UCT?\ ;$^&
MNJ2I')J%YIQ;^*ZM&"CZE=U>K>'?&&A>+;<3Z+J]EJD1&<VLZN1]0#D?C7XH
MW'BKQ)I>!?>&]1L\C=^^MI(^/7D"MCPO\7FL;J.:*ZNM.N$/$T+E67\0<UR5
MN&<HQ"_V2M*#\[27Z?F;0SK,*'\>FI+RT?Z_D?M=17YM>!?VV/&WAV&.'^V(
M-?M5X":BGF.!_OY#?F37J_AW_@H,YF"ZUX=MGB)Y:QG9&'X/G/YBOGZ_"&8T
M[NBXS7E)+\'8].GQ)@I6552@_-7_ "N?9U%>9_#?]HKP/\4"D.EZLMMJ#=+&
M]Q%*3_L\X;\":],KY'$86OA)^SQ$'&79JQ]'0Q%'$PYZ,E)>04445RG0%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T_\ 9:_Y.<^$
M7_8X:1_Z6PU_197\Z?[+7_)SGPB_['#2/_2V&OZ+* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG;(Y&/J!^= 'S=X-^'_B'X@:@+/0-+GU"3.'=%Q''[LYX%?5_P (_P!CG3=
MDAU'QF\.LWB_,-/C)^SKQ_$>"Q!_"OH;0]!T_P ,Z;#I^EV<-C90C"0PJ%5>
M<T:EKEKIN5D?=-MR(UYSZ9]* );:ULM#T](+>&&QLX5PD4*!$4>@ JC<:L;I
MMELS*F<%\8+#^E8DVJ76ID"5\1@\1KT'^-7[&/IQ0!9CMZEFTU+JW>)UW(ZE
M6'J"*M1Q]*T+6'=VH _-[X^?#.7X9^/KFT52=/N_](M7Q@;2>5_ UYO7Z/\
M[0WP5B^*O@F9+>-1K-D#-9RMD<X^9?Q K\Y;JUFL;J6WN(FAGB8H\;C!4@X(
M(H BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#T_\ 9:_Y.<^$7_8X:1_Z6PU_197\Z?[+7_)SGPB_['#2/_2V
M&OZ+* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >G_ ++7_)SGPB_['#2/_2V&
MOZ+*_G3_ &6O^3G/A%_V.&D?^EL-?T64 %%%% !1110 4444 %%%% !1110
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M+X!\9Z7XC>%=\MK!(8[F)<XW/ X615SQDJ!1'WE>.H2]UVEH>D4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZCD57H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3QC_ ,%IO#4&DKO?2Y+5+N2+GF*P:23./12%/TK[9_;^_P"3-?BQ_P!@9O\
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M&_P<T6[^(GP_TKQ!X_U*'S]57Q%:Q7RVC%B5@CC?=&NU< LHRQR<D8 ^;?\
M@J%\ ?"W[,.M?#GXM?"G3H/ VMG5FAEM](7R8/.C0212I&/ECQL9650 P89'
M7/L/PN_8;^+GQO\ "]CXK^-O[0'CJ"[UJV2[;PWX:OS:0VJNN55NL0;:1N5(
M0 <C+=:^9_\ @I1^Q/X,_9B^'GA7Q!X>\0>*]>U/5=7>TN9/$>H1W.5$+/N&
MR)/FR ,^E+$RG3FIM\LDUMTU2M^GX[CH*,HN*]Y-/?KIO_7Y'[%>%=:;Q'X1
MT?5F3RVO[&&Z*?W2\8;'ZU^9W_!''_DJ/Q]_Z^+3_P!'W=?H]\+O^26^$?\
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MK7V7^S;_ ,F[_##_ +%C3?\ TECKX8^+7[0WQI_:L_:ZU_X"?"#Q.OP[\-Z
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M"NGKB?@GH/AWPO\ "'P=H_A#5'UOPM8Z5;V^F:E)*DK7-NL8$<A=%56RH!R
M <]*[:JK<OM)<BLKNPJ=^2/,[NP4445D:!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HJSINFW>L7D=I8VLUY<R'"0PH78_@*^J_@_\
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M;@U9<=T*G6X]Z 'W^G6^HV[PSQK)&PP5(KYM^*'PB\3^#=83Q#X.+:C:;O\
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MV<U-=&?G?_P1U^%WC/X8^#?B7!XQ\(Z[X3FN[^S>WCUS39K)IE6.4,4$JKN
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M6/P]OZ['-_#:TFL?ASX6M;F&2WN(=*M8Y895*NC"%058'D$$$$&ORYTGX?\
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M;Y8QPWZ)?L#_ /)F_P )O^P)'_Z$U>3_ /!7K_DS>_\ ^PU8?^A-7K'[ _\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY6'[[5)+C4I.<Y\R9BO_ (X$KW"O/_V?[!=,^"/@>V3.U-(MR,]>4!_K7H%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP:[O)[Z=IKB5II6.2SG)H ZWQU\5M<\=W4KWEPRPNV=@/)^IKC*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /3_P!EK_DYSX1?]CAI
M'_I;#7]%E?SI_LM?\G.?"+_L<-(_]+8:_HLH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&K^;<\RQY3C9X?[.\7Y/_+;Y']"9+F2S3!0K_:VEZK_/?YA1117@'N!1110
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MZ>(O"^L>$;YK/6],N]*N58J8[N)HSD=0,]?PH S**** "BBB@ HHHH ****
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M3C1BKM6CYM]?76^O8PHMU8RJMZ/7R2Z>FEOFS[*HK\YVT#_@HPNF_P#"2?\
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M4.>-S*/FY<84-O\ Q?\ B9^WS^SOX?/Q%\4ZIX>U?PO;.LE]I5C96<\-FK,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD0CX3_\ !5;X1>)M&1;:YUMM)EN_*&#*9+B2SE)]VB4+^%?IL_Q5\%Q^%?\
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M.UU=P4<9P48!@>",UE0_W;TG._S>GWA6_P!XOWC"WR6OW'Y^?\%7_P#DZ[X
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M;177[&/Q62:-9%72?, 8=&66-E/X$ _A7@G_  17_P"38?%'_8VW'_I):5]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M *^(XES>4X^PBSW,LP:B_:,[RBBBOS,^H"BBB@ HHHH **** "BBB@ HHHH
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M.(XLH+3#TW)^>B_5_D5OCYH6G^-/C?XMUG2]5.H^'[Z]-W!)L9&8LJ[Q\P'
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E_[4O\
MR;'\7?\ L3]7_P#2*:O4*\O_ &I?^38_B[_V)^K_ /I%-0!_.I1110 4444
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MU;CO6;/0!E70JBSXK1NN:RYP0<T (SU"[4ADJ-G% #9F^6J,K58EDS5*9^M
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MH **** "BBB@#T_]EK_DYSX1?]CAI'_I;#7]%E?SI_LM?\G.?"+_ +'#2/\
MTMAK^BR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "J6KZWI_A^Q>\U.^M]/M$^]/=2K&@_$FKM?ECXE\5:_XTOC>^
M(=7NM6N"2P-S(65,_P!U/NJ/8 5]=P]P_+/:DUS\L86OI=ZWV^X^;SK.8Y1"
M'N<TI7MT6EM_O/K?XE?ML:)H;R6?A"P/B&Z7(-[<$Q6JGV_B?\,#WKYQ\9?M
M"_$/QX[B[\0SV%JW'V72R;:/'IE3N/XDUYY)(%XJ&XOX[>,N[*BCJ6-?MF7\
M.Y5E<;QIIR7VI:O_ "7R2/R[%9WC\>[2G9=EHO\ @_,=*QAW2,QD=N2S')/U
M-8M]XC6!L$XKG_$WQ,L=+5ECD65^QS7C^O?$6[U2^6.UCDFFD;:B("2Q/8 <
MG\*TQV>4<,N6#+P>65:VLD>[+KOG+N\Q57U)K"U3QM966?-N%/L#5GX:_LA_
M'CXL1PR6OABYT'392!]NUQOL:!3_ !;&_>,/]U#7U)\-_P#@DWHMNT5U\0_&
M=[K<W5K'1D^SP_0RON=A] M?'XOC"G3C:+U/IL/P_.3NUH?"^H^.]2\5ZM#H
M_A?3KS5]5N&V06MA"TLLA]E4$U]/? O_ ();^*O'SV^N_%W5I/#6GR%9!H&G
MNLEY(O7$LG*Q?0;F_P!TU^AWPL^!/@+X*Z>UIX,\,6.B!QB6XB3=/+_ORMEV
M_$XKO*_.<QS_ !..EO9'V6$RNCA5M=G(_#'X3^$O@WX7@\/^#M#M=#TN+GRX
M%^:1N[R.<L['U8DUUU%%?,-N3NSV5IHA&4,I!&0>"#7G'C[]G+X:?$Z.3_A(
M?!NEW<[@_P"EQ0""X!/?S8]K9_&O2**NG4G2?-3DT_(4HQDK25SXA\??\$NO
M"^I>;-X/\6:EH4IY6VU*-;N$>P(V.!]2U?.'CS_@GG\8?!YFEL=-L_%5I'R)
M-(NAYA'_ %RDVMGV&:_6VBO?H9_CJ.DI<R\_\]&>?4R^A/96]#\-;KX#_$JQ
MF:*;X>>*5D7J%T>X;]0A%5O^%(_$NX<1Q?#KQ6SGIG1;D?J4K]TZ*]%\3UFO
MX:^]G-_9</YF?BAH/[%?QP\52!;;X?:E:J1G?J+Q6BX_[:,*]A\%_P#!*7XA
M:XR2>*/$VB^&X"?FBM0][,/_ $!?_'C7ZG45YM;/<54^&R_KS.F& I1WNSXI
M\+_\$H_A9IEF5UO6_$6NW;+CSEN([9%/JJ*A/YL:\Q\;?\$G]5LKB27P;XRL
M[VWR2EOK4#0R*/3S(]P8_P# 5K])**Y*6:XNE+F4[^J3-I82C-6:/R4N_P#@
MF_\ &FSR(M-T:[ Z&'4U&?\ OH+7&:I^QE\:=%NO)F^'NISM_?LWBG3_ +Z1
MR*_9ZBO5AQ)BX_%&+^3_ ,SDEEE%[-GY(^#/V _C)XGFC%QH%OX>MV&3<:K>
M1KC_ ( A9\_A7U3\(/\ @FWX/\)R0W_CC4)/&%^AW?8HU,%BI]U!WR?B0#W6
MOL6BL,3Q!CL1'D4N1?W=/QW-*674*;NU=^95TO2[+1-/@L=.M(+&RMUV16]M
M&(XXU'95 P!]*M445\W>^K/3"BBBD 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7Y%K<%OB?XY#G<__"0ZCDG_ *^I*_72OR<^)VGGP]^TK\2K
M#8(D_MJ2X1%& %E"RC_T/]:^XX1J*&.:[H^!XSIN>7I]F=2O_'OFI?A3<+;?
M''P&[_=&L0KUQU)']:@B;_0P?:J7@>^6U^+W@J0C.W6[/]9E']:_8,U][!U%
MW3_(_$,F?+CJ;[27YGZDT445_,Y_5H4444 %%%% !1110 54U;2[?6]+O-.O
M(Q-:7<+P31GHR,I5A^1->=?'3X_:%\"])L9=11[W4]1=DL[")MI?;C>[-@[4
M7(R?4@ 5S'P__:T\/>+MBW]J=,W<&:.831*??@$?E1L)ZZ,_-W6M#N/ OBK7
M/#=\NV?3[J:RD![E&*@_B #^-?IW^R?XT;QU\ _"MY+)YEU:P-I\QXSNA8QC
M/U55/XU\1?MP^'X--^.MWJUD\<MCKUC;ZC'-"VY791Y3\^O[L=/45]!?\$W_
M !$NI?#'Q1I88YL-8\P(>RRPH<_BRO7W.:5/K66TZSW5G^C_ !/S'(Z?U'.:
MV&6SNONU7X'US1117PQ^GA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5Y?\ M2_\FQ_%W_L3]7_](IJ]0KR_]J7_ )-C^+O_
M &)^K_\ I%-0!_.I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1173>&_ACXM\88.B^'-2U)#TDAMF*?\ ?6,?K0!S-%>Z:/\ L3_%[5T5
MCX:6P![7ERB']":T9_V#_B[#&SC2;";;_#'?*6/TXH ^>J 2"".".E>D^*?V
M;_B9X-1I-4\&ZE'$O_+2&/SE^OR$UYU/;RVLACFC>&1>"DBE2/P- 'T[^SS^
MT:D<=OX8\5W.%&([/4)#T[!'/\C7U)'<M#@@[D(R&!SQ7Y=5]!_ ']HV;PQ)
M!X?\3SM/H[';#>299[<^A/=?Y4 ?;%C?!\?-71Z?+O*UP-G/'-'%<VTJRP2*
M'22,Y5@>A!KK=%NMQ7F@#O=+3=BNHT^WSBN:T5@P7UKM=*B# 4 :=E;].*V(
M8>!4-M" !Q6C$O% $)A&*IW$?6KEQJ%M!PT@SZ5D7FMVZYQR* *%XO6L.\;D
MU<NM>MW9E)*_A67=3+*NY6R#0!1N'K.E:I[F3&:SY)* (+D\U0F&ZK<S;JJM
M0!G3*5Y%5V:M&50:SIUV-Q0!#(>*HW#5:D;BLZZDPIH I7$O)YJBUQ\W6DO)
M]N>:S)+@[NM &];W7O6C%<9'6N8M9SQS6M;S?*.: -5IN*J3R=:0S>]022?*
M>: ,Z]EV@YKF-6UO[."JGGI6CKFH",$ \URD=C+JET,Y(S0!?T6PEUBZ#,,@
MFO#_ -I[XP0EF\&:%(RK;M_IUW&Q&]L<QCV]:[#XW?&JV^&^AW'A[17E7Q).
MH4W"[=L"'J<YSN_*OCV::2YF>65VDED8LSL<EB>I- #**** "BBB@ HHHH *
M*** "O2OV;_AC-\8OCAX/\)Q*Q2^OX_/90#LA4[I&.>P4&O-:_0;_@DS\-/,
M\0^,_B3=0YCTFU&FV#L!CSY?OE3ZA1C_ (%51BY-174F4E%.3Z'VU^T3\"O"
M?[2G@6Z\&:G;Q6%S8KC0=2C #6LB+M12?[AP 17XC_$SX:^(/A%XUU+PMXFL
M)-/U:PD,;HP.UQGAT/=2.0:_>')SG//K7D_[5W[,NE_M6?#M[>-(K3X@Z5&S
MZ1J+<>?@?ZB4]U/;T->GBL+R+GA\SR\+BN9\E3Y'XG45L>+/!^M>!=<NM'U_
M3+G2M2MG,<EO=1%"""1D9'(XX(ZUC@%B !DUY1ZQZ/\ LZ^%?^$P^,_A;3V#
M&(7:SR%5W85/FSC\*_6N-FDY8%0!@#%?&7P)^#,_P9^%4/C/4(Y+?Q1X@_<V
MH91FVMR,G'HS#G\JZ'2OB=KOAG4OM:WTUT@X>"XD+*P].>E?08/):V,P[Q$)
M)=EWL=5/#RJ0YTST']JCQ!'H?POUV3S"KFV=%(_O$8'ZU\,?LDRP1_'WPO\
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MI=1DG\ :V]C5M?E?W&?M(;<R-:BFI(LB*Z,'1AD,IR"/6G5B:!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%I6KX^PZG9WN>GV>X23^1K1KCE&4':2LQ!1114@%%%% !1110 4444 %%%%
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M:U;<!0!J^=NZ5!=3,L9Q5BWAR*L_V<9NW% '&RZ;+?S'(.#7(?&#XC6'P?\
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MXW*Q.U/E]U#?E7QQX^6]\+K<0:C:3V-S'D/'<1E&&/8UZAJ7QO\ %%OXVO\
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M)#<6[E'1AW!'2OS[-> LMQD7+!_NI^6L?FGM\FO1GV6!XHQ5%J-?WX_<_O\
M\S]@Z*^2OV<_VQ/[>NK'POXX>*"\95AM=:+;5G?H%F'0,?[XX)Z@=:^M:_!<
MURC%Y-B/J^+C9]'T:[I_TUU/TS!8ZACZ7M:#NNO=>H4445XQWA1110 4444
M%%%% !1110 45X_\8OVHO!OP?DEL+B=M8U]5S_9=B06C)Z>:_2/UP<M@@[<$
M5\1?%+]J/Q[\4I)89]4;1=);(&FZ4S0QE3QB1@=TF1U#';GD**^ZR7@[,LY2
MJV]G3?VI=?1;O\%YG'5Q5.F[7NS[K^(7[3'P]^&RM'J&O0W]\K[&L=+9;F=2
M#@[@IPF/1B#Z9KY]\8_\%#+EF\OPKX4BC4<_:-8F+D\=/*C(Q@]]YR.PKXXH
MK]CR_@#*,(DZZ=67F[+[E;\6SF^M.7D>U:]^V1\5M<+!/$,>F1,2?+L+2),9
M&,!BI;]?Z5P>H?&3Q[JD@>Z\:>()F'3.IS #IT&[ Z"N1I,5]K0RG+\*K4</
M"/I%?Y'1&MW+]QXDU>[<//JM],X& TEP[''IR:]&_9IUB_D^/'@M'O;AT:_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\!_A9)>&Y_X031O,)W'_ $8;?RZ5UNCP:3X7L8[+2-+M=.M(_N0V\855^@H
MO:Q]JU+2TMK=/G+@EG& H'>JEKI":>N9'WR=V-27'B1L$# KG]4\1! Q9N:
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M@J79KB0*&4=6 /I7FO[07[6WAG2=%?2_A_=#4M=D+0R:BL9$%NF!\RY^^3G
M[#!H ^=?V;M-N=%_:N^%FGWD1AN[7QII4,L9_A9;Z($5_1%7\Z_[,-Q)=?M1
M_"::5S)+)XRTEW9CR2;Z(DU_110 4444 %%%% !1110 4444 %%%% !1110
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M$4W%?9Q2BK+8]2E5(Z?;W4]G*);>:2"4='B<J1^(I&%--7H]&>O2JGIG@?\
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MBMA=1F.79YB20ETW9\M2"'&"#UZ5U_[)?[+FA?LE?"L>#M%U"XUF:>Z>_O\
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M_P""3GA;X]?'&^^(*^.-1\.VVK3)<:MI,5BDYFD "L89BZ^5N"@_,DF"2>G
MCWO:1_EZ_P!=M_,KW>27?H?<^FZC;:OI]K?V4Z7-G=1+/!/&<K)&P#*P/<$$
M'\:LUF^&_#]CX2\.Z7H>F1>1INFVL5G;19SLBC0(@SWP *TJTER\SY=C*'-R
MKGWZA1114EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT'W.?J*\W\0^(M2\5ZQ=:IJUY+?7URYDDFF8L22<X'H/:LZB@ HHHH ****
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MZOXW\8P-)X5LKE=4U6)CNBCMU.+6P4^C!0I]520]37JG_!7#]IB[\?>-]*^
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MG+<_\%,/VL_A*L-_X[^'L$.ER2A=WB#PQ=Z>K>JI(&C ; .,AOH:^ZOV.?\
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MU7Q%XXT[PS\8=(TFST_4)5MHO$>DH\ M9&.%-Q$S,"A)&74KMZE2,D?J@"&
M(.0:_$W_ (+$?"'2/A[^T)HWB31K.&PC\5Z:UU>10*%5[N*0I)+@="RM&3ZD
M$]2:_5;]D7QA=^/?V8?AAKM_*T]]=Z!:?:)F.6DD6,(S'W)4G\:5.2K4/:6L
MT[?G_E\[A4BZ594[W35_R_S-WXZ?''PI^SO\-]2\:^,;QK72K/")%"H:>ZF;
M[D,2Y&YV(/<  $D@ D?F1K7_  5H^.GQ>\37>E_!SX86Y@5"R6\&G7.LZB%S
MCS&\HJ@'3CRR >-QKO?^"X4VIKX+^%441E_L9M0OFN /]7YXCB\K/OM,V/\
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MSIC[T&EI9??JCQ?X._\ !4;XT?![X8^'/!>@>$?"=]HVBVJVEK<7NF7LDTB
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS'F1O[[?T]* )?C9\:KOXF:B+.SWV?A^U.V"W!QYO^V_J?;M7EU%% !1110
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MD?1C0!B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,%SJ5S:I>II2H<M&RA@H;^]@C^5?.-Y9S6%U+;7$303Q,4>.0892.H(KZ_\
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M9_BD(**?[H8\AZ_36L_P]H&G^%=!T[1=)M8['2]/MX[6UMH5PD42*%10/0
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MKZ?_ .B%KUZ\D>&TGD1=SHC,J^I X%=>,DHUJLGT;_,YL.KTX+R1\8?M@?\
M!3SP9^S3KUUX0T'2G\;^-K? NK:.<06=@Q&0LLN&+/R#Y:CZLIXKYR\/_M4?
MMY_M%:<FH^ / EMH&ES*)(+^UTB&VAF0]&2749&20>Z9%?,'[#/AS2_CA^W1
MX<7QX(M62_U&^U6Y@O0&6\N5CEG57!X8&0!BIX.T@\&OZ %4(H50%4#  ' K
M&--QI1G4=Y2U\E_3-ZDK5I4H+2.GK_7];'Y;:Q\/?^"B.M>&=1EU[QQIFF6
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M_@DS_P F4^&/^PAJ'_I2]9X/?$^J_* \3_RX^?\ [>=I_P %&/\ DROXI?\
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MM;ZS^QA\+)K9PZQ:8UL^#G#QS2(P_-37T57H8G^//U?YGGX;^!#T7Y'XI?\
M!6SX1W7PA_:;TGXCZ)OLK?Q1$E_'<0G!BU"V*+(1Z''D/[DL:_6K]GSXL6OQ
MP^"G@[QS:E,:SIT<\T:-D13@;9H\_P"S(KK^%>(_\%./@A_PN?\ 93\0RVEO
MYVM^%R->LL#YBL0/GJ/7,)D..Y5:^'/V&?VR1\(_V,_C5X>N[T1ZOX=MVO\
MP^LC#):\(@"H.N$G9'/_ %U-<5*?LZ%6E;6'O1\UV7Y?]NG;5ASU:55:<WNO
MU[_E_P"!,X;XBK)^W1_P4N?1X&:[\/R:TNFJR\JNFV0/G,#V#B.5A[RCUK]R
M8(([6".&%%BBC4(B*,!5 P !Z8K\JO\ @BG\%S->>-_BM?P[M@70M-D<=6.V
M6Y8$^WDKGW85^K-=7)["C3H]4KOU?_ L_5LY^?VU:=5;;+T7]6^2"BBD;.TX
MY-8MV5S0^*_VX/\ @FQH7[4NJ-XQ\-ZI%X4^( B$<T\\9>SU)57""8+\R.
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M_P FN?"+_L4M+_\ 22.ORU_X+6_\G)^$/^Q4A_\ 2NZK]2OV3/\ DUSX1?\
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MP?0JG+VD5+N%%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV"JNSE>WJM?RN?15%17-U!9Q&2XFC@C'5Y&"C\S7+:E\6/"FEOY<FL6\TO\
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M@@CH0:UZQ?&W_(F:]_V#[C_T6U?&4-:L/5?F=9^7O_#07Q+_ .AYUW_P.?\
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M[K^M3W\'C)4)*46??_[4G[+EM\2+.;Q3X7ACB\0HF^:&/ 6]7'7_ '\=^]?
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M)$/9U8!@?4"OQ_U[]DW]IW]@;XF7/B/X4+JGB?1)#Y::CX?M#>"ZAR2(KNR
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M8D^RZW:N]SIFBRW"W%P;E\YN;EP6&X;B57<6W'+8*X/Z<45M"2IRYXKWN_\
ME_7XF,XN<>23T[?U_7R"OQ-^ 7[/WQ1T?_@H=I7B34/AMXNL?#J>,KRZ;5[G
M0KJ.T6%I9BLAF,80(01ALX.17[945G#W*T*W6/\ FG^A4_?I2I?S?Y-?J%?,
M'_!0+]DFX_:T^#L&F:+<P6?BW1+DW^E/<G;%,2I62!VP=H<8P>S(N>,U]/T5
M$X*I'E?]6-(2<'='X9_#E?VX/V2["Y\(>%/"?C.STKSFG-E9^'4UJU60XW-'
M*L4RKGN$8 G)QFOU<_8O\6?$?QQ^SSX>UCXL6E_8^.)Y;H7D&I:9_9\ZJL[K
M%N@V)M^0+CY1D<]Z]PIKNL:LS,%51DLQP /6M^=\K4M?/T,N577+H,NK:*\M
MY;>>-9894,;QL,AE(P0?8BOYL_VHO@^WP-_:&\<>!+?]Y;:=J3+9+&V\FWD
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MT445RG0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?!?[4GP^G\,>+;/$J;I-/U:!0+K3YL<21L>W3<A^5AUZ @ ZOX4?%CPM\;?
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MD\0?#FR2=]]UI[-8R$G)^3&TG_@)6I+/1:*** "BBB@ HHHH **** "BBB@
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M)3Z#//J:]<\8>*DMHW4/@#WH =KGBJ.T5L-M KR/QU\6(--MY6><#&>]</\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG_\ HA:[8_[O/UC^4CFE_%CZ/\T?/O\ P6,_Y-%B_P"QBLO_ $":OQ.\-_\
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MKJ[?<]?T^9P'_!;+_DWOP/\ ]C0O_I)<5^2GPB_Y*QX*_P"PW9?^CTK]:_\
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M/#T9*DW+=:OU;U_%_</$55[1*.ST7HE_DOO/R0HK^E/_ (9.^"'_ $1OX?\
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M\*?AO??#YM5-SJ,5U%?&-Q#$A C=00QR3SD8[=J]!HH **** "BBB@ HHHH
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MP((((R""*(^]%RCLM/F$O=:B]WJ='1110 4444 %%%% !1110 4444 %%%%
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MW!<W,M&6INW+T/PJ\*_\$A_VAO$%WY6H:9H/AF+/^OU/5XY%_ 6XE/Z5]O\
MP5_X)0^$OA+\.?%JZAJ,/C#XBZSHEYIEIJE[!Y5EIKSP/'NAC^<@Y?!E.6Q]
MU5R0?O:BM9>]!P[JQ$?=DI]G<_%;_ARI\;_^AI^'_P#X,;[_ .0Z_6OX ^ =
M0^%?P1\"^#M6FMKC4]"T:UTZYELV9H7DCC56*%E5BN1QE0?:N^HJN=J+AT=G
M]U_\R>5<RD5]0L+;5;&YLKVWCN[.YC:&:WF0,DB,"&5@>"""00?6OS7^./\
MP1;T#Q)KEYJWPR\8MX5@G)D&A:M;-<V\;$YQ'.K!T0=@RN?]JOTPHK%Q3?-U
M-5)I<O0_%B3_ ((I_&Q9&$?BOP"R9X9K^]4G\/LA_G7[&^"]&G\.>#=!TFY:
M-[FPL(+65HB2A9(U4E20#C(XR!6U16O,U%QZ/]/^',7%.2GU7ZV_R/QX^(W_
M  1V^,WC#XA>*->L_$W@2*SU35+J^A2>_O1(J2S,ZA@+0@'##."1GN:^UO\
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M+!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0**** "BBB@ HHHH **** "OS4_X+4?&K^P_A[X1^%]E-MN==N3JVH*IY%M
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MR3='DJ#UWO\ E7NY-B5A\2N9V3/A>,<M>89:_9Q<IQV25WKH_P!'\C;OK?\
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MXN_MC7YHE?=$A^<@UY=<2":9W4;4)^52<X'I0!'1110 4444 %%%% !1110
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M&.&H9+2]M6UK26K[+LOU?7T"BBBOC#[H**** "BBB@#Y]_;>&?@S#_V%8/\
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M_P %3_&'QF^*U[H_Q,M/!WAGPE9Z-=ZI<:GI]O<P-"80IRS2W$B[<%N N2<
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M-K<1K+#-&VY9$895@>X((-3TFFG9@FFKH****0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKA]=^.'@W0=ROK$=Y*/^6=D#,3[9''ZU\H:_XNUCQ-QJ^KW-W'G/ES2DJ/\
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MW]S7ZGU)1117Y,?V(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF-=?117X16KU<34E6K2<I2U;>[/NHQC"*C%62"BBBL"@HHHH **** "BBB@
MKR_]J7_DV/XN_P#8GZO_ .D4U>H5Y?\ M2_\FQ_%W_L3]7_](IJ /YU****
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M^3/OZ=OO[6_HCA/AF.5TUB\4OWTE_P" KMZ]W\N]RBBBOAS]'"BBB@ HHHH
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M6MROP/B/C+$YTGAZ"]G1[=9>O^2_$_3<ORJ&#2G-\T_P7H%%%%?G)[X4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >2_%S]K'X1?
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M8_\ "VO^$0\R3[/_ ,(E_:GV#?N/F;/(_=YW9SCG.<U^@O\ P6]_Y)?\,_\
ML,W/_H@5[-_P29_Y,I\,?]A#4/\ TI>JH/VCK=.7\?A_S_ SK>Y[/KS?A\7^
M1^8W_&;W_5P'_E<K]U/A/_:7_"K?!W]L_:O[8_L:S^V_;MWVCS_(3S/,W?-O
MW9SNYSG-=516RE:#A;=K\+_YF;A>:G?9-??;_(****S-#\\_^"RWQL_X0_X)
MZ'\.[*XV:AXLO//NT4\BSMR&(/INE,7U"-70?\$@?@Q_PKW]FVX\7W<'EZIX
MRO6NE9EPWV.',4(/L6\YQ[2"OSB_X*-_&P?&[]K#Q3<PW!ET/07&@V)3D>7
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M[77W,****Y3<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOYY/W \@^-/[,GA;XSW"ZC<M-H^O*@0:C9A3YJCH)4/#X'0Y!Z#.!BOGN_\
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M7QAUV;QQILFL^#M#L#/>0&YEA\^ZF8K"IDC97'25^&_@&>#7Z:_\.N/V8O\
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M-KN_S.'#:4()]E^1^-__  6T_P"2Y^ O^Q=/_I3)7Z6?L:_\FG_"+_L5]/\
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M0],FO6A5HX@I<1*VT$@XSUP:XL1=QC;NOS-L.[2=^TOR9ZU_P2I_Y,C\$_\
M7SJ'_I9-7US7R[_P33\'Z]X#_8_\(:-XET34?#NL07%\9=/U:TDM;B,-=RLI
M:.0!AD$$9'((-?45>GB7>J['!1^'YO\ -A1117,;!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKQE+ 8F.(JTO:<NR;LK]&]'>W8_1_P#X2G1?^@O8?^!*?XT?\)5HO_07L/\
MP)3_ !K\W2M,*U\@N$J?_/Y_=_P3]-_XB-5_Z!E_X$_\C])?^$JT7_H,6'_@
M2G^-)_PE6B?]!BP_\"D_QK\V"M-*U:X0I_\ /]_=_P $/^(C5?\ H&7_ ($_
M\C]*?^$JT3_H,6'_ (%)_C1_PE>B?]!C3_\ P*3_ !K\TV6FE:T_U.I_\_W_
M . _\$/^(C5?^@9?^!/_ "/TN_X2O1/^@QI__@4G^-'_  EFB?\ 09T__P "
MD_QK\SBM,*U2X,I_\_W_ . _\$/^(C5?^@9?^!?\ _33_A+-$_Z#.G_^!2?X
MU/8ZYIVI3&*SU"UNI57<4@F5V Z9P#TY'YU^816O>OV+EQ\4M4_[ TO_ */@
MKBQ_"E/!86IB%6;Y5>UO^">KE?'%3,<;2PCPZCSNU^;;\#[1HHHK\[/UH*\S
M_:&^&[?$SX9W]E;1E]4LS]NL57JTB Y3WW*64>Y4]J],HKJPN(J82O#$4G[T
M7=')B\+3QN'GAJJ]V::?S/R@DC:-V1U*LIP588(/I4;)7T3^UC\&'\(^(I/%
M>EP?\275)2;A(QQ;7!Y.?]ESE@>QW#CY<_/16OZ9R[,*68X:&)I/1_@^J?H?
MR=F>7ULKQ<\)76L?Q71KU*Y7%-*U8*TQDKUE(\LZ3X9_$C6/A3XI@UO1Y!N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !6!\0/\ D0_$G_8-N?\ T4U;]9_B#2O[=T'4M-\WR/MEM);^;MW;
M-Z%=V,C.,],UAB(N=&<8[M/\C6E)1J1D]DT?A[_P2#_Y/(L/^P)??^@K7[I5
M\+?L@_\ !,/_ (93^,D'CS_A97_"4>593V?]G_V#]CSY@ W>9]IDZ8Z;>?6O
MNFNVI)2C!+HOU9QTXN,IM]7^B04445B;A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /(OC]\2%:WG 8[F! &:^4;J.9M+GO"V-\HC)]<@D_R%>F_&::?[9)YRGEL
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MHHKQ3W HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH **** "O+_VI?\ DV/XN_\ 8GZO_P"D4U>H5Y?^U+_R;'\7?^Q/U?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N\^#_P9\1_&KQ5#HV@6C.-P,]TP/EP+GDL?Z4SX/?"/6OC+XRM-"TB%BK,#
M<7)'R01]V)_I7Z]?"7X9^%_@)X'M]-TN".+RT#2S-C?*^.78]R: ,+]G_P#9
M#\'_  /TF*=K>.\U8J#-?7 !<L/[N?NCZ5W?CKXS:%X$L7)N(H]@]0*^9/VE
MOVT+?P;YFG:=+]HO6X$<9Z>YKX!\??&/Q/\ $2[EDU/49?(8G$",0N/?UH ^
MR/C)^W_'#)/::*6O9@<91L*/QKX_\=?'/Q?X_N)&O]4ECMV_Y80L57%>?T4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *CN+>.ZMY()D$D4BE'5NA4C!%244 ?G
MCX-TE_"_B+Q'X=8-C2M2N+1-W78LA"G\5P?QKT;X<W+:?\;_  7(AYF>>!AZ
MJ87KD]+ND\1?$+QIKD6UK>^UBZ>)E& R*Y16_$*#^-=E\+[#^U?C[X40*&2R
MANKR0'L!$44_]].M>W+$<U#E?8_D_!8.*XMBJ&RJ:>BD?85%%%>(?U@%%%%
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M>K$G\Z_3/X\%?"?[)NEV:')AT"W3(&,%T!/\Z_,I>@H 6BBB@ HHHH ****
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M51(RHQ/&X&"QZ8ZUG.:II-]6E]YI"#J.R\W]RN?=E%?@#_P]&_:=_P"BF?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "N?^('B*#PCX'U[6;A_+BL
M;&:?.<9(0X ]R< >YKH*^;?VJ/' UJ\T_P"'6GN6>9H[[5V7HD*G,46?5F4,
M1Z*/[U3*2BKL\[,<9# 86IB)OX5^/0\<^&&ER:7X/LUF_P!;Y2[F/4MCD_G7
MKO[+VD_VI\0/%NO$!HK&WBTR)O\ ;8^9)C\%C_.N \0WT'A?PW-,Y")!$6/X
M"OHO]G7P;/X,^%.DQWL;1ZIJ&[4KU6&"LLN&VG_=78O_  &HIU',_%."<O>*
MS.>/DM(W?S?],],HHHK4_? HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ']H?_@GOKUGXA34+S0;2:58XO$7A>_>2QG<?,(I1A3V^Y,@#8. V#7Z=?\
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M7_!7_P" ?;GA'P1X=^'^CKI/A?0-+\-Z6KEQ8Z19QVL 8]6V1J%R?7%;$O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2OQ-*J_V5I.W,W^"T_\ 2C^E_3]/MM)L;:RLK>.TL[:-88;>% B1HH 55 X
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M_9NNV<E*E#NKK]?U9R17+5G;9V?SV_)(****YS<**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ IDO^K?Z&GTR7_5O]#65;^'+T8UN?DA
MK'_(6O?^N[_^A&OLS]C+XW_VYI8\"ZS<9U"S0MILDC<S0CDQ>Y3J/]G_ ':^
M,]8_Y"U[_P!=W_\ 0C5V&36?A_XH@F7S=,UG3Y4F0_Q(PPRGW!!!]"#7SN!K
M^PLW\+M?^O+_ (!_*679I7R;,I8VDKQ4FI+HTV]/72Z\T?K+7R3^W]_R#?!O
M_76Y_P#08Z]Z^"_Q4LOB]X&M-:MRD5XO[F^M5/,,P'S#_=/4>Q]0:\%_;^_Y
M!O@W_KK<_P#H,=>GF7\%>J/WCB'$TL9P]7Q%!WC**:?S1@?L"_\ (V>*_P#K
MRB_]&&OM6OBK]@7_ )&SQ7_UY1?^C#7VE+*D$3R2.L<: LSL<!0.I)]*[J#M
MAJ;?9_\ I4CEX&_Y$E/UE^8^BOE'XI?MQV^CZC/I_@O3(-4\EBAU*^+>0Q'7
M8BD%A_M%A]*\RB_;A^(L=QYC0Z+*F<^4UH^WZ<2 _K7-]>HWLF;8OC/)\)5=
M%U')K?E5U]^S^5S[[HKYW^"?[7^E?$;5+;0M?LET'6K@A()(WW6UP_\ =!/*
M,>P.0?7.!7T17;&2G'FB[H^DR_,\)FM'V^#GS1_%/S3U045XU\;/VG/#_P '
MI_[-6W?6]?*A_L,,@1(@>AD?!VY] "?I7SY=?MY>-GN&-MH>@109X26*=V ]
MV$JY_*N26,HQ?+<\C,N*,JRNJZ%>I[ZW23=O7HO2]S[G9@BEF(50,DG@"L32
MO'7AS7=6ETS3=>TW4-1B0R26MK=QRR(H(!)522,$CKZU\&_%#]I[Q-\9M%T[
MPZ8+;0H9)<71M[@I'<DD!0Q;[B#DD%B.YZ5[I^S-^S7XF^$OC*?7]9OM*GM[
MBP>W6&RFDD<,SHP)R@7&%/0GM3I5Y5JEHQ]SO\CR\/Q2\RQL,/E=%U*=USS=
MURW\O+O]W<^FJ*\D^.G[16B_!6"&V>!M6UVX3?%I\<@0*O3?(V#M&>G!)Q^-
M?,NI?MS>/[J=FM;+1;&+/RHMO(YQ[EGY_ "E/&4H2<;WL>IF?%&6935]AB*G
MO]4E=KUZ+TO<^]:*^&_#G[=_BVSNHQK6B:5J=H/OBV$EO,?HQ9E_\=KZ]^''
MQ$T?XI>%;;7M%E9[:4E'BD&)(9!C<CCL1D?4$$=:WI5H5DW![&N5<1Y=G$W3
MPL_>6MFK.WEW^1E?&KXFO\(_ =QXC33EU1H9HXOL[3>4#O;&=VT]/I7E'P?_
M &OY_BE\0=,\-/X6CTU;P2'[2M\9"FR-G^[Y8SG;CKWKPKXY?M+>)_'MOK?@
M_4+#28=,AOV59;:&59L12';DM(1VY^7\J\N^'7CW4/AEXOL?$>EPVT]]9[Q'
M'>*S1G<A0Y"LIZ,>]>3#'<U7FO[C_P O\S\WSGC*K3S6E#!56J,6E-<JW4WS
M6NF_AMLS]6:^1/VT?A=XP\6>)M'UC1M,O=<TR*T^SFWL8FF>"3<23L4$X8$<
M@?P_2NP_9E_:+\2?&?Q-J^G:W9:5:P6=F+B-M/BE1BV\+@[Y&XP?2I/VG/VB
M/$?P7U[1;'1++2[J*]MGFD;4(I'8,'Q@;)%XQ75BG2J483FVDWI^*_S/L\SQ
M^6YSD57$5)R5%V3:6MU)6TZZV^10_8M^''BGP/H_B"[U^SN-*M;]XOLUC=J4
MDW*&W2%#RN<@<C)Q["OI:O$OV8?C;KOQJTO7KG6[33[62PFBCB&GQR("&5B=
MV]V]!TQ7CGC[]L/XB^!?&FLZ!<:1X=+V%R\(9K:XRR@_*W^O[J0?QK:6(IT(
MPB]FM/P_S,<OS3*\BR6A5C*3HMM)M:WO)NZZ:IV]#[0HKD?A+XZ'Q*^'>A^(
MBL<<UY!F>.($*DJDK( "20-P.,D\8I_Q4\<+\.?A_K?B$K')+96Y:&.4G:\I
MX13CG!8CI735FJ,7.6R/MJ>*HU<,L7%^XX\U_*U[_<=717QI\.?VOOB)\0/'
M.B^'H-(\/ W]RL3NEK/E(\Y=_P#7]E#'\*^J?'GC[1?AMX<N-;UVZ^S6<7 "
MC+RN>B(O=C6<:T)4_:WM$\G+,]P6;4JE?#MJ$-W)66U]_);]CHJ*^(O%G[>'
MB2\O)%\.:'I^G66<(]\&GF/OPRJ/I@_6LW1?VZ?'-E=(=1TW1]2MMV718GAD
M(]%8.0/Q4USK&T6['A5..,EA4Y/:-^:B[?Y_@?=]%>=?!OXXZ!\:-(EN-,WV
MFHVP'VK3;@CS(L]&!'WE)Z,/Q KT6N_=71]IA<50QM&-?#R4H2V:"BBB@Z@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *Y+XL>.H?AI\-_$/B:;YO[/M&DB3^_,?EB3_ ($[*/QKK:^2/V\/
M' ;_ (1'P+ _SWDYU6]7_IC%\L0/UD)/_;.LZDN2+D<>,KK#4)U>R/$OAS8S
M66EBXNG,MU,3-/*W5Y&)9F/U))KK_A+X5D^+7QTTFQE ;1]!QJ]\K+N5RC 0
MQGMS)@\]D:N>2_33=#+$A=J9KZ0_8I\&C2_AM=^*[B+;?^)KIKA7;K]FC)2$
M?0_._P#P.O)PW[RI=GY/D&"^NYBZ]174=?Z^9]#4445[1^R!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5Y?^U+_ ,FQ_%W_ +$_5_\ TBFKU"O+_P!J7_DV/XN_
M]B?J_P#Z134 ?SJ4444 %%%% !1110 4444 %%%% !1110![Y^SC\9UT'/@W
M796?2;Z0+9RN<BWE;C;[*Q_(UU/Q<^'<UK=274,?0YP!UKY:R1R.#7O/PR^/
MTEW;P>'O%TWG6V!';ZE)RT?H)/4>_:@!G@?Q)+HM_&DK%4#=ST]J[#QE\"M/
M^*4;:MH%Q#IVMN,R0R<0S^^?X6_0U5\4?#=HW^WV;+-$_P RM&05<>HQ3O!_
MBR?P_=+&Y8JIQM/44 >,>-O@KXS^'NY]9T.XBME_Y>X1YD)^CKQ7$5^F/@GX
MG6FH6(M[KRYH6&&CF 93[$'K4VM_ 3X3?$AFFO?#]O:W4F29K!C Q)[D+P:
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M&OYY?@'KTW[*/[:GAZ7Q"?LJ^%_$<FF:G(^0$A+/;32?0([-[@5_1/7YF?\
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ME7GLXT]WL%/ENG/;J?5?[.__  5JE_: ^-GA;X?6_P )6TDZY<M =0'B+SS
MBQL[/Y?V5=V%0\;A]:_0VOS4_P""5O["^O?"Z_E^+?Q!TZ72-:N+5K;1-&ND
MVSV\4@&^XE4\H[+\JH<$ L2.1C]*ZZ:D8P48]>O^7]=[=#FA)SDY=.G^?]=K
M]0HHHK$V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1:K31:$/[9L'@ZX\0:'JOA>ZTJXN;J.5+[^RYHW!92NUG"'AN2,GKCVKM?V
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MGWMX5^&?A7P/=37.@:#9:3<3)Y<DEK$%++G.#[9%?)O[?/\ R./A;_KPD_\
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M&/I7Z>_#.SM-/^'/A:VL"#90Z7:I"R]T$2X/XBOR5\4>;J5K)"1NV]:_3_\
M9CUF/7/@+X)F67S9(=-BMI<]5DC&Q@?R_E7-@VDW$\?AU1I.4.KU/4****]4
M^X"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO0!\8^)M9E\0:]>ZA,VYYI6;\,\5F444 %%%% !1110 4444 %%%% !1110
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M@7_D;/%?_7E%_P"C#7TI\=OAG_PMCX;ZEH<3*E]Q<6;L< 3)RH)]",K^-6_
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MP0!G)K,_8/@NV^)FM31A_L::4RS,/N[C+'L!]^&Q]#6^'JSJ598:KJM?RO\
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MI7N'_!/_ /X^/&W^[:?SFKZ/\7?!GP9XZTG3=,UC0H9M/TW/V2VMY)+:.'(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *9-$EQ$\4B+)&ZE65AD$'@@BGT4FDU9@?)/Q._89&HZG/?^"]
M6M[&*9B_]FZB&$<9/)"2*"<>@*\>M><K^R'\6M*+0V;6PB/)-MJ>Q#^!Q_*O
MORBN#ZC1Z71\/B>#<IQ%5UHQ<)/^5V7W:V^5D?#7AS]A/QAJ-TC:YK6F:7;,
M<N86>YF_[YPJ_P#CU?6?PM^%&@_"+P[_ &3H<+_O&\RXNIB&FN'QC<Q [=@.
M!^))[*BNJE1A17N(]#*^&\MRB?M<-3]_^9N[^71?)!1116Q]0%%%% !1110
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ML-?T64 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#'ZS^LT=5S;$XCB#*\+5E1K5XQE'==CZ/HKYP_X;P\ _\ 0(\2?^ UO_\
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MIR"#T(-.K<^C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPKX4TGP3H-IHVB646GZ;:KMCAB&![DGN2>23R2:^5X?R9XR2QV)7N]%W_P"
M<\:>MV6])TFST'2[33M/MX[2QM8EA@@B&%C11@*!Z "K=%>3_$;X]:?X?6?3
M/#GEZYKWW,H<VUL?[TCC@D?W%Y/?'6OU4Z#T/_A*=('B$Z$=0@&KB$7!L]_S
M["2 <?@>.O%:M?)WPT\!7WQ0\0W5S=7<EU8BX\S6-7;[]U* /W$?;I@''"KP
M.2*^L%4*H4#  P!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %>7_M2_\FQ_%W_L3]7_
M /2*:O4*\O\ VI?^38_B[_V)^K_^D4U '\ZE%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'I_[+7_)SGPB_P"QPTC_ -+8:_HLK^=/]EK_ ).<^$7_ &.&D?\ I;#7]%E
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !3)?]6_T-/IDO^K?Z&LJW\.7HQK<_)#6/^0M>_\
M7=__ $(U[EX<_8M\;^*/#^FZQ:ZIX?CMK^VCNHEFN)PX5U# ,!"1G![$UX;K
M'_(6O?\ KN__ *$:_43X0_\ )*?!W_8(M/\ T2M>)@,/"M2;GTM^*?\ D?S?
MPSD^%SK,<12Q:;4;M6=M>:Q\??\ #!_C[_H+^&__  )N/_C%?7'P5\$7WPX^
M&.A^'-2EMY[ZQ219)+5F:,[I7<;2RJ>C#J!7;T5[-*C"C=0ZG[)E7#.7Y/7>
M)PJ:DTXZN^C:?Z(_/?\ ;2_Y+E=_]>-O_P"@FN>^$?[.7B7XS:/>:EHE]I5K
M!:S_ &=UOY948MM#9&R-AC!]:Z']M+_DN5W_ ->-O_Z":]K_ &"_^2?>(?\
ML)C_ -%+7BX2C"M5JJ?1R?\ Y.?D\\OH9IQ;6PN)3Y6Y;:;1N>6_\,'^/O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2_,\17XX\NQ(\I3_ +4I^4?AD^U>5S?#;XA>.+@RW>CRPPR-N5M<U$;5!/\
MSS4LPQZ$"NQ\._LRPG#>)=9DO(\<6.F*;:'KT+YWM^!6OW/#J,:,%"-E9:=M
M-C@>YYWK_P 1O%WQ2OGTA3-,L@PVBZ$#MVG_ )[2]<>N2J^U=KX%_9MGN(TE
M\62I:6:X,>C:7(0N/264 $_[J8'N:]N\/^&=*\*:>ECH^GV^G6B](K= H)]3
MZGW/-:== BMIVFVND6,-G8VT5I:0KMCAA0(B#T %6:** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O+_P!J7_DV/XN_]B?J_P#Z135ZA7E_[4O_ ";'\7?^Q/U?_P!(
MIJ /YU**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /3_V6O^3G/A%_V.&D?^EL-?T65_.G^RU_R<Y\(O\ L<-(_P#2
MV&OZ+* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "FR<QL!Z&G45,H\T7'N!^7>J?!_QY)JEX
MZ>"?$;*TSD,NDW!!&X\_<K]'/A;9W&G_  T\*6MU!);7,.EVT<L,R%'C81*"
MK*>00>QKJ**Y\-06&@X)WO;\+_YGQN2\,T<EQ-3$TZCDYJUFEWN%%%%=1]D?
M#'[7'P[\5^)/C)=7ND>&-9U6S:S@47%EI\LT9(4Y&Y5(R*]>_8I\+ZUX5\#:
M[;ZWI%_H\\FH!TBO[9X&9?+49 < D9[U]$T5QT,.J$YS3OS7_%W/CJ/#5*CF
M\LW51\SOI96U5@HHHKL/L3P#]L[PSK'BGX;Z9;:+I5]J]RFI*[0V%L\[A?+<
M;B%!.,D<^]>%?LK_  W\6^'?C=H=_JOA;6M,L8X[D/<WFGS11KF!P,LR@#)(
M'XU]Z45QQPRC7=>^K_RL?&YCPS1S',Z69SJ-2IN+M96?++F_$*\*_;"\ WWC
MCX7POI6GW.I:GI]XDT=O:1-+*RL"CX502>H/X5[K16M:DJ]-TWY?@[GTN-PL
M,=AJF%J;337I=;_+<_/K]G7PCXY\!?&#P_J5UX.\0VUC)*;6ZEDTN=$6.0%"
MS$I@!20W/]VJ/[5WB"Z\6_';4[$LS1V)BT^WCSD#@$X'NS&OT3K\[?VKM!N_
M"?QXU*_*L([XQ7]O(1P?E ('T9#7F8BG&DJ4)N\4W_7W<Q^/\09'+(>'YT,/
M4<XRJ1;OT5FONNH_.Q]X^ ?!.G?#WPGIVA:7 D-O:Q*K,J@&63 W2-ZLQY)K
M ^,WP<TOXS>&X]+OY393PS++!?1Q!Y(_[P&>Q'7\*Z#P%XTT_P"(7A/3=>TR
M9);>[B5V56!,3X^:-O1E.0:Y/X]?&:#X+^$8]26&&^U*XF6*VL99"AD'\;<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MX/X^>&=2\:_ OXC>'M&MOMFL:MX;U*PLK;S%C\V>6UD2--S$*N68#+$ 9Y(K
MO** /PC_ .'9W[2?_1./_*[IO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\
M(_\ AV=^TG_T3C_RNZ;_ /)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)
M_P#1./\ RNZ;_P#)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_\ 1./_
M "NZ;_\ )-'_  [._:3_ .B<?^5W3?\ Y)K]W** /PC_ .'9W[2?_1./_*[I
MO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\(_\ AV=^TG_T3C_RNZ;_ /)-
M'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_P#1./\ RNZ;_P#)-'_#L[]I
M/_HG'_E=TW_Y)K]W** /PC_X=G?M)_\ 1./_ "NZ;_\ )-'_  [._:3_ .B<
M?^5W3?\ Y)K]W** /PC_ .'9W[2?_1./_*[IO_R31_P[._:3_P"B<?\ E=TW
M_P"2:_=RB@#\(_\ AV=^TG_T3C_RNZ;_ /)-'_#L[]I/_HG'_E=TW_Y)K]W*
M* /PC_X=G?M)_P#1./\ RNZ;_P#)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X
M=G?M)_\ 1./_ "NZ;_\ )-'_  [._:3_ .B<?^5W3?\ Y)K]W** /PC_ .'9
MW[2?_1./_*[IO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\(_\ AV=^TG_T
M3C_RNZ;_ /)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_P#1./\ RNZ;
M_P#)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_\ 1./_ "NZ;_\ )-'_
M  [._:3_ .B<?^5W3?\ Y)K]W** /PC_ .'9W[2?_1./_*[IO_R31_P[._:3
M_P"B<?\ E=TW_P"2:_=RB@#\(_\ AV=^TG_T3C_RNZ;_ /)-'_#L[]I/_HG'
M_E=TW_Y)K]W** /PC_X=G?M)_P#1./\ RNZ;_P#)-'_#L[]I/_HG'_E=TW_Y
M)K]W** /PC_X=G?M)_\ 1./_ "NZ;_\ )-'_  [._:3_ .B<?^5W3?\ Y)K]
MW** /PC_ .'9W[2?_1./_*[IO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\
M(_\ AV=^TG_T3C_RNZ;_ /)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)
M_P#1./\ RNZ;_P#)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_\ 1./_
M "NZ;_\ )-'_  [._:3_ .B<?^5W3?\ Y)K]W** /PC_ .'9W[2?_1./_*[I
MO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\(_\ AV=^TG_T3C_RNZ;_ /)-
M'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_P#1./\ RNZ;_P#)-'_#L[]I
M/_HG'_E=TW_Y)K]W** /PC_X=G?M)_\ 1./_ "NZ;_\ )-'_  [._:3_ .B<
M?^5W3?\ Y)K]W** /PC_ .'9W[2?_1./_*[IO_R31_P[._:3_P"B<?\ E=TW
M_P"2:_=RB@#\(_\ AV=^TG_T3C_RNZ;_ /)-'_#L[]I/_HG'_E=TW_Y)K]W*
M* /PC_X=G?M)_P#1./\ RNZ;_P#)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X
M=G?M)_\ 1./_ "NZ;_\ )-'_  [._:3_ .B<?^5W3?\ Y)K]W** /PC_ .'9
MW[2?_1./_*[IO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\(_\ AV=^TG_T
M3C_RNZ;_ /)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_P#1./\ RNZ;
M_P#)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_\ 1./_ "NZ;_\ )-'_
M  [._:3_ .B<?^5W3?\ Y)K]W** /PC_ .'9W[2?_1./_*[IO_R31_P[._:3
M_P"B<?\ E=TW_P"2:_=RB@#\(_\ AV=^TG_T3C_RNZ;_ /)-'_#L[]I/_HG'
M_E=TW_Y)K]W** /PC_X=G?M)_P#1./\ RNZ;_P#)-'_#L[]I/_HG'_E=TW_Y
M)K]W** /PC_X=G?M)_\ 1./_ "NZ;_\ )-'_  [._:3_ .B<?^5W3?\ Y)K]
MW** /PC_ .'9W[2?_1./_*[IO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\
M(_\ AV=^TG_T3C_RNZ;_ /)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)
M_P#1./\ RNZ;_P#)-'_#L[]I/_HG'_E=TW_Y)K]W** /PC_X=G?M)_\ 1./_
M "NZ;_\ )-'_  [._:3_ .B<?^5W3?\ Y)K]W** /PC_ .'9W[2?_1./_*[I
MO_R31_P[._:3_P"B<?\ E=TW_P"2:_=RB@#\(_\ AV=^TG_T3C_RNZ;_ /)-
M'_#L[]I/_HG'_E=TW_Y)K]W** /Q>^ ?_!/3]H#P5\=/ASXAUGP#]CT?2?$F
MFW][<_VSI\GE0174;R/M6X+-A5)PH).. :_:&BB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\[^-/P3T;XT>'TLK]C9ZA
M;DM9ZA&H9X6/4$?Q*>,KGMU%>B45G4IQJQY9JZ,*]"EBJ4J%:/-&6C3ZGP<_
M[,'QH^'M[.GA6^EEAE/S3Z+J_P!DW@=-P9XSGVY^M3:/^R)\4/'VLI=>,M2%
M@O"RW6HWWVZY*^BA68'Z%A7W717)'!TTU=MV[GPO^H^67MS3Y/Y.;W?RO^)S
MGP_\!:5\-?"EEH&C1,EG;#EY#EY7/+.Y[L3_ $ X KSW]JKX?Z_\2/AK!I7A
MRP_M&_6_CG,/G1Q?(%<$Y=E'4CO7LM%=-:E'$0Y);:?@[_H?85L!0JX.6 2Y
M:;BXZ:635M#Q7]D_X=^(?AI\.[[3/$FG_P!FWTFI23I%YT<N4,<8!RC,.JGC
M.>*]JHHK9:)+LDON5@R_ T\MPL,)1;<8:*^_?HE^04444'HA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %?(O\ P46^'OQU^(7@OPA;_ JZURUU:WU"634FT/7TTES"
M8\+O=IHMXW=LG'7%?75% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'XK?\,T_P#!0S_H+_$#_P ./#_\G4?\,T_\%#/^
M@O\ $#_PX\/_ ,G5^U-% 'P+_P $[?A/^T[\/_B1XFN_CG?>)KK0)])$5@NM
M^*DU:,7/G(<K&MQ+M;8&^; XR,\U]]444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YT_%+_@KU_PK
M3XG>+_"'_"I_[1_X1_6+S2?MG_"1^5Y_D3/%YFS[(VW=LSMR<9QD]:Y?_A]A
M_P!4:_\ +H_^XZ^$?VI?^3G/B[_V.&K_ /I;-7F% 'Z>_P##[#_JC7_ET?\
MW'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_
M -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##
M[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_
MP^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU
M^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_J
MC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_
MZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85%
M 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_E
MT?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_
MY='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>
M_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\
MW'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_
M -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##
M[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_
MP^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU
M^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_J
MC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_
MZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85%
M 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_E
MT?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_
MY='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>
M_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\
MW'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_
M -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##
M[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_
MP^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU
M^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_J
MC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_
MZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85%
M 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_E
MT?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_
MY='_ -QU^85% 'Z>_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>
M_P##[#_JC7_ET?\ W'1_P^P_ZHU_Y='_ -QU^85% 'Z>_P##[#_JC7_ET?\
MW'7J'[,__!43_AHKXW>&_A[_ ,*S_P"$?_MC[3_Q,O[>^T^3Y5M+/_J_LR;L
M^5M^\,;L\XP?QRKZ?_X)G?\ )[GPX_[B7_IMNJ /W<HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^=/]J7_DYSXN_]CAJ__I;-
M7F%>G_M2_P#)SGQ=_P"QPU?_ -+9J\PH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *^G_P#@F=_R>Y\./^XE_P"FVZKY
M@KZ?_P""9W_)[GPX_P"XE_Z;;J@#]W**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **\+^./[7/A;X/^)-.\&:;97OCSXF:HP2P\'>']KW1
MR,AYW)VV\8')9^<9;! )'N%O(\UO%))$T#LH9HG(+(2.5)!(R.G!(H7O+F6P
M/W7RO<DHHHH **** "BBB@ HHK\-/V^OVB/BMX-_;)^(>B:!\3?&.AZ-:WEJ
ML&G:;K]W;V\(-K Q"1I(%4$DG@=2313_ 'E:%%;R_P TOU*Y?<<^W_!_R/W+
MHJ&S8M:0$G)**23]*FIO1V,XRYHJ7<***_&3_@J1\>OB;\/OVL=1TCPM\1?%
MGAK25TFRD6PT?7+JT@#,A+,(XW"Y/<XYK&=10E&/\SM^#?Z&T8\RD^W^:7ZG
M[-U0UW7],\+Z3<ZKK.HVFD:9:KOGO;Z=888E]7=B%4>Y-<[\&;ZYU3X/^!;V
M]N);N\N-"L9IKB=R\DKM;H6=F/)8DDDGDDU\]_\ !2G]F_QS^TO\#=/T3P%+
M'-JFFZHFH2:3-<BW6_C$;IL#L0FY2X8!R%Z\@XK7$*5&4HK5IV_&U_U,L/*-
M:,9O1-7_  N?4'AGQ5HGC31X=7\/:Q8:]I4^?*OM,NDN8),'!VNA*GGT-:M?
M$_\ P2__ &5?B'^S'X!\6+\0&CT^ZUV\AFM]!ANDN!:"-65I&>,E-[[E&%8\
M1KDYX'VQ6E2*B[1=]OR_0B$G):H****S- HHHH **_'#_@JM\=OB5\._VJ#I
M/A3XA^*_#.E?V%9S?8='UNYM(-[-+N;9&X7)P,G&3@5^M?PUNI[[X=>%KFYF
MDN+F;2K626:5BSNQA4EF)Y)).232I_O*;J+H[?BU^@JC]G45-]5?\O\ ,Z2B
MBBF,**** "N;USXE>$?"^O6&AZSXIT72=:U# L]-OM1AAN;G)P/+C9@S\\<
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M** "BBB@ HHKXZ_;2_:JO?#*W/P\\ WWV?Q#,NS5M;BY.F1D?ZN(]#.P/7^
M<_>(QW8+!5\PK+#X>-Y/^KOR,*U>GAX.I4=DBO\ M=?MR-X'O[WX??"YX-4\
M:J#'J.L-B2TT7/4'M)/_ +'1?XN?EKY$T3XL_$O3K(0'XE>,+V0G=)=7.NW3
M%F[[09, >PXKE=)T*VT>T%O;1[4SN8DY9V/)9B>6)/.36D(Z_H#)>&,-EM+]
M[%3F]VU^1^>XW-*N*G[KM$Z^/XT_$2-<?\)_XI8^K:U<G_V>I!\:OB*?^9]\
M3_\ @YN?_BZXX*!17U*P.%7_ "ZC]R/*^L5?YG]YV8^-7Q$[^/O%'_@YN?\
MXNE_X79\1/\ H??$_P#X.+C_ .+KBZ*KZEA?^?4?N1/UBK_._O.T_P"%V?$3
M_H??$_\ X.+C_P"+H_X79\1/^A]\3_\ @XN/_BZXNBCZEA?^?4?N0O;U?YG]
M[.T_X79\1/\ H??$_P#X.+C_ .+H_P"%V?$3_H??$_\ X.+C_P"+KBZ7;3^I
M87_GU'[D'MJO\[^\[/\ X79\1/\ H??$_P#X.+C_ .+H_P"%U_$3_H??$_\
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M?%RPTV=]EIK]LVGMS@>:3OB/UW+M_P"!U^M-?S-G>%EA\2IM?&E+]'^*/T_
MU54I-+[+L%%%%?/'HA16#XR\>>'?A[I9U'Q)K-GHUGG DNI0N\^BCJQ]@":^
M>O$W[?W@^QN##X>T74_$ 4X-Q(!:Q'W&[+'\5%>M@<IQV8NV%I.7GT^]Z?B<
M6(QF'PJ_?32_/[MSZCHKXS;]O[4')V>#;91VWW[9_P#0*RM6_;T\631E=/\
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M W;#\\9_NNO53]:Z&OSVI3G1FZ=2+4ENGHSZZG4A5BIP=T^J"BBBLRPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH _G3_ &I?^3G/B[_V.&K_ /I;-7F%>G_M2_\ )SGQ=_['#5__
M $MFKS"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KZ?_P""9W_)[GPX_P"XE_Z;;JOF"OI__@F=_P GN?#C_N)?^FVZ
MH _=RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEED8[FBC=_F$8;DD\N1N;^$+]'445M*3D[_TC*,>7^MPHHHJ"@HHHH ****
M"OY\_P#@H]_R?-\3/^OVT_\ 2.WK^@ROY\O^"D+"/]N+XG,>BWMH3_X!V]%&
M2CC:4GLK_G$U_P"7,O5?DS^@:R_X\X/^N:_RJ>OB.V_X*\?L^1V\2->^(MRH
M ?\ B4-Z?[U2?\/?/V>O^?[Q%_X*&_\ BJ<MV<M)-4XI]D?;%?A5_P %=_\
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M,,EW::3&(+.\MVD6-AY(PB.N\,&0#(!!SP0YSC1U>J_K7^ON%",JSLM&]O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOQ(\,>-K=)=$URSO]W_+-)0)!]4.&'Y5^(YID..RF;5:%X])+5/_ "]&?J.
MSC"9A%>SG:7\KT?_  ?D=+1117SI[84444 %%%% !1110 4F1G&>:X[QI\5-
M#\%Q2+-,+R^4<6D# L/]X]%'UY]C7R_=?$3Q/\6_B7'8^%9FG\2,57[3;Y-K
MHMOD9=V_7!Y<\#CH ?:5%1VZR1P1K+)YLJJ TFW;N..3CMFI* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#^=/]J7_DYSXN_P#8X:O_ .EL
MU>85Z?\ M2_\G.?%W_L<-7_]+9J\PH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *^G_^"9W_ ">Y\./^XE_Z;;JOF"OI
M_P#X)G?\GN?#C_N)?^FVZH _=RBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\(/]S5/YVM?JE9?\><'_ %S7^5?E;_P7'_X^?A!_N:I_.UK"O\<?7]&98/\
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MX._\%GOAQXNO(;'Q_P"&-3\!S2-M^WVTG]I6:\=7*HDJY/81O[FOO'QC\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/ $8CZIC^1KBO%W_  3I^(?AUGE\+>)=-\00 96*X+6DQ]L'<A_[Z%>*>+/
MWQ0^%+/_ ,)+X4U.RMX^MUY)D@_[^IE/UKY>&8Y)FFE6G"3?DK_HSTIY=G&7
M:TJDHI>;M_D???@_]M#PWJA6'Q!I]SHD_>6+]_%^@##\C7J>F_&SP'JD8D@\
M5Z6!UQ-<"(_DV*_(Z'XGK)CSU93_ 'NOZUT.F^.[6=?]>#^-<%;A?)\5*]"<
MH>5[K\=?Q.VEQ'F^%C:M%3\VK/\ #3\#]9K/X@>%]0P+;Q'I5P2<#R[V,_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH _G3_:E_Y.<^+O\ V.&K_P#I;-7F%>G_ +4O
M_)SGQ=_['#5__2V:O,* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHK3\.>&=6\7ZM#IFBZ?/J=_*<)!;K
MD_4GH![D@4 9E=K\.?@SXP^*MP$\.Z+-<VV</?S#R[9.<',AX)'HN3[5]/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:*P_!GCCP[\1?#]OKOA;7-/\0Z-<9$5]IERD\+$<$;E)&0>".H/!KRG]IO\
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M6FDV,%E8VL-E9P((XK>WC$<<:CHJJ!@ >@JQ5748*E!6BB;.4W4F[MGX'?\
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M7<S# )PN2"/T.\3?L8? KQ?=/<ZG\)_"KW#N9'FMM-CMG=CU+&(*6)SWK<\
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M^6;>WW3[4 ?!-%:OBCPIK'@O69])US3KC2]1@.)+>X3:P]_<>XXK*H ****
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MIK3P9XF@$<FEO,TBI#+:O,J$L26\N:/*L<D*<9Y)/T!IO_!,&;Q'I:#XD_M
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M-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO_)SGQ=_['#5_P#TMFKS"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX4^+?A?>K:^*-!O-(D;E'GC_ ';^ZN/E;\#7)T %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFXEW=$'"@^E$<32' %<M?>.;:W7%I UP_3=)\JCW]37-:GXHU/4U9))S'"P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!_.G^U+_R<Y\7?^QPU?_TMFKS"O3_VI?\
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MYC*,/SH SZ*** "BBB@ HHHH **** "BBK&FV,NJ:A;6<"-)-<2+$BJ,DDG
M H ^Z?V&_AG;^#/A1XE^*>K6Y2YG#6FG22#&(P/G8'W.!7@/[22ZC?:A#K.J
M3S%K\%XK5F(6)?X>W7O7UK^U9JD/P+_9<\+^!K&3[/<-91I(F3NWL S9/KD_
MI7YV:]XKUCQ0\+:MJ5Q?F%!''YS9"J.  .GX]: ,JBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OI__@F=_P GN?#C
M_N)?^FVZKY@KZ?\ ^"9W_)[GPX_[B7_IMNJ /W<HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBO@S]L[]OC5-&\8Q?!+X$P_\ "1_%34YQ83W]
MLJRQZ9(W!C3/RM,!DL6^2( ELD$+#D[J,5=O9%QC=.3=DMV>_P#QQ_:Y\+?!
M_P 2:=X,TVRO?'GQ,U1@EAX.\/[7NCD9#SN3MMXP.2S\XRV" 2/<+>1YK>*2
M2)H'90S1.060D<J2"1D=."17SK^QU^Q[I?[-/ARYU35KH^)_B?KO[_7_ !-=
M.TLLLC'<T4;O\PC#<DGER-S?PA?HZMG%17+>[Z]O1?Y]?)&2ES.Z5E^/J_\
M+IYA1114%!1110 4444 %%%% !17PG_P52_:7^)/[-_AGX?W?PZ\1_\ ".W&
MJWEW%>/]AMKKS51(RHQ/&X&"QZ8ZU],?LK^-M:^)'[./PZ\4>([W^T==U;1;
M>[O;KRDB\V5ERS;$557)[* *4'[2,I+[+M^%QS]QQ3^TF_N=CU2BBBF(****
M "OQ4_X*0?MC^/K[]J#6O#GP^\=^)/#FA^&85TMX?#^K3VB7%RN7GD81.-Q5
MF,>3T\JOUM^/?Q5L_@C\&_%_CF^*^7HNG2W$<;G EFQMBC^K2%%_X%7Y$?\
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MC#4/#?CR:[T'QCH]KJ?D-L#3+MFC_P!UQR/Y5]6Z_8BSO!(@^3/.VOGKX]?
MPZ]>-XO\/,W]I1QXNK)3Q,H_B7_:'ZT </H_[-7P-EC60>'[R5RN"L^H,5_0
M"KW_  S=\$58_P#%*EA[7KUY=:^+I+&;RVEEC*\,C9!!K27QRI89G8<>M 'H
MR?LW_ Z%E<^$F;:<[6O'(/UYIMQ\$?@;&V%\#V?_ '_E_P#BJ\MU?XE26UN_
ME3R%^@QS7$ZI\6-1MR#AG^@- 'TA8?!/X(HS$> -+E+#&)Y96 ^F'%4]>^#/
MP3\O:W@+3;<8(+6DTJ-]>7/->"^'/B?J5]-F1)A'GTXJ7Q9XZU"2,BU64-ZF
M@#U73OV6?@1K#LYLM>B+=%BU7"CZ#96W??L>_!&>Q,45CJULQ Q,NHDN/?E:
M\&\*^-M=A<><90N?X179W_Q-U"WMCY;3%N@XH Y'XI_LD>&?"=S'-I?B.];3
MYR0GFQJ[(W]UN?UK,^"GP[T+X;_%C1/$NLZ@FLZ5ILWV@6*IMDD<?=SGC&:I
M_$#XI:Q?Z2;5Q(-T@*Y&.AS7E4WB+6S)O#''I7TF%^J5*"]K2O+NF]?Q.R'L
MW'WHZGT9^UEK&L_M#>+K>\TV6W@TV$$I%<3A6#>XZ5XUI_[/-WNW:GK=K;Q]
MUMU,C_X5S2_$+5[3AHW;!ZJ:VE^*%Y)8C,,F_&.:[*='++W<'Z79:C1[&S??
M##P1H<1^UWU_.P'+[U3/O@5E2^%OA]>0_P"C7=]:L."YF$GXX(%>?Z]X@O=<
MNO\ 29&CBSRJGFI],T/2]4Q%#?-!-_=F.W/T[5A*OAIS<*5&-O/<GF@W:,4:
M>M?#J:UMWNM+O8]6MU.2D8Q*H]2._P"%<@RE201@CJ#742:3J_AF02VTDA1>
M<9K+U3&I&2]C7$N?WT8'0_WJ\O%8>,?>A'E?;_(QG%;I6,JBBBO*, HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZ?_X)G?\ )[GPX_[B
M7_IMNJ^8*^G_ /@F=_R>Y\./^XE_Z;;J@#]W**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *_.3]M;]J[XN_LJ_M=^"0WBEG^$&M_9;J;2I
M--M"%C6017<:S>5YN0-L@._(,@'3BOT;KXB_X*W_  7_ .%E?LPR>);.W,NK
M>#;M=24JN6-J^([A?H 4D/\ URK*<_92A5W46KKHUY_G\C6$544J6SDFD^J?
MEY]/F?;-O/'=01S0NLL4BAT=3D,I&00?3%/)P,G@5\S_ /!.7XR?\+H_9-\'
M7L\_GZMHD1T&_P MEO,MP%0M[M$8F^K&NB_;B^,A^!?[+_CGQ+!/Y&J/9G3M
M.8'YA<W'[I&7W7<7^B&M<5_L_-;6VWG?;[]#'#7K\J>E]_+O]Q\M?LW?M:?%
MG]I?]O/Q3H&B>*_L_P '=!EN[AM.CTZT99K:+$$0\\Q&4&64K)]_.-P' K]'
M*^!/^".GP7_X0?\ 9^U/QU>0;-2\87Q:%V'S?8[<M''^<AF;W!6O8?VX/VU]
M(_9!\'V!BT]?$'C36BZ:3I!<J@"X#3S$<B-20,#EB< CEENHEAXPI/5I)/NV
M_P!>GR8J;=><ZD=$V[=DE_6_70^FJ*_.'1[?_@HA\2M'3Q7;>(/"O@6"Y03P
M>&[JTM5FV$9 P]O,R$C^&24,.^#76_LR_M^^,)/C-_PI+]H/PO!X.^($CK#8
M:C:CR[>[D*Y2-UW,N7_@DC8HY(4!3C*C%N7)]KMU_KR!R2CS[Q[_ -=/,^Q/
MBYKE]X7^%/C/6=,G^S:EI^C7EW;3;%?RY8X'9&VL"#A@#@@CUKYB_P""7?[0
M7C[]HKX,^)M=^(6O?\)!JMGKS64%Q]CM[;9"+>%PNV&-%/S.QR1GGK7T=\>_
M^2&?$3_L7=0_])I*^+?^"*'_ ";OXS_[&A__ $EMZBAK4K)](1M_X$:5=*5)
MKK*7_I*/T.HKX>_X*G?M(?$7]G'P'X&U'X=>(O\ A'KS4M2GM[N3[#;77F1K
M$&48GC<#GN #7V%X U2YUOP'X;U&]D\Z\O--MKB>3:%WR/$K,<  #))X Q1!
M^T4VOLM)_-7)E[DHQ?VDW]SL;]%?%'_!4K]HKXA?LY?"_P ':O\ #OQ!_P (
M]J&H:PUK<S?8K>Y\R(0.P7$T;@<@'( -?5OPGUN]\3?"WP=J^I3?:=1U#1K.
M[N9MBIYDLD",[84 #+$G  'I3A[\9R7V6D_FKBD^648O[2;^YV.JHK\H_ ?_
M  4J^)_AGX]?%OPCK%O?_$R_75;K2?!GAFQT^WA(G2\=%#R0Q!RBQ+DEBQ.W
MW+#JOB)KW_!0_P /^&;WQ]-<>'M-T^SC-W<^%=(MK&XEAA4%GX=)&<  Y"3,
MWIS4*2=.-5Z1:O?MZ_FR^5\\J?VD[6[^GY>I^F5%?F]\,O\ @J]K/Q.^%^DZ
M-X;^'LWBKX\W]Q)91Z#IT;KI^% (O'<G*18;E"W!1LNBX:L/XI^,/^"@WPK\
M,W?Q&U?4/#LF@V*F\O\ P]I=I97'V.$<MO'E^8R*.ICF8@ G. 35R]QOFV[]
M/Z[]MGJ3'W[*._;K_7;OTT/T]HKP']B;]J2']K+X)VWBR6RATS7K2X;3M7L;
M=B8H[A%5MT>>=CJRL 22,E<G&3G?ML?ME:3^R+X'L+E=._X2#QAK<C0:-HP?
M:)&7&^60CD1KN48 RQ8*,9+*ZJ=)\LM_SOM;U"G^]5X_\-;<^CZ*_.K2=*_X
M*'_$338O%,7BCP?X%BNE\^/PQ=6EN)47&0I#6TS*2.SS;AG!VGBNU_91_;J\
M7^)/C'>? _XZ^%[?PC\3( ?LEQ:#;;WQ5-Y0KN8!R@WJZ,4<9P%P SC%N7)]
MKM^9+DE'G^SW/N"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_"5>%-:T7S_LO]I64UGY^S?Y?F1LF[;D9QNSC(SCK7Y@_P##C'_JMG_EJ?\
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M[)G_ ":Y\(O^Q2TO_P!)(Z]7KMQ$53K3A'9-_F<=%N5*+>]D%%%%<YL%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"9G5@E9-W7SU_.Y_4/"^->.RBC4D[M+E?_;NFORLPHHHKYP^K"BBB@ HHHH
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MN0E5)7(.54@@BO*?^%=_MIC3O[ _X6?\.39[/*_X2;^R9_[3VXQO\K;Y._\
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M<-7_ /2V:O,*]/\ VI?^3G/B[_V.&K_^ELU>84 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5Z9\!/@M>_&GQ@M@C-;:3:XEO[H=53LJ_[1_\
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MI$DJR]OQTJJT9C;VH NPR<UIVTG2LBWY-:4+8Q0!MVLG3-:4,_2L*"2K\,U
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M_<2_]-MU0!^[E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCMXY,8D8@2-N!VX7Y2WS;?U/^!?_ "1'X>_]B[I__I-'6F'3]C6ET<XV_P#
M6C.M_'I+M&7_ *4C\Y/^";>EV=W^W]^T)=SVL,UU:3ZH;>:1 7A+:F58J3]W
M(X..U?J?/&LT,B.H9&4J5(X((Z5^77_!-/\ Y/Q_:/\ ^N^H_P#IT-?J._W6
M^E1:^#HI_P GZL?_ #$U_P#'^D3\KO\ @C+I-K8_$[XY".%"]H;2VAE9076/
MSKG*@XX!V+D#@[1Z5^F'Q(MX[OX=^*()D$D,FE72.C#AE,+ @U^;7_!''_DJ
M/Q]_Z^+3_P!'W=?I3\0/^1#\2?\ 8-N?_135EBFY8*+?_/O]#KAICJEOY_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG_MM7-B/>BJ?\VGRZ_A?YG10TDZG\NO^7XV/ ?V'_P!A+4?VS)O%,W_"3_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;S(;*^7R=$T]O[L%F/E..F7!SC)7-?45G9P:?:Q6UK!';6T*A(X84"(BC@
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M0S%<QE,_W3V/X&ODKQ1X=NO">O7>E7BXGMWVD@'##L1GL: ,JBBB@#UKX/\
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M50*I(!QQ7L]%$6XJR"24G=A1112&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7GOB3]G7X4^,M<NM:U_P"&/@W7-8NF#7&H:EH%I<7$Q "@O(\99B  .3T
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M_B2^^&WA&]\1/<+=MJ]QH5K)=F92"LIF,>_>" 0V<\"N^HHZWZATL%%%% '
M^*?V?OA=XXUV?6_$GPV\(^(-9N-OG:CJFA6MS<2;5"KND>,L<* !D\  5WJJ
M%4 # '  I:*.EN@;N[.4\<_"7P/\3S9GQEX,\/\ BTV>[[,=<TN"]\C=C=L\
MU&VYVKG'7 ]*U_#/A?1O!>AVNC>'M(L="T>U!%OI^F6R6]O""2Q"1H JY))X
M'4FM2BC960;[A7%^-O@G\._B5J4.H^+_  %X8\5:A#$((KO6]&M[R5(P2P17
MD1B%RS' .,D^M=I12'=E32=)L= TNSTS3+*WTW3;.%;>VL[2)8H8(U 541%
M"J    , "K=%%4VV[L04444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#^=/]J7_DYSXN_P#8X:O_ .ELU>85Z?\ M2_\G.?%W_L<
M-7_]+9J\PH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#V[]FW]
MHJ^^$&L#3=0F>X\+7;?O(6RWV60D?O4'IUW#OG/7K]\6_C3^VK.&\TZ2W-C.
M@>)X0)%=2OW@QSUSFOR9KW3]GG]H>?X=W46AZY*\_AN5L)(>6LV/<?['J.U
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M=/X3Q^E>YF)+.W:5S@*,U\O_ !F\3_\ "1>)?E;,< *@4 >?T444 %%%')X
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MQU:K*5+I?_TE>2/1;._>"S>9^%*G(/2OT$\":M'KW@G0=1B&([JQ@F48Q]Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%?3_ /P3._Y/<^''_<2_]-MU0!^[E%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%17%U#:('GECA0G :1@HSZ<T6]U#=H7@FCF0'!:-@PS
MZ<4[.U["NKV):***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9L<4 /AM<]JOPV?3BK]IIS,!Q6E#IN.U &?#9#'2K,=F/2M..Q*CI4BVV.U
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MEQ-K<&1J=I'\W'_'Q$.QQU8>I[5\G5\X<@4444 %%%% !1110 4444 %%%%
M!1110 4444 %?3__  3._P"3W/AQ_P!Q+_TVW5?,%?3_ /P3._Y/<^''_<2_
M]-MU0!^[E%%% !1110 4444 %%%% !1110 4444 %%%87C7QMHWP]\.W.MZ[
M>QV5A /O,?FD;!(1!_$QP< 5I3ISK35.FKR>B2W9G4J0I0=2H[16K;Z&[7C7
MQ1_:M\#_  SDN;$7;:[K</!L-/\ F"MZ/+]Q?< EAZ5\I_'#]J[Q'\4)IM.T
M>2;P]X:S@6\+[9[@8Q^^<'IU^1<+SSNP#7A%?M&2>'W-%5LUE;^Y'_VY_HOO
M/R3-N.HJ3HY;&_\ >?Z+]7]Q]$>-/VX/'GB O'HL=EX9MV  ,,8N)NAS\\@V
M\Y[*",#FO(-;^*_C7Q'Y@U+Q9K5Y')G=%)?2>7SC(";MH' X KEJ2OUC"9-E
MV!26&H1CYVU^]Z_B? ULXQN,=Z]:3^>GW+021FD=G=BSL<LS'))]32*S1NKH
MQ1U.0RG!!]:=BFU[7D90JG3Z'\5O&?AEE_LOQ5K%BBD'RXKZ01G P,IG:>/4
M5Z_X%_;@\>>&?*AUJ.S\46B[03<)Y%QM'82(,9([LK'OZY^>,4F*\C&9-EV/
MBUB:$9>=M?O6OXGN87-,5AFG2JM?/3[MC](/AC^UUX$^(TRV<]TWAO5&;:EM
MJK*B2\\;)0=I/3@E22< 'K7MM?CC7T)\"_VN_$/P\O+;3/$MQ<>(/#6=K><Q
MDNK88P#&['YE']QCC'3%?DN>>'_)%U\I=[?8?_MK_1_>?H.6<5*;5/&JW]Y?
MJO\ +[C]"J*Q_"?B[1_'&AV^L:#J$.IZ;.,I/"3U[JP/*L.ZD CN*V*_%9TY
MTI.%16:W3T:/T.,HS2E%W3"BBBH*"BBB@ HHHH **** "BBB@ HKB/B;\9?"
M?PCL$N/$FJ+;2R*6@LXAYEQ/C^Z@[9[G ]Z^*?BQ^VUXQ\;>=8^&Q_PB.DME
M=]L^Z\D'O+@;.Q^0 CIN-?79+POF6=M2H0Y:?\TM%\NK^7SL<U7$4Z6C>I]P
M>-OBUX.^'$;-XD\16.ER!0_V>23=.RGNL2Y=A]%-?/OC/_@H'X<TZ5X?#/AZ
M]UDJ2/M-Y(+6)N1RH 9B",]0IZ<5\-7M[<ZE=RW5W/+=7,K%Y)IG+N['J2QY
M)J"OV3+_  [RS#I2QDG5E_X#'[EK^)R?6W+;0^A_$?[=GQ+UAL:>VEZ$@&!]
MDM/,;IU)E+C]!7 :I^TG\4-8QY_C;5H\*5_T686_!_ZYA>??K7F])BON</D.
M5856I8:"_P"W4W][U-HUF]SIY_BOXWN)#)+XR\02R-U=]4G)/XEZCTOQMXBN
M=:L_.U[5)?,N$W[[R1MV6&<Y;G-<W5S1?^0U8?\ 7Q'_ .A"O1EAL/&#Y::6
MG9';"H?LC1117\1C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@S
M]L[]OC5-&\8Q?!+X$P_\)'\5-3G%A/?VRK+'IDC<&-,_*TP&2Q;Y(@"6R00M
M+_@I7^WT?@GIL_PQ^'U[O^(.HP@7VH6[9.CPN!@+_P!-W4\#JBD-U*UO_P#!
M-7]B)/@#X/7Q_P",K3S?B5X@@WE+@;GTNV?YA$"?^6K\-(>HX7L2T4X^VO*7
MP+_R9]EY=W_3N<O8I):S>WDN[_1?TO4_V.OV/=+_ &:?#ESJFK71\3_$_7?W
M^O\ B:Z=I999&.YHHW?YA&&Y)/+D;F_A"_1U%%;2DY._](RC'E_K<****@H*
M*** "BBB@ HKR3]K#XM:Q\"?V>O&?CO0+:QN]7T6U2:WAU*-WMV8RHA#JCHQ
M&&/1ASBORQ_X?5_&_P#Z%;X?_P#@NOO_ ),J%-.3@MU^I;BU%3Z/]+?YGOW_
M  6]_P"27_#/_L,W/_H@5[-_P29_Y,I\,?\ 80U#_P!*7K\J_P!J?]N_Q]^U
MUH.AZ3XPTCPWIMMH]R]U VAVUQ$[,Z;2',L\@(P.P%=-^SS_ ,%,/B?^S3\+
M[#P'X8T+PE?Z19S33QS:M9W4EP6E<NP+1W*+C)./EZ>M&'7LW6YOM6M]T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^U+_ ,G.?%W_ +'#5_\ TMFKS"@ HHHH **** "BBB@ HHHH **** "BBB@
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MXNIEACC09+%B!@54K[._X)V_ V#Q!XDOOB5K\"MHF@?+:+,/EDN<9#>^T<T
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MVQ,GE@<;3]XCZ4 ?)%%%% !1110 4444 %%%% !1110 4444 %%%% !7T_\
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M\\D<>85ST/3^M&N?L]?$CP[:R7-[X/U(01KO=[>,3A5YR3Y9; &.?2O-_M3
M<_L_;PYNW-&_W7/>A@L;R>T]C/E[\KM^1YU25--#);S20S1M%+&Q1XW!#*P.
M""#T-1UZ:9$:@S%)3\4E4=L*IZ=\ _CKJGP3\4+<)YMYH-TP6_TY6XD7H'3/
M =>W3/0GG(_2WP_KUCXHT2QU;3;A;JPO(5GAE0Y#*PR/Q]1V/%?D'BOIW]BS
MXW'PIXD'@C5IO^)3J\P^Q2.Q_<71P @]I.!_O8]37Y1QMPW''4)9EA8_O8+W
MDOM17ZK\5IV/T3AK.G0J+!UG[DMO)_Y/\_F?=]%%%?SN?K84444 %%%% !11
M10 5\O\ [17[8EGX'>X\/>"I8=1\0QN8[J^9-]O9D<%5[/(/Q4=#D@@<K^U9
M^U9_Q^>"O!5YZPZEJT#?@T,3#\F8?0=S7QIBOVSA/@E5HQQ^:1T>L8/KYR\N
MR^_L?,X[-5&3I4'ZO_(O:_K^I>*-5N-3U>^GU&_G;=)<7#EW8_4]O;H*SJ=1
M7[O&,8148JR1XL:UW=L;3=M/Q259VPJC**=28JCMA5$JYHO_ "&K#_KXC_\
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M4A$MG=0W<9YWPR!Q^E6:\=IQ=FB HHHI %%%% !1110 4444 %%%% !1110
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M;Z5_/K^QO_RD \#_ /8T3?SEK+#_ ._TOZZHTK_[C5_KI(_H,HHHJA!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/K2BBBOS _L **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M588XU&2S,< "OTT^-FK6/[*?[+^C>#M,/EZB]L%E. KM,ZY<D>N3C\*^>?\
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M:_II2/YA(&6F,M6"M,9:VC(#2\'^#=5\>>)++0]%MC=ZA=OM1,X  &2S'LH
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M6!R"".A!I*2GZG;"K8_4#]GCXG?\+8^%NEZO,V[4H,V5_P#]=T RW_ E*O\
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MP:[\18]SMB2#0HW^[W!G8=_]@'ZGJH^P+.RM]-M8K6T@BM;:)0D<,*!$11T
M4< 5^29]Q_0P<GA\M2J36\G\*]/YOP7J?78/+:E1*=;1=NO_  #Y3\"_\$_]
M"T_RKCQ;K]UJTHVL;/3U%O"#W5G.6<>XV&O</#O[//PV\+J!8>#-)W#I)=P?
M:7' '#2[CT'KW/J:]#HK\:QO$6;9@VZ^(E;LG9?<K(^BIX>E37NQ(K>UAM$*
M00QPH3DK&H49]>*EHHKYUMO5G0%%%%( HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\5>+M'\$Z/-JFN:C!IMC$/
MFFN'"CZ#U/L.:X+XZ_M!Z%\$]'S<%;[7)ES:Z<C<G_:?^ZO\Z_.CXG?%KQ)\
M6M<?4=?OGG )\FU4XA@7T1>@^O4U^A\-\'8K/+5ZK]G1[]7_ (5^NWJ>?B,9
M"B^1:R/ICXK?M]-YDUCX%TX;!E?[3OUZ^Z1_U)'TKY<\9?%CQ?X]N'EUS7[V
M]#_\LO,*Q_38,#]*Y8TVOZ%ROA[+,HBEAJ*O_,]9?>_TLCDCB93=VR.FD5(1
M3<5],>K2JD9%-(J1A3:H]BE5-_PK\1/$_@>Y2?0M<O=-9#D+#*=G_?)^4_E7
MTU\*_P#@H!JNF20V7CC3EU*UX4ZA8C;*ONR'AOP(^E?(A%-85X699#EN;Q<<
M713??:7WK4]'EIUE::/V(\!?$CPY\3-&34_#FJ0:E;'[PC;YXS_==3RI^HKI
MJ_''P+\0=?\ AMKT6K^'M1FT^\C/)C/RNO\ =9>C#V-?HM^SG^U-I'QHLTTV
M_P#+TOQ3$OSVN<)<8ZM'G_T&OYZXFX(Q.2IXG"MU*/\ Y-'U[KS7S2/.Q&#E
M27/#6)[Q1117YB>:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !6#X9\!^'?!=SK%QH6BV6E7&L7CZAJ,UK"J/=W#G+22,.68^IK>
MHH\P\@HHHH **** "BBB@ HHHH **** /)/VL/BUK'P)_9Z\9^.] MK&[U?1
M;5)K>'4HW>W9C*B$.J.C$88]&'.*_+'_ (?5_&__ *%;X?\ _@NOO_DROV7\
M1^&='\8:+=:-K^E6.N:1=J$N-/U*V2XMYE!! >-P589 /(Z@5YY_PR=\$/\
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M7?&K_@GSXJU#P?JFAS+IAF,MYX3\11/&H;.#-;N.4+;?OKN1ASAN"/K73_\
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MN7<:X+;C@+Z5U_Q&\71_"+PS#8Z=<0GQ'= 87:',$?=SSP?3(- $/QE^)"^
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M_BI/9_ 3]F_3?#T3B-K#3EB/ 4E]N6)QWR:_(K6]2?5]6N[R0[FFD9^N>IH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^'OPPU?X@_$WPAX?\2Q:3#BUCU33H+B>XG/$4$9D4G+-^0R>@->2_P#!/?\
M9YO= T_5_C5XVTJUT_QYXX FM=.M[98(M&TPX,-M%&  FY0A( X54!Y#9]B^
M.7[*_AW]H3QMX*UGQ=JVJW.C^%KD7L'AF)HQI]W.#D23J4+OV&-P& 1_$V?:
M0 H  P!0!\.?\%2M.O/#6A_!_P"*]K;O<6_@'Q=;WEZ(P24MY'C)8^Q:&-?^
M!BOM70=<L/$^AZ?K&EW4=[IM_ ES;7,+!DEC=0RL#W!!%5_%OA/1_'?AG4_#
MWB#3X-5T74H&MKNSN%W)+&PP0?\ $<@X(YKY+L_^">.L>$]-N/#G@CX_^/\
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M>64=['&<?9V+J&$>>O0XSZU\G^(/#^H>%]7NM+U2UDL[ZV<QRPRK@J17T/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HKF_%'Q*\(^";_3['Q%XIT70+W46V65MJ
MFHPVTETV0,1J[ N<D<+GK71T=+AY"T444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !117.^+OB-X3^'XLSXH\4:-X;%X_EVW]KZA#:^>_]U/,8;CR.
M!ZT =%138Y%D171@Z,,AE.01ZBG4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/A_XP_L#1KC0(+V2V_LRSN=TS3SJ6W30NPX11@'''2OD3_AZ-^T[_P!%,_\
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M6BO<EM_EZK_@GUY\(?C#]HN8] UN?]Y]VVN)#S_N,?Y&O;J^%K4G4'2XA?\
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M<-7_ /2V:O,*]/\ VI?^3G/B[_V.&K_^ELU>84 %%%% !1110 4444 %%%%
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ML1./]6W &3A3['CY5Q25Y&;97A\XPLL+B5H]GU3Z-?UKML>Q@\;/"U%4@_\
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MAFY_]$"O9O\ @DS_ ,F4^&/^PAJ'_I2]1AW[1UN;[-K?='_-A6]SV5OM;_\
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M!K3E;7,MC/F2=F=W1169XE\3:3X-T&^UO7=2M='T>QB,US?7LJQ0PH.K,S'
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M'RLIKZ?^+7P)\,?&"QQJML;;5(UVP:I; ">/V/9U_P!EOPQUKX8^('PK\1?
MGQ1#!K,?G:9,^+;4(<^1,/\ V5AW4_AD<U[^'QJDN5[G\T<2\"U,!-XFG[T.
MZ_)KIZ[?D?0WP'^+L^AZX-&U:7_B67C@1._2*0\ _0]#7U-7PSH&FPZ[IL=Q
M&X:11N7;_*OJ;X-^,F\3>&Q:W39U#3\12;CRZ8^5OZ'Z5R8ZFK^T7S/J/#GB
M)N3R7$/:[AY6WC^J^?D>@4445Y!^^!1110 R:%+B%XI%#QR*596Z$$8(KX"\
M$Z6?"/B7Q-X:Y":1J=Q:1@]?+60^7_XX5K] *^(?'5N-)_:2\>6P^59IK:Z&
M1C.^VC)(_P"! C\*^GX?J<F*<>Z/PWQ>PBK9!&O;6$U^*?\ DCN?@[JYT+XN
M6<9.(=3A>V8=MV-ZG\TQ^-=M\?/VO/ OP%N(-%NI+KQ1XYO<+I_@_P /Q_:M
M1N7/W<HO^K4_WFQQG /2OAKQ)XO^*GQ3\5"U\-65U\*_"^GWOV>;Q1J*#^TI
MBC[6:UBS\HZX<GGJ".E?>?P%_95^'_[/-O//X>TZ34/$EY\VH>)]8D^TZG>N
M>69YFY )YVK@>V>:C/>6>(52*=FO2]C?PI57#Y/4P5><7.$KV4E)Q4EHG;1.
MZ;M=M=;,\5A^ WQ?_:VD34/CEJ\GP_\ A](1)#\-/#-T1-<)U U"Z7EO=%X_
MW"*^JO ?P]\-?"_PS:^'O">B67A_1;48BL[&(1H/5CCEF/=CDGN:Z&BOFS]K
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ^</V\83+\&M/8#_5ZU"Q_[\SC^M? >*_1_P#;"T*37/@;
MJOEKDV<T5V?HI(/Z&OSA(K^DO#ZHI90X+[,W^C/P?C2]/-5)[.*_5#"*::D-
M-K]./E:54CVTVI"*:5JCV:54C(II%25=T/0;_P 2ZM;:9IEM)>7MRX2*&,9)
M)HE.,(N4G9(]FC4<FDB/0]!O_$NK6VF:9:R7E]<N$BAC&2Q-?HC^SO\ L\:3
M\#?#[ZWK3P2^(I(M]Q>2$;+1,9*(3T]V[T?L]_L\Z5\#_#[ZUK30R^('BWW-
MU)C9;+C)52>GN:^=OVH_VHI_B%=3^&O#4[0>'8FVS3H<-=D?^R_SK\;S',<7
MQABGE>5OEP\?CGW_ .!V77KH?H&'I0RVDJ^)^-[(A_:L_:>?XF3S>%?#LAC\
M,0R?OY_XKUU.1]$!&0.Y&:^:&6I"*;7ZME>6X;*,+'"86-HK[V^K?FSE^M2K
M3YYLC(IM2,*:17KGI4JI&12$4^FFJ/8I51]C;&[OK>!1EI)%0?B0*_7KX5V;
M:?\ #'PA:L,-!H]G$1[K @_I7Y8?"#P^_BCXH>%],C7<9K^(D?[*MN/Z*:_7
M*VMX[.WB@B7;%$@1%] !@"OPCQ.Q2;PV&ZZR_0[V^=J7:_XV_P B6BBBOPD8
M4444 %%%% !1110!_.G^U+_R<Y\7?^QPU?\ ]+9J\PKT_P#:E_Y.<^+O_8X:
MO_Z6S5YA0 4444 %%%% !1110 4444 %%%% !1110 4444 >H_ 'QY>>#_$T
M]I:W;V?]HIY893P6'(!'0YKKOBYXG\0ZE8SP2[2&!&Z./!/XUX'#,]O,DL3%
M)(V#*P[$'(-?47AVXLOB#X*MM18+YI3RYU_NN.#7U.5PIXVE+#S2YHZI^7_
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ML74[')^9<_7I7E] !1110 4444 %%%% !1110 4444 %%%% !7T__P $SO\
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M.^* _P"+E^+?^PO=_P#HYZYBNH^)_P#R4KQ;_P!A>[_]'/7,8K^M<)_N]/\
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M;K8:,Y?%%\K_ !_5/Y6)J1C2Q#C':2NO+;_-?=YGXN?\%A_^3P#_ -B]8_\
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M3C)I[G-3:<(M=C^8WXX_\EJ^('_8PZA_Z4R5^K'_  1)_P"2&^/_ /L8U_\
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MV(OB<D*&1UM[20@?W5O(&8_@ 3^%?SYUYE/^+->GY'J2_@0]9?E$_IP^!?\
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M$+J#R8XPTQX[C,:?F*^@:^6/VMM036O'_@_05^8V-O-J$N#T\QA&F1_P!_\
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M&..Z=6H _4^BJ>CZS8>(M+M=3TJ]M]2TZ[C$UO>6DJRQ3(1D,CJ2&!]15R@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME?LU?\EW\%_]?Z_^@FO-\5Z5^S7_ ,EV\%_]?Z_^@FOZ_P V_P"1=B/\$O\
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M9^.] MK&[U?1;5)K>'4HW>W9C*B$.J.C$88]&'.*_+'_ (?5_&__ *%;X?\
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M'K>J?#+XB>$=0OO#T-RTDFC73>1>:;*Q^:2W+ J\;_>V_=8D,K#)W?6&O?\
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M,OH]A)#:>+M(E-]HEU/PAEVX>!SV21>,]F"'G&*_+S]F;]L7XF?\$\_$^L^
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M\8:+-_:6C-(0HED"D/;ECP!(IQDD ,J$\ UT9DG]8G-?9DW^:?W7O\C'!/\
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MW_BS4#8Z?I-S$T4MO;)&9$Q$3^YBZA$/S'YF;KEOU1_X)4_\F1^"?^OG4/\
MTLFK/#P<(5U+XKJZ[:+3[K7\[EUY*3I<NVMO/XOUO;R/KFBBBI&%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_\ X2]C_P#&J](T;1=/\.:39Z7I-A;:7IEG$L%M96<*PPP1J,*B(H"JH'
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MU_7]=0HHHK(T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3>W_  &OG.?QEX;\'Z58^']4US3]-U;4+9FLK*YG6.2=5P#L!//)''^%=O\
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M_P"QPU?_ -+9J\PKT_\ :E_Y.<^+O_8X:O\ ^ELU>84 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7U-^S[\/T\,^$9-?O8@-0U ;HRV08X>PQ[]?QK
MRGX)_"*?X@:M'?7D;1Z';.#(S _OF'.P>H]:^F/&6J0Z3I?V>$+''&FU57@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'?(->R>&?#.G>$=(AT[3+=;>WC SCJ[8 +,>Y..M:M% !1110 4444 %%%%
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M1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY\./^XE_Z;;JOF"OI_\ X)G?\GN?#C_N)?\ IMNJ /W<HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&_%*+XV?"7PQXZ@TNXT6#7;07D=C=,&DC4DA<D  Y !!]"*^2_V]-:O/C_\
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MGP=E$LLP'M*JM4J:OR71?K\[!1117Y^?>A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% &=JWA_3M<MG@OK..>)NH(P?
MS'->>:I^R]\,M9D,EYX:\UCR2NH72?\ H,HKU2BN[#X_%X3_ '>M*'^&37Y,
MPJ8>C5_B03]4F>3:?^RK\+M+D$EMX8,;CH3J-VW\Y37H6A^$M'\-VX@TZPCM
MXAVY8_FQ)K7HJL1F&,Q2MB*TI^LF_P V$*%*G\$$O1(****\\W"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP1%9W8X"J,DGT J6SL[C4KR"TM(7N+JXD6**&-<L[L<!0/4FOTW_ &<OV,=
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M>==VL(M+@%@3O08[>V*H_$"W@L+W#-Y0)^]0!^27COP-JOP[\2W>B:Q T-S
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MME("N5II6NE\)^ ]=\=7WV71--FOG!P[J,1Q^[.>%_$U](_#7]D_3M%EBO\
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M[V_KM?\ 7L?NM7EGQZ_:;^'/[-.@PZIX^\0Q:6;G<+2QB0S7=V1U$<2Y8@<
ML<*"1DC(KM_'/C#3_A[X+UWQ/JTGE:9HUC-?W+]Q'$A=L>^!7X=?!?P'XH_X
M*<?M>:IJ?BW4KFTT8!M0U.2!L_8;!7"Q6EOD$*3N"@X_ON03G.,>:I55*':[
M?9?TG]WH:OEITW5GMLO-_P!6^\^Q-6_X+;?#>&^":9\/_%-Y:9YFNI+:!_\
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MX*U?!WXM^)K+P]JMMJW@74KQUB@GUA(WLGD8@*GG(QV$D]755_VJ^VJ_$?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$2_AF=,^''C_ ,>3PXDU;48=*MG8<^7;H7<K[,TX!]X_:@#]+:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YT_VI?^3G/B[_
M -CAJ_\ Z6S5YA7I_P"U+_R<Y\7?^QPU?_TMFKS"@ HHHH ^I_\ @G'X!MO%
MW[0 UB^A6>S\-V,FH;77(\TG9&WU!.:^A?VP_CK=:3#-:VLI#.VP!3C->-_\
M$U]4:S\4_$*%!AVT:-P<]<3 8Q7,?M67TNI>,K:VD)&9>.?>@#YN\0:U>>(+
MZ:XO96EE). QX7V%?I1:Z;'XF_9_\$:Q8.I:31X0<$'HF"#[BOS,NEV7,R^C
ML/UK[\_9,\23:Y^S*UD2)6TB^FMSSRJL=ZC\F% 'R?X^L98O&E_:W"\W$+*!
MG@GJOZ@5Y>P*D@]17LWQ>A/_  G,$@.&:3;@]1S7C4G^L;ZF@!M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'W/\ \$N_B-+8^-=<\%RDM;WT/VR(;N Z?>X^E?7_
M ,>M' L7D QCDU^=7_!/J.YD_:8T(V\C(%BD:7;GYDV\@^U?IQ\;H1/H\W&3
MLH _.&']K+Q5\%?'M]I7DQ:SI$,VX1S,1(%/) /^-?5OPZ^,GPZ_:=\.SZ;B
M!;^=?])T2]4'/N5[_P"\*_/S]I*UCMOB-*T;9,D>YEQC!SBO-]%UJ^\.ZI;Z
MCIMU+9WMNP>.:%BK CZ=J /I/]J3]DQ_AFUSK_AJ&5]'5B]S9?>^S*3]Y#U*
M?7I7R_7Z@? #X\:-^T]X(?0M9$</BRTM_+GMVQMN$Q@L!W4]Q[U\9?M.?L]7
M/PBU^6_L(7;0;B4KMV_\>KGG8?\ 9/8_A0!X91110 4444 %%%% !1110 44
M44 %;'@_5Y=!\5Z/J4#,DUK=Q3(RG!!5P00:QZ?#)Y4T;CJK _D: /W+^).S
M6OABERI619+975O48!S7XV?'&R^P_%+75P0))5D_-1_A7[!^%;P>*OV>?#EW
MN\YI])@=CUR3$I/ZU^3_ .U'8&S^*4[E2OFPJ?;@D4 >0T444 %%%% !1110
M 5]/_P#!,[_D]SX<?]Q+_P!-MU7S!7T__P $SO\ D]SX<?\ <2_]-MU0!^[E
M%%% !1110 4444 %%%% !1110 4444 %%%% 'S/^U\,ZEX9_ZY3_ /H25\]Q
MVLEPQ6*-I& SA%).*_1RBOJL'GKP="-#V=[=;^=^Q^7YOP3_ &MCJF->(Y>>
MVG+>UDEOS+MV/SRL_".N:E@VFC:A= G \FUD?V["NCTOX&>.M8*^3X;NX02.
M;K;!COGYR#7W5171/B:M]BFEZW?^1R4?#O"1?[ZO)^B2_.Y\F^'_ -D;Q#?,
MKZOJ=EID1 )2',\O;((X4<9YR>1^->J>%/V7_!OA_9+?0SZ[<K@[KQ\1AAZ1
MK@8/HVZO7J*\BOG6.Q&CG9>6G_!_$^KP7"63X%J4:/,^\O>_!Z?@065C;:;;
MK!:6\5K O2*% BCZ <5/117BMMN[/KTE%62T"BBBD,**** "BBB@ HHHH **
M** "BBB@ KS7XF?L^^$?B<'GO+,Z?JI!QJ-CA)"<D_.,;7YZY&?0BO2J*Z</
MB:V$J*K0FXR75')BL)A\;3='$P4HOHSXF\<_L:^*M#EFF\.W-OXALARD9807
M/T*L=IQZAN<=!TKQWQ%\//$WA61UU?0=0T_:NXO-;L$QZAL;2.>QK].Z*^ZP
MG&N-HI1KP4_/9_AI^!^=8W@#+Z[<L-.5/R^)?CK^)^4++32*_4V_\+Z-JK,U
M[I-C>%OO&XMD?/.><CUYJC_PKOPI_P!"QH__ ( 1?_$U[L>/*5O>P[_\"7^1
M\_+PZK7]W$JW^%_YGY>LE=/X<^$WC'Q<ZC2/#>I7:,"1-]G9(N,_\M&PO8]^
MU?I7IOAW2=&Q_9^F6=CCI]FMTC]?[H'J?SK1K"MQ[.UJ&'L^[E?\$E^9V8?P
MZ@G?$8EM=HQM^+;_ "/BOP1^Q%X@U.:*;Q/J5OHUKN/F6]J?/N" >.?N#//.
M3CCBOJ#X>_!_PI\+[41Z#I4<-P5VR7TW[RXD^KGD#V&![5VE%?$YEQ!F&:+E
MKU+1_E6B_P"#\[GWV5\.9;E+YL/3O+^9ZO\ X'RL%%%%?.'TP4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'X[?\%;OA=\6_"?Q T_Q_?^,=2\0> +NZ5-,A
MA8P1Z%< %DB\M#MW$ E9L;FVD-R%SZW\*_\ @J%#HW[#%YXD\07<6I_%3191
MX?MK6=LO?W#(3!=2#.2H0,SGC+1,,@N*^Z/VB/@[I_Q]^"_BSP)J*IMU:R=+
M>9QGR+E?FAE'^[(JG\".]?SS_#/]G/Q_\6?BI)\/?#OAZZN_$5M=M:W\>S$=
MAL<I(\[_ '452#R3R1@9) .-)2:EA%ULU]^NO?=-]FF]4:U.7W<2^FC_ $^3
M[>32W/M'_@F'^S/J7[17Q>U7XY?$0S:SINEW[3V\E]\YU+520YD;/58LAO3<
M4 X4BOV-KB/@I\)=%^!?PL\.>!M CV:=H]JL D( ::3K)*V/XG<LQ]VKMZ[*
MCBK4Z?PQT7^?S_*RZ'+3YG>I/XI;_P"7]=;A1116)J%%%% !1110 4444 9O
MB/PSH_C#1;K1M?TJQUS2+M0EQI^I6R7%O,H((#QN"K#(!Y'4"O//^&3O@A_T
M1OX?_P#A+V/_ ,:KU6BEYCOT/RD_X+#?!SP#\,OAS\/;GP?X'\-^$[FZU:XC
MGFT/2;>S>51""%<Q(I8 \X->L_\ !,7X _##Q]^R)X=UGQ/\./"7B/5Y;Z^2
M34-6T.UNKAU6X<*#))&6(   YX%<M_P6]_Y)?\,_^PS<_P#H@5[-_P $F?\
MDRGPQ_V$-0_]*7J,)J\1?HU^4 Q&GL+>?_MY[A_PR=\$/^B-_#__ ,)>Q_\
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M_)FFE?\ 88O_ /T8*X'_ (+9?\F]^!_^QH7_ -)+BN^_X)$_\F::5_V&+_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$O\ TVW5 '[N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,_*O_A]7\;_^A6^'_P#X+K[_ .3*_8;X;>([GQC\._"VOWJ117FJZ5:WTR0
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M"_3[*/6M5M=-:Y76'<Q":58RX7R1G&[.,CI7WC_PR=\$/^B-_#__ ,)>Q_\
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M2R/+X,\#>'_#%Q(GER7.EZ=%#-(OHTBKN8?4FB48U'[^W9#C*5/X-_,^<?\
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M]?&F_P#H-Q7Z8>*?".A^.=#N-%\2:+I_B#1[C;YVGZI:QW-O+M8,NZ-P5.&
M(R." :S/ _PK\%?#&.[3P=X/T'PFEX5-RNAZ9!9"<KG:7\I5W8W'&>F3ZU5%
M^R]I?[7_  /\AU?WD817V7<M?$#_ )$/Q)_V#;G_ -%-7\Z/[,OPA\<?&#XA
M7-O\.;I[7QCH.GR:_I_DN8Y9)()(\)&_17._*YX) !QG-?TDW%O%=V\L$\23
M02J4DCD4,KJ1@@@]01VKC/!GP-^&_P .-6?5/"?P^\+>%]3:(P->Z+HMM:3&
M,D$H7C16VDJIQG' ]*RA%QJRJ7M=67DU>S^]HJ3YH*%NNOFM+K[D?G5\*_\
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M-=-&1[%<5Z#110!B^+/"-AXUTA]-U*748K5SECIFIW.GR_3S;>1'Q[;L5F>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7L7[)/P_\ ^%C?'GPQITL+36D,XNK@*2#L3GJ!Q7CM?H#_ ,$N_AR[
M3>(_&5PF(_EL[?<I&?XF(/0^GXT ?<GC#4$TW3\,=JJG-?F9^V-X\AN+J:P1
M_-EN&P%QD >IK[[^-GB(6.CW3!L':5K\D_CAX@FUSQU>JTK/#"V%7<< ^N/6
M@#SZBBB@ HHHH *EM[J:U9S!-)"71HV,;%=RL,,IQU!'!%144 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?3_\ P3._Y/<^''_<2_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **2N=\,_$GPCXTU#4+#P]XIT77K_3FV7MKI
MFH0W,MLV<8D5&)0YXPV*/(/,Z.BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGQ=_['#5_P#TMFKS"O3_ -J7_DYSXN_]CAJ__I;-7F% !1110 4444 %%%%
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M?M7:U>6S06$,B _QSN!_XZN?YUY1K7C[7M>D=KK490'ZK$Q0'ZXY/XFN?HH
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M83B=Z'S_ /;S]**^;O\ @HQ_R97\4O\ KPB_]*(J^D:^;O\ @HQ_R97\4O\
MKPB_]*(JY,5_ GZ'7A?X\/5?F?G+_P $6?\ DZ/Q)_V*5S_Z5VE?M77XJ?\
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M (+<?#M=1V1_#SQ.]AG_ %[3VRRX]?+W$?\ CU1&2EL6XN.Y^D%%?-W[.?\
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M?1M+$?F0V**]Q*SR+&B1JS*"Q9AU8#J<U,I**NRHQ<G9'?45X#^RK^VAX/\
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M($Q]^+G'9:?G_DRI>[)1>[U_K[SI:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***S=<\3:1X7M5N=9U6QTFW9MJS7UPD*$^@+$#-)
MM+5DRDH)RD[)&E15+1];T[Q!8I>Z5?VNIV;DA;BSF66-B.N&4D5=IA&2FE*+
MNF%%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 444F>E &3XM\4:?X)\,ZGKVJ2^1I^GP-<3-WPHZ#U). !W)
MKX?\"ZO=^(=:U3Q5K;M)J>K3M<RE^?+4GY(QZ!%PH^E>M_M>>,Y-5NM)^'UB
MPV3;=1U1@0?W:M^YB_X$ZEC_ +@]:\0\47B^$_#\LP;RML9)_ 5^)\<9HL16
MCE=)[:OU?^2_,Z(4W;F-[6;S5OBQXTT[P+X:E,5S>9:YNPNY;.W7_63-] <
M'JQ4=Z^R_A_X#T?X:>%+'P_H=L+>RM5P6(&^9S]Z60_Q.QY)KR7]C_X3OX'^
M'H\2:M"O_"3^)@M[<.PR\-N1F"#/;"G<1_><^@KWROO.&<DIY/@TK>_+5O\
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M6E7(MM(M)&&!-(A:27'^Z&B'_ CZ5]4?\%-/AKJGQ-_8]\86NCPO<WVE/!K
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M2C]E[1/V1?B]X2\0_#B6YT/2=;62]M+6.=V?3KNW="3%(26"_/&RY)*D-SC
M'Z]?LP?%"Y^-'[/G@'QK?!1J&KZ5#+=[%VJ;A1LE('8%U8CZUX?^SU_P5$^#
MGQVU*ST2[NKKP+XENF6**QUX*L$\A_ABN%)0\\ /L+'@ U]@545*E2]G+76Z
M?WZ?E]RN1)JI54XZ65FONU_!_>S\>_\ @M=\2-8O/BQX,\"_:'CT"QT@:M]G
M5SMEN999(][#H2J187TWOZFOL']D']A+X)^%O@;X0U.^\$Z%XUUK6M)M=1O=
M6UZSCU 222QB3$:2ADC0;]H" 9 &23S6)_P4H_86U3]J31=)\5>"Y(/^$YT&
MW>W6QN'$::E;%MXB$AX216+%=Q"G>P)'!'YX?#O]KK]I/]A>>+P9J=K=6>EV
MV[R/#?C+3G>!1NY:!\I)LSG'ER;.2<'.:QP\HPA.E+23=[^6OZ->EK&V(C*<
MX5(:Q2M;ST_6_P!]S]&?VRO^">?PF\>_!WQ+JWA7P=I/@OQ;H^G37UA=:#:I
M912M$A<Q2Q1@1L'"[=Q&Y<Y!Z@_,G_!%7XT:M%XT\7_"ZZN9)]$GL#KEE"YR
MMO,DD<<H7T#K(A(Z9C]2<]]\)O\ @MCX7U>Z@L_B+X#OO#H;:C:IHER+V'<>
MK-"ZHZ*.ORM(?8U^@?PO^+7A#XT^$K;Q-X)U^S\1:+.=HN+5CE&P"4D0@-&X
M!&58 C(XK:E&5*4Y[Q:M;[]?OL_5&-24:D8P>DD[W^[3\_O'?%S_ ))3XT_[
M M[_ .B'K\9_^".G_)WDG_8N7O\ Z'#7[,?%S_DE/C3_ + M[_Z(>OQG_P""
M.G_)WDG_ &+E[_Z'#6&&_P![J?X/TF:8C_=H?XOU@?I9_P %%/@G_P +P_93
M\6V%M;^?K.BQ_P!N:=M7+>; "SJONT1E3ZL*^,?^")_QB^R:[XY^&%W/B.\B
M37M/C8\>8FV*X ]RIA./1#7ZR21K-&R.H=&&UE89!![5^#>I6LO[!O\ P49C
M=0UKH.EZ\LT9.0K:3=\''KMBE9?]Z/VK3#>[B73>U16^?]<K_P"W6%?WL/SK
M>#O\OZNO^WC]YJ_+C_@MA\91;Z3X'^%UG/\ O+B1M=U&-6Y"+NBMU(]"QF/_
M   5^HD<R30K*CJ\;*&5U.001D'-?A+XY>;]N_\ X*0/IT#M<Z#?:XMA&R-E
M5TNTR)'4]@T<4CC_ &I*R=-UJU.AW=WZ+_)V?HF:1FJ5*=;LK??_ ,"_X'Z;
M_P#!-7X*_P#"E_V3_"T=S!Y.L>(@=?OMP(;,X!B4YZ%85B!'KFOSP_;^^+_B
M?]KW]KJS^$/A:X:31-(U5=!TZS5R(9KXMLGN9,==K;ESSM2,D?>.?VKD$>EZ
M8P@B5(K>$[(UX 55X ]!Q7\X7P/_ &@[KX(_M%6OQ4GT6'Q-J-I=WET;.XN#
M"LDLZ2(7+A6Y!D)Z=JVG.%;&)S^!:V_"*^Y-?<S*G"=+"2Y?B>E_-W;_ !_#
M0_:CX&?\$Y_@C\&_"-IIU[X*TCQOK1B7[=K'B6RCO6GEQ\Q2.4,D2YSA4 XQ
MDL>3QO[6'_!,[X7_ !<\ ZI<^!O"VF^!_'%K;M+ITVBP+:6MPZ@D0S0H!'M?
MIO"AE)!R0"I^9/\ A^)K_P#T273?_!W)_P#&:/\ A^)K_P#T273?_!W)_P#&
M:FK>K>[L_P AT_W=K:_J5?\ @CS^T;J_A_XB:I\$]>N97TJ^BFO-)@N'.;.[
MB^::% >BN@=R.@:,G&6-?KM7\^G['/C:?Q#_ ,% /!'B:ULOL+ZQXIFN#9P,
M66!+@R[D!QRJK(1G X':OZ"ZWDY3HTZDU:6S]5;_ #2^1@N6-:=.&VZ^=_\
M*_S"LWQ-_P BWJO_ %Z2_P#H!K2K-\3?\BWJO_7I+_Z :X<3_ GZ/\CMH?Q8
M>J_,_GE_82^*?AGX*_M4>"O&7C#4&TKP[IIN_M5VL$DY3?:31I\D:LQRSJ.
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M\0-2MI;&TM=(N$N$L&=2K33R(2J% <A"=Q;'&,D?%'_#E3XW_P#0T_#_ /\
M!C??_(=>/>//V??B#^P)\0M&UOX@_#_POXWTF9REI+J(DOM)N7&"RX#1D.!G
M"RKZD*P%*<8U/W<W9/04)2@^>*NUJ?2O_!'?]E_6;OQQ=?&?7+"6RT.PMI;+
M0VG0K]LGD&R69,]41-Z;NA9R <H:_6K5M)L]>TN\TS4;6*]T^\A>WN+:=0T<
ML;J59&!Z@@D$>]>._LA_M+>%_P!J+X067B7PW9+HLEHPL;_0\J3I\RJ/W8(
M!C*D%6 &0>@(('MM=>(U?LY+1*WRW_&]SEHZ7FGJW^6GX6/PM^*?@_Q+_P $
MP_VT--U_0$FN?"LTK7>F[F.V^TUVQ-:.W=TSMYS@B-\<BOUN^(W[4W@SP'^S
M=/\ &5+U-0\.2Z<EYIRJVU[R608A@ [.7(4C^'#9^Z:YG]O']G/1?VC?V?==
MT_4)[73-6T6&35M*U:[<1QVDL:$L)'/2-T!5L\#ANJBOPCTGQYXM\?>&/"/P
MDN?$BVWA.'63-96]_,([2TGN&6-I7?LBY9O1=\A'WC7)3<ZD'A5\2:Y7Y/\
M7MYZO<ZIJ$9K$OX7>Z\U_7W/RU^M?V$?@+KG[<7[2^N?%GXB*=2\.:;J']HZ
MDTRDQ7UX?FAM%!_Y9H I*\@(J*>'%?M@ %  & .@KSG]GOX(:#^SO\(] \#>
M'E#6FGPYGNBH#W=PW,L[^[-D^PP!P!7H]=4^6*5*G\,=O\_ZZ6.:/--NK/XI
M?U_7F%%%%8FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC/%>_P#[7_PTN-%\70>.+&+-EJ"I!>%!_JYU&%9O9E &?5?<5X8QM=5MSYC
MOCH>H-?SQQ%%4,UE4JTDI*5[J^J>UUM\U;S/4I+FAHS]*M#OK34M&L;NP</9
M30(\++TV%1C]*O5\F?LT_&[^P;=/#6M2_P"@JV+:5O\ EEGM]*^KX+B.ZA66
M)UDC89#*<@U^O9%G^'SFERIVJQ^*/7U7>+[]-GJ<56E*F_(DHHHKZDP"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YT_VI?\
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M'A+XF:?!8>+_  OHOBNQ@E\^*UUO3X;R*.3!7>JRJP#8)&1S@FF>!_AGX/\
MAE:7-KX/\*:'X4M;IQ+/#H>G0V:2N!@,RQ*H8@<9-=+12VV#?<**** &30I<
M1/%*BR1N"K(XR&!Z@CN*\(\8?L'_ +/_ (ZNFN-5^%7A])V;>SZ;"U@6;G)/
MV=DSG/.>M>]44K*]QW>QY!\//V0?@M\*KNVO/#'PT\.Z??VS!H+Z2S6XN8F'
M=9I=S@^X:O7Z**IMO<FR6P4444AG"_$CX%_#OXP+&/&W@G0O$\D:&.*?4K".
M6:)3U"2$;T_X"17E6G_\$Z?V<=+U+[=#\*]+>?<6VW%Q<SQ<G/\ JGE*8]L5
M]'T4DK:H;;>C,+P=X%\-_#S1UTGPMX?TOPWI:G<+/2;..VAW'J=B #)]:W:*
M*IMO<G;8R_$_A71?&VAW6B^(M'L->T>Z"B?3]4M4N;>;:P9=\;@JV&4$9'4
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M#X875O=>'/ACX=M+VW<207EQ:"[N(F'1EEFWNI]P:]FHHC[OPZ _>W"BBB@
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M58!(0 TTG625L?Q.Y9C[M7;T45I*3G)RENS.,5"*BMD%%%%24%%%% !1110
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MC@XP?C/]C[_@K:GQ8\;:7X)^*6A6'A_5-4F6VL-<TEG6S>9CA(I8I&9HRQP
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MG?\ @E/^Q?XG7QY%\;_'>GW.F6EO%(=!M[]2MQ>32J5>Z96Y"!&;:3]XON'
M!/ZQ5I*'LX14OBZ_U^/S,U+GG)Q^'I_7]=0K-\3?\BWJO_7I+_Z :TJS?$W_
M "+>J_\ 7I+_ .@&N/$_P)^C_(ZZ'\6'JOS/P1_X)?\ _)\?PW^M_P#^D%Q7
M] %?S2_LT_'"X_9Q^-7AWXAVNDQZY/HYG*V$TYA67S8)(3EPIQ@29Z=J^[O^
M'XFO_P#1)=-_\'<G_P 9KT*DU*%.*Z)_FV<<8M3E+O;]3];*_(#_ (+=:WI=
MU\4?AMI4#QMJ]GI-S-=A3EEBDE41 ^G,<I_&LWQM_P %K_B3J^GM;^%_ _AW
MPY.Z%6NKR6:^=">C(,QJ"/\ :##VKQ[X'_LG_&C]O+XH'Q=XF.J1:)J4ZW&J
M>,]7A*1R1YP5M@0!(<#:JQC8F #M&*X_92K5(VT2=[_)K]3H]I&E"5]W_FF?
MJC_P3+AO+?\ 8B^&JWRR+(8;QT\SKY1O)S&1[;2N/:OCK_@N-_R,GPA_Z]-3
M_P#0[:OU-\&^$=+\ ^$]&\-:);+9Z1I-I%96D"_P11J%4>YP.O>ORR_X+C?\
MC)\(?^O34_\ T.VJ\9-5,0IK9R?Y2)PL7"C)/>WZH^NO^"7/_)CGPZ^NH?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY'IDCIBN:=64J'L)K6+7_!7ZK_ACQI8S$9'AL9D&-V:]U^=T]/[LEKY/U9]
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MG_LHZ7\+]"\-2:_XLU;03XAGG9(;?5;B+-K$I !".>&8Y.[KC&,<Y]%^-O\
MPIWXA>"=42+7?"\>MPV[R6-U;74*2B102JY4Y8$\;3Z^M>*?!G]DR+XO^!;;
MQ%'XO_LUI)9(9+3^S?.\ME;&-WG+G(P>@ZUV[_\ !/\ 6-&=_'P55&2S:/@
M>O\ KZNI"M.E[/V:2MY=M_7J:93_ &NLKAAZ&70G2DMW*/O7ZN[O?\OD>!?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?E7@5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME5:LFK+OZOU_5LX__@G+H?A+1OV/_A_)X26U9+VS%SJ<]O@O)?DXN/-/4LK
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_.G^U+
M_P G.?%W_L<-7_\ 2V:O,*]/_:E_Y.<^+O\ V.&K_P#I;-7F% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSO\ D]SX<?\ <2_]-MU7S!7T_P#\$SO^3W/AQ_W$O_3;=4 ?NY1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^(O%&KVFAZ)8QF2XOKV0)&@],GJ2> HR22  2:R;45=FB3D[(W**_'CXU_\
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MK8901D<$ ]J_<"NB5-QC&7?_ #:_0R4KR<>P445^7_[=7PR_:V\3?M&:U?\
MPFO/'4/@I[6U6V30_$CV5KY@A42;8A.F#NSD[>37/*7+)*VYM&/,F[[?YGZ@
M45^'DOP7_;]AC>1]2^**HH+,?^$SDX _[>J\1\ _&W]I'XH>,K#PIX6^*'Q$
MU?Q#?NZ6UC%XKNU:1E5G8 M,!PJL>3VJU[SY5N0]%S/8_HQHK\/O^%)?M_\
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ML!:*^=+G]NCP':W$L+Z3XC+1N4)6VM\9!Q_SWJ/_ (;P\ _] CQ)_P" UO\
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MJ<#J3W)Y-:E%%?5)**LCR=PHHHI@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!_.G^U+_R<Y\7?^QPU?_TMFKS"O3_VI?\ DYSXN_\
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M0OT=116TI.3O_2,HQY?ZW"BBBH*"BBB@ HHHH *_GS_X*/?\GS?$S_K]M/\
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M .E=U7.X.C"GS?'-W?DN5V7Y?))]6=<9*LZG+\,%IYOFC=_G]]NA^F/[#_\
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MR@.VQL?>-?I%^P;^QSH7[+GPMT^XN=/AF^(6KVR3:UJCJ&DC+ -]EC;^&-.
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M]%R2 !DD\U^^_P "_P#DB/P]_P"Q=T__ -)HZ_&+_@KO_P GE:I_V!K#_P!
M-?L[\"_^2(_#W_L7=/\ _2:.KPTW/"U)2_G_ %F85XJ.*II?R?\ R!W%%%%(
MT"BH+Z=K6RN)E +1QLX#=,@$U^,%Q_P6G^-T5Q(@\+> "%8J,Z??=C_U^5/,
MN;EZE\KY>?H?H)_P4V_Y,>^)G_7*R_\ 2ZWKY+_X(:_ZSXR?32?_ &\KYO\
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MENM/O:?R*I<N'H2GTBK?U\DS] _^"4_[&6C>!_ASI?Q@\4:;'>^,-=0SZ/\
M:4##3;(\(Z ]))1EM_4(R@8RV?T0K.\.Z':^&?#^F:/8Q+#9:?;16D$:C 6-
M$"J!] !6C756FI3?+\*V]/ZW\SFI1:@G+=[^H5^5/_!7[]DS2--T_3?C%X4T
MM;._N;U;#7[:SBPMPSAFCNBH_CRI1C_%N0GD$G]5J*XYPY[-:-?T_O7^9U0G
MRW3U3_K\#X1_X) _%;5_&G[/.I>$];:=[GPCJ MK1K@$,+.5=\2<]0K"51Z
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MKZL[E5'UK\7_ /@F3\.=7^-7[9NG>*YXFDL] EG\0:G<[?E$K[Q$N?[S2N&
M]$;TI87_ 'Q-;)>]Z?\ #<WX!B/]T=][^[Z_\/R_U<_=NOY_O^"FW_)\7Q$_
MZZ6/_I%!7] -?S_?\%-O^3XOB)_UTL?_ $B@J8?[S3^?YHZ(?PJGR_,_?#P[
M_P B_I?_ %ZQ?^@"M&L[P[_R+^E_]>L7_H K1KHJ_P 27JSAH_PH^B"BBBLC
M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** /YT_VI?^3G/B[_ -CAJ_\
MZ6S5YA7I_P"U+_R<Y\7?^QPU?_TMFKS"@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P ><'_7-?Y5\8?\%>O^3-[_ /[#5A_Z$U<F,^'_ +>C_P"E(G!_"O\ "_\
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M^ZP_QK\X'[&4445105^+W_!:W_DY/PA_V*D/_I7=5^T-?B]_P6M_Y.3\(?\
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MU;]GFHVW=M7..NT>E?;_ /P4V_Y,>^)G_7*R_P#2ZWKY+_X(:_ZSXR?32?\
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M0 "365\9/C-X2^ O@+4/%_C/58]+T>T&!GF6XD(.V*).KNV.%'N3@ D?C/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#Z2V]?H=7.^"?ASX3^&NG3:?X0\+Z-X5L)Y?/EM=$T^&SBDDP%WLL:J"V
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>6"EPW6>7+]S[.?+O_>O\6N]_P!-"#]A7_DDFI?]A>7_ -%15]&U\Y?L*_\
M))-2_P"PO+_Z*BKZ-KTX_!#_  Q_)'3PG_R),-Z/\V%%%%,^M"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** .+^)'P?\*?%FVM8O$NF"\:U),$\<C12QYQD!U(.#@<=.*O>!?AK
MX:^&NGO9^'-(M],BDP9&C!,DI'0LYRS?B>]=-10 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\Z?[4O_)SGQ=_
M['#5_P#TMFKS"O3_ -J7_DYSXN_]CAJ__I;-7F% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^O\ Q(^&L&E>'+#^T;];^.<P^='%\@5P3EV4=2.]>RT5TUJ4<1#DEMI^#O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&?P'_P"!][_\B4?\.<?C1_T,_@/_ ,#[W_Y$K]C:* /QR_X<X_&C_H9_ ?\
MX'WO_P B4?\ #G'XT?\ 0S^ _P#P/O?_ )$K]C:* /QR_P"'./QH_P"AG\!_
M^!][_P#(E'_#G'XT?]#/X#_\#[W_ .1*_8VB@#\<O^'./QH_Z&?P'_X'WO\
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M_P# ^]_^1*_8VB@#\<O^'./QH_Z&?P'_ .!][_\ (E'_  YQ^-'_ $,_@/\
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MS^ __ ^]_P#D2OV-HH _'+_ASC\:/^AG\!_^!][_ /(E'_#G'XT?]#/X#_\
M ^]_^1*_8VB@#\<O^'./QH_Z&?P'_P"!][_\B4?\.<?C1_T,_@/_ ,#[W_Y$
MK]C:* /QR_X<X_&C_H9_ ?\ X'WO_P B4?\ #G'XT?\ 0S^ _P#P/O?_ )$K
M]C:* /QR_P"'./QH_P"AG\!_^!][_P#(E'_#G'XT?]#/X#_\#[W_ .1*_8VB
M@#\<O^'./QH_Z&?P'_X'WO\ \B4?\.<?C1_T,_@/_P #[W_Y$K]C:* /QR_X
M<X_&C_H9_ ?_ ('WO_R)7L?[(/\ P34^)W[/_P"T5X2\>^(==\)WFCZ3]K\^
M#3+RZDN&\VTFA7:KVR*<-*I.6' /7I7Z544 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_
M ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\
MJMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\
M*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6
M/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_
M ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1
M_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_
M ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_
M^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_
MZ+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G
M_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -
M8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G
M_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\
M ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\
M/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!V
MT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#
M_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!V
MT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\
MPJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\
M#C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLG
MP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??
M_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_
M *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'
M_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_
M *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\
M_"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#P
MUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9
M_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".
MT?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9
M_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL
M?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$
M/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6
MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\
M#6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM
M? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR
M?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\
M=M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P
M0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
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M /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\
M\-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\
MCM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ
M+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_
M!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_
M  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
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M /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_
M ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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MT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\
MPJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\
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M *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\
M#6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM
M? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR
M?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\
M=M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P
M0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
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M /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\
M\-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\
MCM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ
M+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_
M!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_
M  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
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M /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_
M ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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MT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\
MPJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\
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M *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\
M#6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM
M? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR
M?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\
M=M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P
M0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
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M /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\
M\-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\
MCM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ
M+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_
M!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_
M  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
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M /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_
M ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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MT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\
MPJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\
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M *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\
M_"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#P
MUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9
M_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".
MT?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9
M_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL
M?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$
M/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6
MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\
M#6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM
M? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR
M?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\
M=M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P
M0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
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M /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\
M\-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\
MCM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ
M+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_
M!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_
M  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
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M /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_
M ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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MT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\
MPJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\
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M *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\
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MI_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\
M#6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6
MI_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM
M? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR
M?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\
M=M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P
M0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\
M=M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_
M  XQ_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__
M ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_
M  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+
M)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M '
MW_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ
M_P"JV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*B
MQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ
M_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_
M /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\
M\-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"J
MV?\ EJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\
MCM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"J
MV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ
M+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_
M!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\
MEJ?_ ';1_P .,?\ JMG_ ):G_P!VT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_
M  UC\$/^BR?#_P#\*BQ_^.U\ ?\ #C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\
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M /#6/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\
MJMG_ ):G_P!VT?\ #C'_ *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_
M ([1_P -8_!#_HLGP_\ _"HL?_CM? '_  XQ_P"JV?\ EJ?_ ';1_P .,?\
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MT ??_P#PUC\$/^BR?#__ ,*BQ_\ CM'_  UC\$/^BR?#_P#\*BQ_^.U\ ?\
M#C'_ *K9_P"6I_\ =M'_  XQ_P"JV?\ EJ?_ ';0!]__ /#6/P0_Z+)\/_\
MPJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[7P!_P .,?\ JMG_ ):G_P!VT?\
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M *K9_P"6I_\ =M 'W_\ \-8_!#_HLGP__P#"HL?_ ([1_P -8_!#_HLGP_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGU)%?55;SBHNR=S&$G)7:L%%%%9EA1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BO,/VH-8O\ P_\
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M01M3!'3BL82]HN:*]WN:RCR/E;U['[DT5^(_PM_X*6?M _LW^.E\._%:"_\
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M@<DE2  2>*^F?^"<O_!2+Q+\9O&]O\,/BA);W^N7D4CZ1K\,*P/<NBEVAF1
M$W; Q5E"YVX().:VA'VC<8O5=#"<O9I2DM.Y^E5%?D/_ ,%;?CA\1OAO^T?H
MFF>$O'_BCPMILGANWG>ST76;FSA:0W%P"Y2-U!8A5&<9P!Z5^G7[/^I7FM?
MGX=:AJ%U/?7]UX=T^>XNKF1I)9I&MHRSNS$EF))))Y)-337M*4JJZ.WY_P"1
M=3]W45-]5?\ +_,[ZBBBD 4444 %%%% !1110 4444 %%%% !1110 45'<7$
M5I;RSS.L4,2EWD8X"J!DDGTQ7\^7QZ_;:^+/Q"^,GC7Q!X7^)'C+0_#4VH2-
M86&DZY=VUM;VBL(X3Y<;A5RH0GCEF/<UGS^^H>5_Z]?T9IR^XYG]"-%?._[
MGQRE^/W[+WA+7K^]>^U^QC.DZM--)OE>Y@PN]SU+.ACD)/\ ?KZ(KHJ0=.;C
M_7K\SGISYXJ04445F:!1110 4444 %%?C)_P5(^/7Q-^'W[6.HZ1X6^(OBSP
MUI*Z392+8:/KEU:0!F0EF$<;A<GN<<U^P?@Z>2Z\(Z'--(TTTEC [R2,69F,
M:DDD]234TG[6FZBZ.WXM?H%3]W45-]5?\O\ ,V****H HHHH **** "BBB@
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M(KJ:<HN+<7NA1DI*Z"BBBI*"BBB@ HHHH **** "BBB@ HKX%_X+ ?$KQ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %9OB;_D6]5_Z])?_ $ UI5F^)O\ D6]5
M_P"O27_T USXG^!/T?Y&]#^+#U7YGX(_\$O_ /D^/X;_ %O_ /T@N*_=3XM>
M&-2\:?#'Q5H6CZK>:'K&H:;<066I:?</!/;3F,^7(DB$,I#;3P17X5_\$O\
M_D^/X;_6_P#_ $@N*_H KT,3'GH4X=XO\V<E*7)7<NUOU/Q__P""6O[3WQ!U
M#]IZ^\#?$+QMXC\11:MIMQ;V]IXAU6>[\B]@82842NVT[$F!QUP/2O4O^"P'
M[1GBWX<W_P ._!?@;Q1K/AG5+I9]4O9="OY;2XDCR(H$+1,&*EO..T\$J/2O
MF#]J#39/V0?^"DZ>*;1&MM*;6[;Q/#Y8^_;7#YN5 ]"WVA,>E>HZG)'^UI_P
M5VM(HR-0\.>%;Q &7YD$.GIO/L5:YR/??7-&^*AAUMOS>7+J_N;V\C65L-.O
M+=67+YN6B7S2^]]SU?\ X(]_M'>*/B=;_$'P?XU\4:OXGU:R>#5+*YUN_EO)
MQ"P,4J!I69@JLL1QG&9#ZUY7_P %)/VA_B3JW[8>D?#/X:^./$7APVMO8Z6U
MKH.K7%FDU]<OO!<1.-QVRPKSG&#7*_!:ZB_8_P#^"J6L>'[F1=/\/ZAJ=UIA
M+?*BVMXHGM1] Q@'X&D_89TJ3]J;_@HYX@^(]Y&T^F:;>7WB3]X,A<N8[1#[
MKO0C_KE6E-K%5,/4:TY>:7_;JV_\!_'YDU+X:->">MTH_P#;VS^]?<^Q]Z?M
MD?M71?L._ WP[;6I;Q1XUO(%TW2EU:X>4RM%&HEN[ERV^0#*D\[F9QR.2/S]
M^'L'[<7[8VF3^-O#OC/Q'::&9)(H;JUUP:):S,IPR0Q0M'O /&[:1D$%L@UT
M_P#P6V:__P"%U?#]9?\ D&#P^Y@Z_P"M^T/YOMT$7^<5^B_["ZZ>O[(/PE_L
MSR_LW]@6Y;R^GFX_>Y]_,WY]\UG1_?0J8B;UYK+RU?\ E^/9%5/W,H4(;6OZ
MZ+_/\.[/S;^$/_!0;XZ?LG_& > OCP;[7=(MYH[?4;?5]DM_8HW/GPW"9\\8
M8-AF<,!A2IYK]D-/OK?5+&VO;29+BTN(UFAFC.5=& *L#W!!!K\:/^"U2Z>/
MVC/"1@\O^T3X9C^U;?O;?M,_E[O_ ![_ #BOT^_8[^V_\,J?"7^T PNO^$8L
M-V[.<>0NW.?]G%:4I.MAW4DM8RMZ[_Y?B15C[&NH1V:O^"_S_K4]&\<7$MIX
M+\03P2/#/%I]P\<D;%61A&Q!!'0@]Z_(/_@EG\>?B9\0OVKK+2/%/Q$\6>)=
M);2+V4V&L:W<W<!=57:WER.5R.QQQ7Z\?$#_ )$/Q)_V#;G_ -%-7XF?\$A/
M^3R+#_L"7_\ Z"M98?7%33_E_288G3#Q:_F7YQ/U3_;V\3:QX/\ V1?B1K.@
M:K?:'J]I91O;ZAIMP]O<0L9X@2DB$,IP2.#T)KY2_P""-_Q9\<?%"3XK_P#"
M9>,O$'BW[$-+^R_VYJD][Y&_[5OV>:[;=VU<XZ[1Z5],_P#!1R1(_P!BGXHE
MV5 ;&%1N.,DW,6!7QY_P0U_UGQD^FD_^WE5A=:E>_P#*OS-:^F'@_P"]_P#(
MG(_\%8_CI\2/AS^T]8Z5X3^(/BKPOI;>'+2=K+1M:N;2$R&:X!<I&ZKN(503
MC/ ]*GU3QY^VU^V!X5LM;^&^GZWX5\!6]O';V4ECJT.FW.H-&@5IVN))$FF9
MSDY4^7GCD@D\#_P66_Y.UT__ +%>S_\ 1]S7[!? E0OP0^'@4  >'=.P!_U[
M1U.'@I8>4GTE^LORL16GRXB,5UC^D?\ /^KGY-?L,_MU?%OP'^T5HWPT^)GB
M#5O$>CZKJG]AW5MXAE:XO=/O&?RD82OF3B3"LC,5P20 1FOL;_@K7\0/%'PW
M_9IT?5/"7B35_"VIR>)K:![S1;Z6SF:,V]R2A>-E)4E5.,XRH]*_./XE*%_X
M*@W8 P/^%E6YX_Z_HZ^_?^"S_P#R:IH?_8UVO_I-=5%2;JX*C6>[:_.#_5_(
MZ*5-4\95I+9*7Y2_R1K?\$B_B'XJ^)7[.OB/4O%WB;6/%6HQ>)Y[>.\UJ_EO
M)DC%K;,$#R,Q"@LQQG&6/K7RU^VQ_P %#_B=\0/C7?\ PN^#6IWNB:39W_\
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MWVD%77/.UQGFOG[_ (+''3?^&2K<7GE_;/\ A(;/[%N^]YFR7=M_X!OK@O\
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M^2K?#7_L"W'_ */K[3_X);L&_8=^'8!!(;4 <=O]/N*^+/\ @MY_R5;X:_\
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MP=TOXC?M'W_B+6+6.]M_".G?;K6*9=RB[D<)$Y!XRH\QAZ,%(Y%?M[7XA_\
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M]L?]KKQMX:\5>$-,\2^&_A=;W]H88[/4(M+6YM4=/,EDD>2-[G>H8MM+)R5
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M\#_L,_$+PY9,S6>D>"+FPA9NI2*T**3[X45^>?\ P1)4?\+O\?G R/#JX/\
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MZA'I7AW58],>UM0NXDV\<JW#X49_>!GZG&*\>^)JAO\ @J!> C(/Q)M\@_\
M7['7[J_$#_D0_$G_ &#;G_T4U<$6X9;3K;M)V^48OYW_  U[G7/WL=.ELF_U
M?W?K\C\<_P!G'_@J%\<--\+7O@*/3)OBGXUU%XX/#=U>(TUS Q!WB4( UP
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M*79%(Z;85*C'0 5_0_I.E6>A:7::;IUK#8Z?:1+!;VMN@2.*-0 J*HX
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M[QT[Q1_Y>>S_ .WOP_X&P5=H>T^7X_\ !/1OVM_^36_BU_V*VI?^DSU^4/\
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M=ON/T&_X+ ?$KQ?\,_A%X&O/!_BK6_"EY<:Z\,UQH>HS6<DJ?9W.UFB921D
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MBOTHKJK_ !KTC_Z2CEP_P/UE_P"E,_(S_@N%_P CY\*_^P;??^C8JTOV0_\
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MS*2%7<6'0772EB802W2=EUT5_1:[>?D*A)QH3G?9M7?35_Y;^1B?%/\ 9_\
MVVOV>_A_?_$G4?C3J.K66DHMU>6-GXKOKN6"/(W,T,Z")U7/(!;C/!%?5O\
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MPKB_V(_V=?VBOB_\,=6U3X/?%NU\$:#;ZJ]O=Z6VNWUBYN?*C8RF."%U.4*
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MO(\EJ+L%H;&W4[3.Z @L2WRHN0"0Q.0NUOSA_P""2K$?MJ>' #@'3=0!_P#
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M7\+?V[O%:6GQ \7P^%M%\06D[:#9ZY<QVK0(L+O"(=_E[6&X%2,'<<]:]^^
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MI2>0Q;RU\UV)P"&^7/&?>OT?_P""(?\ R2?XD_\ 8;@_]$5\O_\ !8?_ )/
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M:@7@8$ 31(C[3M;:RR+M)SC(P:_=NBL5%QFJD79_U_7WFO,G!PDKH_&[XB_
MO]L?]J+X0Z[XE^*]]J\&DZ':&\TKPE'IR)>:I<;E 465LBMD L=TH+#HJX8D
M>R_\$;_A-XX^%\GQ7_X3+P;X@\)?;1I?V7^W-+GLO/V?:M^SS47=MW+G'3</
M6OTLHK:$O9N?*M)*WXWOZO0SDG.*C)[/^E_7<_'O_@K'\#/B1\1OVGK'5?"?
MP^\5>*-+7PY:0->Z-HMS=PB037!*%XT9=P#*2,YY'K7ZI_!FQN=+^#_@6RO;
M>6TO+?0K&&:WG0I)$ZVZ!D93R&!!!!Y!%=C14T_W=-TUU=_S_P PJ+VE55'T
M5OR_R/Q*^(7[/OQ1O?\ @HU=>);?X;>+Y_#C?$""]&L1:%=-:&W%XC&7SA'L
MV!03NSC SFOMW_@K7\/_ !1\2/V:='TOPEX;U?Q3J<?B:VG>ST6PEO)EC%O<
M@N4C5B%!91G&,L/6OMBBLE"V'AA^D;?A;_(Z/:/V\Z_65_QO_F?#W_!(OX>>
M*OAK^SKXCTWQ=X9UCPKJ,OB>>XCL]:L);.9XS:VRAPDBJ2I*L,XQE3Z5\G?M
MI?\ !/GXJ?#/XY:C\3?@_I.HZ]HUYJ)UJW_L$;[_ $J[,GF,HB7YW4.2RL@.
M!P0,9/[)45M5DZE2-5:2BDON27Z)F,+1A*F]4_\ @_YGY&Z/8?MO?M?>'9_"
M?CB74OA_X#\AEUG4-2T=-*FNHE&63R]J32E@"-J!8SDACBO$/^"2W_)ZGAO_
M +!VH?\ I.U?NCXAC>;0-3CC1I)'MI555&224. !ZU^-7_!,/X!?$_P#^UUX
M?UGQ/\./%OAS2(K"^234-6T.ZM;=&:!@H,DD84$G@#/-5AY+ZQ)6LN5_>U+_
M (!CB8OV$=;^\ONYHGVU_P %-OV1M>_:@^%NC7O@^*.[\7>&)Y9[:P=UC^V0
M2JHEB5F(4/E$8;C@[2.]?!/P!/[=/POTE?ASX \-^,-!TGSY&BBU7P_"MK;L
MQRY2YNXMB*3D\/MR20,G)_<&BL:<>1RL]'NCHG+G44]UM_7S/P&_:<_8=^.W
MA'XC0G4-%\5?%77-5T^+4]5U[1](O-0A6Z=G5H//"-O*!%Y..&' &*_<'4/A
M_IOQ$^#)\&^)+1WTS5=%73[VW8%'56A"L.?NL#T]"!7<455E[*5%K1_EKI]S
ML3K[2-5/5?\  U_ _%B7]DO]J3]@KXJ7OB3X46-YXNTAP85OM$M1>K>VY;(B
MN;(9D## )*J0"?E>H_BI9_MI_MTKIGA?Q)\/-4T71+.X6X^RW.CMHMF)<%1-
M(]R0SE5=N Q[X7-?M7122NE&?O);?UZZ_P#!&WJY0T;_ *_+^K'A7[&'[,\/
M[*?P,TWP8UY%J.L23/J&JWL (CENI H;9GG:JHB D D)G S@>ZT45I.;J2YF
M9QBH*R/Y\?VOO#)\;?\ !0#QOX=%S]C.K^+(K#[1LW^5YK1Q[]N1G&[.,C..
MM?17CKQ1^WY\%M%G^&R6?B#Q+ID49L[/Q%H.BC4Y7MP-JE;F.-G7([R@2#/4
M8%<C\</V?OBCJW_!1+4O$EC\-O%U[X=?QM9W:ZO;Z%=26AA6:(M*)A'LV  D
MMG'!K]LJY<-#_8J2?56:^2_X/XF]:7^U5/+9_-_\#\#\M?\ @F[_ ,$Z_&/@
M?XCVOQ7^*NG'1;C3E:31M$N)%>Y>=U*FXG )"!58[5)W;CDA=HW>@?\ !5#]
MBGQC^T$_ASQWX LEUK6]&M&T^]T=71)I[?>9$>(L0&*LSY3.2&&W)X/Z%45O
M5_>J*VY=OZ\^OX6TM%.]-R;UYM_Z_'U^9^1GP/\ C!^W9:> ])^%?AOX83:9
M%IMJFGVGB'Q%X?ELIK2!/D3]]<.D#;%P!^[<D*.&/7Q35_V0OC=X*_;"T5]:
M\->*_'30>(M,OM1\7V>C7<]G<N[PS3R"?8051F=2Q(^X20O0?N]16BG:JJSU
MDOQ,Y1O3E2Z,X7XZ?#*/XS?!WQCX'DN%M/[>TR>Q2X9=PAD93L<CN%;:?PK\
M7_AS\+?VO/V'_'VK2^#O .ORW%Y%]EN9-*T8ZS8WD2L2C9B5P,'YA]UAG! R
M17[M45A&/+-U(O5JWRU_S9JVI0Y)+2]_R_R/A[]MC1/B!\8?^"=6D))X8U?5
MO'VI6VBWFHZ-I^ERM=I<$QO.#;HI=-K%LKCY<<]*YW_@CW\,_&'PR^&?Q M?
M&'A37/"EU=:O#+!#KFG36;RH(<%E655+ 'C(K] Z*UBU&=645;G>W;;;[C*4
M>94TW\'X[_YGY=?M]?\ !.'QOXB^*US\7?@PGVS4KR=+Z_T:"X6VNX+Q2#]I
MMG8JK9*ABNX,&!*[MV%\\U#]I3]OC7_"LG@M_AYXDANKB+[%)KD?@^:*Z8'@
MMYY7R5)!QO"C'4$'FOV(HK&,%&'LMX]OZZ&TIN4O:?:[GYR_\$S_ /@GSXK^
M _BNZ^)?Q)AATWQ UH]GIFB1S)-);+(1YDTKH2H8J-H52<!FS@\#Q7_@K'\#
M/B1\1OVGK'5?"?P^\5>*-+7PY:0->Z-HMS=PB037!*%XT9=P#*2,YY'K7["4
M5I5_>N#>G+M^/^=R*?[M2_O;_A_D<=\&;&YTOX/^!;*]MY;2\M]"L89K>="D
MD3K;H&1E/(8$$$'D$5^/?Q"_9]^*-[_P4:NO$MO\-O%\_AQOB!!>C6(M"NFM
M#;B\1C+YPCV; H)W9Q@9S7[:T5HYWQ2Q75-NWJT_T(C'EPWU;IIKZ)K]3S/]
MI;X0?\+Z^!/C/P$MQ':7&M6#16T\P)2.=6$D3-CG:)$3..<9K\<_A7X%_;!_
M8C\7:W%X/^'GB+S-21(KU;#0SK-G<K&6\M@\*N 1N;&&!^8Y':OW8HK",7&;
MG%[JS-G+F@H26B=_R_R/BG]M?]D_Q3^V1^S?X$N[1H;'XDZ+:1:A]CU!#;+/
M)- GVFW;(_=.752-W *;3@'(^3_A3\9OVW/V5/!MI\.K3X-7GB/3-,W1V;W?
MAN[U+[.A);8D]G($906)&XMC.,X  _8:BKVE-QT4G>W3Y?U^;,U\$(RU<59/
MJ?D%^SC^PK\:OCQ^TO;?&+XRZ0WA+3AJT>NW272K!<WLR,'CACMP2T2 H@)D
MVG;TW')'Z^T455TH1IQ5HK;^ODA6;FZDG=L^6O\ @IAX.U_QY^Q[XMT7PSH>
MI>(M8GN;!HM/TFTDNKB0+=Q,Q6.,%B  2<#@ FOS?_9C_9A_:F^%_A/6_B;\
M-=-U[PEXIT^[%C<>&=8TTVLNIVA0.9$BN5"S!6R-N,_W#N&*_<6BLX1=-R<7
MJ_\ @+\4K/U+DU/E4EHOQW_)N_R/PS^(GP__ &R?VX?%VE:9XR\&^(;>WL'(
MMTU723HVFVFX@/*3(J!S@9)&]\9"CM7ZU?LF_L[6'[+OP1T3P-:7"W]Y#NNM
M2OU3:+F[DP9' _NC 5<\[47/->Q45I&2A!PBK7W\R)1YI*4GML?DA^UU_P $
MV_B9X!^,ES\5/@/')J%K+?G5H]/T^=8;_2KDL78Q*Q DCW<J%)8;MNT@9/#^
M,_B)^WC^T)X7E^'FJ>#?%=OI]_']GO7_ .$9_LH7:=UEN71$53CD*RA@2#D'
M%?M/164(*,%2>L5T-92<I^T6DNY\3_\ !.?]@FX_95TW4O%7C">UO/'^LP"V
M:&T;S(=-MLAC$'Q\[LP4NP^7Y%"Y +-=_P""G/[)WB7]I[X4Z%-X+MXK[Q3X
M:O)+B'3Y)5B-U!*H65$=R%#Y2-AN(!"D=<5]ET5=;]\DGI:UO*VO_#]]2:7[
MEMKK>_S5OR/R%_8=\4?M8_!?QYX(^%FH^!?$UA\-1K*QWCW_ (8E:&SADD+3
M%;L1[50LS-N+$#)P15W_ (*[_!/XB?$K]H#PMJ/A#P%XG\5:?#X9B@EN]$T:
MYO(DD%U<,49XT8!L,IP3G!'K7ZVT45/WG+S;IWOWTL%/]VY\NTE:W;6]_F>9
M_LQZ3?:!^SA\+M,U.RN--U*S\,:;;W-G=Q-%-!(MM&K(Z, 58$$$$9!%?DS^
MT]^S]\4=?_X*"ZYXBTOX;>+M2\/R>*+&X35K30KJ6T:)?(W.)5C*E1@Y.<#!
MK]LJ*TE/FQ2Q76[=O5I_H9<G^SO#]&K?@U^H5X?^V=^S_<_M,_L]>(_ ^GW<
M-EK$WE7>GS7'^K^T1.'57(!(5L%2PZ;LX.,5[A16$X*I'E9O&3@^9'XE_L[2
M?MB?L5ZIKOA3PM\(-3U6#5+A'GM[[0Y[^Q68#:)8[FW=4&5P"?,*\#(XJ#]L
M3]F[]JKXDVGA?Q[\1=(U;Q;X@U.2Y@C\,>&-.DO4T*W78R!EMPZ(9"S=V)$8
MW.3PO[=T54O?LY;KK_7EIZ$QM!NVSZ?UYZ^NY\S?LE_"FYU3]@WPK\/?&.EZ
MAH<]_H%WI>H6-];O;W4"S/,IW(X#*VU\C(]*_//PE^S_ /M7_P#!/7XG:QK'
MP_\ "3>.-)O$-JT^FV3:E;:A"#N0R6\3">)EZ_PX)(#,#S^TM%7.3E6E7CHW
MO^/^;(IQ4:,:$M5&UOE;_)'XN?&#P[^V#_P4&U3P[I/B;X5MX3T[297:(W&E
MSZ/:1-)M5II&NW:1\!>B9.,X4DU^CO@7]D'2O"W[&Y^ ]SJ;SPW.D7%E=ZI&
MG_+S,6D>9%/997RJGLH!KZ&HJ'&+I2I6TEOY_P!?UT*O+GC4OK';R/Q:^&_P
MK_:\_P"">?C/7G\&^ V\9:3JFV*;^S["35K*]$9;RY=D#+/$1O;KL^\<@\4S
MXH?#']KC_@H=XT\.OXN^&X\&V.DJ]O#+?:=+I%G:+(RF25EN&::0G8G"[ONC
M ')K]J**>[BZGO6V!Z7Y-+GDO@W]G#PYX<_9IL?@Q?&35/#T>B'1[J5OD>?>
MI\R0==I+LS#^Z<>E?EE+^R7^U)^P5\5+WQ)\*+&\\7:0X,*WVB6HO5O;<MD1
M7-D,R!A@$E5(!/RO7[3T42<G5=9/WGOY_P!7?WA%1C25&WNK;R_JR^X_%3XJ
M6?[:?[=*Z9X7\2?#S5-%T2SN%N/LMSH[:+9B7!432/<D,Y57;@,>^%S7Z/\
M[,'[(&F_ G]E^Y^%6J74>IW&MP71UZ[M@0DTUS'Y<@CR,[50*@) SLR0,XKZ
M,HI^[[.5.VDM_/\ K] ][GC.^L=O(_%OP[^SA^U3_P $^?BMJNO_  Y\+MXX
MTBX1K3[3IMF=0@U"WW;D$MM&PGC8$ \8P<@,P/+_ (R:7^V'_P % ;KP_H/B
M3X3R>%=,TNX,J>;I,^CVJ.X"F:1[N1G;:N>$)X)PI.*_:&BI^)*-3WDMOS_/
M4>S<H:-[_E^1\\?"K]D'3/ G[';? V_U)KN.^TJZL]0U*%>MQ<[VDDC![*[_
M "@]E&><U^</P_\ @Y^UQ_P3R\>:Y=>"/!#>--)U(+!,^FV#ZK9WZ(28Y#%"
MPGB9=[==OWB/F&#7[2T4Y.3JNJG9M6?:W_ %%)4U2:NEK\S\6/BQ\/\ ]KO_
M (*&>*O#D?BOX9_\(?8Z1YD4#WFG3:/9VWFE?,E?[2[3.3L3A-W"\+R<_J5\
M-/V;_#_@?]FG3?@U?LVL:&FCR:5?2,-AN?-#&=P.=NYG<@<XR/2O7:*?N^R=
M%+1[^>_^;%K[15&]5MY'XM:E^Q]^TY^PC\6KOQ3\(;2]\6Z/AHHK_1K=;QKJ
MV9L^1=6?+[OE4DJI ."K@](_BL?VU?VXK?3_  CXA^'6K:-HEO<+<-:S:,^B
MVC2#($LDER06VAC\H8CT4G%?M314I72C/WDMK_UWU_X)3>KE#1O?^OZ^X^?O
MV*_V6(/V6?@1!X,O;F#5M8OII+_6;B$'R9)Y%52B;N2BHBH"0,X)P,X'YD_'
M']@WXY?LI_&YO&OP=TG5M<T6VOFN]#U+PY!]KN[-6+8@FMP&=MJDH3L9'7KU
M*C]MZ*J;E*JJR=G^G_ Z=A1M&FZ35T_Z_P"'/Q_\1^"_VTOVROAQKL7Q"AU+
MPIX,TG3I[\Z2^DBRN=8N88VDA@6U51-*SN$ # (#@@%@ =C_ ()#_!3XA_#7
MX[>+-0\7^ _$WA6PF\.O!%=:WH]Q9Q22?:83L5I$4%L G YP#7ZT45=.7LYN
M<5NFOO35_P ?P1%2/M(*#>SO]S3M^'XA7 ?'[X8P?&;X*^-/!,X4_P!M:7-:
MQ,P!"3%28G_X#($;\*[^BN>I!5(.#ZFT).G)370_GL^!/[%'Q9\7?&KP7H?B
M3X8^+]&\/3:O"-1OM3T*Z@M8;=7#3%I'C"C**0#GDD#O7['?MZ?!V?XT?LG^
M./#NEV$M]J]O:KJ.FVMK$9)9)[=A(L<: 9+,JL@ Y._%?0M%:5/WM'V3[WOY
MZ?E8FG^[K>U7W>6OYWU/PK_81_8W^)&K?M2^!KKQK\._%/AWPUHMR=6N+O7-
M&N;2#= #)%&'D0*2TOE_+GD;O>OV@^-FGW6K?!OQW965M->7ESH-]#!;V\9>
M261K=PJ*HY9B2  .237:445OWU'V.RL_QZ_E]P4?W57VV[T_ _'[_@DU\#?B
M1\./VFM2U3Q9\/O%/A?3&\.74"WNM:+<VD)D,T!"!Y$5=Q"L<9SP?2OL+_@I
MA^RKXB_:?^#>EIX.BBN_%7AV^-[;6,LBQ?:XG0I+$KL0JM]QAN(!V$9Y%?7]
M%%;]]",']G_.XJ7[J3DNO^5C\>OV*O$?[6GP*\<>#?AA<^!/$]E\.GUV)+YK
M[PQ++!:0R3#SV2Z$>U4.6;=N*CDC&:[7_@L)\&_'_P 3?B9\/[KP?X'\2>*[
M:UTB>*>;0](N+Q(G,V0KM$C!21S@U^J%%*I^]Y.;>+O?OI:WR"'[MSY=I*WX
MWO\ ,\=_8[T+4O#'[+7PNTG6-.NM)U6ST&UAN;&^@:&>"0( 4=& 96'H1FOR
MN_;T_9]^*/C#]N#Q9KV@_#;Q?K>AS7FGM%J>FZ%=7%M(%MH%8K*D94@%2#@\
M$'TK]LZ*UY_]H6(ZIWM\[DQCRT'0Z-6&0@B% 1@[1_*G,H92",@\$&EHK-ZC
MBN5)'Y._MF_\$F_$4WC#4/&OP0BMKRRO9C<S^%6G6VFM92<L;5W(0QYRVQF4
MKT7<" OC=IX\_;[\(Z8?"\-G\4GMHQY(D;0);UP.1Q=F%VQ[B3TYZ5^XU%1&
M/)'D3]WL:2ES/G:U[GXK_ 7_ ():?&'XV^.U\1_&-[SPOHD\PN;^ZU2\6YU;
M4<G)51N8HQQ@O*01G(5NE?LQX?T'3_"NA:=HVDVD=AI>GV\=K:VL(PD42*%1
M0/0  5H45MS>ZH15D8\OO<[=V?#?_!73X=^*OB5^SWX;T[PCX9UCQ5J$/B2&
M>2TT6PEO)4C%M< N4C5B%RRC.,9(]:K_ /!(;X<^+/AK\"/%NG^+_"^L^%;^
M?Q&\\5KK>GS6<LD?V:!=ZK(JDKD$9'&0:^[**FG^[]I;[7_ _P C2H_:<E_L
M_P#!_P PHHHI"/S'_;N_X)7ZE\1/%VI_$/X/"S&IZB[7.I^%[B1;=9ISRTMO
M(V$#.>61RHR20W.VOF[1_$W[>WPETT^$]/T_XF_8K<>2BKH;ZJL:C "QW)BE
MPH  &U\ =*_<FBHA'V:Y8OW>Q<I<[YFM>Y^(?PK_ .":_P ?_P!I+Q\GB+XJ
MMJ/AG3;QUEU#6_$ER)]2G0?P1PEBX;  'F;%4=,XVU^R_P /OAYH7PQ\!:+X
M.T"S6UT'2;1+*WMV^;**,$L?XF8Y+'N23WKI:*VYER>S2LC+E]_G;NS\=_VB
M/^"<OQ>_9]^,C?$CX QW.JZ5#=MJ-A%I3H-0TEB23%Y3?ZZ/YBH"ABRDJZ]V
MYOQ_XH_;J_:I\/GP!K7@KQ/:Z1<[1=Q/X>&C0W>T@CS9Y5C7;D9VA@I[@\5^
MUE%8QBE%4Y:Q6R-92;ESK23ZGR-_P3W_ &'Q^R-X/U.^U^[MM3\>:\$%]-:$
MM!:0H24MXV(!;DEF; R< #"@GXI_X*K? GXE?$3]J@ZMX4^'GBOQ-I7]A6</
MV[1]$N;N#>K2[EWQH5R,C(SD9%?L?155KUI1D_L_Y-?J13M3C)+K_FG^AS?P
MUM9['X=>%K:YADM[F'2K6.6&52KHPA4%6!Y!!&"#7S3_ ,%"OV'S^UQX/TN_
M\/W=MIOCO00XLI+PE8+N%R"\$C $KR RM@@'((PQ(^NJ*=:U>3D]'>_H*A^X
MBHK6RMZGXI^ ?%/[=7[+'AX?#_1?!7B>YTFUW"TCC\/#68;3<23Y4\2R+MR<
M[2Q4>@YKIOV=O^"<?Q=^/_QB7XD?'^.YTO2IKM=0OX=5D0ZAJS#!$7E+_J8^
M I#!2% 55[K^PU%7&;C-5'K)=2913BX+2+Z'S_\ MY>%M5\6?L@_$;0_#ND7
MFLZI<6$4=KINF6SSSRD3Q':D: LV "< =!7R3_P1Q^$?CKX8:Q\4G\8^"_$/
MA)+RWT\6S:YI4]D)RK7&X(947=C<N<=,CUK]-J*BG^[G.?\ ,K&D_?IQI]$[
M_E_D?"'_  5\^''BWXF? SP=8>$/"^M>*[Z#Q&L\MKHFGS7DL<?V6==[+$K$
M+D@9/&2*W/\ @F%\+]>\,_L?ZAX6\:>'=6\-7E[JVH)+8:Q8R6DYADCC7=Y<
MB@X(W8.,'!K[3HJ8Q48U8M74]_P_R%.\I4Y+1PU7X_YGX<6?[,_[3'[!OQZ/
MB3P#X,U'QA%;F:WL]2TG3)-3M;^T?^&:*',D9("Y!VD,ORDC!/J/QY\&_ME?
MM:?!G7==\>:"WA7PWI,,-U9>"-$T^07>L7'FJO\ Q[!Y)_D5F?$IX*#:A.6'
MZ[44-.4%"3O;;^OQ]2DU&?/%6OOY_P!;=[=3\[_^".OPN\9_#'P;\2X/&/A'
M7?"<UW?V;V\>N:;-9-,JQRAB@E5=P!(R1TR*^6OVSOV??BEXH_;S\4^(-%^&
MWB_5]!FUG3Y8M4L-"NI[5T6"W#,LJQE2 58$@\8/I7[:T5O[1_6(8CK%)?=;
M_(Y_9+V$Z%])7_&_^85YA^TU\'[;X]? ?QGX'N @DU2P<6LDAP(KI,20.3Z"
M14)]LUZ?7YC_ +?GQ0_:RM_C)XE\&_"_2/&%Q\/;JQMX4N-!\+M<*QDA'G*M
MVL#,IW$Y*N"OJ*XJ_O1]FMY7M]QVT?=ESW^'7\4?F=\'_AYK/QA^*7A#X;VT
MUP?[2U=;80JY9+?S&03S!<X!$<89B.HC'H*_I:T#0[/PSH>G:/IT*V^GZ?;Q
MVMO"HX2-%"JH^@ K\WO^"7_[ OBSX1>,+GXH_$O2_P"Q-5CMGM=%T>9D>>/S
M!B2XD"D[#LRBJ?F^9\@<9_3"O1F^6G&GUW?Z+Y?A=HX8^_4E42TV7Z_UY7(+
MZZ%C97%RT<LJPQM(8X8S([ #.%4 EB<< <FOP^\!_LZ_%O\ :3_;@L?$_CWX
M:>+M!T'6O$AU74;K6M#NK>VAM(V,BP-)(@4#RXUB SSD"OW(HKFI_NZT:W6.
MWY_HC>?OTI4N_P#PWZL0# P!@5^;O_!8+]FOQ+\4+/P%XS\%>%]5\3ZQ9/-I
M-]:Z+82W<_D./-B<I&I;:K+(,XQF4>M?I'16<X<]GU3O_7RT-(2Y+^:M_7YG
MP;^RRWQ!UO\ X)P^-_!'BOP7XET?Q5H>A:MHMC8:II%Q;W-]"UK(UMY*.@:3
M_6>4 H)R@'<5\]_\$C_@A\1OAM^T?X@U/Q=X \4>%M-E\,7%O'>:UHUS9PO(
M;FV8('D106(5CC.<*?2OUVHKI51JO*O;5JWX-7^=[F/+^YC1Z)W_ !6GRM8^
M3_\ @I]X+\0^/_V1]>T?POH.I^)-7DU"Q=-/TBSDNKAE6=2Q$<:EB .2<<5Y
M7_P1]^&OB_X7_#'X@V_C+PKK?A*XN-7AFABUW3IK)Y4$&"RB55) /&1Q7Z"5
M2UK2XM<T>_TV=G2&\@DMW:,X8*ZE20>QP:YX\U&-5P5W+_@?Y%R2J2I\VBC_
M ,'_ #/P;M=6^(7@S]M#QQ%^S%XMU#QKJ^J75T4U/3;%)C-"\HDE643HT;*C
MX'G'Y6P&!&[%>W>*/C9_P41^%^DS>(?$=IJDFCV:F:Y;^P-+N(TC7EFD^SQ%
MU0#.6R !DY&,USNA_LK_ +3_ .P#\9KWQ=\-_"J^/--$4ME'=V%L;Z.]M78,
M$FMHV6=&RD;';@!EX9AG/I/BK]K#]MSXR>&]3\'V/P&N/#9UBWDLY=0'AJ_M
M7CC=2K;9;J3RD)!(W,#C/&#@TH^[0A&D[M*UG^7I_7K<K.M*5163>Z_/^O\
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MK76]/FLY9(_LT"[U615)7((R.,@U]V45%/\ =^TM]K_@?Y&M1^TY+_9_X/\
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MKIGP[\4ZS9_$NUTNZFFL+K4M(2,6\4ASY2QO)+T8O@@CAL8XK\^;[PEH:_\
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MJ/J&KR@AEC:-<B&+( 8-M(4;54 Y7]?Z*J,W&:JO62ZDRBG'D6D>QY)^U-\
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>figure2a.jpg
<TEXT>
begin 644 figure2a.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" /I#Q<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KS;XR_M'?#7]GW3$O?'_ (OT_P /
M"1=T-K(QENIQG&8X(PTCC/4A2!W(KYL_X*(_\% (_P!F'2T\'>#3!>_$G4H/
M-\V51)%I,#<+,ZGAI&YV(>.-S9&%;\2_%WC#7/'WB.^U_P 2:M=ZWK5])YMS
M?7TIEED;W8]@, #H  !P*Q4W-^YLNO\ D:N*BKRW?0_83QA_P6J^%&DS30^'
M?"/BGQ T9(6:=(+.&3T*DR.^#[H#[5R&D_\ !<3P]->*NI_"?4[2U[R6FLQS
MN.1_"T*#IG^*ORW\$?#+QA\3+R6U\(>%=:\4W,(!EBT;3YKMHP>A81J=H]S7
M::A^R3\;M)M7N;KX1>-HK=!EY/[ NB%'J<)P/>MK<NK,OBT1^POPM_X*R? +
MXC7D=EJ&JZIX&O)'6-!XDLPD+,?^FT+2(B_[4A05]>Z/K6G^(M+M=3TJ^MM3
MTZZC$MO>6<RRPS(>C(ZDA@?4&OY9YH9+>9XI4:*6-BKHX(92."".QKWS]D_]
MM#QY^R?XJAGT6]EU/PI-,&U+PS=2DVUPIX9DZ^5+CHZ^@#!AQ6L>2>CT_(SE
MS1U6I_1361XN\36O@OPIK/B"]CFEL]*LIKZ>.W ,C1Q(78*"0"V%.,D#/<5B
M?!_XL>'OCA\.-#\;>%KK[5HVK0":/=C?$W1XI "<.C JP]0:J_'O_DAGQ$_[
M%W4/_2:2N7$N5&G-]8I_@=.'4:U2"Z-H^//^'U?P0_Z%;X@?^"ZQ_P#DROI[
M]F#]J+PK^UEX$O\ Q9X1T_6-.TZRU%],DBUJ&**8R+''(2!'+(-N)5YSG(/'
MK_-Q7[3_ /!%?_DV'Q1_V-MQ_P"DEI7;3@I0J-]%?_R9+]3EG)Q<4NK_ $9^
M@-%%%<YJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\<_&[_@J9
M\*?@'\4]?\ ^(/#_ (RO-8T62.*XGTVRM'MV+Q)(-C/<HQ&''51SFM?]G'_@
MI)\,_P!I_P")47@?PMH?BRPU:2UFNQ-K%I;1P;(P"PS'<.V>>/EK\GO^"D__
M ">[\4?^ONU_](H*[[_@D'_R>18?]@2^_P#05HPG[Z$7+K&__DMR<4_9-J/\
MR7_DR1^Z5%%%!04444 %?%/Q3_X*S?"+X1?$;Q%X+UCPYXVN=4T.]DL;F:QL
M;-X'D0X)0M=*Q7ZJ#[5]K5_.+^V]_P G=?%O_L8KO_T,UA*;5:,.C3?W./\
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MYG[11\O\B>O!OVAOVW/A)^S*QM/%_B+S]>*>8F@:3']IOB,9&Y 0L>0>#(R
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M)6>,@XX:;?6+?YK]#3"24L1!+I)?H_U/YDZ_:?\ X(K_ /)L/BC_ +&VX_\
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M)UTW?#2?G'\I'<_\$V/@/X=_: _:<T_2/%47VO1-)L9=9FL&&4O&B>-4B?\
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M?A1^S3XGOO$'@+1;O3-3O;0V4TD^H37 :(NKXVNQ .Y%Y%>I_$;Q6G@3X?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#]J[]DWP?^UIX _L'Q$K6.K6FZ72=<MT!GL92!G@_?C; W(2 0!@@@,/P_\
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MCTZ%;W'INK-=M4_S0ZU*TE9[/1]^GZ_(_JDAN(KA=T4BR+ZHP(K^>C_@H/\
M!^Z^#/[6'CFQD@:/3M8O'US3Y,?+)#<L9#C_ '9#(G_ *_0W_@BA_P F[^,_
M^QH?_P!);>O>/VY/V,=)_:\^'<=M%-#I/C;2 \FC:M*IV G&Z";'/E/@<@$J
M0& /*MGB*3I5(SCK9+[I)/\ #3\2J%15(2A+2[_%-K_,_(#_ ()]_M'V/[,W
M[1FEZ_K;M'X9U.W?2-5E52QAAD966; ZA)$1CCG;NP">*_H(T76M/\1Z3::I
MI5];ZEIMW&LUO>6DJRQ3(1D,CJ2&!'<5_,[\7_@?XX^ WBJ7P_XZ\.WF@Z@I
M/EM.F8;A1_'#*/ED7D<J3CH<'BL[PG\5/&O@*VFMO#/C#7O#EO,29(=)U.>U
M1R1@EA&P!X]:W]JJE-+MM_E]]S'V;IS;[[_Y_<?OY^VK^U5X=_9@^#^L7]UJ
M-O\ \)=J%K);Z%I(<&>>X92JR;.HC0G<S'CC&<D _P [CNTCLS$LS'))ZDU;
MUC6M0\0ZE/J&JWUSJ=_.=TMU>3-++(?5F8DD_4U]=_L6_P#!./QM^T9KVFZ]
MXHTZ\\*_#:-TFGOKN,PSZC'P?+M4(R0PP/-^Z 206(VUE2HN4W-O_)+^OO[&
ME2JHP44O\V_Z^[N?:?\ P1E^#=WX.^"OB7QYJ%NT$OBR^2*RWC!:UM@ZAQ[-
M))*/?8#Z5]@_M.Z1<:]^SC\4-.M$,EU<^&=1CB11DLQMI, ?4UW?AOPWIG@_
MP_INAZ+90Z;I&G6Z6MI:0+M2&)%"JH'H !5^:%+B%XI462-U*LK#(((P0:K%
M_OXRC#M9?=9?\$6%O0E&<M6G=_??_@'\K5?KC_P1G^/WAN+X?:[\*]4U2VL/
M$<>J/J>FVUQ($-Y#)&@=8\GYG1HR2HYPP..#CXC_ &Y?V/\ 7_V6?BIJ*I83
M2^ ]4N7FT/544M%Y;$L+=V_AE0<8/W@ PZ\?-5%"LG!NVZL^ZU3_ #0JU&TE
MKL[I_A^3/ZC?&'C;P]\/M"N-:\3ZWI_A_2;<9EO=2N4@B7VW,0,GL.IK\0?^
M"EW[9WA_]JKQMH&E^$+21O"WA?[0MOJUPK))?R3>7O=8SRD8$2[=PW')) Z5
M\C>'_#^N>.]?LM'T73[[7M9NV$-M96<3SS2GLJJ,D\?D*^BOVD/V'];_ &7?
M@7X*\4>,;GR_%_B+4I(9=)@=7BL(%BW*CN.&E)/.T[1C SR:QJ1LE5F]$U;U
M;M\]_D:TZEGR0^)I_=9W/F.V_P"/B+_?'\Z_J=LO^/.#_KFO\J_EBMO^/B+_
M 'Q_.OZG;+_CS@_ZYK_*O0E_NT?\3_*)R/\ BKT?YH_'W_@M=\-;C2OB]X*\
M<QQ,;#6-).FR2!>%GMY&;!/J4F7'^X?2O@+X<^-KWX:_$#PWXLTX!K[0]1M]
M1A5B0&:*17"GV.W!]C7]$'[6W[-NE_M3_!?5?!=]*EEJ&1=Z5J+)N^R7: ['
M(_ND%D8#^%CCG%?SY_&#X+^,?@/XVO/"OC;1;C1M5MV.WS%)BN$S@2POTD0]
MF'T.""!YN'FZ%2W5.Z^^_P"#_"QVUHJM"_E9_E^*_&Y_1S\%_C+X7^/7P\TK
MQCX2U&*_TR^B5G17!DMI< O#*H^ZZDX(/U&00:ROV@/VBO!'[-?@6Z\3>,]6
MBM$5&^R:>C W5_*!Q%#'G+$G&3T7.6('-?SA>$?'WB?P!>2W?ACQ'JWARZE7
M;)/I%]+:NX]"T; D5VWPK^$?Q-_:R^(\>E:%!J?BO6[AE%WJE_-)+':QG_EI
M<3MG8@ /4Y.,*"< ],XNH[4M+_A_7G\[G/!JFKU-;?C_ %Y&/\=/BYJ7QX^+
MGBCQ]JT$5I>ZY=FX-M#RD*!0D<8/?:BHN>^,]Z^F_P#@D'_R>18?]@2^_P#0
M5KP+]JCX&K^S?\<-<^'RZB^K?V3#9E[UT">:\EK%*Y"CHNYVP#R!C.3S7OO_
M  2#_P"3R+#_ + E]_Z"M5A.564-N5V_\!9&,YK7GNW%_?),_=%E#*58!E(P
M0>AJ#^S[7_GVA_[]C_"K%%9FI7_L^U_Y]H?^_8_PH_L^U_Y]H?\ OV/\*L44
M %?SB_MO?\G=?%O_ +&*[_\ 0S7]'5?SB_MO?\G=?%O_ +&*[_\ 0S7)+_>(
M?X9?G$Z8_P "7K'\I%C]BO\ :3/[*_QYTKQE/9'4-&EB?3M5MXP/--K(5+-'
MG^-61& [[2N1G(_H.^'OQ&\,_%?PG8>)O".M6FO:'>IOAO+-]R^ZL.JL.A5@
M"#D$ U_/E^RC^RGJ_P"U=?>.-(T"\2VUW1=$.IV$,Q"Q74PGC3R78_=W(SX/
M0-MR0,UYS+=>/?@;XJU31_M>O>!O$%L_V>^M8;B:RG4CG:X4@D=QV(((ZUZ$
MI^[&$][77I=_K?TOKNCAC'64X/2]GZV7Z6]?DS]^/VTOVIM _9?^#NKZI=7\
M'_"5WUM);Z%I6\&:XN&7:LFSKY:$AF;IQCJP!_G8DD:61G<EG8Y+'N35S6M>
MU/Q+J4VHZOJ-UJNH3',MW>SM-*Y_VG8DG\37LO[*_P"R!X[_ &K/&4&G>'K"
M:S\.Q2A=3\27$1^R6:<%ANX#RX/$:G)R"<+EAA3HRE-RZO[DE_P^YO4JJ,%'
MI^;_ *V/T+_X(G_"^YT7X;^._'EU"T<>N7T.G6;,,;X[=6+LOL7FV_6,UV7_
M  6=OKNV_99T2&!F6VN/$]LEQMZ,H@N&4'VW*#^ K[.^%OPUT/X._#W0?!GA
MNV^RZ+HUJMM G\38Y9V/=F8LS'N6)KB?VLOV?[7]IKX$^(_ DLZ6=[=(MQIU
MY(,K!=QG=$Q[[21M;'.UFQ3QK]HO<U2Y?NBU^+M>W<6#]QWGO*_XII?=I]Q_
M-O7])/[(,/AZW_9?^%Z^%A"-&/A^T9/)QS(8P9BV/X_,W[N^[.>:_G@^)WPM
M\5?!OQC?>%O&.BW6A:W9MA[>Y3 =<D!T;HZ''#*2#V-=/\)_VHOBO\#;*6R\
M#>.]7T#3Y&+M8Q2B2VW'JPAD#(&.!E@,GUK:%6+I.*ZV?W7_ ,S*=.2J*3Z7
M7WV_R/Z-_'OQ \.?"_PI?^)?%>L6NA:'8IYD][>2!$7T [LQ/ 49))  )K^=
M7]KCXN:7\=_VCO'/CK1()[?2-6O%:U6Y $ACCB2)78=BPCW8[;L=JT=/F^.?
M[<'CZST0ZEXB^(FK[]R)=7#O:6"MPTC9_=6Z>IPH/3DX%9'[4'P!N_V9OBY>
M> K_ %.+5[RSL[2>:Z@0K&9)8$D=5!YVJS,H)P2 #@9P.5P<9QJ3TO=+\W^1
MTJ2E&4(=-7^2_,]^_P""0?\ R>18?]@2^_\ 05K]Q]7FN;?2;V6R1);R.!V@
M23.UI I*@XYQG'2OPX_X)!_\GD6'_8$OO_05K]TJZZZ<J<$G;W7^;..@[5*C
M:^TO_28GXRR_\%K/C##(\;^"O!2NA*LIM[S((ZC_ (^*^^_V _VO+G]KKX7:
MIJ^MP:5IOBK2M0:UO--TO>JI"55H9=KNS8;+C.<91O2OSX_X**?\$\_%'P[\
M?:W\1/A_HMSKW@?5II+^\M=/C,L^DS,2T@:-?F,))+!P,*,AL  M\/>!?B'X
MH^&.O1ZWX1\0:EX:U>-=@O-+NG@D*Y!*$J1E20,J<@XY%84*D91?.M;?<_Z_
M#4Z:U-QDG!Z7^]?U^)_3KXB\-:1XNT>YTG7=+LM:TJY79/8ZA;I/#*OHR."I
M'U%?S]?\%#/A3X1^#/[57BKPWX)CCM-%6.WNO[/B?<EE++$'>%?103N"]@P'
M0"GZA_P4@_:1U32I-/F^*6H);R)Y9>WL[2&;&.TJ0AP?<-GWKP2WM_$/Q&\5
M>7#%J7B?Q)JDY;:BR7=W=S,<D]W=B<GN36;IN52,H_\ #^12FHP:E_PWF?1?
M_!,>VN;C]MWX<&V21O+DO))2G\,8LIPQ/MSC\:_?77M'MO$6AZCI5XGF6E];
MR6LR'^)'4JP_(FOA'_@F/^P?JO[/=K>_$/Q_:K:^-]4MOLMGI>X.VFVK$,^\
M@D>:Y"Y ^ZHQG+,!]^UV8A1E3C1>NCO\^GW?C<Y:,I<[JK3:WRZ_>?S!?%;X
M=ZE\)/B5XF\&:O&T>H:)?RV4FX8WA&(5Q_LLNU@>X85]Y?\ !'_]J+1/AMXF
MU[X7>*=0ATNR\27$=YI%U<N$B^VA1&\+,> 9%$>W/!,>.K 5]+_\%'?^">TW
M[1D:^/\ X?PP1_$.TA$5W8R.(DU>%1A!N.%691P&8@,, D84C\8O%G@_7? ?
MB"[T/Q)I%[H6L6C;)['4(&AFC/NK '!['H:YL/6<%R5-7:S\_-?@_+8Z<134
MWSPT5[KR\OT\T?U(U\C_ /!1[]K6?]F3X.QQ^%M=M].^(NKW,2:9"T4=Q)'
MK[IIFB<$;-JE,D?><8Z''XNZ'^U#\8O#.DQ:7I/Q5\9Z=IL2".*UMM>NDCB4
M# 5%$GR ?[.*X'7O$6J^*]6N-5UO4[S6-4N6W37M_<//-*>F6=R68_4TJD7*
MRB[+^OS"$E'62/J?_AZM^TM_T/5K_P""*Q_^,U^UG[.NL^)_$?P)\!ZOXTG^
MT^*M1T>VO-0D\E(<RR('(V( JD!@, #I7Y#_ +!?_!.+Q1\:/%NE>,?B#HMU
MH'PXLY$NA!?QF*?62,,L<:,,B$\;I" &4X7))*_MW'&L,:HBA$4;551@ #H!
M77**A3Y7\3?W+_@W_ Y4W.I=;)?>_P#@?KZGXN?\%G/AO<>'?VB-!\7K#C3_
M !'HR1^:!P;BW8HX_P"_;PU\7?!GXE7?P=^*_A/QM8IYUQH6I0WWDYQYJHX+
MQY_VEW+^-?O[^VA^R[8?M8?!>]\*O-%8:]:R?;M%U"4';!=*" 'QSY;J2K8S
MC(."5%?S^?%#X4^+/@OXQO?"_C/1+K0M:M6PT%RF ZY($D;?==#CAE)!]:X,
M/)X>=NJ=UYZW_!G;7BJT+]&K/[K?BC^E#X6_%+PS\9O VE^+?"6J0ZMHNH1"
M2.6%@61L?-&XZHZGAE/((KD/VD?VGO!'[+_@6Y\0>+=2B6[,;?V?H\4@^UZA
M*!PD:=<9QER-JYR37\Z7A'XB>*OA_-/-X7\3:QX;EG&V632+^6U:0#/#&-AG
MJ>OK7>_!CX%_$S]KKXC#3M!M[_Q!J$TBG4=<U&222&T0_P#+2XG;.. <#)9L
M84$UT2A*J^6EI?\ #^N[^9A&2IJ]36WX_P!=E\CC_BU\2M3^,7Q,\2^-M82*
M+4M<OI+V:* 82/<>$7V48&3R<<\U]A_\$9_^3L-4_P"Q7N__ $?;U\N_M,_!
MV+X _'+Q5\/X;Z34X]#EBA%Y,H1IBT$<A;:. "7.!V&,\U]1?\$9_P#D[#5/
M^Q7N_P#T?;UI@N33V?P\KMZ<K)Q3DVW/>ZO_ .!(_;BBBBLBPHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *:Z+(K*RAE88*L,@CTIU% 'COC#]CKX(>/9IIM:^%?
MA:XN9B6EN8--CMII&/4M)$%8GW)KC]+_ ."<?[-^D70N(/A9ILD@_ANKNZN$
MZY^Y)*R]O2OI*BDO=V&]=SCO ?P:\!?"U7'@[P7H'A=I!MD?2--AMGD'^TR*
M"WXDUV-%%5=O<FR6P4444AB=>#7!>(_V?_A=XQO&O-?^&WA'7+MCEI]2T*UN
M)#UZL\9/<_G7?44AG.^"?ASX3^&NG3:?X0\+Z-X5L)Y?/EM=$T^&SBDDP%WL
ML:J"V !D\X KHJ**J[>XC*\3>$]$\::/-I/B'1]/UW2YO];8ZG:I<0O_ +R.
M"I_$5X7X@_X)Y_LZ>)KS[3>?"G1H9,D[=/>:R3G'\$,B+V]*^B:*FRO<=WL>
M1> _V1?@M\,KFWNO#?PR\-6%[;D&&]DL$GN8R.ZS2AG!]P<UZ[115-M[DV2V
M"BBBD,SO$'AS2?%NCW.DZYI=GK.E72[)['4+=)X)5]&1P58?45X)JG_!.[]G
M+5M6_M&?X5:1'<;@VRUEN+>'(.?]3'(L>/;;BOHRBE97OU'=VL<5\.?@GX ^
M$,,D?@KP9H?A?S5"2R:781PR3 =/,=1N?'^T36CXW^&OA#XF6-O9^,/"NB>*
M[.WD\Z&WUS3H;R.)\8W*LJL <$C(YP:Z2BF_>W$O=V/*A^R?\$5((^#G@ $?
M]2O8_P#QJO5%4*H & . !2T4[NU@"N<\<_#GPK\3M'_LKQ=X;TKQ/IN[>+75
MK..YC5O[RAP<-[CFNCHJ6D]QW:V/G*'_ ()U_LY6^K?VBOPKTDW&[=L>>X>'
M/_7$R&/'MMQ7N'@WP'X:^'6BII'A7P_IGAO2D8L++2;..VAW'JVU !D]SU-;
MM%5=I6)LF[G!>+/@#\,/'VM2ZSXG^''A'Q'J\JJDFH:MH5K=7#JHPH,DD98@
M#@<\"G^#_@-\,_A[K*ZOX6^'?A/PUJRHT0O]'T2VM)PC?>7S(T#8/<9YKNJ*
M2]W8;][<**** "BBB@ KSC7/V:_A%XFU>[U76/A7X*U;5+R0S7-]?>';.:>>
M0]7=VC+,Q]2<UZ/12MK<=^AQ_@?X.> ?AE=75SX/\#^&_"=S=((YYM#TFWLW
MF4'(5S$BE@#S@U5^)7P)^'?QDCC7QOX*T3Q.\2E(I]1LDDFB4]0DF-Z#_=(K
MNJ*;][<2TV/GCP[_ ,$]_P!G7PO??:[/X4Z+-+UVZB9KZ/\ []SNZ_I7O>D:
M/8>']-MM.TNQMM-T^V01P6EG$L442CHJHH 4#T JY13N[6%97N%%%%(9ROQ
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M_-ID0N7^LRJ'/YUZA14V3W*NT?-=G_P3?_9NL;U;J/X6:<TH).V:\NY8^?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH H:]KEEX9T/4=8U*=;;3]/MY
M+NYF<X6.-%+.Q/H ":_'#5_^"UGQA;5KTZ7X3\#IIOGO]E6ZL;QYA%N.P.RW
M8!;;C)  SG@5]H?\%7OC0?A9^ROJ&B6DWE:MXQN%T>+:?F%OC?<-]"B^6?\
MKJ*_">.-II%1%9W8X55&23Z 5SQDY5)=EI\]W^%OQ-Y14:<>[U^6WYW_  /T
MY^ __!8?XB>,OC%X1T#QQH'@^P\+:IJ$=C>W>F6EU%/ )#L5PTERZ@*[*6RI
M^4'IUK];:_E85FC8,I*LIR".HK^C[]C7XS#X^?LV>"/%TDWG:E-9+::D>,_:
MX?W4Q([;F7</9A7H<JE1NMT_P?\ E;\4</,XU;/9K\5_G^A[31117.;GYY?\
M%!/^"AWQ&_91^,VE^$?"6B^%]1TVZT6'47EUJTN99A(\LR$ QW$8VXC7MG)/
M-?/_ (%_X+'_ !H\3^-O#VCW7ACP'':ZAJ-O:2O#I]Z'5))51BI-V1G!.,@U
MSW_!:'_DZ30/^Q6MO_2FYKXQ^$7_ "5CP5_V&[+_ -'I1@OWDXJ6OO-?^36#
M'?NX2<-/=3_\E3/Z?**** "BBB@ KS3]I+XR6_P ^!_C#Q[.L,LFCV+26L$Y
M(2:Y8A((S@@X:1D!P<X)KTNOS _X+6?&HV/AWP7\++*?$M_*VN:DBMSY4>8X
M%/LSF5OK$*YZTFH\L=WI_G]RNS>C%.5Y;+7^O5Z'BO\ P^K^-_\ T*WP_P#_
M  77W_R97T'^PS_P5 \8_M#?':T\!>/M'\,Z5;:I9S'3KC1;>XA=KJ,!PC&6
M>0%3&LG0 Y ]:_'Y8VDSM4M@9.!G ]:Z/X:^/-1^%_Q!\.>+M)<IJ.B7\-_#
MS@,T;AMI]B 0?8FNZCR^T2GL_P!=+_+<XZO-R/DW_K3YG]0E%8G@CQ=I_P 0
M/!NA^)M)E$VF:Q90W]M(.\<B!U_'!K;K.47"3C+=%QDI14ELPHHHJ2@HHHH
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MDI*/O=W]U] HHHK$V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[QS\/]/TC5=5T1H[FZM=9@EFB:TW;9641RQD,NX/G)&U6XK\Q/\ A]7\;_\
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MX"7_ (QTFWL+SQ#)>6]AIEKJ2N\$DKMEMZHZ,0(TD;AAR!7YK_\ #ZOXW_\
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M94Y<\;O^K:!11161H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5^>W_!97XU?\(?\  [1/A]97&R_\67OFW2*>?L=N5<@^FZ4Q?4*U
M?H37\_\ _P %+OC4?C-^UAXH-M/YVC^&R- LL'*_N2?.;\9FEY] M<U;WI1I
M]W?Y+_@V7H=%+W5*IV_-_P# N_D?+MC9S:E>V]I;IYEQ<2+%&@_B9C@#\S7]
M)_P'T+PQ\&?@UX-\$VVMZ85T33(;61UNHQYDH4&5^O\ $Y9OQK^:JBN[GM3Y
M%U=_NV_-G'R7FI]E;[_^&/WU_P""CO@[0OC+^R7XPL[74]/N=6T5%URP5+B-
MG\R#+.%&>2T1E7_@5?@5117-&'+*4EU_/_AK?<=$I\T5%]/Z_P _O/Z O^":
MOQJ_X71^R?X6DN9_.UCPZ#H%]N)+9@ $3'/4M"T1)]<U]35^,?\ P1I^-7_"
M(?&S7?AY>W&RP\5V7GVB,QP+RW!8 #IEHC+GU\M:_9RN[$>])5/YM?GU_&_R
M..C[J=/^73Y=/PT^1^*/_!:'_DZ30/\ L5K;_P!*;FOC'X1?\E8\%?\ 8;LO
M_1Z5]G?\%H?^3I- _P"Q6MO_ $IN:^,?A%_R5CP5_P!ANR_]'I7+E_\ $A_B
M?_I3.C,?X<_\"_\ 24?T^4444 %%%5=4U*VT73+O4+V5;>SM(7GFF<X5$52S
M,?8 &IE)13E+9#2<G9'Y'?\ !:CXU?VSX\\(?#"RN-UMHMN=7U&-6!'VB;*P
MJWH5C#-])A7PA\ _AP/BY\:/!G@^258+;5M3A@N9G<(([?=NF;)Z8C#G\*?^
MT#\5KKXX?&KQCXYNBV=:U&6XA1^L< .V&/\ X#&J+^%>?5.$;I\M22U;NU^G
MRV^1>*7/>G%[*R?Z_?J?U%6?B7PWI]G!:V^L:9%;P1K%'&MU& JJ, #GL!7Y
M^_\ !9+P+I'CCX+^&O&^F7UE=ZGX9U'[/.(+A'?[+<@*3@')Q*D7TW&OQWHH
MJ1]I:[UNG_7KL*G)4]EI:WX%O2-6N]!U:RU.PG:UOK*=+FWGC.&CD1@RL/<$
M _A7]+WP"^*EI\;O@SX/\<V94)K6G17$L:G(BFQMEC_X#('7\*_F6K]??^"+
M/QJ_MSX>^+?AA>S[KG0[D:KIZ,W/V:8[954>BRJ&/O-7;3]^G*'5:K]?PU^1
MR3]R<9]]'^GXZ?,_2NOYC?CC_P EJ^('_8PZA_Z4R5_3E7\QOQQ_Y+5\0/\
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MQ,?9Z^[^!^L?P!_;X_9V^/U_;:3;BT\)>([A@D6E>)+&&W:9R0 (YANB<DD
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MD@D#1L<<!MNX G!%?T#_ !X_9?\ AK^TGH\5CX]\-6^JRVX(M=1C)AO+7/\
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MF?;-?S775U-?74UQ<2--/,YDDD<Y9F)R23ZDU^RO_!7J#XC^/?"/@[X?^!/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _+O_ (*U?%'XA>#/C)\,-%\%^._$7@^'5=/=)8]%
MU:XLXY)&N BNZQ.NX@'J><5K_P##O7]JK_HZW7O_  >ZK_\ ':XG_@L!_P G
M'_!/_KV'_I8M?K'6>'BOJRGU<YK[GI^859/ZPX=%&#^]/_(_)/Q'\8OVK?\
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M2U#QAKU]X5LX+\VVAW.ISR6,!4P;2D#,47&XXP.,GUK]'J_%R^^+?B?X/_\
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MEX,FU?OIP?QK],?V6?B-^T_XP\::G:_&_P"&WASP9X<CL#)9WFCR*TDESYB
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MB)X1T?Q/X?O$U#1=6M8[RTN4R \;C(.#R#V(/(((-/EO'F6JV^9-[2Y7OO\
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M,]5-=;3E%PDXRW0HR4DI+9A1114E!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU^2/WB#&,*XP[9P;J)N*V=G]R?X]%Y&DXJ'+S/XE?\;'Z*T5^2EO\8/V@/\
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M?YG'AW>E%L****Y3H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\C_\
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M:XAM4+R_9'*,954 D^4\:L?16<]J]._9Y_X*.?!SXN?#W3=0U_QKH_@OQ-'
MB:GI>O7:6>R<##&)Y"%D0D$@J20"-P!XJ<.OW,H-ZQE)V\I:IK\GZ"K7]I&=
MM'%*_FM&G^:]3XY_:F^#_P"VO^USI_AVU\8?!CPUIAT*>6>TN-#U6SBES(%#
M*QEU"08^13P!R*_33Q]\++7XP?!'4O ?BDRQQ:SI L;R2,JTD4A0?O%/(+*X
M##J,K7P?^UA^W1XC^+?Q>\"?"S]E_P 63W>L7%TZ:GK&EVZRV[EBH55:1"&2
M-0\CR*-H&,,<''U_^UO)\3=!_9I\17OPMU.XC\>:5;0W4,T-K%/-<)&RF=5C
M=&5F:,.0 N2< <TI66&DY1]QO[]+-KR[][70X\SKP47[R7W7=TO7^F?"7ACX
M2?MG?L"QWNF?#VUL?BC\/5EDN(K*&$7: L?O"VWI<QN0,E(F9,D\L>:[/P5_
MP4L\!?$WQ9I_@7]I'X/VOA358)EC2ZUJQ6[M;69QC=+!<1B2V!X&[Y^#EB ,
MUZC^Q;_P44\ ?$OX0Z3:?$KX@:5H'Q#T]&AU5O$$T.GI=,';;-&Y"1$,N,JN
M"I!XQ@GYU_X*M_&KX9?'VS\ >"_ASJ%AX^\?)JO[NYT "["0R(4%NLR JYDD
M,9V*3C9DXXSM+GISC"2Y]4O-]K/R]/R,X<LXN2]S=^GKZGW5^W-J4FC_ +&_
MQ5GT]UB_XD$T*-'P!&X$9 QVVL:_/7]A3QS^UKX1^ -I;_!KX3^#_$_@R>_N
M9UU35+J..YFGW!9 X-_"?EVA1\@X Z]:_2^[^#\OB_\ 9C7X9>(;G==7GA9-
M#O+K[V)OLHB:0>N'&[\*_/O_ ()^_M,6/['&M^+/@'\;I)/!\]KJCW.G:E>1
MM]E5W"JZ,^/EC?:LB2$;"&;)'&5&*CBJL5+>*2_O6D[_ (:_<+F<\/2GR[.[
M\KQ_ST/0_%WCW]O_ ,;>%-9\/:E\"/ 3:=JUE-87(COX WERH4;&=5(SACU!
MKTC_ ()=? /XC_L[_"'Q5X?^(VAMH%W=:X;VSM3>V]T&C,$2,P,,C@99,8)!
MXZ5L_M,?\%$?A'\+_A3KUUX8\?:-XH\6W%G+#I%CH%VEZWVEE*H\C1DK&JDA
MB6(R%( )P*T/^"=&L?%CQ=\ 4\5?%S6;S5=5UR\:ZTQ;Z".&2*QV*L9*HB\.
MP=QD<JRGH:=*]ZCBNB3??6Z2\^OH.IM33?5M+Y;^G3U/E;4%#?\ !<2TR,_N
MU//_ & C7ZG5^6-__P IQ+7_ *YC_P!,)K]3J<?]UH>C_P#2F:5_]XE_AA_Z
M2?ECH$*0_P#!;C5-B[=T;L<=R='7)K] ?VGO^3;/BM_V*FJ_^DDM? .B_P#*
M;G4O^N+_ /IG6OT4^./AN[\9?!7Q]H%@N^^U30+^RMUQG,DENZ*/S85S5O\
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M35]!?L:_\FG_  B_[%?3_P#T0M?/O_!8S_DT6+_L8K+_ - FKZ"_8U_Y-/\
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MES:?B*JFXT[[<SMZVU_ ^5O^"H?_ ">1^SC_ -?%M_Z<8Z_4:ORY_P""H?\
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M>9!B%G6,E(8HOE*Q@[BR@L!@[OTJHJH-0ESI>\MGV]/,RDG*/(WH]_,^4/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOAK\.]8_LGQ7\0_"GAG5?+6;[#K&MVUI/L;.UMDCAL'!P<8.#2N!W-%>5?\
M#6/P0_Z+)\/_ /PJ+'_X[7H7AWQ1HWC#2XM3T'5K'6]-E_U=YIUREQ"_T="0
M?SJM=P-.BBBD 4444 %%%% !15+6-:T_P[IEQJ.JWUMIFGVZ[YKN\F6**)?5
MG8@ >Y-<WX)^,WP_^)5_<V/A#QSX;\57MM'YL]MHFKV]Y)$F0-S+&[%1D@9/
M<T+5V0/179V-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?CE_P4VF\26__  4-^'DO@Z".
MY\6I8:.VCPRE DEX+V;R%.\A<%]H^8@>I KUZ3Q9_P %)GC91X+T.,D$!EFT
M?(]QFZQ7#?MU?\I4_@G_ -=/#W_IRDK]:**4?]E4K[SG^:_K[BJK_?-?W8_D
M?B_\.)(_'W[7FE:)^VK=>*'\8QRQ1Z+INHI;PZ)N8_(L@BPOENX !B&QF&')
M&:_8_7M070/#NHWR1@K96LDXC48&$0M@?E7YZ?\ !:3X7)JOPF\'?$*T@VZE
MH.J?8)[B/AA;SJ2I)_V98TQZ&0^M?7O[./CQ/CY^S!X,\074WG3:YH*0WTBG
M_EN$,,__ )$5ZAN53"34-)0;6FUVKI^O<5HPQ$'-W4E?7=6=FO3L?DK^P?\
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M+L87N;F[N'"1PQJ"69F/   K>KR.E%M^XXJW:UO^'_,RI\ZJ25O?YG?O>_\
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M$%%%%!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^37[7W_*6[X2_]=M"
M_P#2AZ_66OR'_;E\3:7X,_X*F?#;7=;O8].TC3AHMU=W<V=D,2SN6<X[ "ON
MS4/^"B'[.>FVYGF^*ND.@.,6\5Q,W_?*1D_I11DOJD5?[=3\T*HG]9;_ +L/
MR9]&5^0_[(;+X^_X*U?$'7M,)ET^RO-<NFE5C@Q[C;AN.H+2+^=>G_M1?\%:
M/#>I>&[KP=\"8-3\2^*]8465OKGV&2&*W,GRY@B<"66;G"@HH!(/S8VGT_\
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M9CW9CEB>Y)-%#W5.L]')))=4MW?SZ>@ZWO<M):J+;;[O2R7W7N=+7QC\</\
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MKRI-/U=K?K]WSFK%0]G..G,VFO17O^G]:?>5%?G'^T3^U'\9?CA^U1=?L^?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/P+87/#^=YGW#C_5]?;FFO>ERK?7\-P>D7)[(]\HHHI %%%% !1110 4444
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MO_::OFY;[_#^9[7^QK_R:?\ "+_L5]/_ /1"U\<?\%O?^27_  S_ .PS<_\
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M)+_PNYZ?)GEIR5+$*<](M--]KK1^FK_ ZYQ=6A*G'=-->=MT?J[17QW\)_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_'RQO$_9L_X+#7DVLO\
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M:/KU[XJ6<V[ZA!#";!&%OY[Y;S=_RJ"#\GW@1[UXQ_P6?_Y-4T/_ +&NU_\
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M5FIX^C46TJEUZ>\>?'3!U8/>,+/UT/9_^"PD-Q+^Q_(\*L8X]>LFF*G@+B0
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M?M$?[VK?^G-*]4_X*'?L1ZCXUN8OC7\)$ETOXHZ$RWEU'IY*2ZDD0RLD>/\
MEX0*,?WU^7DA144YJA0HRE\,H*_=>\[->2ZK;KIN:5HNM7K0C\49MKL]%I\^
MCW]=#[WHKY3_ &"OVW-,_:O\#-8:L8=,^(^C1JNJZ:"%%RHP/M4*_P!QC]Y?
MX&.#P5)^K*TG!P=F8QES(_.[_@ME_P F]^!_^QH7_P!)+BOMGX%_\D1^'O\
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M37-OIFNV^D:?<RV;*LR1R32*Q0LK*&P>,J1[5^Q5?DU^U]_REN^$O_7;0O\
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M')@/N4,4D!8C %:MQ_P67\.W>GC3M'^$GBV\\=,/+70Y&C$0FX&S>NZ0X/\
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M $ON*Y7_ (*]?\F;W_\ V&K#_P!":NJ_X)<_\F.?#KZZA_Z7W%<K_P %>O\
MDS>__P"PU8?^A-1FW\27^./_ *6@P/7TG^3/6/V!_P#DS?X3?]@2/_T)J]^K
MP']@?_DS?X3?]@2/_P!":O?JZ,1_&GZO\SEPW\"GZ+\@HHHKG.D**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN2\<_%WP+
M\,)+./QEXU\.^$I+P,ULNN:K!9&<+C<4$KKN W+G'3(]: .MHKRK_AK'X(?]
M%D^'_P#X5%C_ /':/^&L?@A_T63X?_\ A46/_P =H ]5HK"\'>._#7Q$T?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*(XH8U&6=V)P !W-7J^/O^"K>C^(=8_8W\1+H$<\T5O>VESJ<=N"6-FDF7)
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MAXY$895E8<$$$$$=<U^6MC>6^G?\%KM8N[N>.UM8+:226>9PB1H-&4EF8\
M#))K[/\ V&_@IX^_9Z^!-KX%^(&L:5K5[IM[-_9\VDW,T\<=FVUEC+2Q1L"K
MF3  ( *X/8?GC\9?@O9?M _\%;-?\#:IJ5WIFD:BT+7TEBVV66"/3(Y'B![;
MPFTGG .<&M(KEQ453=_=E^,>OIU]-";\V%FZFFWX2Z>O3\3Z[^(G_!73X!^
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M1#X+_M&ZY;Z#H.M7>B>)+C/V?1O$%N+:>?':-E9XG;_8#EC@G&!7TQ7Y9?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2M5.I0><T+^8!,9'R<]1NXKYC_X(D_\ )#?'_P#V,:_^DT5?6\/P7\(? /\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!YO\;OV=?A[^T;HNGZ1\1/#_\ PD.GZ?<&ZMH?MMQ;>7*5*ELP
MR(3P2,$D5VWAOP[I_A#P[I>A:1;_ &32M,M8[.TM][/Y<,:A$7<Q+'"@#)))
M[FM*BA>ZFEUU8/5IOH%%%% 'D7QD_9*^$/[0%Y%>^/? NGZYJ,:J@U!6EM;H
MJ,X5IH721E&3A2Q STJU\'?V7?A3\ F>3P%X'TS0+N13&U\JM/=LAQE3/*S2
M;>!\N['%>IT41]V_+H$O>WU/,/A'^S3\-_@3K?B/5_ WAS^P]1\12++JDWVZ
MYN/M#!G8'$LCA?FD<_*!U]A7HVI:;::QI]S87]K#?6-U&T,]M<1B2.6-AAD9
M2,,I!((/!S5FBE9<JCT6GR[#N[N74^==+_X)Z_L^:'XXT_Q?IOPYMM.U[3[V
M/4;6:SU&\BBAGC<.C+"LPB # ';MV\8QCBN_^.'[-_PZ_:.TO3-.^(OAW_A(
M;/39FN+2/[;<VOER,NUCF"1">.Q)%>ET4/WHJ#V73^O1?<%VGS+<@L;*'3;*
MWM+9/+M[>-8HTR3M50 !D\G@=ZX_XI?!+P%\;=)CTWQUX3TOQ/:Q;O)^WP!I
M(-V-QBD&'C)P.5(/%=O13E[^LM11]W2.A\W>%?\ @G-^SCX-UA-3T_X6Z;-<
MH<JNIW5U?P_]^KB5T_\ ':^C;>WBM8(X88TAAC4(D<:A550,  #H *DHIW=K
M"LKW/+/%G[,/PS\<_%W1/B?K?AK[;XYT585L-5^WW,?DB)F:/]TDHC;#.Q^9
M3G/.:]3HHI+1<JV_SW'N^;K_ )'EOB+]F/X:>+/C%I/Q4U7PU]J\>Z4L:6>K
M?;[E/*"!@@\I9!$V-[=4/6O4J**%HN5;?Y[AN^9[GAOQ8_8A^!WQP\12:]XR
M^'MAJ6M2\S7UM/<64LYQC,C6\D9D. !ELG %>I> ? >A?"_P;I/A3PS8_P!F
M:!I4 MK.T\Z27RHP20N^1F9NIY))KH**%[JY5L#]Y\SW"FNBR(R.H96&"K#(
M(]*=10!\^>.O^"?_ .SU\1M1:_UGX6Z.ETQ+.^E/-IH=B<DL+:2,,2>Y&:UO
MAA^Q5\#O@YJ$6H>%/AMHUEJ,+B2&^NU>^N(6'1HY;AI&0^ZD5[;11'W?AT"7
MO?%J%%%% 'G7Q6_9V^&?QPB5?'7@C1_$DJIY27=U; 7,:==J3KB1![*PKRK1
M/^":O[-?A_4H[^U^%UG+/&VX+?:C>W<1^L4L[(1[%:^FJ*2]W5#;YM&9OAWP
MUI'A#1K;2-"TJRT72K5=D%CI]ND$$2^BH@"J/H*TJ**IMO5D[:(\^^-7P"\!
M_M$>&;7P_P#$'0O^$@TBUNEO8;?[9<6VV8*R!MT,B,?E=A@G'/2NH\&^#](^
M'_A/2/#.@6GV#1-)M8[*RM?,>3RH44*B[G)9L #EB3[ULT4EHFEU&];7Z'D_
MQP_97^%_[2$VD2_$;PTWB)M)$BV2G4KNV6+S"I?Y894!)V+R03Q7J5G9PZ?:
M06MM$L%O BQ11(,*BJ,  >@ J:BA:+E6P/5W85Y+\;/V4OA7^T5J.CW_ ,0O
M"HUZ]TA'CLKA;^ZM'B5BK,,P2INY4$;LXYQC)KUJBCJGU0[O5=QD,*V\,<2;
MMB*%&YBQP!CDGD_4T^BB@E::(****!A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"K7+.FJL=FVOFM_Z_P"'<N\:CIRZ)/Y/8****DH**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#-USPWI'BBU2VUG2K+5K='\Q8;ZW29%;!&X
M!@0#@GGWKY<_X*#?#7PAHO['/Q-O=/\ "NB6-Y#8Q-'<6VG0QR(?M$0RK*H(
M_"OK6OF[_@HQ_P F5_%+_KPB_P#2B*N3%:4)M=CIPVM>G?NOS/'O^"4/P]\+
M>(OV0M,O=5\-:/J=XVKWRFXO+"*:0@.,#<RDX%?;F@^$="\*K,-%T73]'$V#
M*+"UC@\S&<;M@&<9/7UKY"_X)$_\F::5_P!AB_\ _1@K[3KTZ_QKTC_Z2CS:
M&L'ZR_\ 2F?-'@'_ (*#_"GQS>_$J.>35?"MEX ?9J^I:_##%;L?.>("'RY9
M&<EXR NT,<J "3BMC]FS]MGX>_M6>)/%&C^!H-:;_A'XXI9KW4;1(()UD9E4
MQ?O"_P# ?OHO45^;?[&?[-?A[]I3]KSXP:?XQN;NX\*Z)J]SJ=QH4,K1Q:C,
M+R9(A*5(.U \AP.3NQD D']<O!OPK\"?"2SNI?"?A#0?"D1A G?1]-AM3(B9
M(#F-06QDGG/4UR4I?N*=:J]XW_/7[^ATSUJSI4^DK?EI]W7S\CC_ -H/]K3X
M8_LQ:?;S^._$*V=[=*7M-)M(S/>W &>5C7HN01O<JN>,YKY\\*?\%BO@'XCU
MI+&^B\6>&8&./[0U;2XV@'U^SS2O_P".5\M_L>^*OA?^T)^U'\2_C-\=?%/A
M>U^SW*_V!I/BS4[:"$[V<1E8IF <011HHX(#/N^\ :^^OBE\1?V6_C)X+O?"
M_BOXA?##5-+N8FC59/$.G[[=B,"2)O,S&Z]F7!&*?OQIJ<E=M7MV[*_?\"I<
MOM)06R=K_G\CWSPWXETGQCH-CK>A:C:ZOI%]$)[6^LY5EAF0]&5@<$5D_$KX
MG>%?@_X1O?%'C+7+7P_H5F!YMY=,<9/1%4 L[GLJ@L>P-?GC_P $>?B!=:5X
MB^+'PC.KIK>AZ)=&_P!)NH9!)"RB9H97C8$J4DQ"XVG')(ZYKU[]OK]D7XB?
MM8>/OAM9Z3>Z?!\/-'E\W5X+B]>*:1GE42.B!"&985(4DCEV'>KJ*_L_9;3M
M9OHGW]-5ZD0:]]3WA>]NK\O6Z9DZQ_P66^ ^F:M):6VG>,]6MU;:+^STR!87
M']X"6X23'U0'VKZ2_9__ &JOAI^TYI=U=^ O$*ZA<684WFFW$307=MGH6C89
M*]MZY7.1G(-;MC:?#+X+>$H?#<3>&?!_AZWB,:Z?-+!:P[,')8,0&SR23DGD
MFOS)\&2>$?AK_P %<M"A^$NI:4_A#Q A2>#P_<12V($UF[2PIY1*A1+&LFT<
M*0.  !3@XNK&E_-HGYVTNO,4N94I5=N75KRZV?<^NOV\/VUO!'[/FAZI\/\
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M*'QO\4^&;;0]&E,7A_2O%6I6]O;3+YCQP!4F<+(L<<98J 1OD#'D\_H#X_\
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M ,+/".HV/A'2+@SS7NHHN8VD&UKFZ*%DA1$#!4#,6).,DA1^F/QB\(6?P_\
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M+HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ@G'25UIY=;KT/TAK@_CW_R0SXB?]B[J'_I-)7>5P?Q[_P"2&?$3_L7=0_\
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MB'XD_P"P;<_^BFK\]O\ @B'_ ,DG^)/_ &&X/_1%?H3\0/\ D0_$G_8-N?\
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MB5A_OU.%U@I/>E%P];O1^O+?^M"\3\;2_P"7CC+[EK\N9+^M3Q?]FG'[./\
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M](?$CP%I7Q2\ ^(/"&MQF72M:LI;&X5?O!74KN7T89!![$"OR[^$'Q%^+/\
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M;]I[]O+XN?'>[3[1HFAR/I^BR."5W./(A9?<6T3$CUF![U^@OQ>^%_A+XS>
M]2\'>-;&'4="U)0LD,DGELK*05=&!RKJ0""*\1_X)M_!?_A2_P"R=X3M[FW\
MC6-?4Z]?AEPVZ< QJ1V*PB($>H-8?_!2[]E;7OVG/@OI_P#PB,:W/BSPW>-?
M6EB[A/MD;)MEB5F( ?A&&3@E,<9S6N)BJ$(T+74$HO[_ 'G\FVS.A+VTY5KV
MYFVON]U?<E]YX+K'_!*CXF_"'4[O4_@!\;]0T*.:17_L[4KB:R9@HX$DUOE)
MN_#0J.:=\&_VW?CI\ OCUH/PA_:4TJ&^36YXK>RUZ..%)D\U_+AE#P8BFB+X
M4_*'7)+'(VUI^ O^"M5G\+_"NG>&_C7\,/&?A[QGI]NEM-]CL8PMT44+YICN
M)(6C+8R5&X>A[#A+NQ\??\%+/VJ/A_XRM?A_JG@CX5>$9(I?[5UF,HUW$L_G
M-M8@!W<HJ!(RX3J6YK6G=5H13YH7U?3EMOY/;S,IM>QE*2Y9VT[W[>?Y'VY^
MW]_R9K\6/^P,W_H:5YW_ ,$F?^3*?#'_ &$-0_\ 2EZ]$_;^_P"3-?BQ_P!@
M9O\ T-*\[_X),_\ )E/AC_L(:A_Z4O7-0_C5_P#!'_TIFU;^'2_Q2_\ 23YJ
M_8]_T'_@K3\9X=0^2ZF?6_LZS<L<W<3KM_[9\_2OU:K\W?VW_P!F/XE_#3]H
MC2OVEO@EIDFN:M;LDFLZ+;1--,SK'Y32")3NECDB^1U3Y@1N'4E57_@LUI']
MFG37^#_B8>/ /*_L03IY7GYQLW[?-Z]O*SVQWJJ<E]7IT_M07*UZ/=>3N553
M=>=3I-WOZ]'Z'WL?BQX('C@>"SXR\/CQB>GA[^U(/[0_U?F?\>^_S/N?/]W[
MO/2OB;_@M1_R;3X6_P"QIA_]);FLC]@O]G7XE^-_VA?$O[2WQ@TJ7PYJVIB9
M=*T>YA:&;,BB,R&)OFCC2(>6@?YFSN/0%M?_ (+4?\FT^%O^QIA_]);FHQ$7
M&E#F^)\MUV?,M#3#R3JSY?A2E9]_=>I]<?L[745E^S?\-KB=Q%##X6TZ1W;H
MJBUC))_"OA_P_P#M=_M$?MP?$CQ!H?[/XT;X?>!]$E"S>)]6MUGG="S!"V])
M%W2!2PC2/*X^9^]?;'P'TM-<_9>\ :=([1QWGA&QMV=>JA[-%)'YU^8_[.OQ
MB\5_\$L?''C7P5\4O 6LZCX2U6[66UUK2XEVRO&&5986<B.570KE=X9",$9R
M*[,39XVJJCTUMYN_7T6RZG#A^;ZI3<%KI?R5NGSW[?G]1>(_V*?V@-9T>\N]
M>_:Y\2;D@>22UTK1S:QL0G*YCN4!4@$8V^]>9?\ !#W_ )$;XJ_]A&Q_]%2U
MV^K?M9?%G]L[1;CPQ\#? .M> _#-_"R:G\1/%48B%K;D$2+:HA*O*1P"KL1G
MHGWUXK_@B%&8?!?Q80G)74[%?RCEJ**DG6NK+E7_ *4OP*K6:HM._O.__@+L
M9?\ P6*_Y*Y^S_\ ]=[O_P!*+2OU)K\MO^"Q7_)7/V?_ /KO=_\ I1:5^I-1
M2_W6/^.?YH=3_>I?X(?J?ES_ ,%9/^3E/V=O^OC_ -O+>OU&K\N?^"LG_)RG
M[.W_ %\?^WEO7ZC5-#_=5_CG^:*J?[S+_##\F%%%%,H**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KYN_X*,?\ )E?Q2_Z\(O\ THBKZ1KQ
M+]M+X<^(?BU^R_X^\)>%-/\ [5\0ZI9QQ6EGYT</FL)HV(WR,J#A2>2.E<V)
M3E1DDM;'1AVHUH-[77YGC/\ P2)_Y,TTK_L,7_\ Z,%?:=?,/_!.?X->,?@/
M^S/8>%/'6C_V'K\6I7=P]G]IAN,1NX*'?"[KR.V<U]/5Z%9IR5NR_)'GT$U%
MW[R_-GY<_P#!+/\ Y.Z_:,_Z^)__ $OEK].]6M&U#2KVU0A6FA>,$] 64C^M
M?"O[ O[,?Q+^"O[1?QI\4>,_#7]C:%XBFE?3+K[?;3_: ;R20'9%(S+\C _,
M!UQUK[UKCC!2PE&G+^2S_$Z.9QQ-6:_FNON1^+G_  3/_9C^$_QF\6_$_P %
M?%CPL-7\4Z!+$UK!)J-U:/&B/)%<#;!*@;:XCSG.-PK[Y_X=<?LQ?]$S_P#*
M_JG_ ,DUYO\ M,?L$^-E^-7_  N[]GGQ/;^$O'DKM+J.FW;>7;W;E<.Z'8RD
MO@;XY%V,3NR#UYK6-5_X*'_$72Y?#$OA7PAX%BND,$OB2UN[82HI&"P*W,[*
M2.Z1;AGC!K3G<X1TM-*SZ*ZZI]G]_P"0W%1G*S]UNZZM+M\CU7]C73_V7=$^
M*WC;1_@7I%Q8>*]+@>SUJ1I=0EB\M)PI57N)'0_O%X*<D#.<5XC^W!\5_B3\
M9OVQ/"W[-7@KQ9=>!M#O(H3J5]8NT4L[21--(69"&9%A7 C! 9B=V>-OTS^P
MW^QCI_[(/@34+>XU)=>\8ZXZ3:OJD:%8_E!V0Q _-L4LQW-RQ8D@<*/*OVX?
MV'?'/Q&^+&@?&OX,:U;:3\1-'2)9;2ZD$0N&BSY4L;L"F_!V%),(RXR1@AG4
MLIT5-\T5\7;KLNUWM\[BIWY:KA[K=^7\-WWLONT.C\&_\$E_V=_#FFQP:OX?
MU7Q?>]9+[5M8N(I';N=MN\2@9]OQ-?)(^&'@?X._\%=/ 7A7X?Z?;Z3H=FT)
M>RM[F2<13M93,X9G=F#<J<$\9'%?0.DR_M__ !3M1X>UBQ\%?"BTD"QW'B2$
MQ7%WY?1S&D<\Z[R,D?*G/1EZCAO!G_!//QK\&_VZ/AUXM\.Z?J'B7P1IT:W6
MN>+=4U.W-Q<WSQ3B>5HFE\WEW3A5/7JQR:J-_K%*;=DI+\GOV7KUMH1.WL*D
M4KMQ?Z?>_3I<^^_CW_R0SXB?]B[J'_I-)7Q;_P $3V'_  SSXT&>?^$G?C_M
MUMZ_0+6-+MM=TF]TV\3S;2\@>WF3^\CJ58?D37Y=?#?]F;]K[]B#Q5XETWX-
MZ7H'Q!\&ZM<>>BW]U B?+D1N\<LT#I+MP&V,RGCDX&,Z3]G5J7VE%)>JE?4V
MJ>_2@E]F3?WJQ]H?M_?\F:_%C_L#-_Z&E>=_\$F?^3*?#'_80U#_ -*7KT+X
M]>#?B#\8OV*->\.W.AP?\++UOPW#'=:/:SQ1Q+?LL;31)(\A0*'#@$R$8'WC
MUK._X)Y?"'Q=\#/V7]"\(^-])_L3Q#;7EY++9_:8;C:LD[,AWQ.Z'*D'@_6G
M3BZ=>NG_ "Q7D[2>W<SJ/FITK?S-^GN]3$_X*D_\F0^/_P#?L/\ TM@K3_X)
MI_\ )DGPR_Z][K_TKFK9_;V^%?BCXU?LL^,/"'@S2_[9\17[6AMK/[1%!OV7
M44C_ #RLJ#"JQY(Z5>_8>^&GB3X/_LM^!O"'B[3?[)\1:;#.EW9^?%-Y9:YE
M=1OC9D.593P3UJZ.E.LGUE'\F.KJZ5NG-^AX=_P6,_Y-%B_[&*R_] FKW3]B
M%=W[('PD'KX;M!_XX*X7_@I3\$?&OQ__ &<X_"_@+1?[>UT:U;79M?M4%M^Z
M19 S;YG1>"PXSGFO6/V5_!.M?#?]G'X=>%_$=E_9VNZ3HMO:7MKYJ2^5*JX9
M=Z,RM@]U)%8TH^Y7C+K)?=RV*K:SHM=(O_TH_*W_ ()\_LR_"[XH?'?XN?#K
MXN>'%UO7M%D)L(7O[JT9?)N)(KG AE3=RT)^;. ..]??G_#KC]F+_HF?_E?U
M3_Y)K@OVL/V"?%?B;XP6OQL^!/B>'P=\2HF#WEO<L8[>\8+M\Q6"L [+\KHZ
ME)!UV\[N2OO$'_!1/Q=IK>&V\(>#_"GGKY#^*(+FT\U!T+@"YEP3ZK#D=@#5
M1DW2A&WOI6?1.W6^VHZEY5IU&_=D[^GE8])_9-T']E7PC^T!XN\.?!C1;C3O
MB%HUI=6.K.9M1FB6&.XC25 ]Q(\1_>K'@KR<'!QFO ?^"Q7_ "5S]G__ *[W
M?_I1:5]2?L+?L3P?LE^&]7OM8U=?$GC[Q"ROJNIQ[C$B@EA#$6^9AN9F9V +
M'!(& *\M_P""E'[,/Q,^/WQ%^#^J> O#7]O6.@2W#:E+]OMK?R TUNR\32H6
MR(W/R@]/<5O'W:^&N[\K5WT6][=EK]_J<U3WJ&(Y5NG9=7M;Y_H?>]?ES_P5
MD_Y.4_9V_P"OC_V\MZ_4:O@K_@H9^S'\2_CE\;O@SX@\$>&O[;TCP]-OU.X^
MWVUO]G'VF%\[99%9OE1C\H/2L8_[Q0ET4M?N9I4UP]:*W<7^:/O6ORU_X)J,
M/^&\OVCAGDS:EQ_W%*_4JOS3^*7['_[0/P'_ &IO$GQB_9YCTKQ!;>)))I;O
M1[VXBB9#,PDFCD69XU:,R .K)(&'3  ^8IR]G7C-[<LE\VM"JD?:47!/6\7\
MD[L_2RBO+?V;M<^*GB'X8V]Y\9/#VF^&/&S7,RRZ?I4B/ L(/[M@4FE&2.OS
M_@*]2JY+E=B8OF5S\COVV-%T_P 1_P#!5CX8:7JUA;:IIEX=$@N;*\A6:&>-
MIW#(Z,"K*1P01@U^CG_#)_P0_P"B-_#_ /\ "7L?_C5?)'[1W[*?Q2\>_P#!
M1+X=_$[0O"_V[P/I,NDM>:I_:%K'Y0AF9I?W3RB1MH(/RJ<]LU^AE31LL+%/
M?GG]UU;_ ( ZEWB&^G+'\G<R_#?A;1?!VEQZ9H&D6&AZ;']RSTVV2WA7Z(@
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M%C_@FW\2])^,GPG\6:)-J/Q0UO\ M6+5/&GBG4=1MX"9$N8641PRRAMB1JP
M7<<#''RJ%&_UBE*]HJ2_)].B]>MOE$_X%2-KR<7^G7J_3S/TV^('_(A^)/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%5=0U2RTBW-Q?7<%E .LMQ*L:C\2<5Q.K?M#?"O0<_VG\2
M_!^G8Z_:]>M8O_0I!0!Z!17A6K?MT_L_Z+G[1\6_"\F/^?2^%S_Z+W5B3_\
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M;O&/_!;[Q'<22KX4^&&EZ>G2.76-2DNB?<I&L>/IN/UK\QJ* /L'QA_P5?\
MVBO%4<D=MXFTWPU%)U71]*A! ] THD8?@<UXKXG_ &LOC3XQ+?VO\5/%UU&W
M6%=8GBB_[]HP7]*\HHH NZKKFHZ[<>?J6H76HS_\]+J9I6_-B:I444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !6KX7\6:UX)UJVUCP]JU]H>K6S;H;[3[AX)HS[.I!%95% 'W9\#?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%-DD6-&=V"(HR68X 'J: '5RWQ'^*/A/X1>&9_$'C'7['P]I$(^:X
MO90FX_W4'5VY^ZH)KXX_:[_X*I>#/@K]N\-_#W[/XW\9)NB>XC?.GV3@X.YQ
M_K6'/RKQQR:_(+XP_'/QS\>O%4_B#QQXAN]<OI'+)'*^(+=3_!%$/EC4>BCZ
MY/- 'WS^U-_P6(UC7UO/#_P7LFT.Q;]VWB;48@UVX[F&)LK'G^\X+>@4\U^<
M7BOQ?KGCK7;K6O$6K7FMZM=,7FO;^=II7))/+,2<<GCH*R** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 444QI4C^\RK]30 ^BJS:A O1BW^Z*A;5E_
MA0GZFG9BNB_164VK28X"#TZFF_VE,W\0 ^E5RL7,C7HK%-Y*S?ZUA3!=S-_R
MU;\Z.5AS(W:*Q/M4@X,CY^M+]JD'61OSHY6',;5%8RWDVW/FFJ.L:_=:?922
MHZ[U&1N4&GR-NQ,JB@N9G3T5XOJ_QPU318Y':QM+E57./F0G\<G^5>2ZA_P4
M9T3PSK%MI^N>#M00S2^5YVGW23#.<9VN$_G6SPU5*]CA68X:_*Y6^1]A45E:
M/XDLM<T^WO(&=(ID#J)%P<$9YK221)/NL&^AKF::W/0C)25XO0?1112*"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !113))DA7=(ZHOJQQ0 ^BLNX\0VT60FZ4_[(P/UJA-XD
MG;B.-8Q[\FIYD6H29T=12W4,/^LE1#Z,P!KD;C5+B529;A@O?G:*;#9W%PP$
M<$K[EW!MA"D?[QX_6ES=B_9]V=-)KEG'_P M=Q_V5)JM)XEMU^Y'(WUP*S(=
M OIH]QC2%LXV2OS]?ES5H>%Y65<W*(W<>66'X'(HO(+07463Q.Y^Y H_WFS4
M1\27/:.(?@?\:MMX6@;'^D7"'OMVX/YJ:LIH%DJA3&SG^\SD$_E1:07AV,AO
M$5V?^>8^BTUM>O#_ ,M%'T45L'P[8'_EBW_?Y_\ &GQZ'90L"L&2/[S,P_4T
M6?<.:/8PQKUZ/^6@/_ 13U\178[H?JM;<NBV4S9:  XQ\I*C]#4(\.Z>/^6+
M_P#?Y_\ &BS[AS1[&:/$ESW2(_@?\:D3Q-(/OP*W^Z2*T?[!LMN!$1[[V/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&_X*!?\ !3B[\9W&I_#GX1ZA):>'0&M]2\26[%);TY(>. CE8L8^?JV3T')
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MH,C@RVLA'++_ 'XB<[7Q]0#Q7O- !1110 4444 %%%% !1110 4444 %%%%
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MF ;E/(X9<<CFOJG2M7L==L8KW3;R"_LY1E+BVD$B,/9@<5H9%RBBBF 4444
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M3[%[N8(HIV%<GL[N>QN%GM9Y+:=?NR0N48?0BO3O"O[3GQ(\([4B\0RZE H
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M==15&SU2.XP&_=O[]#5ZL]CH33V"BBBD,**** "BBB@ HHHH **** "BBB@
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M8?+^'K_]8\U'-?8V4$M9#;[4I;QMTTF$SPO115BST.ZN\,R_9HSSND'S'O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %0WE[;Z;9SW=W/':VL"-)+/,X1(T R69CP !R2:6YN8K.WEN+B5(((D
M,DDLC!510,EB3P !WK\9?^"D'_!1";XR7E]\,_AS?O!X$MY#'J>J0DJVL.I^
MXIZB $=/XR,GC H C_X*'?\ !2"Z^-%S??#KX:WLMEX"B<Q7^JQ$I)K# \JO
M=8 >W5^IXP*_/JBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,>C=NAYZ_0% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !3)9DAC+R,$4=2QK,U#Q!!:Y2(B67]!7.7M[-?2;I9-WH.PH*43:OO%
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MSQG )R3]:Q;W2].T]4_UDO.&7<3@U6^I.QT5W:Z==:E'?6T,\#* &M0<Q%@
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MM5>//@Q?PW.A:E)_9>_-SHLV);.7)Y.P8*-SU7GFJNUN&CV/VYHKY_\ V?\
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M$MYL@PJ?PKOH;<*O2I5A7TJ;M%VBSQS5OA;9S*W^CKGZ5S;?".T60MY/Z5]
M7%NC+TK+FLXSV&:I39+IQ/*_"^DZQX'O3=^'M0N-,FR-ZPM^[DQV=>C#ZBO?
M_ _QTDN8X[7Q-:?9Y^!]LM5)C;W9>H_#-<;'IT>[H*F72X]WW142M+<J*Y=C
MZ'M+R"_MTGMIDGA<95XV!!J:O"-)U*^\.R>;8W#1?WHSRC?45W_AOXJ:;JDB
M6NH,NG7K' WG]V_T;L?8U@XLZ.9=3N**2EJ"@HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\F^.W[1GA[X
M(Z85N6&H:],N;;3(F^;GHTA_A7]3VJ)SC3CS2=D5&+F^6*.\\9>-M%\ :'/J
M^O7\5A90@DM(?F8_W5'5B?05^=_QV_;2\3_%O5;K0_"K3>&?",19))8VQ<W@
MZ9=A]U?15]>2:X/XM?'#5OB1-=ZQK^HF63E8K<,5A@7^ZB]!]>I/6O,?"]U!
M=V[3$E8LY)/1L?X5X-;&RJI\FD3V*.%4&G+5G7Z'I:^6][/E44?+N[>_U-<[
MXF\3QS7/V6#]]*#@ <@?_7K,\1_$@WF-,TW']W<.1]:Z?P#X%BLX/[2O%W/U
M8MV[_G7F2C[-<\ST(^\^6)S]CX:DLX6U&Z&'(^53VK N+/[!'<ZE=L%)!VYZ
MGVKM/%6OPW-Q(Q;;90>G<^@KRG7KV\\93MC-MIL/?_/6M<.I5-9:(=:T5:*N
MS(CU";6+][@Y:-<\&NP\/7'DKO)&!R >U<DTR6L0@M_W,2_>D/4U77Q #(L4
M)++TR.]>QR\^RT/(E+DW>I[7_P )9#]B$+,&Z9%>M?!?XE?\*Y\=:1K$!Q9.
MOE7D8_BB/4_AUKY9TBVOY+I)+@%(,Y&[K^5>P^'V5K94()E;&.]8.K["2E'<
MUA3=1-2V/J_]KZ2#4O\ A&M5MW62TGEBD213D$%E(KZE\&R+)X=LF4\>4H_2
MOSR/C2YUOPG'X4U1O,2R836;M]],$-LSZ<<?6OOWX:WT%_X1TZ>W;?#)"CJP
M/L.*^GIXB&(HIP/CG@YX/'2YMI+0ZUFZ#OZTN"W?]:8QZ>_O2[N0#R12/2%7
M[W3%'&>1D4C8[4;MS=: #'?&*%7G!!I=P_6D'.: %W%F...*3KG/44N2.!P.
M@S2KWYX'ZT )MY.>#6%XP_Y!,OTK>^][#%8?BP[M+F YXX[5</B1SXC^&SQ7
MQ( ;67DD!<XKX+^/V%\46!'_ #]J/UK[W\3+BVE/8H17P)\>F$GB[38F; :\
M0%@,XRV.E>M?W3XZI&^A^J'PM?=X(TC.?^/>/M_LBNKFN4@C+L./IS7'_#^Y
M@L?!>EQRL%VVZ+Z<@ =*T=5UB)[-Y0^43CY37D2W9];A[QHQ7D5=>\4>2K!'
M6)%YY.TG'J?2N6F\8.\A,UY*0!GY2449Z*!7/ZC9S>(-2CN9R3:0L3L<X5_3
M\!^M.AFLH9OF2*>5!@M*WRK]!_3K6+D=18&J#4"9D@V1.=V^5?O^^3QBKT5Q
M))'_ ,?$:!#@!6Q^N*S;C5+"RC%WJ,^Q(QN1)#@M_P !-8U]XLL=;DC1[[;!
M,?W5K;P2,[CW/'^'N:R=1+=FBA*6R-V]UZ+38V:YGCY.U0,MDGT]ZYE_$<S7
M'^CR--'*=PC8[549[\\_2N>\3>/-)L(9+>VTJZOI8GQY:Y5&([$X/KR<_P"%
M8$GQ.D3B[L8Y';YO(CBVK$ON6.?Q/Y5S2Q,$[7-UA:KC=1/0YKQH3%<A9K:5
M!E)@N0I_X#VKT#P+\1%U+_1-39!,OW+A?E#?[P['WZ5Y5X/\<M>28M8(W^4%
MXWF+,H_W>OY9KJ[RW1HTU"UBC7(R/*;*L.X'H?:NBG+F5TSEE%IVD>TEBFXY
MR,=JMZ;K$MLPCD)EB]^JUR7@;Q NMZ*,L?,@ 5E/WL$<?X5T-J@+<GI6[U,U
M[NQUL,Z7"!XVW"I*YE;J2T_>H_/4KV(K1TKQ'::I)Y D6.Z'6%CR?<>M9V.B
M,D]S5HHHI%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E "U!
M=7D-G TT\JQ1*.78X%4-=\16NAQ?OCOE8?+$O4__ %J\O\2:Y=:U*7G?"9^6
M)?NK^'<^] KECQQ\4[B=7M-(+01,,&XZ.?\ =]/K7E[LTC-)(Q9VZLQR3[UH
MZA&68]AW->;^.OB):^&8FCC_ 'MQT51US7'6JJGJS2E2E6=D=7>ZA;:="9;B
M58U7G+'K7FGB_P".%GI/F167EM*/XVKR;Q-X]O=0=Y=3N_)B/*Q*W->=:IXR
MMH]SP(BX'^LG.?QKS95Y2^$]6&%C#XCT+7?C'XBUIG5;R:),\+$NT?G7&R^(
MO$+7+2"6>;/_ #TN*\NU[XH1+(5^V23R?\\X>@KGO^$VU.^E)M[*YV_WG)K-
M\SZF_+".R/?[/QYXBLQG[*LV/[TW-:UG\;=8T\YETJY '4Q-N%?/VGZWK,C;
MVCD3ZFMVUUS5=W)8_7BF)I=CZ$TW]J:UM)E2^L;J(="7C->E^%_C=X=\1;?*
MN55C_"W!KXZ76]3E.V2W\U.G2M"TOMK*[6GD-_? VU2DT9RI0D?>5G?V]\H:
M"99 ?0U;52W2ODOP7\4/[)GC47BJ5Z@OP:^@_"?Q)T[7(8P\T8E/7!KHA4YM
M&<53#\NL3LQ]W'>G#M3(Y%<#!R#T([U(N,^E;G(T/4XJ1:9CYJ>H"U2)'5(*
M:!4BTP "GB@"E6@!5I:%IP%-  %.6D%/I@%.HI1UH ,8-.I!3L9Z4 &TTZ@4
M[I0 @XIW6@"EH 5&,;!D.UQR&'!!]:[SPM\2IK'R[?52T\'_ #\\EU^H'6N#
MQ2CU'_UZI2: ^B+.\AO[=)X)%EB<95E/6IZ\'\/^)KWPY<;[5\QGAH7Y1O\
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MEI* "BBB@ HHHH **** "BEI* "BBB@ HHHH "-PP>156:Q5OFC.QOTJU2T
M,LM:GL&$=P"\?3/<5T5M=17<8>)@P_E7//&LBX89%55$^FR>; QV]Q0!V-%9
M^F:M'J"XSLE'5?\ "M"@ HHHH **** "LC4O#\=SOEM\0SDEB/X'/7D=L^H]
M<G-:]% TVMCB66:QN-KAH9EY'^(/<5NZ;KRS8CN,(_0/V/U]*U+FUBO(]DR!
MUSD9['U'I7*ZEI<NE_,Q\RW)P)?3T#>GIGI],@5G9QV-N93T9U]%<OI>M269
M6.0EX/U7Z5TL<B31AT8,K<@BK3N92BXCZ***9(4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !117YY?\%0/V[#\(]#E^%O@2_P >,]3B_P")K?PM_P @VV92-BD=
M)GS_ ,!4'N1@ \=_X*A?M]#Q)<:C\'/AWJ6_2828/$.K6K_+<N.&M8V'5!T<
MC@GCD U^8U*[M(S,S%F8Y+,<DGUI* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .]^!OQ
ML\3_ +/OQ(TOQIX3O&M=2LVVR1DGR[F$D;X9!W1L#CU /:OZ$?V8_P!I#PQ^
MU#\+['Q=X<G5)>(=1TUV'G6-P!\T;CT[JW1AR.]?S8U[9^R7^U-XC_93^*-I
MXDTAGN]'G9(=7TG=A+RWW#<!V#@9*MV/MF@#^CRBN7^&7Q*\/_%[P+I'B[PO
M?+J&BZI L\$J\,,]48?PLIR".Q%=10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 445GZIJ\>FQD >9-CA ?YT 6KJZBLXC),X1?YURFK:]<7V4A)A@]C
MRWUK,NKJ[U"X,DK[CV7L/I2*'[BD:J-AHB=><YIR[CG%([%:59=@/%,9#(S#
MJ,U%YHZ8JV&$U0R6W/-041*NZIUA+4^&VJ3RV5J ,^XM&W<4Q;<A>:TF;'45
M4FN%7M3T#4CM[9=V3S6FCI#@5BM,6;*G%6(6+]Z+]@L:RS^8O% A+'FF6[+&
MHJ7SEID$BJ%6C<JG-0R2,?N\"F+'NZGFF(L->#H.E07S,UJY]J?]F Y%5M5N
MQ8Z?+(ZE@!P!W-,#X\\272VFJ:K<38")-)UXR=QX'O7RU\6?BQJNN3&SL)+B
MVT^"0H[1[67<,<\9SBO9_BUXFNK^^NH[2%XUDN9E YY968%3CIZ^]?'VMZ^F
MG7][(80'R1@J58'W'I7FQ]YL[I>[%&CJ7BQI(X3>ZC+<;1P/*W-QR!U'?FN>
MCUJX>.:+3DE@MY&)>2XEVD\>@SVKB_%?C:;5LK$JVZ@Y^4\D>E4=)UV<(B2.
M6BC.XAO0]_P-=*I:7.65;6R.SN+S;(WD6JW4[#YMQ8DGV.<5SFN:C<W;A'M/
M+S_"J!1]#WKTR-M%;1X;]79IU :YBC _>1G@D>Z]?<>]5VTS3[>YE6*2+4HW
M3S;8D_ZU"/T8="*J+2Z&<KL\F_L.?=ONXYE&?X5W5L:<L$.5$DF>_F1]!Z5U
MC7NB?O$,EQ;2 XV%LC\#6+J6JP1J4CD0+R1NC#Y^O&:UYG+2QGRVU);#5IE)
M6V@0D _,S;54>YR:<L=GI]FUQJ-[%&S$LBB,NPSV08ZUE2:I$T:M/<R!0?EC
M"A1GKZ<TZS(U"<,/,GE/^K+YP.>W''YT6 DM+.&\9)Q<C;(3^[G&PL/7VJT^
MM6NFV=U8I<17=U<'".H^6(=.#W/TJGJ4<&EYVV\<UQG@R-O<>O'I6/!"DDDK
MM $8(69L_='<\_6M+7(>A-<:S:VLJ32WANI5'$2 [0?\^M7%U R0O--$J)<'
MS-S,Q8MT'W>F!VJC::?H@D#!I;I^JQKT/Y5<U9I-4:VD\H6\<(/&X _3KUJ?
M(-3J/#EY!=6ABN%F@B7Y45X\!L]2/>LS=!IB2O%YEX\88G)VKSTR!U[GK67#
MJ,=K-$"LC,IRVXDG'M2VFJ20Q/#(D5G%.,G[5DF09QS[=:FQ0:3XLNEO$G+R
MK,I#Q[96781T*GL1Q7Z)?L7_ +?7B'_A)]%\!>.'?7-.OW6WL]6D<-<6S%1L
M1V_C7C'/S GJ1Q7YLW_E6LP\H; 3D(K!X_UYK<^'7BZ?POXLTW4RXA6VN8YS
M+G.-K \?E2<7NA\W1G]&T,\=Q&)(G#H>A%25X!\#?CIHGQ0T0ZQX<U.*^B4J
MMQ"K[MC%0VT^AY].U>Y:;JD.IQ;HSM<?>C;J*H;5B[1110(**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBH[BXCM86EF=8XU&2S' % $E8&M>+(
M+'=%;XGGZ'^ZOU]:Y[7_ !C+J#-;V9:&WZ%^C/\ X"L*,U:CW);+EW?3WTID
MGD,C^_;Z5#NIFZEW51-QVZER*9NHS0%RGJ#?(:\Y\4-F0_6O0=1;Y#7G'B9L
MS?C6M/<RF8<G^K-<QK8ZUT<K_*:YO5FW$UU1,9&# "LGXUH,N4JO%;DR5I+:
MEEJV0CD-<LA("<5PVI:;@DXKU74M.:13Q7+:EH[<G;0@9YQ-;%,U4FBZCH:Z
M/5+,Q,>,5B2>AIB,N2#GI52X4*IK5F8"L74)MH-04C&OYMQQ4-G;F1LGI3O+
M,\W([UO6&FG8#MJA&7<)Y:XQ6?N_>5MZI#Y>16$O^L]Z0,OP]JOVS889K/C[
M5=MS\PXIHEFY:M\H[UJZ5-Y=]"V>C5BVS8%7H9C'*C>AK04CZR^&<AN+&)LY
MX%>M6,/RBO%/@[>B338^:]QT]PT8KGFK,FF[HN>7A:J7$WDYJZS#;6)J=P%S
M6)T)@]\&R,UG37/SU5:;G@TW=N:IL;&G;ONP:T4XK)LV Q6HK?**EC0LAR"*
MYCQ%9B:%P1GBND9N:S-47=&:<=Q/8Y/PW\?->^%MZEO?K)K6@$[3 [?O8!ZQ
ML?\ T$\>F*^G_!7CO1/B%HZ:GH=\EY;MC<O1XF_NNO537QSXTT])D<$5QOAS
M6]:^'NMQZOH%V]I<H?F4<I*O]UUZ,/K7IO"0KPYHZ2/-6*E1GRRUB?HQ17E?
MP?\ CYI'Q.A6SN-NF>(%7Y[-V^63U:,GJ/;J*]4KQJE.5.7+-69[$*D:D>:+
MN@HHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBO /VAOCU-X;TB\TCPK.LFK#Y)[N,Y\CU"_[7OVKFQ&(IX6#J5&;4:,JT
MU"!E?M4?M96WPATB[TGPTT.H>*,!'DSNBL\]V]7Q_#V[U^;7Q \>:MX@NI=3
MU*[FO+R\;S);B9]SLQYR374_$"2XU 2RS,S%GWR%SDL<UY5XOF>X:)(\X0=/
MYU\PL5+&24I[=CZ6.%CAHV6YS>L:Y-J4\%@LC;<C>Q/O5CQ-XND6VCT;3>%4
M 2,A[^E8MK:NOVF[F8(>BYZTNBV9EO (%WOG.6Y_$^IKU^2G'7HOS.&\Y:=_
MR/0/A7X3'VA;BZ/F3,0W/;W->L>+M<@MM*%G!+Y46/F;."?>N(TW6+/PMH>Z
MY9?M*\[<Y ^OJ?:N;M]2O/'.K$*6\O.=W8C_ #VKQ)\^(FZDMD>O"G"BE%;A
M,/[9N&C5F%JIR#_>K)U^_P#[-A^SQ#;&/NBNVUBULO#]BJ2D&Y_AAC&6)]ZY
M5?!NK>(KOSYK9K>$\C<""1]*VHU(+WINT4*M3FURTU=LX'RI]4F*0H3GK[5T
MFD^&X=/C$\C>9,.OH/I7:CP?!I-J5P%<#^+I]<51DTRW$9:2[SC^%2!71+&J
MI[M/8YHY?[+WJNK,Y=:VS!$RS'ID5W?A/7)+&19"N7Z@N,"N/LUT^%@\5I--
M-V8 XKIM+$?EF6Y'E%><GM6$[/H:;';Z;++>ZJETSJ65MY]AZ5]S_LM^*GU+
MP9-:RMEK6X9$1?X8\ K_ #-?G=;^++9+C[+8;I9'/SR-TQ7UM^R+XE*>)GL6
M;]U=0$8SP67D'\LUZ.6U)0K\DMI'BYI252@JD=XL^K?$7BI-&M&D8<#N*J:1
MXVAU"$$,>1GFLOQ[:B:P=3P".:R_#>EI#:QE?2OK_9QL?$.M4]I;H=_'KL;8
MYXI9-<CCDQNS7/K;].U/: 8]34^S1M[:9T*ZY%M)W8-1QZ[&3G-84< ]>*1X
M%5O[M'LT'MIG3_VM#P=U.76(<_?XKGD@_<@]34:(/, !YSTI>SB7[:9U#:E'
M@X.<<US_ (DU 7%LR*<YX-:*6:+'DC';BL/6%2/<H.,_K1"*N*K*3AJ><>)E
M_P!$FP /D.<U\JZ'X-M?&GQBBBO8F,(,B1SPLPGAD((5XQC:Q!.<G&-O>OJ_
MQ5%ML[D9_@/\J@^ OANQTOPM=:\;9/M$L[DS<98YQC'.,8ZUU596IGEX>GSU
MDCN8[$Z+I-OIXF><6T2H9VQE\#&?K]*Q=-GDU[49K:1MMG$=[-_>]CS5?Q9K
MUQ' ZQ7 &[E>.:Q=/U8Z79^3(^^X8!Y6'0$G !KP*N(49V9]CA\+*<+Q.QU2
M$2$1!,1+SY:>F.,^G%9MKIULTY:1XHE'(4'&/K7#>)_'4MG#,4?>K<?>/)SR
M2!7)6.M+J3>9J>H%I6.[RB BX/3 /3ZUQRQT.:R5SMCEM6W,]$>Q2MH45YY-
MMY4]T1CS%4.1[D\BI(9+/2UDF9%C+?>*@AW_ !(KE])\16.FV(V7<-N".LEP
MH)]JO6.K:9JS%KBY1R#\WER*X(_ ]/K70JT7KI<Y'1FNCL7KB\TJ9OW-K9H^
M0V]E4L#_ (UP/C+PB=<>:*S#":<#[1>,1G:#E0/09YP/05VQT_15D=K:3!8<
MJ2",#ZUC>(KNTM;!X6*8+8\N(;S^)KAKRNO>L>GA:>ONWOYG)>$O!5OIVH>;
M.L<!AQY-U"X<,.F2",J<Y]1]*[B:XN-/\Q V]&4[EP/O?WA]:YZUM_MVEPW2
MJUN\<A4A3S&2> ?9A^M)8OJUK>/:WD*W.GRC*S1MG8/< <5UT)+D5CS,5%QJ
M-2.X^'.O"Q%^9W 9HQ(/P)!/\ORKK-/^(%G<,-DRY)QU%>4KJB0LQ=H]L;^4
M[=24;@G]<UR.H>%=2\*^)OW5U*UJV2 3Q^%>E37/H>+B:KHKFM<^F+_Q?;K;
M_+*-V,BOG[XZ_$*]TNSBO]-N'M[FV?S(YHFVLK#H1CT-9DFJZM/JT-FDA99"
M =V<BK'BCP&U]#_I&Z10. 35N'*S".(]O'0[[]E_]L;3_BC+'X6\4R1Z=XK0
M;89S\L5]CL/[LGMW[>E?4-?BWH\/V'XR7UE"<);71V%3@C!K]3?@S\2IM:T"
MSM=:FWW84*ETY_UG^\?7WK2IAVH>T0L)F<:M9T)]-F>KT445Q'O!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%)0 M<EXM\<0Z/NMK0K->G@]UC^OJ?:J'CCQ
MQ]CW6&G2?OSQ),O\'L/>O-E8M(6/)/)-6HF4IVT1J_:IKR=IIY6EE;JS')J&
M]QY>3POK1;LJH69L <DMVKS'XA?%?3M.CNLW2Q6D((=B<;CZ"N?$5XT8W9OA
M\//$2LC.^(GCZ#38[F**98PHYDS7R1XX^)C7NH31V ^TS9P9#SCZ5O>)-5U?
MXEWSRK')IVAYR'D!5IAZXKCM7DTSP;$5M;=99FSF63K7RLZSJ3YI;GU-.BJ4
M.6)QUSI_B/Q%.7D/D*?^6DO]*F7X:62Q[]6U&6Z/78K86J%YX^:XG83704#L
MO K+U+Q1 R?-?]>VZNB+E;8SDH]SHVM?#NAH?LUE!N7^)\$FN=U;Q0LC%8WA
MMXO10*XS5?$5H"W^D&3Z&N:N-2BF?(+$>]7&+9DVCT+_ (28Q, ESO/^[6K9
M>)PB[YYF"_W0.M>6V=T7;$1VCU-;]E:M-C=)N'?)K6UC/F;._7Q])@K;Q83W
MZU8C\774T1!C4@_WAQ7.:?#;QX&[YJW+>WMMN990H[#-1=%V)K>ZMY@SW-DK
M#^\I(-;.EZ]_9!#6;S18Y"E\XK"N;JU6(!&#'L,]*ATS3)]6N WF-%;(<LYX
M_"JB^PG'N?0N@?'K4;.UMC,_[FW'S,W<5[CX#^)]IXQL5FBC^<U\/W$PU*Y6
MUMVQ9Q??_P!JO4/A[XBO-"U"V,+;(>%X'RX]*ZHR..I34EH?9<?S*K>M38&>
M.E8_A_5!JUE%,JY!49/:MA8\^HK='F-.+LQZBG"A4QBGA:H08]Z<*,4X"@ Q
M3MM %+0  8IPI,4ZJ *<*;3Q0 4Z@4M  *=2;:>!0 +2T4NV@ 'Z4M Z44"%
MJ>SNYK"X2>WD:*5#E2IJ"G4P/7/!OCI-=Q:7>V*] ^4CA9/IZ'VKKZ^=D9HV
M#(2K#D,#@BO2?!/CXW+1V&IOF7&([AN-WLWO[UM&7<#T"BBBM!A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %,EE2&,O(P5%ZDTD\Z6T322-M1>M<GJ>J/?.68[
M(5Y"YX'N:ENQ<8\Q-JFKO?,43*0#MW;W-1V6E&ZC%Q<-Y%EC<6SAI!Z#T!]>
MOIUR)K'2Q'']KOQY4"\K$W!;_>'I[?GZ54U/59-1D_NQ _*O^-)*^K+E*VD2
M;4M8-PODP#R;=> J\9_^M672T59B%%%)0 M)2T4 %.CC:1MJC)HCC:5@JC)K
M4@@6!<#KW- #;>U6#GJWK4U%% !1110 455U+5K/1[5KB]N8[6%>KR, *\I\
M4?M#65HS0:):M>R=/M$WRI^ ZF@#V D*,DX'J:Y_6/'WA_0<B[U2!7'_ "S1
MMS?D*^==8\;>*?%S$W-])' W_+.(^6GY#K69!H,>=TTC2-WH ]HU3]H71;;*
MV=I<79[,0%!KG+O]H35;C(L])BC';>2U<5#I]O#]V)?Q&:GP%'8"@#=D^,WC
M"X^Y'#$/:*H#\5O&I_Y;*/\ MFM8K7D"\>:F?8Y-.CE,W^KBFE_ZYPLW\A0!
MMK\7/&L7+-&_UC%7K?X[>);;_CXT^"9?]PK7.^5<[<FQO,?]>S_X5"]PL?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHK US7?+5H+9_GZ,X[>PH&E<77O$T>GJ
M88"'F[MV7_Z]<G_:1F8EF+.3DEN],9!))@\U*UHJKP*C6YNK(2.Y^;I5M+A2
M.16<R[/>G+ENAP*>HG8OM)&U12M'CBHXT/0FF20L?>C4-!8Y%6IE=7ZUGSJR
M+[U16]D5B,$4KE6N=&K+Q@TK,!UK!CU%UZUI03B;DT7$XEO"O_\ JJG<0(>>
M*L%E5>#5*9F)ZTQ(KM&JFIH5PW%0X&[GFKL> !BFALL1P%AG.*5I(X!UYJN]
MP0, TR. RME^E,DL"[,G0'%3QJ6 /2B&-%4 "I?N\T"%7((R>*AU1!)9M\H;
MM@\YS2NS,:2Y;_17!]*8C\]?B]H<UKXHU22P9G@6\8F'=]QP1@C\L8/!P*\H
M^)/A/1O'&CH%TN>VUO[KR! @?'')['/?O7T!\6-%;Q!K6MVT%[+IT_VER)H,
M;N&Z<]J\XMV\9>%[?:\UIK5B. ]W;9*_[VSMZG%>*[QE='JQDI02:/A;QMX)
MOO".IFUOH7".28Y,?>'^(KG[>&6"X4I\W^R.X]*^J_CE\/O$?C+P_P#VM;Z+
MHBQ8619;&_1L$YY4$@\X((KCOV>_@O<>,K637-1MF-GYK0Q;APY7AB#WP>*]
M#ZPH4N>1Y\<.ZE7D@>=Z%8W]LP"1MY)'4CCZ4Z9YM%=H[B-A;%O,CV?>B/JO
M^%?66K?"NTL=/)C@7"\]*\W\0_#>&^@D 3!QD8YXKACC(M^\>M++9*/NNYX9
M?75MJD),DL;N3_K4 &?<C/!K O,:<H*WAE;LHXVU?\4>$[O1=2G@V8*$D>X]
M:H6MH##T1WQRL@S7JQDK73/"G"2ERM:C;6[N)L"..$N1]\X+?K5YI;Z.$QO<
M"&/_ *Z9-9^Y4;(A6-AUVG(^HH402N3-O(_W2/ZXK0SLS3L(UDD)#E5_YZ,1
MDGUQZ51OKOR;I[>RE\T <R$?>]:DO-:LXK<065J48=9&/)^M4;.W#,[2C>['
M<-AVD57F23?VH67:TD@'1L'@^U7EUA5A5&.U0,#CYC522,N^YIV0#HNT,?SK
M.O)=TFV/C;W)R:6X;&Y975@NZ21MC9XWMG\<#J:34-8M]4E6$+OMD79'G)?K
MDGCIS6%#>1+_ *R!)?PK1MM0N[B(V]A:PVJOPSQKER/3)Z46L%QJV-DOF%[I
MT95(5&0YS]:K:7>^3+F96EAZ,JG%,NECBN$C5][)_K&!SEN_X4EY,J[5C4;5
M^8D#FJ)/T@_X)=^#-4A'B'Q2TQCT22!;**'/^LEW;F8CIE1@9_VJ_06WO'M9
M%DC<I(IX(K\8_P!EC]L3Q%^S_.NDI;KJ_AJ[N T]B_#JQP"T9[$C'UP*_7'3
M]<DU2PM;A8GB^T1)+L8<KN .#[\US.2AHSKA'F6AZ[HOB*#5%$3,$N1U7^][
MBMBO&[83&9'5BCJ=P8=01WKT/P[XF74-MK<L%N@.&[/_ /7IQE<4H6.AHHHJ
MS,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHK/UG6K?1;8RSMEC]R,=6- $VH
MZE!I=N9IWVKV'=CZ"O-]>U^XUR;YSLMU/R1#H/<^IJ'5-6GUBZ,T[?[J#HH]
M!5(UHD0V*M2J:AIZM3))MU&ZF;J-U #]U+4>ZESUH S]2;Y37FOB1OWQ%>BZ
MHWR&O-O$'S7%;4S&9@3,6!K'O$+MS70/#\M9]U;8R:Z49,RX80K"M:WB4K6:
MWRMBKUK(3BFQ(GDT]9!TK&U;3D6-N*WI+H0Q\URVO:TD<;<TD/0\^\26ZJ6K
MAKK"LWK74^(=4\]VP:XR^N N<FK(*-Y/MSS6#=2&>0@=*M74QFDP.:6SL6F<
M?+2L _2M-,D@XKL[72Q';_=[=Z30M("[2173S602VZ4BT>8^(+?:6P*Y9(2T
MI..]=UXB@^9N*YZUT\MSBJZ$=2BL96K,.=WM5F:UV]J@5"&H1+-&W;\:M[JH
M0?=%60U6-GT7\%-1W6<:YKZ&TFXW1CGM7RQ\#[S=B//0U],Z*W[M>>U85M&%
M&-T;LDW'6L35)-P-:$A/K69?+\IKGN=/*8WV@*^#4BS#=5"Z5DDS2Q2$M5#-
MRWE QS6K%-\M<]"V*T[>3*BH91H;LU4OEW1FK$?(I+E=T9I+<#S?Q3#\KUP[
MQI*K*1S7H7BU=L;FO)+G6$@N'4MT->_A?>@>'B?=D5+X2Z9>)<V\C03Q,'CD
MC8JRL#D$$="#7T[\!_VH(?$!M_#_ (MG2WU/B.#46PJ7'8!^P;WZ&OE?6-22
M: L#S7#7.M+',1FNJKAXXB/+/<YJ>(E0ES1/UPHKXZ_9J_:N2'[+X6\87>8.
M(K+4Y6R4[".0^G8-^!K[#1UD171@RL,AE.01ZU\K7H3P\N61]-1K1KQYHCJ*
M**YS<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK/U#4!#^ZC
M.93U_P!FFE<3:6YR_P 3/$EUI^D2VNG.8[B4;6F4\H/0>]? 'B;7V\-^+&M+
MEFW;CN5_XAFONSQ9")K92W9QU^M?&'QP\&C5-?N)%*B5"1&V!GZ5\MQ%2M"G
M,]K):JE4G"1Y[\2]!@U.Q,]F-OF+NX'>O"]2T?R;&:60YE^X%_&OJ3P#H=[K
M6@R1WUNT?V<E0SC&]1WS7*^-/@O#JT,HM7-M,<[6ZK7R&'Q7L7RR>A]?*"J+
M0^0=2AEOKU+:+[F><5KV>SP["[*=\P''L?ZUU.J>"9-#OI;61E:[W89EZ"N;
M\46\=M&MM'RYZ]R:^OAB(UN6$=CQY8>5&]1[G.6]Q<Z]>,]Q+M@4[B6Z "NU
M\%2:IKNJ1Z9X>A94SM>Y"\X_I7,Z3X9GOYT2=C!:?><YZCWKUWP[X^T_PR(M
M+T*V4S#Y3*HZGUS3Q56RY*4;O\%ZF6'HROSU'9?BSU?P[\-]$\(V"WNLNMU?
M 9)8@G/N?\*Y3QU\0+*.&7[$D<(484 8!'\S7-^*O&UU-\CR_:[QA@JO*K[#
MU-<3!92W%P9;]VD+'/EYX%>%2PCG+VE=W/8EB>1<E)%3=K'BJ]9TDV1#J2<#
M%=%9:'9VBQ>?,)6[A3@9]SWIDDEKID67E(R.(QV_"N(\1>*!;R,8B5?W/(_"
MO7C&55\E/1'ESG&FG.H[L]*NKJ*"%A&8+>-1P[')KH/ /PSU3XN"2TT*3S%!
MP]T^1$#[>M?.F@VVJ_$#Q+9:5%+*WVF0(QR3M7/)_*OTT\._V-\ _A=90:?&
MOVPHL:!?O,Y%.O2^JV3EKN=&"B\<G)1TV7F_\D?%WCCX6ZY\)?$C6.KE1(XW
M1S1<HX_QKZ/_ &0[AI/&^DNS90EL'_@)KRGXZ^,K[Q_XVT?1[A-\Q&Z1NZ9]
M:^A/V>_!,GAKQ'I$4"&24*Q ^BFNG!U.:M2E+JSS\PH*G2K1CJDCZ=\>G;IL
MASVXK&\-7326:>F,5!XTT_Q1J]N8;+3\DGJ[8JUX7\,ZOIM@BW<!\[')!K[G
MF2CN?EMI2JW2=CH8E=ER!4GDRR9XXI;>VNHUVM$V*TH;>3RQ\AS6/.=BA<H"
MU=5R3S21V<DIZC%:4EK*RXV5-;6LBJ/EP:7.5[,IK8L(MF[O1#IIW9+< \UK
M^2V ,"E\EQD8_(TN<U]F578*1S\HK'U*UBE1ST('K5'QEJ5]I-N\T$#2$=J\
MNNOB5K%];ND6ERQRGC<QR/PJHVWN85)?9LV;7BUH_)N(MV3MZ_A6U\([2VN/
MAC;6MNR/MDD$A3_GH6);/OSBO+EAUBXLYYKO=YC#)&.E8'P2^(R^$_BX_A74
M+UHX-<1OLEL0<>> 2<'ME03COS[5K4?/#1['+AI.G67,K7/5=<L#<7\<'!,3
M;F)'\(YKG]8@AM[&:9I&C>1BX P0P X'Y?RKO6>*;QI=D+^Y\GY>/6O./%E[
M!;^;(VUFW&-0H+NO8D@#@'\J^2QUE>1^BY9>3Y#@+R8WDP!^8*>6SG!]*=9V
MIMY ;>15;GY'0$-[5 S?O"VUPLF=NY2/TJS:M+!&#%"[-VR,#GZU\\I'V4J:
M:T+4?A^?4(BVV+>W/ERKT/H!56Z\*SV["6.]2UD&0 A /TXX-;L+7,JAI&#%
M>D9'3\<U0NY#).ZLH#D9.T\>G7/'%5*6AG"F[F9;PSP_Z^[9I/6+AESW_P \
M5J-JT.Q(9Y#+LPC3!<?@1W-58K/SK,AG((_A;[V/3-9MRQ:154;=OK_%_A6'
M.T:>RBSTKP[<6MOITNT927Y#&QQO_P /;WJS]AT^.99(HWN82W,CDAH6]^01
MG\JY9[@IHJ1Y5 L:MYB\X8<@_P"?_K5;T[7GNI'MYSY$Y0 .@QN4\?SKZG"U
M%R*+/S_'P?M92-/6-,%UIDK6Q)N%7Y5SGYARH]P1Q6QK(75=+TFX1&=GMT).
M#Z#@_P">U<_INH3DSO<?NY%'EO'TPRL"&7V(P:]:\-Z.NJ:'93.F2T>[GWKV
M*4K.YX.(I^TCRGCL=NUCKT3F%B,KR170>*O$=O#IN ,G&!QBO59O!UM</O>(
M;@/2N*\?>"X)-,G55Q\IQ^5;2ES,Y*=!THL_/7PQI=S<_&;5;D_,'NG.[/O7
MWOX1M3;^%XU8<[1_*OB+P-)%:_$[4H2^7CN64^O#5]R^&9E_X1Q&#  KQ^5>
MM=^S1\S0A!5I-,[SX8_%Y+S5/^$<UF7;= #[-<N?]8/[C'U]/6O7Z^&_$&XZ
M^[@D,N,$'!%?0GP9^,T/B=E\/:Q.J:W$F89&/_'R@_\ 9QW]>M>=7HV]^)]+
M@<9S/V51Z]#V"BBBN$]P**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@ KS?XD?$FTT6.6R
MCO(H.")IRX&W_9%<Q\?OCM%X!LY=,TZ53J;K^\E/2$'M[M_*OB3Q=X@NM>9[
MO6;V9H7)*Q,V"WX"O,KXZ-&7+%79Z%'!2JQYI.R/I"Z^-'@RUF,<FNVX?//S
M9KR7XP?MG>'?AKJEC;6$0U2.4YEF4X55[X/K7SIKWQ$TKPZS'^RK9(T'67'/
MO7S;^T%\5K/QE/916$<4?ECYC"*TPV*JU9I2CH36PM*FKIW/T#\0?M<0?$:*
M#3/!X9$F4;[B9MJC/:LG1]-TV2\=M1O1XCU/J4!_<Q'T ]:^*?@/=)>V=LC3
M([))AH?-VG%?<O@W08QHD9L[>WM(R,L\9RWYUY>(A*55\^IZ>'G&-)<JLREX
MJUK3])MW74IDC./EAC( 'X5\Y^+_ !7'J6H/':Q(8P?EW=Z];^('P]MKRXDE
MDO<;L\LW->*ZE\-3#>%XIS, ?X7J(<D=C:7.UN<GJFEZIJTCI%:!%[LHK+?P
M2\<BK<"4GN:]#^Q3VL9CB::*1>X;.:IZM=7=V@C,NRX5?E) P]=',K:'+RN^
MIQ\/@VWAD".H4GH6JM?>%[>UFP8UXY!JU<^+KZ)GM+JV"RKPK8ZUDZAXLEN(
M2K*%D7C-9N,F]S1.*6I6FMY8VQ'$%7UJUI\DH.TYS6,NL7:R9$F[V(J]'K,L
M(W&-?,/?M1RR#FB=1;$Q+E_]8>BBM*-UC7YAEF'\1Z5R.GW]]J4P6"/+'JWI
M6S+)'I.)+N?SYNT:U/+(KFBC?L;59&^T2,(HE[GO5VXUIKQ?LUF#% .-W3-<
M5_:]UJDRH>%SQ&O2NHT\"-4#E5(_NUK%<I$I<VQT&B6_DJ,MM4<L?6NKLO$Q
M,J6UM'NC7@E:YC1=*O/$ETD%J"D>>2*]U\*?"5+6UC"QAI&Y9Z'41<:3>K.[
M^%OCB:PT]8)%^3TS7L>F:Y#J%N)$^7CD&O&8?!\VCQ!HUX7DY[UU&G^(!I]D
MOF'8?[N.:WHU.>5CCQ.'44Y'I+7R**1=33UKS&Z\<11H3YF/QJM:^/(II-N^
MO65%L^6GC%%V/5VU)?6HWUA$_BKS]?% F7(:JEUXA;H&K3ZLSG>811Z5'K*R
M-UK1@N!)CFO+]&U9YY!UKOM)=I ":RE3Y3JHXI5=C;%/QP*:@X%.[5@>@+1_
M.E6EI %*M*M+B@5Q13J0"EH#44"EI%IU :A2CUH%'\J U%I5HY9<]:6@74.?
M6ES2<TX=*H9Z+X&\=;_+T[47^;&(IF[_ .R:]"KYY'MUKT[P#XQ^WJNG7LG^
MD*,0R'C>,=#[UM&0'<44458PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDDBPQL[MM11DDTY
MF"J6)P ,DFN5U;5&OI-B<0*>!Z^YI-V+C'F8S5-4:^DSG;"OW5/\S5O3=*6W
MC%]?#:J?-'$W;T9AZ^@[=>O1NA:<)=M[,,0+\T>[^+_:^GIZ]?3-;6=4-_-L
M0XA4\>_O4I=67*5O=1%J>I/J$V?NQ+]U?ZU2HHJS$**** "BBB@ I44R,% Y
M-)6E9V_DID_>- #[>W6W7 Y;N:EHHH ***RO$GBC3O">FO>ZC.L,0^ZO\3GT
M [T :<DB0QL\C*B*,EF. *\H\=?'BRT@R6>AJM]=#@W#?ZM#[>M>:>//BQJO
MCBX:UMMUIIN<+!&>7]V-<_I^BI#AYOG?^[V% $NI:EK/C"\-SJ5U)-DY&\_*
M/H.U6+/3(+4 A=[_ -YN:LCMC@4X4 .H!Q24M $BUW_PG\'Z+XEM[^ZU.'[;
M=6\_EB&1CL1< @[>^>>M>?+VKK_A7KHT/Q@D$K;;;4D\@D]!(.4_/D4 >T6W
MA_2]-B/V73;6#:.-D*C^E>,_\+;\3M#YL0TR-&+;4^SMD $@<[_:O=G7<I![
M\5Y$_P "[A5\M/$.V,$[0;,$@$D]=WO0!R-W\;?%<.>-,/\ V[O_ /%UAWWQ
M]\4+D-!IC?6!_P#XJNWNOV?9I<[O$A_"R'_Q59%U^S<9/O>)'_\  -?_ (J@
M#7^'.LK\1O#,U]JVG6)F2X>'$<.%( 'KGUK*\;>'].T+['/81_99I9A&8D)V
M,N"3Q[>U=;X#\#K\/]#DTU;QK[?.TQE:,)UQQ@?2N+\9ZB-4\4-&AW06">5D
M=#(W+?D,#\Z ,RFR1),I5U##W%.%% &3<:'LD$MI(89!R,&NL\)_&'6/"SI:
MZJK7MF.,M]]1['O634<UNEPA610PH ^B_#?B[3/%=HL]A<+)Q\T>?F7ZBMFO
MDJW_ +0\,7@O=+G>-E.<*?T/K7MOP[^+UIXF5++42MKJ/09X5_I[T >D4444
M 5[JW+_O(^)%YXK9T75OMB>5+Q.OZUG56N(WAD%Q"2KJ<G% '7T52TO4%U"W
M#CAQPR^AJ[0 4444 %%%% !1110!CZUHOVHFXMQBXQ\R]!(!_P"S>A_ ]B,6
MQOI+"?>N<9PZ-QGV/H:[*L37M+:8&Z@3=(!^\11RP]1ZD?J/P%1)=4:QET9K
M6US'=PK)&<J?T]JEKCM,U)K&0.AWQ-U4'@CU%==#,MQ$LB'<C#(-.+N3*/*/
MHHHJB HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "OQ2_P""K'[83_%[XB/\,O#&H;_!WAJ<B]DMY<QW
MU^N0Q..&2/E1U&[<?2OO#_@I-^UHO[-OP;DTK1;H1^.?$Z26FG!2-]K#C$MS
MC_9!PO'WB/2OP6EE>:1Y)':21R69V.2Q/4D^M #:*** "BBB@ HHHH ****
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M%%%<)T!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVF>)M%G*R6\@\^W8XCN82?GB;V(_(\U^U'PS^(NC_%?P1I?BC0KA9]/OX@X
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M;01H"!BIM-T=5C!Q@UH?9_+'3%149Z.%H>SB0KG%.H_BI3TKA/4"EQ2+2\T
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M8SAEQW'%9\$18J%W,3QM SFOI3]J[X:0^'?'US+#&;59T#J,84\'\LX-<?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR,KMF3AD.:M4A 88Z^M &YIMX+ZT23^+HP]ZMUR^BW)L=0,#'$<G ^O:NHH
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M"[&U68VJE&U68VH NHU3QM52-JL1F@"TIJ=#59#4R&@"RIJ2H%-3+0 M%%%
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M%&7Q/5GYAGN.CCL8W2U@M%_G\V=O=:\+:W;M@?E7DGQ+\>0FV>!&!+*:[/Q
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M+=>W'2NA\.ZAN9[5CR/F3Z=Q7)/74^CHOE]TW:***R.T**** "BBB@ HHHH
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M0VYGB99+"XZKN#?3YA7(-']MGEBB#(S+ENP;GO70D<<I=S/-GITC1K>J%/\
MRSG3#8'H?:LK4+5;"Z$]K*\1B!9) 0P_&IM8T>2)9/+$;JHYC5B&KG[JUO'M
MG%I+&73G;,#N7Z'_ !J[F,HW.C@\.P>(KM)V9(+J\B/*\*Q]QW_G^56X?AI?
MZ3:6TT<[2!@64Y^>,@G(#=US@@'I65X*N9F865SY<3YW(0^54_7/!KW'PW(N
MJZ>VEW2O!=EMZ.P&PL!UXZ9%=,?>//E>+'?"3_1M8N+">/\ =2C]Z&X\P'C=
M^==%XTT9X<R9_P!3(8"C=>._Y$5J:/H8#I<_9O+F@;RY%Z':>.#W]<U)\0(_
MMUQ</&^\! &7!R"!DD_G7=3]TRIR?M$><V>K76BZM;7UI*8;JWD$D;#L0>!]
M#7VIX.\36_B_PY9:K;GY9XP73NC?Q*?H:^'9Y/W@'4=.>:]F_9W\:'2-<;1K
MB4BTO_\ 5ACPLPZ8^O3ZXJ:DDY6/3Q5'FASH^EJ***S/&"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S]:OOL=KA3B63A?
M;U-:%<AJU]]LNW?/[M?E7Z#O4R=D:0CS,BL+-M0O$A&=GWI&&>%'OZGI^.>U
M=@S);0DX"1HO0<  50T&Q-G9;W7$TWSL".5'9>F>!V]2:B\176R!(%/S2'GZ
M"B*LA3ES,R'D:[N))VZL>/855N7YQ5H 1QUGNVYB:H@;2T4E "TE+10 445)
M;Q^9*H[=30!?M(_+A'/)Y-3?K3:* '?C7E'QY^('_".Z+_9=I)B]NQAB#RJ=
MZ]+U348M)T^XO)V"10H78GV%?&/C3Q-/XO\ $MW?R,2)'PB^B]A0!4TJT-Y<
M;FY4<D^M=.OR\=JHZ;:BTM57^(\FKJT 2@TY:8K4X4 2+3MV,5$6Q3/,QGF@
M"<MBF-,*JR3\=:JS7F.] %]KBHFO M8\VH8SS5*34&9@J LQX  R30!T#:B%
M[U&VK*.]<_JEOJFFZ?\ ;;K3[JVLR<">6%E3\\5S$GB>+)(FR/8&@#TA=6'K
M4\>K+ZUY@GB>/(Q,/QR*NP>(E;&)%;Z&@#TV'5!ZU>AU('O7FUOKP)&36Q::
MT&Q\V: /0(;X-5^.=7KA[75.G-:]KJ1W#F@#I2@<5!);U!;WP;O5U9 PYH S
MI(=M1$;:U)(1C-4I8<=J *]%*R[:2@ HHHH 1@&4@\@\&I? _B23P'XIC<M_
MH%P=LBYXP>_X5'534K,7EJ5Q\XY4T ?4\,R7$*2QL&1P&!]C3Z\Q^"7BXZMH
MS:7<OFZL^!GJ4KTR@"O?1G:LBG#+73:9=_;+*.7^+&&^M8++N4@U-X;N##=2
M6S'AN5^O_P"J@#HZ*** "BBB@ HHHH **** "N2UJQ^PWIVKB"7YDP. >Z_U
M'L<#I76U4U2Q_M"RDB&!)]Z-CV8=.W3L?8FDU=%1ERLI^'[_ ,Z$P.?GC'R^
MZ_\ UJUZXJQNFM+B.4 J5.&4C!]"#[UV<<@D174Y5AD&IB]"IJSN.HHHJS,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6M:Q:>
M'M'O]5OYEM["QMY+JXF;HD:*69C] ":NU\2_\%:/CD/A;^S/-X9LY_+UGQI/
M_9JJN,K:J ]PW7H1M3_MI0!^/W[2WQHOOV@OC=XK\<WK/LU*[;[)"Y)\FU3Y
M88QGIA OXDUYE110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >]?"+Q)_:7@^/35;_2;%V4C/.PG(/ZD?A7;0V,C=J^8?#WB"\\
M,ZI#?V3[)8SRI^ZZ]U/L:^E_!?C[3O%6EK<QQ%)5(66($$HW^>E?K'#^94L9
M2CAJTK3@K+S2_K4^3S##SHR=2"NG^9JPZ;(>@%78=)E]!4@UF%<;(B?K3FU\
MJ<*G'M7WD8X>.\CP)2JO9$\.BS-_=_.IVTT6L9>:>&)1W9JR+C7;F081O+'Y
MFLJ3S;J3+LTG/\1S52Q%&&E.+;%&G4E\3L;_ /:@CD(M<2'_ )Z$<?@*6&&2
MZD,DK-(Y_B:JVG6IXR,5T-G:<#BNFC"=;61E4E&GI$BAL^F16WIEJ2PXH@L^
MG%:]G"(\<5]!A\.DSS:E2YK6+?9U%2RR>8>:JJV!2[_>O6Y=;G 2J@JQ'"IJ
MJLE.6;!]*33 T3&GE\'FL?4L1C*_C5U;CWJAJC QG%9).-S2)B3S;LUF7=Z(
M0<G"X)-275QL8BN>UJ?S(]F?O$+^9KQ\5B/9P<NQW4Z=V6?@[\)-.\*M=ZLD
M0>]O)GD\YARD98D(/0 8^M=W=>+K.+6XM,5PTS'D9Y JTLRZ7X2NKH<+;PF1
MCZ #)KXMTSXZWEOXZO-6N8O,L[F3  '[R) >,>ON*^5Q>:87ARE0P\5RJ;U]
M.K^\QP>%KYY5K5Y._+^?1'UY\2_A]I?Q#\-3:9J29B;YX+A!\\$F.&7^H[BO
MS^\2Z!<^%M>OM)O /M%I*8F*]#CH1[$8/XU]]^$/&4'BC1HBDJR)(@96!X((
MX->/?M$_!67Q):2>)M$@:75+6/%W:QC+3Q#HZCNRCJ.X^E>/Q=E4,TPL<PP<
M;SBM;;N/ZM;^ESULAQ[P-=X3$.T7^#_X)\IT445^%'Z@%%%% !1110 4444
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M%ED\K7%B!'<#D>_M5WPHL^A,(+NU7>/NR;<Y'O6FGB!(M1>"38@+X5MWWO\
M"NST^.UU"W"RHK<?>/6N:$KZ(Z:D+(--O?M#*0NTC!PO:NK@94AP6&,9KG?+
M^PL/*VB,#GBK4-\^P$Y4CIGI6ZEW.1T=+FG)<I*I*X"?2L:\FXP#R?X35F29
MA@9W;A@@'-95Y>*B[B1SSN]*PDRXJQD>+-9&G:6TCL"JG+'C('KS]*^9O$6F
M[?%TEQ;EXX4+N%'\ ;C'MABQS[BO0/BQXU2_A_LFV/[V1VAD&>BY!R#] ?\
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MP/(N)F!(('N:U(XV6,"HI-1C4_*"?PJS',)H\]*RDD:)LCD!VFOE[XJ*+?\
M:-\(2]Y(9DQ^ KZCD;Y37RQ\:@\?[0/@:3HI$J_I7/U0Y?#\U^9TVH_%Q_@U
M\<-$U&>0C1;^,6FHIV\LGB3ZH>?IFOM>&:.XACEB=9(I%#(ZG(8$9!!]*_-W
M]JNU)UC2WQUC(KZ3_8@^, \=_#M_#-]/OUCPYM@ 9LM):GB)O^ X*?@*WIS]
M]Q9E4CIS'TE11174<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4T 344@I: "BBB@ HHHH =X/C\[Q%J#_ -U50?C7UQXQF&A?!._?.WR[$_\
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M#D'.>U0RKG3[2L) Y^7BOCS]M:$GPK)WPXX_&OK^W9EA^;( &,D<5\R_M4^
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M_A7;Z)=?;-,@<G+ ;6^HXK.:ZG50EO$O4445F=84444 %%%% !1110 4444
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ML@Q^(Z?UKIJ([!-6844451 4444 %%%% !1110 4444 %%%% !1110 4444
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MK*M9M'3!4^IROB#62T<ASLC49+&O!OB+XB-[<?84/RJ0\GL>R_D<GZ^U=O\
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M&E:["8X)^?DNXQ_JV[?.G*]R485\%_M!?M#77AOQ/J>@Z,726)W2>5^-K9(
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MQAHW9'&UE.T@]B.U5M+U:[TN<S65S-:3%63S('*-M88(R.Q'%2V\IC;(P?\
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M:Z; RV\]CYTGSR#YMP#'<I(X[YY Z5R]EX;,FFPR(&D81X*@$G/K4^@VJ?\
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MZK48'3@<+S5HS3-KP^S22#YR1WKU'0]-W0KWKS+PDN^X0=.17M>@Q!85XK/
MT^>5F>GG-54Z3Y2JVE<]*LVVG!&Z8K8F58P, "JZL >M?9QHQBEH?C]3$2E-
MZDT4*1**G6;:U5&F '6J[W('>KL9\USI+&XRPKH;9^E</IEZ/,QFNNL)=RCG
M-<%<Z:>J--FIA:HV>HVDKSS8G\RCS#ZU4\[%()"V ,Y]A0!?\4^"QX[^%NHV
MIF\I8Y"X(&><<_S%5?V1_!D/AWPG=W("M>M=/!)< <E%Z*/3_P"M71Z/J1M/
M"=VP8.BR-'*@8=U''UKL_ASI<.C^&;=8+=K:.0^<8V/S;F[GBN3V*^L*HCZ2
MGB)?4/8WT;-7Q%,+7)' 4@FOA?PS\ ?#\OQ=^(7B+5['3M8FUC5I#9JZAH[>
M(8WLH/\ &7W G_9-?:7Q"O#9>'=4NHMSS1PNZ!>=V%XKY,6UMY?#L-^6DD8V
MH:-HY"N_<-S,>>A8L3[U=:K*GI$>&IJ2O(Z#Q)\,8= THR>'-=NM)XXM!)Y]
MN3_N-D ?3UKYM\4:UK'AO4))/$%A]ILT8[]0TD%D7_>B/*_4<5VW_"5:CH?A
MQK^UGDOX"[+-;W,I)C7^$Y[#J.AZBO _'GQRM;?4C%<6=W%</G=S@<=P1UKG
M5ZNZ.SF5'=GN'AO6-(U;04OM,OX6C9_FCB^9^/4=JYSQEXG@GU!8+5MJ AG;
MU(KP&U^(-MJ5U-)IUI)IEYU:^LI-LA]W3&UQZY%=#X?CUWQ1J4>FPBUCU&2/
MS%??MCGC! +JIZ,,_=]\TI47N:T\4I:'JUKK$4EJQG"D*,Y]!C@5IV\<,UFL
MI9<.H;:.Q]*\FUB^_L33WL7N2TT9Q)(_&6[U<;QM GEA;D850J\\5S\K.SVD
M3U.WTFUU!L%E0J.1C-2W7A]OM:01A9H@<[UY4^WM7*Z)<2WV@RWUK<;I <'Y
ML^O%=)X%U*74&FWL"R<%<\\^U-1:W,I23V.N\*V<C2+&D#A0<*&'ZU]H>!;-
M=!\$QM(-GEP[FD]21_\ 7KP_X;^"_P"TKJU9%+;0-WICL*]VU0K)I6G:/;Y
M9@&]P#T^E>OAH-*[/G<;54FDC@K..?0=.UN^D+">[D*P,.OS=3^5<E=1A@V3
MS77>,[]K[4%M(_\ 56N8\@8#-W:L)=/++S6LES,YH-P7F<C,A6;@=ZZG04+
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M7QW^V-X5%CXTTW6HTPM_;^7(0/XT./Y$?E0!\X>33'AZUH-#BJ[*: *D>8Y
M>E=+I-UTYK :.K^FR;6 H [BSFZ<UT&GW&,<UR-C+PM;UC+T&: .UT^8X'.:
MVE.Y:Y;3ING-=':R;D% $=S'[5188:M2<9K.D7!- $=%%% !5+6(O,L7(ZK\
MPJ[3+A/,A=/48H ]Y^'NI?VIX/TV<G+>4%/U'%=%7G'P+O3-X3D@8Y,$Q6O1
MMU %34"8Y(91P5:NWA?S(4;^\ :XG4OFM2?0YKJ]%E\[2[=O]G% %ZBBB@ H
MHHH **** "BBB@ IDT*7$,D4@W1R*59?4$8-/HH X:%GMI1EE:6%]K,O3<IP
M<>V17;QN)(U<=&&17+:];F'4I&Y*R ./EP!Q@@>O3/XUMZ'-YVG1^J90_A_]
M;%1'1V-IZQ3-"BBBK,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "HYYH[:&2:5UCBC4N[L<!0!DDU)7B_[9WQ#/PL_99^)GB*-UCN8=&FMK=FS
MQ-/B",\>CRJ?PH _GW^.7CZ3XI?&3QMXNDD\W^V=8NKQ&_Z9O*Q0#V"[1^%<
M/110 4444 %%%% !1110 4444 %%%>@_ _X+ZU\=/'%OX?T@"%,>;=WD@^2V
MB!Y8^I[ =S^- 'GRJ68 #)/  KU#X2>'?B?X=UZT\1>$?#6LRM%SYRV4GD2)
MW5F("XX]>U?4VJ>./@;^R&?[&T+0H_&7B^  7%],JRLL@'.7/"<]E'%><>+/
M^"B'C37DFMK+2-/T^RD!0QY9F*GMD8Q51M=<VQ,N;E?+N>Q^*_'GAKXT?#RW
MC\7^$+.+QI9[%@FW!I;8[AG]XN#COM.1[5XW\9I(['P9>.S?,(RJ^Y/ J#X6
M>)-.\;6EQ<1R"&[+^9<V;-ED.>H/=3ZUQ_[1?C:WF$.@6OSR#$DS^@ZJ/QZU
M]K%T,)E\W3VEMW9^=\V)QF:PIU5K'==%_7XZ'A%%%%?$'Z,%%%% !7;>"_BQ
MK'A&2.,RM>62\>3(WS*/]ENWTZ5Q-%=.'Q-;"S52A)Q9E5I0K1Y*BNC[#\#?
M&:Q\0P*8;A7DQ\T+D"1?JO?ZBN]TSQ-!?,W()]#UKX CD:)PZ,4<<AE."*]&
M\ _%Z\T&X6#5)I;FTZ+-]Z2/_P"*'ZU^J93QM-2C2QB^?3_@'R&,X?C9SH?<
M?:T%ZZKF*5MO]W/%8^O>%[;QOI,EE>6%M=01.9OLTR_*6QP1C'/)KB?"OQ @
MU"%)HKB.X@;I)&V1^/H:[!_$&VUDEMV4S!<J">#[5]SFU.EGF"C*@TYP:G&^
MJ=NC\FM#PL%S8"NU43M)6=M]>OR,?PKX7LK7<(((PB@*JJH"KCL!VK#\0V T
M_6;F/&$+;A]#S777GQ6ANUM\:/%;2)$$=X5"EVR268#J>>M<IXJUB/6)HKB)
M<,5VNI[>E5[6A5P$&H\D]W'MY&BA4AB))N\>Y3AN O!.*M0W)1@0>*PUW]#S
M4J2.O?%<,*SB=,J:9V-IJ'RC)K0COQZUQ4-\\?6K*:MCOS[UZ]/')*S.&6';
MV.CUKQ-#HNGO=3!G12!M0<G-<I<?%*R90QM;H*W1L#!^AS67XZU3S/#\@S_&
MO\Z] \?WDMTOQ2\/3JI\+Z#I.GSZ-%L 2W<M;B%XSC[TJ22$_P![<2<XKYO-
ML]KX>LJ=)Z6_6QZ>#R^G4@Y3W.%D^)EFV2MK=,/4*#_6B/XG6A5F%K<E5^\P
M P/J<U+\"/&6N>$9M;UA=1N;7P]X=MVU"XL>!'<738CMX6!'):0J2/[L;^E=
MK\(?&&FW_A&WO+O5I-+TGPY97D_B+1S8!X-9DF=_*&_.-\A=(P&&4V;EZ<?/
MRX@QB;LU]QZ*RVA8S-#\11ZS8K<PAE0DKM8<@BMNWE\S%<K\)]0\/VOA4+JF
ME:A>W/GN=]O?K"FWC P8V.??-=5??$;P7H\9\OPMJ$\O97UL?T@%?=8;,FJ$
M:E:+V\O\SP*N%_>.,'^?^1)?:A::3:O<7,BQHHR=QKQ'XF?$I'M3-/E+-L_9
MK/.'NCZGT0>O>NA\??&CPEI:!]0\$QW=^?F@T^76)V"^C2A0N![=37CNM_%S
M0]<U"6]N?AMX?N+B3O<WVIL .P 2Z4 #T%?#\0\4-Q>&H*S[:?C9_A]_9^[E
MV5)-5:CO_73_ #^X\_U75+G6KZ6[NGWS2'L, #L .P'I52N\_P"%FZ4G^J^&
M_A*+_P &#_\ H=V:4?%A8_\ 4^"O",/_ '#3)_Z&[5^12DYMRD[MGUZ22LC[
MH_X)K^#WTKP'=ZQ,NW^T;II$R/X5 0']#7R)^V=K$.N?M,^.KF#!5;M86*CJ
MR1HC'\U-?HG^RGXKAN_@GHDK6NEZ>T=H)98;"RCMMA(W=% X.<U^57Q2UC^W
M_B5XIU'<7%SJ=Q(&)SD&1L?I7Y'PY%XGB3'XM]%R_>_\HGMXJ/L\+2CWU,[P
MOXMUCP7JD>HZ)J$^G7B'B2%R,^Q'<?6O;_%'[:'BCQM\+K_PAKVFV&H/=)Y?
MVZ2,,0,8W!2#M8=0P/7TKYYHK]:/%"BBB@ HHHH **** "BBB@":SO;C3[J.
MXM9I+>>,Y22-BK*?8BO7O O[16HZ*Z1:RK748X%U#@2#_>7HWZ&O&Z*[L)CL
M1@I\]"=OR.+$X.AC(\M:-S[;\(_%1?%UJM_:2>?:!_+9L%61@ <$?B*UOB)H
M7A[XG:0FGZY;H]QMVVVI1 ?:+<]L'NOJIX/M7SS^R[J<LWB;4]!;<UM?6C2C
MT25.5;\B1^-?1VD_#_5X])BUZ)([M(0QN(%;;+$%."Q0_>4]<KZ].]?I.!S^
MGCJ/U?&)/FT=]OZ[?F?E./PE/ 8_DI/EDK<MMW=?\!I]_F?%_P 1?ASJWPTU
MXZ;J:!D<;[:ZC!\NXC_O*?YCJ#7+5]T>//#^D?%+PQ-I=\HCD^_:W&/GM9<<
M,/\ 9/0CN*^)M?T.\\-:Q=Z9?Q&&ZMG*.O;V(]01R#Z&OCL\RC^S:JG1=Z4M
MGV\G^G?[S[[),V>8TG"LK58[KOYK]?\ ABA1117S)]*%%%% !1110 4444 %
M%%% !1110 5^Q/\ P1/^(G]K_"'QSX+FG5I=%U:._AC/WA%<QX./;? Q_P"!
M5^.U?=G_  1T^(9\*_M37/AV1U%MXGT:XM@ISS-#B=#_ -\)*/QH _;RBBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC/B!</*UK:
M1MC ,C8/X#^M=G7GFN72W>L3OU ;8I]AQ4RV-*>YSK1SQYP2:J.MTTG4@5T+
MLB]2!40N(&.,KGZUERG1<I0M-'&,G/XU>M+B3^)>.V*EVHR=J8JHOW3BFDT2
MVF22W1]*2.\V\$4WRUW9)-+)&!T8XJ]1:#UU#YL&HYIU+"DVGKGBHI(CUS^E
M+4+(L"3<.M9VH6\DF=C8IMU?-;8PNZLB[\13*#B(U+EW+42=;&=6):2K"^8I
M #<U@_\ "1S3-M$39JW%+=2?,4('6HYNQIR]S=C9^YJ>.X/K6-'=3<!@:DFN
M)-O Q5W(Y31GO,<%N:A^T #.<UEM([')XI7NMJ@ Y%2YV*434BN2Y^\,5>2Z
M$?)Q6+:S+MJYCS.G6FI$N)=DOE8^M127B'BJWV?G'>JUQ:G=P2*?,3RD\DRD
M@U/%)NJE%#C&3FK\,8-4@9;AGVC&<5,N&^;O53[/W!YH1F1OFZ51.A9:0=,T
M*O0XIZM'U[TIF3\*H@C?.,@9IBR/(C C'%3+<1*>HILUPHC;:.U 'Q9^T@Q@
M\;7V1DDQG]*\NT>X+328X&ZO2?VE+P3^-[Y"<%?*_D:\HTF0JTC YYYKQI_$
MSM6R/>? -X'L5&><5Z;X1OMFN0+G&:\8^&US_HX7/ XKTSP_=>7XDM!GK6T-
MB=T?0EFK2,3GC;7YT?\ !3SX-:C8^(M-^)>F6X&GM%'::C(@QMD5@(V/U#;<
M_P"R*_0G2[YV;:JY&WK61\0O!-G\1_".J^'=9MUNM.U"!H)8R/4<$>A!P0>Q
M%>@MCE>K/@[PGK?A2\^$-KJVJ2L%1$'F*<RAG X&/\BL&R\6_#BRCMIY[YU$
M_P OE*<Y;T/H>*\FT_1;WPO?^*OAQ>W/V0Z9<R(LEP,DLAX8=L8Z>N:\;U*Z
M-M]MMDP&2;>C9R-X8!@#Z8_E[UY4,,G)Q;/;_M*K2A%Q_IGWUX#\5>#=8OI8
MM%MO+F0?,TL?/7'!^HK3^(5Q;66GO(J[I54N8R<;P/0U\E? ?QY-8ZB\]Q/'
M"ID"G=SO[G]3^M>R_$[Q)_:'AN0RRLTYB*A8\'!/<^HQGI7G5J+A4Y3U*.)]
MK2YV]3YR^+FI6OBV0&W0Q7D4C @CG /&?7ZUYO:ZM?7"QVS/YQ5LKN.<8K0U
MJ\G;6+C8[.SMA#CD@'@?7BN<NI#'<Y\HPD?>XKZ*E#EBHGR->HY3<COI[Q+>
MUC<M"]\F&\L].,=/?G^=9^LZTTT=M+ 93(V<!CD-ST_.N:%](\DJ.[R;A\K$
M_P"<UT_@SPM=>*-0MT5@MHS;V>1L?*I 8#W.:'%4US2!2E4?+%$O@_X>ZEXX
MO8(M.0NOG'SV).(P3R>G:OT*^!_@'1?A+X1ALK'YI9#YT]RXP\CD 9/TQT[5
MY+X)M-'\)VQ_LZ(QF./RN6R#R3T[\'GZ"M+6_B9=_N-/TZ-[F_NG2""%#R[L
M< ?K7AU\3.L^6*T/H\+@XT/?EN?05C,?'_B.+2+:3=8P;9;]US]S/$?U8C\@
M:]YLX5BA1 H10, #L*\^^#O@$>!_#,%M,_VC4)CY]Y<=Y)2.?P'0>PKT5I J
MXZ5[^#H>PIZ[O<\[%UO:SLMD2[MN2*9X*T.VA\0ZOK21*MU="."21?X@F<9]
M_FK.OM0\BWD8=0,YKJ?!UNUOHMOO&'=?,;ZMS_6NV6QYL]$=''_$,9%8^O>'
MGOOW]HRK+_%&QP&_^O6I&^UJF&?O#BLI14E9F"DXNZ/,KRXGLY##+$T4J]48
M?YS6MI-TS6^6X-=AJ&E6VL0^7<1@D<JXX9?H:R)O"\MLO^CN)%]&X-<<J<EL
M=,:B>YGM(&KYL_;0UBZ\.^#])O[5BC)J$(8KZ%NE?2%Q:W-L?WD#@?WL9%?,
M_P"W$RW'POM5!^;[? /_ !X5RO>S-)6Y&T>1_M-^/-0MOA[I=Q9RM%*Z*2V<
M=J^---^)?B2:^E)U256#9V[Z^W/VJ?!J0? /2-0CY:,1J??(_P#K5^<2^;'K
MN 3C>,C\:Z*/O1=S"O?F/5;CXJ>(X]<MU:\DVG'RYXK]1O\ @F=\8I_'OP[\
M3>&-1G$FH^'[]9H\OEOL\ZEEX]I$EY_VA7Y,:A:E=:M,]PIZ?2OK?_@G7\0#
MX#_:TCT2:7RK+Q/ITM@5(.#*H\V(^QRC*/\ ?JXV4E8RUL[GZ]T445N2%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %87C743IOAVY93B2
M3]TOX]?TS6[7GGQ2U#=-9V2G[H,K?CP/Y&FMQ/8X7=49:E+=:C+5N9CU:I W
M%5U:IE:@!^ZDS3=U(6H AU!]MJY]J_)[]OC6#??%K[.&R((0/S-?JOK<HCL)
M#[5^.'[6VL?VM\:=;.[(C?9^0KMPW5G-4^.*]3@_ ^N66BWRRW5L+A]PV[N@
MK[?UKQ[H$/PMT4:KE;&ZVK(T7&!WK\^H6VL#[UZ?X@^)PU3X?:?X>1&/D'<T
MC5]OE.9_5*56$K;:>I\SF^5_7:]&I&^DM?0]G^)WQN\/_#S5+%?A;BT#6^V>
MX ^9B1S6)^RQI<_Q7_: TB75'\]VG\^5C_%CG^E?/4;K)$J@,9<U]\_\$^_@
MQ_9%T/'FM3_88H_]0LG&Y>A;GM6%/$5L76YOLK6R/1G3I86C9[O2[W/M'Q+K
M5K;7RVMO D<47RDXZXJ/P_<:+;>(;#59K>-+B-_+\T#INXS^M9_B2'1[[4);
MFWUBUQ(=Z*7KE_B'X;N[KX8ZOJ^D:A%'+86\ESYR,6W-&I;:,=^*]V%.E[)1
MDW&^CWZGR'/6]NY1BI6=^A]1R:A%;P--)(J1*NXLS  #UKYF^'G[6VF>,/VD
M->\)P:C;?\(Z8U@L;AN!/=+@.$;H0<X]\"OS;\5?M+?$3Q=ISZ7?^)K[["V5
M>".4J''H<'FN/L]8F\.:Y:7VF2W-O/;F.9&EX</@$D8[9Z>V*^25.C24DGS7
MTVM]VY]Q&$Y-<^A]A?M:?#SQCXM^/7B2SMK>.RT><17#7C#B8! !DC+<= O3
MBOF3Q]\/]0^&^NKINH20S&2,312P-E70D@'V/!XKW/Q)^WAJ_B/1K"*70+.?
M4A9_9;ZZGR#,P/RNI7&WZ5XK\2/%EEXZU+3-0MY[Z;4I+=8[Q;L(L4<@. L.
MWHG^]S7I8F6%J89-.]56ZZ6\CSL+'&T\3RR25+7IK?NSF8FJ]"=V .M1ZAID
MNA:K<6-RT,TL#;&:WF66/..H=201]*V/!/AJ?Q=X@M--@RHE8>9(!GRT[M_G
MO7BPISE-02UVL>Y.I"$'4D]$KW/4/V<_#LR^.]'\37EE]HT?2KI;AEDX65D.
M0H]0#@GZ5ZI^WE\6+;Q[>>&+#35:+2X?.NT5^'E=MJF0CL,@@?0U@^(O%UA\
M/;.TL8[<'3M/ BCM<X:=QR0?ZGZUX-X^\87OCCQ)/K&H$?:K@Y*1\1QJ.$C1
M?X550 !7H9O1P^#POLEK4ZO[O^&1X675L1CJ_MY:4ULOO_X=_(RHVJY&U9T;
M5<A:O@CZPT(FKT'PM#=^'? ^H^)X)#;SR7*:?:RJ<,K8WNR]\@;>:\YB:O7O
MB1'#H?PR^'^CP;=TD$NHW##J9)"#S]!@?A711O'FFNB_X!YF,G[U*@OMRU]$
MG)_DE\SF_$*KJ,<.NP*%CO&*W$:](KD#+CV#9WCZD?PUEQM5GPOJ$,<DVGWK
M[-.O@(Y7//DN#^[E_P" D\_[)8=ZBN[*?2[Z>TN4\N>%RCK[C^8K%ZZGI>1[
MY\.;^V\>> GTK48([Z>Q;,<4SE0Q RF2#D ]#^-<A<?%+6=)N)+2STG2-"6)
MBC6T.G1DJ1V+."Q/U-<]\,_$TGAWQ-;L)-MO.PCE'J#T/YU[=XI\!Z;XJOK#
M565?.C8&1!P+E "0A]\X&?3-?;.C/-\OC7I/][2TEW:Z?A^I\W&<<OQ<J<_@
MGJO)]?Z]#ROQ+/JFJ7VBW&J30R7-S"KI!#"L?E1ECM!"@#)^]]"*]+TNQDDQ
MD8 K*T7P!J!U^;5=;:)[ESN2.$Y1!T ''  X [ 5Z1I^GH@ VC->YD64U:$)
M5<0N6_1[Z'#F6.IU)*-)WMU*-O\ ;+-08I6Q_=;D5JQ^(;R.(AHD+?WEX-:$
M=FCX %5KRQV< 5];[.+T3/!YK[HR)]>*N6\AGD[Y?_ZU8'BSQUJ:Z3-#$B6\
M9^4R#);GL#790^']T9<C.:AU3P7;:UH\]DS>5)(,I)C[K#D&O(QU'$U:,U3G
M9V=COP]2A":<XZ'@2MFIE-=1<?"OQ!:[_P#1HY-IZ)*"37-W%K-8SO#<1M%*
MIPR.,$5^05L+7P]G6@XW[H^[IUZ5;^'),44M-4TZN0W"L+Q>^-,5/[\BK^M;
MM<]XL;<VGQ?WIUK6FKSBO,RJNT),]M^#.D_:M9>7;D6]LH_$BO"OBE%-J/Q;
MUI88WE\A1D(N<8&37T[\!K%O[)U.["\9VY^@KYCU#Q;JND_$3QCJ6EE,RR26
MTK.H;Y,8.,_2O7K6NT]M#R\/>T;>9P3?>-2VMU)97$<\1"R1MN4D9P:B9BS%
MCU)S75^#_!Z>)(9,RQQ,I _>-C.3BO.C%R=D>HVHJ[-SX8_$&?2=>N;G66?5
M=*$+RW%I,=RR,!\N,]#NQS7+>,?&6H^--;DU"^G=SG$,98D1)GA1Z5U&K>#X
M?"_A_7BTJRS+Y,:O"^Y#N))Y^@KSBMZDI0@J=_-BC9ZH^BM8T>;X^?!FT\06
M5O\ :/%6@NMG=*F-\Z\<DD]"I#<]P]>13> (;'"ZGXHT/3YP?GMUF>YD3Z^4
MC+GVW5Z;^R#XGMK/QQJ?AG4/GL?$%FT(B;[KRH"0OME#(/J17*?$SX*S?#37
MO$,-_+*-(M8U?3;I5_X^WE;$4?U #EL=-GN*<ESP52U^C)7NMQ/HO]B'0S_P
MJ_7KR']X6UAU+ 8W*L48!'YGCWKWP^AKA/V1?#+>!_@[:V5^/*OKR:2^EC/5
M-^ JGW"JN??-=EXDOC#YKPOL(Z&O8H)QII,XZFLG8FK/\0II<F@Z@NN" Z,8
M&^V?:<>7Y6/FW9]J\H\6?%'Q)I\IM],-NSYQO> ,?YUY-XV\._$'XI:9?&_U
M2YNX(XF:"Q7$4+R8./E4 $^F:)UDDU%78*'=GRWJ0MUU"Z%F6:T\U_)+]3'N
M.W/OC%47KI+CP/KUOX9D\12Z7/#HL=U]B>\DPJB<=8L$YW#'3%<X]?.GHE=N
MM125,]1/2$SWK]A7XD/\._VD/#BO-Y>GZX6T>Y4OM4^:/W1].)5CZ^]?L-7\
M_P!8ZE<:-JUA?VC^7=6DZW$3_P!UT.Y3^8%?N_\ #OQA;_$#P'X>\2VI4P:K
M80W@V] 70,5_ DC\*SGW*B=%1116904444 5-6NGL=+N[B, R1Q,R ]V X'Y
MXKA-"T9/#^EQ1[O,GVYDD(Y9CU-=OK;A=.D#<AB!^M<9?776M8['/5DUH5KR
MZ;?U^@JNM]MPK=6/Y5%))M^8Y855VM)?(P&<#/TI3ERQ;,J:N[B>+M4BTW3B
M\CX51WKXR^(_Q*F\<>*#IMI-C387Q+(IX;'85U7[9WQI/AFUMM T^?;J%Z2G
MR'[B=V_I7@?A^WDT_1TD<[6<9(SR?J:_-\VKNI4TVV];'WF4X3EI^UENSOO$
M&I&_LXM-T\B-6&UMO6N'UZPM?#UNMO;;6O9NC=:K-XOBTI)'!W2D8![U%X M
M7\3Z\^L:B^;:)LHAZ'%>+"FTG)['T3?+H=+X1\!'1;$WMW\]Y/R >HKU/P_;
MKI^BL&7$A!X_"L[2535KI[B;Y8(^ .U26NL1W%Q=HARB X%<4^:<N:1?-[MD
M9VCPO+XD$NW*CG\#7NOP]TY;W4DF/S%>:\?\-[6-Y<$<(=H/T%>Y?!NV9[,S
MGJU?89'A[5XS\KGRV<8C]U*/R/6+="L8 Z8J;@=.>:@5_EQC_OFG[N/TK]#/
M@2<9;H*<%]?I57SNF,^O-,-RRL=M.S OM&#CH/6G>4>#G(ZUFFXD!SR,]://
ME^@I\K"Z-(VZLO( XZU']E5>5//KFJGVA]O+4];LJW([4K,JY<51MP3^-.6X
MGM,E&+J.QJNMTO0\>E2+/M]\TAG'_&[29_&7PZU:TL1_IOD-L1_XCCI7+?LE
MK/#\,=,AG0QW$.Z.2-NJL&((KUQHXYAZ\8Q6%I&A#POJ\]Q9HJVUPVZ2+H-W
M][ZU:EI8XZE#FK1K+H=E<*?+89.3[UD:C;&3[K<XK<C821AASN&<5%+"K*1C
M.>X[5!U\NMS!T^P&.>M:,=FBMUY'4^E6[>U$8'K7G_QR\:+X-\'RI#($O+T&
M-<'!5/XF_4#\:UI4W5FH1W9SXBHL/2E6GLCY^_:B^,9U1Y-'TZ8K90R%%*?\
MM&'5NO(ZU\>:AK^VZDLK]VDL;B4^7*O6*0C!'T.!^(]Z[+QEKTEUJ%V6G:49
M*A=N0.V/Y_G7"ZE8)JEN\:J9%*XV#@U^C8?#JA24('XCC,8\7B75J/?^OP-I
MX8=0L;)%EP(56(J.%4AB!QGJ3R?PKC/'DA;Q JA0D?E@?*V1^%)X5UR32/$#
MZ1J3;_M43+;7;DX#8)Q@\;SM49ZU7\8*ZW5OM!$9A7;\O.>>OZU?.I0=NC.B
MEAY4:\;NZDM&17,<UOH[0J=@(&T!CAC[?G5"TDE:=;5&)#E4&T=?6MFXC$T$
M+HJMY@S\V>PJYX5T]8WNK^39\H^0D=.>@JU%N2L+VJA3;?\ 3)?'#II_A=_+
MW *BQ+N&#G'/^?:O*_"CF.21PFYF^4,:] ^+&J+#H=E9;\-@R%<'DMR:X;PB
MH102ORYR>:\W$2YL9&/9'TF6TW3R>I-_:?Y&]K$?G1;BN1C/3CI6+<V:ZQHK
M18W/']T]:ZZX5)[4H2Q."1GGM7+6+BTO&#!MAXXY K:O!2=I;,SP%:2I-P^*
M#31R&FW4^EW%Q&?E,<+X![$#@UF*WS'!YKM/%VBQ3*+NSY;!5\=*XQ6#Y1U;
M [C (KXO%T9T9JE)Z+8_1,#B(8JG[>*LWO\ (]-^#OB-_#OB0,96B@E4%L#(
MYZY'I7TS=:YIJZ;'=R:E;1ILX$>"Q:OB#S9(8D>*1E*GB1#BM.V\::M;1E//
M\SC + 5\KCLN=>K[2#/O<KSJ.%H>QJ*]CU?QI\0(IKR[$3F6,?=^;=S_ (UX
MYK&KR:I.S.V5)Z'^7TILS75WME>0!6&X'I57:)&Q&,@=37HX;!1PT=%JSR<=
MF4\=+5^ZC2N"3?6T$O\ JQ&H&#P!CBM'0=+;4O$-BGEDK(^0IX^7KG]*H:/9
MR:M-#&(BSQG:TPS]WL/Z5Z-:Z*OAAI-2N@N]8ML*$\ACQC'IBOKL'AW6?M'\
M*9\'F..AA(.BG[[327F4O&UTHA%N-YWD+ACG_P#55*"!;?3\*K+&P^[ZFJ]]
M<2:IKT*'GG)7'Y5KW4B;=JH <;?7FO:5JDY3^1\THRPM"E1ZOWF8GAF,/K@5
M\YS@>_-=!JUNLGB!%(4!5'6N;\-_\AY>=HW9QQ_G%=I#'%+K4LKC*>65*D]#
MCC%&%CS4K>8LXE[+%<R?V2U8ZHLMPJE]BK@;OX2*P;J9+>W989.9"=X7G'HU
M5?M307D^TG[V%/&:M:;;J\JF4%1@G+ &NOGYM#R/JZH+G>VA4L8WEU2R0'>0
MXDWXY6NNU36(_%FM32[@EA9_*21E7;/W1Z\\US]G<1Z7;W^K\;;<>7$K=6<G
MCBM73;,R6MG#)"6NI1Y\B)\I!/8CTQC!]ZB&_*O4>*LTJC6BT7KN_N7YFMX1
MOCI]X/L;F"+S-TLJMPS>@.*^AY_$">(/#-EJ;.)9E_<3N.,D#Y&([$C]5->!
MJ_DB&-I+2)D&/)C&X)WP3Z^]>F?"O4TU"XN=$NY/-2_78C8PJR#E&_/C\:Y<
M?0]I0=MT8Y;B?9XI<VTCH_#:PZMK]M;2S-Y1YV[B :]_NO!=A=:.;>2TC:W:
M/!R,]J\J\'?#J6;Q5:1NQ4*=S'%?1^L6)70I+6*(AO+VB3'M7PUFV?IJG3IQ
M=U<^.;?X9VTGBVZM8$\R%7R,G..:].TGX-Q6BQ2)%LD0AP5&"".A%1_#_0KW
M^WKQS"\N)67S,5[=9V$_E#=$P]-RUL[H\FG:HN9(^E] OSJFAZ?>$Y:>!)&^
MI49_6K]<G\+YWD\'VL3G+6[O$<_7(_0BNLKSI*SL?;TI<\(R[H****DU"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S=?;_B7LA) <A21Z=3_*
MM*N8\9:B+6$*.H0M]*RJRY8-FE./-)(^4?VE?$7FWC1(W$8VA>U?,7_""7GC
M35!+."EG"<[L<$^@KV[Q?IMUX\\<7+;MNFVKG>W8MGM7<?#_ .'X\2:I#;PP
MA+.$\X'7WKX^\JDW&*U9]9[M.";>B,KX#_ U/M"W7V785'$C#I[U]<>'_#5E
MX?L\11J'Q\S]Z?HFA6^@6,=O!&%VC!(JW?2%;*7!YP:^MPF%5!>9\SBL2ZST
MV.$\7>-GM9G@M_H6KC[;59;JX9Y'+LU+X@Q-=/D<YJMIL?[P5ZL58\QN[+]B
MLBWN['%/UU55@W>K8VQ+NSS63JTYFXJR2I&V.0:5;C#547=^%.:0)UJ -*.Z
M-6XIA(PK'AF#<5?M\A@:!FI%?2VL@P?EK5N[2+5[0NH!..:Q5PPYK3T>8PS%
M#]T^M%KC1\L_&#PJ_AGQ,US$FVWNNO'1JX>27<N#7U;\:_"<7B3P]<^6F9X1
MO4X]*^4D@89##E3@U\_BJ7LZE^Y]9@:WM::ONC&OV/3%94\HSR<UK:L/*SD5
MS\ZE<MGY37.CM;)/.]:07 W8SQ6?)([=ZB5FW>O-;I&'-V.@CN%9<9YJ*:8+
MSWJG$VW&<BGS'='UI-(TBV=)X=U0+<(K'Y:]T\/SI<:?$$YSBOF.VNFAD4HV
M,&O=_A?K8OK>&-V!88[UBUJ.6J)/B[#+H-C;:A$Y2>)Q(H'7BO'/&VO'Q?KS
MZFL/EF5%WCU8#DU[E\7]#N=8U*VC+$V_E@^7CC-<"G@!MOW.GM6-9.?NGLY?
M6IX=<\GJ<IX/4QW66XQ7JUAK20Q@%L5S^G^"FMY"=I_*KEQH,T:\!J[L#'V;
MU/,SC%QK1]TO:OXPBAP#(!^-9B^-H^T@_.N4\3Z7-'AF)K@]2U1K%B.>*^E]
MM'8_.'3E*39[1_PFD>/OC\ZAD\6J^<-7@DGC4QMRV!]:M6OC4,1\V1]:3G<N
M--H^C_#>J?:)%)>O2-)N 54[J^9O"?C0!ERV!7JVC^.(50$RX'UKAJW9M#30
M]7>8?WA4$DR^H-<&?'D#G_6_K5/5_B-::1I-WJ,C[H[="V/[Q["N11;=D;72
M-/XF?%CP_P#"O0VU+7+ORP1^ZMTYDE/H!_C7Q3\5OV\_$?B 3VGALIX?L3D"
M1?GG8>N[H*\:_:"^+VH_$#Q1?7EU.S11DB./=\JCL *\"-U-([%G)+<GFNQ1
MC#?<$G+4_0W]A/\ :BO)M6UOP;K*7FJG4)UOH+]B9/+<XC(8=<<C%?J@MPUG
M8Q1@_=10=W!Z5^//_!+WP:==^,7VADCF18_,)##<JH>5/U)!_"OUTUB<1VLA
M4XW/P&YR*Y:J2=ST\/+FBH=$9/CC5/(T&5R0I8=/6ODKQ-H^I:7:ZA-HB_:;
M:XW.^G,V#"Q.2\1/&"?X3@9Z=:^C?B!-+-IMI&&W;WVG';FLJ\\&VVGZ6DLV
MT,5);/I7CU>:4SZ'#1BH6>[/B#3M:N].NKNWE+M&^?.M)5VRJ#ZH><?3CWKS
MWQKX5MM<D8V:R,Y'"K&=R^PXKZF^)VGZ+KDRPW=I&8T.1/@"2,#N&ZC\*\[T
M>6RT?5T@M=;9(SPJWD:R@'TW$9HIU>QUSPC>K/$?"OP?U;2[6[U.]LVL;"&/
M<UQ=$(SYZ*H)&23_ %JUJGPTBUJ.UN[V*]BN4AV6TEK.T/D9/S$-CDGCVX[U
M]2Q_"2?QWXCTN[U'4C?Z);[9/LR1[(4?^\5'WCZ9JE\8-%33M:@M;&,!%&%&
M.W^%:2K24#*.$IJ5SX%^(4FO>&]0BTU]<>^@D)4"XB_?18[$]Q[U1T-=0U94
MC36)-X&0LJ J3^E>T?%[X6RZQXZU&:V4G[+91RLR]]U>0Q:%>:2\CVX9G4E2
MI'W>:[J;C**ON>'7C5C4;BVT=[X5\0>)O"<;P+"MPDIRWEMC)]1GC]:]"^'O
MQ$M[?4HXM3>337N&QNNE\M5.>H?[OZUY+X3\2:S)=&"ZL9/*4@++MR#[U[_\
M,-$TGQUI6IW)DA2YM<)+;S##(.ARIZCO6$HJ^IO"K+ET9]P? _Q-;:;I\SW\
MXD!B 69%SNP.,8ZY]JYKXH?M&#P_KTUNEG-I4=MNC,]TFT@E,AAC/7=P.O%>
M ^(+K5?V:/@I<_$+PYJ1M)H)XXUT6\3?97>]B-J(?N,<$Y7%=O\ !72=3_:0
MMO#GBOQK8>0LN_5YK-5VHLF1'!&?485VP:Z*DI1I+E,:,:<Z_-5^%'NGA"V?
M6/#-A?3B;[1.OF-]H7:2#R#CMGWK>_L@!?NUT5O9*JHJ?*JC &.U3R6JJ,=Z
MF,FDDS"7O-R1QW]B@L"5[ULZ?IH4#BKK1C<*OV</%;Q9BRG+:[5Z5SFKHL8+
M'MS7<7$(\L]CBO._&ET;>UD(XXK6,K.QDX<R/8_A/JZZMX-M@'W/:N]NWM@Y
M'_CI%=C7SM^RKXP&H:KXJT1F&Z+RKM%[X.4;^2U]$U<E9G.U;0****D04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &/XDFV6L<0ZNV?P'^153PS
M'NO)Y/F&Q O^R=Q_F-OZTWQ))NOE7LJ#]3_^JKWAF,+IS2!RPEE9L'^''RX_
M\=S^-1O(VV@:]8_BR3R]&E[;F"_K6Q7.>-Y-NFQ+_>D_I5F)A:3]UFJIJ$F9
MC5K3_EMV-9UTW[X]Z &[AZTF1ZTS=1NH ?D>M+NJ(-2[J 'Y]Z4'D8-1[J=%
M\TJCWH Z.,;8U'M3Z:O04M %'7;C[+HM_-TV0.WZ&O@NZF,U[,YZM(3^M?<?
MCZ;[/X+UEP<$6K_RKX5B.Z8>[4 =S9KMM8Q_LBK*FJ\/$:CVJ7- $F[BH96]
MZ>S<56F:@"I<2'FLJ=BS8'KBKMU)UJOI</VS6K&#KYDZ+^;"@#[R^%>BKX?^
M'NA607:5ME=O]YAD_P ZZRH+&$6]G!$O 1%4?@,5/0 4444 %%%% !1110 4
M444 %>$?M>:.+WP%I][MRUK> 9]F4C^E>[UY?^TE;"Y^$^HY&=DL3C_OH#^M
M 'PQ);\=*I-#71S6ORGBLF:';GB@#*E7;26S%9*EN*BCQGTH ZC39,J*Z"R?
MI7,:6WRCUKH;-J .JTZ3I736+Y45R6GM]VNGT]NE &E(,K6?,NTFM#^&J-QU
M- %:C-%% !24M% '=? >;:VLVV>%D# 5ZY7BWP1DV>(]7C_O(#^M>T4 17B[
MK60>U;WA23S-'C_V216'-S$_IBM3P6V[2W'I(: .@HHHH **** "BBB@ HHH
MH **** ,/Q1'^ZMI?F)#E,#IR,Y/_?/ZTSPS-\TT)[@,/Y'^E:&O1B72+G<Y
M0(OF$C_9(;'XXQ^-8.B2>7J4/HV5/Y5F])&T=8-'6T445H8A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?"'_!9#QHOA_]E6RT17(FU_7K:W*C
MO'$LDS$_1DC_ #K[OK\F_P#@N!XQ>7Q!\+?"B,!'!:WFJ2KW)=XXT/X>7)^=
M 'Y=T444 %%%% !1110 4444 %%%% !7MWP'_:2E^!_A'Q5IECI,,VHZQ$53
M4.1)$=N%&<] 23T[UXC10!)<7$MW<23S2-+-(Q=Y'.2S$Y))]:CHHH ZKX6^
M*H_!GCK2=4N%+V:2[+A ?O1L-K9]<9S^%?57Q^^",?C#X8R^)--MXTO]"B,B
MR1C_ (^+;.60XZE1EE_X$.]?%=?>7['/Q9?Q[X7/A'4Y5DN+)1"5DY\V(C"-
M^FT_AZUI&6EF?"<31Q&$=/-,+O3:YO./]-KYGP;17M7[57P+E^"WQ"D%K"R^
M'M4S<6+]1&?XX2?52>/]DK7BM9GU^#Q=+'8>&)HN\9*Z_KR"BBB@[ HHHH *
M*** -#1?$&H>'KH7%A<O;OGD*?E;V(Z&O3-&^/DL,:IJ-@S,.LEJ^,_\!/\
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MV7AV;_1$\I8T\M/-QG;G)^ISWKL+JQ-C%E&4[1\JJO45Q'B;79%D$87.!\S
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MO;Q+OED8(BCNS$ "OV/_ &*?M]C\ ]'T74[::TO-(FFM#%,!D+NWK@@G(^?
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M[GPBEQ$'CS$>.?6O0PV%K<WM+7MT/+Q>.PZBJ3GRWZG3:':V&DW"RK)N9,%
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M"JE_$^JOZ(!^M>T4 (WW3]*O^!VS8W ])*H-]TU>\#_\>ES_ -=* .FHHHH
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MMVMW<V\,3EFG@-Q&V/E900#SZC<./>M&CZ[BXO\ BR7S9'U'"2_Y=1^Y?Y'
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MN59BY4,30>T5H^[>^OH5C,)_M%*JNK5_)(\>5JF4U61JF4U\Z>Z35S]C^_\
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MHV>9Y '&"58D@_D:[L=S\D5;W8^[Y:+]7=_,J/Q7,9ZA;I4[U W>O%-65?\
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MA9XH"J)&<!%& />N*U_Q(+B4HC,XZ'VXKT8QC!6B8<MWJ4]2MURTIU'4BZY
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MM]),2B"&-7,AX!?TQ[5X/\+[ZP^&O@77/&VLD>3:P8B$@R3QP![GI7)_"_\
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M74S.!Z+G@?EB@#%O;C Q6-<-N4U9NIMS51D8L: *%TN150+BKEUQ4$:;Y *
M-C25SBNIT^,\5AZ7;[0M=180]* -K3T^[726*X K$L8]N*W+=MH% %UV^6J$
MYY-6)).*IR-N)H 91110 444V5ML;,>PS0!VOP-AWWFL7'^T%%>O5YG\"[4Q
M^';JY(_UTYP?I7I6Z@!6/RFM#P*/] N#ZRFLQFPC'VK6\"C_ (E#M_>D- '1
MT444 %%%% !1110 4444 %%%% !7(:S&\>K7;-]UV5E^FQ1_,&NOKF/$C?\
M$R4?],E/ZM_A4RV-*>YMZ.V[38#_ +./UJY6?H39TN+V+#]36A36Q,MV%%%%
M,D**** "BBB@ HHHH **** "BBB@ HHHH **** "OYK/VKM9_P"$@_:>^+-^
M.4F\5:GLYS\HNI%7] *_I3K^7OXF7S:I\2/%=XYR]QJUW,Q]VF<_UH YNBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,XY'!KZH_9#^-1T^ZE\+Z
MM*L\S9;3Y+ALDY^]$">_<?B/2OE>I+>XEM+B.>"1HIHV#I(APRL#D$'L<UG4
M@JD7%G!CL'3QU%T:GR\F?I9XW_9F\(?M&Z6E]-+I_A3Q&,QIJT,L4;R$=KB$
MD;Q_MC#>YZ5\M>._V!_BUX'GN9!8:7K&D1'Y-5L=6MO)=?7#NK*?8BKOPQ_:
M\GTW[/;^*8I6ECPHU.U&2V.\D?<^Z_E7V#\)?C]8^()(KK3=8BGMF&':"3(^
MCIU4_45YO/5PRLU='Q'UC,LD7+R<\%W>GR=KKT?W'YQ-\$?%&]D4:/*ZG!6/
M7+)B#Z8$U+_PHOQJWW-)BE_ZYW]LW\I*_5CQSX1^%OQ8A^S^)?#&BZM/(,?:
MXXEAN5SW65,,/SQ7SG\0O^":/A_5HGN_ /BZ;3)6)9=/UQ/-B_W1*@W#\5:M
M88ZG+X]#OPO%F#JVCB8NF_/5?>O\CXZ\(_"O.N>(8_%WVK2]/\.Z:VIW\=H4
M>>12\<<4<9R5!=YHQDY &XX.,51^)7@6Q\)ZUHK:7>RSZ%KNG0:I8S7BA98X
MI&9&27;QN22.121P0H/&<5ZTOP#^(/[/]_K]GXO\%ZIJ_A/6M-?3KW4/#P%R
MJ)YB2QS1N 0"LD49VN%R,C(SD>>>+_B+H.KZSITUOI%ZEMX<L[+3]$MKR1&5
MXX93)*;M=OS&1GD;:A 7?CD"N^,HS5XNY]A1KTL1'GHR4EY.YU/QB_9TB\!:
M;:MI4.O-?2:T-%M8]4MD1=:W)N6ZLMO+1$[1WXFBYR2!POQF^%MS\(?%2:!=
MQ7OVF&W07,]U;F**2XQ^^6$G[\:-E-W<J3T(KTVY_::TC3->CU?2=-UG4[B?
MQ-!XDGAUR\1ULC&9"8+5E&1GS2/,('"(-O%<!\1/B)HNL>#-+\+:"FLW-E:Z
MA<:F]]K\R27'F2HB>4@3@(!&"3G+,2<+TJC<\UHHHH **** "BBB@ HHHH *
M*** "BBO;?V9O@&_Q8\1'5-:5K3P;II\R]N6^43$<^4I]^Y["@#&^"O[-GC/
MXXWH.CV7V32$;$^KWF4MX_7!_C/L/TKN/'_[,^B>"OBQX9\+Z/XD7Q1');_:
M-6= H^SLK?,N 3@$8QGGFM[XW_M7ZEKEP/ GPQC_ +%\-VY^R1-IZ[7N.V$Q
MT7WZFK'PE\)I\,_"=]KNK2!M6N%,DLDC;B .@SW]?K7G8[$?5Z+Y?B>B/HLC
MRW^T,4N?^'#63\ET^93_ &COBH_AG2;?PEHKBV>2,>>T/!C0<!1CIFOEDL6)
M).2>IK8\7>(9O%7B.^U.=BS3R$KGLN>!^58]/ X6.$HJ"WZ^IS9MCY9ABY5?
MLK2*[(*]]CU[^Q/V51:=)+^Z:-0>X,A)_0&O!K6WDO+B*")=TLKA%4=R3@5Z
MU\: OA_PMX6\-1OG[/$99/=L8S^IHQ5-5I4H/I*_W'9E4'3PV+Q;VC#E^<FE
M^5SR&OH73?&VA>./V2]3\,:[JEM:>(?#-ZMSHZ7#XDN(W/S1H.IX+?D,U\]4
M5Z!\T%%%% !1110 4444 %%%% !1110 4444 %%%% 'U)_P3Q@,GQJO7#8":
M:^1Z_O$KU+_@H%X=CO/#LNJ)'^\M+Y"6 [$;3_,5Y-_P3SD?_A??DJ<++ITH
M;\&2OJ/]HK18O&^@>+](=<D!E7(Z-M!4_@0#^%?2Y'1^LRQ%'K*G*WK=-'R/
M$>)^IPPN(>T:L;^C4DS\OZ*5T:-V5AAE."*2OFCZX**** "BBB@ HHHH ***
M* "BBB@#]J?^"+6L_;OV8?$M@WW['Q5<8Y_A>UMF'Z[J^_Z_,_\ X(@7S2?#
M?XGV9/R0ZM:3 >[PN#_Z+%?IA0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!PWB699-;F4_P!1^@/]:H[(6X)IOB'=+KMYM'._'Y "JB6
MK\9/Y&L[LZ4E8GFMXSTYIL<,:^WM4D=F6ZD_G3FT_CIS]:-0T*=U#'(IR,U4
MCM8U8$<>U7I--9N[52N+&6 Y4FI=][%IHL+ K8(.*=(I1<AJIVWG,?F8U-,&
MVXS1<8+.S\9J>/?&N=U9\;%&JQYS?A1J%D7(_P!XWS<U(VT9&!BLEKB2/H2*
M7[4Y4G/-/F)Y342-%8FB21?2LA;Z4G&.*E5GDZ\52D)Q+9FV_2FR;)AR>*J3
M^8J\5#$TN>:+A8FEM48]:K3:>C#DFIC(W<4[KVI60[LI1V)SPQJP-/=>C$YJ
M>$8;[M:"XX.*2B@<F9T>F$KR<_6H9-./3M6TTP48J 2(3UJN5$<S,:.,VC\C
M(I+B^R<!<U+J#;F^6JT<(.,FI\C5=Q\4[?2K=OENIJ(0#@TJ^9OVKT]JFX6-
M%2%JQ'?"/@U4ALI&P23^-6X[(=QFM49.PRYU=57CGZ5+IL+:DK2296(<>YJ5
M--CD;[O%7EVP0"-1Q5I-N[,Y25M!BQJB[%X Z"D:7R3A>IIOF?-5:XD^;-:&
M)2NV+2#ZYJU8L%M\^AZ53D5IIMJ]35Q5%O&%7DU0$-U-C()YJK'EJM26YD^M
M.6W,? 6@9!-\D>!UKEO$$(FM)U;HRG'O75RQGJ>E<SJB^:TF[KT49Y-"*/B#
MXH^"5T?XT>(M3N T-M?>%+AC,#C#QL-N#ZY*G\*\]\ ^)K;XT>%;-M0*)XA:
M$^?;[OFF )4RI['!) Y'/;%>T?MW6.IK\/%N=+;RG6XCM+IP/F-M*0&&?3<%
MKY2B\!3Z7IL4]H)+6:-0R2QL592.>".E)Q4E9GH4:DHN\3*^,?P?19O,L<BY
M&=F_C/\ L^^:\I\/ZO<:)<M;3HT;H=K(_!6OH7P1XRU/Q!>"P\121ZH(7VQS
MW$8\U#C@EA@GGUS5?Q;\(+?XE0ROIJ+I_BZRD\N:UZ)=1D\,@ZY'I7/*F[6-
MG:3]I#1FK^R_8VWB[XB0SSQB2'38&NVW<@,,*F?^!-G\*^E?%%ZM]+*L8_=]
M!SRWOFLSP=\/]-^&.@#1-&LX[?"*MQ=$9FN7'5G?J1GHO05=FM?+4&3YL>]7
M2I^SC8Z-7JSROQ5IYL8I)7?=Z"O+[W37;+'):0Y_PQ7MOB6P;5W+#_5Q]!V.
M!7(6GAB74+TY4B*+^(#C-:DR1N_LL_&#_A5_C8>']4F\O0=681[G/$,W16]@
M>A_"OO\ T'2Q<79OWPR)\L/H3W;^GYU^7>H?#B]\5^,-,T"P!>\O[F.!'4$;
M<D98_09/X5^JOAG2%\.^'=/TR)FECL[=(%>0Y9@J@9)]3C/XT[Z'G5I<NAJP
M@-P4!_VJN1C;@=17"W'Q,T;3=3N;2Z-Q!+ _EN0FY#CN*V]-\>Z!J Q#J*9_
MZ:*5_F*1QG3J.E/"X(.*JVFHVMSCRKF&7_=<&KZD,N/UI$BK\N#VIDG&<4!A
M]T]:5@&4^M !#,.C=:BD3;(1Z\BH+K5K+3US=74,(_VW /Y4ZSU2UU92UJ_F
M(O5L$#]:!DX 5<FL*ZD.H7GE)RH.*T=6O/LUJ[#KC ^M5M#M?+@\UN6;I_4T
MP+\<*Q1A%X %21Q#.:,?G4%]>K;KL4_.:0C<\.3AK^6,'_EGG\B/\:Z2N1\)
MVYAO/,<_.Z$8_6NNJ);E!1114@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!X]^T5<;=/T2#/#RROC_ '0H_P#9J\.9N*]B_:(D\S4M&BS]R&1O
MS8#_ -EKQN;Y<UV4Z:<4SBJ5G&3BAK,*C+?2JLMP5[TL,P;O6GLT9^WDRVK5
M,K<576I5I<B'[61*#3MW6H=VVHIIML;G/04^1"]K(YS0;<ZM\8]#AQE8G:0_
MA7UL*^6O@I;_ -I_%Z68\BWA)S]37U+7ITXJ,4D<RDYWDQ:=3*<M:,H6BBBI
M *=]X4VE6@#CI[,>%?$T%Z^\Z3*)(P<_+;2.5)S_ +)*CV!)KM%8,H(.14%U
M:Q7MO)!,@DBD4JRL."*YGPSKD.DS2:%J$_DW5NY6!IC@2Q=5()ZG''X5L_WL
M>;JB%[KMT9T>J:I%I-KY\H9]SK&D<8RSNQPJ@>I)JZ.17EGQ5^)VE^$]<T.U
MN%EGFAG6\=8L<+AD'7J?F)Q[?2O3+&\CO[2&YA;?%,BR(WJ",BL':QTRI5(1
M4Y1LGM_7S+%%%%2R#R?]K#6O[!_9Q\?W0;:QTR2!3[R$1_\ LU?C1&U?JW_P
M4,UK^R?V9M7A!PU]>VEM]1YF\_\ H%?D_&U>7BG[R1V4/A9H1-5N-JSXVJY$
MU<)TFWH^EWNMW:VMA;2W=PP)$4*EF('4U-#;3_O0(G/DC,GRGY.<<^G) Y]:
MN^!O$5EH=Q>K?QSR6]S"J$VQ <;94DQSV.S:?3.><8KK],\>: =.U6+4+*:=
M]1NS=7"+$H,A)4@"3=E C&0@8.[<,XQQK&,6MR6V1_"7QU<_"_Q[I.NB-C'$
MW[V(C'FPL,,/?(.1]*]9^)W[/,^IZIJ'B#P%-;ZWI$P^UMIMO(/M=H'&[;Y?
M5EYXQSCM7DGC"XB\::I)J.C6QEC@B5;CRHO+Z%MI6+<Q5538O''RYXS7:^-_
M$6J^!=4\$Z_HE]+87]SH%I(\L)P'*@IR.A&%'!]*RG1=W.#V_$YIPESJ<'9_
MF>:&.2"1HY$:.13AE88(/H15B)J^@_&/Q"@\5>"[#5I] TF^UJ"RBO=3BN+-
M<7$,CM&'212'4JP7//\ '[5Y#JGB;P[?:?-%9>%8].NY,;;A;V601\\X5N/;
MGUK>=-1^T=$9-]#$C:K<;5H:;X#\2:E;1W%KH=_/!(-R2) VUAZ@XYK1G^&_
MB;3[<3W.C74$1(4-(H')]LYK+EE:]BX^\^6.K,B-JLQFN\\,_#.R^PI=:[<7
M%O)G/V6,*@"]B7)/7V%:MQX@\&^&X6CL-+@NIAQO8&5C_P ";@?@!4Z(]'ZA
M6BN:K[B\]/PW_ Y[P1IL.J320RZ+<:H205:"?R@GU)!%>D6VCQ>'_+>.WT;P
M\F?GN;B8W=RJ]]N1M!^@KS?5/B)J&H1B"T"Z;:XQY=O\N?QK$6:>\E56>25V
M.!DDDU'-4>SM^9E)8>&D;R?W+[MSVOXIZZ_B+PG9/HUU)=Z/;OBZ=B=[2=%9
MO;^1_"H_AEXKLM2TR;0=57?#.GE,N>6'8C/\0_I5;PK'!HELOA>X59Y]0CDE
MON>(%$9*CZC )KS?2[S^S]4@G'(CD#8]0#71EE3ZKHU>$G9^:[^O8XLPI>UM
M;2:U]'V_S-_QAX1N?">I-$X+V[G,4V.&7_&L137O-UIUKXU\.B'?OM90'MKC
MJ8V_NFO%-<T6X\/ZE-9W"X>,XR.A'8BO:S3+OJLE5I:TY;>7E_D>/EV.^LQ=
M.I\:W_K\RMNPI/M5+X7VQO?$A/\ STO@/R-3S/MMY#_LFM3X V(O=>TT_P!^
MZ:0_G7#@E[S9OCO@4>YW/[:5Z;?POX=T\'_63*2/H,U\JU]$_MKW_F>*O#MB
M#D1Q-(1^&*^=JBIT.BBOB?F%%%%8FX4C?=/TI:* /9K'X@7/A_XUZIK'AK4%
MEMKFR>5TCD/E7&VSWE7QW#J>>H(.*HVFLZ/#=6<6I:4\]Y+EY59B7F$K!XV'
MS D[2,>N[WKS/2=3ET>^6ZA56<))'A^F'1D/Z,:MWL>L:HEOJ+V5T8DBB@BN
M8K=PF(U"+A@,9 4?C70JCL9.%ROX@FCN-6G:$;8LX5<YP/3/M6779VOA6Z\<
M:]IYLHI(WU%BMP8K:27R)U&7RD:EL-D,,#^/'8UWOB7X%^'_ (=Z*M[XHUF^
M6>;*Q6\:PPONQD$Q[G?'U"T0HSK2]W_)%74=#R[P[IVB2)<#7TUF'(5K>;2X
MXI/7(97(Z\8(/&#P:]/\)WFA?#_0;[Q+HNB[M7MH"]E=7]T)KJ$GY?,*+B-#
MSTPQ SSG@<SH?C#0-.CL$N=,@OA S^;YA7]\K$<'*Y! &!SP?3G,?A&.TOO%
M[7<P\C2KZ5=+CCCPVYIY NU<]=BMD_0>M=^#C"-5<VN_R\_.W;J9W;W,WX8^
M/ETCQE?R:]>2C2]>BDMM3N0"SH7.]+@ =620*WTR.]=EJ'PYO/B?\,;+7]+L
MVO\ 4HXIG+6J$Y\IV$B$=L@!@/\ : '6O%-0MOL=[<6^X/Y,C1[AT."1G]*]
MJ_91^*&J^"_&%QIP=7\.20S7^HK(K-]GCBC+/(F.C$!5YX)V]Q6>$Q3IJ5&:
MO&6C7GT?JBY+2Z/ 7J!NM>Q_M.^$;+0?B*VKZ.8WT'Q%"NJ6;Q+A/G +X'8$
MG=CT<5XY-\JL?8FO/G%PDXLM/F5R]X3\1S^%=0BU&V4&XCY0L 0"<]C]:Z*Z
M^+%_=?V*LBA5TF<2VNU0-GS(<9ZD?(,5Q.W;&H]!4,E.,Y)6(<4W<_H&BD6:
M-)$.Y& 8'U!HK"^'FH?VMX \,WV=WVK3+6;/KNB5OZT5QFYT%07U];:;:2W5
MY<16MK$NZ2:=PB(/4L> *GKY)_X*)_VW_P ('X9^R>;_ &%]ND^W^7G;YFU?
M(W8[?ZWKQG'?%>WDN6K-\PI8%SY.=VO\F_O=K+S-Z%/VU14[VN>M:EJ%KJE[
M/>V=S%>6D[F2&>!Q)'(IZ,K#@@^HJJ9/FSU%<G\'_P#DE'A C_H$VP_\A+_6
MNFSM8Y/X5EB:*P]>=%.ZBVON=CPJJY9R79LGV[V]OK3Y(PJ\\]^:;;XW%1SW
MI9&SP1^=<Q'0B4=<<=J0C\O;F@X;VQQUH!*C&*"04 9!ZYIW#9]:7'RX_(TF
MWY02>G:@!RYSZU,ORG\.*A3Y>@I^X*1S]:"D[%@?-V_6C)5NF3CTI(?F/7'>
MI]OS>O%!96YSWXI?+W8(R.^*LB$-UZU+';]#0.Q7CMRW;)JRD(5<D5* ."/6
MD:0]?;%0Y#L17#%5X]*SV3=DD\5;F8;LYS51[@+W[U2V$QZG8N.AJI?7PA0Y
M(RW ]:2>^VC-9T2-?3Y)^0>M43?L:VEIM_?/U/K5C4MEQ'@<9%8UPTEG@!\J
M*MVET)AD]34VUN._0JV[/:R8!-:\-P+B/U)]:HW4)ZCBJ\,S0R9!_P *IJY*
M?*:"J89,]!UJU-&)HPRG!QV%0K(&0D\\5)9SA<@\U#-$11[E/EL.]?%W[>7@
M^ZL;6Q\2Z<72:VE\N55Y5XWXPR]",U]MRQY^92!7C/[3WAU/$'POUF,C]XL+
M,I[@CFM\-4]G6C(RQ%-5*4HM7/S.L;N#59 DT/\ 9MPPQYMNI\LG/=,_RQ5?
M7-!OK-3+'&MRH^9I[8EE(]2.HHL?%7V>8"2-)%(P6*]^E7/$E]<M9P7FG-Y9
M1<2&,X)[\^M?>WC*F];V/S%*M1Q44XI)]]OO/.[C4W@:0HWR$X=>X]ZV/AS.
M]JUW=1MCYP!GH./2L[5FAU:$O/$(+D\^=&,!C[BI_"C"'3RGF*IDFP6S@=O7
MZ5X-'FCBXMNZ5S[3&05; 3@HV;M<[#Q?XPU+5K5(Y)E>%?E5%&./Z]ZYG0]+
MEGNH^/F)Z=:OZ@Q6.%%=I0K;0P!())YZ>E;.D/:V<JEI5:0)Z-P>M>RX>VJJ
M4GL?,1J_4L(X48ZN_0Z#2[/R8]KHTBQ\#83[=:S]:N!'>$[07 ^=LYVUJ:3?
M()7,#?-Z[NG'I6/>0O,U]*98P <#)Y^F:]26D=#Y.GK4?,16]PSDY+A0W'IS
M5?70)+J%C)NP#U'"UHZ.L]U;N4VR;,#[HQ]:H^($VK;^>GELRE3@>_6LY?!<
M[J+4:_*C UB-VLPQ!)!Z#I6EI]X4\/J1MWG@&LW4E/\ 9\C-*2%X.<XJSH[@
MZ,N#DKT4<CZUP)_OGZ'T56/-@XM])%#38S'?7I<ACA00.G4UN?VQ)'"8XUV-
MR.0./85CZ>K1R7C%/,)D RI^4<>GXUI:?)&NUG)1QU]<T\/=1LO/\S#'M3J-
MRUM;\D7 T\MO;M(S"-2?EYZG_P#76M>2&WL5:4%5VX&T]:S[K?';Q,P8-))]
M[.<CO^@J/Q%<16^DH0#N(R /PKM<N2+9X<8>VJ0@NK,6\N]T9VL7$AXW'!K:
MT??Y,<NU48].<_A7*Z?;O?WT2@[@J[B/4UZ$81;VL4:JIW=6Q_G!KGP[E4O/
MH>KF<88>,:$=RI)=>9,XE=4'0G9CKCG]*S5C<L<)O"LQ^4$CD_2M&>UWV<TJ
M'YP,_-@?A44<,L>FF=<[00K%>![5TM7/(A-16A7U"Q\AX"T3*V?F)[\=Z[S1
M9--_LX0S9$KC 8G!'' ]JX_7[CY;0'<4(&58'&>X_P ^]<W=>)[JWN2(2BQQ
MN,93)X]ZSE5C1=V:T\'5Q\5&'0]DUJS:?POY66= P8JJG''&3^=>">(E-A#?
M_P!]CL^[@5U\/Q,U"&W$<@A>-1@+CG\:\]\6Z[-K-P&. F<E5'^%>;F6*I>Q
M;B]3Z#(,NQ>'KM55[OJ)HUO%Y:/)\HQ@$\"NDMKZ*&,X*D8[# _.N4TZU\V2
M)+B[$ <X"H-[X^G0?G7?W'AL>'5AD@LTN&V[Q/=GS<\9SMZ#\JXL"IRA>*T1
M[F;5*$)J%1N[V[?>Q^D_:M:;9IME+=$<'RE+*/7GI4]YHMS:8&I:C9:7$S98
M-,KR_P#? -59)M;U2$1R7C/ %V^6DFQ1_P !&!5%?"LZDA@0<Y!C7<3^->G+
MG:LD?,IT(2O*2_/^ON/6?A-XQL_#_C+PU'X5::+4#>1*]Y*OF.Q9@IR6&,$$
M_*JCKUK].+NUD$CD9(R?YU^4OPON(_#/C30]1VR&YL[R&=69L*,/GD?A7ZZ2
M(&)9<%6Y^7H<U\[FL6G!OS/<R649^U47I=?J<??:2;K.]=P'/2N#\3_#4:LQ
M;;CG_P#57LK1@YX&/I4+6J-GY>!VKQ%)H^@GAXU-S@?A#H8\%^*K.\O[N.UL
M+:.66:>X<)'$@C8LS,>   22>PKV[_A=_P .?^A_\+_^#FV_^+KRSQ_9QQ_#
MWQD[+Q_8.HY/_;K)7YL5^C<+\)T>)*56M5JN#@TM$GNKGU&39?"I1DKVLS]>
MO^%W_#G_ *'_ ,+_ /@YMO\ XNC_ (7?\.?^A_\ "_\ X.;;_P"+K\A:*^W_
M .(7X/\ Z"9?<CZ#^RH?S,_7K_A=_P .?^A_\+_^#FV_^+H_X7?\.?\ H?\
MPO\ ^#FV_P#BZ_(6BC_B%^#_ .@F7W(/[*A_,S]>O^%X?#G_ *'_ ,+_ /@Y
MMO\ XNC_ (7A\.?^A_\ "_\ X.;;_P"+K\A:*/\ B%^#_P"@F7W(/[*A_,S]
M>O\ A>'PY_Z'_P +_P#@YMO_ (NC_A>'PY_Z'_PO_P"#FV_^+K\A:*/^(7X/
M_H)E]R#^RH?S,_7K_A>'PY_Z'_PO_P"#FV_^+H_X7A\.?^A_\+_^#FV_^+K\
MA:*/^(7X/_H)E]R#^RH?S,_7K_A>'PY_Z'_PO_X.;;_XNC_A>'PY_P"A_P#"
M_P#X.;;_ .+K\A:*/^(7X/\ Z"9?<@_LJ'\S/UZ_X7A\.?\ H?\ PO\ ^#FV
M_P#BZ/\ A>'PY_Z'_P +_P#@YMO_ (NOR%HH_P"(7X/_ *"9?<@_LJ'\S/UZ
M_P"%X?#G_H?_  O_ .#FV_\ BZ/^%X?#G_H?_"__ (.;;_XNOR%HH_XA?@_^
M@F7W(/[*A_,S]>O^%X?#G_H?_"__ (.;;_XNC_A>'PY_Z'_PO_X.;;_XNOR%
MHH_XA?@_^@F7W(/[*A_,S]DM.\8:+XIT:[OM UC3];MH28VFTVZ2X17 !VED
M) ."#CW%>=2>.+^\O#:,GE+7F?[ #*OP/\2$]?[<FS]/L]OC^M>A^)+$)-Y\
M(PP]*_&<TR^&5YA6P47S*#M=GSF*I^QJ.">QJQWAW+N.6[U7NKHRS;0:YVQU
MU6N%CF.U^E:\<BO?-CD8XKS&CC,UI-]^$'4FNM@M_+M06':N<T>P-QJTLCCY
M5/%:^M:D4Q!%R>G% $%Y=B,E8^3ZUSFIW$C9&[FMY;,PVY=QEFYKF]3NH[?<
MS'FD!E20XRSG-4)KI8\@&H[S4VN&(4X6JBH7Y-!(Z:=I.AIB*3UIY45+&HH
MGA7;BM_2U\T 5CK'OC'%:&C3&*7:W'- &PUN8VR!FMW3=MQ 4)Y]*CM[=;J'
M*U%;[M/O!P=I.*I#L2:E9_Z*RXZ URGA5?+\4,W3=UKT34(%FLRZ],9KSW2_
MW6N3G'*BKCL(U?BOIHDLX;M1EE/)]J\NW8KW#7(5UKPK<@88@&O#'S&Y4]1Q
M7AXJ/+*YV0V)%:K,9JDC59B:N$T+*M4@:H%:GALT7 GS2[JC#4JY9@HR2QP
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MY!_94/YF?KW_ ,+N^'7_ $/WA?\ \'-M_P#%T?\ "[OAU_T/WA?_ ,'-M_\
M%U^0E%'_ !"_!_\ 03+[D']E0_F9^O?_  N[X=?]#]X7_P#!S;?_ !='_"[O
MAU_T/WA?_P '-M_\77Y"44?\0OP?_03+[D']E0_F9^O?_"[OAU_T/WA?_P '
M-M_\71_PMCP3KH-AIGC'0-1OYP5BM;35()99#U(558D\ GCTK\A*]6_99V?\
M+\\)[^GF3_G]GEQ^N*\[,?#C"X+!5L5'$2;A&4K66MDW^A$\MA"+ES/0_2O1
MQ_Q-[3_>;_T!JZ^N5T';_:<>[KAMOUQ_AFNJK\#CL>%4W"N2^(2_Z%:-Z2'^
M5=;7,?$!"VCHP_AD!JS,XR1P;<?2J+-4^_,6*K-]X\T .W4FZF[O>DS[T /W
M4NZF;O>DS0!)N%2VC?Z1']:K9/K4ENV)DY[T =>#THW5&K?*/I2[J '[J^*O
MCMI)T?XE:FN-J3$2K^(K[3S7S3^U?H)CU#2M61?ED0PN?<=* /,?"\WF6)7.
M2IK<4UR'A*YVW$D1/WAD5UJGI0 _M4,RU-3)%W"@#)NH^365<+UXK=N(^M9=
MQ'UH [O]G7QV/ WQ&MEN)-EAJ ^S39Z D_*WY_SK[K5@R@CD'D5^9,BM&ZNI
MPRG(([5]O_L\?$]/'W@Z*WN90=6T]1%.I/+J/NO0!ZQ1110 4444 %%%% !1
M5+5=2;3;?S5MI+INT<1 )_,BO-?$WQPNM"@F_P"*+UPR!3LD:)3'GMDJ3Q0!
MSO[3OQ#73=)C\,V<O^E7>)+K:?N1=E/U/Z"OE>ZGVKBMCQ!K=YXAUJ[U'5)7
M^V7#EY-ZD8]@#V'2LUK&*?GSC^ H QY9.O-1+SS70+H=LWWG=OQQ5B'1[1.!
M'N_WFH XN\SU[58TJT>=QA2>?2NT33[9<$6\?_?(JVBA5P  /:@"C8:>T:J7
M&WZUM6[1PJ.<GV%5:?0!J0ZH(SQ'D?7%:$.O1<;@R_K7/+3A0!TPU:WD_P"6
MH!_VN*>LRR?==6^AKF13E/I0!TZTM<['<RIC;(P_&K":E.O\08>XH VJJ:K-
MY-C*>Y&!5=-6;^*,'Z&H[Z=;[R$^Y'Y@+D^E 'OGPST_^R_!>FQD89T\QOQY
MKJ-U<MI/COPZ]M!!#J$<8C14"R@KT&*W[?4+6[4&"XBE'^PX- $UPX6"0^BG
M^5;_ ()3;X?A/]YF/ZUS.H/ML9ST^4C\ZZ_PM'Y?A^R&,?N\_F2: -6BBB@
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M'8_G:*3'VF11UX/"?CD^U=@_Q8_9_P#@?N3PAX;'B+6H>%OIE,[;AW#OP/\
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M #C7-1/_ $Q7^=<E\3+@W7CC56/\,FS\@!7&O>Q#;Z(^YJJ-'AFGR[U*CO\
M),YBBBBNP^&"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#V+]E/XM:1\%
M_BQ!XCUM9VL$M9(BMNFYBQ*D<?A7V/H7Q:T+XP2>)M8T43)I]PY"+<H%?*J
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MAG_P<6__ ,77Y!44?\0OPG_03+[D']E0_F9^OO\ PNKX>?\ 0^>&?_!Q;_\
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M)E]R#^RH?S,_7W_A=/P]_P"A[\,_^#BW_P#BZ/\ A=/P]_Z'OPS_ .#BW_\
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M9(9T#HX]"IX(J>BOFTW%W1S'D]]I]OI=U<6-E;16EG YCBM[>,)'&HZ*JC@
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MW[_\'N=KI_E2-;-)P "^-IY)/<CJ:NZ5"ES?3O+G;GG''T%9L%NT4*LLK X
M"J,_UK6L[A;.)R\NV3^',9 S^5>[36USXW%N_-R]?\SH)KN'2K>XN9)%*0Q&
M3,BAP%[#!ZFL?1-6TO4=#OW$4,DZ,"ZE><X]1T&<UGZLD^NZ=/$+J,K(FQR"
MI*D8(R#C]*QM%\.2:+%,LCJ\MRBJ8X#NR <\G'&?2IJ5:JK1C&-X6U9EA\+0
M>&DYSM4NK+RT_P"#^!Z/X+TZ#_A'P\RYDD8GY25&.<#@U7\5P0[85B3)C("G
M>2#STZ_I6A8O);Z)#)=1B2;:-B1CA!T"_@!63KNK!I(%V;SN&0P'3=S],5WN
MT::3/#BYU,4YQ[LYWQ=9C3X9+-5W7&7>7$F54 X QZ]ZSO#5VLFDW0D&XJ,8
M)X^OZUH:M<-J5]/*L<VV;>2SC&1DD?H163X7_P!7>PNF0W3;V_"O(E?VZ:ZW
M/MX6EE\HSW33_$L^'[PKH]W/#'N>2Y( X.W@?X5%8^.(;C5([06>]V8KYN/O
MGTQ[8X^M:W@VPANK6<@KMCNG.QAQV_QK8TGPSH^DZI+JD,4C2>9\BN04!(Y(
M'YU4*=>4*;IR277T//Q.(P=.M7C6@W+[-N_2Y#JUW)'#:&2$KR3L.2:S/'$Q
MCMK.V7 \X+EAQP/6KOC2:&X4/"'4+D@EL]^Q_P ]:S->C%T=.:0Y=HP2Q/WL
MUTUKR4H+R.3 1C&=*M)=7^"T-KP5IR6]O)<M$Z[C\O!&5 /.:V]2C5XQ+L=5
M"8R%)W-Q^=5HKJ>X\-6]@S*;=9F5#W4?,=HQVR<_G5?6;7S+5,2LN%'"\!:Z
MZ:Y*:BCRL1+V^)=23W9+.Q73Y(B)2VSY1Y))Y]ZS;B6:SMBIBNBDJX*-#@8Q
MP?:JUI)YD,F]-V%.U23C-<KXM\17%O-;1PQJ$>%PX(SU."/P%<>)Q$:%/VDC
MT<#@98JM[%'4:I?/)&J21$M'S]Y5YKCXY)EN"9!$GF-DALG.!["KVFZD/['B
M\T#S6''!SMQD?SK#FNLRDC'4FO,Q%9349W/K<MPCHN=.WS"ZNFCDD1W3YFY.
MW 7GW/I62LT5S,TDWF+&O&(L9_6B^F:29C][O6GX9^RR%H[H?*>0<XS[5X%_
MK%54[Z'U5EAZ3G;[B?2-8TC1V$D5I-+)GEYCD@>@':O5-&^,'@V\LEMM8TVY
MB;;L\V#DCWP:YG_A!UDMQ<V6+J'W'Z5%;^"9KEE0VJY)QE4/-?14:>,PZY86
MMZ'Q&,J93C7SUG*Z\]5\F=1=3>#]0G#Z'XBA@'.+?4T>/!ZYW*"/Y5;C\/\
MB2&#SK&SL=3@8X$UK>Q,N/Q8']*Y"Y\)Z+X?C\S4[G<^.+>WY)]LUDS:C=:H
MRV]G"UK:]%4GITZUT>VJ1TJ?%V1YRP6'JVE0;<%NY[?)JS9Z1#H_B!IH[B31
M1:J,C=]JB)Z]?O\ &*_2?X#_ !FT?XH:1;:0LCQ>(M.L(7O(,JZD!50N&4D<
MGL>>:_+#2[$6<,#32LVY&7@\9R/\:^[O^"?.L:=I?AOQ-H[V\,&J23I?+-M
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M?AQ_T('A?_P36W_Q%'_"C?AQ_P!"!X7_ /!-;?\ Q%=O11_:&,_Y_2_\"?\
MF'M)_P S.(_X4;\./^A \+_^":V_^(H_X4;\./\ H0/"_P#X)K;_ .(KMZ*/
M[0QG_/Z7_@3_ ,P]I/\ F9Q'_"COAQ_T('A?_P $UM_\11_PH[X<?]"!X7_\
M$UM_\17;T4?VAC/^?TO_  )_YA[2?\S.(_X4=\./^A \+_\ @FMO_B*/^%'?
M#C_H0/"__@FMO_B*[>BC^T,9_P _I?\ @3_S#VD_YF<1_P *.^''_0@>%_\
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M1D/T]*^9_BOX?T^\T5X[S"VJ@RQ8QOC.. #W%9O["\;VOC3Q!@YBFA*(F[H
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M,^A% '24444 %%0W=Y!80--<S1P1*,L\C!0/Q->+_$3]IK2-!22T\/*-6O\
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M<:7%[EC^IK0KNIX[%4X*,*LDEVD_\QNI-.R9P_\ PHOX;_\ 0@>&/_!/;_\
MQ%'_  HOX;_]"!X8_P#!/;__ !%=Q16G]H8S_G]+_P "?^8O:3_F9P__  HO
MX;_]"!X8_P#!/;__ !%'_"B_AO\ ]"!X8_\ !/;_ /Q%=Q11_:&,_P"?TO\
MP)_YA[2?\S.'_P"%%_#?_H0/#'_@GM__ (BC_A1?PW_Z$#PQ_P"">W_^(KN*
M*/[0QG_/Z7_@3_S#VD_YF</_ ,*+^&__ $('AC_P3V__ ,11_P *+^&__0@>
M&/\ P3V__P 17<44?VAC/^?TO_ G_F'M)_S,X?\ X47\-_\ H0/#'_@GM_\
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M_P"(K^:'Q);BS\1:I;JNU8KJ5 H[8<BOZEZ_E_\ BII[:1\4/&%@XPUKK%Y
M?JL[K_2N>MB*V(M[:;E;NV_S)E*4MW<Y>BBBN<D**** "BBB@ HHHH ****
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MO_T('AG_ ,%%O_\ $4?\*)^&_P#T('AG_P %%O\ _$5W-%']HXW_ )_2_P#
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MOABNAZA=ZK;HTURR^4#VC!Y) ]3T_.NTN='CM)!(1][D5N>'(?,M9L#.9?Y
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M?#;_ *$'PS_X*8/_ (BC_A1'PV_Z$'PS_P""F#_XBNZHK3^T<;_S^E_X$_\
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M?VCC?^?TO_ G_F'M)_S,X7_A1'PV_P"A!\,_^"F#_P"(H_X41\-O^A!\,_\
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M-"\JK)A?O$ ]<>W>M3Q=;ZA836MM=6HL+1$(M[=) ZJ,X;)!Y?<#NSSD8P,
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MGLOZL*3TLCQ;QCKK>*/%6KZNY9C?74DX+=<,Q(S^&*Y^?[R#WS^AJV]59/\
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M4'^M<N+3]A+T-:7Q(\CA09JW&H K-M[KGK5M;KWK\MGF].+LV>XJ#+BJ*D
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M=#KL9SL'X=*P:RDOY5&"=U2+J+]Q0![A^S+<+'XSOHF.&DM#M]\,*^F*^&?
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MD\./X9_;6^)L#+M2ZNX+Y#_>$UM%(3^;$?A0!\ST444 %%%% !1110 4444
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M_P 6:Y>:OJDYN;^Z??+*W5C@#^0%9M%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH ^<_VR_$DWA31?#5]&I*-<30L1ZE5(_\
M037RDWQDN'S@&OKC]MW25U#X,K<E<M8ZC#+N] RNA_5Q7YZK)\W7C-;1>AS3
MC[QZ7)\6+Q^@-0M\5+_IM;\ZX:*0!:<TRJN>U5=C4$=DWQ2ONI)'XU5F^*U_
MGAOUK@M0O@H/:N7O=;,<A&ZFKL4HI'L*_%#4)&^]6#K'C*^\0:YIFGD\33HI
MQ]17G$&O,S#YJZ3X6!M?^+F@VQ.Y?M"M^1K2"?,C)VLS]/\ PK:_8O#FG0 8
MV0*/TK5J*UC\JVB0?PJ!^E2L< FO;.4X3XJ^-;?PSX=NP\;/,5VH&7*Y/2O
MOAC\-9/B-KT]W>.XMHW#2R#^,YSMKVS4M%_X6+K=S:WDFRRMFQY8ZGWKM/"_
MA/3_  CIXM-/A$46<GU)]Z[:L(TE&-]>WJ=F$QOLJ,XQ7O-[_P!=NGWFC8V4
M6GVD5O"H6.-0J@>@J6:WCNH'AF19(G&UD89!'H:=2K7$V]SC*]SIMO<6,EHT
M:B%EV%0,#%>$>)-%?0M6GM6R54Y1CW7L:^@:R]8\-:?KNW[7 '9>C#@C\:[,
M+B/8MJ6S.>M2]HM-SPK3=+N=4NDAMHFD=CC@5[OX<T=-$T>WL\ E%^<XZL>2
M:FTW2+32(!%:0+$@]!R?J:N48G%>V]V*LA4J/L]7N8NO>"-"\31JFI:;!<[3
ME6*X8?B.:J_\*S\,K:O!%HUK!NC\OS(XP' ]FZY]ZZ>BO/NT[]3O]M4Y/9\S
MY>U]/N.2\.ZT-!O7\/:O>H+J-_\ 099V"M=0G[N,]64Y4X] >]=>S8C8^U<[
MXV\+1^*-)$8BBDNH7$D/G#Y21U4GJ PR,CIP>H%6Y5_X1[PS+YD\LZVL#,99
MVW/@ GD]^._M6KM*S6[.=7CIT/Q-_:.UO_A(/CQX[O\ =O676+D*W^RLA4?H
M!7 Q-5CQ5J+:KXHU6\8Y:XNI)2?=F)_K5*)J^:J/FFV>Q'1)&A#EF '6O4=3
MT-OAGX7TR:211KNK0F<PE?FMX3]T^Q8<UB?!OPG#XD\41W-^Z0Z/I^+J\DE^
M[L4YV_5CQ6S^T!=RW7Q5UEF.80RB#T\K8"F/;!%6H6IN;-*=:=&I>F[,X@3-
M*Q=V+,3DDU:B:L^)JMPM6!)H0M74>$_%3^&I)R+:*[278WERD@!D8,C<'L>W
M?-<G&U6XVIIN+N@W.SL?&4ED9G@MU2:XGCFFE9B2^P[MOT9_F/T'I5GQ1XGB
M\02VXMK=[:WA\Q@LDF]BSN78DX'<X'L*X^)JMPM5<[M85D:,+5JZ+8OJVI6M
MG')'&\\BQJ\SA4!)QDD]!6)$U7(VJ1GJ'Q6U:P9M"T2QNUU%=%LQ:RWD?W))
M-Q9@I[J,X!K"A\+W;:&=4W1"+;Y@A+?O#'OV;\?W=QQUS7+QM77VOC/;H<>G
M2V:/MB^SM,'(9H1(9 GH/F.<^@ K3F4Y-R)LTM"W<Z;J7B*^ANTM?+-VA= S
M@ JB@,Y)(PO!Y/'7TJA>6,^EWDEM<QF*>,X93S_^NNE_X6?O_LT?8VV6P57C
M9U9&01A#$H*_*C8R0<\FN:U35I]<U*XOK@J9IFW-M&%'H .P X ]!1+EW3U!
M7ZBQM5F-JI1M76^'?",U]Y5W>G[%IQ.3/)P"!UQZTJ=.522C$FI4C3BY2V1V
M7PKT,VEK?^(KD%+>TA<QY_B;&!^I%<)=7375W+,QRSL2:[_QI\0M+F\)VV@Z
M&C1PJW[YB,;@.@_'K7FR-75B9*-J,)7BOSZG-ADY+VTXVE+\NB,;Q$WF:MID
M?^V6KZ'^!>CII_PW\3ZS,,>9YF&/HHKYRU1_,\36R]=D9-?45S_Q2/[+>H3?
M<DEM7/XMG_&NBDOW*]3EK2_?2\D?&'F><TDO_/1V?\R33XU\R15'<XJ*!=L,
M8_V13ZXF[NYZ45:*1ZIXREM9/ $6B6*H?[%DC>:1.?,:1?F;\#@5Y76SH>M)
MIMGJL,NYOM=OY0&,C=N!!/Y5C54I<UF$58****@H**** ))+B66.*-Y7>.($
M1HS$A 3D@#MD\U"W>G4UNM #*8U/IC=Z"6=!H?BV/P]X3UZPM;9EU;5C';M?
M9'[JT&6DC7N"[;<G^ZN.]<DPJPU0M3;;&B!ZAAA-Q>+&#C=A<^F2:F:HH)FM
M[HRJ 64C&>G3_P"O2ZZC-[4/AYJ^GQR236\D<:8#.\3!5R%(R>@^^O\ WT*P
M-,TN35-<L]-C^:6XN4MU /5F8*/U-=)+\3-?GL9K*>^GFM)L>9"TK%7QC&03
M[#\JW?V;]';Q3^T!\/\ 3W+-')K=K+(O7*)()&'Y*:TGR?9,X\U]3]LHHUAC
M2-!M1 % ] **?17&;A1110!ROCR']U93XY5V3/U&?Z5Q0'[[/0>M>B^,+?[1
MH<Q R8V5_P CC^1KSY<+N;'6NFF_=//K+WRG=L2[#GBHK-OFYJ6?#;N>*@M1
MMDQQC/K6QRO<N3=/2JP4JW.*LOAL GFJTF/UH0"Q\L0?UI)%V\GC/6F+D9[B
MI%8M][./>F(;MW88'%/7'.>E-VCC!_*G+E>3D4#'JQ7CJ*1K@ $=Z&8'(SCZ
M5$S?=[FD(AEF;=P.*HW6&X89]*ORJ6Z_I5"\4JI]J9)YQ\0=$2YM791AL9'K
M7 >$_%DND:E]CG?: >_%>QZM;K=1LI.>/SKPKXE:!)ILGVR%2"ISD5K'70Y:
MB<7='T7X;UB/4%0*X/?(K>U2=5A"#\:\1^"/B$ZI9KEB74XYKUS4+H!1SEJP
MDK,ZZ<KQN9-W8I<3*YR ?:MK35%O&I7H/6J<0#8:M"U=)/E/W:?0%HS20^:.
M"#WI6CV\=#ZT^U6*-2!][&!Q4CPDC(QCKQ4FQGLI# 9IYC#+BI9HSG'KWJ*-
M3S@=L4S,7R2%!QQ[U!=,=N,<U<60[>M9U]\S=<4BG:PEF#R>M;6G.1P>*Q[%
M?J?3/2M&W<K)D?SI/8(O4^>_V[/#@U#X3WM\JAFM"LO3T(S^E?FE?+!9R!U;
M,$WS(2H/_ ?PK]A?COX77QA\+M;T\KO,MJZX'KMK\<YK.6QAGLI@S&-VCP_5
M&!Q7JX*;Y'$QQ$=5-,M>"_"4WC#Q[X?TFQ16GOKZ&+:OW=NX%C] H)_"ON;X
M@>-D\*_$+2H2P6#>$=6'*KQFO(/V2=%T'PUX;N_'MVTESKR7<NG" Q_+9(J*
MQ.?[T@;&>P!'K7/_ !H\>+K'C=GO/]#2=1]CO.L3_P"RQ_A.>N:]C!Q48NK+
M1,^ XAK/$5XX6EK*'_#F/\=/"(L->UM%7]W'>22P8Z;';=D?@5KQRV=XR%;U
M'0U]!76L)XULXK._"P:E'"ELSM_&^"$8GT(P,_0UX9KVDSZ-JD]O.C121/M9
M&&"*WQ5/EY9HK(,7SJIAI^J]"];R*<9;<.N"3FM".7]V!Y.#C!;.1^=<_9M\
MVX,V<8.>E7OMCM@D\+[>]:TZNFIWXG#<ST- 3DR!R"8^1Z$?_6JO/(;A7 3"
MYQ@#W'I4<%^DA*MQG@;N#^52!WWLPW.,XPN,=>IK?F4EHSA5)TY7:L3IB.VN
M DRLWEY)_AZGC-1:'CR6<@D@%NN*E6/]S<>8_P"]X4A>_KTINGPFW5F!;9AL
MMM]N]4MTPE+]U.+W;1)X?80Z' "P4LSY+_[Q)QZ5?M]<AMXPKA^!DD#@\UB6
MT<?DPY9_N#^?:K$<"2+@LH)&1N8 GVHIR<8**Z(PKT85*LY2ZMDMS=)/<^8L
M9V\J,CZ5GZ?(VGWSH<Q[U^\PXYIPF59@ 0<DY.>#4%UJ"*Q92IVGJ":RG-?$
MV=]&B^5TDM&C?75"EK"BR!CMQL4_GS65?:DS.3&"!G(QZYK*&H 6J8?<I&=I
M']:J3788$%L9' %85,5I9,Z*&5J,N:2+DUU(5)/';@X-9]Q(=A.0#GH*B:3Y
MFX9N.F>],)W9&!@]NM>;4JN1]!3HJGLB-?WAQNR<Y-:&FZ>U],D$<) )RPSR
M<<\GTIEC#M8EV^7&?:NCT>\GO[JUM=/M3#9LZQM.P^:4[AD?3'I^-94Z:DTY
M'/B\3*":A]_;_@GNWA..U\!?#]CN"S28BB'K*WS,1_N@XKS7X\Z,8KKPGKD+
MQSRZM92(\$)W2*T3X!9>O*N /7;5C5O$'_"3>)+;3;.1_P"S[4;(9!_'SEW
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M4GF74F[.QE*[AVK]3/!"]U!VN",L@//XUCZIIYU#2KV27E7/RM[^M6#,3)>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHJ]H6CS^(-<T_2[4;KF^N([:(>KNP5?U(H _HS_ &,?#+>$/V4?A/ICIY<B
M^';.XD7T>6,2L/SD->SUF^&=#A\,^&]*T>W_ ./?3[2*TCXQ\L:!!^@K2H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^7?V\OB]J?P3\
M'^&=?L+3[5%<7TEC-\V,%H]Z?^BVKXJD_P""@6OX^72@#ZF2OM__ (**>$G\
M5?LL^(98DWRZ1<6VI*/99 CG\$D8_A7XY[1QQ4-ZCN?4C_M]>)3]W2H_^_AJ
M!OV]_%;$[=,B_&0U\Q*N, \$TY0#G/-3S,7,SZ6_X;R\7,QQ80A?]\U7E_;J
M\:.>+*W _P!XU\Y;-N/E[<TA7V_&E<?,SZ'D_;D\;R?<MK5?^!&HF_;:\>-G
M;%:K^=?/N%5B<8]*E5?4\@4#YF>\M^VCX^?H+7IUVFHY/VS/'[=&M5'^Z:\,
MVD\'OVHQWZ#TI7#F9[:?VR/B(<XGM@.Q\O\ ^O4<G[8'Q%;@7D"_]LZ\6V;0
M.YH&#SV_G0',SV;_ (:X^(S#C4(0?^N=0M^U=\1V/_(609](Q7DG3:/:DQ[?
M2BX<S/4I/VIOB0RG_B=;>W$8JO)^TS\2'Q_Q/W!SSA!7FOEC<#GCO1CT[T7%
MS,]+L/VG?B7I]ZES%XADW(<A612#[$5]O_L\?M>#XG>'Q;:S%'9:U;X278<1
MR?[2^F?2OS69>@KTCX!^(6T7QQ%&6VQW  _$?_6S3YG'8:?-I(_5#3[I=0=W
M3!!Y%66\T-@"N;^&EXM]I%O(3SMV'\*[.2':QQ4V.M,H?O&ZTJ0NW?'-6V7T
MIJR;:.4=Q(X61NM2R G@&FB;?]*?!;S7<PCB4GU/859)<TF//F$_2HKO=97
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M!!K9\KJ*R[Z,Y;TK5&9TUNPU+2U[G%<KXQOA9:3Y(.&;BM?PK?;5:)O6N/\
MB!<>;JB0CIG.*N&K%(H^'8=Z2'&/DKT?X:_-ITXZX8UQ'AV']W+Q_!78_"V;
MS+>[3N)"**G44#R;X[6[0^++9R28]NT5YSJ<C+ 2M>Q_M#:>5>SN@, -S7GW
MAG18=6NO-O&V6-JOGSL?0=!]2>*_"\TP52>?RC%7Y['UN$K1IX?FET*^JZDW
MA'P#::)&?*O]8_TR\?\ B6/.(T_&N3\&P^=J5RAW;F P^!P*A^*&HW&I>(&O
MB#"K'Y%[*@P OX "M;P#Y?DS7&W<H7 ;U-?M>&HJA2C371'RE:JZU1S?4Z.:
M$KIQ1<MY0)![\5IZ!>9AC=>X^8>AK&CNGMII0PRI[=C[5-H[-;W#(G&3OP?Y
M5TF1I00^9=3A&SEMO/J:ZFZ"Q.'9<%>!] *YK2U\W58%V['W[S^%:'CS6$T/
M0I[J9MH48!/>EU ^)OVP=<-SKCLKA1&Z!F' Z_\ UJQ?A7J#6?PAU%6Y>^NR
M^[T'2N8_:,U235]#U2\+;MLP;=VQR!_.MKPJ'L?A[I5JSKS"K,/<BI&6X9(H
MV0A3@=?]JIXYD8.><YX/0#IQ_6JMO&6=&=NW&.U7X<"-PH!&?N_U_P ^E*Q1
M:#(K1E@!QPN/UIA9)5?CYL\>E/,<DCQC>I('-.CA,<+#(.3C\:0AUJ$CE3[P
MR/QJSYPVD_Q9]*=';RB1"=N0O4&G[?W!!P$+=N235(DKS-#-.I*LL87CGO6'
MJ6GPW$++(N?F/X5TKQN6Y4 XYQBL^>%OL[?(,;L%O>F!P%]I$VDR,59I+<C/
MN?:KFFZG):^3(I#)T.WL*ZOR#-%MEC!.""#W'K6!<>&_+4S6N5;/*GH:DHY7
MQCI?VFUN)3B6%VR&'.#UKG=/LY&L7A2-I6C&[Y1^M>AQ6VV22&9&B9ERT3CA
MJ71M CM[QU4;(9EP#_=-.X'"Z=J$5Y9SVERFT*,2(PQN]_PKV+X,_ ^RM-*?
MQ3KC+#!R;-9#@>6,_O&/KG@?2N%;P1:77B:VN+Z?[)IT+>9>2C^X/X?0$^];
MGCKXI7GC^]6SL\6/AVSQ%;V<70J ,%O7C%0XQD[O<N-2<$XK9D?Q@^)RZ.##
MX=MF;S/E%U(.OT'I7F_P_P##LVH7\VJ:F7N+DG=YCG)]ZZ'Q1ILFJ7EI;*-R
M1J!N]CVK?TNR&FZ<L"* K'+?6K,A;YDFN]JH=L8PHJ-;1!'WYX^E7(XSYTCD
M;CTJ1H7_ '0VCV'K4CL1Z79^=<-U+"O2-,BCBLX0692!GZ&N7T&W,5TYV9#=
M<]N*[$[8;=$9>H(Z?K2&8]W"9,'S-VU_7UJK<EVNCR <9XJRS#][D8.>/2JD
M^UKA2N5^4#WI%D<5JTVP!L'=Q6S>*\<##.<@;JCL;=5AW8Q\WY_Y_I4M\J^2
MX!YP.M(#A?$>[<QVCIR,4?#6-AJRD8SY4HY]T/-.\1?+D9YV]?6I/AVBKJ"D
MGI%)_P"@FJ0GL:GPYU1/!/PDU>^=MC3.84QZEF/^?K7#7NL2:3X,NM1E)CO=
M0;;&">0IZFI?$]PVH1^'?"5LVR,![^](Z(F<#^M<KXJNF\4W\?D BQMR+>V0
M<[FZ%J"$>Q_L=^"/[7UY;N?B.23>6_V5./Z5]<_$#48KJZ>- S[<*HS^E<!^
MS;X9M_!O@][J6(((X\*Q[C'^-=1HC3^(M5FN&QAGV1QG'S,3A0._4BK$?37[
M,OA\:+\,(;@QF.74KJ6Z8'Z^6/PQ&#^->LUG>'-'3P_H&G:9'REI;I#GUVJ
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MIT?J^7/X_P#UL5GO(VV@:%%%%:&(4444 %%%% !1110 4444 %%%% !1110
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M7P_X;M540:78PV@V]"40 G\2"?QK"1HCH:***R*"BBB@ KCOB!:XC@N@./\
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M5D\V3_>;G_ ?A7@9A95I*+[?D>GDZG.G&4U9J_YLW:***\H^G"BBB@ HHHH
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MDPMSQ$G7\V)_[YI5)<JT%!79]%T445Q'6%%%% !1110 4444 %%%% !1110
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MO>F9]J-U $T3[9%.>]=E"X>)&SG(KA]V.:Z_39?-LXS[4 7-U&:9N]J7)ZT
M.S1GWIE+0 [(HS3<T9- 'E?QB^#-OXVMWU'356#68QGT$P]#[U\T6MU?>$]3
MDM+N%X7C;;)"XP17W77!_$SX2Z9\0K0R%1:ZH@_=W2CK[-ZB@#P?3[^'4(1+
M"X(/4=Q5NN+USP]KGPWUAK>]A:+GY7QF.4>H-;^C^(+?5(P ?+F[HQ_E0!HR
M54G'6K;GBJDQZT 49.]0FII#UJ%OO4 &*<%I*=0 ;:>HQ313EH N6YY%:UKB
ML: UK6IZ&@#4B4'FK*QU7M_NU;7K0![9\+?^12AQ_P ]'_G775R/PO\ ^13B
M_P"NC?SKKJ $I:** "BBB@!,4QK>.089 1]*DHH R;SPS87@.^!3GVKG[_X9
MV-QEHOW9_P!FNVI* /*KOX=ZC9L3:W#''0$U09=?TAOGB:11W%>R5');QR\,
M@/X4 >4VOCJ>U.VXC=#[BMNR\?6TF T@_&NJO/#-C>9WPJ?PKG-2^%]C<9:+
M,1_V: -.U\2VLW.\?G5^/4(I.5E'YUYS>_#74[/+6ETQ]C6/-%XFT=OFB:51
MZ4 >R_: >X-+YHKQ>'XB:A8MBYMI$QUXKH-/^*%M*H$AVD_WJ /2 P/>D/6N
M7M/&ME<@8D7\ZUH-8MYONRC\Z -%J::B6Z5NA!IWF"@!]-/6EW CBFT (U,D
M<1HSMPJC)XS3FZU):Q>=<QKV!WG!P>/_ *^/SI#2N[&IIMJR0P0;5$K8W!>F
MXG)Q^)-=]&@CC5!T48%<WX>M?.O#(1\L8S^)Z?UKIJF/<TJ/6P44459D%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4C*&4JP!!&"#WI:* /YGO
MVD/A\WPJ^/GQ \)E D>EZU=0P@# \GS"T1'U0J?QKSBOOK_@LE\+1X1_:.TG
MQ=;Q!+3Q5I2/(RI@&YMSY3\]SY?DFO@6@ HHHH **** "BBB@ HHHH ****
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M@>E1_%P@+X*3NOAJSS^)D;^M<!0 4444 %%%% !1110 4444 %%%% !1110
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MKKEF<V>JS+CIB0T^%?B-H;9L];O1C^[,W^-5[?NA<A^T*3QR<JZM]#7YE?\
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MX'--F\N.(L>N*+CY3G+C$<)R,#%<??2;ICD\>IK<\5:ND:E5./>O/[K6!(Y
M;+4S&3L;,E]':J3OS[5E7VL3W:E8CA>E9RQO<2\Y(SQBMFQTEI%!VG\J9#;9
MY]XFT.;4(W#,2I%+\&89-'O+BUD.1NXKO=2\-DPEAD=AS6'HVCC2-4,F[YF.
M:ZT^:%CA<7&HF>HI)E1@AN*MLOF0\\'&16=IL@F !/.*U-I6(_TKDZGI;H;:
M2)R"O(K3@F^4J3FLJW3:Q [\&M.!3"0<9&.,4I%0,^^M);>;SHQ\OH.]6[&\
M\]1GK]<5==3<1_,,>G%94D#6T@91QFEN4URNY>G;K5=<;C[>]/:3SH>6VFH(
MV*R<G@FI"^I:4GL?K1)W/4_6FF4KDGY?2EA'F4%B02%6SVZ#-:+J)K*96&<K
M4"VX)_6IXAB-USC<"*ENXTC\WOBMX/O+;XR>)Q:P11Z7-,)FDEN%3+$<D D=
M\UY]J7PSU229GM)K>Y<C)5+F,L?;&:]@^+WP1C^)W[1&I>';C5$T74[RS-W8
M277F^5<!.'0;6&U@/FZ'(SZ5PWB'_@G_ /$;3&9]'U73=753D*E\8Y#_ -]*
M!^M?5QS*$:<8-7LN]OT/S^MP_4J8F=93Y>9_RW7X._X'DMY\./$4=U(9;62-
M0?XAP,^]4U\ WD,F^ZD2/V+"MKQ=\$?C#\.())=3T+64LTY,]NIGB'_ HR0!
M]:\YD\5:NK$3Y<YP0<Y'_P!>CZ[A9:RB_P _R.VGEF90THU86]+/\3K5T$P.
M2&5E7J0,YI&TI=_SAAQ@$#BN6'C"[212Z-Q[U;7QQ-\VRW8YZFNB.-P=NWR$
M\NS2+WO\S>70_,4N6"KG('0GTQ39-!9AEX%9&/\ $/\ "L!_'$FXEH"ISD\X
MJ%O'D[1[1"<?WBU3+&X+O^#-J>"S1/7\R_>>$8)& 1=C-TQQFL2^\+R6K$I*
ML@4\]C3Y/&5ZT@("^PZXI6O]3G59GMM\?4[APPKS*LL'6OR1=_)'NT(XVE;V
MLE8L>&-)GM;>:^DB8+(IAA##&_G+,/88QGWK0:_EMT;:C;3P=QXK*U#5M2UZ
MS>Z>XN6\G".6!$<:]E!'"CVXK&^=E^:0N3R/FSBL88F-&*IT_O!X*>(J.I6:
M]#H)->E.-[ (!]T<<]J=_P ).L*!0,GH,G/^>M8$-@]Q)C@#.3DUT?A?P7)K
M5X-GEL%=49I6"J-S!1U/.,TUBJ_Q7LO,VE@L-%6<;D9\2"2V<D-&1SNQ[4NC
M^#/$'C2.>^AMOLVEPC=+J%X3%;H/]['S'V4$UW^A^#] TG3W\1ZE/<RQ)YJ+
M9_9O+\H#&R9#(,2'AF"$#(SW%7?#_BSP+>N\&M^(=6U#SLJO#0*<C WL2V .
MO _&N:IB?K&DIZ(2HO"_P:>K_ H^!O@SX$U.=%USXF:>TI/-IIJ$$^WF2[0#
M_P !KZ#\._ OX=>'46XM=(_M5#@I<7\HG!&/3.S]*\FNO"?@3P[]B?4=+U[Q
M!<W),]C9VVGF.&ZBS@?O"79P".VT\]JR;/Q%+H>I7ME>E]"CU*4SP:"L_G+
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M4J=I8L3CW) _X#7TA7BXF?/5DSU<#35.A'2UPHHHKF/0"BBB@ HHHH ****
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M5?N8WW/C S69XG#KX+U")6 \R,*#[$B@9RWPYTQFT^WNI\A&4"-2.WK7TO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5[OIUPVC_  N;>NS;:YY]^:\K\"^&T\2:LR22;4@42F,#F3Y@
M,#\Z[GXK>)(;71X](MV_>2D%QZ*/_KUQ5_?E&"/M,CE]2PN(QTW;W7%>;?\
M2/5-':_D;P_(WG'X=M\-KK[61N^Q^9Y4_G;OX?-^V[<?Q;O+]JXKX$Z'%X+\
M.^+O%.J>']?U'7(4M-,L+/2<07=I'>I(6O07BDP#&FQ&"<F8$$'!KQ-?$&J1
MZ,^D+J5XNDO)YS6 G<0,_P#>,>=I/'7&:ET_Q7K>D7WVVQUC4+*\\H0?:+>Z
M>.3RP  FX'.W  QTXKM/C-]3W7P?X?NO@G\4O&][!K=Y-X>\"9O,+*T2W5XV
M%LX)$5L;_-8;QSQ#)V%?/M]?3ZG?7%Y=2M/<W$C2RRN<L[L268^Y)-(;VX:*
M6(SRF.9Q)(F\X=AG#$=SR>?<U#0(**** "BBB@ HKT;X!Z?:7GCV6YNK2'4&
MTS2=1U.WM+A \<L\%I++$&4\, ZABIX(7!XJ]\7)!XB\"_#[Q9=P01:]JT-[
M!>RV\*0BZ$$X6.8H@"[B'*$@<^4.^: .4^(/B*S\1WFBO9%S'9Z1:63[UV_O
M(XP'Q[;L\URU?1GCGX9^'?#GAVPT:QOK?4KOP6MOJ7B^S%FT5Q.\\D2RK%.3
MATB#1Q!?EY+,-V3BQ\=CH]Q\+9M7;5-!U:'5M=)\)1Z1I[6DUEI\:N)DD!BC
M^0%H$VY?YT<ANI(!\UT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'M?[%_PG?XT_M/?#_P ,F)I;)M2C
MO+[:,@6T'[Z3/L53;_P(5_1[7Y/_ /!$_P"#OVC5/'/Q/O( 5MT30M.D9#]Y
ML2SLI]@(A_P(U^L% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0]1E^'4RD^5<*U4YO NIVXR%WCU%<?HOC?5SJ$$9N2RLW->XPZI.NCB1_F;
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M+]0:]4HHKA.P****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/+'D^Y/O7:1H(T5%&%48 K..KN;2]U<HZBBBM#$**** "BBB@ HHHH ****
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M_CZG_>.ISW7<$_X!7NM%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 9/BSPS8>-/#.JZ#JD*W&G:E;26L\; '*.I4]>_/
M'O7X7_%7X=:C\*?B)KWA+4D876F73PB1AQ+&#\D@]F7:WXU^\U?!?_!3CX&_
MVAHNG?$[3+?,]B%L-5V+UB9L12'Z,=F?]I:B2T _.%<D9/6E88SFGX ;D9P.
ME-*_+@="<UB,,': >O6E4Y!]Z%['/4X%._BQC@4"$[@#H*7'S#G)ZFCC@'ZF
MCCDC+>E( +#D^U*>V1QC)IHPN .@ZT-T Z$TQ@<^AR>].5AGGL.E(>V.@XI
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M$WC.\BU3Q?9W4.FPMY@BSL$A'09')^M?>'A_0+71=/BM+*WCAMH1M5!_" ,
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MNEMH5';KC%?.DEY%H]C]DD7,BL0ZCCG-:K4QL%UJD,=G+-(O+8VL.#5_PCK
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M_?[]D7X P_LZ_!72/#DNV77KA1>ZS<@@^9=NHW*#W5  B^RY[U\!_P#!*/\
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M[A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!4-Y9P:C9SVES$L]M/&T4L3C*NK#!!]B":FHH _F^_;"^!,_[.?[0GBOP:48
M:;'/]KTR0X_>6<N6B/7L,H?=#7C%?LQ_P6+_ &>F\<?";2_B?I=J9=4\)O\
M9[_RP2SV$K@;L>D<A!]@['H#7XST %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %='\/%#>+]/W#(#$_\ CIKG*Z3X
M=L$\76)/JW_H)K.I\#._+_\ >Z5_YE^9U7QN<?;M-4?W&/\ *O,:]*^-DR2:
MCIX4<A&Y_*O-:SP_\-'I<0.^9UGYK\D%%%%=!\\%%%% !1110 4444 %%%%
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M<:S=Q6L .YCRQ'"KW->Q:?81:99Q6T(PB#'U/<U,G8VA&^I9HHHK(W"BBB@
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M\S/=O G@G1_AOX.T?POH%HMEHVE6R6MM"O95'4GN2<DGN236]117*=04444
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M57(;^$*!^5<S2HKEII%YM5]MCJL_/\M HHHK8\D**** "BBB@ HHHH ****
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MX[F.)GBP>.HJJ+<GJ3B%&*]UGD^G_LZ_:[?>T1SC/2N>\2? VYL5?R8&)'3
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M4_G6:'N.* - M2;J92T /W4UI-JTW-0R29H ;-)M7K69/+UYJ>XFZXJA(V:
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MO$L:#"*, 5"]YW9M)\BLA]%%%:& 4444 %%%% !1110 4444 %%%% !1110
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M0!/NHWU!YE'F4 3^9^-&^H-]&^@"??[T;O>H/,H\R@"?=1YGO4'F4;Z )]]
M:H/,HWT ;NDC;"6[L?Y5?W>]5+=?)@1/0<U+NH G#4[=ZU7W5)!&]RWR_)&.
M"_K[#_'_ .OA;#2;T0^,M/(8T.-OWG[+[?7^77TSK:;I[7DBQ1C:H^\WH/\
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MINI'WEU377Y_H>,4445U'R04444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU)@/OIV]1V]*B4>P'XM[P,GO3MV,D]!78_%_X,>+/@9XLFT'Q9IDEC<+S#<
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MM_=INJ*.XO+R98H4^9CP *CT[1;VXN!&@!C[R]@*[73]-BT^/:@RW=SU-2]
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M=KOAVRO)L8\UX@'_ .^AS5^#7%7'/%:]KJ$5TH*%2?2LG%HT4NQ\[^*/V#?
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M>'[K2-:M([RPG&THPY4_WE/8CU%?%?Q#_9MNO _B1[,70EL)3OM)V5LLA['
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZUV\6V6>_:46\(@BWQH2L80(%SCD!1W[\]>:P:*=V*R"BBBD,**** "BBB@
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M7Z-7+ZAKEY;W C33I)(R?]9O  J3^TAM!D=(CW!/2NFR6B/.?-)W9THU./\
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M "BBB@ JCK.B:?XBTZ:PU2R@U"RF&V2WN8PZ,/H:O44 ?+WC_P#8OLUE?4?
MUZ=/G!WC3;QRT1/HDG5?QS]:B\#7>N>%YUTKQ%8SZ?>1?*/-'RO[JW0CZ5]3
M57OM/MM2@,-W;QW$1ZI(H8?K6D9M'/.BI:K0\\M;Y+B)"IY^M070$WWN1743
M> [:%BVGR-;<Y\IR67\.X_6L/4-$OM/W-)$S+_?3YA5\R9@X2CN5K6-(R,#
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MB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#%\0^$=-\31D7D&9,869.''XUX?X_\ @7J5JLMQIJ_VE"!G;&/W
MH_X#W_#-?15%;0JSI[,B4%+<^%/LLUI<-"R,&#8*L.01V-<3\3M:2.-+3H6X
M(_G7W_XC\ :%XJ)>_P!/B>X*[1<(-L@]/F'-?,/Q>_8[US4]1EU#P]?PZC $
MREK<GRY5(.<!NA'I]/>O7P^+IN2]IH<52E)+W=3Y:\%:*FH>.[5E *QG>=M>
MU:YJ'RF&!?+CZ>YKB?AW\.O$'A?QE=C6M*O-,D5"H%U$5S@\X-=[J&EENHKN
MJRC.::=R*<7%69Q<T<DDGRCV.:JR7R:3\N_]ZQQ\M=!J2K80,P'S]JXE+5KZ
M^+N,#-*$>97*;MH=EX2\97.BZ@).'W?G727VN:?K=P9KA@DC=C7D'B"X-JP\
MLE6' (JKIOB*_@&9!]HC_NL*4J%_>3%S):'K&H:#&Z[[<A@>FVN;O/#-_NR
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M17-*3EN;I);!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *SK[1(;S++^ZE_O*.#]16C12W&FUL<9?:;+9MMFC
MRF>&ZJ:L6>N75IA6;[3&.-LA^8=OO?XYSZUU3*'4JP# ]0165>>'X9LM"?)?
MTZK4<K6QKSJ6DBS9:Q;7V%1]DI_Y9R<-^'K^&:NUQM[I4]J")8]T?]X<J:DM
M-8N[1A^],T?=)3GOV/4?J/:GS=P=/K$ZZBLBS\203;5G1K=S@?WER?<?S(%:
MD4R3QAXW61&Z,IR#^-5<R::W'T444Q!1110 4444 %%%% !1110 4A4-U%+1
M0!&T*M[54FT]9,_+5^B@#G+O0(Y<_*#6!J'@^.;/R#\J]!V@]JC:W5J /$=>
M^&D%Y&ZM"K ^U>->+O@"8;K[?I,DNGW\?*3VS%&'XBOLF;34=3E1^%95YX>B
MG'* T ?&%G\0/$W@N06WBC3VU.T7C^T+1,2@>KIT;ZC%>A:#XHTSQ/9_:=,O
M8[N+^+8?F0^C+U4_6O7O$'PWM=2C99(%8'U%>)>+OV>7L[PZEH<TVF7Z<K-;
MMM/T/J/8T =#YGO1YGO7F\/C/Q!X3N%L_%&FR7,6=HU"RC);_@4??_@/Y5ZG
MH_AW4=<@CG@MGCAD 99+A3%P1D'##=^E TF]BIYE6+&SN=2D\NVA>9N^T<#Z
MGH/QKK]+^']O!M>^E-RV/]6GRI^?4_I]*['3])9U$5I;JD8_N*%45'-V-%3Z
MR.*TOP']V2_FSW\F'^1;_#\Z[#2M'6.-;:QMUCC7LHP/J3Z^YYKH[/PY''AK
MAO,;^ZO K6CC2%0J*$4=E&*7*WN/FC'X3,L= BM\/-B:3T_A'^-:M+15VL9-
MM[A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M% !1110 4444 9]YH-C>Y+P*KG^./Y3^E<3XN^&NIZE;LFEZFB*>L5PI&?\
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M_=KZ#L[*WTZUBMK2"*UMHEVQPPH$1!Z #@"IZ*S<G+<H****0!1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG]*TH;6&W&(HDC'^RH%:J"6Q#FWN<!9^&]0NL;+;RE_O2?+6U9^".ANKC/\
MLQ#'ZFNJHJ[$<S*-GHME88,-NH8?QL,M^9J]113)"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB;RR&ZD=?I6K;R>8A4$#^(9K[X\1?\$@YHY/,\/_ !-W+VAU+2]O_CZ2'/\
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M %BT;:MK-[J&W[RVEM%; ^W.\X_&O5_"W[$?P:\*D/'X/M]1E'_+34I&F_\
M'2=OZ5A*%+O?Y'13K5H[*WS/Q=\(?$36=6NHK2TT?4KN[DX6&UMGE9OH%!-?
M8?P<^ 'QG\:0HW_"%7FCV$J@M+X@Q9C:?]A_WGY+7Z?Z#X5T7PK;B#1=(L=)
MAQM\NQMDA7'T4"M6N1T87ND>BL94Y;-(^4/#?["UM?:;)9>--=.HZ;,FV32[
M-28_?$C\C\%KUGX4_LM?"WX*QQ?\(IX.T^RNXQQ?3)Y]R3GKYCY8?ABO5J*U
MBN561Q3DZCYI!1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUKJEI);R#'7Y7 - &+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !17L?PN_8\^,_QD\B3PK\.]:O+*9@JZA<P?9;7GOYTNU"![$U]??"W_
M ((I^.M:\BX\>^-=)\,0$YDL]+A:_N,>FXE$4^X+8]Z /S>KOOA9\ OB+\;-
M2BLO!'@[5O$+R-M,]K;-]GC[9>9L1H/=F%?MS\'_ /@F'\!OA(T%S)X:D\9:
MK'M/VWQ-*+D;ASD0@+$.?53]:^I]-TNST6QBLM/M(+&SA&V.WMHUCC0>@50
M!]* /R8^!O\ P19U[5#!?_%7Q9#HD'WFT?0<3W!Y'#3L-B\9^Z'^M?H7\#?V
M/_A+^SM;K_PAGA"TMM1_CU>]S<WKGGGS7R5Z]$VCVKV:B@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/ %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>heartflowlogoa.jpg
<TEXT>
begin 644 heartflowlogoa.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X0]N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(R   R,#(U.C R.C T(#$U.C T.C(P  $
M : #  $    !          @   $$  $      0   0$$  $    L     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   !4#@        @ "  ( /_8_^  $$I&248
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M^KS:CX?N9O+DMIN/?:1G&=N2&&.G(]?0_BE\1/\ A%_ ]M>Z5(OV[55 LV8
M[%*AC)@]< C\6%8&J?!WPK]JM-.U3QEK3SW,F+>WN+R-B[ $\ KZ9Y_#O6-\
M>?"TFF^#_"S6C22V6D(;)G?EL%4",<<?\LR#[D4 5O#7P7U/QKI=OXB\2^)+
MD27T?GQ1@>:^UL%6+,<#(YP!Z<UROQ*\/^*O \%EHU]K4VH:.[M+9S<KM8##
M+R25ZCC)'?UKZ,\!>)+#Q+X/TR[LYHBZVZ)/"C<Q2!0&4CKP>GM7D/[1/B;3
M;T:9H-K.D]U;2M/<>6P(BRN I]SG./IZT 3_ !FEDB^%?@YHY'1BL62K8/\
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MQY:;P<AB 23R.F<>N:].U/3;/6--N-.U"!9[2X0I+&W1@?Y?7M5NB@#Q2_\
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M<E)'0B!865H@!^D  @ $ !4  P ;86-S<$U31E0
M             /;6  $     TRUL8VUS
M                                   -9&5S8P   2    ! 8W!R=
M 6     V=W1P=    9@    48VAA9    :P    L<EA96@   =@    48EA9
M6@   >P    49UA96@   @     4<E120P   A0    @9U120P   A0    @
M8E120P   A0    @8VAR;0   C0    D9&UN9    E@    D9&UD9    GP
M   D;6QU8P         !    #&5N55,    D    ' !' $D 30!0 "  8@!U
M &D ; !T "T :0!N "  <P!2 $< 0FUL=6,          0    QE;E53
M&@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:(        /;6
M  $     TRUS9C,R       !#$(   7>___S)0  !Y,  /V0___[H?___:(
M  /<  # ;EA96B        !OH   ./4   .06%E:(        "2?   /A
MML1865H@        8I<  +>'   8V7!A<F$       ,    "9F8  /*G   -
M60  $]    I;8VAR;0       P    "CUP  5'P  $S-  "9F@  )F<   ]<
M;6QU8P         !    #&5N55,    (    ' !' $D 30!0;6QU8P
M   !    #&5N55,    (    ' !S %( 1P!"_]L 0P ! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\( $0@$N!M) P$1  (1
M 0,1 ?_$ !X  0 " P$! 0$!           !"@(("0<&!00#_\0 ' $! 0$
M @,!              $"!@<#! 4(_]H # ,!  (0 Q    'OX
M       #\GR;\0^O]3Q7ZOU?(_I?2\Q^A]#S[W?=^,]KVOF_/['Y7E\WY^O)
M_I'['B\?Z_B\7U_K>O\ ;^GZGI'H^AZI\_YWL7R_E^X?)^/Z;Z'H9
M                                  'GGM_3\-^GR7QSZ7(?*??^YYM[
MOV/A_:^E\C['O?A^7V_Q_+Y_\J_MQG]?Q>O]'X?3^T];Y_WWJ_*],]'XWK?S
M_A>T_-XY[C\OC?[GC\
M
M
M
M
M
M                                ^1]GSZJ<C^]JSR/[VM7WON>&_6^M
M_+=A=&DT4H*EF7*6"%A9EE2_8^KZNQGP_A;/_ X[M5Q[C>P7QOA_[0
M                              ,3POZG)-4/O<XUD^YS36[[/+_@/=^J
M        /Z,8]J^9QS97XO#]H_A<)VM^#P?[GUOG@
M
M
M
M
M
M                                                  >?>[[.DW+>
M2:4<LY+K/R#[G\VMQ-1;*RLRSFH6E-)HT 5+,UE$$6Q+,LJNHE^X]3T]Q^,<
M4W:XIQ#:SCO&_P"J0                                 ?Y&LGV^9:1
M\G['TTY)V'YM[WV            !_MG.Q?QN([J<9ZZW=XSUQZ=Z7QP
M
M
M
M
M
M
M /YM-/.4?>Y\<WY5J/R;[_\ A=RUB0U*S*MAJ%E96<V94+2KMFF@"I<IJ8@A
M869J1=8KZ%Z/I;Y</X5T'X9P?U7Y_P X
M   >>>W]/G_RWM+03EG:7F'N_=@C2*              _P!<S:;X'".@G$^J
MMTN-==_WYP
M
M
M
M
M
M              /Q?+KG]S?DO-OGG+?*OH>^65+#4K*FH(:E9E742Q;*RN6=
M(0M*;310"IK*68@A8:F60U_M&Y?%^)],>!]>[&?$^&
M           /#?J<AYH\U[?T=Y1V3_#OS&BIK*)RBHTB@             /1
M?1^1T:X;U'T+XCU3]-X?4
M
M
M
M
M
M                       'YN[SRYUR/F1V%ROX+W?<A32:9TE+*EA9:R:A
M86%EJ1-1;"RLRS-3"%IHTFB@%364LQ!"PUE*4NW/&^,=5.O.MM@?C?%
M                      'C/TON\K^>=T:4\E[%_P [H I2FBIK*)B"-(H
M            ?6^KZ/2OA?3G1WAO4?[?C\
M
M
M
M
M
M                                   &E_+/L<E^S>7>2?3]V&BRT6&C
M14TSI+*E+#4KDU"PL+*RIJ)8ME9FLI4(6FC2:* 69J99B#%364O^AO=Q#AG5
MSKKK;T#T_3                         'R/L>YRRYYW)SUYCVG_)ORH33
M-* "E-%-3+.4D5%10            'HWH?(ZN\"Z-WJXOUIF
M
M
M
M
M
M                                               >8_0\_'WM/EFG
M_*?L0U*PU#6*FBRT:A314TSI+*E+#4KDU"PL++4AK%2RN4U,K(+31M*4 U,L
MYLD&-U,OTWK^OU8Z\ZWZ%\*X1_M                        @T5Y5V'R0
M[$[O^)]KZ0-%*$)IFE !2FBFIEG*2*QI0            VC^!PGL3UW^?_9/
MG?!
M
M
M
M
M
M T"YO]CD=VARCYWS^5*FC134-%AK%3134M0IHK.TJ65*6&I:E2PL++4REQM+
M*Y34RL@M-&TI0#4RSFR08M;1<?X[V<ZNZK]2^?\ /
M   'POM>_P ;^R>]-.>2\]!HI04I2A*E9I0 4IHIJ99RDBL:4
M/U_#X.K' NC>CG#NI/\ 4
M
M
M
M
M
M                 ^8]C7&_M?DVDW+_ *ZU:4TS4TE-&H66H6&L5-%EHU"F
MDTFDJ:D*:A<FI6%A8:R5*7&TLM92S*R"Z72:2E -3+.;)]-X/7[']8=6[L<4
MXJ                     -3N0\PXN=F]\_!^U],JZ2@&BE!2E*$K-2E !3
M1319S<H&-12@          -M^.\#[0];?G?[CUOG@
M
M
M
M
M
M                                   >)?8]CAWW'R?R#ZOM%3:4TI:5
M-)4TFBFBFH:Q6&BFI6&C14TFDJ:D*:A<FI6%Q4UDI8EBZ&34RS*R"Z72:2E!
M2SFY'2/@G ^L'777/]68                   ,#F1SKM;E?V!W#_CKR%0A
MD4T4 T4H*4I0E9J:  *:*:+.;E QJ*4         !Z1Z'R.WO6/YMV+^1Q0
M
M
M
M
M
M                                                    #4/E7N\3
MNW^2_.>?R%A9"E3;.EJEI4TE32:*:-%AK%8:*:EHL-%32:9IJ0L-2U*RL+BU
M*RI8:B5634RSFH"Z-&DI04NW'&>,]L^J.J?I?!X0                 !^7
MOR<9NS>[]&>6=A2N30*:*ADA=)2@&BE!2F@$K-30 !31HJ69<H&-12@
M   /U?%X>S/6WYXWBXSUP
M
M
M
M
M
M             !H+SCZ''/MG[O\ +O:5*SJ&I:@D*5G9HJEI4TFF::*:AHIK
M%8:*:EHL-&DJ:9T60T4U*E+BU*RI8:A2Y+,LYJ%I32:- >\_&^-W8Z@ZC^_]
M/U                 !\MY_9X<=K=]:O_?Y;#4+"ER:E04T5#)"Z*E!2E*"
ME- ,U*F@ #1314N4LQ!%1H        /],NLO7_1'2?AO40
M
M
M
M
M
M                                     './L#W^1O:?V,;HILT5*S4W
M"FI 5-)I-+5+325-,TT:*:A8:A8:-%-2L-&DJ:9T60U"RU*EA8:E9E6Q-1;*
MRLS4Y(6E-I37KOS/E]X^GNH?4/G^B                /B_9]SA%VWWYX!]
MCDA311#4+"ER:E0:*5#)!I:E!2E*"FB@,U-)0 #1314N4LQ!&D4       !U
M!X)TKU/X-TJ
M
M
M
M
M
M !SC[ ][D9VG]2+H&BFH:EHT5*SJ)J6H60%32:32U2TTE33--&BFBXM0U"FB
MRU#132:9TE+(:A9:E34+"RLRKJ)8ME96<V94+2F_5/F_/[V=.=0>H?/]$
M            ?B^7R\$NW>_-=OM<D-&C12FBB&H6%+DU*@T4K)"#12@I30!3
M10A*FDH !HIHJ:RB<HJ-(H      #I[P7I;JGP7I0
M
M
M
M
M
M                              #0#G7M<;^VOI0T:-%*#131HT:*E9U$
MU+10"II-E*I::33-3131J%-0L-0IJ5-0T4TFF=)2RI8:E94U"PLK*IJ%BV5F
M69J80M]4^=Z'>SIOJ/U#Y_H@             #_*N)?:G=>E'*N<)60*:-E*
M4T4L+"PIK)94I2E9(2K4I04IH IHH0E324 %*4T5-91,01I%      =7^O\
MHOICPOI\
M
M
M
M
M                                                        #3WE
MOEX<=T?0_FUMG64T#1HT4H-%-&C1HK-3431J5 *FDVE6M#14TS4T:*:A34+#
M4-%EHIJ&BIIG265*6&I7)J%A865E4U"Q;*RUEFH]4^;\_O7TYU)ZC\_T@
M          .4_879_,7GW:$K(:2I60*:-E*:*4L+"PLM2LJ4I4J$)5I4H*:*
M :*4(325* "E-%-3+.4D5%10    RR[/=;?G??#BW68
M
M
M
M
M
M                              '@_P!S7 7O7W?P?/8:-&HFISI-2&C1
MHT"E*:-&RE9J:B:-%D!I-)HI6AHK.DJ:-%-%AJ&H6&BRT:+#14TSI*65*:++
M186%EJ0UBI97*:]4^;\_O;TUU+ZA\_T@            -"^7\VXR=G]Q1E&M
MKJ+J5D-)4K(&C1HI312EA<5++4K*E*5*A"4JZ0"FB@&BE"$TS2@ I3134RSE
M)%8TH   ?H^+Q=Y.JOS!LW\7AX
M
M
M
M
M
M            'R/MJ^/?7L>4_3U#4M2LK#1J&ISM-3*4IHT:!2FBFC94J5-1
M-E+(#2:37]F9^GXY_/K7YGDW_GK3.DJ:-%AJ6H6&L5-%-2U"FBL[2I94I8:E
MJ5+"PLM3*7&TOJWS?0[V],]3^H_/](           #6'[W(N#_;W=OYWD\J:
MC-2B-;B[FTLAI*E9 T:-%*:*4L+BT65E94I32/\ 7./U_#X/Z<Y_/WYORO)[
M0!HI04I2A":9I0 4IHIJ99RF(TQI0  ^\]/Y=@_J+\J>B^I\H
M
M
M
M
M
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MKR/"[*"E*4)4K-* "FBFBSFS$D5C2@!L]\'A?>GJK\P_TS(
M
M
M
M
M
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M>8XW104I2A*S4I0 4T4T6<W*!C44H=3>!=)=0^$=,
M
M
M
M
M
M                          >0?7S7B_0/A_&\EE31HIHJ:34RS-0T:EK)
M84IM-1-3-3*4T:_UEW/XAZO23KWY^S''?7          ^=\^]"N:_9YM=@<@
M\K^C[::*:*:AK%8:*:EHL-%32:2IJ0IHU*RL+BUZK\WT>]W3/5?J/S_3
M     _CU>%';O<&J7(N2S+*EBZB65EHUBT60K-B5*MBZ7:ZD*5FI4>B^E\[H
M]PGK?H!P[K[ZWU_5          \6^E]SF]S7M;0OEO9/YOD\Y2@I30"5FIH
M IHIHLYN4#&O[<^.P+U)^5???E<9
M
M
M
M
M
M            P."O>_J:K<IQ#4S26<ZE31HIHJ:34RS-0T:R:E84T:B:F;2[
M=\5\'6'J[T/=?B^(           #^/3G_P X^WRT[(Y'\-[GL,TT4T:A36*P
MT4U+18:-)4TS34AHIJ5+ZI\[T>]O3'5WJ/S_ $P       !_E7'3L_L[0+F/
M-H(6%F:D+#4+*RT:Q:+(E2Q*E6XW<ZT:D^I];U>G_ .L.B?"^O/U?'XP
M       /,?>^KRLY[W'HERSL?&Z*4H*4T E9J:  -%*:2S+E&P'R.*6 ^IOR
MQ_5,@
M
M
M
M
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M@ &BFBI>O77G0?1;A_5
M
M
M
M
M
M  'X?GS7/_1'RO._HYQ:AJ&BPU"PT:F6<Z2RT4T:*:2IK*:2PUNKP[/9#J/U
M_KO4@               U&Y1]'C!VWRGX?W?.:2II*FC134+#4-0IHLM%AHT
MFDK.BR&O5/G>EWNZ9ZQ]1^=Z@        _QKCIVAV;H!S/F94N4U,00L+,U(
MNL52RLM0W"ED^G]?U^QG6/4F[G%>'               #\7R>;D;V+W5S[Y?
MV<4H*4T 4T4(2II*  :+]=ZWHV,^F_R7]?X/2
M
M
M
M
M
M                   ',/L[T.5W:7SH:Q:+#4-0U#18:A8:-3+.=3*:-%-%
M-?ZYUU>ZLG2_KCQY                 \X]_P W#WN+E>O'W??4M-)IFIHI
MHL-&H6&H4U*FC4*:33.DI?5OG>EWMZ9ZS]1^=Z@        _RKCEVAV9H#S/
MF@!4UE+,00L+,U(:QM2RLM^S_*^1W(ZFZ:]?^;\L                #0+E
MW8W'SLCO'\_7F6I2@I30!310A*FDH +TKX3U!UEX#TB
M
M
M
M
M
M                        !\M[6*X_Z,^#\M[2%@A<5AHU"PU#4-%AJ&H4
MU,K.IFI4U^AX]=K.FKNQPP                 !^)YKQ*[?Y3I_RGZA2J71
M4TS4T4U#134+#4-%-2IJ&BIIG7JOS?2[W=,]:^H_.]0        ?Y5QS[0[*
MT YIS--% *FLI9B"+8FLI2EV8^#Q_N5U+T[]9Z_K@                 :H
M\@Y?P^[4_07SWF]M"5:5*"FB@&BE"$TE2C]CQ^O8XZ:_)OH'J?-
M
M
M
M
M
M                                ',3L[Y?+3M+Y<-0U"PU"P0N*PT:A
MJ%AJ&C4+#4*:G-_2\6^Y727EVZXGH                  #\_=XE]P<FTSY
M;]-*FRE:&BIIFIHT4U"FH:A8:++4-2L-%]4^9ZG>_I?K;U'YWJ@       #_
M "KCGVAV1H!S3F)HTFB@%F:F68@Q79CX/P.[O4/3O[?B\8
M    &N/VN3<(.VOT3\Y['N)4(2E72 4T4 T4H0FF;TLX3U!UDX#TF
M
M
M
M                                  /%31Y-1$UR/&4\T/RS _2/33VI
M=E#;^7>1?6Z      'ETFMUH   ^FC;R@
M
M            /R_+FN1^C>,?#^]C%84U#4-0U"PL$+BL-&H:AK%31J%_VSKM
MWTI[6ZG#/(                   !^?MQ*[@Y+IIRWZ8-)I-%6J-%9TE31H
ML-2L-0UBIHLM&H7U3YOJ=[^ENN?4?G>J        /\JXY=H=D: \SY@%IHVE
M* :F7U?YGS; 73/3'VWJ^J                   !J]][E?"/MK]#?F>3V"
MFD(0E*: *:* :*4?2^OZ=D;I7\F?2^'U@
M
M
M
M           !X/)R&LY9)JC8@     9UM[+U-7KI->UT    !R?2KFP   -K
MEN?-@
M                                            :(<\^9QM[DX_#1J&
MBXK"PT:AJ&H6%@Q6%AHU#4-8M=;^IO<Z2]<>P                    !^?
MMQ*[AY)IIRSZ<+(#2:31I2C16=)4T:*:AHL-8J:++7JGS?4[W=+=>>H_.]4
M       ?Y5QR[1['T YKS"9606FC:4OT_K^MW]Z8Z<]L^5\L
M        #1CE?/N*W:'?$6RI2FD(0E724 T4H!HO7CKGHKHQPWJT
M
M
M
M                              :Y2< +.5=S_'         _1.KK7?E=
MA5    Y/I5S8   &URW/FP
M
M ."/?G$];N2>G#1J&H4U#1<%-0T6&H:A86#%8:AK>/@_M]K>E_H
M             ?G[<2NX>1::<M^E$T65!2II-%6K2II*FDIHT6&BPUBT7U3Y
MOJ=[^ENOO4?G>L        /\JXX]I=C<_N:\NR:F696077]6)W1ZAZGVUXWQ
MX                     #D=V+W%S=YOVD65E94I32$,BKI* :*4>X_)XY8
M?Z=_+P
M
M
M                                           _@DX-6<(6?Q0
M     ?NUWTF^Z$?UV@  <GTJYL   #:Y;GS8
M
M               \<^SZU>G]#\*Q6&L6H:A34-0T:A87%34-%AJ&H7%?4?E^
M6PM^?/L_2^MH                      ?G[<2NX^0::<M^@FHSJ6H4LA2I
MM*:4M*FDJ:313134-8KZI\WU>]W2W /4?G>L        /\JXY=I=B<_N:\NA
MH9-3+,O8'J_K?H?PGAX                      _-WNOSW%^C/!_K\BQ:A
M2RN30*:*A#(IHH!HM@KI_P#,.PWQ^-
M
M
M
M      #S&2JO<Z$H            +$\WW%M   Y/I5S8   &URW/FP
M
M                                !S"[0X_S$[0X\6"%AJ&L6H:A34-0
MT:A87%34-&H7NOT7]O;'B?L@                      #\_;B5W']_33EW
MOE2IIG1HL+(4K.RFE+2II*FDT4T:+ZG\WUN]G2W O4?G>L        /\JXX]
MI=AZ <UY:6&H7H_P/A?77K/K\                       :_?8Y!7X[B_1
M?\^O(4UBL*65R:!314,D+I*4=)N$=3]:NONEP
M
M
M
M            /()*B=SJ\@            _J+K,WL3:  !R?2KFP   -KEN?
M-@
M                                        "OK^AN#>*_:]2%Q6%+!#
M6*FL6H:A3<+#1J%A<5W7X5]'M?TI]H                        ?G[<2N
MX_N::<N]XV4TA-,ZAJ6H)"E9V:*I:5-)IFFBPUZI\WUN]G2W!/4?G>N
M   /\JXX]I=@\_N:\ME=P>+\>[D]0=9?TR                        <@
M.R.X>=W-.RRE-"&H6%+DU*@T4J&2%UZC\_X]C[I;\LR
M           #C1)Q N0      !9_:W74                     #G/)7!N
M0      !WO:ZSJ
M
M                                       /C8I^W&HZ
M =3&K4#0   Y/I5S8   &URW/FP
M
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MW[4                     #ENE5M@       61YOM+:
M
M
M          *M\SRCN0     !^E;Z0?1R?-KYQ7YL@   %Q*;W:M   ')]*N;
M    VN6Y\V
M                                                !S^[#X_R0[>X
M=$T;BZ-8M%2XK"PT((:Q:AJ%AJ&M\N!_6['=-_?
M     _@VXD]Q_8TTY=[AHIJ&I:-%2QG2:EJ%D!4TFC15+325G7J?S?7[V=*\
M(]1^=X        !_E7QWM>?[;U/                          .3G8?:_
M-+G/9I31HT4IHI86%A2Y-2H-%ZQ]=]+]+>#]6
M     #A$E?!@       6\6]^U                      Y;I5;8
M%D>;[2V@
M
M                                <N9*K-P    !]&=0IKI9;NM+[V?U
M4!_+'@IIU9SY3F GD* #>QJX T   !R?2KFP   -KEN?-@
M
M                        <8^Z^$:6\W^%%1*FHFC<79<6BI<5AJ%$+BL-
M3-V#?SWS#V[XGL@                         #\_;B5W']?33EWN%!HIH
MT:-%2LZB:EJ%D!4TFRE4M->I_+]?O9TIPOU'YW@
M              \V][Z%<+N[]'_RZ\K(%-&RE*:*6%A84UDLKMYQOA'=3J?\
M_                            #A$E?!@       6\6]^U
M           Y;I5;8       %D>;[2V@
M
M                                                       #\**5
MMQX$@   '^M=FYKOK->KT    !^='+]."%SJF@M93?3JT   #D^E7-@   ;7
M+<^;
M                                           KJ?I#K#S[Z/K)J%C5
MQI*FHFC<7<-0J6%A8:A1LIQGZ7>3H7EP                           _
M/VXE=R?4TTY;[AHI0:*:-&C16:FHFC4J 5-)M*M:>I_,\'>SI3AOJ/S?
M                               !P\[7[LTRY3S0TE2L@4T;*4T4I86%
MA?JO7]2S)T9^5O\ 6                            .$25\&       !;
MQ;W[4                     #ENE5M@       61YOM+:
M
M
M           ..:5GV    /IRTNWTN4      #\Z3AW7)%FYTW_2    <GTJY
ML   #:Y;GS8
M                                                 \_^CZU=7](]
M4LZBZ+#2:A8U<:2IJ)LU%W%L326%A>O/3_*M_>O_ +(
M          'Y^W$KN3Z>FG+?9-&C1H%*:*:-E*S4U$T:+(#2:31?5/G>OWKZ
M4X?ZC\WP                                  #2GE/,>(G:W=D74K(:
M2I60-&C12FBE+"V+NE?S-['\WXP                           '")*^#
M        MXM[]J                     !RW2JVP       +(\WVEM
M
M
M                    %,MC4=   !_26P)OI':        /C8^RH    <GT
MJYL   #:Y;GS8
M                                                   U+Y?\/B7W
MEUN:BV&DU#1J&DL6Q;C2:B5-FXNHNO\ 3.K'/YMY_P#;>CY@
M               !^?MQ)[E^CIIRWVIE*4T;*"E-%-&RI4J:B;*60&DUZG\S
MP=[.E>(>H_-\(                                 'XGE\M:'O3]&_D
M;\T:W%W-I9#25*R!HT:*4T7MCU;T5N_Q7@H
M  '")*^#        MXM[]J                     !RW2JVP       +(\
MWVEM
M
M KA)XY(      !8'79FT                 #5)*8#    '<1JQ0T
M        .3Z5<V   !M<MSYL
M
M  <Z.RN(<L>VN"1-1-1-&HNH5-0T:AI+%UC44FHSHUL!Q[Z??'H#G8
M                       _/VXE=S>]IER_V&=S-3*4ILT4%*:-&C14J:34
M34K"R#U/YOA[V=)\3]1^;X0                                 .$G;
MG=>I?(^5QFI5L747<VRI2I6:@&C1HO43@/5/4S@/50
M         '")*^#        MXM[]J                     !RW2JVP
M    +(\WVEM
M
M        I4L:TH      !<*>3>(                  X1LU[V0  !Z$MW*
M:^XM              ')]*N;    VN6Y\V
M
M            .2'</7^A78/$U1::B:C-AHU%U$T6&C4-)8NL:BNB_6O*.K/4
MW+                              /S]SB5W-[NF?+_,:3<34S4RE-&C1
M04IHT:-%2II-)J%+ZI\WU^]G2?%?4?F^$
M      <P^>]B\J^P^SY"LV)4JV+J+M=9!2I6:@I=Y>)\%[5]7])@
M                   <(DKX,       "WBWOVH
M'+=*K;        LCS?:6T
M
M                 "E2QK2@      %PIY-X@                 "I8SSF
M9   ';EJQFT              !R?2KFP   -KEN?-@
M
M                   #B3WMU?JIR[C\36,I51::B:C-AI=0U$T:A34-)>RG
M2_.MV.#_ '                              !^?MQ*[F]K33E_FA2FTU
M$U,U,I31HT4%*:-&C14J:9T:]3^;X.]G2?%?4?F^(
M             #4SD?)>$G;O=1K%HLA6;$J5;%TNUU(4K-2[+?"XQWZZ?Z"
M                           X1)7P8       %O%O?M0
M        .6Z56V       !9'F^TMH
M
M                         %*EC6E       +A3R;Q
M  %&2X\ND   %P6;WGM               Y/I5S8   &URW/FP
M
M                           !P,_0_4/B7W?DE+#>,L2EBEIJ,ZB:AI;#
M431J&N_OYZ[+]N^'[X                              'Y^YQ([G]G3/
MEWER:E2PIN)J9M+,I31HT4%-%-&C1I":]3^7XN]G2?%_4?F^(
M                     >=>[[M;7O/OZ%E9:-XJ61*EB5*MQNYUHU(7U3YO
MRK'G2/YS                            X1)7P8       %O%O?M0
M                 .6Z56V       !9'F^TMH
M
M                                  %*EC6E       +A3R;Q
M           \SBB_?&   /HR]K/)^I0              ')]*N;    VN6Y\
MV
M                                       *[_Z4Z2^!^AZF+12E-0UC
M+$T(I;#3.HFH:6INR9^9>W/W/!L                               ?G
M[G$GN?SZ9\NV:-2U*PLM0U$TFYS94IHV4H*:-%-E->I_+\/>SI'C7J/S?$
M                             !@E8GOS]!_E>3S+J)865EHWBI9$J6)I
M"V+MK?[_ (/7LY=#?F@                           #A$E?!@
M6\6]^U                      Y;I5;8       %D>;[2V@
M
M                                             4J6-:4       N%
M/)O$                 #3]*:;    W$6Y0V               .3Z5<V
M !M<MSYL
M                                              5N_P!/]#_C^;PI
MJ&H:Q:*4IK%J)8FA%+J)4U]#ZWM61?S-VZ
M      /S]SB/W1Y=,^7ZRFDL-2U+4K"FC432;G-E2FC92@T4U#4M>I_,\7>S
MI#CGJ/S?$                               !7%[Q[R\J^A].%F:D76*
MI966H;A2R)4L9T%U:'Z#_,W],@                           X1)7P8
M      %O%O?M0                     .6Z56V       !9'F^TMH
M
M                                                   %*EC6E
M    +A3R;Q                  Y[25'+@   =.&K6C0
MY/I5S8   &URW/FP
M                                                     !6H_4OY
MX_RUI-'D2IN%Q:AHI2FL6HEB:$5Z9\OZ%AG\X=N
M            ?G[G$?NG>F?,*FIEF:34++<K*EAHTFXFIS94ILT4H-%->I?,
M\?>WI#CWJ/S?&                               *]W=7<_@7V/NS$$+
M#4RR&L;4LM2U#4*61*FK-71'YN^E\'A                           '"
M)*^#        MXM[]J                     !RW2JVP       +(\WVEM
M
M                                                         I4L
M:TH      !<*>3>(                 ',9*IC    [#-69F@
M    !R?2KFP   -KEN?-@
M                                                          "M
M/^I_SC$U#6-T;-L[-)J%Q:AHI34+#437K?QOIV"/SKVT
M                 /S]N(_=+3/F T5-3+.=&H:EJ5E2PT;349U,LJ:-&BE!
MKU/YF.]G2'P/4?F^,                              "OSW1W'KK]S[I
M4UE+,01;$UE*4N*ER:-0U"ELQ=#_ )S^N]?UP
M   !PB2O@P       +>+>_:@                     <MTJML       "R
M/-]I;0
M
M  *5+&M*       7"GDWB                 !RW2JVP   .R+5EMH
M          <GTJYL   #:Y;GS8
M
M    K4?J;\VKJ+4L34-8W1M-FV=&H7%N%*4UZW\;ZM@7\Z=N@
M                      ?G^2<1^Z)IGS"%-&BIJ<ZF4U#4M2LJ:+#<34YT
MFI#1HT:'J?S/'WLZ0^'ZC\WQ@                             "OSW3W
M%KK]O[I0#4RS+,08VIK*4L6Q*7)HU9@Z(_._UWK>N
M        .$25\&       !;Q;W[4                     #ENE5M@
M   61YOM+:
M
M      !2I8UI0      "X4\F\0                 .6Z56V   !V1:LMM
M              #D^E7-@   ;7+<^;
M
M        %;']3?FS^>Y34-+8M342XM1='D3::31K%J&H7T/YOOV'?S;W.
M                               /S_).(_='CTSYA"FC1314U.=3*:AJ
M6I65AHT:B:G.YE!HT:]3^9X^]G2'Q/4?FX
M    KQ]V]Q>%_8^N:-I2@&IEG-D@QNIEF4L6Q+9VZ$_/'[7B\8
M                 X1)7P8       %O%O?M0                     .6
MZ56V       !9'F^TMH
M
M               %*EC6E       +A3R;Q                  Y;I5;8
M '9%JRVT               .3Z5<V   !M<MSYL
M
M                 5R?T_\ F_\ !]GU2PU$VEAI;%J:B:Q6+LV;9VE-?J>'
MV+)'YA[S                                   _/\DXC=U>+3+F&)EF
M:-%-%-%9W,LS18:EK)H&H:-,[34R@UZG\S/>SI#XWJ/S<
M              "MKWQW1YS[WT&06FC:4H!J99S9(,6I7^C,M#] ?GD
M                      #A$E?!@       6\6]^U
M    Y;I5;8       %D>;[2V@
M
M                     4J6-:4       N%/)O$                 #EN
ME5M@   =D6K+;0               Y/I5S8   &URW/FP
M
M                      !7R_2OYT\Y^G\V&@4L-1-IJ%6Q=)8FL5B[-IM-
MV,?S+WO]7ZGG                                   _/\DXC=U>#3'F
M7C2S-3-3*:*:-%32:F69J%-RN30-0TFXFIFIE]3^;CO9T?\ )]1^;@
M                      ?R:M8']!]X?R;WDU,LRL@NETFDI04LRSFR?6>O
MZMF'H;H4                           #A$E?!@       6\6]^U
M                 Y;I5;8       %D>;[2V@
M
M                                  4J6-:4       N%/)O$
M          #ENE5M@   =D6K+;0               Y/I5S8   &URW/FP
M
M                                   !PC_1/YZ\'Y%QV9Y$\B:AH%+#
M<32:AJ*6LZQ:A8OD[N?GONO8#CGVP
M   !^?Y)Q'[K]73+F/CA8:364J:F4T:*:*FDLS4S4*;EK)2PII-Q->J?,QWM
MZ.^7ZC\W(                           'D/T_>KE]Z]Q%A8:&34RS*R"
MZ-&DI04OM'R?DV*.D>DP                           .$25\&
M!;Q;W[4                     #ENE5M@       61YOM+:
M
M                                             !2I8UI0      "X
M4\F\0                 .6Z56V   !V1:LMM               #D^E7-@
M   ;7+<^;
M                                               '&+O?HC4GFO"(
M;*GDF;9\D-&@4L-Q-)J&HHTEZV]-=L[U]?<T
M            _/\ ).)'=?J:9<Q\)8:Q4U,TEG.I4T:*:*FDU,LS4-2U+4K"
MFC7J?R\][>COG>H_,R                           -*^6<AX@]N=EXM2
MLJEBZA965F6<U 71I-%+M9QSCG>3I[J(                           #
MA$E?!@       6\6]^U                      Y;I5;8       %D>;[2
MV@                  #^9/*8\@/BCXPQ!]!7VD>IK["?04
M                    !_&>11Y&?(6?%P!]8?9K[(GK:_U4
M                          /EH\C/,:^33Y:/6*W04          4J6-:
M4       N%/)O$                 #ENE5M@   =D6K+;0
M   Y/I5S8   &URW/FP
M                                                        !RO[
MBZ;Y^]E]8)J&C4-&IFV?(FX;*4%AN)I-0N]O7O/.M73?:H
M                      _/\DXD=U^CIGS'P0T:+BU#19FDLYU+131314TF
MIEF:-&I:E2^I_,G>SHWT?4?F9                           Y.]D\VYG
M<_YG*RN*PU*RI8FHM+DLRSFH6E-= >%<.[']7]:
M       <(DKX,       "WBWOVH                     '+=*K;
M  LCS?:6T                #YF-';-($T_-5DU\/QD    _P!:]DEV<7<
MW47?&/8K0                           /AXT732&S40U93P*S\^    /
MVUV2-MY=VUW^-K+<P    #0B3FF@      &YB]5[0    *[DR      !UP:V
MSH     8&L,FB9IK9J<:W)Y98@ =+&K8#0          I4L:TH      !<*>
M3>(                 '+=*K;    [(M66V@              !R?2KFP
M -KEN?-@
M                                             #0CLCK3E-W/TDFH
M:C.BPT:AHU,VSY$\D-%*#4->K?&^UW__ #AWX
M             !^?Y)Q*[K^=IIS'P8M0U#136*PT69I-3FRT4T4T:2IK+.BP
MU+4M>J?,G>SHWTO4?F0                          5^.Z^SM<_N_6-0L
MM2I86&I695L-0LK*SFS*CK)UOU[TLX'PD
M#A$E?!@       6\6]^U                      Y;I5;8       %D>;[
M2V@              #R:.6=G,E-"F?PP        #*ML9KIJ=4Y=L;0
M                   /"TY6',EG1]/X         #W=>I*]=)K;B@   .'2
M5V&       .O"V=&P    *";Q@      6I&^I"@   ?XQH>G*>SF:GB:
M#I8U; :   '%J2MQ<                      6I&^I"@  #4).8R     :
MM'*YD   ;CKTO4         =.5V]4    #D^E7-@   ;7+<^;
M        ^0C3*S4--6#7H\43RD^,K\N0?Z5]"OI1ZSE[W;LH;7KN=+LG9_JH
M             Y<IJ>@   [7+Z0H                    'GDG-^M=4^@-
MVI=[*_W4                    #2^3FS8  !_:=GIOS?EG$>(7Z$_-B;-K
MI-0U&=%AHU#1J9Y&=IY(:*4=_?S?^AO5_C_4
M             _/\DXE]U_,TSYCZY36+4-0T6&H6&C4RLZRE-&BFBFDU,LS2
M:A?5?F7O;T;ZGJ/S(                         /A/<\]:SO[MC_&;2EE
M2PU*RIJ%A9695U$L6RLKW5Z=ZIV]XSQ\                           #
MA$E?!@       6\6]^U                      Y;I5;8       %D>;[2
MV@             ?XQSK3C!<\VT_@            !N,O9QKK1+]%0
M               '\4<T$XOV<];G_&           !%;UR]SVNEQ_JH  X=)
M788       Z\+9T;     H)O&      !:D;ZD*  !\[''E.)MSK:@     '2
MQJV T   .+4E;BX                      M2-]2%   '(9FL8R
M            !9S:Z\M     <GTJYL   #:Y;GS8                 T]D
MYDV<YDTSK^"0       #U->@R]*5Z5GWZ@           <D$K!,   "R3-]H
M[0                   ,#B SP L^4D &W2V>IK;BT
M   51F>9C(  '2=JV*U\U[7J5V?U)^2?\M9*SLV:7:6&HSHU"FH:-3/(SY$W
M#73?J?M3H[U?V0                                     /S_).)O=?
MRM-.8^MBL-&H6&H:AHL-0L-&IEG.DU*FBFBFDU,LYUZI\R][>C?6]1^8
M                     YX<ZY'QZ[2YP4TFF=)2RI8:E<FH6%A965346V4^
MA.E?0/2]8                           #A$E?!@       6\6]^U
M                  Y;I5;8       %D>;[2V@            ?X)RSC@K<
MZH(              !ZVO<=>TDOTUH                   '\4<FDX+W.M
MJ              #==;&<UO%: !PZ2NPP      !UX6SHV    !03>,
M "U(WU(4 #^=.0!7_9\:0      #I8U; :   '%J2MQ<
M      6I&^I"@  #D,S6,9                    LYM=>6@    .3Z5<V
M  !M<MSYL               #RXX^IR#9UB0           ?N+TP7LBO0H_U
M4          ?*R4<M8^*@  #=9;BS8                   %>]GA&R  !]
MVMOUK;10                  !Y-)1^UC\V   +4C?4A1P1_27Y<\A^YQZ%
MQJ**SLV:7:6)J)HU#4*:-SG?K?Q?O=]OS?\ H;)0
M                !^?Y)Q.[K^5IKS'U8(7%8:-0U"PU#18:AJ%-3FS-3-%-
M%-&BIKU7Y5[W=&>'U'Y@                        5^^[>P=;_O\ U9:+
M#1HJ:9TEE2EAJ5R:A86%]0^=Z5D3HCIX
M<(DKX,       "WBWOVH                     '+=*K;        LCS?:
M6T            :)25Q=9TZD                 ]R6Q UU77,
M         &@<E<.YU+0               #_ %KLM-6(IKZ^@.'25V&
M  .O"V=&P    *";Q@      6I&^I"@#71*Q":*L@       =+&K8#0   XM
M25N+@                     "U(WU(4   <AF:QC(
M  %G-KKRT    !R?2KFP   -KEN?-@              >"2<*;.0MS\]
M          &UB]VYKJPO]M          5F&>/3(  "KIN=[/V@
M        :1R4\=8Q@   ;B+<C:_U4                  #B))7.N   /2U
MO$37[-HY.=U=$:+=B]6KI-)87&HHK.S9M=)8FHFC4-0T7MKT!^@-G^)<K
M                                   _/\F>)_=?R=-^8^KBL+!"XK#1
MJ&H:Q4T:A8:A34YU,LS13131KU/Y=[W]%8]2^8
M &OWV_>KW]X]APN*FBRT:+#16=)I+*E+#4K+6]?#N,=I^J.NP
M                !PB2O@P       +>+>_:@                     <M
MTJML       "R/-]I;0          !\')75LX]W.,                  #
MH\U9CE]KM                 ^'DKG6<?KG&                 !LRMJ:
M;VMH<.DKL,       =>%LZ-@    4$WC       M2-]2% YC25@[GXA
M   !TL:M@-   #BU)6XN                      +4C?4A0  !R&9K&,@
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M:A86#%86&C4-0UBT4U"PU"IJ9J99FBFC7J?R]=[^BL^I?,H
M         '%+MSE^CG,/N&C4+#6*FBFI:A316=I4LJ4O9?JOK_?SA?&0
M                       !PB2O@P       +>+>_:@
M     <MTJML       "R/-]I;0          -&$JYL^#(
M    !Z0MG>:Z6V@               :8I5D9U\0                  #[!
M;3$UTDMX=)788       Z\+9T;     H)O&      !:D;ZD*.+*5O[C_ !@
M       #I8U; :   '%J2MQ<                      6I&^I"@  #D,S6
M,9                    LYM=>6@    .3Z5<V   !M<MSYL
M  <L9*WMSY&@                 BNJDU9#E]6M        '^24J6=;D
M]R6[?-_UT                 !Y_)1SN/GP    =?FK-S0
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M#                    /T2SY-^,U788       Z\+9T;     H)O&
M !:D;ZD+Q=2MK<(         '2QJV T   .+4E;BX
M   M2-]2%   '(9FL8R                   !9S:Z\M     <GTJYL   #
M:Y;GS8            ^+*UC/)ID                   >KK9X:Z.J
M   .#25^&   !;D;Z$*                 !QD2M<P    !]B7CF_K5
M              KEL\1V0  -N5N9M@ <2OT'^9-<.5\*BV#%%J6&L5AI=,ZA
M86+(M32;-FO>^-\J[G_G;]&_[30
M     _@WGBEW7\/3?F7HXJ:AHL-0U"XJ,5AJ&BPUBU#1HL-8J:364J:]4^5K
MO?T5OU+YF@                    !PF[GY;J1RGZA4TE32:*:*:AK%8:*:
ME34-%V*^#\RP5TCUJ                            !PB2O@P       +
M>+>_:@                     <MTJML       "R/-]I;0        !_,5
MS4XG,                       =B6K*Z_V*             .$<S7OUE
M                   ']E;\S7/ID      #KPMG1L    "@F\8      %J1
MO]B*I6L?X0         !TL:M@-   #BU)6XN                      +4
MC?4A0  !R&9K&,@                   6<VNO+0    ')]*N;    VN6Y\
MV           !K))5(N=94         '])_:OY*         #_6N^LUWLFO]
MJ       'A4E)"X_G   .N#5GQH                 "G5<Z43(     L\S
M?7.T                 ?E24>[GRQ   +&S?;90 -"^R>J>6'<O0$*:-0N-
M185-0N+4-&DL+!&K FD\G5OIGO+?7K?LL
M           #^#R9XI]U_!TXYCZ,+"XJ:AHL-PL+BL$+#4-&H:Q6&C18:A8:
M37JOR==\.BO-ZE\O0                    TAYC]+B;V]RM*:4M*FDJ:31
M31HL-8K#134M=9>L^'=+NO\ BX                            '")*^#
M        MXM[]J                     !RW2JVP       +(\WVEM
M     _C2L:G)%D                       #K0U9XFO[*            '
M F3@3<                              #KPMG1L    "@F\8      %B
M9O@NS\"@          Z6-6P&@  !Q:DK<7                      %J1O
MJ0H   \I37-0    - $KZ,   #W-;2[8         V,3U90    .3Z5<V
M!M<MSYL           :%R51[GS]      !E6U\N]R[?R[/'NR^FGUM#^2//C
MQVS7PU0328T.L\]D       ZT-6;E_64       5(V>=[(  'UJWD)KZ^T
M              #5F*7.O&@     = %MV-@                #F1)5*N
M /UB\+/)ZC0 'QWO?/K]_IS\?_Q^3Q000IHU"XU%A4U#6*Q:FTL-08ZG[OK>
M[WA_.'Z>]2^/]D                                      #^#>>*G=
MG']..8_/AHU"PN*FH:-0U"XM000L-0T:Q:A8:-%Q:A?5?E;[X=$>SZE\O0
M                 ^#]WR5XN]^7?$>YYBE9V:*I:5-)IFFBFH:*:Q7_ %EL
MB=!]:>E>AZX                            '")*^#        MXM[]J
M                    !RW2JVP       +(\WVEM        '^,5EKGD$R
M                       !V7:LJM            </I*ZEP
M                   !UX6SHV    !03>,      #[%?CD           Z6
M-6P&@  !Q:DK<7                      %J1OJ0H         Y;I5;8
M &RRW5FP              !R?2KFP   -KEN?-@          <Y)*I]Q\\
M    ;EKUU:ZA1[5:      /X#163E'9R@L^'D      Z9S5J!?V;0      .
M3DE7:X   %GB;ZZ6@                5WV>&;(     '^I=E;V"4
M          "JDSS 9   ZA-6JF@  .._>_YMU'YOUN;-008A31J%Q(L6IK%8
M:BZ32:A?>>-\K[A?GK])?I>+S
M    ?P>3/%7NOCFG',?G&X6&C4+"XM%AHU#4+BU!!#6*FC6+4+#937J?RM][
M^B/;]2^7H                  ?SV<*.Z>2ZG<F^C"EE05-)I-+5+325-,T
MT:+#6W'&/D]V>FN#@                            #A$E?!@       6
M\6]^U                      Y;I5;8       %D>;[2V@       "OHSP
M>9                          L/S?<VT          #E_)58UC_*
M                          .O"V=&P    *";Q@
M=+&K8#0   XM25N+@                     "U(WU(4         <MTJML
M   #99;JS8               Y/I5S8   &URW/FP         !H!)4PN/P0
M    !72^:[PS6[E         #XV3CO7"MGR%     !T]:M0K_<H      ^:D
MHYW/PB   =!5MSM@               #\Z*0=QY @      [[M=]6@
M         !Y=%'J^/\D   M?-]+E   UCY?P;B]^@?RS"Q-1-&S4$&*E*:BW
M%(HJ;Q6%BZ36[/7O9O7+I+OB5
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M         !K')3AN?C4                               '7A;.C8
M %!-XP                  .EC5L!H   <6I*W%P
M  !:D;ZD*         .6Z56V   !LLMU9L               <GTJYL   #:
MY;GS8         &J$E/G6?B)     -N5LCS6]EH           ^2CA SPUL_
M)0    #LVU91:       K2,\;F0  /\ :KN.=^ZV@               <TTJ
M?L       ;!K=CF_]J                XGLUPV0  /7EN^3?Z5   ?YIPF
M_2/Y%\@^_P 6-PU#6,J:-FH(,0T4WB19 MB:AJ%Z.]5=S]+NI>XP
M                              !_!Y,\6.Z^,:<\Q^9#4-8J:-0L-PIK
M$AHU"FH:AK%8((:Q:-0L->I_+\O>[H?W_4?E[                 YS<_\
M?Y$=J?96FC1HJ5G2:-% *FDTFEJEIKUCY7KV+^AN"?TY
M             #A$E?!@       6\6]^U                      Y;I5;
M8       %D>;[2V@      #5^2F[<_*H        !E6\DUU%7H=&U-O]0
M/'HT'3F=9S)3Y-         /7;;G>=>J6@        ?CQ3IN-04
M  'MJ[FKLN>T2^C5_:?F)YBOB::PFFEGE,@              Z\+9T;
MH)O&                  !TL:M@-   #DPG!!D     #7ZS\J       /<U
M^C       +'TUT8M         '+=*K;    V66ZLV               .3Z5
M<V   !M<MSYL         >:Q3?N-?4    '])WEFN]:_IV@            :
MCR5<[G5=     +*4WV:M      &CJ4]6   !8,:[P-                55
MV>7;(  ']Y_    "WG-[\V@               4V&-.D   [DM6(V@   -*N
MP.K>3'>'YJ*#1N&H:QE39HU!B0&C4-0L618:B7I5U+W;T?ZJ[@
M                             '\'DSQ9[JXMIWS+Y>*PU#4-8M%-8J;A
M36*PIJ&H4UBU"P0N*PT:]3^7Y.]?0_T_4OE[                YZ\\]WCY
MVO\ 6PM!HIHT:-%9J:B:-2H!4TFRE[ ]6<9Z'\$^*
M          !PB2O@P       +>+>_:@                     <MTJML
M     "R/-]I;0      /S)*=EFG+(        _0KKO-=PY=HK0      /B(X
M_,\,;/&4        '5-JTRT        !P#9X'L@         #;9>MTO3A=D+
M0   !@:IIS'3D>FM2             =>%LZ-@    4$WC
M_9K827VU?O#[)/X#SA?!TV;EM3W0          I4L:TH      !<*>3>(
M              '+=*K;    V66ZLV               .3Z5<V   !M<MSY
ML        # JBL\T&0   !Z MIZ:Z'6@             #Y22L59RS9    '
M[9<3;V^4     # I8LZR,@  ;-+=2;               'F$E'G6/R(   L/
M3=>;6/\ *   .O+5G-H               :F24QK@  !5T3.]J+0   /Y=8X
M._I;\=>7_9XVFX66@;-0U#6,J;-&H,2 T:AJ"*BSI3U+W?T?ZI[A
M                               '\'DSQ:[KXMIWS'Y0A<5AJ&H:Q:-0
ML-&H4UBL*:AJ&H6&H6"%Q7T;YWE[H]&_4]X^%Y0             !BG,7LCW
M>5G9GT(:-&C0*4IHT:-%9J:B:-%D!KT?YWAL9]"<,_6\<
M               X1)7P8       %O%O?M0                     .6Z5
M6V       !9'F^TMH      '":9KV7(        W\:LI2[/6@        ?+I
MPBDX5ZS^9        BK:&=]';0       -:$IA,_CH         -_FN^LN_-
MH       _P 8YRIP)LTI9            Z\+9T;     H)O&
M!^L=#FND:[Y1M%;^B              "E2QK2@      %PIY-X@
M        <MTJML   #99;JS8               Y/I5S8   &URW/FP
M   ..$E:*X    'LJVX&MIU               '\Q7,9XGL@   #:NZN2YU^
MY0     '"5FO:R   +B4\F[5               <36:XK(  'IJWA)JIO9SV
M9   ^M6\=-?8V@              5UF>'C(  &ZJW%VP    --N>]7\D.\_R
M_A;#14V4T#9N&L5B:31LL&)"E-0U!THZF[MZ/=5=Q
M                    #^#R9XN=U\3T[YC\O%2C%86&X7%J&C4+#1J&BXK"
MPT:AJ&H6%@_=\&^QG3WTMX^#^V             /GO.XX]N^YHYS3VISM+,T
M4IHT:!2FBFC92LU-1-RL+V*ZIXYT'X+\H
M   <(DKX,       #;M?0                      #RPU70       61YO
MM+:      /"TI6L_,H       /[2PI-]Q*_W4          :8R57KGP)
M   !LZMSZ:_1M       %45GF:R        !Z_;9%FNI"@        #_ "3D
M@5S6?.4           Z\+9T;     H)O&           !ZRO;J7L2UZA0
M             I4L:TH      !<*>3>(                 '+=*K;    V
M66ZLV               .3Z5<V   !M<MSYL        >-24LKGX5    /6+
M;?N=;+V@               # K=L\6F0   !WZ:[Y-      >)24BKC^4
M[0-63&@              *:#.H3(  ';1JQPUR?2KFP   +.$WU\M
M       'YL4@=8\CD   LHM]FU     _RLX@_HO\@^%\DX4;Q7&V&C2:-%!L
MW#6*QG1HV7$@A2F^D_4W=W1WJKN(
M       ?P>3/%SNOB6GO,?DPL-8J48K#4-0N+4-&H6&C4-%Q6%AHU#4-0L+O
M9P7W.M_4OT?L/3V           !JUR;7&SMWVO)OJ^20U#4-,[F:F4I39HH*
M4T:-&BI4U[;\;U[#/1'%?ZL@                             !PB2O@P
M                                      !9'F^TMH      K#L\BV0
M     !].6H9OI):           !Y3)4TLTT9       %FF;[!V@      :42
M4ZM80        .@S5H^:]7H          #Q*2K!<Z/H          .O"V=&P
M    *";Q@          ?WG<::[SK]A:                 *5+&M*
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M?'=K>,>F                              !PB2O@P
M                       !9'F^TMH     &L\4M[X_XP      #]LMCS?0
MJT            #X*2H99J&R      !L2MU:;_MH      50F.:"
M#KJU9EFOTJ            _ BKQ<\N60         .O"V=&P    *";Q@
M      #V];3K6\"@                 "E2QK2@      %PIY-X@
M          <MTJML   #99;JS8               Y/I5S8   &URW/FP
M    -0)*:^L?Y0   !9U;Z[J                  /B)*;=SK<@   '71JS
MPT     !RGDJUW    M3S?46T             "N*SQ-9   W-6X^V!6Z9XL
M,@  ?Z5=BF]AE              JO,\M&0  .KK5H]H      <L.Y_SEHSV3
MTM!!"&I:-8KA=%-)N%E2FS>*Q-1*;-%Q.DW4W>'1SJKN4
M                        ?P>3/%[NOAVGW,?CQ=Q;$J:A<5A2P0L-0UBU
M#4*:AJ&C4+"XJ:AHL->E_,\W1GKKW]].!^Y]AZ>P       ->.03G-V%-&>;
MW^'>BII-3+,U#1J6LE+"FDW$U,U,I31HT4%+O5PKT^TW4'Q0
M                  !PB2O@P
M   !9'F^TMH     %9AGCTR      !%6?L[ZWV@             >*R4W+GR
M!       +5K?3]0     -:Y*5FL?Y0       !UL:L[M?T@            '
MYL58KGF$R         .O"V=&P    *";Q@         ;0K;B:]I4
M          "E2QK2@      %PIY-X@                 <MTJML   #99;
MJS8               Y/I5S8   &URW/FP       *IS/,1D   #JHU:8:
M                 &E$E/76/Y(   ']A=0GDV0H     ?/E'2X\^D   Z:-
M6N&@            !^.4>6/,4   LHM]FU T\DIK7    [XM=^V@
M    !YK%'C6/Q)   +;$WT4M      'S_L^EPM_2/XR\]^M\ L-000AJ6C6*
MX713::*#1LWBL2Q-&S?27J;O#HWU5W*
M          /X/)GB_P!V<+T]YA\4W#:ZQM2IJ%Q6%+!"PU#6+4-0IJ&H:-0L
M+BIJ&C7Z/CWMMQ+VMR>&^WM5Q7V?3?F>0    ?Q;FO/(,:C\MQI+S2>'?:DY
MU*FC1314TFIEF:AHUDU*PIHU$U,VEF4IHT:^Z]+%B+H/X/VGJ9
M                     '")*^#
M      %D>;[2V@    #S(H_WQ_@0      !V$:LT-               <]$J
M0L8       Z(-6W&@     *[S/#1D       #>^:MRK^Q:             !
M\Y)4 N=-4         Z\+9T;     H)O&         /?UN%S?L5
M          "E2QK2@      %PIY-X@                 <MTJML   #99;
MJS8               Y/I5S8   &URW/FP      !K')2TUC_*   !Z MU.;
M]9H                   "N(SQ.9    [0M62V@     *V#/&)D  #],O#3
MR>IT            !R[2JNP  !]);>*SO[Z@!328U 0  #WU;L[7]"@
M       <6DK<,   >XK=PF_ZZ       UPY9P/C)^@?R+_/K&-A34+!BA2RT
M:P:QM*;312E-F\5B:B:Z3=3=Y]&NJNYP
M          !_!Y,\8.[.$:>\S^*S8FC<-KJ%AI+"XK#0@AK%8:AJ&H4W"PT:
MA87%34-&H:^_^?Y?<OA^;UCY/F^\]#7[G@W_ *1_'N_)>WGS?Z,\<^QGPK[F
M?Q_-36*PT69J96=2T4T4T5-)K*5-&C4M2L++4-1-)N<V5E>Y/3'R]QN)>L
M                             !PB2O@P
M              !9'F^TMH     XC)7,8       ]A6ZC-_=4
M    *R;/']D      ?[U=VSOV^T    #^2*0=QXT@       ](6YVU[2H
M           &O,E,NX^-        !UX6SHV    !03>,        #Z$N*3>V
M]H                   %*EC6E       +A3R;Q                  Y;
MI5;8   &RRW5FP              !R?2KFP   -KEN?-@      "N(SQ.9
M  L5-]PE                    'GJ4F6?.T   'UZWB)O[6@    !I3)3I
MN   !8\:[8-             5/F>:C(  '6IJT$T !Q52MZP   +=4WT"M
M           IR,:7(  !WC;L$J       !S@[9Z"YY=K=!+K"3 Q%&H6#% :
MEN%Q:QM*;B:E2FC<-0UTEZD[UZ,]5=T
M          #^#>>,/=G!]/N9?%C2)4L39N+HUBT5+BL+#0@AK%J%AJ&H:-0L
M-&H6%Q:+#1J&H7%J""&L5-&L6H:AHL-0L-%F:9U,LM%-&BFDJ:RFDL-2U+4K
M"FC4371OK[UNN_5/H@                               #A$E?!@
M                                  "R/-]I;0    !3>8TT0      "
MS&WV)4               #QR*35Q\V@      L8-=O&@    -#)*@UP
M  !9S;Z\J               !Q62MXP        .O"V=&P    *";Q@
M   6+&^X"@                   "E2QK2@      %PIY-X@
M      <MTJML   #99;JS8               Y/I5S8   &URW/FP      /
MQ9*.ESYP@   ]C6[/-_14                    !P69K^,@   69V^PJ@
M    4MV-6T   W'6Y*V            /((I WQ_P   %NR;Z 6@ ><Q1XOC_
M     #KDU9Z:            &J\E+K6)@  95=:SO9"T       #^>XXY]^?
MD_6GE_6^--:A<;,(QL*:A8,4!J6X7%K&U=,Z-%*:-]).I.]^C'57=0
M                                 _@WGC%W;P;3_F'Q(6+8TB5-1-&X
MNRXM%2XK"PT(7%8:AJ%AJ&C4+#<*7%8:-0IJ&H:Q6""&L6BPU#4-0T6&H6&C
M4RLZRE-&BFBFDU,LYT:A9;E979+CN>]W1GH_H8
M          #A$E?!@                                      "R/-]
MI;0    / I*2&L(      'O2W7YO].@               !6]9XJL@     #
M?QJW@T    !7;9X;L@      #<I;C;7^Z@               ?PI3%N=6Y
M      .O"V=&P    *";Q@       #:=;FDU^C:                    *
M5+&M*       7"GDWB                 !RW2JVP   -EENK-@
M      #D^E7-@   ;7+<^;       YFR51;@   "PBUW;:
M       'G$4?]>/YJ   !T,:MP-      <,IFO!<@  15T+/DVKH
M   #AHS7>9   V(6Z]-_[4  *MS/*1D  #ZM;QTU]G:           !7A9X8
ML@  ;X-6_&@        /EO<^=Q1_0_X]\O\ L\9A,4QIK4+BF!C8:+"XD(66
MC4-8VXJ:39H%Z1]2=]=&>JN[
M   !_!O'&/NW@NG_ #'X4-)J%C5BHE3431N+LN+18EA8:A1"XK#4-0UBIHUB
MIN%-8D-&H:A36+4+!"XK#1J%AJ&H:+#4+#1J99SI-2IHIHT5-3+.=&O2?G+!
M/0_K>@>A                                 .$25\&
M                          +(\WVEM     XNI6U8       L*-=V&@
M              -6XI;Z\:      /TR]3/)]A0    IF,:C(       +7<WT
MQM                 Y1)5P8        Z\+9T;     H)O&        +3\W
MU-M                     I4L:TH      !<*>3>(
M'+=*K;    V66ZLV               .3Z5<V   !M<MSYL      "LDSR 9
M   'Z=7@\^3U:@                     *Q3/(AD   ?H%YJ;]"M     '
MCD4@KX_XP  #N>U8=:            I<L:LH  !8':[RM   <\4J0L   "S4
MWV"4           ?P12'N/&D   LV-]@%         'EWV..<5_T-^._D_>^
M5#4+"8ICHNH7!,3&PIJ%Q(0LM&H:PMA32;+TDZD[[Z,=5=V@
M                          #^#>.,G=G ]/\ F7P8:+#2:A8U<:2IJ)LU
M%W#4*EA86&H40N*PU#4-8M%-8M&H4UBL*:AJ&H6&H6"%Q6&C4-0L-0T:A8:A
M34YLS4S13131HOTWJZ[[=$^/WCX<
M '")*^#                                       %D>;[2V@    55
MV>7;(      _UJ[[GR>U4                 *:#.H3(      ML3?12T
M #SV2BW<?X@      &Q:W66OZ%                 _-BD=<>+(       .
MO"V=&P    *";Q@       >]+=EF_P"V@                    *5+&M*
M      7"GDWB                 !RW2JVP   -EENK-@
M#D^E7-@   ;7+<^;      &!1\8\90   =+FK7S0
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M1<5A34-0T:Q6%@A<5AHU#4-8J:-0L-0IJ<ZF69HIK]7Q:[M='W:7C
M                           #A$E?!@
M            "R/-]I;0    *-['D:      #=%;C;8
M%?EG@RR      ._<UWQN@   .>$E2*X       '?UKO>T
M  !7DF>%UR       .O"V=&P    *";Q@       =[6N_P"T
M         *5+&M*       7"GDWB                 !RW2JVP   -EENK
M-@              #D^E7-@   ;7+<^;      &L\4J[XP   +-S?7Y0
M                 !^=%&:X\]0   =J6K(;0     '+*2K!<   "VLWT64
M         "M:SQE9   Z/M6S6@   .!;/ =D  #*KK^=[%V@          5:
M&>53(  '7=JSJT          !KSRG@G'WOK\D_C>QZ<+"14-0L&*08ZJW%<4
MP(L-&L2%ADLM&\5QMZ1]2=_]&.J>\
M        !_#Y,<9NZ^O]/N9<>-1;#2:AHU#26+8MQI-1*FS<74742I86&L5*
M,5AJ&H7%J&C4+#1J&BXK"PT:AJ&H6%@Q6%AHU#4-8M%-0U"PJ:F:_3\6NXO2
M?EV^XEH                                  <(DKX,
M                          61YOM+:    /#XI!WQ@      =UVK"K0
M               '.B2I5<      #IXU:P:    X<)7:8       %SV;VOM
M                 TH2G4P       .O"V=&P    *";Q@       7,)Y-O*
M                     %*EC6E       +A3R;Q                  Y;
MI5;8   &RRW5FP              !R?2KFP   -KEN?-@     #D/)6+N
M J\+/)[.                       56F>7#(   W/6XZV     !^')1VN?
M.$   ZQM6B6@         !\Y%'6X^ 0  "U$WU*4   #P62DIK'^$   =[&K
M #0          \\BCKKQ_@0  !;S;WY4           :[\IX'R [Z_)'X_L^
MF7&6""*AJ%@Q2*QM6XKA<XD!HUB00A9:-](>I/T!T6ZJ[Q
M                         '\FL\>NZ.O]*><\9C.H:-1=0J:AHU#26+K&
MHI-1G1HW%U%U$J6%AK%2C%8:AJ%Q:AHU#4*:AHN"FH:+#4-0L+!BL-0T6&H:
MQ:-%AK]OP:[C=(^UMIQ38                                  '")*^
M#                                       %D>;[2V@   #G"E3%@
M    "U2WU#4                 #R:2C9<      #9);K38   %9=GCVR
M    ![(MXAL                  ?RQ1@UCSR0      #KPMG1L    "@F\
M8       ]:6\:U_JH                     I4L:TH      !<*>3>(
M              '+=*K;    V66ZLV               .3Z5<V   !M<MSY
ML      5S&>(S(   V)6[&V                       .)#-<ID   ?NVW
MOIO]$      K=L\5V0  /IK;R&=?;6@         <HDJX,   >HK>#;_ &
M   5)&>=S(  'O2W:6_Z0         #C+)6MN   -AUNOS?^U
M :\\HX'R"[Z_)'XOL>EC2V%B6%Q14-0L&*8U%JW%<$PL*4UB0D!KI%U)^@NB
MW57>8                                       _P ;.5/;?!>>W9'#
MS4349L-&HNHFBPT:AI+%UC44FHSHV;BV&H5-08M0I8(6&H:Q:AJ%-0U#1J%A
M<5-0T6&H:A<5&*PU#18:Q:^V]+R=SNC_ 'MC^.>0
M               <(DKX,
M61YOM+:    .*"5PF       -H5^M@                  :9:D0     !^
ME5\Z>3^P   %1)G0!D      #J,MJ9L                  "I<SSD9
M   Z\+9T;     H)O&       .GS5JYH                     "E2QK2@
M      %PIY-X@                 <MTJML   #99;JS8
M Y/I5S8   &URW/FP     !4E9YVL@  #JLU:6:
M  &AR5!&    +K4WLE:     !II%-Z^,   6:IOL%:         !4F9YV,@
M =O&K&#0    '*5*MK    MQS?0FT         "G@SI$R  !W_:[VM
M       :\\IX'R$[X_(_X_G]3&S&L;8HU$L)B*AJ&L4A,:BU=8I@86%+#4+"
M=(>I/T%T6ZJ[T                                        Y^]B<3Y
M3]N<!_DWE::B:C-AI=0U$T:A34-)K&V*BU+&=&X;74+"IJ%Q6%+!"PU#6+4-
M0IJ&H:-0L+BIJ&C4-0L+BL$+#7MWQ//W(Z/^GZS\K8
M                 '")*^#        ZK->YP                     !K
M37,QD       61YOM+:    *ZC/#YD
M   "[]/)[=0   I4,:U(      !WY:[YM                   5Y6>%K(
M     '7A;.C8    %!-XP      !WV;[[*                     !2I8U
MI0      "X4\F\0                 .6Z56V   !LLMU9L
M   <GTJYL   #:Y;GS8      I/L:YH   ._37?)H
M    ><11:OC    MI-]&E      %,%C5%   -^&K>C0         \-2D=<?S
M0  (JY_G>UUH    'X,E'BY\X0  #K4U:":         &L4E+#6$  #_ &J[
M;GR>\T             ->>4<"Y"]\_D;\?S^F6&L;,:QTA2Q+"XHMQ4N)"8U
M%K6L),3"PIJ%Z0]2?H/HIU5WF
M    !K9R?XW&WNSK;X#W_4+%+349U$U#2V&HFC4-0II-8VQ46LV)HW#;6L53
M26%Q6%+!#6*FL6H:A3<+#1J%A<5-0T:AJ%Q7>#A'N]C.G?I?O^#0
M                            X1)7P8       %O%O?M0
M         .6Z56V       !9'F^TMH    J]L\EV0
M              +D$WN9:   *)EQ\-(      !:&F^LUH
M   ''"2M%<       =>%LZ-@    4$WC       %HR;ZP6@
M        4J6-:4       N%/)O$                 #ENE5M@   ;++=6;
M               ')]*N;    VN6Y\V      *&;'SZ   "T"WUK4
M                "B8Q\,@   LTM]@U      '#U*ZK   '^E79\^38&@
M      .#;-?=D  #=5;B[8     %<%GBBR  !].MXZ;^WH        "O8SPF
M9   Z$M6XV@             !KURG@7(?OC\C?C>?TL0I8:QLPTBC42P8D$6
MPIK%(3"EK6L),#$5T@ZD_0G13JKO4
M        #XOWO6Y%=R==ZC<RX[$L2EBEL-,ZB:AI;#431J&H:*FL;8TB5+$V
M:-Q=8VII+BL+#0@AK%J%AJ&H:-0L-&H6%Q:+]!Z_EZU]2_7W[X#[H
M                              X1)7P8       %O%O?M0
M           .6Z56V       !9'F^TMH    J9,\X&0
M                +;K?0]0  !0;N/YY       +=TWO]:
M    !S22J P      !UX6SHV    !03>,       6_V][5
M        I4L:TH      !<*>3>(                 '+=*K;    V66ZLV
M               .3Z5<V   !M<MSYL     #XJ*)%\8   %NAOH(H
M                 %*]C6-   !85:[KM      #R62C[K'Y\   =_FN]S0
M       _R2E2SK<@  %E=OLJH     &H<E,^X   %F6;[#V@       #^.2D
M9<^)(  !:%F^L]H              &O7*> \A^^/R+^1Y_4@@Q"FH,*QTBH5
M-08D$6PL+!"84UJ%Q3 Z/]2_H/HGU5WL
M           !":1<\XQRM[;Z^^/]WU\6HEB:$4NHE3434-+J&HE-0U#2:A8M
MC2)4U$T;BZ-8M%2XK"PT((:Q:AJ%AJ&C4+#<+MCQ/W^P'3_VO4OE^4
M                               #A$E?!@       6\6]^U
M             Y;I5;8       %D>;[2V@   "HDQH @
M                 %JF;ZAV@  ?*Q0]OC       %R6>3<>@
M       -%9*?MP      !UX6SHV    !03>,       73V]G5
M           I4L:TH      !<*>3>(                 '+=*K;    V66
MZLV               .3Z5<V   !M<MSYL     #Q:*/E\8   %R:>3<:@
M                     *>S&CB   #N^U8-:       JBL\S60  -CUNL-?
MZJ       !H@E0)@  #Z=;Q<W]U0      ILL:<H  !O4U<":        '.J
M2I1<   ?=+>-FOI;0              !KURG@/(GOC\A_C>?TC1J"#$*:Q,:
MQTBH5-0N)"1;#4+"0F%-:A>CO4OZ#Z(=5=Z@
M               #Y+W/7YB]J\$T.[!XA_/J&L6HFHE$6K8FDL34-+J&HEAH
MU#2:A8U8J)4U$T;B[+BT5+BL-0HA<5AJ&H:Q7T[YGL]6NJ/O;K\)^A(
M                                 .$25\&       !;Q;W[4
M              #ENE5M@       61YOM+:    *AS&@B
M                   6D&^KB@  ?)11 OC       %T*>3:J@
M        -,HIP7Q@      =>%LZ-@    4$WC       %X*>3VJ@
M             *5+&M*       7"GDWB                 !RW2JVP   -
MEENK-@              #D^E7-@   ;7+<^;      \!2DBP   !=,>3:
M                      J/L\\V0  !VZ:L9-       <ODJJ,   "X+-[S
MV@       5E&>/S(  '7)JSTT      !Q<9K;,@  95=6GDV4        *N;
M/)]D  #LBU9;:                &OG*> <BN]_R'^+['I00T4U!B0%-8F.
MF-14-)K%(6+(6&H6$Q3'3H[U+^ANA_5?>H
M              'CGVOF\QNU>!Z?<TXSA1J%AJ)J)1%+J)I-8RFEUBTFH:+#
M2:A8U<:2IJ)HW%W%L326%A8:A1"_9^E['2?K3[W0KKSZ_P"KXM
M                             #A$E?!@       6\6]^U
M           Y;I5;8       %D>;[2V@   "H<QH(@
M               %I!OJXH  'R440+XP      !<WGDVUH
M    #26*=M\8      '7A;.C8    %!-XP      !>:GD]2H
M         "E2QK2@      %PIY-X@                 <MTJML   #99;J
MS8               Y/I5S8   &URW/FP     / 4I(L    796]AU
M                  J3L\ZV0  !VI:LAM       ?CE'ECS%   .R;5EEH
M      ?))1Q8^.   +>4WOU:      !Y[)1VUCYZ   .\;=@E0      !\'%
M'.X^;0  "X;-[OV@                :^<HX!R+[V_(/X_L>E%N-L$-%-08
MD!J%@QTQJ*-1+B014+#4+"=&NI_T)T.ZK[V
M                'B?W?E\[NRN%:6\XXM^=Y<%-0U"QG4*(U2Q-)K&:*NL6
MF=1=%AI-0L:N-)4U$V:B[BV)I+"^J?*]SHAUS]W?;@/V/V_!L
M                             <(DKX,       "WBWOVH
M          '+=*K;        LCS?:6T    5'F.>B
M               6KF^GR@  ?E%"AXP      !</F]W;0
M   .?R5%&       .O"V=&P    *";Q@      "\^\GIH
M      !2I8UI0      "X4\F\0                 .6Z56V   !LLMU9L
M              <GTJYL   #:Y;GS8     '@TE(RX    N=O)MB
M                5%&.?R   #N3-6([H       5QV>);(  'WRWCF_H
M    #D2E8E@  #8U;K37^J@      "KLSR<9   ]T6[;-_UT      !QPDK1
M7   &SRW2V\P                 :^<HX!R-[V_('XWL>B6%QUJ"%A318,2
M%+"PN&I%14-)<5A(J&H7HSU-^A>AO5G>H
M              'Q7O>KHYSWB>D'/>*>+?<^4:!J&H7'.BJBTL32:QFC46PT
MFH:-0TEBV+<:342IO]+Q>;;GB/V=\. _;VOXC]/_ 'E
M                        '")*^#        MXM[]J
M     !RW2JVP       +(\WVEM    %4]GF&R
M          !;JF^@5H   H7W'X<@      %KV;Z7V@
M<J9*M-P      !UX6SHV    !03>,       7GWD]-
M    *5+&M*       7"GDWB                 !RW2JVP   -EENK-@
M           #D^E7-@   ;7+<^;      \HBC5?&   !</F]W;0
M              *:C&GR   #OXUWP:       &H$4TKXP  !::F^J5H
M %0UG05D  "P:UW?:        Y\25&K@   6WIOH=:      !3Z9T89   L-
M-]TE                  &OO*.O^1W>WY _']CTL2 L+CK4&*E*:Q((#4+%
M85%1;"Q+"P19T8ZF_0_0SJSO8
M       #Q/[OR]0.:<9U-YAQWP/D/Q_\-"EAJ)K&4JHM+$U$U$T:BZB4U#1J
M&DOU/J^QM-Q7[&WG#?L[=\/^Q]-ZOE
M             X1)7P8       %O%O?M0                     .6Z56V
M       !9'F^TMH    K2,\;F0                                 +
MD;R;D@   H[W'C<@      %DAKM(T                  !PP9KQ,@
M =>%LZ-@    4$WC       %Y]Y/30                     "E2QK2@
M    %PIY-X@                 <MTJML   #99;JS8               Y
M/I5S8   &URW/FP     /RY*%>L?YP   +74WTRM
M    I#L>%H   +&TWVVM        IF,:C(  !TF:MC-      #7E*3MQ_G
M _K+O$\GM-        ?SI2=9U]0  #K&U:):      &M92IOCQ@  ?V%WN>3
MV6@                  -?>4=?<CN]_Q]^1Y_3+"XD!8NL;8,5*:+B00I87
M&L:QI;"Q+!T7ZF_0W0OJWO<
M      #YGVO!KGR;XFOG(_C^%\@^1XS]OYOFOU/1_P -2&HFL92JBTU$U&;#
M7[O@]GU_XWT/;/A?3]^X]]/8OC?U?</@^_\ [R@
M                      #A$E?!@       6\6]^U
M    Y;I5;8       %D>;[2V@   #@:SP%9       ^U7]R
M             +E37N-H   IJL:>H      !VG:LBM
M 5D&>03(      '7A;.C8    %!-XP      !>?>3TT
M     I4L:TH      !<*>3>(                 '+=*K;    V66ZLV
M            .3Z5<V   !M<MSYL      47V/,T   %DEOM&H
M             _/BAG?'^>   "TM-]5K0       .)*5R6   /[R\#/)ZY0
M    ' )."#   '2=JV*T        !P1F> -R  !](MXR;^\H     "OLG!Q@
M  #I*U;':                    U^Y1U]R0[V_'GY'G]/&V%+BL$!8NL;<
M2%*:+B00I8:QLQK&HM-=%^I?T-T)ZM[W
M                  _@\F//?I>I\+[_ *GQ_O>M^#Y_%_'O,&4?J>+S_3>K
MY?L_1]KT/YWN?:>CYP
M    !PB2O@P       +>+>_:@                     <MTJML       "
MR/-]I;0   !R2DK 7       %BAKN(T
M *J+/,%D      #=VZN'S0                  %,9C4Q       .O"V=&P
M    *";Q@      "\^\GIH                     !2I8UI0      "X4\
MF\0                 .6Z56V   !LLMU9L               <GTJYL
M#:Y;GS8      IN,:;(   .VK5C=H                       :V12FOC
M   N&3>\%H       'ED4>=>/\R   +%LWV_M     '\Z4E;GP60  "U3-]0
M[0        /"XI(:\?\ -   %EV;['V@    #^8I)L>$(  !:A;ZEJ
M              -?^4=?<D>]?QU^1Y_3C5Q6%A2XK! 6+K&W$A2FH6""%+#6
M-F-8Z=%NI?T1T)ZM[X
M                                                         '")
M*^#        MXM[]J                     !RW2JVP       +(\WVEM
M   &F4E."X       Z6M6OV@                             !7B9X8,
M@      ?J5>FSY/LJ                  \RDHS7'^(      !UX6SHV
M !03>,       7GWD]-                      *5+&M*       7"GDWB
M                 !RW2JVP   -EENK-@              #D^E7-@   ;7
M+<^;      %6UGE*R   -^&K>C0                       Y=,U6&0
M+T$\GIE        "J@SS"9   V[6YBV     .?$E1JX   ]66[_-_KT
M    *E3/.AD  #>5;@[8     Y[25'+@  #TI;P\U^W:
M    !K_RCKWDCWM^-OR?-ZAN&HMQJ%A86%@@+C=1;B0IHL+!"P%AK&SHIU1^
MB.@_5O?
M                                              '")*^#
MMXM[]J                     !RW2JVP       +(\WVEM    'S<41[X_
MSP      ?4+>;F_J:                              Y%I6'8
M%JAOJ(H                 ').2K_<       #KPMG1L    "@F\8
M O/O)Z:                      4J6-:4       N%/)O$
M     #ENE5M@   ;++=6;               ')]*N;    VN6Y\V      .#
MLS7UN0  !]A;>KSO]&@                      *[K/#5D   >Q+>*;
M      YE252+@   7-'DVX     *O;/)=D  #N*U8G:          Y7259+@
M  !5U7.]E[0    *OS/)1D  #M:U8_:                      U_Y1U[R
M1[W_ !G^3['I,Z39N+K&V#%2PU"0L!K&W&V"%-%A8,0I>B75'Z(Z#=7=\@
M
M                                   #A$E?!@       6\6]^U
M                 Y;I5;8       %D>;[2V@    4W&--D       M"S?6
M>T                             #562E[<       #J8U:@:
M          J:L\W60      !UX6SHV    !03>,       7GWD]-
M              *5+&M*       7"GDWB                 !RW2JVP
M-EENK-@              #D^E7-@   ;7+<^;      '.N2I/<    7"9O>.
MT                      "FZSIJR   .ES5KYH        #\M*/S/E"
M=P6K%;0    ^%BCE?'\T  !5T2;VH4         #\.2CU<^:(  !W<:L(-
M  #XJ*.-\?RP  !<IF]P[0                     !K_RCKODEWO\ C+\C
MV?2-,U-)LW%UC;!BIJ"%Q :QMQM@A31J"#$Z)=4?HGH-U=WT
M
M                         !PB2O@P       +>+>_:@
M       <MTJML       "R/-]I;0    *ZC/#YD      #=]JX:T
M                     !_+%%VX\_0      #]:KNN=^PV@
M    :_24GKC^4       '7A;.C8    %!-XP      !>?>3TT
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M'I&S1IG2:31N+K&V(QM-0L&(6%BW&V"&BFH.B/5'Z*Z"=7=\@
M
M                         #A$E?!@       6\6]^U
M       Y;I5;8       %D>;[2V@    <ZTJ3L       "W%-]"K0
M                      *I#/,ID       =RVK$+0                %
M;%GC"R       !UX6SHV    !03>,       7GWD]-
M    *5+&M*       7"GDWB                 !RW2JVP   -EENK-@
M           #D^E7-@   ;7+<^;       IYLZ/L@  #8U;K37^J@
M              <44K@L    7'IO<ZT         :F24QK@   6R)OI):
M!3U8T=0  "R]-]CK0          -2BF/?',   6UYOHK:   !4%8T-0  "QG
M-]N;0                       / .4==<DN]_Q9^1[/H0T;-&RLU-ILWC;
M"XU"FH6#$+"QK6)!#1>B'5'Z*Z"=7=]@
M
M        <(DKX,       "WBWOVH                     '+=*K;
M   LCS?:6T    #\62C7<_ H      !MTMR.;_OH
M         <:$K5,       #Z5;JDU[G:               !K=)2ZUC\F
M     .O"V=&P    *";Q@      "\^\GIH                     !2I8U
MI0      "X4\F\0                 .6Z56V   !LLMU9L
M   <GTJYL   #:Y;GS8      '!Z9KZ7(   %O2;WXM
M     IJ,:?(   /8%O"-?T*         !388TZ0  #JLU:6:   &LA2NOC0
M /JUO%S7VUH           IP,:9(  !U>:M'-   #7>*3U\>   /U2\)/)ZG
M0                        \ Y3USR2[W_ !5^3Y_2$74*;-FBLZ32;-8W
M46XD*:A<2 L+%N-L+T/ZH_1?03J[OP
M
M      <(DKX,       "WBWOVH                     '+=*K;
M LCS?:6T     5D6>0+(       L'M]W5
M  'CI1]>/^<       '3MJUBT               /\DJ3)SQ9        '7A
M;.C8    %!-XP      !>?>3TT                      I4L:TH
M!<*>3>(                 '+=*K;    V66ZLV               .3Z5<
MV   !M<MSYL      #6B2E5K"   !U":M5-                     #1*2
MH!<    =H6K);0          XJ25OK@  #Z O'3R??4  !7J3A0P  !UX:LZ
M-            <8DK8,   ?1%XJ;] M   X!)P08   Z?M6K6@
M              !X!RGKCDCWQ^)?R//Z4SR3="&H4V;-)I*SH\AK&V+<2&BP
MN) 6%QUKH?U1^C.@75W?@
M                                                        '")*
M^#        MXM[]J                     !RW2JVP       +(\WVEM
M   &A\E0.X       'Z1;HF]\K0                ,#\B3]JT
M "HNQS[0       "S/-]A;0              .)*5R6         .O"V=&P
M   *";Q@      "\^\GIH                     !2I8UI0      "X4\F
M\0                 .6Z56V   !LLMU9L               <GTJYL   #
M:Y;GS8       ITL:4H   /]:N;YWMA:                    !4Q9YPL@
M   7#'DW@          !YF4=[X_QX   LN-]D%  '\*4B&?&$   M]S>^-H
M          'P$4=M>/YN   +*LWV7M  '^"4F6? $   M=S?3&T
M                #P'E'7/)/OC\2?C^Q\_%34O),TJ&H:-&S25-,[-PU%L+
MC4-%A<2 O0WJG]'= >K^_0
M                                                        !PB2
MO@P       +>+>_:@                     <MTJML       "R/-]I;0
M   !@4RV-2D       'IJV_VMH%                _P2N0GB!:CE_JM
M       ')>2KW<        ?OK;M:W@4             #GQ)4LUG\V0
M   #KPMG1L    "@F\8       O/O)Z:                      4J6-:4
M       N%/)O$                 #ENE5M@   ;++=6;
M ')]*N;    VN6Y\V       ./B5EF    .D[5L5H
M <_TJ)7$P   -L5N=M@          "JTSRX9   WK:N M  #F_)4SN   -E%
MNIM?ZJ            *OK/)5D  #=UJX>T  - )*B5P  !ZY;=^SO]*@
M                     !X%RCKCDGWQ^(OR/8]&&H,0W,W-T6%AHV;*FDTS
MHW#474&-L*7$A>AG57Z.Z ]7=_
M:?\ .. ?TYWM'P_FWZGA\P
M                    '")*^#        MXM[]J
M !RW2JVP       +(\WVEM      Y(25@K@       #V%;;<UMA:
M      !\[)61LY1LCMPU8T:          'X<4A[CR=        /1EMQ36XEH
M            &D$E22Y^-0         =>%LZ-@    4$WC       %Y]Y/30
M                     "E2QK2@      %PIY-X@                 <M
MTJML   #99;JS8               Y/I5S8   &URW/FP      !\W%(S6/*
MI    +6DWTXM                   'X\4U;C55    +,LWV'M
M  '-:2IY<   95==SY-C:  JQL\KV0  +";?=E0            .?\E1.X
M 5=/SO9VT "L2SR)9   [CM6)6@                          !X#RGK;
MDIWS^'OQ_/Z,S9N%A<0\DS4W186&C9LJ:9J;-PU&M8D+"EZ%]4_H_?\ ZO[^
M                                 U%YOP'CQWK^=/Y]Y_:];W-H^'\Z
MVPX5SS:3AW./N/G_ $0        /D?<]7Z[T_:
M                         '")*^#        MXM[]J
M      !RW2JVP       +(\WVEM      _/*6[&M:        ?=VV@LZZ7V@
M             :YR59[G3= !8[;[8J          .$#-?)D        ??K:J
MFN@=H           '-&2K;<?)@         '7A;.C8    %!-XP      !>?
M>3TT                      I4L:TH      !<*>3>(
M  '+=*K;    V66ZLV               .3Z5<V   !M<MSYL       #A(S
M7N9    ]B6YQ->I6@                  5]$X/,    >W6W8<[_=H
M      ?G12#N/($   [XM=^V@!YO)1WN/PP  ?W5=ZF_9%             _
MQBE!<:\(  !W8:L*- #Y"2CC<_((  (JZ'G>U5H
M      '@7*.MN2W?'X>_&]KY^,J:ELW!B0IY)FY4N-IHV;*FF=)LW"Q=8U"]
M"^J/T?O]UA^@                                -;^5\.XM]_?FC\SS
M>"+"IK%<IY/9_@<FV2XGS/8?B_+O>N-\J]+^1];-0   !_G9X[]SXNL7+>):
MJ\RXAT"ZS[+VKX?RP
M    <(DKX,       "WBWOVH                     '+=*K;        L
MCS?:6T      <N)*K5P        ,SM(U81E^TM            _BCC'<U[4^
M.0 #^DM53?3FT         #X>2DMK'FD        #^^N_N=]TJ_N4
M  #\>. USPIN?\H          '7A;.C8    %!-XP      !>?>3TT
M                I4L:TH      !<*>3>(                 '+=*K;
M  V66ZLV               .3Z5<V   !M<MSYL       #Y"2D_<^1(   !
MT6:ME+_8H                 '.R2I?<?S    %EAOLHH            KN
M,\-F0  -@UNQS?\ M0'%E*W+   '2Y;7S8             '!=FOVR  ![.M
MW=K^Y0.1"5BF   -TUN,M@                            >!<HZVY*]\
M_AK\GS^E%N-)8FI;-PN*0TFYNYE6XJ;-&S25G2;-Q=0O0CJK]'[_ '5_Z!
M                             \3^_P :XE?H7\O?.>UZ134+C46%36+4
M+%U]#ZGO^N?#Y#Z=\?[?WGSOJ_5^E[WZ?B\Y?Y[/F?<]'X/Z/S_*OL_&\8^]
M\+YKVO3_ *<>7L3T9WSN!PCFH
M            '")*^#        MXM[]J                     !RW2JVP
M       +(\WVEM      &!4A9YZ,@        >RKWS:Z^R_KT         !_
MDG-2*_%SJ4@   ^G6WA-;JV@         <1V:Y;(         W(6QJUO>H
M      '.>2NA<ZM(           .O"V=&P    *";Q@      "\^\GIH
M                 !2I8UI0      "X4\F\0                 .6Z56V
M   !LLMU9L               <GTJYL   #:Y;GS8        X^)668    '
M;!JQXT                 -6I*?5SYZ@   &URW+F_T             :KR
M4NM8F   +?#>^B@4W&--D   M7S?3VT             #Q"2D9<?R@  %L]O
MHZH%1!G0)D  "R<WV>4                             >!\HZUY+]\_A
MO\7V?G)J6H7&HE34MF\2%A4W-W*EQ:-&S1IFII-F^A'57Z1W\ZP_00
M                       'F7UOB<0_T/\ EGXCZ/RX(,5*4UBL5"+4WBL+
M%TFDU!%N-%32;-_[9\O7OH_OC<_@?/0
M                  !PB2O@P       +>+>_:@
M<MTJML       "R/-]I;0      -=9*8]S\J@         ]JM[)R]<)??[0
M      /+).4YQFUG5>0    #UBVXC-;!J         /RY*:-SJJ@
M BN@TUVT7I OZ8     !^!)S$.)UFCS(            Z\+9T;     H)O&
M      +S[R>F@                     %*EC6E       +A3R;Q
M           Y;I5;8   &RRW5FP              !R?2KFP   -KEN?-@
M     #^=*@C.BR    #O:WW_ %                &N<E0W6?$9    /]:M
M\3>]Z@            "G(QI<@  '81JS0T-3(IBZ\<P  /65N_M?J*
M        *F3/.!D  #JLU:6:'@,E):X_R  !^_5XK/D]#H
M               #P/E'6W)OO;\._C>U\S"S&DU+4+B0J;ELUB00TGDR:+%L
M-&C9HTS4WT(ZI_2N_G6'Z#                             ^,][YO$7]
M$?E3R[[7'\94T;-008AHIK%8L@6Q-0U#46II-0N-D6_Z9\G6WI+OO=_K[L0
M                                               #A$E?!@
M 6\6]^U                      Y;I5;8       %D>;[2V@      #C5)
M6HN          !E6W\O1-=YEVZE]SL_U4   >/QJ39I&G/E-&+/XH      &
MSZW!IOT>@        !I!)3\N?Y4          'I=O2>7?U=S%V0CZ&@ /D8U
ME33$Y]V<Y$^(0             =>%LZ-@    4$WC       %Y]Y/30
M                "E2QK2@      %PIY-X@                 <MTJML
M  #99;JS8               Y/I5S8   &URW/FP        -9I*:ES\N@
M  [:-6+9?Z[0              -0Y*FESXT@    [8-6/&@
M.+[-;-D  #[=;R$U]+;729X@,@  =RFK$30              '+5*KK   '[
M]7BL^3T.N!R<!&   .K35I)H                              #P3D_6
MW)OO?\-_D>QZ$5A<X:D$S2:QU8B%3<MFL2%A3R9318MAHT;-EZ$=3_I??SJ_
M]"@                           ?@>SZG%']"?E3Q#D?#S1N&X7&5-FC4
M&) :-0U%018:B:A8:BZ366==7>E^^-[>NNRP
M                        !PB2O@P       +>+>_:@
M      <MTJML       "R/-]I;0       *N3/*!D            ?16^XQZ
MA7U\OZ9^<?)IYF>)'R"         #?9JVS-?NT         *_"<&F
M     !_K7I2^@'^\?R'FM? )C                Z\+9T;     H)O&
M   +S[R>F@                     %*EC6E       +A3R;Q
M        Y;I5;8   &RRW5FP              !R?2KFP   -KEN?-@
M   #CJE9U@    #I U: E],M              Y5I659^10    ;9K<5FOI+
M0             /.HHZWQ_A   %HQOJ7%'^Y\H0  *NEYWM#:
M   !^-%'NX\P0  "R@WV7*4#.NZ   6UYOHK:
M        /!>3];<GN]OP[^-[/SAB19A<X:D+,VFL:BHFIFC<-0L$-3-RV(MA
MHV;Z$]3_ *9W[ZO_ $,                          !^=Y/#QI[^_+.M7
M+^OTW"RT#9N%AK&5-FRP8D!HU#45"11J)J)KJ=TYWQOYUIVD
M                                     !PB2O@P       +>+>_:@
M                   <MTJML       "R/-]I;0       /EXJ#W.F;(
M                       '6)JT)-?[4        !_!)4=N=!$
M                      '7A;.C8    %!-XP      !>?>3TT
M             I4L:TH      !<*>3>(                 '+=*K;    V
M66ZLV               .3Z5<V   !M<MSYL         "LXSQV9     ]FM
MLLYUTMM            'G4E=.SD'<S     ]!MN,YULE:              !
M5E9Y6L@  =&FNS*U3&   -XUN$M@               5SF>(C(  &ZJV)9JH
M+<   >X+=PFO[+0                               /!N3];<H>]/P_^
M/[/S\+G&R"#&S#4QN869LN*XTFIFC<-00L-3-RVJ&H7H3U/^G-^^K_T2
M                     !_A<<B^]/S+J'SOJN%PMAHJ;*:!LW#6*Q-)HV6#
M$A2FH:@QLZ>=0=[=#.K^V@
M           !PB2O@P       +>+>_:@                     <MTJML
M      "R/-]I;0       !Y*E/QG7!                           +"S
M?=90        !Y;)3MN==T                               Z\+9T;
M    H)O&       +S[R>F@                     %*EC6E       +A3R
M;Q                  Y;I5;8   &RRW5FP              !R?2KFP
M-KEN?-@         ?C25+[GGX@    $5TPFK"LNU%H          _(CCLG ?
M6?*Y     /UZMH9WT%M               '.&2IC<   ?U5NQ-:.L@  696^
MPZ@               :HR4P-8F   K>V:T29   [PM6"V@
M                  /!N3]:\H^]/P]^1['HPN-F%SC9!!C9AJ8W,+,V7"U$
M-3-FX:A,0W,\DM*Z#]4?I[?OJ[]%                         0G+3N;\
MZZ*=E=*0A9:-XKC;#1I-E*#9N&L5C.C9HN)!"EZ3]3=X]'>JNX@
M                                         .$25\&       !;Q;W[
M4                     #ENE5M@       61YOM+:        !X3)45N=<
MT                          ]'6X'-;16@         :VR5 [GR%
M                         !UX6SHV    !03>,       7GWD]-
M                *5+&M*       7"GDWB                 !RW2JVP
M  -EENK-@              #D^E7-@   ;7+<^;          'Q*5(F=)D
M   '^U=.)KM0UO\ I_NH       'ET<AK.*3/A2     #^NK2<WU.4
M         #^%*1#/C"      #ZY;Q<U]G:                *=#&E2
M  #*KJT\FR@                                 /!^3=:\I>\_P_P#D
M>Q\Z+<;8MP9QU,4@@QLPUG&R&IFDUCIB)J9LW#4&(;EOH3U/^G]^NK_T6
M                     .<W:W1'.3MK\^E-8D$(:EHUBUC4-&DT:*4V:AK%
M8SHV:+T4ZK[LZ6=2]T@
M         #A$E?!@       6\6]^U                      Y;I5;8
M    %D>;[2V@        #QB2I;<ZF(                        !]^MMV
M:W0M           U-2I&SY"@                     'H"^U+JJR
M.O"V=&P    *";Q@      "\^\GIH                     !2I8UI0
M   "X4\F\0                 .6Z56V   !LLMU9L               <G
MTJYL   #:Y;GS8          'P<5,KC1Q      ![LO3Y>C,N\A]W:    /\
MDUIEY^V<SK.>TS^4      ?IU:$F^JJ@                5YDX6,
M#L U9L:                 XTR5J;@      ;V+< ;
M                 'A')NM.4_>?X?\ Q_/Z,)%F-L6PN&LX60D&)%F&LX46
M9I-8:1!J9LW"PN)T)ZG_ %%OWU?^C@                      !HSV/T[R
MZ[G_ #5AK.$86%+#4$$(66S6*X7132;*4ILWBL3703J_NKIUU!WC*@
M                                            #A$E?!@       6\
M6]^U                      Y;I5;8       %D>;[2V@         ?#15
MQN.;2                        >Q%LR;V^M            UN2I8SKN@
M                   'TY;8F^%EG--D      =>%LZ-@    4$WC
M%Y]Y/30                     "E2QK2@      %PIY-X@
M     <MTJML   #99;JS8               Y/I5S8   &URW/FP
M  !\M)5SLYD,@      #_6MB)=GE]T/5#ZE?ZS\:/@+/'S7<U73X!
M!]NMJ":Z*V@                #6*2EAK"      +@4WO5:
M    !\(E'1GYE      +-+?8-0
M/".3=:<J.\_PY^3Y_1AJ%Q3&R+8MA<-9QLQ9A<3'6<+,;$U+4+"PL34MFH7H
M1U/^H]^>K_T<                      -).P^H>6O='YE_SN,:BU=8I@86
M%+#4$$(:EHUBN%T4VFBE+OAUIW1U*Z:[\R4
M                          #A$E?!@       6\6]^U
M        Y;I5;8       %D>;[2V@         #^63@Y9P-9_B
M            !N&MK&:]XM             \MDJQ)H%<@
M    ?9K:]FM_+:G[/--D      =>%LZ-@    4$WC       %Y]Y/30
M                "E2QK2@      %PIY-X@                 <MTJML
M  #99;JS8               Y/I5S8   &URW/FP           /YC@(SP<N
M?\H                    V:6U<UM(H                  IX,Z1,@
M #9E;J#>8                 *P;/(]D     ?5K>.FOL[0
M                      !X3R;K7E5WC^'/Q_8^=%&H;@Q3&R+8MQ7'6<+F
M$A<3'6<+,:2RW"XU$J:EOH1U/^I-^.K_ -(                     #2;L
M/I_EOW/^9/\ /4A36*0F-1:UK"3 QL*:A8,4*66X7%K&U:F]X.N.X>K'2OZ(
M_P!%                                                    '")*
M^#        MXM[]J                     !RW2JVP       +(\WVEM
M         &D,E8ZYUB0                    #*NT$U8H7Z)0
M    /X). ]G"1/Y4                  'N*VNVMP%%3]GFFR      .O"V
M=&P    *";Q@      "\^\GIH                     !2I8UI0      "
MX4\F\0                 .6Z56V   !LLMU9L               <GTJYL
M   #:Y;GS8            '.]*Q;/BZ                  !77W.K'R_8V
M@                  <:I*U%P     +#3?=)0                 -!9*A
MMP     .NC5GAH                                    >$\FZTY5]X
M_AS\GV/0Q2"*-PUB0F-D6Q=8V868V0SBL&.LX7.-J:F:BW&HEZ$=3_J;?GJ[
M])@                   #2?L/I[EWW/^8_\Z@Q((MA86"$PIK46XR8&-A3
M4+!B@-2W"[G]?=O]9.D?TA_K-
M                  <(DKX,       "WBWOVH                     '
M+=*K;        LCS?:6T           #\*.&=SPFN?E8
M   &Q"V4VNB*@               :0R5G+G51                 !T8:L^
MR^KV@5/V>:;(      Z\+9T;     H)O&       +S[R>F@
M        %*EC6E       +A3R;Q                  Y;I5;8   &RRW5F
MP              !R?2KFP   -KEN?-@            #S^*\]SQRN?\(
M              V#6R/-=(K0                   /@8HYWQ_.@    _0J
M[[GR>OT                 !_DE*5G7)     +>#>_B@
M                     >$\FZSY6=X_AK\CV?12I<;((HW#6)"8V1;%UC9A
M9C<P8D5A<XW.-J:EJ%Z#]3_J???J[])@                  #2KL+I[E]W
M+^8_\=8QTBH5-0N*01;"PU"8IC36HMQDP,;"FH6#%-P^!=M];>C?TS_1-@
M                                                  #A$E?!@
M    6\6]^U                      Y;I5;8       %D>;[2V@
M     >-2<&K./5GX4@                 ]!7NNO;27Z"T
M   #\N3BZ<%;GS-               !Z MAEKL;+_M0 J?L\TV0     !UX6
MSHV    !03>,       7GWD]-                      *5+&M*
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MPU"PF*8TUJ%PLQC&PNV?!NU^N_17Z>_JSY
M                            .$25\&       !;Q;W[4
M         #ENE5M@       61YOM+:             !XU)Q8LXYIY6@
M           ]I7M4O9Q?O5                   ^(DXM5Q.9\@0
M      ?O'9)KO6OJ*@ "I^SS39      '7A;.C8    %!-XP      !>?>3T
MT                      I4L:TH      !<*>3>(                 '
M+=*K;    V66ZLV               .3Z5<V   !M<MSYL
M :-2<,+.:%S_ #0            ![2O:=>SZ_>J
M!XW)3,N?*D   'H5MRW.O?;0                  /P8IUW&HJ   #^TMR3
M>_=H                                      \+Y-UGRP[P_#'Y7F^?
MC=86XU%J6%B2*BTUBU!BS&D76-N*87.-D$$5A<8:G0;J;]5;[]7?I8
M           :6=@]-\P>YOR_A8:@Q("FL3'3&HM+$N)!%0L-0L)BF.BZA=G^
M&=E]@.A_U/\ W>/S
M          #A$E?!@       6\6]^U                      Y;I5;8
M     %D>;[2V@              ?CG-.3E!9S=L^8D            'T5O1^
M7KC+TH7]*@                    /QI.7AR!LY[W/\L           >R+V
M&7M#+[#:   *G[/--D      =>%LZ-@    4$WC       %Y]Y/30
M              "E2QK2@      %PIY-X@                 <MTJML
M#99;JS8               Y/I5S8   &URW/FP               !X+)R*L
MY2)JZ@          ^BMZ/2];5Z6Q^E:                       -/I*H%
MSXF@  ]9MM<YUNU:                   !XM)4ZN=04  'T99S;ZK*
M                                   /"^3=9<L>\/PM^3Y_GFDUC;A;
MA2U-00D$6F\5A,4C2+K%<;,+G&R""*Z!=4?JC?7J_P#2@
M TN[!Z:YB=R_ES_+2"%A2FH,2%+"PN&I%8U+42XD+%D+#4$&R7$>Q^PG0WZL
M_2\7G
MX1)7P8       %O%O?M0                     .6Z56V       !9'F^T
MMH                ^:C0"SGHFAJ:C)^:        #_ 'K:27?1>B"]#8^P
MM                        \FCFI9SE30=/*4        V'7HLO4"7H O]
M]    "I^SS39      '7A;.C8    %!-XP      !>?>3TT
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M3Y_GQ46I4UA;CJX45-00F(M-8M8I%D5%UBN-SA9C9!T"ZH_4^^?6'Z5
M          &F'8'3/,7N7\M_YW,!87'6H,5*4UB00&H6*PJ*BV%B6%A(K8?B
MG8O8?H3]7_K>'V0
M         !^1'Y(       /H:_L                      /SX_"
M !^RGZEH                  ^>C55-5:UN3P8\;/*3Y!/C(^?H?KU]7'V9
MZ>>P+[P;&+M)&W:_:4                           ,#7B-0+-64UU/$#
MR9/A:^1/S8_L/JJ^[CUH]RMV/C;-=TH]JM      'S\?Q       _0K]T
M  ^2@       ?46?ZJ                     !\P?XP      !]$?UT
M              /SX_"   !_M7TX               /SH_#   !_0?2T
M                !XS&K5FO,>)6>5GPY\V?G'[\?:5]X>OGO2[,QLVOT=
M                           ?D1B?LT                       !^?
M'YI]%0                                          \,Y+UCRT[P_"
MOY7G]#%8,:6I4UA;C;AH5-00F-&H:A<4BR+<;87"YQU.@'5'ZFWRZP_2H
M           TQ[!Z7YD=R?EC_.R&BPN) 6+K&V#%2FBXD$!J%QK&L:6POO7%
MN?=C.@_UK^UX/;
M
M
M
M
M
M                                                \-Y+UARW[O\
MPK^1['SX7%8:A,:6II+A;A;CH5-08I%&H:A<4BS&V+8MW^ZI_4N]_6/Z3
M          &F78'2G,KN3\JXK#474&-0T7$A8"Q=8VP8J4T7$@@-0N->V<=Y
MOV/Z!_7GT'K>Z
M
M
M
M
M
M                                               !X=R7K#EQW;^%
MOR?/\Z*QTA<5A8,:6IJ)<=7"W&C26#%(HU#4+BF-D6[^]5?J;>[K+]*
M       #3+L'I'F7W+^4<-1-,Z31N&HUK$A84N*P0%BZQMQ(4IJ%@@]BX_S3
ML?T%^O\ Z;U/H
M
M
M
M
M
M                                                 >'<EZPY<=V_
MA;\OS?/&-D:8U"XM08D:%342XZUA6-&DL1C9%&H:Q6$W?ZU_2G03JK]1_P"L
MV          (313LS\^\Z^VOR]_GK)HV;*FF=)LW"QK6)"PL+"P0%BZQMQ(4
MUZS\+F'9#H']@_5^E]0
M
M
M
M
M
M                                                       #P[DO
M6'+CNW\+?E^;YX QJ-3&L5AJ#$C0J:B7#6L:QM*EQ2"*-PNPW$>W.F/3?[#^
MN]'[8         ^?]GYW,_N3\GZE\[Z13<W<RK<5-FS1I*SI-FXNH7&H6%A8
M6" UC;Z=\;EG9#H#]C?9>A]<
M
M
M
M
M
M
M #P[DO6'+CNW\+?E^;YX $$5&IC6*PU!C44:9L6X76%1:5-8LP17T7I_;W]Z
MK_5&WO >]_Z,^0       8LZI<YZ;YR=N_E+XGZ7'C>)"PJ;F[E2XM&C9HTS
M4TFS<76-L1C::A8/1/D\F['= ?LO[KYWVP
M
M
M
M
M
M
M            /#N2]8<N.[?PM^7YOG@  01J16%0U"XD6Q85G4-8:N%1:E2X
MV0>B?)YCNWUM^D=J^#=W?L^#W@    !_!Y/!JUS?IG1CLS\X>.\BX!"XD*FY
M;-8D$-)Y,FBQ;#1HV:-,Z32:-Q=8VQ'WGS.2=B^@/V;Z#\S[X
M
M
M
M
M
M
M                            'AW)>L.7'=OX6_+\WSP   ((U,:QJ%AK
M$BHHTS<;K&W"HM2PL2?I>+W]B.(]N;#<3[8]JXYV+Z5\?E_]WC\X _EWXO./
MK<4\6Y'U[KURWJO6CF74'SWN?(PN<-2"9HUBL$*FY;-8D+"GDRFBQ;#1LT;*
MS4VF_M/G\A[$= _M'TCY/(P
M
M
M
M
M
M
M   /#N2]8<N.[?PM^7YOG@    01IC9C4-0N)%0&DN-UA;CI"I86$@S>7Z7T
MON?M^K],U^'[7S?EO=^)_CY/'C;BF%SC9!!%F%SAJ0LS::QJ*B:F:-PU"P0L
MSR2V(NH4V;-?6_.^[V&Z!_;'J/QN4
M
M
M
M
M
M
M           >'<EZPY<=V_A;\OS?/      BHK&S&H:Q6%BR*32:QMPMPT*F
MH(3&BF\5Q2+(J+K%<;,-9Q2"#&S#4QL@F;+BN-)J9HW#4$+#4S<W8AKZ;TOL
M]@^@/V]ZU\/EX
M
M
M
M
M
M                                                       'AW)>
ML.7'=OX6_+\WSP      (K&R*QJ&L5@QI:E36%N%N.A4U$19C18;A<4BR+<;
M87&S"YQL@@QLPUG&R)9;-84B&IFS<-0F*FOHO3^SU_Z"_;_L?P.;
M
M
M
M
M
M
M                                    >'<EZPY<=V_A;\OS?/
M  BL;(K&W%86#&EJ5-86X6XZ%34$)C1J&H7%(LBW&V+<&<=3%((,;,-9PL-3
M-)K&L:34S9O]OUOJ=>>@OW%[9QWG@
M
M
M
M
M
M
M             'AW)>L.7'=OX6_+\WSP        ,;(K'2%Q6%@QHIJ)<;<-
M7&BIJ#%(HU#6*PD68VQ;"X:SA9"008ZF%SA8:F:36&G['K?2ZY=!_N7W;C78
M8
M
M
M
M
M
M                                              'AW)>L.7'=OX6_
M+\WSP         ,;(TQK%86%Q(T*FHEQNL-,:-,V#&R*-0U"XIC9%L6PN&LX
MV8I!B8ZSA9C9^EX/>ZU]"_N?8'BW98
M
M
M
M
M
M
M                'AW)>L.7'=OX6_+\WSP          ,;(TQJ%Q:@Q(T*F
MHEPNL-(M*EB,;(HW#6)"8V1;%N*X:SC<PD+_ &>+V^KW1?[=V+XEVH
M
M
M
M
M
M
M                                         !X=R7K#EQW;^%OR_-\\
M           019&F-8K#4&-0+4U$N&M85%)HN*011N&L2$QLBV+K&S^CQ^?J
MCT?^V-E>']M
M
M
M
M
M
M
M>)<CZTY=]V_A;\3V/E@           ""-2*QK%8:Q(J*2IJ&L-7"HM2I<;((
MHW#6)"?VX]KJ/TE^U]E.']L@
M
M
M
M
M
M
M             >4?<X'RY[M_"_R'O\;             $$:F-8U#4+B144:9
MN+6.KA46I8EA(J*^@]3[74WI#]M^[\9[)
M
M
M
M
M
M
M                        ^,^AQSF)W3^(/(?O]<@             ""-3
M&L:AJ%Q(J*-,W&ZPMQJ+4OI?Q>;=2^D?VUZ5\CEP
M
M
M
M
M
M
M                               '\._5Y_=K?DS4+G_YT
M    $5%F-8U#6*P14!I-8V[0\)[SZ/\ 3_Z^_:\'T
M
M
M
M
M
M
M                                  !KGRWI_G9VY^.?DO?XZ
M        !%8V16-L+BL'[_J_9Z%]2_KS:S@_>(
M
M
M
M
M
M
M                                'X/L_+T0[/\ ROJ+S_\ ._\ E?&
M               (K&QK6TG!N^>@'5/ZR^K]+[@
M
M
M
M
M
M
M                                   \N^UP?0SM'\J:[\MZ:
M         'NG&.UM].KOU=[)Q_L0
M
M
M
M
M
M
M                          >0?>Z^TJ['_-&MW,>E?\->$
M  9-;"<2[@W5ZX_3/N/&^S0
M
M
M
M
M
M
M                      !\7]'CFJ/.>A-6.<=$>>?6X8           /M_
MF\JVCX1WIMEP3O\ ] ^7RL
M
M
M
M
M
M
M                        0GE/V^"ZZ<OZ;\"Y5U-X]R#KG^/R>J
M /Z,^QZU\#L'WWBW;&Q7$>X_8>/]A9-
M
M
M
M
M
M
M                                    #^#R>MY3]S@?E/W>!>:_9X5\
M%]3BGQ_T.._->[\+\CS>E_%Y/6']6?/^QZ_O?2>G]SZ_T.0?=_+Y5Z3\;FGJ
MGP^>^M_"Y]^GX?=
M
M
M
M
M
M                                     '__Q  T$   ! ,&!0(& P$!
M 0$    $!08' @,(  $P-T!0$146&" V8! 2$Q07-2%PD( Q(B/_V@ ( 0$
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M  !%8+6FY26GQ8]K1F#3*K1T6YI:]M&Y/7/5"%0Y WB<VAY<V,>FW)+9*O\
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M/%WJ:RD1S5)>9.:C2(V2JB!*Q-^=::UXQ>=)J*ZG<[=%TA0BM"#P PK%Z/\
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MM;E^W'C6&M.=K[SHN1'W1OO"Y0P-6A!X 85B]2VKE?/[$<]QI:4"S9LR?-L
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MUD:-%2:2)J^""&7#X5:9S8U%N:6K17HW;7ES8QZ;<DMDJ_R@P&:S8V"LC*?
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M9(25_]H " $# 0$_ >AD2YDTW94M<Q6I"5+/@D&)-@6Q/:Y03DO_ *8)D?\
MC*1$K<=:J_UBZ60/XIBEJ\)<M2<-+K'5$K</IG6CVIE4[ZOKKFCK'ZO4>J)>
MXJS1^LJ*R8>I4I"?#@E'/^+JZX1N2L1/O4\V9_/43A_X:Y<)W.6(C*SY1_F5
M.7_SS#XYZWA-BV.DN+-H_P#%(0L>"@1WF$V79:2Z;-H$G6FCIP?A+C^CK/\
M_0:/_P"%D?\ T1_1MG$,:"B;_P!ED9:OU<?T19)!']&6?B&PHZ<>!3+!!ZP7
MTO!L&Q59V;2X?NHNY_RD?&%;EK!7_80G!G14522.MN&NOJO PO<78J_=];E?
MR3P?_$ES,OSB9N$I"_ U]0C5PDN5-[/<X%]#Y?'";N#JP_ 5],O5PLN;)?\
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M%0^^\/#]</%Z+T/O/ 5%Z']AX"H>'WGAX>',/#P\/#F'AXO0\/#P\7H>',/
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M.VO?>']EX?V+T/OO#[WI0L?U>T*:V)2&EUZ. J2!@*J0GB*)US:=@-? +/\
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M]>VF+QV B\=@(O'8"+QV B\=@(O'8"+QV B\=@(O'8"+QV B\=@(O'8"+QV
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MO.8#J*4@8D@ :R2S1)EB3*ERA]1"4^ #GM)QZ;Q!<8&)$^_Q5>\/^*'WGB]
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M1=5VI.D'J^>ORG2ER5E"QV'0H:Q]@-S7_P"R4'\DW_QYN]>A_8<PXWGB]OO
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M#08>'AX>'AXLPM:- =5;2GPGRS^7V((;$90\/#P\/JAX>',/#ZH> J+V\\/
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MJH6S^KRILWL)3P0ZG^EP['T/O/#[SP^\\/#[[P\!4/O[JYO!V)5#3-7(E_\
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MY@Z8JZ4R3?1C*^*#J/5J.C(XYN(>'AX>'WWAX>'AX>'B]#PYB]#P\.(>+T/
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M\X4P2"5*X%*O6)20G%1F4YF74 %YJ9>& B]#]?C#F J J']AX"HO1A^<-O/
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M_P G]T5;1(3=III%91,S>JU"E%*0S-P,Q,R0S?LKV$!47H?8;SP%0%0X]AS
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M_'RZ!.1VTCD4Y^/ES1WY)GZ%;3MM^?)CFX_'H!7EAMW\@G>.7QY$9?#;;1T
M>0&7;RA 4"" 00000X(.8(T@_&-WVYI6YFWI\J5+:SJZ]5V<H9)DJ4.%I?=
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M^SJ$%4I3X)643?>EIA:)DM2Y<Q!0N6I:%RUA25H6DE*D+2H7DK27!<!0(ND
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M@,N\_+E3EV[?=S #H(_GMM\>>G$])MS,?8I6?AY<PU=@\NA3D=M(Y%.?CY=
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M7CL!%X[ 1>.P$7CL!%X[ 1>.P$7CL!%X[ 1>.P$7CL!%X[ 1>.P$7CL!%X[
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MCCRIJ'1,01,EDN'O/&V.\Y_* J+T!48?E&/;\(O$9X=N(@+U_" 1H.^^PB]
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M?]9^K+H:V8K^TY(IJE2OTG]5-_2+BZGI52DH2I:U!*$@J4I1 2E*0ZE*4<
M'))(  U1Z1=WQMV<NQ[+F'^AI$SZ:8#A:4Z4L%*\OZM+6D*D EIBP)RAA+N7
MMYX<0"1D8OZQ#I.ENV,1 5%Z K8PX[-Z]%Z+T8'V'@*AQ^4-O;A=PWJ8E6S;
M,IZL@+HJ*8/ZKI3/GI/]ITH0?U&:OI6$K[3'+O'SYB,NCCD=M(YB,N\_+FA#
M=,#;;;X<V(;[ #GAZ.5GX>7,-78/+H4Y';2.13GX^70)R.VD<BG/Q\N;D;:N
M5O:^<OL/O^[H_;OVPY#*"=NWD!EMM^?19/(#SVV[/L)Z1?1U0;N*"^BY26[2
M(/\ 1]H-@L8GU.L8$KI5DFZIE+IEJ,V6% S94VU+,K[%M"ILRTZ:925U),,N
M=)F9@YA22.*N6L<>5-0\N9+4DA2DD%3[S"+L=N&^0#G%W5]\8C\("H"H?NC;
M"'[_ (1>V,!47H<'/&&U'QV^4.1^!@3.^ H'\8?>]%?I4]9]7W,[IZD>M<61
M9-JSEXU7U9=#7+5_:LDTU0HO4X2IQ]9N3*GI3TE[OC7JG;G;%GM1RU*EVG5R
ME#],6DAZ62L'^JH((G*&%2II;B0%\.0>V'[OC#G\H"HO;SPX@$C*+^L1@<HQ
M@*@*@*V,..R-L(O0%;& J,_8>-P>X4RN!MNVY/TW%F4%GS4_J<E(JJI!_;9*
MD2%?J<%S$\-=3)^TYR[Q\^8C+HXY';2.8C+O/RYJ0W2S;;;:/LN.>'HY6?AY
M<PU=@\NA3D=M(Y%.?CY= G([:1R*<_'RYQERSQGES1QV^6VSPYY9FZ#.VWPY
M<="*SYAU:OL+Z1/1W0;N*"\G@Z6W:26?4*^[@H8GU2KN@J73+43=4RETZU&9
M+!"ILJ;:MDUUC5]39EIT\REK:289<Z3-S!&2D')<M8-^5-0I4N9+*%)*DJ!C
M$1>A]ZZ.SLBZ?8(!SB[J/C&(V<0%;"+T/W1MA#GM@*V,!4!6PAP<\8;4?'[X
MO%/4_? F=\7A'HL]*OK/J^YC=-4?I/%D65:L]7]9^K+H:Z8K^TY(IJE9_2OU
M4U7K-Q=3TEZ3?2"9/#[F[$F_2D*E6M72\>""@RJ&F6/VI=JF:G]5^H0>%X;@
M8>'AA!![=YS^4!4/O/#P"1IB\^8\-OG&!R,8B J J J'[MZ] 5L8?>W![@VX
M&V[<DX\6;9]GS4Y:4U54@Z<C(DJ&&$R9C<2G[4'+O'SYB,NCCD=M(YB,N\_+
MFQ'2F<9;;;?'[#"#H[/OY<<\/1RL_#RYAJ[!Y="G([:1R*<_'RZ!.1VTCD4Y
M^/ESC;M@CEW,/M^'XQARSB'CMZ3.VWCX\N.A#EMM^7+C7]A_2+Z.J#=O07T<
M'26[22U?T?:%W!0Q5ZI67053*:8HFZIE3*>8HS)84E4V5-M2S*^Q:^ILRTZ:
M925M),X.=)F:#F%)(P7+6&7*FH>7,EJ04K4%))SAHQ$/OW1V0Q[?8(>+NH^/
MWQB,\(O1>>'V,;:X<_E%^ J J,#LT-J/C]\.4ZQY1Z*?2MZUZON7W3U/Z5Q)
M%E6M/5_6OJRZ&NF*_M.2::I6?TK]3-_2;BZGI#TD>D%-CRYMA6/.2JU9J2BL
MJ4%Q9LI0]Q*A_;5I/%']G3QU-,4AKQ)<DDDNYS).DZR3B2<X:&U'QC+/X;UZ
M'!SC#1&/;O/L("H<;SPX@*(TQ>!S$8:#&(B] 5L(O0^]N!W!&;P-N6Y)^CXL
MV@H)B?UFE%35((_5Z9,D^_A,F"[=2K[4G+O'SYB,NCCD=M(YB,N\_+F[=)-&
M67Y\[(;HW*%:.SYGEQSP]'*S\/+F&KL'ET*<CMI'(IS\?+H$Y';2.13GX^7.
MB-6VVVOF3G7\_.'VQA]G_"'AQU^'XPXZ_#\8<=>W?#[;"'VV:'V_.'Z^99??
MTIMMY="D-RPRVV_/[$>D7T=4&[B@OHX.DMVDEJ_H^T+N"QBKU.L8%4RF6HFZ
MIE+IYBC,EA25394VU+,K[$M"ILRU*6925M),,N=)F#$$8WDD8+EK#+E3$.B9
M+*2%*2H$A4/&<-&(A]^[W0Q[=MM/L71%W5\=OE#D0%1>>._QCX?&'/Y0%1>@
M*C Z.\1Z*/2MZUZMN8W3U7Z5Q9%DVM/5_6L;LJAKIJO[5DBFJ5*_2N+*G?I-
MU=3T=Z0_2(BQ$S;%L::E=L+24U-0EE(LQ*AD-"JU23Q$92 >$7QBA,+4J:M<
MQ:EKF+65KF+45*6M1O+6I1=2E*425*4<23B28:',/O80QU^,=WA VT1>AP<X
M;48QU/'?XQ>@*AQ#P\/ 41%X'..P_?#D9P%1Z/\ < :O@;;MR2U*&F4-#,']
M:TIJ*A)_L^1E2S_6/?7]"PG9?:HY=X^?,1ET<<CMI',1EWGY<X9]MONZ0;GQ
M&VVWPZ-5H[/F>7'/#T<K/P\N8:NP>70IR.VD<BG/Q\N@3D=M(Y%.?CY<[;HL
M!]MMM71!\]OQY4=#';;;+E1]BO2+Z.J#=Q07D\'2V[22U>H5]U@L8J]3K+H*
METRU$W5,I=,M1F2PI*ILJ;:ME5MC6A4V7:=-,HZZDF&7.DS S'0I)#IF2UI9
M<J:B\B:E22%*2H$L8O1>AXSAHQ$/OW=6$,?R]@@'\(NGJ\H<C. J+T;8QEK\
MX<_E%Z+T>BCTL"K]6W,;IZG]*XLBR;6GJ_K7U95#7S%?VK)%-4K/Z5A)G'UF
MZJIZ,](GI$38B)MBV+-2NV%I*:FI2RD68A6@?557*!XB3A(<3)G&NIA:UK6J
M9-*US%J4M<Q9O*F*4ZE+6HDE2E$E2E$J4I3XDDP\/#B&AH>'WL/RPC'1CVQE
MGAV0\7H<'.&U1VB'Z_&+T!6PAWAX>'B\8]'_ */S:G VW;<AK-!$RBHEAC:!
M!=,^>G#]"R*$$?I753X3@&P& &  P9M ^U9R[Q\^8C+HXY';2.8C+O/RYSMM
MMK@CPVV^_HUORVV\N@&VVV[.B!["M'9\SRXYX>CE9^'ES#5V#RZ%.1VTCD4Y
M^/ET"<CMI'(IS\?+GFSP>B -?AMMV=$G+E1EV]#=7*C7W;>7?]B_2-Z.:#=Q
M0%:.#I;=I9:A9]H%."QBKU.LNB\NE67NJ92Z9:C,EA25394VU+,K[%KZFS+3
MIIM)6TDS@I\B8,01B%)(XJY:TLN5-052YLM25)6I*@8>&ACKB]%Z'$-#1B(?
M?NZOOAC[%T=G9#'M^$.1G%Z'C;&,OQB]'HF]+0J_5MR^ZBJ_2N+(LBUYZOZU
M]6705\Q7]KR135*S^E829OZ3<54]%>D;TC(L-$VQ;%FI7;"TW:FI2RDV8A0R
M&856J!XJ<J<$3%\8H3"YBYBU3)BU+F+4I:UK)4I:E$J4I2E$J4I2G*E$WBI\
M22(O-&!_#"&.L=\99X;SQ@8:&,/#[S#\HQT8]L/W1MA%Z'!V^<-J,=L/U^,7
MF@*V$/'H]]'R[75*MJVI:DV4E0724JP0NT5)R6O2FB2<_P#TDX#Z)R4I"0$I
M 2E("4I2&  P  &  &  RT?:PY=X^?,1ET<<CMI',1EWGY<[;;;;LANB6?[]
MLXVVV\>@MMMOO@C;;\NOH4#7^/LJT=GS/+CGAZ.5GX>7,-78/+H4Y';2.13G
MX^70)R.VD<BG/Q\N?-JVVV>,NA .C,NDSRFVWEW?8STC>CF@W<T%]'!TEO4D
MM7]'V@V"ABKU.LNB\NE67NJ92Z9:C,EA25394VU++M"Q:^ILRU*6925M(LRI
MTF9@01B% @W5RUI(F2IB;R9J%(4E:D%)AS#[S1B("HO0XAA#0Y$/O$ Q=U??
M#'\MG]BZ.SLAB.OX0[9P%0^PC/4?A'HF]+/K7JVY;=34_I7$D61:]0O^M?5E
M4%=-5_:LD4M2M7Z5A)G'UJXNJZ(](WI&18:9MBV+-3,MA:;E34H92;+2H9#,
M*K5 \5.5./I%\:ZF%S%3%K7,49BUDK6M9*EK6HNI2E$DDJ4Y4H\92G<DG##L
M^,8C\,8<?E#]?C%Z,/RC'M^$99X0\/&!B[#&'A]YNZ,>WX1\.V'V$7HP,-J.
M]Z//1],MQ<NU[7EJEV-+4#3TZ@4+M):#W%-(DX+6/U[7$87E!*4RTI0A(0A
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M:6F29TLJES9:D+0HH(,,.SLACK!^$/KPWGC PVHPY&</#P%0^^\/#"&,.1G
M5#QG#1B(>/1-Z6?6O5MRVZFI_2N+(LBUYZOZS]670UTQ7]IR12U2U?I6$F<?
M6KBZGG7I/])\O<\B=85A3DS+;F)NU=4EEHLE"QD,PJO4GW$8BF!$V:"NY+*Y
MJYBYDR8M4R9,45S)BU%:UK676I:RY4I1<WB<7))),/#Q>@*@*A]]S#^P\/#C
M?>'AX?7&'9&(C<9N-K]U]?P4N]3V;3J2:^ON\64G/@)+X3*J8!Q9>2!]),XE
MU*K+LNBL:@IK-L^2F124LL(EH3F?WYDQ6%^=-4\R;,5QIBU*4<3_ )C7I)]&
MUG[NK/X27P=)N@I):A9]H%/%F)Q5ZC77053*28HFXME3*28HS90*3.DSK5LJ
MOL6OJK+M2FF4==1S#*GR)HXR59A22'2N6M)$R5-EE4N9+4A:%E!!WV'9V1CV
MP^]>C PQUP[9P\.8??>'AX80Q&4.1 5#QG#1Z,_3+ZLFGL#=C4*5)!1)H;=F
ME4Q4H'!$FU%XJ,H$@(K3^K3_ %H\$A4]"5)F)2M"@M"P%(6DA25I4'2I*@X4
ME0+@C C$:#S?*/2/Z7I5!ZQ86Y6<)U>+TJLM>64JD42LE2:)6(GU20XF3A]%
M3DC@U39P4)*YBIBUS)BUS)DQ2IDQ<Q16I:UJO+6M:N,I:BY4HDE1))427AXO
M0%0%;#>>+T!6PB]#[[F']AX>'WWAQ&X_<A:&ZZT/5Z9Y%#)*37UY2\NGEGZB
M-$RIF $2Y8.?TB[J 3%D630V'9]-9MG21)IJ9 2 &O3%_M)TY0'TDZ:>/,6<
M2HZ R1_F-^DGT;6?NZL_A)?!TFZ"DEJ%GV@4\68G%7J-==!5,I)BB;BV5,I)
MBC-E I,Z3.M6RJ^Q:^JLNU*:91UU',,J?(FCC)5F%)(=*Y:TD3)4V652YDM2
M%H64$'V<.R,>V'AXO1@88C*';.'AS%[?>+T/#0QB]%Z'CT?^EBUMQY19]>)M
MK6 6'JBECUF@#\9=G3)A8(9SZE-4*=9#RU4RE3)B[!W16-NFH4VC8M=*K:<W
M1,""TZFF*2%\!52#])3S@""9<Q(+,I-Y!"CS2U+5LZQ:*=:-JUDBAHY"7F3I
MZ[J=24(&*ILU9XLN5+2J9,40E"%*($>D#TPU^Z'AK*W.F;9MC&\B=//T=?:2
M,4D*(<TE*O'Z*6KAIJ<)TQ OR8O$9X=N(@+U_" 1H.^^PB] 5 5#PY@*@*V$
M7H<;[P_L/#P\;DMR5H[KK131T8X*FE75UU<I),FDDDZ<K\Y;*$B0E5Y:G4HI
MEA:Y=B6)0;G[-I[+LV4)5/3H *F'"SYK#A*B>H 7YTTB\M3 ?52$H2E(_P Q
MWTD^C:S]W5G\)+X.DW04DM0L^T"GBS$XJ]1KKH*IE),43<6RIE),49LH%)G2
M9UJV57V+7U5EVI33*.NHYAE3Y$T<9*LPI)#I7+6DB9*FRRJ7,EJ0M"R@@^VP
M[(Q[8<0\7HPACHA]</#P^^\/#PT8B+T6%NBM?<Y72[0L6NG452GWC+5]%/0^
M,JID%Y51)+GB34J2"RTLL)(W%^G.Q[6$NBW4)E6):&"!6I*C9506'&6M5Y5G
MJ*G!3.5,D!@HU*;UQ,N;+G2T39,Q$Z5,2%2YDI:5RUI.2D+22E23H4"0=',2
M0 22 D DDE@ ,R3J^#1NS],^Y[<YPM'9-VW[602A2*>:UGTRPHH5ZS6)"Q,4
M@@_0TPF$E)0N9).6Z/=A;VZVL]<MJM7472> I4/+HJ48X4U*#<1I2J:;T^8+
MO"39C P%0%0P[.R,=&/P,7R/Q@+UP"^1WN_QB\T7HO0\/#]\7H"H"H<;[P^_
MN6W+6GNLM)-GV>F[+3=76UJTDT]%3DM?F,1?F+8B1(20N>M.:):)DR7N?L"S
M]S=F4]EV;*N2I(>9-('#54\@<)4U"@!?FS&Q8!*$W9<L)EI2D?YC_I)]&UG[
MNK/X27P=)N@I):A9]H%/%F)Q5ZC77053*28HFXME3*28HS90*3.DSK5LJOL6
MOJK+M2FF4==1S#*GR)HXR59A22'2N6M)$R5-EE4N9+4A:%E!!Y#XPPT./C&/
M;V?=#P\7HP.48ZWVVTP^\\7M]S#[S1B.N-R^[W=-N0F#^A[1F)I7==G53U%G
M3<W>F6H<"HE1*IE/,D35,'FX-&YGT][GK1$N1NBIIMAU1(2:B5?K;-620 2J
M6CUJGS!(7)F2T!RJ>T4%I6?:M.FKLRNI:^F7[L^CGRY\HOHO2U* .L%E!F;E
M:BIIJ.2NHJZB32R)8>9.J)J),I &E4R84I3WF-T_ITW*6-PE/9/"[H:U(4QI
M/H;.0L 70NMFAYP458&BDU*"$K!F(4 ^ZOTG[J]UO"2JRM]2LY;C^BK.O4]*
M4F^R:A5Y4^K-T@+]8FF2XO(DH)8./RC/5Y1W^,7H"MA%Z J,-&'Q$8]OG 6=
M?C%\0^H[S]?C%YH"H"HO;SGM@*V,!4!4.-_<ON9M/=7:<NSK.1A@NKJUA7 4
M4B\QG3B-.8E2@;TY?%3@Y1N;W.V=N7LN39EG2V2@7JB>H#AZRI( F5,]0S6M
MF2E[LJ6$RI8"$I'^9%Z2?1M9^[JS^$E\'2;H*26H6?:!3Q9B<5>HUUT%4RDF
M*)N+94RDF*,V4"DSI,ZU;*K[%KZJR[4IIE'74<PRI\B:.,E684DATKEK21,E
M3995+F2U(6A900>2SSQAM6$8_E#P\7H8'*,1UP^\\/OO#Q@8:+/M2T[(G^M6
M7:%903P4_3451-IUFZ7 4J2M-].FZJ\DN1=()BP_3QNQLRY*M)-%;LE."C52
M?5:PC0U52<&A_P".=2SE'22<8LC_ *0.Y:K"$6K06G9,TI!6M"9=H4B58.D3
M)1EU2AB2#ZGDDWF+ V?Z1]PUJ"6:7=/92532 B75U L^<5*8!'!5WJ\R^5&Z
M!=XQP2\2:FGJ4WZ>?)J$YWI$U$U+'+%!4/O]F9.E24WITV7*3^],6F6GQ40(
MM#=]N+LOA!6;IK'2J4DJF2I%7+K*A+!V]7H_6)Y61BF6)96IQ=27#VKZ>]Q]
M%Q;.I[5MB9BRI<@45.XR"YE8I$]-[6FD7U\9DFVO3]NIK@J79%%9]B2U)(X4
M/:56DG2B=4(138:+U#F[D<4&UK?MNWIW#6S:E=:,R]?3ZU4S)DM!9OHI)/ R
M1CE*EH&8 Q)WKNK"&(V:+T!48=G9&VHQW^,7F@*@*B]L88=GQ$8CKZQG F;'
M[XOB'U'>>';J@*@*B]O/ 5L8"HW-;G+3W56G*LVS)5Y2N-/J%/P%'(<7Y\]0
M=DC)*0;\Q;2Y8<QN7W,V=N5LN59MGRP[!=75%($ZMJ;K+GS3CV2Y;W),MD(P
MQ/\ F1^DGT;6?NZL_A)?!TFZ"DEJ%GV@4\68G%7J-==!5,I)BB;BV5,I)BC-
ME I,Z3.M6RJ^Q:^JLNU*:91UU',,J?(FCC)5F%)(=*Y:TD3)4V652YDM2%H6
M4$'E.V&U%NV,=(\(>',.^<,(Q'7#P\/#C?>'C.+L8B),^;(F)FR9LR1,0>+,
ME+4A:7!!NK0R@X4Q9G!(B5NLW3R&X#=';TIF(X*U[00Q T7:@9 ,_9F \4_I
M!W;TU[@]U=O*O /ZQ:=35-==KOK4R<$9F]< O8/>8-/](.[BI2$S-U=NI"5.
M/5[1GTJLFQ53+DJ4,<$J44OB [1,W6;JYS\+NFW03G9^$MFT5NPP)OU)RP9W
MPPXH$3JFHJ5\)4SYT];!/"3IBYJV#L+TPJ+!\!E#C>9XNZOCM\O9NZL/C&(_
M#[HO0%;&'[HVU1MC%[7 5 5#@YQAHP^,8C\($SO[8"QV0^H[SQ>@*V$7HO1N
M=W/VGNFM.39=E2>$GS>-,F%Q)II ("ZBIF '@Y2'Q.*UKNRY25S" =R6Y6SM
MR-E2K.H4A<TA*ZZM*+LZMJ694U>*BE +B3)O%,I& =16M7^9+Z2?1M9^[JS^
M$E\'2;H*26H6?:!3Q9B<5>HUUT%4RDF*)N+94RDF*,V4"DSI,ZU;*K[%KZJR
M[4IIE'74<PRI\B:.,E684DATKEK21,E3995+F2U(6A900>6SSAM1\?OC+1#P
MYAP<X8=G9&/;#P\7H<;[P\9PVJ,1 5%Z,(:,1#PXWFB[J^,99[Y .<7=LXQ'
MX0%1>A^Z-L(?OB] 5 5#@YXPVHM\8XP__&!,[X"@>J'U;S]\6#8EI[H[3D61
M9-.9U5/+XX29$E+<+4U$QE"33R009BV<DHERPN<N7+5N-W'V=N.LI%#2)3-J
MY@2NT:\HNS:RH SQ*BB1+<IIY 44RTDDWIBIBU?YD_I)]&UG[NK/X27P=)N@
MI):A9]H%/%F)Q5ZC77053*28HFXME3*28HS90*3.DSK5LJOL6OJK+M2FF4==
M1S#*GR)HXR59A22'2N6M)$R5-EE4N9+4A:%E!!YAVPVH^,99B'AX<'.&U&,1
M#B'B]#C?>'$9PVJ',!47HPAHQ$7H?>81=CMPWR 8NZCXQB/P@*@*A^Z-L(?O
M^$7MC 5%Z'!SQAM1\8=0QR[,H$SOBP['M+=%:5/9-DTZZFKJ5&ZGW9<J6&OU
M$^8UV5(E#]9,/4P4I2$*W#[BK.W%64*2G"9]H5 0NT[1*6F54X \1#XRZ225
M*33R<@+TQ=Z=,F+5_F4^DGT;6?NZL_A)?!TFZ"DEJ%GV@4\68G%7J-==!5,I
M)BB;BV5,I)BC-E I,Z3.M6RJ^Q:^JLNU*:91UU',,J?(FCC)5F%)(=*Y:TD3
M)4V652YDM2%H64$'F6'Y0VH^,99X;SPX.<-J,8C.'$/%Z'WWAQ#0VJ'(SB]%
MZ,##1B(>'WF'9V1=/L$ YQ=U'QC$9X?& K80[]>]MKASVP%1>B]%CV1:%OVC
M3659=.JKK:E02A"< E/UYTZ9E*DRTF],6MDH2/JJ3&X+<+9VXBRQ(E!$^U:E
M*56I:+<:?,&/ R2KC2Z2221*E87B\V8\Q1;_ #*_23Z-K/W=6?PDO@Z3=!22
MU"S[0*>+,3BKU&NN@JF4DQ1-Q;*F4DQ1FR@4F=)G6K95?8M?567:E-,HZZCF
M&5/D31QDJS"DD.E<M:2)DJ;+*I<R6I"T+*"#S3#\H8ZP?A#Z\-YXP,-J,.=,
M.(> K?>'AX80QUPY&<7H>,XNQB(??NCLACV^PSQ=U'Q^^'(SB]%YXVQC;#$1
M95E6A;5?3699=-,JZRKF"5)E2\]96LNR):$\>9,F742T KF$ 8>CW<#0[B;,
M"&EU%LU2 JT[0 >\OWO5:8J 4BDE'W4LDS5#A5@<1"/\RWTD^C:S]W5G\)+X
M.DW04DM0L^T"GBS$XJ]1KKH*IE),43<6RIE),49LH%)G29UJV57V+7U5EVI3
M3*.NHYAE3Y$T<9*LPI)#I7+6DB9*FRRJ7,EJ0M"R@@\VP[.R,>V'AX>,##'7
M#MG#B',7M]X>'AA#'1#D0%0\9PT8B'W[NK"&/;MMI]BZ(NZOC#D9Q9U!6VM6
MTUG6=33:RNK)J9-/3R1>5-6<=+!"$!US9JRF7+EI7,F$2PN8CT<>CRBW$6:E
M<U,JHM^LE)_I*M''2A^-ZG1J4E*DTLM69NI5/6+ZP$B5+E?YE_I)]&UG[NK/
MX27P=)N@I):A9]H%/%F)Q5ZC77053*28HFXME3*28HS90*3.DSK5LJOL6OJK
M+M2FF4==1S#*GR)HXR59A22'2N6M)$R5-EE4N9+4A:%E!!YPP[.R,>V'AXO1
M@88Z(=LX>',/&&\\7H>&$,8O0%0\8&&C$0^_=VSAC^6_0T-7:=93V?04\RJK
M*J:F33T\E-^;-FKR2D9!@ZE*40A"$JF3%)0"4^C3T;4>XBA]:JDRJG='6R@*
MZL#+32RU,KU"C40")2"$^L3O?JYR;ZB)29,J5_F8^DGT;6?NZL_A)?!TFZ"D
MEJ%GV@4\68G%7J-==!5,I)BB;BV5,I)BC-E I,Z3.M6RJ^Q:^JLNU*:91UU'
M,,J?(FCC)5F%)(=*Y:TD3)4V652YDM2%H64$'G3#1A&/;#[UZ,##'1#Z]YS%
M[?>'AX:&,7H"H<0PAHQ$/OTE%45]5(HZ*1,J:JIFHD2*>2DKF3)BBR4I2 Y<
MMG@/>P ,>C'T:4NXRB375R)=1NDK)7Z5/P6B@E+Q]1HSH&7K,\%Y\P%(/ I2
MG_,T](GHVLO=W1WR4T5N4LI::"TTI'&&*DTE: "J=1J67#?2TZBJ9)+*G2YU
MM6):>YZT:BRK7I)E)6TRB%RY@-U:7(3.DK]V=(F,3*FRR4+#MB&'.V&C#RC'
MM[(>'B]&!C'MA]</#Q>WW,/O-&(@*B]#B&$-%#0UMIUE/9]GTLZKK:M8ET]-
M)05S9JR"62!D$I2HS%EDRI8,Q2TI"E1Z-O1C1;C*9%?7B76;HZB4T^HP5)H$
MK'&I:%QFW%GU/O3L4HNRN*K_ #-=W>X"Q]W=G>KUH]6M&G0K^C;5EHO3Z-9+
MW%IO(]8I)A'TU,M0P)7)7)GW9J=U&Y2VMR%IKLRV:8RI@=5/42W52ULEPT^D
MG$ 3$8B^EA,E*-R:B6O#GOQAM1;XQCJ\(<0\!4,#E&(ZX?>>'WW,/&!AHQ@*
MBP;$M3=):5/9-CTJZJLGEV2XER988+J*F8>+)D2KR3,F+P#I2+TQ4M)]'_HX
MLO<12":R*VW9\N[66FI#% 5<*Z2C!QE4H4D.?UL\I"IN 1+E_P"9ONGW*V+N
MNLR995M4HGR3QI$]+(JJ*>S)J*2>Q,J:G2"%2YJ7E3Y<V4I2%;O_ $;6UN&J
MRJ<E5=8TY?Z%:\I!X(OE3UB1>]5J@/JJ/!3AQJ=:VF2Y//L\\8;5A&/Y0\.8
MO0PC&'WGA]]X>-QFX6W-V]<)%FR>"HY*T)KK4G)/JE&@XG$,9]24.95-+(6L
MW"I4F3],G<AN+L7<79PH;*DO-6$FLKYP2:RNFCZ\Y8&"$DG@I"&ERAD"HJ6K
M_,YK*.EM"FGT5=3R:NDJ9:I5135$M,V3.EJS1,EK!2H=HSQS8QZ1?0?569ZQ
M;.X^7-K;.2%3:BQG5-KJ1(XRC1$WEUL@!SP.-6AF3ZP"Z"""00006(.!!&8(
MUC2.@,\X;4?'>>',.#G&&B,>V'AXO0XCT>^ABTMT)D6MNB$ZRK$)$R73%-RT
M;3EL".#2?ZG33'_7S$&:M+\!*:8FH39EF6?8U%(LZS*65145,BY)D24W4)&E
M2C[RUJ/&F3%E2YBB5K4I1)_S/?2!Z(+$W8\+:%#P=C[H%<8UDN6]+7*#86A3
MH:\M0%T5<IIZ7O3$U*4IEQNDW*6]N2K30VY03:19*N G>_25:$EN%I*E/T<Y
M!#*(!$V6%!,^5*6Z1T#VPVH^,99C><PX.<-J,6'N?MK=)72[.L6@GU]4O$IE
M) 1*1C])43EW9-/*&1F3ERTN0B]PBD@[@/0O9.YO@+3M_@;9MQ-R8B64W[,L
MZ8GC T\J8A)JIZ%,14U"62I"5R),I2>$5_F?VO8UEV_0S;-MBAI[0HYPXTFH
M1>NG(3)2PTR3.0[RYTE2)LLXH6#C&[?T"6A0&;:&X]:[3H[Q6JR9RDBT:<%7
MNTLTW9=;*0D^ZLRJJZD "JF$F)TF=3S9DBHDS)$^2M4N;)G(5*FRIB#=6B9+
M6$K0M*G"DJ2"D@I+9=![:H;4?&$H6M:9:$*6M:@B6A"2M2UJ8)2E(!*EJ+)"
M0"5$I QC</Z#+:MS@+0W2F;8-EJ"9B:6Z!;%4A6+<$L%-GI(S55(5/&7JC$+
M%@;G+%W,4*;/L.@DT-.&*[@*IU1,"0GAJF>N].J)Q  OS5J( "$W4)2D?YH6
MZ[T>[F-V<IK6H0BM";LFU*-J>T).!"1PP24SY:7)$FJ1.D@XI2E;*C=CZ%-U
M&YKA:NS4_P#E#9222)M%)7_2$A&+&IL]-]9"1[TZE5/0,5S!)3A!!!((((+$
M' @C,$:QI'06Y'T.[K=U/!U$VG_H.RUL?7K3EK1,FHQXU)0\6HGY.E4SU>0M
M*@43U1N.]&.Y;<8E$VBI376F ;]K6A<G5;DNU,D)3)HTCW1ZO+3-*&3.G3BZ
MC_FC;J_1EN2W7IF3*^SD4MHK<BU;."*6NOLP5/4E!E5>C"KE3B$AD*1F-U7H
M)W56,J946)<W1T *B$T[2+3E(XQ'"44Q5V<PNI>CG3ILQ>(II:<JBGGTLY=/
M52)U-42E79LB?+7)G2U,]U<N8E*TEB[*2,,6YZA"YJT2Y:%S)LQ:9<N7+2I:
MYBUJNH0A"74I:E$)2E(=18 $F-RWH1W8;H!+J*Z6C<[0+8\-:2%&M4D@&]*L
MQ)3.?' 52Z1]"C&Y+T3[D-R7!U$FC_I2TT,1:5J"7/FRU!^-2R;B::E9R$KE
MRN'9@J<O/_-+M_<EN<W42>!MRR*2OXI2B<M'!U<D'_05DDRZF3V2YH2690(C
M=)_T=I"^$G[E;85)/&4FSK729DM\PB77TZ1,0D>ZD3J6>K2J?@8W0>C[=AN8
M,PVK8E8FF0%DU]*CUR@N2\3,554O"2Y"2DWDBI,A9 )*1=5=YQ8.XC=5NF4C
M^AK$KJJ4O^V&7ZO0IXUTE5;4&5388DH$Q2R$JNH=Q&YS_H[3E&7/W56RF6G-
M=G6.F_,.(("[0J4!".*"E:)5),][B3Q==6YW<1N7W*H";$LBEI9K,JL6#45\
MQR20NMJ#,J+I*C]&E8EC)*$I  _S3LXM[T:[B=T95,M&P:1-2M5]590A5GU:
MEW;@5-G49D^L$)P J1-3@CBFXEK:_P"CE(5>7N=W0397O%--;,A,X$GW1Z[1
M)DE"<P?T&:6(S(+VQZ&_2!8]]7]"FU)*$WN'L>?+K;S.Z44HX.T%*87F]3-Z
M\R+RG0FLH:VSYO 5]'544X#&35T\VFF]\N<A"^K+/F-/2559-3(I*:?53U^[
M)IY*YTU6MI<M*EG$@'BYG&+']$>[^V2A4NP)U!(F8\/:RT6<E UJIYY%:0=%
MRD62#> ;&+%_Z.*C=F;HMT('%X])8U.Y"G!PKZT,R0X;^CN,2"XNLNPO17N&
MW/%$REL.15U*+I%9:A-HSKZ<IB4U-ZGDK&=ZGD22X!S 8 ) 2D!*4@!*0&
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M0(  Y(%1RS4^+ J/-B4I$J4$CB3 S]=*N+=/6?9$\74#9[:\+MO]Y8_OF_\
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ME*05*42  !F22<@ ,R3ZZTDTR4YSEC@ZREO-#U^DD+7N*+4^@C^?'25^BU
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M)0.8,CEBH/+'#RL5%:7V&LVUB+8Z3<,W!&]"C[DH_LK)03MZ:!L3^^%E7?\
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MN)^#<!PLXMB3-M!YD>ZW*AZ+""-83N+AAM)&8*YW&DI2D!*0$I2 E*1L  @
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MX]+%61PU;5:OQ>3_ *TU^3AD>_8JZO\ HK5+7WJ?>W[X]E,_D_P5LRZ[?/\
MS5/-(1_ELI7_ (ZM]%-'[;J88RL\;@N7,^Q];B?8$@?::9MV+=.HPRRP@9!+
M+:&T_P!E  ^[QHJ/(145'D8J*CD]>SOW-:68[_*MWX/;KFPM%$-D')][JK?X
M%(S0S\S67^D('T(]_P ?*CZA?0+2:0G KUS-,_R<ZL[1M-F2=XZUOQ&LT"(:
M29\O/&H'&H/D-,M#=7G<7PAKHYN7MDV.KO5<6Z1Z.]UH#+-QL:LI3\D&G7&'
M$/,K4VZVH+;<0=52%),@@C,$&M%M*&\8;%K=%+6)-IS&24W2$[76AN6-KK0V
M9K1T)")J14"HY9J>-0-U0?@B!4>0BHJ/(Q6F>/BV;5A-HOW=Y'YVM.UEE7Z&
M=SCPZV]+1XN CZ$N_P"/U!7?U=^_;YRA2VU)6A12M"@I"DF%)4DRE22,P08(
M/9-:):2HQRTYE\A.(VJ +A.0Y]&P7*!P5D'4CJ+W:JTS4U(\M-3QJ.%1XVF6
MANKSN+X0UT<W+VR;&S>JXMT@=7:76@.CFM B0GY(-.N,.(>96IMUM06VX@ZJ
MD*29!!&8(-:+:4-XRV+6Z*&\3;3F.JFZ2G:ZT-@6-KK0V=='0UDHCDFI%14<
MLU/&HX5'P1 K5\A%1X^D>.MX)9E2=55Z^%(M6CGGO>6/U;4S\]6JB1)(==<>
M<6\ZLN.NK4MQ:C*E+494H]I)^A/O^/R//[BO?O\ =\E^_K[]^SY4V%_<X9=L
MWMHX6WF52/BJ3Z;:QZ3;B>BI)W;(,&L#QJVQRQ1=L'56(1<,$RMAZ,TGYBMK
M2_31P(4!RS4CRTU/$5'"H\33+0W5YW%\(:Z.;E[9-CJ[U7%ND>CM+K0'1S6@
M:NLE/R0:=<8<0\RM3;K:@MMQ!U5(4DR"",P0:T7TI;QEL6MV4MXFVG,9)3=)
M2,W6ALUP,W6ALS6@<WK!&51PY9J0:BH/+)J1OJ.%1\$14>0@5'+BF)VV$V;E
MY<JZ*<FVQUWG3U&D=JMYV(3*U=%)K$L1N,5O';RY,K<R2D3J--CJ--SL2F?:
M25'I*/T*=_Q_>T[]^_W_ "RP/&KG [U%U;G6081<L$PBX9F2D\%C:TY!+:MQ
M25)5AV(VN*6C5[:.!;+J9.?2;7EKM. =5QLY*3ZBDE!2KQIJ1Y:34BHX5')I
MEH;J\[B^$-='-R]LFQU=ZKBW2/1WO- =#-;?1UDI^2#3KC#B'F5J;=;4%MN(
M.JI"DF001F"#6BVE#6,-BUNBEK$FTYC((NDI&;K0W+C-UH;,UHZ$I1%2:RJ.
M')-:U9&HJ#RR:RJ.%1\$14>0N[JWL;=VZNEAIAE.LM1^X) S4I1R2D9J40!6
M/8X_C=X7ERW;-ZR;6WG)I!B5*W%UR 7%>I .JE/T*]_Q\[]?[J1^CK1O2*XP
M&[U@5.63R@+NVGK#8'6Y@)>1N.Q:>@HQ!39WEO?VS5W:.I>8>3K(6D_:E0VI
M6DY*2H I,@@$5/C34U/EI-95%:9:&ZG.XOA#71S<O;)L=7>JXMTCT-I=: Z.
M;C8U=9*?D@TZXPXAYE:FW6U!;;B"4J0I)D*21L(K1?2EO&6Q:W92WB32<QD$
MW24[76A\>,W6ALZZ.A(1WSJ.^WDFLJCDFM:LC45!Y9K*HX?!,"H/B//-6S3C
M[[B6F6DE;CBS"4I&TD_@-I.0DFM)=(W<<N-1O6:L&%'F&M[AV<^\-A61U4[&
MDDI&965?0KW_ !^37#]X,_(O1C29_ ;C47K/8>^H>$6^]!R'/LSD'4@ *3DE
MU("5$$(4FUNF+UAJZM74O,/)"T+2<B#]X(,A22 4F4J ((%9^NI\::UO+S6F
M>ANKSN+X0UT<W+VR;'5WJN+= ]':7F@.CFML:LA'R0:=<8<0\RM3;K:@MMQ!
M*5(4DR%)(V$5HOI2UC#0M;LI;Q)M.8R2F[2/TK0W.;W&AVK0-0D-YBIXBLO^
M]1WVU!J:R]51R34UD:U:CEFLO54?!,4\ZW;MK>?6AIIM)6XXM02A"1M)4=@K
M2?25S&7C;VY4WAK2O<T9I5<K'Z=T</U39ZHZ2@%DA/T+=_Q^2!_=M/RLT8TG
MN,!N-1>L]A[ROSBWG-!V<^Q.0< ZR<DNI 2HA00M%K=,7MNW=6KJ7F'DA3;B
M#M!^\*2<E)/22H:JLP0.7.I\:36MY;3+0W5YW%\(:Z.;E[9-CJ[U7%N@>CM4
M\T!T<W&^CK)1\D$+6TM#C:U-N-J"T+02E2%),I4E0S!!S!&8-:*Z6MXJE%A?
M*#>))3"%Y);O0D;49@)?U<UM9!4%QO+60W J*S%3Q%??45!%3651R2:FLJU:
MCEFLC4? UQ<L6C+EQ<N)99:25..+,  ?>2=B4B5*,!()-:2Z3O8VYS+(4QAS
M2I;:GI/J&QY^,ICJ-YI;XJ5TOH8[_C\JC^X%N^C[1G29_ 7]1>L]A[ROSBWG
M-!V<^Q.0< ZR<DNI 2HSJ+3:W3%XPU=6KJ7F'DA3;B=A'MS!!D*284E0*5 $
M$#6\2*S\>34^4TRT-U>=Q?"&NCFY>V38ZN]5Q;I'H[WF0.CFX@:LA/R0"E)4
M%))2I)"DJ22%)4#(4DC,$',$9@YBM%],Q=<WA^+K"+G)%O>*R1<'();>W(>.
MQ+AA#IR.JY'.<D"HJ34BOOJ*S%3650>234UD:CQ)K(]E1\!7^(6F&6R[J\=#
M32/:M:CL0V@9K6=P'K,)!(T@TCNL=>Z4LV3:IM[4&0#LYUXB.<>(GYK8.JV,
MUJ7]#'?\?W8Q])&C.DS^ W&HO6>P]Y7YPQ,E!V<^Q.0< C63D'4PE1!"5)M;
MJWO&&KJU<2ZP\G6;<1F"/Q!&84DPI*@4J ((%2:GQ(\A)J?):9:&ZO.XOA#7
M1S<O;)L=7>JXMTCT=I=9'5S6V-762GY(Z,Z:+M.;L,66IRU$(9O#K+=M^"7M
MJG60,DJS6V!$+1&HVXAU"'6UI<;<2%H6@A2%I4)"DJ22E0(S!!@BI'+%14FI
M]E??4=S68J>-95!Y)J:@5'B3QK*H\^QO'K' V.<N%:[RP>8M4$<Z\>/S&AZ;
MJLAL3K+(0<7QF]QJY-Q=KZ(D,L)D,L(/HMIXG+7<,K7 DP$A/T,]_P ?WV^_
MJ[]^WS4_#>C.DS^ OZB]9[#GE#GV)S0=G/L3L<'I)D)= A1!"5)MKFWO6&KF
MV=2\P\D+;<1L([>!!D*2J%)5*5 $$#EFI\7/_MX\U/D-,M#=7G<7PAKHYN7M
MDV.KO5<6Z!Z.TO,@='-QL:LA/R1T?THO<#6&L[FP4J7+52LT2>DNW5^C7O*?
M>UG: HZXPW%++%[<75B\'$9!:3DZRO:6WFYE"OM2KK(4I,&H.XU/$5/+%0:D
MU(]7)'<UF*GB*@5!Y)J14"H\2:RJ#YUI%IC;X7KVE@475_FE1ZUO:G9[H0?=
M'1^J2829YU28U%7-U<7CZ[FZ>6^^X96XX9)[!N2D;$H2 E(R2 !'T-]_Q^36
M[]PG_I\-CX []^_W>:]^_?U?#9_'S_1G29_ ;C47K/8<\H>$,3)0=G/L ['1
MZ29 =2 E1!"5)M;JWO&&KJU<2\P\D*;6DY$'[TE)D*284DC54 00/%FI\I-3
MXVF6ANKSN+X0UT<W+VR;'5WJN+=(]':7F@.CFXV-762CY(X?B-YA=PFZLGE,
MNIR,9H<3O0Z@]%:#P(R,*3"@"-'],++%]2WN=6SQ Y<VI7N+ZN-NM7I';S*^
MF-B5.];D@5G4\14\L5!J:D>JH[BHK.IXBHX&HY)J14"HY9J>-0*@^:W5W;63
M*[B[>;881UG'# [ -ZE'8E"05*.2036D&FUQ?:]IA>O:VAE*[CJW-PG9T8]X
M;/ 'G5"-92)4W]#O?\?DB?W;N_?ON^5^C.DS^ W&HO7=P]Y0Y]B9*#LY]B<@
MXD=9.270-4D'54FUNF+QAJZMG$O,/)"FW$'(@_>% Y*20%)4"E0!! \>:GRD
MU/B:9:&ZO.XOA#71S<O;)L=7>NXMTCT=I>9 Z/7;&KK!/R2P+3B\L-2VQ+7O
MK00D.S-VRD<%*R?2/BN$+C8["0FK#$;+$V!<V5PA]L[=4])"OBN-F%MJ^:M*
M3O&4'E@5F*GCXD5!J:R]51W%168J1OJ.%1R34BH%1RS4\:@;C4'S''-+L/PC
M69;(O+X2/!VE#4:5_P#F'1(1'ZM.L[Q2D'6K%,9Q#&'N=O7RL">;93T&&9W-
MMR0.!6K6<4(UEJCZ'N_X_47Z,Z37& OZB]9[#G5#GV)S03ES[$Y)<2(UDY)=
M "5$*U5)MKJWO6&KFU<2ZP\D*;<3L4/Q"@9"@0%)5*2 1'DIJ1RQ6?\ WJ>/
MCS4CDTRT-U>=Q;"&NCFY>V38ZN]5Q;I'H[2\T.KFML:NLE'R2L<0O,->%Q97
M#ENZ-Z#T5CXKB#*'$_-6E29SB:P33VUNM5C%DILWS %RB3:.'BL9KMR3QUV]
MY<0,J0M#B4K;4E:%"4K00I*AN(4DE)!XCQ(%9U/B14&IK+_O4=Q45)J14<.6
M:D5%1RR:D;ZCA4>4Q/&,.PEKG;ZX2V2.@T.F^[_1M#I'M480GTE)%8WIM?XC
MKL6.MA]H9!U5?G3R?GNI]Z!WMM=J5.N)^B#O^/R9/F/_ +_OC:,Z37& W&HO
M6>P]Y0Y]B<T$Y<^P#D' .LG(.I 2H@A*DVMU;WMNU<VKJ7F'DZZ'$G(@_>%)
M/14DC6204J (R\GK5(Y8Y)\?6K3'0[5YW%\(:Z.;E[9-CJ[U7%ND>CM+K(ZO
MOB.C(3\D\)T@Q/!E?F;Y+,RJU>ERV5Q]SD<VH[UM%"SO41E6$:;X5B&JU=G^
M3KDY0\H&V6KYEQ "?4\&^ 4LT"" 000<P1!!!V$'/(]F1\6*S]=3RQ6K68J:
MR_[U%14FLJCARZU9&HJ#RR:RJ.%1X]]B-CAK7/7URU;MYQKGIK($ZK;8EQQ7
MS4)4:QC3]YS69P=KF$9CPM](4\=HEIJ5(;&\*<UU9]1!%//O7+BGKAUQYU9E
M;CJU+6KUJ42?^F[Z(>_X_)D_NG=_P^@K1K25_ 7]1>L]A[RAS[$YH.SGV)R2
MX!M&0= U59ZBTVURQ>,-W5JZEUAY.NVX@R"#Z\TJ!R4E4*2H%*A(,3Y76J>6
M*SJ?&TQT.U>=Q?"&NCFY>V38ZN]5Q;I'H[2\T!T<W&QJZR4?)3"M),6PC53:
MW)5;@R;5^7;<]@22%-3OYE39)VS6%:?8;=ZK>((5A[QRU\W;51_I -=N>"T:
MJ=[N4TT\S<-I=8=;>:6)2XTM+C:AQ"T$I/L/C16?KJ>6*BLQ4\:R_P"]1R36
M51R34UD:BH/+)K*HX<N(XWA>%))O;MMM<2&4GG+A7#591*X/QB @;U"L5_*!
M=/:S6%,"U1F/"'PERX/ H;S9:/[7/_U:N+FXNW2]=/.W#JMKCRU.*WF)43"1
M)A(R&X?1'W_']Z?O^'T%Z-:37& W&HO6>P]Y0Y^WG-!V<^Q.0<&6LG(.I&JJ
M#J+3;75O>V[5S;.I>9>3KMN(S"@<O6"-BDF"D@I4)!J.%9U/E9\2*S]?BZ8Z
M':O.XOA#71S<O;-L=7>JXMTCT=I=: Z.;C?1UDH^2MEB=_AJ^<L;MZV.TAM?
M07_2-&6G/ZZ5;!6'?E$>1",5LP\/U]I#;G]9AP\VM1XI=9 ^+6'Z1X-B<"VO
M6N=/Z!X\P_/ -NZO.'M:*T]OCQ6=3RQ45F*GB*[YU'?;4'_M4UEZJCDFM:LC
M45'(Z\S;H4Z^ZVPTG-3CKB6T)]:UD)'VUB.G6#V>LBV+F(/"<F!J,3'I7"Q!
M'SF4/>RL2TUQJ_UD-.)P]@R-2UZ+I'SKD^ZSMS:YH?-RI2E+45*45*494I1)
M42=I).9)XGZ)>_X_)K=^^SHUI*_@+^HO6>P]Y0Y]B9*#LY]B<@Z!M&QT#55!
M"5)MKFWO;=JYM7$O,/)UFW$;".$;0H'HJ28*2"E0D5F*RWU'"LQ4^4FI\7/U
MU/)ICH=J\[BV$M='I.7MFV.KO5<6Z1Z.TNL@='WQL:FL$_)>PTEQO#H%O?O%
ML?H7_P X9@"(2ET**!_1E%6/Y1SDG$L/GB[9+C_(?/M_\QMW<++2S +V B_;
M968'-W<VRI.[6=AI1W=!Q6>5)4E8"T*"DJS"DD%)'$$9'V>-%9U(Y8%168J>
M-??45!J:R]51R76(6=D-:\N[>V&[GGD-ZW[(405'L2)J]T^P6WD6WA%\L2!S
M39::D<7']143Z2&W!O$C;?Z?XO<ZR;1NWL$$9%(\(?''W1T<WLX, C:#PNKV
M\OE\Y>7+]RO/-YQ;D3N2%$A ^:D #8!]%'?\?H2'[EY\P[]^_P!WPUW[]_O^
M"=&M)7\"?U%ZSV'O*'/L3F@[.?8G(. =9.0= "5$$)4FVN6+VW:NK5U+S#R0
MIM:3D1^*5 Y*284E0A4$$5/&H%9CMJ1OJ.%2=]3Y236MXD5G6F.AVKSN+82U
MT<W+RR;'4^-<6Z?B[2ZR!T<W&QJZR4?)FVOKVR.M:7=S;&9/,/.-2?G!"@%<
M"% @C(Y5:Z<Z06V2WV;Q/"Z83,<-=CF%GUJ4HU;?E(3D+S#".*[9\'[&G4)_
MYU6^G6CS\:[[]J3NN+9PQZS;\^D#M)@;3 SIC'<&N8#.*6*U'8@W#:'#/S%J
M2O[LO;25H6-9"DK3Q20H'V@D>)'"LZD<L"HK,4]=VMN";BYMV !)+SS;0 VR
M2M28 &?WU<:5:/VW7Q.W7V,:]S]G@Z'!GQ)CMJY_*#A#>5NQ>W)^-J-LMG^L
MMPN?Y6P[S-7/Y1<06(M+&UMNUU;ERH>K5\'3/:4*'95WI1CUY(=Q)]"">I;Z
MMLF/B^X!M2ANZ:E=LTI2EJ*EJ*E*,E2B2HGB2<R?HK[_ (_*H_OEZ-:3/X$_
MJ+UGL/>4.?8G-!V<^Q.0< ZR<@Z $J((2I-M=,7K#=S;.H>8>2%H<09!'^B@
M>BI*H*52E0!! RK,=M3QKU5GZZRJ.%2:D>4FI\33'0[4YW%L):Z.;EY9MCJ[
MU7%ND>AM+K0ZN:T=&0GY.MNNLG6:=<:5\9M:D'[4D&FL=QIGWO%<0'8;MY:=
MWH+6I.[;$QEL)I&F&DC?5Q-PY1TV+1S?/Z1A7V[1L&5)T\T@&UVU7^U:H$?V
M"G[YH?E"QP&2UARNPL/Q_ANDG[Z_\1,;_P!UPO\ N;O_ /FU_P"(F-?[KA?]
MS=__ ,ZO_$/&MUMA@[>9NLNW.](^T$=E'\H&/'8+%/:+=?\ ^YY0^ZG-.-(U
M]6\;:S)]SM;8[=WNK3F0W;^VG-*=(7<E8K<C^CU&?O:0@CV>O;3N)XD][]B%
M\[_2W;[G#XSAX#[!P^C'O^/[L??\?D_W[]_9\M-&M)7\"?U%ZSV'O*'A#$YH
M.SGV)R#@]).QT )5!"5IMKEB\8;NK9U+S#J0IMQ&PCMWA0.2DJA25 I4 00*
MGC4"LQ4BHX&LZR]514\:D>4DU/)ICH?J<[BV$M='I.7EDV.IO7<6Z!Z&TNM#
MJ==OH:P3^XQW_'ZC?1K25_ G]1>L]A[RAX1;SF@[.?8G(.@=9,A+J0$J((2I
M-M<,7MNU<VKB'F'DA;;B#DH?B% R%)5!2H%*@"(')-3QJ.%9U(WU' U)%9&H
M-2=]3Y2:TPT/U>=Q;"6NCFY>6;8ZF]5Q;I'H[2ZT!T>N@:NLE/[B_?\ ']YT
M?0WHUI+<8#<:B]9[#WE#PBWG-!R'/L3L<&6LF0EU("500E2;6Z8O;=JZM7$O
M,/)UD.).1'#BE2<PI*H4E0U2 9B*CEFI'"HX5G651PJ3PK*H-34CR>F&A^KS
MN+82UT<W+RS;'4WJN+=(]'>ZT.KUT='62C]Q;O\ C^_L?D'HUI*_@3^HO6>P
M]Y0\(MYS0=G/L3L=&].0= U500E2;6Z8O6&KJU<2\P\D*0XG,*'XI4DY*2H
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MU!J3OJ:FIXU%0>2>YJ/94>4TPT/U.=Q7"FNCFY>6;8ZF]5Q;H'H>DZT.IFM
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MK%"$GWM/I>3@5'+-3Q%1PK,5(J.!J3OK*H-3QJ:QO'+3 [0W%P=9Q4IMK=)
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MH>M2UGJM-IVK<6>JGUDD)"E5CV.W6.WA?=)1;H)%K;3*&6SQB IU< N.1),
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M?S"U>B-O-+Z&70+<DUA^)V6*,\_9/I=3 UT;'&E'T76STD':!/15M0I2<S\
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MV9BG(:<$BHY5NBJBHXS#2SKPV,U99,'#D52K2W9LZ4>=U]XKK^"V ^2TRV/
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M;JM/-&G_ )7&UY.,NC9QET>!QLA,55%ZM/PA*=\%-0ZE2D+S9;(?#F _\:*
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M)[GGM- ^D7^,JIO-GGA4TN]$"RYAW,(C%UT%311D3"DO@7[VXV-U047JO?\
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MEN0J^J)<E34BN++#3;+0)8&F@%ML$]0@"((I\B)]03+[3;S1I8VG0%QLT]1
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MH+$&*%A0E!D;$\[E04.1(<SR)+MKO/N..EQ&O7X7ME1_=U;\3W//::!](O\
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MN]ISZHB>'@&RI$(;\7VQW:F_1S6!688"55P[,=!9\*^4=^R0Y4G4XG"0 FM
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M9O3.99:F YSWL\D;C;1:U0*E%JM+F!GCS(;B.-&G:*^<VZ"\+K+H@\R=P=;
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MMX^IT/E=NET.34LW+,*/2Y]*R=MCW!]G@]51 [XXTQ%*2[>\Z%"IL!2%/KR
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MU.0X/W.51WB%Y0)LVK@89BYRL2/ULB5I,V7,YT6%)14MQ^"5TLMN'/P;?9[
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M+LS*2EIB6MMY26KXA!J9NW434H-.R= A)GN;1[EZ8W?*LT[(O42;<$3 Q4#
MT0@,"2Q"0K="$D545%2RHMEV?ETZ'^PVMN\0SZ"RV$ W/NIE#NU"=1>)36&M
M.D..+G<DGJA.RZC 2L8?#5,1487I,!L%443O@V38R:8=S$%64VD8G>"/*?\
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M?V^/']6L'_\ #^WQX_JU@_\ X?V^/']6L'_\/[?'C^K6#_\ A_;X\?U:P?\
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M"3"PDI"["AZ9FSKI#<)LE%XEIP$4)NPC*.6I.1V@:: 6VVQ$&VP% !L 3*(
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M(9Q7"RN--=6KWL#5/SBPMZ#8A08S\R9*=!B-%BM&_(D/.+E!IEEI"<=<,M!
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M<$20X%GY.'*HKTK#=4<2^_BB2;R#(,40.^%.WC;4I$0-Z!L2Q; ) @/4Z][
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MEH=6J;5H+3@W\N%2UWS961<M6-/%3>Z758P],K*.TS#6\&YQZ6R\H5&>"$/
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MJ.6Q2I HMFPOQ#$C9S",VMM%-TTWKKGWB]SG\LQ-_8T/[T,8>U#7NF)XQVE
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MH4.J-6LJ*10'W]W=%RN[LTL0HJ-OLN \R\ .LO-&+C3K3@H3;C;@JHFV8JA
M8JHD*HJ*J+U:C8*BNY9.*)O3:B(GKWHHQMN VZ*>9*J;D5QM577O>ZEE[/J\
M+X8R$46;4FWJHHV3)2("%.JBYEX1(H4=YIE5YON- B$1()"VV(@ "@  (@@
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M_::B?1F]1QA[4->Z8GBZ;&L2#3\&TMG5;H3CU3K<LG!]5P?:;5%[6K\OO&P
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M*;:C2718PO5I)\-*E/.+EI$MS*J][Y;SEH;[A(%/>7<FJ0G1*'U:H4FH-(_
MJD*73IK*\GHDU@XTEI?D<9=,%_'M7\*3T+?4:H/1@=(5'I4-;.P)HH0AP3(3
MC$D%RHF5W3J4'$F&YSD"J0',S;@\33[1?7HDMGR9$.0/ ^P>AIJF5P0,>E1<
MD#$, &QKU!)S,[$=+3I46_%(ID@K[A^V9LO@\C*\/'UM1+=U/%D^.9T2@H?/
M7=C4*H0*AQ::T=_N7YQMG&BJ-GY$:?B"OSGJC5:D^4B5)>6ZJJZ VV/DM1V
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M-45%3DJ+JBIL(PZ_-)H>3$TAJ#.7[D0FH_NQ^1I6[=BIL(U>BP)R)H3D)YZ
MZOX2BXDUHB^04:%>7#SV!)J5*DFNAK(B])8%?P7()R'2'Y5C@M[\-M53H.(:
M4\9<FEF-,2%__-I"M/\ _P"CV0A5%14145%NBHO)47M1>Q>WQ:D2H(BBD1$M
MA$4U555=$1$U55Y<UV7IN(:?G1/K,1Q:@]?[E6H*2" E[-YD]:J@Z[$%#H\V
M>?)'Y[C<!B_80MM]*?='\$TBESY:*H0H<LH'2G198@T)HH[SCCJY&VQDYG9Z
MF2K:P21%56^5-+=]JN23L3S 59$DRWZ0!=\N-'<*^\>+E*EWNYJTTNYS$_\
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M4>IU9@2($H+"I(#X**.M9D5 D1SR/QG+7:?:;='B%-JUA:KMJ$ZC3G8I$H$
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M185J=$U6ZHP^ FOEB7+9Z=W.:^,H.(TH.(E%F1HET;B5B.VD=XC6XMMS8L,
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M'<MK!9$1$\15O\ST#W>'CZ][ U3\XL+=<PE[,T'W7%]'=T;VRQ![Q?ZA@/\
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M_=S7GI-__LS/<?S,I\O9MNX<2-$;Y9(S#3 63LRM"*?[/Y/_ /_$ "X0 0$
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MP @@YI"3]W"4@")2?TP@6[OYU[,_/OAF[8+^8B>7*"DJUOK9DZWI/'?G-?\
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MH48IL= $=W:9;NHO[NH@#\/H*G9$42K&83K,GPY]F:R9,W]YKZR=9D>DR=$
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MM1"C=^"?#GV9K(]89/'^;$GM2V.TEY&S]$)_BE5 %$ \_.0X@34W;6)G?/\
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MH72(@<W0R1YY=Y*YRJ)^T'E^&& GLMDW3'=L@CSO> TD$3>/N&UPZ0=MP7]
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MVTE@_"XX=&A<VG)8VIT+Z.UW*CQ;*S%?[YO)\""K2 SF34'[,SF/'Q"!HTF
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M/#L!7<UB=I !$R%905#:FUM7S=N^UALTO:B*>RSTQ"!H<1!,W(O(1;O4A8Q
MN(B!E#Z&*IK!ET#S3X8"4$\!5_,=,SB/##KOPB^5TF1\$,G@AD\297/)DVE1
M;?;G$01,)?&W82(0;](0)?J9) %$(;^\E:BFI?((@REPR.?9D^,F3XS?WFLG
M29.LR/69/!,V992?REN8FS]!D<UT \?[7N>3]H!]I,=XH&TQ:.LHP/\ >\,
M$(X8W&_1#4,F)L-.:C:(,5 "N#6-^0CFP%*/**_L\.L(#$LNM -HB>X0QO=W
MU.@CPRO^Z>' ^2W,VN@Z/51KNOEU"F6QH.;]-SM()1I#M/VO2X.@<#"!#&B
M)6(_PJ?N7\((-+<,V5YA!7G8OBHD(S"RV6:1CDY>\<N*>**([@.% RUOS$L
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MLO#;NL8')HB(JF;L+%:HJ8!TN@ >=B^FIDW<8=C-?FALM/[)XQQ#&B (G *
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M$_ DABQ0)_/(/]IF-E06&9O/LR9.L,G@F3I,G6&1S[,GPXF3-_>:R89V ^(
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MV"HGD7RXM\=,4C<>1V>3,X'G!ID17DR4W7$,2"*7:.]2(/UA-^RG9:9T9+$
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MF=IV#U_VB/)PX9$VG7"AR3KD@)2>>:0Z3D?.[RFH^S2/Z< ](UKBGBO/<7E
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M?B>&H>F+Y!6IP.PI[P4S7\%EUH M$3W"'JM"UDT(LS5UE3EW-T4\01*MZ'5
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M9'K,G6=/LR?&1ZPR>"9'I,G69'MGV9/AQ,F;^\U]9'I,F3I,CG&"P&P4*[F
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MA$'VPZ:D389YH(!H _:[&.(8T0 P;L=+;K0+OG3^Y8I+<5Q:4.'O8K7D6-7
M7'G*CAH+^@--ONG#3W^)0%Y)=T_325X*NN?15N>1*<DD:BC?(]U=.]SKWP^.
M0/GNY&1C2! >A5\@2#OB,1>!V@1!&X1@%' [W*X:T/17:P&PW ['>1/6^)7W
M"HE40]C'1"2'P:$49KI@1G7/[VL01%3F<CU$R/@GA3'_ (9$S[.LR=)D_.?9
MD,K)G^B#\B?I0E8%HL2&&E:4I8,'LWP)]_RI!- A1_0$4>!R  1!/!,CUF;S
M[,F3K,W]YKZR>%.LZ:R>"9'K# ]V[P8$CDJZ&@9+DZBC3WJG2^S]W;N3$OM1
M4RBE_?(=80&6)H6;-*1'4BPULB+U 16"24B*@*%^!+>T T8<5.*"?A')1(?:
MSH2^# 5;V8?@_:[&.(8T0 Q=S9<%30_M.C/>Y0W1ECV%D7\U#O'X]!VFKLX'
M.&,:AO-T-4YS%X/H<B>1\L.&+$0 FN]?H9/RL-[;]K;# -9P1$?!K-P[3QT3
M% 1I-1+#TKSP@@ DCCIBQ<F1+\(3\JF N&ZCR-%!XA,KH@;T,@C_ !L%46GB
M4XE+E[G,(8!,EBHAX[6#&)H$A^7>Q[)K_P#)L0J5WC1#CDUS28(E>X=2;)B?
M.3(^"&3PG_AD3/\ &3I,G29/SGV9#'__  3\B?I6IXZQ.<I W\A/@QQ:1QY
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MH;TV^G'C2 W*H."3Y _D"2H0$5 @B((W)$)== ^3HLAYC3)1-:6YADFX;Y'
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MK8PT0O9']H[.-$KP'&W[IG0>,<0QH@"0N8BT.4::5QO)JDWX$2N%7E8UFOV
M1%Y7""CVX9I6M@$<J:NH*4\F3MVW&48&$@;]+OQQM2>D^\G227D+>:@W:JUJ
MMT?*W+S2 .4*J@WD0#X&6^Q@F/&)O49V$"@L$#5@1+E1%$1&(Z1.1-;UL\BE
M4O:O:!RK'E$!E:<H^%0J&R7R.I9 C@"M\U1M@A]RZ/\ 2;**,[T&(9]R7=@
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M_0X;E<U+W(;4_?8M8P4K*"43\(NKJY95/"E/:.MB'H6,J8JC34--F$]A-?L
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M%8 1Z=HM/3($8W@;$!\)Q W?+RTI^(#AZ+MJ5  00WN6B8 :<W:$"[#Z-*0
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M1*7*!J<I MHR(4/($->.OWXEPW #?#<^(22]UCM@A68SNU4#=2]1>2GCE"6
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MAK$ ?BP^Z!BC'+ZR(ED9-#T8<L'.3#5$QJ-/I?[@ =80&,HFHX>Z.)M%IZ,
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MS25I!Z%9$('WY_#IX>EV?NEN&41S_,+L"54/M9HC/QS9ER&)?C_\<GY_O_\
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MZV\@9$-"(ZH=J+$$=.,LTE80>Q61" Z1>M2!=:GYT?/D.G\<,-N&M>K^@(D
MES[.O*D=#L,IY*WS% ++OKMI,CB'+[.5R]'\/]9/S_?_ .YQSKP3)TO1IR>+
M_6^!?O>J$&<H])@4IQUT+D9#N_M9@2# H!8GX2>&&3PS(^%'J"90"H8 VE #
M:Z,,M^,C0U=5H7\G]QXZP@,1>(R@1 ]7S1=DF1%<G:I:VIS^=AQ]$.  $ )
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MP2LET]3+!\IE"HM5S\,CU1EY)X4>M^<B_&+[;R3QHH5*LT\H  6 :F00
M @ : .#]T1UA 8G95K8DD_\ V!G(0C[B"&HK(L+G</,4:@,T@?;QQN7I:NQ
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MJU@3XR)[/8@!^C+-@P@+9 JV7JCI5M^\'OUP=!XQQ#&B 1,'+%E,[#"-3M%
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M\ID^,F/=US B_9$94N"AY-$BF2(0 ?ZCUYZ*1/!Z7*D=;L,_G_(878B5(/\
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M +\*<K9#7)QZ!S1+ALK26EH;R1O#EPU!%'P* $X>G.B%XCY^ 450'0<>#H!
M  ! T:_JJTG5NR"/>)I[C*"K2F/?^]J]X3:0?+>H\]F;<1X-GS7L_FY":FS:
MTQC1]47OMRB[XO%O1S[ZTVMG ZC2A6:H@\Q_:0";%$<^CZ%7QG$TR1XG56K!
M[Q*?>XD=_P"S&E&3ND3:@>R'?>G-#L$[L4V>22MAJ,E;[^<@H1P\* CN8,5B
M1KQ[$NA#F@@PNWZ(010&X4)4#",CN64<#+[\ANR "@H .M )<  T.W]/_P#_
MV@ , P$  @ #    $                   %,D'[4\$SE
M                            ?%&:MLM:J0
M
M
M
M
M
M                                                   ,@&FFR /Q
MMV_OT0                                    $.(        !Z.P
M
M
M
M
M
M
M      !6R< :@$V !\,'^%3\                                 !Y
M             3P
M
M
M
M
M
M                      "!:+#R +P PP >!G]Q6\
M             !S1@              #A0
M
M
M
M
M
M                                      .4X!#98?$!4 &D 3@,U.B:
M                              4R#AL               7
M
M
M
M
M
M                                                      /*"2G
M;1)1< ?@&B@ < W!N(                           !2@ "2<!@
M       !BP
M
M
M
M
M
M          !@ 08"4P#*(#:&;D TP 2 'X"4
M !+0PP  00,              !U@
M
M
M
M
M
M                          !T::*"!02R ;1#9114$VT0"!@X&:
M                  '000&&  ""!@,             R
M
M
M
M
M
M                                           !F2"910:*2F039(;,
M[:@FV" 0<'L                       .P0  "  P "20,!@
M ,>
M
M
M
M
M                                                           /
MR 0P0***:12D0"*"3!G; $T 0"#A@                      &F$"" "0
MV  00,!L           #0
M
M
M
M
M
M                6"" "F 00+##842 1038)Y0 F@2 ![X
M       DP$&T@00 2 &  2"#@-@          L
M
M
M
M
M
M                                *"8 0@@42" !88#"BP; "8!)J*DT
MR0 /                   'S02 $PD"" "  P "0!\!L         )P
M
M
M
M
M
M                                                 B$'1 "@$2PB
M3**3 8&5" #3 +!!4 FP!V                 !T9!0"0 F"@"0"0 V  0
M>!L         F
M
M
M
M
M
M     +00 &K "F@B&&01;2+20RA11;8>< 8@&F*0                % 0#
M"* 0 $T4 2 0 &  ""#P,        !P
M
M
M
M
M
M                      N" (  N( 6TD0PR"#013" E#*+)#X@+P T@
M            !720" 830""$FF@" 2 &P  00<-@       *
M
M
M
M
M
M                                      '0"000" %0 2P$R D0+*""
M80$X!#9*3F#\ "@              #$$#0"0!"8  0@BP"0"0 V   "3@,
M     P
M
M
M
M
M                                                       ?>""2
M""20&K "6&B &@!90 " 0F 91(;<Q8@Z              #80@J2"0 "2" 2
MD$2 0 00&   ""!@     !0
M
M
M
M
M
M           )#(*\02  20 S; 0 404P"#000 "48"+(#**:JP
M  !8P+"&%1 2" :10"4@F 2 "" PP  00,!@   '@
M
M
M
M
M
M                           !<+:9(D "0 02"V9(" 7J2B0:**#104R"
M;)#9G;<            $[.F,800C 2003 * 0CZ4"   0&&  "2!L,  !4
M
M
M
M
M
M                                            ,@\A;"+< "  "  6
MJ%)P!FD="#9132*2B01029(QP           V )9P!B "D120""!0R@ "B'R
M0 2  P ""!L!@ &
M
M
M
M
M
M $0"E59 ;5@    2EP      !LL""+8:1"D0"*"+!6          &P@  )*
M] "4("0E@       ,?B "0 V "00<!L @
M
M
M
M
M
M                  9B  4J9()8N  2L          -R 00+# 842#0 3-P
M         TG.$ 8!/0&@ 6 30          ]@0 0 &  2"#@,J
M
M
M
M
M
M                                  -S1>2"2]3*!), ,
M '*$"1188# RP0 ;<         *-FOTB#0,Z#B!60           !-P2 2
MP " 1\%@
M
M
M
M
M                                                   ""+*#P02'
M(P0+>              #^PR3+:102&5"*+         +_A@_PG2*)F T0
M          ! @"0"  P  00?0
M
M
M
M
M
M        4* 98"N" 0Z'6                /2&"01:"*20BI1:
M!0#P,_N**91(                -$T 0 0 V  "">
M
M
M
M
M
M                         "(;0## 40""(L                 BF0$B
M#9002" G!         ! "<!GYU;1P                 ,D6@2 2 &P  $
M
M
M
M
M
M                                         #9 )!:"8+#L &
M            "@$P T1+* (0"4X         &4 #@&8,HP
M    X@B0" "  P
M
M
M
M
M                                                          *9
M+ !:(2113YP                  !D&"B"& 18 "( =0         6F "0
M_P @                  !XI!, $ $$!AX
M
M
M
M                  Q]FG5(      #@   (
M
M                6@4R2 "D04BQ@                   #\$($$%,@TD4
M$"S@        #)MH@$#(                    0@A -H$@ @@#@
M
M
M
M                                <O@     5W     "@   4
M
M                                 &TP"V6$"4DB,
M      <F @$ @LD$RB@E8         )!-L$%                      *@
M$(!A @ $&@
M
M
M                                                -4        #V
M@   "@   4
M                                                  .D2F"R6P@4
M#@                     #L2@ $D I@D&40\@         4,)KX
M               6"T$A!,($$!
M
M
M
M    .L          "S@  "@   4
M
M      "$&0F0262F&.@                      <L8V $$ %, @@6T
M     &R@!                       6& 4$@(-I @D
M
M
M
M                    !\            !   "@   4
M
M                       !T4DP$B"VRBD                       #@
MEADP HA L@$ +         !"R<                        \D2&@D )AH
M8
M
M
M                                     -             =@  "@
M4
M                                         @4BBF$@44T
M                >D$,.B % (EADUT         ."(
M       4$@R6@$ !,(                             .VVVVVVVV
M                  #VVVVVVVVD
M
M                                                     #<
M        8   "@   4
M                                                         5N@
M2@$2P@&]                         !L @@-6 %-!$,,_@        %"
M                        /D @&$4 @@+
M                                   "@       (
M
M
M          #@      27     <   "@   4
M
M              145X"D B0D$                          )D 0 #<0
MMA,AJ<         D                         !FD@$ 0F@$&@
M                                                    "@
M (
M
M                           ,     -!8 ; 0 #    "@   4
M
M                                !@B/ 4 "%8
M        #8@@@$ *B %@)D=@                                  "\
M(6@$@"DP"@
M         "@       (
M
M                                           !8    %8     ;<!@
M   "@   4
M                                                ;KBL$C9V@#
M                          8DD$$D@-6 $L-&0
M                4@!4D$@  DT
M                          "@       (
M
M
M     !@       >6    "@   4
M
M     U;M<5@'U.F                            # @D  $@!FV @ @
M                                 06$,*@ D$ @
M                                           "@       (
M
M
M                  @   -         (    "@   4
M
M                     "Q>SI$BB@4 @
M :H $  @D%LRP$#4                                  "L8P@A& D@
MD
M"@       (
M
M       !)))))))<                  4    $              "@   4
M
M                                      !DPK4= C48L
M                  #.X $  $  M"& R
M       !3@#$ % BD\
M                 "@       (
M
M                        4                          4   #<
M           "@   4
M                                                       #H$#U
M;'H$:H                              =6K     D E@&R@
M                        # 34!Z $H0X
M                                  "@       (
M
M                                         4
M            "@              "@   4
M
M            "%= @<C8=$P                              #,2Q<
M@ D@DL,T@                                 @P">@-  L4
M                                                   "@
M(
M                                                          4
M                         0   !@              "@   4
M
M                             " $?KD-(O#<
M           >T 6< $$ D$$AAD                                #)
M$" 9T/$ <
M        "@       (
M
M               4                         !    -
M  "@   4
M                                               " $#I<QA%8
M                            #M@@4'SDD$$@$$-
M               !OA&D43<!H
M                         "@       (
M
M                                4                         "@
M   <               "@   4
M
M    D@0DB5+CN@                                ?T.D"R^<$@@@"
M(                                =_<44RB>IY
M                                          "@       (
M
M                                                 4
M               #    (               "@   4
M
M                    !I@@V$$4I<
M   #D @44FT7D@D$$5@                               4#/3JF"V3B
M@                                                          "
M@       (
M
M      4                         "    (               "@   4
M
M                                     !Y=!@&PD6@@
M                     :  %B"DT'\@$@@,
M       <G (P9>@TQ@
M                "@       (
M
M                       4                         "@   4
M          "@   4
M                                                      #DEKME
M PDA                                  "@D@A,4T@BO$$@3
M                        8 $ !V#7T$@
M                                 "@       (
M
M                                        4
M      "@   4               "@   4
M
M           "=XD/=)HR&                                   5@D$
M$IB6F05 @G\                              1M$ @X. :]
M                                                  "@       (
M
M                                                         4
M                       "@   4               "@   4
M
M                            #@7/$A?()G@
M             "#$@@@I(6@BE $Y                              $)
MM@@$'!X8
M       "@       (
M
M              4                         "@   4
M "@   4
M                                             " D"Y<@+L-8
M                               53P$$ I=64$58"8
M              "6AA- $  X
M                        "@       (
M
M                               4                         "@
M  4               "@   4
M
M  !>0DDC+<K=4                                   "D&8 @ %>NR
M6KU@                           !"644)I$@ T
M                                         "@       (
M
M                                                4
M              "@   4               "@   4
M
M                   #T'3TDD];I0
M      4 BT7D @O4P 23@                           "F >0"I--D$
M                                                          "@
M       (                    OY_C[
M       )#_K/                                       )0<@
M     4                         "@   4               "@   4
M
M                                    !T4 #>$$FKX
M                       "VDFPJ\$$EVD$ $
M     "@FP X0U )H
M               "@       (                 *G1     \$<
M                     +_<@   !/;P     /\ _P#_ /\ _P#^@    !__
M /\ _P#_ /\ 0     $^6W             %
M  H   %                H   %
M
M       94QH /T((.                                     !(H!%E
M,X()#J=)!                           5%%MAY %X"
M                                              H       "
M           T7         !%8                         HK
M '.            %             H    SO         "
M        %          0   %                H   %
M    "%6:@#@^(5              @   %                     #%KH
M                   P   J)9*F-! ^I!0
M            AA- ,,!Q ((1 H                          #"4 ALD/
MB K
M   H       "              &YX            'B
M     "2(           &\H          %             H   68
M  "                      %    H                    H     H
M %                  _8        & (                "
M          $,  K                     P   0\@2(9PI)&IP
M                             %(D%H)AD*P!! +1
M         !A!3@,HDI.!
M                    H       "             %7               "
MO                    "7               ?          %
M   H  L8           "                      %    H
M        H     H   %                 G            V-
M  =   #                    !   &H                   '(    '(
MU"93>$I'"                                      A $(A!-%/0()!
M*8                        #(,!*8!E$!P
M                                     H       "             Y
M                 "$                   ;                !&
M      %             H !0            "                      %
M    H                    H     H   %               #Y
M       'R              !X                   \    ]
M         "   '8 P!&!; ;YD*
M    %@H M$%(HIQ!)(O                        <%!  +9 ,LP
M                                                      H
M  "            \@                   H                 \(
M             #0        %             H 2             "
M                %    H                    H     H   %
M       '_                !H         %    X
M H    !                   '   ! !%&:$P3"*5O
M                      @DE E(@A%%^()&X
M!(HH-%)3()X
M           H       "                                 V
M           X                   2        %             H$H
M          "                      %    H                    H
M     H   %              2                  RX        %X   ^
M                 #X                        P   ' "O#0Y8Z"09%
M0                                       @EL(% )$ !CP(^
M                !@(%%%-(I2,@
M                            H       "           4
M          !T               [                    #8       %
M           H'              "                      %    H
M                H     H   %             #
M U         @   %                        #H
MH   X  0@X9_+N9++O                                       ;ED
MIA@H!,@(LP#X                     '!3 ((%AA$*
M                                             H       "
M    D                       %(             #X
M      J       %             N(              "
M       %    H                    H     H   %            '8
M       #0         %.        ?   $                         0
M                'P      #(+D".R=8+1
M              !HMLA%,M  M!!FY                     H(0*(!  L,
M
M  H       "         !H                        F
MP                              %             &
M "                      %    (         '          (     H
M%            >       C.:P"=!@       "(       "   "X
M        1      H                 "   'P  &[9",@0I3BL
M                                8%%-% LE((E(-KH
M       @!0")80)E%O
M                   H       "         Q
M   %            "                               %
M  X               "                      %          H   %
M             H   %           '8      8X       Y       Q
M  "    P                 (      =                 &   &   $0
M'_(;[)]#4Q                                       !)!HIAH!DHI
M$H(4                   [5H!301##(,(
M                                    H       "         H
M                     0           5
M     %                             "                      %
M         H   %                H   %           ;     '&
M    8P     $(      #P   8                &8      %
M       W        I+ [@+')&8?8
M       M) ,M,-!,E$(H!@                  0 ?$ (:2(89H
M                                                     H
M "        &X          %<M89P          Z          #0
M                      %                             "
M               %          H   %                H   %
M  '@     /            7P     H       (   +                %
M      #P                (   >   &Q%$)#?!7;/K
M                        %<@H!EE@I(@(@M!                 #0!
M"8 );29 H
M          H       "        :         !0X    "B          X
M      7            *>UHD               %
M         !MMMMMMI       'MMMMMMMO          H   %
M    H   %          W     _8             ?     &       (   #
M               $   #    0                X   X    P!)HH)?X&@
M(_                                        K%L$)LLD$I@ D!@
M             2!!((#5@!+!4
M                           H       "       #@        !7
M  ">         P         H          '_      (;P            !0
M                   #Y:0^          !0
M *   !0               *   !0        !     !F               P
M    !R      (@  !P               /0  !B   "               !P
M   6    -&H "302_P #<&
M  & "D""RV"F2T 4H              #M@D  DDAFR C\
M                                              "@       (
M   ,        #,         'T       #,        %          1@
M  ;(            4                  #R>               4
M                   "@   4               "@   4         (
M#$               "$     (      $   #               "@  !/
M!,               $   ,     (%,D$ 2,)\ ](
M                   "$0"4&P6F 6R2 4@             .Q, $@ @D$,P
M2@                                      !
M   !        (      "H       !Z@          ?@       ?@       8
M         "@         6H           4                 #]
M          4                         "@   4               "@
M  4        #H    1@                2@    $      =@  "@
M        #   #@    ,              #0         0V5I, D"XA7@A
M                                     ".B@4 V"TP"VV&D@
M    !J$6X $  $  L4@
M                             (      "        /@           #X
M       !       !D        "8           <@          4
M       !M@                 4                         "@   4
M              "@   4        !    !\                 "8    %@
M     "   #,              <   :!(   (              !@  #H
M " B"X)D D5 OL<                                        ,,$46
M@&$2F2R4Q/          !/*R@BK  @  D!
M                                              (      )@
M !\             .       #H      #@        !            !0
M       4                *@                  4
M          "@   4               "@   4        >@   "
M          -    !@     #    8              4   < $   $@
M           !       *4 0',B  3(%^@
M            2-!@2B$&0D0262E6@        Z@I4R0"U<  @ D
M
M   (      $       9              #X              .@        0
M             )          4               !0
M 4                         "@   4               "@   4
M  0    <                   #D   !X     "0   8             "8
M     ,    @             (   #       7@P@REY@ D"ML4
M                             "1C:D"T6DP$BBVBB$D     \R\D$%ZF
M4"28 $$W
M                    (     "4       (               '@      0
M      4        +@             !\         4               )
M                  4                         "@   4
M     "@   4       !T   #8                    ,    (      4
M /                 "8 #@  "4             0   +       "OT""B4
MY,$@DU(                                        1ALYL 4"BV$@T
M4TT#]/<7OD65'@@DN$@@47SB@
M                                     (     #        8
M        "@      '@    #(       #T               -@        4
M             #L                    4
M "@   4               "@   4       "    "
M  %    )      ,    @            !           <             4
M  0        <C[$TTV7IB$ 2(
M    #?!."O 2@$2T@&FF&@F2BD4 RRG<$ AT.DBR\@
M                                                      (
M#@                       !(       @    #@
M               4                                    4
M                  "@   4               "@   4       /    9
M                    @   "@     !   #@            +@  !@ #,
M              !X  "<        =SCCD@FFRIA@@!@
M                      :+8-41X"D 20D RVP4$0$0V@&& X@$$ H44%
M
M           (     ?@      =                 <      !      @
M     >@                T        4              /@
M         4                         "@   4               "@
M 4       ,    $                     !4   !      !@  #8
M      $   /   (   )@           #@  !          B#<9( "T"P-($X
M                                       #S]<!@B/"4 "V"@V66"4R
M 2"T$PV%8 @ %C@
M                            (     0       $
M8@     !X    #@       ,                          4
M    8                     4                         "@   4
M             "@   4           #X                          !\
M     #,   4            <   4   0                )
M   /40*CY$DRD45I$                                        ?3=
MKBL C9V@ 4@0F&P026 "T0DBBGL$$@M
M                                             (     (       H
M                 #       ,    ?@      !T                 9
M      4             !H                     4
M         "@   4               "@   4      "(   !
M           ,    $      (   )@          !@  !D   3@  #
M     ,   )@         "-B@A5G\@&@BB-\
M              "CV;MD5@"YND 2DV"RP"F00 4B"D46X@FX
M
M  (     (      !@                  @      <    ,       "@
M              !@       4              @
M4                         "@   4               "@   4      !
M                            (    (      8   "@           @
M"     @  ",               $           "Z,@FH/+$"0&R,
M                                %1>CI$BB@>-T0"@&@6F 6R2@2DT0
M@"_"@
M                   (    #       "@                 !@      (
M            #@                 "@       4             #
M                 4                         "@   4
M    "@   4      #    $                            ,      ?
M             9   "    #D   $          !4   0           #4'-D
M$T!ZD@0$V\                                       #L^K4] C$8E
MALB@4 V"4P62V$"@$B !8
M                                    (     @      "
M        !@      $    4       (                  !0       4
M           >@                     4
M"@   4               "@   4      !@   <
M  "@   "      "@  ",              :         *          !   #
MX            /OFT8@FAO:@FD#
M       3D#E;'HD:C!-L&46@R$2"2R4PP4 F2@
M                                                     (    "
M       __P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#Y      !    &
M   '                   &       %             $
M        %                          H   %                H
M%       @   !                        (    X      P   "
M    &   '     $    8              H              %>DCY M"3]!
MD&                                        %T(').'1&P&&3(%HI!
M@)$%MD )EHN                                             '_\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ \        @    "
M                             ,    P       0
M  0      !0                                   !0
M             *   !0               *   !0      .    0
M               ,    "      !P             "   ,P    !\
M        R   <             !Z",[:QQ32&.J!*
M                     %.N0TBX-R,@W<* +113"0**:*!:F
M                                                         *
M      @    ,                                  &            @
M                   @      !0             @
M   !0                         *   !0               *   !0
M   ,                             @   (      !@   <         "
M   &      .   ,@         P  !@              (300K1C_ "BC,?8\
M                                        #RM<UI%X[$8)@MT"4"B6
M$ T4PR
M               "@       (    !
M    "            (                   4       4             $
M                      4                         "@   4
M         "@   4      (    0                        $   "@
M   ,@  "@        5@  "      #@   (        #X   ,
M   6"F@'V7G^6T<?8@                                       !RB
M5+CM,+G9;!*BO 4@$2$@&4H
M                                "@       (    !@
M                     #@  !@       8                   ,
M  4             $                      4
M     "@   4               "@   4      (    8
M        8    @      #   #T        4   9       4            !
M@  !,               "0@$TC^F\1R0+CT
M                6D4)(9A@6[+@-41X"@ 2045
M                                                 "@       (
M                                      "@  #@       (
M           (       4             (                      4
M                      "@   4               "@   4      4
M0                            "@      "@   ,        8
M   4   &        "    @                $P@@VD<DR:"B!5
M                                 #+D6A)G"M6;]<5@D7.T "J
M
M      "@       (                                       "@  #
M@       8                   8       4             ,
M             4                         "@   4
M"@   4      4    $                            "@      "8   ,
M       "L   <       .@  "        +   #@                "+N$$
M&T3A$FL40$                                          '$B%) ,1
MJK=KBL VIT^@
M                       "@       (    !@
M            "@           <                           4
M       4                      4                         "@
M 4               "@   4      <                             <
M   #@       $   :       "   "T           !X       8   .
M             )0>  $V"*LPQ@#
M         "9D$0] %B+V9(D44*7
M                                        "@       (    !
M                             !@   0       8
M  (       4             4                      4
M             "@   4               "@   4      ,    ,
M                4   !        (   #       !    @       #@   <
M       (                      #8:#P0$VD4UBZ P
M                            0V@"+H F1;CI'!D
M                                                         "@
M      (     @                                 "    0       $
M                   4       4             4
M    4                         "@   4               "@   4
M   =@   (                        ,   !        #@  !       $@
M  ?        "L          "$  !X                   > B B"$&D"U\
MVO@                                           !'% E= @>_IC
M
M              "@       (    "@      !)))))))))))))))))))))))
M)))+@   ,       <                   4       4             4
M                     4                         "@   4
M        "@   4      #                            !,   !
M       #X          0         ,   9      "   #
M     !] ' $20@T@BKR(
M      68M4[\
M                               "@       (    !        @
M                         0       0                   <
M 4             4                      4
M    "@   4               "@   4      !@   0
M      #    #@       #<   (     "@   ,         (   #      1
M                       !<P$J @2D6D$5W
M
M                                                "@       (
M  !@                                      $       7
M         !\       4             4                      4
M                     "@   4               "@   4      #    (
M                        @   #         0   <     !@  !8
M   !   !@     ,   )@                    !-#* V G"4&D AD
M
M
M     "@       (    !4      #(                              0
M        @                 #        4             4
M            4                         "@   4               "
M@   4      !@   #                       #@   <         8
M     #    @         !@  #L     (   $                      ;!
MD"2&,$>4@TT%@
M
M                      "@       (     <       8
M                <       !                  !        4
M      4                      4                         "@
M4               "@   4      #@   !@                      #
M  8         5   "@    +@  $@         #H   $    !<   <
M               #HALD0450CPD"FD
M
M                                       "@       (     $
M  8                              )       !L
M-@       4             4                      4
M            "@   4               "@   4      !<   "@
M               @   <          @  #(        (           <   ;
M@   "   #                        8$D($B:B"#^$$$
M
M                                                        "@
M     (     4       #@                             "        $
M                 $        4             4
M   4                         "@   4               "@   4
M   (   #T                      0    <         #@   ,    ,
M(           3   !@   "@  !                        #:T$!@#ZT(
M080@T
M
M             "@       (     -        X
M       "        9@               !T        4             4
M                    4                         "@   4
M       "@   4       <    <                      ,    T
M    <        <  !,           #@  "@   +@  ?
M        &+P $HD\6A2#L"@
M
M                              "@       (              (
M                         <       !                4
M4             4                      4
M   "@   4               "@   4       <@   ,
M    !@   !@          8   ?       #@           "   #L       8
M                          4H&$@(,#B@C0>0
M
M                                               "@       (
M  !@       ?                 "<           ,        ,
M                 4             4                      4
M                    "@   4               "@   4       !@   7
M@                    "    "           2@      '@  !
M   !4   8  "\   <                          ;&D<@$AE#]4$0%
M
M
M    "@       (     "<       !                 6S@          (
M        (@             #0         4             4
M           4                         "@   4               "@
M   4            #                     '    ,           "   !
M   ,   &@                   #@  "8
M!800(P  @(=($^                                   =@
M
M                     "@       (      (        +@
M  !H"@          +         $             +          4
M     4                      4                         "@   4
M               "@   4       #0    ,                   !,
M,           !@  "(  0   0             ,   %@ "    @
M                  0DDBCT$@$-GB &
M     "H,O@        #
M                                      "@       (      1@
M   "<              ?@             @        +@           #\
M        4             4                      4
M           "@   4               "@   4        $    )@
M                 H           #,   $ #L  "T             ;
M@ =   ;@                           #L; &T;JD@A(=0,
M                      &R%</L8    ":3
M                                                       "@
M    (      !         <\            (H  ?          #D
M"X@         !&@          4             4
M  4                         "@   4               "@   4
M   =@    $                  =@   "             <   /     #@
M            "@  #D     4                             :; X 6:
M<4$@) +@                              #0!N$F(*X*SDL4P
M
M            "@       (      "(         *(          5\   #(
M        $          D         /@           4             4
M                   4                         "@   4
M      "@   4              4                 !H    6
M    /   "@!@  #              #L   $ (   0
M          !B84;DR#PF $-DL                              +#N O
MAD0A@B LK@
M                             "@       (       =          0L
M       /4     0@         -@         9       #X             4
M             4                      4
M  "@   4               "@   4        "\    "
M .@    D             "@    ;   :@              0    !L  "H
M                            3A#A>X&D9^P@AA
M           !<4D-\%]L^@D"P8
M                                              "@       (
M   !           1T:@   *<T      #H         !H          " #  #
MM9              4             4                      4
M                   "@   4               "@   4         =
M 7@              !X     @             "@  !,$   4
M    0   5    "                               !>!0'SW T"/VD@8
M                            "@F"@E_@: B) ?@
M
M   "@       (                     ".B!-          ;
M              TW@@               4             4
M          4                         "@   4               "@
M  4         "     "<              5     =@             !<
M3H   L               ;   "7@  !@
M   +X8N@;"$2 ->@"                           !5J@ $T@O\C1D34
M
M                    "@       (        )
M       X         /@                               4
M    4                      4                         "@   4
M              "@   4          0     1@            *X     ,
M             8   "@  #@                @  !\   /@
M                     5?2:$@^0FD%\PL
M >0%-D$ 2,)\$Y<
M                                     "@       (        "L
M                                  #\
M       4             4                      4
M          "@   4               "@   4          '@    #;@
M      +      5@               ,   7                    !X
MP   4                                 &=+Z!0DF, 0TKF
M                 !X$V5I @D"\ =@H
M                                                      "@
M   (         <@                         #<          =@
M                        4             4
M 4                         "@   4               "@   4
M     T      @4        88     "@                '@      )@
M             ,      "0                                 #TKCG
M (D'"@"" $                        ! B@""-)D $U L
M
M           "@       (         #D                         9@
M         "L                      :       4             4
M                  4                         "@   4
M     "@   4           +@      ,M@    72,      4
M    "       0                 8      #@
M             <]'=649& N<DD3@                       !'T&4 P/L
M@@ 3!@
M                            "@       (          +@
M             #\            '@                    !H       4
M            4                      4
M "@   4               "@   4           #X       "M'@+*(
M  #,                 !D      ,                 7      "
M                              #$UK[HAC7WGL8$X
M       #<!IJ@PDREY@ &8
M                                             "@       (
M     #E@                      /@            #X
M      ;@       4             4                      4
M                  "@   4               "@   4            2D
M                   ,@                         P
M    "@     )@                                   !P$%?O#L8J<8
M;!@                     'RBE,?4"BB2Y$;
M
M  "@       (           #4                     %D
M  .H                  #4        4             4
M         4                         "@   4               "@
M 4             !                   'L                   8
M  "                  #@     <
M     "(V@#+]6!S%S>!4                    "'N^6T83X$4PV4
M
M                   "@       (            *T
M  #T                8@                 )@        4
M   4                      4                         "@   4
M             "@   4             !,@                !L
M             ;@    '                  "T     0
M                       3A.H@)?H9B3N8:@                   #<V
M\?RP3B+D@FG@
M                                    "@       (             <
MP                 !'@                ![                88
M      4             4                      4
M         "@   4               "@   4              #C
M       ##@                          0
M !X                                     #6(-]$A7!1L0=#X
M             #*D=$SZ"R#<>(',
M                                                     "@
M  (              <X                4@                  #C@
M           ?D          4             4
M4                         "@   4               "@   4
M        !P              4@                     #X    <
M             (@   /@                                      6,
M5!WH&+D2_2!V                  :$&TCE NL40*CR@
M
M          "@       (               3*              +
M             !O4           (L           4             4
M                 4                         "@   4
M    "@   4                #W@          "U@
M     ?   !@                   #\  !@
M                5I+<BE 5\A;Z08                 &  DV"JND\"BA
M0
M                           "@       (                #&V@
M     'VL                        (=        !UH            4
M           4                      4
M"@   4               "@   4                  >X       &EX
M                      !AN<\                     8>AE@
M                                 .%A+BD58F\D)_3@
M   +Z#P0$6D4UBZ,B@
M             ;__ /\ _P#_ /\ P                      -_P#_ /\
M_P#_ /\ P                  %U]@DA$_".@
M     (H8G(./S8P      -__ /\ _P#_ /@     ?_\ _P#_ /\ _P#0
M                  /_ /\ _P#_ /\ Z                  W_P#_ /@
M              !?_P#_ .0                   !JK0DHZ'@
M                   !D                        -
M                             /#1@QW2*8(N5UQP              *:
M"("((0:2+7S<P
M
M
M
M
M
M                                               C!8\$GR0)!4CN
M"              F.D2? 0!"#23:\
M
M
M
M
M
M
M    #/Z*7@.001**U^P            /2$SQ "@2!*1:>
M
M
M
M
M
M
M                      8#R!!Z0P""I2>F0          *5200D.(#8"0)
M0R
M
M
M
M
M
M                                       #  <18=2&$ ;"#@
M   !U-.* 0$@% ; 1T0
M
M
M
M
M
M                                                         8
M/B*#2&0@!4N(        QR9!Z3 "&R!-1(<
M
M
M
M
M
M
M              #   !R;!("T$&ZP8     !BPN<#2,_800@2)A@
M
M
M
M
M
M
M                                8    .?282&$@[_J@  6U0H"=[@:
M#'[00&!0
M
M
M
M
M
M                                                 #     !AJ!2
MTPB#0@71Q/\ 3%T#80F0%KP #P
M
M
M
M
M
M
M        &       !T2,I%4BJ$7DA.Z+0$'R$T@L&'
M
M
M
M
M
M
M                          P       CNB'!CZ$<0R\KI?0(GD1@"&'4
M
M
M
M
M
M
M                                           &        $=BUX,/D
M@&"+E<<X!&@Y4$1
M
M
M
M
M
M
M P         _P4O)5@DB47XYJRA$T%P<
M
M
M
M
M
M
M                  &          'D6GTBH$-:&M?= (:^W@
M
M
M
M
M
M
M                                    P           \DP:D/0 J$#+
M]Z=C$
M
M
M
M
M
M                                                     &
M      ?D6&\ABEFT 9?JY@
M
M
M
M
M
M
M          #$            #DBB4MI(-U$!(@
M
M
M
M
M
M
M                            $              <^PPD/!![HE
M
M
M
M
M
M
M                                              4
M #GT&@ABH,4
M
M
M
M
M
M
M   /<                NB5MI'@
M
M
M
M
M
M
M                     9@                =00Z
M
M
M
M
M
M
M                                       *@                CR(
M
M
M
M
M
M
M                                                         C@
M              #@
M
M
M
M
M
M
M              !Y              9T
M
M
M
M
M
M
M                                 /            -H
M
M
M
M
M
M
M                                                  "YF@
M #D@
M
M
M
M
M
M
M         #(2(^VH&H$
M
M
M
M
M
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M2X2O"P*U0Y7- D/-U% F0_;%ZZ008F4F+MV8/8$L6C(A*\X;1V)J?\I-H;B
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M\\AEL,! 9$$JC8?$F'>W'B073$@U$8/$" H<+#F,EG\I2E%#\C..6((0J?\
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M4P%_^:<=V)(ZD5A Q,V.(-"0P6VUPW812VN@NL<;4(UY/GI4=1._G>C8>_\
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MI0B(3! 0OT?LX!0(L"@1$$2&53]CF )6P$[3<S,V,K1<9NP%* @\-H$&UPA
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M_ 6L\?)H+FW?^4(X9^DIABAZW[4%W<??WCZBF&A:G2@.O)LS]13&N:-LZ?-
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M[>OU$8>6E&V=/FA'#_Y&;^/O[S0=;=Z'4>90];]J&UCCY'WF ]M0NY19(4B
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MMM2X+:2603?\ Z5X.,Z)[[^#@)3;(7,D][)I%B"IXQ D=.62G<"0LL#1JUQ
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MO\]ZB+ DC'@1- D&A04(Z^0%BD"+@2"I'X8B!0-0#(A"(@B(B21%"" LXAE
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MI%&V=/FMH\X-&V=//:@.O7ST^D*02/)$%6]XT!2 4(P*2"JEVP@A .F"'\(
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MMO3SR:-"&1@P()(6X" 1@48%Z2!*%L J2$8$F"_X0(E/HH9$+I0B(B21 T0
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M )04W+M95M$S:$1EY9H32-[":MTN:H0NR:,6QRMLQB2\9C,?<[(^R8>'J?\
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M@,!H:WVK=UF[^O#LI!02(7F?<2+D'!ZP$F88 D(7LC$*",-&T=//[6P9W/\
M)_E1U$[^=Z$<)_>GU$8Z-'$;Q\_M;P>.??K0=9._G2I'"/T$;^,O]H+FW?\
ME#L>C4M0]/>@N[CY%#-9XWH.MN]&P]'U^:'K?M0VL<?(H#6>-_FH:CZ^U19!
M(@N VZF!&!%DK0*19F_18L5D@287_"0 D04 9$+I7$B(T 0P $/@ @=8-H5
MEBXH'63OYTJ1PC0IA?-U&V=/F@.O)\]/IH89$!R&<NV7A^O%%C?< B%AB2):
M'++C5BH$H7(-@E#*"6H>GO07=Q\BN% :SQO07-N_\^@IAH9F_;^4-K''R/\
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M7KYZ5KT#:B38B528F7?WP@11&0T_I#?28!:6Z #.!>X=D^%0U'U]J'HCQO\
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M#U/T&+J!JMA;3&J@EB4-NB8L"[72(2#;I*HZBE6)O!!PV;@T/Y'YPC>6@FY
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M:;GY>%!T8YQ0]8>SYRH.U'?;N6H2!1&1" ,) P% 0&\C5YP0L1A-BP"+LO\
MCZ*  EP!LB.F1$A)$I(:C,1,HA)5:[\&$U&UCCY%#VB;[]R]!UD[^=*'HSBV
M?\[4;9T^: X?J/6'L^<J#P?-?\H>T3??N7H.LG?SI0]&<6S_ )VHVSI1L/+X
MHVCI[?- =>OGI0&L\;U#4?7VHV'?9]3WH9F_;^4-K''R*$:SQO4-1]?:C8>7
MQ6UOJZ7EW-R(,02(E&])YWZNV<GZV%$#=+XMU&BFPI$J(L,I * "Q ! 6TDM
M07=Q]_>*$8;=:-HZ>WS1L/1O0];]J"[N/O[Q0C#;K1MG3YH&C_&AF;\<]?\
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MZ! 8@T^Z/4YL](G;$@;]L6C#:P;[%QF;V.PJ^"Q&@ [)")WKNW_?OI9I!F0
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M[M0MF69+_:$O/CMY+:Q-^$U@@Q&NO%X6W& F_P"@'KYX-7%++D,<3-]8G-X
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MGK_M!<VX^_\ GT UGC?YH.I'GFVA'#])3"E#U)\\V4'1CM0];]O.E!X/FO\
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M8F(Q%OL! $;V<*PS$V2QQWOOB19-*2@)@H6R57&R!5,X"1 2I"!=$>SQB_\
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MJ6G66=^RK-#&;F]L<-'C3:P#:%'\4GOPH6UF\L[W]>52,J+MN?VO$N<R^.=
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MKG:M#];EX>A^!IX+/TO9'V3#P]3]#V1]DP\/4^_.N(%O.0PAD\)^T &+[DZ
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M_0#6>-Z#K;OYTH1P^;ZV>?YYQ^@Q<:'K??KYTH;6./D?49OXYZ^]!<VX^_\
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M(PVZGM4'#I_O]Y5!]!\_G.IS8WW[_-!L)&#=\'6@.'W]Z#?+"XWM0@#-!_\
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MS_>5;V.%S^WH#OVH_P H36^S6_FGU'J#YYI0VL<?(^GC]!&O6YYPH.MO/-M
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M;Y_O*MZFS4\Y<Z YOP\_M <)_:X4*8:'K?MYTH;6./D5%>/T"UGCY-!UMO\
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MQYRK_5=L_P!HGJ/9\Y4%B7B+_?3TS0XAC'#_ #%KT(SV8<WDX\.];5ZV>O\
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M->/)QC&;Z[(_\*!VMFELKF&UG@U(^QI U1?.F9F]XO(-M']V@"7*( -JEP
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M;7+WLFT9W<3@WOB(G\&.,3F0.$MNNVUX*2VKNL=?81-:6$P,R$ZYEE4MA4-
M^X221<A#$>_L-YFB($N+ER6QK"8YS+,OX@NZ3@RP.'T:$K6$L[-IEPXO,0Q*
M?C#U.J&+LSN<J/$BA,-W1L^J;B&7,7BKZ_>VNPEX=-..N,4@YG<0\+XAPYC9
MM5I9NR\URRE@&"1S^7F\/Z?F9/%]?UV7AZ'X&G@L_2]D?9,/#U/T/9'V3#P]
M3\.\_P"[8DF-DV[R-"&2PRVT386>%K"Q(+]N2SP-L#=T?HY8)?/G.MKWB6D5
MO:^LY\A3?=$/M9XX S/EK?[  1@E7$LSRT(TE8F_YF<Y+L[<VC*DZD)N^PYD
MO,ZN3SPN[J^F)LM?=.)#:)0=V['_ +$@TR[8F]]NR8TW5F^KGRV^-+S'YXN.
MTC=)G7@N]?L:S:*<3+M)%9VD1B/HP73!+.L:;9F(8M.^F<MYO._.>=__ &$H
M;4)\TBZ[N-:L8TO@+!@F"TM[7G3]Z]"ZI @O4R8@T$G3-1LX<EF4,:*8G@QB
M,,]E:9Y+NBPF-3A0AAR181_G]W5O8W..NG:A+Q&]1T,;JXEUP<_2-U7([.;4
M])]J%E.QJ5\LOY\U+L>SYRK#>,9N?VVW%0HEOI8\EVXC?-(,0;XMT1Z#&K:C
M;6Z_9K/:=MJ&R)W#I?M[T*V,39OS,FG/(1>=I._#UUYC0K0.2.K?UH64D[(3
MCY+4N^(Q9\Z48WY/]?F@,3)W#SA0ED=MQ]/[>AFQ._OS3G6]\;Y_O*ALZZU#
M<-%J/$?WB NW3G)KV)*=)9>E$!5PU1DH.&@[KT,X1W-GSESH+,G&YUTYQ6]C
M>7.G^T+F_#/3_*$U-+._S2HV,>G39PBK[)VQ;L^]"/'9AZ-!:SQ\FH-IW.G^
MT%OW%'BFWC%1@Z-EZ6Y1.VD2-YK =;D=]V)OS<$?4H>M^WG2H,2]??YH&D]Q
MWUH1OM=5^EFMZ.+-F_F^@N;>;?>*-AMU/:I'(TN6;=G.RH'"<[>YWKB'<]J+
MO"H@6KP(I)QL:,0>TBP0W_I&)WF;OP6+GZOZ[LC\$\S=^"@6N)@VFSC>1K>S
M^/CCFU!-XXKSQ1G&]0=1UE(>A:QQ:&R'*YDZL;6UTXT"X)C-T.9;KQTNF;7O
MI_FS[*)$R&UL;,OO2A-DA;+W)ESJ3-]HG07C!?\ CIZTZ4%H8)G?+,.\C=2K
M*J[UG=KQ^_ WF'/>Y.QG6\N*YR-Q,/:>MQD02/Q4$3;MT0ZQ.R<R$Q#;9(W'
M2-.N3G*RGXP%IM>UDG@B=JPN;B&+VNS=P@XN*DUBVACPS:K,0C. 1>DSVJ$R
M1KA,^NWIMG_T"X&#88JVT7O<G8R%^@O'%3="[Q,.PO(V6NWS=V )B)93;L+[
M%>ZKE4&8+!P  Y!P_-S>']/S,GB^OZ[+P]#\#3P6?I>R/LF'AZGZ'LC[)AX>
MI^(@B.-QC8\3=$BFM!%&)/3)&[4B,\OM@V<[6%TG9B)U;L7:2)M?4N89XB,[
MYWPGY]@P&S5X?U@ 8$H4V)P8,^3:5E['VV+M<&Z\O7&=6"S^<%,8OI:;//#N
MA9U^PH1T'M>0=)%V5M,FV7DCZ0VMM^F ;=S%PWYNQV3_ .S!+K;E9C@VAM<3
M] DAJ2D',*[IXH:3]@81V(QYI%DW\:U8QI;(W'+$EX;WO&M* (R]0W:BQL<-
M9^QK=EC.>S%N9K'_  "X))&"6Y'=F*&ND @0(A8@TY]?9@ARU;R^Y8-T1PIP
MKG(])OR9OBB>H]GSE5FSR<8V[/(H#NWPA[/+.M1.(WAD,YCX^;D= /4>8*%D
M)/,\X;J^67\^:)['LOG"@)"B;!)S_P!J2)/!<SHLSC5X5%X""7&$8MOF;3$9
M"C;6Z_9K/:=MJ&R)W#I?M[T!F!VP^L5)J'$L^W:A:,[LNL_WE0X3/<?/2M7,
M:F>G^5O1Q9L^::[J"P+'''70VXJ<)UGCB.G7A1QYP$41"]UU!83]T#*IOA8
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M;I>]\9UMEOEG?:MX-UQU#AIMO4RLA=5)SA12=[?&*&<(\;/;EI4B)>OO\U:
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MGZ7LC[)AX>I^A[(^R8>'J?F(.9W"[8U-39B]B-1&\T<B3P(==NN']/WGR#Q
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M\8T:L:KMHWPXY6VD"/6U[UX/#9UJ5!*@,Q8X7X6DMF^;;YJ(-UXPORU<^#-
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M,,M$),35OG@V%@KSS%#L>C[4/6'L^<JB WC SLVEPYZ8HU03MN;[AMQ;;>M
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M:-^-_>DN+5!AGS8VH1D1W6HGJ/9\Y4%W>G6EL433B*J&@1TS=-U*(H+>%/\
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M?S3ZV$[9&Y(;$)P!6#.,+P(26 ")KG_TA1 [, (I4BF/T0<8F"A2^T^MJ W
M$#;,[[E[\]-E0M)XKGG+;5A*2;5/+- <-"->3BC0EG-I'B)TS6H1_>3?^6J)
MH8;\Z0QGD+%^-!UMW\Z4.QZ/M0S-^S077;G^OS[59[;SC;Y^@C6>/O0=9._G
M2HV#&_VI+$6ZL]7THLKPDZW<>YQ+7@!1.P0YB0 !U8P@C2*&+'B&,EIEC$OT
MDSB"[.3TF:.@&:15N)AF-'_EL?N/,9-9")V;:,+<*DEO H!4,&RT1.)$P9<
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M_*%H]&WM0C)LN6;>;J&SWL]<>MJ\X>_EJN?#_2AZP]GSE07<[_?SA2 VAO\
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M!L85$TX6:E$,+";_ .I9A&D+"-R(5% )%6%;$W,+736DE,VXJN+%0@014_\
M)S9L%GEWC,0U$"&,L,(LYP!3D->E[3,HD#(8/3_ZGXQ (DC9&&9,.=M1OJ$<
MT"0UAR)5YT@E.%R*J52"6JE,*R84[1X#-,+56(XA8F)"B2$PT/X,V+$OA!7J
MD++@;U.JH7]8=K!1(H,1:EDI1$H*R0TW6TNM4.T?,=63Z'Y D?L8  P  !_]
M51M)!_81$D$*6:/+B1^#(,IF%POA!RJ)+ (_06]D(JRX-6P#9=;-!!JD%2B%
M(D9)"GPSR5.R0;Q*82 %05@<O543'"T:>:P38V 3AR)A@2$4F@^MJU?3T0\A
M4P BDH@2)4_G(A,X8-&SQ(226+KJ,#33D"S5H:+\&C;V"5,2!C'$K=UZ4'!"
M&DI4/*RS:_H03HCF"TNI:$4)V7+54D!40<16L0A]3)  #_Y__P#_Q  N$0$
M 0(#!@4% 0$! 0     !$2$Q $%187&!D:'P,+'!T>$0($!0\7!@D(#_V@ (
M 0(! 3\0_31,:)'YF,_0Q2L.)NF!+A-T> J@U9$"\EL*5N-W8@)7A+H.15,Q
MF:D(M2SU&KKJ,1&6%94IE+082$KVN4DI(SE+D-[R4P;"R"J(H*HG668EPX*X
M(@G2HD[46:S.%#.6-*20&&"90P6:X<A^!@H7@J01% 0H&1&*#"Q")%@,U "(
MN('>F(B:$P14[G)G(5HP;"X) TUF$8$BP-$+#Z@F%U((2-F2%4@: 5):W K
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MHBJ@"JQ@TQ)1:"4E1G F4$C0C5)LPN0*P*!B<E^1@$H$X;3&$ U"MH!&3(D
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M4<2)!2I$DY) SB!FLKE*P$R))10)*1+L$%6LP04LP#-^Q#<PZ7G\8@9)M^3
MR]>GI@;.-_<?G3&8B*W0M?5!,DD05/5(;E7(.0!()EL72*P1E(0Y50F4B/\
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M^?M@1L_D'M4P(2"!561#08P.AQ@$SX":\M,F C_S'H4 4*K8JL"4L+0*:2,
M600,HI"B^MDMJ=Z?S$%GYX6Q,N>9YWP)G&^GQ]4&Y.$MJ=?7"&4[J_/CH-S"
M<J7OW[X0RG=7Y\3=BNG+YC$S_$\_JARXG?GA>2.^G?3")<>]N)2RG&?CIB#9
MR_OKPQ%AAV_WRPAE.ZOS]L#<G"<J=>^> 80(B0@P1$1RW2-PQ8=Q2961"2I%
MUCB? ,\%&P8@!!$$_4@H!4@ *JL !55H!5<&7=H%)FC400:")CE[ 8.0" *
M "Q0^JF1Y>6'2\_C")<Q+G7?[WZXHYQOKU#I''"KW-2OB+91N[C"RU>GKX4#
M<G"<J=<+-N[V]IP(SG?7$,Q\_; C9_&,FE@D(*>40() ,8.YEH3>E 3,"84_
M^8P[XVZ0 X10GC,/$\8+^@9C3*%$EAC[G;''WG$-GD^^)ED=Z. -GZH-S",G
MGA1<IL[]/'0;F'2\'W_N%&6O3/\ OBUS\Y]# CPX>?U4RC=3"\H>CWQPB7'
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MC9+TA!?S@3.&4$ "H0 %5@)P9VPD*'69@H2%<9Q5!N'KSPZ7G\847./?K^)
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M01=F1)38 ##*K0LQ "!)9HA,KT\7,412+$2ZO*4O1574$S>"</+YE)!!*5:
M5;'V:[ADY9SADWPG2J4=P J2H" JD.%1%7("L2TU9E# *E,  8BJ.MPZ10,T
M1 004KMZ"K<2$Q)%<(.EI*>8@:M$6JDK@!,0!D 4(HB0A)#))X*F4;J?&%9/
M/")<\)+:F%Y5Z8@S>/S@UG+YP(V?M5K2T$;@1( ;1)PN!W2(4X)!0(!$1)/_
M "U 9(*LD @\"D+ 4^Q!N8CDIKG[849<2O._IB-*]^>Z? @;@\,)RDZ]\\(9
M3NKX;FP&5126MN*8C,826*B"C>"Z09A.7$:@@@?(0H40U92CXYLOH#YH!^&#
M[^ ,N86E4@X%#"E> Q9VDPVN4*T@N**: 8%$$!$8E()$\=!N&$Y4Z]\\(93N
MK\^)%Z23K$0"2@N*4$P8*"2>U"+%1LE^8@OXJKLL@ PY#T1E(+ QTQU@/(4A
M<.\3!$#9C?[GJ&$2Y]\#<G#MCC[SA9MW>WM.+;,",^#WY8#F1UP(V3UY?9 W
M)PEM3O3^87E7IWSQ"7(^ZV@$GL9AH3+8%PE&,!8 0,,5 O$$2P<7[0RPM6,U
MR$(B<&[9*UL9<].4Q^  2B:'(R'4\@DRQ+.&PNF0XA6A6!(T1%80M1T"L!4P
MT 91@L !  H$54!A&9$HD51CP5LHW=QA9:O3UPB7/!@;DX3E3KA9MW>WM. &
MJ[9K\]3$,Q\_; C9^MH,+PD,4 U"3-U7_P#+1.JVF19D2H 0@1Q!E*P@$"JI
MFST(X(ES[T&YATKQZ=UPHRW1;W\L=]SZ> @W#UYX3DQUPHRXG?G]KQ'#@"5
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MZ%JT+_E-]*=;#MVBZ1%/]:*ZU3+!()N*E85-S\10%4 JJ@ "JY$=,*]!X(W
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M^Y!N8=+S^,7L]M7^<<!;TZ^F!&S/UB:LCU!)X';S,@C J)JDV4W<;)>G9?\
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ML%U_PG-W'G_\1"BZ5OKP<K$D6\'+88]HIEL:;#!3E?;7E/+=G_MS))!!)N"
M0P),&!)N3N[],#9\^X^JV7+N,+RAZ/?'$ZG&U-/C ,RNI?G,]7%-&]1YA;AQ
MP[QOMS*''UQ&IPM37YQ/,'OETQ#LH[?/M-V%Y5-G?E.+;,!9\^YP'.3KWRQ&
MAPO77YQ42'Q@@@41<628?WR"95I12%!1X-,4TK^&U@!#J@%?7P-P>&$Y2=>^
M>$,N)7YZ>.@W#UYX=#S]_C"B_/[-<,-1(6X#W)S@:Z:WB+&X9K,M_P"%0F(G
MVI&QF,*Y)J^Q+:CTPLV[O;VG%MF!&?![\L!S(ZX$;)Z\OL@;DX2VIWI_,+RK
MT[YXA+D?4-1+ST1#.0L@(%_PK-W'G_\ $0I6^G"C:]9GB94\!9>:\>KQWS-_
M]OIT2; *&& 90ADH(:!A#<]^=\2+N#WZ8@N3M//N,"9QOI\?5+L[[M&%Y5Z=
M\\07G<]S@.9"YGGW.(',WJ-*7"7B:81JG1S*8WAY>V-@/GM[(Q#LQO[]<)9<
MNYQ;9A22N!$/9G7.4F)E?WP)E6E%(4%'@TQ.V^<9*  -I0^W4&X>O/"<F.N%
M&7$[\_'0W,.EY_&$2Y]*Z:M/ BVM!TF'@:Z<99T+<"^)##_PB<V&"8@+1$4+
MIO '[4&X._"<I,+-IL]L6V8 SG?7$,Q\_; C9/M2VIY=\<+-N[V]IP#PR]F*
M:))%J;"H(@_PG-W'G_\ $0A-(&VN;6&[%:BW@\'A?2,BCQ XWK+_ +@8F\5K
M+K3-4L6)@?M0Y<<\0:&W+H^F)'F'?K@#GS[\OI&M=^$Y4ZX2M7=?O=. */7N
M<&@ITMWPP@UH[J)/.7?&W#M1R=2CP],;P\O9Q!L.TOWQP(J2;)D(S9@)$C"%
M*O[\/.X2BL* 1'8TQ/W^<%Y  -H0?O\ 0W,.EY_&%&7$[\_'0W./?KATO/XP
MJ,S,"" %;NE1Q-=,-4@L;AVM.S_P9S&"6E0+32&9DHM2^(TZP>N$2Y]Z#<,0
MR7S]L+-N[N<6V8&7KOOS_N YR8D;(_8Q!*QD:$!"*$7I%/\ "<W<>?\ \0G9
M?+?X+Y'?-9K&F*7[Y>G^X4HH>.9T1#E"!)34\!#EQSPA<[GN/+$BSB?WUX8
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M"0PO_ N&@YI*JLJF 23G+CC.GMU,+RAZ/?'")<3?@4LXD;D;O9]$Q59'H]?
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M,)(1$D$E:P8IHRDOWI=F[VPO*O3OGA$N)O\ "A!%Z6""IK43:O\ A>;N//\
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M78IB&<K-:YQH:R9F_+]6%69B\E*Y%JS&<ZM &('80%F)ZYB96FD'YV9N?/\
MQ!KKW?KKG%9, 7:W%,ZY4@N4O2K;\5BU+Q-M#=EGKG?$FI4I8V[*RA09F!/Q
M:1E;WFD7R%WFR+I8K%T'3G&;E!0Q?ON1[A*?@9<HRMP(VF(9@)FVW;--.%G/
MP+AUIER:96(SBPGZ83$H#G363C$3,0NV'Q(K;39EU+M<V39^DRK3/=I;KK@
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M!9GO1IC)Y'D/OB2SWN:X$;&I?Y[KB2@C?V1Y83E3KWSQ3M#C\]Z8DN=[[XV
MQDP]<K98FY[GOS=::$IV:5Z7Z9?6"L4=GM;#*2FQZP^,Y-5'?\C@L[A**0H!
M$=],37KE"61 D!F.?Y6U'X%7"QNNR.<"A+T0,KO!VR_T057$6B@LD@27A4,1
M<03   ! !      0>$EM3"RU?/[T&X>O/#K<_<Q-ZISZWYX#G3KZ8&93)T[F
MK0"-&07_  [-W'G^ SZL:5BFKLTO0D-;[X,[-(@<[Q7(_#I&5*7A;&IV)FN%
MDM%+UX4TULS6:N(UK;N_/4I7\#3^;XZQ%=L3BM+;=G2N=SB08F1I6.52N:NK
M,%IJ'X:9YYTUKMV4H7FH3^&5O8TI6+:=V4K^,@UFX":P3;;%1T(Q,V(*EYG1
MG;I$<JY\KVX:,Q.L&?AM>^^F.^^_7$IMZ'KMBU[S<2UIB9V#GMVK,0M/^'4U
MLTBVR#6)+%4I))$5](-M:U=E9R<24HH\(O<;:Z95<4C/I>MV<MALV_2>.[/2
M[PRH6UG8G+WS_NT28GC"CIE8]LCA1B,FL7KY0TW91_B9IWWTP)K&;%,M8F),
MYWM%#PI*KF04J^>FI%I 46\VTBE=E96W0 _/]_G;\998G)N9P5FTL[\JMX(\
M.+E,IV'*9M,,SDMK*._.S:C4SY3GXS7OOI@L5*))GG72IPM)X#SS (,[*WN:
MUJS)^AMV]6O=<01EOK$Z9UK.E*4*_?FULTH93-;3EF7K.-Z_";M+[LIVU\"&
MVT;]+T- ME7]#WG,-]W\J> $[$B6+;7;RM+FFN4Z<O(,HW^$I2?X,JU0X<D.
M- ^PG(8A"&9E&$&93L>_0PK,INI[> ME&[N,9!G9W[F,GD>0^^)+H>]SB3<G
M=WZ8E42':1URPYQCOGYXFY4Y]8GGB2YWO*XB;)#*#UOPQ1<>B''WG!*?2OL]
M(I?Z>HI#']L/_D3*%G<)12% (COIC+K5<E$!&T!OY72N)+!A'1A*(B:])EUQ
M X YE(\H$W\^"H JL 55; 9KB\*N$B]Q+<,0D08(       18@RB(C2 9GQ8
M&Y.$Y4ZX6;=WM[3A(^XR22EDR%%:"B8V)<,"N&HL+ I 4$  !_AV;N//\ %<
MZ<39,Z,5K7.Y^')EN:&POMM%Z,Q1AZQ3KI$;Y%S9_%G4DE*3.^,]<K14C F<
M&4ZZR5J9.25K^#:I$1Z-K2M3R3"T&M+US^<[6R/PM/:>^S$%:[I9TCUEZ# _
MB21KN^!GXU5Q-M_/W\B]K_@7[[D>X2E9OP[=.LNP'@A3C,\*MX9M9_X&F?\
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M]^Z_>[$1E&^_7[T&YA.2G?>>.$Y_/IB;A#WG;G@16YQZ_&)'H5./]X8.6<T
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M[W1BN<.ZCR??$SW'G]VKWMC[O[;83_R1>#B @,7\ 0'&#Q UB_(I!B7 19C
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M"93$9>!EH]-(=)?.UAW3/QJSIMK"GZ$2[,,HI @)(0P&.Y5J911&0%"P+(>
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MFU[?@]]WO;RQQBU\W<3SCJ^!.>L1?89Z\-WZ0ZZ0<FP@5##HI0X)F-H*,1
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MG.^OSB&8^?M@1L_6 TIY<3VC.IC@=U'K)U,6+5\[1YG?^::C$Y3#&%!0.@
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M'=O<4A+#>+FZBVOLE@KX$U*=U^.;%O "E,Z<:L.:H --*L^!WYZYS68A(O\
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M?GIIND239&W4ROLI?<%/]9LVOY_.W0,Z^"PFTML:;MN?FK?4[BCOM1DN5/U
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M]H)@5 %5@"JK8#-< 9">J) 4B8J&3]X>=2W?SB7,DMG<=,+RKT[YX34W2??
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M;/W#+UZ>D4YUP%V=Z_S"#<'?B')YU^>;B=3E+Z3T\.&YY!-8*M22$$+$1?\
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MNX=T>F)EG&S\],!<XWTQ[,-O;+)N=OT<A^4D/D=$!2RQ<&&2R!8. @"B"!
M'B"EG!K.7S@#9^L-SJ4^,4;=]'G;H8!G)O\ ?^?<WE4>!* [%%9$:A: N2.2
M<1*M  !D/\_S=QY_HU)RGKW7 Q$<FLYYRVGNTP;=3TTKMTRG$VRV1-YKIEK(
M1G@Z9QS\J_AKP@BJ6&UB'6U)Q-(KGK74S!T:6S8Q*6(D1V;(YW8XQCCKWG;L
MQ&<5;_V*VS^/V73*E-D=<#>;;:<O=DKRRM7Y]<[;[S(A+&57R*.DL-+4(?P5
M((=9C?&^N=J1-IQ.P-C6'*ALK5KG,X9[ )W"4I4SF]\06,LM+\IG=%(_W+^^
ME=?YBN>D5B:6M!;4MB32&&:*?W0#;LP1-S2_$HEJ)4298IXZD,N[2Y2I.V^;
M-9F2_2%&OE[5UQ,Q3?DZTBC?YR%<VG("[M-ZO(QYTEUZ7OTM^UWY5HUSIER_
MK+:+6??*M_0S4")THD5=)T@*;=IBD$1$7VQ>MYA)-FABA6:$FF:TFD)1,IE-
M5R+YV2!I8CWC$R6BFR?;UU7%^XUX_P!I^L*\8?Y_#G.)3:6BT31=M+SS@C A
M?;_5L#_2XR99&I>C._4JMMIC5F8W-LDKE%I,JS2=F>?I&6^N=+8BJM9[B+1P
MTFI/_)U!N')4(T!"J$0P>G-\TR@&!R4[I82EF,#SAZ/?#'"Z?'KAUI-Y_,(E
MS S;I.N_/ 79O]_>,3/<>?T0Y1N]L0+,[&_/^4IB&8U;RNWGGZX$LK]DZG*G
MI'2=N!2SP?29.+&)%G?D\(P)G&^F(,J3IW'&, 9R&7I_$W8 T'2_._!Q$D=*
M=/C$%GO<R8MREF3R6SGYF_0P/E@E55H89;+&FQS.<#! ,   @   Q*LAVC;?
M$X@U41O_ *=<3>J>F\]?? <Z=>^6)&S/AB,\&LY?.!&S]8"8I.GM;IBC3H?;
MOG#.3?3K;K]'\G6=62"%EU,BYCT\]="Y5R @(.$C_L/D-?/9Y6AQ!H<C$&AR
M,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'
M(Q!H<C%+\=-N?7]<@W[S[USQ!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR
M,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C';W&67Z?WSV_VG+$;4RB9[
M=M<RM,2]^>_;B78GOI(][UP.20PVWE[+[A.VJ*-,J)%+0SZ!22,2.N>26-U/
M79BC/3*U+5797:XDU.9BF2)6SOB8FNF26?I)$2;<@O&UO-LLRTD4A$O3*F5N
MLZM<26B'<PG$RH3Q7/$D$5S:<J0ZVRSGAP8C+,5JZ;6EL9V+:_!OWWF[7Y*0
M6\ME8K$X>I;*=M(F^<:4(QG:LG'>QO\ )O'[EKWWTP'"OQKRT(I3%>D5RTV_
MR-_9%/?XVQ6:6H3H[VH<I8I7,&]Z=MG,IJVB4@0DB=&(]+\9BS%<*5M:,]^<
M0$9SRL)4FKK5C-Y]8JU^DYHLO$D)VRWG:Y8ILJ%#)K>6D:V:T:XF&V-%-<H*
M:.I9A7$QRCG1ST^"V)+13:_R^>N4086U OM+4TLL7EB8JN)5O!H129F*3&C,
M\B-W;?;VVMX_G##%K<\ME*N(-#D8@T.1B#0Y&(-#D8@T.1B#0Y&(-#D8@T.1
MB#0Y&(-#D8@T.1B#0Y&(-#D8@T.1XL&AR,0:'(Q!H<C$&AR,0:'(Q!H<C$&A
MR,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR/U\&G9;$&AR,0:'(Q
M!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C
M%"A2UN&^]JUHZ3^E0;]Y]ZYX@T.1B#0Y&(-#D8@T.1B#0Y&(-#D8@T.1B#0Y
M&(-.V_Z'?$;N\L0:'(Q!H<C$&AR,0:'(Q!H<C$&AR,0:'(Q!H<C %@B-G*NM
M<ZYQ9_54Y.6>?/."NM\2Q&SAPG::[VN);4G5,M:<KDUR(Q+>#.UHRI#.5()C
MCA9B@:UZE.E#"FV(J@:Z3I"^KB=C20F-6]7;EIMB;T9G.&CI77.!;D,F)='I
M[XF+%KUB^CLIE%67+$DVIE7S];;'$[#KKOC9"8OLN6ZU.66F6*UK+$7Y25-,
MN$4QPZY5Y\>K^\O<'O=R],;H/4V<7N?V2#?O/O7/$5MGY9[6K";F/^7J'<,*
ML(T!"N  8:7U)+E($$I%AHD^P>=>G?+'"Z?'KA>5>G?/$)<C S;OP%O3ZK91
MN[C%&8-M^#[O"F 9'12_>[%R2IKE]12V=\25DY4CTZ8%+<#3SDZSB9='>C[X
M VQ!E3=[6]<![>]KZ\,1;GD^V"VB NPGG&C\^4EI( KY2)44LH7!@&P0T8 B
M  ""  3A#9GO1_N-.\_C[XDNA[UKBG:<_G$ED/>E<:]Q_3VP)N3WJ?W 79O[
M\X\01GP>_+$,Q\_; C9^L/D3(2+@50 *!##-U=*53&1$0B" _P#16C<R850C
M0.*A@O%$S:<!11$H$3DGVA2S@>8/?>6-)EWPY.%EJ^?+^XE)ZB>C@9>N MZ=
M?3ZH<HW>V-P.3SOPG$,Y'1]_@^P4X\?/$F9R]O9,2W.:_63DKUQ?"1M^&O=L
M".9WLO\ 3RZ[=5M8%IOS8#. 9>RE#4"86* Q!,">#H=@"   !!+Z"EG%=P>]
ML^F(=F-CWZXBU4[R]L0:"(W_ -.N)(E#WE?$WB&S^3W? NY'>I_,;+N_I[8@
MN3WJ4P-G&_N/$ SG?7YQ3EX0!2H&AHH9<Q+=QK)5O"'$$ @'_HQ3^Y!%80T!
M"O@  B@^]*I$& 2,  I@9>O1[WX#G3J?:*6<;(>^],23"CI3IKSPO>:E>G>_
M%1S'DX'F<LL!=F_Z0-R<(RD:U._*,4;')[YXAG(Z/O\ !]DQW/GBF[=7HO6>
M&!<I>VYKU>6#*B=U=W/!UOVB+ _Y=I$X 9>&$-Q%48Q3LJ2MH8@B (  'T4R
MC=3XPO)]^^6$2Y[<[?04LX-+E[.)+->]87%.T./SWIB#00ZQVF(-8.^9QG$F
MY.T[],3>H]Y^^(+N'=/+$%R=OR4P)G&^G@NX40@2&XDJ.J&)A_[F29HZ%+!R
M2?\ HT4_N016$- 0KX  ,Z#9BI$$!2-4 3ZCSKTP%V;_ ']X^T19Q%N'O1]\
M9!C9W[N$LIW=SB5,2;STP/,[V>LSLTP)GW?Z0-R<471U.N)-S@^#TTK@#G#H
MT^.;]@IQX^>*9R;O9]\$3(.1"&%#$DH <+V8I(@X'(P B")^."L!*T NNF$I
M(*@(ED%$G:(K%EW)"/@A    "#[5LHW=QA>5>G?/")<3?]!2SB+0<N^LXDJH
M]/)Q3M#C\]Z8DN=[R'!FYW\],9@G;W[&*]B\/CO7$B[AW1Q,L]/[TP)G&^GQ
M]J)!8_.*J"M4!06'&7"85C*MD<A+01_Z.;4_N016$- 0KX  ,Z#9BI$$!2-4
M 3[1YUP-G&_N/M%+.(MP]Z/OB2S&S^UPEE.[N<"EG!K.6 -GOONGT0;@[\47
M1U.N(,PIH3HSRTK@#G&QI]BHD,/G!B4N0#&1B\-_D-,T/+A1EL@?Q9)^1+C,
M* T'D,.(2C C?"[&+>2##P@W/I.IRKZ3TC;]ZV4;NXPO*O3")<3?]!&>(/43
MOUQ!JHC?_3KB;U3O/WQ)<[WE<$)]!Y_S$%DG>E.&*]CR^,06>]S)@TN7LX Y
M\Z<-O#!?SDIR0:U"<C@8$7&>%82*&0#*%_\ 1[)4_N016$- 0KX  ,Z#9BI$
M$!2-4 3[A2S@>=<"9QOI\?:(SIM[DX8@V<3N3KB#9KH]R1:LX49<J\=G' C/
MO3=@UG+YP(V?H@WQ(N3?7=RXXE+RV^S^>F -GT\\(EQ-^ V7F[(@%HVH4(ZI
M"#.6 O +=2Y@4KXXUK:3$!,S\%$" "14 "558 E5@PI , %PF,&A=@],2%"*
M8:(&FF)11%?N(-S%=^_XRYN.'?>L?>EV7M;E[87E7IWSQ"7(^@&<[Z_.)+\G
MO3 &MCAU^,";D]ZG]Q+N0^OD\:=<0E9-E/Y/+$LA.GJ. /B:J-*#4B93AX7X
MY0&E?,1KFS4?^C]/[D$5A#0$*^  #.@V8J1! 4C5 $\ 4LX%F<L"9QOIUMU^
MT+.=_<X@V<>ZF(-5P>Y.ZX@R?/RP(MWWW=P#,Y=[\"-GZ(;F)%T:S;RQ+,[:
M<\\ ;/#/"\54-#@ BF-3:\/$A(B!*E)1B:"@3*+:4 142J7&,RB+XC>"A 9"
MI-4LK[<./\,#*S'+ C-#0,!R!DTV@J144/:,L%&NQKYUP F).2=8Q1GJ]CYQ
M[XEDSKDG!PB7$W_= ^^?.^*DUG0:=3VQ.LF^W,DZ_= W)PG*G7"&4[JXA+D?
M0+/GWYXS!'>L=+8 UL<.OQB%^)EU89F:"H% 5.>E+(5*$!)(!]A?^D2G]R"*
MPAH"%?  !G0;,5(@@*1J@">$*6<&LY?. -G[0,YWUQF"-O?LXBV#WJ>V%%S
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MSCSQ(WKH-1Q*<XMA&W>J<_GA.$,IW5^LXES5:?9I@H +"*@5*'(4BIJIG_\
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MPBJE4I'8<Q!) :@0@-0D$31R:-14)3K E )(S^C$;=\OK@+>G7TPF/827+%
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MS1-),L'$$ )D !-%(P*I3"5I HE9H4Q 0B)(J42$4ZBJC%*J555O7_S^_\0
M+A !  $" P4( @,! 0       1$ (3%!\%%A<9&A$#! @;'!T>$@4&!P\9"
M_]H " $!  $_$/TQ%]%'@ 9J9E',2A.W8U3E\GB*4"0D$$M(9BBPJ!?J?B7\
M9"$)VJY%[0SM6ZH !<UGL\@EH2"!) 0B!H&'XW&I<("*J^5O$$@H33.3H4-
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M--.XG2G(50RCW@#&\V?*:>7 FH\216Z+F1FU$XG9P/:\$0(H)?M!\/()Y5M
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MB5?NG-D)2BY_8Z ,/1\E8FP$0JGX0#[:0"LTE0_!.5NM(8=,=<Z&8WXX\_\
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M2I2#(;USG_K!8132+(AX@#VM4^*6>_4O(HI"VQ1%<N1X42"@#?"D).R'5O\
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M:,C6_P"+O!HL(\L<#6EJ"_(@@]-64A+FZSAW\  EVQ4,%::!3M+1+1;0=)D
M/[;?:QWAK(PZL4)P44T3$CZ[$'$IV'G\_5*,M:V]L#"WIR?:*O>22^'N/LM(
M]SLP>%[4O)GI2)B/8@XD_=)RDZZYTEERU/:0<3)YF)DA1,!^X/M6VK_ZS$)
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M@Y(%_8BINH +=\9A)^O495_!@ -R:Q<-V AKA :*=2(Q%&AW(#EV*91PM]5
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ME/+W2D6R<=CYY\ZD8O)PUJ:D8/,_WWH#@]_;MJV N+=.= 4K"\0Q-^OTQO\
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MF4'\2;*4JT7%&VQ7E6R0E+VS=<QJD4 H:!$48GX)=W#X^(I>5^G<*91PM]5
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MTG*W6EF_6L)[%LN6HI>4/1UYU/-.MJO<:R!8\:(]1(E'>X.OCGC.9!TH0%,
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MYW2$J!J6?CJ4Y4-)'&IKF4YQ#QMIX=+9XY9X$HM<GSF;7H+L_/\ P6>"/M9
M#<_-U3A>'2&DS\#2D\## )V23^0B8WPAI)61;'!Y'AKC$#([LTSI!'!!X/\
M2_"# "10-#91"'K.NA)745*+Q6(43^]*25K"OK$Y5/T+I!FY(D*J*97(1XD
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MN$'M2S"_3WI$Q/P2[L<,.7Q2\K]-<ZA,2.W*7@*S WS'!_B*NE;^>N]16I"
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M9A::"G94I?3L_P"E==8$1D?N>&PTV7T5AVF4=UF1H &0^R.]Y?RD%CVPA+!
M<&T NF]J!NB#L?S+_>GNC/YA@'QN_P"7)FQ@B $"B@I89_??RQH[B)I2 M%,
MDN-4<XK^!IQE?S(4UK7<[80^"TE8=P<\:$!F;"<OWLN7E(43GKWE K1<!#W
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M*S#-P>7@V_;.Y[B&I&+@7=5.Z\+#V5BB<DHB!@_G%05.JB:O82GO(39XAR"
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M>UV454L7AM/Y2"U[82E@D.+W]JA!*3H!4*=Q8 ,Q4$ZI%;%8U '@_P!+\(,
M!'@1!@ZPCB_<9CN*VT=2D@;0.GK$NP64 ()K9D+P$1;;/W,3>8,NXTO&'DP;
M;L>.AJ&I_:B$@X- BT8?I(SSCH5*'P#'S?88*&X;8#VQ;%IUC@O*K]R^7UK;
M2\H>CKSI#9,/*D9/.E&7F:]?P6RCAJ*687Z>](EGL0<:0_#?AJ];$Y7Z?Y4'
M!D]O4\K]*<I'>O?R?FMQ'ACRQ[$N%NOO264\-3V(>.L=M2,6O1\XIWA%:B^#
MRV;6QS_%BS>K\U-",ZQ!DK,F[5;"KY+HQ5,XBX1*DW,".:(A^)!Q*3E;<Z^:
M49>>7:C$D=UOJK-G0_%78)7\]\X<_>G9>=(F)V(.)/W4<E-<^M,,0&[TT/&K
M]JZ3]>5+RN;M>D]J'+6MM.P\_GZI$Q.Q!Q)^ZLP4ZAS^:$F6V1#&BC[ 2T2;
M#4XK(K>QBT8]/%73Y #Z5K&&+]%B*N2@S^L$TBR(=*Y"H9+AJ#K^#43&B&!6
M0#7N0_!')2<RMM? @0_ <-O%U$F1D0C]0L(N6@!E3M_:"%K)(KUC6>O:R)[C
M8+OD/,6 ,WNCSRZ9F&\($*_93M#E0J+!F")$ )A'<$%!UP=DV",NSP,M+3RS
M?'-2T!'<KLRW2B.4\L:KP F"4/ DW@%W[@TT8P)%'&(Z_P#!*TWT&? JGQOW
M<VL?+%GB/ '5 'N!Z=^=Q$#5]W%F/@#@MR8>D,_]/O#0_P! 6A% BF(E"5TK
MJFB4W=RDMT'R>])8X<2SOEAU;.E@,;A#[<;VJ'A:?79?T/BEF%_6D-DP\J=E
MY_5*,3\$N%J7E?IVH<2@<.3AZ4[J<+FO.K-R>,^J>DU9M"L-IYS"<VMQ'ACR
MQI!Q*2X6Z^]*-_"7V[$?IUZ(6[#C#^,%F_3-U;,H&&<6B'P5HF #70D%&C!!
MI?X5>:E'-JB-FZ8*$ L\7X(<2G8>?S]4HR\\NV!A;TY/M%6;.AJ_$ER^N=+R
M9XZ^*1,3L0<2MXGINTS3#$!K6%0\%'?ZZ3A2\KF[7I/:-5"G*@%^2?HBAJ\F
M-E#LX"Z<*I;9K7%H.J*0IT0\[UI@=?\ ZS3'SY-(LB/-@E79@6!9AEQ_!L):
MN"U@EF4*1/<Y/R,"!*ZINEX#D+"4'H$KN T_U!E7-2F-U'^T!X DDBO6-9Z]
MK"^&@Q"H5:Q @T]P?)>C'P 4<7<*0NE S@Z+]E0$"-=F-[MF,L+'N1T3F99$
M+4BRQ(KX&)*!<F?%$G<!E  SG);]U)P'A=^%U32-.RT>"5,[!;N5(@M'_P#,
MO)4"?; V1(,K--X9-$ @,]5\5X%*'P-8PJS-Z%50@ % 7<0PR2!K_4 \COWM
MC+!Q9P+VK-FHJL=,#O6,07W[*?SD"IT2D4K^>[4Y<W%,!7:"PDI/TZ ZK^1:
M.,":(8$6F2Y2B<EXNVY_)4&)._[+4[XW0=,.4-,:P\CHJ1OF;X59;I>SZU)B
MUP;TLW\/BD.)#RUYT[+S^J1,3\$Y6ZTLW\/CXGM0XE(=CLD]_JH=IU->=)F(
M'G\-7;>H^=<I97X?&/2D'$I&3SII[\30AD27\:#0[OI/L6W-L[-"GPD)DAE8
M)A$(G$-[$JHO[$0"&5WE<%*VBVQ3!9FUIH( C%5QQ/009X=.&-R!L\%(<M:V
MT[+S^J48GQSP[;,&.O1IAD)N^YY$TCW.S#UM2\H>CKSI$Q(^J'4G40L3R A:
ME^*Q: U)I1Y,*AQ"A-5.BR:K#HJ=X 9G(8$I$: R2KI=0Y<%"O*=4M!N*NN8
M2W];)I%D1!9 ";]3BTG#%=^)-%0B+5S(QC?[8JU:M6K5JU:M6K5JU:M6K5JU
M:M6K5JU:M6K5JU:M6K5JU:M6K5JU:M6K5JU:M6JD8]'.1]4PK4^XG!B5LJFB
M%(\ 2)-DCGV92^][]0<P[X8C(S=_[1 QDD5ZQK/7M8)"XA)*DTGC%5W)R_\
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M;#\(9$J/?\D:(PMC@2$51XU3W'(52?G)U;%WN=)1@CW8CQ4@YV-!-U](1;1
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M7N*;6V2MXJL5^]W,!$[V>*HZ\4@:FQ<@1B [W"NTC#"H@W4 23^Q40->T#
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MRB;D2_?J>+&;"U5-5,M&QT$[$)4D(2 P3!\Q_,H+KD'^!M2D_!V  )@V8=-
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M3-1K[4D6R\ [*-YA=1*S$K(R#L"LXF:>=)/J DDHUI@DD^LAO06A=>PPXI[
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M8FQ *H4)DO4]P';EPI"0Q$;5,'F=G!6@O0*%2=Y==_J0X=47]6">AAIRM F
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2LQ%$(I5P0 C3    @C_G]__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>picture5a.jpg
<TEXT>
begin 644 picture5a.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ,^ P,# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)^UEX9>Z\/W/]G>(K-5_M'P_=L!<6Y(^\O\ STC/]Y?H<&@#WRBBB@ HHHH
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M-N!G!]EZ"OH<'D6,Q5I./+'N_P#+<\VMF%&CI>[\CQOP_P##W7/$BJ]M:&*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5^E/\ P1M_:0?PYXXU?X0:Q=D:;KBMJ&CK(W$=XBYEC7)XWQKNP!UC
M]Z_-:NH^%OQ!U'X4?$CPUXQTIBNH:'?PWT0!QOV."4/LPRI]B: /Z@**SO#F
MO6GBGP]I>M6#F2QU*UBO+=CWCD0.I_(BB@#^=3]MCQPWQ#_:P^*6LF9IXO[=
MN+.!F/\ RRMV\A,>VV,5XG6OXPOSJOB[6[UF+M<WT\Q8G).Z1CG]:R* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***EMK6:\F$5O$\\K=$C4L3^ II-NR BJ2WMY;N98H(VEE8X5
M$4DFO1O"OP7O=0"7&KR&P@//D+S*1[]EKUK1/#>F^';=8K"TC@ '+XR[?5NM
M?4X'A_$XGWZON1\]_N_S/)Q&94J.D/>9Y)X8^"U_J!2;5Y/L$'7R5P93_05Z
MEH/@O1O#>#8V:++C!F?YG_,]/PK<HK[S!Y5A,$DZ<;R[O5_\#Y'SM;&5L1\3
MLNP444E>N<0&BBC-!(?6DS3EC:1L*I8^@%:-KHKR8:8[!_='6@-3-52S *"3
MZ"M*UT5VPTQV#^Z.M:T-M%;KB- OOWJ1J5RN4JQV\=NN(U"_SILE3O4$E4@*
MTAJ(U))UJ.J :QJ-C3FJ-JH38QNE>7_';2?M&BV.H*N6MY3&Y_V6''ZC]:].
M8UC>,M*&M>%]2L\99X6*?[PY'ZBO.S+#_6L)4I=6M/5:HZL+4]C6C/S/EVBB
MBOPX^\"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.)^L4M=UN)1117SYZ(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@"6[_X^IO\ ?;^=15+=_P#'U-_OM_.HJ "BBB@ HHHH **** "BBB@
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M+WEOYK_-'V'#.=O#U%@J[]R6S[/MZ/\ ,^7:***_/C]<"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"6[_P"/
MJ;_?;^=15+=_\?4W^^W\ZBH **** "BBB@ HHHH **** "BBB@ HHK4\,Z#-
MXEUNUL(0W[UP'=1G8O=ORJX0E4DH15VR)SC3BYR=DBSX3\':AXPOA!9Q[8E/
M[RX8?)&/?W]J]BTOX-:!I\*"Y22_G ^9G<A2?H*ZW1-%LO#NGQV-A$(H4_-C
MW)/<U=ZYK].R_),/AH)UDI3\]EZ'YUC<XK8B=J3<8>6[]3G;7P%X?L7WQ:5;
M[O5EW?SK5CTVWA7;%!%&/14 JZJ[J>J5]!##TJ>D(I>B/'E6J5/CDWZLS)K"
M*3(:)&_WE!K*NO!^DWF?-TVV;/7]V!_*NJ$ ;M3OLP]*F>$IU/BC<N&)J4_A
M9P;_  YT'.1ID(_/_&I;?P5I-K_JM-MU_P"V8/\ .NS:T]J;]C'I7)_9E!.Z
M@ON1T_VA6>CD_O,.UTU+9=L4:1+Z(H _2M6'/EA:G^R^U'E;:[Z5!4MC15_:
MJS*KV^[M4+6?M6AM]J7R_:M'1C+=&L:LH[,S?L:XZ4T0[:T)5Q5<BLI48Q>A
MV0K2EN0;:>%IU%"B7S!2J.] YIZKGBMHHR;'(M2TU13UKHB9L<*D44Q:E2K$
M2*M.I%IU0:(5:<.M-6EIDDRFIE-5E:I%:I&34A--W4A:D*PK5!)UI[/4;-FJ
M 8U,:I*8: (VIE/:F&J$-8X^M,W8H8TR@0NXU'-)M4GO2/(%S5*XN"_ KGJ5
M5%&L*;DRO.VYLU78<$5*U1FO#GJ[GL1T5B KFM2%1Y8 [5G,M7K/.WFG0^(B
MK\)+BO2?AMK$=U8F%95>2U?RG4')7@$ _@17@GQ,\:-X9L$MK-U&H7'0]3&G
M]['J>U5/V9?&4FG^,[K3+F4LFI)O#.<YE7G]1G\J\#-\?2518:.KZOMY'B9M
ME\\5ETZR^SJOEO\ @?;EK)NC4U?B?*E?RK"TNYWQ+S6O"QR*\%5+NQ^"XRDU
M[Q^??[1'@B3P/\4M5B"$6=\YO;=CW5SEA^#9%>:5]Q_M;?#_ /X2GP#_ &K:
MP>9J&CMYV5'S&$\./PX;\#7PY7BUZ?LYM']*<+YG_:F64ZDOBC[LO5=?FM0K
MJ/ OC:;PG?8;,EA*1YL?I_M#WKEZ*SIU)4Y*<7JCZBK2A6@Z<U=,^I-(U6*\
M^SW5M,L]M+]UU/%>N:9=))I:L/X1DU\1>"O%EWX=U.!$F(LI9%$T3<KC.,CT
M(K[&\&S+>6'E,<K(FT_E7WF4XQ5V[*S/R7B++WA(QDW=&_%>*V,&IW5+B%XW
M4/&ZE64\@@\$5Y_9:I-8WDUI,V7A<H<^QZUUUCJ D5><U[U'$*>C/E<1A72M
M*.Q\C?&7X63_  ZUYI(5,FC7;%K:7^YW,;>X_45YW7WMXM\,6/C3P_=:3?IN
MAG7AL<HW\+#W!KXD\9>$+_P1KUSI>H1E9(V^23'RRIV9?8U\'F^7?5*GM::]
MR7X/M_D?K'#N=?VC2]C6?[V/XKO_ )F)1117SI]B%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2W?_ !]3?[[?SJ*I
M;O\ X^IO]]OYU%0 4444 %%%% !1110 4JJSL%4%F)P !DFM_P '>!]4\;WQ
MM]/B&Q,&6=^$C!]3_2OHSP+\)](\&Q*XB6^U#JUU,H)'LH[#]:];!9;6QFJT
MCW_R[GBX_-:&!]V6LNR_7L>(>%_@OXA\21B:2$:;;'I)=9!/T7K6_>_LZZE
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M E9<IGTW#BOG\1@<1AFU4@[=^GWGVF#S?!8])T*B;?39_<<_1117">P%%%%
M!1110 4444 %%%% !1110!+=_P#'U-_OM_.HJEN_^/J;_?;^=14 %%%% !11
M10!]1_LU:";'P/-?."&OKAG&?[JC:/UW5Z-KMQ'I^GW5S*=L<,;2,?8#-,\
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MXBU+Q!-YFH7DMRW8,?E'T'2LZBBOF9SE4DY3=WYGKQBHJT59!1114%!1110
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M=MI<<VYD/"2?W1Z _P Q7T#YE?7X'&1Q5)3CIW1\=F&!E@ZSIRU[/N<;\6_
M?_"<:"!;!1J5J=\#-QN'=,^_\Z^6;BWDM9Y(9D,<L;%71AR"."*^US)QR:\6
M^,?PPDU":;7M)CWRXW75NO5L#[Z^_J*\/.,#[7_:*2][J?09'F'L7]6JOW7L
M^S['AU%%%?%'WP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7K_ .R[-J4?Q("6D8>RD@87A8<*G53]
M=V/UKR"OKC]F'P>^B^"VU*:/;<:G)YJY'/E#A?SY/XUV82FZE5>1\MQ+BH87
M+:BDKN?NKY_Y;G6_&[X2O\4+#3HH]1FLOLFYE0+NC8GN5]>.M<+X+_9=TO1V
M>?6G_M-EY_>CRXD'N,\_B:]&^*GQNTGX5Z:L<R?;M8E7,%BK8./[SGLOZFOD
M?Q[\9O%/Q$E8:CJ#0V6<K96W[N)?J!U_&O2Q+PU*5VKR/@\APV=8S"JC2J>S
MH=^ORMJ_O2/H_P 3_%CP-\*+4V5GY.I7\0PECI^/+0_[3C@?ADU\M>//'VK?
M$379-3U:<NWW885/[N!.R*.P_G7.45Y-6O*KILC]$RS),/EK=1-RJ/>3W^7;
M^M0K:\)^%KGQ;JGV.W81A5,DDC?PJ._ZUBUZ%\#;CR_&C0_PSVTBG\,-_2O/
MQ$Y4Z4IQW2/I()2DDRGXU^&%SX2TN+44N!=VC.(G.W:48C(_ X-<37U'\2-&
M^U_"_7#C_4HLP_X"P/\ +-?+E<N Q$L13;GNF:5H*#5@HHHKTC **** "M[P
M3X+U'QYX@M])TV/=+(?GD(^6)>[-[4GA/P+KOCB^6TT739KV0G!9%^1/=FZ"
MOO'X _L_K\,] S=;9M3N,27,V.,XX4>PKCKXJE0TD]7T/"S;,EE]!N&L^B_5
MFS\,? EOX)\.V.FP[G6WC"!VZD]S^>:[ZW^7BF236,+&)+F-W7JJL#BK%JJR
MG*G(HC%S7.S^>\36J5:SE4W93\12&+P_J;CJMK*?R0U^43L79F/))R:_5'XE
M77]E?#_Q)=D9$.G7#X^D;5^7.CZ/=Z]J4%C90M-<3-M55'3W/H*TIR5G=['Z
MGP3!QIXB;ZN/ZG:?!/P6?%WC"%I(]]I9D2N".&;/RC\^?PK[*\3>([+X2_#N
M^UNY52\,>RWB/669N%7\^3[ US/P/^&,7A'38(0N^4_-+)CEV/4_3TKQ;]K3
MXH6WB[Q5;>']+F$VF:-N621#E9+@\-CU"@;?SKYFK)YEC%2C\"W]/^"?;U(_
M6JRCT1XAK&K7>O:I=:C?S-<7ES(9997.2S$UK_#_ ,:77@/Q-:ZI;,VQ6VS1
M@\21GJ/ZCZ5SE%?5N$91Y&M#U7%2CRM:'ZB_#7Q?!KFFVT\<ZS13(&1E.05(
MX-?+/[97P)B\(:LOC/0[?9I.HR[;V"-?E@G/.\>BM_/ZUA_LM?%<Z#JZ>&[Z
M7$$[[K1V/"MW3Z'J/?/K7W,;+3O'/AF[TC4HENK*\A,4L3=U(_GZ5^>UG4R7
M&>UCK%[^:/E^667XCF6WYH_):BNY^,GPJU+X0^-KS1+Y&:WR9+.YQ\L\))VL
M/?L1V(KAJ_0:=2%:"J0=TSZB,E.*E'9A1116A04444 =M\&--MM5^)>BP72A
MXA(TFUNA949E'Y@5]D+M3GO7QG\'8&N/B;X>53M*W.\_1021^E?8L;;I@IZ9
MYKW<OE:F_4_(N,4WC*>NG+M\V?,G[1WC";6/&']BH2MGI8 *YX>5@"S?@"!^
M=>1UL^--5;7/%VLW[C!N+N1\>@W' _*L:O(K3=2HY,_2\MPT<'@Z5&*M9*_K
MU_$****Q/2"BBG0Q/<2I%&I>1R%55&22>@H [KX(Z?->?$+3Y8XO,CM@\DC=
MD&T@'\R*^EKB'SY%';-<?\)? K^"]!;[3AK^Z8238'W..$S[?S-=['& "[$*
MH&2S'  ]:^QP.'=*BHRW>I^4YSCH8C%.<=HJR\R"XA4"(C&<XQ6SX;B6>^-L
MXW(]>$Z#\0CXN^,ZBVD;^R8[>6WMTZ!@ "7QZDC\L5]#>!;-KK5O.Q\B\"MZ
M=6%9MP[V/GLWP\\'2C&MNU?TOT]3I=%LTTFZN5O[V&". !PTD@7*G."<G@<5
M\2_M%:QX;USXI:C<^&%C^Q[56>:$8CFG&=[K['CGN037IO[;DFWQ#X;*,5S:
MRHP4XR X//YFOF:O$S*O[SPZ6W7Y'U/"&3^SC'-95&W.-N79+7KWVT[!1117
MA'Z<%%%% !1110!+=_\ 'U-_OM_.HJEN_P#CZF_WV_G45 !1110![U^R/9Z7
M<>*M4DN7C_M1(%%JLA ;:2=Y7U/3\*^O(U$*_2OS/L[N:QNHKBWED@GC8,DD
M3%64CN"*^_-+UZ^FT6T#2;V>!,NPRW*CDGUK[/):O/3=)+X?U/QSC' 2ABHX
MKGNIZ6[6M^!#XIUDW%P8D/[M6Y;U-9D,FX9-2W=GN0@_6JGF"+Y?3BO<DW'<
M^=I\JHJ-,\=_:,\;-:6=MX=M9-KW \ZZVGG9GY5_$\_A7S]71?$+7G\1^,]6
MO6;<C3LD?IL4[5_0?K7.U^?8RN\17E+ILO0_;<IP:P.#A3MJ]7ZO^K #@YKZ
MNUY%UWX>6[1G<EQ8+CWR@_K7RC7TS\)-:7Q-\-([4G-QI^;=Q_L]5/Y''X5W
MY5)<U2D_M+\CS,_BXPI5U]F7Y_\ #'S/\T;]U93^1KZ8^#OCK_A+/#_V6ZDW
M:G9 ))D\R)_"W]#7@WCK07\/>)+J C]T[&6,_P"R3T_#I5;PKXFNO".MV^I6
MA_>1G#(W1U/537/@L3+ XCWMMF>CCL+',L*G#?=?UYGUU(YZ4V-3WZ5G>%O$
MUEXRT>+4+%AAAB2(GYHV[J:V$C.>:_0(M5$IQ=TS\TG&5-N$U9H\+^*GP?GM
MY+K6]&3S+9LR3VJCYD/=E'<=\5X[7V_''NR",CH17B'Q=^"QA6;6] @)3[UQ
M91CIZL@_F*^7S+*6DZ^'7JOU1]=E.=)M8;$OT?Z/_,\/HH(*D@C!HKY(^W"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBM[P_P"!-?\ %#*-,TJYN48X\T(0@_X$>*J,7)VBKF=2I"C'GJ227GH1
M>#=!/BCQ5I6E#@75PD;?[N?F_3-?=NM:I9?#CP-=ZEY2BVTZV_=PC@,0,(@^
MIP*\K^"_P)B\$WT>KZI,EWJVS"1H/W<&>I![G'&:]?\ $&+ZW^RK&L@'SD,H
M(R.G6OI,'AITJ;<M),_%N)<UHYCC*=.F^:E#?I?76WRTN?$VO6/C+XJ>(+K6
MYM)O+N>X8#,<+!$7^%1GH *GA^ OCNXCWIH$N.N#+&#^6ZOKK2HW\PI("*Z*
MSMF#!1]VDLLA+6<FV=DN+\11BJ>'HQC%:):O3\#\[]5TF]T.^DL]0M9;.ZC.
M&BF4JPJI7Z%>+OASX>\<1K!K.G17C 828C;*OT8<UX?XL_8\XEF\/:P0<DK;
M7R\8]-X_J*X:V6U8:T]5^)])@.,,%B$HXK]W+[U]_P#G]Y\RUZ9^S]I_V[QQ
M(P&7AM)'4?4@?UKFO%WPS\2^!Y"-8TF>VBS@7 7=$?HPXJ/X?^-KGP!XFM]7
MMXEN-@*20N<!T/49KP<72J.E.FE[UC[K#UZ59*I2DI1[IW/IWQEI^IWG@76]
M+LK;S;NZB$<8) !!8;OTS7S#>?#KQ-I\GES:)>!O]F(L/S%?6G@SXV^"_%L*
M;[^/3+MA\UO?$(0?9NAKTFS73;J-7AFAE1AD-&X8'\J^,I8^ME]X3I[]SMJ>
M_K<_/O\ X0GQ 7"#1;XL>WV=O\*+SP1X@TZW,USHM]!$.KO P _2OT*FFTNQ
MC9YKB&!%&2TCJH'YU5LY-(\2"06-]:WZ(<.+>59-N?7!XKLCGDY:^ST/.KU?
M8KF:T/@3P3X#UKX@ZPNFZ):-<S]7;HD:^K'L*^O_ (5?L4Z3I\,-WXE?^U[S
MAC#RL"^V/XOQ_*O9/ 7@71/"[7,EC8P61N'\V5HD"[V]37D'Q\_;(3P?>S>'
M/!<=O>WL/R7&H2?/%$W]U /O$=ST^M85LPQ>/J>PP:LNO_#GS=3&8C'3]EAM
M%_74]W;3O"'PG\/O=W36.C:=;KEFPJ+QV]S^M?'/QZ_; U+QN[Z1X/>?1=$'
M#W0.R>X_+[J^W6O"_&/Q"\1>/KXW6OZM<ZC)G*K*_P B?[JC@?@*YZO5P>4Q
MHOVE=\TOP.O"93"E+VE=\TOP_P"">G_ CQ/J%O\ $BS5[^X8W*2(=\K'<VW<
M,Y/M7WSX$U:6^A3S>7Z&O@CX&^ ]5U;Q5I^M)']GTZSEWF:0?ZSL57U^M?=G
MP[P)V3'.<UEFF82PMU3=SRL[R6ECZBJ)6:1TOQ+\.OK_ (!\0:<C>6UYI\T(
M8#.-R$9_6OG/X;_!W3?"*(+:#=,P'F3OR[_CV'L*^P9K47-GL8<,NT_C7YS_
M !D_:'U]=7UKPSI-NNB6]K<2V<LRMNN'VL5(W=%!QVY]Z^<R_%8G-)3I0=EU
M.K)\"\)2E3CU=ST7X\?'6R\#Z'<^&_#MV)?$%POES7$# K9H>HS_ 'R...G6
MOCQF+L68EF)R2>IH9B[%F)9B<DGJ:2ONL)A(8.'+'5O=]SZ:G35-604445W&
MI-9WDVGW<-S;N8IX7$D;KU5@<@U^@G[.?Q>@\=:!!,6"7L.(KF+^Z^.H]CU%
M?GK7?_!7XDR?#3QG!>.6.GW&(;I1_=SP_P!5//TS7D9G@UC*#27O+8X\505:
M'FC[N_:>^"Z_&CX?>;IR+_;^F[I[)O\ GIQ\\1/^T!Q[@5^:LT,EM-)#*C1R
MQL4=&&"I!P01ZU^M'@/Q)!JVGQ.DBRPRJ&5U.001P17QK^VY\$I/"?BK_A--
M,@_XE&K/B[6->(+C'7Z.!GZY]:^6R#'.A5> K/3[/^1P8&JX/V,OD?+U%%%?
MH![84444 ==\);Y=.^)'A^9V"I]J5"3_ +0*_P!:^RHFVW(STSS7P?IMXVGZ
MA:W2??@E65?JI!_I7W9O\R1''1@&_.O6P4O=:/R_C"C^^I5>Z:^Y_P#!/B'Q
M;I[Z3XIU>SD^_!=RQG'LY%9-=]\=K$6/Q3UL* %F=)AC_:12?US7 UYDURR:
M/T3!5?;X:E5_FBG]Z"BBBH.P*]+^ WAN/6O%DMY,@>/3X_,52./,)PI_#D_E
M7FE?3'P)\,?V+X/CNY%Q<ZBWG'/78.$'Y9/XUZ. I>UKKLM3Y_/,5]5P4FGK
M+1?K^!Z3#:EEXKQ7X]?$B>QFE\+:>[1':IO)E."01D1CVQC/Y5[5K.J1^'=
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MHYW2;6C;7WII?B?'M%%%?#G[X%%%% !1110 4444 2W?_'U-_OM_.HJEN_\
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MG7T?<\/%Y9CLAJO&96^:GUAOI^J\]T?)\D;PR,CJR.IPRL,$'T(IM?;WQ5^
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MZBZK.K//+@Y6/)SC/L*^//%%Y%J/B75KN Y@GNYI8SZJSDC]#7IWQ'_:(O\
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M\!/$P< [+=''U$J8K\^J^T/VO_&T>A?#RT\.03*+S5IE:2-3R($.23[%MH_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!G_QH ^9J^GOV'='$VN^(=09>4CA@1O]XLS#_P =6B']A?6)O^9JL1_VZO\
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M[M7^%SZKT'3Y+RQO(0^Q9HVA)]-RD9_6O@Z_LWT^^N+64%9()&B8'J"I(/\
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M#W1?+B:_D7YI/ECS_=[FHG+EC<]++L(\9B8TNG7T.MTC38[&WC@B7;&@P/\
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M<Q)"J.>@]Z3X9^/+#XQ>!Y=0M;>:RM[@RV<L,Q!9#C!P1UX85G+8H^:_A?\
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M_:X HY)4'<!]5S6LFI(_)\IQ5?)\T]A6E:-^67;LG^M^Q\)4445SG[@%%%%
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M_E_P-ON.W^%]XWV>6+/"29'XC_ZU6OC##OLM,G[AW3\P#_2L;X8R;;NZ7/\
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M5,!3>,CRR6FN[71OL_\ APHHHH/?"BBB@ HHHH **** "BBB@ HHHH ****
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MJ'P(Z>)/^1E/T7Y(^R_V0_%(U3P*^F/*6GTVX9 K=HW^9?UW?E7EG[8G@_\
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ME%>4?$GQ8-4NO[-MSFWMWR[C^-QQ^0KTCQ)?_P!E:%>W(.UHXSM/^T>!^M>
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MQKBG1<?>@?HV7Y]2QL5A,PBG?2_1^O9_UH<GXF\+W7AF\\J<;XFYCF4<-_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% !1110!+=_\?4W^^W\ZBJ6[_X^IO\ ?;^=14 %%%% !1110 4444 %%%%
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MFN [G\ 5'X&OGNM<HA*G@J:EUU^_4O!Q<*$4PHHHKV#M"BBB@ HHHH ****
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M44 %%%% !1110 4444 %%%% $MW_ ,?4W^^W\ZBJ6[_X^IO]]OYU%0 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#CZF_WV_G452W?_'U-_OM_.HJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [
M_P"&NEI]GGOF7,A;RT/H.]=W''NKG? D7E^&K;U8LWZUU$<=>=4?O,_9<HHJ
ME@J48K=7^_4-OM5&]UFPT]2UQ>0QX[,XW?EUKG?B=J4UCIMM!#,T9F<[MIP2
MH'3]:\OZ\FJIT>97;/*S3/OJ-9X>G"[75O\ 0]5D^)6D1L0OGR#U6/\ Q-5+
MOXJ6D<9^RV<LDG;S2%7],UYK5_1=%GUN\$,(PHY>0]%%;^Q@M6?-+/\ ,J\O
M9TK7?9?YW-Q)]8\>71$TWEV:MEE7A%]@.Y^M=UI.BP:5;B."/8G=N['U)J71
M='BT^SCAC&V.,?B3ZFN?\8^-ET]FLK$AK@</)VC_ ,36+;F^6.Q]-3HTLLI/
M%XR7--[MZOT1KZQXIL=!4+*Y,IZ1Q\M_]:N0U+XE7<S$64*P)_>D^9O\*X^6
M9YY&DD=G=CDLQR33:WC2BM]3Y/%Y]BZ[:I/DCY;_ '_Y%O4-6O-4DWW5Q),>
MVX\#Z"JE%%;;;'SLIRJ2YIN["BBBF0%%%% !1110 5/8WUQIMPL]M*T,J]&4
MU!105&3BU*+LT>N>#?&Z:XHMYQY5ZHR<=''J/\*['RUO(RK $X[]Z\&\+RO#
MX@L60X/F ?@>#7N6GR?=->=6@H/0_7.'\?4QV':K:N+M?N>.>.O#O_"/ZP1&
M,6T_[R,>GJ/PKG*]0^,<:?9=.?\ C\Q@/I@5Y?792DY039^>YUAH83'U*5/;
M?[U<****U/#"BBB@ HHHH **** "BBB@ HHHH *T?#OA^_\ %6M6FE:9 US>
MW3A(XU_F?0 <D^U5+.SGU"\AM;:)I[B9Q''&@R68G  _&OO;]G']GJ'X>Z:M
M]?(MQKUT@\^7&1"O_/-/;U/<^U>7F&/IX&ES2W>R,*U54HWZG6_!'X.Z7\+?
M"**QC0I'Y]]>R?+O8#+,2>B@9QZ"OC_]J/XVP_%[QI%%I1;_ (1S2E:*S+#!
MF8XWRD=LX 'L!ZUZ=^US^T6+D7'P_P#"UU_H<9V:K>PG_6,#S I'\(_B/<\=
M <_)%>1E."J3F\?BOBELNR[_ #_(XL+0?-[>IN]@HHHKZL]0**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** );O_CZF_P!]OYU%4MW_
M ,?4W^^W\ZBH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ***V=)\*7^K*'1/)A/(DDX!^GK2
M;2U9M1HU*\N2E&[,:BM_4/!.HV>#&BW2GO'U'X&LZ30M1B8*UE.#_N&DI)[,
MVJ8/$4G:=-KY'I'P_N!<^'H4_BB9D/YY_K771C:M<CX#TN;2M(_?J4DF?>48
M8*CI781L"!7FU/B=C]ARI36$I*HK.R/,OB997=QK5JRJTL4B;(E49PV>1532
MOAW=W0#7<@ME/\"C<U>HWEN&PQ ..0?2H9)H+&'S9Y4AC_OR$ 5HJK45%'DU
MLCP]7%3Q-=MIZVV1Q+?"V)E.R\D#=MR BMS0?#JZ#:B%1O<G+R8^\:U;77M.
MO)/+@O()9/[JN":TN"OM42J3VD=^%RW TY>VPR5^Z=_U.;\6:L^AZ#++'Q*_
M[M#Z$]Z\>9B[%F.6)R2:]OU;3;/Q)I\ELTJNN?E:-@=K#WKB9/A7="0[+I2O
MO'S_ #K>C*,5J?-Y]@,9BZT945S02TMWZG"T5W0^%-WWNA_W[_\ KU7NOAAJ
M$*DQS1R>S K6_M(=SY>62YA%7=)_A_F<;16M?>%=4T_)DM79?[T?S#]*R>G!
MK1-/8\JI1J47RU(M/S"BBBF9!1110 4444 %%%% '2^ ],>\UA9RI\J$9W=M
MQX KV*SBV**Y7P/8+;Z/: +AF7>WN35[QIJ-]8Z6(--B=[J?Y=Z#[B]S]:\Z
MH_:3LC];RJC#+,O]M/7J[;W?3]#B_BGKB:AJT5E"0R6@(9AW<XR/PP*XBM=?
M"NKS-G[&Y)Y)9@/YFK$?@;5Y%S]G4>Q<5V1Y814;GY]BX8S,,1/$.E*\O)_(
MP**UKOPGJUDI>2RDV?WDPW\JR2"I((P1VK1-/8\NI1J47:I%I^:L%%%%,Q"B
MBB@ HHHH **** "BBNN^%/@*?XD>-]/T:,%8';S+F0?P1+RQ^O8>Y%14G&G%
MSEL@/>OV.O@V=2NCXOU*VW*"8].5Q^#R8_0'ZUZ/^UK\?)?ACID/@WPS<>1K
MUY%ON[J/[UK"PX"GL[>O8>Y%>JZGKFB_ WX77>M3PQP6>GVXCM;5<+YCXQ'$
MON3^F37YI>+O%6H^-O$NHZ[JLQGO[Z9II7[9/0#T & !Z 5\-@J;SG&RQ59?
MNX;+N_\ @;OS.10]I/FD9+,SL68EF8Y)/)-)117WAUA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 2W?_'U-_OM_.HJEN_\
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M** "BBB@ HHHH **** "BBB@"6[_ ./J;_?;^=15+=_\?4W^^W\ZBH ****
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M7SS3X9Y+=MT4C1MZHQ!K"6'3^%GT^&XJQ$%RXB"FON?^1]!C2;96W"-%/J%
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M\=3?9_!]Z<??"I^;"N.MK.*/T'('['+L166ZO^$3QBBBBNP_/@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH EN_\ CZF_WV_G4537RF.]N%8899&!
M'XFH: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %/AN)+:19(I&BD7HR'!%,HH&FT[H
MWKKQMJM]I,EA<3"6-\9D*X?'ID5@T44E%1V-JV(JXAIU9.36FH4444S ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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71GNS'JS'NQY-=+10 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>plaqueanalysis.jpg
<TEXT>
begin 644 plaqueanalysis.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 29! D# 2(  A$! Q$!_\0
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M9117]>'[(%%%-ZT '6E Q0!BEH)"BBB@ HHHH)"BBB@04444 %%%%!(4444
M%%%% !1110 4444""BBB@D**** "BBB@ HHHH$%%%%!(4444 %%%% !11102
M%%%% !1110(****"0HHHH ****!!11102%%%% !1110 4444 %%%%!(4444
M%%%% @HHHH)"BBB@ HHHH)"BBB@04444 %%%% !1110 4444$A1110 4444
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M"RM8Q[9C#?\ LU?/?6OW[A.BJ&1X2"ZP3_\  O>_4_4LH@J> HI=K_?J'6E
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M+23,B%@B@-DDD8'UK\S_ !9^T)\1?&.M7&I7OB_5H'E8E;>QO)+>"(=E2-&
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M?#OP?;_#_P "Z%X<M<&+3;2.WW@8WL%^9S[LV2?K7S7\3OCM_8?[:'@_1UN
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MCWQ7V.6X6OC.$:='"S<*CIWBXMIW6J5UWV?DSUO9SJ9;%4FU+E5K;Z+]=C]
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M3+7B'[<>I?%;2]6TZX\-7&L6G@V.SW3SZ*[IMG#/O,[1_,%V[,;CMZ]Z\&^
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M\7U85N)ZDJ;NE*"T[I137R>A\+CY1GFK<7=<T?P21^-U?J[^RO\ \F]^"/\
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ME3=USTUIW2BG]ST/DL9*,\WYHNZYH_HC\A*_:K3;=+73;2"/;Y<<2(NWI@*
M,5^*M?L;\,_$T7C/X>>&]<A/R7^GP3D9SM8H-RGW!R/PK[;Q2IS=+"5%LG-?
M-J-OR9Z?$B?[E_XOT'>)/AMX2\97D=YK_AG2-;NXX_*2?4+&*=U0$D*"RD@9
M)./<UD_\*'^&W_0@>&?_  40?_$5\I?\%%_ ]RFM>&/%\4;/9R6[:7.X^[&Z
MLTD>?=@\G_?%?&=>3D/!]?-LNI8NCF,H*5_=47[K3LU\:_)&6$RF>(H0JPQ#
M2:VMMY;G[*^%_ ?AKP3]I/A[P_IFA_:=OG_V=:1P>;MSMW; ,XW-C/3)]:YO
M]H2%)O@7X]5UW :+=-SZB-B/U K\]?V?_P!F/5_C]9ZS=V>J0:/:Z=)'%YMS
M"SB9V#$JN#P5 4G_ 'Q7=?$#]A+6/A_X)UKQ)<^+-/N8-,M7N6A2V=6DVC[H
M)/!)X_&N>7#>6X+-(4\3FMZT91T=.3;>C2OS/R]#*. P]+%14\3>::TY7OII
M>Y\O4445_21]Z%?H]^P;\._^$3^$#Z[<0[+[Q#<&XW,N&^SQY2(?3/F,/9Q7
MY\>$?#-UXS\5:1H-B,W>I74=K&<$A2[!=Q]AG)]@:_8OP[H=IX7T'3M'L(Q%
M96%O';0H.R(H4#\A7XSXF9G['!4LO@]:CN_\,?\ -V^X^/X@Q%H0H+KJ_1;?
MC^1S_P 7_!^I_$#X;ZYX<TF_ATR[U.#[,;J="ZI&Q'F# [E=R_C7Q]_P[AU_
M_H<M-_\  23_ !KZI\??M&_#OX7Z_P#V+XF\1+IVIB)9C;BSN)L(V=I)CC8#
M.#QG/YUS?_#:/P;_ .AQ_P#*7>__ !FOS/),7Q/E>&Y<LH3]G-\UU2<KZ;WY
M7I^!XF%JYCAZ?+0@^5Z_#?\ &QL?LX_"76/@KX#E\-:KJ]OK,27;SVLEO&R>
M6C@%D(/^T&;/^T:D_:8^'G_"S/@OXCTF*+S;^&'[;9@ %O.B^<!?=@&3_@9J
MKX;_ &KOA5XNUZQT72O%:W&I7TJP6\+6-U$'<]%W/$%!/3DUZU7@8JOF>#S*
M.88RFX5G)3UBXW:>]K+=[G#*I7P^)5>I&TK\VJM?7]3\3:^^_P#@G+_R3WQ7
M_P!A1/\ T4M?)_[1WP]_X5C\9/$FC1Q>58M<&[LP$VKY$OSJ%]ER4^J&OK#_
M ()R_P#)/?%?_843_P!%+7] <;8FGC.&'B:7PSY&O1M,^RSJ4:F!4X[-IGM?
M[3'_ "0/QU_V#)/Z5^3-?K-^TQ_R0/QU_P!@R3^E?DS7E^&'_(NK_P"/_P!M
M1/#_ /NTO\7Z(]Y_8@_Y.+T#_KA=?^B'K].J_,7]B#_DXO0/^N%U_P"B'K].
MJ^'\2_\ D<P_Z]Q_]*D>!GG^^?)?J?CI\4_^2G>+_P#L,7G_ */>ND^"G[/W
MBGXZ:I+#HD4=MIMLP%UJEV2L,6>=HP,L^.=H]LD YKF_BG_R4[Q?_P!AB\_]
M'O7Z<_LP>&+3PK\!?!D%I$(_M>GQ7\S=WDF42,2>_P!['T ':OU;B;B"KP_D
M]&IATG4G9*^R]V[?GY?TCZ;,L=/!T(NG\4OP/*/"/_!/3P/I4<+Z]K&K:]=+
M_K%C9;6W?_@(!<?]]UWD'[&_P;T]=[>$T; P7GU&Z(_(RX_2N3_;@^-7B#X6
M>%=$TOPY<-IU[KCS"34(^)(8HPF5C/\ "S&0?,.0 <<G(_/+6-<U'Q!>O>:I
MJ%UJ5V_WKB\F:60_5F)-?$Y+E?$7$N&685\QE3A*]K7UL[/2+BEK<\O"X7&X
MZFJ\Z[BGM;UMT:/V \!^"?"_@/29;#PII]IIM@\OF21V9RK2;0NXG)R<*OY5
MYA^VU_R;?XE_ZZVG_I3%7*?\$]])O=-^#>IW%U:R6\-[J\DUL\BX$L8BB0LO
MJ-RL,^H-=7^VU_R;?XE_ZZVG_I3%7PE'"RP7%5+#3JNHXUH)R>[]Y;ZOTW/&
MHP]EF,8<W-:6Y^8-?MA%_JT^@K\3Z_:^WD$EO$ZG*LH(_*OO_%/;!?\ <3_V
MP]7B'XJ/_;W_ +:?GE_P4._Y+/I'_8#A_P#1\]?+M?4__!1"UEC^+VASM&PA
MDT6-4DQPQ6:;(!]1D?F*^6*_2^$6GD6$M_+^K/I,#_NM+_"OR/TZ_8M^(W_"
M??!'3;6>3?J&@M_9DWJ40 PGZ>657/<H:XO_ (*$> ?[;^'&D^*8(\W&B77E
M3,/^>$V%R?I(L?\ WT:\,_8/^(W_  B'Q>?0;B398^(H/L_. !<1Y>(D^X\Q
M?JXK[^^(O@^#X@>!=>\.7.!'J5G);AB,[&*_*_U5L'\*_#\WIOA;BN.*CI3<
ME/\ [=EI)?\ I2^X^.J+^S<RYOLWO\GO]VOW'R3_ ,$YO _R>*O&$T:DDII=
ML^.1TDE_#F'\J]R_:Y^(7_"O/@;KLT4OEW^J*-+M<'!W2@AR/<1B0_4"M?\
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M-5.6+WLW^1^CWA_XB>'O$'BS5O#&CWD=Y?:+%&UZMO@QP%BP6/(XW#:<@=.
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M(**** "BBB@ HHHH ****"0HHHH **** "BBB@04444$A1110 4444 %%%%
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M4""BBB@D**** "BE IU KGM7[:/_ "<MXQ_[<_\ TB@KQ*O;?VT?^3EO&/\
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M%%%%!(4444 %%%% !11102%%%% !1110(****"0HHHH ****!!11102%%%%
M!1110 4444 %%%%!(4444 %%%% @HHHH)"BBB@ HHHH)"BBB@04444 %%%%
M!1110 4444$A1110 4444 %%%% @HHHH)"BBB@ HHHH ****!!11102%%%%
M!11102%%%% !1110(****"0HHHH **** "BBE H  *4F@FFT$A1110(****
M"BBB@D*4"@"G4 %(3033:!!11102%%%% !113@*  "EHHH *:30324""BBB@
MD**** "E H IU @HHHH$%%(33: /;?VT?^3EO&/_ &Y_^D4%>)5[;^VC_P G
M+>,?^W/_ -(H*\2KP>'_ /D3X/\ Z]4__24?09?_ +G1_P ,?R04445[QZ 4
M444 %%%% @HHHH)"BBB@ HHHH ****!!11102%%%% !1110 4444$A1110 4
M444""BBB@D**** "BBB@04444$A1110 4444 %%%% !11102%%%% !1110(*
M***"0HHHH ****"0HHHH$%%%% !1110 4444 %%%%!(4444 %%%% !1110(*
M***"0HHHH **** "BBB@04444$A1110 4444$A1110 4444""BBB@D**** "
MBBB@ HHI0*  "E)H)IM!(4444""BBB@ HHHH)"E H IU !2$T$TV@04444$A
M1110 444X"@  I:** "FDT$TE @HHHH)"BBB@ I0* *=0(****!!2$T$TV@
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MS]9ZY_PTUXH_Y\-(_P"_,O\ \<H_X::\4?\ /AI'_?F7_P".5Y'11_K=GO\
MT%R_KY!_:N._Y^L]<_X::\4?\^&D?]^9?_CE'_#37BC_ )\-(_[\R_\ QRO(
MZ*/];L]_Z"Y?U\A?VKC?^?K/7/\ AIKQ1_SX:1_WYE_^.4?\-->*/^?#2/\
MOS+_ /'*\CHH_P!;L]_Z"Y?U\@_M7&_\_6>N?\-->*/^?#2/^_,O_P <H_X:
M:\4?\^&D?]^9?_CE>1T4?ZW9[_T%R_KY!_:N-_Y^L]<_X::\4?\ /AI'_?F7
M_P".4?\ #37BC_GPTC_OS+_\<KR.BC_6[/?^@N7]?(/[4QO_ #]9ZY_PTUXH
M_P"?#2/^_,O_ ,<H_P"&FO%'_/AI'_?F7_XY7D=%'^MV>_\ 07+^OD']J8W_
M )^L]<_X::\4?\^&D?\ ?F7_ ..4?\-->*/^?#2/^_,O_P <KR.BC_6[/?\
MH+E_7R#^U,;_ ,_6>N?\-->*/^?#2/\ OS+_ /'*/^&FO%'_ #X:1_WYE_\
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M $%R_KY!_:>,_P"?K/7/^&FO%'_/AI'_ 'YE_P#CE'_#37BC_GPTC_OS+_\
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M^&D?]^9?_CE>1T4?ZW9[_P!!<OZ^0?VCB_\ GXSUS_AIKQ1_SX:1_P!^9?\
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MS25^AGJA1110 4444 >V_MH_\G+>,?\ MS_](H*\2KVW]M'_ ).6\8_]N?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\K_M-_\ !.?X4?M'6M[?KID?@_QC*"R:]H\00N_K/",)*#W/#?[5?D-^T_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ;O@/_ )'GP[_V$;?_ -&K7VW7Q)X#_P"1
MY\._]A&W_P#1JU]MU_1/A?\ [IB?\2_(^ERGX)>I\#T445_.Q\T%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5]$_LZV_E^%[B3'^LN6/Y "OG:OI?X"Q^7X+MCTWL[?^/D?TH
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M** -WP'_ ,CSX=_["-O_ .C5K[;KXD\!_P#(\^'?^PC;_P#HU:^VZ_HCPO\
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M_:(CUJ>VT[6)!8:QPD5TIQ'.??\ NL?3H?TK[)^'/QRN-'DCAO)F0?W\\?\
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M:X0?[I/>LJDN5:;E15V>;_M4_%33?AYX7;3[=X[&QL8=GEHNU$51@*H'8
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M9_6<#[J>\'O%^3ZQ_%=3FQ:P]1^VPVB>\7T].Z_(\NHHHKQ#S0HHHH ****
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M4 %%%% !1110 4444 %%%% !1110!N^ _P#D>?#O_81M_P#T:M?;=?$G@/\
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M[KV20]>A^;KX!Y1\;4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH W? ?_(\
M^'?^PC;_ /HU:^VZ^)/ ?_(\^'?^PC;_ /HU:^VZ_HGPO_W3$_XE^1])E7P2
M]3X'HHHK^=CYL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *_07_@F/9K=>&_$^1_S$D'_ )"%?GU7Z/?\$K;<-X6\4.XX.J)@_2):F6PU
MN=K^WE:BQ^"^M,H*CA2<>K 5^5E?K!_P4:GBB^"6I*I!+21K_P"1%K\GZ4=@
M844458@J]HNMWWA_4([W3KE[6YCZ.AZCT([CV-4:* /H7P#^T!#J4D5EK2I8
MW3<+<KQ"Q]\_=/Z?2O;M-UHR%2"4;J&%?!E>Z_ ?XK1PR1>'-:G(5B%L;J0Y
M"_\ 3)CZ>A[=/2M$[Z,5C] _@#K37%PJ329PV,YK7_;8_9+TW]H+P&=<T>VB
M@^(.F0?Z)<*0GVV,<^1(>_?:3T/?!->/?#GQ-_PCFJ#<=JL1^=?6/A'QI_;]
ME'$&W$].:YJL6GS(TBULS\)]0L+G2KZYLKR%[:[MI&AFAD&&C=20RD=B""*@
MK]/?V[OV%;_QUI5S\4/ >GK)K-M%NUC2;>/#WB+SY\8'60#[PZL ".1@_F$<
MC@\&JC)25T2U8****L04444 %%%% !1110 4444 %%%% !1110 4444 >G_#
MOX\:QX/V6E_OU?3!P$D?][&/]ECV]C^E?3'@/XN:;X@C6;1-4S(!EK=CMD3Z
MJ?YBOABI;6ZFLITGMY7@F0Y62-BK ^Q%4I"L?J=X7^.%W9[%N3N5?XEY->\?
M#_\ :"MYO+7SB>QRU?D5X1_:%US16CBU11JMLO!?[LP'UZ'\?SKZ \!_%33/
M%T7FZ7>'SU&7@8[)4^H[CW'%)QC(=VC]@_!_Q1MM2C1?.# ]C77:UX=\._$3
M2?L>MZ18:Y9$[OL^H6R3H#Z[6!&?>OS/^&WQOOO#]U#%=2%H<X$A/2OM3X3_
M !@MM9MX]\JEL<E6KEE!T]MC12YO4\[_ &H?V&_!6K?#C4]9\ ^&6T;Q;I<9
MN;6UT1"%O2"-T31#@G:#MVX8''7I7AO@'X)_%Q=%N(O&WAJZMH8[1;FUO)PI
M<*21Y<A4GYA@<-AA7Z2V.L6VH1AHI5<?6FZPT<FG31L RNI7!KZ!YY5EE\L#
M62FKW3E=RCM\+OI^6IZBS"K+#O"U4I+HWNO0_)CQ-X1:.:3";)%)R/2N3^RR
MVS%77\:^I/C/X6@T[Q9="%0(Y#N %>-:OX? =B%KQX2NCR&CA1S2ULSZ+C.!
M4 TDYK4DS0">E2I;GN*U8]-V_P#ZJM1Z:&[4",9;459AMSV%:ITS;_#3H[,K
MVXH I+9@U/'9XZ"M6&USU'%65LU]*+@9D5OM]ZLK'[9J^MF!VJ5;4T#*,<1Z
MFK,<=6!:_C3EAVT@)[6$5J6T);'%4;?BMK3\'%)C+=K:GBMVQM3QQ4%C &P:
MW[.W'%9LHLV-KTXKH=/M\8XJE90CCTK<M8QQ6;&:-G'C%;-JO%9EJ.!6O:J,
M"LV46DC+5-';G=S3HL+4_F!:R&/CMQBIEC"U LWI3B[&D5H/EP!63?3;0U7)
MF;;6+J$NU30!\;?\%&-!>Y\*>%/$:LSKI]Z]C)%G@"9=P?\  Q8_X%7PN-2,
M+<'BOTV_:J\&S_$3X*^)-)M"/MT<:WMN&[O"PDV_4@,/QK\H6U!I,'O]:_7.
M%LS=+!.C?6+T]'K_ )GU>58QTZ+A?9GH%CK ;HW.*Z[PCXZU?P?K5KJ^A:E<
M:9J5K()(KBW<JRL/T(]CD&O';/5-K<G::Z#3-4+-M)Y'2OU3!YM&M'V535/1
MI['VF'QZJ+DGJF?K%^S/_P % +3XCZQH/@_Q?I4MEXBO2EK%JELRM;W,V.KI
MP8RQ' 7<,D=!7USXF\,Z5XR\/ZAH>N:?;ZKI&H0M;W5G=('CFC88*L#7X->%
M?$EUH.KV.IV,OEWUE-'<P.><2(P93^8%?NC\,=;U'Q)\/?#>J:N;1M5O-.@N
M+HV+;H/-:-6;8<G*Y)QS7Y)QEDN$RJK1K8)<L*E]+WLUVOT:>W0^(X@RZA@Y
M0K8=6C*^GFC\$_VZOV/=3_9+^*36D GOO!.KEKC1=3=#C;GYK=V_YZ1\?[RE
M6[D#YJK^DG]JS]GG1_VF_@MKG@S4XT6\DC-QI=ZP&ZTO$!,4@/8$_*WJK,*_
MG'\1^']0\)^(-2T35K9[+5-.N9+2ZMY!AHY48JRGZ$&OSGR/CS.HHHI@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH W? ?_(\^'?\ L(V__HU:^VZ^)/ ?_(\^'?\ L(V__HU:
M^VZ_HGPO_P!TQ/\ B7Y'TF5?!+U/@>BBBOYV/FPHHHH **** "BBB@ HHHH
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MD).]@=I'?BORG5BK @X(Y!K["^ _Q\3PEH3ZH@6XUIH0D,;+N19@<%G&1@<
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M2G\+U7^1_,YJ6FW6C:E=Z??0/:WMK*\$\$@PT<BL592.Q!!'X56K[>_X*T?
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M[A%MM01?1>=DIQZ%2>RU^?FL:/?^']4N=-U2RN-.U"UD,4]K=1-'+$XZJRL
M0?8UR7.8IT444P"BBB@ HHHH **** "NT^$GC#_A#_&%M+*^VRNL07'H 3PW
MX''X9KBZ* /O2TD# $'(K04Y KQOX$_$)?$VAKIEW-G4[%=IW'F6/^%AZXZ'
M\/6O7X'W5H2:MK=E  QJZMYW#5D#M2\K[4P-M+S-#7C*<BL82,O0T];PC@T
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M* "BBB@ HHHH **** .M^$.EG7/BSX)TU<EKS6[*W&/]N=%_K7],/_"&Z/\
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M1C(-?!W[4G[.T'P3\066I^&=67Q1\.]>#3:+K4?)&.6MI^/DF3(RIP2,' Y
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M?X;Z;]HU)[DKGR_E7ZGK7M=@A"BOVS@3+XPIRQ<E[TM%Z'Z/PSA5&#KM:O\
M(TH(P!FIMV*;"ORT,17[E!<L3]'6B&-D<U5DF'?BENKP1J<G&*S7N/-!8G"@
M<FO-KUXQ=D<E2HHZ(LK<?,?2B\W-;LP7H*H:7J$=_</MSY*_*K_WCWKH?EDB
MV]L8K##M8JFW&6C,J5JT&TS]*/V#?BL;[X<^']-O9#YT-FD#ACTVC"_H!7/_
M /!6#]EO_A<7P=C^(6@VJR>*/!\3S3"-,O=:>>94XZF,_O![;_6OE?\ 9?\
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M?YU\AXA97"MAXYE37OQLI>:Z?<_S/'XFP<9P6+BM5H_3_@'K7_!8OX(KXX^
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MSYROD^/P]_:4G9=M?R.6HI71HV*NI5@<%6&"*2OF=CQ@HHHH **** "BBB@
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M!3IIA&O':L#4K[:I)/T%?TO1HX?)<'#"X=6C%6/UF,*6 H1HTM$BKKFL!58
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MLL<(^HV4D4;_ .ZY&UOP-<96V^Q 4444P"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /3_ -EG_DYSX0_]CAH__I;#
M7]+-?S3?LL_\G.?"'_L<-'_]+8:_I9H _E7HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJHY(_'I^-?06EVVT>8R@,W.%& /8>U?IG!F34\=6EBJR3C%V2??>_P#E_P
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MGOYH6VM';KC?@]BQ(4?7/:OW@\.V-KH_AVSL[&%+>RM8%@@AC&%CC10JJ/8
M 5^E9MGTLLRZCEV#E:<HIR:Z*VR\W^7J?:XO,'A<'3PM!VDTKOR_X)P_Q \1
M6'@'P[#IVGP0Z?86D*PPPVZ!$B11@*H'  %>:Z7\33J5MYL<P8=/F->2?MH?
M$JZM-8M_#UK-Y<MQF1P&Y$8ZG\R*\<\$_$J:Q@%K=3;=K<8[U^71IN4>9[L^
M.E*SL?3OBKQ9-;^._ .MQWEQ:):ZY;17+6O\4,Q\ED8=T)D&1[9'(%?/'_!;
MK3PWAGX;7V#E+VXA/_ HP?\ V6N_T_QK'>0VKEM[0RI,H#$'*L&'/;I7D/\
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M ?@!\4KCX-?%SPYXKA=EBL[E1<*IQNA;AQ^7/X"OU'_X*8?#ZW_:(_9-\/\
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M'#1__2V&OZ6:_FF_99_Y.<^$/_8X:/\ ^EL-?TLT ?RKT444 %%%% !1110
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M -H4JZZ?'NS_ +@J)[%+<^!_^"G]BL/QVTN["X-SI$8+?WMLC_XU\>5]D_\
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MU!'0CV-9]% '1>+/B'XA\;^6-9U.:ZAB):.WX6)">I"# S[]:YVBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T_P#99_Y.<^$/_8X:
M/_Z6PU_2S7\TW[+/_)SGPA_['#1__2V&OZ6: /Y5Z*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@JRY!!]P0:\%=C([,>2QR:^R_P!M_P !Q> OB]X^L(%2*TO#_:D* \_OAO?
M[#S-XKXSKZ'BC&O'QPM;I*%_F]_R.K.L0\0J,^CC<****^$/F0HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!T/@7QQ?\
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'I_[+/\
MR<Y\(?\ L<-'_P#2V&OZ6:_FF_99_P"3G/A#_P!CAH__ *6PU_2S0!_*O111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M +'#1_\ TMAK^EFOYIOV6?\ DYSX0_\ 8X:/_P"EL-?TLT ?RKT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'J/[,WQ6G^#?QH\.>(XY6CM4
MN%ANP#PT+D!L_3@_A7[W_%WP#9_M.?LRZ_X;<JS:UI;?9Y#SY=PHW1-^#A37
M\W]?N_\ \$Q_C6WQ2^ ^F6MS-YE_IJ?9)@QRVZ/ S^*X/XUG+=,I'X4ZIIMS
MHNIW>GWD307=I,\$T3=4=6*L#]"#5:OL#_@J5\#Q\(?VH=4U&S@\G1_%<?\
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MO'6L2ZEJ]V]S.Y)523MC!/W5'85B5^2RDY-RD[ONSX.4G)WDPHHHJ20HHHH
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M?\$HOC)+X)^-$WA2:Y$5KK">; C' :9!RH]RO_H-?#-=-\,O&ES\.?B#X?\
M$MHY2;3+V.XRO4J&^8?BN1^-3)75AK1G[(_\%>?@JGQ$_9UM_&MG!YFJ>$;D
M7#,HY-I*0DH^@.QO^ U^)%?TK:"--^/WP!>RNS'=:=XATA[67N"LD9&?UK^<
MGXA>"[_X<>.M?\+:I&8]0T>^FLIE88RR.5S]#C/XU,7<;.?HHHK0D***%4L0
M ,D]A0 45IV_AG5KI08M.N6'KY9 _6NN\,_"F>\*S:JYMX\Y\A""Q^I[5[6#
MR;'X^HJ="D]>K5E][/1P^78K%24:<'Z[+[SA]/TVZU2X6"T@>>4_PH,_GZ5Z
M1X<^$8B9+C5I1)CG[/']W\3W_"N_T_2K'1;<0V=O'"O^R.3]34K72*IWL%^M
M?KN5<&8/!6J8Y^TGV^RO\_G]Q]Y@N'L/AO?Q+YY?A_P?G]P^U$5G&L<*+'&H
MP%48 HNKQ(HVD;D*,G'-=_\ #']GGQS\7K%]3TNTM]&T!>%UC7)&@AD;TC4
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M** "BBB@ HHHH *]D^'OAMM(TI9)1BXG^=N.@QP*XOX=>%_[9U 7<ZYM;<Y
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M3XF-K,D4KGK\IK@?VA_V-_$GQDU*]\<_#VV75M3,:MJ.BJP6:78H EASPYP
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MT3BZN$P&RY)EE..A))5?8#TKX*K^;\WQSS+&SQ/1Z+T6WW[GY+C\5];KRJ]
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M%?+79XP4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<A_N(??J2#R,"OBFBBFM-!!1113 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ]/\ V6?^3G/A#_V.&C_^EL-?TLU_
M--^RS_R<Y\(?^QPT?_TMAK^EF@#^5>BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH ***EM+6:^NH;:VB>>XF=8XXHQEG8G 4#N230
MR*)YI$CC1I)'(5449+$] !ZU^B?[&W_!,"7QI9Z?XR^+0N-.TF3$UOX;&8IY
ME[&=NJ*>NP8;U(Z5Z/\ L&_L#P_#:.S^(/Q$M(Y_%1/F6&DR8=-/']]NQE_1
M?KT^X?$'BA-/MF9CM"C. >*Y9U&WRP-8QMJS1\+Z;X2^%'A^'1/"^C6&B:9;
MC"6UC"L2#W('4^YYKF?%GQ6AMHY-UPH4>AQ7@?Q.^.2Z?)+%"^&R1C-?+_Q&
M_:,M+%I1JNM0VI.?W"MNDQ_NC)IPH=6#J=CZJ\6?M VMDTJB;)] >:\3\;?'
M:6YM9I-_D1*I+2S.%5!ZDU\@>*/VIH-SIHVFR7+_ //Q>-M'UVC)/YBO&_%W
MQ(U_QM(?[2OF-OG(M8ODB'_ >_XYKI48QV,KMGJGQH_:)F\1"XTK0;AS%)\D
M^H@E2Z]UC'8>_>O!***=[@%%%%(#T7]GGQ<W@?XR>%]4\SRXQ=K#(>VU_EY_
M,?E7[-_&CP<OQJ_9G\2:-'!YT]QIKF$=Q(%W(1_P("OPABE>&1)(V*.A#*PZ
M@CH:_=3]AWXE6_Q3^#^F7,[?Z1-:*DB;L@LHVO\ J#6-3:Y<=S\*YH7MYGBD
M0I(C%65A@@C@@TVO<?VUOAFOPH_:4\9Z/#%Y5E/=&_M5Q@>7+\^![!BP_"O#
MJU3NKD!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'I_[+/\ R<Y\(?\
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M]QO^"@WPY;XM?LEZY=V\(EOM*C3580HR<Q'+X_X!OK\.:SI/W;%2W"BBBMB
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MFOYIOV6?^3G/A#_V.&C_ /I;#7]+- '\J]%%% !1110 4444 %%%% !1110
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ML;>,1QV\*QA0.@ X%:GC34EM;<KNVX&3]*YOB9KLC\^O^"F'C!+B'POH:/\
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M/E!M["$E;6U!X1?4^K'N:X^MF^Q 4445(PHHHH **** "BBB@ HHHH ****
M/JW_ ()[_$Z;P;\3[C2/,(BU!5E1?]M#@_CM;]*^L_\ @I9X&/Q ^ =GXIM[
M=FGT&X6<OU(C<A'_  Y4_P# :_,3X:>+I/ OCW0M=C<H+*Z21RO]S.''_?)-
M?J_\3/VPO@7-^SCKF@ZOXHM-9U'4-.EMH],TQ#<32,Z?+D@;4Y(Y8C&*RGNF
MBH]C\>Z***U)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG=\LMRW'JCPVBBBMB HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /3_V6?\ DYSX0_\ 8X:/_P"E
ML-?TLU_--^RS_P G.?"'_L<-'_\ 2V&OZ6: /Y5Z*** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU*W*P.(HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /3_ -EG_DYSX0_]CAH__I;#7]+-?S3?LL_\
MG.?"'_L<-'_]+8:_I9H _E7HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% 'I_[+/_)SGPA_['#1_P#TMAK^EFOYIOV6?^3G/A#_ -CAH_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;]K\JY(QW*8_]EKFIZ3:-);7/G&BBBN@S"BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'I_[+/\ R<Y\(?\ L<-'_P#2V&OZ
M6:_FF_99_P"3G/A#_P!CAH__ *6PU_2S0!_*Q)&T4C(PVLIP1Z&DK=\>:>=(
M\<^(K%E*-:ZC<0%2,$;967'Z5A4 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVW1D>J>A!(!X'1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7Z__L+:U_;W[/OAV)3O\FU$#8[%&9,?H*_("NH\-_%/
MQCX.TV;3M"\4:MH]C-GS(+&\DA5LYSPI'J?SI-75AH]%_;,T>+1/VBO%4,4B
MOOD25PISM8J,@^AXSCWKQ*GS327$SRRR-+*YW,[DEF/J2>M,H$%%%%, HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR&2?70OV6)@004ME^7J/XR]?8UI:06%K%;6T,=M;Q*$CAA0*B*.@ ' %344
/%%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>productportfolioa.jpg
<TEXT>
begin 644 productportfolioa.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" >$#P8# 2(  A$! Q$!_\0
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M95')/T%?*/Q&_P""B,4,DMKX(\/^>,$+J&K$J,^JQ*<_FP^E?197P]F><O\
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M6W_R17YWTA-'_$.\B_EE_P"!!_JQEW9_>?HA_P /$OAQ_P! 7Q3_ . EM_\
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M'>1?RR_\"'_JCEG:7WGZ)?\ #Q+X<?\ 0$\4_P#@);?_ "11_P /$OAQ_P!
M3Q3_ . EM_\ )%?G;12_XAWD7\LO_ A_ZHY7VE]Y^B7_  \2^''_ $!/%/\
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M  (K_4[*NTO_  (_1+_AXE\./^@)XI_\!+;_ .2*/^'B7PX_Z GBG_P$MO\
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MOY9?^!'Z)?\ #Q+X<?\ 0$\4_P#@);?_ "11_P /$OAQ_P! 3Q3_ . EM_\
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M^P2&_2NSK\2:[OP7\=/'WP_FC?0_%6I6L2$$6TDQF@..QC?*_I7S&-\+G9O
MXGY37ZK_ .1/"Q7 +M?"U_E)?JO\C]>Z*^%/AU_P42U&U>"V\:^'XKV'H]_I
M1\N0<]3$QVGCT*U]9?#?XU^#?BM9B?P[K4%U+C+VDA\N>/V9#S_2ORS-N&<U
MR7WL71?+_,M8_>MOG8^ S#(LPRS7$4_=[K5?>MOG8[FBBBOESP HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***H:QKVF>'K4W.JZC:Z;;#_ );7DRQ)^;$"JC&4VHQ5
MV-)R=D7Z*\3\2?MD?"?PW(8CXF&IRC^'3;>2<?\ ?8&W]:\\UK_@HGX*M9"N
MF>'=;U #^.810*?I\[']*^FP_"^=8I7I86=O-<O_ *58]2GE6.JZQHO[K?F?
M5]%?%]U_P4DLDS]G\!7$OIYNJJG\HC53_AY1_P!4Y_\ *Y_]SUZBX%XBDKK#
M?^30_P#DCJ_L',O^?7XQ_P S[;HKXE_X>4?]4Z_\KG_W/1_P\H_ZIU_Y7/\
M[GI_ZB<1?] W_D\/_DA_V!F7_/K\8_YGVU17Q+_P\H_ZIU_Y7/\ [GH_X>4?
M]4Z_\KG_ -ST?ZB<1?\ 0-_Y/#_Y(/[!S+_GU^,?\S[:HKXE_P"'E'_5.O\
MRN?_ '/1_P /*/\ JG7_ )7/_N>C_43B+_H&_P#)X?\ R0O[!S'_ )]?C'_,
M^VJ*^)?^'E'_ %3K_P KG_W/1_P\H_ZIU_Y7/_N>C_43B+_H&_\ )X?_ "0?
MV#F/_/K\8_YGVU17Q+_P\H_ZIU_Y7/\ [GH_X>4?]4Z_\KG_ -ST?ZB<1?\
M0-_Y/#_Y(/[!S'_GU^,?\S[:HKXE_P"'E'_5.O\ RN?_ '/1_P /*/\ JG7_
M )7/_N>C_43B+_H&_P#)X?\ R0?V#F/_ #Z_&/\ F?;5%?$O_#RC_JG7_E<_
M^YZ/^'E'_5.O_*Y_]ST?ZB<1?] W_D\/_D@_L',?^?7XQ_S/MJBOB7_AY1_U
M3K_RN?\ W/1_P\H_ZIU_Y7/_ +GH_P!1.(O^@;_R>'_R0?V#F/\ SZ_&/^9]
MM45\2_\ #RC_ *IU_P"5S_[GH_X>4?\ 5.O_ "N?_<]'^HG$7_0-_P"3P_\
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M#_Y(/[%Q_P#S[_&/^9]M45\2_P##RC_JG7_E<_\ N>C_ (>4?]4Z_P#*Y_\
M<]'^HG$7_0-_Y/#_ .2#^Q<?_P ^_P 8_P"9]M45\2_\/*/^J=?^5S_[GH_X
M>4?]4Z_\KG_W/1_J)Q%_T#?^3P_^2%_8V._Y]_BO\S[:HKXE_P"'E'_5.O\
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MGKYEP[?S-468LQ+$L3U)ZTE%>W&$8:15BPHHHJR&PHHI0,T$@!F@GL*">PH
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M I: "BBFTQA2444%!1112 *4"@"G4#"FDT$TE4,****!A1114E!113ON_6@
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M?S^_<***;UKUSL#K3J**"0HHHH ****"0HHHH$%%%% @HHHH$%%%% !1110
M4444 %%%% @HHHH)"BBB@ HHHH ****!!11102%%%% !1110 4444$A1110
M4444""BBB@D**** "BBB@04444$A1110 4444 %%%% !11102%%%% !1110(
M****"0HHHH ****"0HHHH$%%%% !1110 4444 %%%%!(4444 %%%% !1110(
M****"0HHHH **** "BBB@04444$A1110 4444$A1110 4444$A1110(****
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M-^]1]ZG4$A11100%%%%!FV%*!F@#-!/84B&P)["DHHI$!2@4 4I-!+8$T@%
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MAGA;*LIZ$&NGT_4!=+M;B4?K[U^!-.+<9*S1^CZ-76Q=HHHI""BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?$W[=WQP,<<?@+2;@AYE6;4FC)&(^JQ'_>^\1Z >M?5
MOQ2\=6?PY\#:MKUZP$5G T@7/+MT51[DD#\:_(OQ-XAO/%GB'4=9U"4S7M].
M]Q*Q/\3'.![#H!V %?KGA[D*S#&/,*Z]REMYSZ?^ [^MC[7AG+UB*[Q-1>[#
M;U_X'^1F4445_3)^K!3:*2@8444H% P IU%% !112$TP FFT44%!1112&%.
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MH*"BBB@84444 %(30324 %.HHH*"BBB@ HHH)H ":;1104%*!0!2T#"BBB@
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M44B I0* *4F@EL":0"@"G4&;84G6CK2T$-A11100%'2CI100%*!0!0300!-
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MK$?UJ]7X,?I84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7<%'%^R]I>2C:_+NF[WL^W8]O.,T_LC#QK\G-=VM>W1OL^Q^8=%?MJRAE*L
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M$Q&->\I**](J_P"+E^!^E<*T.6C4KOJ[?=_PX444WK7[8?<!UIU%%!(4444
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MJ 3@$X]C7.TZ=6G6CSTY*2[IW'&2DKQ=PHHHK084444$A1110 4444 %%%%
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M^:?60*%<_P#?0-?@GBA@E_LV.7G!_FO_ &X^7SJG\%3Y'=4445^"GRX4444
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MCD6,^5\0%=^P?1BH_/SS7DWQ*_8V^(7P[L9M0CMK?Q'IL66>;269Y(U'=HF
M;_OG<!@Y-?;'@']J#X<?$;5H=*TG7Q'J<W$5K>PO TAST5F&UF/90<GTKU:M
M5QIQ)E5=1S!7_NS@HZ>5E%_/5"5.G+8_%RBOI7]N3X2V/@/Q]8:_I,"6MAX@
M21Y;>-=JI<(5\P@#@!@ZM]=WK7S57]!97F5+-L%3QM'::V[/9KY.Z.&K!TY<
MK"E S0!F@GL*]4YVP)["DHHI$!2@4 4I-!+8$T@% %.H,VPI.M'6EH(;"O1?
M@1\&KKXX>./[ @OO[+@CMGN;B^,'G")5P!\NY<DLRCJ.I/:O.J^^?V _ /\
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M/LV>H%8'[7?B[4O ?PD3Q!I$WD:CI^JV<\3'."1)RK8(RK#*D=P2*]$^&?Q
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MZRSH]HG^KM;@<E4]%89(7MM8# P!]+PUQU'.<4L!BZ7LZKO:ST;6ZUU3^_\
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M_P!>X_G(PX@_WZ7HC\=/BG_R4[Q?_P!AB\_]'O7+UU'Q3_Y*=XO_ .PQ>?\
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M:;R/.CB^1<9.Z1E7N.]?NE6K3H0=6K)1BM6V[)>K9]9*<:<7*;LD<W17MO\
MPQ=\9/\ H3O_ "J67_QZO+_"?@7Q!X[UM=(\/Z3=:MJ)ZPVR;M@SC<QZ*N?X
MB0/>N&CFF Q,9SH8B$E#XFI1:7K9Z;=3*.(HU(N4)II;ZK3U,*BOHO2_V"_B
MIJ%FLT\&D:9(1G[/=7P+CV_=JZ_K7G/Q,_9\\>_"6'[3XBT&6#3RVQ=0MW6>
MWSG RR$[,D\!]I/I7+A\^RK%U?84,3"4^RDM?3O\C.GC,/5ER0J)OU/.J***
M]TZPHKJ_ ?PI\7_$ZX:'PQX?O=7V':\T*;88SC.&E;"*<=B17L&E_L%_%34+
M999X-(TQR,^3=7X9Q[?NU<?KWKQL9G66X"7)BL1"$NSDK_=N<57%X>B[5)I/
MU/G2BO?-?_8?^+.B*7@T:TUA!R6T^^C)'_ 9"A/X UXCK6AZEX;U.;3M6L+G
M3+^$XDM;N)HI$R,C*L 1Q@_C6V#S3 YA?ZI6C.W9IM>JW1=+$4JW\*2?HRC7
MZB?L5_\ )M7A'ZWG_I9-7Y=U^HG[%?\ R;7X1^MY_P"EDU?F_B;_ ,B>E_U\
M7_I,SP.(/]VA_B7Y2.*_X*'_ /)&]&_[#D7_ *(GK\\*_0__ (*'?\D:T;_L
M.1?^B)Z^$/ O@+7/B5XBBT+PY9KJ&JS(TD=NUQ%"7"C+8,C*"0,G&<\&NKP_
MJPH\/JI5DHQ4I-MZ)+NV=.4SC# 1E)V6OYLY^BO;?^&+OC)_T)W_ )5++_X]
M7D&NZ'?>&=:OM)U.W:TU&QG>WN(&()212589!(/(Z@X-?H&%S+ XZ3CA:\*C
M6_+)2M]S9ZM.M2K7]G).W9W*-%%>A?#O]G_Q]\6-'N-4\*Z =4L()S;23?:X
M(0) JL5Q)(I/#*>..:Z,1BJ&#I^UQ-10CWDTE][*J5(4ES5))+ST//:*]3\8
M?LO_ !,\ >'+S7M?\-KIVDV@4S7#:C:OMW,%'RK*6))(& #UKRZ.-YI%1%9W
M8[551DDGH *C"XS#8V#J86K&<5I>+35^UT%.I"K'FIR37EJ-HKV3PG^R'\5O
M%]O#<0>%I=.M9<D3:I*EL1]8V/F?^.UUE[^P+\4;6V:6+^Q;QP.(8;XAS]-Z
M*OZUY-7B/)Z,_9U,7!/_ !+\>WS.26.PT7RNHOO/F^BNT\?_  8\;?"XH?$_
MAR\TN%B MR0LL!)SA?-0LF>.F<UQ=>W0Q%'%056A-2B^J::^]'5&49KFB[H^
ME_V KS1;;XU7*:D8EU"739$TYYB!^]W)N5<_QE-V,=@WK7Z,7$L4,$DDSK'"
MBEG:0@*% Y))[8K\>/AS\/?$WQ*\1C2_"5DU_J\49NE1+B.!E5",L&=E&02O
M?->V:M\ ?VF-?TU]/U1=>U*PD #VMWXFAEB8#H"C7!!_*OQKB[AW!YEF:Q%;
M'PHMI)QFU=)=4G);_GUU/ELPP-*MB?:2K*-[73>ORU/#/B)+I<WC_P 2R:((
MQHSZE<M9"(83R3*VS:/3;C'M7/5+=VLMC=36TZ[)H7:-UR#A@<$9'N*BK]GH
MQ5.G&"=TDM>Y]2%%>M>#?V5/BEXXMH;JP\*7-M92D8N-2=+48_O;9"'*^ZJ<
MUW$W[ ?Q0BMC*K:',^,^2EZV\^W*!<_C7AUN(LHP\_9U<5!2[<R_'M\SBEC<
M-%V=17]3YMHKOOB!\!O'WPO@^T>)/#-Y8V?>\CVSP#)P-TD995)/0$@UP->S
MA\30Q=/VN'FIQ[IIK[T=,9QJ+F@[H****Z!A1110 4444 %%%. H  *0F@FD
MH)"BBB@04444 %%%%!(4X"@"EH *:30324$A1110(**** "BBG 8H  ,5^FW
M[#^L/JG[/>CQN<FRN;FV!]A(7'Z.!^%?F57Z+_\ !/NX\[X&WJ9SY.MW"?3]
MU"W_ +-7Y7XD4U/)5)_9G%_@U^IXF<*^&OYH^F:***_EX^*"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH \7_;(F:#]FWQDR]2MJG_?5W"#_ #K\
MN:_4+]L[_DVOQA_VY_\ I9!7Y>U_2_AG_P BBJ_^GC_])@>W@OX;]0HHHK]<
M.UL***4#-!( 9H)["@GL* ,T$ !FG44G6D0V'6EHHI$-A1112,VPHHHH("BB
MEH);"DHI0*#-L *4F@F@"@AL *6BB@D****#-L***7IR:" Z<FDZT=:<!BD2
M &****1#9]__ /!//_DE'B#_ +#;_P#HB&O9?VA/^2&^.O\ L#W/_HLUXU_P
M3S_Y)1X@_P"PV_\ Z(AKZ6\0^'[#Q5H=_H^J0?:M.OH6M[B'>R;XV&&&Y2".
M.X(-?R9Q%6CA^)JM:>T:B;^5F*F[:^?ZGXU45^GG_#&OP>_Z%#_RIWG_ ,>H
M_P"&-?@]_P!"A_Y4[S_X]7ZS_P 1*RC_ )]5/NC_ /)D<K/S#KIOAA_R4KPE
M_P!A>T_]')7TC^V9\"_ _P )_!^@7WA71/[+NKJ_:&:3[7/-N01DXQ([ <CM
M7S=\,/\ DI7A+_L+VG_HY*^UP>;4,ZRN6-PZ:BU)>]:^EUT;_,PK1<8N_8_8
M"OSQ_P""@'_);=/_ .P)!_Z.GK]#J\[^('[/O@'XI:W'J_B?0?[3U&.!;99O
MMEQ#B-2S!<1R*.K-SC/-?S-PKG%#(\Q6+Q,6X\K7NV;U]6OS.N6L6C\GJ*_3
MO_AC7X/?]"A_Y4[S_P"/4O\ PQK\'O\ H4/_ "IWG_QZOV3_ (B5E'_/JI]T
M?_DSF]E(_,7I7W?_ ,$[C_Q0OBO_ +"4?_HH5\6>/M,MM%\=^(].LH_)L[/4
MKFWACW%MD:2LJC)))P .2<U]I_\ !.__ )$7Q7_V$H__ $4*]'CJHJO#LZD=
MFX/[VC"W+5BO-_DSZ!^-/_)'_&__ &!;S_T2]?D?7[#>.O#LGB[P5KVAQ3+;
MRZE83VBS."50R1E0Q'<#-?&?_#NS7O\ H<=._P# 63_&O@> \]R[*<-7AC:J
M@Y236C?3R3.RNG*$5'S_ $/DB">2UFCFAD:*:-@Z21L596!R"".A!K]B_"=U
M=7WA;1KF]&V]FLH9)P1C$A0%OU)KY>^&G[ >F>'=>M=3\5:\NO0V[B1=-M[;
MRHI&!R/,8L2R^J@#/KC@_4GB#Q%I?A'1[C5-8OK?3-.MUW27%PX1%'8?4] !
MR>@KBXYSW!9Y4P]#+WSN-];/5NUDKJ[V[=K'/1I34^9GRO\ \%$KR!?"/@^U
M8C[5)?32H,<[%C ;]66OA<#->N_M,_&P_&[X@&\M \6@Z>AMM/C<8++G+2D=
MBYQQV 4=0:\B)["OV3A3+JN5Y/1P]=6GJVNUVW;Y+?S,,3-2GIT GL*2BBOK
M3C"E H I2:"6P)I * *=09MA2=:.M+00V%%%%!!;TG2[G7-5LM-LX_-N[R=+
M>&/^\[L%4?B2*_7CP+X4MO O@W1?#]H/W&G6D=N&_O%5 +'W)R?QK\_OV(_A
M_P#\)?\ &2#5)X]]EH$+7K9&5,I^2('WR2P_ZYU^B6KZI;Z'I-[J-W((K6SA
M>XED8X"HJEF/Y"OY[\1\P>(Q='+:>O(KO_%+9?)?F>IE]/F;G\O\_P!#Y^O_
M (Y&']L:R\("=O[*&FG373("B[<"<-[G"HGU)KWKQ-X?M?%?AW4]%O5WVFH6
MTEK*/]EU*G\>:_)J_P#'VH7OQ)F\:!MNI-JG]J)N).U_-\Q1]!P/H*_6;PSK
MUMXI\.Z9K-FV^TU"VCNHC_LNH8?SKQN+\C>1QP56CI[BBVOYXZM_._X'1AL1
M[2M42]5^7Z(_(3Q-H-UX5\1:GHMZNV\T^YDM9<=-R,5./;BLT"OI3]NWP!_P
MC7Q6M_$$$>VTU^V$C'MY\0"./^^?+/U)KYLK^A<HQ\<TP%'&1^VDWZ[-?)W1
MXF)I^RJR@MOT/J#]ES]E_P *_&WP)J.M:Y?ZQ:75MJ3V:)I\T2(4$43@D/$Q
MSESW].*Z3XY_L8^&?A]\.[O6/#-SXAU36UN+>"WM)Y8I5D:254QM2%6)^;C!
MZUW?_!/K_DD.N?\ 8=E_])X*^D]6U*RT;3;G4-1GBM;&TC:>:XF("1JHR6)/
M3 K\'SGB;-<!G]6G2JMPA->YT:TTVZGJX?#TZF'3:U:>OWGQ[\*_V X9]-AO
MO'NJW$-U( _]EZ6RCRN^V24AMQ[$*!CLQKU*Z_8A^%=Q9-!'IM_:RD8%S%?R
M&0>^&)7/_ :\I^(G_!02XAU2:V\$Z#:S6<3[5O\ 6-Y\\#NL2,I4'MELXZ@=
M*]6_9E_:>_X7D]_I.JZ?#IGB"RB%P1:L3#<19"EE#$E2I*@@D_>!SV%YJ^,8
M4'F>)G*$%K:,DN5=+Q3V];OOU(I_4HR5):ON]3Y?_:+_ &3;_P"#-G_;ND7D
MFL^&"X22250)[0DX428X92>-P Y."!QGY]K]A?&?ANV\8>$M8T.\7?;:A:26
MS^HW*1D>X/(]Q7X^RQM#*\;##*2I^HK]"X(X@Q&=86I3Q;O4IM:]T[VOYZ/\
M#BS##1HN,X*R9M^"?!&M?$3Q):Z%H%D]]J-P?E1>%51U=F/"J.Y-?8W@C_@G
MQHMO912>+?$5Y>7I 9[?20L,*''*[W5F<>^%^E'_  3U\*VD?A;Q/XD,:M?S
M7HT]9".4C2-9"!Z9,@SZ[1Z5[G^T!\5V^#7PTOO$,%O'=7_F);6<,V=C3.3@
MMCG  9L C.W&1G-?)\2\39I6S7^Q\KER6:C=6NY.W5[)7_-MFF"P=.5+V];7
M?[EU.03]B?X3K#L.BW;MC'F-J$V[Z\-C]*X[Q;_P3^\(ZA;3/X=UO4](O#RB
MW12Y@'MC"M^.X_0U\WS?M?\ Q:DO&N1XL:/+;A$EE;^6OL 8^GUR:^Z?V<_B
MS/\ &3X8VFNWL$=OJ4<KVEVD.1&9$P=R@] 593CMDBO*S6CQ5PW2CC*V,<HM
MVTDY6?FI*UC6E4P6(G[)0M\O\C\W?B=\+_$'PE\3R:'XAMEAN OF130MNAGC
MR0'1L#(X/4 CN!5#P&,>./#W_81M_P#T:M?<_P"WKX3MM5^$]EKAC47NDWR*
MDN.?+E!5E^A8(?\ @-?#'@7_ )'CP]_V$;?_ -&K7ZMD.<2SS)WBJBM-*2E;
M:Z73U5F>'F6'6&FXQV:O_7W'Z_U^=?[=G_)=#_V"[?\ F]?HI7YU_MV?\ET/
M_8+M_P";U^,>'?\ R.G_ ()?FCZ3,_\ =9?+\P_97^ _@OXY66N0:YJ&L6>L
M:?(CK'831)&\#C .'B8Y#*V><<K7KWCC]@OPEI?@_6KW0=3U^XUFVM))K2&Y
MN(&CDD520I"PJ><8X(ZU\Y?LN_$/_A7'QFT.\FD\O3[YO[.N_3RY2 "?8.$;
MZ*:_4+K[BOH.,,TS?),UC*A7E[*:4DNFFC7X7]&>=EE+#XBFXU(W:?X/;]5\
MC\9:DMX)+J>.&)&DED8(B*,EF)P *] _:"\"'X<_%_Q)HZ1>5:?:3<V@VX7R
M9/G4#V7=M_X":U_V5?!7_"<?''PY;O'YEK82G4I_98OF7\"^P?C7['4S*C'+
MGF2^#DY_E:Y\[5HRA6=#K>Q].:7_ ,$__ [:;:&_UGQ%]N,*&?R;B!4\S:-V
MT&$D#.<9)KYO_:?^$_A3X,^+M.T#PY>ZG>W#6OVF\;4)8WV;F(C5=D:X.%8G
M.>JU^F,TR6\+RR,$C12S,W0 <DU^5/CGQ,/C!\;KW4IY&%KJ^JI#&V,%+<NL
M<?'J$"_C7Y%P3FF:YIC:M?%UY2I4XW:Z7>R^Z[^1[^9T</A,-[L?>>GGIN_Z
M[G=? W]D/Q'\7+"+6K^Z7P[X>DYBN)8C)-<C/6./(^7_ &B1[!J^E]#_ &%?
MAII:$7@U;6&/4W5YL ^@B5/US7T!86-OI=C;V=I$L%K;QK%%$@PJ(HP !Z "
MOD;]KSX]_$7X;^.+71] F.A:,]JLL=ZMJDANW/WQO=6 V\#"X/.3P17AT\^S
MWBK,'A<%7]BG=I7Y;)>:3DW_ %9(Z%@L-@:'M:T>9K?K^&QW>N?L+_#/5(P+
M1-6T=Q_%:7F_/U$JO^F*^9?CM^R3K_P?L9-:LKI?$'AQ#B2Y2/RYK;)P/,3)
M^7D#<#UZA>*[K]GC]L#Q5=>/+#1/&VJVM_HU\S1F_NTCMVM&VDJV]0JE21@[
MO4'/&#]::E\0O .LZ;=6%[XI\/7%G=1-#-#)J4!5T8$,I&[H0:ZY9EQ+POC8
MT<9-UH.S>\DUY-JZ?]6:,X4L!F%-N"Y7]W_ 9^3-?4G[,O[+7A3XS_#ZXUW6
M]0UFUNX[^2U"6$T21[51"#AXF.<L>]?-?B+3X=)\0:G8VTZW5O;74L,<\;!E
MD57(# C@@@9R/6OO;]@G_DB][_V&)O\ T7%7Z+QEF&(P64?6<'-PDY1U6]F?
M/Y?1C/&1I5%=:_@F>:?'_P#9#\'?"KX4ZOXFTG4M<N+^S:!8X[V>%HCOF1#D
M+$IZ,>_6OD2OTL_;+_Y-W\3?]=+3_P!*8J_-.L.!<PQ6999.MBZCG)3:N^W+
M'3\33.J-/#UXQI1LN6_XL]G^!?[+?B3XU0G4A,FA^'5<I_:-Q&7:5AU$4>1O
MP>"20.HR2"*^I/#_ .PA\.=+4'4)M7UJ3 W"XNA$F?81JI'XL:]T\&:#9^%_
M"6C:381B*SL[2*&)1Z!0,_4]3[FOG/\ ;%^-GC[X7ZGHUGX9/]DZ5=0&2351
M;)*9)=S P@N"JX4!NF3GK@&OS>7$.=\39E]3P%;V,7?E5^71=VDY-^GW'LT\
M!A<%AO;UX\S23?7?LMCI-8_8;^&&I0[+:VU327_YZ6E\6/Y2AQ^E?.OQR_8U
MUOX9:5=:]H-Z?$.A6X+SHT>RYMH_[S <.H'5AC'7: "1=^"_[9'C:U\<Z58>
M*]4AUC0KZYCMIY+J&*%K8.VWS0ZA>%)!.[(P#TZU]J2?%#P1+&R/XM\/NC##
M*VI0$$'M]ZNBMC>)^%\7"&)J.M!Z]9)KJKM<R?\ 6J)IT\MS*G+ECR->B?\
MDS\D@*6NG^*&DZ?H?Q$\26.DS07&E0W\RVDEM()(S#O)3:P)! 4@?A7+_>^E
M?O\ 1J*M3C5CM))_>?"UH.E4E3?1M?<'WOI2T45J8!11102%%%. H,VP I":
M":4"D0V %+112,VPHHHH)"BBB@AL****"&PHHI?N_6@@/N_6DHIP&*"  Q11
M100V%+1100%%%%!(444O2D9MATKZ(_8=F*_%'6(^S:-(Q_">'_&OG;K7T/\
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M*=117]D'[F%%%(33 ":;1104%%%%(84X"@"EH ***;3&%)1104%%%%( I0*
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MQJEG80#,]U,D$?\ O,P4?J:_9S0=%M?#FAZ?I5E$L-G8V\=M#&HP%1%"J!^
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ML^8SBMB:^/\ :8NGR3=M/R/Q2K]//V'O^3<O#_\ U\7?_I0]?F'7Z>?L/?\
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M_2(A1117P)\:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\2?\
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MV%V+;0LT@8 9P >P%?@."X1MC9XCBBO&">NM2*<I/NV]CX.AE*C5E/,II?\
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MQC7PYXNTZ:TUEM+N#<:?J5JWSQ,5*O&>X!!Y1NX!(R!7<U^:7[$/Q#U?PO\
M&C3= MIR^D:[YD-U:N3MW+&SI(H[,"N,]P2/3'Z6U\MQ5DM3(<:L&ZCG"UX7
MZ1;>GWWVT>_4\C,L++!5_8RE=6T]+O\ 6Y^2_P"TM_R7SQU_V%)?YU]3?\$X
M?^11\9_]?T'_ *+:OEG]I;_DOGCK_L*2_P Z^IO^"</_ "*/C/\ Z_H/_1;5
M^T\4?\D='_#2_.)]AG/_ "+H_P#;I[[^T5_R0GQY_P!@>X_] -?DC7ZW?M%?
M\D)\>?\ 8'N/_0#7Y(UP^&'^X8C_ !_^VHGAS_=I_P"+]$>R_L=_\G(>#/\
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M:-]G+9PLZ_/$?P=5_#-<%:7^JO%KFM*:G?\ [<GO]R?WHYX/^S<SMM&_X/\
MRO\ @?D#7T=^P/\ \E\7_L%W/\TKYTEB>"5XY%9)$8JRL,$$<$&OHO\ 8'_Y
M+XG_ &"[G^:5^_<4?\B3%_X)?D?89I_N=3T_4_26O,M!T?X>?LQ^"8[>2]L?
M#]B[%I;R]D FO)<$DD_>=NN%4' X  KTVOR,^.WCS6OB!\4?$%[K5X]T]O>3
M6MO'D^7!$CE51%_A&!^)))R2:_G'A'(:O$%6KAG6<*2LY6W>_+Y::ZO;L?%9
M7@I8YSIN=H*S?F];?J?I=X"_:&^'?Q.U4Z9X;\3VU]J&"5M9(I;>23 ).Q95
M4O@ D[<X KN]4TNSUS3;G3]0MHKRQNHVBFMYE#)(A&"I!Z@BOQR\"ZU<^'?&
MN@ZI:.T=S9WT,\;*<<JX./H>GXU^RPY -;<8<-TN&L11>%J-QFFU>UTXVZI+
MNK:$YG@HY?5BJ;=GKYGY$_'3X=CX4_%;Q#X:B+-:6L^^U9^IA=0\>3W(5@"?
M4&G_  '^&9^+OQ4T3PT[O%9SR-+=RQ]5@12SX]"0-H/8L*]3_;]B6/X\(RC!
MDTFW9O<[I!_("O*/@S\7M3^"?C!O$6DV5G?736SVOEWH8H%8J21M8'/RCOW-
M?T%@\5C<?P_"OAW^_G35F_YK6O\ ?J?;^TK5\$ITOCE%?>T?K+X;\-:7X/T2
MTT?1;&'3M-M4V0V\"[54?U)/))Y)))KP;QY^W7\/?!?B"YTB"#5-?EMG,<UQ
MIT4?D!P2"H9W4L01U QZ$UXWH_[:GQ;^(%O=V?A_P%9ZJ[(8GDTRRNIC%N!
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MK_P&OS1^$7@IOB+\3O#7AP*7CO[V..8 D'R0=TI_!%8_A7[!1QK%&J(H5%&
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M[\$?#CQ+X@L8X9;S3;":ZACN%+1LR*2 P!!(X[$5X#_P3S_Y)3X@_P"PT_\
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M]I+N7]?UB;Q%KNI:M<I&EQ?W,EU*L0(0,[%B%!).,GC)-?<'_!.__D1?%?\
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M+<GM!7:3LKNU[MMIV6E]%?U9S8?!T84/;U]=+F1:_L _#R'F75?$5P<8PUU
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M\M_^ _UK6K^2$?OCW"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH ****
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MSCLR2*,$$<XZCN >*^WO@O\ MQ>#_'%A;67BVXB\*>( H61YR193,!RR2'A
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MI-))^['HO7O?7OV/-S2GF.(QBK8JFU*5G9+9=%_6O<_(BOT\_8>_Y-R\/_\
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M?,5K[\_X81^$_P#T#]2_\&#U^:<$\EK-'-#(T4T;!TDC8JRL#D$$="#7Z"_
M/]N+PYXDT>RTCQY=C0]?B58CJ,J_Z+=X&-Y8#]VQ[[L+Z'G ^BXYP^>15/&9
M34GRI6E&#=^ZE9;]GVTZ'J\5T<UCR8G+YRY4K246_OLM_/T1\7_&;X8ZE\)_
M'^KZ+>V%Q:6<=S+]@FF4[;BWW?NW5\8;Y2N<=#D'!XKT+]BO6/%5K\;]&L=!
MFO#I5P['5;>/<;<P!&R\@Z @XVL><D 'G!_1W3_$/AGQM8;K+4M)UZR?O!/%
M<1G\B127VN^%_ U@SWFH:3X?LEY+3316T8S]2!7Q6)X^K8S+YY;7P?-5E'E;
MOUM:_+RWOUM??J?,XGBZIB\'+ U<-><ER[];;VM>_6U]^IOU^2/[2&I6VK?'
M?QS<V>#!_:DT8*C@LAV,?Q92:^N?V@/VY-!T/1;S1OA_=?VQKLRF(ZJB$6UI
MG(+(3_K''\.!LY!R<;3\ 22/-(TDC,[L2S,QR23U)-?0>'>08S+W5Q^+@X<Z
MY8IZ.U[MM=-E:_G\_<X+R?$X/VF+Q,7'F223WMNVUT\OF?IG^PM_R;OI/_7Y
M=?\ HTU%^W=_R;WJ'_7]:_\ H=<[^QG\4/!OA?X$:7I^L^+="TB_2ZN6:UOM
M2A@E4&0D$JS @$5'^VA\3_!OBKX%WUAHOBW0]7OFO;9EM;#4H9Y2H?DA58G
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M?R+QY_R46)_[<_\ 3<3^:>,/^1YB/^W?_2(A1117P)\:%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\2_\ !2C_ )IU_P!Q'_VUKXFK[9_X*4?\
MTZ_[B/\ [:U\35_7' G_ "3N&_[?_P#2Y'[!D'_(MI?/_P!*84445]Z>\%%%
M% @HHHH$%%%% @HHHH **** "BBB@ HHHH$%%%%!(4444 %%%% !1110(***
M*"3ZP_X)T_\ )4/$G_8'/_HZ.OT#K\_/^"=/_)4/$G_8'/\ Z.CK] Z_E/Q"
M_P"1]4_PQ_(_*<]_Y&%3Y?DC\R/$'[8_Q@L=>U*V@\7[(8;F6-%_LRS.%#D
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MFC_8O@3PW(X2ST/0]-@:1A&BPP01*,DX    %?+GC#_@HIX9TN[>'PYX9O\
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M7\21PN&J<T7*46UM**OK^%T>=E<I4\8J<'=.Z?9VOJ? -%%%?U8?>!113@*
M "D)H)I*"0HHHH$%%%% !11102%. H I: "FDT$TE!(4444""BBB@ HHIP&*
M  #%+110 4TF@FDH)"OT0_X)W?\ )%=:_P"QAG_])K:OSOK]$/\ @G=_R176
MO^QAG_\ 2:VK\S\1/^1%+_%$\;-?]V?JCZCHHHK^5CXH**** "BBB@ HHHH
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M(-?.I/85XW!61XS(L/6IXQ).335G?H;XBM&I&*CTO^@$]A7Z4?L3^+/^$F^
M^FVSR&2XTBXFL'W=<!O,0?0)(H_"OS6KU;X+_M(^*/@98ZG9Z%;:9>6]_(DL
MB:E%(X1E!&5V2)C((SG/05Z'%V2U<\RWV&'2]I&2DKZ>3U]&SDIRY*BD_P"O
MZT/N_P#:P\'#QG\"/$T*H&N+"(:E"<9(,)W-CW*;Q^-?._[ OPGM=9U35/'.
MHP+.--D^QZ>KC(68J&DD^JJR@'_;/H*YNZ_;\^(%]:S6T^A^%WAF1HW4VEQA
ME(P1_K_0U]&_L/P11? '37C #37MT\F/[WF%?Y*M?EV)PN:<,\-U\)B;+VDT
MDT[Z27O+_P EM\V=DYPKU()=+_YK\0_:L_:.E^">C6>FZ*D4WB?4U9XFF&Y+
M6('!E*]R3PH/&0Q.<8/Q?_PU-\5CJ/VW_A-+_P [^[LC\KKG_5[=GZ5V7[=E
MQ-<?'B5)<^7#IMLD7'\/S-_Z$S5\]5]_PGP_EU/*:-6I1C.=1<S<DGOTUV27
M0QQ=62J<J=DC]'OV7OVEE^+'AB]@\3W%E8:_I;(LLQ=84NHV!VR $X#95@P'
M'0C&<#Q']M:&S\*?$CPYXW\(:O'::M?12I<7&F7 #K)&%4294Y!9)-I]0OUK
MY.ZTM;X/@_#Y?FLLPPU3EA*Z=.VEFM5>^U];6\C#ZRW3=.2OYGH^F_'SXD2:
MC:H_CG7F5I4!4W\F",CWK]1_$$TEOX;U*6-VCE2TD974X((0D$'UK\>])_Y"
MME_UV3_T(5^P'B;_ )%75?\ KRE_]%FOA/$3#4,/6P2HTU&_->R2OK'L;Y=)
MRK23=]OS9^6G_#0'Q*_Z'K7_ /P/D_QKB=2U*[UC4+F_O[F2\O;F1I9KB9BS
MR.QR68GJ2:K=**_<J.%P^';=&FHM]DE^1Y,IRDK-A7T]^P3\/_\ A(/B5?\
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M/.,DS>.)23I7:>NKB^MON=O(]NIC:5:@X3W:_'_ASZ6_X)]?\DAUS_L.R_\
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MZ=:C1<IQJV4E.ST5]-(K>[ON883*Z&#A.G&[4M[V_P D?IO\,_VTOASX[T^
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M65>FW=7]-4UV\PK[I_X)S^,KR\T7Q5X7E222SLI8KZ"7)*H9 5=/;/EA@/\
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ME$NHZ1>!5OM,D<JLN/NNK8.UQDX.",$@CICRNBOL,3@</C,,\)B(\T&K-/\
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MK]$/^"=W_)%=:_[&&?\ ])K:OSOK]$/^"=W_ "176O\ L89__2:VK\S\1/\
MD12_Q1/'S7_=GZH^HZ***_E8^*"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH \4_;._Y-K\8?]N?_I9!7Y>D]A7Z@_MG?\FU^,/^W/\ ]+(*_+X#
M-?TQX9_\B>K_ -?7_P"DP/6PG\-^H 9IU%)UK]:.IL.M+112(;"BBBD9MA11
M100%%%+02V%)12@4&;8 4I-!- %!#8 4M%%!(4444&;8444O3DT$!TY-)UHZ
MTX#%(D ,4444B&PHHHI&;84444$-A11100%+1100%%%.Z4$-ATIOWJ/O4Z@D
M****" HHHH,VPI0,T 9H)["D0V!/84E%%(@*4"@"E)H); FONC_@GSX^@O/"
MNN>$)I@+VSN?M]O&Q&6A<*K;1_LNN3_UT%?"P%;_ ('\;ZQ\.O%%CK^AW1M=
M0M'W*V,JZ]&1AW4C@BOFN(LH_MO+JF#3M)ZQ?FMOOV^8HS]G-370^POVZO@G
MJGB*33_'.B6<M_\ 9+?[)J,$"EG2-6+)*%') W,&QT&T] 2/A_K7Z+_"[]MS
MP-XRL8(?$4Y\*:R<+(ERK-;.WJDH!"C_ ']N,XR>M>@?\+&^$#7PU+_A)?!7
MV['_ !]&^M/.ZY^]NW=:_+<KXBS;AS#K+<=@93Y-(M76G:]FFNS3V/0J0IXA
M\\969\X?LD_LMZ9XF\+ZCX@\?>'C<6]ZT:Z7;W320MY8!+2X5@<,2H&>RY'!
M!/%_MI^ ? _PUUKPUH_A/2(=+O9();J]$<TCDH658L[V..5DZ5]%_$W]M3P#
MX*L9X]$N_P#A*]8'RQV]CD0 XX+3$;=O^YN/\Z_/_P =>.-6^(WBK4/$.MS_
M &C4+Q][[1A$ X5%'95   ]NYYKV>'*>>9IFLLVQ_-2HZV@VTGI9>Z^B6M[:
MO5=;95/94:7LUK)]?Z^XR])_Y"ME_P!=D_\ 0A7[ ^)?^16U7_KRE_\ 0#7X
M_:6RQZE:,Y"JLR$EC@ ;AS7ZG^(/C/\ #^;PWJ44?CKPU)(]I(JHNKVY))0@
M #?UKB\1,/6K5L$Z4'*W-LF^L",MDHUI7?;\V?E-2@4 4$U^UGD 30!0!2T$
MA11100V%%%%(AL****1FV%%%%(S"G?=H^[2=:!!UI0,4 8I:#-L****" HHH
MH)"BBB@S;"G=*.E)UH(;-CP;;QWGC#0X)XUFADOH$>-QE64R*"".X(K]5=+^
M$?@?1;Z&]T_P=H-E>0MNBN+?384D0^JL%R#[BOR:L+V;3+ZWN[9_+N+>198W
MP#M92"#@\'D=Z]?/[8GQ>/'_  EW_E-L_P#XS7YQQ9P_F6=RI/ U5!1333E)
M7O;LG?YGIY?BZ.%<W6C>]K:)[7[^I^EE[>V^FV<UW=SQVUK"ADEFF8*B*!DL
M2>  .]?FI^U1\:(_C%\1"^G.S>']*0VMB2,>;DYDEQVW$#'^RJ]#FN+\;?&3
MQM\1HS%XB\2WVHVQP3:EQ' 2#D'RD 3/OC-<;7-PMP:LCK/%XJ:G5M96VC??
M?5M[;+3U.C,,U^LT_94U9/>_4****_3CYQL****1FV%%%*!00V %!-!- %!
M 4M%)][Z4$-A][Z4M%%! 4444$A113@*#-L *0F@FE I$-@!2T44C-L****"
M0HHHH(;"BBB@AL***7[OUH(#[OUI**<!B@@ ,4444$-A2T44$!11102%%%+T
MI&;8=*3K1UIU(AL****1FV%%%%! 5]"_L0_\E7U;_L"2_P#H^"OGJOH7]B'_
M )*OJW_8$E_]'P5\IQ5_R),5_A/=R'_D9T/\1]YZ%_RW_P" _P!:UJR="_Y;
M_P# ?ZUK5_)*/Z >X4444Q!1110 4444 %%%% !1110 4444 %%%% !1110
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MD@'Z$UR%%%?44*,</2A1I_#%)+T2L>E%**45T"BBBMB@HHHH$%%%%!(4444
M%%%%!(4444""BBB@ HHHH **** "BBB@D**** "BBB@ HHHH$%%%%!(4444
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M/_TL@K\ONM?TOX9_\B>K_P!?7_Z3 ]3"_ _4.M+117ZT=+84444C-L****"
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MH **** "BBB@ HHHH *^7O\ @H=_R1'2?^P_!_Z3W%?4-?+W_!0[_DB.D_\
M8?@_])[BOK>$_P#D>X3_ !(]K)?^1C1]3\ZJ<!0!2U_9!^[!113:8PI***"@
MHHHI %*!0!3J!A32:":2J&%%%% PHHHJ2@HHIWW?K0 ?=^M-HHJB@HHHIC"B
MBBI **** "BBBJ*"BBB@ HHHJ2@HHHIC"BBBF4%%%% PHHHI %%%% !1110,
M****D84444QA1115%!1110 4445(!1110,****HH**** "BBBI*"BBBF 444
M4R@HHHH&%%%%( HHHH*"BBBF,**** "BBB@84444#"BBB@84444%!112=>30
M =>32T44%!1110,**** "D)H)I* "G444%!1110 444$T !--HHH*"E H I:
M!A1110 444A- P)I***"@HHIU !11104%!-!--H&%%%%!0444H%  !2T44 %
M(30324%!1110,**** /MO_@FI_S4;_N'?^W5?;M?$?\ P35&/^%B_P#<._\
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M44 >*?MG?\FU^,/^W/\ ]+(*_+^OU _;-_Y-K\8?]N?_ *605^7]?TOX9_\
M(GJ_]?'_ .DP/2PWP/U"BBBOUDW;"BBB@@***6@EL*2BE H,VP I2:": *"&
MP I:**"0HHHH,VPHHI>G)H(#IR:3K1UIP&*1( 8HHHI$-A1112,VPHHHH(;"
MBBB@@*6BB@@***=TH(;#I3?O4?>IU!(4444$!11109MA2@9H S03V%(AL">P
MI***1 4H% %*302V!-(!0!3J#-L*3K1UI:"&PHHHH("CI1THH("E H H)H(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5\O_ /!0[_DB6D_]A^#_ -)[BOJ"OE__ (*'?\D2TG_L/P?^D]Q7UO"?
M_(]PG^)'M9+_ ,C&CZGYV444VO[)/W<*2BB@H****0!2@4 4Z@84TF@FDJAA
M1110,****DH***=]WZT 'W?K3:**HH****8PHHHJ0"BBB@ HHHJB@HHHH **
M**DH****8PHHHIE!1110,****0!1110 4444#"BBBI&%%%%,84445104444
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M^W/_ $W$_F;C'_D>8C_MW_TB(4445\"?&!1110 4444 %%%% !1110 4444
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M%%%!FV%.Z4=*3K00V'6EHHI&8444M(04444$-A1112,VPHHI0*"&P H)H)H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ_\ WYB_^.4?ZW9%_P!!<?Z^0_[=RW_G^CUNBO)/^&F/"_\ SX:O_P!^8O\
MXY1_PTQX7_Y\-7_[\Q?_ !RE_K=D7_07'^OD']NY;_S_ $>MT5Y)_P -,>%_
M^?#5_P#OS%_\<H_X:8\+_P#/AJ__ 'YB_P#CE'^MN1?]!<?Z^0?VYEO_ #_1
MZW17DG_#3'A?_GPU?_OS%_\ '*/^&F/"_P#SX:O_ -^8O_CE/_6[(O\ H+C_
M %\BO[=RS_G^CUNBO)/^&F/"_P#SX:O_ -^8O_CE'_#3'A?_ )\-7_[\Q?\
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M\-7_ ._,7_QRJ_UNR+_H+C_7R*_M_*_^?\3UNBO)/^&F/"__ #X:O_WYB_\
MCE'_  TQX7_Y\-7_ ._,7_QRC_6[(O\ H+C_ %\A_P!OY7_S_B>MT5Y)_P -
M,>%_^?#5_P#OS%_\<H_X:8\+_P#/AJ__ 'YB_P#CE+_6[(O^@N/]?(/[?RO_
M )_Q/6Z*\D_X:8\+_P#/AJ__ 'YB_P#CE'_#3'A?_GPU?_OS%_\ '*/];<B_
MZ"X_U\@_M_*_^?\ $];HKR3_ (:8\+_\^&K_ /?F+_XY1_PTQX7_ .?#5_\
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M7^MV1?\ 07'^OD/_ %@RK_H(B>MT5Y)_PTQX7_Y\-7_[\Q?_ !RC_AICPO\
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M_P#OS%_\<H_UNR+_ *"X_P!?(?\ K%E/_01$];Z\FEKR3_AICPO_ ,^&K_\
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M_P"?#5_^_,7_ ,<H_P!;LB_Z"X_U\A_ZR91_T$1/6Z*\D_X:8\+_ //AJ_\
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M/#'_ #X:O_WYB_\ CE)_PTOX8_Y\-6_[\Q?_ !RC_6[(O^@N/]?(?^LF4?\
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M:RL&Q<WEO;GTFE5?YFIE.,%>3LB')15V6J*Q)?''AR#_ %FOZ7'_ +UY&/\
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M .ADTC_P.B_^*H_M#!_\_H_^!+_,7MJ7\R^\WZ*P/^%@>%_^ADTC_P #HO\
MXJC_ (6!X7_Z&32/_ Z+_P"*H_M#!_\ /Z/_ ($O\Q>VI?S+[S?HK _X6!X7
M_P"ADTC_ ,#HO_BJ/^%@>%_^ADTC_P #HO\ XJC^T,'_ ,_H_P#@2_S)]M3_
M )E]YOT5@?\ "P/"_P#T,FD?^!T7_P 51_PL#PO_ -#)I'_@=%_\51_:&#_Y
M_1_\"7^8>VI_S+[S?HK _P"%@>%_^ADTC_P.B_\ BJ/^%@>%_P#H9-(_\#HO
M_BJ/[0P?_/Z/_@2_S%[:G_,OO-^BL#_A8'A?_H9-(_\  Z+_ .*H_P"%@>%_
M^ADTC_P.B_\ BJ/[0P?_ #^C_P"!+_,7MJ?\R^\WZ*P/^%@>%_\ H9-(_P#
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M/^%@>%_^ADTC_P #HO\ XJC^T,'_ ,_H_P#@2_S#VU/^9?>;]%8'_"P/"_\
MT,FD?^!T7_Q5'_"P/"__ $,FD?\ @=%_\51_:&#_ .?T?_ E_F'MJ?\ ,OO-
M^BL#_A8'A?\ Z&32/_ Z+_XJC_A8'A?_ *&32/\ P.B_^*H_M#!_\_H_^!+_
M #)]M3_F7WF_3@*P!\0/"_\ T,FD?^!\7_Q5+_PL#PO_ -#)I'_@?%_\51_:
M&#_Y_1_\"7^8>VI_S+[S?II-8)^(/A?_ *&32/\ P.B_^*IO_"P/"_\ T,FD
M?^!T7_Q5']H8/_G]'_P)?YD^VI_S+[S?HK _X6!X7_Z&32/_  .B_P#BJ/\
MA8'A?_H9-(_\#HO_ (JC^T,'_P _H_\ @2_S%[6G_,OO-^BL#_A8'A?_ *&3
M2/\ P.B_^*H_X6!X7_Z&32/_  .B_P#BJ/[0P?\ S^C_ .!+_,/:T_YE]YOT
M5@?\+ \+_P#0R:1_X'1?_%4X?$#PL/\ F9-(_P# ^+_XJC^T,'_S^C_X$O\
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MW_)%=:_[&&?_ -)K:OS/Q$_Y$4O\43Q\U_W9^J/J.BBBOY6/C HHHH ****
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M=**" I0* *":" )H H I:"0HHHH(;"BBBD0V%%%%(S;"BBBD9A3ONT?=I.M
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M +AW_MU7V[7\B\>?\E%B?^W/_3<3^9.,O^1[B/\ MW_TB(4445\"?%A1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6Z9]+1K4Z\>:F[H****]4W"OT0_X)W?\D5UK_L89_P#TFMJ_.^OT0_X)W_\
M)%=:_P"Q@G_])K:OS/Q$_P"1%+_%$\?-?]V?JCZCHHHK^5CXP**** "BBB@
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M?]#-K'_@?+_\57/T4?VAC/\ G]+_ ,"?^8'0?\+$\5?]#-K'_@?+_P#%4?\
M"Q/%7_0S:Q_X'R__ !5<_11_:&,_Y_2_\"?^8'0?\+$\5?\ 0S:Q_P"!\O\
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M6/XL_P"AHUK_ ,&$W_Q5'_"Q_%G_ $-&M?\ @PF_^*KG:*/K^+_Y_2_\"?\
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M_(ON1T7_  LCQ;_T-&M?^#";_P"*H_X61XM_Z&C6O_!A-_\ %5SM%'U_%_\
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M?_/Z7_@3_P P^KT?Y%]R.B_X61XM_P"AIUK_ ,&$W_Q5'_"R/%O_ $-.M?\
M@PF_^*KG:*/K^+_Y_2_\"?\ F'U>C_(ON1T7_"R/%W_0TZU_X,)O_BJ/^%D>
M+?\ H:=:_P#!A-_\57.T4?7\7_S^E_X$_P#,/J]'^1?<CHO^%D>+O^AIUK_P
M83?_ !5+_P +)\7?]#3K7_@PF_\ BJYRBCZ_B_\ G]+_ ,"?^8?5J'\B^Y'1
M_P#"R/%W_0TZU_X,)O\ XJC_ (63XN_Z&G6O_!A-_P#%5SE%'U_%_P#/Z7_@
M3_S%]6H?R+[D='_PLGQ=_P!#3K7_ (,)O_BJ/^%D^+O^AIUK_P &$W_Q5<Y1
M1]?Q?_/Z7_@3_P P^K4/Y%]R.C_X63XN_P"AIUK_ ,&$W_Q5'_"R?%W_ $-.
MM?\ @PF_^*KG**/K^+_Y_2_\"?\ F'U:A_S[7W(Z/_A97B[_ *&G6O\ P8S?
M_%4?\+)\7?\ 0TZU_P"#";_XJN<HH^OXO_G]+_P)_P"8?5:'_/M?<CH_^%E>
M+O\ H:=:_P#!C-_\51_PLKQ=_P!#3K7_ (,9O_BJYRBCZ]B_^?LO_ G_ )A]
M5H?\^U]R.C_X65XN_P"AIUK_ ,&,W_Q5'_"RO%W_ $-.M?\ @QF_^*KG**/K
MV+_Y^R_\"?\ F+ZKA_\ GVON1T?_  LKQ=_T-.M?^#&;_P"*J:'XJ>,K?&WQ
M1JQ_W[MW_F37+44UF&,CJJTO_ G_ )B>$P[WIQ^Y'?Z?\>O'>FL"GB":9>ZW
M$4<H/_?2DUV.B?M8>(K/"ZGIMCJ29Y:/="_YC(_2O#Z*]3#\1YOA7>EB9_-\
MR^YW1PULFRZNK3H1^2M^*L?7WA;]IKPGKS)%?F?1+AN/])7=%_WVO]0*]5T[
M4;35K1+JRN8;NV<96:!PZGZ$5^=E;?A;QMK?@N\%SH^HS6;9RR*<H_LRG@]*
M^^RSQ%Q-)J&8TU./>.C^[9_@?(X[@VC43E@Y\K[/5??NOQ/T )I0*\(^&_[3
MVGZQY5EXH1-,N^@O8\^0_P#O#JGZCZ5[K#-'<0I+%(LL3@,KH058'H01U%?L
M^6YO@LWI>UP=1275=5ZKI_5C\QQV7XG+JGL\3"WGT?HQ])UHZTM>P>4V%?0G
M[$7_ "5;5?\ L"R_^CX*^>Z^A/V(O^2K:K_V!9?_ $?!7RG%7_(DQ7^'_(][
MA_\ Y&N'_P 1]XZ%_P M_P#@/]:UJR="_P"6_P#P'^M:U?R2C^C7N%%%%,04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?+W_!0[_DB.D_\ 8?@_])[BOJ&OE[_@H=_R1'2?^P_!_P"D
M]Q7UO"?_ "/<)_B1[>2?\C&CZGYU4H% %.K^R#]Y&R2)#&\DC*D: LS,<  =
M2:^:?B]\:IO$DDVCZ)(T.DJ2LMPIPUSCT]$_G6C\>OBHU]<2^&M*GQ:QG;>3
M(?\ 6-_<!]!W]3]*\1K^>N..,)U9SRK+Y6BM)R75]8KR77OMMO\ E_$6?2G*
M6"PK]U:2??R7EW[^FY1117X>?G84444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M92<MPHHHKYPD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!9?_ $?!73Q5_P B3%?X3FX=_P"1KA_\1]XZ%_RW_P" _P!:UJR="_Y;_P#
M?ZUK5_)2/Z/>X4444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)%9CRW'//I7Y($%201@TZ-:->/-$*]"6'ERR"BBBN@Y@HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5]/\ P$^(S>*-';2+^7=J5BHV,QYEBZ _4=#^%?,%:_A+Q)<^
M$?$5EJMJQ#V\@+*#]]/XE/L1D5];PQGD\AS"%>_[N6DUW7?U6Z^[J=N#Q#PU
M52Z=3[AK]#O^">'_ "176O\ L8)__2:VK\Y]+U*#6--MKZU<26]Q&LL;#N",
MU^C'_!/#_DBNM?\ 8P3_ /I-;5^\^(4HU,@<XNZ<HGTF9N^&NNZ/J*BBBOY9
M/C@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /%?VS/^3;/&'_;G
M_P"ED%?F 37Z??MF?\FU^,/^W/\ ]+(*_+;5-2M]%TVZO[M_+M[>-I9&/8 9
MK^E/#:4:>35IR=DJDO\ TB!T4_A/._CA\2_^$(T,6-E)C5[Y2$8=84Z%_KV'
M_P!:OE!F9V+,2S,<DGDFMKQGXJNO&GB.[U:[X>9ODCSD1H/NJ/H*Q*_&^*,^
MGGV/E53_ '<=(+R[^KW?R70QE+F84445\>2%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>M_L
M_P#Q7?P/KRZ5?RDZ+?R!3NY$$AX#CT!Z'\Z\DHKTLNS"OE>*AB\.[2C^*ZI^
M3.''8.EF&'EAJRO&7X>:\T?HZ"& (Y%?0O[$8_XNMJO_ &!9?_1\%?$7[.?Q
M$;QEX/-A>R;]3TO;$Q)^:2+'R/\ 7@J?H/6OMS]B/_DJVJ_]@67_ -'P5_2.
M<XZEF7#5;%T?AG"_IKJOD]#\+RO"5,!G]+#5=XR_X9_-'WCH7_+?_@/]:UJR
M="_Y;_\  ?ZUK5_+:/Z#>X4444Q!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\O?\%#_P#DB.D_]A^#
M_P!)[BOJ&OE[_@H?_P D1TG_ +#\'_I/<5];PE_R/<)_B1[>2?\ (QH>I^5_
MQJ\3?\(SX!OFC;;<WG^B18.#\V=Q_P"^0U?)%>V_M.:WYVK:1I*M\L$37#K[
ML<#]%/YUXE7O>(.8/&YU.BG[M)**]=W^+M\CTN)\4\1F$H+:"M^K_P OD%%%
M%?FA\D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 445);VLUY,L4$,D\K'"I&I9C] * (Z*]K^&_P"Q_P#$GXCM%+%H
MS:/82?\ +WJ7[I<>H!Y-?5'PY_X)X^$-!$<_BW5KCQ!<C!-O;?N8?IGJ:Y*F
M*I4]WKY'K8?*\7B=8PLN[T/SVT[2[S6+E;>QM)KR=CA8X(R[$_05[U\-?V&/
MBC\1/+FDTM/#UBV#]HU1MAQZA!R:_2/P;\/?!_P]MTM_#OAW3]*51@/'"N\_
M5CS76K?,_P#%D_6O+J9E)Z4U8^DH</0CK7G?R1\M?#C_ ()H>!M$:"?Q=KE]
MXBF7!:WM?]'A)_#YB/Q_.OKOX8_#/P'\++=(?"_A;3=+*C_71P RGZN>:H)>
M-V-7;74&&,$CUYKRJF(JU/BD>Y3R_#4E:G!'L>GZS]H4?-D]ZU%F\Q?6O,-&
MUC:PYSFNYTV^$T8YJ(SZ,\[$8;DU1)J=M'=PRP3('AE4HZ-T*D8(K\,OVV/V
M?9_@'\9M1M((&7P_JCM>:;)CY=A.2F?]DG%?NG<*'!KYP_;:^ ,/Q\^#&H6=
MO K>(-*!O=.EQ\VY1\R9_P!H9%=V%K^QJZ[,\K%X?ZQ1TW1^'=%37EI-I]U-
M;7$;13PN4=&&"K X(J&OJ3X\**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?+W_!0_P#Y(CI/_8?@_P#2
M>XKZAKY>_P""AW_)$=)_[#\'_I/<5];PE_R/<)_B1[F2?\C*A_B/PU^.6H?V
MA\3-5Q]V#RX!_P !09_4FN"KI?B9+YWQ!\1-Z7TJ_DQ']*YJO+SJJZ^9XFJ^
MLY?^E,XLPFZF,K3?64OS"BBBO&. **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7Z6?\$;=7>Z\4>+=.9LBTL))%'H))8./S0U^:=?H#_P $9[MD
M^//C6VS\LGAII"/=;J #_P!#-=^#KNBYKI*,D_FO\TCCQ-%5E!]8RB_Q_P K
MG[(Z%_RW_P" _P!:UJR="_Y;_P# ?ZUK5YZ.U[A1113$%%%% !1110 4444
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MC[6;?PS:MAFL;4B>YQZ$CY5/YU]_>#O"?AGX8:.--\)Z%9:%9@;6%K$%=_\
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M@ HHHH **** "FNBR(R.H96&"K#((]*=10!XC\3/V*?@A\6S-)XB^'&B/>3
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M![&JN!7HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445)!:S73A(8GE8\!44DTTF]$!'17167P
M[\2:AM\G1KLY_O1,/Z5T4'P!\:W$2.FE\-T!?!_$5Z-++<;75Z5&3]$SFGBJ
M%/XYI?,\[HKT.;X!^-81SI+-SC"MFLC4/A1XNTS/G>'[[ _B2!F'Z"G4RS'4
M?XE&2_[=8HXK#S^&HG\T<G15J^TF]TUMMW:36S>DL97^=5:\Z47%VDK,Z4T]
M4%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8?[Y6_Q2_-GF8K^/4]7^84445P',%%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7]5%?RKU_510 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!^ /\ P5'_ .3[/B;_ -PS_P!-=I7RK7U5_P %1_\ D^SXF_\
M<,_]-=I7RK0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !7[S_\$K_^36;7_K^7_P!(;2OP8K]Y_P#@E?\
M\FLVO_7\O_I#:5[^#_Y%V+_[<_\ 2CHI_P *?R/L&BBBO .<**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#Y5_X*C_\ )B?Q-_[AG_ITM*_ &OW^
M_P""H_\ R8G\3?\ N&?^G2TK\ : "BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH **** "BBB@ HHHH **Z7X<?#G7_BQXPT_PQX9L6U#5[Y]L<2]
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M]*FD;_7PYR8N?XDSP/[O^[7V/6=@"BBBD 4444 %%%% !1110 4444 %%%%
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M** "BBB@ K]Y_P#@E?\ \FLVO_7\O_I#:5^#%?O/_P $K_\ DUFU_P"OY?\
MTAM*]_!_\B[%_P#;G_I1T4_X4_D?8-%%%> <X4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'RK_P5'_Y,3^)O_<,_P#3I:5^ -?O]_P5'_Y,3^)O
M_<,_].EI7X T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%.CC>:1412[L<!5&237KG@7X'RWJPWVNMY4+<BT4_/_P "]*]' Y?B
M,PJ>SP\;^?1>K.:OB*>'CS5&>>^%_!>J>+KM(;&V9D+8:9AA%^IKW[P-\#=(
MT"19[_;JMR.1YB?(#_NUV^EZ;;V,2PVL$=O$  %C4 ' QSBM<XM%;>-K+USV
MK]CR?A?"8*U6NN>?GLO1?YGQF-S2M6]RG[J_$D>6/3K8!55<#"J.@K#FNFE8
MDGDFFW=XUQ(3_#VJ.-2QKZJK6]H^6.R/,A3Y5>6Y)&I8U,6$?RC[U-+")<#[
MU6;"T,C;WZ40BV^5"D[*[+>EV)<AFKHK?"* O K.A8;0!P*OPM7O8>*IJR/.
MJ-RU9IPGI3+ZXVX%$+<"LV_N,S=>*]*=3E@<L8WD65N*?'<8?V-9BS^].\_\
M^U<JK&O(=!$RR$;^GM1RC'TJE;7'F1JV:O(P=<&O0C+FU.9JV@DC*8\2KOB/
M#J>A4]17PO\ &3P:W@GQ]J-F%(MI'\Z%^S*W/'T)Q7W3)'YD;(?XABO!/VD?
M"G_"1>&8]9ACS=Z:2LA[^5W_ %Q7Y]QOEGU_+_:P7OT]5Z?:7W:_(^BR/$_5
M\3RO:6G^1\M4445_-A^FA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/[B]%SUR3W%?G'5I %%%%4 4444 %%%% !1110 4444 %%%% !1110 4444
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M->45VGQBOOMOQ!U( Y6';"/P49_4FN+H&%%%%( HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *_>;_@E?_P FLVO_ %_+_P"D-I7X,U^\W_!*_P#Y
M-9M?^OY?_2&TKW\'_P B[%_]N?\ I1T0_A3^1]A4445X!SA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?*O_!4?_DQ/XF_]PS_TZ6E?@#7[_?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5]W_\$;_^3G/$_P#V)]U_Z6V5?"%?=_\
MP1O_ .3G/$__ &)]U_Z6V5)C6Y^T>A?\M_\ @/\ 6M:LG0O^6_\ P'^M:U"!
M[A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M><5)JB+CH?UJ!E#=.F>!4[-CH3^51MZ#GO2*(3G!&>*B [D86IN-W/0TQL<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC9)_P-37J7A?XA6VHQJCS*QQD<\UVMO=Q7*!HV!!J(U(RWT9BXM'X*_M6?\
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MR)KF1Q]"QQ^E9M!)/)Y-%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9BO]XJ>K_,****X#E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB7<XP/SK/MGSCC:U:EOEL$=*PD%R583D=C5NVA)8=\'%.@@W9XY_G6C:V_S
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M5_*O7]5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X
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M#_TGN*^H:^7O^"A__)$=)_[#\'_I/<5];PE_R/<)_B1[N1_\C*A_B/P6\?\
M_(^>)/\ L)7/_HUJP:WO'_\ R/GB3_L)7/\ Z-:L&O!S#_?*W^*7YL\S%?[Q
M4]7^84445P'*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)8)4,<L;%'5NH8'!%1U[C^V5\,)?AC\==;1;<PZ=JQ_M.T;;A2).9 /I)O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVULPZG:WUA-IVIVL&I:?<+LFM;I!)'(IZ@@U%#$3P[MO$K,,MIXU<\=)=_\
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MY.M;6:^NH;:WB::XF<1QQQC+.Q.  .Y)K^@W]DGX$V?[)W[,.EZ1>QQP:[-
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MV,#YCS732EI9F4UJ?FG16AX@\.ZKX3UBZTG6]-NM(U2U?RY[.^A:&:)O1D8
MBL^NDS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]Y_^"5__)K-
MK_U_+_Z0VE?@Q7[S_P#!*_\ Y-9M?^OY?_2&TKW\'_R+L7_VY_Z4=$/X<_D?
M8-%%%> <X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'RK_P5'_Y
M,3^)O_<,_P#3I:5^ -?O]_P5'_Y,3^)O_<,_].EI7X T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K[O\ ^"-__)SGB?\ [$^Z_P#2VRKX0K[O
M_P""-_\ R<YXG_[$^Z_]+;*DQK<_:/0O^6__  '^M:U9.A?\M_\ @/\ 6M:A
M ]PHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_JHK^5>OZJ*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P!_X*C_ /)]
MGQ-_[AG_ *:[2OE6OJK_ (*C_P#)]GQ-_P"X9_Z:[2OE6@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /I3]@:Q\):?\=M-\7^-8KB]T7PRRWL=
MC:QK(\MSSY+,K,/D1AO/NJBOTV_;'_;*\(6/P)NM7\.:J+V2Y4P10;2DJS$<
M*RM@C%?BAX1\9:IX'U8:AI4PBF*['1UW)(I_A8=QP*W/B!\6M6^(EI:6U[#;
MVL%NQ?9;AAO;&,G)/X#WI.*D.[1Q]_?3ZG?7%W<R&6XGD:221NK,3DFH**Z7
MX9^&/^$T^(7AS0R,I?W\,#_[A<;O_'<TQ'Z;?L'_  \'P7^ H\074(_MKQ)C
M4),CYDAQB%,_[IW?5J^7OV[/BM<>(-6@T3S/OR&:51_=!X_7_P!!K[=\<^)$
MTOPR+2W ABCB"*B<!548 &/85^4OQQ\02>(OB5J\SOO6)_)7\!S^I-3%=6-]
MC/\ ACX^N/AYXFBOXP9+23]W=0 _?CSU^HZC_P"O7U%J/@GPMX^M[?51%N2Y
MC#QW5JVPN#T)[$_49KXPKUCX)?%P>#KDZ/JTC-HUPWR2$Y^S.>^/[I[_ )^M
M=%*K.E*\'8%*47>+L?5_PBT/P]\,[HR6%D#J+C;_ &A<'?+CN%./E!]L5[[H
M;6GC&X:UU&VBO;&:,PW%O.H>.2-N"I!Z@U\Y)-NVLK9&,AAW'K7HWPW\7_V7
M=)$S8Y[TJSE6;E-W8^>4G>3N> ?M?_L(ZK\'(;OQMX.5M6\!2,))8%R]QI>[
ML_\ >B!X#]1D;O4_(-?NCI7Q"M;O1)+2Y$=S!-&4D@D 9'4C!4@]1BOS3_;"
M_99_X5SK$GBOP9832^$+LE[FVA4N-,DSDKQR(CV)Z=,]*Y(2>TAM+='RU111
M6Q 4444 %%%% !1110 4444 %%%% !1110!<T?6K[0+^.]TZZDM+J,Y62,X/
MT/J/8U]"?#7]HRWU Q:?XFV6EP?E6^48B?\ WA_"??I]*^;Z*:=@/TA\)^-+
MK0GBGLY_-MCA@%;((]17TS\,?CE'=)$LEQ@C (SS7Y!?#OXQZUX D2!7-_I6
M?FLYF^[[H?X3^GM7U!X!^+&D^+D6XTB^,-XF"]M(=LB_4=Q[CBFXJ8DVC]:O
M"?CZ'4(T_?*_X\UZ/INM),H&[(K\S/ /QQO-%FBANR3'G&_-?4G@+XU0WD,1
M-PL@8#&6KDG2<7=&JDGHSV/XW? 7P/\ M&>"IO#?C;1H=4LF!,%PH"W-H_\
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MY;^7F?$-%!!4X(P:*_G(_8 HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K[O\ ^"-__)SGB?\ [$^Z_P#2VRKX0K[O_P""-_\ R<YX
MG_[$^Z_]+;*DQK<_:/0O^6__  '^M:U9.A?\M_\ @/\ 6M:A ]PHHHIB"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!4?\ Y/L^)O\
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M?P(F9&N((LWM@G)_?QK]Y0/^6B<>H6OBJOZBM'\46NJ1 %E^8?@:^0?VIO\
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M)OV8_BGJ/@OQ*BRO#B:SU"%2(;VW;[DJ9Z=P5_A8$<XR?+:S,@HHHH ****
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M9.A?\M_^ _UK6H0/<****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *^7O^"A__)$=)_[#\'_I/<5]
M0U\O?\%#_P#DB.D_]A^#_P!)[BOK>$O^1[A/\2/>R'_D9T/\1^"WC_\ Y'SQ
M)_V$KG_T:U8-;WC_ /Y'SQ)_V$KG_P!&M6#7@YA_OE;_ !2_-GEXK_>*GJ_S
M"BBBN Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBI;6UGOKJ*VMH7GN)6"1Q1J69V/   ZF@";2=)O->U.UT[3K:6]O
MKJ18H;>%2SR.3@  =37ZZ?L/_L%V'P3L8/&7CFUAU'QK.@:"TD4/%IRGTSPT
MGOVJM^P/^P_:?!W1[+Q]XVLTF\;72>;:6<@##38R.#_UT(Z^G2OLVZOLYYS7
ME8C$<WN0V/H<%@K6J5$)>71)XK%NKK;DT75W\QY(-8>H:DL>3NR*\QGTM.F2
M75T.>>]8E]J &<GI5"\U@%FP<=_I[U\Y?&W]LGP3\*_.LTO!X@UM,@6-A(&5
M3_MR=!^&:F,)5':"N=\JE+#PYZTK(]]OM6'S<X [YKP'XM_M<>!/AF);>XU/
M^V=37(%CIQ#L#Z,_1?U^E?"WQ<_:\\>_%5IK8WQT31WR!8Z>2@8>C-U:O$6=
MI&+,Q9B<DDY)KTZ6 6]1GS>*S]_#A8V\W_D?2_Q"_;S\>>)+QAX>$'AFP&0J
MQ())C[EV[_2J'[,7[47B'P#\?](\1^(];O=4L+Z3['J/VJ=G'E2$#=@G P<'
M/UKYVHKTE2A&/*EH?,SQ=>I-5)S;:/Z'!<Q74,=Q;RK-!*HDCD0Y#J1D$?4&
MF^9NKX9_X)V?M/MXNT&7X=^)K]6U73U#:5+,V&GBZ&/W(Z_05]LM<;6Z\U\]
M5INE/E9]_A,1'%4E4C\RU<?,.G;FL^X8JI_QJTEUNJO<8P>>M9G6KHR+U5?)
M(P<5BW"@YQVYK:O8^"0*Q;A3].:S:.VG*Q1DC^[\N15=H]O('Z5/(Y1O:J[7
M&/84T;W;!I-N<G([5$]Q\W'6HIKCKR#GI5":X)Q].HJB>4FGGW9'0Y_.J$TH
M8-SDTV:4GH3D56E7W.XTBU$@N) .AS6=<<MM'%7I8^<'(/M4+QC/'%%S:,3,
MF0]NQJO+#WSC/.,5HR+\Y!Q5:1>N>E(V6A1DCPH'<5"R'=P*N2*=W SZTQ8R
MW';^5,4I6156,D8(JU!;;LC.!TJU;V1].]:$-CCMBJ.64KE**U.00.3Z5<BM
M>>E7H[7G:>*L16W/2LVP14CM>"".>U68+/=@?TJ_!:%@">% R23^M?,W[17[
M9>F_#_[3X?\ !C1:IKH!26^R'AMCZ#'WF_E4PISK2Y8(PQ&*I8.G[2J[(]4^
M,'QN\+?!71VFU6Y6?474^1IT)!ED/T[#ZU^>/QC_ &@_$_QBU&0WMR]EI0/[
MK3H'(C [;O[Q^M<'XC\2ZGXNU>?5-8O9K^_G;<\TS%F/_P!:LROH</A(4-7J
MS\ZS#-ZV-;A'W8=N_J%%%%=YX 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7T3^Q=^RS/^TEX^D-^[VOA+1RDVISQG#R9/RPH<$;FP<^@S7SNB
M-(ZHJEF8X"@<DU^ZG[*/P-3X%_ /PUI2V3P7M] M]J,[#/F7+J"PR/[HPH^E
M?%<69Q4RG -T/XDM%Y+K+Y72]6CU,NPRQ%9*>R_JQMW7AG3?"WAZVT?1K&'3
M=+LXA%!:VZ!410/0=ZT_AG)G1YXS_P LYV _$ U=\10;K=C[5D?#=C'>:I"?
MNAE;^=?BW"]:4LQ3D[N2?^?Z'ZL[/!-+HU_D>G0W M+-F+A#V;BJD-_]LCN'
M>V9<+@S %5:JL^KO:QMC3Y+I1SNQ64_C^&X66)T\I$',;'!K]C9X$:4I-M(\
MYTV;R?$VH@C=&TS*589!'3!%?F?^WU^S>GP7^(D/B#0[4Q>$O$1>6W5!\EM.
M,&2'V&&!'KSZ5^E]J\=QXAO98?\ 5-*2M5OCI\*;7XV?!SQ!X2N(4ENIH&GL
M&8 F.Z128ROH3DK_ ,"K\MR7.)91FTE)_NY2:E]^_P CT\^P:QF'BTO>237W
M'X95^OO[*MXTW[+'P_8MEA9.GY2N,?Y_^M7Y%:A8S:7?7%G<(8YX)&CD1A@A
M@<$5^I_[$=^^I?LK^'=Y8FUN;J $CL)6(_G7[YC?>I)H^"R33%-/L_T/2-4O
M.H/'-?G)^W-IXM?CA)<J#MO-/MYMQ'4X*G^5?HEK<)Y?JOI7RQ^V[\-AXF^'
MUAXMLX<WVBOY%UM')@8\-^#?SKS\')0JJ_70^GSJ@ZN#;C]EW/A ,5((.".A
MK[K_ &)?VVCH,]GX"^(5^TNF2%8--U:X.3;DE56*1O[GHQZ?2OA2BO=J4XU(
M\LC\_P /B)X>:G39^^ES8),B3P.'CD4,K*<J01D$&DTG59=*F(QOA<%)(G&5
M93P00>HQ7@?[%.L>(=+_ &??#/\ PEMU)=K=!I;*27EHK8G$:L3VP,CV-?04
MT,5W&'CPP/(9:^)C6H8B=2%&5W!V?J?I]-SE2A*K&RDKF9J_@IX?,U;PNYEM
M^7FT?^./IS">XZ_*?PJ?PWXD%P I+!E)5E8$,I'!!!Z&H8]0N-)O%D61EV]Z
M=XJN;>ZT_P#X2&V7;=PLHO548W1]/,QZCO7P&?\ #T*T)8G#1M-:M+9^GG^?
MJ>E2K.RI57>+V?5>O=?D=[9W?F*,&LOQYX%\-?%+P[-H7B[1K77-+DZPW*9*
M'LR-U4CU%4/#6K+<PH0X((R"#75K^\3-?C\*]7"U%4I2<6NJ.#$T(IN$UH?D
MQ^UE_P $]-?^#@N_$W@KSO$O@T$N\2*7N[%<9.\#[R#^\/QKXXZ<'@U_1:LQ
MA)XRK AE/((/4'VK\J_^"C_[+/\ PK?Q</B)X8L/+\*ZY*WVV&W3"6-V>3P/
MNJ^3CW4BOZ!X1XN>:-8+&O\ >='_ #>OG^9\-F66_5U[6E\/Y'Q-1117ZP?/
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?U45_*O7]5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY'_"1,IZ,N37T#I+>9;I@<5.42YE)^;/E,^O&LEY'GW[23G_ (55JP!Q\O\
MC7P!7Z*?'C3H]2^%VO1'_6+;-(OU -?G77YEQY%K'4Y='']6?<<%R3P51=I?
MH@K=\%^)9/"VO07BL1%G;*OJIZUA45^<TJDJ,U4@[-'WTXJI%QELS[/\+Z\D
MD4,\,BO!*H964Y'/:O0]/OQ*JG.:^+_AC\2G\+W L;YV?3I#P?\ GF?4>U?2
MOAWQ)&\,4T4RSV[C*R*<@BOW;(<\IXNFM;-;KM_P#\OS;*YT9MI:'K%K&DPS
MT-4/$WA_2O%VCS:1KEJMU9R# )QNC/\ >4]C5#3=>CD48;-7+B[%PHP>:^\E
M*CB*3A)*2>ZZ,^/Y:E.::=FOP/D/XJ?LV^(/ LDU[IL;:QHA)*30+ET'HRCG
M\:\?92K%6!!!P0:_2/3=5DM<QO\ /&W#*W*D>XKS;XM_L]:%\287OM$2#1M>
MQP% 2&;V(' /OBOR+.."VE*OEKO_ ''O\G^A]]EW$SBU2QZ_[>7ZK]4?$E%=
MSXD^"/C;PK))]N\/WGDH?^/B*,M&WN#Z5P[HT;%64JPX((Y%?EE:A5P\N6K%
MQ?FK'W]*O2KKFI24EY.XE%%%8&P4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5]W_\$;_^3G/$_P#V)]U_Z6V5?"%?=_\ P1O_ .3G/$__ &)]U_Z6V5)C
M6Y^T>A?\M_\ @/\ 6M:LG0O^6_\ P'^M:U"![A1113$%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R]
M_P %#_\ DB.D_P#8?@_])[BOJ&OE[_@H=_R1'2?^P_!_Z3W%?6\)_P#(]PG^
M)'O9#_R,Z'^(_!;Q_P#\CYXD_P"PE<_^C6K!K>\?_P#(^>)/^PE<_P#HUJP:
M\',/]\K?XI?FSR\5_O%3U?YA1117 <H4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% "HC2.J(I9V. JC))]*_5+_@G_\ L+Q^
M ;?3_B;X]M4EUZ:(3:3I<HR+-6&1,_\ TT(Z CC/K7F?_!-?]C+_ (3'4(/B
MEXTT_?H-J=VC6<Z\74H/^N(_NKCCU-?J#J4AVD#CCBO+Q5>WN1^9[N7X12:J
M5/D4+[4ASSR>M8USJ  SN'2JFL731;N?TKB]2UXH6RV![UX_/8^QIT>8W-6U
MY8<_-CU->)?&S]HSPK\&=)%WXBO7-S,";;3K5=T\Y]AD +[D_G7'_M)_M'V/
MP8\*R7+,EUKMVI73[$G[S?WVQT5>OOTK\N/%_C#5_'GB"ZUK7+V2_P!1N6W/
M-(?R '8#TKNP^&=;WY['FYAF$<%^ZI:S_+_@GM?QL_;2\:?%;S[#3Y#X:T!B
M0+6TD/FR#_;DXS^&*^?&9I&+,2S$Y))R3245[<81@K15CXFK6J5I<]25V%%%
M%68A1110!=T76[_PYJEOJ6F7<ME?6[AXIX6*LI'H17Z:_LO_ +<^D_$RULO#
MWBV9=*\3(HC6>1L0W6!][)Z-[5^7M+'(T4BNC%'4Y#*<$'UK&K1C65I';A<7
M4PD^>G\UW/WSMM06XCWQN&7J"#D5)+>.(R,U^3'P3_;@\9_"]8[+5)7\0Z4N
M%2.=OWD8]F[_ (U]\_"']JSP1\7+.V%IJ"V>HRCYK*Y8+(IKQJN%G3U6J/L\
M+FE#$63]U]F>ORW&YASD50N)@WL:NO&LB"1&#(>A4YK/GA(8Y[UPL]^,D]C/
MF^7)'2J$V&6M":/=[$53ECVTCIB477KD8 JJ5//H>E76C..F:KR+MQ@?6F:%
M-E^7K@$>M0.O0]_KTJY(AZ=JK,#M/&!T%!17D^49SFJ;D;N>*NNAW'CFH)(B
MS=.:+#YDBC(OIS4+1[E'9<UHO;EN@Z=Z?!8F1O:JL2ZAEK:EL@ _6K=OIO(^
MOI6U:Z4<?=K3M](PO*X/O3,'4,.#30O4<]>E7%L_E&03^%;BZ?Y8SC%,:WV\
M=:AB3,H6Y&!T_"J^M:MIWAC1[G5=6NXK'3[9"\L\S!54#WK*^*'Q0\._"/PW
M-K&OWB0H ?*MU8>;.W944GDU^:?QV_:/\1_&_5&%U(UAH43$V^F1-\H'8N?X
MF_2MZ.&E7?9'EX_,Z6!C;>?1?YGI/[0O[:6J^._M6@^#VET?P_DH]T#MGN1T
MZC[J_0U\NLQ=BS$LQ.23U-)17T-.E"E'E@C\XQ.*JXJ?M*KNPHHHK4Y0HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#UG]E#P%#\3/VBO ?
MA^Y3S+2?4HY9T[,D>9"#['9C\:_H\TW3K6#1K>Q=8WB2,*4."/>OP,_X)LV<
M%U^U;X?:=E5H;2[EB#'&7$1P/KR:_9".>12?WC?]]&OROB/B2.29FHSH^TO!
M+>UKMWZ.][+[CZ# X%XN@VI<MG^AUWC+X7_;K>272)%$AY^SR-P?H:\;\(:;
M>:3XMU2TO+:2W98E)608.=Q_I71:Y?31V[;9Y%X[.16%X%N)KN\U.6:629P5
M0-(Q; Y]:^,RW%X#'YK3JX3#NE+6Z4KQV?2RM\M/(^XPE+$4<).-6?,M.FNZ
MZW.[DUJ.RM0&"G' W5RGB?0TURU.I62H+NV^8>4PRR]PR_UIWB:806OWL>N:
MXFU\236%\#"_)XQV;VK]+UN*G1LN>.Y3\/1XO)3URY;IZ\UV?VG[,H8'!'2N
M0T1@EW<$G_EHQY^M6==U@6\9&[%?SY7O/$2EW;_,^IE2=6<8KLC\NO\ @H/\
M/;/P7^T+J%]IL/DV?B"%=3\M1\HF?(EQ[%P6_P"!8[5^@?P!\ +\-OV>?!6A
MRQK'<_8ENKGG.99?WC?^A ?A7%?%S]EF?]H[QYX&UF]N(;'0]&=O[1WG][/'
MO5A&@]3@C)XYKWOQ3<0VNV !8XE7:JYX4#H!7]%Y?BGB,LH<SUMK\M$?"QR_
MZKF59VTZ?/5G :A$TLCHOS#/;H*YG6]%M=2LKO3=0B\W3=0B:WG0]-K#%3^*
M/$\7ANTOM4GE5+*SB>:9L]%49_/BOB70?V^/$%O-J":[HT&M6LUTTMLR,+>2
M"(GB/Y5PV!CDUZ-/#SJ)N/0Z\7F%#"RC3K;2/!_B]\.[KX6_$#5?#]S\RV\F
MZ"7'$D1Y1A]17)V=NUY>00(,O+(J*/4DXKU?]I3XS:;\;/%NFZKIFFS:=#:V
M*VS"X8%W8$DDXXP,X%>:>&;R+3_$>E74R!X8;N*1U/0J'!(_(5[T7+DO+<_-
M:RIJK)4G>-]/0_=E?!\>F^$]$T](E1+73[>$*@  VQJ.,5D:3<7'AV],,A+6
M4G #?\LSZ_2O35N(-:T^SOH I@NK>.>/;R-K(&'Z&L/5O#ZW,;?*#7\CT\UQ
M&!Q\J]-VE=W\]=F?L.%KPGAXT:NUC,U"WAO(\@C/UK#CDDM+QHF7= ^4E4CA
ME/7-37$-UI9V\O$.F1G%6[>ZMO$4#Q1'R[M!RK#!QZCUK]FRS/L'F]J<?=J6
MV?Z/K^9G.A.BKO6'<P]$;_A%=8;2Q/YUFW[RSD)Y,9_@/NO]:]3TF^%Q$O-<
M9)H-IKFE_P!F3.MIJ,+^997C?P2#LWJI[U#X-UZ5U\JZC:WNXF,<T+]4<<$5
M^8<49.\'6^L4E[DW]S[?/=&KMB(<K^*/XKO_ )GH\RY7(KE/B)X-L_B5X!\0
M>$]1C62UU:SDMOGZ*S*0K>Q!QSVKIH9Q-&"#52X/EMD5\9A*T\-6C5INSB[G
M![-5(NG+J?S[>*/#UWX2\2:IHE]&T5[I]S):S(PP0R,5.1VY%9E?7?\ P4Q^
M&</@_P".\?B.SA\JV\3VBWDH484W"?)(1_O85C[DGO7R)7]D9=C(X_"4L5'[
M23_S_$_+<11>'JRI/HPHHHKT3G"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K^JBOY5Z_JHH **** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %%%% !1110!\J_\%1_^3$_B;_W#/_3I:5^ -?O]_P %1_\
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MXI?FSS,5_O%3U?YA1117 <H4444 %%%% !1110 4444 %%%% !1110 4444
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MY58_)&/[JKV%<S117LI**LCXF4I3;E)W;"BBBF2%%%% !1110 4444 %%%%
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M110 4444 %%%% !1110 4444 %?U45_*O7]5% !1110 4444 %%%% !1110
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M(Z,/1EB*L:<-V?JYXB_;=T_X)Z7::3X3M+7Q3KO!O'FD86ULH)!3*D;I,@\
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MZDTU='D_Q<^)=_\ %#QA>:I=RLT&\B"//"KG^M<3112&%%%% !1110 4444
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^[_P#@C?\ \G.>)_\
ML3[K_P!+;*OA"ON__@C?_P G.>)_^Q/NO_2VRI,:W/VCT+_EO_P'^M:U9.A?
M\M_^ _UK6H0/<****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^?OVZ-,DU#]GK5)(UW?9+RVN&^G
MF;"?_'Z^@:\X_:(T%_$WP7\6Z=$GF32V$S1I_>=4+J/S45[62XA87,\-7>T9
MQ;]+JYZ66U51QM&H]E)?F?S>>/\ _D?/$G_82N?_ $:U8-;WC_\ Y'SQ)_V$
MKG_T:U8-<F8?[Y6_Q2_-G/B_]XJ?XG^84445P'*%%%% !1110 4444 %%%%
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M55>-[^C[G[D0S>],OE$L9%<A\./B5X>^+'A&R\3^%KY;_2KI<@])(F[I(O\
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M:M@.VT^AK[C"YMA\1%.+/FJV6UJ+LT=^K20<H<BL>;2-,\XRPV,%M,S;G>-
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M2T:5FQ&SLK9Z'*FOBLYPL,9@*M*:OI?[M3UL//V=6,C]*/CSX;_X7A^SW?\
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MXE\/1G(FMAFXC7^])&,[0/7-?.1R.#P: "BBB@ HHHH **** "BBB@ HHHH
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MG.>)_P#L3[K_ -+;*OA"ON__ ((W_P#)SGB?_L3[K_TMLJ3&MS]H]"_Y;_\
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M@HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,>.[VL3G]6-?S@5_21^Q_P#\FL_"3_L4M(_](8:?,[<O0?0]@HHHI""BBB@
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M0*P+9/3<O4#ZU^=GQZ\5:9XT^*&L:KI-O%!:3,I_=)M#-M&XX^N: //:***
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M.>)_^Q/NO_2VRI,:W/VCT+_EO_P'^M:U9.A?\M_^ _UK6H0/<****8@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *S]:_P"/5?\ ?'\C6A6?K7_'JO\ OC^1I,:W/YMOVIO^3G/B]_V.
M&L?^ELU>85Z?^U-_R<Y\7O\ L<-8_P#2V:O,*8@HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY;/19PK#>P( )KYH//-?&9U4YJRCV/T/A^GRX=S[A1117SI]2%%%% !1110
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MH^#M//\ $9YYC_Z#&:_*\VSCD;IT)\U1_%+HO*/ZL^MPF$NDYQM%;+]7_D>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M':N&KXRK4E4FYSW9^MX*5"6'A+#.\&M HHHK([0HHHH **** "BBB@ HHHH
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M-XK8G5Y]P(#5[;I/QR\ ?$/P'H'ASXJZ/?2WGAY##8:QI;-YDD& %A=1C(
M )-?G6-DUB74WU9]%12]FH^AO^(E?3?^"?OA[[2P5M0\4+/:QL?F:-4E5F ]
M-W>OF!K@<X->E_'KXWP_%2\T+3=&TS^P?!_AZ#[+IFF*Y;"E@SNYQRS-D\],
MUS7Q2\6>%O%5UHDGA7PZWAR*UTY+>\C:<R^?<!B3+D@8R"./:N*G-Q6JW;?H
M;R2/8OV0](M_#:^+?BSJB8LO"-H38^8,++?.#Y 4GKAD_6O"[KQ5J.H>*I_$
M33O'J<UVU]YH/*NSE_ZUW7B3XVVUW\!_#GPST336TZUM;N2^U.[:0EKR5BI7
M(QP%(./K7E\;CK3I7<G.77\A2V21]A^#?%G@+]J[XDZ2OB7P'J;^+[D;]4U#
M2[R.&UF2-<O-(I4G[JGJ><8KSW]KCXK:;\1OB0FE>&HEMO!OAF(:7I4*="J#
M:9!_O  USGPY^-T'PS^&'B;1='TS9XHUW$#ZYO(:"W!!*(,<$_,"<]#7F"R"
MM*5%*?-T6Q,I.UNY[S\.?BEXQT'P3IVF:=XDU"RTZ'?Y5K#( B98DX&/6MV7
MXJ>+YO\ 7>)-0D_WI?\ ZU><>%YA;^';4-\IPW7ZT^\U8\A#QZU^E4(T*5"$
MG%7LNB['S,_:2J-)O<Z[4/B1K.T^=K%W(?>4UQ6N?$+5K@,HU"Y_[^&LJXDE
MNGVKEB:CU-M,\(V)O]9G56QF.WS\[GT KDKUY5(NUHQ6[V2-Z=.,6KZM]".&
MWN]0C>]U34)K>RC^9GDE(&/SKS7Q]\5'U*-]+T.66#3,;6EW,'E_7I6)XX^(
MU_XPF,>/LFGJ?DM8VX_'UKD:_-<RSI23H8+2+WEUE_DCZ3#8-W52MOT71?\
M!%\QO[Q_.DW'UHHKX\]<**** "BBB@!8_OK]:_4_]EN^M#X'TBU9PDH@7Y37
MYO\ PH\!W?Q"\::?ID$$DL!D#7#J,B.,'DFOOGP?;-X<^(%OIUJ-EK%;*1M]
M<D8K\XXTI/$8:%+7J[]-.A[65K]Z?5>K7BZ;I!8LI&W(.:_&SX^^(G\5?%WQ
M)J,GWI+DIUS]T!?Z5^J/B_6)(?!VISLV3%;LRY/<"OQ[UZ9KG7-1E8Y9[B1C
M^+&OF_#S!JE4Q%9[Z+[]?T/0SN/LU"/<HT445^UGRH4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 +'(T;JZ,5
M93D,.H-?>6CH?$GPXTV28[Y3;(&)[X45\;?#?P9)XW\2P60!\@'=*1_=]/QK
M[JTW3XM \-Q0K\D4$8 !] *Z:-3D;7<_..+JD9.C"/QQ=RK\,_AQHWCG0[N+
M4DDTG5;5O+M=5A."1G[KCJR]:C\5?#77O )$]T8KNR)Q%J%N?E?ZKG*_C7CS
M?M6IX=\3W%A_9V+".7:;F&3)QZ[<<U]'>!/C)H'Q*\.2VBW4=W:RIM=21NC)
M'!9?X37MX+-I8)Q4=8]?^!YGGY?D>8UJ]6>)?+3DKQ3UL]-NJ6]T<'8Z\67R
MY3S6I;ZM]G8;</&1AE/<'@BN>\0:,^BZE+;$[@IS&Z]&7M4^E_O5&3GUK];P
MN,=:,7%W3V9X&+P:HMJ2LUNCYL_:&^&J>$M?75]-B;^R-2+/\HR(I,_,I]!D
M\5Y#7WCJFCV7B*PNM&U*,2V5TI4Y&=A[,/<5\A?%/X8ZC\,?$#6=RIELI?GM
M;H#Y95^OJ*_,^(,H>%J/%45^[D]?[K_R?3[C]$R#-EB::PE9_O(K3^\O\UU^
M\XNBBBOC#[(**** "BBB@ HHHH **** "BBB@ K[O_X(W_\ )SGB?_L3[K_T
MMLJ^$*^[_P#@C?\ \G.>)_\ L3[K_P!+;*DQK<_:/0O^6_\ P'^M:U9.A?\
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M%% !1110!\J_\%1_^3$_B;_W#/\ TZ6E?@#7[_?\%1_^3$_B;_W#/_3I:5^
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M_P"#N%%%%>&>X%%%% !1110 4444 %%%% !7W?\ \$;_ /DYSQ/_ -B?=?\
MI;95\(5]W_\ !&__ ).<\3_]B?=?^EME28UN?M'H7_+?_@/]:UJR="_Y;_\
M ?ZUK4('N%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %9^M?\>J_P"^/Y&M"L_6O^/5?]\?R-)C
M6Y_-M^U-_P G.?%[_L<-8_\ 2V:O,*]/_:F_Y.<^+W_8X:Q_Z6S5YA3$%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5^G__  2#^&%_;Z+XL\>W
M=Q*NFSR+IME:LQV,Z_-)+CIGE5S]:_, 9/ Y-?OM^RGX#7X7_LV^ ]"\I8;A
M=-CNKC9WEE'F,3ZGYOTKCQ37)9H]+ 0<JMUT.J^)%X8[1R#7BENWVO4&+'C-
M>K?$JY_XE+YQ^->-:?>".;=G^+/%?/U7J?HN"A^ZL>&>+OVS/AY\+I[ZS22Z
MU[6+:5XVM+:,JBN"00SM[^F?PKYC^+'[?/Q'^(<,]AI-Q'X3TB0%?*T__7,O
MH93R/PQ]:XK]KOP]'X;_ &A_&%O"JK!/<+=QA01Q(BOW]R:\=K3+N'LOP5JD
M(<TN[U/D<US['8VI*G4ERI:66A)<7$MY/)//*\TTC%GDD8LS$]22>IJ.BBOJ
M#Y8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC_\ )]GQ-_[AG_IKM*^5: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHMV,O;O\C]F4\J?R(KGJ_#ZE.5*;IS5FM&?N=.I&M!5(.Z>J"BBBLS0****
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M** "BBB@ HHHH NZ';K=:WI\#C*27$:,/8L :_HMA86NFVD**(HH[:-50=%
M4<5_.CHMT;'6+&Y7K#/'(/P8'^E?T,-J'VSPKI%ZK_-=64,N<\'=&IKSL9LC
MWLI2<Y+T.-^)-T)M)8(V>>U>-27 MY1'G#8S@FO2O&&I0.AA Y)^;=VKQ?5-
M3"ZG,IZHY4>E>%4U/T3"1:C8^.?^"A&CQV_Q'\.:NBX;4=+VN<<%HY"O7/H1
MQ_C7RM7W;^W9X8>^^&_AOQ/$ID&GW1LKE<<;) 67/_ E.#VS[U\.2VHDC::V
MRT0^\I^\G/'U^M?1X67-1B?F>;4W3QM1=W?[RK11176>2%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_517\J]?U44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_ ,%1_P#D
M^SXF_P#<,_\ 37:5\JU]5?\ !4?_ )/L^)O_ '#/_37:5\JT %%%% !1110
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M=2/48/6O9P$OB@_4^(XBHKGA7771_H>=LVYBV ,G/%)117K'QH4444 %%%%
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MO_<,_P#37:5\JU]5?\%1_P#D^SXF_P#<,_\ 37:5\JT %%%% !1110 4444
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M!TKX]JHOF5T#T"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH *_I(_8_\
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M7[-<@[F"@_P,"=H[;&%?,%??PFJD5)=3^7,9A:F!Q$\/5WB[!1115G&%%%%
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M5'_Y/L^)O_<,_P#37:5\JT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?"_]K3QK9VL8BLM3F75X448 \\;G_P#(F^OFRMT[JY(4444Q!1110 5](_L
M?%3_ (5C^T5HAFG:"RU0_8Y&!P V<H?S&/\ @5?-U6=-U"?2=1M;ZUD,5S;2
MK-$XZJRD$'\Q2WT _27_ (+,?"6./7O _P 5=.BW6^K6YTF^E4<&1!YD+'W*
M&0?\ %?FC7[<:7I]I^W=^P3J.BK(DNMM8K=V1/6&^B^91[ LK(?9S7XEW%O+
M:7$L$\;131,4>-QAE8'!!'8@UG3VY>Q4NY'1116I(4=.:** /TB_9A\?"^\.
MZ+>&7+3P*'_WU^5A^8-?1OQ1T<?%#X/^(_#QP[7UC+"@/]XJ=I_ XK\[OV3O
M%K?V/?Z67_>V$XN8AG^!^H_ C_QZOO?X;^)?MUNB-G#KC!-*<;JXTS\;KJVE
ML[F6WF0QS1.8W1A@JP."#^-1UZ]^UGX13P7\?_%MG#$(;:XN!>PJ.F)5#G'_
M  (M7D-"$%%%%,#>D\>^(I=&&DOK5X=.">7]G\T[=O\ =]Q[=*P:** "BBB@
M HHHH *]%^&O@]IF&IW,9'_/%6'_ (]_A57P+\/Y=4E2]OXBELIRD3#!?W/M
M_.O8+>%+>-408 X %?J_"?#,ZLXX_&*T5\*?7S_R^\^YR/)I3DL5B%9=%^O^
M1]R?\$Z?A1#=+J7BB>'YHI!;0L1V #,1^) _X#7Z*0^5]E_>*-N,$,*^4_\
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M:_=\+O)_NW$7_P 55G:>'T5[/)^QO\8U^[X(O)/]V:$_^SU7F_9%^,%O_K/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD^*UGI=C\0]=CT:_74M.-T[QW"#@[CD@?0DB@#DZ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M[WX$R-'\5O#Q49/VE1^HK@J]*_9UMQ=?%S0E;H)-WY$4 ?KGX79I-+Y/\%?/
MOQD\,Q7XUF,(/WRR!OEZG:<5]#>'XQ'I8 _N9KR;QM!Y\FH;AG]X<_I7W/"<
M%4Q56#ZP?YH_/.-:LJ.#HU(])K\F?E#JEDVFZE=6C?>AE:,_@<55KL_C%I)T
M?XBZS%MVB29IE'LQ)KC*^-KT_8U94WT;1]WAZJKT855]I)_>%%%%8'0%%%%
M!1110 5]W_\ !&__ ).<\3_]B?=?^EME7PA7W?\ \$;_ /DYSQ/_ -B?=?\
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MSM7T5&7-3B_(_*L7#V>(J1[-_F%%%%;'(%%%% !1110 4444 %%%% !1110
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MG:OC8)T\0EV?ZGW]64*F'YG]J/Z'X%T445]D?GX4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5_517\J]?U44 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?@#_ ,%1_P#D^SXF_P#<,_\ 37:5\JU]
M5?\ !4?_ )/L^)O_ '#/_37:5\JT %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+2/_ $AAH&>P4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5O^"_A_P"(_B+K$>E^&=%O=;OWZ0V<)D(]SCH/<U]'_LI?L"^*?CU)
M!KWB#SO"W@A6#&]GB(EO!W6%21D=MW0>]?IGX5\-^!/V=_"XT;P=IEKI<2J
M\B@&:9@/O2/U8_6O.Q&-A1?+'5GKX/+:N+=]D?G=\/\ _@E;\5?%%HEUK]]I
M'A*)EW"*[E::;Z%4! _/_"OH;X<_\$O_ (:^"]EYXR\077BNYCPS6\0^SV^?
MH"6(^I_*O6[WXQ7MS]J43.Q;[N#QBO/O&'QNT_PYIKRZWK5OI]OGK-. Q/H!
MG)KS'B,56T3MZ'U,,EPN'7-5>W<]KM]8\)?##13I?A+2;'2+5!M$=E$$)QZD
M<D^YKYS^.G[4>@^#[-O[6O\ S;T LFG0,#+(>V?0?6OESXS?MH7.J>?I?@L2
MV\.2KZK,!O?_ '%[#W/-?+>H:E=:M>2W=[<27=U*=SS3,69C[DUUT,#]JIN<
M.*SBG17LL&OGT^1V/Q<^+FL?%SQ&VHZ@?(M(_EM;%6!2!/3.!N/J3S7#445[
M"22LCY"<Y5).4G=L****9 5[M^QO^T!:_L]_%M-7U6.27P_J%NUAJ(A7<ZQ,
M00X'<J0#BO":*F45).+-*<Y4Y*<=T?4/[:W[17A?XS7FE:;X5A:YL=/E><ZC
M-$8V<N -B@\@<9/O7R]112A!4XJ,=BZ]:>(J.K4W844459@%%%% !1110 44
M44 %%%% !1110!+]H;[-Y&%V;M^<<YQZU%110 4^&%KB:.)?O.P4?4G%,J6U
M81W4+'HK@G\Z!K<_6+P7X?C\+^$] T>';Y=C8PP@IT)"#)_/-=UIZX4?2N6T
M>5;BQT^5>4DMHF'T* UUMC]P5^=XIMR=S^O&HPPU.$-DE^15UB3;"WTKTCX+
MV!TOP'?:DZX:\G9@Q[JHVC^M>7:^^V%OI7M>B6ZV/PGT94X5K8.Q]R22:XL!
M'FQ$I/HCY7B"IRX.%-?:E^2/)/%6J/<:U)Y.0%R*S/#(&<]>:MZC*6U24H.-
MK<U4\-\**69ZU::]?T'DONX>K\OU.M9_W=8VH2<&M"63Y*P]1FZ\U,(Z'HX:
M3]H8.NWHTWPQXDO&<1K!IETY8]L1-S7Y#LVYB?4YK]/?VC_%L'@OX#^+KJ5@
M)K^W_LVW7NSRG!_)=Q_"OS!K[K*HM46^Y^5^(%:,\?3I+[,?S84445[1^7!1
M110 4444 %%%% !1110 4444 %%%% '["_\ !+V^N=4_9AM[=PTHM-6NH8O9
M25;&?8L?Y>E?4_CS6HM%T62SO'017$11T!^;!&#_ #K\]/\ @DW\=9;&37_A
MU?()+>-&U.P(X;)($B?R/XGTKZ@^,&L:AK'B2*ZFD\JSC;'V=?3W-?,XNBU6
M<NY]WE=L13A%[)'XQ?$GPVW@_P"('B+12 !8W\T*X&/E#G;QVXQQ7-U[5^V-
MHBZ/^T%XE>(L;>^,5Y$6[J\:_P!0?Y=J\5KZ.$N:*EW/BJT/9U90[-A1115F
M(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7]5%?RKU_510 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^ /_!4?_D^SXF_]
MPS_TUVE?*M?57_!4?_D^SXF_]PS_ --=I7RK0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 6--T^?5M0
MM;&UC::ZN95ABC4<L[$!0/J2*_I2_9W\ K\+?@SX7\/MS+8:=##*?5E0!OUS
M7XC?\$X_@Z?BY^TWH+SP&;3/#_\ Q-KG*Y7<A B!_P"!D'_@)K]U_&7B"+PE
MX7EGD94$<18LQP  .M<M67O)(TBM#\>_^"OWBJ/7OCEH%DCY:SL)&91_"'<
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M_D>%>*M%ET76KF)HV2)G+Q-C@J>1BL>OJ)M)M-2LV@NH$GB88*R#(KQ?Q_\
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MPS_TZ6E?@#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!T'A/Q]KO@F\6YTC4);9E_P"6>=R'_@)XKWKP?^UW'&D2
M:]IL@G'!N+/'/N02*^9:*RG2A/='GXC 8?%?Q8Z]^I]_Z'^U7X<NH5$>OPVQ
MQPER2&_05W'A_P"+C:U&+JTNH;VW)P&A?/Z5^9%:&B^(M2\.WBW6FWLUG<+T
MDB;!KDE@X]&?.UN&L/)-TW9^9^M/A_XE1N525BC^C5WMCXRBN%4"0?G7Y?>$
M/VK]>TE8X=;M8]5@48,J_+,?J<X_2O9/"_[6/A>Z53->SZ2__/.=2X_-17GU
M,'-=#Y#%\-XBF[J%_37_ ()]\V.N;V!1R#[&KFK^']%\;6?V?Q!H]GK$."!]
MIB5F /7#$9'X5\P^"_CMINKQK)::G;7:9QQ*%;_ODG->Q:!\5K,HGF2;3CO7
MF2ISINZ/F:V!KX:5TFFODSB?&W_!//X1^+_-ETZSN_#4\@.6LY&D 8]\.V*^
M:/B7_P $Q?&&@02W?A+5K7Q# F2+5R5N#Z8 &/UK] =-^(VGW2@>?&?;-;4/
MB"WNL&*0<^]:0QV(I];^IZ&&S[-,&[.;DNTM?QW/P]\:?"/QE\.KA8?$GAO4
M-(D;@"XBZ_B,UR3(T;892I]",5^_K-!J,)AN8H;F-Q@I*@8$?E7D?Q&_9/\
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M#X JN6'JTWY/\RC1117YX?K 4444 %%%% !7W?\ \$;_ /DYSQ/_ -B?=?\
MI;95\(5]W_\ !&__ ).<\3_]B?=?^EME28UN?M'H7_+?_@/]:UJR="_Y;_\
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M.X7^\WL*_0;X9_L._!7X,K;WVL+-XUUZWP_F7QVVX<?W8QVSZYKUWQ)XEL/
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M=C(S%4NP5068G  ')K[8_93_ ."7WCOXY&TUSQB9? WA%]LBFXC_ --NT/\
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MS>OIFWO RX/(]Z\G^*7@V/2[@:I8Q;+68XEC7HCGO]#_ #K\NXKX9ITH2S+
M*T=Y1[>:\NZZ>A\=GF3PA%XS"[=5V\UY=SSZBBBOR0^%"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OZ2/V/_ /DU
MGX2?]BEI'_I##7\V]?TD?L?_ /)K/PD_[%+2/_2&&@9[!1110(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#Y5_X*C_ /)B?Q-_[AG_ *=+2OP!
MK]_O^"H__)B?Q-_[AG_ITM*_ &@ HHHH **** "BBB@ HHHH **** "BBB@
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MA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5Y4KN]DK)>22/S2K4]K.4VK7[:(****P,@HHHH **** "BBB@ HHHH ****
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MU\"Z;TE>Z?\ 70Y+P_J$MCJ%NYW1R1N.]>P:E:M9PPZY;G-I/_K]O2)L=3Z
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M=S75U,]Q<3,7DED8LS$]R:AKW:.'A15EN?-8[,:V.E[VD>B"BBBND\H****
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MXJA<707OS7ZS@\'ALHHJAAE:*_'S9]Q0HT<!35*BK)&E-<C;DG K#U+6! "
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M%"_$C10.OV23_P!#H ^6**** "BBB@ HHHH *^[_ /@C?_R<YXG_ .Q/NO\
MTMLJ^$*^[_\ @C?_ ,G.>)_^Q/NO_2VRI,:W/VCT+_EO_P !_K6M63H7_+?_
M (#_ %K6H0/<****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG\3?^X9_Z=+2OP!K]_O^"H__ "8G\3?^X9_Z=+2OP!H **** "BBB@ HHHH
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M@> ;BXFTV F1I&9;BXY=$SP/;B@#Y_\ "W@GQ'X'U<6,VH2VCS1[KBT@D.T
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M#_6M:LG0O^6__ ?ZUK4('N%%%%,04444 %%%% !1110 4444 %%%% !1110
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M^@-7;?\ X)7?&B1D\UO#\"MU)U DC\ O/^>W-8?6J'\Z^\Z/JM=_8?W'QW0
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M110 4444 %%%% !1110 5^K7_!*S15TO]GSQ/J^T"6_UEDW8Y*QQJ!S]6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK\7+_P",WC^]URZ=A:@F.TA)XCC!_F>I_P#K4J<;OF&]%8\]HHHKH,PHHHH
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MG\3?^X9_Z=+2OP!K]_O^"H__ "8G\3?^X9_Z=+2OP!H **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^[_ /@C?_R<YXG_ .Q/NO\ TMLJ
M^$*^[_\ @C?_ ,G.>)_^Q/NO_2VRI,:W/VCT+_EO_P !_K6M63H7_+?_ (#_
M %K6H0/<****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *S]:_X]5_WQ_(UH5GZU_QZK_OC^1I,:W/
MYMOVIO\ DYSXO?\ 8X:Q_P"ELU>85Z?^U-_R<Y\7O^QPUC_TMFKS"F(****
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M5'_Y/L^)O_<,_P#37:5\JT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:5^ - !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHH **** "BBB@ K0\/\ A_4O%6L6FDZ193:AJ-W((H;:W0L[L>P K/K]+_\
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M%%% !1110!^DO_!)+5)IM!^(FF,28(YK:X5<\;F#+_[+7U9\2OE9_05\@_\
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M%%% !1110 4444 %%%% !1110 4444 %%%% 'RK_ ,%1_P#DQ/XF_P#<,_\
M3I:5^ -?O]_P5'_Y,3^)O_<,_P#3I:5^ - !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7LGPG\'?9+8:E<)^^E'R9[+_ /7K@OA_X:/B'6H_,5C;1'<Y'Z"OHBSA2UMU
M50%51@"O.Q56RY$?H_">4JM4^NUEHMO7N>E?"'P;I?BJQ\:RZFC-_9.AR7]O
MM8C$JNB@GUX8U\\_$/QS'I<30QGS)6R H->]?#/Q(NC^"?B]<@_-%X4F./\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7W?\
M\$;_ /DYSQ/_ -B?=?\ I;95\(5]W_\ !&__ ).<\3_]B?=?^EME28UN?M'H
M7_+?_@/]:UJR="_Y;_\  ?ZUK4('N%%%%,04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU'T;->;EU6TY47ZGM9]1=2,,3%:;'SK1117O'QH4444 %%%% !1110 4444
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MC1C1C9'Q6.QT\;4YI:);(****W/-"BBB@ HHHH **** "BBB@ HHHH ****
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MU?\ 1';A);IE89SZ(OS'W9:^7_VGOC-/\9/B5=W<<K-I%DS6]FN>& /S2?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K[O\ ^"-__)SGB?\
M[$^Z_P#2VRKX0K[O_P""-_\ R<YXG_[$^Z_]+;*DQK<_:/0O^6__  '^M:U9
M.A?\M_\ @/\ 6M:A ]PHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/UK_CU7_?'\C6A6?K7_'J
MO^^/Y&DQK<_FV_:F_P"3G/B]_P!CAK'_ *6S5YA7I_[4W_)SGQ>_['#6/_2V
M:O,*8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *[_X ^.9?AO\ &;P?XABD\L6>HPF0YQF,L%8?D37
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MC_\ )]GQ-_[AG_IKM*^5: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!GL%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E7_@J/\
M\F)_$W_N&?\ ITM*_ &OW^_X*C_\F)_$W_N&?^G2TK\ : "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ?"[QQJWAK5X'@N[&=HQO7&],_*X]B,'\:Y>OL$TU='Y(TXNS"BBBF(****
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M --=I7RK7U5_P5'_ .3[/B;_ -PS_P!-=I7RK0 4444 %%%% !1110 4444
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M%F=CDL3U)/K3***T)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JSIFJ7FBZA;WVGW4UE>V[B2&XMW*21L.C*PY!JM10!ZY\1?VJ
M?B+\5_!%KX7\4:R-4M(&5C=/&!<3!?NK(XX8#@YQDX&2:\CHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"OZ2/V/_ /DUGX2?]BEI'_I##7\V]?TD?L?_ /)K/PD_[%+2/_2&&@9[!111
M0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y5_X*C_ /)B?Q-_
M[AG_ *=+2OP!K]_O^"H__)B?Q-_[AG_ITM*_ &@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *[[X1:
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M\>J_[X_D:T*S]:_X]5_WQ_(TF-;G\VW[4W_)SGQ>_P"QPUC_ -+9J\PKT_\
M:F_Y.<^+W_8X:Q_Z6S5YA3$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 Z.1HI%=#M=2&!]"*_:
M3X!_%J+XS?LW^&_$!</J=O"+"_7.2)HQMR?J #[\U^+-?<7_  2]^*2Z7XZU
M[P!?ONL]8@^W6*L?E6YB^\O_  *//XH!WKCQ5/VE/T/7RO$>PQ"[/0^BOC]X
M3'CKX-^,=#,$DUQ]C>ZMUC&3YL?SKCWXZ=Z_).OWRU[3+2QNS')"&MIUVR>I
M!&,?K7XO?M+?"BZ^#GQB\0:#-$RV9G:YLI67 D@<[D(_ X/H0:X<OGRN5)^I
MZ^?4^?V>)BMU9GEU%%%>T?(A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7ZI?\$IYHD^!OBLH?WZ:NQ?Z>4N/Y5^5
MM?J'_P $HX-WP7\>LJX=]7C4L1P0(1Q^I_SFN3%?PF>IEO\ O,?F?9SZ>NJZ
M1)=[?G.<$\UP[6)MKC..AKI+7Q5::3ILT4DJQA)"A5C56UOK#7[PI:RI(S#)
MVG.*^>J4U,_0*,Y4[WV/F3]N3]F4?&SP&/%OAZVW^+M!A/F1(!NO+8<E?=EY
M(]ABORH=&C=D=2K*<%6&"#Z5^].HS2^'Y Q;"DX^HK\W_P!O[]F^#P=JL'Q'
M\,V31:%K,[KJ,$:_):W1.[< .BODX'8J?6N_ 5W']Q4^7^1\SG&!7^]TMGO_
M )GQK1117NGR(4444 %%%% !1110 5ZE^RUHJ^(OVBOAW8/&LJ2:U;LR-T(5
MPQS_ -\__KKRVOI#_@GKX>7Q!^U-X89P2MA%<7OXK$P'ZM45':#9M1CS58Q[
MM'Z(?M47[6O@/QC>>84*:9=%6![^61C]:_%^OUM_;D\1+HOP;\6DMM,EN+5<
M]2TC!<?EFOR2KAP2]QOS/=SN5ZM./:/ZA1117HGS@4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_517\J]?U44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?@#_P5'_Y/L^)O
M_<,_]-=I7RK7U5_P5'_Y/L^)O_<,_P#37:5\JT %%%% !1110 4444 %%%%
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MJ-)EHXB47.-S'A1^)Q7-3CJ:29^=/[87Q$D\=?%V]@67S+72Q]G3GC>>7/\
M(?A7AM3WU[-J5]<7=PYDGGD:61CW8G)/YFH*ZS(**** "BBB@ HHHH ****
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MU'_D>>O"UY8?6O>OVKD\FS^$<79/!EJ/_(TU '@E%%% !1110 4444 %%%%
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZD_\$KY)%^
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MBB@ HHHH **** "BBB@ HHHH **** "OZJ*_E7K^JB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#\ ?^"H__ "?9\3?^X9_Z:[2OE6OJ
MK_@J/_R?9\3?^X9_Z:[2OE6@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK?\!^ ]<^)GBS
M3_#?AVQ?4-6OI/+BA3H/5F/\*@<DGH!0!)\/?A[K_P 5/%VG^&?#.G2:GJ]\
M^R.&,<*.[L>BJ!R6/ K]G_V/OV)/"?[,.CIK%\8_$'C>YC7[1J4L8VV_',<
M/*KGJW5N_'%3_LD_LK^'/V9/"""*&&^\5WD"C4]7(RTC=2B9^[&#T ZXR>:]
M1\8>.+;1;60R2[#CKFN.<G4?+'8V24=6=!XH^(2Z7&VZ0(@'0'%>'>-OC]:V
MF]1<*6] :\0^-7QT@A^TR?;EAM8@?-GD?:B>V>Y]J^)_'G[4EU=7<L6@6ZN@
M./MEV"2WNJ=A]?RK>-&,=69N3>Q]D>+/C9?ZE)(T4GDQ\Y9CQCUKP3X@?M%:
M1HJRK/JCZI><_P"C6CAN?0D<+7R?XA\?>(/%+'^TM5N+A#_RR#;8_P#OD8%8
M%;W2V(WW.P^('Q1UCX@W/^ER?9[!&S%90GY%]S_>/N?PQ7'T45(PHHHH *_9
M?_@G+\0%\<?!W1K>60RSVZ-9S+G)!CXY'N,'\:_&BON'_@EU\2I/#OQ#U706
MGV).J7<2L>"00KC\BOY5$E>+&MS@O^"CWPD;X6_M):K/%$8]/U^)=1@/;<?E
MD _X$,_\"KY;K]8_^"OOP[&N?#+PQXTAC!FTF\^SRLH_Y93#&?\ OI4_.OR<
MI4W>*')684445H2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7Z#?\$VH?)\*ZQ/MQNO#SZX5:_/FOTM_8#\/RZ?\)+2Y==IN;B2
M8<=5+$ _I4RV&C[-U+5&@T8#.,KS7YB_\% _B<=6\2V'A6UF)BA7[5= 'J3D
M(I_4_E7Z,>++IK?3&). D9-?BS\9/$DGBSXH^)M3<DB2^D5,G.%4[5_0"I@A
MLXVBBBM"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "OZ2/V/\ _DUGX2?]BEI'_I##7\V]?TD?
ML?\ _)K/PD_[%+2/_2&&@9[!1110(**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#Y5_X*C_\F)_$W_N&?^G2TK\ :_?[_@J/_P F)_$W_N&?^G2T
MK\ : "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#;\&6;WGB"UV#(C;>WTKZ#TY?+MQVXKS3X5:"T=O)=
MRQX9S\N1SBO3KB9+2S9B<8&:\C$RYIV70_7N&<*\-A/;3TYM3QGXL7GF:YY0
M.?E!->__ +6FAW/Q/^$OPA^)>@6DVH65QI;:7J1@'F&VN8G*(C!>1N5">:^7
M/%FI?VIKUS,/N[MH_"NO^%/[0GCOX+PWMMX5UN6QLKQ@]Q9MEH9& P&*YZ@=
MZ]*G'E@D?F>95OK&+J5%LVSW/Q%!/\'/V"+#0=9B,&N>-]=;4(;-N)(K-$CV
M2,IY&6C85\WIX-U'PS)X<U7Q%I=Q9Z%J<@DAGE7"SQ*5WE?7@C\Z/B/\3_$_
MQ:\1/KGBO5KC5]19=@DG8G8HZ*H[#VIOBCXF>)_&?A_0M$UK6;K4=+T.-HM.
MM9GRELC8R$'8':OY5J>:?2O[>G_";7GQ8TJZT]M1G\'RZ/9?V$^GEF@\L01A
MPNSH=^<YYS4O[47VJW_9,^"]MXP93X_$DKQK/S=KI90^4)<\_P"LW]>:\;^'
M_P"U=\3OAKX?CT/1O$UPNDQ'=!:3DR)"?5!G@\UP?CKX@>(OB9XAFUSQ/JUS
MK.J3<-<73EFQV ]!0!](_LNZ6/@W\%/'WQMU*+R;CR&T+PY(W62YE#+(Z>\9
MV'/O7RG>7DVH7D]U<.99YY&ED=NK,QR3^9K<OOB%XBU+P7IWA*XU6XD\.:?-
M)<6VG%CY4<CD%V ]3@5SM !1110 4444 %%%% !1110 4444 %%%.CC:6144
M99B !ZDT -HKZVU3P1\)?V9?#?A>Q^(?AJ_\<>,M>LDU*\@M+U;:/3(7) BP
M4;,GRDYXZBO-_P!ISX*Z1\,]0\.^(/"=S+=^"O%5DNH::T_,D!(!D@8_Q,FY
M03CF@#Q%3M8'TKLOB1\4-0^)A\/G4+>&W_L73(]+@\G/S1HS,"<]\N:XVOH#
MX%? _0-0^&/B[XH?$)YK7PCI,9M=.@AD$<NI7S8 C3/9-RL>.@- 'S_171^
M?!=Y\2O'NB^&=+58[O5[V.T@W<A"[ #/TS7TAXONOV=_@]XHN/ USX.UKQG-
M8,MMJ'B&/4EM]\V!YGEQF,E0C9'7G;0!\F45[%^T]\$;+X+^,M-_L+4#JWA+
MQ!I\>KZ+>L/F>V=F4!O]H%6%>.T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5]W_\$;_^3G/$_P#V)]U_Z6V5?"%?
M=_\ P1O_ .3G/$__ &)]U_Z6V5)C6Y^T>A?\M_\ @/\ 6M:LG0O^6_\ P'^M
M:U"![A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !6?K7_'JO^^/Y&M"L_6O^/5?]\?R-)C6Y_-M
M^U-_R<Y\7O\ L<-8_P#2V:O,*]/_ &IO^3G/B]_V.&L?^ELU>84Q!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK1116AF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^S+XT_X0/XW>%]29]D#W(MIO]R3Y?YD'\*\NI]O.]K/'-$Q22-@ZL.H(.0:
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M2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5_21^Q__ ,FL_"3_ +%+2/\ TAAK^;>OZ2/V/_\
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M*_E7K^JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\
M?^"H_P#R?9\3?^X9_P"FNTKY5KZJ_P""H_\ R?9\3?\ N&?^FNTKY5H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/[GT7^?TKPZE9BS%F)))R2>])6@@HHHI %%%% !1110 4444 %%%% 'Z9_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_21^Q__ ,FL
M_"3_ +%+2/\ TAAK^;>OZ2/V/_\ DUGX2?\ 8I:1_P"D,- SV"BBB@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'RK_P %1_\ DQ/XF_\ <,_]
M.EI7X U^_P!_P5'_ .3$_B;_ -PS_P!.EI7X T %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-_AJ?BA^T#X9T]X?-LK.7[?<\9&R/D _5MHKQ, L0 ,FOV$_X)H_LAZI\,/
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M 4444 %%%% !1110 4444 %?TD?L?_\ )K/PD_[%+2/_ $AAK^;>OZ2/V/\
M_DUGX2?]BEI'_I##0,]@HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!\J_\%1_^3$_B;_W#/_3I:5^ -?O]_P %1_\ DQ/XF_\ <,_].EI7
MX T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4Z)=\B*.<G%-J[HL!NM6M8AU9P*3T5RZ<>>:BNI]#>&8H[?28$48"
MH.*X/XL:FT=N(%;;O/.*] TF%H;-1CM7DWQ8D/\ :$"_4FO(H+FJGZ_G=1T<
MJY5IHD<#1117L'XZ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7W?_P1O_Y.<\3_ /8GW7_I;95\
M(5]W_P#!&_\ Y.<\3_\ 8GW7_I;94F-;G[1Z%_RW_P" _P!:UJR="_Y;_P#
M?ZUK4('N%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %9^M?\>J_[X_D:T*S]:_X]5_WQ_(TF-;G
M\VW[4W_)SGQ>_P"QPUC_ -+9J\PKT_\ :F_Y.<^+W_8X:Q_Z6S5YA3$%%%%
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MTKY5KZJ_X*C_ /)]GQ-_[AG_ *:[2OE6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ZWX2^$7\>?$GP[H2)
MO6[O(UD&,_NP=S_^.@U^QT-Y_8^EQ0PC9&L8&SH.!7Q#_P $Y_@D^L:GJ/CV
M_A(@@!M-/+?Q-_RT<?HO_?5?</B>W%G9R,WRCUK.]W8KH?/_ ,8O&GEQW,D\
MHAM8D,DO/\(&3_*OS@\=>,+SQQXCNM3NW)5V*PQY^6*,'Y5 _P \U]8_M@>,
MXM+\/2:=;M_I%\_DY[[>K'\N/QKXOK7R)"BBBD 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *_I(_8_\ ^36?A)_V*6D?^D,-?S;U_21^Q_\ \FL_"3_L
M4M(_](8:!GL%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
ME7_@J/\ \F)_$W_N&?\ ITM*_ &OW^_X*C_\F)_$W_N&?^G2TK\ : "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *W_
M  +$)?$5L3_"=U8%='X!_P"1@B^G]:SJ? SNP.N*IW[H^@K0 6H^E>)?%=PV
MMHHSD U[3;96T'TKP_XH-N\0?\!KS,+_ !#]1XHE_P )\5YHXZBBBO7/R **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "ON__ ((W_P#)SGB?_L3[K_TMLJ^$*^[_ /@C?_R<YXG_
M .Q/NO\ TMLJ3&MS]H]"_P"6_P#P'^M:U9.A?\M_^ _UK6H0/<****8@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *S]:_X]5_WQ_(UH5GZU_P >J_[X_D:3&MS^;;]J;_DYSXO?]CAK
M'_I;-7F%>G_M3?\ )SGQ>_['#6/_ $MFKS"F(**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGBO8[6ZQ9X/7%>)?$B0R>(&/^S7FX5>^?I?%%2,L!%+NCE****]8_)0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *^[_ /@C?_R<YXG_ .Q/NO\ TMLJ^$*^[_\ @C?_ ,G.>)_^
MQ/NO_2VRI,:W/VCT+_EO_P !_K6M63H7_+?_ (#_ %K6H0/<****8@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *S]:_X]5_WQ_(UH5GZU_QZK_OC^1I,:W/YMOVIO\ DYSXO?\ 8X:Q
M_P"ELU>85Z?^U-_R<Y\7O^QPUC_TMFKS"F(**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *^U/^"4VF7-U\>M<O8RPM;/0YC-CH2SJ%'YY_*OBN
MOU=_X)=_".3PC\%=9\9WL8BNO$UR%MV9<,+6'(!SZ,Y;\A7/B)<M-G?@8.>(
MCY:GN?C*'R_M=ZW,H.T>PKQ>ZO)FOC*C;>:]5^(FM)-=/;6QX9B#SUKRVXM]
MCEFY)/X5\_8_4:.D=3)^+GPRL_V@?AY<:'?0I)K-HC3:9? ?O(I /NGU4XQC
MWK\N?$&@WWA?6KW2M2@:VOK.5H9HG&"K X-?K-HM]-I]TDT)V+GC [5XQ^VS
M^S /''AF3XF>%@)M;L85_MBPC',T(!_?*/[R@ $=\YKJP=?V4O92V>Q\WGF
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M.QR22<DFNBW*K&=[C**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]<_95T
M^74OC9H<,0+'$C$#TVFO(Z_1O_@FM^RSJ$UE/\2-<LGMX[Q##I2S+@O%_%*
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M /Y-9^$G_8I:1_Z0PU_-O7])'['_ /R:S\)/^Q2TC_TAAH&>P4444""BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ^5?^"H__)B?Q-_[AG_ITM*_
M &OW^_X*C_\ )B?Q-_[AG_ITM*_ &@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "M?PBQ7Q)8$?\]*R*Z/P#:?:O$$
M9Q_JQNJ*CM%G;@HN>)II=T>WV<1:US[5XW\2H3'K0..&%>SI)Y-G^%>&>/+S
M[9X@E(^ZHQ7G8:_.?HG$KC'!1CUNCG:***]0_+@HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X _P#!4?\ Y/L^)O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_I(_8_
M_P"36?A)_P!BEI'_ *0PU_-O7])'['__ ":S\)/^Q2TC_P!(8:!GL%%%% @H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E7_@J/_P F)_$W_N&?
M^G2TK\ :_?[_ (*C_P#)B?Q-_P"X9_Z=+2OP!H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KN_A?$/M%Q+CE<"N$K
MT?X66Y^S7+X^\XQ^585W:#/<R6/-C8?,[_5+KR=/<YQA:\"U.8W&H3R'^)S_
M #KVSQ,QCTN;_=/\J\,D;=(S>IS7/A5HV>YQ-5;E3@QM%%%=Y\.%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%%% !1110 4444 %%%% !1110 4444 %?U45_*O7]5% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KU?X5+_Q+23TW5Y17KGPKC/\ 9:D\ L3^M<N)^ ^GX=5\<O0Z
M+Q?&/[)N.WR-_*O :]_\:MLT:?!P=A_E7@%9X7X6>AQ598F"\@HHHKN/B HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M444 %%%% !16_P"'?A_XG\7745MHOA_4]4FD.%6UM'?]0, >YKZ=\ _\$_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M110 4444 %%%% !1110 4444 %?U45_*O7]5% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7])'['_ /R:S\)/^Q2TC_TAAK^;>OZ2/V/_ /DUGX2?]BEI
M'_I##0,]@HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\J_
M\%1_^3$_B;_W#/\ TZ6E?@#7[_?\%1_^3$_B;_W#/_3I:5^ - !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %;/A"\-
MGXALWSA6?:WTK&I]O*89XY%."K U,ES)HVHU'2JQJ+HTSZ9M56:Q'':O O'.
MGG3_ !)=)MVASY@_&O<_"]ZNH:;&Z<JZ@BO-_C#H[17$%\/NG*-_2O+P\N6I
M9GZIQ%1^LY;"O#7EL_D>:T445ZQ^2A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]W_\$;_^3G/$
M_P#V)]U_Z6V5?"%?=_\ P1O_ .3G/$__ &)]U_Z6V5)C6Y^T>A?\M_\ @/\
M6M:LG0O^6_\ P'^M:U"![A1113$%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?K7_'JO^^/Y&M"L_6O
M^/5?]\?R-)C6Y_-M^U-_R<Y\7O\ L<-8_P#2V:O,*]/_ &IO^3G/B]_V.&L?
M^ELU>84Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "OZ2/V/_\ DUGX2?\ 8I:1_P"D,-?S;U_21^Q__P FL_"3
M_L4M(_\ 2&&@9[!1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#Y5_X*C_\ )B?Q-_[AG_ITM*_ &OW^_P""H_\ R8G\3?\ N&?^G2TK\ :
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5]W_ /!&_P#Y.<\3_P#8GW7_ *6V
M5?"%?=__  1O_P"3G/$__8GW7_I;94F-;G[1Z%_RW_X#_6M:LG0O^6__  '^
MM:U"![A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNN_-'_ E!_GFO**M$A1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<Q,0/FJ/K$TGX@5^#]"'+<****9(4444 %%%% !1110 4444 %%%% !1110
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M:[<+&<:=IGS6:O#RQ'-A]GO;:X4445UGC!1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!7\\W_!0SX4/\(?VM_'FGI L&GZI=?VW9!?NF*YS(<?20R+_ ,!H ^<****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %=S\#_A1J?QP^+'A
MKP1I*M]JU>[6%I%!/DQ#+2R'@\*BLWX5PU?K_P#\$J/V6&^'7@:;XH^([ P^
M(O$,1BTV*XC DM;'/WL'E3*0#V^4+ZT#6I]]?##PGIO@/PGIOAS1[=;72M*M
M(;.VA4 ;8T7:.G? Y]ZZ^LG0O^6__ ?ZUK4D#W"BBBF(**** "BBB@ HHHH
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M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKZR_8D_
M8-U[]IW68]=UL3Z'\.K23$]_C;+?,.L-OG_QY^B^YH V_P#@G;^Q5=?M >-(
M/&7BBQ=/AWHTVX^:"!J=RA!$"^J#JY'H%[G'[6PPQVT,<,,:Q11J$2-% 55
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *^Q_^"<O['LW[0'Q#C\6>(;5U\">';B.6
M7?PNH7*D,L ]5& 7]L#O7E_[(W[)OB3]JKX@1Z98K)IWAFS99-7UIDREO'D?
M(F>&E8'A?Q/ K]W_ (9_#7P]\(? ^E>$O"VGIINB:;%Y<,*\DDDEG8_Q.S$L
M3W)-(I(Z956-0JJ%51@*!@ 4M%%26:NA?\M_^ _UK6K)T+_EO_P'^M:U4C-[
MA1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !6?K7_'JO^^/Y&M"L_6O^/5?]\?R-)C6YB4445)H%
M,FACN(7BEC66*12KQN 592,$$'J*?10!^=G[8W_!+33_ !O)>^+OA#';:-KL
MC>;=>'9&\NTN3_$T+=(G/7:?E//*U^6/C3P/K_PZ\176@^)M(N]#UBU.);.]
MB*.O;//4<'D<&OZ8:\Z^,O[/?P_^/VBKIWCCPW:ZRL:LMO=,-ES;;NIBE7#+
MV. <' R#3N2XG\X]%?I!\=/^"/.OZ9<S7_PI\10:U9,2PT?7'$%S&,G"I,!L
M?L/F"?4U\-_$SX#_ !"^#ET8/&?@_5O#_.%GNK9O(?G'RRC*-^#&J)L<'111
M0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBNH
M\!?"WQA\4M373_"/AG5/$=VQP4TZU>4+W^9@,*/<D"@#EZN:/HM_XBU2VTW2
M[*XU'4+EQ'!:VL9DDD8]E4<DU]X?!'_@D-\0/%L]O>_$75K3P5I3*':RM&6[
MOVR,[<#]VG;DLQ']VOT@^ _[)OPR_9RM1_PAWAV*'5&C,<NLWA\Z]E4G)!D/
M0'^ZN!QTI7*Y3X2_9!_X)3WEY<6GBKXT1?9;1&26V\*Q29DE[_Z4P^Z,X^12
M2><D=#^H6C:+8>'=+M=,TNS@T_3[6,106MM&$CC4= JC@"KE%(NU@HHHI :N
MA?\ +?\ X#_6M:LG0O\ EO\ \!_K6M5(S>X4444Q!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 9.N_\L/\ @7]*RJU==_Y8?\"_I654LT6P5G>(
MO#NF>+M#OM&UJP@U/2KZ)H+FSN4#QRH>H(-:-%(9^0O[97_!+_6?AS]O\7_"
MF&Y\0>&%4S7.A@&2\LAGDQ@<S(!S@#<,'J.:_/Z:%[>5XI4:.1&*LCC!4C@@
MCL:_I[KYB_:9_P""?7PS_:/\S4WMF\)^+&.[^V])C4&8XZ3Q?=D'OPW^U57)
M<>Q^#]%?47QZ_P""<WQA^!\D]W%HK>,_#R'C5/#Z-,57CF2 #S$Z]<%>/O5\
MP30R6LSPS1M%+&Q5XW4JRD=00>AID#**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **]%^$O[._Q&^.6I0V?@KPEJ6L
MK(VUKQ82EI%S@EYVPBX]SFOT:_9S_P""1&C>'KBQUOXM:LOB"[C(E/A[369+
M0' .V67AY,'LNT''4B@=CX+_ &:_V1_'W[3_ (B%GX;T]K318B/MFOWD;+:6
MZYP0&_C?K\B\\'H.:_:G]F/]D_P5^RUX5?3?#=N;O5KI5_M#6[I1]HNB.W^R
M@/(0<?6O6/#OAO2O".C6NDZ)IUMI6F6J"."TLXA''&H[!1Q6C4EI6"BBBD,*
MV]$_X]7_ -\_R%8E;>B?\>K_ .^?Y"FA2V-"BBBJ,PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "L_6_P#CU3_?'\C6A6?K?_'JG^^/Y&DQK<Q*
M" P((R***DT/SA_;D_X)EIXRN]1\>?".SAM=8DW7&H>&8\1QW3]6>W[*YYRG
M )Z8)K\J]6TB^T'4[G3M2M)K"_MG,4UM<1E)(V'4,IY!K^G*OGW]IC]B'X<?
MM.V\EUK-C_8_BD($B\1:<@6XXX42#I*H]&Y'8BG<EQ/P$HKZ8_:"_P""?'Q:
M^ ,EU>RZ0WBKPS$S%=:T1&E54S@-+%]^,\C.05'/S'K7S/5$!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#0S^//_!A9?_(E'_#F_P""_P#T,_CS_P &%E_\B5]WT4!9'PA_PYO^"_\
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M_P#T,_CS_P &%E_\B5]WT4!9'PA_PYO^"_\ T,_CS_P867_R)1_PYO\ @O\
M]#/X\_\ !A9?_(E?=]% 61\(?\.;_@O_ -#/X\_\&%E_\B4?\.;_ (+_ /0S
M^//_  867_R)7W?10%D?"'_#F_X+_P#0S^//_!A9?_(E'_#F_P""_P#T,_CS
M_P &%E_\B5]WT4!9'PA_PYO^"_\ T,_CS_P867_R)1_PYO\ @O\ ]#/X\_\
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M_P""_P#T,_CS_P &%E_\B5]WT4!9'PA_PYO^"_\ T,_CS_P867_R)1_PYO\
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MT4!9'PA_PYO^"_\ T,_CS_P867_R)1_PYO\ @O\ ]#/X\_\ !A9?_(E?=]%
M61\(?\.;_@O_ -#/X\_\&%E_\B4?\.;_ (+_ /0S^//_  867_R)7W?10%D?
M"'_#F_X+_P#0S^//_!A9?_(E'_#F_P""_P#T,_CS_P &%E_\B5]WT4!9'PA_
MPYO^"_\ T,_CS_P867_R)1_PYO\ @O\ ]#/X\_\ !A9?_(E?=]% 61\(?\.;
M_@O_ -#/X\_\&%E_\B4?\.;_ (+_ /0S^//_  867_R)7W?10%D?"'_#F_X+
M_P#0S^//_!A9?_(E'_#F_P""_P#T,_CS_P &%E_\B5]WT4!9'PA_PYO^"_\
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M_P"#"]_^1*/^'-_QH_Z&?P'_ .#"]_\ D2OV.HHN'*C\<?\ AS?\:/\ H9_
M?_@PO?\ Y$H_X<W_ !H_Z&?P'_X,+W_Y$K]CJ*+ARH_''_AS?\:/^AG\!_\
M@PO?_D2C_AS?\:/^AG\!_P#@PO?_ )$K]CJ*+ARH_''_ (<W_&C_ *&?P'_X
M,+W_ .1*/^'-_P :/^AG\!_^#"]_^1*_8ZBBX<J/QQ_X<W_&C_H9_ ?_ (,+
MW_Y$H_X<W_&C_H9_ ?\ X,+W_P"1*_8ZBBX<J/QQ_P"'-_QH_P"AG\!_^#"]
M_P#D2C_AS?\ &C_H9_ ?_@PO?_D2OV.HHN'*C\<?^'-_QH_Z&?P'_P"#"]_^
M1*/^'-_QH_Z&?P'_ .#"]_\ D2OV.HHN'*C\<?\ AS?\:/\ H9_ ?_@PO?\
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M?_D2OV.HHN'*C\<?^'-_QH_Z&?P'_P"#"]_^1*/^'-_QH_Z&?P'_ .#"]_\
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M^'-_QH_Z&?P'_P"#"]_^1*/^'-_QH_Z&?P'_ .#"]_\ D2OV.HHN'*C\<?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %9^M?\ 'JO^^/Y&M"L_6O\ CU7_ 'Q_(TF-;F)1
M114F@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!JZ%_P M_P#@/]:UJR="
M_P"6_P#P'^M:U4C-[A1113$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!DZ[_RP_P"!?TK*K5UW_EA_P+^E952S1;!1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5MZ)_QZO_ +Y_D*Q*V]$_X]7_ -\_R%-"EL:%%%%49A11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %9^M_P#'JG^^/Y&M"L_6
M_P#CU3_?'\C28UN8E%%%2:!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &K
MH7_+?_@/]:UJR="_Y;_\!_K6M5(S>X4444Q!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZU_QZK_OC
M^1K0K/UK_CU7_?'\C28UN8E%%%2:!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &KH7_+?_ (#_ %K6K)T+_EO_ ,!_K6M5(S>X4444Q!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 9.N_\L/^!?TK*K5UW_EA_P "_I654LT6
MP4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %;>B?\ 'J_^^?Y"L2MO1/\
MCU?_ 'S_ "%-"EL:%%%%49A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %9^M_\ 'JG^^/Y&M"L_6_\ CU3_ 'Q_(TF-;F)1114F@4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!JZ%_P M_P#@/]:UJR="_P"6_P#P'^M:U4C-
M[A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRD9!'L14M/;1C335T%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#DV^+G@5?%G_"+-XT\/#Q-YH@_L4ZK!]M\PC(3R=^_=CG&,XKK
M*_)O4/\ E+ O_8S1_P#I.M?K)13]^A"K_-_DG^I,GRUITNW^;_R"BBB@HY/Q
M!\7/ OA/7HM$USQIX>T;6I0ACTW4-5@@N'WG"8C=PQW'@<<UUE?DW_P4"_Y/
MN\+_ /7+2/\ T>U?K)1#WJ2J><E]S)D[573[)/[PHHHH*"BBB@ HHHH ****
M "BBB@"KJFJ66AZ;=:AJ-W!I]A:QM-<75U*L<4,:C+.[L0%4 9))P*QO!_Q*
M\(_$1;IO"OBG1?$RVI47#:/J,-V(2V=H?RV.W.#C/7!KE/VH/^3<?B;_ -BY
M?_\ HAZ^-/\ @CS_ ,@KXG_]=K#_ -!GJJ:YW-?RI/[W851\D827VFU^"/T9
MHHHJ1E/5]9T_P_I\U_JE];:;8PC=+=7DRQ1(/5F8@#\:YOPM\9/ 'CG5CI?A
MOQSX;\0:F$:4V6EZO;W,VQ<;FV(Y.!D9..]?FI^WAK6N?';]M#0_A-'J<UMH
MMM<V&FP0KEHHYK@(\MP4_B8++CGLF.YK[,_9_P#V#_A_^SGXT3Q5X=U/Q!?:
MN+22S8ZE<PO$RN5+':D2D'Y1CG\Z=+WX>TEHG>WR_I"J>[/V:WT;^?\ 3/8M
M<^+O@7PSXBBT#6/&GAW2==E*"/2[[58(;IRYP@$3.&.XGCCGM76U^3?[;G_*
M0WPU_P!?.B?^C$K]9*5/WZ2J><E]SL.7NU'#R3^\**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBO@WP'^U[\1M?_;UN_A3=WMBWA"/5M0M%A6R03>7%
M!*Z#S.N<HO/>G'WZBIK=IO[MPE[M-U'LO^#_ )'WE1112 **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6M:
MU8>&])O-4U6]@T[3;.)I[B[NI!'%%&HRS,QX  [U=KCOC#\,;#XS?#/Q!X+U
M.YGL[/6+;R'N+?'F1$$,K#/!PR@X/7I4S<E%N*NRHV<DI;#OAO\ %[P9\7M/
MNKWP;XDL/$5M:R"*=K.3<8F(R RG!&1G&1S@XKKZ^=?V0?V-]._90M/$+1>)
M)_$VIZTT0EN7M!:QQQQ[MBK'O?G+MEBW/& ._P!%5K)13]UF<7)WYD%%%%04
M%%%<!\?O&.I?#WX)>./$VC21Q:KI.D7-Y:O*@=1(D9925/49'2IE)0BY/H5&
M+E)174[^BODW_@GK^T7XT_:+\&^+=2\9W-K<W.G7\5O;FUME@ 1H]QR!U.:^
MLJUE%P=G_5]3*$E-77G^&@5SOCSXB>&OA?X?DUSQ7K=GH.DHZQFZO9 BEST4
M=V8X/ R>#715XO\ M6?LS:?^U)\/;7PW>:U/X?N+.]6^M;Z& 3JL@1D(>,LN
MY2KGHP.<'/8Y2YDO=-8VOJ>G>#?&FA?$+P[:Z]X:U:UUO1[H$PWEG('C;!P1
MD=""""#R".:VJ\L_9J^ >G_LV_"RT\&Z?J4^L>7/)=7%]/&(S-,^-Q" G8N%
M4 9/3J:]3K6?*G[NQG!R:]Y:A1114%!1110 4444 %%%% !1110 4444 :NA
M?\M_^ _UK6K)T+_EO_P'^M:U4C-[A1113$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?K7_'JO^^/Y
M&M"L_6O^/5?]\?R-)C6YB4445)H%%%% !1110 4444 %%%% !1110 5XU^V1
M_P FL_$[_L"3_P J]EKQK]LC_DUGXG?]@2?^588C^#/T?Y&U'^)'U1\E_P#!
M'G_D%?$__KM8?^@SU^C-?B'^R7I?[0VI6OB0_ Q[E(5>#^U?L]U90_-A_*S]
MH89XW_=_'M7T%_PB_P#P4"_Y[:C_ .#/1O\ XY7?6?-).UM%^2.&BN5/KJS]
M.J^7_P!L+XZ_&CX0ZUX<MOA9\/?^$UL[VVFDOIO[$O;_ ,AU90BYMW4+D$G#
M9)Q7F7[-F@_MAV?QH\.S?%"6];P,IG_M$2WVF2+_ *B3R\K"Y<_O-GW1]>,U
M]V/]UOI7-4C:*E?S_-6?YF\9:M6/PN_9E^*WQ-^&WQ?UKQ#\/?!O_"7>*KFT
MN(KK33I=U>F&-YD:1_+A977#JJY)P-V#R17W?H/[4_[2E]\$_%?B.]^$/V?Q
M?I^IV5MIVD_\(SJ2_:;>02&:3RC+YC[2J?,I &[GJ*\(_P""8G_)W/C?_L#7
M_P#Z66]?JU6F]"G;K%?+WME]UOF*2M7GY2?ST_X-_D?A9X_^*GQ,\1?M467C
M77?!HLOB1%?V,\7AIM+NHPTT21B!/LSL9CN"H<!LG=D8R*_0K]EW]I3]H/XH
M?%:#0_B/\+/^$2\,O:32OJ7_  CVH66)% *+YD\C)R<\8R>U?-OQV_Y2J:/_
M -AW1/\ T1;U^K=.B_\ 9H3MH[Z=M%_7R%5B_;N-];0=_P!/T/A_]KK]N'QW
M\ _C_HW@;P_I/AV\TF\L[2XDFU*VG><-+,Z, 4F1< (,?+USUK[@K\F?^"E7
M_)YGA?\ [!FF_P#I3-7ZO:C?1Z;I]U>2G$5O$TKGV4$G^59IJ.&527\T_N5A
MN[Q#@OY8_>[GR[^UY^WEH/[-=VOAO2=/7Q/XWDB$K6;2[+>R5AE&F89)8\$1
MC!(Y)7*Y\%L?VB/VV?%%BOB'3OAQ#!I;+YBVHT7R]Z]<K'++YS @\8Z]J\T_
M82\-K^TI^V)K_CKQ5$-16P\_7VCG&]/M#RJL"D'LFXE1V\M?2OUOIQ@XTXSG
M\4M?)>7]?\,Y24JDH0VCIZ_U_7=_"7[.O_!26Z\3^/H/ /Q=\,Q^#_$,]P+.
M.^@CE@B2X)PL4\$I+Q$G W;B,D9"CFONVOE+]K/]@NP_:<\::1XHM/%*^#M4
MM+;[-<RQZ7]J:[ ;,;$^='@KEAGG((Z8KZBTFUFL-*LK:XN/MEQ#"D<EQMV^
M:P4 OC)QDC.,GK5)J4$VK2_-='_7EYDV<9V3O'\O+^NWH?%G[-_[<'CKXP?M
M2:Q\-M9TGP];:'9OJ"QW%C;3I<GR'*IEFF9>0.?E^F*^W))%CC9W8(BC+,QP
M /4U^3O[#/\ RD&\3?\ 776O_1K5]O\ [?/Q NOAU^RQXRO+"5H+Z_CCTN*1
M6VLHG<(Y!]?++USN?+AJ53JXKYMMHT@N:O4@WHI?<K)GA/Q4_P""C7B;Q1\1
M)? WP"\')XQOHG:-M5G@DN%GVG#-#%&RXC!Q^]=MI] ,$\_KG[17[9_PCT^7
MQ#XN^'>G7^A0_O+C%G',L,8Y9B;68M& /XG! QS57_@G/\6?@S\$/A+J%[XF
M\7Z5H_C'6KUVN4N0WG1V\?RQ1Y"GC.]^O\=?63_MN_ B1&1_B3HS*PP5;S""
M/3[E;RC[-)1=W_70SC+VC;DK(C_93_:X\-?M2>&KF>PMWT;Q'IP7^T=%FD\P
MQAONR1O@;XR01G ((P0.">Q_:*^(VI?"/X(^+_&.CP6MSJ>CV1N((KY&>%FW
M*,.%96(Y[,*_-#X$>+?#W@/_ (*.I_PK[48+GP7K>IS64#6GRP/!<Q;Q&HX^
M5)2H Q_ *_07]M[_ )-0^)?_ &"S_P"C$K+$2_V;VT%:\7\FE_PQI1_C^QD[
MV:^:;_X<^9?AW_P5*DD^$M_JWBW1-/U/QY-JC6.D>'/#L<L0FC$<9$DI=Y2H
MWN5!&2Q& IPQ'.:_^U-^V9+9OX@B^&#Z-H\2F9K=/#LS$1@]761S)TZD <<\
M"KO_  24^%OAG5-'\4^.KW3([SQ)87ZV%E=3C=]EC,2LQC!^Z[;B"W7 P,9.
M?T@KHJQY7IO9>FW]-^9C3DY+7:[]=_Z1\B_L1?MT']I:YOO#'B;3;71_&5G
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MV#1Y[YUM_,42&6X'[I3MR3@#;ZG&:^Y?C+\8O#?P)\ W_B[Q3=-!IUKA$BB
M::YE/W(HUR,LV/4  $D@ FNOT_3[72;&WLK&VAL[.W010V]N@2.- ,!54<
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M))7C9^OK^MC6BI2G%MVE^'H>*_\ !('_ ))O\0/^PM!_Z)K[_KX _P""0/\
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M/,RE%\DI1?O+7U\C[9_;N_:8^(O[,6F^&-;\):5H&IZ)J,LEI=OJ]M/(\,X
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M44 %%%% &KH7_+?_ (#_ %K6K)T+_EO_ ,!_K6M5(S>X4444Q!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 9.N_\L/^!?TK*K5UW_EA_P "_I65
M4LT6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY+K]W( .-F2,$D5B(QC6@G\#:;]&K_G85"4I4I-?%9V]4[?E_P  6P_X)O\
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M\(_^"B?B+QC=6DM_#HVM+=&UA(#2D6RA5!/3)(Y[#L>E?02_L^_M-?M96_\
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M_'SXC:9#K7CKXS7VDZQ.OG+8R7EU?20;L'8S"150CT3<HQP:\Y_9SMA\7/\
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MC30?'?COQ<N@V*ZE;W[Z#?ZI/"4A617V):PHT:948VL0W][G->:?!NS@OO\
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M+65HS!<$H7C8$J2JG&<<#TKRS_@CY_R*/Q*_Z_K+_P!%RUW'_!63_DVW1_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K/UK_CU7_?'\C6A6?K7_ !ZK_OC^
M1I,:W,2BBBI- HHHH **** "BBB@ HHHH **** "O&OVR/\ DUGXG?\ 8$G_
M )5[+7C7[9'_ ":S\3O^P)/_ "K#$?P9^C_(VH_Q(^J/DO\ X(\_\@KXG_\
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M]-VU2"> RC. 2:PDW&4*EK\KO;\/U+BE*,J;=N96_4CLO^">?[.6H6<%U;^
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M\'*$HQU5GKTMW_X'78Z:,US1<M'?;S['I7_!('_DF_Q _P"PM!_Z)K[_ *^
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MV6&;+&U?+P'Z#YT'M&*^PJ_([]C#Q!=_LP?ML:M\/=7G:*QU*ZF\/S&0X5I
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MK2, 3CG K1T37--\3:3;:IH^H6NJZ9=)YD%[8S+-#*O]Y'4D,/<&@"]1110
M4444 %%%9GB3Q1HW@[1Y]6U_5K'0]*@VB6^U*Y2W@CW$*NYW(49) &3U(H&:
M=%8_A7QGX?\ '6E_VGX:UW3?$.F^88OMFE7<=U#O&,KOC)&1D<9[BMBF*]]@
MHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 45E^)O%&D^"]!O=;UW4;;2=)LT\RXO+N01QQKTR2?<@>Y(%9?P\^*'A/
MXL:*^K^#]?LO$&G1RF%YK*3=LD !*L.JG!!P1T(-"UO;H&VYU%%%% !1110
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M ;1<,"?;H?RK]8Z^/OV\OV*M3_:2;1_$WA&\M+7Q7I<#6KV]ZQCCO(-Q=0'
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M5(!P>0?C[X<V_P"VI^SGI\?@_2/#$NN:);DQV4=Q'!?00KNZQRJX95.<A7(
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M,;<G'%?H)54],+3B]U?\HDU-<3.2VM']3\G/VY5-G_P4&\+S38BB:719 [$
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MI*S\K.Z_KR^ZYQ=2"4=XN_K?1GZ%U\Q?%W]NK0_A7\>M.^%:>&;W7M7O);.
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MTO[0_P#P4SL;?1'%[86>N6<!FBRR^39!&G;/IF.3!Z=/6OT4_:V_Y-B^*/\
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M;,Z%1B:1"<@'IFNG%^]7BXZJ_P#[:SGH>[2DGY_^E'V9\,_^2<>%/^P3:?\
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M^C T:/X<TGP]&8]*TNRTR,]4L[=(@>_10*T:* "BBB@ HHHH **** "BBB@
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M*?=V_+_,_16BO-OVBOC19?L__"'7O&MW +Q[*-4M;0MM^T7#L%C0GL,G)/8
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MKJ*_,KXX?M0?%S]I3]H"[^$?P8U&;0-+M;F6S:^L9C!+/Y1Q+<2W"C=%$I!
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M1(^ZJ*_.CP__ ,$Z_C+XXTF#5O'/QTU33=>D7S#9K)<ZB82<':TK7"8/KM!
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M$HHHJ30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 %%%% !1110!JZ%_P M_P#@/]:UJR="_P"6_P#P'^M:U4C-[A1113$%%%%
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MO@[XH7'Q$T?PO]A\87$\]Q)J*W]TP:2;=YI\II3&-VYN N!GC%<!_P %'/\
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M;1(YFC5$C8%0V4W%B-V3@$ 5]OS2:3X1T6XN9/LFCZ59PM++)A8888U!)8]
M !DUO43IMJH[M;_+_(PIOG7N*R/RE_X)OZQ;ZS^VEX@U"PBDMK&^L-2GBAE
M#K&T\;*K $\@8[GD5]P_\%"_^3/OB#_USM/_ $L@KX>_X)R7\&J?MK>(+VUD
M\ZUN;+4YHI "-R-,A4\^H(K[A_X*%_\ )GWQ!_ZYVG_I9!7+5_W2EI;W5IV]
MXZ</_O<M;^__ )'DW_!(^S@C^ OBBZ6"-;F7Q')&\P0!V5;: JI/4@%FP.VX
M^M?<AY&*^(?^"2/_ ";SXD_[&:;_ -);:OJWXR^+KKP#\)/&?B2Q56O=)T>Z
MO8 XR/,CB9ES[9 KMQDE!N3Z1C_Z2CFPL7.T5U;_ #9\\&Q_9E_8>\=:AK\N
ML)H?BO4;=X9K4W4]_<F.1Q(?W*[S&&*##$*..M8FK?\ !63X.V%P\5KI'B[4
M@O2:"QMTC;_ON=6_\=KYU_X)R? /PU^T1XP\:>-OB*A\5W.F30E;/4)#(D\\
MQ=FFF!_UGW, -P23D' K]1_#_A+0_"-FEGH>C:?HMH@PL&GVL<$:CT"H !6;
MA*$8QF];;=$MQJ:J2DX=]^K9^.OQ$^-6B_'?]N3P7XV\.:?J&E6=UJ^C)Y>I
M(B3%XY8EW81V&" N.>U?J/\ M9>)+GPE^S7\2-4LW:*ZCT6XCCD3@HTB^6&'
MTWY_"OS@_:;\1:9XD_X*1:1/I5[#?PV^NZ-:2R0-N59HWA61,]"58$''0@CM
M7Z5?M.>#[KQ]^SY\0=!L8S-?7FCW MXEZO(J[T4>Y90/QKGJ6>77BK?'^2.B
MG=8Q7>ON?U\CX[_X) ^$;1/#OQ!\4-&K7\EW;Z:CD?,D:H9& /HQ=?\ O@5^
MB5?F[_P2%^(%G#'X\\$3RK%J$DD.K6T3'#2* 8I<#_9/E?\ ?5?I%7=7WCVL
MORU_&_S.*CM)=;N_Z?A8\H\;?LK_  N^(OQ$M/'7B#PN+[Q7:- \.H+?W4)5
MH3NB.R.54)4@=5.<<YKU>ODWXU_MZ1?"G]H;2_A3IO@L>*+R[DL[>6]CU?R#
M!-<. (S%Y#Y(5D;[PSN[5]95SQ_AIQ^&[^_K_74Z'\;3WLONZ'Y2_P#!.G_D
M]OQM_P!>6J?^E<5?JU7Y1_\ !/>0:;^W1XRM+C]W/);ZM"%)'WUN48C\E/Y5
M^KE*G_NM#_ OS8I?QZW^)_DC\9/B1\;+'P5_P4(\2>/?$6ESZ[9Z#K\\:V,;
MJK,;=#!"03D#:R(W_ ?6OI?_ (? >%?^B>:Q_P"!T7_Q->0:S=Q_L[?\%07U
M362;32=0UI[DW$APGDWT3+YF3_"KRG)[;#Z5^L><\CD444_JM+72WXZ7_3\N
M@ZMOK-2W]+6Q^1G[7W[>GAC]IOX51^%K;P9?Z3J%O?Q7UO>W5S'(J%0RL,
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MC;_!#,C1[C_P/RQ^-3BI.:3\X_\ I2'AX<FB[/\ )GBG[/\ _P %*/"'P/\
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MA*MNS_,_5^OG3_@H7_R9]\0?^N=I_P"ED%?1,<BS1I(C!T8!E8="#T-?,?\
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M=5M([N"13GY74'!]QG!'8@U!\1O'%E\-? /B'Q7J*E[+1K&:^DC5@ID"(6V
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M1N.Q8D].37<?L%_MN>*OBAXUN_AG\3&6?Q(D<KV.HM;K;S2/%GS;>:-0%W@
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M#O'W[8'[8$=SX@\(ZG9^ O!TDC+:R?):P-M."$D,<D\A&,%A\F01QR!'XO\
MBE^US^QQ-9ZSXXO;/QWX-,JQ33-LN+?<Q^Z9E1)XF/0,PVY(X;I65N6RG[M^
MYM>]^36Q^F=%<!\"_C3H/Q^^&NF>,?#Y=+6Z!CFM9B/-M9UX>)\=P>_<$'O7
MS1_P4F_:)^(7P!M? #^ _$']A-JCWPO#]BM[CS1&(-G^NC?&-[=,9SS2J?NY
M*,M]BJ?[U7CV;^X^UJ*_-C7_ -LCXY?M"+I/A?X#Z->7,UGI]M_;7B-+2$--
M=F%3*N^4"&!-^X#H6(RN!U^M/V>K[QS\-/V=7U3XV7DZ^(=,6\OM2N+JYBN7
M2W4LZ_-$Q4X0= ?:JDN52E+1+\?3\R(RYW%15V_P]3W.BOS*TC]IO]I3]LOQ
MIJME\(%MO!?A>Q;$EPPB'E(V=AGN'5V,AP?EA48]"!FK?CBP_;3_ &;-!E\6
MWGC*T\9Z'8_Z1?Q0.E\L40QDR++"D@3U,9R!DY YJ=DI3T3[E?$^6&K\C]*J
M*\(_8_\ VI+']J+X<RZJ;1-+\1:;(MMJNGQL61'(RLD9/.QP#@'D$,,G&3[O
M5RBX.S)C)35T%%%%04%%%% !1110 4444 %%%% &KH7_ "W_ . _UK6K)T+_
M );_ / ?ZUK52,WN%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &3KO_+#_ (%_2LJM77?^6'_ OZ5E5+-%L%%%%(84444 %%%% !1110 4
M444 %>+_ +3G[*WA/]I_PI'I^M;M-UJS#'3=;MD#36S'JI!QOC) RA(Z<$'F
MO:**F45)692DX['Y7Z3^S/\ M=?LMWUU:_#757UC0G<N/[+N[>6W;)^\;2Z^
MZY&,E5/^\:X?XL?M:?M9?#XV^D>--8O_  G+J,3-#YFD6EM)(@.TE)!%D8)'
M(((XK]B*\=_:?_9G\/?M/> 1H.KRMIVI6CF?3-6A0,]K*1@Y7C<C# 9<C. <
M@@$$I2LK^]_D*,8WTT/D3]F__@FW=^*-;LOB#\8?$EOXH2\V7\>FV=XUX+XL
M RO<W)^^/]E"P;CY\9!_1J"&.UACAAC6*&-0B1HH"JH&  !T %?E78?LI_M@
M? .8Z;X!URZU'18V8Q+H^N1"T&3G/V>Y9 K'J<(?J:^Y/V/;7XM6OPNNT^,Q
MN&\5_P!I2F+[3);R-]FV1[.8"5QNW^]=-U.+Y=$NGX?UY&"3A)<RNWU'_M@?
MLWQ?M-_"6;P]#=1:?KMG.+[2KN?/EK, 5*/CG8RL5) ..#@XP?@OP#X1_;4_
M9WL#X2\+:5JBZ.LS&&&.*SU"V0EN6C=]_EJ2<XRHY)(SFOUDHKGBN5MI[[F\
MO>23Z;'YX^'OV/?CA^T5,=>_:%\37$EE8Q22:?X4M[B%#-/M;9O$&(8@20"P
M)<C()7K70?\ !-W]F?XD_ /Q)XWNO'?AO^PK?4K2VBM7^W6UQYC([EAB&1R,
M!AUQUK[NHK2,N23E%=+?GKZZF<H\RM)_U_D?/7[:7[+"?M1?#FVL;&\AT[Q1
MH\K7.EW-QGR6+ !X9" 2%<!?F )!53@C(KY0^&.L?MI_ #0[;P18^ HO$6F6
M8\JQ;4(X[M((\\*D\4Z_)Z!R=HP.  *_32BLXKEO;9[HTE[R5]UL?!%K^R;\
M:?VE'FU[]H+7Q!8VD$LFE>"M)FC2,7!1@AD,9\M0"1SO=R#@LHX.C_P3;_9L
M^(_P"U7QW-X\\._V%'J<-FEHWVZVN/,*-*7'[F1\8W+UQUK[FHK2,N1MQ6ZM
M_P 'U(E'G24GU_KY'RO_ ,%$O@GXT^.OP@T/1/ ^C?VWJEMK4=W+!]JAM]L0
MAE4MNE=%/+*, YYKT/\ 8\^'VO\ PL_9R\'^%_%%A_9FNZ?%,MS:^='-Y9:>
M1Q\\;,I^5@>">M>RT5,7R1E%?::?W*Q4_?<9/[*M]^I7U")I["YC0;G>)E4>
MI(.*^ ?^">?[*_Q1^!OQ@\2:WXW\,?V)I=YI+VL$_P#:%K<;Y#/&P7;%*[#Y
M5)R1CBOT&HHIOV<W-;M6_/\ S"?OPY'M=/[C-\3>'K+Q=X=U30]2C\[3]2M9
M;.XC_O1R(58?D37YE:=^QO\ M/\ [+_C+5KCX,ZK!JNFW_[LW-K<6B&6)22G
MG07>$WC)Y7=C)P>2*_4>BI2Y9<Z=GL-OFCRO8\D_9=_X6I_PJFW_ .%R?\CK
M]KF\S_CT_P!3D>7_ ,>O[OIGISZU\E_"W]E'XI^'/^"@%[\2=1\+?9_!<FNZ
MM>+J?]H6K9AFCN!$WE+*9/F,B<;<C/('-?H?16BERU%52U2:^]6_0FW[ITF]
M&[^?7_,*_/S]B[]EGXH?";]J3Q3XO\5^&/[*\.WMK?QV]Y_:%K-O:2X1T&R.
M5G&54GD<8YK] Z*B/NU%46]FOOW'+WH\C[I_<%8?CGPCI_C[P;K?AO58Q+IN
MK6<MG.I_N.I4GZC.1[BMROS#^-?_  4O\8^.[7Q#\/O!'@%M)UBYFGTO^T(+
MU[^X9-S1L88EA3:Y'0Y;&>!G!K&I[R=-*[:>G]>II#W6IMV2>YX!^Q_\$&^)
M'[5>D>%YIH]4T3P_?S7]]-"=T$L5NXPP[%9'6)?<-7[=U\>_\$X_V7=3^!?@
M'4O$?BJQ:P\6>(BF;.88DL[1,E$<?PNQ)9AU'R@X((K["KMJ>[&-*]VM_5[_
M *(Y:=I2E42LGMZ+^G\@IDT*7$+Q2*'C=2K*W0@\$4^BL&DU9F^Q^8/BK]CG
MXX?LK_&"[\:? M3KFB3&3RX(9(FEC@9@QMIX9"/-7( #)D_*#\IKO8?$'[;O
MQNMUT5M$TGX8:=<9CN=:6-;:5$Z'&Z664'T,:@YQ\PZU^@-%$=(J$M4NXI:R
M<HZ-GY7?'#_@FOXV\/>*O"/_  KK2[OQE"EJLVN:U>:C;0//>^>S.^R652!M
M*X STY);)/ZG0J5A13P0H!I]%7S/DY.EV_O_ $70GE7/S];)?=^O<_/3]E/]
ME3XI?#7]L37?''B/PO\ V=X7N9-4:*__ +0M9=PFD)C_ ':2LXR#W7COBOT+
MHHJ(^["--;15AV]Z4_YG<^#_ /@I#^S+\2OCYXH\%7G@3PW_ &[;Z=9W$5T_
MVZVM_+9G0J,32(3D ],U]J^!]-N-'\$^'["\C\F[M=/MX)H]P;:ZQJK#()!P
M0>E;=%$/W<'36S=_S_S"2YIJH]TK?E_D?!'[:G[!'B#QWXZ/Q.^$\J0>)W=)
M[W2Q<"VDEG3&VXMY20JR< D$KR-P.<@\GHOQ$_;PNK >'H_"W^FH-G]L7MC9
MQR =,^8SB%L>NTD^]?I'12@N2/)]GL5+WGS=>Y^7?QC_ ."=/Q2UKX?0^)+B
M\D^(OQ=U;55FU1O[0CBBM;3RI!L1YV17._R\], !54 $G[R_9=\%ZS\.OV??
M WAKQ#9_V?K>FZ>L%U:^:DOEN&8XW(S*>HZ$BO4J*M2LG%;.WRLK:?UN9\MY
M*3W2:];N^H50\0:#I_BG0]0T?5K6.^TR_@>VN;:4966-U*LI^H)J_14-*2LS
M1-IW1^9?B+]B7XY_LO\ Q"N_%'P"UAM7TFX)7[()H5N5BR3Y4\4V(YE' # E
MN^U3S5G7_%7[<OQ>TN7PZGA=O"]M< PW-Y:PP6#LC<']])(64>\6&]/2OTKH
MHM[O++5>8GNY1T;['RK^Q+^Q-!^S'9WVNZ]>V^L>.-3B\B6:U!-O9PY#&*(L
M S%B 68@9VJ !@ENY_;5^&_B/XM_LX^*/"WA/3O[5UV]:U,%IY\<._9<1NWS
MR,JC"J3R>U>XT557][I+^K!3_=.\=SYC_P"">_P;\8? _P""-]X?\;:1_8NK
MR:S/=I;_ &F&XS$T<2AMT3LO56XSGBOIRBBKG-U'=^2^Y6(A!4U9>?XNY^>/
MP-_92^*?@_\ ;LU/XAZOX7^R>#YM5U:YCU+^T+5\QS";RF\M93)\V]>-N1GG
M%?7_ .TA\#=/_:)^$NK^#+ZY-C+<;9[.]5=WV>X0Y1R.XZJ1W5CC!YKT^BLI
M14J<:3VBK+\_O-+M595>LG<_+KX9>%/VP?V0UO/#'AKPI!XJ\.O.TD$6%OK/
M>>LD161)8PW]UMHSSMR23Z=9_ ?]H[]K"_MX?C?K$/@3X?QR++-X;T5XUEO<
M$$*0C/A?>5V*D A,\U][T5?->SEJUW(Y;7Y=+]C\]/V./V0?B%\$?VKM?\0Z
MEX6.E>!A#J%KIUX=1MIBT33+Y V+*TG**/O#/KS7U'^V1\//$'Q6_9O\8^%O
M"VG_ -J:]J"6XMK3SHX?,*W,3M\\C*HPJL>2.E>T45$ESPC3D]OOWN:4W[.H
MZD=[W/EG_@G;\%?&?P*^#>MZ'XXT;^Q-5N==EO(K?[5#<;H3! @;=$[J/F1A
M@G/'2OI?Q!H=GXGT+4='U&$7&GZA;26EQ">CQNI5E_$$U?HK2K+VWQ+HE]RL
M137L_A]?QN?EO;_LN?M%_L:_$S4]:^$,/_"6>';KY/W9CD^T0[LI'<V[,K;U
M_OQ^^&&XK7I"Q_MH_M%0KHFKV^F?"3PY<C9>ZE:H()VC)^957S9)@V,X"F,'
MH6&:_0"BI6RC/WDNX-:N4=&^Q^8/B;_@G?XQ^'_[1G@2]^'_ (>N-8\%:7<:
M9<WVL7>I6J2/+',&N)#&\JOT&=JKCL,FOT^HHI\SY.1]V_O_ $["Y4I<R[)?
M=_6I^>?[0W_!/WQIX;^)[_$_X!ZDNGZHUPUZVC+<"VE@G8_.;=V^1D;+9C<@
M $CYE.T9+_%+]NW4+'^P8_!JV]_M$9U9=/M4D)_O>8S^1DYZA<?2OTBHJ(KE
MCR=.Q<O>ES]3X4_9"_8)\0>"_B$/BE\7=335O%XD:ZM=/6X-RT4[#F>XE/#R
M#)P%) .#N)P!]UT45HY72BM$NA"C9N3U;ZGYT_M _L+?%3PQ\=K[XK? _483
M>WEV^H"S6YCM[JUN),^:%\W$4D;$L<,1]XJ5(Y/N_P"Q[_PTE_;'B7_A>_\
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M]@\CR_M$FS_5>:V=O7[PS[4J=_;0_P 6B[Z;>7S[!4M[&>O37RVU/W0KX?\
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M_9(G._?YZ[-^>FTX]36->+C1ESOE?Y*SU^6FAI2ES58\BNOS=UI\]=?(SO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO-;1]6NY5',C2,=F3[1B,?A7DO\ P5P\-W.H?!?PGK,*,\&FZUY<Y7HBRPL
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M1\#O^?G7O_!6?_BJ^2OBMHNC^"?^"FY'C/3;/4?#>J:U!-)!JENDUM+%=0A
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MVMN@2.*-1A54#H !7Y3_ /!0+_D^[PO_ -<M(_\ 1[5^LE.E_NZ_Q3_,B?\
MO#_PQ_)GPI_P5N\87.D_!OPKX>@D:./6-7,LX&?G2",D*?;>Z'_@(KGOV8OV
M[O@?\#_@9X3\(3/K$.HV=J'OS!II97NG)>4[MWS?,2 ?0"M?_@KMX7N=0^%/
M@O78D=X--U:2WFVC(43195CZ<Q8_X$*]*_9!^%/P@^)_[-_@/7)?ASX.U._.
MG):WMS<:#:R3/<0_NI#(S1DEBR%B3R=V>]30OR5?\2_])_KYEUK<U+T?YO\
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M:/3TD4D%1/*D3X(Z?([5\#:9IND:/_P5(M+'0;6RL=)MO$R0PVVG1I'!%M@
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "MO1/^/5_P#?/\A6)6WHO_'J_P#O
MG^0IH4MC0HHHJC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/
MUK_CT7_?'\C6A5+5UW63'T(-(:W,&BBBI- HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ K\IOVZO\ E()X)_WM%_\ 2DU^K-?E#_P4+N!X
M;_;E\'ZO>8CLX[?2KLR-D+LCN7W$GVV&BG_O%'_%^C%4_@5?\/ZH_5ZOA_\
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M $IFKZ@_X);_  XO/!?[.<NL7\+02^)=2DOX5=<'[.JK%&?H2CL/4,#7R_\
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MZPJ?[A#2WNO3MH=-+_?GK?5?FSXT_P""//\ R"_B?_UVL/\ T&>OT9K\YO\
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M1=0\1_LW?$33-)L+K5-2NM'FBM[.SA:::9R.%1%!+'V KYX_X)8_#WQ5\/?
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M)XAVA6,3W5JK/TR(&MW8#/;>?K7Z%T5G%.,?9W]U?@7*TI<_4_+_ ,(?L_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "MS1A_H?_ C6'70Z8FR
MQC]^?UIH4MBU1115&84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_9S\2?LS?"O5O#7BB]TJ_O[O6)-0CDTB662(1M#"@!,D:'=F-NV,$<U\J_\
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M?)NW'8G</QJM6SK-OYD2R@<KP?I6-4FBV"BBBD,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "GP1&:9$'\1Q3*T]%M]SM,>@X'UI@:X&T #H*6BBJ,@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@""^C\ZTE7OC(_"N;KJJYJZA^SW
M#IV!X^E)EQ(J***DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!5!9@!U/%=/%'
MY<:(.BC%8.F0^==IZ+\QKH:I$2"BBBF2%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 8VM0[95E X88/UK-KI;NW%S;LG?M]:YME*L01@CK
M4LTB)1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !5W28?-N@Q^ZG-4JZ#3;;[/;#
M(^=N330F6Z***HS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** &NHD4JPR",&N;NK=K:9HS
MVZ'U%=-5+4K/[5%N4?O%Z>_M2929@T445)84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M.CC:614499C@5TEO"+>%(Q_"*I:39F-?.<?,WW1Z"M*J1$F%%%%,D**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *RM:M_NS#_=:M6F31B:
M-D;HPQ0-'+T5)<0M;S-&W4&HZ@T"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ>SM3
M=3A/X>K'VH U-'M_*@,A^\_\JT*10%  X XI:LS"BBB@04444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5CZQ9[6\]1P?O?XUL4UE$BE6&0>
M"*!HY:BK-]9M:2>L9^Z:K5!H%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%36ML]U*$7\3Z4
M 6-+L_/FWL/D3]36[4<,*P1JBC %251FW<****8@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH RM4T_K-$.?XE_K6375UE:AI?66$?5!_2D6F9-%%%24%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5H:;I_GL)9!^['0>M+I^F&;$DHPG9>YK950J@ 8 Z51+8M%%%,@***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"CJEC
M]HCWH/WB_J*PJZNLG5-/ZS1#W91_.DRDS*HHHJ2PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7ZB5^5<:Y+A,CS&&&P::BX*6KOJY27Z(\G'488>HHPVM_F%%%%? 'G!1110
M4444 %%%% !1110!'-"MQ&4<94U@7EF]G)@\J>C>M='3)8EF0HXW*:0T['+T
M5>O=+>WR\>7C_451I&@4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBK=GI\ET<GY(_[Q_I3 AM[9[J0(@^I
M["N@M;5+6,(O7N?6EM[=+:/8@P/YU+3,V[A1113$%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 4KS34NOF7Y)/7L:QKBUDM6Q(N/0]C734UD612K ,
M/0TK%)G+45LW&C))S$WEGT/(K/FT^>'K&6'JO-(JY6HHZ=:*0PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***LVNGRW1X&U/[S4P*ZJ78*HR3V%;6GZ:(<
M22C,G8>E3VMC':+\HW-W8]:LTR&PHHHIDA1110 4444 %%%% !1110 4444
M?EW^VA_R<MXQ_P"W/_TC@KQ.O;/VT/\ DY;QC_VY_P#I'!7B=?VOP_\ \B?!
M_P#7JG_Z2C[C#_P8>B_(]L_8O_Y.6\'?]OG_ *1SU^HE?EW^Q?\ \G+>#O\
MM\_](YZ_42OP3Q-_Y'%+_KTO_2IGS^:?QEZ?JPHHHK\C/'"BBB@ HHHH ***
M* "BBB@ HHHH *I76EQ7'S#]V_J.AJ[10!SMQI\UOU7<O]Y>:K5U=5YK&"X^
M]&,^HX-*Q?,<Y16Q)H:'_5R%?9AFJ[Z+.OW61OQQ2'=&?15PZ3<C^ '_ ($*
M3^R[K_GE_P"/#_&@=T5**M_V7=?\\O\ QX?XT?V7=?\ /+_QX?XT!<J45;_L
MNZ_YY?\ CP_QH_LNZ_YY?^/#_&@+E2BK?]EW7_/+_P >'^-']EW7_/+_ ,>'
M^- 7*E%6_P"R[K_GE_X\/\:/[+NO^>7_ (\/\: N5**M_P!EW7_/+_QX?XT?
MV7=?\\O_ !X?XT!<J45;_LNZ_P">7_CP_P :/[+NO^>7_CP_QH"Y4HJW_9=U
M_P \O_'A_C1_9=U_SR_\>'^- 7*E%6_[+NO^>7_CP_QH_LNZ_P">7_CP_P :
M N5**M_V7=?\\O\ QX?XT?V7=?\ /+_QX?XT!<J45;_LNZ_YY?\ CP_QH_LN
MZ_YY?^/#_&@+E2BK?]EW7_/+_P >'^-']EW7_/+_ ,>'^- 7*E%6_P"R[K_G
ME_X\/\:/[+NO^>7_ (\/\: N5**M_P!EW7_/+_QX?XT?V7=?\\O_ !X?XT!<
MJ45;_LNZ_P">7_CP_P :/[+NO^>7_CP_QH"Y4HJW_9=U_P \O_'A_C1_9=U_
MSR_\>'^- 7*E%6_[+NO^>7_CP_QH_LNZ_P">7_CP_P : N5**M_V7=?\\O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7:_\\O\ QX_XT?V7:_\ /+_QX_XT6#F.?HKH/[+M?^>7_CQ_QH_LNU_YY?\
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M%@YCGZ*Z#^R[7_GE_P"/'_&C^R[7_GE_X\?\:+!S'/T5T']EVO\ SR_\>/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#\N_VT/\ DY;QC_VY_P#I'!7B=>V?MH?\G+>,
M?^W/_P!(X*\3K^U^'_\ D3X/_KU3_P#24?<8?^##T7Y!1117O'0%%%% !111
M0 4444 %%%% !1110!]1?\$\/^2U:U_V+\__ *4VU?H=7YX_\$\/^2U:U_V+
M\_\ Z4VU?H=7\K^(G_(]E_AB?)YE_O#]$%%%%?F1Y84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#*7>__ !FC_AM+X-?]#C_Y2[W_ .,U^7'2DI_\0QR?_G[5^^/_ ,@/_4_
M?SS^^/\ \B?J1_PVE\&O^AQ_\I=[_P#&:/\ AM+X-?\ 0X_^4N]_^,U^6]%/
M_B&.3_\ /VK]\?\ Y ?^I^ _GG]\?_D3]2/^&TO@U_T./_E+O?\ XS1_PVE\
M&O\ H<?_ "EWO_QFORWHJ?\ B&63_P#/VK]\?_D _P!3\!_//[X__(GZD?\
M#:7P:_Z''_REWO\ \9H_X;2^#7_0X_\ E+O?_C-?EO15?\0QR?\ Y^U?OC_\
M@/\ U.P'\\_OC_\ (GZD?\-I?!K_ *''_P I=[_\9H_X;2^#7_0X_P#E+O?_
M (S7Y;T4?\0QR?\ Y^U?OC_\@'^IV _GG]\?_D3]2/\ AM+X-?\ 0X_^4N]_
M^,T?\-I?!K_H<?\ REWO_P 9K\MZ*7_$,LG_ .?M7[X__(%?ZFX#^>?WQ_\
MD3]2/^&TO@U_T./_ )2[W_XS1_PVE\&O^AQ_\I=[_P#&:_+>BG_Q#')_^?M7
M[X__ " ?ZFY?_//[X_\ R)^I'_#:7P:_Z''_ ,I=[_\ &:/^&TO@U_T./_E+
MO?\ XS7Y;T4?\0QR?_G[5^^/_P @5_J9E_\ //[X_P#R)^I'_#:7P:_Z''_R
MEWO_ ,9H_P"&TO@U_P!#C_Y2[W_XS7Y;T4O^(8Y/_P _:OWQ_P#D _U,R_\
MGG]\?_D3]2/^&TO@U_T./_E+O?\ XS1_PVE\&O\ H<?_ "EWO_QFORWHI_\
M$,<G_P"?M7[X_P#R ?ZF9?\ SS^^/_R)^I'_  VE\&O^AQ_\I=[_ /&:/^&T
MO@U_T./_ )2[W_XS7Y;T4O\ B&63_P#/VK]\?_D!_P"I>7_SS^^/_P B?J1_
MPVE\&O\ H<?_ "EWO_QFC_AM+X-?]#C_ .4N]_\ C-?EO12_XAED_P#S]J_?
M'_Y /]2\O_GG]\?_ )$_4C_AM+X-?]#C_P"4N]_^,T?\-I?!K_H<?_*7>_\
MQFORWHJO^(8Y/_S]J_?'_P"0*_U*R_\ GG]\?_D3]2/^&TO@U_T./_E+O?\
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M_?'_ .0'_J1EW_/R?WQ_^1/U(_X;2^#7_0X_^4N]_P#C-'_#:7P:_P"AQ_\
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M_?'_ .0'_J-EO_/R?WQ_^1/U(_X;2^#7_0X_^4N]_P#C-'_#:7P:_P"AQ_\
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MX-?]#C_Y2[W_ .,T?\-I?!K_ *''_P I=[_\9K\MZ0FC_B&.3_\ /VK]\?\
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MB?J5_P -I?!K_H<?_*7>_P#QFC_AM+X-?]#C_P"4N]_^,U^6]%'_ !#')_\
MG[5^^/\ \@'^H>6?\_*GWQ_^1/U(_P"&TO@U_P!#C_Y2[W_XS1_PVE\&O^AQ
M_P#*7>__ !FORWI":/\ B&.3_P#/VK]\?_D!_P"H66?\_*GWQ_\ D3]2?^&T
M_@S_ -#E_P"4N]_^,T?\-J?!G_H<O_*7>_\ QFORUHH_XACD_P#S]J_?'_Y
M?^H66?\ /RI]\?\ Y$_4K_AM3X,_]#E_Y2[W_P",T?\ #:7P:_Z''_REWO\
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MC_AM3X,_]#E_Y2[W_P",U^6M%'_$,<G_ .?M7[X__(#_ .(?97_S\J??'_Y
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M99/_ ,_:OWQ_^0%_JS@_YY?>O_D3]1O^&T?@W_T./_E+O?\ XS1_PVC\&_\
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M?_C-?ES11_Q#+)_^?M7[X_\ R ?ZLX/^:7WK_(_4;_AM'X-_]#C_ .4N]_\
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M1O\ AM'X-_\ 0X_^4N]_^,T?\-H_!O\ Z''_ ,I=[_\ &:_+FBC_ (AED_\
MS]J_?'_Y 7^KV%_FE]Z_R/U&_P"&T?@W_P!#C_Y2[W_XS1_PVC\&_P#H<?\
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M_P#D _L#"_S2^]?Y'ZC?\-H_!O\ Z''_ ,I=[_\ &:/^&T?@W_T./_E+O?\
MXS7Y<T4?\0RR?_G[5^^/_P @+^P,+_-+[U_D?J-_PVC\&_\ H<?_ "EWO_QF
MC_AM'X-_]#C_ .4N]_\ C-?ES11_Q#+)_P#G[5^^/_R ?V!A?YI?>O\ (_4;
M_AM'X-_]#C_Y2[W_ .,T?\-H_!O_ *''_P I=[_\9K\N:*/^(99/_P _:OWQ
M_P#D!?V#A?YI?>O\C]1O^&T?@W_T./\ Y2[W_P",T?\ #:/P;_Z''_REWO\
M\9K\N:*/^(99/_S]J_?'_P"0%_8.&_FE]Z_R/U&_X;1^#?\ T./_ )2[W_XS
M1_PVC\&_^AQ_\I=[_P#&:_+FBC_B&63_ //VK]\?_D _L'#?S2^]?Y'ZC?\
M#:/P;_Z''_REWO\ \9H_X;1^#?\ T./_ )2[W_XS7Y<T4?\ $,LG_P"?M7[X
M_P#R O[!PW\TOO7^1^HW_#:/P;_Z''_REWO_ ,9H_P"&T?@W_P!#C_Y2[W_X
MS7Y<T4?\0RR?_G[5^^/_ ,@+^PL-_-+[U_D?J-_PVC\&_P#H<?\ REWO_P 9
MH_X;1^#?_0X_^4N]_P#C-?ES11_Q#+)_^?M7[X__ " ?V%AOYI?>O\C]1O\
MAM'X-_\ 0X_^4N]_^,T?\-H_!O\ Z''_ ,I=[_\ &:_+FBC_ (AED_\ S]J_
M?'_Y 7]AX;^:7WK_ "/U&_X;1^#?_0X_^4N]_P#C-'_#:/P;_P"AQ_\ *7>_
M_&:_+FBC_B&63_\ /VK]\?\ Y 7]AX;^:7WK_(_4;_AM'X-_]#C_ .4N]_\
MC-'_  VC\&_^AQ_\I=[_ /&:_+FBC_B&63_\_:OWQ_\ D!?V'AOYI?>O\C]1
MO^&T?@W_ -#C_P"4N]_^,T?\-H_!O_H<?_*7>_\ QFORYHH_XAED_P#S]J_?
M'_Y /[#PW\TOO7^1^HW_  VC\&_^AQ_\I=[_ /&:/^&T?@W_ -#C_P"4N]_^
M,U^7-%'_ !#+)_\ G[5^^/\ \@']AX;^:7WK_(_4;_AM#X-_]#C_ .4N\_\
MC-'_  VA\&_^AQ_\I=Y_\9K\N_NTVC_B&63_ //VK]\?_D"?[$P_\TOO7^1^
MHW_#:/P;_P"AQ_\ *7>__&:/^&T?@W_T./\ Y2[W_P",U^7-%'_$,LG_ .?M
M7[X__(!_8F'_ )I?A_D?J-_PVC\&_P#H<?\ REWO_P 9H_X;1^#?_0X_^4N]
M_P#C-?ES11_Q#+)_^?M7[X__ " O[%P_\TOP_P C]1O^&T?@W_T./_E+O?\
MXS1_PVA\&_\ H<?_ "EWO_QFORYIP&*/^(99/_S]J_?'_P"0#^Q</_-+\/\
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M];L]_P"@N7]?(?US$?SL^7?^'>'PX_Z#7BC_ ,"[;_Y'H_X=X?#C_H->*/\
MP+MO_D>OJ*BC_6[/?^@N7]?(/KF(_G9^27[07P[TWX4?%[7O"ND3W5QI]A]G
M\J2]=6E.^WCD.XJJCJYQ@#C%>>5[9^VA_P G+>,?^W/_ -(X*\3K^KLEK5,1
ME>%K57>4J<&WW;BFV?74).5*$GNTOR/0_P!GWX=Z;\5_B]H/A75Y[JWT^_\
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M]%8&A'I<^V/^'DO_ %3K_P KG_W/1_P\F_ZIU_Y6_P#[GKXGI0*Z?]1>'?\
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M_P"'C7_5/?\ RM__ '/1_P /&O\ JGO_ )6__N>OB^BC_4?A[_H&_P#)Y_\
MR1'URM_-^1]H?\/&O^J>_P#E:_\ N>E_X>,_]4]_\K7_ -SU\7@8H^]]*/\
M4?A[_H&_\GG_ /)$?7*_\WX(^S_^'C6?^:>_^5K_ .YZ7_AXS_U3W_RM?_<]
M?&%%'^H_#W_0-_Y//_Y(GZ[7_F_!'V?_ ,/&?^J>_P#E:_\ N>C_ (>,_P#5
M/?\ RM?_ '/7QA12_P!1^'_^@;_R>?\ \D0\=B/YOP7^1]G_ /#QG_JGO_E:
M_P#N>C_AXS_U3W_RM?\ W/7QA11_J/P__P! W_D\_P#Y(S>/Q'\WX+_(^S_^
M'C/_ %3W_P K7_W/1_P\9_ZI[_Y6O_N>OC"E [FE_J/P_P#] W_D\_\ Y(C^
MT,3_ #?@O\C[/_X>,?\ 5/?_ "M?_<])_P /&/\ JGO_ )6O_N>OC'K2@8H_
MU'X?_P"@;_R>?_R1+S'$_P _X+_(^SO^'B__ %3[_P K7_W/1_P\8_ZI]_Y6
MO_N>OC'K2T?ZC\/_ /0-_P"3S_\ DB/[2Q7\_P""_P C[-_X>+_]4^_\K7_W
M/1_P\7_ZI]_Y6O\ [GKXRHH_U'X?_P"@;_R>?_R1']IXK^?\%_D?9O\ P\7_
M .J??^5K_P"YZ/\ AXO_ -4^_P#*U_\ <]?&5.^[1_J/P_\ ] W_ )//_P"2
M(>:8O^?\%_D?9G_#Q;_JGW_E:_\ N>@?\%%L_P#-/O\ RM?_ '/7QE]ZG4?Z
MC\/_ /0-_P"3S_\ DB'FN,_G_!?Y'V9_P\6_ZI]_Y6O_ +GH_P"'BW_5/O\
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MOC3I2=?I1_J1P_\ ] W_ )//_P"2(>=8[_GY^"_R/LS_ (>*?]4^_P#*U_\
M<]'_  \4_P"J?_\ E:_^YZ^-**/]2.'_ /H&_P#)Y_\ R1']M8__ )^?@O\
M(^R_^'BG_5/_ /RM?_<]'_#Q3_JG_P#Y6O\ [GKXTHH_U(X?_P"@;_R>?_R1
M+SO'_P#/S\(_Y'V7_P /%/\ JG__ )6O_N>E_P"'B7_5/_\ RM?_ '/7QK]V
MD^]2_P!2.'_^@;_R>?\ \D9O/,P_Y^?A'_(^RQ_P42_ZI_\ ^5K_ .YZ/^'B
M7_5/_P#RM?\ W/7QM12_U)X?_P"@;_R>?_R1#SW,/^?GX1_R/LG_ (>)?]4_
M_P#*U_\ <]'_  \2_P"J?_\ E:_^YZ^-J*/]2<@_Z!__ ">?_P D3_;V8_\
M/W\(_P"1]D_\/$O^J?\ _E:_^YZ/^'B7_5/_ /RM?_<]?&U%'^I.0?\ 0/\
M^3S_ /DB'G^8_P#/W\(_Y'V3_P /$O\ JG__ )6O_N>C_AXE_P!4_P#_ "M?
M_<]?&U+1_J3D'_0/_P"3S_\ DB/]8,R_Y^_A'_(^R?\ AXC_ -4__P#*U_\
M<]'_  \1_P"J?_\ E:_^YZ^-NM+TH_U)R#_H'_\ )Y__ "1'^L&9?\_?PC_D
M?9/_  \0_P"J?_\ E9_^YZ3_ (>(?]4__P#*U_\ <]?&_6EH_P!2<@_Z!_\
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M$T !-)UHZTZ@84444#"BBD)H&!-)10!F@H ,TZBB@ HHI":!@32444%!2@4
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M814)<\/A?X'5T445^7'D!1110 4444 %%%% !1110!^7?[:'_)RWC'_MS_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"=_Y5++_ ./4[_AB[XR?]"=_Y5++_P"/5G_K!D__ $&4O_!D?\R?[3P/_/\
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M*=[HSR2-&60 !   Q)W$G&.?T,KJJ**Y;=M?Z]+'/!R;=^^@4445D:!1110
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M)JV$<K>TK2C?M>;5S\,K8?ZUFU2@W;FJ25_63/9/^$RT#_H.:;_X%Q_XT?\
M"9:!_P!!S3?_  +C_P :_&,FFU^G_P#$+:7_ $%O_P  7_R1]A_J=#_G^_\
MP'_@GZ:_MC^)M'U#]G7Q3!:ZK8W,[FUVQ0W".QQ<Q$X .>E?F5117Z3PWD,>
M'<)+"1J<]Y.5[6W25MWV/KLJRY97AW04N;5N]K;I+] HKVKX9_L@_$CXH:?#
MJ-KIL&C:7,N^&\UB4PK*IZ%4"LY!'(;;@CH:]?L?^";VL/;JUWXWL8)^Z0V#
MR*..S%USSGM1C.*LEP-1TJ^)BI+=*\K>O*F36SK+\/+DJ5E?RN_RN?' %!-?
M4_B;_@GIX\TN&671]8T?6U121"SO;S.?10RE,_5Q7S=XK\(ZUX&UN?2-?TRX
MTK4H3\]O<IM.,X# ]&4XX89![&O1R[.LNS6ZP5>,VNBW^YZ_@=F%Q^%QG^[U
M%+\_NW,>BBNE\!_#?Q-\3M8_LSPQH]QJ]V!N<0@!(AS@N[$*@X/+$9Z5ZU:M
M3H0=2K)1BMVW9+U;.Z<X4XN=1V2ZO1'-45]8>'?^"=?C2^57UGQ#HVDJP!V6
M_F7,B^Q&U%_)C5[6O^"<7B6WM]VD^+]*OINZ7EO);K_WTOF?RKX^7&601G[-
MXI7])6^^UOQ/$_M_+%+E]LOQ_.UCY!I>E=_\4O@3XU^#=PH\2Z.\%I(^R'4(
M&$MM*>> XZ$@$[6PV!TK&^&OP_U'XI^-M,\+:3-:V^H:@SK%)>,RQ#;&SG<5
M5CT0] ><5]-#'86IAGC(5$Z:3?,G=66^J['L1Q%&5%XA33@E>_2RW.^_9?\
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M="#J59*,5NV[)>K9^D5*D*47.I)**W;T1SE%?6?AS_@G5XQOHU?6O$>CZ3N
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M;$_X3]$Z***_C8_E(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK\@OCC_R6KX@?]C#J'_I3)7Z^U^07QR_Y+5\0/\ L8=0_P#2F2OVOPO_ -\Q
M/^%?F?<\*?QZOHOS.)IOWJ/O4ZOZ*/T@****!!11102%%%% C[7_ .";/^L^
M(GTT_P#]N:^Q?%__ "*>M_\ 7C/_ .BVKXZ_X)L_ZSXB?33_ /VYK[%\7_\
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M/-6>KV75GPM17[(>'_AOX3\*Q>7HWAG2=+4]?LEE'&6^I"Y)^M1^(OA?X/\
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M_P#^QAT__P!*8ZX,P_W.M_AE^3,ZGP2]#]?:***_AD^ "BBB@ HHHH ****
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MX]ZDUKX9>,/#>GR7^K^$]<TJQC(#W5[ITT,2DG !9E &20*^Y/V"/^2+7O\
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M!G/V(Z6?*^F?,WX_X%7W7^Q+^W]IG[4DT_AG7-,A\.>.[6#[1]GMW+6M]&N
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M-NK? !O$,NJZO9ZG)JR6X"6:.%B,9D[L!G/F#L.E>@_M _\ )#?'W_8#O/\
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MFB+QW^VY\,? ^J2:>MY?>(;F)RDO]BP++&A'_31W16_X"6KTCX4_&#PQ\9M
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M;4^%]G\-?C),^EP+;:7K5NNHQPQKA(I"S+(BCTW+NQVWX'2C]AO_ ).,T/\
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M<&Y?]1RFG*2]ZI[S^>WX6^\****_1#[D****"@HHHH *^I?^"=?_ "6S6_\
ML7I__2FVKY:KZE_X)U_\ELUO_L7I_P#TIMJ^0XN_Y$6+_P /ZH^8XH_Y$V)_
MPGZ)T445_&Q_*(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y
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M5922LJC_ ($-_MY@K]$?AG<R7GPW\*W$S;Y9=*M7=CW)A4DU\B_\%)(4^U>
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MP'0 #  ^@K\O/VDOV@-0^.OC S+YEKX;L6:/3;%CR%[RO_MMC\!@#N3]4?\
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M)/@+X;T\:?8+?:YJQE2T:?\ U$(0+N=P#EC\ZX48SSD\8/<? O\ Y(GX _[
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M7<1Z, &'^][&OU[Q-IUYX##U(? I/F]6O=?YKYGMYY&7N-?"F_\ @?J?-?\
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M %+110(****!!32:":2@ KM_@:/^+U?#_P#[&#3_ /TICKB0*[CX'_\ ):O
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M@]ZX6OK7]M?XS>#/BAX=\,VWA?7(]6GM+J:298X9$V*4 !^=1W]*\R_9;^!
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MLQN 3F=D_B8C;P>,@M@DY"RKQ(FHSCFE.[2]UQ5KOLTW^/3L*IADU>&Y\">
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MABU_]&+7ZY3S*EBLN>885WBXN2OY)Z/T>C/B,1AJF%KNA55FF=9_PQ[\7?\
MH4O_ "I6?_QZO.=4\ ^(-'\7S>%KC2IW\0Q2"%M/ML3R%RH; \LL&X.>,U^N
ME<1;^$?"/PWU?Q%XTO'M;"]U*027NK7\BH(UPJK&K-PJ\#@=3Z\8_&\%XC8R
M3FL31C)V]U135Y76]Y/2U]E>]C[C$<+T;1]C-K75NVBL[]%KMU/AO0?V*?B?
MK5N)I]/L=(!&52_O%W'\(]^/H<5@>/OV7/B+\.[&>_O]%%]IL(W27FFRB=$
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M'C/HZ, RGV8"O)/VF?V;].^)VA7FNZ/:);>+[6,R*\("_;E4?ZM_5L#"MUX
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MX$AA#YVEP.F=IZ^AKKJ>]3A;HG^;?ZF$?=J3OUM_D=O1117,= 4444 %%%%
M!1110 4444 %%%% '$?'+_DBGQ _[%[4/_2:2OR#K]?/CC_R17X@?]B]J'_I
M-)7Y!U_17A?_ +GB?\2_(_4.$?X%7U7Y!113:_;#[X*2BBD4%*!0!3J "D)H
M)IM,9^H/[$O_ ";;X8_ZZ7G_ *52U7_;D_Y-SUS_ *^;3_T>E6/V)?\ DVWP
MQ_UTO/\ TJEJO^W)_P FYZY_U\VG_H]*_DV/_)9?]S'_ +D/Q:G_ ,C[_N*_
M_2F?F-113@*_K$_:P K[G_8-^!FDS>'6^(>L6<=[J$UP\.EK,H98$0X:4 _Q
MEPP![!>.IKX8)K],_P!A?6K74_V>='M()%:?3KJZM[A5ZJS3-*,_\!D6OS3Q
M"Q6(PN2/V#:YI*,K?RM-_BTE\['R'%5:I1R^U-VYI)/TL_U2/4_BE\3M%^$/
M@V[\2:[(ZVD)$:0P@&6>1ONQH"1DG![X !)X%?&'B/\ X*->++JZSH7A?1].
MMO[NH/+=2'WW*T8'Y&OIC]J[X.ZG\:OA;_9.BRQ+JUG>)?V\4S;$F*JZ&/=V
M)#G!/&0 < Y'Q#HO[%/Q<U;4TM)O#<>EQ%L/=WM[#Y4?N=C,Q'^ZIK\[X.P/
M#53 RQ.:S@ZJ;TG*UETLKJ]^^O9'S>18?*)89UL9*//=Z2=K+R77\>Q]8?L@
M?M#^*/CM=>*D\1PZ=$NF);-!]@A://F&7=NW.V?N#'XUZG^T#_R0WQ]_V [S
M_P!$M61^SW^S[I/P#\-SVEK<-J.L7Y1[_4'7:)"H.U$7^%%W-CJ3DDGH!K_M
M _\ )#?'W_8#O/\ T2U?&8VM@<1Q!&IEL>6CSPY5:VW*F[>;NSY^K4P]7-5/
M"*U/FC;IV7XO4_(FNH^'_P 3/$WPMUG^T_#&KSZ5=, )!&0T<JC/RNC95QR>
MH.,Y&#6#IMY_9NI6MWY2S>1*DOEO]UMI!P?8XK]@_#NE^$_%&@Z?K&G:3I=Q
M8WT"7$$JVD>&1E!';WK^A.+.(:614Z<,1AO;4ZMT]5;2VC33O>_X'ZAGF:PR
MV,85J//&=_32VCT9\B>!?^"C5U"D4'C#PK'<_P!^]T>;8<=OW,F03[[Q]*^A
M?AC^U9\.?BK>6]AINL-I^KS_ .KTW5(O(E8_W5;)1F_V58GVKYW_ &IOV/\
MQ3KWCZ\\4^!]-M]1T_4%C:;3K>2."2WD5 K%5;:I4[0>#G+'CO7F'PT_9 ^*
M6I>,M(>[T&;0+*"[CEFU"ZGC3R55@Q95#%F;CC ZXR0.1\%6R?A#-<!]=HUE
M0FXW:4UH[;.,M=]-+7Z'S5;+\BQF%^LTJBIRM>W-L[;-/]+>1^E]]8V^I6<]
MI=P1W5K.ACEAF0.DBD8*L#P01V-?E+^TY\,+7X2_&+6=$TY#'I,@2\LD8Y*1
M2#.S/HK!E&><*,U^L-?E]^VGXPM/&'Q\U@V+K-;Z9#%IWFH<AG0$O^3NR_\
M :\3PSJXA9G5I0;]FX-R[735GZ[_ "N<?!TZOUNI"/P<MWZW5OGO^)WO_!.?
M_DJ'B7_L#_\ M:.OO77_ /D!:E_U[2?^@FOSM_8#\2PZ+\<9;">41C5M,FMH
ME/\ %*K)*!G_ '8WK]'Y(UEC9'&Y6&"/45Y_B%&5+/W.2T<8M?E^:.#B=.GF
MLIM;J+_"WZ'XET5]I:[_ ,$X[Z35[M])\86L>G/(S01W5H_F1H22%)#8) P,
M\9QG KXVU*R;3=0NK1V#M;RM$67H2I(S^E?T5E6?9=G2E]1J\W+:^C5K[;I=
MC];P6987,%)X:?-:U]&K7VW]"&&&2XD"11M(YZ*@))_"F].#P:_8'X2_"[0O
MA-X-L-%T2SBAV1*;BZ51YEU+@;I';^(D_@!@#  %>#_MZ_";1]4^&\GC>WM(
MK;7-+GB6:YC0!KB"1A'M<CJ0S*03G !'>O@<O\1,-C\SC@50<83ERQE?6[T5
MXVTN_-V/E\%Q71Q>,CAO9M1D[)W^ZZMU]3\]:***_7#[TD@@DNIHX8D:261@
MB(HR68G  K]:/@/\$=%^"?@NUTVQMXWU::)6U'42@\VXEQDC/4("2%7H!ZDD
MG\I?#>J)HGB+2]1DC\V.TNHKAH\9W!'#$8]\5^SME>0ZC9P7=M(LUO/&LL<B
M'*NK#((/H0:_#/%#%8BG2PV&@VJ<N9OS:M9/TO?_ (8_,N-*U:*HT4[0=V_-
MJWY?J>)_M%?M5:-\!9K73%TZ37?$-U%YZV:2B*.*,DJ'D?!QDAL* <[3G'!/
MS#J'_!1#XB7$TGV71_#MI"3\BFWFD<#T+&4 _D*]&_;*_9C\9?$;QU;>*_"E
MG'K$<EI':W%FLR12Q,A;#C>0&4@CH<Y'3%>7_"_]@WQUXFU>)O%L<?A71D<&
M8F:.:YE7N(U0LH/;+D8SG#=*YLAPG".'RFGBL=*$JC5Y<TKROV4+_=9:AEM#
M(*. A7Q#BYVUN[N_;E_X!]R?!/QE?_$+X4^&O$>J+"NH:C:^=,MNI6,-N(^4
M$G X]:^;_P#@I#_R+'@G_K\N?_0$KZR\*^&-.\%^'-.T+2(/LVFZ?"L$$6XL
M0H'<GDD]23U)KY-_X*0_\BSX)_Z_+G_T!*^'X3G2J<4T9T(V@Y3:79<LK+Y(
M^9X>E&6=4Y05DW*WIRR//?\ @G7J:V_Q6\06+'!N=':1>.I2:/C\G/Y5^@MQ
M#]HMY8NF]2OYC%?D?\ _B8?A'\5M"\1ON-E#*8;U$ZM;N-K\=R =P'<J*_6O
M3-2M-:TZVO["XCN[*ZC6:"XA8,DB,,JRD=00:]GQ(P-2AFL<9;W:D5KYQT:^
MZS.WB[#3HY@L1;2:6OFM/\C\7-4T^?2-2N[&YC,-S:S/!+&W565BI!^A!JK7
MWK^T3^P]>^/?&5WXG\%7]A93:@_FWNG7Y:-/-/WI(W56^\>2I'4L<\X'+?"O
M_@GUK5OXJL[[QQJ>FG1[6196L=/=Y7NL'.QBR*%0\9(R2,CC.1^LT..,FG@E
MBJE9*5KN.O-?LEZ[/;S/T&/$V6RP_MY5$G:_+UOVM_2/'H?V,_C%<0I+'X/W
M(ZAE/]IV8R",C_EM7GGQ#^&?B7X4ZW%I'BG3?[+U&6!;E(?M$4V8RS*&S&S#
MJK<9SQ7[&,RQH22$11DD\ "ORH_:J^)=M\4OC5K6IZ?*L^E6H73[.9>1)''D
M%P<\AG+L#Z$5X7"'%F:<18V=*O2@J<8W;BI7O?17<FM=>G1GF</9[CLWQ$H5
M814(J[:3WZ+5OS^X^X?V(;Q+K]G#PY&K M;S7<3#T)N9'Q^3C\ZROV]M';5/
M@#-<*I(T_4[:Z;'8'=%G_P BBO(/^"?/Q<MM)O\ 5? .HSK#_:$GV[36<X#3
M!0LL>2>I558#_9;VK[6\6>%].\:^&]2T+5H?M&G:A UO/'G!*L.H/8CJ#V(%
M?F&<*IP_Q7+%58OE]I[3UC)W=OQ7JCXC&N649\Z]1:<_-ZQD[Z?>UZGXOUT7
M@/X>^(/B=X@30_#6G_VEJCQM*(/.CB^51ECN=E7]:^B_$O\ P3P\;VFL7":'
MK.C:AI>[,$MW+)!-M]'4(P!^A.>O'2O?_P!EO]E'_A1EQ=Z[K5_!J?B6ZA-L
MOV3=Y%M$2"P4L 69BJY8@8Q@=R?V;->.,KPN!E7P=:,ZC7NQUW\UHTEUU7WG
MZ-C^)L%0PLJN&J*4^BU_':WX'R#_ ,,6_&7_ *$[_P JEE_\>KQ6X@>UGDAD
M $D;%& ((R#@\C@_A7Z\_&KXE67PF^&VM>(;R9$EAA:.SB8X,UPP(C0=^3R<
M= ">@K\@V8L23R35<&9_F/$%*M7QE.,8Q:47%-7>O-O)[:?>:\.9IB\VI5*V
M)@DDTE9/7ONWY'[&?"O_ ))AX0_[ ]G_ .B4KY$_X*3?\A+P#_UQO?\ T*"O
MI7]F7Q-;>*O@+X*NK:3S/L^G16,F>HD@'E,#^*9^A![UF?M+?L]V_P ?O"UG
M;1WJZ9K6FR-+974B%HSN #QN!SM;:O(Y!4<'D'\-R3&4LDXF5;&/EC"<T_*Z
ME'\V?EN4XBGEF<*>)=E%R3\MU^9^5=?H+_P3G_Y);XE_[#)_]$15YOX5_P""
M<WB>;5(_^$D\3Z39Z<I!<Z5YL\SC/*C>B!<COSCT-?:GP]^'^@_"_P ,6OA[
MP]:+9V%N-Q&=TDC'K([=68XZ^V!@ "OT#CGBK+,?E_U#!U/:2DTVULDM=WNW
MY?,^LXHSS!8K"?5<-+GDVG=;*W]=#SK]LS_DVOQE_NVO_I7#7Y9U^IG[9G_)
MM?C+_=M?_2N&ORSKV_#'_D45?^OC_P#28'M<$_\ (LG_ -?)?^DP/UR_9W_Y
M(3X"_P"P-:_^BQ7SY_P4A_Y%GP3_ -?ES_Z E?0?[.__ "0GP%_V!K7_ -%B
MOGS_ (*0_P#(L^"?^ORY_P#0$K\PX<_Y*^/_ %\J?E(^%R+_ )*&/^*?Y2/A
M"OJ#]AOX&Z9\2O%&I^(_$%JM[I.B&-8;290T4]P^3\X/4(!G:>"67L"#\OU]
MX?\ !.'7[63POXOT3<HO8;R*\*]VC=-F1Z@&/\-P]:_=.-<5B,'D=>IAFU+1
M76Z3:3_R^9^G\45ZV'RNI.B[/17[)O7_ "^9]9^(->T[P?X>O]7U*9;/3-/@
M:>>3:2$C49. .O X Z]*^)O&G_!1K5I+R2/PEX5LK:U5R$N-9D>9Y%[$QQL@
M0^VYOK7UY\7_  /+\2OAEXC\,P3I;7&HVC10RR9V+(,,F['.-P&<=LU^=!_8
MO^+XU(V8\*Y4/M^T_;K?RB,XW9\S.._3/MGBOQG@G \/XBG5K9O./.GHIRY5
M:V^ZOKZV/SSAC"Y/6IU*F8RCSIZ*3LK6WW5_Q/HG]E_]K#QG\9OBG_8&N6VD
MP:?]BFN?]!MW1]RE0!EI&XY-?7U?/7[,/[*-M\#C+KFKWB:IXKN83 7MR1;V
ML9(+(F<%B2!EB!TP .2?H6OE.**V65LRE_9,4J226BLF^K7^9\YGE3!5,;)Y
M>K4TDM%9-]6?B;<?Z^3_ 'C_ #K[E_X)N?\ (#\=?]?%I_Z#+7PU<?Z^3_>/
M\Z^R/^"<'B6&WUSQGH$DH$]U!;WD$9ZD1LZR$?\ ?R/_ #FOZ*XZIRJ<.XA1
M6W*_NE&Y^T<7PE/*JW+T:?\ Y,CZD_:,_P"2#^//^P/<?^@&OR/K]H/%GANU
M\8>%]6T*^W"SU*TEM)BAPP5T*DCWYKX6\4?\$]=9\.Z+JVIQ^,;&ZM[&VEN0
MK6;H\BHA;'WB 3CU-?FWA]G^797AZV&QE3DE*2:T;OI;HG^)\7P?FV#P-&I0
MQ$^64I)K1ZZ6Z(R?^">>I?9?C5JEJSA5NM%F"KQ\SK-"P_0-7Z)3;_*?RP#)
MM.W=TSVS7Y!?!?XBR?"GXG:!XG5&EALI_P#2(DZO"X*2 <\G:QQGN!7ZZ:/K
M%GX@TFSU/3KF.\L+N)9X+B(Y61&&0P/N#7!XE8&I1S.&,M[E2*5_..Z^ZW](
MX.-L+.ECXXFWNS2^]:-?=8_/^\_X*$?$VQNIK:XT'PQ%/"[1R1M9W(*L#@@C
M[1U!%0_\/$OB/_T!/"W_ ("7/_R17??M*?L2:QXH\7:AXJ\!M:S'4':XN](N
M)!"PF)RS1,?E(8Y8AB,'."0<#S+P#^P7\1=?UF%/$EO;>&-*5QY\TEU%/,R=
MQ&L3,-W^\0.>_2OM,)/@C$8..+G"G%VNXM^\GU7+>[^2=SZJC+A:KAEB)1A'
M35/XEY6W?R.JA_;:^-ES#'-#X$TN6*10R21Z/>LK*1D$$3<BO&OV@?C%XT^+
MU]HTWC+0K;0YK&.5+9;>SFM_,5RI8D2NV<%1TQUK]4M+TVWT?3+2PM$\JUM8
M4@B0?PHJA5'Y 5^<G[>'Q M/&/QC32["=+BVT&U%E(Z8(^T%BTHS_LY53Z%6
M%>5P?F>!S'-E#!Y?&GRJ3YTVVEMVZWL</#..PN-Q_+A\'&GRIOF3>G3MUN?-
MU%%%?O)^MGU!^PW\#=,^)7BC4_$?B"T6^TG1#&L-I,H:*>X?)^<'J$ SM/!+
M+V!!_0/Q!KVG>#_#U_J^I3+9Z9I\#3SR;20D:C)P!UX' '7I7R9_P3AUZUD\
M+>+]$W*+V&]BO"O=HW39D>H!C/TW#UKZ6^,'@>7XE?#+Q'X9@G2VN-1M&BAE
MDSL60$,F['.W<!G';-?RIQGB)XOB25#&S:I1<5_ABTFVO6[9_/O$=:6)SR5+
M%R:IQ<5Z1TNU^9\A>-O^"C>K27DD?A+PK96]JKD)<:S(\SR+V)CC90A]MS?6
MNN_9=_:Q\:?&CXIG0-=MM(@T_P"Q37/^@V[H^Y2H RTC<?,:^=3^Q;\7_P"T
MS9CPJ"H?;]I^W6_E$9QNSYF<=^F?;/%?8G[,'[*-M\#?-US5KQ-4\5W,)@+V
MY(M[6,D%D3(!8D@98@=, #DG[#/J7"&6Y54A@U"=62M'E?/*_=N[MWUMY'TF
M<4^',%@)PPJC*HU:-GS._=N[M_5CZ%K\39_]=)_O'^=?ME7XFS_ZZ3_>/\ZG
MPKWQO_</_P!O-/#[X<7_ -N?^WGZ8_L+?\F[Z3_U^77_ *--1?MW?\F]ZA_U
M_6O_ *'4O["W_)N^D_\ 7Y=?^C347[>'_)O6H?\ 7]:_^AU\<O\ DM?^X_\
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MIMK90#;!;1)#&/15  _05^?O_!0GQE#K7Q0T?0('60:+8YFVG.V69@Q4_P#
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MCN47[-(V Z!@,YYZUX[\;/@YK7[._C6PTZ75/M,\MLMY;ZA9*\./F92 <Y#
MKV/\0KZV_8S_ &D]'U_P?IO@77[V'3M?TR-;:Q:X<(E[ .(U4GCS%&%V]2 "
M,\X^@?B'\*?"GQ6TV.Q\4Z+!JL41)A=RR2Q$XSLD4AES@9P><<YKRJG%^;Y'
MF\L-G*YJ*;T48JZZ23TO]_D]3@6:8G"8AT\;K'T7WGYO_#W]KKXF^ +J'_BH
M9]>L%;,EEK+&Y#CT\QOWB^V&Q['I7Z>>'-8'B+P]I>JK"]NM]:Q7(AD^\F]
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M(_7KX%?\D3\ ?]@"P_\ 2=*^5O\ @I)_R$/ '_7*^_G!7U3\"O\ DB?@#_L
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M *3,^-RK_?U_V]^3/B:OT-_X)V_\D9US_L/S?^D]O7YY5^AO_!.W_DC.N?\
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M^0U>7+L#3=!O9/[3_P 5W=_XM>B/H<'C,/.U*DN7R/J#]@WQ;#KOP-BTH/\
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MI;A1UHZTH&*"&P Q2T44$-A1112,FS?^'W_(_>&O^PG;?^C5K]C*_'/X??\
M(_>&O^PG;?\ HU:_8ROY]\4/X^%])?FCRZW\7Y+]3\]?^"A7_)8M&_[ D7_H
M^:OEZOJ'_@H3_P EBT?_ + D7_H^:OEZOU3A+_D1X7_#^K.Z3T7HOR05]R_\
M$Y;61=!\;7!7$3W-LBMZD)(2/_'A^=?#BJ68 #)/  K]0OV2?A;<_"OX/V-M
MJ,+6^KZG*VHW<+YW1,X 1".Q"*F1V):OGO$+&4Z&2RH2?O5)))>C4F_E;\4<
M-=WY5YGK.N2K!HNH2/C8EO(S;NF I-?CKX=T=O$'B#3-+C;8]]=16RMZ%W"Y
M_6OU*_:6\91^!_@?XLOVD*336;65OM.&,LW[M<?3<6^BFOS(^&MU'8_$;PK<
MRE1%#JMK(Y;I@3(3GVXKYOPXHU*.7XS%1ZM)>L4W_P"W()>[1<K]S]?--T^#
M2=-M;&UC$5M;1+#%&HP%50  /P%?+O[4/[,OCSXX>/K;4]*U/1X-&L[-;>WM
M[ZYE5E;):1MJQ,!DD#.>0HKZKKYJ^.7[9$OP5^(-UX9D\%_VJD<,4\=Y_:GD
M>:KKG[GDMC!W+U/2OR_AF6:_V@ZF4P4ZR3>MMM+OWFM=?4BFG%-1VL>#_P##
MOGXC_P#05\-?^!<__P 8KZP_9B^&/B?X0_#F3PWXFO;&]>&\DELS82.Z1PN%
M)4ED4YW^8>G\5>$?\/(/^J>?^5O_ .YZ/^'D'_5//_*W_P#<]?H.;8+C/.L-
M]5Q>'BXW3T=-.Z_[?):YK7/4?VYO#L.M? 6]O73,^E7EO=1-W&YQ$WX8D/Y5
M^;E?3_QD_;8_X6U\.=6\*_\ "&_V5]O\O_2_[4\[9LD5_N>2N<[<=1UKY@ZU
M]_P3EN.RK+)8;'PY9<[:5T]&EV;6]RI27*C]>_A-_P DM\'_ /8'M/\ T2E?
M)7_!1G_D->!O^O>[_P#0HJ^M?A-_R2WP?_V![3_T2E?)7_!1G_D,^!O^O>[_
M /0HJ_'.$/\ DJ8>M3_TF1A1_@KT7Z'QS7Z/_L*^&X='^!-MJ"#]]J][<7,C
M?[C^2!]/W?ZFOS@K].OV,[I;K]G3PN%"*8FNHV"#'(N9.ON00?QK].\2)SCD
MT(QV=2*?W2?YI&6\T;7[2'P]\3?%+X9S^&_#%Y965Q>7$?VJ2^E>-&@7+%04
M5CDL$[8QFOD;_AWW\1_^@KX:_P# N?\ ^,5]>?M!?&B3X%^#;37UT,Z\DUZE
MH\/VK[/Y>Y'8-NV/GE,8QWZU\]_\/'O^J>?^5O\ ^YZ^ X8J<44L!_PCT8RI
M.3U?)>^E]Y)]NAO4MHI&_P#LT_LM^/O@K\24UO4=3T672)K:2VNX+*YF=W!
M*85HE'#JO?IFOJV^LX=2LKBTN$$MO/&T4B,,AE88(/X&OC/_ (>/?]4\_P#*
MW_\ <]+_ ,/'?^J>?^5O_P"YZSS7AWBK.,2L7B<,N>R6DJ:VV^UN91E"FVXL
M^/\ Q)HY\.^(]5TMFWM8W<ML6]=CE<_I7Z>?LK_\F^^"_P#KT;_T:]?F)XJU
MS_A)O$^KZOY/V;^T+R:[\G=N\OS'+;<X&<9QG K]._V5_P#DWWP7_P!>C?\
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MP?\ M]>.M:D\=:?X3%XT6A16,=XUK&2HEE9W&Y^?FP$&/3)]:^4:^C_V]O\
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MR6[B2+P[I1<VC,#D>?*P5I!ZHJ@<<LPR#^C=O;Q6L$<,,:PPQJ$2.-0JJH&
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MWX(_\$I?BIX\UR"X^((A\"Z '#3F2YCNK^=.I$:1LRJ3TS(PQUVMTJ/X^?\
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M?2O$/AK^W%<V_P 5-:\3^.8;Z?2KFQ^R6.FZ.B.MIB16  =USD [GSDG'&
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MHL$JZ#I^J>(KO;F,^6+6 GT9W^<?@AK\[*0FOCJ/AMDE.?-)SDNSDK?A%/\
M$^9I<"933GS2<Y+LVK?@D_Q/1?C3\>/$_P <M<2]UR=8;*W)^R:;;9$%N#W
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M6_(481@K15C1T'Q%JWA;4%O]%U.\TB^52JW5A</!* >" RD'!KI?^%X_$?\
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M4;]DE^1,:<(?"DA\,TEO,DL3M%+&P9'0D,I!R"".AKL_^%X_$?\ Z*!XI_\
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M/$&J>&M2CU'2-2O-*U",$)=6,[PRKD8.'4@C()'6NE;XX?$9@1_PG_B@CO\
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M3=2Z71?J<M^TG^RCJ?QT\;66NV6OVFE16]@EF89X&=B1([;L@]/G_2O+[/\
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M""!S@C:.N>/D/XI?"?7_ (0:];Z1XA2W2[GMQ=)]FE\Q=A9E'..N5-??MO\
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M*,*-2,GS+1-/I+L><5^JGP&_Y(KX'_[ ]K_Z+6ORKK[_ /A)^U)\,/#'PO\
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MQ=7IQ5!PC';1QBKVNW)[_P!60L+2RG(*<YRK*4GYIO3HDOZ\SR+]LW6-+O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)7\[>(O_ "-:?_7M?^E3/Z"\/O\ D5U/^OC_ /28!1117Y:?IP4444 %%%%
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M@D *6BB@04444""FDT$TE !2@4 4ZD(****"0HHHI@%%%% !7;? _P#Y+5X
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MQGX_T^W\*Z3X?N?MJV_V^&YN+N15.Q5$+NJKN(+%F' P <\?6G[?W[4WBO\
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M#G\)^%M&\,W^G37LE^TNL6MQ),)'5%(!CG0;<(.V>O-?HG\//VLOB?\ $?\
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M]-N&MY< X;!X9<_PL,,#W!%8M?TQ3J1JP52#NFKI]TS^@(2C4BIP=T]4% %
M%!-:%@31110 4444%!1110,****"@HHHH ****!A11104%%%% !1110 4444
M %?4O_!.O_DMFM_]B]/_ .E-M7RU7U+_ ,$Z_P#DMFM_]B]/_P"E-M7R'%W_
M "(L7_A_5'RW%'_(EQ/^$_1.BBBOXV/Y0"BBB@ HHHH **** "BBB@ HHHH
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MMH9WW?K0!F@#->P_LN_"'3OC#\1FT_6)'&E6-LUY/#$^QY\,JB/(Y );DCG
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MRT_3@HHHH **** "BBB@ HHHH *^:?\ @H]_R9A\1O\ KG9_^EL%?2U?./\
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M_P %DO\ DMG@C_L7S_Z425^N5?D;_P %DO\ DMG@C_L7S_Z425S5FW.E?O\
M^VR.BBDH5+=O_;D2?\$:_P#DL_CK_L7U_P#2F.OO7]NW_DT/XH_]@D_^C$KX
M*_X(U_\ )9_'7_8OK_Z4QU]Z_MV_\FA_%'_L$G_T8E=&8?[I_P!N2_.1S8+_
M 'E_XE^43\%/#_\ R'M-_P"OF/\ ]#%?TP6_^HC_ -T?RK^9_P /_P#(>TW_
M *^8_P#T,5_3!;_ZB/\ W1_*NN7^[Q]7^43'_E^_3]3\^O\ @LM_R2'P#_V'
M9/\ TG>OB_\ X)L_\GH?#S_>OO\ TAN*^T/^"RW_ "2'P#_V'9/_ $G>OB__
M ()L_P#)Z'P\_P!Z^_\ 2&XKGP/\>I\__2$=&*_@+_"_S9^P/QN_9;^&O[15
MUI-QX^T!]:ETI)([-DOKBV\M9"I<?NG7.=B]<]*_#G]JCP-HOPT_:'\>>%_#
MMH;'1-+U-[>TMVE>4QQ@# W.2QZ]237]#U?S_P#[<?\ R=O\4O\ L,R?^@K7
M&_=KQBMK2_./^9OO2DWO=?DSZV_X)T_L;_"7X^_ J^\1^./#,FL:Q%K4]FEP
MNHW5N!$L43*NV*15ZNW.,\U^B/PO^"?@WX-^ V\&^$](_L_PXSRR-92SR7 8
MR??RTC,Q!],XKY8_X)#?\FP:I_V,EU_Z)@K[@KTL0DI<JV<8W^Y'!1;<>9[I
MO\V?SM?M,?".;X%_'/Q?X,=&%MI]ZQLF<??M7^>%O?Y&7/N#7ZZ_\$R_BX/B
M=^RWHMA<3^;JGA>5]%N >OEIAH#]/*9%^J&OG?\ X+%?!?<OA'XHV-O]W.B:
MFZ+V^:2W=O\ R*N?=17F7_!(SXM?\(C\=-7\%74VRR\56),*L>/M5OEUQ]8S
M-^0K#!MRIRHRW7YQU3^<?S-\6N6<:RV?ZZ/Y)_D?5/\ P5H^*)\&_LYVWABW
MEV7OBK48[=E5L'[-#B60_3<(E/LU?GQ_P3Y^$'_"XOVHO"EK<0^;I6BN=;ON
M,C9 08U/LTIB7'H37I/_  5F^*7_  FG[1UOX8MYM]EX4TZ.V91T%S-B60_]
M\F$?\!KZ4_X(_P#P@_X1[X6^)/B%=P[;KQ#=_8K-F'_+K 2&8>S2LX/_ %R%
M+!;SK^K_ $C^.H\9\,:/>R^_5_AI\C]!J*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#B/CE_R13X@?\ 8O:A_P"DTE?D!7Z__'+_ )(I\0/^Q>U#
M_P!)I*_("OZ*\+_]SQ/^)?D?J?!_\"KZK\@HHIP%?M9^@ !03033:HH****!
MA1114E!2]*.E)5#"BBBF4%%%%2 4444QA1113&%%%%(H****!A113X8GGE2.
M-2\CL%51U)/ %,K8^H_V0?V5;7XIQMXN\61NWAF&1HK2Q5BAOI%.&9F'(C4\
M<'+,",@*0?T"T;0].\.Z=#I^E6%MIMC"-L=M:1+%&@]E4 "L_P !>%+7P+X+
MT3P_9KMM]-M([=?]HJH!8^Y.2?<U\P_M\?&K5/".GZ3X+T*^EL+C4XFN]0FM
MW*2?9P=J1AAR [!\XZA,="0?Y.Q>*QW'&=+#0G:#;Y5]F,5UMWMOW>FUC\+J
M5L5Q-F*I*5HMNRZ1BNMN_P";T/JK4K/2?$EG<Z7?PV>IVTJE)[.X5)48=PR'
M/ZUY[\(?@'I'P7\6>+[[P^[1:/KJVKQV#$L;62(S;PK'DH?,4C/(Y'I7Y3:;
MJ5YH]]!>V%U-97D#;XKBWD,<D;>JL#D'Z5^F'['OQYO/C5X'O+?6CYGB+0WC
MANKA5VBXC<-Y<IQP&.QP0.ZYXSBO5S_A/'\-9=4GA\1[2A.RFK6MJG%VNUND
MKZ-7MLV=V:Y'BLGPDG2J\]*5E)6M;5-.UWU2UWZ=3T3XZ_\ )%?'G_8"O?\
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M/UT9\(_'KX(:K\"O&C:/>R?;+"X4S6&H*A59X\XY'9UZ,N>,@]"*^X?V"O\
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M_LNSD^Q:9:JLVH:@5W"",G  '=VP<#V)Z UYC7Z@_L7^ 8?!/P)T:Y\I5O\
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MGSX_DD)^3N5+?1A7E'[<GP9T+0?!.B^(_#>@:?HPL[LVUXNF6<<"ND@^5G"
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M9#5R^@Z\III6_$\=Z4=:[3X1_"O5?C%XTM?#^F,L&X&6XNI 2EO",;G([]0
M.Y(&1U'Z ^ OV6/ASX$L8X_[ M]<O0!YE[K$:W+.>N0C#8G_  %1VR3UKMS[
MBK Y#)4JMYU'KRKMW;>WXOR//R[)\1F=Y4[**ZO\C\RZ*_7N/3-$TX);)::?
M:C^&%8T3\ABN>\3?!/P'XP@ECU7PGI4[2C#3QVRQ3?A*@#C\#7Q=/Q*H.7[W
M"R4>ZDF_NLOS/H)<(U+>Y63?I_P7^1^4M%>[_M.?LVGX+7MMJFD3RWGAF^D,
M49GP9;:7&?+8C[P(!*GV(/3)]<_8A\ >&/%?PZURYUSPYI.LW,>JM&DVH6,4
M[JODQG:"ZD@9)./>ON,7Q-A*&5+-J*<X-I66CU=M;]CYJGD^(GCOJ%3W9=]U
MM<]?_9+_ .3??"?_ %SG_P#1\E>>_M_#_BV7A[_L,#_T3+7TII.CV&@:?%8:
M98VVFV,.1':VD*Q1)DDG"J !R2>/6J_B#PKHOBRUCMM<TBPUFWC?S$AU"V2=
M%;!&X!P0#@D9]Z_G/"YQ##YW_:K@W'GE*W76^GXGZM++YO*U@.;7D4;]-%8_
M(6NO^%?Q.UCX1^+X/$&C&-IU1H98)@3'-$V-R-CGJ <CH0*^P/VPOAQX3\,_
M!FXOM'\+Z+I-Z+ZW07%CI\,,@4DY&Y5!P:\%_8U\.Z3XH^,#66LZ79ZO9_V;
M/)]GOK=)H]P9,-M8$9&3S[U^_P!'/\+FN2U\?4HMTX\R<7;5)*_YGY1B<IK9
M?F%'"QJ>]*S372[:7Y'H>L?\%!M2N=*FBTSP;;V.H,N$NKC4#.B'U\L1KG_O
MJOE#4M0N=6U"ZOKR5KB[NI6GFE;J[L2S,?<DDU^J?_"F/A]_T(OAK_P46_\
M\17Y<^+(8[;Q5K,,,:Q11WLR)&@ 55$C   =!7D\&8W*<3*O#+<,Z5K7N[WO
M>VK;9Z/$F&S"C3ISQM?G5[))6_*QDT5M^#?!VK>/O$EEH6BVQNM1NWVHF<
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M,G"2DNA_-#XK\+ZGX)\3:IH&LVCV.K:9<R6EU;R#!21&*L/S'7O7Z._L,_\
M!2CPKX%^'.F?#_XJ376F)H\?V?3=>AMGN(FMQ]R*9(P7#*/E#*I!4#.",M]%
M_MB?\$]_"_[35P_B72;Q/"GCQ8PC:@L.^WO@HPJW"#!W   2+R!P0P"@?G1X
MR_X)F_M ^$;Z:*#PA#XBM8_NWNC:C!)')]$D9)/S055.I*,7":_R]0J4XRDI
M0_X/H?IKKW_!2#]GK0=+^V#Q_'J3M&9([6PT^ZDFD_V<>6 I/^V5K\G/VR/V
MHKS]JKXL-XA%G)I>@6$'V+2=/E8,\<(8L7DQQYCDY..  JY.W)=I_P"P?\?M
M3N!##\+]:1SWN/*A7KC[SN!W]:]V^#/_  2.^)?BO4+:X^(-_8>"-'#9FMH9
MTO;]P".%$9,2Y&?F+G''RGI1[/GDI/H+VG+%I=1O_!)'X,WGBSXX7OC^XMF&
MC>%[22.*X93M>\F4HJ*>Y6-I&/IE/6OV%KC?A)\(_"_P/\"V'A+PAIRZ=I%F
M"0,[I)I#]Z61NK.QZD^P&  !V5;U)*5HQV2M^IC3BU>4MW_7]>9^+_\ P5KT
M2?3?VJDO71A#J.A6DT;GH=K21D#Z%/UKH?\ @E;^T;X(^"^M>.=$\;:Y;>'8
M=:2UGL[Z\RL)>+S0Z,^,*2) 1G X(SG K[N_;2_8STK]K3POIX341H/BS1]Y
MT[4FC\R)E?&Z&51R4)4$$<J><')!_-/Q-_P2T_:#T&]:"Q\.:9XCB'2YTS6+
M=(S^%PT3?^.]ZY</)T5*#6]_Q=_Z].QT5XJK:2>UOPT/V0^'GQ:\&_%JSN[O
MP;XETWQ+;6<@BN)=-G$JQ.1D*Q'0XYK\NO\ @LE_R6SP1_V+Y_\ 2B2OJ3_@
MF9^SWX__ &?/ OC33_'^@?V!>:AJ4-Q:Q_;+>Y\Q%BVDYAD<#GL2#7G'_!2[
M]DWXJ_M ?%'PMJ_@'PK_ &]IUEH_V6XF_M&TMMDOG.VW$TJ$\,#D#'-+$0M4
MI\NJO?\ \E?ZNP\/*].IS:.W_MR_34\F_P""-?\ R6?QU_V+Z_\ I3'7Z#_M
MG:+-K_[*GQ2LX$:27^PKB8*O4^6OF']$KY3_ .":'[)_Q5_9]^)WBS5O'WA;
M^P=/OM'%K;S?VA:7.^3SD;;B&5R. 3D@#BOT-O+.#4+.>UN8DGMIXVBEBD&5
M=6&"I'<$$BM\5'VM!4T]7%K[W(Y\,_9UI3DM.9/\(G\S%C=-8WD%PH#-#(L@
M!Z$@YK^@3X0_M??";XQ0Z#:>'_&FFS:YJD0\O19)#'>+($W/&8V ;*X;D<'&
M02.:^!_CY_P2+\6V/B34-2^%6IZ?J^@S.TL.CZG.;>[M\G/E*Y'ER*.S,R'&
M 0>IJ_L:_L*?&_X2_M->"O%7BGP6--\/Z;/.UU>KJUE,$5K>5%.Q)BYRS*.%
M[UI1FJB5.>BW] JPY&ZD=6E]Y[%_P66_Y)#X!_[#LG_I.]?%_P#P39_Y/0^'
MG^]??^D-Q7Z)?\%,/V?_ ![^T%\./".E^ =!_MZ_L-6>YN8OMEO;;(S"RALS
M2(#R0, DU\Q_L1_L.?&WX0_M.>#?%OBWP5_9/A_3S=&YO/[5L9O+WVDT:_)'
M,S'+.HX!Z^E98+W:TW+1:_\ I"1IB?>HI+L_S9^L=?@C_P % =$GT']L'XE1
M3(R>??)=H6_B66&-P1[?-^E?O=7QY^W)^P%;_M1W5IXI\.ZK;Z#XWL[<6I:\
M5C:WT0)*+(5!9&4L<. W!P0>".><7SQJ+I=?)V_R1M!KEE!_TU_P[/!?^"7/
M[4WPY^&7PH\0>#?&GB:Q\,:BFK/J-M)J+&**>&2*-2 Y&W<K1G@D'## .#7Z
M.^!OB!X;^)F@KK?A36[/Q!I#2-$M[82B2(NOWE##N*_%G6_^"7_[1&E7SP6O
M@^SUF)3@7-CK5FL;>X$LJ-^:BOTS_P""??PA\6_!#]G2S\+^-=)_L778]2NI
MVM?M,,^$=@5.^)V7G'3.:[G)5;REHTE^%E^1Q\KIM1CLV_QN_P ST?\ :2^$
M<'QT^!_B[P7,J&?4;)OLCN.([E/GA?\ "15_#-?@/\.?&6J?!OXJ:#XDACEM
M]4\/:G'</ WRMNCD^>)O3(#*1[FOZ1*_"O\ X*0_#73_ (:_M8>*(]+EA-KK
M21ZT;>(\V\DV3(C#L2ZL^/205Q1DZ->,X]?S6J_"_P!R.MQ56C*#Z?D]'^GW
ML\4\;>(M6^.'Q@U?6%ADN-8\4:P\L-N#EO,GE_=QCZ;E4?05_09\&_AQ:?"'
MX5>%?!MD 8-%T^*T+C_EI(%_>/\ 5G+-^-?CQ_P3!^#Y^)W[3FFZM<P>;I/A
M.!M7F+#*^</DMU^N]MX_ZYFOVZKL451H1IQZ_DM%^OX'*Y.K7E-]/S>K_0**
M**Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH XCXY?\D4^('_8O:A_Z
M325^0%?K_P#'+_DBGQ _[%[4/_2:2OR" K^BO"__ '/$_P")?D?J?!_\"KZK
M\@ H)H)IM?MI^A!1110,****DH*7I1TI*H84444R@HHHJ0"BBBF,****8PHH
MHI%!1110,****905N>!3&/&WAXRAC%_:-OOV]<>:N<5AT^&5X)4DC8I(C!E8
M=01T-958\\)0[JQG5A[2G*'=-'[9U^<?_!0;S/\ A>=GO^[_ &+;[/IYLW]<
MU^@'@?Q/;^-/!NB:]:MN@U*SBNE]MR@D'W!)'X5\K_\ !0#X.ZEXBL=)\<Z1
M9O>?V9 UIJ20J6=(-Q=),?W5+/N/;<#T!(_E3@;$0R_/X0Q+Y;J4->DNWWJW
MJ?B/"]:.&S11K:73C\_Z5O4^#:^VO^":_P![XB_33O\ VYKXMT_3[O5KZ"RL
M;6:]O)V"16]O&9))&/0*H&2?85^EO['7P%U#X*^"[^ZUPB/7]<:*6XM5;(MH
MXPWEQD]"_P [DD<<@<XR?V3Q!QV'H9)5PTY6G4Y>5=7:2;^22W^1^@<68FE2
MRV="4O>G:R]))OY:'I'QU_Y(KX\_[ 5[_P"B'K\DO#[0KKVFFXX@%S%YF,?=
MWC/7CI7ZV_'7_DBOCS_L!7O_ *(>OR"KYSPQCS8'%1[R7Y'F\&QY\%6CWE^B
M/VU7H,5YQ\0/VBOA[\+=>71O%'B#^R]2:%;@0_8KB7]VQ(!W1QL.JGOGBMCX
M0^.(/B/\,_#GB*"17-[9QM,%;.R8#;*A]PX8?A7S)_P4 ^#>I:]'I?CS2+22
M\6PMS9ZFD(+-'"&+QRX'\(+.&/;*GH"1^29%E6%Q6;K+<SDX*[CHTGS+9:IK
M5Z;;V/@,IP-#$XY8/&R<=UI9>\NFJ?IZGKO_  VE\&O^AQ_\I=[_ /&:/^&T
MO@U_T./_ )2[W_XS7Y;U]C?LI_LCZ'\1O -SX@\<:9?1_:KC_B6JL[0;X HS
M)@=0S$X)_NY'!%?J.<<%<.Y'A?K6+K5>6Z5DX7;?9<B]?0^VS'AS)\KH^WQ%
M2I:]M'&__I)Z/\=OVK/A9XS^$'BO1-(\4?;-3OK%X;>#^S[I-[DC W-$%'XD
M5^>5?<_[1G[*OPR^%?P>U_Q'IUG?1ZG;K%':F6]9U\QY53[IZ\$G\*^&*^PX
M'IY9# U)94YN#GK[2U[V6W+TM8^EX9A@HX23P+DX.3^*U[V7;H?KG^SO_P D
M*\!?]@:U_P#18KYK_P""E'_'O\//][4/Y6U?1W[-MY%>_ 7P))"V]%TF",D?
MWD7:P_ J:\;_ ."@'PYUGQAX/\,ZMHVG76IOI-S,D\-G$TKK'*JG>54$X!B
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MS_\ )3_$O_8'_P#:T=?>GB#_ ) .I?\ 7M)_Z :^"O\ @G+_ ,E/\3?]@?\
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M%5'+JR=>36UI<JZWO=:[)/76YY_%'$L,!05+ 55[9OI:5EUONM>WS/DS6?\
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M.SKY;-_WX_E+_P!M_$^E\/<P_C8"3_O+\I?I^)]*_P#!-O\ Y ?CG_KYM?\
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MW?E93CT(/>O&OVVO^3;_ !+_ -=;3_TIBK\@P>-_M+BBCC.7EYZT7;LG)6_
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MC6CA\6Y2VNT?8/[4W@'Q9\1OA?)I?A"Y*7HN%EN+19O)-Y"%8&+<2!U*G#$
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MTL31J0=I<KU7K_P6?I]^S/KFH^)/@CX:U+5;V?4;^=)C+<W,A>1\3.!DGD\
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M<!54!0!T %?L=\5?^"7OPK^+_P 1-?\ &>LZ_P",+;5-:N6N[B&QO+5(%8@
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M+@7!YW6>+HS]E5>^ET_-JZU\T_DV>9F_"^'S*HZ].7)-[Z73^6FOG^!^PO\
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MT]%LOS\PHHHK[P^T"BBB@84444%!1110 4444#"BBB@H**** "BBB@ HHHH
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M@J!QOC(VNWN"OT)YKY!HJLUR7 9U35+'4^:VSV:]&M?T?4G$86CBE:K&]C]
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M%R]9-K[KZ_.YQQRO"P=^6_JS6\5>*]7\;:]=ZUKM_-J>IW3;Y;B<Y)]  .
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MT2N>?A\GAA:T:M:I>ST6UWT_X8[K6/\ D$WO_7!__037XZ]*_8K6/^03>_\
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MB'#?]O?^ER/+X@?_  I5?^W?_24==\'_ /DK7@G_ +#EC_Z4)7ZRU^37P?\
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M\C\0R=_\*6&_QP_]*1^AU?D=XTY\8Z[_ -?\_P#Z,:OUQK\C_&?_ ".&N_\
M7_/_ .C&K\L\-?XN*](_G(_3N/O]VH?XG^1CT445^ZGXFV%%%'2@S;#I113O
MNT$-A]VD]S1[FEI&384444C-L****!!1110 4444 %%%% !1110 4444 >Q?
MLB?\G#^$_P#M[_\ 22:OTDK\V_V1/^3A_"?_ &]_^DDU?I)7\[>(O_(UI_\
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M]4?+<4NV2XF_\OZH_0VBBBOXW/Y0"BBB@ HHHH **** "BBB@ HHHH ****
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MJ=:/+4BI+S5S/FZHZ;6OBAXR\2:=+I^K>+==U2PE(,EK>ZE--$^"",JS$'!
M/3J*YJBBE3HTZ*Y:45%>2L9RDWN%%%%;&;9VGA#XT^.O <,<.A>*M3L+:,82
MU$YD@7Z1OE1^5==-^UU\7+B(H_C&8*>Z6=LA_,1@UX\!BC[WTKRJN4Y?B)^T
MK8>$I=W&+?WM JLXJT9-&WXG\;>(?&URL^OZWJ&LR(24-]<O*$SU"ACA1[#%
M8M%%>C3IPI14*<4DNBT1C*3D[MA5O2M6OM!U"&_TV]N-.OH#NBNK65HI8SC&
M592".">GK52BG)*2<6KIF39VG_"[/B)_T/OB?_P<7'_Q=8'B'Q5K?BZZCNM=
MUB_UJYC3RTFU"Z>=U7).T%R2!DDX]ZRJ*YJ>%P]&7-3II/NDD3*I)JS8444H
M'<UTF!W'@GXW>._AW;BW\/\ B>^L+1?NVI<2P+SD[8Y RCGT%;&O?M._%+Q)
M:FWO/&>H)$>OV,):L?\ @42J?UKR_K2@8KS)Y7@*E7VTZ$'/NXQO]]KE*M4B
MN6,FEZEW3=:U'1]4CU.PO[JRU*-BZ7EO,T<RL<Y(<'()R><]ZZ?_ (77\0_^
MA\\3?^#BX_\ BZXOK2UU5,+0K.]2FI/S29C[24=F27%Q+>7$L\\KSSRL7DED
M8LSL3DDD\DD]ZCHHKHVT1BW<[7PI\:O'?@B*.'1?%>J65M$NV.U^T&2!![1O
ME1^5=7+^US\6YHC&WC"4*1C*V5LI_,1YKQ^G?=KRZN4Y?7G[2KAX2EW<8M_B
MBEB*L%:,VOFS<\4>.?$7C6=9O$&N:AK,B$E/MMR\H3/7:"<*/88K"^]1]ZG5
MZ-.G"E%0IQ22Z+1'-.;D[R=V%365[<:;=175I/+:W,+!XYH7*.C#H0PY!J"E
MJG:2LS(]2T7]J'XIZ#:K;VOC.^DC7H;Q8[IO^^I58_K57Q%^T=\3/%4!AO\
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MJ:72FO\ TJ1_0GA_%K*IM]:C_P#28A1117Y>?I@4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5M2L8]4T
MZZLIAF&XB:%_]U@0?T-?C%X@T6?PWKVI:3=#%S87,MK*,8^='*GCZ@U^TU?F
MY^W9\,7\&_%H^(+>(C3/$4?VC< <+<+A95^I^5O^!'TK]E\,\QC0QU;!3?\
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MF4<MR6LV_>J+D7_;VC^Y79P8ZJJ="7=Z'U#1117\A'QP4444 %%%% !1110
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MBBB@04444$A1110 4444""BBB@D****!!1110(****!!11102%%%% !1110
M4[[M'W:;02%%%% @HHHH$%%%. Q0( ,4$T$TV@04444$A1110 4X#% &*6@
MI":":;0(****"0HHIP%  !2T44$A32:":2@ HHHH *<!0!2T$A1110(*:303
M24""BBG 4$@!2T44""BBB@04TF@FDH *4"@"G4A!11102%%%%, HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***]D^ '[,WB'XX:BEP%DTKPS')MN-4D
M3AL=4B!^\WZ#O7#C<=ALNH2Q.*FHP75_UJ_)&=2I&G'FF[(/V9O@#>?&_P 8
MKYZ20^&M/=7O[H# ;N(E/]YOT'-?J-9V<&GV<%K;1+#;01K%%&@P$51@ >P
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M09A11100V%%%+09MA1UHZTO2@S;#I1UHZTM!FV%%%%! 444OW?K2,VP^[]:
M,T 9I:1FV%%%%(S;"BBB@S;"BBB@AL*7I1THZT&;8=:=THZ4G6@S;#K2T44&
M384444B I?N_6C[OUI*1FV%%%.Z4C-L.E)][Z4?>^E.H(;"BBB@S;"BBCI09
MMATHHIWW:"&P^[2>YH]S2TC)L****1FV%%%% @HHHH **** "BBB@ HHHH *
M*** "BBB@ HHI\<;S2)'&C22.0JJHR23T 'K2 97U?\ L>_L^-J]Y;>//$%L
M5L(&W:9;RC'G../-([J#T]3SVIO[//[']QK;6OB'QU;26NG<20:1)E9)_0RC
MJJ_[/4^U?:=I:PV%K#;6T206\*+''%&H544# 4 =  *_&>+^+J:IRR[+Y7D]
M)26R75)]^[Z>NW[%PGPG4=2.89A&R6L8O=OHVNW9=?3>:BBBOPL_;@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KB/BA\&?"7Q@TL6?B72TNG12L%Y'\EQ!GNC]1]#D'N
M*[>BNC#XBMA:BK4)N,ELT[,UI5:E&:J4I-275'Y]_$K_ ()\^*=#DFN?!VI6
M_B*R'*VETPM[H>P)^1OKE?I7@/B3X+>//"#LNK^$-8LU7K*;-WB_[[4%3^=?
ML%17ZG@/$G-,-%0Q4(U4NOPO[UI^!]IA>+L;12C6BI_@_P -/P/Q-FMY;9ML
MT3Q-_==2#^M1U^VU%?0?\14[X+_RI_\ :'J_ZZ_]0_\ Y-_]J?B317[;44_^
M(J?]07_E3_[0?^NW_4/_ .3_ /VI^)-%?MM12_XBI_U!?^5/_M!_Z[?]0_\
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M[;44?\14_P"H+_RI_P#:!_K[_P!0W_D__P!J?B317[;44?\ $5/^H+_RI_\
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M"_\ *G_V@_\ B(/_ %"_^3__ &A^(X&:=7[;44?\14_Z@O\ RI_]H'_$0?\
MJ%_\G_\ M#\2:*_;:BC_ (BI_P!07_E3_P"T#_B(/_4+_P"3_P#VA^)!-)7[
M<44?\14_Z@O_ "I_]H/_ (B%_P!0O_D__P!H?B/2@5^V]%'_ !%3_J"_\J?_
M &@_^(A?]0O_ )/_ /:'XDT5^VU%'_$5/^H+_P J?_:#_P"(A_\ 4+_Y/_\
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M4,9_T#1^]B_UEK?\^U][/R"_X4=\1_\ HG_BG_P2W/\ \11_PH[XC_\ 1/\
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M1WQ'_P"B?^*?_!+<_P#Q%?K[11_Q%#&?] T?O8?ZR5?^?:^]GY!?\*.^(_\
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M%?KU11_Q%#&?] T?O8?VK/\ E1^0O_"C_B/_ -$_\4?^":Y_^(H_X4?\1_\
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M_&'_ *%#_P J=G_\>K]/**Z?^(E9O_SZI_=+_P"3%[-'YB#]C7XP_P#0H?\
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M^Z7_ ,F+_5W"?S2^]?Y'YG_\,>?%[_H4?_*E9_\ QZE'['OQ=_Z%+_RI6?\
M\>K]+Z*/^(D9M_SZI_=+_P"3)_U;PG\TOO7^1^9__#'OQ>_Z%+_RI6?_ ,>I
MW_#'OQ=_Z%+_ ,J5G_\ 'J_2ZBE_Q$C-O^?5/[I?_)B_U:PG\TOO7^1^:/\
MPQ[\7?\ H4O_ "I6?_QZC_ACWXN_]"E_Y4K/_P"/5^EU%'_$1\V_Y]4_NE_\
MF3_JS@_YY?>O_D3\T?\ ACWXN_\ 0I?^5*S_ /CU'_#'OQ=_Z%+_ ,J5G_\
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MK_Y$_-/_ (8_^+G_ $*7_E2L_P#X[1_PQ_\ %S_H4O\ RI6?_P =K]+**/\
MB(^;?\^J?W2_^3%_JE@?YY_>O_D3\U/^&/\ XN#_ )E+_P J5I_\=I/^&/\
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MI311_P 1&S;_ )]4_NE_\F+_ %+R_P#GG]\?_D3\UO\ AD'XM]_"?_E2M/\
MX[2_\,@_%O\ Z%/_ ,J5I_\ ':_2BBC_ (B-FW_/JG]TO_DR?]2<N_Y^3^^/
M_P B?FO_ ,,@_%O_ *%/_P J5I_\=H_X9!^+?_0I_P#E2M/_ ([7Z444?\1&
MS;_GU3^Z7_R9/^I&7?\ /R?WQ_\ D3\U_P#AD'XM_P#0I_\ E2M/_CM+_P ,
MA?%L?\RG_P"5*T_^.U^D]%+_ (B-FW_/JG]TO_DQ?ZCY=_S\G]\?_D3\U_\
MAD'XM_\ 0I_^5*T_^.T?\,@_%O\ Z%/_ ,J5I_\ ':_2BBC_ (B-FW_/NG]T
MO_DQ?ZC9;_S\G]\?_D3\V!^R#\6A_P RG_Y4K3_X[1_PR%\6S_S*?_E2M/\
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MOB:\\/\ B#Q)_9^KV>SS[?[!<R;-Z*Z_,D94Y5E/![UZC7Y=_MH?\G+>,?\
MMS_](X*^ZX/R+#<08^>%Q4I**@Y>ZTG=2BNJ>FIWX/#QQ%1PGV/U$HHHKX4X
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#Q/_ (;0^#?_ $./_E,O/_C-%?EW
M17],_P#$,LG_ .?M7[X__('U']ET>[_#_(_;"BBBOYF/EPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ K\N_VT/^3EO&/_ &Y_^D<%?J)7Y=_MH?\ )RWC'_MS
M_P#2."OUSPR_Y'%7_KT__2H'L97_ !GZ?JC]1****_(SQPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#\3Z***_O4_0#]L****_@H_/PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K\N_VT/^3EO&/_ &Y_^D<%?J)7Y=_MH?\ )RWC'_MS_P#2
M."OUSPR_Y'%7_KT__2H'L97_ !GZ?JC]1****_(SQPHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#\3Z***_O4_0#]L****_@H_/PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K\N_VT/^3EO&/_ &Y_^D<%?J)7Y=_MH?\ )RWC'_MS_P#2."OU
MSPR_Y'%7_KT__2H'L97_ !GZ?JC]1****_(SQPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &??%?CK0+:QO-7TE+=H(=2C=X&WW$41W*CHQ^5SC##G'TK\U?\ A\5\9O\
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M@EXXL_%E@NN>(-6L9!-9?V[=QRQ6L@Z.B1Q1@L.Q?=@@$<@&BA[M5RJ:QO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?B?1117]ZGZ ?MA1117\%'Y^%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ5'_ !#_ /ZCZ7W_ /!#^SO^GB/U$HK\N_\ C(W_ *JC_P"5*C_C(W_JJ/\
MY4J/^(?_ /4?2^__ ((?V=_T\1^HE%?EW_QD;_U5'_RI4?\ &1O_ %5'_P J
M5'_$/_\ J/I??_P0_L[_ *>(_42BOR[_ .,C?^JH_P#E2H_XR-_ZJC_Y4J/^
M(?\ _4?2^_\ X(?V=_T\1^HE%?EW_P 9&_\ 54?_ "I4?\9&_P#54?\ RI4?
M\0__ .H^E]__  0_L[_IXC]1**_+O_C(W_JJ/_E2H_XR-_ZJC_Y4J/\ B'__
M %'TOO\ ^"']G?\ 3Q'ZB45^7?\ QD;_ -51_P#*E1_QD;_U5'_RI4?\0_\
M^H^E]_\ P0_L[_IXC]1**_+O_C(W_JJ/_E2H_P",C?\ JJ/_ )4J/^(?_P#4
M?2^__@A_9W_3Q'ZB45^7?_&1O_54?_*E1_QD;_U5'_RI4?\ $/\ _J/I??\
M\$/[._Z>(_42BOR[_P",C?\ JJ/_ )4J/^,C?^JH_P#E2H_XA_\ ]1]+[_\
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M/^(?_P#4?2^__@A_9W_3Q'ZB45^7?_&1O_54?_*E1_QD;_U5'_RI4?\ $/\
M_J/I??\ \$/[._Z>(_42BOR[_P",C?\ JJ/_ )4J/^,C?^JH_P#E2H_XA_\
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M]#;R@BOWOKJJ>]",^NJ?RZ_<SFA[LY0Z:/[_ /AC^;SXR?\ )7O'/_8=OO\
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M\0/A?XJ\.ZO;1W>GZAIL\,D<BY'*':P]"K ,#U! -?S=TZ=5PJN-MK?C?3\
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M:_5?_@E/\$_".A_ BP^(L6EQS^,-:FNH9=2N '>&&.9HQ%%Q\BD)EL<L3R2
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M^/\ D?J)17Y=_P##:'QD_P"AQ_\ *99__&:/^&T/C)_T./\ Y3+/_P",T?\
M$,LX_P"?M+[Y?_(!_9=;NOQ_R/U$HK\N_P#AM#XR?]#C_P"4RS_^,T?\-H?&
M3_H<?_*99_\ QFC_ (AEG'_/VE]\O_D _LNMW7X_Y'ZB45^7?_#:'QD_Z''_
M ,IEG_\ &:/^&T/C)_T./_E,L_\ XS1_Q#+./^?M+[Y?_(!_9=;NOQ_R/U$H
MK\N_^&T/C)_T./\ Y3+/_P",T?\ #:'QD_Z''_RF6?\ \9H_XAEG'_/VE]\O
M_D _LNMW7X_Y'ZB45^7?_#:'QD_Z''_RF6?_ ,9H_P"&T/C)_P!#C_Y3+/\
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M^/\ D?J)17Y=_P##:'QD_P"AQ_\ *99__&:/^&T/C)_T./\ Y3+/_P",T?\
M$,LX_P"?M+[Y?_(!_9=;NOQ_R/U$HK\N_P#AM#XR?]#C_P"4RS_^,T?\-H?&
M3_H<?_*99_\ QFC_ (AEG'_/VE]\O_D _LNMW7X_Y'ZB45^7?_#:'QD_Z''_
M ,IEG_\ &:/^&T/C)_T./_E,L_\ XS1_Q#+./^?M+[Y?_(!_9=;NOQ_R/U$H
MK\N_^&T/C)_T./\ Y3+/_P",T?\ #:'QD_Z''_RF6?\ \9H_XAEG'_/VE]\O
M_D _LNMW7X_Y'ZB45^7?_#:'QD_Z''_RF6?_ ,9H_P"&T/C)_P!#C_Y3+/\
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MK\'_ )'W/1117\BGQP4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %9OB;_D6]5_Z])?\ T UI5F^)O^1;U7_KTE_] -<^(_@S]'^1
MO0_BP]5^9_,]7[Q?\$Z?^3-?AS_UPN?_ $KFK\':_>+_ ()T_P#)FOPY_P"N
M%S_Z5S5Z,?X$_5?^W'GS_BP^?Z'C_P#P6(_Y-W\,?]C+%_Z37%?G_P#L _\
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MZ1PU]K?\$:_^2,^._P#L/K_Z3QU\4_\ !2#_ )/,^(7^_:?^D<-?:W_!&O\
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M%1B/]Y5G?XM>YIA=*$E:WNK3MJCZ]_X(R_\ ),OB+_V&+?\ ]$FOT2K\[?\
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M /8MWW_HEJ6)@UAYRZ6:^Y?\$,/).M%=;K\S^>^/_6+]17],'AO_ )%W2_\
MKUB_] %?S/Q_ZQ?J*_I@\-_\B[I?_7K%_P"@"NW_ )<?/]#E?\5>C_0_G:^/
MVDSZ'\<_B'87*E)[?Q!?HP(Q_P O#\_B*_7K_@E?KEKJW[(6B6L$BM-INI7U
MK<*#DJYE,H!_X#*I_&OE+_@JM^RQJ7AWQY+\7M L9+GP_K 1-9\E"WV*Z4!%
ME;'1)%"_-T#@Y/S"OGS]D']M#Q-^R7KFH&RL(_$/AG5-K7VBSSF$&11A98I
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MZW_)6/TO^#O_  1UL[S0;._^)?C.^MM0N(EDDTGP_'&GV8GG:T\H<.0,9P@
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MW_(MZK_UZ2_^@&OYGJY8_P :7HOSD;R_A1]7^2/Z(?V6/^39_A3_ -BMIO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3_@D'\$]0O))H-7\9:;&QR+>UU&W9%]@9+=V_,FON"BHY4G=%<S:LSB/@O\
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M_!E6!_X2;QUQS_Q_V7_R)7W712BN5\RW*YFUR]""QM4L+."VC+&.&-8U+=2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !65K'A71?$2[=5T>PU-?2\M4F'_ (\#
M6K10!A:3X#\,Z#-YNF>'=)TZ7.=]I8Q1-^:J/4UNT44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>prospectussummary1ba.jpg
<TEXT>
begin 644 prospectussummary1ba.jpg
M_]C_X  02D9)1@ ! 0( @0"!  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         "!     0
M ($    !    1TE-4" R+C$P+C,T   R,#(U.C R.C U(#$T.C,R.C,P  $
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M0   ;6YT<E)'0B!865H@!^D  @ % !, '  R86-S<$U31E0
M                     /;6  $     TRUL8VUS
M                                           -9&5S8P   2    !
M8W!R=    6     V=W1P=    9@    48VAA9    :P    L<EA96@   =@
M   48EA96@   >P    49UA96@   @     4<E120P   A0    @9U120P
M A0    @8E120P   A0    @8VAR;0   C0    D9&UN9    E@    D9&UD
M9    GP    D;6QU8P         !    #&5N55,    D    ' !' $D 30!0
M "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,          0    QE
M;E53    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:(
M     /;6  $     TRUS9C,R       !#$(   7>___S)0  !Y,  /V0___[
MH?___:(   /<  # ;EA96B        !OH   ./4   .06%E:(        "2?
M   /A   ML1865H@        8I<  +>'   8V7!A<F$       ,    "9F8
M /*G   -60  $]    I;8VAR;0       P    "CUP  5'P  $S-  "9F@
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M P$1  (1 0,1 ?_$ !X    & P$!               %!@<("0,$"@(!_\0
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M$?!DQ(EA07%?XH2R,4IOF DR3\ <F$Z(PR46  #.2XKPC;6EPTB9X\WQ$
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MWJZI7NKHY2  #D> R!*;)*\= 29'L182&R.4+ A 74'2( KT0VD<)7N4)U
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M)*M00M.I25@=UTBWAB.E,9A##2$V;N$*6 24=R-K=#B77XT0J\XTMJ0#V4[
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MO[L?(_9<_P#CU1_+FO\ \MA%#[+SBTMHKM1UK("?%FG=2N@WC6W)]OUXXWY
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M-F=-A\KZ9,>.>6\\([3-U%*G=+?B-AOB11)].JX@2&7T*:EI9*W&7&]12\$
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MD2*WG%J,B+-EQZ<PPE#T>',=22IQW6%K2RXVH DA/+-K6Q1QRJ72@ ?HH$,
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M(79N^H)4F]MU6OOCM'YSC\).$M7<HC;42HU>%+IL'EL!*D-+94A;RB ;N6=
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M<:Z$AZ!),<*W\/\ &4[^Q.^^,U3E94SA4*#)46DTO.3U7C,J%T'G/JC+NO\
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M25^*R3A50X6S,JQJC46Z<F8Y&/,#<934GGI2KQ;(4%(4+:5!1!/6QOC+>?\
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MF&6&/HF'!%GQU)?<0WRUAYYGZ!_5XU&^H;#'%/*U-_A+X=YU@M\@5NH4MRH
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MGJDTG9YD,G<JVL%[K\^_$U?DWQ5V6/,,V2WI_*8X39%3>""F@EGJ"@U81&Q
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MU\EA(#]/^&-7 ]=_\,?CD^O'X],?CD^G_I@*LJDG0#'NE?R._O5Y)7!(/O\
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ML@B:K&6+' @:/G-K$)K#Q%>O> >C N.B?/WL2K0.A'Y-%VD&3H1 CV8MJ%K
M) ("I0;Z/W>(D(L";.BW*.3  2M !7IECS'R5-AZ/7%X9X5P[1XK+WA((*5V
M-V3DL% -$KX1XS92VR)\/7C%Z"DM]C4X2-%0GI29,6?CG9R0: .=92X?"6_#
M-]WD7(</?CO[.) <&Z8U#.#K#G.^EJ"'*93&%9CE.!^,ED01 *!PETT-O762
M((E$ 3+DN2Y%$W:8WIC\QDC%0(>J?*"*XWA3J]D=D@A0!&G)<ER7)<EP1DO^
MCK'9U90>I.?LNOT"Q'E(IXGE[P-L4 N/H7&,2>:6X#81$NM&(71) #&C:*;(
MQV85@&X^J %6UMQV<M"J=@3!MB3-/V48431,#ZN()$M3"R96$.N\C8A.UVV]
M1=Y'M*7M$P>A%X9RIG041#Y9;;Q?_P!1'K&CV^YT5^7C_,%N<(0R2UV:&\8H
MJN RH*5O*;*4\1GOG@P4>!?8N9[Y_&-P"HM, NLE^ND@K0;QMW,*A(]J8)<^
M]P"5/3;A:J$6%./7DQH&9*U?+R8$"94+KB?';WQ!KNR>XGST:[QQ).0@%5IY
M<71".XA9]'&G<J793,<_S]G$I6F$B.#0XB)18'CJ_F#78RWNICF5%M&5Y"7.
MDXNP"<L2\IV]E3]4,*%CT)=^,-&[CV0AA3QD\"DC(L 9ROL9>9WB9) B1V"C
M+O$2"$41[-_<H4FY1*5.7'[+K],+F\*2W1'[K-6#=@&I.OV\.E-5M1?$MSKT
MQJ;)@2 10P\)[YT["A=@1]G,SAZ,1];) > $<Q>!7Z*,4T4$+P=?[N\06X(.
M?$<8%A6Q_MR83:@Y$"-5O)RM@ '0PT/6\3<G7C<_OIE/O)BD * !;+@Q>CWJ
M;")YMRN;C MEP1PB<Y3:,2RF-N6\.J\N/*1LR8=P61'/FO/G 0B>.ED2EX,J
M*ZY+E7G\>V2&:)62MU<8$ 4IS^Y71D)!W(A$#(X7QD!P9<KEMZIK V@N@B=A
M ?;^<BN>^%PD_$@NBSP!CRO7UH<2&ML*IG+9(3C@1B=P3&)P+\)S!?G- '(2
MA3O;:XJJK*V^5W](B:WY(@"342):,%4<!$P6!2D<O&'P%B$X6:TV"';%V;^0
M2GL0[.<CRHUGF-#%,*RC("\6Y<*53Y;Y^XOBLH8!FISG[+K]**^71V!:&HG;
MX<@IG17K S]V(@4^8,C0:W\9B5 =D[P5%S&J8B=KZ?.L:I& QL/+T8;]\22Z
MD)2:CER6N0 @EU=^Q&^,!-D$@5;?M(Q)"J8XAX?IY!SB !FED%-H@28G3XUF
MWT\8T,TH$@=G&$(14PJ9?'U&'"-90 HM,EF;D@:A63/$9X;8C24VZ/&5:A*
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M2KP09AW&)9?I^M C.AF/.;?3=71$N%0O:$B>7Q''> %C5\-R G9A@0K*2AX
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MI3Y,'8# 8"Z=O;(*,624=C9N%LXR"K9!45(C9>L&&1EKMSTCCZ__V@ , P$
M @ #    $)!DEITDDH)T(?(&/(! )(! )  ! - @$     (\E0 4V )(()()
M))!(  @ ) N  ,$8PUO+C$!  (!)!()(  ( :R(@ ()C 5E7X2! )(!))!!
M   ,!F;@! /L^#VPQD!(!(!!()!(   !LL< !(.JP-KRG^ ) !!)( )!   !
ML?P^ ((T'A..H,!((! )! !   -D_&V"@(.3L;#_ *:@ 00" "00   "+#2C
M*T"#?$76A+NB0 0022  0  "H%= /4"#8UFNYF @00022"" 0  2G+,4RD"#
M7;HF>P%B22"2 00 "   <A0I3L"#5ST7(=Y 2222 0000 " +8;$:H""?L>W
M[[N@ 22 " 00  #7>V.29 !",H)YAV$  " 20 0   !="$*(  ,!>OZW:-(
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M*@%.(8% >U#<7INPQD.8T<>KHOQ0'65PCQZ5R!X0 NE<$ISZ7:?'?0-AJ/\
MX4'9>?W]\SWP20LBT('H*DZN\X]K/TA(7BD(X$Z\)VR6^ PY>7@Y 49PIF?\
MH,2Y>3B"=%I/9HG,@((Q6-::80$#U/;$.#O6CIXB$54#C*K0FFZS :#J98<,
MLI6(E; .5T"JSM6_^"H/?IQ>,"=<">H[].>5O]N<^*&X/%2]>OO),[W%1W28
M13-G7V&U(!6L%"L 4YWQ&]4@-830[U7.?0<" 0@Q!K%"B!5$IP''=R'HD:SF
MQ($Z<60"(0%KU #(7JILYD@P$[!A>F]GQWKA99%HM3S#.S?A.04LCL5>U[]7
MIQ<7-0$&0&92]>S7B9'LJ!\LN)BY,@DS,Y9O3R[\!HT6@;XHE'T].?\ -XC5
M0*X:MZF.O&+ZJ=(&,TWN5BWXU07^^Y]^ 5#L\N^?)QV\^@HGRYC*D?'P7Q.F
M;[.KT_/O%?ZQ$#H>L?1,[<^S@_FE>#(T<;7+W>&-UR>43#%BQ;G"R$9_'09\
MWNH$%M0],+E@0:.*GW4^8D2.$XZ)^7,(I %JQ$@!&"&;S0<:H3$U<X\^(IH*
M)O 2L LRR]./#8Q*QH"-:^FW%EVP$IH+0@-8 4F)"O%:10J ""'(^C!9EDJD
MH.[>CQ =!RZ&<?GDXR?B+\?&Z/-3,Y+? =?OT]AH0=^??B)T^>.W]^>S"U#6
MV=^4=-]T#XSDR/9%ZW1+C/L8.ZT=^AZ\0F-6P0A"X7NN$MSV-C@!)F"%C2D_
M,B82,4%6HEX),(*5/!KM#?HHK<*8&64T3JU&3\A:*@ 0P", Z,-&!34J]L[G
M7KQ5_-"(([@)@4AO P*KX\="LQ3LG!U%:"P-(B@A2N1*<+6GF"!D4"""K>%[
M<PI4+, 14 %+ 'I:--)HYUI[<0HZX^T(<=Y?$^-.4.VAN4OUW\]<T?W3VE9K
M%WCG74?MW/MUZ=>:/G_?WG_@.J!"S6N5JD!N-+#/(]K[0,,32K %0<K2$14&
MZB!%*4"1Y:T 90F4 : 8 :SB56_(8R)6HX P\QB9!9 A4<7L0,&>"N[3>_0/
M/,<;ZO(]*@PDM,,18*2IDY!@*)3HTS/E[2&27$V!7%;,1K1Q#$7"CF@?OL.=
M"A7F8(PPF2 <&H7&>(Q(1@,9$9B5;D-HH8(3Z^M\<$!P#W[YO]Y<;6KJ]^W+
MA&1_#R<F9#;>D_[X8QPE&=[WZ=>"F3S2X6VS'T_40E*G=Z^/O!9(1\^' Z18
MH!4% H:,3U!@<0GY3N/!"P56,7><.9_0JU!A +EK7M@B$]-H1 .R!'&,+4<:
M&9"( 4T'P<RR$$2[;=9ESQMW=7'B7'"ND=@L@*CB%BLT]#C:;5@SY&I'A<1+
MRKK5#&(/0M&</%6;0HZ R+@],#_JS,!,&*X@ H/#+1.Q,D6&$;DU#53=AQ)/
MC504XKK$PSNV&[)A>["4X8^GZZ]>IZ<U]?WP1KK/[?S^G%19CV?29]!_/]&>
M[KYR&/'^.W*T(-B%,H(-SFZ=M*:!2_PZA V 6H\8(:)02W!7(9\3'7)N(%C,
M>M:8UTCBZ#V0"Y2$ $JWC'Q[)E\MZ!DN09OC] 774*SY_3E%U7)"D$ZXT)R
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MG[&@1F3\\R-:"X\>O:9?UMY T![4+4LQ_'KU.!,'O,+16\ $"#!3(1,T9Y9
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M0)!*4&GO,IF02-+. D7"4C*RO<)-H:1>EXT8,C =WIQW&"$049KH+#-[#A'
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M_\0 *!$! 0 " @$#! (# 0$      1$A,0!!46%Q@1"1H;$@0,'1\.'Q_]H
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MB"ZQVY%QT!V=M1%P9Q'I(J.@_*&9P- FXJ[3[.W>IG1Q:I8S;MLUTICO<X-
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MQI]_65[6J8QG7%7_ *G[^_I9U]=WQ^SZ,*(4,H6^3RD]\<2+5/E9E:,9I([
M.$GD%<E"<@[A1V8<@BQP&.1B8<F2TPO2T%+2ZA(<AR"F$,+A2Z!<[%$7(&4"
M6<9X?(\B;-/^;KCV619F%-CD#B4Q$SA8ZR90AU1>1\ &?%G@F*ZV'"5*@8$V
M)KTP@1XT2A)<,LA495X!EY=\N3*]V]\\>6'^+^QJ^?V_1R)YX!$!DWDW>^1.
MPM,!CT<^:^TMPJAZ&D2YTGA?EC"$)F[??;^/'IPAF_"UC,$A?UGBHA214RM
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MN 3<'2^!^EA>XCXH8U9P3KQYHP&G0(PS@<_J3KU!F@AE%1?#MU<[@F1,D 0
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M20L&O)FF=.+9F=<20*$@(I5T*H[P/?0*-UI5_&;=U\NL\@T*:TQ'T9ZD7T\
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M1MY;_P ].V!-.SV*+;]5.6Q7QUH\:W46E":[!3*JCUF!K BT865+Z0XF<6E
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MX@CARSFGJ<6VV';((* ^>&&G $8'!" ,6,=!2_9:,<^TW)HWL3AMNA!I2LH
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M/KS/N5A=^72CT/!V+V?1#$EE#'BVY5% LGHQ$4H_LQ[;O+W09PCA.BC 4:\
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M%ZY* HK*;N'["IH@>M_=_L]_3*PBJ(#2.A-=YQL4_%>>ZR[1(05.!,E@2+-
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MIHN^N$V$&*RK.ZL8GQ)Q2EHSA1&#$L3OR)4[%:[,0*('I5P9AQP+HS5'V8/
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M78>P7$KQ)6K  S4MB!LA2G7VL*\*LR'8$6 $1DMMAPT30U,E:ARH )PR^,9
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M\0V#AY$529JK_#SFY(</$CY<%*2PRFL&!Y<I)P)@F>O #O!J+9XXY1PF4
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MPB.C B(EF+&HA:J@K6J=% Z>(F.3R?A6Y#H\'<FEF':8C]@7M7"# @OK8O\
M)T_5?@%P,$ -F\R&;&M$!F#$J25<(!A\@-L,1$*0UDM?WR%)\@.V?0Y:"*"C
M2H%A0&L3O. P@H.8$T*PZ $.%W)/)DR$FT8*\#751);D$:0$.R9,Y") WTD]
MW/NP]B47KBJAV#3N?1""R^CVZ==_].^ ?X,@ ,34@UKKQ>,M008A0XT"DW:P
M<<,&R;=J !1"VQ%2_>=#1@*0AT2\UY7)TJ+%!([N1'P),^'D1B.Q'*,S"GAF
MU&--IV3> IC$KJZ ^*" K;R+A494-'H\E/0AWPTS@JI+T?DQGXP4I-71%SI
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MBE^PB2I^13AW1,"[+[[]OORDX4'21LD9-NA@@@4\&V-0 @T=5J'%M,Z66'L
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M^%!V)CH&X3B@0.;8CN8*R[3PG!?&D-DM=I=M;Q'#$2+R$: (L1^JM#Z:-:!
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M @XN+T!>SBIW8%%5</N )90 =H @&GG@^HU"L/P+,/C>IQ5E\?\ ;]MQP2F
M" ;>,V'ZH;00Z7)P*R(U XHH2ILX4$ 1<"@(,XZD9%FD';%KB>PD\,<!1Z(2
MA&%G2J@^_C7B[*DG51B8;9\U3HU7M[YU'R!] L^,_O?3R'+4=K?P$42T]\H5
M?MT"0:@P5A$X+:PM-/-+$:07F@]K&4_M9*E@/#*+EL@1*M[ G=I(HG:Y4S=2
M@++W?*ER:'^WT00,$$!)&P?+,X^!B8=/:4+<1#V#PD7F8;=TH3,#K%/P%KC3
M'%VJ" !)P!(@505"*7?&SWKAS&Y3#4E,>CG<S!AH:50,(G7NG;U\=1*!>MA,
MQG!PP,9(6TB*T3H8<0 HHS J1H+A+BG2)]T"8,Q"0ED7>7@8L;"$AA.ZJO$"
M"@WPDRTZ-;/'-%!?T[@)906^.^.]FQ(*D2(8.!D'UB#XWD%LQTHN1XYD"T&B
M; $&$]PG%*UG?F"H9(Z#O(;YD#"PRZ?-'B\<D!R1TP=!H8GFOU$ 7ZOH[61=
M Y;3XR>B!D"3M&=C0;(/A)4 948%4EBZU]_8CQX_\9/A]?'GE8G: FKU(TBO
MAG(1+/$GJ^9]^?NCQX\>.!5R#2R79=PGQ;5-.I!E2S&@I4(>3 %_R?OEEB4
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&9=[^O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>roadmapanalysisa.jpg
<TEXT>
begin 644 roadmapanalysisa.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_X0"N17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E         !* 0   0
M $H!   !    1TE-4" R+C$P+C,X   R,#(U.C S.C$X(#$Q.C W.C,Y  $
M : #  $    !         /_A#,UH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53
M>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T
M82\B('@Z>&UP=&L](EA-4"!#;W)E(#0N-"XP+45X:78R(CX@/')D9CI21$8@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS
M>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL
M;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM
M;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O
M4F5S;W5R8V5%=F5N=",B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O
M96QE;65N=',O,2XQ+R(@>&UL;G,Z1TE-4#TB:'1T<#HO+W=W=RYG:6UP+F]R
M9R]X;7 O(B!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\B('AM<$U-.D1O8W5M96YT240](F=I;7 Z9&]C:60Z9VEM<#HV.#8T,#=E
M,2TR,3-D+30X96,M8C8U9BTY-#DU9C8U-&4P8CDB('AM<$U-.DEN<W1A;F-E
M240](GAM<"YI:60Z,S9D-F0W-3$M,&8S.2TT83@Q+6$S93 M9&0W.69B9#8Q
M865C(B!X;7!-33I/<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z9#AB9#)C
M-60M8S,X-RTT-6(P+3@R8S<M-30U93EA-&8W.68P(B!D8SI&;W)M870](FEM
M86=E+VIP96<B($=)35 Z05!)/2(R+C B($=)35 Z4&QA=&9O<FT](E=I;F1O
M=W,B($=)35 Z5&EM95-T86UP/2(Q-S0R,S$T,#8R,C@T.#0S(B!'24U0.E9E
M<G-I;VX](C(N,3 N,S@B('AM<#I#<F5A=&]R5&]O;#TB1TE-4" R+C$P(B!X
M;7 Z365T861A=&%$871E/2(R,#(U.C S.C$X5#$Q.C W.C,Y+3 U.C P(B!X
M;7 Z36]D:69Y1&%T93TB,C R-3HP,SHQ.%0Q,3HP-SHS.2TP-3HP,"(^(#QX
M;7!-33I(:7-T;W)Y/B \<F1F.E-E<3X@/')D9CIL:2!S=$5V=#IA8W1I;VX]
M(G-A=F5D(B!S=$5V=#IC:&%N9V5D/2(O(B!S=$5V=#II;G-T86YC94E$/2)X
M;7 N:6ED.C9F96%D8F0V+38V93<M-&0T-2UA931F+30Q,35E834W,S8T9"(@
M<W1%=G0Z<V]F='=A<F5!9V5N=#TB1VEM<" R+C$P("A7:6YD;W=S*2(@<W1%
M=G0Z=VAE;CTB,C R-2TP,RTQ.%0Q,3HP-SHT,B(O/B \+W)D9CI397$^(#PO
M>&UP34TZ2&ES=&]R>3X@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@
M/"]X.GAM<&UE=&$^(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T
M(&5N9#TB=R(_/O_B K!)0T-?4%)/1DE,10 ! 0   J!L8VUS!$   &UN=')2
M1T(@6%E:( ?I  , $@ 0  < %F%C<W!-4T94
M          #VU@ !     -,M;&-M<P
M                                #61E<V,   $@    0&-P<G0   %@
M    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)865H
M  'L    %&=865H   (     %')44D,   (4    (&=44D,   (4    (&)4
M4D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M)&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &( =0!I
M &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P   !H
M   < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #VU@ !
M     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #
MW   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0  +;$
M6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP  #5D
M !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /7&UL
M=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
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M 5UID!; !76F0%NLE62*R0  %NLD !76F0%L %=:9 6ZR0"LD !76F0 "LD
M!;K)%!7769  'S/O8C?L'X^RM5UK(3FNBY=\5Y=F)QCF'(/!XK)CZ3560
M I%.CF_@)]!]+C'^K^Q=9[UG;4V57B*UQ=;75@+"BLD"\J4+ K) N5W)^=9(
MK)6P 5UID!; !76F0%NLE62*R0  %NLD !76F0%L %=:9 6ZR0"LD !76F0
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M0"NY-Q\ZR:R5L %=:9 6P 5UID!;K)5DBLD  !;K)  5UID!; !76F0%NLD
MK)  5UID  K)  6ZR105UUF0 !\RJN]( %M-=M4BM*^D +*ZZ)I;B5CXQ^8)
M//E[Y[J#35O/7^CGU-T?U#:TQ8K)%Q< 6%%9(%Y4H6!62!<KN3\ZR162M@ K
MK3("V "NM,@+=9*LD5D@  +=9( "NM,@+8 *ZTR MUD@%9( "NM,@ %9( "W
M6302K56F0 /F5+U9( M+59-:5]( 65J362HCFFL87T@?F)\";_X/#4QQZ+M4
M /Z3?4U+MRP N+@"Q71( O*E"Q62 5W)N/G6362M@ KK3("V "NM,@+=9*LD
M5D@  +=9( "NM,@+8 *ZTR MUD@%9( "NM,@ %9( "W62*"NNLR  /F55WI
M MIKMJD5I7T@!97729*R;RI--^?_ ,;YS<*XY]%<6?U9V:+W[#[9:E5(N+@"
MPHK) O*E"P*R0+E=R?G7"9*R5L %=:9 6P 5UDI!;K)5DBM$I$$@!;K)  5U
MID!; (+E:9""BL$@K)  5UID!!(K!( 6ZR:"5:JTR !\RI>K) %I:K)K2OI
M"RM2:R2N]-09T_-7"IH_A[Y+O3!A][_1^'W>>BUJ"XN +%=$@"\J4+%9-+<9
M&\CTF0+YGY-5-*IZFWC:(ZOI_KO'L][*S>( 5UID!; !76F=;B/#+W\.?.V
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M^FNJ-KRL_P#^=WR7M'J]7GB_2C[$ZGW_ &>67XG^;I*/F;C>'_7^EP9?H?\
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MO\[==8\OG#_3;ZUZOWG8BFR5%9(%Y4H6!62!<KN3\U&='SES":+X>^<O-?\
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M2  KK3*"5+#(SD&@S_?GA\A^=_\ 2K[6Z5Z5LU5026ZR0"LD !76F0@""X2
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MTV^N.K=YV(B^52A8K) *[DW'SK)K)6P 5UID!; !76F0%NLE62*R0  %NLD
M!76F0%L %=:9 6ZR0"LD !76F0 "LD !;K)%!7769  'SA6:[T@ 6TUVU2*T
MKZ0 LKKI,E9-Y4%I:K) J7BW7\ZY2##XSU"_E5^=>OL>7S@_IM]<=6[SL5Z*
MRH6!62!<KN3\ZR162M@ KK3("V "NM,@+=9*LD5D@  +=9( "NM,@+8 *ZTR
M MUD@%9( "NM,@ %9( "W6302K56F0 /F5+U9( M+59-:5]( 65J3625WIJ"
MTM"LD5+P?-62 P^,]0OY5?G7K['E\X/Z;?7'6.\[$125BLD KN3<?.LFLE;
M!76F0%L %=:9 6ZR59(K)   6ZR0 %=:9 6P 5UID!;K) *R0 %=:9  *R0
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M(%RNY/SK)%9*V "NM,@+8 *ZTR MUDJR162   MUD@ *ZTR M@ KK3("W62
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MCQ#GG77.M3XMKV/T]BS28!( 0 "0 K$"B168)  0H5F B: %9 !  ) !  5
M !0)J@ 4    !02    0       !( (  %RK[WK_ "/.9/L+?=T[E[=U?OKO
M7;MXV/-T+9!A\?ZAORJ_.376/-YP?TV^NNK=YV.E%-TRM3CQ\Z\IQ&^2>&\6
MUO%?.W!(
M   'TFK?L[D<I?J'Z+R<^I?HOZ^WUTFNN)QOJ&_*K\X]=8\WG!_3;ZZZMWG8
MZTTZ7$V<'_B7YSZ X)S:T%L$
M                    /I$VU1<=P=;Z7G9]Y?9V[[)FZXGP>H;\JOSCUUCS
M><']-OKWJ_>=B^>/\^ WP9\T='\4Y_2
M                               ':/2]]D&_0S[DW&[7ZAORJ_.376/-
MYPOTV^O>L-YV+$CX_P"$XE?*/%_G%)(
M                              %ZK(GZ%[5F]]I_6WJ$_*[\YM=8\WG#
M_3?[!QW\_EC3_-SY.T?CL@                         7"8I,\ZL7I#\9
ME8^LIB>NKEH                               5/O>N2%_=WV/ZV?A+X
M]U]CS><']-_KV-WY8XWC+\W\FH                         "L.Q+7OSO
MPFQR>8G(2%^2=P\WK@ZV+ 0=;3I]$@
M)5.Z^E;[[?\ G.F;A:\GF\_2GZWAI_/CY<X[KN,
M  %Z:(K3/-K/OS@P^W9V8/=,PL1L&^^>_P L>3M+T:UR.]B>OWH\DW0^9=*>
MSP4B4                               -175[F8GMNBCS!?=_P!(Q!_"
M7S;8E                       (<KH]>8F(VW.##[GESB-LW*SZ?K3&X6I
MU]N-XHHY^Q_;'NU;Z6*8NM@P'G5W?GUJ
M   !4]7D1)],^5+Z][M%K\@\*LF*                    %Y26X47LC/%F
M\H<?LV66)V[(W';#JJ?1\+=5A6W7JJ)W2U;WFVW2EOBQVM<PG.KV V.+WF!W
M_FN$F6P=$@                              #T9$Y1Y0/JWM48?RKQ2E
M$@                   :B)RUQ^;D1P&]9F8O<=ZIRFR*=!57H+<?!<MMS>
M?:W7JJ)W2TWZVWJS8W)'*8\G:_IUG5U>;'#W^3RA]%Y;QRY:
M                   'H$)^#R?_ %3VF,7Y7XK;$@                "]
M-)BZARRCU2%8?:)2<!T#N#Q['QM7LR-$G1S7I9::BY8GYVZ_HK^ENK[VFX46
M^06W)[%O<UK<XHYW>PO/O1KNUT^V'C;-*@DV_2K:9
M            G])_SR?_ %3VF,7Y7XK;$@                #=*;V9N/S4
MC.(W#.C#[A];/OV:IM5'HT:=$:<^-->F3\J:_FFRU7\E:*K[;4T-SMN5V+7*
M5O<E&^QX>QO3KV\7L=L%-_S5="YI'YEL/0
M    $_I/^>3_ .JNU1B?*_%:4@              E40U*K,_Q9&2#$[-('CM
MKYEY<QQN+NP6_1LT7MN7-';N?!.EMM.KT]NYIT_ ^"OX1*W71-)?2W7JK<[I
M33S&W8Y#9M[FL<QOX_L;U:Q?11P/UVO+YT'F^)60QUM(
M             "?TG_/)[]5=JC&^5^*TI              "IR^U?E!QN<EH
MQ.U9$^7,[-3[-KBC::?9M%-[9+7HV>U>VY<TENYHTZ<TJO2V[FE3IC2J_A5/
MRHKNHFXOMU_>W.LIIWRVYA9L[DIW59Y?<QO8OMUR^BWPCT^;ST;WS^/7*X;:
MY@                             3^D_YY/?JOM48WRKQ:D0
M    *G+XNS!8K/R]87;N=>?)Z)=T:K1KFAMU[<N;;;O[1;]&Q6?1M#T;?3=T
MR=&:,T2O2)TRO3)TUNO3IN5_2W/UH:FVUD-QMN1T4\BMV[HIUJCE$^/LJ_@-
M>L?6YYNE\IKT<^;PN,/NQ_0'O\O0GI\O7EZWIZK=9JI$532%9BV
M               $_I/^>3WZK[5&-\J\6I$             "^7JTU;H.8]C
M+;;8]FW4W]&K^)\%>DMUZ%<T$5[91Z.,V?7Q]Z=ILW=(G2&C-&KTB=.KTR=.
MK^2;;=?TMSJ:&LMM=#<+;=J*>16[>IB=(N?>F.8SX>QIP^X7?-UMY\ULT>CF
M5S%ZV?+]+_DXE?\ +U)Z_#U'[<=U9ZO!TO[<?CK[\?B;E<5U;>L4
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MFW:-Q^NV                     )_2?\\G_P!4=JC%^5^+6H
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MO;\$:V?UKST=!Y;9$                    3^D_P">3WZK[;&-\J\3I$
M            #ZU/1!K/0Y0L5LMLQMMOT[8]&E7/F6+?Q-J7-@7^.6/1QNW?
MV>+^@7-,KTA\3Y'RMU_!.G5Z9.CEHE>VS<T,S\*BAK+36VVX45[G1.HL-5;O
M[U79P4VOET/&[\;I   "Y*8U,5R8Z[N\N^I]/Y1Y/5R>W:YQ&+W*OQ>8+H?+
M<,,SA$                   !/Z3_GD]^J^VQC?*O$Z1
MJ9%>?)>L72^K;K<G1Q>VRCT[?;N:97:HN1HT;*O\>FYQBWZ.-VO3MB[I$Z8^
M"OYITRO2ITBO0)T<ML-)55I)N::W5]344-=;M[C0WNPW>Q<W.Q<WY:Q-VG1(
M)]_X91%H@   !E%X,[/'I/7.],+EN7//S6Y@^B?7B_*ATOEW"KEJV8
M             G])_P \GOU7VV,;Y5XG2(              %T16X]&FL]#D
MDPNVUN4[;1?VVWZMM72WK%C2IXZ]&Q3<XY;]'&HO;0N;:N:5/PMU_!/PKKTD
MSMZO0IVXT)H57R7/E;JO-0:VBWN5#?+#DODGDEBODMJC>/5X/.WTW@>,&6UV
MV     NEV+8]OH4TGK>8FO;!S*C%;Y/@P_RMKSN[[S/'7VXR@
M       )_2?\\GOU5V^,?Y7XA;2               '?7FR/K'T_K>[47/@J
MVJCU;/;]'TJHWNOP;%YLAUI;R&RW:-KKJVB+FWJ]&N:$TRO2)TJO2IV^NO0S
M.B-&N:%78GYVXJ:E9U-N-QMU;SY[G*/)5RNPY=Y:^:V_+QC)X7R_]9^?NO/1
MX0    !VAY_7Z@M [-D9AK>]W<;U;<SF./H]D#N^<;Q+RF L@
M      !/Z3_GD^^JNW1C?*_$;:0               ^DO0GK70I-,-NUTVM)
M1>V&W[M1-B[Q7>)X_*[-+K"]Z=J]-/QOVM+-?PJI^$QI5>G3H5>E3H*Z]!,Z
M,T:YIE>G3]+=JA]5&LMM;;JW;SW-\\]SE-B>8>=S2Q1L'JQ'EM[%\W\;N^:D
M@   !<9E^'W3FZAN>;FO9Q5'6,YK$')Y_=*?#!?O'%L4<E@0
M     )_2?\\GWU3V^,7Y7XA2                K$Y"6/?ZM=*Z]K(]5+=6
MSX_W?'QWOC%SC%-_KNO)<*NSLGKL:NJWIJZ?A-WYGRKH^$M$JT*O15U:*6@5
MZ5.F 6ZGUMV]117K[=S<//<W>U<W6W/(_.Y#3;A-Z%PO!S9=#M$    EJJ9F
MXU_89K=0W#K7Q;C1;[<N:O@=E;F-&2]??&,VO?;7DCBV?F,4VQ:3M$T$@
M            "?TG_/)]]4]OC%^5^(4@               *S'U3Z9M/Z=FO
MKFXZ'S7=!7=X]1Z>&QZN"5>[@M?MXE[+>GNV.:W/%KJ:-OM^CY'QKGY2T:-"
MJT-=6CEH%>C3:HH7K5Q]K;5T5ZVW<UGGN:FFY]Z)W";<<NU<HC2VWD]*HI2
M  "6\45>B_4-KSXUK?NAZ<[K+61[GJUWMOV:?"_F_-!%N>BS.:OT?,[#]!^O
MCN]4Y72X!=TY1PBY9                $_I/^>3WZK[?&-\J\1I$
M       "Z!/>]CU3LZEO^<&O[KQJ/=L,^CCZ_P 6N7^)+_')]6QUWMEOV]1-
MOE\^/E%?BVR;NU1<^-$Z=<TB=";?77MTSHSYEJFJCZ+/W1J[=W56+FLMWOI;
MKJFVJW'7M7)XZ]GY7\E     NJB</6=LD_U#I4<^7QD,NY\N])&D]1R]P/M[
M'R>I0H9[P0)[9IOTJB=W5>DY9X?>M-Y?9LE_7H*MWY)C%[<8*0
M     G])_P \GOU7V^,;Y5XC2(              '.K=R7_ ;C+;K6^;7Y<Q
ML-SU\?7>/37QUZ./S>VQ>K;A75LTW[IIY77YM^N8S25SL,UZ.W5MZO:ES0)V
MZNO0S.F+2JU]UO4*-6:JQZ-9Y[FKHN?*W5US[L/$SNW$\><GJ2E9,    "I.
M]@=YZ/L^R)W8^>:2JB5O7-TGZT/H/864U"&+/8V 7;--5Q*?@]PE-U3J>XW(
M^?F]FKH\,.>X\DC7SNMTIB@              )_2?\\GOU7V^,;Y5XC2(
M          5-515*?BL].-K>^[QXL[Q6/7QMZ]@H]/'%SCB_JKUOF,>3F:QL
M5GW\;L>SB$^K;[].]7?'NUSR:>JG9U6T+FS+FQJ]G7] N:4^2:+'W>;6HUIK
M;'HUEF=PHN:>FG"'8]!C'VGD/%K_ (+8      ()#ZS,M/-.ESV8[9.5>G 1
MJ>_S>:_H7.M/-,A>-S\SVG=GPKR.L]4Y'6Y3=7Z)J//?BRVSD\0NRZIOWAN<
MLL4];Y&SHK]-*9M@           !/Z3_ )Y/?JOM\8WRKQ&D0
M $N5V[OI U[<,\<-MG&V0X]Y_7Q:C(\3>KI3UXW!G.:7)MC,SD)XLFKIVM<V
M:CV\2\^0X[;]6V7K?UN^;Z5V]'%6T*]D7-C7-D7MM>C3*]*?%:^CSZ]9W,W*
MQ.K\][<J*NKO9A(CMPY!C3F-11%L        )0.'[U,7\[_0&17U!S?>:L9T
M[SC=8FLWHL+7T#R7.O'Y^;K2NW8AY'6X%]VXO(KA]IG,U'J5GC]O6NIX[G'S
M1N?=FN:MPS<=8@:^K='C?ZUKE@@           )_2?\ /)[]5]OC&^5>(TB
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M*;9^/8&9W1I,N0[[,'\Z?0///IG1.*4^_9N-Y#N3YK\W,O%A=-E)\W/WWR#
MSI.O60           G])_P \GWU5V^,7Y7XC2F           !J)>BW7=OD=
MU[>N QDN$6O5'SG-8A.VGD_&:[(  ^T)$,?M4OVN[_V;X-AVBW>VJJ[M"_H%
MW0FE7-$G2JM$:.MIYLZBNUN\V-ZMTZZW76W5U9Z<;"7MW%N@<C@;0
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MUX\(V?G_ &/6<;?@_L>/>[;KN'U;KNP_/6S]J\0\GTS]GR<_H;\W]:Y;P
M        3^D_YY7_ *9[)%+\S\;M@          )'/#EO2]KFY[73[MOIGDU
M=KJ?#[+%'EL!!UNO)K*20   %Y1/-;=V>G6>HY=8G;]M7-(BA]KMO4S;UE,?
M=7J:7%O3YX/=@YA@/E=5^:D           73/8.*]/IZ^!._<AWS;.P^]Z1N
MOGCH#DV_[1S+:(B/L;YQXUM>N2NZ?V:.S/\ +8L=FYR/O5/J4XOLV:OS/NO'
MN29WK/);7Q#Z]\'7FS7>2_(VY;UG=6\G_P!]_,FWW?.          !/Z3_GF
MJ[1TN%KB_-;4        "ZJ-_P#%>SUY7MG<V/V^=[H.#^UG+=;V,OBE>\_#
M<SHDB^K;SBO8R'EAZ;PK2Q2     %3>K5Z>76^FYV8?<+*WU6_JH^BND5UIC
M%#)8&"38^8]*>K%4             ,M^>;KZ&^0]M[6Z?K.D\?HZ'YUN4+G3
M>11_=5Y-?+T6:EUKDF%W:!'>^!].^W&6TQW%AO7Z9O@KL/>?/<SM/H]W3?4]
MI^_U;IO%N+;?AUE-5@E^G_G"V()          $_I/^06[-F_.OKF$MH
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M.E<)P&RQ$;1H\)VV\]M0     !67(*+N:V/S_17J\&/WIQ54J8M0F0
M       +CFMN_P"NSGW9OCA\YB+E];\SO2.,TID5EOMJ]Z,-0[)M&/V*!K?.
M!]7W\?:"ZLIGL.QZ/55SGO6(5[$^=#I/$;*)           G])_R( \P0
M    !WOK.0]A'RGO'9_?]0Q&^0.Z<F^L-9ZLVCW]3\(W;L7YCR_.\C@/+7^C
MWS3T)GO!5,^>'V66;4N@;%XO=#3M.E0M[1H?SFD
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M^\#W[NOY9C=KMGIGO6O^5S[:^>]/52!?#NFW[N/1'6M[Q4
M           ,_/!G?0[HW7L=_+E?,AT_YXX[7Y@!66;N-V*974NWX<>K385=
MVY H6R%Q(3C=AGBYSW&,S9.=PB[IS$          "?TG_(@#S!        &7
M.F9+T[?G1WCIO-;MDG]U<<Q:KVG:_CCH/;_,L)I]GN0=_</!8RNGZ5;,4@!?
M 62                         &5GBRGIET'M75GE]_F Z=\^\ O\ D %T
MKTS[ZQU/N77N@P8;QP?&_(8*V N1VO9]WK3Y_P!BZ7IQOD^Z-R2RJD
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M%3ZH-M]X1AGD]>)  O.047] M[;<HM@ )3,1N,I6J=>BES_-8Q=EYS;3(
M      $_I/\ D0!Y@@       "LQFOY<AZE]8Z'AOC=]POOZS!UNO']NO>>B
M                           +I#L.QZ,],5FLY\+L_8/CRO=^.S.TV<_T
M7[[L-&]<!Q0R&"0      R"\^0])>D=PP>]&+@5WGBEL0@         )_2?\
MB /,$        5)I<5LLU>N[[AQX-QZ"OXCS[;_P3YH
M          ^L,PO!EY0]5W?,[%;CPAF=L]%G07*-YHCJ5Z]VM4P-]!^>^C_5
MC      !JZ+GI_TWLNPXK8/-QT;Y^XU<\Q(         G])_R( \P0
M !4G"Q>T2OZQTG%7S[#U[$^>KH7SGQZ;"0                         &
MNEZ(=0Z;D'KO1.H[_OZTR.%QIR6I\9]&/[>\WLD8Q>TX^^3.;S3X_.+T3YWX
M]<L4      +I3]ZMTG+75.FP?[UQ/ W,:JD         )_2?\B /,$
M  5)>,7L<M>K=<QL\>P<,F_$%O7SOC9[L%H4
M  :^9G\UGJ&-$>["'-:+CI[==T]-%$_6FOUM:5V?H[&[7Q.YC?-_T?Y]^<4@
M     "Z4J>$V^;W0.KQ0[1S^$O<><@         3^D_Y$ >8(        NA(
MQX\U.#I?:N@/-G>"7F&VP\MBGV/F                  "58FM46T@
M   !<;]YLAZV].Z[TMX=CQ3OXJ![H7"/E%L      5ED]X\KZE^:=CP;RNO^
M:WH7)T         !/Z3_ )$ >8(        N1G9X\K/!HO=>G+.5XY[_ "=4
MWL1 MNW!=--(                &YQ5FSC<ISZQ>PVR>+Z?O^>@
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MWKJ]YP          *R[Q\OKENU?=<W]<Z;AMF+6!^Q\[Q)R6G]8^G%VT@
M       !(5KGT%*=SKZFY%A,'OTZQR'?.3]&<]['SBB-%E7%\ILWG^ZU\"=;
MW\(F0     /HGTMZEUC@7BV'SP[WP7YP         G])_P B /,$
M7P]36K=/PFMY:#W;N-43/Q@-Y[RPG4NI[&2Z'R7-89]PY7J8:HT!\
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M[QH'GG^U^98H;3XJ      %U:07!Y^:O3.OX"YSPPX[;QGB]SRVP%Z:3%"D
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M]*=IUCR@_=7)]NKH1(    N)RM2WN1+4NC>3;J_!=LKL6@
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M;[Y\]=YL;YS^C<$ZQO\ CI(      #M6S[/3!H7>X+]LY/@[F-2LBD
M "?TG_(@#S!           J>CS6.E7<D[+V)\A[QW;S#4.-9#(]:?6N,V/N^
M"[6X1GMJY)LO#^L\V\QOV7\V6ET57TMVBYEKCLA(QK^V91XC-]U>#-?"G*=!
M^O)]57K_ #[P4]Z^?S<#]^N0O;SR[ W-:S2I2D              +I9-^7W^
MEG3>S8T^?/Q@;'SR-_8>6YCX[99S-/['I?-[.C_;JT*.Y<CZ7]7@L*)
M ^T5>I/0^YPO[%SS G-Z=8@       "?TG_(@#S!           $F&/SLIFE
M=WW_ .=ML[.^;&\:YC.M=EVC9OM_2. ;BR P-GJS&6(_.I\ARYQF7RQQF7YC
M;O[7:]^R,GTIZ,AUGZYV3U4[#Z?#TM[,%P.YC.=*>],=G>[<=G^8^-#+NG&H
M[]AT^T0              K+/_&YJ?_3.Q8N6LY&)M/.(WMAY;=3.1'CS4O\
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M>D[3/OX35>X;:]N%^9TZ'O;>*V54T3=2NJF1S%[7,GJ'6HT,QIL/VV<KL@
M   %3MGSW^-USPVJQ:II,@      "?TG_(@#S!                WFFO>8
MN<8JMZ2:      !GEC]BGBT7LL9N:T.&#<>:V4PD         !<4EKZ:Y2L!
MM<J.L]"^5O8.GO?8PAR^GRTXK-]+>/9.L;N.\^'0/GO2J !]57H#UCIW;F$W
M+S9[_P "V>NT               !/Z3_ )$ >8(                J4
M    /I*?S6^BYG:CTCSQ;[PW$[*X1          "^J<A?'[)Z=2ZAS/&[?T=
ME?+'5E]#P1S.C<4K\7IBU7J7:.#W;KJU[X&]\X+CC[\#29 ^B,D/+EO1GHO;
MX/\ :>5Q\9O3P               )_2?\B /,$
M  70[:L>SU1:-V;BV"R43N\\JB>V/4]MJH        %:GTIJDMPNR3,ZEU'A
M_HR& V7UJ*K8.8=:>G%VQ(DRQFQSAZEUS&SSYN(?<.-8*YC2@ +SU$:1V7J7
MR9'SK]"X7IYBD0              !/Z3_D0!Y@@
M  "J4Q-3A-QDQT7L+%^CSQ]5X'B!D\"        .2V[LY^L[_F!A>A8@Y?'Q
M6Y[EV,&0UNR"FFV92[#L^GUHZ/V7$+S[7$/MW&\(,QI0  GRUKHV0FK]4AYW
M+BV"6:TZRJ$2              )_2?\ (@#S!
M  '*J;OJ8T?M'6^#W""3I'S[C![L(       *IW^FOTBZ?U/F^-V^+W9--C$
MSO,M@K\Y( &Y6[OKXTKL>&WFV^%G=.$XR>W7D@ )1\5M4D^H]IXO1C81]WXC
MT%[<?H*[=4HG*WQ>WBE4X]>OP            3^D_P"1 'F"
M             +B:+#;EFWI?8X3]YXEACE-7H       )=IV[TP^#Z)&[D=;
MQ*]VM5IBR5)  <CMW_75I79,%K>UP4;Q\[]97/"D !RJ+T^.J=?YIB]M[I\=
MK<JO!CIZ,)%OM?/^)W+,[NF]<A\V?0XV\]H5            3^D_Y$ >8(
M                       NF.X;'K],FB]QP:].JP/;ORVB0
M .R[/I]8>E=FPCM[1 ?O7SMU]<\%)D "IO5-[,WP;)VKY<I;'KR4QNQYK838
M]!8],<.W<ZB9V+E^VQ;3(           G])_R( \P0
M      !4NEZ4]4Z7V-JW0_,?TWY[XG>\H            &^47?6WI?8<3?%N
MD6^S\AP#SVAT@  +BDJP'V3-5@>B]SXO;//?N'$/C719            "?TG
M_(@#S!                          $N6)VJ2#3>SPJ[?Q[!K-:?9
M        5JCT=:QT?L7"=*Z$G&P [[P/X54@    =P6/;Z ];ZKYG-KXZ
M         !/Z3_D0!Y@@                         #N:SZ_2QI/;HUO9
MA8;MNY#\ZH            %24;%[++9JG7^AO-FX,]]^=ND_7B;0    9'^;
MWS+:]T3SM;5RP            "?TG_(@#S!
M %\QZ4M1ZOJ<)N7FNZ/\]Z*;8            NJ96^/(>D32>U]+XK98E-UX
MK'%L6E64P    )2<5LW8GCV&'+8><             3^D_Y$ >8(
M                  K*8##[;);I79_/IO'"L7,I@            !<=N6?7
MZTM/Z[T_A=EZFKQGFRZ3PKBMVT@   !.QK?0\-O9XX\,SI"
MG])_R( \P0                         !=4[2\_K]/^D=OB?R.G1&[;S6
MD2           !=7'9/E]GK8T_KVB\_MX5CLK@'GM%@=W3E]L4TB0  !Z*=5
MZA%9F-:PIR.J)            "?TG_(@#S!
M %8FLQZ+-;Z#W_K&\^7WHW#.*7;            %U<=I>7U^IS4.TXK>79N6
MY+1NT\%M$(FW\@CUSNK6B   'H_UKJ$$6=T'IV_C4@           !/Z3_D0
M!Y@@                          #,[S9/T0:%VV+?+:/"YN/.+$(
M      7':=KU>JC4>RX*8_=H==W^>I8<1L68V WKS2[SP_JOT^.@  !V#3>Z
M_JLT             )_2?\B /,$                           ?27HDU
M?HN3&I](@6WSB&%&7P(           2Y7:N^M#3.T8B^'<8EMOX;B+E=5]+6
MG]=CP]N%B6V7G*)   J4             !/Z3_D0!Y@@
M          "XY=;]$_>L=1S,U[->=S=>4X7YG!6TS28I          #ZQ5ZP
M]1ZUTUA]]P^R6EPP;KQJ0;'YV1/!;[YX]LY*D                 )_2?\
M(@#S!                           %\32J-WBY-WKV_R8:WN&'^1UR'+9
M='Q*R&&M$2         -3%7KGT_JF.V+WWH/U>"!???GJ^*N66K_  ZYYJ)
M                $_I/^1 'F"                            !>9>^/
M-29XG;HKLEJV+V0U^B0        !4R]\>6],FJ]0P9L[3TM[\3!?MG!K)
M                3^D_Y$ >8(                             N328J
ME$6H)         N)DL-N.;.$Z1J;?MP?RFJPU[)R*U(
M $_I/^1 'F"                                        *PK+.G'9N
M0O%[7%[F=4GZU;L,.6:T2.'.<_LBDD                  3^D_Y$ >8(
M                                      K+N*U?E_P^WP9YK3>RJ+WI
MQT[ML)^:TN.+.\]^=-*9                  $_I/\ D0!Y@@
M                               #ZI]4.G]<PMI]D%VZ<6LH)
M           "?TG_ "( \P0
M    !=$S-X?=,]M6ZS"AM/&\',UJM(                  "?TG_(@#S!
M                                        %T3W!9]OI5TSN/77B]<&
M6Z\4Q=R> L@                 !/Z3_D0!Y@@
M                    "LKI>J'3.R]<>+;>)6;$&^\\)Z7]>*
M        G])_R( \P0                                         !
M5/(Z:_6OIW7L3_-N/#;?JXU=T^![>>*;;732                 $_I/^1
M'F"                                          *DHF-STP6L]<P6]
MGF[A\.?UOB].">P<OB@V?F]$                 3^D_P"1 'F"
M                                  -P3ZD-2ZM&!D/)%/G>:SF:UTON
MC#=(V./-Y^M[^>]CN><                "?TG_ "( \P0
M                            !W99]$O&#Z'!GL'.=JFUV39]OHIT[N'5
M-K,12;5Q'#O)ZP                !/Z3_D0!Y@@
M                       ()"^)D[Q6Y9YZUV'#K):#$IM?*;D4F5*T0
M           $_I/^1 'F"
M     +D]ZV/=Z9=/[1UCB\OL_KT[&G(X*,#8-3Q@]^+M               )
M_2?\B /,$                                            #Z0]2FH
M=?ZB\VV='Y+2=OM>R-K/\[QK]V"M@              !/Z3_ )$ >8(
M                                        G<U[H7<>$ZM!)N?SSTY[
M,;6F5,6B0              G])_R( \P0
M                 !*-C-DE!U3MD.VQ\JP$S6BV3                $_I
M/^1 'F"                                             ,A['O]%V
ME=SC+RNO1 [-Q^R8                G])_R( \P0
M                          !]IGT::EUW;\?NT1NT\/Q)RFN$6P
M         G])_P B,/+L
M     72RI\>:FIU3MG&/-<AYVWB>+64P-M(              #T%$^1&:>34
M                                              D$QNURE:QU_<O'
M,:&Q<JC3V'2K:HL              /2439&-QXE
M                         "M3,?';)+EK?6J^#+X_Y31H:=KY3QNNS0
M           'KL)#SYGB/,>
M          =PV,A*9@NG9"XS:XA]GXIB+D,"             .7GN@.6%2 0
M\_P                                              +BLN=6?;P:_
MX_G3              F#/3P5!UD>*,ZL
M                                 !OY[13)@ $3QY92@
M                                                 !Z%R>0J #XD
M ) .
M    "7\].Q]P  ?(A//.P<?
M                     !J2=<]"9J0   #%(\\I&B?
M                                        'T,]CT)F=X     !CV1G
MF&QTV;(
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M0Z15@2%=E25G+R]^9CW[WU#?9NG/^]$^MRZ0)U[-'7#4?_S-N.8_[S3&]P%
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M=:<SA78LD$@/@M0W!;R^D(,$0%& K%>,T=P!" &H'[XTYE LP9&-N3!J0?\
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M]_;Y(TS/$\;FBV/8MA,&IK<4;P@U(;^UXE\Q*6IHM.4S5B"!-"Y0H(2$98G
M)F__ !I$IRY5'FDEB8]1$AX2-FG=^N:WR5G*D#%CU.<CR+65_,&H']D:D/\
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M&GEFEYB0$2?'?4:&=FM7RLZ'&L9%+YNU.Z=N*LJ;G(J6)#&D<60W0,L@7;S
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M-_D)%^Q0*N,L(I8]#D,C^?B]X'(,5S-B-=HW?I-#.S6KY6=%CT\E-AO+1_!
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MI+B/S@!V&-*+':MJQYNS7DWBZVL-;PI2: @["-D6G).6;:$Y(NBBY5]QA6!
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M5;Z0_H]:[9V2CU/FP_@\ZG<HB!&B_P"+]C_W&7_<'<'('>!R#X,<+7] 2O\
M>D>:&^:4\[;NBP%,"P+/4221+M7J5^#T0%)+M6A5"F*J"L!_W1IPIC^4$VVE
M*1>4H*NT/.OG.FVZ4]E-D<&<LM>D<N&L4,!UU1_-N*;P)QP4XGQY80F]<6[M
M;5=3TTC2S3"S-'4-'!^;=0"9=*L;YSJ1ENQWTW1:O"/I%.O>PS'%&"3=:;2E
M=T'(*4H$JN[^;7=D SIMI"%G56DX"#SO8FZ$[\4>:-'N%:T67T2MM?SN4)2E
M3H%Q30R*KJ?#V$@7<*T!-$Q)3\G:4FW.V8L.LD U'5X^L;\X<NNZHY5NWNC?
M&FO"&Q8+QD)) ?F/!O5P0H\WG4SQQ\E16L3NGVD\RK"?*0K)E#2"D#K4E1':
M?/"=,-*$+2XW:#B+M*E2$U%-U49>.+ X5;3EYE#%J+$RRN@6_="5(!.*BE(Q
MIAX(!H":$F@DW9><D6YN64%K>0'D4-04* (ILQB8G6Y>55,.D)U0]DKT9QI+
MPHVHZ\ZQ9"PPRE11KA15<Q45'4=V!H",3_+728KUGW66H[:-M_9I7LKTQ9/"
M;,.V?.63:_LJGV5I9FP*$$IH$+0!=()]V,B?!I4AT>RNK)_M%%(Z!MC@E_%M
MT_\ K'/KCA&_%U_]6Y_E&,2"=N79%M6(]9LK9<XA),M/2LNZI6P.NHO%.6[>
M3XHX.-)_N);#<H\K^:3J@A-2:-S"R A8_=5@/<DFB(TTTAEK"L%Z9*PJ9F@I
MJ7 50E:T\U0.P=AWT,-B9M>=2D!3LS-S&6TN.'IH!4GH Q. K32&QTV)-M2A
M55?%T+<S'LQ*DJPJ=J<O]XX+OQF']T5_G-0<_P#!&F&G4MHV RA&MGG$40V%
M4 1\-2L0*;L\L-TUPCZ33:W0F?4AHDT0AIO#/F\Y"CEN,)TUTKEDJ6FT714$
MTU:*>(H(KTT!BPN%>W)!YE-I.<<EE@%=;B%T)%:710T%1=(%ZHJL"+&M%BV+
M)^Z3*TNMN>R)2DUNBF*=X*<E @$$4(!%(TTM:=DK"7-V;5IQIM9O8$I*6RJ]
M10I@<:8@[8'"3I8HD?==P?#3J6-F8^]=F$6]PHF7LFRFK.H_::Y"74_,DTU+
MA3SDJ32ZH@]0V[*1,Z=Z4S*M9]TG+^LYPU;0 WGP,?'2+!X6+>D'V&[67Q^2
MO)0LT0A:$$BMV[="KJ:T21SB<7 (LV?E;6DFK1E'DOR\R$A%WW(5L(S!&T$
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M30#H$<+%L+DI-J2EEW%S0 > .)2H&^:;MA/3VB6EW9Q]$HU>UCRT(%/=*60
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MLVT9N3?QXJI: K*]=.!ILJ.S<8X%;9<,S,6*MR^G5F<:2HFJ<DJ J2D)!NT
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MRF9,<$7XM/?WMR.$?\7'OT'?\F-G;&@_XKV7_<Y?_*$%(4-2XE#C9%]06D*
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M?5LVM*W02K )3B#M,<'Y+>B%D*5\@EKOZ>I32.&+1&8M63EK7ET*<FF0+R
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M'-#UBMTFF8SRAS19Y.1/BK#NC\\W4C$0Y*S3)HI"_%6,=N>WWSTT_J_T6_\
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M1;;MEN WE%&ZM:?P[(LFV9:TD!5\7Z90N]C=R$."^**B93JUBF^+7E./RM
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M>XF>?U8:75I5U39%#D"F\@U(/-(K2A$.H2IPU-><>W&$2B%-]D:-LEMYX5)
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M3J-=9[S%,5I4JG6(FVBU-O-G-"U>0^]FB[=^TAN":^44^N%D!+?Z0$-RXF'
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MZ+>E%2=I/MTH XJFP>%G"C4]GO78%KNV/-!]LGJW[?4^.)ZU7;=?8FU$\P(
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M4;^>8L]#=F6?*M)=HM#*$J%W:!C6-=Q@\]0(.].?76.%S0)1)MR08YJ#>?N
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M[#>K2.$1P#1M#/NC,-GS")(482-R8T3'_@J_U_U1,^SOT. 0:>*)-E1?1<&
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M6#@4K.?5GU1*O+GT3*+U4%!N]5*'KQBT&]5/33?P7ECR^]EB.ZJ?;)PRBR'
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M^<KTP7%G-2CUJ/?[#M94B^E*B:$@#&)&<3,-)=SPC3*PS=,^RFM[GKH-^>4
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MRZK"Z4GWM%\\"4#9 O87U[?A [ ]@.P/8#L#U!VH]D.P/8#L#VH=L/5/F@?
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M6,9!UGN1NK;ATC2J<Y7]$T.!B3%YRF*6XZ0A&)2WVG'%*7B2-;859219"0L
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M4D$&8"<(F&;LOI Q6&^-85*2"HJP**D8CFDF&O<W:*LS <5.S\RQC!,LM;:
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M=T@.RZVUC%8!S"OC()2O)9N=P3<Q5QNL3R%#6>N=0)MX9A5O ;QHYHE1=$Y
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M,J0@X5(E)=)!U$]P#F,LM=[9B&T-MME*&TM-_$2A( SVV3JV0 G D[$YGI$
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MM./_ (2K%?E%LCV-?_F6I_V1WS1-?I+OUU>CJ;FWZA:(?W#3?W=$&%.$+0A
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MF%G"#<ZDG(6O:Y!VF*TXAZ@S[C9"D+DG%)(-P04ZQRQ-?I+OUU=3<VRT#T1
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M@\T7MLC% 7 5&+VO&* >:,4)O>\(?4D=TKQF)>MU)H@%=VT]SJ/%V1+Z2RP
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MZ^$Y?\,.%"FTKMF%^&-Q/2!3$^NF.J.]OI-@HZB;8<MN8MR"^+9$\K\E=O\
M%22/!%[Y_.],*3A%XHTWOB0@GN?8QK5&[/57)'1W A6$.N*OF0KWM%@!S'?"
M3KOER9Z(:=S5,F)9EU9,JM:,=SL.OGU1+S;55:;F9122%)"N*H'QPZ@8L?\
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M)9?-Y]7@]A"A:8(MMB@+XKR>?S>C.$]RKVV?)-;-RJ)=HJFVNE/GAL6:;3R
M?A$VUC;/+K_'VYH(WMTWB9&_<8?%BC3H<_)B<QJOY?)YH(L;<GPC58P5*,)
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M&8BK,#>RJT3/%4C+DBDN7E4Y^UO;V'P$BUH=3OB"/!!IF)9-LKQ+R*&]E_-
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M*^7/:'#>\!%XD$^^>'TP-0Z?VF!SM"A"21XH&OPZX/P0JBJ/ (L-FOV]O)&
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M$  ! P(# P0&$0T-! D"!04" 0,$!1$ $B$&$S$0(C)!%"-"46%Q!Q4@,S9
M4%)B<G:!AI&2IM8D,$-3@J&QM;;!QM'P%C1$8&-S=(.BLK.TX254==4U<(23
ME:/"TO%DE%:%I,/B\D5&Q-3_V@ ( 0$ !C\"\V3\EYIAEM%(W'3%ML!3NC,U
M%!3OWP3<64=<DIP:I:(XS>]N=-<)N+EOW31O%;40+3!!1Z53Z6-[(X^;E1?M
MU*FD-H2\!,NV\."W^TL\$*_-A[J$*7ZD*&RP=DZKE?PX4I%8J;ZEJJNU"6Y>
MVBWWCFM^O';77'/YPS/^]_&B[9D"^P)0_NX[55*BUPMNYLINUN]E=3\&$[&V
MEJ=AM9)3B3D1$ZLLM'TLOBP@U6)3JNVEKEE.#(7UUS9S,W7J^I$'O:8!JIC)
MH+Y:+V4._B(6G\*81<H^S?99'PX"73ID:;&<Z#T5YMYLO$;:JGC3JX?7R==,
M6VP12,S)!$1'55(BT1$P[!V:;;K,X<PG,)2&FL$B=RHY7)A)WFE!GK[(MA7:
MS4GY(7N$45W4-G73=16E1K[HT-RW%57'[?Z?@3^.*2J-49,%VZ*2-'VERW<O
MLEVM\2[SG#N,-0=L& B&64$J\02[&4KVS2HR\]G7BXTKK>EU%M-,-RX4AJ5&
M>'.V\P8N-D*]8D/[=7UPZC6)*,M=%EH>?(DNVONF&4Y[BHFI*.@)J5L&PA.4
MZBB9;FG,N+VY.HYQA?LA<MUW:=K;+@)IS_X[;VG/D]")4[)I;Y&L5]+YK@BZ
M1W=51'PTN5CPKU.>1N8R(]F4YY4&1'5436WV1E5Z+[7:S7FJN9%3"?62J$Q=
MY(<7)"@@2;^8\O<@B]%L$7.\Z7, !]?NT5RIU9Y3748\<5^IHC-ULS' N \-
MZ[TS)+KKC]OS_P =V*I2I)Q9D=;@8+H2:*33@KS7&7$\\:/M>;5.=;"@:#$K
M45$29#S)STLGU5&S:E',KHF;G 8J)Z65?-RZQ47,C$8.:**F\?>7SMAK-TC=
M*PB@ZWOWL/5:IN:E<8L4%7<0H^;M;#5]>;Q><75PM?X]1JK2Y!1Y<5Q" DOE
M)-%-EX/LK#B:. 722V3HX:J+.5J6UE9J,2]UCRD'GVZU:<Z3)+;,VO?OYI25
M;(B*JJNB(G%57Q6P<2*Y_L.E/&Q"05*TIY+B].+P*J9(_P#)V^V?Q\8J+*D4
M-Y08JD;6S\3,G.'^5CW)UOPYA^R8CSHC@NQI+0/LN"N83;<%"%4\:+?S(TB"
M[DJ5=1QE2$E0X].$524\F77.\I!%:_G#+['C]OSZ_'_'V3LA.=N48%F4DC4E
M(F,_U5%UT3<D8.,HGV)P[:->8(E6R"BK[V*E4<V:*V\4*G#>Z)"BF0LJGADJ
MI2"_G?X_4^L0_/X$D'4&]A=#4767%]8\RI@7MQQ"J,8\[$V,Q)9*_2;?;%P+
M_<DG+5Y+99),MORLBDEKB_.NUO/ZEI7'OZO_ *@"I;I*3]#E+&2]OWH\BOQE
M3P"JO,I_,\M H(%]OJSXW_[)%7)X5*7KX/\ J E4PUYE8IQB"7MFDPB[(;T\
M$=9?+-:1;^5\&!#X\%W*S5_S?I-^D5)^9'8;I4F<)P7&6W5<9D0F40BD1I3:
MMY7RS(C:+GRZX_Z6VD_^ZIG_ "?'_2NT?_W5,_Y/C2J[1_\ W-,_ E(&^''=
MG:XD@DMD@U1@6R/55.\Z+VNZCH"+3^/2<'CB13:K%=AS8IY7V'4N2<VZ+F%2
M:<:=#G-NMDH&G.%51;^D([)7077VFB4="LX6553UI()<U2SC['"*55VC2_>E
M4S\](7\.&:137YLAARF1YBG--AQ_>.R9;2HBL1HS:#E8#)VO-?><[%(H<TWV
MHU0<?!YR*0"\.[BOO#NR>:>#4FQO<"TSZKC_ *6VC_\ NJ7_ ,GPW6J%)J,Z
M.P\@51N<<=TFF7,HL/M]C18W:P?LV^.1PU1\#3(VVYRP:/3PWDNH2 CM(M\J
M9LV9UQ1%PT;9!"==,4LVPV9%T<!GJVT.\RIGRR*8 9K<[(*TDE$;\!4B5$TS
M+QQ,KE/GUF1)CO1&Q;F/P285'Y3;)YT9IK!K8'"M9Q,?M^=57[Z^/ZY1ZS+J
M5;9DU"&CSS<:33Q: R,D7=B[37R%+"FBFI6XZZXNM7VB1/Z52_\ E&*MLVM0
MK78<"C0:DT^$B!V2;TJ0^R:.'Y7;O=H+2(B;H2]D6'*W0)53G+",7)[,TX[Z
MI"X&\P,6%'RI'/*Z\A X.YWKNFY03EU>M2)\.!O^QZ=V"<=MV23/[Z=)7H<@
M"8 \K+2MW4G4DBYYVEZ*U2Y50DI46YQNE/=CN$*Q2B;O=]C0XUOWP5[HNN7S
M'[=Z^GA7HXIDNK3ZY'J4F%'?F1H[\$&6'WFQ<-D1=IK[O:KH!=N5%4;XJDVD
M3ZW(J4.&])C,27(#K3Y,#O58)MFG1W"5X$)L%;=!=X:*6;5#^O3JE4YM5C/1
M:J<(!@/0VP5L(L20.='X$DMYFD%W7G>[Q4JY!GUI^3#[$1MN7(@$PJR)L:*2
MF+=.9.Z-O]3@740X_7*=06'>QRG.DAR% C%AAEHWWWLJ*EU!L"1L")L7)"B.
M\3-G'L?>U?LG+^_NS!WV;,JW1G<+#MW.7L:ZATES\_%3H3SR25@O((OBF7?,
M.M!)9)6[KD<5EP5<&ZV72Z\?3&S$E5RIY;1HZKX)N>']]'^7:D[WM5'6O>9%
MMFW]GTG,]SL[_/4S"KWM<3Z>Y0JDX<"9)AF8.Q4$RBO&P1CF<1<I*"J-TO;C
MK@&IM,J\!IPQ$I*@Q)::15LIN@R]OLB:*J,,R'"X !*)(,>9#>;D19+0/,/M
M*AMNM."AMN 270@,"0A)%5%1<-[1@V 3J0^PTXZB(BO09;R1U9-5TLU(>9>;
M,]&>W9;(ZYC]OSZ_']?A_P!*C?XHX'Q)B-[GX/\ G:EC9G^DR_Q;+Y),&6T#
MT:6R['?9<1"!UMX%;,"1>HA6R^#$ZC.YR9 ]_ ?7^$P'27L=S^<%15A_2ROM
MO*FBIR/;7SV[2)P+&I &))NX2']42K%Q68X M@2A=([&=H]U*Y*G_2:;^,(W
MUW97_C<#_,!BG:__ .1Q?Q=5,5__ (9'_P RN*GL=+ %>&E1Z@(.95&9 ED_
M%DMY%5<RL.-IO45$S-2FT$5L98V=V(IK0-DY"D&Q'$K]C4^GM6WKJDI&3CSY
M"B&XJF^2272)2!<;*_T>K_WJ=YBBTXF]Y%"0DZ>BIF;["A+OW4<3[6^0C#7V
M3^%)500;&ZKP1!'5?O)A4T(33QHJ+^O%:I:!NXX2CDP>:0!V#*L_'1OUPQQ)
M8RKUNM.K]>K'NC>_%E,Q7O\ \N_&T#ZY3:[$ '7H#ZGNG2RMN-NM.1Y#1'9=
MVCL=TQ0LA9#5'=<N,WE+6^R]WYRHPNQ][;H]D+,WV[S:9^P]Y;G;CJQ4:[*;
M%EV>^CFX:52%EMIH&8[2*J"KA R#8F[E'.J9LHWMZ8ICW#=5"$?R)318'Q)R
M;6*O_P"(:NB>)N=('TG+]SL[_/4S"XVB_P".U?\ &$CDH?9&\NJU FD<S7['
M*HRU8MFUW:@MVK<S=VR\VV*N)JEWW*<RT*KJ9^6<1Y0\/:VC+Q"7(80K1*;'
M(1FU1\%)AHEU1AD4W92967MBLH:"+:CO7&Q<94F^RX+U:E MUD5"2]E5>M$B
M,&S#R(O1%QATT30G#77!-'LM2!%=%)B*$9WWGHZ-.IXT-,.R-E9+M+F -P@2
MW#ET]W*G0WKN:9')Q;9WB<E(B(@BT@ZXDTRI1G(DZ(YN9#+J92 K71;HI(;1
MMEO6WFB)EY%0@)15%Y/+6H2#IM 1PP!UI$694' +=N#%WB$VVTT26.4X+B(Z
M!1Q8>%#)H5\H6YC@B*$[4'Y,S>**WS*PZX4455=5W48$\"<,;H]EZ.B%?5B*
M$9W7UKL7=.#[QIAR1LJZ[2IK8W"%(>=EP'\J$N4G'U=F,.FI F\W[S(B*#V*
MO221#EM*Q*B/.QY#)VS-O,F33K:Y55%4'!(5LJIIHJX;98;-UYUP&F66@(W'
M7#+*TVV =L-QQRP@(<XR5!'4BPU-VS)R7+=;S+28T@X\6*A=R_)CJR^^\ ]/
M<.,QQ)3!!?&SB]C_ +EJ2C>7+F[''?VX?OJ_9"+[+>YNN]\!5MCD=:.*ZRZ_
M1C<<?!UELQ5PH+SQ%(%]!S%N3<=!U>:UNS00,4]BGX,1O<]!_P [4L;,_P!)
ME_BV7R;2T(E0*CL_4-R3?VZ#(;%Z+)'VJJ<9W+J+C2$7GH8*?"9S5FB Y*C(
M*$KDB+;-+AH+=U(R01>CHB$9/-(TWE1YW$*D@A)%S=DU-X>+%.85-\O78WC4
M([''(\Z#NJ"YC[#"IU,B62]FV8T2*S;BO-!MEL>/! 2V/+M W3,F?40BMKH2
M1(\QZ-&4TULZXTR+KB=1N*G#%3_I5-_S\;D<<1WL"C0W$;F3U!#,G%%'.QH;
M:\UR1D4"(C[5';<1PMX>[8)K/2BJ3[8V)^I2Y$C>9N.\C"3,+Q?4B84%V7HN
MJ67=PV&W/^\:%'$7PH>'"H&_H4X<V[LZ]-A&2DA*CL>4\3B)EN K&?9%M#Z#
MR#NL3*14VT:F07=VZ(EG$N:!M.-%E#,T^V;;@+E&XJG-'ABB4FJL]DP)CT@)
M+2.NLYT"#)>;[;&-MUNSC8]!Q%++S\>A\K_\7K7_ #'J7%;D5C?TW9V)6JC&
MID)I3[,GQ(TUYMHE>?5QQF&K0"V#I9I4QM">0@!6I,C<M[,4QP>_+:6:[K_*
MRU>=\7.TPZY0 *A5+G&UNW77H#QZ<Q^*Z9[IM=0%8BM(TI[PFGD[44NDU)G<
M383NZ>;OS;KE4#%4T-I]L@<;+K%47&RW>\NH&O\ V@,4VRHJ_NBB\%O_ /V^
MJ8K]U1/]EQ^/])7$:I4N6Y#EL4.)NI#"HABA/5!MQ$N"@2."2@J%W\1JA69S
MTZ6M*G,J^^0W%IMOM8B(V%L$4S4&TT57'7NZQLME5%LQ5^'MJ;YBL;3O!SI!
MC28*J-BW+.61,)L^MIYU8P*GVV*YBKN"0I)J#7E3&3-D53GW:<4%]>W%W[Z?
MS6*)+<-3D1XWE=+(RS&3\!5C*ZZOKGP;!_\ K<4;:9D.@JTB:2(2JH%GDP2)
M$^Q@YV6!+]L>9Y*#2ZDUOX,V>#,EK.XWG:(2N.\9-MY.<F;FN)CT/G_XQ7/^
M98K3DG>T;9:)47V*>PT1.SIK+9*@[IV4KZLL"J(B2GMZX]E40#HOANVMFH#W
M?*:AU []:H<TY"AXF\@]Y$33#OE=#\HIZBNYE0"<W"&B+EWD C[$)O,5RW0L
MNE:R/AB;1JD A+@/*V[D52 TR@;3K)$@DK,AHVW6\PB64DN*+IC[W7X->;K=
M;H(IW6(]8VL>D1&GT!Z/1XUF9!,KS@.<_8R95X%7ZE809#($V12FW\[(96MF
MH#GAF[V>M_'.<D*GO*F,CNS5/;336%O*>7RX)QS6W>4B3P8E5K9-Z0\S%%Q^
M31Y"[UT(XH1.'!D(*.GN1L78SR.ON )DT^3N5IS%8]T3WXMIF*[XZ=^-8.(#
ME4C=ETX9<=9\=#> G8F]RR0;)DVG!<5G,H*VXG.1,V&WF:"IMN@)MF%8K>4@
M-+B8_P"T;*BIJEM+899I;!QZ3/A!)B@3KKJ-NMKN)3 .O.//GE)&I"DX2$'9
M65OF\E9J>T4'LZ,U)8@P025-BJ#H-*[+.\-]A7,POQ L2V3*:8J]9"@J,F/&
M)(>:J5HT[.?LQ#11\L%0A[(-I32RINT6Z8&FTP4  1'9TYR^XA1UYJ.'P(S-
M44&(X*AO&BIG9;:== /+&/)KDL;$4B7*>CM9[<Y&HD)QEG=9N /]D$@V0W7%
MYR[M=EZ+:UKI#91SWG$3>(OLA)%Z[X-:)V109B(:MD#[\Z*9E8D21'F.N'NQ
MYV4(DB)EOQ5$0<2:/5F=U*CKHHW5F0R2KNY$8R0=Y'>35"$45#%QIQ$DLFF*
M'2ZFSV3!FR7&Y#.=UK>"D:0:=LCFVX-B >[2V/0^?_C%;_YCBNTNFL=C08<Q
M&H[.\>=R-[ADE[<^1O%SR/B17]<O'#%'I#".RG^<1&I"Q&9"V>3()$41CM9Q
MSY44R4Q; ''G!$Q\NNRZ]+5 4U<?=@Q0-,WG+$)QH\JITDDOR$7+S4!.;C=?
MN8HMO##9(_\ O%%7/?S7PYY71I%$F$JD+\.2\XUFMS4*)*==:W-]5:C]BJJ)
MS7 XX<I=2%#14WL28V*HQ.CJN1'F[JI 0%VM]E55R.?5NG&7R])"8\05"'VR
M*BI]]%PU[1.3:SW1UO\ &$CTG+]SL[_/4S"IB=4#KM2;.?,DS# 6HJB!2GC>
M(156U7**FJ#=56W'#;TZHU6I--E=8A.,QV'DUYKZL,]D9-?L#[!6YI$H7' G
M*?A4BEPVVV&MZ;46*RV Y&F6D50#HB@-,A==$$!ZL-0*;G"@4YTG&5<%0=GR
M5$V^RS!2SM +2JD1H@!_(;QO6)Q66(T-@<\B4^U&8"UU-Z08M@'OF0K[^*=1
M88IEB,"+KEN=(DESY,D^^;[RDXJ]RI9>K#%%H:,K5Y4<I+TEX-X,&,2FTR33
M2INW9#S@.*&\WC3*,YGH[@N". ?<K03VQ.Y195/IZ1WM.B:L1H<E$O9$W3[*
MWYQ$O=0ZW&#<J^BA)C*2FL:6TN5]C.H@IBA:MN* *;)-GD'-9(VU+#8#+ICC
M4282(G;8$MU&V\W,+.4>6XVK>HY6WY'?QX_"G>73,7]I>YMBDTQG:&A@W!IT
M.,*+58-[LL@"D=WT53(D52NEU)>%\,T39>M;JFC#:D2YE)EAO'Y+CKF5CLV*
M:O,M- R&=&7&U>WQMOW;Q&J"5NJ3F6G 63"GSY,J-*CYDWK)MR#<!LR!%R/"
MVCK=\PED7#9\$,$+7P]6'G&!RK4*;"G/]XGKOPR5/9;J(WFQ,K$D4-N@QFBC
M@J%;LV<KS;+NG-+<LM2K"NMW&335M,.OO*@-,MDX9DJ91 152557J04527O7
MP^="F^4M*;,PB--QHS[[S2>=OR7)+#A(^[92W3.5EI%R'O%3?E'H.USK4A*@
MXC$*KBVTPXU*<6S<>:#2-,.,ODHM,O-L-FV\H;Y'6WB>C_MPQ&]ST'_.U+&S
M/])E_BV7R5BM1\Q S41;FLC_  JGNL1TEL>-!%'&>I)33+BZ)B+.B.B_$FQV
MY##@ZB;3P(8EXE%>"_AQ6Y=+:R.5N=V8]?@P&7]Z,]0QP>.1( >HI"AT&FK-
M;(0'K2*@(R:H39<YJ#>S,9?#,>%2=!?X*R8&F20*XI7])JGXRE8J?]*IO^?C
M\E B+7:/'?*&,J6V]4H3;PRYA%*?%T"=0A-LG-UE),P@VB+PQ I>R=9C_5HR
MCGSZ9*8??::;0!:8;=:(^QM]O#/? HO(K(("Y-YAF;'VDK1.M%GR2*A+E1W+
M7YK\:2Z\P\V27%4<SH)<_F'BC5<@W95.F0IY-IKNRE1VWE#PY5/+B@3P%!?F
M0)<9XDZQA/-$RJ^U[.>^/&S/])E_BV7R'0=G19>JX@A39CR;QBG[P;MLBWF1
M'):AD=57>T, K>\%U7<C;,J16/+)@#S/09,2GMLR T10SQ8K#[*](D,#;LY9
M+.AVHZ=6H5TCU&,W($2MG9(DLZRY953>L.";3EE5,XK95XXHVT[0(+J/+2)6
M5-70('9<0E_F":E)[)7A3['A%0K*G AS7O[;JQ9UYUQ+WL;AE_>TPJM.$VJ]
M8$H?W<9G#,RX9C)27[^OQZX0@(@)+\X54"_LX3>NN.6X;PS)4^7RB "IF9"(
M (JIN$JZ &77.O1#V2IBC48<N>+";[(445!.6[=Z6XE];'*<=)+ZHBXHNS[9
MKDBL.522*<%=?)8\6W\JVVU+5/8R,5S9MPTLZ#=8B#:W.;R0YRYNOF%3[)X#
MQ6*1E1778CAQ;JJ(DQBS\15(=4'LAMK,G6"DF%0DL2:*EE2RIQ2RZIXEQLO_
M ,4:_N/<CE#H++,VM (+*>D76' SIG%HFVS;>?DDU9S=H0 T#C;AF=]U@)$^
M:Q5(2N)OJ>Y"B1AW.85(([T5IJ2T[DS;DWCDB.I$#^7$::RMV93#4AI>^V\
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MX0+G:<:<:,XSMT+(1CANH,4?>R6'$=C]ERY4MIDTZ)(PZZK#A-](''@=< D
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M-<C3R--9U>:?!K9G^FN>'^!R>3:?_B"?Y=C$NBU5X8]/K*MFQ(=, 9BU!E%
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M_7&JX_7CJY$PB<J;3TYC-5J *]D(V/;)%/7IHOKB8Z0^M#'O_P 0H<0W=X5
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M(P%V%+&U\MUON7Q[M@UOZU51+^I'DH? G]+>3:7W<5/_ !ZGZA4FNM&2,-2
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MP9=Y5^^N$)>O7D#VR>#K1/O)C:J:"Y@D[0U=P"]<*SG\J^^FO*Q+BNFQ)CN
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M^V-/LGI?R4/@3^EO)0/=_2_R=VI])[:5@D'.Q!IL%K2Y]O>D/.Y%ZO.&;_\
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MN!55U0D^]WO7(J+JF*W9G<,5!X*K#44LVZS/!'#-F_<;_? 2?8G0)ON<9LJ
M?="*(@+X13J\*>JS+[:V<8=!T%ZLS9(8+[Q)B(_,J4:C5AJ,VU/@S7-U=UEH
M1>D,.ES' =LI "<X$6V#"EYZS)NN56LS<45X)FD'YZG@ ++U'UX-D9GE7%*_
M::=F8-47N2D)=_*O#*!MB2=/-C.Z9N$O=&2FOQK=>5%31??TMXL49V^;>T:
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MH-.D+9*G42@B*J=2^E?)0^!/Z6\E ]W]+_)W:GTGL\MK[EFJO^+=4V2M_O\
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MO<-ASC,O$@J0^+%8K)JJ]G3GG&D5>A'1<L</N&! ?>](;/3'4S/QV#I;A>&
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MEW:+9S(J\UPF^D0ISA5<0IN5Q6Z?54&2*= !F1U!MXT\+C0M(XO#> 'V3TY
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MJ>+TCL[5&BRE$K$!Q5TZ&_ '$NO-U;,M"YGVS3"&((G!4T7\^OQZXB'UNT&
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M?,";9D!@J*) 2B0JBW0A(=45%PS2]KE>JE,N(!41LM1AW)$[:6BR6!&^;49
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M'HZ**)WNK%.VF9CH,FCN)!F$*>>0)*]J-?"Q)LG]<XOV/Z^U6:!+[&DB.[=
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MIP&I!!>^YDZ@_'+^49D"8%X1P):94<$;7L=N^@]>-IS=4EW$T8K*'W+##+0
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M/M</+=B4[_,P;S'?[#"XK8"HBL@H,37BJ.S 4_[ +Z<\E#X$_I;R4#W?TO\
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M;O"Y4X$O'C=5S8H57%.=/I[D9]>^[ =$04O;,NH@KW63)]B]0_)0^!/Z6\E
M]W]+_)W:G^+FS56(E!ENH,QY2I_NTM>QW;^!$<1?N<*Z)"0NHA XG#(27$D\
M!)JF"E1@WDB@R2G61.?V&ZFYDV\"*V#R^U]GZA^2A\"?TMY*![OZ7^3NU/\
M%Q%314LJ+XL4R9O1.ITUORLJ@7NXCD4!;:?4>K>MY"1?7J[AYE\ <9>$V7VU
MZ!M.ID,/:6YWML+.@HLC9FI/&=.E"G[V(B4O*^3ZUYD53*7=CKZA>2A\"?TM
MY*2:?P?;JDNE]U1=HF$^^\/\74-Y5<HE308U6C+T=TI<R2"?;8RJI(OK;X:J
M,$QD0I3826'VN>!M."EM>I;*F)-"JT09D&<*-NLO+UW1<X'Q;<%43*;?;.;E
MZ.$4A=F422J+ J63OB"[B7DYC,@"+*B)S7K;P-%LGJ!Y);_4X]L@RGC8':9Q
M?\?DJKX"I)2JS0J@Y9+J@%.2G7\"9J@.O\7F]F-HY!GLY)- C2352*D/.<U%
M$EX0U4LSB=%G4TTX-RXSK4B,\ R&7V"0F7FE2XFT::9514(+:6MAVE5J&S4:
M;)!8[\:2 NB8JF;KYR."JYFS3HX<KVQ"OU6EJN\DTCSVI4X54KDWE_?<8."9
M>V *=LUP0DBB0JHD))8A)%LJ*B\%1=%1>'I_;&IJ-FYNTD6""VZ14ZF-OG\2
M5,.3;BBLIFD2MG9[D8%X'+A-^6$4/&4B*V/O_P 7VZ754*I[-F?.C*JK(@70
MNVP25;(*&HDZPNAHG-UQ'J5!FLU""8J:2(Y)FS)]C='IL&' Q+G9KHNN +.8
MZJ.G-T\&;0D7K3#M0I;<:E;4(!.;UM-U%JI-ME9J8V/:VWW5RB,H>>1>>=>)
M5,J4<XLV&Z3+[)IJ)@JI=%X$*VT)-%37T]LZ3J6>K;U1KY#[";*)J(O]9"BQ
M3]_D5%2Z+HJ+WO%\>-JMFS!6VH55?<@<PFT.F3%[-IQMYM%#L1]H+CIO *W\
M7^RJ1*5&G,J2X3G;(DMOK!QI>;FM=$<3GBOBPRPXZ%!JF44<A3'4!AUR_P#
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M,'Z; ?%6BVF? B4"5-"\IV#!-^7,[/NC+2JSO34&F@!IIH!;:;;% ;;;!$$
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M9#2EBE;Y*W3X B::;+QKB-SXY N*4#4$6TE6+K1)+Z:KW1;=9FL\PN/(HB"
M'$3IH6048H)"*JN+[ZRR^Y9=T\0\J^=?)_4KKM.WBM#R+Y3P6/,'APU"%M)$
MP_J:;\7:[MK:9!)9:QXHVX9REG1,L%[<)]F0=$,/I-S:Y)REVHI?$!>M D@
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M2KK9LTQ855I4D(JV?\CI#W0Q6=@I^GKF<S+4<28(F];D3[!RJ<+H/0"@WQ^
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M8O/ )IR_5>!4,@^$JYFU4^N*2BV !-@@,0&@BH.BVMT6"B8PR6BVAMD&88
M  4D77'.]3![[:CD%F(4TY?Z#-/'V"6B\^1=!:M"&S@/;PXT+I'.E1KS5-\S
M@BP- CZE';45/5SN"V^,$14\7)6.R>2UZ6(M36+5#*+ (P4UA*?E<_Q*0$9$
M&#%-/=]Z00'(/):A++%)6":M?J(7!XGC"H7@&FG#D_8$4Y>N?Z"AH9$IACRZ
M'%*T1R"7H,":\7X2GTV@7U=-_>_U%K;#(C&6#B@XTXIF ZE$,)46)$ID (!X
MI#HEP@0BT;7PQXAH(/R7J;9&=:?KACHIE-)KN9M2J&]S>F,8+5!NX?BI-*&?
M(2*6!=A:H$*)"(C;^@A48(.,_P T%-I M,4I[ 6X?--3^>_S3GZ5'96M20/#
M-_2*:(T=1+=D,!=!CBU=SUO[%PKDDRY)%2Z@MK"+ZHPY1/$FC"50(F4 7%3!
M69WR<+QC6QR*1$7N^U6-G(U)2;84G*HH=@)YTR";[5.9BGR:6KHQ'M0\5%6,
M^9I7>-0AJJ!B"4)WT39AR\_Z#(5\,78"A%@5??Z4E3@F\7PNP:M'S908TY@+
M6#-(F2TE"V090,8PH0?W'@!:S"Q,I6].,M-(81I&@X:5"7XJ9I;IX;4RMB#&
M^E2+>U=2V=JQ2Q0"%9EK:;32P:5OW::2+5<3#40X'XIKM)7&_2$;IO.TW5-3
M8$NFAY2S:G^@.>VO\?5GWZ_1?>K<:636BP,FNL26#<QU@*5!S FH"HW4'5%X
M3$@=0,"PD=>R5$LID $ :0 !&  :05+RY4+S,TF1I:FZTC:^M J;XI2Q@I+D
M8I/"TUO&->T4A@GC0$,\*Q%,AFDG0WJP.U0R.U*QS'Q4YHUJ0^@TE:ZM9%./
M/7^@=[GX\^_7Z+!8:-B346&!B8S4V;(<>4DH83CDE1>S!K$@BE-?E4%/U #
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M5",&8?Q71[S5O'7?_M 2JNQQJ0ZNO!KBDXTILP/Q02WBBXM?2KQ6@$OTHR+
MAKQI)E@ML%8)T9WK;SVY(C]E5OW!SN7 AFPKJ82N00H.)2 + &A3Z$+ 4P&[
M1?D^0  +[2886I&><7WXWO>ID5RK.$.39D1&;R&Y4H>LA#FXR#<1&OW1+=B
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MR):?2][GZ3%VZ4A(DA.5_P#A1Q#'%2B( -: N4K*2@:3Q\!<E20K*8XU1%1
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MR&P9I$TR?-J]E58X-.?Y6G*U1JX-'T]\$HZ\XYH4"*DBN%!IHA:T]8#Z9?\
MW 9%S3GZ%A0)!S@('-4\.\+C.>-*$4P;Q.O&*2*[ N3E%7=]2GQG!^X-*1]K
M!5#N%;D&?1#KM#9P8AO]E*SP=27MR6276@X<71+RNIT0J<B0CR3T?>Y^HQ9I
MV8PTGIJIJAD?94*V04&?&.ZH'*C)$S^E%7C$_P":(H1KD<T0;)CV%&CW%2)F
M@05-B^U.9JV)''3:GU?NT&'S)11[@3A9QHO>5.?XXT)T@-5J(05&B!Y"HT"2
M8_P"I)>W:Y,!..YW-88K_;_0SMPUDB'4N*B,Q#L7K>3!L%M1G6?=GVE,<9L_
MGG#6-8]!'3N<O=TY]%-T6S(*C1>T;IRN1H<5QQH9H1AB4'PG^C[W/U&*?-:%
M/!@REV7ARZ<V$F^;DF+8VM3G(L[D;%XWH1:9^%721(P]W4H@ X(8B;1PK@'+
MK8.0I&\B2:$T$C@* -'[3PIRF"AJ<P<3J:*8.A8(VHX=WJY_@FNM.;@%6%*M
M "]^=-VGF9,N(!$GE"B+(Z]DF0%I  48BJ^^PF5>-,R_0IBC 9N6]_S!5GD[
M0E=9)W6H:+MXQ-\<-N%15G4 Q-FG>#I7*C:I &G(D4!*E ^]C:TZ0MTH/=B)
MWIN>U^A/\K@WL07+YB,"M?0E!-8C,M,Y7,-H$:EL=&H_->)]QM_G3Z+O<_48
MNG2ACB9+R@[Z%)SEX]BUH$ YVM.C9+U;Y5Q$PJ \Q(F859G,<L42&'^.765
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MFB<RVI@_9=:+V-0P!5"I)NL@I+L3'3\T4&Q^:&P_1H;PF_=KAE;14<*33"!
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M$FV"T"4X-$20VU"8I;*93]]PL4',P *$;UT]<@Y X$477PH+H5+H%S4T9O\
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M 0 $ $8$(", ( , ,($   ,  , ( , , $  ,  $  ,8,  2$  $$Z9 "DM
M@  "@ 0 @ @8A "@! !@!A @  !@ !@! !@!@ @ !@  @ !@9@  2@ !@8!
M+@<K,$  "$ 0 $ $8$(", ( , ,($   ,  , ( , , $  ,  $  ,8,  2$
M $8 $)D"$ @  "@ 0 @ @8A "@! !@!A @  !@ !@! !@!@ @ !@  @ !@9@
M  2@ !@8 !K@@6P$  "$ 0 $ $8$(", ( , ,($   ,  , ( , , $  ,  $
M  ,8,  2$  $8  $<V"@@  "@ 0 @ @8A "@! !@!A @  !@ !@! !@!@ @
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MA $ ! !'@_C1"F*!0;9+#PKE=*'/XC( #%[RCXIO0+)O7Q*SJ0-]QW  !%@
M! AAY@ $ ( (&:/-W7RLHNWB.4GX*4[5.53L@8 3""P8;T5>0D.7,XRVV/,
M 8,@ ( @,/H $ ! !& U*@M$%P!<L0I*:#,G,JGS_)# !\U?SE/YG^Q1T/S<
M>V0G# !%@ ! @%AR $ ( (&(1*Y:  8082(  98!((0A>;08 (#( ";22#(6
M;^5.A()8'8 8,@ ( @>$.0$ ! !&!" C " # #"!   #  # !TV # !  #
M!  #&#"]"A  !&  !%@ ! @% AB4 ( (&(0 H 0 8 80(   8  8 0 0 8 (
M  8  (  8&8  &H  8&  8,@ ( @> $,6 ! !&!" C " # #"!   #  # "
M# # !  #  !  #&#  $A  !&  !%@ ! @%  A"0( (&(0 H 0 8 80(   8
M 8 0 8 8 (  8  (  8&8  $H  8&  8,@ ( @>  !$2! !&!" C " # #"!
M   #  # " # # !  #  !  #&#  $A  !&  !%@ ! @%  $(I( (&(0 H 0
M8 80(   8  8 0 8 8 (  8  (  8&8  $H  8&  8,@ ( @>  ,)!) !&!"
M C " # +"!   #  + " + # )  +  !  #&#  $A  !&  !%@ ! @$  %#(H
M0(;21(QM))  !):222("28   :2"(882:0 ::23?(8 $@:2($22!-X ))K(1
MV4 0!P!&&)4H "24DC.Q  "UJ_X "24DEMK;9)#;?_\ _P#_ /))))+;;;;;
M;;>VW_\ _)O9D"@*H).Z
M               !$91 !5S@?
M                      ^P*@(S  @
M                             @R!#U0
M                                  !L@)R
M     *7A0                               ,>!*@
M          N)$"P                               H!5Z
M             $5<2N0&0                               $E&
M                  F:A0L=-P                                E$
M6                    #\=DP'_ (1Y!@
M      >@                  " ]4><(-+<$/:
M            T                 !1_2 AGCV9[5<D'
M                0&@                 2*YH &6>Y)>AR_@
M                     "!T              #  ;"*WC%R7=#K_P!B4OX
M                            $'H              47A;5WKD/ N\'72
MK)N(P  0                          @F              VM](=F0, ,
M,8*6&[,;R$9J\"#0                       $$P             "-:HC
MOGGD%!!'VTS9H%9.$Q[S* 0                      @]
M _\ 58&:&+2)=1%/LG[68]A'&16*"X                     ! :
M        8JB([9IS0*K IUE_!Q"32ZZ&6[!<                     ($@
M             '(;K( /2#0&#$&)@H$:8=^?*G>4?&
M  ! D             !@W]0!)A0*)Y8@X(PI@D[/9 7?ZH(8
M        ($@              .N4" " J9)/*$?,@**\,  !S9%, N
M             !!D               5KH 83/")!Y9#Y(E1U@P  !@=)PI
M                   (,@              +$NM*1"G!"*+('4-UP=M8
M ,''/H                  !!D               ^I^Q2#=99PP9 2HF B
M3 @    TIVE@                  (,@               *D&MT!M9**&*
M*%!K<)_H     &\3B\                 !!4                *KD?#$
M[C18Y89Y43TX8@     U(,)0                 (!@               (
MF\4*,&1/"5+ "&S[L-@   $-0#R#7Z                ! ,
M    !^V--=LCAH*A919N?Y5*    "C0_OD+(@               (.@
M         /N_)(ZH;@^(/ *)$N\:H@   *SY/.O>@(L              !!T
M               ZX183XP3KA8Q ::N$9G     B7XH-#V"H@@
M   (.@            $!@G4.'+7K)39()0+".',     !R&[[83O2O)"H
M        !!T             LM4,ADY'N;[;8((0F5HH       @UI8_UL_G
MTL            (.@           (#A1$O!S*H<"*6+./$$D        *]:=
ML!CY&/9,           !!T           !:LVNCALX&)@X9(Y:/0E
M  ;<94$ ML[>#Y@          ()            '='/   P420" .</ZQP
M       /#ZA1G9><LXJD          !!8           ,MG)    ]ZH!!XK*
MY3^@         TRPPV5K;@^,'0          (%8          !C-5>    ')
M-8'>6(Y           &$</H-@*8;S]H          !!^          !W6B8P
M    J728;27E            TU$$USQ1K,_$@          (/H        +W
MZT0F0     (9A 4;P             /%6'<;'/!NEN          ! /
M    %(%S==      )[X[F4              FMWPQ6+=0R+@          (,
M        / 4BR!;<0     (O1'               *A>.,6E$B:%(
M   !!         !XB8S!M4      @GO'P              K1? '^( ,+P@
M         ((        /B*2A[$?                         !'.@ "PX
M!$&0          !!         8TZR)P2A                          D
M\@!F[0 -R0          ((        $/L]0H ]P
M    #%  $D@@,RD          !!         9*O4:  W
M         !SZ@!J;; X\@          ((        +M\2
M               "L   "YR 7.0         !!        !,K!K0
M                   $AK+0  +Q !$:@         ((        ':#8@
M                       !6=UN,  $    !          !!        !MF
M=@                          'B5=R)P      D=P         ((
M   !<0L                          #$9PO)&      !&L         !!
M        !%7K8                         !8@#K6A@     !/+0
M    ((        -.7H                 -4,       0 .M'4      (I*
M         !!        !>@W8                !!Z@        !CT'(
M   (8P         ((        &FI3$               #$( KUD     %!/
MM]<     !-CX        !!        ![?(1@              !<1G*.,
M   Z<CWB0(     N!         ((        *-WIJ             ,.-.(%
MU9      "UN(+-      +G8        !!        !B9=[@           %
M S6 !/<(    ( ^Y[MG0     !^;         ((        .PYQF
M   %.K+C  +        '_P F;5      "^<         00        =EL+N
M          !G!*(           $Z"!#<      #VP        ""        !
MGVZ_&@        ");?-Q           "#=TU       "+6         00
M     :(DC6H)        72#X3            &[HR[8       MP
M""         "!*HM@1      "4_]R:X           "S;:?       "=U
M      00          (C(R.H      *]# #Z            #\G.$
M;)(        ""           0]X6ZO      N9 "(             3O6L
M      2Z@        00          !BX'5'<     1V0
M?LK0        9V        ""          ##I\>Y?@  #?!W@
M    !YEP]"@       0$        00          -NE!_P"C @2Z]%=@0
M           $O!.U6       %($        @@          $?N9E"\2JUJG=
M&80              %/3)4;(      ^Z        $$           #FAC,&-
ME.A^&^ L              &$A_/&A      ![&        @@           7
MB46;VN<TOHG_ .D             *G'O4,PA      %P8       !!
M      **[V_ES2Z3@!O#X            (7,]$1T+"@     'FP       ((
M             ! *G(      MC<          /?OUKT0 .C\
M   !!                !        X_@          ")''UTP 9Q$
M         ((                        -$A\        %K@\P*%( ).YH
M              !!                        !(:*@       !WWQ-A9#
M  !R'0$             ((                         +?\       $#
M*( '@^  +"#P#^           !!                         !<X0
M  !OA&P !NI@  B%.-,            ((                         "_
MR             'P^  (CH@B>           !!
M   !Z5(            !L<0 !!6C:S0           ((
M          %<L            +1G     *Z            !!
M               !;Q0            ,Y4    !'@            ((
M                     .@              UJ4    !L            !!
M                           *-            !!07    !=0
M    ((                          +FB            +AG)P   !L
M         !!                          !GO8           !7/RP
M))@            ((                             X           !C
MDS    $0            !!                           !6K0
M   !+%O#0  !              ((                           'CE?X
M         )MRIN                 !!
M 2;C#0        !)$1<P                 ((
M       !<5\         "D8@                  !!
M              M9P        !Z_$                   ((
M                              .@('*                  !!
M                                   !.V9!P                  (
M(                                         +,"^
M    !!                                          !I0
M          ((                                           :9D
M               !!                                          !
MZLA                  ((
M     /1K+P                !!
M           EQ2M@                ((
M                %P$^>                !!
M                      K"&;$                ((
M                           !P)!^ZX              !!
M                                    Q)M@              ((
M                                        !SA-H              !
M!                                              ;T/@
M     ((                                             '/Z
M          !!                                              =<
MD               ((
M   #"KJ              !
M         <-G                !
M               $4N8             !!(
M                    !YZP@             !)(
M                           #V<             )(!
M                                ![B              (!!
M                                                     !
M                                                           !
M  (
M    )   !!
M         !     !
M             )(      ))
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MAT6H%QPY&&F@%; 6-HH#"=9A-"@N#LI 7M[;:F>)5ELQ?@]]4,;@/)&D8@(
M'*U.*TB)2PL!"&!!'0PVVS^ <8[JTT"KTIQ"V!+N,[K-NI_8:*4ZZ3D0B@+
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M(F"8]-K1$E,3,1<("=B=1^0P Y K(2DL00J"),L6<#TG@EVS("=EVZ'IC1"
MC1@SKGKKTN/WHH@Y?@Q[[<+J!.3@"BB!&L4X1I'6L4*)<U%:**U#@!"H>46T
M2R1F-$P"E"KY4@M(:RXF].5#V;I&)0@(@%B=%5X+@Y"$&3O&#3)O29,4&59@
M8-*R3!5+) 18H-A&2(A94:(( PNLBZD2+!JAHCJ&!+" T!!&B+P+P2SP-ZPU
MI%<WX(BECM^\: C^<8B:#$,B0!"@TH/$BU(&@$@H4$#3(# E@&1 U(0D2%3@
MUQQF88UR+:8 :%)60H  %8V(B W7+L1M<._W8'8\?3 ['C[L#L>/L^2X:^!Y
MU@=CQ],F)W_3]<#L>/X,#L>/LP.QX^GY3I@R@1RU>*]^F=*0Q$=SK>=_:(SH
MPXQ3%0YCOSQ'&A"BI4B \RDQ'4SN("I6HQ  6!N)9U)RC(4O,RXHDRA&J;BT
M#G@.4F@@=M-U*!;%(B"$<#LZ9CC$ICR4H("0$H +@$=@"4JJ009F,2[Z/3B(
M1&*20094!G5MO8D1 JQ.&)6T0DQ-_'*'0(HRB"R@DD1)EJG06V P>FSHA'JT
M(8D1% D(Z4<N1- ;22:_J-"\(V 6B"1*(#'X&IA$U=WN+E]>= >KF"0N8 @B
M&8!M% #FI,R"2,(%$I:;JY!UK"G\>VI-9X@A"I  RH 8&? IKEWB*;(V)Z,:
M0H<D<3^??5):Y*W'FN^E-YC^(GVTB*25@W3+'&A4<=8!"(8$5T0TUJ@4Y!"2
M(:VB[=$2 D VQ5P_C?KIP>]9NM-;NK:#@"%RSC)*_G2LSMT$2)-@8BW$5J$,
M-!94R0$DH %4 U(]9(J/Q&P24FEM"B$8&6C*<+7#,@ 7YA8!%$&<4C3%ZA$1
MP'BU6;6 0Q##HPJ=A@F?QH:I$R%=G2(D6)(2-&//$$4K,J7)C&IZ LF4Y8A#
M+)>]M2&)RC RR4N1$()AT42( #&^VV\[SMK'V8'8\?2L STE;YVZG&,.IR9N
MB89) N.5#+2[;B26Z1(1-V$[@%R@@^W%EBR!5<TZ810@F%X$)Q;/)(:+32,7
M) $8"+OE)0%NL8%R\64*-2,F5Y&"?<P"=/68QG.^L??'OI"L"?\ LT'!_P"]
MXOMH#8^B4#8$PQ!_NM,1( \ )*E<@T*,4LJ%T07 R2"Y@F+.&7$E,Q"HH%"%
MZC(I?L#@:B I(9(:@(AQ0H3NS)!OO[6(%D]&<$$%;3&I+9AG1'3M,)6<3DTB
MLK$&.)F-R+LTJV9QA!=FCJQIOA<,%4['<N75TWZCAHP2=.61!-2SFT4(8( Q
M3I0J$RH;4#68H52.0C5/Z'(4@  6(]([Z#U4C9$S;A),04%(7"$W8*2!6;$9
M$AVO2\3,&)MDLBI4 *$6<@Y5:T( (*"%<.H176*X1$881?;%V+!0%=-%BNT]
M=FE 8+@IHDC)!2=7.@/-Q8@I#R9$%A@;-*\67TE*17,P@PM'%-_:+#"PHPE!
M$-$O6WG3,@@L@AFM<X>HDC(QG;2PJT+24-DZN?NP.QX^F!V/'W8'8\?9\EPU
M\#SK ['CZ>\CN>?X<#L>/LP.QX^Q%4X1D+DEPWP3>FBP>80"DA 3?QT!U&")
M?;UV8N>NH%92.!()>-X]9[:+012"42,+B(Z9C&E6U2,$,A!"" FRSMI>I/69
M60S"P<!.33Q%QNXA+)$0A=9*TP)%GRE@FX(4,YSH1"!(<Q(*S8&:F 2COVC*
M4V(68!N@64Y;!%I.8110B1*.SP0V4$[+E*,*P,DZ! TLPQ4")8E,A3?C(8*3
M89@F(*$P&$ X= X2Q!1 @PW06E],,H<A$\JJ;E+1,Z,(@2:,P:FQ%DW Y"T-
MVC9FAC"U!+,*RC<QB%'0*8)E(!8I$(402T1"F4 D957(%"%!+N"8[S@!JNG.
M@'L##2GE,"J) (A$G(-"K1RE59!FXN8VG2'I!$TIUO&8;0[P(*E#$*%;-[03
M^2=!D6;N(,R$"[RG5-U+:C#NV[=-01$5,QM/,8GKJP,!D]8*SP6Q[T:A,J"J
MI%,&<>D1C1)+* 3$ Z(*,\WJ44N;+&<Q),S3>F#*;;0LP% H:D J"AEH($($
M2+8A)-*FW'8$&4"0B@K 1:&Y*#("MT3'5#,@M2%-GE$SZ,5J#,"I<S5<3D[>
MFIXA**&6(9F5EPMK)TTNE.[7$-A(34)[%94R!1:495( )U* F[J 2!&XV<FD
M7&G H0""(*E%%I]P^DQ>W;U]=>6^8^F!V/'V*(A4+B!BYX<XJC3'R4,J,H"
M(2,(I.G$'N2,EX"J46R2Z0HH2MI$+/)>([&D:8)"0FTB2,W'))PE(,)I#=21
MB6%&DR&F1E?:*1"4QP#)6C\40#F"&8Z25JB1F=0ISF9G'ZT$!)#2LE&\;[*7
MJ  #2@[)+K*%;<3H$"*494ZIS!HJ7TN,[DH1O1^(#QHTFAB+0DD3 4K! 0>D
M**BB#Q"1$9%FF,9.3 (6*(IR4!+2]E FR!(S)$+<.I%9K<$K"&\._?;5XI&P
M3,LH9)Q/62VO)DP!4H,:B+3"2!/=N ,9!$9$(,1J"B/7N!&CLA4"$3 $$J3
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M[ ['C[$D4(*%34SWB.(TZ=ZLQ !4&Y$B:IU"1,&R((8P7TZ:#)T@B'!! @
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MX,#L>/NP.QX_@P.QX^S ['C[,#L>/NP.QX^[ ['C[L#L>/LP.QX_@P.QX^[
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M2!3(D/%A_P#  / _?^;^3RTG2[H2!@O8W*<,-5%R4DU)883D>3K'*\GB(,U
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MQ4@?BKTPZ4F)^.=_^:)U'(,PB&9RK7'Y=[DAJLI*F1%RS$+B5E6(EF.)V_\
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M@GE_$[\>FI@%J0S6D(0S1B_&HV]+!P,)-</R56 E$PS4#DXX+(9(6DDZBS1
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M+>L_(_S,(IU#O$*9R$\8C3U$7 9@-TKB('-&L3ZD@7!E;DG$%63J(F(F0/\
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M?2G*>L5^*\Z!-4+8)0=HQQB]]2JX3A<8<77<N=.64L $T4Y8DG 4WLY>_;_
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MB[,=>-]S.D$C H19!1BO_GR9@Y'O^_G&D(D6S'"^GYT.4YFB;%,@BFU[&D
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M2HPA@FV0"DM#2F$*2$F*23.;3A="()")48CZ5U)&HAUD=L VSLZD<YF>J]'
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M+ (O8).BR2SDL\S36:[ZVG;G;STH$J!RT>>N.N.LXCF=)P: $2&,(I>AY$Y
M>BZMR:3:B&%^'H-VROT+XF@),,FF30T)6+%26B&"%8;=$$BO"9!!@C)6V- (
MK@$1FF,XFZC*M&/@XU,.9A)H07%!QHB42.Y,LA$9(;2M&0A$%8*0@GOH$T!
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M*;R8"%-6D@#(9!&X(!"#706B,RET,)R B@1HC9>L$" @DD(!($;)QX*Z@M9
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MCD6RR&C@(#RQF.VA)FK@,;*9(!M2BI,PL3ESJ $U""D)" C3>G=SK%UXN$L
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M&&2%Q-R\F^HI\!=HEG.$LTH2)(3HA&*2K&RMB-(E9<PDHY:N )&C9:E%@62
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MV[?"<_5A)"[ ^?S/Z&!V/;ZY/=]_L@PZ GSTT4!Q]<GN^_V8'8]OLR>[[_3
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MQ\?XZOCXI^1KTWQ8_!ZZ]-\6/P>NO3?%C\'KH_R?CGX\'7R?CX_QU\GX^/\
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M,T<P\L57XU8) 62+<VY0..G&@3*23+,M<1(D,#@!.!S+/F]OAIRG5_\  ,:
M *-$)&Y<.SUT*IBTX[,'F1 8XP,@\DZ,ZY\@?BYEE67,<HC*S.5(?[XXK1 &
M!C^.AX?+2AE#OI;@*4X1P9'9,$;8=+JS"N 3$"0O,;P<HNAA 0A+*ST*O+G2
M-!/6(EWE,.';&=(G981,HQZOXKB]"=TC_O./B$!")#@EUF=ORZ8J1AC/^:%@
M1<[9\36?;;\P(9>\G,Z>1),)61VOK)<\UHLT%I())#*,@ADD-BZI!&0R8W_\
M"B$I3I(1Y=]! '%>6HB.M"D[S$L)AITI%$1.&E^>>EE/-_Q1"I9>]B[QP/$.
M=M+& ,,B>39QE6.VC !$J=\-BPZEZ:H20) 5P"M[6@ULZH H25+I$  9I)/)
M,N)>DD(3-D"+2^W&GQ94-4])C2KE7NSH$M&78U*88T^HZR\/[TY>[[ZR>[[Z
M8J1AC/\ FNSU_P T:.).>2L=[.7G4)CB#O'4X@V,.F/L,DIDO;+>^8CC3OF)
ME*B14T YN8IA=)#'%?\ @TL0AO(OR^.@78E.'@G'#?YQ_#R<_2'C6[!B GS3
M0SL6Z IM,52@CL;Z<181"%N25N=J@@@+=-)K,F;6[6^V7?49I<RXN.N;U9 E
M*F]H>'GWT<Y=_ W,;XV7;4)81*CI],GN^_TR>[[ZS.WY=9/=]]9/=]]6JF^=
M=GK_ )J0C.]$'ECUU"9B6;QQ([5V-YT[=Y05TC^J\=+%H3,\)&3'-V.;C2NB
M0I1 87=)AJW_ ,'A;2QUSZK!4B?+^%#6(HQ#Y77E_>A%$GAV_L\^NC+#E8(&
M9XGWVBM1*9LV3=DDN:A:O!(B*C-"$,$R VH9(-E@3MK4@@EP" = "B(C2KBM
MF4MVS/KHK%=J^DO+\_X>6B,5M$S_ )TUV>O^:9F]WG^M=;T?ZU*;W>==;T?Z
MU:?C?6)W_#K![/MK![/MK)[OO])"KU>%:AAQO.>*B-(AFTQSZZD8ARI5DS@^
M3J+8%#$;FT'(4*--*6%E.O&<)AEQIR]WW_\ !9RX=GL?T^7\*+<K,C'>%WS%
M]-5A%E*.=X%9"B")1$T !+-DBD)F)B\3%8QI6@[H\K"NZ:"S7DFW??V,:)R2
MI-WGQG3 L8G[&[4^/^:[/7_-+*O+/T KW>==;T?ZUB[_ (=8G?\ #K![/MK!
M[/MK)[OUBLPQQ->732*)VDI4*;M]O+O:&4/7;>P?D:>]2BDJ5FXL.\;:AJC!
M,J)1)E;1X$0:,$:A<$_^!N^X]G]^" ;!YQ$:3H.>NDBPP/7\:,DLB5(D63-W
M/5O?3P2I$&,+NC=<".1D)<"+PVQ%K,1WME3$^SFH !X$Q4;&E)4K+E6N<]>^
MB$(*(P;3JJ15;5S]7+W??Z9/=]_ID]W[!(^G?0F1_P".@@#@CZ9/=]]9/=]]
M8^/X_P -8G?\.LGN^_T$.0'E5X]-]!4L^(XZ: M# 00*VRF30-!A&E2$!(Q9
M3!*SG1/<0%(Q* HBY,&Q&$3-3S<Q^(OPO2K,M_\ @+ON/;]\AS#',?0^#51-
MU48I=I(Z[ZODRA!,A%#?P&+S&F86]S@F8"0 7 @V.&"\*<K./QXS.F0">>Y6
MYRZ!)PP."':L<<1J1C#Z(O\ S3F73\NLSM^73E[OO],GN_9D]WW^R"*O#RT#
M,YQVTD*<,?3)[OOK)[OOK$[_ (=8G?\ #K)[OT0PT-G7?;3]%1'2MXTFR$DN
M_>;\2<NDP%3^2<316=$"""!A+GPC8S0Y-#54) .]C 1<148!%3&QF(#[+MJ%
MP+X?=#P^3_,E,WM_7[T92'5>:7H2(5ZF"PV88&X%A1TXG08FI@J1BJQ$M9K6
M;BLHJS**YW?<G.E)66WQ^S)[OT$HY4T(D?\ IJU>[DG7=Z?[I(4X8_0R>[[_
M %R>[[ZS.WY=9G;\OTR>[[ZS\/[UF=OR_4D!5@Q/CMJ6IEFIS<;Q.2[WZZ&N
M&>O:,:2W;805PGEHF'*Y<H.2V<6Q')HD)<RPW(QF+Z#351IN24EFBQ,<$XDH
M\=!RB7+Z(+._7\ V!4JM1 A2YD( 38DS@B@)BR977EAO4"XFU)C:EGS[ZQL0
M?.9Z;QI65.JPO\:'*'2?\?/.)B6##;GYO51HWR$;R^T:8EV;3Q_*%,WM_7[T
MW8N[9.._SC2C6"-+1Z("0Q%0UJ8>I\S._+_MNI;)OUWAS'IMIRQB6/LR>[[_
M $02/DZ!8W#JQ>[MKN]/]UD[^]_I9/=]]9/=]]9G;\NLSM^7Z9/=]]9G;\NL
MSM^7ZLU9RSC_ '0)O)$1$:D0Q/K1..'F-)%O=EZ-_7STO0J(;N(]YGIC4_</
M$,>\^B:+9(2398AD\?/1M.*.6/.0_'5T*$&5DU%0BO6]YT"8Y+Y8QYLZ (58
M*R$Q)/6IT$$B&464FT7;-[Q$LV2 I'=5J14I&=MQ"_-<>&K+)J2H=U739D Q
M,T+29.A:K!C4DN8[B3A$[E#T2M-O([?5$R)W_D;ON/;]Z8)5SWY_/KMI:T%?
M,.S'7;;QTH#R3],GN^_V9/=]_L87$QX_)T@SLOJS7WY/=]_LR>[[_3)[OOK)
M[OOK)[OOK)[OOK,[?EUF=OR_7)[OO],:H,AB&/7;5X<AQ,>?$3WTS0C$N<'_
M +J%,BIQ/7&^==GK_FL$3(7;TG;4O5SQ'IJ?7X[:[/7_ #0P,)@OP[:[/7_-
M("274+B1V=%@(Z8F+[ND&0@. Y3*US/4M-&LA 7<W1*2Y1$J@-'D2"1%F)28
MBX*I:U-63D3$+6YX_P BT]Q[?O21$L$;;"3/AHEDM/2*ZS5YQ.%-""O!G/T<
MO=]_LR>[[_8+9WGR9T(?7WUD]WW^[)[OO]F3W??Z9/=]]9/=]]9/=UD]WWUF
M=ORZS.WY?KD]WW^F-(3=35?YI(RH29GJ2]C'ATUG;R<R!%?CM&O./FY[:[=
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M 7%K!=5,#P3QJ[=,MO5'<\/'HZ@)(F"/"D^^A"AT]C](<&A5!*W)"UF8<[1
M:;<A6$8#9XB3M>FPDT-)Z&/?'@'L)@X@]UO&L6VI*)[Q*U,^O390%)#(R6/+
MZ]#PLXAF9M#(KG/CI=X1(PQ1_D&YC6?XJV4)X^_[]$&/]1,Z3 ^)'3QS1$OK
MIE2$DCE:=T,2I.=[:#)V(S@#UO&C!V-9/=]]9/=]_N]A^=9G;\OVY/=]_I@=
MCV_0R>[]% .R'F[:,,Q3[WH">GA>LD&%\B?G.LNS\:W]WYTX28!8QFHT711_
MSCIM@YY06,\#"!7*SF6%"26BD8,I@B(FB+:H7@-+*O/Z0-N9F+&&#C'2-]-%
M" F&#$-!<P&\VD*:2FT0AB&6NG;'AI(.$*1T.\?F(T)QUN)WYR\YTTI"\%\Q
MS4Y_W32T4R(UI&2**1A!F0B/S29, I"0)$[@AE J16<%(<=J]OXJ[A[?X&($
MD$;_ .*)YF TH,@83603P\:JJF0]SS^F9V_+K,[?EU% .AXUK=:VF[\-$A5(
MS\7.@G.8G%%+MF1C06+SZ=]%5TS?]:;7N_H8'8]ON<O=]_KD]WWU\GCKY/'5
MW!DGT_&@CT*GK+IB7$;8V6.E^6HW'<Z5<QX1H0SKH+=D1Q,QIV#9=RLSQ$WL
MC&#417%7;7+O^E+S]#\K(@E@A3BV+(F("*7K<0'.U 26:;8VLP]8K>-S1"#<
M\F$C2C<M)W7&8YJK=1R1"0HS,C_7KI,H0K,   E)&7!?("(82B0XN3>Q.]:D
M/*Z_B&F'M_@<QN8.2S?)>#4@PE0$)&$F$IBKI&IU0#@,YQJ3$WQK,[?EUF=O
MRZ LM\E>NT:DLICAPYG?CSTG;ETNKG./]TAE\JN(Z=]-DZ1UD/\ K2(3T\:*
MQOSH:$.V*K_FNMZ']:+#L?=@=CV^[)[OO]<GN^^OD\=?)XZ.=Y%\YU$M5A[W
M/S&MWFSTO'5\9ZFK):NU$'=N8T Q@*@Q -RHG?I;RB8$M.90' I1-$%%Z%07
M*2]]_P!-K-02S4'-[:##N $*&%9 [&(,I-"PH(F4J=Y>R108BH"LK<;7==#C
M7)X36(CCU\=!RJ!B"$]I\>_&A[RG.UIGG)3XZ4P#@FB1,%(\ZB$$C JL[AEN
M$&0N- 0)'!G^(SY_%7\"TGA[QZZ+&82G.!2YIB>^,V^(($FQX-1??08_K6\7
M3QK-,,0,\UT_&8C-0[5$/H<^GGI8T2F)&>DZ5S+W1]W0VPB/QTC3VXOV^3IU
M&,X8N3KI (JBLU5Y]-2%;;Y[=<5QTVT(/7ZX'8]OLP.Q[?H9/=]]9G;\NM_=
M^=9G;\NA*.5-02/_ $TJ<3E5%D]L?[JU=FQ!+#;IQMSJ]L$(RYFB[1,)*0-.
MD%C^XR>;S>@"!D'/Z"KG8CPT9>U\[GEHJ(4E $QE+(!0"M 3J.2(N 4:8@@)
MF(!2D!O-(LI)J^UA'YTI6>WIY[3XZ*$)$!WDDR/??2HU#OSOL,]V)-)7)628
M!; I2*6"8%TER64B2HD[E#N;4B@QC&1$PU1->$=@U$)","AD<#&VICE"6W F
M"5ZJ)=M0&%R A42=F#6W;5-F'';;^&SY_%7\"0HE$3_?EJ:*"#=BHWF@,RN,
M5&FPT95BRVC>RW-3#C3@(*+O8F&$PM@YZZOKB#"W=OC>J!SNHKQO)DQCIH2J
M&U4ZAX?)T4,9N^OC^- @C&/EZA>,@?2=SV-!",^97GJ$A5&\[<3\\=;#W/6Z
MTEL#FOGB>>H>'Y_T\]&#L?9@=CV_0R>[[ZS.WY=;^[\ZS.WY=()'R=;"5-9)
MU.@ D"^+?,<=8TH8X!H4<;@PI-PD1)J:48;DDOY**TR"("6''IK/Z WH-SF<
M=>- @!DJ&Z"S@6NJY(=2P )!5 %D"9V"C!NG2*/>+]ML]? 6(A(BD,7,=,]#
M5\<)(9K$UX\9U8,)3-S'N_W1("[&W3OIY"%9>7KS/D$(:IT2 !#(&EXAZU0W
M6E75"1A: 69J8GBT$5( &T.#9#??OH()!9C-&28[WESHL@T(69*C%S ]>:43
MQG V D$F1Z/A)](7 O\ !DP[WCET8&T??]_!*&&(;D[1AU>MQ 3L02$0!\PZ
M9@$3<$,6H,U=X5:;0E%A-H*3;<5$<&GEY<A+$]WH:GC#B/\ =58GQ?[UTO5_
MO0(*,&QQJ#@\CZ8'8T0)BFSQKK>C_6APY,Z&23X_G7@>7S@\M0<'S_AY:<O=
M]_LP.Q[?H/.T">4ZD6Z+:WN=25&^?/1-</K9&E H46;W$R2?W7?2),FT94=+
MG,GYT660 JJ"21A,2[E9.@$< !@"@,04=N]F"-2XECB?T1P9ESNQ_6A!BLPH
M#,J -8!6+2)&C=Y96;LQ,O5_&E!'.Q,. *59@8RR2XMW(41"L$H#^\NER@J-
MA5D)45%.1Q#J6ZSS_L]=8OF0-<6?[Z<?D[NHF+:\.-  B(Q"!V$@K;KC1.
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M3)!%$QA8LW#T0G4#*1&1)=QKTCB#09D1"'!K=WK<.U:RA>2(@H$N:N6<NF^
M02.!,S'CAE94R =K=37><;[FZZ4I9*\OY-H"PB645@*EEDD"<S5&=.% %8H+
M=C> 0V">2QHE.65F^:U%\?ZT:$M0SO4_YG.I5*%,M*8EV,[88E@3H( D+1U
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M+7JF!Z-X1B2=Z$182G)5UZ?9*D[&W^Z[O3_=)"G#'T9--X>IOMJ)%2D *JQ
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M9Q"4DR<U+%?Y^;TG2V!W!$-%Y_.@4:W A-[F>L2X[Z" * (J#<+C RO!$EH
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MH61XZ*/"9?'QTTEI)JT)<@1UF^NVB0*=FF:&29,\4[V: &QG+*/ 2*G.FDC
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M)Z7$==;CKJ:"!,QL$L9'3B]* 8+4I)Q!-@S I*CA)']?[^M2&+GRCB,$WG3
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MT=,VAP\W\=,Z4['-1<QT_.G526<JD"7,?\=M,&,'*)&;B2MB-YC3EW_9#8B
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MH5"8F =0\?NZA_* %3OO$P$S5<KIG8!-H )@B[R:B)514U5=UXY]]4[;G?\
M[^<8U!@++'9_[ZZE:)JGC/6XTRU*@EC("#>[Z]30L)JHVH76?I# @)9)N??Y
MMI5 8+;1=ZXJ>,:+:$ +):PED%H%"Z,A$):61O7R\Z>%'" P '-*$<.&)% 0
M@4AZ%)>,W_>DA3K^HT8J8GQ+T<RHE4D$D-*DK'$]- U43 =LN-@8YZ2RADL&
M-Z5:]*Z[:&0>2?XV7G[H').E<OW#^-?-OQV/!Y=!X#L'ZRKE7OI *50%HQ@B
MZE; "7E1%'7?.9B9KYNP*(J"@UA$Q#!!!8-)QAE-7N,.)@GVT8-J*X_;#O,7
M.-]2 (BLTH$3T[9G.I]PJD'-W>]%K1+J'1!B1E(V<!(RLB,PLB,T$@/:*"3P
MZ:CD4W9OXKS?.K>T317;!7%[XX8/,"-<!=W"F3.H%*%>E)]!YQJ8DQ;^=3DB
MXC%A;%,)E'JZG32Y!* 184F(G_)UG[$14Q(DD6B.S0LALQ,:I,1,$4["5@9+
MMA6)U,9,%*@),1+.S,;;&HM6U>B*-R44[\EZR>[[_K2N6?\ P],12)8:QCA'
M$V<;'1"JD'F+B5M-"3G4"#,\$F(=MX/SV01#(6R() 8(R*9@ I *+Q^VJ 6W
MPA'ATZSY&(7 !-7*JPA$J02 5)<11"Q#52PU=VP9SI4J%4E7*<*ORS:1EH$B
M+[P5AG&-1) PQ4I2;^N@P: $!>"[,="=0U+%,_ES/B<\FF>F%QB)'"3,0N)H
MITAIB9:VF]GK.G5)$G,%UP[^SPQM)<<H(+F67R"M8'8]OL)SFDB20SMG8'4@
MD@4WP6!)%"SEB#+I""%PWKUZ1&-. JA10%)3$RP$2,NN^H>'_P INF<L5MMQ
MYZ-H!%4@PL4L6[K9AY$6H!A+K)'1]=/T(P%#,I!4U/.A@DD$$M2QN2S8@ &]
M'*0L%Y&,UF\G%:R>[[_LFI.AUSC-</YT$;Q-VMK\CKTZ),DH%JJ@PO*C;"J6
M3)DM87EOSGQU.%$$)(]Y^;3HXI.95>(RFS P-UHK$DD!8".I.Y?$LZJ H.L^
MF-9^@A+!.,I."%,W<5I@4))XF>&]PZZ[._[UR'!6V$_C1@_YZ;?9G.V.FLYT
MZI PJH7B3-UW(U."D"2$B)$):B8G(T4Q"*6,(1,)(R5N=M*- :N<T>3YZQ_Y
M,ZF_F?C0L$1=;^&/D: 4,:&XE:F\*3.]4 BR':S'!)UT#H$#:6MYIZ&.KJ=$
M8;9!)ZK'-[WI(4X8_91'0Q4E&*,G (IR@%)R=XMFXO$LX/+3Y0/?N<9;CI^-
M%P[C,)[@9W^(L"E-;.$6(N\U&C!0PXAL$''4IQRS:P62)S=;<;^FH(!2[G/C
MYSH( X(^DQ4&0F:I'C7'373\NF^/+YOKH$R//1@$1K)&+?C7SYG[C9"^'#$X
MF^^9T32--'7IMY9DU5Z$F; [.+*K%0$ZA:(V3##%=(XXUDU#Q\^)](>'Y_T\
M]0F2/_(V*) )@D4-5Q(3QI#U%-#1Q4B38\8=7@ I&V2*LB^#42&51%)",8@)
MN2\D)"G#'[!,%$0$;^NA6@2(EB A"2J@6%W!,B!HI!8!8!<Q,*O==58V[RWM
M?A75WU*)4L9W@,QW8.;@0(  T$T%L!.-B. QJ9O,W]Q*N?Q1'W=?%ZNECB93
MQ8ZD]M#3C?&ST#$5HP=C.?'[E$DAFYLG=HJ:JWH:3)$)(<\1CM5Z6-21$M))
M&(E$@9L&9T<*$98):,@A:"B4R85S'" BP; LD193QH1-P90EF:AY,=-(JT&$
M!7C&+F%_W4T1<6C U$>%7'34!E0@ 7*.N 3$L@FDL,2"6X8HBQ:S(P+=24,R
MB?G_ #_QX"W* =]U>";TH=FY-Y)7,YS9[:,G9%8@&928JS#HQ HAA6)&;@Q5
MJV5^Q)F+).FI89J1VBX.UD;3M1I221CEVO,;9>-"C!$1B$8D05EEF W&4T.H
M(F<Q76"*V>ANI4<#$$UL8F)\W&B0)9?N+.SU'EXK'3;6;YRZ&4[J[N0]CKJH
M01-[SY0>&C!C&V/#I]P2H0$H"$Q.+&3;=5M*R)!!2)Y*BDVNLUI ""9R,SZ;
M?]T]2X!CGKVSS>J$/22B9Q/YGIHLH#BB:%5)C=/'2QQS$2; EP0*TEV:XUT
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MLK)H5ZWJ#&S:EL']FA&)"))  4#X_P!X@,,6P.6N3GGP PSGVX >S$:V) U
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M=E5P_F>].'Y_ER,^L);*S$PE0P@!&A#3<WY\.:,3? 9>!%.4N)MUFS3"3<,
M> .0T*A2_P#3(NH4]OL8?BJ\(P,W6KX\"O01Z%T),*1+#'&5 "(^J221;:LS
MX$&!D0@6S DK?;6(I"W<E*(JZK^P,NLF6F,DMU[_ #YV_1,IH%_ZYOZ!+&!
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M];C%,R4O<Q-OSWPR:2SJ'J4$[JE%X6*6;W+;MW>IWCMN>\1_G_8^O!Z)U?\
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M6"7W^_3132"&#E./L1]LW"LK9(Y)X=G;-> D&A,SX=]Q/2MEU_F\VV^O&<$
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MYIQA7GZVP[TD7T\Y4$1#ZM]S>^?366<JC<M][WT]L1V]GD>MT>WV)&YR^/\
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M+Y+DJZF6?L^^(@20IS*1N*2/)&$ 0W!V)OS$.[\WEL8&@$-1Q!%<8J^6,D!
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MBY=1 G,'GFGO4X?+[S$U3/V]7)W3=1HGQHT^^$[50O/VYZ_G6=M_Q-8B>O\
MRV%0@#^/;>%"W$92""(. X\<8&*HHT+$Q6CB8UAH\PD_)]V4GKQE"8'Q!0==
MAA9;$K/6\]L:Z>K5#3-':8]NITPD8:Q=(OT)_'&1F.VGHJ2\SN>[712 !E"(
M@90CB.G&C.>S5_F>O5ZO; %E%(=M3[(9=*A4WM9Z,[]=1FH-BNZ;D;J&NAUW
MB (B=FA3.NT]\/@Z^@Z^=?.1",CFY<])Z\<&5(A)U7-W4^<E$S6><..>GPG&
MN-@ZT3^?7OC"!2"':"#[5Z8J K2LWJSKU\OC!0<0S$5 \G S=<SGW)UK'X_-
M"*R: \'P\,J]E*F94REEHS*K:3<]><=L[Y_\A)D%@>D3.XOQWQ4016XQ*3DQ
M\)&9*N*?B90&(4P#LU/"S!L;A4JC&*!4LY%S 2KRMN[],D:BS3N]^A.H8KSB
M T0E!R=WR=(Q5*P0&&H2DCJ\#5UE44D-JHV&[^XG_#^Q_@N[DIICZ(/I9,"F
M7 +8R)A!RE@,A;KYB'44B!0: IF()&9Z(^,L1!"^FT>L1WUQ@2? [Y[^>>W7
MC( B2JKU6_S7/XC#!M;3U5WZOQY\[7\]^7YK-RD([B]]#/3VR-Q(.D+4G1+_
M (QA",CR;3T9'G?C$W/,O-U]ZW>L /%^YO-:5O:802C)D*ZGI<]"L (!!0I"
M@VM(D-13)FS 28+D)H>9"#IA2)62!02P'8[WUZYKI R=[P^9=Q/\XEC)"GJB
M[:;OMYP B*5=UE?X]"C"+*>6GL?4\??)]RNR%]-XNI*J=S+*_=]W%$E&2ZBM
M\;W\N!3(%YS[VO;;CIUBAV?8_P#.,VC=/6?3FO;C"A_#!3V*R39"A=((/M7]
M\58FR+V:@]-/.#(0B10]6+I+Z1S@&:R1'.%?NWS.LM5"S,FIHGHR'M4Y.-5
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M[X1G$ =ZKB9#NGMAO[#$H)KD(LWC@R"W0M6P@R$QAJMXH7&CB#J%P34 %:3
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M!!@E+.F(0)Z_:9[9"80SJ:ZW'!#JI,.4$&ATMKC7C"N+W'$Z#G20"T/0 N.
M&";)/*BIP!A%A&.E*D=IP]"8HB $':2WG9A.)*!G$ U.O#D5F9QDD>%X8(1L
MDD5%]C\&"-%7*Z>=]"L9EG<W^_\ 8^O=_+T_?IX.%3_^A=/$L8BVG\]16-<-
M4(=%,Q<D&1=5N8G"9"H@I13)PT2RHP"PJM^5_&2!R#J*O$CK\36/=LILL4?5
MC_6C+!$$>AJGW_&0JC%GIO#Y@.GNXHEU)%GS7%8R!DI<'1YH>FXR5HF>N4D/
M6_SOIC8"PR;EE]Y\?EMY'A035<5'C!!/D!%0SS)S7IC]*@CP!_IWQB*D,)I
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M_3G>$?LA2SA@>D8>)I1A)+CHZ2M6K/E7(D(:DGIU3EGTNGG([UDI-E5A 8A
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M99$A+,L.VTN!\Y"=@@TUJ>TV_P ]+J!>0UZ:^1C@%,@D\]/7V_,U";3P=?\
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M2@)-U%\EZH@"WA7"O'!VX*QA=(;Y+Z(CU3%+809YI,;XF/3TR-ZBZO;:K?\
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MK;F7G?; B =DC#)X%P-@\0P9(IK$@% R@Z*G<XF/&-J]?_02B8J<$#YH.[H
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MK3>&,0A4*F.WR^_^6FY;/%%5"NV&DG&F.16]GX$0$,:FV+SA -0*P#)^8)I
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MN.PR-,'<E DY*A=]P()SR-<2B1'"](5"$7IUP*!0@6(2%9( + _D/;T]-?N
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M70E$G'DHXJ1$/&>^STRY363H]U5/$>2),BP9YMG\'V,<3$&*+:&8B)I$DP6
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MML['E*"&%KY0$D; "BB?!PW <J!=3B)L3S^S,,E  $DC%FU"1#J$*![2^3D
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M8)-WM*X2$0*J*QZ%O#!B502C_3M=AL.PENZ"A)$T;1-<CC)=HB3 B$AEK?\
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MP$Z)$$J08)%@GP#B=I)F%"$>Q8TGR1YQRU"I]U!RF%)(X_H8/9IG")#AJ2+
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M>I\*#"8$'IWK0R"@%EP27Y'R\!C#JA*C!M:=)(@7,RB+H871_/\ X5)%5+J
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MIZ[QW4W,N2.7^LX4%2WL02*<)4QT^^?A'&@\![W&+[TEA[*2^ F(K\G]YO\
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M,Q0C4ANR]=))P!&!7H696&P$ I,C"?7'AF.\@Q8 2Q)#L28'$EC:L_X7V/\
M-=3+UQ5VKY^D^D$I%214,UL6R1D7/]E4'Q(A G$PJ@Y%EH&<,T$'@/),!)'+
M&:*H2<,:MC<G;7\XLL_M)YFR (X\_?-DWQ40-?BM.CF6Q!9!)MLZW&#AJE>D
M<C5T+KT8Q4A$L12'Y"YV5&*9W*Q=M7;6C==_\1['^>ZF]IB*U$17?$UP<Q,'
M@CU>^")VFQ8N8)T_;ISG\('MZOX,4KQ_JOVA#<O'!_W?3&8I;T.05K(F7*B(
MN5U=H6\%S8*]AM"H5EC+;55M<EU)5.)V&P)T89SD=GW+B'O7Y_Q'L?\ RG4K
M]B7SR>V+6I='DD]OSQD!V78VAK0 QRN'-G6?>79)GC.E6,'I%'/ ( )Q&#!I
M$4HG6WSCB:DA8J=L+0IE2'D>^\V?+_A_8_\ E.I#9T_EN/QO&P)8!4 ?"0/F
M$/0S!)6=Y?&!^ [?32&Y52JH2X>^<SZZ66;X0X9A69G37H([.L=^!Q3BH7C+
M!)(VIH4D411/4:B@B#-GGWO_  _L?_+=3+U?ODO5^^3C/8!P41!%"*Q=2.('
M01GQ(R2<^K D<^;0U$6=)[H J 0"62!DF$2><V99N)ZQ7^']C_YCJ:@3OW1/
MC2_?%$G!*-TX3JVKTGY@"0KP4N6:QPA.E1"9_C4F2F-LUJ5X@ O0!&HJ,A-D
M?X;V/_F.IB*;0 ^-CT_YB$ 6(QI<ER3Q# &,GBN5I1O0PP> "%@Q*64;,G=#
MV$J-8P[)DJ4S [=GCDQ7?JK*NWSTC\<>/\+['_S'4R8'84YNI_O[UBLX!J45
M4+HRE\\+"+@'((S3N@E6:WZTQ$^8!T%]9IO3X:&&9ABV=LB3<:H@(%4@2V"L
M2Q,2Q.X[]^O^%]C_ .8ZD;"=8[NO4_WBPQ]1SU)"J0"4%PZ%$*T,7)%HIJ\0
MEZ *'2CX9Q-HV9A!)8L%@V0"&$1R2$:: K0 H4&!P%^V(KDTJV,59=L[5D9;
MZGR[;G&99W-^?\'['_S'4K,2='G=_?)/H\M8S9B")8RHD]D!8E;\^=BSG)]@
M@[0!AW++69^@B;#')R>"1,AJ0.Q)=ZB.<61(B')\NM$RC)"@(DFG4D;[:L>L
M8[?+K7I_@_8_^8ZDTN>K?*=3:$9&,/J9^R8W2\2IK*/#L4*:2S(V0X$0PQHD
M7$O*\=#A='L*8R !\R6 #8$KU%'8$ >A?3']=/CJR.DX_;(]J61J6>(QTAWD
M!8U+'B?\'['_ ,QU(\:D0J98BM#A=2"0'Q0$SRCS(B1&1=!9$H(:9:B!L#-*
M2:@2=G3!%G4,G';6A.0A/83X)8#.S"C+%8$'2&A(P4&]6>9VC3SU4LEQG+*W
MMW,[YFY\WD+H7Z0]/\!['_S'4R]<EU+'2<E-*?0@HB *W7?[1?&R\3TR%39*
MND/""4 GW)EGIN.IXQ\>ASP62-<2E)F,:5N9;4EO:),S/!$8#RNM6?8RG<(T
M5PQ<W?\ WKBK'FGANI#7O6.V=RS^_P#8_P#G.I)0G0GO._%>^'UOHCM %:HL
M_$"I;&E8H$4#2T3(5[E.0#NB+0!"$Q,H,F8#MJXI0S;U^BHARQ&$F9&&0X4P
M(P/C.1U1064)<JE'RJ1UQ(4Z?O\ V/\ YWJ79F03)!-4@W5763][>$P3HU5
M##;1^0 !/S@J8Y?-MVAL@,K3!*'(G$=!H"2SI<'K X053?J<P ;BV4CGJFJ8
M4U4.,RSOG]_['_SW4J&,<Q7S*SQ@A8)J61@LV!$@4]&<@8,!JU@/E2P1PP-W
M$TR1QUJ@WKHQ@!=Q./X.,C*6T$_>7^NL8I6:^1^_]C_Y[J9,RR3LC2+NR(9!
M(X*Q I&HJD*M$F2T@ HM4A3/$9)(S)&5CE&BHA6I8O<16)5GA]/3_ ^Q_P#/
M=2^4IIE=.6 Q$ER91I, =)[/.\DB.^8W@H8 P$8Y4C#(A'C9)V3U\9O(>G^
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M.LK@T;T;(?4@A[0>#ZM?G97OZ="'2L#F_%<B[JU(/'';$1+$3'I-QTF^M_\
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F0".!Q%$C5!?F^0LPNT)^PN^:JA!*D,S(,B(UN0!G<@#P'_A__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
